Citrus Sinensis ID: 045493

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------105
Protein Sequence
VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR
Secondary Structure (PSIPRED)
cEEEEccccccEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccEEEEEccccccccccccEEEccccccccccccccccccccccccccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEccccccccccccccccccccccccccccccEEEEcccHHcccccccccccccccccEEcccccccccccccEEEccccEEEEcccccHHccccccEEcccccEEEEEccccccccccccEEEcccccccccccHHHHccccccEEEccccEEcccccccccccccccEEEccccccEEcccccccccccccEEEccccEEEEEccccHHccccccEEEccccccEEcccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHHcccccccccccccccccccHHHHHcccccccccccccccccccHHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHcccccccccEEEEccccEEEEEEEccccEEEEEEEcccccccccccHHHHHHHHHHccccccccEEEEEEcccccEEEEcccccccHHHHcccccccccccHHHHHHHHHHHHHHHcccccccccccEEccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
ccEEEEccccccccccHHHHcccccccEEEEEEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHHHccccccccHHHccccccEEEEEccccEEccccccccccccccEEEcccccccccccccccccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEcccccEEEEEccHHHHHccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEccccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEEEcccccccccccccccccccHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHccccccEEEccccEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEccccccHHHHHcHHEEccccccccEEEEEcccccccHHcEEEEEcccccHHHHHHHHHHHHcccccccccccccEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
vvsinltgsnlkgtlqefpfllfpqlayldlsvnqlfgtiptqishlsklkhldfstnqfsgiippqigILTNLVVLRLSVNqlnglipeelgeltslNELALSYnrlngsipaslgnLSNLVQLslsnnslsgqippnwgylisphygsipqdlgnlespvsvslhtnnfsgviprslgglknltfvylnnnrivgsipseignlrSLSYlglnknqlsgsipptagnlsnlkflylhdnrlsgyippklgsFKSLLYLYLSHnqlngslpssfgnlsslKHLHVHNInklsgsipkeignlkSLSHLWLSktqlsgfippslgnlsnirglyirENMLygsipeelgrlksLSQLSLSVnklngsiphclgnlsnlkfFALRenelsgsipQEIENMKKLNKYLLFEnqftgylpqnvcqsgslthfsvrnnnfvgpiprslqncTSLYSLRLERNqltgnisevfgiypdlelldlsnnnffgeissnwikcpqlatlnmggneisgtipseignmtqlhkldfssnrlvgqipkqlgkltsltsltlngnqlsgdiplELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQlskldlshnslggnipseicnLESLEYMNLLQnklsgpipscfrrmhglssIDVSYnelqgsiphskafQNATIEAFQGnkelcgdvtglppcealtsnkgdsgkhmTFLFVIVPLLSGAFLLSLVLIGMCFnfrrrkrtdsqegqndvnnqellsastfegkmvlhgtggcgtvykaeltsgdtravkklhslptgeiginqkgfvsEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSymhhdcfppilhrdissKKVLLDLEYKahvsdfgtakflkpdssnwselagtcgyiapelaytmranekcdvfNFGVLVLEVIEGKHPGHFLSLLlslpapaanmnIVVNdlidsrlppplgeVEEKLKSMIAVAFLCldanpdcrptmQKVCNLLCR
Flexible Loop (DISEMBL)
vvsinltgsnlkgtLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKrtdsqegqndvnnQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKlhslptgeiginqkGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATaaeldwskrvNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSdfgtakflkpdssnwSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR
Low Complexity Region (SEG)
VVSINLTGSNLKGTlqefpfllfpqlAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPAslgnlsnlvqlslsnnslsgqIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPkqlgkltsltsltlngnqlsGDIPlelgllaelgyldlSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPllsgafllslvlIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFlslllslpapaaNMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR
Disordered region (IsUnstruct)
*********NLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTS***DSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFR***********************TFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL**
Disordered Region (DISOPRED)
VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVT**********************FVIVPLLSGAFLLSLVLIGMCF*******************QELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSL**********GFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR
Disordered Region (DISEMBL)
VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRR*********NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR
Disordered Region (DISPRO)
VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCE*****KGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT*QKVC**L**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1048	2.2.26 [Sep-21-2011]
Q9LP24	1120	Probable leucine-rich rep	yes	no	0.969	0.907	0.470	0.0
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.860	0.863	0.455	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.934	0.889	0.376	1e-174
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.987	0.828	0.348	1e-168
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.962	0.805	0.357	1e-165
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.940	0.894	0.369	1e-164
O49318	1124	Probable leucine-rich rep	no	no	0.925	0.862	0.377	1e-164
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.943	0.829	0.351	1e-144
P93194	1109	Receptor-like protein kin	N/A	no	0.916	0.865	0.337	1e-138
Q9FZ59	1088	Leucine-rich repeat recep	no	no	0.913	0.879	0.334	1e-136

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  900 bits (2326), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 500/1063 (47%), Positives = 682/1063 (64%), Gaps = 47/1063 (4%)

Query: 1    VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            +  +NLT + ++GT Q+FPF+    LAY+DLS+N L GTIP Q  +LSKL + D STN  
Sbjct: 79   IEELNLTNTGIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHL 138

Query: 61   SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
            +G I P +G L NL VL L  N L  +IP ELG + S+ +LALS N+L GSIP+SLGNL 
Sbjct: 139  TGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLK 198

Query: 121  NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
            NL+ L L  N L+G IPP               +LGN+ES   ++L  N  +G IP +LG
Sbjct: 199  NLMVLYLYENYLTGVIPP---------------ELGNMESMTDLALSQNKLTGSIPSTLG 243

Query: 181  GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
             LKNL  +YL  N + G IP EIGN+ S++ L L++N+L+GSIP + GNL NL  L L  
Sbjct: 244  NLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQ 303

Query: 241  NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
            N L+G IPPKLG+ +S++ L LS+N+L GS+PSS GNL +L  L+++  N L+G IP E+
Sbjct: 304  NYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYE-NYLTGVIPPEL 362

Query: 301  GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
            GN++S+  L L+  +L+G IP S GNL N+  LY+  N L G IP+ELG ++S+  L LS
Sbjct: 363  GNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLS 422

Query: 361  VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
             NKL GS+P   GN + L+   LR N LSG+IP  + N   L   +L  N FTG+ P+ V
Sbjct: 423  QNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETV 482

Query: 421  CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
            C+   L + S+  N+  GPIP+SL++C SL   R   N+ TG+I E FGIYPDL  +D S
Sbjct: 483  CKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFS 542

Query: 481  NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
            +N F GEISSNW K P+L  L M  N I+G IP+EI NMTQL +LD S+N L G++P+ +
Sbjct: 543  HNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAI 602

Query: 541  GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS 600
            G LT+L+ L LNGNQLSG +P  L  L  L  LDLS+N  S  IP+      KLH +NLS
Sbjct: 603  GNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLS 662

Query: 601  NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
             N+F   I  ++ KL QL++LDLSHN L G IPS++ +L+SL+ ++L  N LSG IP+ F
Sbjct: 663  RNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTF 721

Query: 661  RRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV--TGLPPCEALTSNKG 718
              M  L+++D+S N+L+G +P +  F+ AT +A + N  LC ++    L PC  L   K 
Sbjct: 722  EGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKK 781

Query: 719  DSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRK-----RTDSQEGQN--------D 765
            +       ++++VP+L    +LS+      +  R+RK      TD + G+N         
Sbjct: 782  NGN---LVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGK 838

Query: 766  VNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDT-RAVKKLHSLPTGEIG--INQKG 822
               Q+++ ++       L GTGG   VY+A L   DT  AVK+LH     EI   + ++ 
Sbjct: 839  FKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQ--DTIIAVKRLHDTIDEEISKPVVKQE 896

Query: 823  FVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV 879
            F++E+   TEIRHRN+VK +GFCSH +H FL+YEY+E+GSL  +L+N+  A  L W+KR+
Sbjct: 897  FLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRI 956

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
            NV+KGVA+ALSYMHHD   PI+HRDISS  +LLD +Y A +SDFGTAK LK DSSNWS +
Sbjct: 957  NVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAV 1016

Query: 940  AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVV 999
            AGT GY+APE AYTM+  EKCDV++FGVL+LE+I GKHPG  +S L S P  A    + +
Sbjct: 1017 AGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA----LSL 1072

Query: 1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + D R+  P G+  EKL  M+ +A LCL ANP+ RPTM  +
Sbjct: 1073 RSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  785 bits (2027), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 431/946 (45%), Positives = 593/946 (62%), Gaps = 44/946 (4%)

Query: 116  LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVI 175
              +L NL  + LS N  SG I P WG      Y                 L  N   G I
Sbjct: 114  FSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEY---------------FDLSINQLVGEI 158

Query: 176  PRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKF 235
            P  LG L NL  ++L  N++ GSIPSEIG L  ++ + +  N L+G IP + GNL+ L  
Sbjct: 159  PPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVN 218

Query: 236  LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS 295
            LYL  N LSG IP ++G+  +L  L L  N L G +PSSFGNL ++  L++   N+LSG 
Sbjct: 219  LYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFE-NQLSGE 277

Query: 296  IPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLS 355
            IP EIGN+ +L  L L   +L+G IP +LGN+  +  L++  N L GSIP ELG ++S+ 
Sbjct: 278  IPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMI 337

Query: 356  QLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGY 415
             L +S NKL G +P   G L+ L++  LR+N+LSG IP  I N  +L    L  N FTG+
Sbjct: 338  DLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGF 397

Query: 416  LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
            LP  +C+ G L + ++ +N+F GP+P+SL++C SL  +R + N  +G+ISE FG+YP L 
Sbjct: 398  LPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLN 457

Query: 476  LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQ 535
             +DLSNNNF G++S+NW +  +L    +  N I+G IP EI NMTQL +LD SSNR+ G+
Sbjct: 458  FIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGE 517

Query: 536  IPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
            +P+ +  +  ++ L LNGN+LSG IP  + LL  L YLDLS+NR S  IP  L  L +L+
Sbjct: 518  LPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLY 577

Query: 596  HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP 655
            ++NLS N   Q I   + KL QL  LDLS+N L G I S+  +L++LE ++L  N LSG 
Sbjct: 578  YMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQ 637

Query: 656  IPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVT---GLPPCEA 712
            IP  F+ M  L+ +DVS+N LQG IP + AF+NA  +AF+GNK+LCG V    GL PC  
Sbjct: 638  IPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSI 697

Query: 713  LTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKR-----TDSQEG----- 762
             +S K    +++  ++++VP++ GA ++  V  G+   FR+R +     TDS+ G     
Sbjct: 698  TSSKKSHKDRNL-IIYILVPII-GAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLS 755

Query: 763  ----QNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG- 817
                   V  QE++ A+       L GTGG G VYKA+L +    AVKKL+      I  
Sbjct: 756  IFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISN 814

Query: 818  -INQKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAEL 873
               ++ F++EI   TEIRHRN+VK +GFCSH ++ FLVYEY+ERGSL  +L N+  A +L
Sbjct: 815  PSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKL 874

Query: 874  DWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS 933
            DW KR+NV+KGVA+ALSYMHHD  P I+HRDISS  +LL  +Y+A +SDFGTAK LKPDS
Sbjct: 875  DWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDS 934

Query: 934  SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA 993
            SNWS +AGT GY+APELAY M+  EKCDV++FGVL LEVI+G+HPG  +S L S P  A 
Sbjct: 935  SNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDAT 994

Query: 994  NMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTM 1039
               + +  + D RLP P  E++E++  ++ VA LCL ++P  RPTM
Sbjct: 995  ---LSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  612 bits (1578), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 389/1032 (37%), Positives = 559/1032 (54%), Gaps = 53/1032 (5%)

Query: 45   SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS 104
            +HL  +  +D +    SG + P I  L  L  L +S N ++G IP++L    SL  L L 
Sbjct: 64   THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLC 123

Query: 105  YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSV 164
             NR +G IP  L  +  L +L L  N L               +GSIP+ +GNL S   +
Sbjct: 124  TNRFHGVIPIQLTMIITLKKLYLCENYL---------------FGSIPRQIGNLSSLQEL 168

Query: 165  SLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIP 224
             +++NN +GVIP S+  L+ L  +    N   G IPSEI    SL  LGL +N L GS+P
Sbjct: 169  VIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLP 228

Query: 225  PTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHL 284
                 L NL  L L  NRLSG IPP +G+   L  L L  N   GS+P   G L+ +K L
Sbjct: 229  KQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRL 288

Query: 285  HVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSI 344
            +++  N+L+G IP+EIGNL   + +  S+ QL+GFIP   G++ N++ L++ EN+L G I
Sbjct: 289  YLYT-NQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPI 347

Query: 345  PEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNK 404
            P ELG L  L +L LS+N+LNG+IP  L  L  L    L +N+L G IP  I      + 
Sbjct: 348  PRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSV 407

Query: 405  YLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI 464
              +  N  +G +P + C+  +L   S+ +N   G IPR L+ C SL  L L  NQLTG++
Sbjct: 408  LDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSL 467

Query: 465  S-EVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLH 523
              E+F +  +L  L+L  N   G IS++  K   L  L +  N  +G IP EIGN+T++ 
Sbjct: 468  PIELFNL-QNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIV 526

Query: 524  KLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL 583
              + SSN+L G IPK+LG   ++  L L+GN+ SG I  ELG L  L  L LS NRL+  
Sbjct: 527  GFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGE 586

Query: 584  IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSHNSLGGNIPSEICNLESL 642
            IP + G+L +L  L L  N  S+ I +++GKL  L   L++SHN+L G IP  + NL+ L
Sbjct: 587  IPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQML 646

Query: 643  EYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCG 702
            E + L  NKLSG IP+    +  L   ++S N L G++P +  FQ      F GN  LC 
Sbjct: 647  EILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCN 706

Query: 703  DVTGLPPCEALTSNKGD------SGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRK- 755
              +    C+ L  +         +G     +  I  ++ G+  L +  +G+C+  +RR+ 
Sbjct: 707  --SQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFL-ITFLGLCWTIKRREP 763

Query: 756  ---------RTDSQEG----QNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDT 802
                     + D  +     +     Q L+ A+    + V+ G G CGTVYKAE++ G+ 
Sbjct: 764  AFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEV 823

Query: 803  RAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCSHTQHLFLVYEYLERGS 859
             AVKKL+S   GE   +   F +EI+   +IRHRNIVK YGFC H     L+YEY+ +GS
Sbjct: 824  IAVKKLNS--RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGS 881

Query: 860  LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH 919
            L   L        LDW+ R  +  G A  L Y+HHDC P I+HRDI S  +LLD  ++AH
Sbjct: 882  LGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAH 941

Query: 920  VSDFGTAKFLKPD-SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            V DFG AK +    S + S +AG+ GYIAPE AYTM+  EKCD+++FGV++LE+I GK P
Sbjct: 942  VGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPP 1001

Query: 979  GHFL----SLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPD 1034
               L     L+  +     NM I   ++ D+RL         ++  ++ +A  C   +P 
Sbjct: 1002 VQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPA 1060

Query: 1035 CRPTMQKVCNLL 1046
             RPTM++V  ++
Sbjct: 1061 SRPTMREVVAMI 1072

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  594 bits (1531), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 409/1174 (34%), Positives = 600/1174 (51%), Gaps = 139/1174 (11%)

Query: 1    VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            V+++NLTG  L G++  + F  F  L +LDLS N L G IPT +S+L+ L+ L   +NQ 
Sbjct: 73   VIALNLTGLGLTGSISPW-FGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQL 131

Query: 61   SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIP------- 113
            +G IP Q+G L N+  LR+  N+L G IPE LG L +L  LAL+  RL G IP       
Sbjct: 132  TGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLV 191

Query: 114  -----------------ASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHY-------- 148
                             A LGN S+L   + + N L+G IP   G L +           
Sbjct: 192  RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251

Query: 149  -GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR 207
             G IP  LG +     +SL  N   G+IP+SL  L NL  + L+ N + G IP E  N+ 
Sbjct: 252  TGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMS 311

Query: 208  SLSYLGLNKNQLSGSIPPT-AGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
             L  L L  N LSGS+P +   N +NL+ L L   +LSG IP +L   +SL  L LS+N 
Sbjct: 312  QLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNS 371

Query: 267  LNGSLPSSFGNLSSLKHLHVHN-----------------------INKLSGSIPKEIGNL 303
            L GS+P +   L  L  L++HN                        N L G +PKEI  L
Sbjct: 372  LAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISAL 431

Query: 304  KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNK 363
            + L  L+L + + SG IP  +GN ++++ + +  N   G IP  +GRLK L+ L L  N+
Sbjct: 432  RKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNE 491

Query: 364  LNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV--- 420
            L G +P  LGN   L    L +N+LSGSIP     +K L + +L+ N   G LP ++   
Sbjct: 492  LVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISL 551

Query: 421  --------------------CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQL 460
                                C S S   F V NN F   IP  L N  +L  LRL +NQL
Sbjct: 552  RNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQL 611

Query: 461  TGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMT 520
            TG I    G   +L LLD+S+N   G I    + C +L  +++  N +SG IP  +G ++
Sbjct: 612  TGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLS 671

Query: 521  QLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRL 580
            QL +L  SSN+ V  +P +L   T L  L+L+GN L+G IP E+G L  L  L+L  N+ 
Sbjct: 672  QLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQF 731

Query: 581  SKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQL-SKLDLSHNSLGGNIPSEICNL 639
            S  +P+ +G+L KL+ L LS N  + EI ++IG+L  L S LDLS+N+  G+IPS I  L
Sbjct: 732  SGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTL 791

Query: 640  ESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKE 699
              LE ++L  N+L+G +P     M  L  ++VS+N L G +   K F     ++F GN  
Sbjct: 792  SKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTG 849

Query: 700  LCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDS 759
            LCG  + L  C  + SN    G     + VI+  +S    + L+++ +   F++R     
Sbjct: 850  LCG--SPLSRCNRVRSNNKQQGLSARSV-VIISAISALTAIGLMILVIALFFKQRHDFFK 906

Query: 760  QEG--------------------------QNDVNNQELLSASTFEGKMVLHGTGGCGTVY 793
            + G                          ++D+  ++++ A+    +  + G+GG G VY
Sbjct: 907  KVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVY 966

Query: 794  KAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCSHTQHL-- 848
            KAEL +G+T AVKK+  L   ++ ++ K F  E+     IRHR++VK  G+CS       
Sbjct: 967  KAELENGETVAVKKI--LWKDDL-MSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLN 1023

Query: 849  FLVYEYLERGSLATILSNEATAAE-----LDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
             L+YEY++ GS+   L  +    E     LDW  R+ +  G+A  + Y+HHDC PPI+HR
Sbjct: 1024 LLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHR 1083

Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKP------DSSNWSELAGTCGYIAPELAYTMRAN 957
            DI S  VLLD   +AH+ DFG AK L        DS+ W   A + GYIAPE AY+++A 
Sbjct: 1084 DIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKAT 1141

Query: 958  EKCDVFNFGVLVLEVIEGKHP-----GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012
            EK DV++ G++++E++ GK P     G  + ++  +           + LID +L P L 
Sbjct: 1142 EKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLP 1201

Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              E+    ++ +A  C   +P  RP+ ++ C+ L
Sbjct: 1202 FEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  583 bits (1503), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 393/1099 (35%), Positives = 579/1099 (52%), Gaps = 90/1099 (8%)

Query: 26   LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLN 85
            L  L L  N+L GTIP    +L  L+ L  ++ + +G+IP + G L  L  L L  N+L 
Sbjct: 146  LKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELE 205

Query: 86   GLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS 145
            G IP E+G  TSL   A ++NRLNGS+PA L  L NL  L+L +NS SG+IP   G L+S
Sbjct: 206  GPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVS 265

Query: 146  PHY---------GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIV 196
              Y         G IP+ L  L +  ++ L +NN +GVI      +  L F+ L  NR+ 
Sbjct: 266  IQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLS 325

Query: 197  GSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFK 255
            GS+P  I  N  SL  L L++ QLSG IP    N  +LK L L +N L+G IP  L    
Sbjct: 326  GSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLV 385

Query: 256  SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQ 315
             L  LYL++N L G+L SS  NL++L+   +++ N L G +PKEIG L  L  ++L + +
Sbjct: 386  ELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYH-NNLEGKVPKEIGFLGKLEIMYLYENR 444

Query: 316  LSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNL 375
             SG +P  +GN + ++ +    N L G IP  +GRLK L++L L  N+L G+IP  LGN 
Sbjct: 445  FSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNC 504

Query: 376  SNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV--------------- 420
              +    L +N+LSGSIP     +  L  ++++ N   G LP ++               
Sbjct: 505  HQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNK 564

Query: 421  --------CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYP 472
                    C S S   F V  N F G IP  L   T+L  LRL +NQ TG I   FG   
Sbjct: 565  FNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS 624

Query: 473  DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL 532
            +L LLD+S N+  G I      C +L  +++  N +SG IP+ +G +  L +L  SSN+ 
Sbjct: 625  ELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKF 684

Query: 533  VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
            VG +P ++  LT++ +L L+GN L+G IP E+G L  L  L+L  N+LS  +P  +G+L 
Sbjct: 685  VGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744

Query: 593  KLHHLNLSNNQFSQEISIQIGKLVQL-SKLDLSHNSLGGNIPSEICNLESLEYMNLLQNK 651
            KL  L LS N  + EI ++IG+L  L S LDLS+N+  G IPS I  L  LE ++L  N+
Sbjct: 745  KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804

Query: 652  LSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCE 711
            L G +P     M  L  +++SYN L+G +   K F     +AF GN  LCG  + L  C 
Sbjct: 805  LVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCG--SPLSHCN 860

Query: 712  ALTS--NKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQE-------- 761
               S   +  S K +  +  I  L + A ++ ++++    N    K+             
Sbjct: 861  RAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSS 920

Query: 762  -----------GQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHS 810
                        ++D+   +++ A+ +  +  + G+GG G VYKAEL +G+T AVKK+  
Sbjct: 921  SSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI-- 978

Query: 811  LPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCSHTQHL--FLVYEYLERGSLATIL- 864
            L   ++ ++ K F  E+     IRHR++VK  G+CS        L+YEY+  GS+   L 
Sbjct: 979  LWKDDL-MSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLH 1037

Query: 865  SNEATAAE--LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD 922
            +NE T  +  L W  R+ +  G+A  + Y+H+DC PPI+HRDI S  VLLD   +AH+ D
Sbjct: 1038 ANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGD 1097

Query: 923  FGTAKFLKPDSSNWSE----LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            FG AK L  +    +E     AG+ GYIAPE AY+++A EK DV++ G++++E++ GK P
Sbjct: 1098 FGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMP 1157

Query: 979  G-----------HFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL 1027
                         ++  +L  P P +        LIDS L   L   EE    ++ +A  
Sbjct: 1158 TEAMFDEETDMVRWVETVLDTP-PGSEAR---EKLIDSELKSLLPCEEEAAYQVLEIALQ 1213

Query: 1028 CLDANPDCRPTMQKVCNLL 1046
            C  + P  RP+ ++    L
Sbjct: 1214 CTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  581 bits (1498), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 384/1039 (36%), Positives = 560/1039 (53%), Gaps = 53/1039 (5%)

Query: 38   GTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTS 97
            G + +  S   ++  L+ S+   SG + P IG L +L  L LS N L+G IP+E+G  +S
Sbjct: 63   GVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSS 122

Query: 98   LNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGN 157
            L  L L+ N+ +G IP  +G L +L  L + NN +S               GS+P ++GN
Sbjct: 123  LEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRIS---------------GSLPVEIGN 167

Query: 158  LESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN 217
            L S   +  ++NN SG +PRS+G LK LT      N I GS+PSEIG   SL  LGL +N
Sbjct: 168  LLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQN 227

Query: 218  QLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGN 277
            QLSG +P   G L  L  + L +N  SG+IP ++ +  SL  L L  NQL G +P   G+
Sbjct: 228  QLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGD 287

Query: 278  LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
            L SL+ L+++  N L+G+IP+EIGNL     +  S+  L+G IP  LGN+  +  LY+ E
Sbjct: 288  LQSLEFLYLYR-NGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFE 346

Query: 338  NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
            N L G+IP EL  LK+LS+L LS+N L G IP     L  L    L +N LSG+IP ++ 
Sbjct: 347  NQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLG 406

Query: 398  NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
                L    + +N  +G +P  +C   ++   ++  NN  G IP  +  C +L  LRL R
Sbjct: 407  WYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLAR 466

Query: 458  NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIG 517
            N L G          ++  ++L  N F G I      C  L  L +  N  +G +P EIG
Sbjct: 467  NNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIG 526

Query: 518  NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA 577
             ++QL  L+ SSN+L G++P ++     L  L +  N  SG +P E+G L +L  L LS 
Sbjct: 527  MLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSN 586

Query: 578  NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSHNSLGGNIPSEI 636
            N LS  IP  LG L +L  L +  N F+  I  ++G L  L   L+LS+N L G IP E+
Sbjct: 587  NNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPEL 646

Query: 637  CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQG 696
             NL  LE++ L  N LSG IPS F  +  L   + SYN L G IP     +N ++ +F G
Sbjct: 647  SNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIG 703

Query: 697  NKELCGD-----VTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNF 751
            N+ LCG      +   P   + ++ K    +    + +   ++ G  L+ + LI   +  
Sbjct: 704  NEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALI--VYLM 761

Query: 752  RRRKRT---DSQEGQ-------------NDVNNQELLSASTFEGKMVLHGTGGCGTVYKA 795
            RR  RT    +Q+GQ                  Q+L++A+    +  + G G CGTVYKA
Sbjct: 762  RRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKA 821

Query: 796  ELTSGDTRAVKKLHSLPTGEIGIN-QKGFVSEITE---IRHRNIVKFYGFCSHTQHLFLV 851
             L +G T AVKKL S   G    N    F +EI     IRHRNIVK +GFC+H     L+
Sbjct: 822  VLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLL 881

Query: 852  YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVL 911
            YEY+ +GSL  IL +   +  LDWSKR  +  G A  L+Y+HHDC P I HRDI S  +L
Sbjct: 882  YEYMPKGSLGEILHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNIL 939

Query: 912  LDLEYKAHVSDFGTAKFLK-PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            LD +++AHV DFG AK +  P S + S +AG+ GYIAPE AYTM+  EK D++++GV++L
Sbjct: 940  LDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLL 999

Query: 971  EVIEGKHPGHFLSL---LLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL 1027
            E++ GK P   +     +++        + + + ++D+RL      +   + +++ +A L
Sbjct: 1000 ELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALL 1059

Query: 1028 CLDANPDCRPTMQKVCNLL 1046
            C   +P  RP+M++V  +L
Sbjct: 1060 CTSVSPVARPSMRQVVLML 1078

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  580 bits (1496), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 390/1034 (37%), Positives = 541/1034 (52%), Gaps = 64/1034 (6%)

Query: 53   LDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSI 112
            LD S+   SGI+ P IG L NLV L L+ N L G IP E+G  + L  + L+ N+  GSI
Sbjct: 90   LDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSI 149

Query: 113  PASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFS 172
            P  +  LS L   ++ NN LSG +P   G            DL NLE  V+   +TNN +
Sbjct: 150  PVEINKLSQLRSFNICNNKLSGPLPEEIG------------DLYNLEELVA---YTNNLT 194

Query: 173  GVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN 232
            G +PRSLG L  LT      N   G+IP+EIG   +L  LGL +N +SG +P   G L  
Sbjct: 195  GPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVK 254

Query: 233  LKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL 292
            L+ + L  N+ SG+IP  +G+  SL  L L  N L G +PS  GN+ SLK L+++  N+L
Sbjct: 255  LQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQ-NQL 313

Query: 293  SGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLK 352
            +G+IPKE+G L  +  +  S+  LSG IP  L  +S +R LY+ +N L G IP EL +L+
Sbjct: 314  NGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLR 373

Query: 353  SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
            +L++L LS+N L G IP    NL++++   L  N LSG IPQ +     L      ENQ 
Sbjct: 374  NLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQL 433

Query: 413  TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYP 472
            +G +P  +CQ  +L   ++ +N   G IP  +  C SL  LR+  N+LTG          
Sbjct: 434  SGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLV 493

Query: 473  DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL 532
            +L  ++L  N F G +      C +L  L++  N+ S  +P+EI  ++ L   + SSN L
Sbjct: 494  NLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSL 553

Query: 533  VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
             G IP ++     L  L L+ N   G +P ELG L +L  L LS NR S  IP  +G L 
Sbjct: 554  TGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLT 613

Query: 593  KLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSHNSLGGNIPSEICNLESLEYMNLLQNK 651
             L  L +  N FS  I  Q+G L  L   ++LS+N   G IP EI NL  L Y++L  N 
Sbjct: 614  HLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNH 673

Query: 652  LSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCG--------D 703
            LSG IP+ F  +  L   + SYN L G +PH++ FQN T+ +F GNK LCG         
Sbjct: 674  LSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPS 733

Query: 704  VTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQ 763
             +  P   +L +     G+ +        + S    +SL+LI +  +F R     +    
Sbjct: 734  HSSWPHISSLKAGSARRGRIIII------VSSVIGGISLLLIAIVVHFLRNPVEPTAPYV 787

Query: 764  ND------------VNNQELLSASTFEGKMVLH-----GTGGCGTVYKAELTSGDTRAVK 806
            +D            V  +        E     H     G G CGTVYKA + SG T AVK
Sbjct: 788  HDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVK 847

Query: 807  KLH---SLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCSH--TQHLFLVYEYLERG 858
            KL                 F +EI    +IRHRNIV+ Y FC H  +    L+YEY+ RG
Sbjct: 848  KLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRG 907

Query: 859  SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA 918
            SL  +L     +  +DW  R  +  G A  L+Y+HHDC P I+HRDI S  +L+D  ++A
Sbjct: 908  SLGELLHG-GKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEA 966

Query: 919  HVSDFGTAKFLK-PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKH 977
            HV DFG AK +  P S + S +AG+ GYIAPE AYTM+  EKCD+++FGV++LE++ GK 
Sbjct: 967  HVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKA 1026

Query: 978  PGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK--LKSMIAV---AFLCLDAN 1032
            P   L     L     N +I  + L    L P L +VE+   L  MI V   A LC  ++
Sbjct: 1027 PVQPLEQGGDLATWTRN-HIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSS 1085

Query: 1033 PDCRPTMQKVCNLL 1046
            P  RPTM++V  +L
Sbjct: 1086 PSDRPTMREVVLML 1099

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  513 bits (1321), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 398/1131 (35%), Positives = 557/1131 (49%), Gaps = 142/1131 (12%)

Query: 38   GTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTS 97
            G IP +IS L  L+ L  + NQFSG IPP+I  L +L  L LS N L GL+P  L EL  
Sbjct: 79   GQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSELPQ 138

Query: 98   LNELALSYNRLNGSIPASLG-NLSNLVQLSLSNNSLSGQIPPNWGYL---------ISPH 147
            L  L LS N  +GS+P S   +L  L  L +SNNSLSG+IPP  G L         ++  
Sbjct: 139  LLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSF 198

Query: 148  YGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR 207
             G IP ++GN+    + +  +  F+G +P+ +  LK+L  + L+ N +  SIP   G L 
Sbjct: 199  SGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELH 258

Query: 208  SLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL 267
            +LS L L   +L G IPP  GN  +LK L L  N LSG +P +L     LL      NQL
Sbjct: 259  NLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIP-LLTFSAERNQL 317

Query: 268  NGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL--- 324
            +GSLPS  G    L  L + N N+ SG IP EI +   L HL L+   LSG IP  L   
Sbjct: 318  SGSLPSWMGKWKVLDSLLLAN-NRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGS 376

Query: 325  ---------GNL------------SNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNK 363
                     GNL            S++  L +  N + GSIPE+L +L  L  L L  N 
Sbjct: 377  GSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNN 435

Query: 364  LNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS 423
              G IP  L   +NL  F    N L G +P EI N   L + +L +NQ TG +P+ + + 
Sbjct: 436  FTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKL 495

Query: 424  GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN 483
             SL+  ++  N F G IP  L +CTSL +L L  N L G I +       L+ L LS NN
Sbjct: 496  TSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNN 555

Query: 484  FFGEISS------NWIKCPQLATLNMGG------NEISGTIPSEIGNMTQLHKLDFSSNR 531
              G I S      + I+ P L+ L   G      N +SG IP E+G    L ++  S+N 
Sbjct: 556  LSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNH 615

Query: 532  LVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELG------------------------LL 567
            L G+IP  L +LT+LT L L+GN L+G IP E+G                        LL
Sbjct: 616  LSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLL 675

Query: 568  AELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNS 627
              L  L+L+ N+L   +P +LG L++L H++LS N  S E+S ++  + +L  L +  N 
Sbjct: 676  GSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNK 735

Query: 628  LGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQ 687
              G IPSE+ NL  LEY+++ +N LSG IP+    +  L  ++++ N L+G +P     Q
Sbjct: 736  FTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQ 795

Query: 688  NATIEAFQGNKELCGDVTGLPPCE----ALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLV 743
            + +     GNKELCG V G   C+     L S  G +G  + F  ++       F+ SL 
Sbjct: 796  DPSKALLSGNKELCGRVVG-SDCKIEGTKLRSAWGIAGLMLGFTIIVF-----VFVFSLR 849

Query: 744  LIGMCFNFRRRKRTDSQE--------GQN-------------------------DVNNQE 770
               M    ++R   +  E         QN                          V   +
Sbjct: 850  RWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGD 909

Query: 771  LLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT-- 828
            ++ A+    K  + G GG GTVYKA L    T AVKKL    T       + F++E+   
Sbjct: 910  IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQ----GNREFMAEMETL 965

Query: 829  -EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVA 886
             +++H N+V   G+CS ++   LVYEY+  GSL   L N+    E LDWSKR+ +  G A
Sbjct: 966  GKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAA 1025

Query: 887  NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE-LAGTCGY 945
              L+++HH   P I+HRDI +  +LLD +++  V+DFG A+ +    S+ S  +AGT GY
Sbjct: 1026 RGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGY 1085

Query: 946  IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPG--HFLSL----LLSLPAPAANMNIVV 999
            I PE   + RA  K DV++FGV++LE++ GK P    F       L+       N    V
Sbjct: 1086 IPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAV 1145

Query: 1000 NDLIDSRLPPPLGEVEEKLKS----MIAVAFLCLDANPDCRPTMQKVCNLL 1046
             D+ID  L      V   LK+    ++ +A LCL   P  RP M  V   L
Sbjct: 1146 -DVIDPLL------VSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKAL 1189

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2

 Score =  494 bits (1273), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 362/1074 (33%), Positives = 539/1074 (50%), Gaps = 114/1074 (10%)

Query: 24   PQLAYLD------LSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
            P++++L       LS N  FG+IP+Q+ + S L+H+D S+N F+G IP  +G L NL  L
Sbjct: 86   PEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNL 145

Query: 78   RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
             L  N L G  PE L  +  L  +  + N LNGSIP+++GN+S L  L L +N  SG +P
Sbjct: 146  SLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVP 205

Query: 138  PNWGYLISPH---------YGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV 188
             + G + +            G++P  L NLE+ V + +  N+  G IP      K +  +
Sbjct: 206  SSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTI 265

Query: 189  YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIP 248
             L+NN+  G +P  +GN  SL   G     LSG IP   G L+ L  LYL  N  SG IP
Sbjct: 266  SLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIP 325

Query: 249  PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSH 308
            P+LG  KS++ L L  NQL G +P   G LS L++LH++  N LSG +P  I  ++SL  
Sbjct: 326  PELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYT-NNLSGEVPLSIWKIQSLQS 384

Query: 309  LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSI 368
            L L +  LSG +P  +  L  +  L + EN   G IP++LG   SL  L L+ N   G I
Sbjct: 385  LQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHI 444

Query: 369  PHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTH 428
            P  L +   LK   L  N L GS+P ++     L + +L EN   G LP  V +  +L  
Sbjct: 445  PPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFV-EKQNLLF 503

Query: 429  FSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEI 488
            F +  NNF GPIP SL N  ++ ++ L  NQL+G+I    G    LE L+LS+N   G +
Sbjct: 504  FDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGIL 563

Query: 489  SSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTS 548
             S    C +L+ L+   N ++G+IPS +G++T+L KL    N   G IP  L +   L +
Sbjct: 564  PSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLN 623

Query: 549  LTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEI 608
            L L GN L+GDIP  +G L  L  L+LS+N+L+  +P +LG+L+                
Sbjct: 624  LQLGGNLLAGDIP-PVGALQALRSLNLSSNKLNGQLPIDLGKLK---------------- 666

Query: 609  SIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSS 668
                     L +LD+SHN+L G +   +  ++SL ++N+  N  SGP+P           
Sbjct: 667  --------MLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVP----------- 706

Query: 669  IDVSYNELQGSIPHSKAFQNATIEAFQGNKELC----GDVTGLP------PCEALTSNKG 718
                        P    F N++  +F GN +LC     D    P      PC  + SN G
Sbjct: 707  ------------PSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCN-MQSNTG 753

Query: 719  DSGKHMTFLFVIVPLLSGAFLLSLVLIGM-------CFNFRRRKRTDSQEGQNDVNNQEL 771
              G     + +IV    GA L  + L          C    +     +QEG   + N+ L
Sbjct: 754  KGGLSTLGIAMIV---LGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLNKVL 810

Query: 772  LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKL--HSLPTGEIGINQKGFVSEITE 829
             +      K V+ G G  GT+YKA L+     AVKKL    +  G + + ++  +  I +
Sbjct: 811  EATENLNDKYVI-GKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSMVRE--IETIGK 867

Query: 830  IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
            +RHRN++K   F    ++  ++Y Y+E GSL  IL        LDWS R N+  G A+ L
Sbjct: 868  VRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGL 927

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SELAGTCGYIA 947
            +Y+H DC P I+HRDI    +LLD + + H+SDFG AK L   +++   + + GT GY+A
Sbjct: 928  AYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMA 987

Query: 948  PELAYTMRANEKCDVFNFGVLVLEVIEGKHP--------GHFLSLLLSLPAPAANMNIVV 999
            PE A+T   + + DV+++GV++LE+I  K             +  + S+      +  +V
Sbjct: 988  PENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIV 1047

Query: 1000 -----NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
                 ++LIDS        V E++   +++A  C +   D RPTM+ V   L R
Sbjct: 1048 DPSLLDELIDS-------SVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQLTR 1094

Possible role in short-day photoperiod floral induction.

Ipomoea nil (taxid: 35883)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1

 Score =  486 bits (1252), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 360/1077 (33%), Positives = 549/1077 (50%), Gaps = 120/1077 (11%)

Query: 1    VVSINLTGSNLKGTL-QEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQ 59
            V ++NL+ S L G L  E   L    L  LDLS+N   G +P+ + + + L++LD S N 
Sbjct: 78   VETLNLSASGLSGQLGSEIGEL--KSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNND 135

Query: 60   FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNL 119
            FSG +P   G L NL  L L  N L+GLIP  +G L  L +L +SYN L+G+IP  LGN 
Sbjct: 136  FSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNC 195

Query: 120  SNLVQLSLSNNSLSGQIPP------NWGYLISP--------HYGSIPQDLGNLESPVSVS 165
            S L  L+L+NN L+G +P       N G L           H+GS      N +  VS+ 
Sbjct: 196  SKLEYLALNNNKLNGSLPASLYLLENLGELFVSNNSLGGRLHFGS-----SNCKKLVSLD 250

Query: 166  LHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPP 225
            L  N+F G +P  +G   +L  + +    + G+IPS +G LR +S + L+ N+LSG+IP 
Sbjct: 251  LSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQ 310

Query: 226  TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLH 285
              GN S+L+ L L+DN+L G IPP L   K L  L L  N+L+G +P     + SL  + 
Sbjct: 311  ELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQML 370

Query: 286  VHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIP 345
            V+N N L+G +P E+  LK L                        + L +  N  YG IP
Sbjct: 371  VYN-NTLTGELPVEVTQLKHL------------------------KKLTLFNNGFYGDIP 405

Query: 346  EELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKY 405
              LG  +SL ++ L  N+  G IP  L +   L+ F L  N+L G IP  I   K L + 
Sbjct: 406  MSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERV 465

Query: 406  LLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS 465
             L +N+ +G LP+   +S SL++ ++ +N+F G IPRSL +C +L ++ L +N+LTG I 
Sbjct: 466  RLEDNKLSGVLPE-FPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIP 524

Query: 466  EVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKL 525
               G    L LL+LS+N   G + S    C +L   ++G N ++G+IPS   +   L  L
Sbjct: 525  PELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTL 584

Query: 526  DFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGY-LDLSANRLSKLI 584
              S N  +G IP+ L +L  L+ L +  N   G IP  +GLL  L Y LDLSAN  +  I
Sbjct: 585  VLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEI 644

Query: 585  PKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEY 644
            P  LG L  L  LN+SNN+ +  +S+ +  L  L+++D+S+N   G IP           
Sbjct: 645  PTTLGALINLERLNISNNKLTGPLSV-LQSLKSLNQVDVSYNQFTGPIP----------- 692

Query: 645  MNLLQN--KLSGPIPSCFRRMHGLSS-IDVSYNELQGSIPHSKAFQNATIEAFQGNKELC 701
            +NLL N  K SG    C +  + +S+ I   +   +G +  S  ++ A I A        
Sbjct: 693  VNLLSNSSKFSGNPDLCIQASYSVSAIIRKEFKSCKGQVKLS-TWKIALIAA-------- 743

Query: 702  GDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTD--- 758
                            G S             LS   LL  + + +C   R  K  D   
Sbjct: 744  ----------------GSS-------------LSVLALLFALFLVLCRCKRGTKTEDANI 774

Query: 759  -SQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG 817
             ++EG + + N+ L +    + K ++ G G  G VY+A L SG+  AVKKL         
Sbjct: 775  LAEEGLSLLLNKVLAATDNLDDKYII-GRGAHGVVYRASLGSGEEYAVKKLIFAEHIRAN 833

Query: 818  INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL--SNEATAAELDW 875
             N K  +  I  +RHRN+++   F    +   ++Y+Y+  GSL  +L   N+  A  LDW
Sbjct: 834  QNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAV-LDW 892

Query: 876  SKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN 935
            S R N+  G+++ L+Y+HHDC PPI+HRDI  + +L+D + + H+ DFG A+ L   + +
Sbjct: 893  SARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDDSTVS 952

Query: 936  WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP--------GHFLSLLLS 987
             + + GT GYIAPE AY    +++ DV+++GV++LE++ GK           + +S + S
Sbjct: 953  TATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDINIVSWVRS 1012

Query: 988  LPAPAANMNIVVNDLIDSRLPPPL--GEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            + +   + +     ++D +L   L   ++ E+   +  +A  C D  P+ RP+M+ V
Sbjct: 1013 VLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDV 1069

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1048
297846638	1123	hypothetical protein ARALYDRAFT_473694 [	0.969	0.904	0.478	0.0
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.866	0.879	0.531	0.0
15219699	1120	putative leucine-rich repeat receptor-li	0.969	0.907	0.470	0.0
359491509	1032	PREDICTED: probable LRR receptor-like se	0.866	0.879	0.528	0.0
225456159	1038	PREDICTED: probable LRR receptor-like se	0.885	0.894	0.517	0.0
356577797	1204	PREDICTED: probable LRR receptor-like se	0.991	0.862	0.455	0.0
225456161	1037	PREDICTED: probable LRR receptor-like se	0.883	0.892	0.512	0.0
357438961	1137	Leucine-rich repeat receptor-like protei	0.975	0.898	0.458	0.0
147772402	996	hypothetical protein VITISV_022117 [Viti	0.852	0.896	0.527	0.0
359487164	1378	PREDICTED: probable leucine-rich repeat	0.942	0.716	0.479	0.0

>gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata]

 Score =  937 bits (2421), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 509/1063 (47%), Positives = 688/1063 (64%), Gaps = 47/1063 (4%)

Query: 1    VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            +  +NLT + ++GT Q+FPF   P LA +DLS+N+  GTIP Q  +LSKL + D STN  
Sbjct: 82   IEKLNLTDNAIEGTFQDFPFSSLPNLASIDLSMNRFSGTIPPQFGNLSKLIYFDLSTNHL 141

Query: 61   SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
            +  IPP +G L NL VL L  N L G+IP +LG + S+  L LS+N+L GSIP+SLGNL 
Sbjct: 142  TREIPPSLGNLKNLTVLDLHHNYLTGVIPPDLGNMESMTYLELSHNKLTGSIPSSLGNLK 201

Query: 121  NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
            NL  L L  N L+G IPP               +LGN+ES + + L TN  +G IP SLG
Sbjct: 202  NLTVLYLYQNYLTGVIPP---------------ELGNMESMIDLELSTNKLTGSIPSSLG 246

Query: 181  GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
             LKNLT +YL++N + G IP E+GN+ S+  L L+ N+L+GSIP + GNL NL  LYL+ 
Sbjct: 247  NLKNLTVLYLHHNYLTGVIPPELGNMESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLYK 306

Query: 241  NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
            N L+G IPP+LG+ +S+ YL LS N+L GS+PSS GNL +L  L++H+ N L+G IP E+
Sbjct: 307  NYLTGVIPPELGNMESMTYLDLSENKLTGSIPSSLGNLKNLTVLYLHH-NYLTGVIPPEL 365

Query: 301  GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
            GNL+S+  L LS  +L+G IP SLGNL N+  LY+  N L G IP ELG ++S+  L+LS
Sbjct: 366  GNLESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNMESMIDLALS 425

Query: 361  VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
             N L GSIP   GN + L+   LR+N LSG+IP+ + N  +L + LL  N FTG+LP+N+
Sbjct: 426  QNNLTGSIPSSFGNFTKLESLYLRDNHLSGTIPRGVANSSELTELLLDINNFTGFLPENI 485

Query: 421  CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
            C+ G L +FS+  N+  G IP+SL++C SL   +   N+  GNISE FG+YPDL+ +DLS
Sbjct: 486  CKGGKLQNFSLDYNHLEGHIPKSLRDCKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLS 545

Query: 481  NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
            +N F GEISSNW K P+L  L M  N I+G IP EI NM QL +LD S+N L G++P+ +
Sbjct: 546  HNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNMKQLGELDLSTNNLTGELPEAI 605

Query: 541  GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS 600
            G LT L+ L LNGN+LSG +P  L  L  L  LDLS+NR S  IP+      KLH +NLS
Sbjct: 606  GNLTGLSKLLLNGNKLSGRVPTGLSFLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLS 665

Query: 601  NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
             N F   I   + KL QL+ LDLSHN L G IPS++ +L+SL+ +NL  N LSG IP+ F
Sbjct: 666  KNNFDGRIP-GLTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTF 724

Query: 661  RRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDS 720
              M  L+ ID+S N+L+G +P + AFQNAT +A +GN+ LC ++    P + L S +G  
Sbjct: 725  ESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGLCSNI----PKQRLKSCRGFQ 780

Query: 721  GKHMT---FLFVIVPLLSGAFLLSLVLIGMCFNFRRRK-----RTDSQEGQN-------- 764
                     ++++VP+L    +LS+      +  R+RK      TDS+ G+N        
Sbjct: 781  KPKKNGNLLVWILVPILGALVILSICAGAFTYYIRKRKPHNGRNTDSETGENMSIFSVDG 840

Query: 765  DVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG--INQKG 822
                Q+++ ++    +  L G+GG   VYKA L      AVK+LH     EI   + ++ 
Sbjct: 841  KFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA-IVAVKRLHDTIDEEISKPVVKQE 899

Query: 823  FVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV 879
            F++E+   TEIRHRN+VK +GFCSH +H FL+YEY+E+GSL  +L+NE  A  L W+KR+
Sbjct: 900  FLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRI 959

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
            N++KGVA+ALSYMHHD   PI+HRDISS  +LLD +Y A +SDFGTAK LK DSSNWS +
Sbjct: 960  NIVKGVAHALSYMHHDRSTPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAV 1019

Query: 940  AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVV 999
            AGT GY+APE AYTM+  EKCDV++FGVL+LEVI GKHPG  ++ L S P       + +
Sbjct: 1020 AGTYGYVAPEFAYTMKVTEKCDVYSFGVLILEVIMGKHPGDLVASLSSSPGET----LSL 1075

Query: 1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + D R+  P G+  EKL  M+ VA  CL A+P  RPTM  +
Sbjct: 1076 RSISDERILEPRGQNREKLIKMVEVALSCLQADPQSRPTMLSI 1118

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  906 bits (2342), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 506/952 (53%), Positives = 640/952 (67%), Gaps = 44/952 (4%)

Query: 115  SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV 174
            S  +  NL    ++ N LSG IPP  G+L    Y               + L TN FSG 
Sbjct: 105  SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKY---------------LDLSTNQFSGR 149

Query: 175  IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLK 234
            IP  +G L NL  ++L  N++ GSIP EIG L+SL  L L  N+L GSIP + GNLSNL 
Sbjct: 150  IPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLGNLSNLT 209

Query: 235  FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
             LYL +N+LSG IPP++G+   L+ L L+ N L G +PS+ GNL SL  L ++N N+LSG
Sbjct: 210  NLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYN-NQLSG 268

Query: 295  SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
             IP EIGNLK L +L LS   LSG IP SLG+LS ++ L + +N L G IP+E+G L+SL
Sbjct: 269  PIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSL 328

Query: 355  SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
              L +S N+LNGSIP  LGNL NL+   LR+N+LS SIP EI  + KL +  +  NQ +G
Sbjct: 329  VDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSG 388

Query: 415  YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
            +LP+ +CQ GSL +F+V +N  +GPIP SL+NC SL   RL+RNQLTGNISE FG+ P+L
Sbjct: 389  FLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNL 448

Query: 475  ELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG 534
              ++LSNN F+GE+S NW +C +L  L++ GN I+G+IP++ G  TQL  L+ SSN LVG
Sbjct: 449  YHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVG 508

Query: 535  QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKL 594
            +IPK+LG ++SL  L LN N+LSG+IP ELG LA+LGYLDLS NRL+  IP++LG    L
Sbjct: 509  EIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDL 568

Query: 595  HHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG 654
            ++LNLSNN+ S  I +Q+GKL  LS LDLSHN L G IPS+I  L+SLE +NL  N LSG
Sbjct: 569  NYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSG 628

Query: 655  PIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALT 714
             IP  F  MHGL  +D+SYN+LQGSIP+S+AFQN TIE  QGNK LCG V GL PCE  +
Sbjct: 629  IIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRS 688

Query: 715  SNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSA 774
            + K   G H     +I  LL GA L+    IG+     + +R    E   DV  + L S 
Sbjct: 689  ATK---GTHKAVFIIIFSLL-GALLILSAFIGISL-ISQGRRNAKMEKAGDVQTENLFSI 743

Query: 775  STFEGK---------------MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGIN 819
            STF+G+               M   G GG G+VYKAEL SG+  AVKKLH         +
Sbjct: 744  STFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRFDIDM--AH 801

Query: 820  QKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
            QK F++EI   TEI+HRNIVK  GFCSH++H FLVYEYLERGSL TILS E  A E+ W 
Sbjct: 802  QKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWG 861

Query: 877  KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             RVN+IKGVA+ALSY+HHDC PPI+HRDISS  VLLD +Y+AHVSDFGTAKFLK DSSNW
Sbjct: 862  TRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNW 921

Query: 937  SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN 996
            S LAGT GY+APELAYTM+  EKCDV++FGVL LEV+ G+HPG  +S   SL A     N
Sbjct: 922  STLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLIS---SLSASPGKDN 978

Query: 997  IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
            +V+ D++D RLPPP    E ++ S+I +A  CL+ +P  RPTMQ V  +L +
Sbjct: 979  VVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQMLSQ 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15219699|ref|NP_174809.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana] gi|75175345|sp|Q9LP24.1|Y1571_ARATH RecName: Full=Probable leucine-rich repeat receptor-like protein kinase At1g35710; Flags: Precursor gi|8778966|gb|AAF79881.1|AC021198_1 Contains similarity to receptor protein kinase-like protein from Arabidopsis thaliana gb|AL161513. It contains a eukaryotic protein kinase domain PF|00069. EST gb|AI997574 comes from this gene [Arabidopsis thaliana] gi|332193703|gb|AEE31824.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana]

 Score =  900 bits (2326), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 500/1063 (47%), Positives = 682/1063 (64%), Gaps = 47/1063 (4%)

Query: 1    VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            +  +NLT + ++GT Q+FPF+    LAY+DLS+N L GTIP Q  +LSKL + D STN  
Sbjct: 79   IEELNLTNTGIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHL 138

Query: 61   SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
            +G I P +G L NL VL L  N L  +IP ELG + S+ +LALS N+L GSIP+SLGNL 
Sbjct: 139  TGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLK 198

Query: 121  NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
            NL+ L L  N L+G IPP               +LGN+ES   ++L  N  +G IP +LG
Sbjct: 199  NLMVLYLYENYLTGVIPP---------------ELGNMESMTDLALSQNKLTGSIPSTLG 243

Query: 181  GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
             LKNL  +YL  N + G IP EIGN+ S++ L L++N+L+GSIP + GNL NL  L L  
Sbjct: 244  NLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQ 303

Query: 241  NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
            N L+G IPPKLG+ +S++ L LS+N+L GS+PSS GNL +L  L+++  N L+G IP E+
Sbjct: 304  NYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYE-NYLTGVIPPEL 362

Query: 301  GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
            GN++S+  L L+  +L+G IP S GNL N+  LY+  N L G IP+ELG ++S+  L LS
Sbjct: 363  GNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLS 422

Query: 361  VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
             NKL GS+P   GN + L+   LR N LSG+IP  + N   L   +L  N FTG+ P+ V
Sbjct: 423  QNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETV 482

Query: 421  CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
            C+   L + S+  N+  GPIP+SL++C SL   R   N+ TG+I E FGIYPDL  +D S
Sbjct: 483  CKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFS 542

Query: 481  NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
            +N F GEISSNW K P+L  L M  N I+G IP+EI NMTQL +LD S+N L G++P+ +
Sbjct: 543  HNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAI 602

Query: 541  GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS 600
            G LT+L+ L LNGNQLSG +P  L  L  L  LDLS+N  S  IP+      KLH +NLS
Sbjct: 603  GNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLS 662

Query: 601  NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
             N+F   I  ++ KL QL++LDLSHN L G IPS++ +L+SL+ ++L  N LSG IP+ F
Sbjct: 663  RNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTF 721

Query: 661  RRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV--TGLPPCEALTSNKG 718
              M  L+++D+S N+L+G +P +  F+ AT +A + N  LC ++    L PC  L   K 
Sbjct: 722  EGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKK 781

Query: 719  DSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRK-----RTDSQEGQN--------D 765
            +       ++++VP+L    +LS+      +  R+RK      TD + G+N         
Sbjct: 782  NGN---LVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGK 838

Query: 766  VNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDT-RAVKKLHSLPTGEIG--INQKG 822
               Q+++ ++       L GTGG   VY+A L   DT  AVK+LH     EI   + ++ 
Sbjct: 839  FKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQ--DTIIAVKRLHDTIDEEISKPVVKQE 896

Query: 823  FVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV 879
            F++E+   TEIRHRN+VK +GFCSH +H FL+YEY+E+GSL  +L+N+  A  L W+KR+
Sbjct: 897  FLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRI 956

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
            NV+KGVA+ALSYMHHD   PI+HRDISS  +LLD +Y A +SDFGTAK LK DSSNWS +
Sbjct: 957  NVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAV 1016

Query: 940  AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVV 999
            AGT GY+APE AYTM+  EKCDV++FGVL+LE+I GKHPG  +S L S P  A    + +
Sbjct: 1017 AGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA----LSL 1072

Query: 1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + D R+  P G+  EKL  M+ +A LCL ANP+ RPTM  +
Sbjct: 1073 RSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  899 bits (2324), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 503/952 (52%), Positives = 638/952 (67%), Gaps = 44/952 (4%)

Query: 115  SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV 174
            S  +  NL    ++ N LSG IPP  G+L    Y               + L TN FSG 
Sbjct: 105  SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKY---------------LDLSTNQFSGR 149

Query: 175  IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLK 234
            IP  +G L NL  ++L  N++ GSIP EIG L+SL  L L  N+L G+IP + GNLSNL 
Sbjct: 150  IPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLGNLSNLT 209

Query: 235  FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
             LYL +N+LSG IPP++G+   L+ L L+ N L G +PS+ GNL SL  L ++N N+LSG
Sbjct: 210  NLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYN-NQLSG 268

Query: 295  SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
             IP EIGNLK L +L LS   LSG IP SLG+LS ++ L + +N L G IP+E+G L+SL
Sbjct: 269  PIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSL 328

Query: 355  SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
              L +S N+LNGSIP  LGNL NL+   LR+N+LS SIP EI  + KL +  +  NQ +G
Sbjct: 329  VDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSG 388

Query: 415  YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
            +LP+ +CQ GSL +F+V +N  +GPIP SL+NC SL   RL+ NQLTGNISE FG+ P+L
Sbjct: 389  FLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNL 448

Query: 475  ELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG 534
              ++LSNN F+GE+S NW +C +L  L++ GN I+G+IP++ G  TQL  L+ SSN LVG
Sbjct: 449  YHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVG 508

Query: 535  QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKL 594
            +IPK+LG ++SL  L LN N+LSG+IP ELG LA+LGYLDLS NRL+  IP++LG    L
Sbjct: 509  EIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDL 568

Query: 595  HHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG 654
            ++LNLSNN+ S  I +Q+GKL  LS LDLSHN L G IPS+I  L+SLE +NL  N LSG
Sbjct: 569  NYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSG 628

Query: 655  PIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALT 714
             IP  F  MHGL  +D+SYN+LQGSIP+S+AFQN TIE  QGNK LCG V GL PCE  +
Sbjct: 629  IIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRS 688

Query: 715  SNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSA 774
            + K   G H     +I  LL GA L+    IG+     + +R    E   DV  + L S 
Sbjct: 689  ATK---GTHKAVFIIIFSLL-GALLILSAFIGISL-ISQGRRNAKMEKAGDVQTENLFSI 743

Query: 775  STFEGK---------------MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGIN 819
            STF+G+               M   G GG G+VYKAEL SG+  AVKKLH         +
Sbjct: 744  STFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRFDIDM--AH 801

Query: 820  QKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
            QK FV+EI   TEI+HRNIVK  GFCSH++H FLVYEYLERGSL TILS E  A E+ W 
Sbjct: 802  QKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWG 861

Query: 877  KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             RVN+IKGV++ALSY+HHDC PPI+HRDISS  VLLD +Y+AHVSDFGTAKFLK DSSNW
Sbjct: 862  TRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNW 921

Query: 937  SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN 996
            S LAGT GY+APELAYTM+  EKCDV++FGVL LEV+ G+HPG  +S   SL       N
Sbjct: 922  STLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLIS---SLSDSPGKDN 978

Query: 997  IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
            +V+ D++D RLPPP    E ++ S+I +A  CL+ +P  RPTMQ V  +L +
Sbjct: 979  VVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQMLSQ 1030

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  887 bits (2293), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 503/972 (51%), Positives = 642/972 (66%), Gaps = 44/972 (4%)

Query: 97   SLNELALSYNRLNGSI-PASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
            S+ ++ L+ + LNG++   S  +  NL  + +S N+LSG IPP  G L    Y       
Sbjct: 89   SVIKINLTESGLNGTLMDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKY------- 141

Query: 156  GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLN 215
                    + L  N FSG IP  +G L NL  ++L  N++ GSIP EIG L SL  L L 
Sbjct: 142  --------LDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALY 193

Query: 216  KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF 275
             NQL GSIP + GNLSNL  LYL++N+LSG IPP++G+  +L+ +Y ++N L G +PS+F
Sbjct: 194  TNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNNNNLTGPIPSTF 253

Query: 276  GNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
            GNL  L  L++ N N LSG IP EIGNLKSL  L L +  LSG IP SL +LS +  L++
Sbjct: 254  GNLKRLTVLYLFN-NSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHL 312

Query: 336  RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
              N L G IP+E+G LKSL  L LS N+LNGSIP  LGNL+NL+   LR+N+LSG IPQE
Sbjct: 313  YANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQE 372

Query: 396  IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
            I  + KL    +  NQ  G LP+ +CQ+GSL  F+V +N+  GPIP+SL+NC +L     
Sbjct: 373  IGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALF 432

Query: 456  ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSE 515
            + N+LTGNISEV G  P+LE +DLS N F GE+S NW +CPQL  L + GN I+G+IP +
Sbjct: 433  QGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPED 492

Query: 516  IGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDL 575
             G  T L  LD SSN LVG+IPK++G LTSL  L LN NQLSG IP ELG L+ L YLDL
Sbjct: 493  FGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDL 552

Query: 576  SANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSE 635
            SANRL+  IP++LG+   LH+LNLSNN+ S  I +Q+GKL  LS+LDLSHN L G IP +
Sbjct: 553  SANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQ 612

Query: 636  ICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQ 695
            I  L+SLE ++L  N L G IP  F  M  LS +D+SYN+LQG IPHS AF+NATIE  +
Sbjct: 613  IQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLK 672

Query: 696  GNKELCGDVTGLPPCE-ALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRR 754
            GNK+LCG+V GL PC+     ++    K    +F+I+  L GA +L    IG+     RR
Sbjct: 673  GNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERR 732

Query: 755  KRTDSQEGQNDVNNQELLSASTFEGK---------------MVLHGTGGCGTVYKAELTS 799
            +RT   E + DV N +L S S F+G+               M   G GG G+VYKAEL S
Sbjct: 733  ERTPEIE-EGDVQN-DLFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPS 790

Query: 800  GDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLE 856
             +  AVKKLH  P+     NQK F++EI   TEI+HRNIVK  GFCSH +H FLVYEYLE
Sbjct: 791  SNIVAVKKLH--PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLE 848

Query: 857  RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
            RGSLATILS E  A +L W+ RVN+IKGVA+AL+YMHHDC PPI+HRD+SS  +LLD +Y
Sbjct: 849  RGSLATILSREE-AKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQY 907

Query: 917  KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
            +AH+SDFGTAK LK DSSN S LAGT GY+APELAYTM+  EK DVF+FGV+ LEVI+G+
Sbjct: 908  EAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGR 967

Query: 977  HPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCR 1036
            HPG     +LSL       NI + D++D RLPP   + E ++ +++  A  CL ANP  R
Sbjct: 968  HPG---DQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSR 1024

Query: 1037 PTMQKVCNLLCR 1048
            PTMQ V  +L +
Sbjct: 1025 PTMQTVSQMLSQ 1036

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  874 bits (2259), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 514/1128 (45%), Positives = 690/1128 (61%), Gaps = 89/1128 (7%)

Query: 1    VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            V +INLT   L+GTLQ   F L P +  L++S N L GTIP QI  LSKL  LD S N  
Sbjct: 77   VSNINLTNVGLRGTLQNLNFSLLPNILTLNMSHNSLNGTIPPQIGSLSKLARLDLSDNFL 136

Query: 61   SGIIPPQIGILTNLVVL------------------------------------------- 77
            SG IP  IG L+NL  L                                           
Sbjct: 137  SGEIPSTIGNLSNLYYLSFYDNSLSGAIPSSIGNLVNLDSMILHKNKLSGSIPFIIGNLS 196

Query: 78   RLSV-----NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
            +LSV     N+L G IP  +G L +++ L L  N+L+GSIP ++GNLS L  L +S N L
Sbjct: 197  KLSVLSIYSNELTGPIPTSIGNLVNMDSLLLYENKLSGSIPFTIGNLSKLSGLYISLNEL 256

Query: 133  SGQIPPNWGYLISPHY---------GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK 183
            +G IP + G L++            GSIP ++GNL     +S+H+N  +G IP S+G L 
Sbjct: 257  TGPIPASIGNLVNLEAMRLFKNKLSGSIPFNIGNLSKLSKLSIHSNELTGPIPASIGNLV 316

Query: 184  NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
            NL  + L+ N++ GSIP  IGNL   S L ++ N+L+G IP + GNL +L  L L +N+L
Sbjct: 317  NLDSMILHKNKLSGSIPFIIGNLSKFSVLSISFNELTGPIPASIGNLVHLDSLLLEENKL 376

Query: 244  SGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNL 303
            SG IP  +G+   L  LY+S N+L G +P+S GNL +L+ + +   NKLSGSIP  IGNL
Sbjct: 377  SGSIPFTIGNLSKLSGLYISLNELTGPIPASIGNLVNLEAMRLFK-NKLSGSIPFTIGNL 435

Query: 304  KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNK 363
              LS L +   +L+G IP S+GNL ++  L + EN L GSIP  +G L  LS LS+S+N+
Sbjct: 436  SKLSKLSIHSNELTGPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSKLSVLSISLNE 495

Query: 364  LNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS 423
            L GSIP  +GNLSN++      NEL G IP E+  +  L    L +N F G+LPQN+C  
Sbjct: 496  LTGSIPSTIGNLSNVRELFFIGNELGGKIPIEMSMLTALESLQLADNNFIGHLPQNICIG 555

Query: 424  GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN 483
            G+L +F+  +NNF+GPIP SL+NC+SL  +RL+RNQLTG+I++ FG+ P+L+ ++LS+NN
Sbjct: 556  GTLKNFTAGDNNFIGPIPVSLKNCSSLIRVRLQRNQLTGDITDAFGVLPNLDYIELSDNN 615

Query: 484  FFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKL 543
            F+G++S NW K   L +L +  N +SG IP E+   T+L +L  SSN L G IP  L  L
Sbjct: 616  FYGQLSPNWGKFRSLTSLRISNNNLSGVIPPELAGATKLQRLQLSSNHLTGNIPHDLCNL 675

Query: 544  TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
              L  L+L+ N L+G++P E+  + +L  L L +N+LS LIPK LG L  L +++LS N 
Sbjct: 676  P-LFDLSLDNNNLTGNVPKEIASMQKLQILKLGSNKLSGLIPKQLGNLLNLWNMSLSQNN 734

Query: 604  FSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRM 663
            F   I  ++GKL  L+ LDL  NSL G IPS    L+SLE +NL  N LSG + S F  M
Sbjct: 735  FQGNIPSELGKLKSLTSLDLGGNSLRGTIPSMFGELKSLETLNLSHNNLSGNL-SSFDDM 793

Query: 664  HGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKH 723
              L+SID+SYN+ +G +P+  AF NA IEA + NK LCG+VTGL PC   +++ G S  H
Sbjct: 794  TSLTSIDISYNQFEGPLPNILAFHNAKIEALRNNKGLCGNVTGLEPC---STSSGKSHNH 850

Query: 724  M--TFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKM 781
            M    + VI+PL  G  +L+L   G+ ++  +   T+ ++    +    + +  +F+GKM
Sbjct: 851  MRKKVMIVILPLTLGILILALFAFGVWYHLCQTS-TNKEDQATSIQTPNIFAIWSFDGKM 909

Query: 782  V---------------LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE 826
            V               L G GG G VYKA L +G   AVKKLHS+P GE+ +N K F  E
Sbjct: 910  VFENIIEATEDFDDKHLIGVGGQGCVYKAVLPTGQVVAVKKLHSVPNGEM-LNLKAFTCE 968

Query: 827  I---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
            I   TEIRHRNIVK YGFCSH+Q  FLV E+LE GS+   L ++  A   DW KRVNV+K
Sbjct: 969  IQALTEIRHRNIVKLYGFCSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVK 1028

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
             VANAL YMHH+C P I+HRDISSK VLLD EY AHVSDFGTAKFL PDSSNW+   GT 
Sbjct: 1029 DVANALCYMHHECSPRIVHRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTF 1088

Query: 944  GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL-SLPAP--AANMN-IVV 999
            GY APELAYTM  NEKCDV++FGVL  E++ GKHPG  +S LL S P+   A+ ++ + +
Sbjct: 1089 GYAAPELAYTMEVNEKCDVYSFGVLAWEILVGKHPGDDISSLLGSSPSTLVASTLDHMAL 1148

Query: 1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047
             D +D RLP P   + +++ S+  +A  CL  +P  RPTM++V N L 
Sbjct: 1149 MDKLDPRLPHPTKPIGKEVASIAKIAMACLTESPRSRPTMEQVANELV 1196

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  871 bits (2251), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 499/973 (51%), Positives = 640/973 (65%), Gaps = 47/973 (4%)

Query: 97   SLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
            S+  + L+ + L G++ A S  +  NL  + +S N+LSG IPP  G L    Y       
Sbjct: 89   SVIRINLTESGLGGTLQAFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKY------- 141

Query: 156  GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLN 215
                    + L  N FSG IP  +G L NL  ++L  N++ GSIP EIG L SL  L L 
Sbjct: 142  --------LDLSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALY 193

Query: 216  KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF 275
             NQL GSIP + GNLSNL  LYL++N+LSG IPP++G+  +L+ LY   N L G +PS+F
Sbjct: 194  TNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTF 253

Query: 276  GNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
            GNL  L  L++ N N LSG IP EIGNLKSL  L L    LSG IP SL +LS +  L++
Sbjct: 254  GNLKHLTVLYLFN-NSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHL 312

Query: 336  RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
              N L G IP+E+G LKSL  L LS N+LNGSIP  LGNL+NL+   LR+N LSG  PQE
Sbjct: 313  YANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQE 372

Query: 396  IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
            I  + KL    +  NQ  G LP+ +CQ GSL  F+V +N+  GPIP+SL+NC +L     
Sbjct: 373  IGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALF 432

Query: 456  ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSE 515
            + N+LTGN+SEV G  P+LE +DLS N F GE+S NW +CPQL  L + GN I+G+IP +
Sbjct: 433  QGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPED 492

Query: 516  IGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDL 575
             G  T L  LD SSN LVG+IPK++G LTSL  L LN NQLSG IP ELG L+ L YLDL
Sbjct: 493  FGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDL 552

Query: 576  SANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSE 635
            SANRL+  IP++LG+   LH+LNLSNN+ S  I +Q+GKL  LS+LDLSHN L G IP++
Sbjct: 553  SANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQ 612

Query: 636  ICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQ 695
            I  LESLE ++L  N L G IP  F  M  LS +D+SYN+LQG IPHS AF+NATIE  +
Sbjct: 613  IQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLK 672

Query: 696  GNKELCGDVTGLPPCE-ALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRR 754
            GNK+LCG+V GL PC+     ++    K    +F+I+  L GA +L    IG+     RR
Sbjct: 673  GNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERR 732

Query: 755  KRTDSQEGQNDVNNQELLSASTFEGK---------------MVLHGTGGCGTVYKAELTS 799
            +RT   E + DV N  LLS STF+G+               M   G GG G+VYKAEL S
Sbjct: 733  ERTPEIE-EGDVQNN-LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPS 790

Query: 800  GDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLE 856
            G+  AVKKLH  P+     NQK F++++   TEI+HRNIV+  GFCS+ +H FLVYEYLE
Sbjct: 791  GNIVAVKKLH--PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLE 848

Query: 857  RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
            RGSLATILS E  A +L W+ RV +IKGVA+ALSYMHHDC PPI+HRDISS  +LLD +Y
Sbjct: 849  RGSLATILSREE-AKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQY 907

Query: 917  KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
            +AH+S+ GTAK LK DSSN S+LAGT GY+APE AYTM+  EK DV++FGV+ LEVI+G+
Sbjct: 908  EAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGR 967

Query: 977  HPG-HFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDC 1035
            HPG   LS+ +S        NIV+ D++D RLPP   + E ++ ++I +A  CL+ANP  
Sbjct: 968  HPGDQILSISVS-----PEKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQS 1022

Query: 1036 RPTMQKVCNLLCR 1048
            RPTM+ +  +L +
Sbjct: 1023 RPTMEIISQMLSQ 1035

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357438961|ref|XP_003589757.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|357438991|ref|XP_003589772.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355478805|gb|AES60008.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355478820|gb|AES60023.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula]

 Score =  869 bits (2246), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 488/1065 (45%), Positives = 662/1065 (62%), Gaps = 43/1065 (4%)

Query: 1    VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            +  +NLT   LKGTLQ   F   P++  L L  N  +G IP      S L  ++ S N+ 
Sbjct: 80   IYKVNLTNIGLKGTLQTLNFSSLPKIQELVLRNNSFYGVIP-YFGVKSNLDTIELSYNEL 138

Query: 61   SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
            SG IP  IG L+ L  L L VN LNG+IP  +  L+ L+ L LSYN L+G +P+ +  L 
Sbjct: 139  SGHIPSTIGFLSKLSFLSLGVNNLNGIIPNTIANLSKLSYLDLSYNHLSGIVPSEITQLV 198

Query: 121  NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
             + +L + +N  SG                 PQ++G L +   +   T NF+G IP+S+ 
Sbjct: 199  GINKLYIGDNGFSG---------------PFPQEVGRLRNLTELDFSTCNFTGTIPKSIV 243

Query: 181  GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
             L N++ +   NNRI G IP  IG L +L  L +  N LSGSIP   G L  +  L +  
Sbjct: 244  MLTNISTLNFYNNRISGHIPRGIGKLVNLKKLYIGNNSLSGSIPEEIGFLKQIGELDISQ 303

Query: 241  NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
            N L+G IP  +G+  SL + YL  N L G +PS  G L +LK L++ N N LSGSIP+EI
Sbjct: 304  NSLTGTIPSTIGNMSSLFWFYLYRNYLIGRIPSEIGMLVNLKKLYIRN-NNLSGSIPREI 362

Query: 301  GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
            G LK L+ + +S+  L+G IP ++GN+S++  LY+  N L G IP E+G+L SLS   L+
Sbjct: 363  GFLKQLAEVDISQNSLTGTIPSTIGNMSSLFWLYLNSNYLIGRIPSEIGKLSSLSDFVLN 422

Query: 361  VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
             N L G IP  +GNL+ L    L  N L+G+IP E+ N+  L    L +N FTG+LP N+
Sbjct: 423  HNNLLGQIPSTIGNLTKLNSLYLYSNALTGNIPIEMNNLGNLKSLQLSDNNFTGHLPHNI 482

Query: 421  CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
            C  G LT FS  NN F GPIP+SL+NC+SLY +RL++NQLT NI++ FG++P L+ ++LS
Sbjct: 483  CAGGKLTWFSASNNQFTGPIPKSLKNCSSLYRVRLQQNQLTDNITDAFGVHPKLDYMELS 542

Query: 481  NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
            +NN +G +S NW KC  L  L +  N ++G+IP E+G  T LH+L+ SSN L G+IPK+L
Sbjct: 543  DNNLYGHLSPNWGKCMNLTCLKIFNNNLTGSIPPELGRATNLHELNLSSNHLTGKIPKEL 602

Query: 541  GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS 600
              L+ L  L+++ N LSG++P ++  L +L  L+LS N LS  IPK LG L  L HLNLS
Sbjct: 603  ESLSLLIQLSVSNNHLSGEVPAQVASLQKLDTLELSTNNLSGSIPKQLGSLSMLLHLNLS 662

Query: 601  NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
             N F   I ++ G+L  L  LDLS N L G IP+    L  LE +NL  N LSG I    
Sbjct: 663  KNMFEGNIPVEFGQLNVLEDLDLSENFLNGTIPAMFGQLNHLETLNLSHNNLSGTILFSS 722

Query: 661  RRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKG-D 719
              M  L+++D+SYN+L+G IP   AFQ A IEA + NK+LCG+ + L PC   TSN+  +
Sbjct: 723  VDMLSLTTVDISYNQLEGPIPSIPAFQQAPIEALRNNKDLCGNASSLKPCP--TSNRNPN 780

Query: 720  SGKHMTFLFVIVPLLSGAFLLSLVLIGMCFN-FRRRKRTDSQEGQNDVNNQELLSASTFE 778
            + K    L VI+P+  G FLL+L   G+ +  FR   R +S+  + + + + L S  +F+
Sbjct: 781  THKTNKKLVVILPITLGIFLLALFGYGISYYLFRTSNRKESKVAE-ESHTENLFSIWSFD 839

Query: 779  GKMV---------------LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
            GK+V               L G GG G+VYKAEL +G   AVKKLHSL  GE+  N K F
Sbjct: 840  GKIVYENIVEATEEFDNKHLIGVGGHGSVYKAELPTGQVVAVKKLHSLQNGEMS-NLKAF 898

Query: 824  VSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
             SEI   TEIRHRNIVK  G+CSH  H FLVYE+LE+GS+  IL  +  A   DW++RVN
Sbjct: 899  ASEIQALTEIRHRNIVKLCGYCSHPLHSFLVYEFLEKGSVDKILKEDEQATMFDWNRRVN 958

Query: 881  VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW-SEL 939
            VIK VANAL YMHHD  P I+HRDISSK ++LDLEY AHVSDFGTAKFL P++SNW S  
Sbjct: 959  VIKDVANALYYMHHDRSPSIVHRDISSKNIVLDLEYVAHVSDFGTAKFLNPNASNWTSNF 1018

Query: 940  AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN-IV 998
             GT GY APELAYTM  NEKCDV++FGVL LE++ GKHPG  +S +L   +    ++ ++
Sbjct: 1019 VGTFGYTAPELAYTMEVNEKCDVYSFGVLTLEMLLGKHPGDIVSTMLQSSSVGQTIDAVL 1078

Query: 999  VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043
            + D++D RL  P  ++++++ S+I +AF CL  +P  RPTM++VC
Sbjct: 1079 LTDMLDQRLLYPTNDIKKEVVSIIRIAFHCLTESPHSRPTMEQVC 1123

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  868 bits (2242), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 496/940 (52%), Positives = 627/940 (66%), Gaps = 47/940 (5%)

Query: 130  NSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVY 189
            N+LSG IPP  G L    Y               + L  N FSG IP  +G L NL  ++
Sbjct: 81   NNLSGPIPPQIGLLSELKY---------------LDLSINQFSGGIPSEIGLLTNLEVLH 125

Query: 190  LNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP 249
            L  N++ GSIP EIG L SL  L L  NQL GSIP + GNLSNL +LYL++N+LS  IPP
Sbjct: 126  LVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPP 185

Query: 250  KLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHL 309
            ++G+  +L+ +Y   N L G +PS+FGNL  L  L++ N N+LSG IP EIGNLKSL  L
Sbjct: 186  EMGNLTNLVEIYSDTNNLIGPIPSTFGNLKRLTVLYLFN-NRLSGHIPPEIGNLKSLQGL 244

Query: 310  WLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP 369
             L +  LSG IP SLG+LS +  L++  N L G IP+E+G LKSL  L LS N+LNGSIP
Sbjct: 245  SLYENNLSGPIPASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIP 304

Query: 370  HCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHF 429
              LGNL+NL+   LR+N+LSG IPQEI  + KL    +  NQ  G LP+ +CQ GSL  F
Sbjct: 305  TSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERF 364

Query: 430  SVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS 489
            +V +N+  GPIP+SL+NC +L       NQLTGNISEV G  P+LE +++S N+F GE+S
Sbjct: 365  TVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELS 424

Query: 490  SNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSL 549
             NW + P+L  L M  N I+G+IP + G  T L  LD SSN L G+IPK++G +TSL  L
Sbjct: 425  HNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKL 484

Query: 550  TLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEIS 609
             LN NQLSG+IP ELG LA+LGYLDLSANRL+  IP++LG+   L++LNLSNN+ S  I 
Sbjct: 485  ILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIP 544

Query: 610  IQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSI 669
            +Q+GKL  LS+LDLSHN L G+IP +I  L+SLE +NL  N LSG IP  F  M GLS +
Sbjct: 545  VQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDV 604

Query: 670  DVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCE--ALTSNKGDSGKHMTFL 727
            D+SYN+LQG IP+SKAF++ATIEA +GNK LCG+V  L PC+  +    +     H    
Sbjct: 605  DISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVF 664

Query: 728  FVIVPLLSGAFLLSLVLIGMCFNFRRRKRT-DSQEGQNDVNNQELLSASTFEGK------ 780
             +I PLL GA +L    IG+     RR+RT + +EG+  V N +L S STF+G+      
Sbjct: 665  IIIFPLL-GALVLLFAFIGIFLIAARRERTPEIKEGE--VQN-DLFSISTFDGRTMYEEI 720

Query: 781  ---------MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---T 828
                     M   G GG G+VYKAEL S +  AVKKLH  P+     NQK F++EI   T
Sbjct: 721  IKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH--PSDTEMANQKDFLNEIRALT 778

Query: 829  EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
            EI+HRNIVK  GFCSH +H FLVYEYLERGSLATILS E  A +L W+ RVN+IKGVA+A
Sbjct: 779  EIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREE-AKKLGWATRVNIIKGVAHA 837

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
            L+YMHHDC PPI+HRDISS  +LLD +Y+AH+SDFGTAK LK DSSN S LAGT GY+AP
Sbjct: 838  LAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAP 897

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
            ELAYTM+  EK DVF+FGV+ LEVI+G+HPG     +LSL       NI + D++D RLP
Sbjct: 898  ELAYTMKVTEKTDVFSFGVIALEVIKGRHPG---DQILSLSVSPEKDNIALEDMLDPRLP 954

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
            P   + E ++ ++I  A  CL ANP  RPTMQ V  +L +
Sbjct: 955  PLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQMLSQ 994

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359487164|ref|XP_003633525.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  868 bits (2242), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 512/1068 (47%), Positives = 672/1068 (62%), Gaps = 80/1068 (7%)

Query: 26   LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLN 85
            L  L L  N+LFG IP +I  L  L  L+ STN  SG IPP IG L NL  L L  N+L+
Sbjct: 317  LTTLYLYQNELFGLIPQEIGLLRSLNDLELSTNNLSGPIPPSIGNLRNLTTLYLHRNELS 376

Query: 86   GLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS 145
              IP+E+G L SLN LALS N L+G IP S+GNL NL  L L NN LSG           
Sbjct: 377  SSIPQEIGLLRSLNNLALSTNNLSGPIPPSIGNLRNLTNLYLYNNELSG----------- 425

Query: 146  PHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGN 205
                 IPQ++G L S + + L  NN +G  P S+G L          N++ G IPSEIG 
Sbjct: 426  ----PIPQEIGLLRSLIELDLSDNNLTGSTPTSIGNL---------GNKLSGFIPSEIGL 472

Query: 206  LRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL---------------------- 243
            LRSL  L L+ N L GSIP + GNLSNL  L++H N+L                      
Sbjct: 473  LRSLKDLDLSNNNLIGSIPTSIGNLSNLVTLFVHSNKLNGSIPQDIHLLSSLSVLALSNN 532

Query: 244  --SGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIG 301
              SG IP  LG   SL  LYL +N L+GS+P S GNLS L  L +H+ N+L GSIP+E+G
Sbjct: 533  NLSGIIPHSLGKLGSLTALYLRNNSLSGSIPYSIGNLSKLDTLDLHS-NQLFGSIPREVG 591

Query: 302  NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
             L+SL  L  S  +L+G IP S+GNL N+  L+I +N L GSIP+E+G LKSL +L LS 
Sbjct: 592  FLRSLFALDSSNNKLTGSIPTSIGNLVNLTTLHISKNQLSGSIPQEVGWLKSLDKLDLSD 651

Query: 362  NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
            NK+ GSIP  +GNL NL    L +N+++GSIP E+ ++ +L    L EN  TG LP  +C
Sbjct: 652  NKITGSIPASIGNLGNLTVLYLSDNKINGSIPPEMRHLTRLRSLELSENHLTGQLPHEIC 711

Query: 422  QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
              G L +F+   N+  G IP+SL+NCTSL+ +RLERNQL GNI+E FGIYP+L  +DLS 
Sbjct: 712  LGGVLENFTAEGNHLTGSIPKSLRNCTSLFRVRLERNQLAGNITEDFGIYPNLLFIDLSY 771

Query: 482  NNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG 541
            N  +GE+S  W +C  L +L +  N ISG IP ++G  T+L +LD SSN LVG+IPK+LG
Sbjct: 772  NKLYGELSHKWGQCNSLTSLKISNNNISGMIPHQLGEATKLEQLDLSSNHLVGEIPKELG 831

Query: 542  KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
             L SL +L ++ N+LSG+IPLE G L++L +L+L++N LS  IP+ +   RKL  LNLSN
Sbjct: 832  MLKSLFNLVIDNNKLSGNIPLEFGNLSDLVHLNLASNHLSGPIPQQVRNFRKLLSLNLSN 891

Query: 602  NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR 661
            N+F + I  +IG ++ L  LDL  N L G IP ++  L+SLE +NL  N LSG IP  F 
Sbjct: 892  NKFGESIPAEIGNVITLESLDLCQNMLTGEIPQQLGELQSLETLNLSHNNLSGTIPPTFD 951

Query: 662  RMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSG 721
             + GL+SI++SYN+L+G +P+ KAF++A  EA + NK LCG++TGL  C     N G   
Sbjct: 952  DLRGLTSINISYNQLEGPLPNLKAFRDAPFEALRNNKGLCGNITGLEAC-----NTGKK- 1005

Query: 722  KHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKM 781
            K   F  +I+ L+    LLS +  G+ F  RR  R+     +    +Q+L +    +G+M
Sbjct: 1006 KGNKFFLLIILLILSIPLLSFISYGIYF-LRRMVRSRKINSREVATHQDLFAIWGHDGEM 1064

Query: 782  VLH---------------GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE 826
            +                 GTGG GTVYKAEL +G   AVKKLHS   GE+  + K F SE
Sbjct: 1065 LYEHIIEGTEDFNSKNCIGTGGYGTVYKAELPTGRVVAVKKLHSTQDGEMA-DLKAFKSE 1123

Query: 827  I---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
            I    EIRHRNIVK YGFCS +++ FLVYE++E+GSL  ILSN+  A E DW  R+NV+K
Sbjct: 1124 IHALAEIRHRNIVKLYGFCSCSENSFLVYEFMEKGSLRNILSNKDEAIEFDWVLRLNVVK 1183

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            G+A ALSYMHHDC PP++HRDISS  VLLD EY AHVSDFGTA+ LK DSSNW+  AGT 
Sbjct: 1184 GMAEALSYMHHDCSPPLIHRDISSNNVLLDSEYVAHVSDFGTARLLKSDSSNWTSFAGTF 1243

Query: 944  GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANM-----NIV 998
            GYIAPELAY  + + K DV++FGV+ LE I GKHPG  +S L S  + +++      +++
Sbjct: 1244 GYIAPELAYGPKVDNKTDVYSFGVVTLETIFGKHPGELISSLFSSASSSSSSPSTVYHLL 1303

Query: 999  VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +N+ ID RL PP+ +V E++   + +A  CL ANP  RPTM++VC  L
Sbjct: 1304 LNEEIDQRLSPPMNQVAEEVVVAVKLALACLHANPQSRPTMRQVCQAL 1351

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1048
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.970	0.908	0.433	1.1e-220
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.717	0.682	0.344	1.7e-154
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.827	0.829	0.379	2e-150
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.655	0.550	0.340	1.6e-145
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.527	0.491	0.369	4.3e-143
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.654	0.547	0.335	1.7e-135
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.937	0.891	0.341	1.3e-132
UNIPROTKB|P93194	1109	INRPK1 "Receptor-like protein	0.949	0.897	0.318	1.1e-126
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.952	0.888	0.316	1.1e-126
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.625	0.574	0.313	2.2e-126

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 2131 (755.2 bits), Expect = 1.1e-220, P = 1.1e-220
 Identities = 460/1062 (43%), Positives = 633/1062 (59%)

Query:     1 VVSINLTGSNLKGTXXXXXXXXXXXXAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
             +  +NLT + ++GT            AY+DLS+N L GTIP Q  +LSKL + D STN  
Sbjct:    79 IEELNLTNTGIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHL 138

Query:    61 SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPAXXXXXX 120
             +G I P +G L NL VL L  N L  +IP ELG + S+ +LALS N+L GSIP+      
Sbjct:   139 TGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLK 198

Query:   121 XXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
                                  YL     G IP +LGN+ES   ++L  N  +G IP +LG
Sbjct:   199 NLMVLYLYE-----------NYLT----GVIPPELGNMESMTDLALSQNKLTGSIPSTLG 243

Query:   181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
              LKNL  +YL  N + G IP EIGN+ S++ L L++N+L+GSIP + GNL NL  L L  
Sbjct:   244 NLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQ 303

Query:   241 NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
             N L+G IPPKLG+ +S++ L LS+N+L GS+PSS GNL +L  L+++  N L+G IP E+
Sbjct:   304 NYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYE-NYLTGVIPPEL 362

Query:   301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
             GN++S+  L L+  +L+G IP S GNL N+  LY+  N L G IP+ELG ++S+  L LS
Sbjct:   363 GNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLS 422

Query:   361 VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
              NKL GS+P   GN + L+   LR N LSG+IP  + N   L   +L  N FTG+ P+ V
Sbjct:   423 QNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETV 482

Query:   421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
             C+   L + S+  N+  GPIP+SL++C SL   R   N+ TG+I E FGIYPDL  +D S
Sbjct:   483 CKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFS 542

Query:   481 NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXX 540
             +N F GEISSNW K P+L  L M  N I+G IP+EI NMTQL +LD S+N L G++P   
Sbjct:   543 HNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAI 602

Query:   541 XXXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXXSANRLSKLIPKNLGELRKLHHLNLS 600
                              G +P              S+N  S  IP+      KLH +NLS
Sbjct:   603 GNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLS 662

Query:   601 NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
              N+F   I  ++ KL QL++LDLSHN L G IPS++ +L+SL+ ++L  N LSG IP+ F
Sbjct:   663 RNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTF 721

Query:   661 RRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTG--LPPCEALTSNKG 718
               M  L+++D+S N+L+G +P +  F+ AT +A + N  LC ++    L PC  L   K 
Sbjct:   722 EGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPK- 780

Query:   719 DSGKHMTFLFVIVPXXXXXXXXXXXXIGMCFNFRRR---KRTDSQEGQN----DVNN--- 768
              +G  + ++ V +                C   R+    + TD + G+N     V+    
Sbjct:   781 KNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFK 840

Query:   769 -QELL-SASTFEGKMVLHGTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIG--INQKGF 823
              Q+++ S + F+   ++ GTGG   VY+A L   DT  AVK+LH     EI   + ++ F
Sbjct:   841 YQDIIESTNEFDPTHLI-GTGGYSKVYRANLQ--DTIIAVKRLHDTIDEEISKPVVKQEF 897

Query:   824 VSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
             ++E+   TEIRHRN+VK +GFCSH +H FL+YEY+E+GSL  +L+N+  A  L W+KR+N
Sbjct:   898 LNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRIN 957

Query:   881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
             V+KGVA+ALSYMHHD   PI+HRDISS  +LLD +Y A +SDFGTAK LK DSSNWS +A
Sbjct:   958 VVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVA 1017

Query:   941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVN 1000
             GT GY+APE AYTM+  EKCDV++FGVL+LE+I GKHPG              ++     
Sbjct:  1018 GTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLR---- 1073

Query:  1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + D R+  P G+  EKL  M+ +A LCL ANP+ RPTM  +
Sbjct:  1074 SISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 999 (356.7 bits), Expect = 1.7e-154, Sum P(2) = 1.7e-154
 Identities = 274/795 (34%), Positives = 389/795 (48%)

Query:    38 GTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTS 97
             G + +  S   ++  L+ S+   SG + P IG L +L  L LS N L+G IP+E+G  +S
Sbjct:    63 GVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSS 122

Query:    98 LNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQDLGN 157
             L  L L+ N+ +G IP                          +   IS   GS+P ++GN
Sbjct:   123 LEILKLNNNQFDGEIPVEIGKLVSLENLII------------YNNRIS---GSLPVEIGN 167

Query:   158 LESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN 217
             L S   +  ++NN SG +PRS+G LK LT      N I GS+PSEIG   SL  LGL +N
Sbjct:   168 LLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQN 227

Query:   218 QLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGN 277
             QLSG +P   G L  L  + L +N  SG+IP ++ +  SL  L L  NQL G +P   G+
Sbjct:   228 QLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGD 287

Query:   278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
             L SL+ L+++  N L+G+IP+EIGNL     +  S+  L+G IP  LGN+  +  LY+ E
Sbjct:   288 LQSLEFLYLYR-NGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFE 346

Query:   338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
             N L G+IP EL  LK+LS+L LS+N L G IP     L  L    L +N LSG+IP ++ 
Sbjct:   347 NQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLG 406

Query:   398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
                 L    + +N  +G +P  +C   ++   ++  NN  G IP  +  C +L  LRL R
Sbjct:   407 WYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLAR 466

Query:   458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIG 517
             N L G          ++  ++L  N F G I      C  L  L +  N  +G +P EIG
Sbjct:   467 NNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIG 526

Query:   518 NMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXXSA 577
              ++QL  L+ SSN+L G++P                    G +P              S 
Sbjct:   527 MLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSN 586

Query:   578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSHNSLGGNIPSEI 636
             N LS  IP  LG L +L  L +  N F+  I  ++G L  L   L+LS+N L G IP E+
Sbjct:   587 NNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPEL 646

Query:   637 CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQG 696
              NL  LE++ L  N LSG IPS F  +  L   + SYN L G IP     +N ++ +F G
Sbjct:   647 SNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIG 703

Query:   697 NKELCGDVTGLPPCE-----ALTSNKGDSGKHMTFLFVIVPXXXXXXXXXXXXIGMCFNF 751
             N+ LCG    L  C      A + + G  G   +   + +               + +  
Sbjct:   704 NEGLCGPP--LNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLM 761

Query:   752 RRRKRT---DSQEGQN-----DV--------NNQELLSASTFEGKMVLHGTGGCGTVYKA 795
             RR  RT    +Q+GQ      D+          Q+L++A+    +  + G G CGTVYKA
Sbjct:   762 RRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKA 821

Query:   796 ELTSGDTRAVKKLHS 810
              L +G T AVKKL S
Sbjct:   822 VLPAGYTLAVKKLAS 836

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1468 (521.8 bits), Expect = 2.0e-150, P = 2.0e-150
 Identities = 346/912 (37%), Positives = 489/912 (53%)

Query:   149 GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRS 208
             G IP +LG+L +  ++ L  N  +G IP  +G L  +T + + +N + G IPS  GNL  
Sbjct:   156 GEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTK 215

Query:   209 LSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
             L  L L  N LSGSIP   GNL NL+ L L  N L+G IP   G+ K++  L +  NQL+
Sbjct:   216 LVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLS 275

Query:   269 GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
             G +P   GN+++L  L +H  NKL+G IP  +GN+K+L+ L L   QL+G IPP LG + 
Sbjct:   276 GEIPPEIGNMTALDTLSLHT-NKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEME 334

Query:   329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
             ++  L I EN L G +P+  G+L +L  L L  N+L+G IP  + N + L    L  N  
Sbjct:   335 SMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNF 394

Query:   389 SGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT 448
             +G +P  I    KL    L +N F G +P+++    SL     + N+F G I  +     
Sbjct:   395 TGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYP 454

Query:   449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEI 508
             +L  + L  N   G +S  +     L    LSNN+  G I        QL+ L++  N I
Sbjct:   455 TLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRI 514

Query:   509 SGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXX 568
             +G +P  I N+ ++ KL  + NRL G+IP                     +IP       
Sbjct:   515 TGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLP 574

Query:   569 XXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
                    S N L + IP+ L +L +L  L+LS NQ   EIS Q   L  L +LDLSHN+L
Sbjct:   575 RLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNL 634

Query:   629 GGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
              G IP    ++ +L ++++  N L GPIP      +          +L GS+       N
Sbjct:   635 SGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSV-------N 687

Query:   689 ATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPXXXXXXXXXXXXIGMC 748
              T               GL PC   +S K    +++    ++              I +C
Sbjct:   688 TT--------------QGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFIC 733

Query:   749 FNFRRRK---RTDSQEG---------QNDVNNQELLSAS-TFEGKMVLHGTGGCGTVYKA 795
             F  R ++    TDS+ G            V  QE++ A+  F+ K ++ GTGG G VYKA
Sbjct:   734 FRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLI-GTGGHGKVYKA 792

Query:   796 ELTSGDTRAVKKLHSLPTGEIG--INQKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFL 850
             +L +    AVKKL+      I     ++ F++EI   TEIRHRN+VK +GFCSH ++ FL
Sbjct:   793 KLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFL 851

Query:   851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKV 910
             VYEY+ERGSL  +L N+  A +LDW KR+NV+KGVA+ALSYMHHD  P I+HRDISS  +
Sbjct:   852 VYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNI 911

Query:   911 LLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
             LL  +Y+A +SDFGTAK LKPDSSNWS +AGT GY+APELAY M+  EKCDV++FGVL L
Sbjct:   912 LLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTL 971

Query:   971 EVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLD 1030
             EVI+G+HPG              +  + +  + D RLP P  E++E++  ++ VA LCL 
Sbjct:   972 EVIKGEHPGDLVSTLSSSPP---DATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLH 1028

Query:  1031 ANPDCRPTMQKV 1042
             ++P  RPTM  +
Sbjct:  1029 SDPQARPTMLSI 1040

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 977 (349.0 bits), Expect = 1.6e-145, Sum P(2) = 1.6e-145
 Identities = 240/704 (34%), Positives = 352/704 (50%)

Query:    29 LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
             L L+  +L G IP+Q+  L +++ L    N   G IP ++G  ++L V   + N LNG I
Sbjct:   172 LALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTI 231

Query:    89 PEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYL----- 143
             P ELG L +L  L L+ N L G IP+                     IP +   L     
Sbjct:   232 PAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQT 291

Query:   144 --ISPHY--GSIPQDLGNLESPVSVSLHTNNFSGVIPRSL-GGLKNLTFVYLNNNRIVGS 198
               +S +   G IP++  N+   + + L  N+ SG +P+S+     NL  + L+  ++ G 
Sbjct:   292 LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351

Query:   199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
             IP E+   +SL  L L+ N L+GSIP     L  L  LYLH+N L G + P + +  +L 
Sbjct:   352 IPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQ 411

Query:   259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
             +L L HN L G LP     L  L+ L ++  N+ SG IP+EIGN  SL  + +      G
Sbjct:   412 WLVLYHNNLEGKLPKEISALRKLEVLFLYE-NRFSGEIPQEIGNCTSLKMIDMFGNHFEG 470

Query:   319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNL 378
              IPPS+G L  +  L++R+N L G +P  LG    L+ L L+ N+L+GSIP   G L  L
Sbjct:   471 EIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGL 530

Query:   379 KFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVG 438
             +   L  N L G++P  + +++ L +  L  N+  G +   +C S S   F V NN F  
Sbjct:   531 EQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTI-HPLCGSSSYLSFDVTNNGFED 589

Query:   439 PIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQL 498
              IP  L N  +L  LRL +NQLTG I    G   +L LLD+S+N   G I    + C +L
Sbjct:   590 EIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKL 649

Query:   499 ATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXG 558
               +++  N +SG IP  +G ++QL +L  SSN+ V  +P                    G
Sbjct:   650 THIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNG 709

Query:   559 DIPXXXXXXXXXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQL 618
              IP                N+ S  +P+ +G+L KL+ L LS N  + EI ++IG+L  L
Sbjct:   710 SIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDL 769

Query:   619 -SKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ 677
              S LDLS+N+  G+IPS I  L  LE ++L  N+L+G +P     M  L  ++VS+N L 
Sbjct:   770 QSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLG 829

Query:   678 GSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSG 721
             G +   K F     ++F GN  LCG  + L  C  + SN    G
Sbjct:   830 GKL--KKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQG 869

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 908 (324.7 bits), Expect = 4.3e-143, Sum P(2) = 4.3e-143
 Identities = 205/555 (36%), Positives = 294/555 (52%)

Query:   149 GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRS 208
             G +P+++G+L +   +  +TNN +G +PRSLG L  LT      N   G+IP+EIG   +
Sbjct:   171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230

Query:   209 LSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
             L  LGL +N +SG +P   G L  L+ + L  N+ SG+IP  +G+  SL  L L  N L 
Sbjct:   231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290

Query:   269 GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
             G +PS  GN+ SLK L+++  N+L+G+IPKE+G L  +  +  S+  LSG IP  L  +S
Sbjct:   291 GPIPSEIGNMKSLKKLYLYQ-NQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKIS 349

Query:   329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
              +R LY+ +N L G IP EL +L++L++L LS+N L G IP    NL++++   L  N L
Sbjct:   350 ELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSL 409

Query:   389 SGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT 448
             SG IPQ +     L      ENQ +G +P  +CQ  +L   ++ +N   G IP  +  C 
Sbjct:   410 SGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCK 469

Query:   449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEI 508
             SL  LR+  N+LTG          +L  ++L  N F G +      C +L  L++  N+ 
Sbjct:   470 SLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQF 529

Query:   509 SGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXX 568
             S  +P+EI  ++ L   + SSN L G IP                    G +P       
Sbjct:   530 SSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLH 589

Query:   569 XXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSHNS 627
                    S NR S  IP  +G L  L  L +  N FS  I  Q+G L  L   ++LS+N 
Sbjct:   590 QLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYND 649

Query:   628 LGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQ 687
               G IP EI NL  L Y++L  N LSG IP+ F  +  L   + SYN L G +PH++ FQ
Sbjct:   650 FSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQ 709

Query:   688 NATIEAFQGNKELCG 702
             N T+ +F GNK LCG
Sbjct:   710 NMTLTSFLGNKGLCG 724

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 915 (327.2 bits), Expect = 1.7e-135, Sum P(2) = 1.7e-135
 Identities = 237/706 (33%), Positives = 344/706 (48%)

Query:     1 VVSINLTGSNLKGTXXXXXXXXXXXXAYLDLSVNQLFGTIPTQISHLSK-LKHLDFSTNQ 59
             ++ +NL+G  L G+             ++DLS N+L G IPT +S+LS  L+ L   +N 
Sbjct:    73 IIGLNLSGLGLTGSISPSIGRFNNLI-HIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNL 131

Query:    60 FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPAXXXXX 119
              SG IP Q+G L NL  L+L  N+LNG IPE  G L +L  LAL+  RL G IP+     
Sbjct:   132 LSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRL 191

Query:   120 XXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL 179
                                          G IP ++GN  S    +   N  +G +P  L
Sbjct:   192 VQLQTLILQDNELE---------------GPIPAEIGNCTSLALFAAAFNRLNGSLPAEL 236

Query:   180 GGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLH 239
               LKNL  + L +N   G IPS++G+L S+ YL L  NQL G IP     L+NL+ L L 
Sbjct:   237 NRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLS 296

Query:   240 DNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF-GNLSSLKHLHVHNINKLSGSIPK 298
              N L+G I  +      L +L L+ N+L+GSLP +   N +SLK L +    +LSG IP 
Sbjct:   297 SNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSE-TQLSGEIPA 355

Query:   299 EIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLS 358
             EI N +SL  L LS   L+G IP SL  L  +  LY+  N L G++   +  L +L + +
Sbjct:   356 EISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFT 415

Query:   359 LSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQ 418
             L  N L G +P  +G L  L+   L EN  SG +P EI N  +L +   + N+ +G +P 
Sbjct:   416 LYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPS 475

Query:   419 NVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLD 478
             ++ +   LT   +R N  VG IP SL NC  +  + L  NQL+G+I   FG    LEL  
Sbjct:   476 SIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFM 535

Query:   479 LSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPX 538
             + NN+  G +  + I    L  +N   N+ +G+I    G+ + L   D + N   G IP 
Sbjct:   536 IYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYL-SFDVTENGFEGDIPL 594

Query:   539 XXXXXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXXSANRLSKLIPKNLGELRKLHHLN 598
                                G IP              S N LS +IP  LG  +KL H++
Sbjct:   595 ELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHID 654

Query:   599 LSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPS 658
             L+NN  S  I   +GKL  L +L LS N   G++P+EI +L ++  + L  N L+G IP 
Sbjct:   655 LNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQ 714

Query:   659 CFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV 704
                 +  L+++++  N+L G +P +    +   E       L G++
Sbjct:   715 EIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEI 760

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1300 (462.7 bits), Expect = 1.3e-132, P = 1.3e-132
 Identities = 351/1029 (34%), Positives = 496/1029 (48%)

Query:    45 SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS 104
             +HL  +  +D +    SG + P I  L  L  L +S N ++G IP++L    SL  L L 
Sbjct:    64 THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLC 123

Query:   105 YNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPH----Y-----GSIPQDL 155
              NR +G IP                      IP   G L S      Y     G IP  +
Sbjct:   124 TNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSM 183

Query:   156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLN 215
               L     +    N FSGVIP  + G ++L  + L  N + GS+P ++  L++L+ L L 
Sbjct:   184 AKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILW 243

Query:   216 KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF 275
             +N+LSG IPP+ GN+S L+ L LH+N  +G IP ++G    +  LYL  NQL G +P   
Sbjct:   244 QNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREI 303

Query:   276 GNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
             GNL     +     N+L+G IPKE G++ +L  L L +  L G IP  LG L+ +  L +
Sbjct:   304 GNLIDAAEIDFSE-NQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDL 362

Query:   336 RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
               N L G+IP+EL  L  L  L L  N+L G IP  +G  SN     +  N LSG IP  
Sbjct:   363 SINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAH 422

Query:   396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
                 + L    L  N+ +G +P+++    SLT   + +N   G +P  L N  +L +L L
Sbjct:   423 FCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALEL 482

Query:   456 ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSE 515
              +N L+GNIS   G   +LE L L+NNNF GEI        ++   N+  N+++G IP E
Sbjct:   483 HQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKE 542

Query:   516 IGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXX 575
             +G+   + +LD S N+  G I                     G+IP              
Sbjct:   543 LGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQL 602

Query:   576 SANRLSKLIPKNLGELRKLH-HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPS 634
               N LS+ IP  LG+L  L   LN+S+N  S  I   +G L  L  L L+ N L G IP+
Sbjct:   603 GGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPA 662

Query:   635 EICNLESLEYMNLLQNKLSGPIP--SCFRRM--------HGLSSIDVSYNELQGSIPHSK 684
              I NL SL   N+  N L G +P  + F+RM        HGL +   S+   Q  +PHS 
Sbjct:   663 SIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSH--CQPLVPHSD 720

Query:   685 AFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPXXXXXXXXXXXX 744
             +  N  I   Q  K L   +T    C  + S          FL   +             
Sbjct:   721 SKLNWLINGSQRQKILT--IT----CIVIGS---------VFLITFLGLCWTIKRREPAF 765

Query:   745 IGMCFNFRRRKRTDSQEGQNDVNNQELLSAS-TFEGKMVLHGTGGCGTVYKAELTSGDTR 803
             + +    +          +     Q L+ A+  F   +VL G G CGTVYKAE++ G+  
Sbjct:   766 VALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVL-GRGACGTVYKAEMSGGEVI 824

Query:   804 AVKKLHSLPTGEIGINQ-KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT 862
             AVKKL+S   G    N  +  +S + +IRHRNIVK YGFC H     L+YEY+ +GSL  
Sbjct:   825 AVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGE 884

Query:   863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD 922
              L        LDW+ R  +  G A  L Y+HHDC P I+HRDI S  +LLD  ++AHV D
Sbjct:   885 QLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGD 944

Query:   923 FGTAKFLKPD-SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP--- 978
             FG AK +    S + S +AG+ GYIAPE AYTM+  EKCD+++FGV++LE+I GK P   
Sbjct:   945 FGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP 1004

Query:   979 -GHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRP 1037
                             NM I   ++ D+RL         ++  ++ +A  C   +P  RP
Sbjct:  1005 LEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRP 1063

Query:  1038 TMQKVCNLL 1046
             TM++V  ++
Sbjct:  1064 TMREVVAMI 1072

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)]

 Score = 1244 (443.0 bits), Expect = 1.1e-126, P = 1.1e-126
 Identities = 333/1047 (31%), Positives = 504/1047 (48%)

Query:    29 LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
             L+LS   + G    +ISHL  LK +  S N F G IP Q+G  + L  + LS N   G I
Sbjct:    73 LNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNI 132

Query:    89 PEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHY 148
             P+ LG L +L  L+L +N L G  P                           G  ++   
Sbjct:   133 PDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFT------------GNGLN--- 177

Query:   149 GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRS 208
             GSIP ++GN+    ++ L  N FSG +P SLG +  L  +YLN+N +VG++P  + NL +
Sbjct:   178 GSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLEN 237

Query:   209 LSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
             L YL +  N L G+IP    +   +  + L +N+ +G +PP LG+  SL         L+
Sbjct:   238 LVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALS 297

Query:   269 GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
             G +PS FG L+ L  L++   N  SG IP E+G  KS+  L L + QL G IP  LG LS
Sbjct:   298 GPIPSCFGQLTKLDTLYLAG-NHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLS 356

Query:   329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
              ++ L++  N L G +P  + +++SL  L L  N L+G +P  +  L  L   AL EN  
Sbjct:   357 QLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHF 416

Query:   389 SGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT 448
             +G IPQ++     L    L  N FTG++P N+C    L    +  N   G +P  L  C+
Sbjct:   417 TGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCS 476

Query:   449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEI 508
             +L  L LE N L G + + F    +L   DLS NNF G I  +      +  + +  N++
Sbjct:   477 TLERLILEENNLRGGLPD-FVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQL 535

Query:   509 SGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXX 568
             SG+IP E+G++ +L  L+ S N L G +P                    G IP       
Sbjct:   536 SGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLT 595

Query:   569 XXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
                      N  S  IP +L +  KL +L L  N  + +I   +G L  L  L+LS N L
Sbjct:   596 ELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIP-PVGALQALRSLNLSSNKL 654

Query:   629 GGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKA-FQ 687
              G +P ++  L+ LE +++  N LSG +      +  L+ I++S+N   G +P S   F 
Sbjct:   655 NGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTKFL 713

Query:   688 NATIEAFQGNKELC----GDVTGLP------PCEALTSNKGDSGKHMTFLFVIVPXXXXX 737
             N++  +F GN +LC     D    P      PC  + SN G  G     + +IV      
Sbjct:   714 NSSPTSFSGNSDLCINCPADGLACPESSILRPCN-MQSNTGKGGLSTLGIAMIV--LGAL 770

Query:   738 XXXXXXXIGMCFNFRRRKRT------DSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGT 791
                    +   F F   K++       +QEG   + N+ L +      K V+ G G  GT
Sbjct:   771 LFIICLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVI-GKGAHGT 829

Query:   792 VYKAELTSGDTRAVKKL--HSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLF 849
             +YKA L+     AVKKL    +  G + + ++  +  I ++RHRN++K   F    ++  
Sbjct:   830 IYKATLSPDKVYAVKKLVFTGIKNGSVSMVRE--IETIGKVRHRNLIKLEEFWLRKEYGL 887

Query:   850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKK 909
             ++Y Y+E GSL  IL        LDWS R N+  G A+ L+Y+H DC P I+HRDI    
Sbjct:   888 ILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMN 947

Query:   910 VLLDLEYKAHVSDFGTAKFLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGV 967
             +LLD + + H+SDFG AK L   +++   + + GT GY+APE A+T   + + DV+++GV
Sbjct:   948 ILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGV 1007

Query:   968 LVLEVIEGKH---PG-HFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL--GEVEEKLKSM 1021
             ++LE+I  K    P  +                  +  ++D  L   L    V E++   
Sbjct:  1008 VLLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEA 1067

Query:  1022 IAVAFLCLDANPDCRPTMQKVCNLLCR 1048
             +++A  C +   D RPTM+ V   L R
Sbjct:  1068 LSLALRCAEKEVDKRPTMRDVVKQLTR 1094

GO:0005524 "ATP binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0019199 "transmembrane receptor protein kinase activity" evidence=NAS

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1244 (443.0 bits), Expect = 1.1e-126, P = 1.1e-126
 Identities = 333/1052 (31%), Positives = 507/1052 (48%)

Query:    27 AYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNG 86
             A L+ + +++ G +  +I  L  L+ LD STN FSG IP  +G  T L  L LS N  + 
Sbjct:    78 ASLNFTRSRVSGQLGPEIGELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSENGFSD 137

Query:    87 LIPEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISP 146
              IP+ L  L  L  L L  N L G +P                         ++  L  P
Sbjct:   138 KIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYL-----------DYNNLTGP 186

Query:   147 HYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNL 206
                 IPQ +G+ +  V +S++ N FSG IP S+G   +L  +YL+ N++VGS+P  +  L
Sbjct:   187 ----IPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVGSLPESLNLL 242

Query:   207 RSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
              +L+ L +  N L G +   + N  NL  L L  N   G +PP LG+  SL  L +    
Sbjct:   243 GNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGN 302

Query:   267 LNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGN 326
             L+G++PSS G L +L  L++   N+LSGSIP E+GN  SL+ L L+  QL G IP +LG 
Sbjct:   303 LSGTIPSSLGMLKNLTILNLSE-NRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALGK 361

Query:   327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN 386
             L  +  L + EN   G IP E+ + +SL+QL +  N L G +P  +  +  LK   L  N
Sbjct:   362 LRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNN 421

Query:   387 ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQN 446
                G+IP  +     L +     N+ TG +P N+C    L   ++ +N   G IP S+ +
Sbjct:   422 SFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIGH 481

Query:   447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN 506
             C ++    L  N L+G + E F     L  LD ++NNF G I  +   C  L+++N+  N
Sbjct:   482 CKTIRRFILRENNLSGLLPE-FSQDHSLSFLDFNSNNFEGPIPGSLGSCKNLSSINLSRN 540

Query:   507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXX 566
               +G IP ++GN+  L  ++ S N L G +P                    G +P     
Sbjct:   541 RFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFSN 600

Query:   567 XXXXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSH 625
                      S NR S  IP+ L EL+KL  L ++ N F  EI   IG +  L   LDLS 
Sbjct:   601 WKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSG 660

Query:   626 NSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKA 685
             N L G IP+++ +L  L  +N+  N L+G + S  + +  L  +DVS N+  G IP +  
Sbjct:   661 NGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFTGPIPDNLE 719

Query:   686 FQNATI-EAFQGNKELC---------GDVTGLPPCEALTSNKGDSGKHMTFLFVIVPXXX 735
              Q  +   +F GN  LC            + L  C+  + ++         + + V    
Sbjct:   720 GQLLSEPSSFSGNPNLCIPHSFSASNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSL 779

Query:   736 XXXXXXXXXIGMCFNFRR-RKRTDS-----QEGQNDVNNQELLSASTFEGKMVLHGTGGC 789
                      + +C   R+ R   D+     +EG + + N+ L +      K  + G G  
Sbjct:   780 LVLVVVLALVFICLRRRKGRPEKDAYVFTQEEGPSLLLNKVLAATDNLNEKYTI-GRGAH 838

Query:   790 GTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGFCSHTQH 847
             G VY+A L SG   AVK+L  +    I  NQ     +  I ++RHRN++K  GF      
Sbjct:   839 GIVYRASLGSGKVYAVKRL--VFASHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDD 896

Query:   848 LFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALSYMHHDCFPPILHRDIS 906
               ++Y Y+ +GSL  +L   +     LDWS R NV  GVA+ L+Y+H+DC PPI+HRDI 
Sbjct:   897 GLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIK 956

Query:   907 SKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY-TMRANEKCDVFNF 965
              + +L+D + + H+ DFG A+ L   + + + + GT GYIAPE A+ T+R  E  DV+++
Sbjct:   957 PENILMDSDLEPHIGDFGLARLLDDSTVSTATVTGTTGYIAPENAFKTVRGRES-DVYSY 1015

Query:   966 GVLVLEVIEGKHP--GHFXXXXXX-----XXXXXXNMNI--VVNDLIDSRLPPPL--GEV 1014
             GV++LE++  K      F                 N N+  +V  ++D  L   L    +
Sbjct:  1016 GVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSL 1075

Query:  1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              E++  +  +A  C   +P  RPTM+    LL
Sbjct:  1076 REQVMQVTELALSCTQQDPAMRPTMRDAVKLL 1107

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 805 (288.4 bits), Expect = 2.2e-126, Sum P(2) = 2.2e-126
 Identities = 213/679 (31%), Positives = 317/679 (46%)

Query:   149 GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRS 208
             G IP  L  L +  ++ L++N  +G IP  +     L  + L +N + GSIP+E+G L  
Sbjct:   143 GDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSG 202

Query:   209 LSYLGLNKN-QLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL 267
             L  + +  N ++SG IP   G+ SNL  L L +  +SG +P  LG  K L  L +    +
Sbjct:   203 LEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMI 262

Query:   268 NGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNL 327
             +G +PS  GN S L  L ++  N LSGSIP+EIG L  L  L+L +  L G IP  +GN 
Sbjct:   263 SGEIPSDLGNCSELVDLFLYE-NSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNC 321

Query:   328 SNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE 387
             SN++ + +  N+L GSIP  +GRL  L +  +S NK +GSIP  + N S+L    L +N+
Sbjct:   322 SNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQ 381

Query:   388 LSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNC 447
             +SG IP E+  + KL  +  + NQ  G +P  +     L    +  N+  G IP  L   
Sbjct:   382 ISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFML 441

Query:   448 TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNE 507
              +L  L L  N L+G I +  G    L  L L  N   GEI S      ++  L+   N 
Sbjct:   442 RNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNR 501

Query:   508 ISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXX 567
             + G +P EIG+ ++L  +D S+N L G +P                    G IP      
Sbjct:   502 LHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRL 561

Query:   568 XXXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS-KLDLSHN 626
                     S N  S  IP +LG    L  L+L +N+ S EI  ++G +  L   L+LS N
Sbjct:   562 VSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSN 621

Query:   627 SLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAF 686
              L G IPS+I +L  L  ++L  N L G +      +  L S+++SYN   G +P +K F
Sbjct:   622 RLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLF 680

Query:   687 QNATIEAFQGNKELCGDVTGLPPCEALTSNKG----DSGK-HMTFLFVIVPXXXXXXXXX 741
             +  + +  +GNK+LC        C  LT  KG    D G    T    +           
Sbjct:   681 RQLSPQDLEGNKKLCSSTQD--SC-FLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVV 737

Query:   742 XXXIGMCFNFRRRKRTDSQEGQN--DVNNQEL--LSASTFEGKMVLH--------GTGGC 789
                +G     R R+  D++      +    +        F    ++         G G  
Sbjct:   738 LMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCS 797

Query:   790 GTVYKAELTSGDTRAVKKL 808
             G VY+A++ +G+  AVKKL
Sbjct:   798 GVVYRADVDNGEVIAVKKL 816

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LP24	Y1571_ARATH	2, ., 7, ., 1, 1, ., 1	0.4703	0.9694	0.9071	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh2_kg.1__3648__AT1G35710.1 annotation not avaliable (1123 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1048
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-134
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-95
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-20
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-19
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-15
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-13
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	9e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-06
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	8e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.001
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.003
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  428 bits (1102), Expect = e-134
 Identities = 289/899 (32%), Positives = 451/899 (50%), Gaps = 116/899 (12%)

Query: 101 LALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLES 160
           + LS   ++G I +++  L  +  ++LSNN LSG IP +     S              S
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS--------------S 119

Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
              ++L  NNF+G IPR  G + NL  + L+NN + G IP++IG+  SL  L L  N L 
Sbjct: 120 LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
           G IP +  NL++L+FL L  N+L G IP +LG  KSL ++YL +N L+G +P   G L+S
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237

Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENML 340
           L HL +   N L+G IP  +GNLK+L +L+L + +LSG IPPS+ +L  +  L + +N L
Sbjct: 238 LNHLDL-VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296

Query: 341 YGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMK 400
            G IPE + +L++L  L L  N   G IP  L +L  L+   L  N+ SG IP+ +    
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356

Query: 401 KLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQL 460
            L    L  N  TG +P+ +C SG+L    + +N+  G IP+SL  C SL  +RL+ N  
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416

Query: 461 TGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMT 520
           +G +   F   P +  LD+SNNN  G I+S     P L  L++  N+  G +P   G+  
Sbjct: 417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-K 475

Query: 521 QLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRL 580
           +L  LD S N+  G +P++LG L+ L  L L+ N+LSG+IP E           LS+ + 
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE-----------LSSCK- 523

Query: 581 SKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLE 640
                                            KLV L   DLSHN L G IP+    + 
Sbjct: 524 ---------------------------------KLVSL---DLSHNQLSGQIPASFSEMP 547

Query: 641 SLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKEL 700
            L  ++L QN+LSG IP     +  L  +++S+N L GS+P + AF      A  GN +L
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL 607

Query: 701 CGD--VTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRR---- 754
           CG    +GLPPC+ +           ++ F I   L    +L+LV  G  F   R     
Sbjct: 608 CGGDTTSGLPPCKRVRKTP-------SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL 660

Query: 755 KRTDSQEG-----------QNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGD-- 801
           KR ++++G              +   ++LS+   E  +     G  G  YK +       
Sbjct: 661 KRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVIS---RGKKGASYKGKSIKNGMQ 717

Query: 802 --TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS 859
              + +  ++S+P+ EI        +++ +++H NIVK  G C   +  +L++EY+E  +
Sbjct: 718 FVVKEINDVNSIPSSEI--------ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769

Query: 860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH 919
           L+ +L N      L W +R  +  G+A AL ++H  C P ++  ++S +K+++D + + H
Sbjct: 770 LSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823

Query: 920 VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +        L  D+  +   A    Y+APE   T    EK D++ FG++++E++ GK P
Sbjct: 824 LR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  324 bits (833), Expect = 2e-95
 Identities = 211/605 (34%), Positives = 298/605 (49%), Gaps = 93/605 (15%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLS-KLKHLDFSTNQ 59
           VVSI+L+G N+ G +    F L P +  ++LS NQL G IP  I   S  L++L+ S N 
Sbjct: 71  VVSIDLSGKNISGKISSAIFRL-PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129

Query: 60  FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNL 119
           F+G IP   G + NL  L LS N L+G IP ++G  +SL  L L  N L G IP SL NL
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL 179
           ++L  L+L++N L GQIP                                       R L
Sbjct: 188 TSLEFLTLASNQLVGQIP---------------------------------------REL 208

Query: 180 GGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLH 239
           G +K+L ++YL  N + G IP EIG L SL++L L  N L+G IP + GNL NL++L+L+
Sbjct: 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLY 268

Query: 240 DNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKE 299
                                                             NKLSG IP  
Sbjct: 269 Q-------------------------------------------------NKLSGPIPPS 279

Query: 300 IGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSL 359
           I +L+ L  L LS   LSG IP  +  L N+  L++  N   G IP  L  L  L  L L
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339

Query: 360 SVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQN 419
             NK +G IP  LG  +NL    L  N L+G IP+ + +   L K +LF N   G +P++
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399

Query: 420 VCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDL 479
           +    SL    +++N+F G +P        +Y L +  N L G I+      P L++L L
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459

Query: 480 SNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ 539
           + N FFG +  ++    +L  L++  N+ SG +P ++G++++L +L  S N+L G+IP +
Sbjct: 460 ARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518

Query: 540 LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNL 599
           L     L SL L+ NQLSG IP     +  L  LDLS N+LS  IPKNLG +  L  +N+
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578

Query: 600 SNNQF 604
           S+N  
Sbjct: 579 SHNHL 583

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (333), Expect = 1e-34
 Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 14/193 (7%)

Query: 785 GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G GG GTVY A       + A+K +    +       +  + EI    ++ H NIVK YG
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYG 58

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                 HL+LV EY E GSL  +L       +L   + + ++  +   L Y+H +    I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 901 LHRDISSKKVLLD-LEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANE 958
           +HRD+  + +LLD    K  ++DFG +K L  D S    + GT  Y+APE L      +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 959 KCDVFNFGVLVLE 971
           K D+++ GV++ E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  130 bits (329), Expect = 1e-33
 Identities = 74/269 (27%), Positives = 114/269 (42%), Gaps = 29/269 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G+G  GTVYKA    +G   AVK L      E     +    EI     + H NIV+   
Sbjct: 8    GSGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                  HL+LV EY E G L   LS       L   +   +   +   L Y+H +    I
Sbjct: 66   AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL-----AYTMR 955
            +HRD+  + +LLD      ++DFG AK L   SS+ +   GT  Y+APE+      Y   
Sbjct: 120  IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG-- 177

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
               K DV++ GV++ E++ GK P  F            +   ++  ++   L     +  
Sbjct: 178  --PKVDVWSLGVILYELLTGKPP--FSG------ENILDQLQLIRRILGPPLEFDEPKWS 227

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
               +    +   CL+ +P  RPT +++  
Sbjct: 228  SGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (326), Expect = 3e-33
 Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 29/266 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VY A +  +G   A+K +      +I  +++  + EI    +++H NIV+ Y 
Sbjct: 8    GEGSFGKVYLARDKKTGKLVAIKVIKK---KKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L+LV EY E G L  +L      +E D ++    ++ + +AL Y+H      I
Sbjct: 65   VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEARF--YLRQILSALEYLHSKG---I 118

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRD+  + +LLD +    ++DFG A+ L P     +   GT  Y+APE+       +  
Sbjct: 119  VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKAV 177

Query: 961  DVFNFGVLVLEVIEGKHP--GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018
            D+++ GV++ E++ GK P  G    L L           +         PPP  ++  + 
Sbjct: 178  DIWSLGVILYELLTGKPPFPGDDQLLEL--------FKKIGKPKPP--FPPPEWDISPEA 227

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044
            K +I      L  +P+ R T ++   
Sbjct: 228  KDLI---RKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (319), Expect = 2e-32
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 56/284 (19%)

Query: 785  GTGGCGTVYKAELT--SGDTR---AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
            G G  G VYK +L    G  +   AVK L    + +     + F+ E     ++ H N+V
Sbjct: 8    GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ---QIEEFLREARIMRKLDHPNVV 64

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            K  G C+  + L++V EY+E G L + L       +L  S  ++    +A  + Y+    
Sbjct: 65   KLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN----------WSELAGTCGYI 946
                +HRD++++  L+       +SDFG ++ L  D             W         +
Sbjct: 122  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW---------M 170

Query: 947  APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-PAANMNI--VVNDLI 1003
            APE     +   K DV++FGVL+ E             + +L   P   M+   V+  L 
Sbjct: 171  APESLKEGKFTSKSDVWSFGVLLWE-------------IFTLGEQPYPGMSNEEVLEYLK 217

Query: 1004 D-SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +  RLP P          +  +   C   +P+ RPT  ++  +L
Sbjct: 218  NGYRLPQP----PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  126 bits (318), Expect = 3e-32
 Identities = 69/279 (24%), Positives = 107/279 (38%), Gaps = 45/279 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
            G G  G VYK  L           AVK L            + F+ E     ++ H NIV
Sbjct: 8    GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKLDHPNIV 64

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            K  G C+  + L +V EY+  G L   L       EL  S  ++    +A  + Y+    
Sbjct: 65   KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESK- 122

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELA 951
                +HRD++++  L+       +SDFG ++ L  D           G +     APE  
Sbjct: 123  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD----DYYKVKGGKLPIRWMAPESL 176

Query: 952  YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-PAANMNI--VVNDLID-SRL 1007
               +   K DV++FGVL+ E+              +L   P   M+   V+  L    RL
Sbjct: 177  KEGKFTSKSDVWSFGVLLWEI-------------FTLGEEPYPGMSNAEVLEYLKKGYRL 223

Query: 1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P P          +  +   C   +P+ RPT  ++  +L
Sbjct: 224  PKP----PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  120 bits (303), Expect = 3e-30
 Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 53/278 (19%)

Query: 790  GTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G VYK  L           AVK L    + E    ++ F+ E     ++ H NIV+  G 
Sbjct: 13   GEVYKGTLKGDGEGTETKVAVKTLKEGASEE---EREEFLEEASIMKKLSHPNIVRLLGV 69

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPI 900
            C+  + L++V EY+  G L   L       +L     + +   +A  + Y+   +     
Sbjct: 70   CTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESKNF---- 123

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYTMR 955
            +HRD++++  L+       +SDFG ++ +  D           G +     APE     +
Sbjct: 124  VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPESLKDGK 180

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-PAANM-NIVVNDLIDS--RLPPPL 1011
               K DV++FGVL+ E             + +L   P   M N  V +L++   RLP P 
Sbjct: 181  FTSKSDVWSFGVLLWE-------------IFTLGEQPYPGMSNEEVLELLEDGYRLPRPE 227

Query: 1012 G---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                E+ E +         C   +P+ RPT  ++   L
Sbjct: 228  NCPDELYELMLQ-------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 4e-29
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 42/281 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVK 837
            G G  G VYK +L   D +    AVK L    + E    +K F+ E     ++ H N+V+
Sbjct: 4    GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVR 60

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV------IKGVANALSY 891
              G C+  + L+LV EY+E G L   L              +++         +A  + Y
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI----- 946
            +        +HRD++++  L+  +    +SDFG ++ +  D         T G +     
Sbjct: 121  LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY---RKKTGGKLPIRWM 174

Query: 947  APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID-S 1005
            APE         K DV++FGVL+ E+            L + P P  +   V+  L    
Sbjct: 175  APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVLEYLRKGY 224

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            RLP P    +E    +  +   C   +P+ RPT  ++   L
Sbjct: 225  RLPKPEYCPDE----LYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  114 bits (287), Expect = 3e-28
 Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 46/268 (17%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G GG G VYKA    +G   A+K +  L + E    ++  ++EI    + +H NIVK+YG
Sbjct: 9    GKGGFGEVYKARHKRTGKEVAIKVIK-LESKE---KKEKIINEIQILKKCKHPNIVKYYG 64

Query: 841  FCSHTQHLFLVYEYLERGSLATILS------NEATAAELDWSKRVNVIKGVANALSYMH- 893
                   L++V E+   GSL  +L        E+  A         V K +   L Y+H 
Sbjct: 65   SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--------VCKELLKGLEYLHS 116

Query: 894  -HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY 952
                   I+HRDI +  +LL  + +  + DFG +  L  D+   + + GT  ++APE+  
Sbjct: 117  NG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVIN 170

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012
                + K D+++ G+  +E+ EGK P         LP   A   I  N       PP L 
Sbjct: 171  GKPYDYKADIWSLGITAIELAEGKPPYS------ELPPMKALFKIATNG------PPGL- 217

Query: 1013 EVEEKLKSMIAVAFL--CLDANPDCRPT 1038
                +  S     FL  CL  NP+ RPT
Sbjct: 218  -RNPEKWSDEFKDFLKKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  110 bits (277), Expect = 8e-27
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 48/277 (17%)

Query: 779  GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRN 834
            G+++  G G  G+VY A +  +G+  AVK +      E  +       EI   + ++H N
Sbjct: 5    GELL--GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA--LEREIRILSSLQHPN 60

Query: 835  IVKFYGFCSHTQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN--- 887
            IV++YG     +     +FL  EY+  GSL+++L       E        VI+       
Sbjct: 61   IVRYYGSERDEEKNTLNIFL--EYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQIL 111

Query: 888  -ALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE--LAGTC 943
              L+Y+H +     I+HRDI    +L+D +    ++DFG AK L    +      + GT 
Sbjct: 112  EGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167

Query: 944  GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
             ++APE+          D+++ G  V+E+  GK P   L           N    +  + 
Sbjct: 168  YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL----------GNPMAALYKIG 217

Query: 1004 DSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPT 1038
             S  PP + E      S  A  FL  CL  +P  RPT
Sbjct: 218  SSGEPPEIPE----HLSEEAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  105 bits (265), Expect = 6e-25
 Identities = 74/266 (27%), Positives = 121/266 (45%), Gaps = 38/266 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VYKA +  +G   A+KK+          N++  ++EI    + +H NIV +Y 
Sbjct: 28   GEGASGEVYKATDRATGKEVAIKKMRLR-----KQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 841  FCSHTQHLFLVYEYLERGSLATILS------NEATAAELDWSKRVNVIKGVANALSYMHH 894
                   L++V EY++ GSL  I++      NE   A         V + V   L Y+H 
Sbjct: 83   SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA--------YVCREVLQGLEYLHS 134

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                 ++HRDI S  +LL  +    ++DFG A  L  + S  + + GT  ++APE+    
Sbjct: 135  Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
                K D+++ G++ +E+ EG+ P       L  P P   +      LI ++  PPL   
Sbjct: 192  DYGPKVDIWSLGIMCIEMAEGEPP------YLREP-PLRALF-----LITTKGIPPLKNP 239

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
            E+           CL  +P+ RP+ +
Sbjct: 240  EKWSPEFKDFLNKCLVKDPEKRPSAE 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 6e-25
 Identities = 75/269 (27%), Positives = 124/269 (46%), Gaps = 36/269 (13%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  G VYK   L +GD  A+K+  L  +    +    K  + EI     ++H NIVK+
Sbjct: 9    GRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL----KSIMQEIDLLKNLKHPNIVKY 64

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGVANALSYMHHDCF 897
             G    +  L+++ EY E GSL  I+       E   +  V  V++G    L+Y+H    
Sbjct: 65   IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLHEQ-- 118

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
              ++HRDI +  +L   +    ++DFG A  L   S + + + GT  ++APE+     A+
Sbjct: 119  -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
               D+++ G  V+E++ G  P + L        P A +  +V D      PP    +  +
Sbjct: 178  TASDIWSLGCTVIELLTGNPPYYDL-------NPMAALFRIVQD----DHPPLPEGISPE 226

Query: 1018 LKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
            LK      FL  C   +P+ RPT +++  
Sbjct: 227  LKD-----FLMQCFQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  103 bits (258), Expect = 3e-22
 Identities = 52/119 (43%), Positives = 75/119 (63%)

Query: 25  QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQL 84
           +L  LDLS NQ  G +P ++  LS+L  L  S N+ SG IP ++     LV L LS NQL
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535

Query: 85  NGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYL 143
           +G IP    E+  L++L LS N+L+G IP +LGN+ +LVQ+++S+N L G +P    +L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594

Length = 968

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 93.3 bits (233), Expect = 6e-21
 Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 52/280 (18%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  G VY     + G    +K+  L ++   E    ++  ++E+    ++ H NI+K+
Sbjct: 9    GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKLNHPNIIKY 64

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAE-------LDWSKRVNVIKGVANALSY 891
            Y        L +V EY + G L+  +  +    +       LDW  ++        AL Y
Sbjct: 65   YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKY 118

Query: 892  MH--HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-CG---Y 945
            +H        ILHRDI  + + L       + DFG +K L    S+  +LA T  G   Y
Sbjct: 119  LHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKTVVGTPYY 169

Query: 946  IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
            ++PEL      N K D+++ G ++ E+   KHP  F            N+  +   ++  
Sbjct: 170  LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--FE---------GENLLELALKILKG 218

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045
            + PP   +   +L++++      L  +P+ RP++ ++   
Sbjct: 219  QYPPIPSQYSSELRNLV---SSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.8 bits (233), Expect = 8e-21
 Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+K+  L   P  E+ IN+   +  + E +H NIV +   
Sbjct: 28  GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE---ILVMRENKHPNIVNYLDS 84

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E++EG+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 54/277 (19%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVK---------KLHSLPTGEIGINQKGFVSEITEIRHRN 834
            G G  G VY A  L +G+  AVK         K       E+ +        +  ++H N
Sbjct: 9    GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKV--------LELLKHPN 60

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN----ALS 890
            +VK+YG   H + +++  EY   G+L  +L +     E       +VI+         L+
Sbjct: 61   LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE-------HVIRVYTLQLLEGLA 113

Query: 891  YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE----LAGTCGYI 946
            Y+H      I+HRDI    + LD      + DFG A  LK +++   E    LAGT  Y+
Sbjct: 114  YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 947  APELAYTMRANEK---CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
            APE+    +        D+++ G +VLE+  GK P   L              I+ +  +
Sbjct: 171  APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD---------NEFQIMFH--V 219

Query: 1004 DSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPT 1038
             +   PP+ +  +   S     FL  CL+++P  RPT
Sbjct: 220  GAGHKPPIPDSLQ--LSPEGKDFLDRCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQ-KGFVSEITEIRHRNIVKFYGFC 842
            G G    VY A  L + +  A+K++  L   +  +++ +  V  +++  H N+VK+Y   
Sbjct: 10   GVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 843  SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILH 902
                 L+LV  YL  GSL  I+ +      LD +    V+K V   L Y+H +     +H
Sbjct: 69   VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIH 125

Query: 903  RDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE----LAGTCGYIAPELAYTMRA-N 957
            RDI +  +LL  +    ++DFG +  L        +      GT  ++APE+   +   +
Sbjct: 126  RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
             K D+++FG+  +E+  G  P          P     M  + ND      PP L    + 
Sbjct: 186  FKADIWSFGITAIELATGAAPYS------KYPPMKVLMLTLQND------PPSLETGADY 233

Query: 1018 ------LKSMIAVAFLCLDANPDCRPTMQK 1041
                   + MI+   LCL  +P  RPT ++
Sbjct: 234  KKYSKSFRKMIS---LCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 67/259 (25%), Positives = 113/259 (43%), Gaps = 24/259 (9%)

Query: 785  GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYG 840
            G G  G VYK     +G   A+KK+H     E    +K  + E+  +R      +VK YG
Sbjct: 10   GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCESPYVVKCYG 66

Query: 841  -FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             F    + + +V EY++ GSLA +L       E   +    + + +   L Y+H      
Sbjct: 67   AFYKEGE-ISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHTK--RH 120

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
            I+HRDI    +L++ + +  ++DFG +K L+      +   GT  Y++PE       +  
Sbjct: 121  IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019
             D+++ G+ +LE   GK P  FL      P+    M  + +         P  E   + +
Sbjct: 181  ADIWSLGLTLLECALGKFP--FLPPG--QPSFFELMQAICD---GPPPSLPAEEFSPEFR 233

Query: 1020 SMIAVAFLCLDANPDCRPT 1038
              I+    CL  +P  RP+
Sbjct: 234  DFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 83/274 (30%), Positives = 131/274 (47%), Gaps = 37/274 (13%)

Query: 783  LHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGIN---QKGFV----SEITEIR--- 831
            L G G  G VY A  +T+G+  AVK++  LP    G +   QK  V    SEI  ++   
Sbjct: 8    LIGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALS 890
            H NIV++ GF +  ++L +  EY+  GS+ + L       E L       V++G    L+
Sbjct: 67   HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LA 122

Query: 891  YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA--GTCGYIAP 948
            Y+H      ILHRD+ +  +L+D +    +SDFG +K       N   ++  G+  ++AP
Sbjct: 123  YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 949  ELAYTMRA--NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
            E+ ++     + K D+++ G +VLE+  G+ P           A AA     +  L + R
Sbjct: 180  EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAIAA-----MFKLGNKR 228

Query: 1007 LPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPT 1038
              PP+        S +A+ FL  C   NPD RPT
Sbjct: 229  SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.3 bits (226), Expect = 6e-20
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTV+ A ++ +G   A+K+  L   P  E+ IN+   +  + E+++ NIV F   
Sbjct: 28  GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE---ILVMKELKNPNIVNFLDS 84

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 LF+V EYL  GSL  ++    T   +D ++   V +    AL ++H +    ++
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  VLL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E++EG+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 21/214 (9%)

Query: 780 KMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQK--------GFVSEITEI 830
           K  L G+G  G+VY     +SG+  AVK++          ++K          ++ + E+
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
           +H NIV++ G      HL +  EY+  GS+A +L+N     E   +   N ++ +   L+
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLN 120

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCG 944
           Y+H+     I+HRDI    +L+D +    +SDFG +K L+ +S +         L G+  
Sbjct: 121 YLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++APE+        K D+++ G LV+E++ GKHP
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 89.0 bits (220), Expect = 3e-19
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+++  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 85

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E+IEG+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 45/275 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G+G  G V+  +       A+K +      E  +++  F+ E   + ++ H N+V+ YG 
Sbjct: 13   GSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 842  CSHTQHLFLVYEYLERGSLATILSN----EATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            C+  + +F+V EY+  G L   L        T   LD      +   V  A+ Y+  + F
Sbjct: 68   CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD------MCSDVCEAMEYLESNGF 121

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTM 954
               +HRD++++  L+  +    VSDFG A+++  D    S+  GT     +  PE+    
Sbjct: 122  ---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKWAPPEVFDYS 176

Query: 955  RANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
            R + K DV++FGVL+ EV  EGK P    S          N  +V +     RL  P   
Sbjct: 177  RFSSKSDVWSFGVLMWEVFSEGKMPYERFS----------NSEVVESVSAGYRLYRP--- 223

Query: 1014 VEEKLKSM--IAVAFLCLDANPDCRPTMQKVCNLL 1046
               KL       + + C    P+ RP  +K+ + L
Sbjct: 224  ---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G G  G VYK  L      AVK   S    ++   ++ F+ E     +  H NIVK  G 
Sbjct: 4    GKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL---KRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C   Q +++V E +  GSL T L  +     L   K + +    A  + Y+        +
Sbjct: 61   CVQKQPIYIVMELVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYIAPELAYTMRAN 957
            HRD++++  L+       +SDFG ++  + +   ++   G       + APE     R  
Sbjct: 116  HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVE 1015
             + DV+++G+L+ E                 P P  + N    + I+S  R+P P    E
Sbjct: 174  SESDVWSYGILLWETFSLG----------DTPYPGMS-NQQTRERIESGYRMPAPQLCPE 222

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            E  + M+     C   +P+ RP+  ++ N L
Sbjct: 223  EIYRLML----QCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 90.6 bits (225), Expect = 1e-18
 Identities = 44/89 (49%), Positives = 55/89 (61%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
           L L    L G IP  IS L  L+ ++ S N   G IPP +G +T+L VL LS N  NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 89  PEELGELTSLNELALSYNRLNGSIPASLG 117
           PE LG+LTSL  L L+ N L+G +PA+LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 25/257 (9%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLH-SLPTGEIGINQK--GFVSEITEIRHRNIVKFYG 840
            G G  G VY+   + +G   A+K ++   P  ++   Q+    +S++ + +  NI K+YG
Sbjct: 10   GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYG 69

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L+++ EY E GS+ T++     A  +       +I+ V  AL Y+H      +
Sbjct: 70   SYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV---GV 122

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA-NEK 959
            +HRDI +  +L+       + DFG A  L  +SS  S   GT  ++APE+    +  + K
Sbjct: 123  IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK 182

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019
             D+++ G+ + E+  G  P         + A  A M      LI    PP L E     K
Sbjct: 183  ADIWSLGITIYEMATGNPP------YSDVDAFRAMM------LIPKSKPPRL-EDNGYSK 229

Query: 1020 SMIAVAFLCLDANPDCR 1036
             +      CLD  P  R
Sbjct: 230  LLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 87.1 bits (215), Expect = 1e-18
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+K+  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 28  GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 84

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E++EG+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.6 bits (218), Expect = 2e-18
 Identities = 70/269 (26%), Positives = 109/269 (40%), Gaps = 22/269 (8%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVKFYG 840
            G G  G VY A        A+K L            + F+ EI  +       NIVK Y 
Sbjct: 9    GEGSFGEVYLARDR--KLVALKVLAK-KLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            F      L+LV EY++ GSL  +L        L  S+ + ++  + +AL Y+H      I
Sbjct: 66   FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122

Query: 901  LHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSN------WSELAGTCGYIAPELAYT 953
            +HRDI  + +LLD +     + DFG AK L    S        S   GT GY+APE+   
Sbjct: 123  IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 954  M---RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
            +    A+   D+++ G+ + E++ G  P        +       +  +    + S L P 
Sbjct: 183  LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTM 1039
                E   K+   +    L  +P  R + 
Sbjct: 243  NP--ELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 68/265 (25%), Positives = 113/265 (42%), Gaps = 29/265 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  GTV K    + G     K++   ++   E    ++  VSE+    E++H NIV++
Sbjct: 9    GKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRY 64

Query: 839  YG--FCSHTQHLFLVYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALSYMHH- 894
            Y        Q L++V EY E G LA ++   +     ++      ++  +  AL   H+ 
Sbjct: 65   YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 895  -DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
             D    +LHRD+    + LD      + DFG AK L  DSS      GT  Y++PE    
Sbjct: 125  SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH 184

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
            M  +EK D+++ G L+ E+     P             A N   + + + + +       
Sbjct: 185  MSYDEKSDIWSLGCLIYELCALSPPFT-----------ARNQLQLASKIKEGKFRRIPYR 233

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPT 1038
               +L  +I      L+ +PD RP+
Sbjct: 234  YSSELNEVIK---SMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 89.5 bits (222), Expect = 4e-18
 Identities = 41/89 (46%), Positives = 52/89 (58%)

Query: 477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQI 536
           L L N    G I ++  K   L ++N+ GN I G IP  +G++T L  LD S N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 537 PKQLGKLTSLTSLTLNGNQLSGDIPLELG 565
           P+ LG+LTSL  L LNGN LSG +P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 33/267 (12%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------RHRNIVK 837
            G G  G+VYKA    +G   A+K +   P  E           I EI          IVK
Sbjct: 12   GEGSYGSVYKAIHKETGQVVAIKVV---PVEE------DLQEIIKEISILKQCDSPYIVK 62

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            +YG       L++V EY   GS++ I+  + T   L   +   ++      L Y+H    
Sbjct: 63   YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
               +HRDI +  +LL+ E +A ++DFG +  L    +  + + GT  ++APE+   +  N
Sbjct: 118  NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
             K D+++ G+  +E+ EGK P         +      M  +   +I ++ PP L + E+ 
Sbjct: 178  NKADIWSLGITAIEMAEGKPP------YSDIHP----MRAIF--MIPNKPPPTLSDPEKW 225

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                      CL  +P+ RP+  ++  
Sbjct: 226  SPEFNDFVKKCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 30/260 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G+G  G V++    +    A+K L S    +  + Q+ F  E+     +RH++++  +  
Sbjct: 15   GSGYFGEVWEGLWKNRVRVAIKILKS----DDLLKQQDFQKEVQALKRLRHKHLISLFAV 70

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            CS  + ++++ E +E+GSL   L +      L  +  +++   VA  ++Y+        +
Sbjct: 71   CSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ---NSI 126

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
            HRD++++ +L+  +    V+DFG A+ +K D    S+      + APE A     + K D
Sbjct: 127  HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186

Query: 962  VFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVEEKL 1018
            V++FG+L+ E+   G+           +P P  N N  V D I +  R+P P    +E  
Sbjct: 187  VWSFGILLYEMFTYGQ-----------VPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIY 234

Query: 1019 KSMIAVAFLCLDANPDCRPT 1038
            K M+     C  A P+ RP+
Sbjct: 235  KIMLE----CWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 31/269 (11%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR----NIVKFY 839
            G G  G V K     +G   AVK +       I   QK  + E+ +I H+     IV FY
Sbjct: 10   GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI---QKQILREL-DILHKCNSPYIVGFY 65

Query: 840  GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
            G   +   + +  EY++ GSL  IL             ++ V   V   L+Y+H      
Sbjct: 66   GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKH--K 121

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE----LAYTMR 955
            I+HRD+    +L++   +  + DFG +  L    +      GT  Y+APE      Y+++
Sbjct: 122  IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVK 179

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
            +    D+++ G+ ++E+  G+ P  +             +  +VN+      PPP     
Sbjct: 180  S----DIWSLGLSLIELATGRFP--YPPENDPPDGIFELLQYIVNE------PPPRLPSG 227

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            +          LCL  +P  RP+ +++  
Sbjct: 228  KFSPDFQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 70/277 (25%), Positives = 114/277 (41%), Gaps = 30/277 (10%)

Query: 785  GTGGCGTVYKA--ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFY 839
            G G  G V     +    +T     + SL       ++  F  EI  +R   H NIVK+ 
Sbjct: 13   GEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYK 72

Query: 840  GFC--SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            G C     + L L+ EYL  GSL   L  +    +++  + +     +   + Y+     
Sbjct: 73   GVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGSQ-- 128

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTM 954
               +HRD++++ +L++ E    +SDFG AK L  D   +           + APE   T 
Sbjct: 129  -RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 955  RANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIV---VNDLIDS-RLPP 1009
            + +   DV++FGV + E+   G       +  L +   A    IV   +  L +  RLP 
Sbjct: 188  KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247

Query: 1010 PLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043
            P     EV + +K       LC +A P  RP+   + 
Sbjct: 248  PPSCPDEVYDLMK-------LCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.1 bits (203), Expect = 5e-17
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + ++G   AVKK  L      E+  N+   V  + + +H NIV+ Y  
Sbjct: 28  GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE---VVIMRDYQHPNIVEMYS- 83

Query: 842 CSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
            S+     L++V E+LE G+L  I+    T   ++  +   V   V  ALS++H      
Sbjct: 84  -SYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQ---G 135

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APE+   +    +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195

Query: 960 CDVFNFGVLVLEVIEGKHPGHF 981
            D+++ G++V+E+++G+ P +F
Sbjct: 196 VDIWSLGIMVIEMVDGE-PPYF 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 67/262 (25%), Positives = 110/262 (41%), Gaps = 34/262 (12%)

Query: 785  GTGGCGTVYKAELTS-GDTRAVKK--LHSLPTGEIGINQKGFVSE---ITEIRHRNIVKF 838
            G G  G V+K    +     A+K+  L  +   E    ++  + E   + ++    I+++
Sbjct: 9    GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE----REEAIDEARVLAKLDSSYIIRY 64

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYMHHD 895
            Y        L +V EY E G L  +L  +       +  W   + ++ G    L+++H  
Sbjct: 65   YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHSK 120

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
                ILHRDI S  + LD      + D G AK L  +++  + + GT  Y++PEL     
Sbjct: 121  ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
             NEK DV+  GV++ E   GKH           P  A N   ++  +I    PP      
Sbjct: 178  YNEKSDVWALGVVLYECCTGKH-----------PFDANNQGALILKIIRGVFPPVSQMYS 226

Query: 1016 EKLKSMIAVAFLCLDANPDCRP 1037
            ++L  +I     CL  +   RP
Sbjct: 227  QQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A E  SG   AVK   L      E+  N+   V  + + +H+N+V+ Y  
Sbjct: 30  GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNE---VVIMRDYQHQNVVEMYKS 86

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
               + L+++ E+L+ G+L  I+S       L+  +   V + V  AL Y+H      ++
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVI 139

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL L+ +  +SDFG    +  D      L GT  ++APE+        + D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 35/268 (13%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR------HRNIVK 837
            GTG   + Y+A ++ +G   AVK++ +         ++   +   EIR      H +I++
Sbjct: 9    GTGAFSSCYQARDVKTGTLMAVKQV-TYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G      H  L  E++  GS++ +LS      E   +  +N  + +   LSY+H +  
Sbjct: 68   MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 898  PPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSE----LAGTCGYIAPELAY 952
              I+HRD+    +L+D    +  ++DFG A  L    +   E    L GT  ++APE+  
Sbjct: 123  -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHP--GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
              +    CDV++ G +++E+   K P      S  L+L    A+              P 
Sbjct: 182  GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----------APS 231

Query: 1011 LGEVEEKLKSMIA-VAFLCLDANPDCRP 1037
               + E L   +  V   CL+  P+ RP
Sbjct: 232  ---IPEHLSPGLRDVTLRCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 71/264 (26%), Positives = 112/264 (42%), Gaps = 32/264 (12%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G VYKA ++ +G+  A+K +   P  +  I Q+    EI+   E RH NIV ++G
Sbjct: 12   GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ----EISMLKECRHPNIVAYFG 67

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L++V EY   GSL  I     T   L   +   V +     L+Y+H       
Sbjct: 68   SYLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLHET---GK 122

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA---YTMRAN 957
            +HRDI    +LL  +    ++DFG +  L    +      GT  ++APE+A        +
Sbjct: 123  IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182

Query: 958  EKCDVFNFGVLVLEVIEGKHPG---HFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
             KCD++  G+  +E+ E + P    H +  L  +                +  PP L + 
Sbjct: 183  GKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-------------KSNFPPPKLKDK 229

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPT 1038
            E+           CL  +P  RPT
Sbjct: 230  EKWSPVFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 81.4 bits (201), Expect = 1e-15
 Identities = 41/80 (51%), Positives = 51/80 (63%)

Query: 62  GIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSN 121
           G IP  I  L +L  + LS N + G IP  LG +TSL  L LSYN  NGSIP SLG L++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 122 LVQLSLSNNSLSGQIPPNWG 141
           L  L+L+ NSLSG++P   G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 43/266 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G+G  G V+  +  +    A+K ++     E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 13   GSGQFGVVHLGKWRAQIKVAIKAIN-----EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C+  + L++V E++E G L   L       +L     +++ + V   + Y+  + F   +
Sbjct: 68   CTQQKPLYIVTEFMENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNSF---I 122

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG------YIAPELAYTMR 955
            HRD++++  L+       VSDFG  +++  D     E   + G      +  PE+    +
Sbjct: 123  HRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSK 177

Query: 956  ANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
             + K DV++FGVL+ EV  EGK P  F           +N  +V       RL  P    
Sbjct: 178  YSSKSDVWSFGVLMWEVFTEGKMP--F--------EKKSNYEVVEMISRGFRLYRP---- 223

Query: 1015 EEKLKSMI--AVAFLCLDANPDCRPT 1038
              KL SM    V + C    P+ RPT
Sbjct: 224  --KLASMTVYEVMYSCWHEKPEGRPT 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 51/276 (18%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V   +   G   AVK L      +    Q  F++E   +T +RH N+V+  G 
Sbjct: 15   GKGEFGDVMLGDY-RGQKVAVKCLKD----DSTAAQA-FLAEASVMTTLRHPNLVQLLGV 68

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                  L++V EY+ +GSL   L +   A  +  ++++     V   + Y+    F   +
Sbjct: 69   VLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKNF---V 124

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSS----NWSELAGTCGYIAPELAYTMR 955
            HRD++++ VL+  +  A VSDFG AK      DS      W+         APE     +
Sbjct: 125  HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT---------APEALREKK 175

Query: 956  ANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-RLPPPLG- 1012
             + K DV++FG+L+ E+   G+           +P P   +  VV  +    R+  P G 
Sbjct: 176  FSTKSDVWSFGILLWEIYSFGR-----------VPYPRIPLKDVVPHVEKGYRMEAPEGC 224

Query: 1013 --EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              EV + +K        C + +P  RPT +++   L
Sbjct: 225  PPEVYKVMKD-------CWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 48/279 (17%)

Query: 785  GTGGCGTVYKAELTSGDT-RAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYG 840
            G G  G+V K  L +     A+K + + P  ++   QK  + E+   +      IVK+YG
Sbjct: 10   GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL---QKQILRELEINKSCKSPYIVKYYG 66

Query: 841  FC--SHTQHLFLVYEYLERGSLATI----LSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                  +  + +  EY E GSL +I            E    K   + + V   LSY+H 
Sbjct: 67   AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK---IAESVLKGLSYLHS 123

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE----L 950
                 I+HRDI    +LL  + +  + DFG +  L   +S      GT  Y+APE     
Sbjct: 124  R---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGK 178

Query: 951  AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
             Y++      DV++ G+ +LEV + + P  F         P   ++ +VN      +P P
Sbjct: 179  PYSIT----SDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELLSYIVN------MPNP 226

Query: 1011 LGEVEEK--------LKSMIAVAFLCLDANPDCRPTMQK 1041
              + E           K  I     CL+ +P  RPT   
Sbjct: 227  ELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 31/276 (11%)

Query: 785  GTGGCGTVYKAELTSGDTR--AVKK--LHSLPTG----EIGINQKGFVSEIT----EIRH 832
            G+G  G VYK    +      A+K+  +H+   G    E   +    VSE+T    ++RH
Sbjct: 9    GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68

Query: 833  RNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGVANALSY 891
             NIV++Y        L++V + +E   L    ++     +    +R+ N+   +  AL Y
Sbjct: 69   PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA 951
            +H +    I+HRD++   ++L  + K  ++DFG AK  K   S  + + GT  Y  PE+ 
Sbjct: 129  LHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCPEIV 185

Query: 952  YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP-P 1010
                  EK DV+ FG ++ ++             L  P  + NM  +   ++++   P P
Sbjct: 186  KNEPYGEKADVWAFGCILYQMCT-----------LQPPFYSTNMLSLATKIVEAVYEPLP 234

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             G   E +  +I     CL  + + RP + +V  ++
Sbjct: 235  EGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 79.9 bits (197), Expect = 4e-15
 Identities = 57/192 (29%), Positives = 78/192 (40%), Gaps = 38/192 (19%)

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNI 632
           L L    L   IP ++ +LR L  +NLS N     I   +G +  L  LDLS+NS  G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 633 PSEICNLESLEYMNLLQNKLSGPIPSCF--RRMHGLSSIDVSYNELQGSIPHSKAFQNAT 690
           P  +  L SL  +NL  N LSG +P+    R +H       S+N                
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR-----ASFN---------------- 521

Query: 691 IEAFQGNKELCGDVTGLPPCEALTSNKGDSGKHMTFLFVIVPLLSG-AFLLSLVLIGMCF 749
              F  N  LCG + GL  C          G H++    I          L LV+  MC+
Sbjct: 522 ---FTDNAGLCG-IPGLRAC----------GPHLSVGAKIGIAFGVSVAFLFLVICAMCW 567

Query: 750 NFRRRKRTDSQE 761
             RR+    +Q 
Sbjct: 568 WKRRQNILRAQR 579

Length = 623

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.0 bits (189), Expect = 4e-15
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 29  GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 85

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.6 bits (188), Expect = 5e-15
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A E  +G   AVKK  L      E+  N+   V  + +  H N+V  Y  
Sbjct: 31  GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNE---VVIMRDYHHENVVDMYNS 87

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALSY+H+     ++
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APE+   +    + D
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+I+G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 64/276 (23%), Positives = 126/276 (45%), Gaps = 40/276 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQK-GFVSEIT---EIRHRNIV 836
            G G  G V +  L     +    A+K L +  +      Q+  F++E +   +  H NI+
Sbjct: 13   GGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD----KQRLDFLTEASIMGQFDHPNII 68

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +  G  + ++ + ++ EY+E GSL   L       +    + V +++G+A+ + Y+    
Sbjct: 69   RLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG--YIAPELAYTM 954
            +   +HRD++++ +L++      VSDFG ++ L+   + ++   G     + APE A   
Sbjct: 127  Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAY 182

Query: 955  RA-NEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPP 1010
            R      DV++FG+++ EV+  G+ P   +S            N  V   ++   RLPPP
Sbjct: 183  RKFTSASDVWSFGIVMWEVMSYGERPYWDMS------------NQDVIKAVEDGYRLPPP 230

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +       + M+     C   + + RPT  ++ + L
Sbjct: 231  MDCPSALYQLMLD----CWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 73/269 (27%), Positives = 128/269 (47%), Gaps = 32/269 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V++    +    AVK L     G +  + K F++E   + ++RH  +++ Y  
Sbjct: 15   GAGQFGEVWEGLWNNTTPVAVKTLKP---GTM--DPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C+  + +++V E ++ GSL   L   A  A L   + +++   VA+ ++Y+    +   +
Sbjct: 70   CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNY---I 125

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD++++ VL+       V+DFG A+ +K D     E A     + APE A   R + K 
Sbjct: 126  HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 961  DVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+           +P P    N  V   +D   R+P P G  +E 
Sbjct: 186  DVWSFGILLTEIVTYGR-----------MPYPGMT-NAEVLQQVDQGYRMPCPPGCPKEL 233

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               M+     C   +PD RPT + +   L
Sbjct: 234  YDIMLD----CWKEDPDDRPTFETLQWKL 258

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 75.2 bits (186), Expect = 7e-15
 Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 38/168 (22%)

Query: 827 ITEIRHRNIVK-FYGFCSHTQ-HLFLVYEYLERGSLATILSNEAT---------AAELDW 875
           ++ I H  IVK  Y F   T+  L+LV EY   G L + LS E           AAE+  
Sbjct: 47  LSRINHPFIVKLHYAF--QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI-- 102

Query: 876 SKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
                       AL Y+H       I++RD+  + +LLD +    ++DFG AK L  + S
Sbjct: 103 ----------VLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148

Query: 935 NWSELAGTCGYIAPEL----AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             +   GT  Y+APE+     Y        D ++ GVL+ E++ GK P
Sbjct: 149 RTNTFCGTPEYLAPEVLLGKGYGK----AVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 28/262 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G VYKA+       A  K+  + + E     + F+ EI   +E +H NIV  Y  
Sbjct: 14   GDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
              +   L+++ E+ + G+L +I+        L   +   V + +  AL+++H      ++
Sbjct: 71   YFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY--TMRANE- 958
            HRD+ +  +LL L+    ++DFG +   K          GT  ++APE+    T + N  
Sbjct: 126  HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 959  --KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
              K D+++ G+ ++E+ + + P H L+           M +++   I    PP L +  +
Sbjct: 186  DYKADIWSLGITLIELAQMEPPHHELNP----------MRVLLK--ILKSEPPTLDQPSK 233

Query: 1017 KLKSMIAVAFLCLDANPDCRPT 1038
               S       CL  +PD RPT
Sbjct: 234  WSSSFNDFLKSCLVKDPDDRPT 255

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 77.3 bits (190), Expect = 9e-15
 Identities = 79/219 (36%), Positives = 116/219 (52%), Gaps = 8/219 (3%)

Query: 440 IPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLA 499
              +L N   L SL L  N+L  NISE+  +  +L  LDL NNN         +    L 
Sbjct: 85  GSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNLK 143

Query: 500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGD 559
            L++  N+I  ++PS + N+  L  LD S N L   +PK L  L++L +L L+GN++S D
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200

Query: 560 IPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS 619
           +P E+ LL+ L  LDLS N + +L+   L  L+ L  L LSNN+        IG L  L 
Sbjct: 201 LPPEIELLSALEELDLSNNSIIELLSS-LSNLKNLSGLELSNNKLEDLPES-IGNLSNLE 258

Query: 620 KLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPS 658
            LDLS+N +  +  S + +L +L  ++L  N LS  +P 
Sbjct: 259 TLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPL 295

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 78.3 bits (193), Expect = 1e-14
 Identities = 41/90 (45%), Positives = 54/90 (60%), Gaps = 1/90 (1%)

Query: 212 LGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSL 271
           LGL+   L G IP     L +L+ + L  N + G IPP LGS  SL  L LS+N  NGS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 272 PSSFGNLSSLKHLHVHNINKLSGSIPKEIG 301
           P S G L+SL+ L++ N N LSG +P  +G
Sbjct: 483 PESLGQLTSLRILNL-NGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 76.2 bits (187), Expect = 2e-14
 Identities = 91/263 (34%), Positives = 131/263 (49%), Gaps = 12/263 (4%)

Query: 136 IPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI 195
           +      L S     +P  L  L S   +S    + S     +L  L  L  + LN NR+
Sbjct: 47  VNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRL 105

Query: 196 VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNL-SNLKFLYLHDNRLSGYIPPKLGSF 254
             +I SE+  L +L+ L L+ N ++  IPP  G L SNLK L L DN++   +P  L + 
Sbjct: 106 RSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNL 162

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
            +L  L LS N L+  LP    NLS+L +L +   NK+S  +P EI  L +L  L LS  
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG-NKIS-DLPPEIELLSALEELDLSNN 219

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN 374
            +   +  SL NL N+ GL +  N L   +PE +G L +L  L LS N++  S    LG+
Sbjct: 220 SIIE-LLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQI--SSISSLGS 275

Query: 375 LSNLKFFALRENELSGSIPQEIE 397
           L+NL+   L  N LS ++P    
Sbjct: 276 LTNLRELDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+          A+K +      E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 13  GSGQFGLVWLGYWLEKRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+    + LV+E++E G L+  L   A   +      + +   V   ++Y+        +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSNV---I 122

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    + + 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 959 KCDVFNFGVLVLEVI-EGKHP 978
           K DV++FGVL+ EV  EGK P
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 36/266 (13%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
            G G  G V+K       T+ V  +  +   E     +    EIT +   +   + K+YG 
Sbjct: 13   GKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                  L+++ EYL  GS   +L     A   D  +   ++K +   L Y+H +     +
Sbjct: 71   YLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKI 123

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
            HRDI +  VLL  +    ++DFG A  L       +   GT  ++APE+      + K D
Sbjct: 124  HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 962  VFNFGVLVLEVIEGKHPG---HFLSLLLSLPAPAANMNIVVNDLIDSRLPPP--LGEVEE 1016
            +++ G+  +E+ +G+ P    H + +L  +P                +  PP   GE  +
Sbjct: 184  IWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------KNNPPTLTGEFSK 227

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKV 1042
              K  I     CL+ +P  RPT +++
Sbjct: 228  PFKEFIDA---CLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 77/297 (25%), Positives = 116/297 (39%), Gaps = 64/297 (21%)

Query: 774  ASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR- 831
               FE   V+ G G  G VYKA    +G   A+K +  +   E  I +     E   +R 
Sbjct: 5    TGIFELVEVI-GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE-----EYNILRK 58

Query: 832  ---HRNIVKFYG-------FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN- 880
               H NI  FYG         +  Q L+LV E    GS  T L            KR+  
Sbjct: 59   YSNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGS-VTDLVKGL----RKKGKRLKE 112

Query: 881  -----VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN 935
                 +++     L+Y+H +    ++HRDI  + +LL    +  + DFG +  L      
Sbjct: 113  EWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 936  WSELAGTCGYIAPEL---------AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL 986
             +   GT  ++APE+         +Y  R     DV++ G+  +E+ +GK P      L 
Sbjct: 170  RNTFIGTPYWMAPEVIACDEQPDASYDAR----SDVWSLGITAIELADGKPP------LC 219

Query: 987  SLPAPAANMNIVVNDLIDSRLPPPLGEVE---EKLKSMIAVAFLCLDANPDCRPTMQ 1040
             +    A   I  N       PP L   E   +K    I+    CL  N + RP M+
Sbjct: 220  DMHPMRALFKIPRNP------PPTLKSPENWSKKFNDFISE---CLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 64/272 (23%), Positives = 121/272 (44%), Gaps = 31/272 (11%)

Query: 785  GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V++  L   G       + +L  G     ++ F+SE +   +  H NI++  G
Sbjct: 14   GAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEG 73

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  +   ++ EY+E G+L   L +     E    + V +++G+A  + Y+    +   
Sbjct: 74   VVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMNY--- 128

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---TCGYIAPELAYTMRAN 957
            +HRD++++ +L++   +  VSDFG ++ L+ D       +G      + APE     +  
Sbjct: 129  VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIV--VNDLIDSRLPPPLGEV 1014
               DV++FG+++ EV+  G+ P   +S          N  ++  +ND    RLP P+   
Sbjct: 189  SASDVWSFGIVMWEVMSFGERPYWDMS----------NHEVMKAINDGF--RLPAPMDCP 236

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                + M+     C   +   RP    + NLL
Sbjct: 237  SAVYQLMLQ----CWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.0 bits (187), Expect = 4e-14
 Identities = 41/120 (34%), Positives = 58/120 (48%), Gaps = 7/120 (5%)

Query: 485 FGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLT 544
           F      W     +  L +    + G IP++I  +  L  ++ S N + G IP  LG +T
Sbjct: 411 FDSTKGKWF----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT 466

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHH--LNLSNN 602
           SL  L L+ N  +G IP  LG L  L  L+L+ N LS  +P  LG  R LH    N ++N
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG-RLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 69/267 (25%), Positives = 124/267 (46%), Gaps = 35/267 (13%)

Query: 785  GTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 15   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 70   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 125

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 126  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 182

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL-IDSRLPPPLGEVE 1015
            + K DV+ FGVL+ E+       + +S     P P  +++ V   L    R+  P G   
Sbjct: 183  SIKSDVWAFGVLLWEIAT-----YGMS-----PYPGIDLSQVYELLEKGYRMERPEGCPP 232

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            +  + M A    C   NP  RP+  ++
Sbjct: 233  KVYELMRA----CWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.4 bits (180), Expect = 5e-14
 Identities = 59/240 (24%), Positives = 117/240 (48%), Gaps = 31/240 (12%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V +  L   G       + +L +G     ++ F+SE +   +  H NI+   G
Sbjct: 13   GAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEG 72

Query: 841  FCSHTQHLFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              + ++ + ++ E++E G+L + L     + T  +L     V +++G+A  + Y+    +
Sbjct: 73   VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLSEMNY 127

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRD++++ +L++      VSDFG ++FL+ D+S+ +  +   G I     APE   
Sbjct: 128  ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 953  TMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011
              +     DV+++G+++ EV+  G+ P   +S          N +++     D RLPPP+
Sbjct: 185  YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------NQDVINAIEQDYRLPPPM 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 53/279 (18%)

Query: 780  KMVLHGTGGCGTVYKA------------ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI 827
            ++VL G G  G VY A            E+   D+R V+ LH     EI ++        
Sbjct: 13   RVVL-GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSY------ 61

Query: 828  TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
              ++HRNIV++ G  S      +  E +  GSL+ +L ++    + +    +   K +  
Sbjct: 62   --LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119

Query: 888  ALSYMHHDCFPPILHRDISSKKVLLDLEYKA--HVSDFGTAKFLKPDSSNWSELAGTCGY 945
             L Y+H +    I+HRDI    VL++  Y     +SDFGT+K L   +       GT  Y
Sbjct: 120  GLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQY 175

Query: 946  IAPEL------AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVV 999
            +APE+       Y   A    D+++ G  ++E+  GK P         L  P A M  V 
Sbjct: 176  MAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPPFI------ELGEPQAAMFKVG 225

Query: 1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
               I   +P     +  + K+ I     C + +PD R +
Sbjct: 226  MFKIHPEIPE---SLSAEAKNFI---LRCFEPDPDKRAS 258

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 33/265 (12%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            GTG  G V   +       A+K +      E  +++  F+ E   + ++ H  +V+ YG 
Sbjct: 13   GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C+  + +++V EY+  G L   L           S+ + + K V   ++Y+    F   +
Sbjct: 68   CTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLESKQF---I 122

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
            HRD++++  L+D +    VSDFG ++++  D   ++   G+     +  PE+    + + 
Sbjct: 123  HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 959  KCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
            K DV+ FGVL+ EV   GK P    +          N   V       RL  P       
Sbjct: 181  KSDVWAFGVLMWEVYSLGKMPYERFN----------NSETVEKVSQGLRLYRP----HLA 226

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKV 1042
             + + A+ + C     + RPT Q++
Sbjct: 227  SEKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 70/267 (26%), Positives = 119/267 (44%), Gaps = 31/267 (11%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  G VYKA  L +G+  AVK +   P  +  + Q+  +  + E +H NIV ++G   
Sbjct: 18   GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE-IFMVKECKHCNIVAYFGSYL 76

Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              + L++  EY   GSL  I       +EL  +    V +     L+Y+H       +HR
Sbjct: 77   SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLHSKG---KMHR 130

Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA---NEKC 960
            DI    +LL       ++DFG A  +    +      GT  ++APE+A   +    N+ C
Sbjct: 131  DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLC 190

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D++  G+  +E+ E + P   L  + +L             +  S   PP  ++++K K 
Sbjct: 191  DIWAVGITAIELAELQPPMFDLHPMRALFL-----------MSKSNFQPP--KLKDKTK- 236

Query: 1021 MIAVAF-----LCLDANPDCRPTMQKV 1042
              +  F     + L  NP  RPT +++
Sbjct: 237  -WSSTFHNFVKISLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 785 GTGGCGTVYKAELTSGDT----RAVKKLHSLPTGEIGINQKGFVSEI-------TEIRHR 833
           G GG G V   ++ S +     + VKK H        I + G    I        E  H 
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRH--------IVETGQQEHIFSEKEILEECNHP 53

Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            IVK Y      ++++++ EY   G L TIL +       D       I  V  A  Y+H
Sbjct: 54  FIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLH 110

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
           +     I++RD+  + +LLD      + DFG AK LK     W+   GT  Y+APE+   
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILN 166

Query: 954 MRANEKCDVFNFGVLVLEVIEGKHP 978
              +   D ++ G+L+ E++ G+ P
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 18/219 (8%)

Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
            +  ++ ++H NI+ +Y        L +  EY   G+L   +         +    +  + 
Sbjct: 50   IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLF 108

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
             + +A+SY+H      ILHRDI +  + L       + DFG +K L  + S    + GT 
Sbjct: 109  QIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Query: 944  GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
             Y++PEL   ++ N K D++  G ++ E+           L L     A N   +V  ++
Sbjct: 166  YYMSPELCQGVKYNFKSDIWALGCVLYEL-----------LTLKRTFDATNPLNLVVKIV 214

Query: 1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                 P    V      +I++    L  +P+ RPT  +V
Sbjct: 215  QGNYTP---VVSVYSSELISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 1e-13
 Identities = 34/89 (38%), Positives = 52/89 (58%)

Query: 164 VSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSI 223
           + L      G IP  +  L++L  + L+ N I G+IP  +G++ SL  L L+ N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 224 PPTAGNLSNLKFLYLHDNRLSGYIPPKLG 252
           P + G L++L+ L L+ N LSG +P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 41/96 (42%), Positives = 57/96 (59%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRL 79
                +L  L LS N+L G IP ++S   KL  LD S NQ SG IP     +  L  L L
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554

Query: 80  SVNQLNGLIPEELGELTSLNELALSYNRLNGSIPAS 115
           S NQL+G IP+ LG + SL ++ +S+N L+GS+P++
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 74/315 (23%), Positives = 112/315 (35%), Gaps = 100/315 (31%)

Query: 777  FEGKMVLHGTGGCGTVYKA-ELTSGDTRAVK---KLHSLPTGEIGINQKGFVSEIT---E 829
            F+   ++ G G   TV  A E  +    A+K   K          + ++  V  +    E
Sbjct: 3    FKFGKII-GEGSFSTVVLAKEKETNKEYAIKILDKRQ--------LIKEKKVKYVKIEKE 53

Query: 830  I-----RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----NEAT----AAELDW 875
            +      H  I+K Y      ++L+ V EY   G L   +      +E      AAE+  
Sbjct: 54   VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI-- 111

Query: 876  SKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN 935
                        AL Y+H      I+HRD+  + +LLD +    ++DFGTAK L P+SS 
Sbjct: 112  ----------LLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Query: 936  WSELA--------------------GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEG 975
             S                       GT  Y++PEL     A +  D++  G ++ +++ G
Sbjct: 159  ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Query: 976  KHPGH----------FLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVA 1025
            K P             L L  S P    N      DLI            EKL       
Sbjct: 219  KPPFRGSNEYLTFQKILKLEYSFP---PNFPPDAKDLI------------EKL------- 256

Query: 1026 FLCLDANPDCRPTMQ 1040
               L  +P  R  + 
Sbjct: 257  ---LVLDPQDRLGVN 268

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 66/272 (24%), Positives = 107/272 (39%), Gaps = 44/272 (16%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIR------HRNI 835
            G G  G+VYK + L+     A+K+  L S+       +QK     + EIR      H NI
Sbjct: 9    GKGSYGSVYKVKRLSDNQFYALKEVDLGSM-------SQKEREDAVNEIRILASVNHPNI 61

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAA-----ELDWSKRVNVIKGVANALS 890
            + +         L +V EY   G L+  +S           +  W   + +++G    L 
Sbjct: 62   ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQ 117

Query: 891  YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
             +H      ILHRD+ S  +LL       + D G +K LK + +      GT  Y+APE+
Sbjct: 118  ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--TQIGTPHYMAPEV 172

Query: 951  AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
                  + K D+++ G L+ E+     P             A +M  +   +   + PP 
Sbjct: 173  WKGRPYSYKSDIWSLGCLLYEMATFAPPFE-----------ARSMQDLRYKVQRGKYPPI 221

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                 + L++ I      L   P  RP   K+
Sbjct: 222  PPIYSQDLQNFIR---SMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 25/209 (11%)

Query: 787 GGCGTVYKAELTS-GDTRAVKKL--HSLPTGEIGINQKGFV-SE---ITEIRHRNIVKFY 839
           G  G V+ A+  S GD  A+K +    +    I  NQ   V +E   +++ +   +VK Y
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADM----IRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
                 ++L+LV EYL  G LA++L N  +  E D ++    I  +  AL Y+H +    
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVAR--IYIAEIVLALEYLHSN---G 113

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKF--------LKPDSSNWSELAGTCGYIAPELA 951
           I+HRD+    +L+D      ++DFG +K         L  D      + GT  YIAPE+ 
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHPGH 980
                ++  D ++ G ++ E + G  P H
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 27/265 (10%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  G VYKA  + +G+  A+K +   P  +  + Q+  +  + + +H NIV ++G   
Sbjct: 18   GSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM-MKDCKHSNIVAYFGSYL 76

Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
                L++  E+   GSL  I       +E   +    V +     L Y+H       +HR
Sbjct: 77   RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYLHSK---GKMHR 130

Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA---NEKC 960
            DI    +LL       ++DFG +  +    +      GT  ++APE+A   R    N+ C
Sbjct: 131  DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLC 190

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK- 1019
            D++  G+  +E+ E + P   L  + +L             +  S   PP  ++++K+K 
Sbjct: 191  DIWAVGITAIELAELQPPMFDLHPMRALFL-----------MTKSNFQPP--KLKDKMKW 237

Query: 1020 --SMIAVAFLCLDANPDCRPTMQKV 1042
              S      + L  NP  RPT +K+
Sbjct: 238  SNSFHHFVKMALTKNPKKRPTAEKL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 45/270 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G+V K        +    AVK L       I   +K F+ E   + ++ H  IV+
Sbjct: 4    GHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ---EHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G C     L LV E    G L   L         D      +   VA  ++Y+    F
Sbjct: 61   LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPELAY 952
               +HRD++++ VLL   ++A +SDFG ++ L   S  +   A T G     + APE   
Sbjct: 117  ---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECIN 171

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-PAANM-NIVVNDLIDS--RLP 1008
              + + K DV+++GV + E               S  A P   M    V  +++S  RLP
Sbjct: 172  YGKFSSKSDVWSYGVTLWEA-------------FSYGAKPYGEMKGAEVIAMLESGERLP 218

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
             P    EE  + + ++   C    P+ RPT
Sbjct: 219  RP----EECPQEIYSIMLSCWKYRPEDRPT 244

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 70/263 (26%), Positives = 111/263 (42%), Gaps = 32/263 (12%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITE-------IRHRNIV 836
            G+G  G+VY+   L  GD  AVK++     G+ G   +  V ++ +       ++H NIV
Sbjct: 9    GSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG---QEAVKQLEQEIALLSKLQHPNIV 65

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            ++ G      +L++  E +  GSLA +L                  + +   L Y+H   
Sbjct: 66   QYLGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR- 121

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMR 955
                +HRDI    +L+D      ++DFG AK +   S   S   G+  ++APE +A    
Sbjct: 122  --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGG 178

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
                 D+++ G  VLE+  GK P         L   AA   I  +      LPP    + 
Sbjct: 179  YGLAADIWSLGCTVLEMATGKPPWS------QLEGVAAVFKIGRS----KELPPIPDHLS 228

Query: 1016 EKLKSMIAVAFLCLDANPDCRPT 1038
            ++ K  I     CL  +P  RPT
Sbjct: 229  DEAKDFIL---KCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 19/217 (8%)

Query: 827  ITEIRHRNIVKFY-GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGV 885
            +++++H NIV +   +      L++V  + E G L   L  E     L  ++ V     +
Sbjct: 53   LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQI 111

Query: 886  ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY 945
            A AL Y+H      ILHRD+ ++ V L       V D G A+ L+      S L GT  Y
Sbjct: 112  AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168

Query: 946  IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
            ++PEL      N K DV+  G  V E+   KH  +           A +MN +V  +I+ 
Sbjct: 169  MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-----------AKDMNSLVYRIIEG 217

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            +LPP   +   +L  +IA     L   P+ RP+++ +
Sbjct: 218  KLPPMPKDYSPELGELIATM---LSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 33/219 (15%)

Query: 785 GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNI 835
           G G  G V+  E    +        AVK L    + +    +K F  E   +T  +H NI
Sbjct: 14  GEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHENI 70

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATIL-----------SNEATAAELDWSKRVNVIKG 884
           VKFYG C+      +V+EY+E G L   L           S ++   EL  S+ + +   
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-- 942
           +A+ + Y+    F   +HRD++++  L+  +    + DFG ++ +   ++++  + G   
Sbjct: 131 IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTM 185

Query: 943 --CGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
               ++ PE     +   + DV++FGV++ E+   GK P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 35/268 (13%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF------VSEITEIRHRNIVKF 838
            G G  GTVY      G   AVK++  L T  +   +K +      V  +  ++H NIV++
Sbjct: 9    GKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
             G C     + +  E++  GS+++IL+      E  + K     K + + ++Y+H++C  
Sbjct: 68   LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYT---KQILDGVAYLHNNC-- 122

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE------LAGTCGYIAPELAY 952
             ++HRDI    V+L       + DFG A+ L     + +       + GT  ++APE+  
Sbjct: 123  -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012
                  K D+++ G  V E+  GK P      L S+   AA   I  +  +  RLP    
Sbjct: 182  ESGYGRKSDIWSIGCTVFEMATGKPP------LASMDRLAAMFYIGAHRGLMPRLPDSFS 235

Query: 1013 EVEEKLKSMIAVAFL--CLDANPDCRPT 1038
                      A+ F+  CL  +   RP+
Sbjct: 236  AA--------AIDFVTSCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + K+YG       L+++ EYL  GS   +L        LD ++   +++ +   L Y+H 
Sbjct: 64   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS 119

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            +     +HRDI +  VLL    +  ++DFG A  L       +   GT  ++APE+    
Sbjct: 120  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPG---HFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011
              + K D+++ G+  +E+ +G+ P    H + +L  +P          N+      PP L
Sbjct: 177  AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---------NN------PPTL 221

Query: 1012 -GEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
             G   + LK  +     CL+  P  RPT +++
Sbjct: 222  EGNYSKPLKEFVEA---CLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 9e-13
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 830  IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
            +RH  +V+ Y  CS  + +++V EY+ +GSL   L +     +L   + V++   +A  +
Sbjct: 58   LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGM 116

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAP 948
            +Y+    +   +HRD++++ +L+       ++DFG A+ ++ D     E A     + AP
Sbjct: 117  AYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-- 1005
            E A   R   K DV++FG+L+ E++  G+           +P P    N  V + ++   
Sbjct: 174  EAANYGRFTIKSDVWSFGILLTEIVTYGR-----------VPYPGMT-NREVLEQVERGY 221

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
            R+P P    EE    M+     C D +P+ RPT
Sbjct: 222  RMPRPPNCPEELYDLML----QCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 9e-13
 Identities = 70/264 (26%), Positives = 117/264 (44%), Gaps = 39/264 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGE---IGINQKGFVSEITEIRHRNIVKFYG 840
            G G  G VYKA +  +    A+K +  L   E     I Q+     +++ R   I K+YG
Sbjct: 10   GKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQF--LSQCRSPYITKYYG 66

Query: 841  FCSHTQHLFLVYEYLERGSLATILS----NEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                   L+++ EY   GS   +L     +E   A         +++ V   L Y+H + 
Sbjct: 67   SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF--------ILREVLLGLEYLHEE- 117

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
                +HRDI +  +LL  E    ++DFG +  L    S  +   GT  ++APE+      
Sbjct: 118  --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL--GEV 1014
            +EK D+++ G+  +E+ +G+ P       LS   P   M ++   LI    PP L   + 
Sbjct: 176  DEKADIWSLGITAIELAKGEPP-------LSDLHP---MRVLF--LIPKNNPPSLEGNKF 223

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPT 1038
             +  K  ++   LCL+ +P  RP+
Sbjct: 224  SKPFKDFVS---LCLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 22/202 (10%)

Query: 787 GGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQ-KGFVSEITEIRHR----NIVKFYG 840
           G  G+VY A+  ++GD  A+K L    +  I  NQ     +E   +  +     + K Y 
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKK--SDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                 +L+LV EYL  G  A+++       E DW+K    I  V   +  +H      I
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAK--QYIAEVVLGVEDLHQR---GI 118

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
           +HRDI  + +L+D      ++DFG ++               GT  Y+APE    +  ++
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDK 172

Query: 959 KCDVFNFGVLVLEVIEGKHPGH 980
             D ++ G ++ E + G  P H
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.4 bits (175), Expect = 1e-12
 Identities = 34/87 (39%), Positives = 54/87 (62%)

Query: 190 LNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP 249
           L+N  + G IP++I  LR L  + L+ N + G+IPP+ G++++L+ L L  N  +G IP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 250 KLGSFKSLLYLYLSHNQLNGSLPSSFG 276
            LG   SL  L L+ N L+G +P++ G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 43/215 (20%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G +Y A+  S     V K   L  +P  E   ++K  V  + +++H NIV F+  
Sbjct: 9   GEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKE-VILLAKMKHPNIVTFFAS 67

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGV------------ANAL 889
                 LF+V EY + G L                KR+N  +GV              +L
Sbjct: 68  FQENGRLFIVMEYCDGGDLM---------------KRINRQRGVLFSEDQILSWFVQISL 112

Query: 890 SYMH-HDCFPPILHRDISSKKVLLDLEYK-AHVSDFGTAKFLKPDSSNWSELAGTCG--- 944
              H HD    ILHRDI S+ + L      A + DFG A+ L    ++  ELA TC    
Sbjct: 113 GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTP 166

Query: 945 -YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            Y++PE+      N K D+++ G ++ E+   KHP
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 41/272 (15%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V + E T G   AVK +      +  +  + F+ E   +T++ H+N+V+  G 
Sbjct: 15   GEGEFGAVLQGEYT-GQKVAVKNI------KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY---MHHDCFP 898
              H   L++V E + +G+L   L     A        V+VI+ +  +L     M +    
Sbjct: 68   ILH-NGLYIVMELMSKGNLVNFLRTRGRAL-------VSVIQLLQFSLDVAEGMEYLESK 119

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
             ++HRD++++ +L+  +  A VSDFG A+ +     + S+L     + APE     + + 
Sbjct: 120  KLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSS 176

Query: 959  KCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-RLPPPLGEVEE 1016
            K DV+++GVL+ EV   G+            P P  ++  V   +    R+ PP    E 
Sbjct: 177  KSDVWSYGVLLWEVFSYGRA-----------PYPKMSLKEVKECVEKGYRMEPP----EG 221

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
                +  +   C +  P  RP+  K+   L +
Sbjct: 222  CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 35/89 (39%), Positives = 49/89 (55%)

Query: 525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLI 584
           L   +  L G IP  + KL  L S+ L+GN + G+IP  LG +  L  LDLS N  +  I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 585 PKNLGELRKLHHLNLSNNQFSQEISIQIG 613
           P++LG+L  L  LNL+ N  S  +   +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.0 bits (171), Expect = 2e-12
 Identities = 86/266 (32%), Positives = 121/266 (45%), Gaps = 28/266 (10%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISHL-SKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV 81
              L  LDL  N +   IP  I  L S LK LD S N+    +P  +  L NL  L LS 
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172

Query: 82  NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWG 141
           N L+  +P+ L  L++LN L LS N+++  +P  +  LS L +L LSNNS+         
Sbjct: 173 NDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-------- 222

Query: 142 YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPS 201
                    +   L NL++   + L  NN    +P S+G L NL  + L+NN+I  S  S
Sbjct: 223 --------ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQI--SSIS 271

Query: 202 EIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLY 261
            +G+L +L  L L+ N LS ++P        L  L L  N L      +L     LL   
Sbjct: 272 SLGSLTNLRELDLSGNSLSNALPL---IALLLLLLELLLNLLLTLKALELKLNSILLNNN 328

Query: 262 LSHNQLNGSLPSSFGNLSSLKHLHVH 287
           +  N    S P +   L SL +L   
Sbjct: 329 ILSNGE-TSSPEALSILESLNNLWTL 353

Length = 394

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 69.6 bits (170), Expect = 2e-12
 Identities = 92/288 (31%), Positives = 136/288 (47%), Gaps = 24/288 (8%)

Query: 88  IPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWG------ 141
             E L  L  L  L L+ NRL  +I   L  L+NL  L L NN+++  IPP  G      
Sbjct: 85  GSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNL 142

Query: 142 ---YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGS 198
               L      S+P  L NL +  ++ L  N+ S  +P+ L  L NL  + L+ N+I   
Sbjct: 143 KELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SD 200

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
           +P EI  L +L  L L+ N +   +  +  NL NL  L L +N+L   +P  +G+  +L 
Sbjct: 201 LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLE 258

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLS 317
            L LS+NQ+  S  SS G+L++L+ L   + N LS ++P      L     L L  T  +
Sbjct: 259 TLDLSNNQI--SSISSLGSLTNLRELD-LSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN 365
             +  +   L+N     I  N    S PE L  L+SL+ L    N L+
Sbjct: 316 LELKLNSILLNNN----ILSNGET-SSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 11/163 (6%)

Query: 827 ITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV-IKG 884
           + E+ H  +V   Y F    ++++LV + L  G L   LS +   +E    ++V   I  
Sbjct: 54  LQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSE----EQVKFWICE 108

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           +  AL Y+H      I+HRDI    +LLD +   H++DF  A  + PD+   +  +GT G
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPG 164

Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS 987
           Y+APE+      +   D ++ GV   E + GK P    S  + 
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR 207

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 56/224 (25%), Positives = 109/224 (48%), Gaps = 25/224 (11%)

Query: 827  ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
            + ++RH  +V  Y   S  + +++V E++ +GSL   L  E     L   + V++   +A
Sbjct: 55   MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIA 112

Query: 887  NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGY 945
            + ++Y+    +   +HRD+ +  +L+       ++DFG A+ ++ +     + A     +
Sbjct: 113  DGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 946  IAPELAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004
             APE A   R   K DV++FG+L+ E++ +G+           +P P   +N  V + ++
Sbjct: 170  TAPEAALYGRFTIKSDVWSFGILLTELVTKGR-----------VPYPGM-VNREVLEQVE 217

Query: 1005 S--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               R+P P G   E L  ++    LC   +PD RPT + + + L
Sbjct: 218  RGYRMPCPQG-CPESLHELMK---LCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 11/156 (7%)

Query: 821 KGFVSE---ITEIRHRNIVKFYG-FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           + F++E   +T++RH N+V+  G        L++V EY+ +GSL   L +   +  L   
Sbjct: 44  QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGD 102

Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     V  A+ Y+  + F   +HRD++++ VL+  +  A VSDFG     K  SS  
Sbjct: 103 CLLKFSLDVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQ 156

Query: 937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
                   + APE     + + K DV++FG+L+ E+
Sbjct: 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 20/177 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR------HRNIVK 837
           G G  GTVYKA +L +G   A+KK+  +P  E GI     + EI  ++      H NIV+
Sbjct: 8   GEGAYGTVYKARDLNTGRFVALKKVR-VPLSEEGIPL-STLREIALLKQLESFEHPNIVR 65

Query: 838 FYGFC-----SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
               C          L LV+E++++  LAT LS       L      ++++ +   + ++
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFL 123

Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           H      I+HRD+  + +L+  + +  ++DFG A+    + +  S +  T  Y APE
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-TLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.5 bits (170), Expect = 6e-12
 Identities = 45/122 (36%), Positives = 67/122 (54%), Gaps = 19/122 (15%)

Query: 82  NQ-LNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNW 140
           NQ L G IP ++ +L  L  + LS N + G+IP SLG++++L  L LS NS +       
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN------- 479

Query: 141 GYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGG--LKNLTFVYLNNNRIVGS 198
                   GSIP+ LG L S   ++L+ N+ SG +P +LGG  L   +F + +N  + G 
Sbjct: 480 --------GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG- 530

Query: 199 IP 200
           IP
Sbjct: 531 IP 532

Length = 623

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.0 bits (163), Expect = 7e-12
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 34/265 (12%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
            G G  G VYK       T+ V  +  +   E     +    EIT +   +   I ++YG 
Sbjct: 13   GKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                  L+++ EYL  GS   +L        L+ +    +++ +   L Y+H +     +
Sbjct: 71   YLKGTKLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSE---RKI 123

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
            HRDI +  VLL  +    ++DFG A  L       +   GT  ++APE+      + K D
Sbjct: 124  HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183

Query: 962  VFNFGVLVLEVIEGKHPG---HFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL-GEVEEK 1017
            +++ G+  +E+ +G+ P    H + +L  +P  +               PP L G+  + 
Sbjct: 184  IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---------------PPTLEGQYSKP 228

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKV 1042
             K  +     CL+ +P  RPT +++
Sbjct: 229  FKEFVEA---CLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 67.4 bits (164), Expect = 8e-12
 Identities = 70/262 (26%), Positives = 114/262 (43%), Gaps = 33/262 (12%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VY A    + +  AVKK+ S    +     +  + E+    +++H N +++ G
Sbjct: 30   GHGSFGAVYFATNSHTNEVVAVKKM-SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 841  FCSHTQHL-FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             C   +H  +LV EY   GS + +L  E     L   +   +  G    L+Y+H      
Sbjct: 89   -CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE- 958
            ++HRDI +  +LL    +  ++DFG+A    P +S      GT  ++APE+   M   + 
Sbjct: 142  MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEGQY 197

Query: 959  --KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
              K DV++ G+  +E+ E K P      L ++ A +A  +I  ND        P  +  E
Sbjct: 198  DGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQND-------SPTLQSNE 244

Query: 1017 KLKSMIAVAFLCLDANPDCRPT 1038
               S       CL   P  RP 
Sbjct: 245  WTDSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.7 bits (168), Expect = 9e-12
 Identities = 36/82 (43%), Positives = 51/82 (62%)

Query: 292 LSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRL 351
           L G IP +I  L+ L  + LS   + G IPPSLG+++++  L +  N   GSIPE LG+L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 352 KSLSQLSLSVNKLNGSIPHCLG 373
            SL  L+L+ N L+G +P  LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 9e-12
 Identities = 73/279 (26%), Positives = 117/279 (41%), Gaps = 35/279 (12%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G V K     +G+  A+KK       E    +K  + E+    ++RH NIV    
Sbjct: 10   GEGAYGVVLKCRNKATGEIVAIKKFKESEDDED--VKKTALREVKVLRQLRHENIVNLKE 67

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPP 899
                   L+LV+EY+ER  L  +   EA+   L      + I  +  A++Y H H+    
Sbjct: 68   AFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSHN---- 120

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLK-PDSSNWSELAGTCGYIAPEL--AYTMRA 956
            I+HRDI  + +L+       + DFG A+ L+   +S  ++   T  Y APEL    T   
Sbjct: 121  IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180

Query: 957  NEKCDVFNFGVLVLEVIEGK--HPGH------FLSLLLSLPAPAANMNIVVND------- 1001
                DV+  G ++ E+++G+   PG       +L      P P ++  +  ++       
Sbjct: 181  KP-VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239

Query: 1002 LIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPT 1038
              +   P  L        S  A+ FL  CL  +P  R T
Sbjct: 240  FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)

Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAA-----ELDWSKR 878
            V+ ++ ++H NIV++        +L++V +Y E G L   ++ +          LDW  +
Sbjct: 50   VAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ 109

Query: 879  VNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
            + +      AL ++H      ILHRDI S+ + L  +    + DFG A+ L    ++  E
Sbjct: 110  ICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVE 156

Query: 939  LAGTC----GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN 994
            LA TC     Y++PE+      N K D++  G ++ E+   KH              A N
Sbjct: 157  LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-----------AGN 205

Query: 995  MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            M  +V  +I    PP        L+++++  F     NP  RP++  +
Sbjct: 206  MKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF---KRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.7 bits (168), Expect = 1e-11
 Identities = 35/88 (39%), Positives = 49/88 (55%)

Query: 306 LSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN 365
           +  L L    L GFIP  +  L +++ + +  N + G+IP  LG + SL  L LS N  N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 366 GSIPHCLGNLSNLKFFALRENELSGSIP 393
           GSIP  LG L++L+   L  N LSG +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 1e-11
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 20/174 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G VYKA +  +G+  A+KK+  L   E GI     + EI+   E++H NIVK   
Sbjct: 8   GEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGI-PSTALREISLLKELKHPNIVKLLD 65

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA----NALSYMHHDC 896
                + L+LV+EY +   L   L               N+IK +       L+Y H   
Sbjct: 66  VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP------NLIKSIMYQLLRGLAYCHSHR 118

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
              ILHRD+  + +L++ +    ++DFG A+        ++    T  Y APE+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 31/262 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 15   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 70   VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 124

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 125  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVEEKL 1018
            DV++FG+L+ E          L+    +P P   +N  V D ++   R+P P  E  E L
Sbjct: 185  DVWSFGILLTE----------LTTKGRVPYPGM-VNREVLDQVERGYRMPCP-PECPESL 232

Query: 1019 KSMIAVAFLCLDANPDCRPTMQ 1040
              ++     C    P+ RPT +
Sbjct: 233  HDLM---CQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 785 GTGGCGTVYKAE---LTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKF 838
           G G  G V+ AE   L+    + +  + +L    +   +K F  E   +T ++H +IVKF
Sbjct: 14  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVKF 72

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAA-------------ELDWSKRVNVIKGV 885
           YG C     L +V+EY++ G L   L      A             EL  S+ +++   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---- 941
           A+ + Y+    F   +HRD++++  L+       + DFG ++ +   S+++  + G    
Sbjct: 133 ASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGHTML 187

Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
              ++ PE     +   + DV++FGV++ E+   GK P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 30/210 (14%)

Query: 785 GTGGCGTVYKAELT-SGDTR----AVKKL--HSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G+G  GTVYK      G+      A+K L   + P     I  + +V  +  + H ++V+
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV--MASVDHPHVVR 73

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATA----AELDWSKRVNVIKGVANALSY-- 891
             G C  +Q   L+ + +  G L   + N          L+W  ++      A  +SY  
Sbjct: 74  LLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126

Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC--GYIAPE 949
                   ++HRD++++ VL+       ++DFG AK L  D   +    G     ++A E
Sbjct: 127 EKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                    K DV+++GV V E++  G  P
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 28/204 (13%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G V+KA +  +G+T A+KK+  L   E GI     + EI      +H  +VK   
Sbjct: 9   GEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGI-PNQALREIKALQACQHPYVVKLLD 66

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVA----NALSYMH 893
              H     LV EY+    L+ +L +E      A+         +K         ++YMH
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQ---------VKSYMRMLLKGVAYMH 116

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELAGTCGYIAPELAY 952
            +    I+HRD+    +L+  +    ++DFG A+    +    +S    T  Y APEL Y
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173

Query: 953 TMRA-NEKCDVFNFGVLVLEVIEG 975
             R  +   D++  G +  E++ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 37/267 (13%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQK-----GFVSEITEIRHRNIVKF 838
            G G  G VY A    + +  A+KK+    +G+   N+K       V  + ++RH N +++
Sbjct: 24   GHGSFGAVYFARDVRTNEVVAIKKM--SYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 839  YGFCSHTQHL-FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
             G C   +H  +LV EY   GS + IL  E     L   +   +  G    L+Y+H    
Sbjct: 81   KG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE- 135

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM--- 954
               +HRDI +  +LL       ++DFG+A  + P +S      GT  ++APE+   M   
Sbjct: 136  --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDEG 189

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
            + + K DV++ G+  +E+ E K P      L ++ A +A  +I  ND       P L   
Sbjct: 190  QYDGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQND------SPTLSSN 237

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQK 1041
            +            CL   P  RP+ ++
Sbjct: 238  DWSD-YFRNFVDSCLQKIPQDRPSSEE 263

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 44/172 (25%), Positives = 87/172 (50%), Gaps = 20/172 (11%)

Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL----------ATILSNEATAAELDWS 876
           +T ++H +IVKFYG C     L +V+EY++ G L          A +++     AEL  S
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
           + +++ + +A  + Y+    F   +HRD++++  L+       + DFG ++ +   S+++
Sbjct: 121 QMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDY 175

Query: 937 SELAG----TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLS 983
             + G       ++ PE     +   + DV++ GV++ E+   GK P + LS
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 60/252 (23%), Positives = 118/252 (46%), Gaps = 30/252 (11%)

Query: 772  LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT-- 828
            + AS  + + V+ G G  G V    L     R +   + +L  G     ++ F+SE +  
Sbjct: 1    IDASCIKIEKVI-GAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59

Query: 829  -EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSN---EATAAELDWSKRVNVIKG 884
             +  H NI+   G  + ++ + +V EY+E GSL   L     + T  +L     V +++G
Sbjct: 60   GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRG 114

Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTC 943
            +A+ + Y+    +   +HRD++++ +L++      VSDFG ++ L+ D  + ++   G  
Sbjct: 115  IASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Query: 944  G--YIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVN 1000
               + APE     +     DV+++G+++ EV+  G+ P   +S          N +++  
Sbjct: 172  PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS----------NQDVIKA 221

Query: 1001 DLIDSRLPPPLG 1012
                 RLP P+ 
Sbjct: 222  IEEGYRLPAPMD 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 39/270 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G V+   L + +T  AVK        ++   +  F+ E   + +  H NIV+  G
Sbjct: 4    GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLIG 60

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+  Q +++V E ++ G   T L  E     L   + + +++  A  + Y+        
Sbjct: 61   VCTQKQPIYIVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYIAPELAYTMRA 956
            +HRD++++  L+  +    +SDFG ++  + +   ++   G       + APE     R 
Sbjct: 116  IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-PAANM-NIVVNDLIDS--RLPPPLG 1012
            + + DV++FG+L+ E               SL A P AN+ N    + I+   RLP P  
Sbjct: 174  SSESDVWSFGILLWEA-------------FSLGAVPYANLSNQQTREAIEQGVRLPCPEL 220

Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              +   + M      C + +P  RP+   V
Sbjct: 221  CPDAVYRLMER----CWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 75/295 (25%), Positives = 123/295 (41%), Gaps = 59/295 (20%)

Query: 774  ASTFEGKMVLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR- 831
            A  FE   V+ G G  G VYK   + +G   A+K +      E  I       EI  ++ 
Sbjct: 15   AGIFELVEVV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL-----EINMLKK 68

Query: 832  ---HRNIVKFYGF------CSHTQHLFLVYEYLERGSLATILSN-EATAAELDWSKRV-- 879
               HRNI  +YG         H   L+LV E+   GS+  ++ N +  A + DW   +  
Sbjct: 69   YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
             +++G+A+   + H      ++HRDI  + VLL    +  + DFG +  L       +  
Sbjct: 129  EILRGLAHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181

Query: 940  AGTCGYIAPEL---------AYTMRANEKCDVFNFGVLVLEVIEGKHP---GHFLSLLLS 987
             GT  ++APE+          Y  R+    D+++ G+  +E+ EG  P    H +  L  
Sbjct: 182  IGTPYWMAPEVIACDENPDATYDYRS----DIWSLGITAIEMAEGAPPLCDMHPMRALFL 237

Query: 988  LPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            +P                R PPP  + ++  K  I     CL  N   RP+ +++
Sbjct: 238  IP----------------RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G G  G V+     +    AVK   +L  G + +  + F+ E   +  ++H  +V+ Y  
Sbjct: 15  GAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYAV 69

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            +  + ++++ EY+ +GSL   L ++    ++   K ++    +A  ++Y+    +   +
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKNY---I 125

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
           HRD+ +  VL+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 961 DVFNFGVLVLEVIE-GKHP 978
           DV++FG+L+ E++  GK P
Sbjct: 186 DVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 40/283 (14%)

Query: 780  KMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITE-------IR 831
            K+ L G+G  GTV+K   +  GD+  +K   ++ T +    ++ F  EIT+       + 
Sbjct: 11   KLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTF-QEITDHMLAMGSLD 67

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
            H  IV+  G C     L LV +    GSL   +     +  LD  + +N    +A  + Y
Sbjct: 68   HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYY 124

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPE 949
            +       ++HR+++++ +LL  +    ++DFG A  L PD     +SE      ++A E
Sbjct: 125  LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 950  LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-PAANMNIV-VNDLID--S 1005
                 R   + DV+++GV V E             ++S  A P A M    V DL++   
Sbjct: 182  SILFGRYTHQSDVWSYGVTVWE-------------MMSYGAEPYAGMRPHEVPDLLEKGE 228

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
            RL  P  ++      M+ V    +D N   RPT +++ N   R
Sbjct: 229  RLAQP--QICTIDVYMVMVKCWMIDEN--VRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 32/207 (15%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFV----SEITEIRHRNIVKFYG 840
           GTG  G V+       +     K+ ++P   I + Q+  V      + E+ H  I++ + 
Sbjct: 10  GTGTFGRVHLVRDRISEHYYALKVMAIPE-VIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEAT---------AAELDWSKRVNVIKGVANALSY 891
                + L+++ EY+  G L + L N            A+E            +  AL Y
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE------------IVCALEY 116

Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA 951
           +H      I++RD+  + +LLD E    ++DFG AK L+     W+ L GT  Y+APE+ 
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPEVI 170

Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
            +   N+  D +  G+L+ E++ G  P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 6e-11
 Identities = 34/80 (42%), Positives = 44/80 (55%)

Query: 149 GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRS 208
           G IP D+  L    S++L  N+  G IP SLG + +L  + L+ N   GSIP  +G L S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 209 LSYLGLNKNQLSGSIPPTAG 228
           L  L LN N LSG +P   G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 26/268 (9%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G    VYKA  L  G   A+KK+      +    Q   + EI    ++ H N++K+  
Sbjct: 11   GKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQLDHPNVIKYLA 69

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGVANALSYMHHDCFPP 899
                   L +V E  + G L+ ++ +      L   + +      + +AL +MH      
Sbjct: 70   SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
            I+HRDI    V +       + D G  +F    ++    L GT  Y++PE  +    N K
Sbjct: 127  IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI--VVNDLIDSRLPP-PLGEVEE 1016
             D+++ G L+ E+             L  P     MN+  +   +     PP P     E
Sbjct: 187  SDIWSLGCLLYEMAA-----------LQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            +L+ +++    C++ +P+ RP +  V  
Sbjct: 236  ELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.2 bits (156), Expect = 8e-11
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)

Query: 785 GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
           G G  G V+ AEL  +    A+K L      ++ +        + E R  ++   + F +
Sbjct: 4   GKGSFGKVFLAELKGTNQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 844 H-------TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
           H        ++LF V EYL  G L   + +  +  + D  +       +   L ++H   
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK- 115

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              I++RD+    +LLD +    ++DFG  K      +      GT  YIAPE+    + 
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 957 NEKCDVFNFGVLVLEVIEGKHPGH 980
           N   D ++FGVL+ E++ G+ P H
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 14/157 (8%)

Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNE-----ATAAELDWSKRVNV 881
           + +++H NIV F        HL++V EY + G L   +  +          L W  ++ +
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
                  + ++H      +LHRDI SK + L    K  + DFG+A+ L    +      G
Sbjct: 112 ------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162

Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           T  Y+ PE+   M  N K D+++ G ++ E+   KHP
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 41/271 (15%)

Query: 796  ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR--------------NIVKFYGF 841
            +L +G+  +V K+  +PTG +   +   +   + +R +               IV FYG 
Sbjct: 12   DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA-------LSYMHH 894
              +  ++ +  E+++ GSL  I               V ++  +A A       L  +H 
Sbjct: 72   FLNENNICMCMEFMDCGSLDRIYKKGGPI-------PVEILGKIAVAVVEGLTYLYNVHR 124

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                 I+HRDI    +L++   +  + DFG +  L   +S      GT  Y++PE     
Sbjct: 125  -----IMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGG 177

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL--PPPLG 1012
            +   K DV++ G+ ++E+  GK P  F    +        M I+  DL+   +  PPP  
Sbjct: 178  KYTVKSDVWSLGISIIELALGKFP--FAFSNIDDDGQDDPMGIL--DLLQQIVQEPPPRL 233

Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043
               +  + +      CL  +P  RPT Q++C
Sbjct: 234  PSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VY A ++ + +  A+KK+ S    +     +  + E+    ++RH N +++ G
Sbjct: 24   GHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 841  FCSHTQHL-FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
             C   +H  +LV EY   GS + +L  E     L   +   V  G    L+Y+H H+   
Sbjct: 83   -CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
             ++HRD+ +  +LL       + DFG+A  + P +       GT  ++APE+   M   +
Sbjct: 136  -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190

Query: 959  ---KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
               K DV++ G+  +E+ E K P      L ++ A +A  +I  N+        P  +  
Sbjct: 191  YDGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQNE-------SPALQSG 237

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN--LLCR 1048
               +        CL   P  RPT + +     + R
Sbjct: 238  HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 67/281 (23%), Positives = 122/281 (43%), Gaps = 34/281 (12%)

Query: 785  GTGGCGTV--YKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFY 839
            G G  G V  Y  +  +  T  +  + +L       N  G+  EI  ++   H NIVK+ 
Sbjct: 13   GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYK 72

Query: 840  GFCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            G CS    + L L+ EY+  GSL   L       +L+ ++ +   + +   ++Y+H   +
Sbjct: 73   GCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY 128

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA----GTCGYIAPELAYT 953
               +HRD++++ VLLD +    + DFG AK + P+   +  +         + A E    
Sbjct: 129  ---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 954  MRANEKCDVFNFGVLVLEVI-----EGKHPGHFLSLLLSLPAPAANMNIV-VNDLIDS-- 1005
             + +   DV++FGV + E++     +   P  F  +   +      M +V + +L++   
Sbjct: 185  NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM---IGPKQGQMTVVRLIELLERGM 241

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            RLP P    +E    M      C +     RPT + +  +L
Sbjct: 242  RLPCPKNCPQEVYILMKN----CWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 29/222 (13%)

Query: 785 GTGGCGTVYKAE---LTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKF 838
           G G  G V+ AE   L     + +  + +L        Q  F  E   +T ++H++IV+F
Sbjct: 14  GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTVLQHQHIVRF 72

Query: 839 YGFCSHTQHLFLVYEYLERGSL----------ATIL--SNEATAAELDWSKRVNVIKGVA 886
           YG C+  + L +V+EY+  G L          A IL    +    +L   + + +   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC--- 943
           + + Y+    F   +HRD++++  L+       + DFG ++ +   S+++  + G     
Sbjct: 133 SGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRTMLP 187

Query: 944 -GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLS 983
             ++ PE     +   + D+++FGV++ E+   GK P + LS
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 28/203 (13%)

Query: 785 GTGGCGTVYKAE-LTSGDTR---AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
           G G  G V + E  TSG      AVK    L + ++      F+ E      + H N+++
Sbjct: 4   GDGSFGVVRRGEWSTSGGKVIPVAVK---CLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAEL-----DWSKRVNVIKGVANALSYM 892
            YG    T  L +V E    GSL   L  +A    L     D++ ++      AN + Y+
Sbjct: 61  LYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYL 113

Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS---ELAGTCGYIAPE 949
               F   +HRD++++ +LL  + K  + DFG  + L  +  ++     L     + APE
Sbjct: 114 ESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 950 LAYTMRANEKCDVFNFGVLVLEV 972
              T   +   DV+ FGV + E+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 33/232 (14%)

Query: 783 LHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVK 837
           L G G  G VYK   + +G   A+K +      E  I Q     EI  ++    HRNI  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-----EINMLKKYSHHRNIAT 67

Query: 838 FYG-FCSHT-----QHLFLVYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALS 890
           +YG F           L+LV E+   GS+  ++ N +    + +W     + + +   LS
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLS 125

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           ++H      ++HRDI  + VLL    +  + DFG +  L       +   GT  ++APE+
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182

Query: 951 AYTMRANE-----KCDVFNFGVLVLEVIEGK------HPGHFLSLLLSLPAP 991
                  +     K D+++ G+  +E+ EG       HP   L L+   PAP
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.8 bits (151), Expect = 4e-10
 Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 46/214 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKG---FVSEI---TEIRHRNIVK 837
           GTG  G V       SG   A+K L      +I +  K     ++E      IRH  +V 
Sbjct: 10  GTGSFGRVMLVRHKGSGKYYALKILSK---AKI-VKLKQVEHVLNEKRILQSIRHPFLVN 65

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL------SNEAT---AAELDWSKRVNVIKGVANA 888
            YG      +L+LV EY+  G L + L              AA+            V  A
Sbjct: 66  LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ------------VVLA 113

Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
           L Y+H      I++RD+  + +LLD +    ++DFG AK +K  +  ++ L GT  Y+AP
Sbjct: 114 LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGTPEYLAP 167

Query: 949 EL----AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E+     Y        D +  G+L+ E++ G  P
Sbjct: 168 EIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 48/287 (16%)

Query: 785  GTGGCGTVYKAELT------SGDTR-AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRN 834
            G+G  G VY+   T      SG  R AVK   +L  G     +K F+ E   ++   H N
Sbjct: 4    GSGAFGEVYEGTATDILGPGSGPIRVAVK---TLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATA----AELDWSKRVNVIKGVANALS 890
            IVK  G C   +  +++ E +E G L + L +          L   + +++   VA    
Sbjct: 61   IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 891  YMHHDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAG---- 941
            Y+    F   +HRD++++  L+     D +    + DFG A+ +    S++    G    
Sbjct: 121  YLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGLL 175

Query: 942  TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVND 1001
               ++APE     +   + DV++FGVL+ E++               P PA N N  V  
Sbjct: 176  PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ----------PYPALN-NQEVLQ 224

Query: 1002 LIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + +  RL  P     +K+  ++     C   +P  RPT  ++  +L
Sbjct: 225  HVTAGGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)

Query: 830  IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
            + H NI+++Y      + L +V EY   G+LA  +  +   + LD    ++    +  AL
Sbjct: 56   LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLAL 114

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
             ++H      ILHRD+ ++ +LLD       + DFG +K L   S  ++ + GT  YI+P
Sbjct: 115  HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISP 170

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
            EL      N+K D++  G ++ E+             L     AAN+  +V  ++     
Sbjct: 171  ELCEGKPYNQKSDIWALGCVLYELAS-----------LKRAFEAANLPALVLKIMSGTFA 219

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            P        L+ +I ++ L LD  P  RP + ++
Sbjct: 220  PISDRYSPDLRQLI-LSMLNLD--PSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 65/268 (24%), Positives = 120/268 (44%), Gaps = 31/268 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 15   GNGQFGEVWMGTWNGNTKVAVK---TLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  +     L     V++   VA  ++Y+    +   +
Sbjct: 70   VSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ S  +L+       ++DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 125  HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 961  DVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-RLPPPLGEVEEKL 1018
            DV++FG+L+ E++ +G+           +P P  N   V+  +    R+P P        
Sbjct: 185  DVWSFGILLTELVTKGR-----------VPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            + M+     C   +P+ RPT + + + L
Sbjct: 234  ELMLQ----CWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 6e-10
 Identities = 48/197 (24%), Positives = 90/197 (45%), Gaps = 13/197 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA +  +G+  A+KK+  L     GI +     +  + E+ H NI+K    
Sbjct: 8   GEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPI 900
             H   L+LV+E+++   L  ++ +      L  S   + +  +   L++ H H      
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSHGIL--- 120

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA-NEK 959
            HRD+  + +L++ E    ++DFG A+        ++    T  Y APEL    +  +  
Sbjct: 121 -HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 960 CDVFNFGVLVLEVIEGK 976
            D+++ G +  E++  +
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.3 bits (149), Expect = 7e-10
 Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 8/142 (5%)

Query: 841 FCSH--TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
           FC+    +HLF V EYL  G L   + +  ++   D ++       +   L ++H     
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKK--- 115

Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            I++RD+    VLLD +    ++DFG  K         S   GT  YIAPE+    + NE
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 959 KCDVFNFGVLVLEVIEGKHPGH 980
             D ++FGVL+ E++ G+ P H
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.7 bits (147), Expect = 8e-10
 Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 25/255 (9%)

Query: 799  SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLE 856
            +G+  AVK L     G    + K  +  +  + H NIVK+ G C+      + L+ E+L 
Sbjct: 32   TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 857  RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
             GSL   L       +++  +++     +   + Y+    +   +HRD++++ VL++ E+
Sbjct: 92   SGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEH 146

Query: 917  KAHVSDFGTAKFLKPDSSNWS---ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
            +  + DFG  K ++ D   ++   +L     + APE     +     DV++FGV + E++
Sbjct: 147  QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 974  ----EGKHPGHFLSLLLSLPAPA-ANMNI--VVNDLID-SRLPPPLGEVEEKLKSMIAVA 1025
                    P   ++L L +  P    M +  +V  L +  RLP P    EE  + M    
Sbjct: 207  TYCDSESSP---MTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRK-- 261

Query: 1026 FLCLDANPDCRPTMQ 1040
              C +  P  R T Q
Sbjct: 262  --CWEFQPSKRTTFQ 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 1e-09
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 6/127 (4%)

Query: 330 IRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELS 389
           I GL +    L G IP ++ +L+ L  ++LS N + G+IP  LG++++L+   L  N  +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 390 GSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTH---FSVRNNNFVGPIPRSLQN 446
           GSIP+ +  +  L    L  N  +G +P  +   G L H   F+  +N  +  IP  L+ 
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL--GGRLLHRASFNFTDNAGLCGIP-GLRA 536

Query: 447 CTSLYSL 453
           C    S+
Sbjct: 537 CGPHLSV 543

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 1e-09
 Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 15/104 (14%)

Query: 101 LALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLES 160
           L L    L G IP  +  L +L  ++LS NS+ G IPP+               LG++ S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS---------------LGSITS 467

Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIG 204
              + L  N+F+G IP SLG L +L  + LN N + G +P+ +G
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 51/276 (18%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYG 840
            G+G  GTVYK     +G   A+K ++      +   ++    EI  +R   H N+VK + 
Sbjct: 83   GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICREIEILRDVNHPNVVKCHD 139

Query: 841  FCSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
               H   + ++ E+++ GSL  T +++E   A+        V + + + ++Y+H      
Sbjct: 140  MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD--------VARQILSGIAYLHRR---H 188

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP--DSSNWSELAGTCGYIAPE-----LAY 952
            I+HRDI    +L++      ++DFG ++ L    D  N S   GT  Y++PE     L +
Sbjct: 189  IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNH 246

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHP------GHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
                    D+++ GV +LE   G+ P      G + SL+      A  M         S+
Sbjct: 247  GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-----AICM---------SQ 292

Query: 1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
             P        + +  I+    CL   P  R +  ++
Sbjct: 293  PPEAPATASREFRHFIS---CCLQREPAKRWSAMQL 325

Length = 353

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 62/268 (23%), Positives = 121/268 (45%), Gaps = 31/268 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          A+K   SL  G +    + F++E   + +++H  +V+ Y  
Sbjct: 15   GAGQFGEVWMGYYNGHTKVAIK---SLKQGSMSP--EAFLAEANLMKQLQHPRLVRLYAV 69

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L       +L  +K +++   +A  ++++    +   +
Sbjct: 70   VTQ-EPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKNY---I 124

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 125  HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 961  DVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPA-ANMNIVVNDLIDSRLPPPLGEVEEKL 1018
            DV++FG+L+ E++  G+           +P P   N  ++ N     R+P P    EE  
Sbjct: 185  DVWSFGILLTEIVTYGR-----------IPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            + M     LC    P+ RPT + + ++L
Sbjct: 234  ELMR----LCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 37/268 (13%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VY A ++ + +  A+KK+ S    +     +  + E+     I+H N +++ G
Sbjct: 34   GHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 841  FCSHTQHL-FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             C   +H  +LV EY   GS + +L  E     L   +   +  G    L+Y+H      
Sbjct: 93   -CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE- 958
            ++HRDI +  +LL    +  ++DFG+A    P +S      GT  ++APE+   M   + 
Sbjct: 146  MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQY 201

Query: 959  --KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE- 1015
              K DV++ G+  +E+ E K P      L ++ A +A  +I  N+       P L   E 
Sbjct: 202  DGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQNE------SPTLQSNEW 249

Query: 1016 -EKLKSMIAVAFLCLDANPDCRPTMQKV 1042
             +  ++ +     CL   P  RPT +++
Sbjct: 250  SDYFRNFVDS---CLQKIPQDRPTSEEL 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 58/263 (22%), Positives = 108/263 (41%), Gaps = 20/263 (7%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
            G G    VY+A  L  G   A+KK+      +          +  + ++ H N++K+Y  
Sbjct: 11   GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGVANALSYMHHDCFPPI 900
                  L +V E  + G L+ ++ +      L   K V      + +AL +MH      +
Sbjct: 71   FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RV 127

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRDI    V +       + D G  +F    ++    L GT  Y++PE  +    N K 
Sbjct: 128  MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP-PLGEVEEKLK 1019
            D+++ G L+ E+   + P +             N+  +   +     PP P     E+L+
Sbjct: 188  DIWSLGCLLYEMAALQSPFY---------GDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238

Query: 1020 SMIAVAFLCLDANPDCRPTMQKV 1042
             ++    +C++ +P+ RP +  V
Sbjct: 239  QLVN---MCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 69/262 (26%), Positives = 113/262 (43%), Gaps = 43/262 (16%)

Query: 799  SGDTRAVKKL-HSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVY 852
            +G+  AVKKL HS        + + F  EI     ++H NIVK+ G C  +  ++L LV 
Sbjct: 32   TGEVVAVKKLQHSTAE-----HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86

Query: 853  EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL 912
            EYL  GSL   L        LD  K +     +   + Y+    +   +HRD++++ +L+
Sbjct: 87   EYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKRY---VHRDLATRNILV 141

Query: 913  DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI---APELAYTMRANEKCDVFNFGVLV 969
            + E +  + DFG  K L  D   +         I   APE     + +   DV++FGV++
Sbjct: 142  ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201

Query: 970  LEV-----IEGKHPGHFLSLLLSLPAPAANMNIVVNDLID-----SRLPPPLG---EVEE 1016
             E+          P  F+ ++           ++V  LI+      RLP P G   E+  
Sbjct: 202  YELFTYSDKSCSPPAEFMRMM----GNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA 257

Query: 1017 KLKSMIAVAFLCLDANPDCRPT 1038
             +K        C + +P  RP+
Sbjct: 258  IMKE-------CWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 46/271 (16%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VYKA+   +G   A K + +    E+    + ++ EI       H  IVK  G
Sbjct: 21   GDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYMVEIEILATCNHPYIVKLLG 76

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVI-KGVANALSYMHHDC 896
                   L+++ E+   G++      +A   ELD      ++ VI + +  AL Y+H   
Sbjct: 77   AFYWDGKLWIMIEFCPGGAV------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM- 129

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFG-TAKFLKPDSSNWSELAGTCGYIAPELAY--T 953
               I+HRD+ +  VLL L+    ++DFG +AK +K      S   GT  ++APE+    T
Sbjct: 130  --KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-FIGTPYWMAPEVVMCET 186

Query: 954  MRA---NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
            M+    + K D+++ G+ ++E+ + + P H L+ +  L      + I  ++      PP 
Sbjct: 187  MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSE------PPT 234

Query: 1011 LGEVEE---KLKSMIAVAFLCLDANPDCRPT 1038
            L +  +   + +  +  A   LD +P+ RP+
Sbjct: 235  LSQPSKWSMEFRDFLKTA---LDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)

Query: 847  HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDIS 906
            +L+LV +Y   G L T+LS        D ++    I  +  A+  +H   +   +HRDI 
Sbjct: 75   YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--IAEMVLAIHSIHQLHY---VHRDIK 129

Query: 907  SKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTM-----RANEKC 960
               VLLD+     ++DFG+   +  D +  S +A GT  YI+PE+   M     +   +C
Sbjct: 130  PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D ++ GV + E++ G+ P +  SL+            ++N     + P  + +V E+ K 
Sbjct: 190  DWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEERFQFPSHITDVSEEAKD 242

Query: 1021 MI 1022
            +I
Sbjct: 243  LI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 39/215 (18%)

Query: 785 GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V KA +     R   A+K++    + +   + + F  E+  +     H NI+ 
Sbjct: 16  GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIIN 72

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE-------------ATAAELDWSKRVNVIKG 884
             G C H  +L+L  EY   G+L   L                +TA+ L   + ++    
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           VA  + Y+    F   +HRD++++ +L+   Y A ++DFG ++           +  T G
Sbjct: 133 VARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMG 183

Query: 945 -----YIAPE-LAYTMRANEKCDVFNFGVLVLEVI 973
                ++A E L Y++      DV+++GVL+ E++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 59.1 bits (144), Expect = 3e-09
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 32/205 (15%)

Query: 785 GTGGCGTVYKAELT-SGDTRAVKK--LHSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
           G G    VYKA    +G   A+KK  L      + GIN      EI    E++H NI+  
Sbjct: 9   GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHPNIIGL 67

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH----- 893
                H  ++ LV+E++E   L  ++            K  +++   A+  SYM      
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVI------------KDKSIVLTPADIKSYMLMTLRG 114

Query: 894 ----HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
               H  +  ILHRD+    +L+  +    ++DFG A+     +   +    T  Y APE
Sbjct: 115 LEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 950 LAYTMRA-NEKCDVFNFGVLVLEVI 973
           L +  R      D+++ G +  E++
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 44/287 (15%)

Query: 781  MVLHGTGGCGTVYKA-----ELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIR 831
            +   G G  G V+ A     E   G+T   VK L       +   Q  F  E+    ++ 
Sbjct: 10   ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL---QSEFRRELDMFRKLS 66

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL------SNEATAAELDWSKRVNVIKGV 885
            H+N+V+  G C   +  +++ EY + G L   L        +     L   ++V +   +
Sbjct: 67   HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 886  ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT--- 942
            A  + ++ +  F   +HRD++++  L+  + +  VS    +K     +S + +L      
Sbjct: 127  ALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIP 181

Query: 943  CGYIAPELAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVND 1001
              ++APE       + K DV++FGVL+ EV  +G+           LP    +   V+N 
Sbjct: 182  LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----------LPFYGLSDEEVLNR 230

Query: 1002 LI--DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            L      LP P G      K M      C   NP  RP+  ++ + L
Sbjct: 231  LQAGKLELPVPEGCPSRLYKLMTR----CWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 796 ELTSGDTRAVKK-LHSLPTGEIGI--------NQKGFVSEI---TEIRHR----NIVKFY 839
           EL SG+   VKK ++ +   +I +        N+K    E+    EI H+     IV+  
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           G C   + L LV E    G L   LS      E+  S  V ++  V+  + Y+    F  
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF-- 116

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPELAYTM 954
            +HRD++++ VLL  ++ A +SDFG +K L  D S +   A + G     + APE     
Sbjct: 117 -VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFR 173

Query: 955 RANEKCDVFNFGVLVLEVIE-GKHP 978
           + + + DV+++G+ + E    G+ P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 260 LYLSHNQLNGSLPSSFGNLSSLKHLHVHNI--NKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
           L L +  L G +P+   ++S L+HL   N+  N + G+IP  +G++ SL  L LS    +
Sbjct: 423 LGLDNQGLRGFIPN---DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELG 349
           G IP SLG L+++R L +  N L G +P  LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 785 GTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           G G  G VYK ELT      S  + A+K L      ++    +     +++++H NIV  
Sbjct: 14  GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCL 73

Query: 839 YGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVIKGV 885
            G C+  Q   +++EYL  G L   L              +E   + LD S  +++   +
Sbjct: 74  LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133

Query: 886 ANALSYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT- 942
           A  + Y+  HH      +HRD++++  L+       +SDFG ++ +   S+++  +    
Sbjct: 134 AAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADYYRVQSKS 186

Query: 943 ---CGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
                ++ PE     +   + D+++FGV++ E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 58.7 bits (143), Expect = 4e-09
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 30/179 (16%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKL-HSLPTGEIGINQKGFVSEITEIR----HRNIVKF 838
           G G  G+VY A    +G+  A+KK+     + E  +N +    E+  +R    H NIVK 
Sbjct: 8   GDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKL 63

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                    L+ V+EY+E      +   +        S   ++I  +   L+++H   F 
Sbjct: 64  KEVFRENDELYFVFEYMEGNLYQLMKDRKGKP--FSESVIRSIIYQILQGLAHIHKHGF- 120

Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFL--KPD-----SSNWSELAGTCGYIAPEL 950
              HRD+  + +L+       ++DFG A+ +  +P      S+ W        Y APE+
Sbjct: 121 --FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW--------YRAPEI 169

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 20/197 (10%)

Query: 783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFY 839
           L G G  G V+K  L      AVK        E+ I    F+SE   + +  H NIVK  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK---FLSEARILKQYDHPNIVKLI 58

Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
           G C+  Q +++V E +  G   + L  +    EL   + V      A  ++Y+   +C  
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG----TCGYIAPELAYTM 954
             +HRD++++  L+       +SDFG ++  + D   +S  +G       + APE     
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSS-SGLKQIPIKWTAPEALNYG 169

Query: 955 RANEKCDVFNFGVLVLE 971
           R + + DV+++G+L+ E
Sbjct: 170 RYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ----KGFVSEITEIRHR 833
           GK++  G G  G VY   ++ +G   AVK++   P       +    +  +  +  ++H 
Sbjct: 7   GKLL--GQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64

Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            IV++YG     + L +  EY+  GS+   L        L  +      + +   + Y+H
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLH 121

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP---DSSNWSELAGTCGYIAPEL 950
            +    I+HRDI    +L D      + DFG +K L+      +    + GT  +++PE+
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 951 AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                   K DV++ G  V+E++  K P
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.4 bits (141), Expect = 7e-09
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 6/135 (4%)

Query: 846 QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI 905
           +HLF V E+L  G L   + ++      D  +       +   L ++H      I++RD+
Sbjct: 69  EHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDL 122

Query: 906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNF 965
               V+LD +    ++DFG  K      +  S   GT  YIAPE+   ++     D ++F
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 966 GVLVLEVIEGKHPGH 980
           GVL+ E++ G+ P H
Sbjct: 183 GVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.8 bits (142), Expect = 8e-09
 Identities = 75/263 (28%), Positives = 108/263 (41%), Gaps = 10/263 (3%)

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
           +PS +  L SL  L  +    S        NL  L  L L+ NRL   I   L    +L 
Sbjct: 62  LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLT 119

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
            L L +N +    P      S+LK L + + NK+  S+P  + NL +L +L LS   LS 
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSD-NKIE-SLPSPLRNLPNLKNLDLSFNDLSD 177

Query: 319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNL 378
            +P  L NLSN+  L +  N     +P E+  L +L +L LS N +   +   L NL NL
Sbjct: 178 -LPKLLSNLSNLNNLDLSGN-KISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234

Query: 379 KFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVG 438
               L  N+L   +P+ I N+  L    L  NQ +           +L    +  N+   
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLT--NLRELDLSGNSLSN 291

Query: 439 PIPRSLQNCTSLYSLRLERNQLT 461
            +P        L  L      L 
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLK 314

Length = 394

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 14/142 (9%)

Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       E + ++ V+    V+  + Y+  
Sbjct: 58  IVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYLEE 113

Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L  D + +   A T G     + APE
Sbjct: 114 TNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPE 168

Query: 950 LAYTMRANEKCDVFNFGVLVLE 971
                + + K DV++FGVL+ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 827 ITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV-IKG 884
           + E+ H  IVK  Y F +  + L+L+ ++L  G L T LS E    E D    V   +  
Sbjct: 52  LAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAE 106

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           +A AL ++H      I++RD+  + +LLD E    ++DFG +K             GT  
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163

Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           Y+APE+       +  D ++FGVL+ E++ G  P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 36/271 (13%)

Query: 785  GTGGCGTVYK-AELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G G  G VYK      G   AVK L  +   +  I  +  + +     H N+VKFYG   
Sbjct: 31   GKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-NHPNVVKFYGMFY 89

Query: 844  HTQH-----LFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALSYMHHDCF 897
                     L+LV E    GS+  ++       + LD +    ++ G    L ++H++  
Sbjct: 90   KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL-----AY 952
              I+HRD+    +LL  E    + DFG +  L       +   GT  ++APE+      Y
Sbjct: 148  -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHP---GHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009
                + +CDV++ G+  +E+ +G  P    H +  L  +P                R PP
Sbjct: 207  DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP----------------RNPP 250

Query: 1010 P-LGEVEEKLKSMIAVAFLCLDANPDCRPTM 1039
            P L   E+  +S       CL  + + RP++
Sbjct: 251  PTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 26/266 (9%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G    VY+A  L      A+KK+      +    Q   V EI    ++ H N++K+  
Sbjct: 11   GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD-CVKEIDLLKQLNHPNVIKYLD 69

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGVANALSYMHHDCFPP 899
                   L +V E  + G L+ ++        L   + V      + +A+ +MH      
Sbjct: 70   SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
            ++HRDI    V +       + D G  +F    ++    L GT  Y++PE  +    N K
Sbjct: 127  VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI--VVNDLIDSRLPP-PLGEVEE 1016
             D+++ G L+ E+             L  P     MN+  +   +     PP P     E
Sbjct: 187  SDIWSLGCLLYEMA-----------ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKV 1042
            KL+ +++   +C+  +PD RP +  V
Sbjct: 236  KLRELVS---MCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 46/286 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRA---VKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  G V   E   G ++A   VK+L +  T +    Q  F+ E+    E+ H N+++ 
Sbjct: 4    GNGWFGKVLLGEAHRGMSKARVVVKELRASATPD---EQLLFLQEVQPYRELNHPNVLQC 60

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGVANALSYMHHDC 896
             G C  +    LV E+   G L   L +          K V   +   VA+ L ++H   
Sbjct: 61   LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTA------KFLKPDSSNWSELAGTCGYIAPEL 950
            F   +H D++ +   L  +    + D+G A       +      +   L     ++APEL
Sbjct: 121  F---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPEL 173

Query: 951  AYTMRAN-------EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
                  +       +K ++++ GV + E          L      P P  +   V+  ++
Sbjct: 174  VEIRGQDLLPKDQTKKSNIWSLGVTMWE----------LFTAADQPYPDLSDEQVLKQVV 223

Query: 1004 ---DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               D +LP P  +++   +    + F  LD  P+ RPT ++V  LL
Sbjct: 224  REQDIKLPKPQLDLKYSDRWYEVMQFCWLD--PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 30/223 (13%)

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL-SNEATAAELD--WSKRVNVIKGVANA 888
            H NIV   G C+    + ++ EY   G L   L     +   L+   S    V KG+A  
Sbjct: 98   HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGY 945
             S    +C    +HRD++++ VLL       + DFG A+ +  D SN+           +
Sbjct: 158  AS---KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKW 209

Query: 946  IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
            +APE  +      + DV+++G+L+ E+          SL  + P P   ++     LI  
Sbjct: 210  MAPESIFNCVYTFESDVWSYGILLWEI---------FSLGSN-PYPGMPVDSKFYKLIKE 259

Query: 1006 --RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              R+  P     E    M      C DA+P  RPT +++  L+
Sbjct: 260  GYRMAQPEHAPAEIYDIMKT----CWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 36/256 (14%)

Query: 785  GTGGCGTVYKAELTSGDT-RAVKKLHSLPTGEIGINQKGFVSE----ITEIRHRNIVKFY 839
            G G  GTVY  +         +K L  +P GE+  N+    ++    ++++ H  IVKF+
Sbjct: 9    GKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFH 68

Query: 840  GFCSHTQHLFLVYEYLERGSLATILS----NEATAAE---LDWSKRVNVIKGVANALSYM 892
                      ++ EY E   L   L        T +E    +W   + ++ GV     YM
Sbjct: 69   ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQLLLGV----HYM 122

Query: 893  HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY 952
            H      ILHRD+ +K + L       + DFG ++ L       +   GT  Y++PE   
Sbjct: 123  HQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHP---GHFLSLLLSL---PAPA------ANMNIVVN 1000
                + K D+++ G ++ E+    H     +FLS++L +   P P+        +N ++ 
Sbjct: 179  HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238

Query: 1001 DLI--DSRLPPPLGEV 1014
             ++  D  L P   E+
Sbjct: 239  SMLNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 61/269 (22%), Positives = 123/269 (45%), Gaps = 33/269 (12%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+ A        AVK   ++  G + +  + F++E   +  ++H  +VK +  
Sbjct: 15   GAGQFGEVWMATYNKHTKVAVK---TMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV 69

Query: 842  CSHTQHLFLVYEYLERGSLATIL-SNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             +  + ++++ E++ +GSL   L S+E +   L   K ++    +A  ++++    +   
Sbjct: 70   VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 123

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEK 959
            +HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K
Sbjct: 124  IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 960  CDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-RLPPPLGEVEEK 1017
             DV++FG+L++E++  G+           +P P  +   V+  L    R+P P    EE 
Sbjct: 184  SDVWSFGILLMEIVTYGR-----------IPYPGMSNPEVIRALERGYRMPRPENCPEEL 232

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               M+     C    P+ RPT + + ++L
Sbjct: 233  YNIMMR----CWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 18/210 (8%)

Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLP-TGEIGINQKGFVSEI---TEIRHR 833
           GK++  G G  G VY   ++ +G   A K++   P + E          EI     ++H 
Sbjct: 7   GKLL--GQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64

Query: 834 NIVKFYG-FCSHTQHLFLVY-EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
            IV++YG      +    ++ EY+  GS+   L       E   S      + +   +SY
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSY 121

Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP---DSSNWSELAGTCGYIAP 948
           +H +    I+HRDI    +L D      + DFG +K L+      +    + GT  +++P
Sbjct: 122 LHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E+        K DV++ G  V+E++  K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 20/183 (10%)

Query: 847  HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA-NALSYMHHDCFPPILHRDI 905
            +L+LV +Y   G L T+LS        D ++       +A +++  +H+      +HRDI
Sbjct: 75   NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY------VHRDI 128

Query: 906  SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTM-----RANEK 959
                +L+D+     ++DFG+   L  D +  S +A GT  YI+PE+   M     +   +
Sbjct: 129  KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPE 188

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019
            CD ++ GV + E++ G+ P +  SL+            ++N     + P  + +V E  K
Sbjct: 189  CDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERFQFPAQVTDVSEDAK 241

Query: 1020 SMI 1022
             +I
Sbjct: 242  DLI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 55.6 bits (135), Expect = 4e-08
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 50/217 (23%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKL--HSLPTG-------EIGINQKGFVSEITEIRHRN 834
           G G  G VYKA    +G+  A+KK+   +   G       EI + QK        +RH N
Sbjct: 8   GEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQK--------LRHPN 59

Query: 835 IVKFYGFC-SHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVA--- 886
           IV+      S  +  +++V+EY++   L  +L +     T ++         IK      
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ---------IKCYMKQL 109

Query: 887 -NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSELAGTCG 944
              L Y+H +    ILHRDI    +L++ +    ++DFG A+     +S +++    T  
Sbjct: 110 LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166

Query: 945 YIAPEL-----AYTMRANEKCDVFNFGVLVLEVIEGK 976
           Y  PEL      Y      + D+++ G ++ E+  GK
Sbjct: 167 YRPPELLLGATRYG----PEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 63/267 (23%), Positives = 112/267 (41%), Gaps = 30/267 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G VYKA+       A  K+    + E     + ++ EI       H NIVK    
Sbjct: 14   GDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 842  CSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  +L+++ E+   G++ A +L  E    E    +   V K    AL+Y+H +    I
Sbjct: 71   FYYENNLWILIEFCAGGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN---KI 124

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE-- 958
            +HRD+ +  +L  L+    ++DFG +              GT  ++APE+     + +  
Sbjct: 125  IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 959  ---KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
               K DV++ G+ ++E+ + + P H L+ +  L      + I  ++      PP L +  
Sbjct: 185  YDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSE------PPTLAQPS 232

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                        CL+ N D R T  ++
Sbjct: 233  RWSSEFKDFLKKCLEKNVDARWTTTQL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 68/276 (24%), Positives = 110/276 (39%), Gaps = 53/276 (19%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEI------GINQKGFVSEITEIRHR 833
            G G  G VY   L   D +    AVK L+ +    E+      GI  K F        H 
Sbjct: 4    GKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-------SHP 56

Query: 834  NIVKFYGFCSHTQHLFLV-YEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANAL 889
            N++   G C  ++   LV   Y++ G L   + +E    T  +L     +     VA  +
Sbjct: 57   NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK------FLKPDSSNWSELAGTC 943
             Y+    F   +HRD++++  +LD  +   V+DFG A+      +    +   ++L    
Sbjct: 112  EYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--V 166

Query: 944  GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
             ++A E   T +   K DV++FGVL+ E++    P          P P  +   +   L+
Sbjct: 167  KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----------PYPDVDSFDITVYLL 216

Query: 1004 DS-RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
               RL  P    E     +  V   C    P+ RPT
Sbjct: 217  QGRRLLQP----EYCPDPLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 7e-08
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 33/187 (17%)

Query: 847  HLFLVYEYLERGSLATILSN-----EATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            +L+LV +Y   G L T+LS          A    ++ V  I  V + L Y         +
Sbjct: 75   NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV-HQLGY---------V 124

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTM-----R 955
            HRDI    VLLD      ++DFG+   L  D +  S +A GT  YI+PE+   M     R
Sbjct: 125  HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLL------------LSLPAPAANMNIVVNDLI 1003
               +CD ++ GV + E++ G+ P +  SL+               P    +++    DLI
Sbjct: 185  YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244

Query: 1004 DSRLPPP 1010
               +  P
Sbjct: 245  RRLICSP 251

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 13/153 (8%)

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
           FY F    ++L++V EY+  G L  ++SN     +  W++       V  AL  +H   F
Sbjct: 109 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHSMGF 163

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTMRA 956
              +HRD+    +LLD      ++DFGT   +  +     + A GT  YI+PE+  +   
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 957 N----EKCDVFNFGVLVLEVIEGKHPGHFLSLL 985
           +     +CD ++ GV + E++ G  P +  SL+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 7e-08
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 16/206 (7%)

Query: 783 LHGTGGCGTVYKA-ELTSGDTRAVKKLHSLP-TGEIGINQKGFVSEITEIR---HRNIVK 837
           L G G  G VY   +  +G   AVK++   P + E          EI  ++   H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 838 FYGFCSHTQH--LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
           +YG         L +  E++  GS+   L +     E + +++    + +   +SY+H +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHSN 125

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP---DSSNWSELAGTCGYIAPELAY 952
               I+HRDI    +L D      + DFG +K L+      +    + GT  +++PE+  
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 953 TMRANEKCDVFNFGVLVLEVIEGKHP 978
                 K D+++ G  V+E++  K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 54.8 bits (132), Expect = 8e-08
 Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 16/201 (7%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKKLHS----LPTGEIG-INQKGFVSEITEIRHRNIVKF 838
           G GG G V   ++  +G   A KKL         GE   +N+K  + +++    R IV  
Sbjct: 2   GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS---RFIVSL 58

Query: 839 -YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            Y F +    L LV   +  G L   + N         ++ +     +   L ++H    
Sbjct: 59  AYAFETKD-DLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR-- 114

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
             I++RD+  + VLLD      +SD G A  L          AGT GY+APE+      +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 958 EKCDVFNFGVLVLEVIEGKHP 978
              D F  G  + E+I G+ P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 31/85 (36%), Positives = 43/85 (50%)

Query: 433 NNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW 492
           N    G IP  +     L S+ L  N + GNI    G    LE+LDLS N+F G I  + 
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 493 IKCPQLATLNMGGNEISGTIPSEIG 517
            +   L  LN+ GN +SG +P+ +G
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 39/176 (22%), Positives = 74/176 (42%), Gaps = 38/176 (21%)

Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN---VIK 883
           + ++ H +++K YG CS    L L+ EY + GSL + L           S++V    +  
Sbjct: 57  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE---------SRKVGPSYLGS 107

Query: 884 GVANALSYMHHDCFPPI------------------------LHRDISSKKVLLDLEYKAH 919
                 SY+ +     +                        +HRD++++ VL+    K  
Sbjct: 108 DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMK 167

Query: 920 VSDFGTAKFLKPDSSNWSELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
           +SDFG ++ +  + S      G     ++A E  +      + DV++FGVL+ E++
Sbjct: 168 ISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 47/197 (23%), Positives = 88/197 (44%), Gaps = 15/197 (7%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G V+K     +G   A+KK   + + +  + +K  + EI    +++H N+V    
Sbjct: 10  GEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPP 899
                + L LV+EY +   L  +   E     +       +I     A+++ H H+C   
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY-TMRANE 958
            +HRD+  + +L+  + +  + DFG A+ L     ++++   T  Y APEL     +   
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 959 KCDVFNFGVLVLEVIEG 975
             DV+  G +  E++ G
Sbjct: 181 PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 43/220 (19%)

Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEI----RH 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  +    +H
Sbjct: 24  GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 80

Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L                    ++ +   V
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    VA  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 141 SCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDY 192

Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 18/154 (11%)

Query: 841 FCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
           FC+    ++L++V EY+  G L  ++SN     +  W+K       V  AL  +H     
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYTA--EVVLALDAIHS---M 161

Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTMR 955
            ++HRD+    +LLD      ++DFGT   +K D +         GT  YI+PE+  +  
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 956 AN----EKCDVFNFGVLVLEVIEGKHPGHFLSLL 985
            +     +CD ++ GV + E++ G  P +  SL+
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 74/274 (27%), Positives = 115/274 (41%), Gaps = 57/274 (20%)

Query: 784  HGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR----NIVKF 838
            HG GG  TVYKA  L +    AVK +    T E+   QK  +SE+ EI ++     I+ F
Sbjct: 11   HGNGG--TVYKAYHLLTRRILAVKVIPLDITVEL---QKQIMSEL-EILYKCDSPYIIGF 64

Query: 839  YGFCSHTQHLFLVYEYLERGSLAT-------ILSNEATAAELDWSKRVNVIKGVANALSY 891
            YG       + +  E+++ GSL         +L   A A          V+KG+    S 
Sbjct: 65   YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA----------VVKGLTYLWSL 114

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA 951
                    ILHRD+    +L++   +  + DFG +  L   +S      GT  Y+APE  
Sbjct: 115  -------KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERI 165

Query: 952  YTMRANEKCDVFNFGVLVLEVIEGKHP-----GHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
               +     DV++ G+  +E+  G+ P      +  SL+     P   +  +V++     
Sbjct: 166  SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-----PLQLLQCIVDE----- 215

Query: 1007 LPP--PLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
             PP  P+G+  EK    I     C+   P  RP 
Sbjct: 216  DPPVLPVGQFSEKFVHFIT---QCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 17/198 (8%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G V K +   +G   A+KK   L + +  + +K  + EI    ++RH N+V    
Sbjct: 10  GEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 841 FCSHTQHLFLVYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
                + L+LV+E+++     T+L + E     LD S+    +  +   + + H H+   
Sbjct: 68  VFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120

Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY-TMRAN 957
            I+HRDI  + +L+       + DFG A+ L      +++   T  Y APEL     +  
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 958 EKCDVFNFGVLVLEVIEG 975
              D++  G LV E++ G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 22/205 (10%)

Query: 785 GTGGCGTVYKAELTSGDTRAVK---KLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKF 838
           G G  G VY+      D  AV+    + +LP      ++  F+ E   +++  H+NIV+ 
Sbjct: 15  GHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRL 74

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAE----LDWSKRVNVIKGVANALSYMHH 894
            G        F++ E +  G L + L       E    L     +   + VA    Y+  
Sbjct: 75  IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134

Query: 895 DCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSELAGTC----GYIA 947
           + F   +HRDI+++  LL  +     A ++DFG A+ +    +++    G       ++ 
Sbjct: 135 NHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIKWMP 189

Query: 948 PELAYTMRANEKCDVFNFGVLVLEV 972
           PE         K DV++FGVL+ E+
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 20/197 (10%)

Query: 796 ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKF-----YGFCSHTQHLFL 850
           E  +GD  A+K +              F  E  +I   +   +     Y F     +L+L
Sbjct: 22  EKATGDIYAMKVMKKSVLL--AQETVSFFEEERDILSISNSPWIPQLQYAF-QDKDNLYL 78

Query: 851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKV 910
           V EY   G L ++L+      + D       +  +  A+  +H   +   +HRDI  + V
Sbjct: 79  VMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMGY---VHRDIKPENV 133

Query: 911 LLDLEYKAHVSDFGTAKFLKPDSSNWSEL-AGTCGYIAPELAYTMRANEK------CDVF 963
           L+D      ++DFG+A  L  +    S+L  GT  YIAPE+  TM  + K      CD +
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193

Query: 964 NFGVLVLEVIEGKHPGH 980
           + GV+  E+I G+ P H
Sbjct: 194 SLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA +  + +T A+KK+  L   + G+       +S + E++H NIV+    
Sbjct: 11  GEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----VANALSYMHHDCF 897
               + L+LV+EYL+   L   + +       D++K   +IK     +   ++Y H    
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSP-----DFAKNPRLIKTYLYQILRGIAYCHSH-- 121

Query: 898 PPILHRDISSKKVLLDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
             +LHRD+  + +L+D    A  ++DFG A+        ++    T  Y APE+    R 
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180

Query: 957 -NEKCDVFNFGVLVLEVIEGK 976
            +   D+++ G +  E++  K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 18/203 (8%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIG-----INQKGFVSEITEIRHRNIVKF 838
           G G  GTVYKA +  SG   A+K +  + T E G     + +   +  +    H NIV+ 
Sbjct: 9   GVGAYGTVYKARDPHSGHFVALKSVR-VQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 839 YGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
              C+ ++      + LV+E++++  L T L  +     L      ++++     L ++H
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLD-KVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
            +C   I+HRD+  + +L+    +  ++DFG A+      +  + +  T  Y APE+   
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLLQ 181

Query: 954 MRANEKCDVFNFGVLVLEVIEGK 976
                  D+++ G +  E+   K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 23/184 (12%)

Query: 804 AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL 860
           AVK L   P       ++ F+ E+   + +   NI +  G C+    L ++ EY+E G L
Sbjct: 50  AVKVL--RPDASDNA-REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 861 ATILS--------NEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL 912
              L             +  L +S  + +   +A+ + Y+    F   +HRD++++  L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCLV 163

Query: 913 DLEYKAHVSDFGTAKFLKPDSSNWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVL 968
              Y   ++DFG ++ L   SS++  + G       ++A E     +   K DV+ FGV 
Sbjct: 164 GKNYTIKIADFGMSRNLY--SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 969 VLEV 972
           + E+
Sbjct: 222 LWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 57/239 (23%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVS--EITEIRHR--NIVKFY 839
           G+G CG VYK     +G   AVK++      E     K  +   ++    H    IVK Y
Sbjct: 24  GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN----------VIKGVANAL 889
           G+      +F+  E +            +T  +    KR+           +   +  AL
Sbjct: 81  GYFITDSDVFICMELM------------STCLD-KLLKRIQGPIPEDILGKMTVAIVKAL 127

Query: 890 SYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
            Y+   H     ++HRD+    +LLD      + DFG +  L  DS   +  AG   Y+A
Sbjct: 128 HYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGCAAYMA 182

Query: 948 PEL--------AYTMRANEKCDVFNFGVLVLEVIEGKHPGH-------FLSLLLSLPAP 991
           PE          Y +RA    DV++ G+ ++E+  G+ P          L+ +L    P
Sbjct: 183 PERIDPPDPNPKYDIRA----DVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 14/195 (7%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 9   GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPI 900
                 L+LV+E+L +     + ++  +   L   K  + +  +   L++ H H     +
Sbjct: 68  IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHR----V 121

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           LHRD+  + +L++ E    ++DFG A+ F  P  +   E+  T  Y APE+    +  + 
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180

Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 181 AVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 28/117 (23%), Positives = 58/117 (49%), Gaps = 6/117 (5%)

Query: 857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
              L T L+  +    +D  + + + K +   L Y+H      I+HRD+ ++ + ++   
Sbjct: 140 SSDLYTYLTKRSRPLPID--QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVD 194

Query: 917 KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
           +  + D G A+F    +  +  LAGT    APE+    + N K D+++ G+++ E++
Sbjct: 195 QVCIGDLGAAQF-PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 18/202 (8%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-------HRNIV 836
           G G  G V  A L  SG   AVK L      ++ +        +TE R       H  + 
Sbjct: 4   GKGSFGKVMLARLKESGRLYAVKVLKK----DVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
           + Y        LF V E++  G L   + +   +   D ++       + +AL ++H   
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDK- 115

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              I++RD+    VLLD E    ++DFG  K    +    S   GT  YIAPE+   M  
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
               D +  GVL+ E++ G  P
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 57/203 (28%), Positives = 86/203 (42%), Gaps = 17/203 (8%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR------HRNIVK 837
           G GG G V   ++  +G   A KKL+     +    +KG+   + E R       R IV 
Sbjct: 2   GKGGFGEVSACQMRATGKLYACKKLNKKRLKK----RKGYEGAMVEKRILAKVHSRFIVS 57

Query: 838 F-YGFCSHTQHLFLVYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALSYMHHD 895
             Y F + T  L LV   +  G L   + N +         +       + + L ++H  
Sbjct: 58  LAYAFQTKTD-LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               I++RD+  + VLLD +    +SD G A  LK   S     AGT G++APEL     
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173

Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            +   D F  GV + E+I  + P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 10/198 (5%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVS-EITE-IRHRNIVKF-YG 840
           G GG G V   ++  +G   A KKL      +    +   +  EI E +    IV   Y 
Sbjct: 2   GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA 61

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
           F S T HL LV   +  G L   + N      L+  + ++    +   + ++H      I
Sbjct: 62  FESKT-HLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---MDI 116

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           ++RD+  + VLLD +    +SD G A  L  D    ++ AGT GY+APE+      +   
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 961 DVFNFGVLVLEVIEGKHP 978
           D F  G  + E++ G+ P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 4e-07
 Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 13/146 (8%)

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            Y F    ++L++V EY+  G L  ++SN        W++       V  AL  +H   F
Sbjct: 109 HYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWARFY--TAEVVLALDAIHSMGF 163

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTMRA 956
              +HRD+    +LLD      ++DFGT   +  +     + A GT  YI+PE+  +   
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 957 N----EKCDVFNFGVLVLEVIEGKHP 978
           +     +CD ++ GV + E++ G  P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 42/179 (23%), Positives = 89/179 (49%), Gaps = 16/179 (8%)

Query: 808 LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL 864
           +H+L  G     ++GF++E     +  H NIV+  G  +    + +V EY+  G+L + L
Sbjct: 38  IHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL 97

Query: 865 SNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG 924
                  +L   + + ++ G+A+ + Y+    +   +H+ +++ KVL++ +    +S F 
Sbjct: 98  RKH--EGQLVAGQLMGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFR 152

Query: 925 TAKFLKPDSSN--WSELAGTCG--YIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
               L+ D S   ++ ++G     + APE       +   DV++FG+++ EV+  G+ P
Sbjct: 153 R---LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.8 bits (126), Expect = 5e-07
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 15/142 (10%)

Query: 842 CSHTQ-HLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVIKGVANALSYMHHDCF 897
           C  T+  LF V EY+  G L   +  +    E     +S  +++      AL+Y+H    
Sbjct: 64  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER-- 115

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRA 956
             I++RD+    VLLD E    ++D+G  K  L+P  +  S   GT  YIAPE+      
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDY 173

Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
               D +  GVL+ E++ G+ P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 43/220 (19%)

Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEI----RH 832
           G G  G V +AE    D        T AVK L    T +   +    +SE+  +    +H
Sbjct: 21  GEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK---DLADLISEMELMKLIGKH 77

Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L               +    +L +   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 880 NVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK------FLKPD 932
           +    VA  + Y+    C    +HRD++++ VL+  +    ++DFG A+      + K  
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
           S+    +     ++APE  +      + DV++FG+L+ E+
Sbjct: 194 SNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 64/233 (27%), Positives = 96/233 (41%), Gaps = 53/233 (22%)

Query: 835  IVK-FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            +VK FY F    ++L+L+ E+L  G + T+L  + T +E         I     A+  +H
Sbjct: 63   VVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSE---EATQFYIAETVLAIDAIH 118

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK--------------PDS------ 933
               F   +HRDI    +LLD +    +SDFG    LK              P S      
Sbjct: 119  QLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 934  -----------SNWSELA----GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                        N  +LA    GT  YIAPE+      N+ CD ++ GV++ E++ G  P
Sbjct: 176  MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 979  GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDA 1031
              F S       P      V+N   ++ + PP   + EK K +I     C D+
Sbjct: 236  --FCS-----ETPQETYRKVMN-WKETLVFPPEVPISEKAKDLILR--FCTDS 278

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 52.0 bits (125), Expect = 7e-07
 Identities = 39/139 (28%), Positives = 59/139 (42%), Gaps = 9/139 (6%)

Query: 842 CSHTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPP 899
           C  T+  LF V EY+  G L   + +   +   D  +       +   L ++H       
Sbjct: 64  CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---- 116

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           I++RD+    VLLD E    ++DFG  K         S   GT  YIAPE+         
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA 176

Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E++ G+ P
Sbjct: 177 VDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 7e-07
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 17/160 (10%)

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPE 949
            +HH     ++HRDI S  +LL       + DFG +K      S+       GT  Y+APE
Sbjct: 156  VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 950  LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009
            +      ++K D+F+ GVL+ E+           L L  P    NM  V++  +  R  P
Sbjct: 216  IWRRKPYSKKADMFSLGVLLYEL-----------LTLKRPFDGENMEEVMHKTLAGRYDP 264

Query: 1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL-LCR 1048
                +  +++ ++  A L  D  P  RP+  K+ N+ +C+
Sbjct: 265  LPPSISPEMQEIVT-ALLSSD--PKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.9 bits (124), Expect = 9e-07
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 13/265 (4%)

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKL 402
              E L  L  L  L L++N+L  +I   L  L+NL    L  N ++  IP  I  +K  
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141

Query: 403 NKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG 462
            K L   +     LP  +    +L +  +  N+ +  +P+ L N ++L +L L  N+++ 
Sbjct: 142 LKELDLSDNKIESLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLSNLNNLDLSGNKIS- 199

Query: 463 NISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQL 522
           ++     +   LE LDLSNN+   E+ S+      L+ L +  N++   +P  IGN++ L
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 523 HKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSK 582
             LD S+N++   I   LG LT+L  L L+GN LS  +P    L+A L  L      L  
Sbjct: 258 ETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALP----LIALLLLLLELLLNLLL 311

Query: 583 -LIPKNLGELRKLHHLNLSNNQFSQ 606
            L    L     L + N+ +N  + 
Sbjct: 312 TLKALELKLNSILLNNNILSNGETS 336

Length = 394

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 8/132 (6%)

Query: 848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDIS 906
           LF V EY+  G L   +     + + D  +       V  AL ++H H     +++RD+ 
Sbjct: 71  LFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG----VIYRDLK 123

Query: 907 SKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFG 966
              +LLD E    ++DFG  K    +    +   GT  YIAPE+   +      D +  G
Sbjct: 124 LDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALG 183

Query: 967 VLVLEVIEGKHP 978
           VL+ E++ G+ P
Sbjct: 184 VLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.9 bits (124), Expect = 1e-06
 Identities = 57/172 (33%), Positives = 90/172 (52%), Gaps = 5/172 (2%)

Query: 509 SGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLA 568
           S      + N+  L  LD + NRL   I + L +LT+LTSL L+ N ++   PL   L +
Sbjct: 82  SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKS 140

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
            L  LDLS N++   +P  L  L  L +L+LS N  S ++   +  L  L+ LDLS N +
Sbjct: 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Query: 629 GGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSI 680
             ++P EI  L +LE ++L  N +   + S    +  LS +++S N+L+   
Sbjct: 199 -SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP 248

Length = 394

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 777 FEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPT-GEIGINQKGFVSEITE-----I 830
           FE   VL GTG  G V+     SG      KL+++    +  I QK   +E T      +
Sbjct: 2   FELLKVL-GTGAYGKVFLVRKVSGHDSG--KLYAMKVLKKATIVQKAKTTEHTRTERQVL 58

Query: 831 RHRNIVKF-----YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG- 884
            H     F     Y F + T+ L L+ +Y+  G L T LS      E    + V +  G 
Sbjct: 59  EHIRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE----QEVQIYSGE 113

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTC 943
           +  AL ++H      I++RDI  + +LLD      ++DFG +K F + +        GT 
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Query: 944 GYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGKHP 978
            Y+AP++        ++  D ++ GVL+ E++ G  P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLP-TGEIGINQKGFVSEI---TEIRHR 833
           GK++  G G  G VY   +  +G   AVK++   P + E          EI     +RH 
Sbjct: 7   GKLL--GRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 834 NIVKFYGFC--SHTQHLFLVY-EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
            IV++YG C     +    ++ EY+  GS+   L       E + ++R    + +   +S
Sbjct: 65  RIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVS 120

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP---DSSNWSELAGTCGYIA 947
           Y+H +    I+HRDI    +L D      + DFG +K ++      +    + GT  +++
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           PE+        K DV++    V+E++  K P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 22/213 (10%)

Query: 770 ELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGEIGINQKG-FVSE 826
           +LL   TF GK++L      G  Y  ++   +    K    H+L    +  N +  F++ 
Sbjct: 1   KLLGKGTF-GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-V 885
           +           Y F +H +  F V EY   G L   LS E   +E     R       +
Sbjct: 60  LK----------YSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE----DRARFYGAEI 104

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY 945
            +AL Y+H +    +++RD+  + ++LD +    ++DFG  K    D +      GT  Y
Sbjct: 105 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162

Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +APE+          D +  GV++ E++ G+ P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 21/212 (9%)

Query: 770 ELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEI 827
           +LL   TF GK++L      G  Y  ++   +    K    H+L    +          +
Sbjct: 1   KLLGKGTF-GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRV----------L 49

Query: 828 TEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
              RH  +    Y F +  +  F V EY+  G L   LS E   +E D ++       + 
Sbjct: 50  KNTRHPFLTSLKYSFQTKDRLCF-VMEYVNGGELFFHLSRERVFSE-DRTRFYGA--EIV 105

Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           +AL Y+H      I++RD+  + ++LD +    ++DFG  K    D++      GT  Y+
Sbjct: 106 SALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYL 162

Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+          D +  GV++ E++ G+ P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 15/209 (7%)

Query: 776 TFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLP----TGE-IGINQKGFVSEITE 829
           TF    VL G GG G V   ++  +G   A KKL         GE + +N+K  + ++  
Sbjct: 1   TFRQYRVL-GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
              R +V           L LV   +  G L   + +   A   +  + V     +   L
Sbjct: 60  ---RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-FEEGRAVFYAAEICCGL 115

Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
             +H +    I++RD+  + +LLD      +SD G A  + P+        GT GY+APE
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPE 171

Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +    R     D +  G L+ E+I G+ P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 41/162 (25%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G VYKA +  +G+  A+KK+  L T + G+     + EI+   E+ H NIV+   
Sbjct: 8   GEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN----------VIKG----VA 886
                  L+LV+E+L                +LD  K ++          +IK     + 
Sbjct: 66  VVHSENKLYLVFEFL----------------DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 887 NALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
             ++Y H H     +LHRD+  + +L+D E    ++DFG A+
Sbjct: 110 QGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 41/176 (23%)

Query: 835 IVK-FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
           IVK +Y F    +HL+LV EY+  G L  +L  +    E + ++    I  +  AL  +H
Sbjct: 63  IVKLYYSF-QDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARF--YIAELVLALDSVH 118

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSEL------------ 939
              F   +HRDI    +L+D     H+  +DFG  K +         L            
Sbjct: 119 KLGF---IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173

Query: 940 -----------------AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                             GT  YIAPE+        +CD ++ GV++ E++ G  P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 39/215 (18%)

Query: 785 GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A +     +   A+K L    +     + + F  E+  +     H NI+ 
Sbjct: 11  GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN---DHRDFAGELEVLCKLGHHPNIIN 67

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVIKG 884
             G C +  +L++  EY   G+L   L                 TA+ L   + +     
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           VA  + Y+    F   +HRD++++ VL+     + ++DFG ++           +  T G
Sbjct: 128 VATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR------GEEVYVKKTMG 178

Query: 945 -----YIAPE-LAYTMRANEKCDVFNFGVLVLEVI 973
                ++A E L Y++    K DV++FGVL+ E++
Sbjct: 179 RLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 12/145 (8%)

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-VANALSYMHHDC 896
            Y F + T+ L L+ +Y+  G L T L       E      V V    +  AL ++H   
Sbjct: 71  HYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTE----SEVRVYIAEIVLALDHLHQ-- 123

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMR 955
              I++RDI  + +LLD E    ++DFG +K FL  +        GT  Y+APE+     
Sbjct: 124 -LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182

Query: 956 A--NEKCDVFNFGVLVLEVIEGKHP 978
              ++  D ++ GVL  E++ G  P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 15/163 (9%)

Query: 823 FVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV 879
           F+ EI   + +++ NI++  G C     L ++ EY+E G L   LS     +    +  +
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 880 ------NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS 933
                 N++       S M +      +HRD++++  L+   Y   ++DFG ++ L   S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY--S 181

Query: 934 SNWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            ++  + G       ++A E     +     DV+ FGV + E+
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 28/162 (17%)

Query: 831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSK 877
           +H+NI+   G C+    L+++ EY  +G+L   L             + +    +L +  
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 878 RVNVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
            V+    VA  + Y+    C    +HRD++++ VL+  +    ++DFG A+    D  N 
Sbjct: 136 LVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DVHNI 187

Query: 937 SELAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
                T        ++APE  +      + DV++FGVL+ E+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.0 bits (122), Expect = 3e-06
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 21/160 (13%)

Query: 830 IRHRNIVKFY--GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
           + H NIV     G       LF V+EY+   +L  +L+ +      +      ++  V +
Sbjct: 35  LYHPNIVALLDSGEAP-PGLLFAVFEYVPGRTLREVLAADGALPAGE---TGRLMLQVLD 90

Query: 888 ALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSSNW-------- 936
           AL+  H+     I+HRD+  + +++    +   A V DFG    L P   +         
Sbjct: 91  ALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRT 146

Query: 937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
           +E+ GT  Y APE           D++ +G++ LE + G+
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 8/135 (5%)

Query: 845 TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRD 904
           T  LFLV EY+  G L   +  +    E     R    + +  AL+++H      I++RD
Sbjct: 68  TSRLFLVIEYVNGGDLMFHMQRQRKLPE--EHARFYAAE-ICIALNFLHER---GIIYRD 121

Query: 905 ISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVF 963
           +    VLLD +    ++D+G  K  L P  +  S   GT  YIAPE+          D +
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 964 NFGVLVLEVIEGKHP 978
             GVL+ E++ G+ P
Sbjct: 181 ALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 62/230 (26%), Positives = 94/230 (40%), Gaps = 52/230 (22%)

Query: 835  IVK-FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            +VK FY F     +L+L+ E+L  G + T+L  + T  E    +    I     A+  +H
Sbjct: 63   VVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTE---EETQFYIAETVLAIDSIH 118

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP---------------------- 931
               F   +HRDI    +LLD +    +SDFG    LK                       
Sbjct: 119  QLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 932  -----DSSNWS----ELA----GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                  +  W     +LA    GT  YIAPE+      N+ CD ++ GV++ E++ G  P
Sbjct: 176  MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 979  GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLC 1028
              F S       P      V+N   ++ + PP   + EK K +I + F C
Sbjct: 236  --FCS-----ETPQETYKKVMN-WKETLIFPPEVPISEKAKDLI-LRFCC 276

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.4 bits (120), Expect = 4e-06
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 9/198 (4%)

Query: 506 NEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIP--LE 563
           +     +PS +  +  L  L  S         + L  L  L SL LN N+L  +I   LE
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISS-LDGSENLLNLLPLPSLDLNLNRLRSNISELLE 114

Query: 564 LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDL 623
           L  L  L   + +   +  LI      L++L   +LS+N+    +   +  L  L  LDL
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKEL---DLSDNKIES-LPSPLRNLPNLKNLDL 170

Query: 624 SHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS 683
           S N L  ++P  + NL +L  ++L  NK+S  +P     +  L  +D+S N +   +   
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSL 228

Query: 684 KAFQNATIEAFQGNKELC 701
              +N +      NK   
Sbjct: 229 SNLKNLSGLELSNNKLED 246

Length = 394

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 785 GTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIGINQKGFVSEITE------IRHRNIVK 837
           G GG G V++    +G DT  +  +  L    I  NQK       E      ++H  IV 
Sbjct: 5   GKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVD 64

Query: 838 F-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
             Y F +  + L+L+ EYL  G L   L  E    E D +     +  ++ AL ++H   
Sbjct: 65  LIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFME-DTACFY--LSEISLALEHLHQQ- 119

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              I++RD+  + +LLD +    ++DFG  K    + +      GT  Y+APE+      
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
            +  D ++ G L+ +++ G  P
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 65/273 (23%), Positives = 117/273 (42%), Gaps = 46/273 (16%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR----NIVKFY 839
            G G  G+VYK     +G T A+K++  L   E   NQ   + E+ +I H+     IV FY
Sbjct: 10   GKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQ--IIMEL-DILHKAVSPYIVDFY 65

Query: 840  GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
            G       +++  EY++ GSL  + +       +       +   V   L ++  +    
Sbjct: 66   GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE---------- 949
            I+HRD+    VL++   +  + DFG +  L    +  +   G   Y+APE          
Sbjct: 124  IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQN 181

Query: 950  LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS---R 1006
              YT+++    DV++ G+ +LE+  G++P          P   AN+   ++ ++D     
Sbjct: 182  PTYTVQS----DVWSLGLSILEMALGRYP--------YPPETYANIFAQLSAIVDGDPPT 229

Query: 1007 LPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPT 1038
            LP     + ++ +         CL+  P+ RPT
Sbjct: 230  LPSGYSDDAQDFVAK-------CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 4e-06
 Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 52/289 (17%)

Query: 779  GKMVLHGTGGCGTVYKAELTSGDTR----AVK--KLHSLPTGEIGINQKGFVSE---ITE 829
            GK++  G G  G+V + +L+  D      AVK  KL      EI    + F+SE   + +
Sbjct: 4    GKIL--GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI----EEFLSEAACMKD 57

Query: 830  IRHRNIVKFYGFCSHTQHL------FLVYEYLERGSLATIL--SNEATAAE-LDWSKRVN 880
              H N++K  G C     L       ++  +++ G L + L  S      E L     + 
Sbjct: 58   FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 881  VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG-TAKFLKPDSSNWSEL 939
             +  +A  + Y+ +  F   +HRD++++  +L  +    V+DFG + K    D      +
Sbjct: 118  FMVDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 940  AGT-CGYIAPE-LA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN 994
            A     +IA E LA   YT     K DV+ FGV + E+                P P   
Sbjct: 175  AKMPVKWIAIESLADRVYT----SKSDVWAFGVTMWEIATRGQT----------PYPGVE 220

Query: 995  MNIVVNDLID-SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
             + + + L   +RL  P    E+ L  +  + + C  A+P  RPT  K+
Sbjct: 221  NHEIYDYLRHGNRLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKL 265

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 65/294 (22%)

Query: 785  GTGGCGTVYK---AELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNI 835
            G G  G VY+     +  G+     A+K ++   +    I    F++E +   E    ++
Sbjct: 15   GQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE---FLNEASVMKEFNCHHV 71

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE-------LDWSKRVNVIKGVANA 888
            V+  G  S  Q   +V E + +G L + L +    AE           K + +   +A+ 
Sbjct: 72   VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK------FLKPDSS-----NWS 937
            ++Y+    F   +HRD++++  ++  +    + DFG  +      + +          W 
Sbjct: 132  MAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187

Query: 938  ELAGTCGYIAPEL----AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA 993
                    +APE      +T     K DV++FGV++ E+            L   P    
Sbjct: 188  --------MAPESLKDGVFTT----KSDVWSFGVVLWEMAT----------LAEQPYQGL 225

Query: 994  NMNIVVNDLIDSR-LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +   V+  +ID   L  P    ++ L+ M     +C   NP  RPT  ++ + L
Sbjct: 226  SNEEVLKFVIDGGHLDLPENCPDKLLELMR----MCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 77/279 (27%), Positives = 106/279 (37%), Gaps = 58/279 (20%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR----NIVKFY 839
            G G  GTV K     SG   AVK++ S         QK  + ++  +        IVKFY
Sbjct: 13   GRGAFGTVNKMLHKPSGTIMAVKRIRST---VDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 840  G---------FCSHTQHLFL------VYEYLERGSLATILSNEATAAELDWSKRVNVIKG 884
            G          C     + L      VYE L+      IL   A A              
Sbjct: 70   GALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-------------- 115

Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
               AL+Y+  +    I+HRD+    +LLD      + DFG +  L  DS   +  AG   
Sbjct: 116  TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRP 172

Query: 945  YIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHP-GHFLSLLLSLPAPAANMNIVVN 1000
            Y+APE       +    + DV++ G+ + EV  GK P   + S+   L        +V  
Sbjct: 173  YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL------TQVVKG 226

Query: 1001 DLIDSRLPPPLGEVEEKLKSMIAVAF--LCLDANPDCRP 1037
            D      PP L   EE+  S   V F  LCL  +   RP
Sbjct: 227  D------PPILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 17/210 (8%)

Query: 776 TFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLP----TGE-IGINQKGFVSEITE 829
           TF    VL G GG G V   ++  +G   A K+L         GE + +N+K    +I E
Sbjct: 1   TFRQYRVL-GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEK----QILE 55

Query: 830 IRHRNIVKFYGFCSHTQH-LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
             +   V    +   T+  L LV   +  G L   + N       +  + +     +   
Sbjct: 56  KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCG 114

Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
           L  +H +     ++RD+  + +LLD      +SD G A  + P+  +     GT GY+AP
Sbjct: 115 LEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAP 170

Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E+    R     D +  G L+ E+IEG+ P
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLH---SLPTGEIGINQKGFVSEITEIRHRNIVKFYG 840
           G G   TVYK    T+G+  A+K++H      T    I +   +S + E++H NIV+ + 
Sbjct: 9   GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIRE---ISLMKELKHENIVRLHD 65

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                  L LV+EY++   L   +        LD +   +    +   +++ H +    +
Sbjct: 66  VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA-NEK 959
           LHRD+  + +L++   +  ++DFG A+      + +S    T  Y AP++    R  +  
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 960 CDVFNFGVLVLEVIEGK 976
            D+++ G ++ E+I G+
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 14/198 (7%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V K +         +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 14  GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 71

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + V++G+A  L   H      I
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA-YLREKHQ-----I 125

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 183

Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 184 DIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 6e-06
 Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 23/191 (12%)

Query: 776 TFEGKMVLHGTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEIT---E 829
             EG +   G G  G VYKA+  +G      A+KK         GI+Q     EI    E
Sbjct: 3   EIEGCI---GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLRE 58

Query: 830 IRHRNIVKFYG-FCSH-TQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGVA 886
           ++H N+V     F  H  + ++L+++Y E      I  +            V +++  + 
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAH----VSDFGTAKFLKPDSSNWSELAG- 941
           N + Y+H +    +LHRD+    +L+  E        + D G A+         ++L   
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 942 --TCGYIAPEL 950
             T  Y APEL
Sbjct: 176 VVTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 14  GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 71

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK--HKI 125

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 183

Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 184 DIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.4 bits (118), Expect = 6e-06
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 22/202 (10%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEI-------GINQKGFVSEITEIRHRNIV 836
           GTG  G V  A+   +G+  A+K    L   EI        + Q+   S + E+ H  IV
Sbjct: 27  GTGSFGRVRIAKHKGTGEYYAIK---CLKKREILKMKQVQHVAQEK--SILMELSHPFIV 81

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                      ++ + E++  G L T L  +A     D +K  +    +  A  Y+H   
Sbjct: 82  NMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHA--ELVLAFEYLHSK- 137

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              I++RD+  + +LLD +    V+DFG AK + PD +    L GT  Y+APE+  +   
Sbjct: 138 --DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT--FTLCGTPEYLAPEVIQSKGH 192

Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
            +  D +  GVL+ E I G  P
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 31/213 (14%)

Query: 783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVKF 838
           + G G  G V KA +     R    +  +       + + F  E+  +     H NI+  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSN-------------EATAAELDWSKRVNVIKGV 885
            G C H  +L+L  EY   G+L   L                +TA+ L   + ++    V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK----FLKPDSSNWSELAG 941
           A  + Y+    F   +HRD++++ +L+   Y A ++DFG ++    ++K           
Sbjct: 122 ARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP---- 174

Query: 942 TCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVI 973
              ++A E L Y++      DV+++GVL+ E++
Sbjct: 175 -VRWMAIESLNYSVYTT-NSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 49.0 bits (117), Expect = 7e-06
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 31/185 (16%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF----VSEIT---EIRHRNIV 836
           G G  G VYKA +  +G+  A+KK+       +   ++GF    + EI    ++ HRNIV
Sbjct: 16  GEGTYGQVYKARDKDTGELVALKKV------RLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 837 KFY----------GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
                         F       +LV+EY++   L  +L  E+           + +K + 
Sbjct: 70  NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHIKSFMKQLL 126

Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELAGTCGY 945
             L+Y H   F   LHRDI    +LL+ + +  ++DFG A+    + S  ++    T  Y
Sbjct: 127 EGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183

Query: 946 IAPEL 950
             PEL
Sbjct: 184 RPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 46/286 (16%)

Query: 780  KMVLHGTGGCGTVYKA-ELTSGDT----RAVKKL--HSLPTGEIGINQKGFVSEITEIRH 832
            K+ + G+G  GTVYK   +  G+      A+K L  ++ P     I  + +V  +  +  
Sbjct: 11   KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV--MAGVGS 68

Query: 833  RNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNE----ATAAELDWSKRVNVIKGVANA 888
              + +  G C  T  + LV + +  G L   +        +   L+W   V + KG    
Sbjct: 69   PYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKG---- 121

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC--GYI 946
            +SY+       ++HRD++++ VL+       ++DFG A+ L  D + +    G     ++
Sbjct: 122  MSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 947  APELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
            A E     R   + DV+++GV V E++  G  P         +PA        + DL++ 
Sbjct: 179  ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD------GIPARE------IPDLLEK 226

Query: 1006 --RLP-PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
              RLP PP+  ++     MI V   C   + +CRP  +++ +   R
Sbjct: 227  GERLPQPPICTID---VYMIMVK--CWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.8 bits (116), Expect = 7e-06
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-VANALSYMHHDCF 897
           Y F +  + L L+ +Y+  G + T L      +E      V    G +  AL ++H    
Sbjct: 72  YAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHLHK--- 123

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRA 956
             I++RDI  + +LLD E    ++DFG +K FL  +        GT  Y+APE+      
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183

Query: 957 NEKC-DVFNFGVLVLEVIEGKHP 978
           + K  D ++ G+L+ E++ G  P
Sbjct: 184 HGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.7 bits (118), Expect = 8e-06
 Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 39/219 (17%)

Query: 824  VSEITEIRHRNIVKFYG--FCSHTQHLFLVYEYLERGSLA-TILSNEATAAELDWSKRVN 880
            V+ + E++H+NIV++         Q L+++ E+ + G L+  I        +++    V+
Sbjct: 63   VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122

Query: 881  VIKGVANALSYMHHDCFPP----ILHRDISSKKVLLDLEYK-----------------AH 919
            + + + +AL+Y H+    P    +LHRD+  + + L    +                 A 
Sbjct: 123  ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 920  VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY--TMRANEKCDVFNFGVLVLEVIEGKH 977
            + DFG +K +  +S   S   GT  Y +PEL    T   ++K D++  G ++ E+  GK 
Sbjct: 183  IGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241

Query: 978  PGH----FLSLL--------LSLPAPAANMNIVVNDLID 1004
            P H    F  L+        L +   +  +NI++ +L++
Sbjct: 242  PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLN 280

Length = 1021

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 8e-06
 Identities = 36/131 (27%), Positives = 58/131 (44%), Gaps = 6/131 (4%)

Query: 848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISS 907
           L+ V EY+  G L   +       E    + V     ++  L ++H      I++RD+  
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFFLHRR---GIIYRDLKL 129

Query: 908 KKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGV 967
             V+LD E    ++DFG  K    D        GT  YIAPE+       +  D + +GV
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 189

Query: 968 LVLEVIEGKHP 978
           L+ E++ G+ P
Sbjct: 190 LLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.8 bits (116), Expect = 8e-06
 Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 9/141 (6%)

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-VANALSYMHHDCF 897
           Y F +H +  F V EY   G L   LS E    E    +R       + +AL Y+H    
Sbjct: 62  YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHSR-- 114

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
             +++RDI  + ++LD +    ++DFG  K    D +      GT  Y+APE+       
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 958 EKCDVFNFGVLVLEVIEGKHP 978
              D +  GV++ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.5 bits (116), Expect = 9e-06
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 35/197 (17%)

Query: 775 STFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQK-GF-VSEITEIR 831
           S +E K+   G G  G V+KA    +    A+KK+          N+K GF ++ + EI+
Sbjct: 12  SKYE-KLAKIGQGTFGEVFKARHKKTKQIVALKKVLME-------NEKEGFPITALREIK 63

Query: 832 ------HRNIVKFYGFCS--------HTQHLFLVYEYLERGSLATILSNEATAAELDWSK 877
                 H N+V     C         +    +LV+E+ E   LA +LSN+     L   K
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIK 122

Query: 878 RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL----KPDS 933
           +V  +K + N L Y+H      ILHRD+ +  +L+  +    ++DFG A+          
Sbjct: 123 KV--MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 934 SNWSELAGTCGYIAPEL 950
           + ++    T  Y  PEL
Sbjct: 178 NRYTNRVVTLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 27  GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 83

Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L               +    +L +   V
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    VA  + Y+    C    +HRD++++ VL+  +    ++DFG A+ +         
Sbjct: 144 SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 939 LAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
             G     ++APE  +      + DV++FGVL+ E+
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 1/79 (1%)

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           I++RD+  + +LLD      +SD G A  + P+        GT GY+APE+    R    
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  G L+ E+IEGK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 27/79 (34%), Positives = 40/79 (50%)

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           I++RD+    V+LD E    ++DFG  K    D        GT  YIAPE+       + 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181

Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D + FGVL+ E++ G+ P
Sbjct: 182 VDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 63/281 (22%), Positives = 123/281 (43%), Gaps = 46/281 (16%)

Query: 785  GTGGCGTVYKA-ELTSGDTR----AVKKLHSL--PTGEIGINQKGFVSEITEIRHRNIVK 837
            G+G  GTVYK   +  G+T     A+K L+    P   +    +  +  +  + H ++V+
Sbjct: 16   GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI--MASMDHPHLVR 73

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAAELDWSKRVNVIKGVANALSYMH 893
              G C  +  + LV + +  G L   +     N  +   L+W  ++      A  + Y+ 
Sbjct: 74   LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT--CGYIAPELA 951
                  ++HRD++++ VL+       ++DFG A+ L+ D   ++   G     ++A E  
Sbjct: 127  ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 952  YTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID--SRLP 1008
            +  +   + DV+++GV + E++  G  P         +P         + DL++   RLP
Sbjct: 184  HYRKFTHQSDVWSYGVTIWELMTFGGKPYD------GIPTRE------IPDLLEKGERLP 231

Query: 1009 -PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
             PP+  ++     M+ V    +DA  D RP  +++     R
Sbjct: 232  QPPICTID---VYMVMVKCWMIDA--DSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 38/118 (32%), Positives = 58/118 (49%), Gaps = 17/118 (14%)

Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLK-PDSSNWSELAGTCG 944
           AL Y+H      + HRD+  K +L + + K  + DFG A+  F   P +  W++   T  
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 945 YIAPEL--AYTMRANEKCDVFNFGVLVLEVIEGK--HPG----HFLSL---LLSLPAP 991
           Y APEL  ++  +     D+++ G +  EV+ GK   PG    H L L   LL  P+P
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 3e-05
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 18/150 (12%)

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +HRD++++ +LL       + DFG A+  +  PD     +      ++APE  +      
Sbjct: 195  IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 959  KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN-IVVNDLID-SRLPPPLGEVEE 1016
            + DV++FGVL+ E+          SL  S P P   ++      L + +R+  P     E
Sbjct: 255  QSDVWSFGVLLWEI---------FSLGAS-PYPGVQIDEEFCRRLKEGTRMRAPEYATPE 304

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                M+     C   NP+ RPT  ++  +L
Sbjct: 305  IYSIMLD----CWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 3/94 (3%)

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           +A  L ++H      I++RD+    V+LD E    ++DFG  K             GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166

Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           YIAPE+       +  D + FGVL+ E++ G+ P
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 17/200 (8%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G VYK     +G   A+KK+  L + E G+     + EI+   E++H NIV    
Sbjct: 9   GEGTYGVVYKGRNKKTGQIVAMKKIR-LESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66

Query: 841 FCSHTQHLFLVYEYLE---RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
                  L+L++E+L    +  L ++   +   AEL  S    +++G+     + H    
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHSR-- 120

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRA 956
             +LHRD+  + +L+D +    ++DFG A+        ++    T  Y APE L  + R 
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 957 NEKCDVFNFGVLVLEVIEGK 976
           +   D+++ G +  E+   K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 29/240 (12%)

Query: 750 NFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGD--TRAVKK 807
           N +  K+ DS   + +   +  +    F     L GTG  G V  A   + D    A+K+
Sbjct: 6   NLQLHKKKDSDSTK-EPKRKNKMKYEDFNFIRTL-GTGSFGRVILATYKNEDFPPVAIKR 63

Query: 808 LHSLPTGEIGINQKGFVSEITE------IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA 861
                     I QK      +E      I H   V  YG      +L+LV E++  G   
Sbjct: 64  FEKSKI----IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119

Query: 862 TIL-SNEATAAELD--WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA 918
           T L  N+    ++   ++ ++ +I     +L+         I++RD+  + +LLD +   
Sbjct: 120 TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFI 170

Query: 919 HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            ++DFG AK +  D+  ++ L GT  YIAPE+   +   +  D +  G+ + E++ G  P
Sbjct: 171 KMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 7/148 (4%)

Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           ++  NIV+          L+LV+EY+E+  L  +L         +  K  + I  +  A+
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPE--KVRSYIYQLIKAI 113

Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSELAGTCGYIAP 948
            + H +    I+HRDI  + +L+       + DFG A+ L   S +N++E   T  Y +P
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGK 976
           EL       +  D+++ G ++ E+ +G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.7 bits (111), Expect = 4e-05
 Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 9/141 (6%)

Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-VANALSYMHHDCF 897
           Y F +H   L  V EY   G L   LS E   +E     R       + +AL Y+H    
Sbjct: 62  YSFQTH-DRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALGYLHSC-- 114

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
             +++RD+  + ++LD +    ++DFG  K    D +      GT  Y+APE+       
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 958 EKCDVFNFGVLVLEVIEGKHP 978
              D +  GV++ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 10/163 (6%)

Query: 820 QKGFVSE----ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDW 875
           QK  ++E    +  ++H  +V  +     T+ L+ V +++  G L   L  E +  E   
Sbjct: 39  QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE--- 95

Query: 876 SKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN 935
            +       +A+AL Y+H      I++RD+  + +LLD +    ++DFG  K     S  
Sbjct: 96  PRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152

Query: 936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            +   GT  Y+APE+      +   D +  G ++ E++ G  P
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 19/198 (9%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G V  A +  +G   A+KK+  +      +  K    E+     +RH NI+    
Sbjct: 19  GMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76

Query: 841 -FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
            F S  + ++ V E L    L  +L++     +        +++G    L Y+H      
Sbjct: 77  IFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---AG 128

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANE 958
           ++HRD+    +L++      + DFG A+   P  + +     T  Y APE+  T  + + 
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY---VSTRYYRAPEIMLTWQKYDV 185

Query: 959 KCDVFNFGVLVLEVIEGK 976
           + D+++ G +  E++EGK
Sbjct: 186 EVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYI 946
           AL+++H      I++RD+    VLLD E    ++D+G  K  ++P  +  S   GT  YI
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT-STFCGTPNYI 163

Query: 947 APELAYTMRANE---KCDVFNFGVLVLEVIEGKHP 978
           APE+   +R  +     D +  GVL+ E++ G+ P
Sbjct: 164 APEI---LRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 46.3 bits (110), Expect = 5e-05
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 49/223 (21%)

Query: 785 GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSEITEI----RHRN 834
           G G  G V KAE    D        AVK L    T +   +    VSE+  +    +H+N
Sbjct: 21  GEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKHKN 77

Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSL-------------ATILSNEATAAELDWSKRVNV 881
           I+   G C+    L++V EY   G+L             A+          L     V+ 
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK------FLKPDSS- 934
              VA  + ++        +HRD++++ VL+  ++   ++DFG A+      + +  ++ 
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 935 ----NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
                W         +APE  +      + DV++FGVL+ E+ 
Sbjct: 195 RLPVKW---------MAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 8/153 (5%)

Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-V 885
           +  ++H  +V  +        L+ V +Y+  G L   L  E    E     R       +
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEI 105

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY 945
           A+AL Y+H      I++RD+  + +LLD +    ++DFG  K     +   S   GT  Y
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEY 162

Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +APE+ +    +   D +  G ++ E++ G  P
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 1/79 (1%)

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           I++RD+  + +LLD      +SD G A  + P+        GT GY+APE+    +    
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  G L+ E+I+G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 69/287 (24%), Positives = 126/287 (43%), Gaps = 43/287 (14%)

Query: 771  LLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDT----RAVKKLH--SLPTGEIGINQKGF 823
            +L  + F+   VL G+G  GTVYK   +  G+      A+K+L   + P     I  + +
Sbjct: 3    ILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAAELDWSKRV 879
            V  +  + + ++ +  G C  T  + L+ + +  G L   +     N  +   L+W   V
Sbjct: 62   V--MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 116

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
             + KG+ N L          ++HRD++++ VL+       ++DFG AK L  D   +   
Sbjct: 117  QIAKGM-NYLEERR------LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 940  AGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMN 996
             G     ++A E         + DV+++GV V E++  G  P   +        PA+ ++
Sbjct: 170  GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEIS 221

Query: 997  IVVNDLIDSRLP-PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
             ++      RLP PP+  ++     MI V   C   + D RP  +++
Sbjct: 222  SILEK--GERLPQPPICTID---VYMIMVK--CWMIDADSRPKFREL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 8e-05
 Identities = 24/77 (31%), Positives = 40/77 (51%)

Query: 414 GYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPD 473
           G++P ++ +   L   ++  N+  G IP SL + TSL  L L  N   G+I E  G    
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 474 LELLDLSNNNFFGEISS 490
           L +L+L+ N+  G + +
Sbjct: 492 LRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 34/160 (21%)

Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE---LDWSKRVNVIKGVANALS 890
           N+V  + +      +FLV ++ E G L + +S      E     W+  + V      AL 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG------ 944
            +H +    I+ RD++   +LLD      ++ F            WSE+  +C       
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS----------RWSEVEDSCDGEAVEN 146

Query: 945 -YIAPELAYTMRANEKCDVFNFGVLVLEVIEGK-----HP 978
            Y APE+       E CD ++ G ++ E++ GK     HP
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 8e-05
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 777 FEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIV 836
           +EG  V  G G  G VYKA+   G       L  +    I ++    ++ + E++H N++
Sbjct: 4   YEGCKV--GRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 837 KFYG-FCSHT-QHLFLVYEYLERGSLATILSNEATAA-----ELDWSKRVNVIKGVANAL 889
                F SH+ + ++L+++Y E      I  + A+ A     +L  S   +++  + + +
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 890 SYMHHDCFPPILHRDISSKKVLLDLE----YKAHVSDFGTAKF----LKPDSSNWSELAG 941
            Y+H +    +LHRD+    +L+  E     +  ++D G A+     LKP  ++   +  
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-LADLDPVVV 177

Query: 942 TCGYIAPELAYTMRANEKC-DVFNFGVLVLEVI 973
           T  Y APEL    R   K  D++  G +  E++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 61/297 (20%), Positives = 120/297 (40%), Gaps = 50/297 (16%)

Query: 772  LSASTFEGKMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSE 826
            LSA  F  ++   G    G +YK  L           A+K L  +   +     +   S 
Sbjct: 4    LSAVRFMEEL---GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 827  ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL------------SNE--ATAAE 872
            + E+ H NIV   G  +  Q + +++EYL +G L   L            S+E     + 
Sbjct: 61   MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 873  LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD 932
            LD    +++   +A  + Y+    F   +H+D++++ +L+  +    +SD G ++ +   
Sbjct: 121  LDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY-- 175

Query: 933  SSNWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLS 987
            S+++  +         ++ PE     + +   D+++FGV++ E+   G  P +  S    
Sbjct: 176  SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---- 231

Query: 988  LPAPAANMNIVVNDLIDSR--LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                    N  V +++  R  LP      E+    M ++   C    P  RP  + +
Sbjct: 232  --------NQEVIEMVRKRQLLPCS----EDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 21/209 (10%)

Query: 780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIV 836
             VL       ++YK      +   + +          +      +EI  +R     NI+
Sbjct: 24  TSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81

Query: 837 KFYGF----CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
           K YGF          L L+ EY  RG L  +L  E    +L +  ++++       L  +
Sbjct: 82  KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNL 138

Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK-PDSSNWSELAGTCGYIAPELA 951
           +     P  +++++S   L+   YK  +   G  K L  P   N + +     Y + ++ 
Sbjct: 139 YKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKML 192

Query: 952 YTM--RANEKCDVFNFGVLVLEVIEGKHP 978
             +      K D+++ GV++ E+  GK P
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 45.6 bits (108), Expect = 1e-04
 Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 5/69 (7%)

Query: 3   SINLTGSNLKGTLQEFPFLL--FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
           SINL+G++++G     P  L     L  LDLS N   G+IP  +  L+ L+ L+ + N  
Sbjct: 446 SINLSGNSIRG---NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

Query: 61  SGIIPPQIG 69
           SG +P  +G
Sbjct: 503 SGRVPAALG 511

Length = 623

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 12/157 (7%)

Query: 832 HRNIVKFYGF-----CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
           H N+VKFYG        +   L+LV E    GS+  ++       E      +  I  + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI--LH 131

Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
            AL  + H      +HRD+    +LL  E    + DFG +  L       +   GT  ++
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191

Query: 947 APELAYTMRA-----NEKCDVFNFGVLVLEVIEGKHP 978
           APE+    +      + +CDV++ G+  +E+ +G  P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 11/134 (8%)

Query: 848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNV-IKGVANALSYMH-HDCFPPILHRDI 905
           L+LV +Y+  G L   L  E   +E     R    I  +  AL ++H +D    I++RD+
Sbjct: 71  LYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEHLHKYD----IVYRDL 122

Query: 906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK-CDVFN 964
             + +LLD      + DFG +K    D+   +   GT  Y+APE+    +   K  D ++
Sbjct: 123 KPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS 182

Query: 965 FGVLVLEVIEGKHP 978
            GVLV E+  G  P
Sbjct: 183 LGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 1e-04
 Identities = 62/264 (23%), Positives = 102/264 (38%), Gaps = 63/264 (23%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSE----ITEIRHRNIVKFY 839
            G G  G V        DT A+  + +L   + +  NQ   V      + E  +  +VK Y
Sbjct: 10   GIGAFGEVCLVRKV--DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67

Query: 840  GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
                   +L+ V +Y+  G + ++L       E D ++    I  +  A+  +H   F  
Sbjct: 68   YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE-DLARFY--IAELTCAIESVHKMGF-- 122

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFG---------TAKFLKP------DS----SNWSE-- 938
             +HRDI    +L+D +    ++DFG          +K+ +       DS      WSE  
Sbjct: 123  -IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 939  ----------------------LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
                                  L GT  YIAPE+       + CD ++ GV++ E++ G+
Sbjct: 182  RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 977  HPGHFLSLLLSLPAPAANMNIVVN 1000
             P  FL+       PA     V+N
Sbjct: 242  PP--FLA-----DTPAETQLKVIN 258

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 28/219 (12%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGF 841
           G G  G V   E+ SG T A   +  L        Q  F+ E    R   H N+++  G 
Sbjct: 4   GNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQ 63

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGVANALSYMHHDCFPP 899
           C+      LV E+   G L   L +   A  +         +   +A  L ++H + F  
Sbjct: 64  CTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF-- 121

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAK-------FLKPDSSNWSELAGTCGYIAPELAY 952
            +H D++ +  LL  +    + D+G +        ++ PD   W  L     +IAPEL  
Sbjct: 122 -IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WIAPELVD 175

Query: 953 TMRAN-------EKCDVFNFGVLVLEVIE-GKHPGHFLS 983
            +  N       ++ +V++ GV + E+ E G  P   LS
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 10/133 (7%)

Query: 848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISS 907
           L+LV  ++  G L   L  E      D S+       +  AL  +H      +++RD+  
Sbjct: 68  LYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHK---FNVIYRDLKP 121

Query: 908 KKVLLDLEYKAHVS--DFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNF 965
           + +LLD  Y+ H++  DFG  K    D    +   GT  Y+APEL       +  D +  
Sbjct: 122 ENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179

Query: 966 GVLVLEVIEGKHP 978
           GVL+ E++ G  P
Sbjct: 180 GVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 20/203 (9%)

Query: 785 GTGGCGTVYKAELTS-GDTRAVKKLHS---LPTGEIGINQKGFVSE----ITEIRHRNIV 836
           G G  G V  A+  S G   AVK L     L   E    Q   ++E    +  ++H  +V
Sbjct: 4   GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE----QNHIMAERNVLLKNLKHPFLV 59

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-VANALSYMHHD 895
             +      + L+ V +Y+  G L   L  E    E     R       VA+A+ Y+H  
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE----PRARFYAAEVASAIGYLHS- 114

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               I++RD+  + +LLD +    ++DFG  K         S   GT  Y+APE+     
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            +   D +  G ++ E++ G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 24/62 (38%), Positives = 30/62 (48%), Gaps = 3/62 (4%)

Query: 232 NLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
           NLK L L +NRL+  IP        +L  L LS N L    P +F  L SL+ L +   N
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG-N 58

Query: 291 KL 292
            L
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 15/103 (14%)

Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +  AL Y+H      ++HRD+    VL++   +  + DFG + +L  DS   +  AG  
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCK 167

Query: 944 GYIAPEL--------AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            Y+APE          Y +++    DV++ G+ ++E+  G+ P
Sbjct: 168 PYMAPERINPELNQKGYDVKS----DVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 825 SEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG 884
           S + ++ H++IV  YG C       +V E++E G L   +  ++      W  +  V K 
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQ 113

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLE 915
           +A+ALSY+       ++H ++ +K +LL  E
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 23/155 (14%)

Query: 841 FCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
           FCS    +HL +V EY+E G  AT+L N   A  +D + R+   + V  AL Y+H+    
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMA-RMYFAETVL-ALEYLHN---Y 120

Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKF-LKPDSSNWSE--------------LAGTC 943
            I+HRD+    +L+       ++DFG +K  L   ++N  E              + GT 
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 944 GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            YIAPE+       +  D +  G+++ E + G  P
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 44/222 (19%)

Query: 785 GTGGCGTVYKAE---LTSGDTR---AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNI 835
           G G  G V++A    L   +     AVK L    + ++   Q  F  E   + E  H NI
Sbjct: 14  GQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAEFDHPNI 70

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATIL-SNEATAAE------------------LDWS 876
           VK  G C+  + + L++EY+  G L   L      A                    L  +
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG------TAKFLK 930
           +++ + K VA  ++Y+    F   +HRD++++  L+       ++DFG      +A + K
Sbjct: 131 EQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
              ++    A    ++ PE  +  R   + DV+ +GV++ E+
Sbjct: 188 ASEND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 51/226 (22%), Positives = 88/226 (38%), Gaps = 31/226 (13%)

Query: 825  SEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG 884
            S ++++ H+++V  YG C       +V EY++ GSL T L        + W  ++ V K 
Sbjct: 51   SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQ 108

Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE------ 938
            +A AL ++         H ++ +K VLL  E        G   F+K      S       
Sbjct: 109  LAWALHFLEDKGLT---HGNVCAKNVLLIREEDRKT---GNPPFIKLSDPGISITVLPKE 162

Query: 939  -LAGTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN 996
             L     ++ PE +      +   D ++FG  + E+  G          LS       + 
Sbjct: 163  ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG------DKPLSALDSQKKLQ 216

Query: 997  IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                   + R   P  +  E L ++I     C+D  PD RP+ + +
Sbjct: 217  -----FYEDRHQLPAPKWTE-LANLINQ---CMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 28/118 (23%), Positives = 57/118 (48%), Gaps = 14/118 (11%)

Query: 823 FVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSN--------EATAA 871
           F+ EI   + ++  NI++    C  +  L ++ EY+E G L   LS         +A   
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 872 ELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL 929
            + +S  + +   +A+ + Y+    F   +HRD++++  L+   Y   ++DFG ++ L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 31/209 (14%)

Query: 785 GTGGCGTVY---KAELTSGDTRAVKKLHS----LPTGE-IGINQKGFVSEITEIRHRNIV 836
           G GG G VY   KA+  +G   A+K L      +  GE + +N++  +S ++      IV
Sbjct: 3   GRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 837 KF-YGFCSHT-QHLFLVYEYLERGSLATILSNEATAAELDWS-KRVNVIKGVANALSYMH 893
              Y F  HT   L  + + +  G L   LS     +E +       +I G    L +MH
Sbjct: 61  CMTYAF--HTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMH 114

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA---KFLKPDSSNWSELAGTCGYIAPEL 950
           +     +++RD+    +LLD      +SD G A      KP +S      GT GY+APE+
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEV 166

Query: 951 AYTMRA-NEKCDVFNFGVLVLEVIEGKHP 978
                A +   D F+ G ++ +++ G  P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 44/238 (18%)

Query: 830  IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK------ 883
            ++H NI++  G C       LV+EY E G L + LS E       W +R + +       
Sbjct: 52   LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMA 105

Query: 884  -GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA------KFLKPDSSNW 936
              +A  +++MH   F   LH D++ +   L  +    V D+G         +++ +    
Sbjct: 106  CEIAAGVTHMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162

Query: 937  SELAGTCGYIAPELA-------YTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSL 988
              L     ++APEL         T    +  +V+  GV + E+ E    P   LS    L
Sbjct: 163  VPLR----WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218

Query: 989  PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                   N V+ D    +L  P  E+    +    + F  L  +P+ R T ++V  LL
Sbjct: 219  -------NHVIKDQ-QVKLFKPQLELPYSERWYEVLQFCWL--SPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 44/225 (19%)

Query: 785 GTGGCGTVYKAELTSGDTR-AVKKLHSLP-----------TGEIGINQKGFVS--EI--- 827
           G G  G V KA  T      A+KK+  +             G  GI+   F +  E+   
Sbjct: 18  GEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH---FTTLRELKIM 74

Query: 828 TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
            EI+H NI+           + LV + +    L  ++  +    E   S+   ++  + N
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQILN 130

Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA---------------KFLKPD 932
            L+ +H   +   +HRD+S   + ++ +    ++DFG A               + ++  
Sbjct: 131 GLNVLH-KWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 933 SSNWSELAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGK 976
               S++  T  Y APEL     + +   D+++ G +  E++ GK
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 4e-04
 Identities = 51/208 (24%), Positives = 91/208 (43%), Gaps = 34/208 (16%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKK-----LHSLPTGEIGINQKGFVSE----ITEIRHRN 834
           G GG G V+ A+   +G+  A+K+     L  L       N+   V      +T  +   
Sbjct: 10  GQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL-------NEVRHVLTERDILTTTKSEW 62

Query: 835 IVK-FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
           +VK  Y F    ++L+L  EY+  G   T+L+N    +E     R  + +    A+  +H
Sbjct: 63  LVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE-AVDALH 118

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTAK-FLKPDSSNWSELAGTCGYIAPEL 950
                  +HRD+  +  L+D     H+  +DFG +K  +   +S    + G+  Y+APE+
Sbjct: 119 E---LGYIHRDLKPENFLID--ASGHIKLTDFGLSKGIVTYANS----VVGSPDYMAPEV 169

Query: 951 AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                 +   D ++ G ++ E + G  P
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 20/190 (10%)

Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NV 881
            VS + +++H NIV  +      + L LV+EYL++  L   L +   +  +   K     +
Sbjct: 55   VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQL 113

Query: 882  IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
            ++G    L+Y H      +LHRD+  + +L++   +  ++DFG A+     +  +S    
Sbjct: 114  LRG----LNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166

Query: 942  TCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGK--HPG-------HFLSLLLSLPAP 991
            T  Y  P+ L  +   + + D++  G +  E+  G+   PG       HF+  +L  P  
Sbjct: 167  TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226

Query: 992  AANMNIVVND 1001
                 I+ N+
Sbjct: 227  ETWPGILSNE 236

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.4 bits (105), Expect = 4e-04
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 34/219 (15%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE--IT-EIRHRNIVKFYG 840
           G GG G VY A +       A+KK+      E  + +K F+ E  I  ++ H  IV  Y 
Sbjct: 11  GKGGMGEVYLAYDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 841 FCSHTQHLFLVYEYLERGSLATILSN----EATAAELDWSKRV----NVIKGVANALSYM 892
            CS    ++    Y+E  +L ++L +    E+ + EL     V    ++   +   + Y+
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129

Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD------------SSNWSELA 940
           H      +LHRD+    +LL L  +  + D+G A F K +            +  +S + 
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 941 ------GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
                 GT  Y+APE    + A+E  D++  GV++ +++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 47/205 (22%), Positives = 96/205 (46%), Gaps = 29/205 (14%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYG- 840
           G+G  G+V  A +  +G+  A+KKL      EI   ++ +  ++ +  ++H N++     
Sbjct: 24  GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 841 FCSHT-----QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
           F S       Q  +LV  Y+ +  L  I+ +  +  ++ +     ++  +   L Y+H  
Sbjct: 83  FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHS- 135

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---TCGYIAPELAY 952
               I+HRD+    + ++ + +  + DFG A+         +E+ G   T  Y APE+  
Sbjct: 136 --AGIIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAPEVIL 187

Query: 953 T-MRANEKCDVFNFGVLVLEVIEGK 976
             M  N+  D+++ G ++ E++ GK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 5e-04
 Identities = 54/198 (27%), Positives = 75/198 (37%), Gaps = 68/198 (34%)

Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLAT------ILSNEAT---AAELDWSKRVNVIKGV 885
           +VK Y       +L+L+ EYL  G + T        + E T    AE             
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET------------ 110

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTAKFLK------------- 930
             A+  +H   +   +HRDI    +LLD   K H+  SDFG    LK             
Sbjct: 111 ILAIDSIHKLGY---IHRDIKPDNLLLD--AKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 931 ------------PDSS-----NWSE----LA----GTCGYIAPELAYTMRANEKCDVFNF 965
                       P SS      W      LA    GT  YIAPE+      N++CD ++ 
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225

Query: 966 GVLVLEVIEGKHPGHFLS 983
           GV++ E++ G  P  F S
Sbjct: 226 GVIMYEMLVGYPP--FCS 241

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.8 bits (100), Expect = 6e-04
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 23/211 (10%)

Query: 774 ASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITE---- 829
           A ++E K+   G G   TVYK     G ++   KL +L    +   +    + I E    
Sbjct: 4   ADSYE-KLEKLGEGSYATVYK-----GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57

Query: 830 --IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGV 885
             ++H NIV  +      + L LV+EY+    L   +         +  K     +++G 
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRG- 115

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY 945
              LSY+H      ILHRD+  + +L+    +  ++DFG A+     S  +S    T  Y
Sbjct: 116 ---LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWY 169

Query: 946 IAPELAYTMRANEKC-DVFNFGVLVLEVIEG 975
             P++         C D++  G + +E+I+G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 20/178 (11%)

Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK--RVNV 881
           VS +  ++H NIV  +      + L LV+EYL+   L   L N      +   K     +
Sbjct: 54  VSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQL 112

Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
           ++G    LSY H      ILHRD+  + +L++ + +  ++DFG A+     +  +S    
Sbjct: 113 LRG----LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165

Query: 942 TCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGK--HPG-------HFLSLLLSLP 989
           T  Y  P+ L  +   +   D++  G ++ E+  G+   PG       H +  LL  P
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 42.8 bits (101), Expect = 6e-04
 Identities = 37/152 (24%), Positives = 76/152 (50%), Gaps = 12/152 (7%)

Query: 780 KMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIV 836
           K+   G G  GTV+KA    + +  A+K++  L   + G+       +  + E++H+NIV
Sbjct: 4   KLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HD 895
           + Y      + L LV+EY ++  L      ++   ++D     + +  +   L++ H H+
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQ-DLKKYF--DSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
               +LHRD+  + +L++   +  ++DFG A+
Sbjct: 120 ----VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 43/208 (20%), Positives = 90/208 (43%), Gaps = 32/208 (15%)

Query: 790 GTVYKAEL---TSGD---TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
           G VYK  L     G+     A+K L     G +    K      + ++H NIV   G  +
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78

Query: 844 HTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVIKGVANALS 890
             Q L +++ Y     L   L              ++   + L+ +  V+++  +A  + 
Sbjct: 79  KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138

Query: 891 YM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC----G 944
           ++  HH       H+D++++ VL+  +    +SD G   F +  ++++ +L G       
Sbjct: 139 FLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGL--FREVYAADYYKLMGNSLLPIR 191

Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEV 972
           +++PE     + +   D++++GV++ EV
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.7 bits (101), Expect = 6e-04
 Identities = 58/224 (25%), Positives = 86/224 (38%), Gaps = 61/224 (27%)

Query: 785 GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------------- 830
           G G  G V  AE   +G+  A+K L           +KG +    E+             
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIKAL-----------KKGDIIARDEVESLMCEKRIFETA 56

Query: 831 ---RHRNIVKFYGFCSHT-QHLFLVYEYLERGSLATILSNEA--------TAAELDWSKR 878
              RH  +V  +  C  T  H+  V EY   G L   +  +          AA       
Sbjct: 57  NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC------ 109

Query: 879 VNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
                 V   L Y+H +    I++RD+    +LLD E    ++DFG  K         S 
Sbjct: 110 ------VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST 160

Query: 939 LAGTCGYIAPEL----AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             GT  ++APE+    +YT RA    D +  GVL+ E++ G+ P
Sbjct: 161 FCGTPEFLAPEVLTETSYT-RA---VDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 43/206 (20%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 15  GQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A     K + +   +A+ ++
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 134 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 188

Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.7 bits (101), Expect = 7e-04
 Identities = 51/266 (19%), Positives = 81/266 (30%), Gaps = 48/266 (18%)

Query: 412 FTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLR---LERNQLTGNISEVF 468
               L Q + +   L    + +N         L++     SL+   L  N L      + 
Sbjct: 69  GLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL 128

Query: 469 G-----IYPDLELLDLSNNNFFGE----ISSNWIKCPQLATLNMGGNEISG----TIPSE 515
                 + P LE L L  N   G     ++        L  LN+  N I       +   
Sbjct: 129 AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188

Query: 516 IGNMTQLHKLDFSSNRL----VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELG 571
           +     L  LD ++N L       + + L  L SL  L L  N            L + G
Sbjct: 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN-----------NLTDAG 237

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ----IGKLVQLSKLDLSHNS 627
                    + L    L     L  L+LS N  + + +      + +   L +LDL  N 
Sbjct: 238 --------AAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNK 289

Query: 628 LGGNIPSEIC-----NLESLEYMNLL 648
            G      +          LE + + 
Sbjct: 290 FGEEGAQLLAESLLEPGNELESLWVK 315

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 8e-04
 Identities = 22/60 (36%), Positives = 28/60 (46%)

Query: 73  NLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
           NL  L LS N+L  +       L +L  L LS N L    P +   L +L  L LS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 8e-04
 Identities = 22/59 (37%), Positives = 27/59 (45%)

Query: 570 LGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
           L  LDLS NRL+ +       L  L  L+LS N  +         L  L  LDLS N+L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.3 bits (100), Expect = 8e-04
 Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 48/229 (20%)

Query: 452 SLRLERNQLTGN----ISEVFGIYPDLELLDLSNNNFFGEISSNW-------IKCPQLAT 500
            LRLE N L       ++      P L+ L LS N   G I            K   L  
Sbjct: 27  VLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQE 85

Query: 501 LNMGGNEISGTIPSEIGNMTQ---LHKLDFSSNRLVGQIPKQLGK-LTS----LTSLTLN 552
           L++  N +       + ++ +   L +L  ++N L  +  + L K L      L  L L 
Sbjct: 86  LDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLG 145

Query: 553 GNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQI 612
            N+L G                 S   L+K +  N    R L  LNL+NN         +
Sbjct: 146 RNRLEGA----------------SCEALAKALRAN----RDLKELNLANNGIGDAGIRAL 185

Query: 613 GK----LVQLSKLDLSHNSL---GGNIPSE-ICNLESLEYMNLLQNKLS 653
            +       L  LDL++N L   G +  +E + +L+SLE +NL  N L+
Sbjct: 186 AEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 44/188 (23%), Positives = 81/188 (43%), Gaps = 16/188 (8%)

Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
            VS + +++H NIV  +      + L LV+EYL++  L   + +      +   K    + 
Sbjct: 55   VSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKI--FLY 111

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
             +   L+Y H      +LHRD+  + +L++   +  ++DFG A+     +  +S    T 
Sbjct: 112  QILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168

Query: 944  GYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGK--HPG-------HFLSLLLSLPAPAA 993
             Y  P+ L  +   + + D++  G +  E+  G+   PG       H +  LL  P    
Sbjct: 169  WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228

Query: 994  NMNIVVND 1001
               I  ND
Sbjct: 229  WPGISSND 236

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 22/61 (36%), Positives = 31/61 (50%), Gaps = 2/61 (3%)

Query: 617 QLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNE 675
            L  LDLS+N L   IP      L +L+ ++L  N L+   P  F  +  L S+D+S N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 676 L 676
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 21/158 (13%)

Query: 888  ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCG 944
            AL  +H      ++HRD+ S  + L       + DFG +K    DS +    S   GT  
Sbjct: 181  ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPY 236

Query: 945  YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004
            Y+APEL    R ++K D+++ GV++ E++    P          P+    M  V+    D
Sbjct: 237  YLAPELWERKRYSKKADMWSLGVILYELLTLHRP-------FKGPSQREIMQQVLYGKYD 289

Query: 1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
               P P+         M A+    L  NP  RPT Q++
Sbjct: 290  P-FPCPVSS------GMKALLDPLLSKNPALRPTTQQL 320

Length = 478

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 31/209 (14%)

Query: 785 GTGGCGTVY---KAELTSGDTRAVKKLHS----LPTGE-IGINQKGFVSEITEIRHRNIV 836
           G GG G VY   KA+  +G   A+K L      +  GE + +N++  +S ++      IV
Sbjct: 3   GRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 837 KF-YGFCSHT-QHLFLVYEYLERGSLATILSNEATAAELDWS-KRVNVIKGVANALSYMH 893
              Y F  HT   L  + + +  G L   LS     +E +       +I G    L +MH
Sbjct: 61  CMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG----LEHMH 114

Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA---KFLKPDSSNWSELAGTCGYIAPE- 949
           +     +++RD+    +LLD      +SD G A      KP +S      GT GY+APE 
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEV 166

Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           L   +  +   D F+ G ++ +++ G  P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 22/162 (13%)

Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMH 893
           IV FYG       + +  E+++ GSL  +L       E    K  + V++G    L+Y+ 
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRG----LTYLR 116

Query: 894 --HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA 951
             H     I+HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE  
Sbjct: 117 EKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 170

Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA 993
                  + D+++ G+ ++E+  G++P         +P P A
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYP---------IPPPDA 203

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.0 bits (98), Expect = 0.002
 Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 30/172 (17%)

Query: 830 IRHRNIVKFYGFCSHTQHLFLV---YEYLERGSLATILSNEATAAELDWSKRV------N 880
           + H NI+K         + +++   Y++     L + + +EA     DW  R        
Sbjct: 220 LNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEA----FDWKDRPLLKQTRA 271

Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA-KFLKPDSSNWSEL 939
           ++K +  A+ Y+H      ++HRDI  + + L+ + K  + DFGTA  F K   +     
Sbjct: 272 IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW 328

Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---------GKHPGHFL 982
            GT    +PE+       E  D+++ G+++L+++          G  PG  L
Sbjct: 329 VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380

Length = 501

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 22/204 (10%)

Query: 785 GTGGCGTVYKAELTS-GDTRAVK---KLHSLPTGEIGINQKGFVSE----ITEIRHRNIV 836
           G G  G V  A+  + G   AVK   K   L   E    QK  ++E    +  ++H  +V
Sbjct: 4   GKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE----QKHIMAERNVLLKNVKHPFLV 59

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
             +        L+ V +Y+  G L   L  E +  E    +       +A+AL Y+H   
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS-- 114

Query: 897 FPPILHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
              I++RD+  + +LLD   + HV  +DFG  K     S   S   GT  Y+APE+    
Sbjct: 115 -LNIIYRDLKPENILLD--SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 955 RANEKCDVFNFGVLVLEVIEGKHP 978
             +   D +  G ++ E++ G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 29/200 (14%)

Query: 854  YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVLL 912
            Y+++   + IL  +  A  LD    ++    VA  +S++   +C    +HRD++++ +LL
Sbjct: 194  YIDQDVTSEILEEDELA--LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILL 247

Query: 913  DLEYKAHVSDFGTAKFLKPDSSNWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVL 968
                   + DFG A+ ++ D SN+  + G       ++APE  +      + DV+++G+L
Sbjct: 248  THGRITKICDFGLARDIRND-SNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 305

Query: 969  VLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAF 1026
            + E+            L S P P   ++     +I    R+  P    E     M  +  
Sbjct: 306  LWEIFS----------LGSSPYPGMPVDSKFYKMIKEGYRMLSP----ECAPSEMYDIMK 351

Query: 1027 LCLDANPDCRPTMQKVCNLL 1046
             C DA+P  RPT +++  L+
Sbjct: 352  SCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 25/165 (15%)

Query: 783 LHGTGGCGTVYKAELTSG---DTRAVKKLHSLPTGEI-----------GINQKGFVSEIT 828
           L G GG G VY+ +  S    + +AV K+ +L    I            I++      I 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEY--LERGSLATILSNEATAAELDWSKRV--NVIKG 884
            I H  I K+YG C   +   + Y +  LE+    T    E        +K++  N++K 
Sbjct: 79  NIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENT---KEIFKRIKCKNKKLIKNIMKD 134

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL 929
           +   L Y+H      I H DI  + +++D   + ++ D+G A   
Sbjct: 135 MLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.003
 Identities = 23/60 (38%), Positives = 27/60 (45%)

Query: 521 QLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRL 580
            L  LD S+NRL          L +L  L L+GN L+   P     L  L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 51/225 (22%), Positives = 81/225 (36%), Gaps = 48/225 (21%)

Query: 777 FEGKMVLH-----GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR 831
           FE  M++H      T     V K  L S     +K L      EI I  +         +
Sbjct: 10  FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ----QEI-ITSRQL-------Q 57

Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           H NI+ +         L++V   +  GS   +L        L       ++K V NAL Y
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDY 116

Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK------------FLKPDSS----N 935
           +H   F   +HR + +  +LL  + K  +S    +                P SS     
Sbjct: 117 IHSKGF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 936 WSELAGTCGYIAPELAY-TMRA-NEKCDVFNFGVLVLEVIEGKHP 978
           W          +PE+    ++  NEK D+++ G+   E+  G  P
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 57/282 (20%), Positives = 121/282 (42%), Gaps = 41/282 (14%)

Query: 785  GTGGCGTVYKA---ELTSG--DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRH---RNI 835
            G G  G VY+    ++  G  +TR AVK ++   +    I    F++E + ++     ++
Sbjct: 15   GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE---FLNEASVMKGFTCHHV 71

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-------VANA 888
            V+  G  S  Q   +V E +  G L + L +    AE +  +    ++        +A+ 
Sbjct: 72   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CG 944
            ++Y++   F   +HRD++++  ++  ++   + DFG  + +    +++    G       
Sbjct: 132  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 186

Query: 945  YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004
            ++APE           D+++FGV++ E+          + L   P    +   V+  ++D
Sbjct: 187  WMAPESLKDGVFTTSSDMWSFGVVLWEI----------TSLAEQPYQGLSNEQVLKFVMD 236

Query: 1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                       E++  ++    +C   NP  RPT  ++ NLL
Sbjct: 237  GGYLDQPDNCPERVTDLMR---MCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.004
 Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 208 SLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
           +L  L L+ N+L+  IP  A   L NLK L L  N L+   P       SL  L LS N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 267 L 267
           L
Sbjct: 60  L 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1048
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.87
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
PRK09188	365	serine/threonine protein kinase; Provisional	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.72
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.71
PRK10345	210	hypothetical protein; Provisional	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
PRK14879	211	serine/threonine protein kinase; Provisional	99.62
smart00090	237	RIO RIO-like kinase.	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.61
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.5
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.44
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.42
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
PLN03150	623	hypothetical protein; Provisional	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.33
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.31
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.27
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.25
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.23
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.2
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.19
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.18
KOG1243	690	consensus Protein kinase [General function predict	99.17
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.16
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.12
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.11
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.1
PLN03150	623	hypothetical protein; Provisional	99.05
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.05
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.98
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.95
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.94
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.86
COG4248	637	Uncharacterized protein with protein kinase and he	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.8
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.68
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.68
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.68
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.67
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.65
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.62
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.56
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.54
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.49
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.39
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.38
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.3

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-104  Score=1015.57  Aligned_cols=861  Identities=33%  Similarity=0.523  Sum_probs=699.2

Q ss_pred             CCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccc-cccccceeccccccccccCCccCcCCCCCCeEec
Q 045493          160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIG-NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL  238 (1048)
Q Consensus       160 ~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  238 (1048)
                      .+..|+|++|++++.++..|..+++|+.|+|++|++++.+|..+. .+++|++|+|++|.+++.+|.  +.+++|++|+|
T Consensus        70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L  147 (968)
T PLN00113         70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL  147 (968)
T ss_pred             cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence            466677777777777777888888888888888888776666544 888888888888888776664  45788888888


Q ss_pred             cCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeec
Q 045493          239 HDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG  318 (1048)
Q Consensus       239 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  318 (1048)
                      ++|.+++.+|..++.+++|++|++++|.+.+.+|..|+++++|++|++.+ |.+.+.+|..++.+++|+.|++++|.+++
T Consensus       148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS-NQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccC-CCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            88888877888888888888888888888888888888888888888876 67777788888888899999999998888


Q ss_pred             ccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhh
Q 045493          319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIEN  398 (1048)
Q Consensus       319 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~  398 (1048)
                      .+|..++.+++|+.|++++|.+.+.+|..+..+++|++|++++|++++.+|..+.++++|+.|++++|.+.+.+|..+.+
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  306 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ  306 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence            88888888999999999999888888888999999999999999998888888888999999999999998888888889


Q ss_pred             hcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeee
Q 045493          399 MKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLD  478 (1048)
Q Consensus       399 l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~  478 (1048)
                      +++|+.|++++|.+++..|..++.+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++..+..++.+++|+.|+
T Consensus       307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~  386 (968)
T PLN00113        307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI  386 (968)
T ss_pred             CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence            99999999999999888888888899999999999999988999999999999999999999988888888899999999


Q ss_pred             CcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccC
Q 045493          479 LSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG  558 (1048)
Q Consensus       479 Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  558 (1048)
                      +++|++.+..|..+..+++|+.|++++|.+++..|..|..++.|+.|++++|++++.++..+..+++|+.|+|++|++.+
T Consensus       387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~  466 (968)
T PLN00113        387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG  466 (968)
T ss_pred             CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence            99999999999999999999999999999999999999999999999999999999999989999999999999999998


Q ss_pred             CCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCC
Q 045493          559 DIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICN  638 (1048)
Q Consensus       559 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  638 (1048)
                      .+|..+ ..++|+.||+++|++++..|..|..+++|+.|+|++|++.+..+..+..+++|++|+|++|.+++.+|..+..
T Consensus       467 ~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  545 (968)
T PLN00113        467 GLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE  545 (968)
T ss_pred             ecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence            888766 4589999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCcccccccccccccCCccccCCC--CCCCCCCCCCCC
Q 045493          639 LESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV--TGLPPCEALTSN  716 (1048)
Q Consensus       639 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~--~~~~~c~~~~s~  716 (1048)
                      +++|+.|+|++|++++.+|..+..++.|+.+++++|+++|.+|...+|.......+.||+.+|+..  .+.++|...   
T Consensus       546 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~---  622 (968)
T PLN00113        546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV---  622 (968)
T ss_pred             cccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc---
Confidence            999999999999999999999999999999999999999999999999988888999999999864  235566321   


Q ss_pred             CCCCCCceeeEEEEehhhhhHHHHHHHhhhhceeeeeecccccc-cCCCC--CCcc----------hhhhcccCCcceee
Q 045493          717 KGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKRTDSQ-EGQND--VNNQ----------ELLSASTFEGKMVL  783 (1048)
Q Consensus       717 ~~~~~~~~~~~~i~~~~~~~~~~~~lv~~~~~~~~r~~~~~~~~-~~~~~--~~~~----------~~~~~~~~~~~~~~  783 (1048)
                          .+...+ ++++++++++++++++++++++++|+|++.... .+...  ...+          .............+
T Consensus       623 ----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  697 (968)
T PLN00113        623 ----RKTPSW-WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENV  697 (968)
T ss_pred             ----ccccee-eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccE
Confidence                111222 223333333333333322233333333221111 01000  0000          00000011233456


Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      ||+|+||.||+|+.. ++..||||++.....     ....+++.+++++|||||+++|+|.+.+..|+||||+++|+|.+
T Consensus       698 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~  772 (968)
T PLN00113        698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE  772 (968)
T ss_pred             EccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHH
Confidence            899999999999874 788999998864322     12345777889999999999999999999999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT  942 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  942 (1048)
                      +++.      ++|.++.+++.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+......    ....+|
T Consensus       773 ~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t  841 (968)
T PLN00113        773 VLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFIS  841 (968)
T ss_pred             HHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCcccc
Confidence            9953      7899999999999999999997656699999999999999999888875 6655433221    223688


Q ss_pred             cccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC-cc--cccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP-AP--AANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       943 ~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++|||||++.+..++.++|||||||++|||+||+.||+......... ..  ..........+.++..........++..
T Consensus       842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (968)
T PLN00113        842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV  921 (968)
T ss_pred             ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence            99999999999999999999999999999999999985321110000 00  0000111223334444332223345567


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ++.+++.+||+.||++||||+||+++|++
T Consensus       922 ~~~~l~~~Cl~~~P~~RPt~~evl~~L~~  950 (968)
T PLN00113        922 EVMNLALHCTATDPTARPCANDVLKTLES  950 (968)
T ss_pred             HHHHHHHhhCcCCchhCcCHHHHHHHHHH
Confidence            78999999999999999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-60  Score=610.33  Aligned_cols=539  Identities=38%  Similarity=0.611  Sum_probs=368.7

Q ss_pred             CCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCc-CCcCCCceEEeecccccCccCCCCCcccCCCCCC
Q 045493           72 TNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGS  150 (1048)
Q Consensus        72 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~-~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~  150 (1048)
                      .+++.|+|++|.+++..|..|..+++|+.|+|++|++.+.+|..+ .++++|++|+|++|.+++.               
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~---------------  133 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS---------------  133 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccc---------------
Confidence            456677777777776666666666777777777666665555443 3666666666666665432               


Q ss_pred             CCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCC
Q 045493          151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNL  230 (1048)
Q Consensus       151 ~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  230 (1048)
                                              +|.  ..+++|++|+|++|.+++..|..++++++|++|+|++|.+.+.+|..++++
T Consensus       134 ------------------------~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  187 (968)
T PLN00113        134 ------------------------IPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL  187 (968)
T ss_pred             ------------------------cCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhC
Confidence                                    222  346778888888888887888888888888888888888877788888888


Q ss_pred             CCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEE
Q 045493          231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLW  310 (1048)
Q Consensus       231 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~  310 (1048)
                      ++|++|+|++|.+++.+|..++.+++|++|++++|++.+.+|..|+++++|++|++.+ |.+.+.+|..++++++|+.|+
T Consensus       188 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~  266 (968)
T PLN00113        188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY-NNLTGPIPSSLGNLKNLQYLF  266 (968)
T ss_pred             cCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcC-ceeccccChhHhCCCCCCEEE
Confidence            8888888888888877888888888888888888888776676666666666666654 445555555555566666666


Q ss_pred             ccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccC
Q 045493          311 LSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSG  390 (1048)
Q Consensus       311 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~  390 (1048)
                      +++|.+++..|..+..+++|+.|++++|.+.+.+|..+..+++|++|++++|.+++..|..++++++|+.|++++|.+++
T Consensus       267 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~  346 (968)
T PLN00113        267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSG  346 (968)
T ss_pred             CcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcC
Confidence            66665555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCC
Q 045493          391 SIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI  470 (1048)
Q Consensus       391 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~  470 (1048)
                      .+|..+..+++|+.|++++|+                        +++..|.++..+++|+.|++++|++.+..+..+..
T Consensus       347 ~~p~~l~~~~~L~~L~Ls~n~------------------------l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~  402 (968)
T PLN00113        347 EIPKNLGKHNNLTVLDLSTNN------------------------LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA  402 (968)
T ss_pred             cCChHHhCCCCCcEEECCCCe------------------------eEeeCChhHhCcCCCCEEECcCCEecccCCHHHhC
Confidence            555555555555555555444                        44444555555555555555555555555555555


Q ss_pred             CCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEe
Q 045493          471 YPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLT  550 (1048)
Q Consensus       471 ~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  550 (1048)
                      +++|+.|++++|++++..|..|..+++|+.|++++|.+++.++..+..+++|+.|+|++|++.+..|..+ ..++|+.|+
T Consensus       403 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~  481 (968)
T PLN00113        403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLD  481 (968)
T ss_pred             CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEE
Confidence            5566666666666665556666666666666666666666666666667777777777777766666544 346777888


Q ss_pred             ecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccC
Q 045493          551 LNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       551 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                      +++|++++..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|||++|++++
T Consensus       482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  561 (968)
T PLN00113        482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG  561 (968)
T ss_pred             CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence            88888877777777778888888888888887778888888888888888888888888888888888889999999988


Q ss_pred             cCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccce-ecC
Q 045493          631 NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNE-LQG  678 (1048)
Q Consensus       631 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~-l~~  678 (1048)
                      .+|..+..+++|+.|++++|++++.+|.. ..+..+....+.+|+ +.|
T Consensus       562 ~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~  609 (968)
T PLN00113        562 EIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCG  609 (968)
T ss_pred             cCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccC
Confidence            88888888889999999999998888754 333445555667776 444

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-47  Score=418.57  Aligned_cols=282  Identities=36%  Similarity=0.564  Sum_probs=230.5

Q ss_pred             CCCCcchhhhcccCCcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee
Q 045493          764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS  843 (1048)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~  843 (1048)
                      ..+...++..+++.+....+||+|+||.||+|...+++.||||++....... ...+..++..+.+++|||+|+++|||.
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            3467788888888888888899999999999999988999999886654432 334777788889999999999999999


Q ss_pred             eCC-eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          844 HTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       844 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                      +.+ +.++|||||++|+|+++++..... .++|.+|.+||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            988 599999999999999999875443 789999999999999999999999888999999999999999999999999


Q ss_pred             cccccccCCCCCCcccc-ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC--CCc--ccccchh
Q 045493          923 FGTAKFLKPDSSNWSEL-AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS--LPA--PAANMNI  997 (1048)
Q Consensus       923 fG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~--~~~--~~~~~~~  997 (1048)
                      ||+|+............ .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+.......  ...  .......
T Consensus       221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            99997654312222222 899999999999999999999999999999999999988764331111  111  1111222


Q ss_pred             hhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          998 VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++|+++........++...+..++.+|++.+|++||+|.||+++|+
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            56778888876311111267778999999999999999999999999884

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=380.66  Aligned_cols=250  Identities=23%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC-eEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ-HLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g  858 (1048)
                      ...||+|+.|+|||++++ +++.+|.|.+..........+..+|++.+.+.+||+||.+||.|.... ...++||||.+|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            345899999999999997 677889999855444443334455566667778999999999999888 599999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|+++++..   +.+++....+|+.++++||.|||+..  +||||||||+|||+...|+|||||||.+..+...  ....
T Consensus       164 SLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~t  236 (364)
T KOG0581|consen  164 SLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANT  236 (364)
T ss_pred             CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hccc
Confidence            999999764   34888999999999999999999632  9999999999999999999999999999887654  4467


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ++||..|||||.+.+..|+.++||||||++++|+++|+.||...      .......-+....+.++..|.....  .++
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~------~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS  308 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP------NPPYLDIFELLCAIVDEPPPRLPEG--EFS  308 (364)
T ss_pred             ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc------CCCCCCHHHHHHHHhcCCCCCCCcc--cCC
Confidence            89999999999999999999999999999999999999997532      0111222334455555443333221  467


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .++..++..|+++||.+|||++|++++
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            789999999999999999999999863

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=394.25  Aligned_cols=246  Identities=28%  Similarity=0.486  Sum_probs=202.4

Q ss_pred             ecccccccEEEEEEcCCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCC-eEEEEEEccCCCCHH
Q 045493          784 HGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQ-HLFLVYEYLERGSLA  861 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~  861 (1048)
                      +|+|+||+||+|.+.....||||++........ ......|+..+.+++|||||+++|+|.+.. ..++|||||++|+|.
T Consensus        49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~  128 (362)
T KOG0192|consen   49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLS  128 (362)
T ss_pred             cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence            799999999999998555599999976543332 234566777788899999999999999887 799999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeeCCCCCCeEECCCC-ceEEeccccccccCCCCCCcccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP-ILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      ++++.. ....+++..+.+++.|||+|+.|||++   + ||||||||+|||++.++ ++||+|||+++.........+..
T Consensus       129 ~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~  204 (362)
T KOG0192|consen  129 VLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSV  204 (362)
T ss_pred             HHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCC
Confidence            999764 345699999999999999999999999   7 99999999999999997 99999999998766443444557


Q ss_pred             ccccccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc-cCCCCCCchhHHH
Q 045493          940 AGTCGYIAPELAY--TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI-DSRLPPPLGEVEE 1016 (1048)
Q Consensus       940 ~gt~~y~aPE~~~--~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 1016 (1048)
                      .||++|||||++.  ...|+.|+||||||+++|||+||+.||.....           ......+. ....+...   ..
T Consensus       205 ~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------~~~~~~v~~~~~Rp~~p---~~  270 (362)
T KOG0192|consen  205 AGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------VQVASAVVVGGLRPPIP---KE  270 (362)
T ss_pred             CCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhcCCCCCCC---cc
Confidence            8999999999999  56899999999999999999999999874432           11122222 22222211   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +...+..++.+||+.||+.||++.+++..|+
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence            5567888899999999999999999999886

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-44  Score=375.27  Aligned_cols=250  Identities=22%  Similarity=0.310  Sum_probs=209.9

Q ss_pred             CcceeeecccccccEEEEEE-cCCCceeeEEeccCCCCc------ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGE------IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~~~------~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~l  850 (1048)
                      +...+.+|+|+||.|-+|.. ++++.||||.+++.....      ......+++..+++++|||||+++++|+..+..||
T Consensus       174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym  253 (475)
T KOG0615|consen  174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM  253 (475)
T ss_pred             eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence            33344689999999999965 489999999997643322      11223578888999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEecccccc
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAK  927 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~  927 (1048)
                      ||||++||+|.+.+-..+.   +.+..-..+++|++.|+.|||+.   ||+||||||+|||+..+   ..+||+|||+|+
T Consensus       254 VlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  254 VLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence            9999999999999976543   55666788999999999999999   99999999999999765   789999999999


Q ss_pred             ccCCCCCCccccccccccccccccccCCC---CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMRA---NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ... ....+.+.||||.|.|||++.++.+   ..++|+||+|||+|-+++|..||...          .......+.+..
T Consensus       328 ~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~----------~~~~sl~eQI~~  396 (475)
T KOG0615|consen  328 VSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE----------YTDPSLKEQILK  396 (475)
T ss_pred             ccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc----------cCCccHHHHHhc
Confidence            876 5567788999999999999987654   45889999999999999999998621          112224566777


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ++.......+.+..++..++|.+|+..||++|||++|+++
T Consensus       397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            7877777778888999999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=387.16  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=211.4

Q ss_pred             cCCcceeeecccccccEEEEEE-cCCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          776 TFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       776 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ..+.+..+||+|||+.||.+++ .+|+.||+|++.+..-  .........|++..++++|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4556777899999999999998 7899999999976422  222334456677789999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |+|+.|+|.+++++.   +++++.+++.+++||+.|+.|||+.   +|||||||..|++++++.++||+|||+|+.+..+
T Consensus        98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999999743   4589999999999999999999999   9999999999999999999999999999999888


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .+...+.||||.|.|||++....++..+||||+|||||-++.|++||+...           ..+.+..+.......+  
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------vkety~~Ik~~~Y~~P--  238 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------VKETYNKIKLNEYSMP--  238 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------HHHHHHHHHhcCcccc--
Confidence            788888999999999999999999999999999999999999999987322           2333334333333322  


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ...+.+..++|.++|++||.+|||+++|+.
T Consensus       239 --~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  239 --SHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              234456778899999999999999999985

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.5e-47  Score=393.30  Aligned_cols=502  Identities=32%  Similarity=0.477  Sum_probs=349.5

Q ss_pred             CCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceE
Q 045493           46 HLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQL  125 (1048)
Q Consensus        46 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L  125 (1048)
                      .-..|..|++++|.++ .+...+..+..|.+|++++|++.. .|.+++.+..++.|++++|++. ..|...+.+.+|+.|
T Consensus        43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l  119 (565)
T KOG0472|consen   43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL  119 (565)
T ss_pred             hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence            3345777788888777 445567777778888888888774 5667777888888888888887 777777777888888


Q ss_pred             EeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCccccc
Q 045493          126 SLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGN  205 (1048)
Q Consensus       126 ~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~  205 (1048)
                      +++.|.+.                                        ..|++++.+-.|..|+..+|+++ ..|..+.+
T Consensus       120 ~~s~n~~~----------------------------------------el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~  158 (565)
T KOG0472|consen  120 DCSSNELK----------------------------------------ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVN  158 (565)
T ss_pred             hcccccee----------------------------------------ecCchHHHHhhhhhhhccccccc-cCchHHHH
Confidence            87777664                                        34456667777788888888887 67777888


Q ss_pred             ccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhh
Q 045493          206 LRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLH  285 (1048)
Q Consensus       206 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~  285 (1048)
                      +.+|..|++.+|++.. .|+..-+++.|++||...|.+. .+|+.++++.+|+.|||.+|++. ..| .|.+++.|++|+
T Consensus       159 ~~~l~~l~~~~n~l~~-l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh  234 (565)
T KOG0472|consen  159 LSKLSKLDLEGNKLKA-LPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELH  234 (565)
T ss_pred             HHHHHHhhccccchhh-CCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHH
Confidence            8888888888888874 4444444888888888888887 67778888888888888888886 444 566666555555


Q ss_pred             hccccccCCCCCcccCCCCCCcEEEccCceeecccccc-cccccccceeeeccccccCCCCcchhccCCCCeEeccCCcc
Q 045493          286 VHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPS-LGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKL  364 (1048)
Q Consensus       286 l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  364 (1048)
                      +.                         .|+|+ .+|+. ...++++..|||++|+++ .+|+++..+++|.+||+|+|.|
T Consensus       235 ~g-------------------------~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~i  287 (565)
T KOG0472|consen  235 VG-------------------------ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDI  287 (565)
T ss_pred             hc-------------------------ccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcc
Confidence            54                         34444 23333 336777777777777776 6888999999999999999999


Q ss_pred             ccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCc
Q 045493          365 NGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL  444 (1048)
Q Consensus       365 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l  444 (1048)
                      + ..|..++++ .|+.|-+.+|++. .+..++-+...-+.|-.-+..++...+..- .-++-..-     ..........
T Consensus       288 s-~Lp~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~s-e~~~e~~~-----t~~~~~~~~~  358 (565)
T KOG0472|consen  288 S-SLPYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQS-EGGTETAM-----TLPSESFPDI  358 (565)
T ss_pred             c-cCCcccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCC-cccccccC-----CCCCCcccch
Confidence            8 678889999 8999999999987 343333221111111000111111111000 00000000     0000111122


Q ss_pred             ccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcE
Q 045493          445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHK  524 (1048)
Q Consensus       445 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  524 (1048)
                      ..+.+.+.|+++.-+++.++.++|.....                      .-++.++++.|++. ++|..+..+..+.+
T Consensus       359 ~~~i~tkiL~~s~~qlt~VPdEVfea~~~----------------------~~Vt~VnfskNqL~-elPk~L~~lkelvT  415 (565)
T KOG0472|consen  359 YAIITTKILDVSDKQLTLVPDEVFEAAKS----------------------EIVTSVNFSKNQLC-ELPKRLVELKELVT  415 (565)
T ss_pred             hhhhhhhhhcccccccccCCHHHHHHhhh----------------------cceEEEecccchHh-hhhhhhHHHHHHHH
Confidence            34556667777777777777666653211                      12455666666665 66666666655443


Q ss_pred             -EEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccccccc
Q 045493          525 -LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ  603 (1048)
Q Consensus       525 -L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~  603 (1048)
                       +++++|.++ .+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|.|++... |+.+..+..|+.+-.++|+
T Consensus       416 ~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~l-P~~~y~lq~lEtllas~nq  492 (565)
T KOG0472|consen  416 DLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRML-PECLYELQTLETLLASNNQ  492 (565)
T ss_pred             HHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccc-hHHHhhHHHHHHHHhcccc
Confidence             455555554 78888888888888899888887 7888888888899999999988765 7888888888888888899


Q ss_pred             ccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcccc
Q 045493          604 FSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSC  659 (1048)
Q Consensus       604 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  659 (1048)
                      |..+.+..+..+.+|..|||.+|.|. .+|..+++|.+|+.|+|+||+|. .++..
T Consensus       493 i~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~  546 (565)
T KOG0472|consen  493 IGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQ  546 (565)
T ss_pred             ccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHH
Confidence            98888888889999999999999998 88899999999999999999998 44433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=377.32  Aligned_cols=245  Identities=24%  Similarity=0.400  Sum_probs=204.0

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      .||+|.||.||.|.+.....||+|.++......  ....+++..|+.++|++||+++|+|...+..|||||||+.|+|.+
T Consensus       213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~--~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~  290 (468)
T KOG0197|consen  213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP--EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD  290 (468)
T ss_pred             HhcCCccceEEEEEEcCCCcccceEEeccccCh--hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence            489999999999999988899999997753332  345578888999999999999999999889999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc-cccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS-ELAG  941 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~~~g  941 (1048)
                      |++. .....+...+.+.++.|||+|++||+++   ++|||||.++|||++++..|||+|||+|+...++....+ ...-
T Consensus       291 yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kf  366 (468)
T KOG0197|consen  291 YLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKF  366 (468)
T ss_pred             Hhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCC
Confidence            9986 3345588899999999999999999999   999999999999999999999999999995554433222 2233


Q ss_pred             ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       942 t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      ...|.|||.+..+.++.|||||||||+||||+| |+.||..           ....+.++.+..+...+.+   ..+...
T Consensus       367 PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-----------msn~ev~~~le~GyRlp~P---~~CP~~  432 (468)
T KOG0197|consen  367 PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-----------MSNEEVLELLERGYRLPRP---EGCPDE  432 (468)
T ss_pred             CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-----------CCHHHHHHHHhccCcCCCC---CCCCHH
Confidence            558999999999999999999999999999999 8888653           3344555555555433332   334556


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ++++|..||+.+|++|||++.+...|+
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            889999999999999999999888775

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-43  Score=362.41  Aligned_cols=191  Identities=27%  Similarity=0.482  Sum_probs=170.2

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCC-CCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLP-TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~-~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ||+|+||+||+|+++ ++..||||.+.... ..+..+....|+..++.++|||||++++++..++..|+|||||.||||.
T Consensus        18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs   97 (429)
T KOG0595|consen   18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS   97 (429)
T ss_pred             ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence            899999999999887 67899999997654 2222334467788889999999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC------CceEEeccccccccCCCCCC
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE------YKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~------~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +|+++.+   .+++..++.++.|+|.|+++||++   +||||||||+|||++..      -.+||+|||+|+.+.+ ...
T Consensus        98 ~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~-~~~  170 (429)
T KOG0595|consen   98 DYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP-GSM  170 (429)
T ss_pred             HHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc-hhH
Confidence            9998754   488999999999999999999999   99999999999999865      4589999999998873 344


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      ..+.+|++-|||||++...+|+.|+|+||+|+++|||++|+.||+.
T Consensus       171 a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  171 AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            5678999999999999999999999999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-43  Score=347.11  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEee-EeeeCCe-EEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYG-FCSHTQH-LFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~~  857 (1048)
                      +.||+|+||+||+++.. +|..+|.|+++-.... ........++..+++++|||||++++ -+.+... .++|||||.+
T Consensus        25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~  104 (375)
T KOG0591|consen   25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDA  104 (375)
T ss_pred             HHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcc
Confidence            35899999999999765 8899999998732111 11222345667778999999999998 4444444 8999999999


Q ss_pred             CCHHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.++++..+. ...+++..+++++.|+++||+.+|+.. ++  |+||||||.||+++.+|.||++|||+++++.....
T Consensus       105 GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t  183 (375)
T KOG0591|consen  105 GDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT  183 (375)
T ss_pred             cCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence            999999975432 345899999999999999999999942 25  88999999999999999999999999999987777


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+|||.||+||.+...+|+.|+||||+||++|||+.-++||...           +......++..+..++.+.  
T Consensus       184 fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----------n~~~L~~KI~qgd~~~~p~--  250 (375)
T KOG0591|consen  184 FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----------NLLSLCKKIEQGDYPPLPD--  250 (375)
T ss_pred             HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----------cHHHHHHHHHcCCCCCCcH--
Confidence            777889999999999999999999999999999999999999998743           3344555666666665432  


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                      ...+.++..++..|+.+||+.||+....+
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~v  279 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDTVPYV  279 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence            44566788888899999999999844333

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=355.14  Aligned_cols=239  Identities=25%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....+||+|+||.||.++.+ +++.+|+|++++..-.+.  ......|...+.+++||+||+++..|++.+..|+|+||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            45567999999999999876 578899999877543332  233456677778899999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      .||.|..++++++.   +++..++-++..|+.||.|||+.   +|||||+||+|||+|++|+++|+|||+++.....+..
T Consensus       108 ~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  108 NGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             CCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999999987554   88899999999999999999999   9999999999999999999999999999977666667


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ..+++||+.|||||++.+..|+..+|.||+|+++|||++|..||..           .......+.+...+.+.+...  
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-----------~~~~~~~~~I~~~k~~~~p~~--  248 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-----------EDVKKMYDKILKGKLPLPPGY--  248 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-----------ccHHHHHHHHhcCcCCCCCcc--
Confidence            7789999999999999999999999999999999999999999863           223444555555553333221  


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP 1037 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP 1037 (1048)
                       ...+..+++.+.++.||++|.
T Consensus       249 -ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  249 -LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCHHHHHHHHHHhccCHHHhc
Confidence             234577888889999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.3e-43  Score=346.09  Aligned_cols=258  Identities=21%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .-.+|+|+||+||+++++ +|+.||||++......+ ......++++++++++|+|+|.++++|...+.+++|+|||+. 
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-   85 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-   85 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence            345799999999999987 68999999998765533 334456788889999999999999999999999999999999 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.+-+.+.  ...++.+.+.+++.|+++|+.|+|+.   ++|||||||+|||++.+|.+|+||||+|+.+...+...+.
T Consensus        86 TvL~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   86 TVLHELERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             HHHHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            454555433  22377889999999999999999999   9999999999999999999999999999998876777788


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccc-------hhhh--hhhccC-CC
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANM-------NIVV--NDLIDS-RL 1007 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~--~~~~~~-~~ 1007 (1048)
                      ++.|..|+|||.+.+ .+|+..+||||+||++.||++|.+.|...++..-........       ...+  ..++.+ ++
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~l  240 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRL  240 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeec
Confidence            999999999999987 789999999999999999999999886544321111100000       0000  001111 11


Q ss_pred             CCC------chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPP------LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      |.+      .........-+++++..|++.||++|++.+|++.
T Consensus       241 P~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  241 PEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111      1111233457899999999999999999999874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.1e-44  Score=372.21  Aligned_cols=488  Identities=30%  Similarity=0.421  Sum_probs=326.1

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      .++.|++++|.++ .+.+.+.+|..|++|++++|++. ..|.+++.+..++.|+.|+|++. .+|+.+..+.+|.+|+.+
T Consensus        46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s  122 (565)
T KOG0472|consen   46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS  122 (565)
T ss_pred             chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence            6889999999999 66778999999999999999999 78999999999999999999999 579999999999999999


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|.+. ..|++++++..|..|+..+|+++                ++|.++.++.++..+++.+|++...+|..+. |+.
T Consensus       123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~----------------slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~  184 (565)
T KOG0472|consen  123 SNELK-ELPDSIGRLLDLEDLDATNNQIS----------------SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKR  184 (565)
T ss_pred             cccee-ecCchHHHHhhhhhhhccccccc----------------cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHH
Confidence            99999 78889999999999999999986                5667777777777777777777755555444 777


Q ss_pred             cceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccc-ccccccceeecc
Q 045493          185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKL-GSFKSLLYLYLS  263 (1048)
Q Consensus       185 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~  263 (1048)
                      |+.||..+|-++ .+|+.++.+.+|+.|+|.+|++. .+| .|.+++.|+.|++..|.|+ .+|.+. ..++++.+|||.
T Consensus       185 L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR  260 (565)
T KOG0472|consen  185 LKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLR  260 (565)
T ss_pred             HHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence            777777777775 66777777777777777777776 455 6777777777777777776 455544 367777777777


Q ss_pred             cccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccccccccccc--ccceeee--cccc
Q 045493          264 HNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS--NIRGLYI--RENM  339 (1048)
Q Consensus       264 ~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~l--~~n~  339 (1048)
                      .|+++ ..|..+.-|.+|.+|++++ |.++ .+|.+++++ .|+.|-+.+|.+..+-.+.+..=+  -|++|.=  .+-.
T Consensus       261 dNklk-e~Pde~clLrsL~rLDlSN-N~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dg  336 (565)
T KOG0472|consen  261 DNKLK-EVPDEICLLRSLERLDLSN-NDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDG  336 (565)
T ss_pred             ccccc-cCchHHHHhhhhhhhcccC-Cccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCC
Confidence            77776 5666677777777777765 5555 566667777 677777777766532222111111  0111110  0000


Q ss_pred             ccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcc---cceeeccccccCCCC
Q 045493          340 LYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKK---LNKYLLFENQFTGYL  416 (1048)
Q Consensus       340 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~---L~~l~l~~N~l~~~~  416 (1048)
                      ++..  ++ +   +-..-+    ...+.. .....+.+.+.|++++-+++ .+|++++...+   .+..+++.|++. .+
T Consensus       337 lS~s--e~-~---~e~~~t----~~~~~~-~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-el  403 (565)
T KOG0472|consen  337 LSQS--EG-G---TETAMT----LPSESF-PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-EL  403 (565)
T ss_pred             CCCC--cc-c---ccccCC----CCCCcc-cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hh
Confidence            0000  00 0   000000    000000 01122334455555555555 34444433333   445555555554 23


Q ss_pred             CcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCC
Q 045493          417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCP  496 (1048)
Q Consensus       417 ~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~  496 (1048)
                      |..+..+..+.+.-+.+|+..+.+|..++.+++|..|+|++|-+..++.+.++ +-.|+.||+|.|+|. ..|.......
T Consensus       404 Pk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~-lv~Lq~LnlS~NrFr-~lP~~~y~lq  481 (565)
T KOG0472|consen  404 PKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGS-LVRLQTLNLSFNRFR-MLPECLYELQ  481 (565)
T ss_pred             hhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhh-hhhhheecccccccc-cchHHHhhHH
Confidence            44444443333322333333335566666777777777777777766555444 344788888888775 5565555556


Q ss_pred             CccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCcccc
Q 045493          497 QLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLS  557 (1048)
Q Consensus       497 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  557 (1048)
                      .++.+-.++|++....|+.+.+|.+|..|||.+|.+. .+|..++++++|++|++++|.++
T Consensus       482 ~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  482 TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            6666677778887666666888888888888888887 67778888888888888888887

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=363.92  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=208.9

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ++...+.||+|+.|.||.|+.. +++.||||++....- ......-.|+..|+..+|+|||.+++.|...+..|+|||||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4445566899999999999654 688899999865432 22334556677788889999999999998889999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +||+|.+.+..    ..+++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+......
T Consensus       353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            99999999854    3388999999999999999999999   9999999999999999999999999999999888878


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ..+.+|||.|||||+.....|++|+||||+|++++||+.|+.||-....+...            +.+...-.+.....+
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------------yLIa~ng~P~lk~~~  493 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------YLIATNGTPKLKNPE  493 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------------HHHhhcCCCCcCCcc
Confidence            88999999999999999999999999999999999999999997643332221            122222233334455


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+..+.+|+.+|++.||++||+|+|+++.
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            667789999999999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-40  Score=378.51  Aligned_cols=248  Identities=23%  Similarity=0.400  Sum_probs=209.9

Q ss_pred             eecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          783 LHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -||+|+||.||+|+..      +...||||.++.....+....++++...+..++|||||+++|+|.+++..++|+|||.
T Consensus       493 eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~  572 (774)
T KOG1026|consen  493 ELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMD  572 (774)
T ss_pred             hhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecc
Confidence            3799999999999754      3456999999887776666677788888899999999999999999999999999999


Q ss_pred             CCCHHHHHhcccc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          857 RGSLATILSNEAT-----------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       857 ~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      .|||.++|+....           ..+++..+.+.||.|||.|++||-+.   .+|||||..+|+||.++..|||+|||+
T Consensus       573 ~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGL  649 (774)
T KOG1026|consen  573 HGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGL  649 (774)
T ss_pred             cccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEeccccc
Confidence            9999999964321           33488899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC-cc-ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhh
Q 045493          926 AKFLKPDSSN-WS-ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       926 a~~~~~~~~~-~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ++.+-..+.. .. ...-..+|||||.+..+++|.+|||||||||+||+++ |+-||...           ..+++++.+
T Consensus       650 sRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl-----------Sn~EVIe~i  718 (774)
T KOG1026|consen  650 SRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL-----------SNQEVIECI  718 (774)
T ss_pred             chhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-----------chHHHHHHH
Confidence            9976443322 11 2334679999999999999999999999999999999 88886633           345667777


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..++.-   +.++.+..+++++|..||+..|++||+++|+-..|+
T Consensus       719 ~~g~lL---~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  719 RAGQLL---SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             HcCCcc---cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence            666653   334667778999999999999999999999998886

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-41  Score=352.97  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=204.2

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCC-eEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQ-HLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~g~  859 (1048)
                      .+|.|+||.||+|+.+ +++.||||++++....-.+...-+|+..+++++ |||||++.+++.+.+ ..|+|||||+. +
T Consensus        17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-N   95 (538)
T KOG0661|consen   17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-N   95 (538)
T ss_pred             HhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-h
Confidence            4799999999999765 788999999987665544445567777788888 999999999998887 99999999988 9


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |+++++.+  ...+++..++.|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+.+.. ....+.+
T Consensus        96 LYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-kpPYTeY  169 (538)
T KOG0661|consen   96 LYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS-KPPYTEY  169 (538)
T ss_pred             HHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc-CCCcchh
Confidence            99999765  56799999999999999999999999   999999999999999999999999999998764 3456778


Q ss_pred             cccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccch-hhhhhhccCCCC
Q 045493          940 AGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANMN-IVVNDLIDSRLP 1008 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~-~~~~~~~~~~~~ 1008 (1048)
                      +.|..|+|||++.+ +.|+.++|+||+|||++|+.+-+..|.+.+..         .+-|....+.. ......+.-+++
T Consensus       170 VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P  249 (538)
T KOG0661|consen  170 VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFP  249 (538)
T ss_pred             hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCC
Confidence            99999999998765 56899999999999999999999888654432         22222222211 111111222222


Q ss_pred             CCch-----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1009 PPLG-----EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1009 ~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+     -......+.++++.+|+++||.+||||+|++++
T Consensus       250 ~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  250 QVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1111     112356788999999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=355.44  Aligned_cols=239  Identities=27%  Similarity=0.472  Sum_probs=198.1

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +.+.+|.|+.|.||.|+.+ +++|||||++..        .+..+.-++.++||||+.|.|+|+....+|+|||||..|-
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3456899999999999998 899999998643        3345677889999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |+.+++....   ++......|.++||.|+.|||..   .|||||+|.-||||+.+..|||+|||-++...+- ...-.+
T Consensus       199 L~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSF  271 (904)
T KOG4721|consen  199 LYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSF  271 (904)
T ss_pred             HHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhh
Confidence            9999976443   77788999999999999999999   9999999999999999999999999999876544 333457


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      +||..|||||++...+.++|+||||||||+|||+||..||.+.+...    ..+   .+-...+  .++    .+..+.+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw---GVGsNsL--~Lp----vPstcP~  338 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW---GVGSNSL--HLP----VPSTCPD  338 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE---eccCCcc--ccc----CcccCch
Confidence            89999999999999999999999999999999999999987544221    111   1111111  111    1234455


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.-+++.||+-.|..||++.+++.+|+
T Consensus       339 GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  339 GFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            6777888899999999999999998874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=353.04  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=197.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .++||.|+|++||+|+.+ ++++||||++.+..-  +........|-..|.++ .||.|++++..|.+....|+|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            346899999999999776 688999998755311  11111222333345556 89999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|.+++++.+.   +++...+.++.+|+.|++|||++   |||||||||+|||+|.||++||+|||.|+.+.+.... 
T Consensus       158 nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  158 NGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             CCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence            9999999987654   89999999999999999999999   9999999999999999999999999999987643211 


Q ss_pred             ------------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          936 ------------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       936 ------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                                  ...++||..|.+||++.....++.+|+|||||++|+|+.|.+||....           ....+.+++
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-----------eyliFqkI~  300 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-----------EYLIFQKIQ  300 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-----------HHHHHHHHH
Confidence                        144789999999999999999999999999999999999999987433           233444444


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +-....+..    ..+.+.+++.+.+..||.+|+|++++.++
T Consensus       301 ~l~y~fp~~----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  301 ALDYEFPEG----FPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HhcccCCCC----CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            444433322    22457888999999999999999998764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=343.52  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||.|..++||+|+.. .++.||||++.-......-.....++..++.++||||++++..|..+...|+||+||.+|+
T Consensus        31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS  110 (516)
T KOG0582|consen   31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS  110 (516)
T ss_pred             EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence            456899999999999875 6789999999766555544556777888899999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc---
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~---  936 (1048)
                      +.++++..-.. -+++..+..|.+++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+..+...+...   
T Consensus       111 ~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~r  186 (516)
T KOG0582|consen  111 LLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTR  186 (516)
T ss_pred             HHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEe
Confidence            99999765433 389999999999999999999999   99999999999999999999999999987766544322   


Q ss_pred             -ccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCC-----
Q 045493          937 -SELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP----- 1008 (1048)
Q Consensus       937 -~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1008 (1048)
                       ...+||+.|||||++..  ..|+.|+||||||++..|+++|..||.....+..+.           ..+....+     
T Consensus       187 f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----------~tLqn~pp~~~t~  255 (516)
T KOG0582|consen  187 FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----------LTLQNDPPTLLTS  255 (516)
T ss_pred             eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----------HHhcCCCCCcccc
Confidence             45689999999999653  468999999999999999999999997654321110           00111111     


Q ss_pred             -CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1009 -PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1009 -~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       ..........+.+.+++..|+++||++||||+++++
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence             011222344557888999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6e-40  Score=321.14  Aligned_cols=261  Identities=23%  Similarity=0.296  Sum_probs=204.9

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .+.+.+|+|.||.||+|++. +|+.||+||++.....+ ......+|+..++.++|+||+.++++|.+.+...+|+|||+
T Consensus         5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~   84 (318)
T KOG0659|consen    5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP   84 (318)
T ss_pred             hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence            34456899999999999775 79999999998764432 33455677888899999999999999999999999999998


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      . +|+..++..  ...++...+..++.++++|++|||++   .|+||||||.|+|++++|.+||+|||+|+.+.+.....
T Consensus        85 t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   85 T-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             c-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            8 999999753  34578889999999999999999999   99999999999999999999999999999998776666


Q ss_pred             cccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccch--hhhhhhcc
Q 045493          937 SELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANMN--IVVNDLID 1004 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~--~~~~~~~~ 1004 (1048)
                      ...+-|..|+|||.+.+. .|+..+||||.|||+.|++-|.+-|.+.+++         .+-|..+.+.+  ...+...-
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            666889999999998875 5899999999999999999988776544432         11111111111  11111111


Q ss_pred             CCCCCCch--hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 SRLPPPLG--EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 ~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...|.+..  -...+..+.++++..|+..||.+|+|++|++++
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11221111  123445667999999999999999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=362.39  Aligned_cols=393  Identities=23%  Similarity=0.216  Sum_probs=289.0

Q ss_pred             CcEEeCCCCcCCCCCcccccccc--ccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCC
Q 045493           74 LVVLRLSVNQLNGLIPEELGELT--SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSI  151 (1048)
Q Consensus        74 L~~L~ls~n~l~~~~~~~~~~l~--~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~  151 (1048)
                      -+.||.+++.|..+.-..+.++-  .-+.||+++|++..+.+..|.+|++|+.++|.+|.++                .+
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt----------------~I  117 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT----------------RI  117 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh----------------hc
Confidence            45677777777754333333322  3345888888888888888888888888888888876                34


Q ss_pred             CccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCC
Q 045493          152 PQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLS  231 (1048)
Q Consensus       152 p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  231 (1048)
                      |........++.|+|.+|.|+.+-.+.+..+..|+.|||+.|.|+.+.-.+|..-.++++|+|++|+|+..-...|..+.
T Consensus       118 P~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ln  197 (873)
T KOG4194|consen  118 PRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLN  197 (873)
T ss_pred             ccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccc
Confidence            44444444577777777777777777888888888888888888765556677777788888888888766667788888


Q ss_pred             CCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEc
Q 045493          232 NLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWL  311 (1048)
Q Consensus       232 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L  311 (1048)
                      +|.+|.|++|+|+..++..|+++++|+.|+|..|+|.-..-..|.+|++|+.|.+.. |+++..-...|-.|.++++|+|
T Consensus       198 sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqr-N~I~kL~DG~Fy~l~kme~l~L  276 (873)
T KOG4194|consen  198 SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQR-NDISKLDDGAFYGLEKMEHLNL  276 (873)
T ss_pred             hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhh-cCcccccCcceeeecccceeec
Confidence            888888888888866666777788888888888888744456777777777777766 6666555566777777777777


Q ss_pred             cCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCC
Q 045493          312 SKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGS  391 (1048)
Q Consensus       312 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  391 (1048)
                      +.|+++.....++.+++.|+.|+|+.|.|..+.++.+...++|+.|+|++|+|+...+..|..|+.|++|+|++|.++..
T Consensus       277 ~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l  356 (873)
T KOG4194|consen  277 ETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHL  356 (873)
T ss_pred             ccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHH
Confidence            77777766667777777777777777777777777777777777777777777766667777777777777777777644


Q ss_pred             chhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCC
Q 045493          392 IPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIY  471 (1048)
Q Consensus       392 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~  471 (1048)
                      -...|..+++|++|+|.+|.++..+.+                     ....|..+++|+.|.+.+|+|+.++..+|.++
T Consensus       357 ~e~af~~lssL~~LdLr~N~ls~~IED---------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl  415 (873)
T KOG4194|consen  357 AEGAFVGLSSLHKLDLRSNELSWCIED---------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGL  415 (873)
T ss_pred             HhhHHHHhhhhhhhcCcCCeEEEEEec---------------------chhhhccchhhhheeecCceeeecchhhhccC
Confidence            445555666666666655555433221                     13457788899999999999999999999999


Q ss_pred             CCCCeeeCcCCcccCcccccccCCCCccEEEecC
Q 045493          472 PDLELLDLSNNNFFGEISSNWIKCPQLATLNMGG  505 (1048)
Q Consensus       472 ~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~  505 (1048)
                      +.|+.|||.+|.|..+.+.+|..+ .|++|.+..
T Consensus       416 ~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  416 EALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             cccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            999999999999988888888888 888877654

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=359.35  Aligned_cols=375  Identities=25%  Similarity=0.266  Sum_probs=302.1

Q ss_pred             CcEEEccCceeecccccccccc--cccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEe
Q 045493          306 LSHLWLSKTQLSGFIPPSLGNL--SNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFAL  383 (1048)
Q Consensus       306 L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  383 (1048)
                      -..|+.+++.+..+....+..+  +.-+.|++++|++....+..|.++++|+.+++.+|.++ .+|.......+|+.|+|
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L  132 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL  132 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence            3567777777764433333322  33456888888888877888888888888888888887 67766666677888888


Q ss_pred             ecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccC
Q 045493          384 RENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGN  463 (1048)
Q Consensus       384 ~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~  463 (1048)
                      .+|.|+....++++.++.|+.++|+.|.|+.+.-..|..-..+++|+|++|.|+......|.++.+|..|.|++|+++.+
T Consensus       133 ~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittL  212 (873)
T KOG4194|consen  133 RHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTL  212 (873)
T ss_pred             eccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccccc
Confidence            88888877788888888888888888888876666677777888888888888888888888888888888888888888


Q ss_pred             cccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCC
Q 045493          464 ISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKL  543 (1048)
Q Consensus       464 ~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  543 (1048)
                      +...|..+++|+.|+|..|+|.-..-.+|.++++|+.|.|..|.|+....+.|..|.++++|+|+.|++......++-++
T Consensus       213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgL  292 (873)
T KOG4194|consen  213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGL  292 (873)
T ss_pred             CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccccc
Confidence            88888888888888888888876656778888888888888888887777788888888888888888887777778888


Q ss_pred             CccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEEC
Q 045493          544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDL  623 (1048)
Q Consensus       544 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  623 (1048)
                      +.|+.|+||+|.|...-+..+.-.++|++||||+|+|+.+.++.|..+..|++|+|++|+|+.+....|..+.+|++|||
T Consensus       293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL  372 (873)
T KOG4194|consen  293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL  372 (873)
T ss_pred             chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence            88888888888888777778888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCCcccCcC---CcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCC
Q 045493          624 SHNSLGGNI---PSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       624 s~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      ++|.|+..+   ...|..|++|+.|+|.+|+|..+...+|..++.|+.|||.+|.+...-|
T Consensus       373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~  433 (873)
T KOG4194|consen  373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQP  433 (873)
T ss_pred             cCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecc
Confidence            888887633   3456678888888888888887777888888888888888888765444

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=348.89  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=195.2

Q ss_pred             cceeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC--eEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--HLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  855 (1048)
                      .+.+.||+|+||+||++...+ |+..|||.+....... ......+++.+++++|||||+++|......  .+++.|||+
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            345678999999999998874 8899999886542222 334577888899999999999999855444  689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCC-
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDS-  933 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~-  933 (1048)
                      ++|+|.+++.+.+.  .+++..++.+++||++||+|||++   +||||||||+|||++. ++.+||+|||++....... 
T Consensus        99 ~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             CCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999987653  589999999999999999999999   9999999999999999 7999999999998766311 


Q ss_pred             --CCccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 --SNWSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                        .......||+.|||||++..+. ...++||||+||++.||+||+.||...         .......+........|..
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---------~~~~~~~~~ig~~~~~P~i  244 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---------FEEAEALLLIGREDSLPEI  244 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---------cchHHHHHHHhccCCCCCC
Confidence              2234578999999999999633 345999999999999999999998642         0111111111112222211


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                         +.....+..+++.+|+..||++||||+++++.
T Consensus       245 ---p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  245 ---PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ---CcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence               22344567888999999999999999999874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=349.78  Aligned_cols=248  Identities=26%  Similarity=0.400  Sum_probs=210.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.+...||+|+||.||+|.+. +++.||+|.+.-..........++++..+.+++++||.++|+.|..+..++++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            344567999999999999775 6788899998776666655666778888899999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      ||++.+.++...   .+++..+..|++++..|+.|+|++   +.+|||||+.||++..+|.+|++|||.+..+.......
T Consensus        95 gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   95 GGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             CcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            999999996533   247778888999999999999999   99999999999999999999999999999887766666


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      .+++|||.|||||++.+..|+.|+||||+|++.+||++|.+|+....++            .+...+.+..||....  .
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------rvlflIpk~~PP~L~~--~  234 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------RVLFLIPKSAPPRLDG--D  234 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------eEEEeccCCCCCcccc--c
Confidence            7899999999999999989999999999999999999999997654431            1222333344444333  5


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+.+.+++..|+++||+.||+|+++++.
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            66778899999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-39  Score=346.61  Aligned_cols=261  Identities=23%  Similarity=0.317  Sum_probs=201.7

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCC-CcccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT-GEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYE  853 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  853 (1048)
                      +.+...||+|+||.||+|++. +|+.||+||+.-... .+......+++..++++.||||+++.+...+.  ..+|+|+|
T Consensus       119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe  198 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE  198 (560)
T ss_pred             HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence            345556899999999999875 788999999976553 33445567788888999999999999998776  68999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      ||++ ||.-++...  .-.++..++..+++|++.||+|||++   +|+|||||.+|||||.+|.+||+|||+|+++....
T Consensus       199 YMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  199 YMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             cccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            9999 898888653  34589999999999999999999999   99999999999999999999999999999887665


Q ss_pred             CC-ccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccchhhh--h
Q 045493          934 SN-WSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANMNIVV--N 1000 (1048)
Q Consensus       934 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~--~ 1000 (1048)
                      .. .+..+-|..|+|||.+.+. .|+.++|+||.|||+.||++|+..|+....+         -+.+....|.....  .
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            33 6677889999999998875 6999999999999999999999998754432         11111111110000  0


Q ss_pred             hhccCCCCCC---chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 DLIDSRLPPP---LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+..+-.   .+.........++++..+|..||.+|.||.++++
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0011110000   0011222456888999999999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-40  Score=350.68  Aligned_cols=242  Identities=26%  Similarity=0.380  Sum_probs=204.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .+.||+|+||.||||+.+ +.+.||+|.+.+....+. -....++++.+++++|||||.++++|+...++|+|+||+.| 
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-   85 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-   85 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence            346899999999999877 678889998876544432 23456778888999999999999999999999999999988 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|..++..++.   ++++.++.++.+++.||+|||+.   +|+|||+||+|||++..|.+|+||||+|+.+.......+.
T Consensus        86 ~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   86 DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            99999976554   88999999999999999999999   9999999999999999999999999999988776666777


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..|||-|||||...+.+|+..+|.||+||++||+++|++||...+           ....+..+......++    ....
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----------i~~Lv~~I~~d~v~~p----~~~S  224 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----------ITQLVKSILKDPVKPP----STAS  224 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----------HHHHHHHHhcCCCCCc----cccc
Confidence            889999999999999999999999999999999999999986322           1222333333332222    3556


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+..++...+.+||..|.|..+++.
T Consensus       225 ~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  225 SSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHHHHHHhhcChhhcccHHHHhc
Confidence            67889999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=364.21  Aligned_cols=249  Identities=22%  Similarity=0.417  Sum_probs=207.5

Q ss_pred             eeeecccccccEEEEEEc----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .++||.|.||.||+|+++    ....||+|.++....+.....+..+...|.+..||||+++.|+.+..+.+++|+|||+
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME  713 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME  713 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence            457999999999999886    2356899999876665544445555666778899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|+.+|+..  .+++++.+...+.++||.|+.||.+.   ++|||||.++|||++.+-.+|++|||+++.+.++.+. 
T Consensus       714 NGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  714 NGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             CCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            99999999764  35699999999999999999999998   9999999999999999999999999999988766533 


Q ss_pred             cccccc--ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 WSELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ~~~~~g--t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .+...|  ..+|.|||.+...+++.++|||||||||||.++ |..||.+           +..+.++..+.++..-+++ 
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd-----------mSNQdVIkaIe~gyRLPpP-  856 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD-----------MSNQDVIKAIEQGYRLPPP-  856 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc-----------cchHHHHHHHHhccCCCCC-
Confidence            233333  458999999999999999999999999999988 8888653           3344555555555333322 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                        .++...+.++|..||++|-.+||++.+++.+|.|
T Consensus       857 --mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  857 --MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             --CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence              4566779999999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=351.40  Aligned_cols=245  Identities=21%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC----cccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG----EIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~----~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....||+|+||.|+.|.+. +++.||+|.+......    .......+++..+++++ ||||+++++++......|+|||
T Consensus        21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmE  100 (370)
T KOG0583|consen   21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVME  100 (370)
T ss_pred             eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEE
Confidence            3456899999999999765 6799999966553111    22334456777888898 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~  932 (1048)
                      |+.||+|.+++.+.   ..+.+..++.+++|++.|++|||+.   +|+||||||+||+++.+ +++||+|||++......
T Consensus       101 y~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~  174 (370)
T KOG0583|consen  101 YCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE  174 (370)
T ss_pred             ecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence            99999999999763   3477799999999999999999999   99999999999999999 99999999999977534


Q ss_pred             CCCccccccccccccccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          933 SSNWSELAGTCGYIAPELAYTMR-AN-EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .......+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++..           .......+..+....+
T Consensus       175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-----------~~~l~~ki~~~~~~~p  243 (370)
T KOG0583|consen  175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-----------VPNLYRKIRKGEFKIP  243 (370)
T ss_pred             CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-----------HHHHHHHHhcCCccCC
Confidence            45567889999999999999987 84 88999999999999999999998522           2222333444443332


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....   ..++..++.+|+..||.+|+|+.|+++
T Consensus       244 ~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  244 SYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            2111   567889999999999999999999984

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=319.07  Aligned_cols=234  Identities=24%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....+|.|+||.|..++.+ ++..+|+|.+.+......  ......+.+.++.+.||+++++++.|.+.+..|+||||+
T Consensus        47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv  126 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV  126 (355)
T ss_pred             hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence            34556899999999999887 577889998865432221  222345667778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +||-|..++++.+.   +++..++.++.+|+.|++|||+.   +|++||+||+|||+|.+|.+||+|||.|+.+...   
T Consensus       127 ~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  127 PGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             CCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999999976544   88999999999999999999999   9999999999999999999999999999987533   


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ..+.||||.|+|||++..++|..++|.|||||++|||+.|..||....           ....++++..++...+.    
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~-----------~~~iY~KI~~~~v~fP~----  262 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN-----------PIQIYEKILEGKVKFPS----  262 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC-----------hHHHHHHHHhCcccCCc----
Confidence            557899999999999999999999999999999999999999986332           24556677776655442    


Q ss_pred             HHHHHHHHHHHhccCCCCCCC
Q 045493         1016 EKLKSMIAVAFLCLDANPDCR 1036 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~R 1036 (1048)
                      ....++.+++...+++|-.+|
T Consensus       263 ~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  263 YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCHHHHHHHHHHHhhhhHhh
Confidence            334457778888899998888

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=336.78  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~  856 (1048)
                      .+++|+|.||.||||++. ++.||||++.......  ...++.+..+-.++|+||++++++-....    .+++|+||.+
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kqs--~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQS--FQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHHHHHH--HHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            346899999999999997 6999999996543332  12223333445678999999999875544    8999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC------FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      .|+|.+|++...    ++|....+|+..+++||+|||+..      .|+|+|||||++|||+.+|+++.|+|||+|..+.
T Consensus       292 kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  292 KGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             CCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            999999997543    899999999999999999999753      3789999999999999999999999999999887


Q ss_pred             CCCCC--ccccccccccccccccccCC-C-----CchhhHHHHHHHHHHHHhCCCCCcc--cc--------cccCCCccc
Q 045493          931 PDSSN--WSELAGTCGYIAPELAYTMR-A-----NEKCDVFNFGVLVLEVIEGKHPGHF--LS--------LLLSLPAPA  992 (1048)
Q Consensus       931 ~~~~~--~~~~~gt~~y~aPE~~~~~~-~-----~~~~Dvws~Gvvl~elltg~~p~~~--~~--------~~~~~~~~~  992 (1048)
                      ++...  ...-+||.+|||||++.+.- +     -.+.||||+|.|+|||++....++.  ..        .+...|..+
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            65433  23468999999999987642 1     2468999999999999997654421  11        111122222


Q ss_pred             ccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          993 ANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....++.+..++.++..+... .....+.+.+..||..||+.|.|+.=|-+++.
T Consensus       448 ~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  448 EMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             HHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence            2233344444555555444433 45677889999999999999999987776653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-39  Score=347.10  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=197.9

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|.||+||+|+|.  ..||||++...... +..+.++.|+..++.-+|.||+-+.|||..+.. .+|+.+|+|.+
T Consensus       397 ~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS  473 (678)
T KOG0193|consen  397 GERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS  473 (678)
T ss_pred             cceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence            346899999999999996  56899998765333 233455677777788899999999999998886 99999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC--CCCCCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~--~~~~~~~  937 (1048)
                      |+.+++-..  ..++..+.+.|++|||+|+.|||.+   +|||||+|..||++.+++.|||+|||++..-.  .......
T Consensus       474 LY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~  548 (678)
T KOG0193|consen  474 LYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLE  548 (678)
T ss_pred             hhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccC
Confidence            999997543  4588999999999999999999999   99999999999999999999999999986432  2233344


Q ss_pred             cccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC-CCCCchh
Q 045493          938 ELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR-LPPPLGE 1013 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1013 (1048)
                      ...|..-|||||+++.   .+|++.+||||||+|+|||+||..||...           ..+..+..+-++. ++.....
T Consensus       549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-----------~~dqIifmVGrG~l~pd~s~~  617 (678)
T KOG0193|consen  549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-----------NRDQIIFMVGRGYLMPDLSKI  617 (678)
T ss_pred             CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-----------ChhheEEEecccccCccchhh
Confidence            5567888999999874   46899999999999999999999997621           1122222222221 2222333


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+.+++.+++..||..++++||++.+++..|+
T Consensus       618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            4556678999999999999999999999999664

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-38  Score=347.25  Aligned_cols=242  Identities=23%  Similarity=0.359  Sum_probs=205.9

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +.+|+|+.|.|..|++. +|+.+|||.+.+....  ......++++.+|+-+.||||+++|+++++..++|+|.||+++|
T Consensus        18 kTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gG   97 (786)
T KOG0588|consen   18 KTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGG   97 (786)
T ss_pred             ccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCc
Confidence            35899999999999875 7999999998765221  22234567788889999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      -|.+|+.+.+   .+.+.++.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|.... .+....+
T Consensus        98 ELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklLeT  170 (786)
T KOG0588|consen   98 ELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLLET  170 (786)
T ss_pred             hhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-CCccccc
Confidence            9999997644   488899999999999999999999   99999999999999999999999999998644 4455677


Q ss_pred             cccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      .||+|.|.|||++.+.+| +.++||||+|||+|.++||+.||++           .+......++..+.+.-+    ...
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----------dNir~LLlKV~~G~f~MP----s~I  235 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----------DNIRVLLLKVQRGVFEMP----SNI  235 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----------ccHHHHHHHHHcCcccCC----CcC
Confidence            899999999999999998 6899999999999999999999983           234455666666655433    334


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..++.+++.+|+.+||++|.|++||.++
T Consensus       236 s~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  236 SSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             CHHHHHHHHHHhccCccccccHHHHhhC
Confidence            4567889999999999999999999874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-38  Score=340.31  Aligned_cols=246  Identities=22%  Similarity=0.279  Sum_probs=193.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||.|+-+ +|+.+|+|++++.....  .....+.+...+....+|.||++|..|.+.+.+|+||||++
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            4557999999999999776 68889999998753322  22334556666677889999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC-----
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP-----  931 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~-----  931 (1048)
                      ||++..+|.+.+   .+++..++.++.+++.|+..+|+.   |+|||||||+|+|||..|++||+|||++.-+..     
T Consensus       225 GGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  225 GGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             CccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            999999997543   488899999999999999999999   999999999999999999999999999854321     


Q ss_pred             ------------------CCCC----c--------------------cccccccccccccccccCCCCchhhHHHHHHHH
Q 045493          932 ------------------DSSN----W--------------------SELAGTCGYIAPELAYTMRANEKCDVFNFGVLV  969 (1048)
Q Consensus       932 ------------------~~~~----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl  969 (1048)
                                        +...    .                    ...+|||.|||||++.+..|+..+|.||+|||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                              0000    0                    125799999999999999999999999999999


Q ss_pred             HHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 045493          970 LEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT---MQKVC 1043 (1048)
Q Consensus       970 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl 1043 (1048)
                      |||+.|.+||....           ..+.+.+++..+.....+.......+..++|.+|+. ||++|.-   ++|+.
T Consensus       379 yEmLvGyPPF~s~t-----------p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  379 YEMLVGYPPFCSET-----------PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHhCCCCCCCCC-----------HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            99999999987332           223333333333211111223334678899999999 9999975   55554

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=329.70  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=207.0

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  857 (1048)
                      +.||+|.||.||+|++. |+.||||++.+..  +.....+.++.+-..++|+||+.+++.-..+.    +.|+|++|.+.
T Consensus       217 e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~  293 (513)
T KOG2052|consen  217 EIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH  293 (513)
T ss_pred             EEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence            35899999999999998 9999999997644  44455667777777889999999998754322    57999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD-----CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |||.||+.+.    .++....++++..+|.||++||..     ..|.|.|||||+.|||+..++.+.|+|+|+|.....+
T Consensus       294 GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  294 GSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             CcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence            9999999753    388899999999999999999964     3479999999999999999999999999999877655


Q ss_pred             CC----CccccccccccccccccccCC----C--CchhhHHHHHHHHHHHHhCC----------CCCcccccccCCCccc
Q 045493          933 SS----NWSELAGTCGYIAPELAYTMR----A--NEKCDVFNFGVLVLEVIEGK----------HPGHFLSLLLSLPAPA  992 (1048)
Q Consensus       933 ~~----~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dvws~Gvvl~elltg~----------~p~~~~~~~~~~~~~~  992 (1048)
                      ..    .....+||.+|||||++...-    +  -..+||||||.|+||++...          .||.  +.....|..+
T Consensus       370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy--d~Vp~DPs~e  447 (513)
T KOG2052|consen  370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY--DVVPSDPSFE  447 (513)
T ss_pred             CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc--cCCCCCCCHH
Confidence            32    234678999999999987532    1  23689999999999998643          3433  3345566666


Q ss_pred             ccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          993 ANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....+..+..++.++..+.. .+....+.++|+.||..+|..|.||-.+-+.|.
T Consensus       448 eMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  448 EMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             HHhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence            666666777777777777654 567788999999999999999999988877664

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-37  Score=351.91  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=191.0

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeC-CeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHT-QHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~  852 (1048)
                      ...||+|+||.||+|.+.      +++.||||++..............++..+..+ +||||++++++|... ...++||
T Consensus        12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~   91 (338)
T cd05102          12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV   91 (338)
T ss_pred             eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence            456899999999999742      34679999986543322222344556666777 899999999988754 4689999


Q ss_pred             EccCCCCHHHHHhcccc-----------------------------------------------------------cccc
Q 045493          853 EYLERGSLATILSNEAT-----------------------------------------------------------AAEL  873 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~-----------------------------------------------------------~~~l  873 (1048)
                      ||+++|+|.+++.....                                                           ...+
T Consensus        92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  171 (338)
T cd05102          92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL  171 (338)
T ss_pred             ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence            99999999999964321                                                           1347


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--cccccccccccccccc
Q 045493          874 DWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELA  951 (1048)
Q Consensus       874 ~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~  951 (1048)
                      ++.++..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++........  .....+++.|+|||++
T Consensus       172 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  248 (338)
T cd05102         172 TMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI  248 (338)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence            7888999999999999999998   9999999999999999999999999999865433221  1223456789999999


Q ss_pred             ccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccC
Q 045493          952 YTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLD 1030 (1048)
Q Consensus       952 ~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 1030 (1048)
                      .+..++.++|||||||++|||++ |+.||.....          .......+..+.....   .......+.+++.+||+
T Consensus       249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~  315 (338)
T cd05102         249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----------NEEFCQRLKDGTRMRA---PENATPEIYRIMLACWQ  315 (338)
T ss_pred             hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----------cHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcc
Confidence            98899999999999999999997 9999864221          0111111112211111   11233568899999999


Q ss_pred             CCCCCCCCHHHHHHHhhC
Q 045493         1031 ANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1031 ~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .||++|||+.|++++|++
T Consensus       316 ~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         316 GDPKERPTFSALVEILGD  333 (338)
T ss_pred             CChhhCcCHHHHHHHHHH
Confidence            999999999999999873

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=371.67  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=202.0

Q ss_pred             eeeecccccccEEEEEEcC--CC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELTS--GD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||.|...+  +.    .||+|.+....+.+....+-.|...|+.++|||||+++|+|-+....++++||
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley  776 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY  776 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence            3468999999999998763  32    38999988766665555556666678889999999999999999999999999


Q ss_pred             cCCCCHHHHHhcccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          855 LERGSLATILSNEAT----AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      |++|+|..++++.+.    ...++....+.++.|||+|+.||+++   ++|||||.++|+|+++...|||+|||+|+.+-
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            999999999986532    34588899999999999999999999   99999999999999999999999999999654


Q ss_pred             CCCCCcc-cc-ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhh-ccCC
Q 045493          931 PDSSNWS-EL-AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDL-IDSR 1006 (1048)
Q Consensus       931 ~~~~~~~-~~-~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1006 (1048)
                      ....... .. .-...|||||.+..+.++.|+|||||||++||++| |..||..           ....+....+ ..++
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-----------~~n~~v~~~~~~ggR  922 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-----------RSNFEVLLDVLEGGR  922 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-----------cchHHHHHHHHhCCc
Confidence            3333222 22 23468999999999999999999999999999999 7888653           2333444433 3444


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ++++    ..+...++++|..||+.+|++||++..+++.+.
T Consensus       923 L~~P----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  923 LDPP----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             cCCC----CCCChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            4444    345556889999999999999999999998764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-38  Score=341.17  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=210.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCe-EEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQH-LFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~  856 (1048)
                      ..+.+|+|+||.++.++++ ++..+|+|++.-....+. ......++..+++++|||||.+.+.|.+++. .++||+|++
T Consensus         8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen    8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE   87 (426)
T ss_pred             hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence            3456899999999999887 567899999866443332 2244556777788999999999999999888 999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      ||++.+.+.+.+ ...++++++..|+.|++.|+.|||+.   +|+|||||+.||+++.++.|||+|||+|+.+.+.....
T Consensus        88 Gg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a  163 (426)
T KOG0589|consen   88 GGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA  163 (426)
T ss_pred             CCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence            999999997655 56689999999999999999999988   99999999999999999999999999999998777677


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.||.||++.+.+|..|+||||+||++|||++-+++|..           .+....+.++......+..   ..
T Consensus       164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-----------~~m~~Li~ki~~~~~~Plp---~~  229 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-----------SNMSELILKINRGLYSPLP---SM  229 (426)
T ss_pred             heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-----------cchHHHHHHHhhccCCCCC---cc
Confidence            788999999999999999999999999999999999999999763           3344555566555544443   33


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...++..++..|+..+|+.||++.+++.+
T Consensus       230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  230 YSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            44567788889999999999999999864

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=373.23  Aligned_cols=508  Identities=29%  Similarity=0.335  Sum_probs=326.9

Q ss_pred             EEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccccee
Q 045493           28 YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNR  107 (1048)
Q Consensus        28 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~  107 (1048)
                      .+|++..+++ .+|..+-....++.|++++|-+....-..+.+..+|+.||||+|++.. .|..+..+.+|+.|++++|-
T Consensus         2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~-fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS-FPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeecccccccc-CCchhhhHHHHhhcccchhh
Confidence            4678888888 777777777778899999987764333445666679999999999884 78888999999999999999


Q ss_pred             cccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcce
Q 045493          108 LNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF  187 (1048)
Q Consensus       108 ~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~  187 (1048)
                      |. ..|.+...+.+|++|.|.+|++.                                        ..|..+..+++|++
T Consensus        80 i~-~vp~s~~~~~~l~~lnL~~n~l~----------------------------------------~lP~~~~~lknl~~  118 (1081)
T KOG0618|consen   80 IR-SVPSSCSNMRNLQYLNLKNNRLQ----------------------------------------SLPASISELKNLQY  118 (1081)
T ss_pred             Hh-hCchhhhhhhcchhheeccchhh----------------------------------------cCchhHHhhhcccc
Confidence            98 77888888999999999988875                                        34556666777777


Q ss_pred             eeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccc
Q 045493          188 VYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL  267 (1048)
Q Consensus       188 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l  267 (1048)
                      |+++.|.+. .+|..+..++.++.+..++|...    ..++... ++.+++..|.+.+.++..+..+..  .|+|..|.+
T Consensus       119 LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~  190 (1081)
T KOG0618|consen  119 LDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----QRLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEM  190 (1081)
T ss_pred             cccchhccC-CCchhHHhhhHHHHHhhhcchhh----hhhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchh
Confidence            777777775 66677777777777777777222    1222222 777777777777777766666655  677777776


Q ss_pred             cCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcc
Q 045493          268 NGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE  347 (1048)
Q Consensus       268 ~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  347 (1048)
                      .   ...+..                         +.+|+.|....|+++..    -..-++++.|+.++|.++...+  
T Consensus       191 ~---~~dls~-------------------------~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--  236 (1081)
T KOG0618|consen  191 E---VLDLSN-------------------------LANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--  236 (1081)
T ss_pred             h---hhhhhh-------------------------ccchhhhhhhhcccceE----EecCcchheeeeccCcceeecc--
Confidence            4   111222                         23344444444444321    1123456666666666653222  


Q ss_pred             hhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCccc
Q 045493          348 LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLT  427 (1048)
Q Consensus       348 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~  427 (1048)
                      -..-.+|+++++++|+++ .+|.|++.+.+|+.++..+|.++ .+|..+..+.+|+.+.+..|.+. ++|          
T Consensus       237 ~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip----------  303 (1081)
T KOG0618|consen  237 HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIP----------  303 (1081)
T ss_pred             ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCC----------
Confidence            222367899999999998 56699999999999999999996 78888888888888888888876 333          


Q ss_pred             EEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCC-CCeeeCcCCcccCcccccccCCCCccEEEecCc
Q 045493          428 HFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPD-LELLDLSNNNFFGEISSNWIKCPQLATLNMGGN  506 (1048)
Q Consensus       428 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~-L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N  506 (1048)
                                    .....+++|++|+|..|+|...+...|..... |..|+.+.|++.......               
T Consensus       304 --------------~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~---------------  354 (1081)
T KOG0618|consen  304 --------------PFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYE---------------  354 (1081)
T ss_pred             --------------CcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccccc---------------
Confidence                          33444555566666666655555544443333 455555555543221111               


Q ss_pred             ccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccc
Q 045493          507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPK  586 (1048)
Q Consensus       507 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  586 (1048)
                               =..++.|+.|.+.+|++++..-..+.++..|+.|+|++|++.......+.++..|++|+||+|+++.+ |.
T Consensus       355 ---------e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~L-p~  424 (1081)
T KOG0618|consen  355 ---------ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTL-PD  424 (1081)
T ss_pred             ---------chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhh-hH
Confidence                     11234455555555555555555555556666666666666544444555666666666666666654 46


Q ss_pred             cccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCc
Q 045493          587 NLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGL  666 (1048)
Q Consensus       587 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  666 (1048)
                      .+..+..|++|...+|+|...+  .+..+++|+.+|+|.|+|+......-..-++|++|||+||.-....-..|..+..+
T Consensus       425 tva~~~~L~tL~ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l  502 (1081)
T KOG0618|consen  425 TVANLGRLHTLRAHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSL  502 (1081)
T ss_pred             HHHhhhhhHHHhhcCCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhh
Confidence            6666666666666666665433  56666777777777777764222221222677777777777544455555556666


Q ss_pred             cEEEeccc
Q 045493          667 SSIDVSYN  674 (1048)
Q Consensus       667 ~~l~ls~N  674 (1048)
                      ...+++-|
T Consensus       503 ~~~~i~~~  510 (1081)
T KOG0618|consen  503 SQMDITLN  510 (1081)
T ss_pred             hheecccC
Confidence            66666555

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-37  Score=313.08  Aligned_cols=259  Identities=21%  Similarity=0.259  Sum_probs=199.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEee--eCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCS--HTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~  855 (1048)
                      +...|++|+||.||+|+++ +++.||.|+++.....+ ..+...+++..+.+++|||||.+-++..  .-+..|+|||||
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~  159 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV  159 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence            4446899999999999887 67889999997654332 3455577888889999999999998774  456799999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +. ||...++.-+  .++...++..++.|+++|++|||..   .|+|||+|++|+|+...|.+||+|||+|+.+......
T Consensus       160 Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  160 EH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             Hh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            99 9999997643  4688899999999999999999999   8999999999999999999999999999999877777


Q ss_pred             ccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccchhhhhhhc-c
Q 045493          936 WSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANMNIVVNDLI-D 1004 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~-~ 1004 (1048)
                      ++..+-|..|+|||.+.+. .|+.++|+||+|||+.|++++++-|...+.+         .+.|....+..-..-..+ .
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            7888899999999998875 4899999999999999999999887654321         122221111110000000 0


Q ss_pred             CCCCC-CchhHH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPP-PLGEVE------EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~-~~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      -.++. +.....      .....-.+++...+..||.+|.||.|.++
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            01110 000000      02245678888899999999999999875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=308.46  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=202.6

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +.||+|.|+.||++.+. +|+++|+|.+....-.. ..+..+++.+.-..++|||||++.+.+.+....|+|+|+|+||+
T Consensus        17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d   96 (355)
T KOG0033|consen   17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   96 (355)
T ss_pred             HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence            45899999999999654 78999999876543222 22334566677788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEeccccccccCCCCCCc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      |..-+-..   ..+++..+-..++||++|+.|+|.+   +|||||+||+|+++.+.   .-+|++|||+|..+. ++..+
T Consensus        97 l~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~  169 (355)
T KOG0033|consen   97 LFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAW  169 (355)
T ss_pred             HHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-Ccccc
Confidence            97665432   3366777888999999999999999   99999999999999643   459999999999988 66777


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+|||+|||||+....+|+..+||||.|||+|-++.|+.||.+.           .....++.+..+....+...++.
T Consensus       170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----------~~~rlye~I~~g~yd~~~~~w~~  238 (355)
T KOG0033|consen  170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----------DQHRLYEQIKAGAYDYPSPEWDT  238 (355)
T ss_pred             ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----------cHHHHHHHHhccccCCCCcccCc
Confidence            8899999999999999999999999999999999999999998632           23344556666665554445566


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..++..+++.+|+..||.+|.|++|.++
T Consensus       239 is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  239 VTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            6677888999999999999999999885

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-38  Score=307.14  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchh-------hHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQ-------KGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~-------~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      .+++|+|..++|.++.++ +++++|+|++......+.....       ..++..++++ .||+|+++.++|+.+..+++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            446899999999999765 7889999998765444333221       2223333433 599999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      +|.|+.|-|.||+...   -.+++.+.++|++|+.+|++|||.+   .|||||+||+|||+|++.++||+|||.|+.+.+
T Consensus       102 Fdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence            9999999999999653   3488999999999999999999999   999999999999999999999999999998864


Q ss_pred             CCCCccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          932 DSSNWSELAGTCGYIAPELAYTM------RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                       +...+..||||+|.|||.+.+.      .|+..+|.||+||+||-++.|..||.-...+           ....-+..+
T Consensus       176 -GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----------lMLR~ImeG  243 (411)
T KOG0599|consen  176 -GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----------LMLRMIMEG  243 (411)
T ss_pred             -chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----------HHHHHHHhc
Confidence             4566788999999999988643      4678999999999999999999997522211           123344566


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.....+.+.+....+.+++.+|++.||++|.|++|+++.
T Consensus       244 kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  244 KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            6666677788888899999999999999999999999863

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-38  Score=345.68  Aligned_cols=247  Identities=26%  Similarity=0.326  Sum_probs=190.7

Q ss_pred             eeecccccccEEEEEEcCC----Cc-eeeEEeccC--CCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELTSG----DT-RAVKKLHSL--PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~----~~-vavk~~~~~--~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ..||+|+||.||+|+.+..    .. ||||..+..  ...+.......|.+.|..++|||||++||++....+.++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            4689999999999987632    22 788887642  2222223334556667888999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |.||+|.+|++..+.  .++..++..++.++|+||+|||+.   ++|||||.++|+|++.++.+||+|||+++.-..-..
T Consensus       243 ~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             cCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence            999999999976443  588999999999999999999999   999999999999999999999999999875431111


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc-CCCCCCch
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID-SRLPPPLG 1012 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1012 (1048)
                      ......-..+|+|||.+..+.|++++|||||||++||+++ |..||.....           ......+.. +...+...
T Consensus       318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-----------~~v~~kI~~~~~r~~~~~  386 (474)
T KOG0194|consen  318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-----------YEVKAKIVKNGYRMPIPS  386 (474)
T ss_pred             ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-----------HHHHHHHHhcCccCCCCC
Confidence            1111124568999999999999999999999999999999 7888764332           223333312 21111111


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                         .....+..++.+||..+|++||||.++.+.++
T Consensus       387 ---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  387 ---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             ---CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence               23345667777999999999999999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=341.68  Aligned_cols=238  Identities=24%  Similarity=0.299  Sum_probs=191.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccc--hhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGI--NQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~--~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      -..++|+|+||.|+.|..+ +++.+|||.+++..--+...  ....+.+.+... +||.++.++.+|...+++|+||||+
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~  451 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV  451 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence            3457899999999999887 57789999998754322211  112222222222 6999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      .||++..+.+    ...+++.+++-++..++.||.|||++   +|||||||.+|||+|.+|++||+|||+++.....+..
T Consensus       452 ~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~  524 (694)
T KOG0694|consen  452 AGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR  524 (694)
T ss_pred             CCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence            9999544432    34589999999999999999999999   9999999999999999999999999999976655667


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .++++|||.|||||++.+..|+.++|.|||||+||||+.|..||...           ..++.++.++.....-    +.
T Consensus       525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd-----------dEee~FdsI~~d~~~y----P~  589 (694)
T KOG0694|consen  525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD-----------DEEEVFDSIVNDEVRY----PR  589 (694)
T ss_pred             cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC-----------CHHHHHHHHhcCCCCC----CC
Confidence            78899999999999999999999999999999999999999997632           2344444444333222    23


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      -.+.+.+.++++++.++|++|.-+
T Consensus       590 ~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  590 FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cccHHHHHHHHHHhccCcccccCC
Confidence            345678889999999999999866

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=339.69  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=202.9

Q ss_pred             cceeeecccccccEEEEEEcCCC-ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~-~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ++..++|+|.||+||.|++.+.+ .+|||.+..... .......+++..-++++|+|||+++|.+.+++..-+.||-++|
T Consensus       578 ~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  578 NERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             CceEEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence            34557899999999999987554 567777755433 3345567788888999999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC-CCCceEEeccccccccCCCCCCc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD-LEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      |+|.+.++..-..-.-.+.++-.+.+||++||.|||+.   .|||||||-+|||+. -.|.+||+|||-++.+..-++..
T Consensus       657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            99999997643333337788899999999999999999   999999999999996 57999999999999888777778


Q ss_pred             cccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          937 SELAGTCGYIAPELAYTMR--ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .++.||..|||||++..++  |+.++|||||||++.||.||++||.....      +...+-.+-.....+.      .+
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAAMFkVGmyKvHP~------iP  801 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAAMFKVGMYKVHPP------IP  801 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHhhhhhcceecCCC------Cc
Confidence            8899999999999998764  88999999999999999999999863321      1111111111222222      23


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ++...+...+|.+|+.+||.+||+|+++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            566778889999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.2e-37  Score=334.34  Aligned_cols=245  Identities=19%  Similarity=0.284  Sum_probs=192.9

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      ..||+|++|.||+|.+ +++.||||++........  .....+++..+.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4689999999999998 488999999875433221  1233467778889999999999999876    34689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.++++..   ..+++....+++.+++.|+.|||+..  +++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            999999999754   34789999999999999999999742  78899999999999999999999999998654322  


Q ss_pred             cccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 WSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....           ......+.........+ 
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~-  244 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----------KEIYDLIINKNNSLKLP-  244 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhcCCCCCCC-
Confidence             23468899999999876  6789999999999999999999999864321           11122221111111111 


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       ......+.+++.+||+.||++|||++|+++.|++
T Consensus       245 -~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        245 -LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence             1234568889999999999999999999999863

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.1e-37  Score=346.22  Aligned_cols=241  Identities=20%  Similarity=0.237  Sum_probs=192.5

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +||+|+||.||+|+.. +++.||+|++......  ........+...+++++||||+++++++...+..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5899999999999875 6788999988653211  111223345666788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++...+   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++............
T Consensus        82 L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          82 LFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            999986533   478899999999999999999999   99999999999999999999999999998644334444556


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      +||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.......+    .....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----------~~~~~~~~~~~~~~p----~~~~~  220 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------EKLFELILMEEIRFP----RTLSP  220 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----------HHHHHHHHcCCCCCC----CCCCH
Confidence            799999999999999999999999999999999999999863221           111122222222111    12334


Q ss_pred             HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      ++.+++.+||+.||++||     +++++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            678899999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=300.77  Aligned_cols=245  Identities=25%  Similarity=0.346  Sum_probs=201.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -...+|+|-||.||.|+.+ ++-.||+|++.+..-  ........+++...+.++||||+++|+||.+....|+++||..
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~  105 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP  105 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence            3446899999999999876 567789998866432  1222334455555578899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|.+...+.... ..++++.....+++|+|.|+.|+|.+   +||||||||+|+|++.++..|++|||.+..-+  ....
T Consensus       106 ~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR  179 (281)
T KOG0580|consen  106 RGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKR  179 (281)
T ss_pred             CchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCc
Confidence            999999997543 45588889999999999999999999   99999999999999999999999999997543  4566


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      .+.|||..|.|||+..+..++.++|+|++|++.||++.|..||...           ..++.+.++..-+...+    ..
T Consensus       180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-----------~~~etYkrI~k~~~~~p----~~  244 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-----------SHSETYKRIRKVDLKFP----ST  244 (281)
T ss_pred             eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-----------hhHHHHHHHHHccccCC----cc
Confidence            7889999999999999999999999999999999999999998622           23344444444443333    23


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......++|.+|+.++|.+|.+..|+++.
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cChhHHHHHHHHhccCccccccHHHHhhh
Confidence            34467889999999999999999999864

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-36  Score=315.66  Aligned_cols=262  Identities=20%  Similarity=0.252  Sum_probs=200.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCc-eeeEeeEeeeCC------eEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRN-IVKFYGFCSHTQ------HLFL  850 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~n-iv~~~~~~~~~~------~~~l  850 (1048)
                      +.+.+|+|+||+||+|+.+ +|+.||+|++.-.... .......+++..++.++|+| ||++++++...+      ..++
T Consensus        15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l   94 (323)
T KOG0594|consen   15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL   94 (323)
T ss_pred             HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence            3445899999999999876 6889999999876542 33445567788889999999 999999998766      7899


Q ss_pred             EEEccCCCCHHHHHhccccc-cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          851 VYEYLERGSLATILSNEATA-AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      |+||++. +|.+++...... ..++...+..++.||++|++|||++   +|+||||||+||+++++|.+||+|||+|+..
T Consensus        95 vfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   95 VFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             EEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            9999988 999999765432 3366678999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccchhhh
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANMNIVV  999 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~  999 (1048)
                      .-.....+.-++|..|+|||++.+. .|+..+||||+||+++||++++.-|.+.+..         .+.+....+.....
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~  250 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS  250 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence            6444555667889999999999887 6899999999999999999999888654331         22222221111110


Q ss_pred             hhhccCCCCCC---ch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1000 NDLIDSRLPPP---LG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1000 ~~~~~~~~~~~---~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..-.+..++..   ..   ..........+++.+|++.+|..|.|++.++++
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00001011110   00   011112478899999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=342.34  Aligned_cols=240  Identities=22%  Similarity=0.288  Sum_probs=190.1

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||.||+|+.. +++.||+|++.....  .........+...+.+++||||+++++++.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999886 577899998864321  11112233456667888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++............+
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99996533   478899999999999999999999   999999999999999999999999999986544444445567


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||....           ...............+    ......
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----------~~~~~~~~~~~~~~~~----~~~~~~  219 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----------VNEMYRKILQEPLRFP----DGFDRD  219 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----------HHHHHHHHHcCCCCCC----CcCCHH
Confidence            9999999999999999999999999999999999999986322           1122222222222211    123346


Q ss_pred             HHHHHHhccCCCCCCCCC---HHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPT---MQKVCN 1044 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt---~~evl~ 1044 (1048)
                      +.+++.+||+.||++||+   +.|+++
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            788999999999999985   556553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=324.16  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=192.3

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc---------c----cchhhHHHHHHhhcccCceeeEeeEeee--C
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE---------I----GINQKGFVSEITEIRHRNIVKFYGFCSH--T  845 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~---------~----~~~~~~~~~~l~~l~h~niv~~~~~~~~--~  845 (1048)
                      .-||+|.||.|-+|+.. +++.||+|++.+.....         .    .+...+++..+++++|||||+++++..+  .
T Consensus       103 ~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s  182 (576)
T KOG0585|consen  103 KEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPES  182 (576)
T ss_pred             hhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCccc
Confidence            34799999999999876 68889999886532111         0    1234667888899999999999999876  4


Q ss_pred             CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          846 QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       846 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      +.+|||+|||..|.+...=   ....++++.+++++++++..||+|||.+   +||||||||+|+|++++|+|||+|||.
T Consensus       183 ~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGV  256 (576)
T KOG0585|consen  183 DKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGV  256 (576)
T ss_pred             CceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccce
Confidence            5799999999999876542   2233389999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCC-----CCCccccccccccccccccccCC---C-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccch
Q 045493          926 AKFLKPD-----SSNWSELAGTCGYIAPELAYTMR---A-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       926 a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      +......     .......+|||.|||||...++.   + +.+.||||+||++|.|+.|+.||-...           .-
T Consensus       257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-----------~~  325 (576)
T KOG0585|consen  257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-----------EL  325 (576)
T ss_pred             eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----------HH
Confidence            9876332     12234578999999999987733   2 678999999999999999999975322           22


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +...+++...+..+.  ..+....+.+++.++|++||+.|.+..+|..+
T Consensus       326 ~l~~KIvn~pL~fP~--~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPE--NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHHHhcCcccCCC--cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            334444444433332  23456678899999999999999999998643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=320.04  Aligned_cols=258  Identities=22%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeee-----CCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSH-----TQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e  853 (1048)
                      .+.||+|+||.|+.|.++ +++.||+||+........ .....++++.++.++|+||+.+++.+..     .+.+|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            456899999999999876 789999999975433332 2223455666788899999999998854     457899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC--
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP--  931 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~--  931 (1048)
                      +|+. +|.+.++.+..   ++...+..++.|+++||.|+|+.   +|+|||+||+|++++.++..||+|||+|+...+  
T Consensus       107 lMet-DL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  107 LMET-DLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             HHhh-HHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence            9966 99999975433   78889999999999999999999   999999999999999999999999999998764  


Q ss_pred             CCCCccccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccccc-------CCCcccccchhh-----
Q 045493          932 DSSNWSELAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL-------SLPAPAANMNIV-----  998 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~-------~~~~~~~~~~~~-----  998 (1048)
                      ....++..+.|..|+|||+.. ...|+.++||||.|||++||++|+.-|.+.+.+.       ..+.+....-..     
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            234567788999999999865 5679999999999999999999999886654321       111111111000     


Q ss_pred             hhhhcc--CCCCC-C-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 VNDLID--SRLPP-P-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 ~~~~~~--~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....+.  +..++ + ...........++++.+|+..||.+|+|++|+++.
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111111  11111 1 11122344678899999999999999999999863

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-36  Score=334.60  Aligned_cols=249  Identities=20%  Similarity=0.244  Sum_probs=193.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|... +++.||+|++.......  .......++..++.++|++|+++++++.+.+..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence            3457899999999999875 68899999886532221  11223456677788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++...... ...
T Consensus        84 ~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~  158 (285)
T cd05631          84 GGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETV  158 (285)
T ss_pred             CCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Cee
Confidence            999998886432 23478999999999999999999999   9999999999999999999999999999875432 223


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......       ................    ....
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~----~~~~  227 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-------VKREEVDRRVKEDQEE----YSEK  227 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-------hhHHHHHHHhhccccc----CCcc
Confidence            4457899999999999999999999999999999999999998743210       0001111111111111    1122


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++||+     ++++++
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            3456788999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-36  Score=336.84  Aligned_cols=257  Identities=19%  Similarity=0.274  Sum_probs=189.6

Q ss_pred             eeecccccccEEEEEEcC-----------------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee
Q 045493          782 VLHGTGGCGTVYKAELTS-----------------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH  844 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-----------------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~  844 (1048)
                      ..||+|+||.||+|.+.+                 +..||+|.+.............+++..+..++||||+++++++.+
T Consensus        11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   90 (304)
T cd05096          11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD   90 (304)
T ss_pred             eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence            458999999999997642                 235899988654332222234456677788899999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhccc----------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCC
Q 045493          845 TQHLFLVYEYLERGSLATILSNEA----------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK  908 (1048)
Q Consensus       845 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~  908 (1048)
                      .+..++||||+++|+|.+++....                ....+++..+.+++.|++.|++|||+.   +|+||||||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~  167 (304)
T cd05096          91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATR  167 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchh
Confidence            999999999999999999985432                113467888999999999999999999   9999999999


Q ss_pred             CeEECCCCceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCccccc
Q 045493          909 KVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE--GKHPGHFLSL  984 (1048)
Q Consensus       909 NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~p~~~~~~  984 (1048)
                      ||+++.++.+||+|||+++.+......  .....++..|||||++.++.++.++|||||||++|||++  +..||.....
T Consensus       168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  247 (304)
T cd05096         168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD  247 (304)
T ss_pred             heEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence            999999999999999999865433221  123345788999999988899999999999999999997  4556553221


Q ss_pred             ccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          985 LLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .       ............................+.+++.+||+.||++|||+.|+.+.|+.
T Consensus       248 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         248 E-------QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             H-------HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            0       00000000000000000000011223468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.4e-37  Score=340.72  Aligned_cols=241  Identities=21%  Similarity=0.242  Sum_probs=191.8

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +||+|+||.||+++.. +++.||+|++......  ........+.+.++.++||||+++++++...+..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5899999999999875 6788999998653211  111122345667788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++............
T Consensus        82 L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          82 LFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            999886533   478999999999999999999999   99999999999999999999999999987644333344456


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.......+    .....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----------~~~~~~~~~~~~~~p----~~~~~  220 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------ERLFELILMEEIRFP----RTLSP  220 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhcCCCCCC----CCCCH
Confidence            799999999999998999999999999999999999999863221           111222222222111    12234


Q ss_pred             HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      .+.+++.+||+.||++||     ++.++++
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            678899999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=312.80  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=206.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....+|+|+||.||+|.++ +|+.+|+|++.....   -.....++..+.++..|+||++||.|......|+|||||.-|
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            3445899999999999776 788999999854322   223344566667788999999999988888899999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +..++++..  .+.+++.++..+++..++||+|||..   .-||||||+.|||+..+|.+|++|||.|-.+.+.-....+
T Consensus       114 SiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  114 SISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999754  34589999999999999999999998   7899999999999999999999999999877666566677


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      +.|||.|||||++..-.|..++||||+|++..||..|++||.+..+....            .++.-+.|+.+..++..+
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------------FMIPT~PPPTF~KPE~WS  256 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------------FMIPTKPPPTFKKPEEWS  256 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------------EeccCCCCCCCCChHhhh
Confidence            88999999999999999999999999999999999999998765543222            123334455556667778


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .++-+++++|+.+.|++|-||.++++.
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            889999999999999999999998874

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-36  Score=339.45  Aligned_cols=242  Identities=21%  Similarity=0.242  Sum_probs=192.1

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +||+|+||.||+++.. +++.||+|++......  ........+++.++.++||||+++++++...+..|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5899999999999876 6788999998653221  111223445566788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++............
T Consensus        82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          82 LFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            999986533   478999999999999999999999   99999999999999999999999999997644333344456


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      +||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.......+    .....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----------~~~~~~~~~~~~~~p----~~~~~  220 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------EKLFELILMEDIKFP----RTLSA  220 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----------HHHHHHhccCCccCC----CCCCH
Confidence            799999999999988999999999999999999999999863221           111112211111111    12234


Q ss_pred             HHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      .+.+++.+||++||++||     +++|+++.
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            678899999999999997     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.4e-36  Score=330.78  Aligned_cols=247  Identities=21%  Similarity=0.245  Sum_probs=192.7

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||+||++.+. +++.+|+|++........  ......+++.++.++|+||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999876 678899999865322211  11223456677888999999999999999999999999999999


Q ss_pred             HHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          861 ATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      .+++.... ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+..+..........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            98875422 234588999999999999999999999   99999999999999999999999999998765544444456


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||......       ................    .......
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~~  226 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-------VENKELKQRILNDSVT----YPDKFSP  226 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-------hhHHHHHHhhcccCCC----CcccCCH
Confidence            7899999999999999999999999999999999999998632210       0011111111111111    1123345


Q ss_pred             HHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      .+.+++.+||+.||++||     |++++++
T Consensus       227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            688899999999999999     7777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-37  Score=317.18  Aligned_cols=256  Identities=22%  Similarity=0.279  Sum_probs=189.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC-----eEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ-----HLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e  853 (1048)
                      ...++|+|+||.||+|... +++.||||++-....     ....|...|+.+.|||||++..+|....     ...+|||
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            4557899999999999876 468999999865433     2346677788999999999998885422     2358999


Q ss_pred             ccCCCCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccCC
Q 045493          854 YLERGSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~  931 (1048)
                      ||+. +|.++++.. .....++...+.-+..||++|++|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.+.+
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9988 999998742 1223467777888999999999999998   99999999999999977 9999999999999877


Q ss_pred             CCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccch--hhh
Q 045493          932 DSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANMN--IVV  999 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~--~~~  999 (1048)
                      +....+ +.-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..         .+.|..+....  ...
T Consensus       179 ~epniS-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  179 GEPNIS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCCcee-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            665533 4458899999998764 6899999999999999999999988653321         11111111000  000


Q ss_pred             hhhccCCCCCCc-h--hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1000 NDLIDSRLPPPL-G--EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1000 ~~~~~~~~~~~~-~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+...+.+.... .  .......+.++++.++++.+|.+|.++.|++.+
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            011111111111 0  112234578899999999999999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.4e-36  Score=341.78  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=191.5

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...||+|+||.||+|.+.      ++..||||+++.............+++.+..+ +||||++++++|.+.+..++|||
T Consensus        40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E  119 (375)
T cd05104          40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE  119 (375)
T ss_pred             hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence            356899999999999642      35578999886543322222344566667777 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhcccc----------------------------------------------------------------
Q 045493          854 YLERGSLATILSNEAT----------------------------------------------------------------  869 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~----------------------------------------------------------------  869 (1048)
                      |+++|+|.++++....                                                                
T Consensus       120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (375)
T cd05104         120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV  199 (375)
T ss_pred             hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence            9999999999864321                                                                


Q ss_pred             --------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--cccc
Q 045493          870 --------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSEL  939 (1048)
Q Consensus       870 --------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~  939 (1048)
                              ...+++..+.+++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++........  ....
T Consensus       200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  276 (375)
T cd05104         200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA  276 (375)
T ss_pred             HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCC
Confidence                    12478889999999999999999998   9999999999999999999999999999866433221  1123


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .++..|+|||++.+..++.++|||||||++|||++ |..||.....           .......+........  +....
T Consensus       277 ~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~--~~~~~  343 (375)
T cd05104         277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-----------DSKFYKMIKEGYRMLS--PECAP  343 (375)
T ss_pred             CCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-----------hHHHHHHHHhCccCCC--CCCCC
Confidence            35668999999999999999999999999999998 8888753211           0011111111111100  01123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .++.+++.+||+.||++|||++|++++|++
T Consensus       344 ~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         344 SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            468899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.4e-36  Score=330.22  Aligned_cols=259  Identities=19%  Similarity=0.233  Sum_probs=192.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||+||+|+.. +++.||+|++.............++++.++.++||||+++++++...+..++||||+++ +
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~   88 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D   88 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence            456899999999999876 67889999886543333333445677788899999999999999999999999999985 9


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++............
T Consensus        89 l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~  163 (288)
T cd07871          89 LKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE  163 (288)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence            999886432  3468889999999999999999999   99999999999999999999999999997654333334455


Q ss_pred             cccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccc----hhhhhhhccC
Q 045493          940 AGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANM----NIVVNDLIDS 1005 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~----~~~~~~~~~~ 1005 (1048)
                      .+++.|+|||++.+ ..++.++||||+||++|||++|+.||.......         ..+....+.    .........+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (288)
T cd07871         164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP  243 (288)
T ss_pred             eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence            78999999998865 568999999999999999999999986432110         000000000    0000000001


Q ss_pred             CCCC-C-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1006 RLPP-P-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1006 ~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .... + .........+..+++.+|++.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1000 0 00001123467899999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.4e-36  Score=325.01  Aligned_cols=249  Identities=19%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             eeeecccccccEEEEEEc----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|.++    .+..||+|.++............+++..+..++||||+++++++...+..++||||++
T Consensus        10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (266)
T cd05064          10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS   89 (266)
T ss_pred             eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence            346899999999999764    3557888988764333322334456666778899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|.+++...  ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+......... 
T Consensus        90 ~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~  164 (266)
T cd05064          90 NGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT  164 (266)
T ss_pred             CCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence            99999999653  23588999999999999999999999   9999999999999999999999999987654322111 


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....++..|+|||++.+..++.++|||||||++||+++ |+.||.....           ......+.+....+.   .
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~---~  230 (266)
T cd05064         165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----------QDVIKAVEDGFRLPA---P  230 (266)
T ss_pred             ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----------HHHHHHHHCCCCCCC---C
Confidence            112335678999999999999999999999999999775 9999864321           111222222211111   1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+.+++.+||+.+|++|||++|+.+.|++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            2234568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-36  Score=327.97  Aligned_cols=247  Identities=30%  Similarity=0.486  Sum_probs=187.6

Q ss_pred             eeecccccccEEEEEEc-----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..||.|+||.||+|.+.     .+..|+||.+......+......++++.+++++||||++++|++...+..++||||++
T Consensus         5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~   84 (259)
T PF07714_consen    5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP   84 (259)
T ss_dssp             EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred             eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence            46899999999999887     2467899988554333323444556677788899999999999998888999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|.++++.. ....+++..+.+|+.||++||+|||+.   +++||||+++||+++.++.+||+|||++......... 
T Consensus        85 ~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   85 GGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            99999999764 234589999999999999999999999   9999999999999999999999999999876322111 


Q ss_pred             -ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 -WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .........|+|||.+.+..++.++||||||+++||+++ |+.||...           ........+.+....+..  
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----------~~~~~~~~~~~~~~~~~~--  227 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----------DNEEIIEKLKQGQRLPIP--  227 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----------CHHHHHHHHHTTEETTSB--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-----------ccccccccccccccceec--
Confidence             123446778999999999889999999999999999999 67886532           122223333333222221  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                       ......+.+++.+||+.||++|||+.++++.|
T Consensus       228 -~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 -DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             12344578899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-36  Score=342.74  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=191.7

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...||+|+||.||+|...      ++..||+|++......+.......+++.++.+ +|+||++++++|...+..++|||
T Consensus        43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e  122 (374)
T cd05106          43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE  122 (374)
T ss_pred             hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence            346899999999999753      23479999986543332222344566677777 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhcccc----------------------------------------------------------------
Q 045493          854 YLERGSLATILSNEAT----------------------------------------------------------------  869 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~----------------------------------------------------------------  869 (1048)
                      |+++|+|.++++....                                                                
T Consensus       123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (374)
T cd05106         123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED  202 (374)
T ss_pred             hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence            9999999999854211                                                                


Q ss_pred             ---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--ccccccccc
Q 045493          870 ---AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCG  944 (1048)
Q Consensus       870 ---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~  944 (1048)
                         ...+++.++.+++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+++........  .....++..
T Consensus       203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~  279 (374)
T cd05106         203 TEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK  279 (374)
T ss_pred             cCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccc
Confidence               12478888999999999999999998   9999999999999999999999999999865433221  112335668


Q ss_pred             cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHH
Q 045493          945 YIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIA 1023 (1048)
Q Consensus       945 y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1023 (1048)
                      |||||++.+..++.++||||+||++|||++ |+.||.....           .................  .....++.+
T Consensus       280 y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-----------~~~~~~~~~~~~~~~~~--~~~~~~l~~  346 (374)
T cd05106         280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-----------NSKFYKMVKRGYQMSRP--DFAPPEIYS  346 (374)
T ss_pred             eeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-----------cHHHHHHHHcccCccCC--CCCCHHHHH
Confidence            999999998899999999999999999997 9999863221           00111111111111100  112356888


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1024 VAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1024 l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ++.+||+.||++|||+.+++++|++
T Consensus       347 li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         347 IMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.6e-36  Score=334.02  Aligned_cols=257  Identities=21%  Similarity=0.266  Sum_probs=193.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||++++. ++..+|+|.+.............++++.++.++||||+++++++...+..++||||+++|
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (331)
T cd06649           9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (331)
T ss_pred             EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence            3456899999999999887 567778887764322222233455677778899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++......  ....
T Consensus        89 ~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  161 (331)
T cd06649          89 SLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS  161 (331)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--cccc
Confidence            9999996533   4788899999999999999999862  6999999999999999999999999999765432  2234


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc-----CCCcccc--------------------
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL-----SLPAPAA--------------------  993 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~--------------------  993 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.......     ..+....                    
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS  241 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence            578999999999999899999999999999999999999986322100     0000000                    


Q ss_pred             ----------cchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          994 ----------NMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       994 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                                ........+.....+...  ......++.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         242 GHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                      000000001111111000  01234568899999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=311.14  Aligned_cols=240  Identities=20%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             eecccccccEEEEEE-cCCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+|+|.||.|-+|.. ..|+.||||-+++..-..  .-...+++++.|+.++||||+.+|++|+..+...+||||..+|.
T Consensus        60 tLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge  139 (668)
T KOG0611|consen   60 TLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE  139 (668)
T ss_pred             HhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCcc
Confidence            479999999999965 689999999987654332  22344778888999999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |++|+.+.+.   +++.+++.+++||..|+.|+|.+   +++|||+|.+|||+|.++++||+|||++..+.. .....++
T Consensus       140 LYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~kfLqTF  212 (668)
T KOG0611|consen  140 LYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-KKFLQTF  212 (668)
T ss_pred             HHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc-ccHHHHh
Confidence            9999976544   89999999999999999999999   999999999999999999999999999987754 3445778


Q ss_pred             ccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ||+|-|.+||+..+.+| ++.+|.||+||++|-++.|..||+..+.           ...+..+..+....+..     .
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------k~lvrQIs~GaYrEP~~-----P  276 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------KRLVRQISRGAYREPET-----P  276 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------HHHHHHhhcccccCCCC-----C
Confidence            99999999999999998 6889999999999999999999985432           22333343443332211     1


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....-+|+.|+.++|++|.|+.++...
T Consensus       277 SdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  277 SDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             chHHHHHHHHHhcCcccchhHHHHhhh
Confidence            234467888999999999999999764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=360.52  Aligned_cols=485  Identities=27%  Similarity=0.284  Sum_probs=282.1

Q ss_pred             EeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCC
Q 045493           77 LRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLG  156 (1048)
Q Consensus        77 L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~  156 (1048)
                      +|+|..+++ .+|..+..-..++.|++.+|-+...+-+...+--+|+.|+|++|.++                       
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-----------------------   58 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-----------------------   58 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-----------------------
Confidence            456666666 45555444444666666666655221112222223566666665543                       


Q ss_pred             CCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeE
Q 045493          157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFL  236 (1048)
Q Consensus       157 ~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  236 (1048)
                                       ..|..+..+.+|+.|.++.|.|. ..|.+..++.+|++|.|.+|++. ..|..+..+.+|+.|
T Consensus        59 -----------------~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~L  119 (1081)
T KOG0618|consen   59 -----------------SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYL  119 (1081)
T ss_pred             -----------------cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccc
Confidence                             22333444455555555555554 44555555555555555555554 455555555555555


Q ss_pred             eccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCcee
Q 045493          237 YLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQL  316 (1048)
Q Consensus       237 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  316 (1048)
                      +++.|.+. .+|..+..+..++.+..++|......+.    ..                          ++++++..|.+
T Consensus       120 dlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~~--------------------------ik~~~l~~n~l  168 (1081)
T KOG0618|consen  120 DLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----TS--------------------------IKKLDLRLNVL  168 (1081)
T ss_pred             ccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----cc--------------------------chhhhhhhhhc
Confidence            55555555 4455555555555555555521111111    11                          34444444444


Q ss_pred             ecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhh
Q 045493          317 SGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI  396 (1048)
Q Consensus       317 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~  396 (1048)
                      .+.++.....++.  .|+|+.|.+.   --.+..+.+|+.|....|+++...    -..++|+.|+.++|.+....+.  
T Consensus       169 ~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--  237 (1081)
T KOG0618|consen  169 GGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--  237 (1081)
T ss_pred             ccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--
Confidence            4444433333333  3444444443   112334444555555555544211    1234455555555555411110  


Q ss_pred             hhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCe
Q 045493          397 ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLEL  476 (1048)
Q Consensus       397 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~  476 (1048)
                      ..-.+|+.++++.|++++. |.+++.+.+|+.+.+.+|.++ .+|..+...++|+.|.+..|.++.+             
T Consensus       238 p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yi-------------  302 (1081)
T KOG0618|consen  238 PVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYI-------------  302 (1081)
T ss_pred             cccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhC-------------
Confidence            0112333333333333322 233333333344444444442 2344444444555555555544433             


Q ss_pred             eeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCC-CcEEEcccCcccCCcCccccCCCccCEEeecCcc
Q 045493          477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQ-LHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ  555 (1048)
Q Consensus       477 L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  555 (1048)
                                  |....+...|++|+|..|+|....+..|.-... |+.|+.+.|++.......=..++.|+.|++.+|.
T Consensus       303 ------------p~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~  370 (1081)
T KOG0618|consen  303 ------------PPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNH  370 (1081)
T ss_pred             ------------CCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCc
Confidence                        333444556666666666666333333443333 7777788888774432233346789999999999


Q ss_pred             ccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcC
Q 045493          556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSE  635 (1048)
Q Consensus       556 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  635 (1048)
                      +++..-..+.+.+.|+.|+|++|+|..++...+.+++.|++|+||+|+++.+. ..+..+..|++|....|+|. ..| .
T Consensus       371 Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ahsN~l~-~fP-e  447 (1081)
T KOG0618|consen  371 LTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAHSNQLL-SFP-E  447 (1081)
T ss_pred             ccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhcCCcee-ech-h
Confidence            99887788999999999999999999998899999999999999999998865 78889999999999999998 566 8


Q ss_pred             cCCccccCeEECCCCcccCCccccccccCCccEEEecccee
Q 045493          636 ICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       636 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l  676 (1048)
                      +..++.|+.+|++.|+|+...-......+.|++||+++|.+
T Consensus       448 ~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  448 LAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            89999999999999999865444333448999999999975

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=328.38  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=201.8

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      .||+|-||.|..++...+..||||+.+..........+..+++.+.+++|||||+++|+|..++.+++|+|||++|+|.+
T Consensus       545 kiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnq  624 (807)
T KOG1094|consen  545 KIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQ  624 (807)
T ss_pred             hhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHH
Confidence            48999999999999988899999999887766655677788888999999999999999999999999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--cccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SELA  940 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~  940 (1048)
                      ++..+.... ..-....+|+.|||.|++||.+.   ++||||+.++|+|+|.++++||+|||+++.+-......  ...+
T Consensus       625 Fl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~v  700 (807)
T KOG1094|consen  625 FLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAV  700 (807)
T ss_pred             HHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeeccee
Confidence            997653322 34556678999999999999999   99999999999999999999999999999654443322  2344


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE--GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      -..+|||||.+.-++++.++|||+||+++||+++  ...||....+....       ++...-..++........+.-+.
T Consensus       701 lpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-------en~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  701 LPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-------ENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-------HhhhhhcCCCCcceeccCCCcCc
Confidence            5679999999999999999999999999999886  55676543321100       01111111111111122223455


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+++++.+||..|-++||+++++...|+
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            67889999999999999999999998876

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-36  Score=336.29  Aligned_cols=242  Identities=22%  Similarity=0.319  Sum_probs=192.3

Q ss_pred             eeecccccccEEEEEEc----CCCceeeEEeccCCC---CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPT---GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.||+|+||.||+++..    .++.||+|.+.....   .........++..++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            35899999999999763    567899998865321   11112234566778889999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++.+.+   .+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999986543   367788889999999999999999   999999999999999999999999999876544333


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+.   
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----------~~~~~~~~~~~~~~~~---  221 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----------KKTIDKILKGKLNLPP---  221 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---
Confidence            34456799999999999988899999999999999999999999863221           1222233333322211   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                       .....+.+++.+||++||++||     ++.++++
T Consensus       222 -~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         222 -YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             1234678999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=331.13  Aligned_cols=241  Identities=23%  Similarity=0.273  Sum_probs=192.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|... +++.||+|++......  ........++..++.++||||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   85 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG   85 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence            456899999999999886 6788999988643211  1122344566778889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.++++..+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   ..
T Consensus        86 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          86 GELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            99999996543   478899999999999999999999   9999999999999999999999999999866432   23


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.......+    ...
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----------~~~~~~~i~~~~~~~~----~~~  221 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----------PFGIYEKILAGKLEFP----RHL  221 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCcCCC----ccC
Confidence            4578999999999999889999999999999999999999986322           1122223323222211    112


Q ss_pred             HHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPT-----MQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 1045 (1048)
                      ...+.+++.+||+.||.+||+     ++|+++.
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            345788999999999999995     8888753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.3e-36  Score=335.89  Aligned_cols=236  Identities=24%  Similarity=0.301  Sum_probs=185.1

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||+||+|+.+ +++.||+|++......  ........+...+... +||||+++++++...+..|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5899999999999886 5778999988653211  1111122333344443 6999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9999986543   478899999999999999999999   9999999999999999999999999998765433344455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~----~~~~  220 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----------DDLFEAILNDEVVYP----TWLS  220 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----------HHHHHHHhcCCCCCC----CCCC
Confidence            6799999999999998999999999999999999999999863221           112222222222211    1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      .++.+++.+|++.||++||++
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCC
Confidence            457889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.4e-36  Score=333.50  Aligned_cols=240  Identities=25%  Similarity=0.328  Sum_probs=185.2

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHHHh-hcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSEIT-EIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|+.. +++.||+|.++........  .....+...+. ..+||||+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999876 5678999988653211111  11112222232 347999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          82 DLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999986533   478899999999999999999998   9999999999999999999999999999865444444455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~----~~~~  220 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----------DELFDSILNDRPHFP----RWIS  220 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCCCC----CCCC
Confidence            6799999999999998999999999999999999999999864321           111222211111111    1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHH-HHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQ-KVC 1043 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~-evl 1043 (1048)
                      .++.+++.+||+.||++||++. +++
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            4577889999999999999876 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.7e-36  Score=337.75  Aligned_cols=249  Identities=21%  Similarity=0.263  Sum_probs=188.7

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +||+|+||.||+|+.. +++.+|+|.+........  ......+...+.++ +||||+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            5899999999999876 567899999875432211  11123334444444 7999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            999988653   3478899999999999999999999   9999999999999999999999999999764433334445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchh-hhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI-VVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.......   ........ ....+.......+    ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~i~~~~~~~p----~~~  228 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---NPDQNTEDYLFQVILEKQIRIP----RSL  228 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcC---CcccccHHHHHHHHhcCCCCCC----CCC
Confidence            679999999999999999999999999999999999999986322110   01111111 1112222222111    122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTM------QKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~------~evl~ 1044 (1048)
                      ...+.+++.+||+.||++|||+      +++++
T Consensus       229 ~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            3457789999999999999984      56654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=329.37  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=211.2

Q ss_pred             eeecccccccEEEEEEcC-CCceeeEEeccCCCCc--ccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGE--IGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ..+|+|.||.||+++.+. |+.+|+|.+.+.....  .......+++.++++. |||||.++++|+....+++|||+++|
T Consensus        41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G  120 (382)
T KOG0032|consen   41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG  120 (382)
T ss_pred             hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence            568999999999998874 9999999997754432  2245678888899998 99999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC----CceEEeccccccccCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE----YKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~~~~~~  933 (1048)
                      |.|.+.+...    .+++..+..++.|++.|+.|||+.   ||+|||+||+|+|+...    +.+|++|||+|..... .
T Consensus       121 GeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~  192 (382)
T KOG0032|consen  121 GELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-G  192 (382)
T ss_pred             chHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-C
Confidence            9999999765    289999999999999999999998   99999999999999743    4799999999998876 5


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......+||+.|+|||+.....|+..+||||+||++|.|++|..||....           .......+..+......+.
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~-----------~~~~~~~i~~~~~~f~~~~  261 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET-----------EFEIFLAILRGDFDFTSEP  261 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC-----------hhHHHHHHHcCCCCCCCCC
Confidence            66788999999999999999999999999999999999999999987432           2233335556655555556


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ++.....+.+++..|+..||.+|+|+.++++.
T Consensus       262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            67777889999999999999999999999873

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.7e-36  Score=340.62  Aligned_cols=243  Identities=21%  Similarity=0.332  Sum_probs=186.8

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|++. +++.||+|++.............++++.++.++|+||+++++++.+.+..++||||+++|+|
T Consensus        80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  159 (353)
T PLN00034         80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL  159 (353)
T ss_pred             hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence            45899999999999876 67899999986543333233445667778889999999999999999999999999999998


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+..       ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...........
T Consensus       160 ~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~  229 (353)
T PLN00034        160 EGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV  229 (353)
T ss_pred             cccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccc
Confidence            6532       245677889999999999999999   999999999999999999999999999987654433344567


Q ss_pred             ccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          941 GTCGYIAPELAYT-----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       941 gt~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ||..|+|||++..     ...+.++|||||||++|||++|+.||.....        ...............+.   ...
T Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~---~~~  298 (353)
T PLN00034        230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--------GDWASLMCAICMSQPPE---APA  298 (353)
T ss_pred             cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHHhccCCCC---CCC
Confidence            9999999998743     2345689999999999999999999862110        00011111111111111   112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....++.+++.+||+.||++|||++|+++.
T Consensus       299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        299 TASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            334568899999999999999999999864

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=343.05  Aligned_cols=246  Identities=24%  Similarity=0.314  Sum_probs=197.8

Q ss_pred             eeecccccccEEEEEEcCC-CceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEe-ee------CCeEEEEE
Q 045493          782 VLHGTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFC-SH------TQHLFLVY  852 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~-~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~-~~------~~~~~lv~  852 (1048)
                      ++|.+|||+.||.|+...+ .+||+|++... .+......++|+..|+.++ |+|||.+++.. ..      .-++++.|
T Consensus        43 ~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm  121 (738)
T KOG1989|consen   43 KVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM  121 (738)
T ss_pred             EEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence            3689999999999998866 99999999776 4444556688888899997 99999999932 11      13678999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |||+||.|-|++....... |++.++++|+.++++|+++||.. .|+|||||||-+||||+.+|+.||||||.|+-....
T Consensus       122 EyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~  199 (738)
T KOG1989|consen  122 EYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS  199 (738)
T ss_pred             hhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence            9999999999997544333 99999999999999999999986 468999999999999999999999999999754322


Q ss_pred             CCCc---------cccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhh
Q 045493          933 SSNW---------SELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       933 ~~~~---------~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ....         -....|+-|+|||++.   +.+.++|+||||+||++|-++....||+..+.+               
T Consensus       200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------------  264 (738)
T KOG1989|consen  200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------------  264 (738)
T ss_pred             CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------------
Confidence            2111         1234789999999874   667899999999999999999999999844322               


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .++.+++..+..  ......+.++|..||++||++||++.+|+..+.
T Consensus       265 aIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  265 AILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             eEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            233444433321  355667888999999999999999999998875

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-36  Score=338.83  Aligned_cols=242  Identities=20%  Similarity=0.235  Sum_probs=190.9

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .||+|+||.||+|+.. +++.||+|.+......  ........+.+.+..++||||+++++++...+..|+||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            5899999999999875 6788999998653211  111222345556677899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      |.+++....   .+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          82 LFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            999886533   47899999999999999999997 6   9999999999999999999999999998765444444445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----------~~~~~~i~~~~~~~p----~~~~  220 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------EKLFELILMEEIRFP----RTLS  220 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----------HHHHHHHhcCCCCCC----CCCC
Confidence            6799999999999998999999999999999999999999853221           111122211221111    1123


Q ss_pred             HHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      .++.+++.+||+.||++|+     +++++++.
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            4578899999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.4e-36  Score=335.45  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=188.6

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhh-cccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITE-IRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +||+|+||.||+|+.. +++.||+|.+.......  .......+.+.+.. .+||||+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            4899999999999886 56789999986532111  11112223333443 37999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9999986543   478899999999999999999999   9999999999999999999999999999865444444455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+.    ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-----------~~~~~~i~~~~~~~p~----~~~  220 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-----------DDLFESILHDDVLYPV----WLS  220 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCC----CCC
Confidence            6799999999999998999999999999999999999999863321           1222222222222111    123


Q ss_pred             HHHHHHHHhccCCCCCCCC-------CHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRP-------TMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RP-------t~~evl~ 1044 (1048)
                      .++.+++.+|++.||++||       +++++++
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            4678899999999999999       7888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4e-36  Score=336.63  Aligned_cols=250  Identities=20%  Similarity=0.266  Sum_probs=190.3

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +||+|+||.||+|++. +++.||+|.++.......  ......+...+..+ +||||+++++++.+.+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5899999999999876 578899999875322111  11223344445555 6999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            999988643   3488999999999999999999999   9999999999999999999999999999754333334455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||+....... + ...........+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~p----~~~~  229 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN-P-DQNTEDYLFQVILEKQIRIP----RSLS  229 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc-c-cccchHHHHHHHHcCCCCCC----CCCC
Confidence            6899999999999999999999999999999999999999874322110 0 00011111222222222211    1223


Q ss_pred             HHHHHHHHhccCCCCCCCCC------HHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPT------MQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt------~~evl~ 1044 (1048)
                      ..+.+++.+|++.||++|||      ++++++
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            45788999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2e-35  Score=324.76  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=195.7

Q ss_pred             eeecccccccEEEEEEcCC------CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELTSG------DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~------~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +.||+|+||.||+|.....      ..+|+|.+.............++++.+..++||||+++++++...+..+++|||+
T Consensus        11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   90 (283)
T cd05048          11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL   90 (283)
T ss_pred             hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence            4589999999999986532      4688888764433222233455667778889999999999999989999999999


Q ss_pred             CCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          856 ERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                      ++|+|.+++.....             ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.+||+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~d  167 (283)
T cd05048          91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISD  167 (283)
T ss_pred             CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECC
Confidence            99999999965321             13478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhh
Q 045493          923 FGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVV  999 (1048)
Q Consensus       923 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |..||....           .....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-----------~~~~~  236 (283)
T cd05048         168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-----------NQEVI  236 (283)
T ss_pred             CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-----------HHHHH
Confidence            999986543321  1233456788999999988899999999999999999998 999976322           11122


Q ss_pred             hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+..+..+..   ......++.+++.+||+.||.+|||++|++++|++
T Consensus       237 ~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            22222222211   23345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.3e-36  Score=332.96  Aligned_cols=240  Identities=23%  Similarity=0.293  Sum_probs=186.1

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHh-hcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEIT-EIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|+++ +++.||+|.++.....  ........+.+.+. ..+||+|+++++++.+.+..|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            5899999999999886 5788999988653211  11111222333333 348999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          82 DLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            999998653   3478899999999999999999999   9999999999999999999999999998754333344455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----------~~~~~~~~~~~~~~~----~~~~  220 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----------DELFESIRVDTPHYP----RWIT  220 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCC----CCCC
Confidence            6799999999999999999999999999999999999999863221           111222211111111    1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHH-HHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQ-KVC 1043 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~-evl 1043 (1048)
                      .++.+++.+||+.||++||++. +++
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHH
Confidence            4577899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.1e-36  Score=334.60  Aligned_cols=237  Identities=22%  Similarity=0.239  Sum_probs=186.0

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCccc---chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG---INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||+||+|+.. +++.||+|++.........   ....+....++.++||||+++++++...+..|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5899999999999886 6888999998653211111   11112222346789999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9999986533   478889999999999999999999   9999999999999999999999999998764433344455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+.    ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----------~~~~~~~i~~~~~~~~~----~~~  220 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----------TAEMYDNILNKPLRLKP----NIS  220 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----------HHHHHHHHHcCCCCCCC----CCC
Confidence            679999999999999999999999999999999999999986322           11122222222221111    123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQ 1040 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~ 1040 (1048)
                      ..+.+++.+|++.||++||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCC
Confidence            4678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-36  Score=336.13  Aligned_cols=240  Identities=24%  Similarity=0.242  Sum_probs=191.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|++. +++.||+|.+......  ........++..+++++||||+++++++.+.+..|+||||+++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  102 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG  102 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence            346899999999999886 5788999988653211  1112334566677889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   ..
T Consensus       103 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~  173 (329)
T PTZ00263        103 GELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TF  173 (329)
T ss_pred             ChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---cc
Confidence            99999997543   478888999999999999999999   9999999999999999999999999999866432   22


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+.    ..
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~~~p~----~~  238 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----------FRIYEKILAGRLKFPN----WF  238 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----------HHHHHHHhcCCcCCCC----CC
Confidence            45799999999999998999999999999999999999999863221           1122223233222111    12


Q ss_pred             HHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      ...+.+++.+||+.||++||+     ++++++
T Consensus       239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            345778999999999999997     677764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-35  Score=327.62  Aligned_cols=259  Identities=21%  Similarity=0.271  Sum_probs=191.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|+.. +++.||+|++.............+++..++.++||||+++++++.+.+..++||||++ +
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~   87 (303)
T cd07869           9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T   87 (303)
T ss_pred             EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence            3456899999999999887 6788999998754433333344567777889999999999999999999999999996 5


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        88 ~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          88 DLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            888887543  23478889999999999999999999   9999999999999999999999999999765433333345


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC----------CCcccccchh-hhhhhccCC
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS----------LPAPAANMNI-VVNDLIDSR 1006 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~~~~~-~~~~~~~~~ 1006 (1048)
                      ..+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........          .+....+... .........
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd07869         163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER  242 (303)
T ss_pred             CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence            678999999998865 4578999999999999999999999975322100          0000000000 000000000


Q ss_pred             ----CCCCchhH---HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 ----LPPPLGEV---EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 ----~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                          .+......   ......+.+++.+|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                00000000   011245778999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=332.54  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=197.6

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEe--cc-CCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC--eEEE
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKL--HS-LPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--HLFL  850 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~--~~-~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--~~~l  850 (1048)
                      |..-.++||+|+|-+||+|.+. +|-+||--.+  .. ....+.......+++.++.++|||||++|+++.+..  ..-+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            3333456899999999999775 4666653222  11 122222244567788889999999999999987644  4789


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEecccccccc
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFL  929 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~  929 (1048)
                      |+|.|..|+|..|.++.+.   .+...+..|++||++||.|||++ .|+|||||||.+||+|+.+ |.|||+|.|+|+..
T Consensus       121 iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            9999999999999987554   78899999999999999999997 5799999999999999865 99999999999987


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ....  .....|||.|||||++. ..|.+.+||||||++|+||+|+.+||....          ....++.++..+.-|.
T Consensus       197 r~s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----------n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  197 RKSH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----------NPAQIYKKVTSGIKPA  263 (632)
T ss_pred             hccc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----------CHHHHHHHHHcCCCHH
Confidence            5433  33478999999999987 689999999999999999999999976322          3345666777776665


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+....  ..++.++|.+|+.. .++|||+.|++.
T Consensus       264 sl~kV~--dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  264 ALSKVK--DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HhhccC--CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            443322  45788999999999 999999999985

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=336.87  Aligned_cols=245  Identities=19%  Similarity=0.212  Sum_probs=192.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|++. +++.||+|++.......  .......++..+..++||||+++++++.+.+..|+||||+++
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g   85 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG   85 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence            456899999999999887 57889999986542211  112234456667888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....   ...
T Consensus        86 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          86 GDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            99999996533   478899999999999999999999   999999999999999999999999999986543   234


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc--CCC--CCCchh
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID--SRL--PPPLGE 1013 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~ 1013 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......           .....+..  ...  +.....
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~  225 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----------ETWENLKYWKETLQRPVYDDP  225 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----------HHHHHHHhccccccCCCCCcc
Confidence            467999999999999989999999999999999999999998643211           01111100  000  110000


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......++.+++.+||+.+|++||+++|+++.
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            01234568889999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-35  Score=332.68  Aligned_cols=242  Identities=23%  Similarity=0.291  Sum_probs=188.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHH---HHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVS---EITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|.+. +++.||+|++.......  .......+.+   .+..++||||+++++++...+..|+||||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~   83 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY   83 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence            456899999999999876 67889999986532111  1111222222   23567899999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|..+++.    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          84 AAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             CCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence            999999988853    3489999999999999999999999   999999999999999999999999999876544444


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+    
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-----------~~~~~~i~~~~~~~p----  221 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-----------EEVFDSIVNDEVRYP----  221 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCC----
Confidence            44556799999999999998999999999999999999999999863221           112222222221111    


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      ......+.+++.+||+.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            11234578899999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-35  Score=330.38  Aligned_cols=241  Identities=22%  Similarity=0.307  Sum_probs=185.9

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHh-hcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEIT-EIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|++. +++.||+|.++....  .........+...+. ..+||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            4899999999999886 467899998865321  111111222333343 358999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          82 DLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            999998653   3478899999999999999999999   9999999999999999999999999998754333333445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----------~~~~~~i~~~~~~~~----~~~~  220 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----------EELFQSIRMDNPCYP----RWLT  220 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCC----ccCC
Confidence            6799999999999998999999999999999999999999863221           111111111111111    1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHH-HHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQ-KVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~-evl~ 1044 (1048)
                      ..+.+++.+||+.||++||++. ++.+
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            4577889999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-35  Score=322.82  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             eeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..||+|+||.||+|...+      ++.||+|++......+......++++.++.++|+||+++++++......++||||+
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   90 (280)
T cd05049          11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM   90 (280)
T ss_pred             hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence            458999999999998643      36789998876544333344556677788899999999999999999999999999


Q ss_pred             CCCCHHHHHhccc-----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          856 ERGSLATILSNEA-----------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       856 ~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      ++|+|.++++..+           ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcc
Confidence            9999999997542           124478889999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhh
Q 045493          925 TAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       925 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .++.......  ......+++.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----------~~~~~~  236 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----------EEVIEC  236 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHH
Confidence            9976533221  1123345788999999999999999999999999999998 9999753221           112222


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +..+......   ......+.+++.+||+.||++|||+.|+++.|++
T Consensus       237 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 ITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            2222222211   1234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.8e-36  Score=334.59  Aligned_cols=241  Identities=21%  Similarity=0.238  Sum_probs=191.1

Q ss_pred             eeeecccccccEEEEEEcC--CCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTS--GDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|.+..  +..||+|++.....  .........+...++.++||||+++++++.+.+..|+||||++
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence            4568999999999998653  35799998864321  1111223456677788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....   .
T Consensus       115 ~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---~  185 (340)
T PTZ00426        115 GGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---T  185 (340)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---c
Confidence            999999997543   478899999999999999999999   9999999999999999999999999999865432   2


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|||||++.+..++.++||||+||++|||++|+.||.....           ......+.......+.    .
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~p~----~  250 (340)
T PTZ00426        186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----------LLIYQKILEGIIYFPK----F  250 (340)
T ss_pred             ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----------HHHHHHHhcCCCCCCC----C
Confidence            346799999999999988899999999999999999999999864321           1122222222222111    1


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      ....+.+++.+|++.||++|+     |++|+++.
T Consensus       251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            223567899999999999995     89998763

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-35  Score=331.12  Aligned_cols=241  Identities=23%  Similarity=0.279  Sum_probs=188.5

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||+||+|++. +++.||+|.+.......  .......+.+.+..+ +||||+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999886 56789999887532111  111122333444444 6999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...........
T Consensus        82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          82 DLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9999986543   488999999999999999999999   9999999999999999999999999998754333333445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.......+    ....
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----------~~~~~~i~~~~~~~~----~~~~  220 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----------DELFQSILEDEVRYP----RWLS  220 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----------HHHHHHHHcCCCCCC----CcCC
Confidence            6799999999999999999999999999999999999999864321           111122222221111    1223


Q ss_pred             HHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTM-----QKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~-----~evl~ 1044 (1048)
                      ..+.+++.+||+.||++|||+     .++++
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            467889999999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=345.03  Aligned_cols=247  Identities=22%  Similarity=0.244  Sum_probs=194.0

Q ss_pred             ceeeecccccccEEEEEEcC--CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELTS--GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~--~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....+|+|+||.||+|....  ++.||+|++.... .........++..++.++|||||++++++...+..|+||||+++
T Consensus        71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g  149 (478)
T PTZ00267         71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG  149 (478)
T ss_pred             EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence            34568999999999997653  4667777654322 22223345567778889999999999999999999999999999


Q ss_pred             CCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          858 GSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       858 g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      |+|.++++.. .....+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....  
T Consensus       150 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            9999988643 2234578889999999999999999999   999999999999999999999999999987654322  


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....           ..........+...+..   
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----------~~~~~~~~~~~~~~~~~---  292 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----------QREIMQQVLYGKYDPFP---  292 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCC---
Confidence            2345679999999999999999999999999999999999999986322           11222222222222111   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+||+.||++||++++++.
T Consensus       293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            122346888999999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.3e-35  Score=316.13  Aligned_cols=245  Identities=22%  Similarity=0.362  Sum_probs=193.7

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||.||+|+++++..+|+|.+......  ......++..+++++||||+++++++...+..++||||+++|+|.
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~   87 (256)
T cd05114          10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL   87 (256)
T ss_pred             eEecCCcCceEEEEEeccCceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            458999999999999988888999987643222  223455677788999999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  940 (1048)
                      ++++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++........ .....
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05114          88 NYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK  162 (256)
T ss_pred             HHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence            9986432  3478999999999999999999999   9999999999999999999999999999865432221 12234


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||++.+..++.++||||||+++|||++ |+.||.....           ......+.........   .....
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----------~~~~~~i~~~~~~~~~---~~~~~  228 (256)
T cd05114         163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----------YEVVEMISRGFRLYRP---KLASM  228 (256)
T ss_pred             CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHHHHCCCCCCCC---CCCCH
Confidence            5668999999998889999999999999999999 8989763221           1112222221111111   11234


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+++|++|||++|+++.|.
T Consensus       229 ~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         229 TVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            6889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.7e-36  Score=335.16  Aligned_cols=240  Identities=20%  Similarity=0.220  Sum_probs=185.8

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchh-hHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQ-KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~-~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||+||+|++. +++.||+|.+.......  ..... .++...++.++||||+++++++...+..|+||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5899999999999887 56678999886432111  11111 11222346789999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+.+..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9999996533   367788889999999999999999   9999999999999999999999999999865444444456


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+........    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------~~~~~~i~~~~~~~~----~~~~  220 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------AEMYDNILNKPLQLK----PNIT  220 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----------HHHHHHHHhCCcCCC----CCCC
Confidence            6799999999999999999999999999999999999999863221           111222222211111    1223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                      ..+.+++.+|++.||++||++.+.+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCH
Confidence            4578889999999999999987433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.5e-35  Score=335.88  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=192.4

Q ss_pred             eeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ..||+|+||.||+|.+..      +..||||++..............+++.++++. ||||++++++|.+.+..|+||||
T Consensus        43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey  122 (400)
T cd05105          43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEY  122 (400)
T ss_pred             heecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEe
Confidence            468999999999997631      23689999865433332233455667777885 99999999999999999999999


Q ss_pred             cCCCCHHHHHhcccc-----------------------------------------------------------------
Q 045493          855 LERGSLATILSNEAT-----------------------------------------------------------------  869 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~-----------------------------------------------------------------  869 (1048)
                      +++|+|.+++.....                                                                 
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (400)
T cd05105         123 CFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSD  202 (400)
T ss_pred             cCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhh
Confidence            999999999864211                                                                 


Q ss_pred             ----------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEe
Q 045493          870 ----------------------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVS  921 (1048)
Q Consensus       870 ----------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~  921 (1048)
                                                  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+
T Consensus       203 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~  279 (400)
T cd05105         203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKIC  279 (400)
T ss_pred             cccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEE
Confidence                                        12377888899999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhh
Q 045493          922 DFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIV  998 (1048)
Q Consensus       922 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      |||+++........  .....+++.|+|||++.+..++.++|||||||++|||++ |..||.....          ....
T Consensus       280 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~----------~~~~  349 (400)
T cd05105         280 DFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV----------DSTF  349 (400)
T ss_pred             eCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----------hHHH
Confidence            99999865433221  223456788999999998889999999999999999997 8888753210          0111


Q ss_pred             hhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          999 VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+..+....   ........+.+++.+||+.||++|||+.++.++|++
T Consensus       350 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         350 YNKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             HHHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            11111111111   112334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-35  Score=339.08  Aligned_cols=246  Identities=21%  Similarity=0.276  Sum_probs=187.3

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||+||+|+.. +++.||+|++......  ........++..++.++||||+++++++.+.+..|+||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            44567999999999999875 5788999998653221  11223455666778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-  934 (1048)
                      ++|+|.+++.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++++||+|||+++.+..... 
T Consensus        84 ~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          84 PGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999996533   378888999999999999999998   999999999999999999999999999764321000 


Q ss_pred             ----------------------------------------------CccccccccccccccccccCCCCchhhHHHHHHH
Q 045493          935 ----------------------------------------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVL  968 (1048)
Q Consensus       935 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvv  968 (1048)
                                                                    .....+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                          0123479999999999998889999999999999


Q ss_pred             HHHHHhCCCCCcccccccCCCcccccchhhhhhhcc----CCCCCCchhHHHHHHHHHHHHHh--ccCCCCCCCCCHHHH
Q 045493          969 VLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID----SRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKV 1042 (1048)
Q Consensus       969 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~ev 1042 (1048)
                      +|||++|+.||.....           ......+..    ...+..    .....++.+++.+  |+..+|..||+++|+
T Consensus       238 l~elltG~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         238 LFEMLVGQPPFLAPTP-----------TETQLKVINWENTLHIPPQ----VKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHhCCCCCcCCCH-----------HHHHHHHHccccccCCCCC----CCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999863221           011111111    111111    1123345666666  566777779999999


Q ss_pred             HHH
Q 045493         1043 CNL 1045 (1048)
Q Consensus      1043 l~~ 1045 (1048)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=321.35  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=195.6

Q ss_pred             eeecccccccEEEEEEcC---CC--ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELTS---GD--TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~---~~--~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..||.|-||.||+|...+   |+  .||||..+.....+..+.+..+...|+.+.|||||+++|+|.+ ...|+|||.++
T Consensus       395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~  473 (974)
T KOG4257|consen  395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP  473 (974)
T ss_pred             HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence            358999999999997653   22  4788888765554444445555666788899999999999975 45899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      -|-|..|++...  ..++......++.||+.||+|||+.   +.|||||.++|||+.+...||++|||+++.+.++....
T Consensus       474 ~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  474 LGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             chhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence            999999997643  4578889999999999999999999   99999999999999999999999999999987665443


Q ss_pred             cc-cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          937 SE-LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       937 ~~-~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .. ..-...|||||.+...+++.++|||.|||+|||++. |..||+....           ..++..+..+...+.   +
T Consensus       549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------sDVI~~iEnGeRlP~---P  614 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------SDVIGHIENGERLPC---P  614 (974)
T ss_pred             ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------cceEEEecCCCCCCC---C
Confidence            32 223558999999999999999999999999999998 9999874321           111222222222222   2


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +.+...++.++.+||+.||.+||++.|+...|+
T Consensus       615 ~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            345567889999999999999999999988775

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.4e-35  Score=321.64  Aligned_cols=251  Identities=18%  Similarity=0.322  Sum_probs=191.3

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|.+.      .+..+|+|++..............++..++.++||||+++++++.+....++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~   90 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL   90 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence            346899999999999764      24568999875432222122234455667788999999999999999999999999


Q ss_pred             cCCCCHHHHHhcccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          855 LERGSLATILSNEAT-------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      +++|+|.++++....       ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||+++
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~  167 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCcc
Confidence            999999999965322       22357888999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .........  ....+++.|||||++.+..++.++|||||||++|||++ |+.||....           ..........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----------~~~~~~~~~~  236 (277)
T cd05062         168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----------NEQVLRFVME  236 (277)
T ss_pred             ccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----------HHHHHHHHHc
Confidence            654332211  12345778999999998889999999999999999999 688875321           1111111122


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+...   ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       237 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 GGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2221111   1223468889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.8e-36  Score=335.68  Aligned_cols=238  Identities=24%  Similarity=0.301  Sum_probs=189.3

Q ss_pred             eecccccccEEEEEEc----CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          783 LHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .||+|+||.||+++..    +++.+|+|++....... .......+++.+++++||||+++++++...+..|+||||+++
T Consensus         3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (318)
T cd05582           3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG   82 (318)
T ss_pred             eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence            5899999999999752    57889999986533221 112234456677889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++.+.   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        83 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          83 GDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            9999998653   3478999999999999999999999   999999999999999999999999999987654434445


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+    ...
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----------~~~~~~i~~~~~~~p----~~~  221 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----------KETMTMILKAKLGMP----QFL  221 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----------HHHHHHHHcCCCCCC----CCC
Confidence            56799999999999988899999999999999999999999863221           111222222222111    122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQK 1041 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~e 1041 (1048)
                      ...+.+++.+||+.||++||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            345778999999999999999654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.9e-35  Score=328.96  Aligned_cols=195  Identities=24%  Similarity=0.331  Sum_probs=163.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|.+. ++..+|+|.+..............+++.++.++||||++++++|.+.++.++||||+++|
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence            3446899999999999887 567777877754332222233456677788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.++++..+   .+++..+..++.+++.|+.|||+..  +|+||||||+||+++.++.+||+|||++......  ....
T Consensus        89 ~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~  161 (333)
T cd06650          89 SLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS  161 (333)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cccc
Confidence            9999996533   3788889999999999999999752  7999999999999999999999999999765322  2234


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      ..||..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            5689999999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-35  Score=320.58  Aligned_cols=246  Identities=21%  Similarity=0.250  Sum_probs=190.0

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||.||+++.+ +++.||+|++.......  .......+...++.++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999876 58899999886432211  111223456677889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++...... .......
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA  155 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence            99886433 23478899999999999999999998   9999999999999999999999999999866432 2223456


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||.....       ....................   .....+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~---~~~~~~  225 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE-------KVAKEELKRRTLEDEVKFEH---QNFTEE  225 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc-------hhhHHHHHHHhhcccccccc---ccCCHH
Confidence            89999999999988899999999999999999999999863211       00111111222222222111   123446


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +.+++.+||+.||++||+++|+++
T Consensus       226 ~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         226 SKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHHHhccCHhhCCCCccchh
Confidence            789999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-35  Score=332.62  Aligned_cols=253  Identities=16%  Similarity=0.198  Sum_probs=190.5

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +...+.||+|+||.||+|.+. +++.||+|+...       ....++++.+++++||||+++++++......++|+|++.
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            334556899999999999876 677888886532       123567778899999999999999999999999999996


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC-CCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~-~~~  935 (1048)
                       ++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+..... ...
T Consensus       167 -~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        167 -TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             -CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence             5898888643   3478899999999999999999999   9999999999999999999999999999754322 222


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc----------------c--cccc--
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA----------------P--AANM--  995 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~----------------~--~~~~--  995 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...........                .  ....  
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            3456799999999999998999999999999999999999988643221110000                0  0000  


Q ss_pred             --hhhhhhhcc-----CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          996 --NIVVNDLID-----SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       996 --~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        .........     +...+.+........++.+++.+||+.||++|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              000000000     0011111122234457889999999999999999999985

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.6e-36  Score=334.61  Aligned_cols=238  Identities=21%  Similarity=0.255  Sum_probs=185.9

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHH-HHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGF-VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~-~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|+.. +++.+|+|++.........  .....+ ...++.++||||+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            4899999999999876 6788999988653221111  111112 22346689999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            999988643   3478899999999999999999999   9999999999999999999999999999764433344455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.           ......+.........    ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----------~~~~~~~~~~~~~~~~----~~~  220 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----------AEMYDNILHKPLVLRP----GAS  220 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----------HHHHHHHHcCCccCCC----CCC
Confidence            6799999999999999999999999999999999999999863221           1122222222221111    123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQK 1041 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~e 1041 (1048)
                      ..+.+++.+|++.+|++||++.+
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCC
Confidence            45778899999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=317.67  Aligned_cols=249  Identities=22%  Similarity=0.401  Sum_probs=194.3

Q ss_pred             eeeecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||+||+|.+..    ...||+|.+..............++..++.++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   88 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME   88 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence            4568999999999998753    346888887654333322233456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....  ..+++..+.+++.|++.|++|||+.   +|+||||||+||++++++.++++|||.++.........
T Consensus        89 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd05033          89 NGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY  163 (266)
T ss_pred             CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence            999999996532  3588999999999999999999998   99999999999999999999999999998775222221


Q ss_pred             --cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          937 --SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       937 --~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                        ....++..|+|||...+..++.++||||+|+++||+++ |+.||....           .......+......+..  
T Consensus       164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~--  230 (266)
T cd05033         164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-----------NQDVIKAVEDGYRLPPP--  230 (266)
T ss_pred             eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-----------HHHHHHHHHcCCCCCCC--
Confidence              12334678999999998899999999999999999998 998875321           11112222222111111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       ......+.+++.+||+.+|++||++.|++++|++
T Consensus       231 -~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         231 -MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             1234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=289.97  Aligned_cols=254  Identities=20%  Similarity=0.280  Sum_probs=193.4

Q ss_pred             eeeecccccccEEEEEE-cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-----CCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-----TQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~  854 (1048)
                      ...+|+|||+.||.++. .+++.||+|++.-... +......+++..-++++||||++++++...     ....|++++|
T Consensus        26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Py  104 (302)
T KOG2345|consen   26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPY  104 (302)
T ss_pred             eeeecCCCceeeeeecccCcccchhhheeeccch-HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence            34589999999999975 4688999999976542 222333455566688899999999998743     3458999999


Q ss_pred             cCCCCHHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          855 LERGSLATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      +..|+|.+.+.+... +..+++.+++.|+.++++||++||+.. ++++||||||.||++.+++.+++.|||.++...-.-
T Consensus       105 y~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i  183 (302)
T KOG2345|consen  105 YKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI  183 (302)
T ss_pred             hccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence            999999999976543 346899999999999999999999983 369999999999999999999999999997654211


Q ss_pred             C---------CccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhh
Q 045493          934 S---------NWSELAGTCGYIAPELAYTMR---ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       934 ~---------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .         .+..-.-|..|+|||.+..+.   .++++||||+||++|+|+.|..||+..-..         .+...-+
T Consensus       184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------GgSlaLA  254 (302)
T KOG2345|consen  184 EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------GGSLALA  254 (302)
T ss_pred             echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------CCeEEEe
Confidence            1         112234688899999987544   478999999999999999999998743221         1111112


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +..+.+..+...  ..++.+.+++..|+++||.+||++.+++..++
T Consensus       255 v~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  255 VQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             eeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            222222222211  14567899999999999999999999998875

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7e-35  Score=314.41  Aligned_cols=247  Identities=22%  Similarity=0.358  Sum_probs=191.7

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      .||+|+||.||+|+.. +++.+|+|.+......+.......+++.++.++||||+++++++...+..++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            4799999999999876 678899998764433332333455666678889999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--ccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SEL  939 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~  939 (1048)
                      +++...  ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+..........  ...
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            999643  23478999999999999999999999   99999999999999999999999999987654221111  111


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..+..|+|||.+.++.++.++||||+||++|||++ |..||.....           ... ............  .....
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----------~~~-~~~~~~~~~~~~--~~~~~  222 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----------QQT-REAIEQGVRLPC--PELCP  222 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----------HHH-HHHHHcCCCCCC--cccCC
Confidence            23457999999998889999999999999999998 8888753211           011 111111111111  12234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.+||+.+|++|||+.|+.++|++
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.4e-35  Score=323.55  Aligned_cols=259  Identities=23%  Similarity=0.300  Sum_probs=192.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||+||+|+++ +++.||+|++......+ .......++..++.++||||+++++++...+..|+||||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN   85 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence            456899999999999886 57789999886543222 1223445677788899999999999999999999999999998


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  937 (1048)
                      .+..+.+.   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........ ...
T Consensus        86 ~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          86 MLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            77665432   23478899999999999999999998   999999999999999999999999999987643322 233


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC--------Ccccccch-----hhhhhhcc
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL--------PAPAANMN-----IVVNDLID 1004 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~-----~~~~~~~~ 1004 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....        +.+.....     ........
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            457899999999999888999999999999999999999998643221000        00000000     00000000


Q ss_pred             CCCCCCch----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 SRLPPPLG----EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 ~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.......    ........+.+++.+|++.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000    001234568999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.6e-35  Score=316.73  Aligned_cols=254  Identities=20%  Similarity=0.293  Sum_probs=198.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|+.. +++.||+|++.......  .......++..++.++||||+++++++.+.+..++||||+++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence            345899999999999876 67889999876432221  112234566677888999999999999999999999999999


Q ss_pred             CCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          858 GSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       858 g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      |+|.+++.... ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+..........
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~  163 (267)
T cd08228          87 GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHH
Confidence            99999885432 233478889999999999999999998   99999999999999999999999999998765443333


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....|++.|+|||.+.+..++.++||||+|+++|||++|+.||....         .........+.....++..  ...
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~--~~~  232 (267)
T cd08228         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------MNLFSLCQKIEQCDYPPLP--TEH  232 (267)
T ss_pred             hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---------ccHHHHHHHHhcCCCCCCC--hhh
Confidence            44568899999999988889999999999999999999999975211         0111111222121222211  123


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+.+++.+||+.+|++||++.+|++.+++
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            44668899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=311.77  Aligned_cols=243  Identities=20%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc-chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG-INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~-~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .+.||+|.|+.|-.|++- +|++||||++.+..-.... -....+++.|+-++|||||++|++.......|+|+|.-.+|
T Consensus        23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G  102 (864)
T KOG4717|consen   23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG  102 (864)
T ss_pred             hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence            345899999999999876 8999999999775443322 23456788999999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.+|+-++..  .+.+.-+.+++.||+.|+.|+|+.   .+||||+||+||.+-+ -|-||++|||++..+.++ ....
T Consensus       103 Dl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~  176 (864)
T KOG4717|consen  103 DLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLT  176 (864)
T ss_pred             hHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc-chhh
Confidence            99999965433  378888999999999999999999   9999999999998865 489999999999887654 4567


Q ss_pred             ccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRAN-EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      +.||+..|-|||++.+..|+ +++||||+|||+|-+++|+.||+..           +..+....++|.+...+    ..
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-----------NDSETLTmImDCKYtvP----sh  241 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-----------NDSETLTMIMDCKYTVP----SH  241 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-----------cchhhhhhhhcccccCc----hh
Confidence            78999999999999999985 7899999999999999999998733           33445556666666544    45


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++.++|.+|+..||++|.+.+|++.
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            5677899999999999999999999874

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-35  Score=331.49  Aligned_cols=237  Identities=22%  Similarity=0.257  Sum_probs=184.7

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcc---cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI---GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +||+|+||.||+|+.. +++.||+|.+........   .....++...++.++||||+++++++.+.+..|+||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5899999999999886 577899998864321111   111122223356789999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          82 ELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            999988643   3477888899999999999999998   9999999999999999999999999998764333333445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------~~~~~~~i~~~~~~~~----~~~~  220 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----------VSQMYDNILHKPLQLP----GGKT  220 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----------HHHHHHHHhcCCCCCC----CCCC
Confidence            679999999999998889999999999999999999999986322           1112222222222211    1223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQ 1040 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~ 1040 (1048)
                      ..+.+++.+|++.||++||++.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCC
Confidence            4678899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.2e-35  Score=328.92  Aligned_cols=238  Identities=21%  Similarity=0.264  Sum_probs=184.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhccc-CceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRH-RNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|+.. +++.||+|++......  ........+.+.+..++| ++|+++++++.+.+..|+||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence            456899999999999876 4678999988653211  111122334444556655 568899999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        85 ~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          85 GGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            999999986533   478899999999999999999999   99999999999999999999999999987543333344


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+    ..
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----------~~~~~~i~~~~~~~~----~~  223 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----------DELFQSIMEHNVSYP----KS  223 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCCCC----CC
Confidence            456799999999999999999999999999999999999999863221           112222222222111    12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      ....+.+++.+||++||++|+++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCC
Confidence            23467889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-35  Score=334.14  Aligned_cols=196  Identities=26%  Similarity=0.331  Sum_probs=164.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|+.. +++.||+|++......  ........+...+..++|++|+++++++.+....|+||||++
T Consensus         5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence            3456899999999999876 5788999998653211  111223445666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      +|+|.+++.+.   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....  
T Consensus        85 gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          85 GGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            99999999753   3488999999999999999999999   999999999999999999999999999875432110  


Q ss_pred             ---------------------------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          935 ---------------------------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       935 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                                                       .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                             01235799999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-35  Score=328.88  Aligned_cols=238  Identities=21%  Similarity=0.278  Sum_probs=185.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|+.. +++.||+|.+.........  .....+.+.+... +|++|+++++++...+..|+||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            456899999999999877 5678999988653221111  1112223333333 58999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        85 ~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          85 GGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            999999986533   478899999999999999999999   99999999999999999999999999997654333344


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.......+    ..
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----------~~~~~~~i~~~~~~~p----~~  223 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----------EDELFQSIMEHNVAYP----KS  223 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCC----Cc
Confidence            45679999999999999999999999999999999999999986322           1122222222222211    12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      ...++.+++.+|++.||++|+++
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCC
Confidence            34567889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-34  Score=312.68  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=193.2

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||+||+|++.++..+|+|.+......  .....+++..++.++||||+++++++...+..++||||+++|+|.
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   87 (256)
T cd05113          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL   87 (256)
T ss_pred             eEecCcccceEEEEEecCCCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence            358999999999999887777999987643221  123455677788899999999999999888999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  940 (1048)
                      +++.....  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++........ .....
T Consensus        88 ~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05113          88 NYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK  162 (256)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence            99965332  578999999999999999999999   9999999999999999999999999998865433221 11233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+..+..++.++|||||||++|||++ |+.||.....           ................   .....
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~~~  228 (256)
T cd05113         163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----------SETVEKVSQGLRLYRP---HLASE  228 (256)
T ss_pred             cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----------HHHHHHHhcCCCCCCC---CCCCH
Confidence            5668999999988889999999999999999999 9999753221           1111222222111111   11245


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+.+|++|||+.++++.++
T Consensus       229 ~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         229 KVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            6889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.9e-35  Score=334.36  Aligned_cols=248  Identities=21%  Similarity=0.242  Sum_probs=191.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|++.....  ........+++..++.++||||+++++++.+.+..|+||||++
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05596          47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCC
Confidence            3456899999999999886 578899998864321  1111223456667788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-C
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-N  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~  935 (1048)
                      +|+|.+++.+.    .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+........ .
T Consensus       127 gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         127 GGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999998642    367788889999999999999999   999999999999999999999999999987643322 2


Q ss_pred             ccccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          936 WSELAGTCGYIAPELAYTM----RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ....+||+.|+|||++.+.    .++.++||||+||++|||++|+.||...+.           ......+.........
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~~~~~~~~~  268 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGTYSKIMDHKNSLTF  268 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----------HHHHHHHHcCCCcCCC
Confidence            2346799999999998653    378999999999999999999999864321           1122222222111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCNL 1045 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1045 (1048)
                      .........+.+++.+|++.+|++  |||++|+++.
T Consensus       269 ~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111123456788999999999998  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-35  Score=330.04  Aligned_cols=243  Identities=21%  Similarity=0.243  Sum_probs=185.8

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|+.. +++.+|+|++.......  .......+...+.++ +||+|+++++++...+..|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5899999999999876 56789999987532211  111223344445555 6999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...+   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          82 DLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9999886433   488999999999999999999999   9999999999999999999999999999764333334455


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||+........    .........+.......+    ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~p----~~~~  227 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM----NTEDYLFQVILEKPIRIP----RFLS  227 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc----ccHHHHHHHHHhCCCCCC----CCCC
Confidence            67999999999999999999999999999999999999998643211100    011111122222221111    1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      ..+.+++.+||+.||++||++
T Consensus       228 ~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         228 VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHHHHHhccCHHHcCCC
Confidence            457789999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.7e-35  Score=321.69  Aligned_cols=258  Identities=20%  Similarity=0.302  Sum_probs=185.5

Q ss_pred             eeeecccccccEEEEEEc--CCCceeeEEeccCCCCc-ccchhhHHHHHHh---hcccCceeeEeeEee-----eCCeEE
Q 045493          781 MVLHGTGGCGTVYKAELT--SGDTRAVKKLHSLPTGE-IGINQKGFVSEIT---EIRHRNIVKFYGFCS-----HTQHLF  849 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~--~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~---~l~h~niv~~~~~~~-----~~~~~~  849 (1048)
                      ...||+|+||.||+|+..  +++.||+|++......+ .......++..++   .++||||++++++|.     .....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            346899999999999874  45778999886543222 1122233444444   447999999999885     245689


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             EEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            9999997 59999986533 23478999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccccchh--h
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAANMNI--V  998 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~--~  998 (1048)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........         .+........  .
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             cCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            433 333455789999999999888999999999999999999999999875432100         0000000000  0


Q ss_pred             hhhhccCCCCCCchh-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          999 VNDLIDSRLPPPLGE-VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...........+... .......+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000001111111100 0122345778999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-34  Score=313.78  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=195.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|...+++.||+|++.....  .......++..++.++|+||+++++++.+.+..++||||+++|+|
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL   88 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence            345899999999999988888899998764322  122345567777889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-cccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  939 (1048)
                      .++++... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+......... ....
T Consensus        89 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          89 LDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence            99996542 34578899999999999999999998   9999999999999999999999999999876433211 1223


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .++..|+|||+.....++.++||||+||++|||++ |+.||.....           ......+......+..   ....
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~~  230 (261)
T cd05072         165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----------SDVMSALQRGYRMPRM---ENCP  230 (261)
T ss_pred             ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---CCCC
Confidence            45678999999988889999999999999999998 9999753211           1111111111111111   1233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .++.+++.+||+.+|++|||++++.++|++
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         231 DELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            468889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=336.90  Aligned_cols=247  Identities=22%  Similarity=0.264  Sum_probs=189.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..+.||+|+||+||+|+.. +++.||||++.....  .........++..+..++||||+++++++.+.+..|+||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (364)
T cd05599           5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence            3457899999999999886 678899999865321  1112233456777788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      +|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+.....  
T Consensus        85 ~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          85 GGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            999999996533   488999999999999999999999   999999999999999999999999999875432110  


Q ss_pred             ------------------------------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045493          935 ------------------------------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP  978 (1048)
Q Consensus       935 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p  978 (1048)
                                                          .....+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                00124699999999999998999999999999999999999999


Q ss_pred             CcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 045493          979 GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT---MQKVCN 1044 (1048)
Q Consensus       979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 1044 (1048)
                      |......           .....+..................+.+++.+|+. +|.+|++   ++|+++
T Consensus       239 f~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNPQ-----------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCHH-----------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            8643211           1111111111100000001123456778888886 9999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.7e-35  Score=330.63  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=187.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e  853 (1048)
                      ...||+|+||.||+|... +++.||+|++...... ........+++.++.++||||+++++++...     ...|+|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            356899999999999876 6889999998643221 1112234566777889999999999988543     35799999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |++ ++|.+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          85 LME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             cCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            996 5899988643   3488999999999999999999999   99999999999999999999999999998653222


Q ss_pred             C---Ccccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccccc-----
Q 045493          934 S---NWSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAAN-----  994 (1048)
Q Consensus       934 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~-----  994 (1048)
                      .   ......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.......         +.+.....     
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1   2234579999999999865  578999999999999999999999986432110         00000000     


Q ss_pred             --chhhhhhhccCCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          995 --MNIVVNDLIDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       995 --~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        .......+ ....+.+. .........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         238 EKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              00000111 11111111 011112346789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-34  Score=316.99  Aligned_cols=250  Identities=21%  Similarity=0.349  Sum_probs=192.7

Q ss_pred             eeecccccccEEEEEEc-----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..||+|+||+||+|...     .+..+++|.+......+.......++..++.++||||+++++++...+..|+||||++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   90 (283)
T cd05090          11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN   90 (283)
T ss_pred             eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence            45899999999999752     4577899988654333222334556777889999999999999999999999999999


Q ss_pred             CCCHHHHHhcccc--------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          857 RGSLATILSNEAT--------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       857 ~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                      +|+|.+++.....              ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~d  167 (283)
T cd05090          91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISD  167 (283)
T ss_pred             CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEecc
Confidence            9999999853221              23478889999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhh
Q 045493          923 FGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVV  999 (1048)
Q Consensus       923 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ||+++.......  ......++..|+|||+..+..++.++|||||||++|||++ |..||....           .....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-----------~~~~~  236 (283)
T cd05090         168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-----------NQEVI  236 (283)
T ss_pred             ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----------HHHHH
Confidence            999986543321  1223445678999999988889999999999999999999 888875221           11111


Q ss_pred             hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .........+..   ......+.+++.+||+.||++||++.++.++|.+
T Consensus       237 ~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRKRQLLPCS---EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCcCCCC---CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111111111   1233467889999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=320.85  Aligned_cols=250  Identities=22%  Similarity=0.253  Sum_probs=193.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||++... +++.||+|++.......  .......++..++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05605           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence            3456899999999999875 67889999886532221  11223446677788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++...... ...
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~  158 (285)
T cd05605          84 GGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETI  158 (285)
T ss_pred             CCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Ccc
Confidence            999999886432 24588999999999999999999999   9999999999999999999999999999865432 222


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||......       .........+ ......   ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-------~~~~~~~~~~-~~~~~~---~~~~  227 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-------VKREEVERRV-KEDQEE---YSEK  227 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-------hHHHHHHHHh-hhcccc---cCcc
Confidence            3457899999999999888999999999999999999999998632210       0001111111 111111   1122


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      ....+.+++.+||+.||++||     +++++++.
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            345678899999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-34  Score=312.34  Aligned_cols=245  Identities=24%  Similarity=0.316  Sum_probs=188.5

Q ss_pred             ecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||.||+|.+.   .+..||+|.+..............++..+++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            799999999999764   344588888765433222233455677788899999999999885 4568999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc---c
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---S  937 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~---~  937 (1048)
                      .+++...  ...+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++..........   .
T Consensus        82 ~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          82 NKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            9998643  23588999999999999999999998   99999999999999999999999999998654433221   1


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...++..|+|||++.+..++.++|||||||++||+++ |+.||.....           ......+........   ...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~---~~~  222 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----------PEVMSFIEQGKRLDC---PAE  222 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----------HHHHHHHHCCCCCCC---CCC
Confidence            1223578999999988889999999999999999996 9999763321           111111111111111   112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...++.+++.+||+.+|++||++.++.+.|++
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            34568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.2e-35  Score=327.44  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeee-CCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSH-TQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~  852 (1048)
                      ...||+|+||.||+|...      +++.||+|++..............++..+.++ +|+||++++++|.. ....++||
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~   91 (337)
T cd05054          12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   91 (337)
T ss_pred             hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence            356899999999999643      24679999886533222222233455666777 79999999998864 45789999


Q ss_pred             EccCCCCHHHHHhcccc----------------------------------------------------------ccccC
Q 045493          853 EYLERGSLATILSNEAT----------------------------------------------------------AAELD  874 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~----------------------------------------------------------~~~l~  874 (1048)
                      ||+++|+|.+++.....                                                          ...++
T Consensus        92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (337)
T cd05054          92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT  171 (337)
T ss_pred             ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence            99999999999854221                                                          12578


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--ccccccccccccccccc
Q 045493          875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAY  952 (1048)
Q Consensus       875 ~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~  952 (1048)
                      +..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++.+......  .....++..|+|||++.
T Consensus       172 ~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         172 LEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            999999999999999999999   9999999999999999999999999999876443322  12334567899999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCC
Q 045493          953 TMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDA 1031 (1048)
Q Consensus       953 ~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 1031 (1048)
                      +..++.++||||+||++|||++ |+.||.....           ................  ......++.+++.+||+.
T Consensus       249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-----------DEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc-----------cHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccC
Confidence            9999999999999999999998 9999753210           0111111111111110  112345688999999999


Q ss_pred             CCCCCCCHHHHHHHhhC
Q 045493         1032 NPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1032 dP~~RPt~~evl~~L~~ 1048 (1048)
                      +|++||++.|++++|++
T Consensus       316 ~p~~RPs~~ell~~l~~  332 (337)
T cd05054         316 NPEDRPTFSELVEILGD  332 (337)
T ss_pred             ChhhCcCHHHHHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=335.61  Aligned_cols=245  Identities=24%  Similarity=0.312  Sum_probs=193.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+|+.. +++.||+|++......  ........+...+..++||||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG   85 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence            456899999999999886 6889999998653221  1122344566667888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC----
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS----  933 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~----  933 (1048)
                      |+|.+++.+.   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......    
T Consensus        86 ~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          86 GDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            9999999754   3478899999999999999999998   99999999999999999999999999998765433    


Q ss_pred             -------------------------CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC
Q 045493          934 -------------------------SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL  988 (1048)
Q Consensus       934 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  988 (1048)
                                               .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~----  235 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL----  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH----
Confidence                                     122345689999999999999999999999999999999999999864321    


Q ss_pred             Ccccccchhhhhhhcc--CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 045493          989 PAPAANMNIVVNDLID--SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT-MQKVCNL 1045 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~ 1045 (1048)
                             ......+..  .....+.  .......+.+++.+|++ ||++||+ ++|+++.
T Consensus       236 -------~~~~~~i~~~~~~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 -------QETYNKIINWKESLRFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             -------HHHHHHHhccCCcccCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                   111111111  1111111  01134567888999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.9e-35  Score=340.20  Aligned_cols=251  Identities=25%  Similarity=0.281  Sum_probs=193.5

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCC--------e
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--------H  847 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--------~  847 (1048)
                      +.....||+|+||+||+|+.. +++.||||++......+ .......++..+..++|+||+++++.+...+        .
T Consensus        34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~  113 (496)
T PTZ00283         34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM  113 (496)
T ss_pred             EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence            334557899999999999865 68899999986543222 1122344566667789999999988764322        3


Q ss_pred             EEEEEEccCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccc
Q 045493          848 LFLVYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA  926 (1048)
Q Consensus       848 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a  926 (1048)
                      .++||||+++|+|.++++... ....+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||++
T Consensus       114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls  190 (496)
T PTZ00283        114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFS  190 (496)
T ss_pred             EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence            689999999999999996532 234588899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC--CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          927 KFLKPDS--SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       927 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      +.+....  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....           ..........
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----------~~~~~~~~~~  259 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----------MEEVMHKTLA  259 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHhc
Confidence            8764321  22345679999999999999999999999999999999999999986322           1122222222


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....+..   .....++.+++.+||+.||++||++.+++++
T Consensus       260 ~~~~~~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRYDPLP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            2222111   1233568889999999999999999999864

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.7e-35  Score=324.53  Aligned_cols=248  Identities=19%  Similarity=0.348  Sum_probs=189.2

Q ss_pred             ceeeecccccccEEEEEEc-CCC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||.||+|.+. +++    .||+|++..............++..++.++||||++++|+|... ..++|+||
T Consensus        11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~   89 (316)
T cd05108          11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL   89 (316)
T ss_pred             eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence            3456899999999999865 333    37888876433322223344566677888999999999999764 47899999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        90 ~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          90 MPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK  164 (316)
T ss_pred             CCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence            99999999997532  3478889999999999999999999   999999999999999999999999999987654333


Q ss_pred             Cc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 NW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ..  ....++..|+|||++.+..++.++|||||||++||+++ |+.||.....           . ....+.......+.
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----------~-~~~~~~~~~~~~~~  232 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------S-EISSILEKGERLPQ  232 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------H-HHHHHHhCCCCCCC
Confidence            22  22334678999999999999999999999999999998 9999763211           0 01111111111110


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                        ...+...+.+++.+||+.+|++|||+.+++..+.
T Consensus       233 --~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         233 --PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              0112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-34  Score=313.02  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=196.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||++... +++.+|+|.+..............+...++.++|+||+++++++...+..|+||||+++|+
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   84 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD   84 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence            346899999999999876 6788899987643332222334556667788999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +.+++.... ...+++..+..++.|++.|+.|||+.   +|+|+||||+||++++++.++++|||.+.............
T Consensus        85 l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (255)
T cd08219          85 LMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY  160 (255)
T ss_pred             HHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence            999886432 33478889999999999999999999   99999999999999999999999999998765444444456


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .|++.|+|||++.+..++.++||||+|+++|+|++|+.||...+           ..............+..   .....
T Consensus       161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~---~~~~~  226 (255)
T cd08219         161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----------WKNLILKVCQGSYKPLP---SHYSY  226 (255)
T ss_pred             cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----------HHHHHHHHhcCCCCCCC---cccCH
Confidence            78999999999998889999999999999999999999986322           11112222222222111   12234


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         227 ELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            57889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-35  Score=332.53  Aligned_cols=248  Identities=21%  Similarity=0.246  Sum_probs=188.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.+|+|.+.....  ........++...++.++||||+++++++.+.+..|+||||++
T Consensus        47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~  126 (370)
T cd05621          47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP  126 (370)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence            4456899999999999887 567889998754221  1112223456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-C
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-N  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~  935 (1048)
                      +|+|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+|........ .
T Consensus       127 gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         127 GGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            99999999643    367888999999999999999999   999999999999999999999999999987643322 2


Q ss_pred             ccccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          936 WSELAGTCGYIAPELAYTMR----ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ....+||+.|||||++.+..    ++.++||||+||++|||++|+.||...+.           ......+.+.......
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~~  268 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----------VGTYSKIMDHKNSLNF  268 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCcccCC
Confidence            23567999999999987543    78899999999999999999999864321           1122222222211111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCNL 1045 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1045 (1048)
                      .........+.+++.+|+..+|.+  |||++|+++.
T Consensus       269 p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         269 PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            111223445677888889866654  8999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=322.34  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=193.3

Q ss_pred             ecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHHH
Q 045493          784 HGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATI  863 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~  863 (1048)
                      +|.|+||.||+|..++....|+-++......+.-....-++..+..+.||+||++++.|...+..|+..|||.||-.+.+
T Consensus        40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDai  119 (1187)
T KOG0579|consen   40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAI  119 (1187)
T ss_pred             hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHH
Confidence            69999999999988865555443333323322222233345667888999999999999888999999999999999988


Q ss_pred             HhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccccccc
Q 045493          864 LSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC  943 (1048)
Q Consensus       864 l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  943 (1048)
                      +-.-  ...+++.++..++++++.||.|||+.   .|||||+|+.|||++-+|.++++|||.+............+.|||
T Consensus       120 mlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTP  194 (1187)
T KOG0579|consen  120 MLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTP  194 (1187)
T ss_pred             HHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCc
Confidence            7543  23488999999999999999999999   999999999999999999999999999976655555667789999


Q ss_pred             ccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          944 GYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       944 ~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      +|||||+..     ..+|++++||||||+++.||..+.+|......+           .++.+ +...-|+..-.+....
T Consensus       195 YWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----------RVllK-iaKSePPTLlqPS~Ws  262 (1187)
T KOG0579|consen  195 YWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----------RVLLK-IAKSEPPTLLQPSHWS  262 (1187)
T ss_pred             ccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----------HHHHH-HhhcCCCcccCcchhh
Confidence            999999875     457899999999999999999999995533321           11112 2223333333445566


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+.+++.+|+.+||..||+++++++.
T Consensus       263 ~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  263 RSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             hHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            778899999999999999999999863

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-35  Score=330.49  Aligned_cols=247  Identities=20%  Similarity=0.260  Sum_probs=187.8

Q ss_pred             eeeecccccccEEEEEEc----CCCceeeEEeccCCCCc---ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGE---IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~---~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ...||+|+||.||+++..    +++.||+|.+.......   .......+...+..+ +|++|+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL   84 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence            456899999999999763    57889999886532211   112234455566777 5999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus        85 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          85 DYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            9999999999986533   378899999999999999999999   9999999999999999999999999999865433


Q ss_pred             C-CCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          933 S-SNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       933 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      . .......||+.|||||++.+. .++.++||||+||++|||++|+.||......       .........+.....+.+
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-------NTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-------CCHHHHHHHHhcCCCCCC
Confidence            2 223346799999999998865 4789999999999999999999998632210       011111112211111111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                          ......+.+++.+||+.||++||     +++++++
T Consensus       232 ----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         232 ----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                12234577889999999999999     6778765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=322.30  Aligned_cols=259  Identities=19%  Similarity=0.260  Sum_probs=191.8

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|+.+ +++.+|+|++.............+++..+++++||||+++++++...+..++||||+++ 
T Consensus        10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   88 (309)
T cd07872          10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-   88 (309)
T ss_pred             EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence            3456899999999999876 56789999886544333333445677778889999999999999999999999999986 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.+++...+  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++...........
T Consensus        89 ~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          89 DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            8888875432  3478889999999999999999999   9999999999999999999999999999765443333344


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccccc----hhhhhhhcc
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAANM----NIVVNDLID 1004 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~----~~~~~~~~~ 1004 (1048)
                      ..+|+.|+|||++.+ ..++.++||||+||++|||+||+.||...+....         .+....+.    .........
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            568899999998865 4578999999999999999999999864321100         00000000    000000000


Q ss_pred             CCCCC-C-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPP-P-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +...+ . .........++.+++.+|++.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000 0 0001122346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-34  Score=310.31  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=192.8

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      +||+|+||.||+|...+++.+|+|.+..............+++.++.++||||+++++++...+..++||||+++|+|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            58999999999999888889999988654433322334456667788899999999999999999999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc-ccccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW-SELAG  941 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~g  941 (1048)
                      ++....  ..+++..+..++.+++.|+.|+|+.   +++||||||+||+++.++.+|++|||++.......... ....+
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            986432  3478999999999999999999998   99999999999999999999999999987543322111 12234


Q ss_pred             ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       942 t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      +..|+|||+..+..++.++||||||+++||+++ |..||.....           ...............   .......
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~---~~~~~~~  222 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----------QQAREQVEKGYRMSC---PQKCPDD  222 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----------HHHHHHHHcCCCCCC---CCCCCHH
Confidence            567999999998889999999999999999998 8989753221           011111111111100   1123356


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +.+++.+||+.+|++||++.|+++.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-34  Score=314.12  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=198.3

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||.|+||.||+|...+++.+++|.+....... ......++..++.++|+||+++++++.+.+..++||||+++|+|
T Consensus        11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (261)
T cd05148          11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL   89 (261)
T ss_pred             hhhhccCCCccEEEeEecCCCcEEEEeccccchhh-HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCH
Confidence            34589999999999999888899999886543322 22345566777889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .++++... ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.+..............
T Consensus        90 ~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~  165 (261)
T cd05148          90 LAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK  165 (261)
T ss_pred             HHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCC
Confidence            99997543 34578999999999999999999998   999999999999999999999999999987654333333445


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+.....++.++||||+|+++|+|++ |+.||....           .......+......+.   ......
T Consensus       166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~---~~~~~~  231 (261)
T cd05148         166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----------NHEVYDQITAGYRMPC---PAKCPQ  231 (261)
T ss_pred             CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----------HHHHHHHHHhCCcCCC---CCCCCH
Confidence            6778999999988889999999999999999998 899975322           1112222222111111   123345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+.||++|||++++++.|+
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         232 EIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            6889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-34  Score=317.88  Aligned_cols=249  Identities=19%  Similarity=0.320  Sum_probs=192.9

Q ss_pred             eecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          783 LHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .||+|+||.||+|...+      ++.||+|++..............+...++.++||||+++++++...+..++++||++
T Consensus        12 ~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~   91 (283)
T cd05091          12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS   91 (283)
T ss_pred             HhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCC
Confidence            47999999999998643      467899988754332222233455566678899999999999999999999999999


Q ss_pred             CCCHHHHHhccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          857 RGSLATILSNEA-------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       857 ~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                      +++|.+++....             ....+++..+..++.|++.|++|+|+.   +|+||||||+||++++++.+||+||
T Consensus        92 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Df  168 (283)
T cd05091          92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDL  168 (283)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEeccc
Confidence            999999985321             123478888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhh
Q 045493          924 GTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       924 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      |+++........  .....+++.|+|||++.++.++.++||||+||++|||++ |..||....           ......
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----------~~~~~~  237 (283)
T cd05091         169 GLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----------NQDVIE  237 (283)
T ss_pred             ccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----------HHHHHH
Confidence            998865433221  223446789999999988889999999999999999998 777865321           122233


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+..+...+..   ......+.+++.+||+.+|++||+++++++.|+.
T Consensus       238 ~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            33333322211   2334568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-34  Score=311.02  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=197.0

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.||+|... +++.|++|.+...... ........+++.++.++||||+++++++.+.+..++||||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08529           6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD   85 (256)
T ss_pred             EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence            45899999999999876 6788999987643221 122233445666788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.++++... ...+++..+..++.+++.|+.|||+.   +++||||||+||+++.++.++++|||++.............
T Consensus        86 L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  161 (256)
T cd08529          86 LHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI  161 (256)
T ss_pred             HHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence            999997542 34588899999999999999999998   99999999999999999999999999998776544444556


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .|++.|+|||+..+..++.++|||||||++|||++|+.||....           .............+...   .....
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~---~~~~~  227 (256)
T cd08529         162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----------QGALILKIIRGVFPPVS---QMYSQ  227 (256)
T ss_pred             ccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHcCCCCCCc---cccCH
Confidence            78899999999999889999999999999999999999976322           11112222222222221   13345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.+++.+||+.+|++||++.++++.
T Consensus       228 ~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         228 QLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHhhC
Confidence            68899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-35  Score=335.87  Aligned_cols=246  Identities=21%  Similarity=0.271  Sum_probs=184.8

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||+||+|+.. +++.||+|++.....  .........++..++.++||||+++++++.+.+..|+||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~   83 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence            45567999999999999876 577899998865321  111223345666678889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--  933 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--  933 (1048)
                      ++|+|.+++.+.+   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....  
T Consensus        84 ~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          84 PGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999986543   478888999999999999999999   99999999999999999999999999975331100  


Q ss_pred             ---------------------------------------------CCccccccccccccccccccCCCCchhhHHHHHHH
Q 045493          934 ---------------------------------------------SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVL  968 (1048)
Q Consensus       934 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvv  968 (1048)
                                                                   ......+||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCcccccccCCCcccccchhhhhhhcc--CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 045493          969 VLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID--SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT---MQKVC 1043 (1048)
Q Consensus       969 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl 1043 (1048)
                      +|||++|+.||......           .....+..  .....+.  ......+..+++.+|+ .+|++|++   ++|++
T Consensus       238 l~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         238 LYEMLVGQPPFLAQTPL-----------ETQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHHhCCCCCCCCCHH-----------HHHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            99999999998643211           11111111  1111110  1112334566666654 59999997   88776


Q ss_pred             H
Q 045493         1044 N 1044 (1048)
Q Consensus      1044 ~ 1044 (1048)
                      +
T Consensus       304 ~  304 (382)
T cd05625         304 A  304 (382)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2e-34  Score=314.04  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=184.8

Q ss_pred             eecccccccEEEEEEcC---CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELTS---GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~---~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .||+|+||.||+|...+   +..+|+|++.............+++..+++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            47999999999997653   346888887654433222234456677788999999999999999889999999999999


Q ss_pred             HHHHHhcccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--
Q 045493          860 LATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--  935 (1048)
Q Consensus       860 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--  935 (1048)
                      |.+++.....  ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++........  
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999965332  22456778889999999999999999   9999999999999999999999999999754332211  


Q ss_pred             ccccccccccccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          936 WSELAGTCGYIAPELAYTM-------RANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .....++..|+|||++.+.       .++.++|||||||++|||++ |+.||........       ....... .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~-~~~~~  230 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTYTVRE-QQLKL  230 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHhhc-ccCCC
Confidence            1234577889999988642       35789999999999999996 9999863221100       0000000 00111


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +.+. ........+.+++.+|| .+|++|||++||+..|+
T Consensus       231 ~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1110 00112334677888899 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=315.14  Aligned_cols=250  Identities=21%  Similarity=0.316  Sum_probs=193.7

Q ss_pred             eeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..||+|+||.||+|....      +..+|+|.+..............++..++.++||||+++++++......++||||+
T Consensus        12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   91 (277)
T cd05032          12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELM   91 (277)
T ss_pred             eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecC
Confidence            468999999999998753      35788898754332222223345566677889999999999999999999999999


Q ss_pred             CCCCHHHHHhcccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          856 ERGSLATILSNEAT-------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      ++|+|.+++.....       ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||.++.
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~  168 (277)
T cd05032          92 AKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRD  168 (277)
T ss_pred             CCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchh
Confidence            99999999965332       22368889999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          929 LKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       929 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ......  ......++..|+|||...++.++.++|||||||++||+++ |+.||...+.           ..........
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----------~~~~~~~~~~  237 (277)
T cd05032         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----------EEVLKFVIDG  237 (277)
T ss_pred             hccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----------HHHHHHHhcC
Confidence            543322  1223456789999999988889999999999999999998 8888753221           1111222222


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......   ......+.+++.+||+.+|++|||+.++++.|++
T Consensus       238 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         238 GHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            211111   1124568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-34  Score=324.40  Aligned_cols=239  Identities=20%  Similarity=0.269  Sum_probs=185.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||+||+|+.. +++.||+|++.......  .......+.+.+..+ +|++|+++++++...+..|+||||+
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~   83 (323)
T cd05615           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYV   83 (323)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCC
Confidence            3457899999999999876 67889999886532111  111122333444444 4678889999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          84 NGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            999999998653   3488999999999999999999999   9999999999999999999999999999865433333


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.......+    .
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----------~~~~~~~i~~~~~~~p----~  222 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----------EDELFQSIMEHNVSYP----K  222 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCC----c
Confidence            445679999999999999899999999999999999999999986322           1122222222222211    1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      ....++.+++.+|++.+|++|++.
T Consensus       223 ~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             cCCHHHHHHHHHHcccCHhhCCCC
Confidence            223467889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-34  Score=310.09  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=194.2

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|...+++.||+|.++.....  ......++..+++++||||+++++++...+..++||||+++++|
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   88 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL   88 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCccc--HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence            3568999999999999887888999988653321  22344566777889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-cccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  939 (1048)
                      .+++.... ...+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.+||+|||+++........ ....
T Consensus        89 ~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          89 LEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             HHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            99996543 34578999999999999999999998   9999999999999999999999999999876532211 1112


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..+..|+|||+..+..++.++||||+|+++|||++ |+.||....           .......+ ......+  ......
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----------~~~~~~~~-~~~~~~~--~~~~~~  230 (261)
T cd05068         165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-----------NAEVLQQV-DQGYRMP--CPPGCP  230 (261)
T ss_pred             cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-----------HHHHHHHH-HcCCCCC--CCCcCC
Confidence            23457999999998889999999999999999999 998875321           11111111 1111111  012234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+.+++.+||+.+|++||+++++++.|+
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            56888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.7e-35  Score=322.74  Aligned_cols=190  Identities=23%  Similarity=0.333  Sum_probs=161.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-c-----CceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-H-----RNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .++||+|+||.|.+|.+. +++.||+|+++....  .......|++.+..++ |     -|+|++++||...++.|+|+|
T Consensus       191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE  268 (586)
T KOG0667|consen  191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE  268 (586)
T ss_pred             EEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence            457899999999999765 689999999976432  2233445666666665 3     489999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC--CceEEeccccccccCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE--YKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~--~~~kl~DfG~a~~~~~  931 (1048)
                      .++. +|+++++..... .++...++.++.||+.||.+||+.   +|||+||||+|||+.+-  ..+||+|||.|+....
T Consensus       269 LL~~-NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  269 LLST-NLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             hhhh-hHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            9977 999999876543 489999999999999999999999   99999999999999754  4799999999997643


Q ss_pred             CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          932 DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      .   ......+..|+|||++.+.+|+.+.||||||||++||++|.+.|.
T Consensus       344 ~---vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  344 R---VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             c---ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            2   336788999999999999999999999999999999999987663

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.9e-35  Score=330.59  Aligned_cols=247  Identities=22%  Similarity=0.248  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+|+.. +++.||+|+++....  .+......++...++.++|+||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG   85 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence            456899999999999876 678899999875422  11222334556667778999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-c
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-W  936 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~  936 (1048)
                      |+|.+++.+.  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......... .
T Consensus        86 ~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          86 GDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            9999999754  23588899999999999999999999   9999999999999999999999999999876543322 2


Q ss_pred             cccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          937 SELAGTCGYIAPELAY------TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ....||+.|+|||++.      ...++.++||||+||++|||++|+.||.....           ......+........
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~  229 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----------AKTYNNIMNFQRFLK  229 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----------HHHHHHHHcCCCccC
Confidence            3346899999999986      45678999999999999999999999863221           111112111110000


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..........+.+++.+|++ +|++|||++++++
T Consensus       230 ~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00111223457788889998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.1e-34  Score=314.04  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=184.4

Q ss_pred             eeeecccccccEEEEEEc-CCCc----eeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDT----RAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~----vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ...||+|+||+||+|.+. +++.    +++|++..............++..++.+.||||+++++++.. ...++|+||+
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~   90 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS   90 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence            346899999999999875 3443    566665432221111222333445577899999999998864 4578899999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-  934 (1048)
                      ++|+|.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++....... 
T Consensus        91 ~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          91 PLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             CCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            9999999996532  3488999999999999999999998   999999999999999999999999999987644322 


Q ss_pred             -CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccC-CCCCCc
Q 045493          935 -NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-RLPPPL 1011 (1048)
Q Consensus       935 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1011 (1048)
                       ......++..|+|||+..++.++.++|||||||++||+++ |+.||.....            ....+.+.. ......
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~~  233 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------------HEVPDLLEKGERLAQP  233 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHHCCCcCCCC
Confidence             1233456778999999998899999999999999999998 9999763321            001111111 111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                         ......+.+++.+||..+|++|||+.|+++.|.
T Consensus       234 ---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         234 ---QICTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence               112345778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=322.64  Aligned_cols=245  Identities=23%  Similarity=0.326  Sum_probs=198.2

Q ss_pred             eeeecccccccEEEEEEc--CCC--ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT--SGD--TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~--~~~--~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .+.||+|.||.|++|.|+  +|+  .||||.++.......-..+.+|+..|.+++|||++++||+..+ ....||||+++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            446899999999999886  344  4799998776555433445666677788899999999999987 67899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      .|+|.+.++. .....+-......++.|||.|+.||.++   +.||||+.++|+++.....|||+|||+.+-+......+
T Consensus       194 lGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  194 LGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             cchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999987 4556688888999999999999999999   99999999999999999999999999999887655443


Q ss_pred             c---ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          937 S---ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       937 ~---~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .   ...-...|+|||.+....++.++|||+|||++|||+| |+.||-....           ..+.+.+-++..-   .
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------~qIL~~iD~~erL---p  335 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------IQILKNIDAGERL---P  335 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------HHHHHhccccccC---C
Confidence            2   1223457999999999999999999999999999999 7888764332           1222222222222   2


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .++.+.+++++++..||..+|++|||+..+.+
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            23567788999999999999999999999864

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=320.82  Aligned_cols=243  Identities=24%  Similarity=0.354  Sum_probs=189.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...-||.|+||.||-|++. +.+.||+||+.-......  -.....+++.+..++|||++.+-|+|-.....|+|||||-
T Consensus        30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl  109 (948)
T KOG0577|consen   30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL  109 (948)
T ss_pred             HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence            3445899999999999876 678889999864433221  1223445666788899999999999998889999999996


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      | +-.|++.-.  .+++.+.++..|+.+.+.||+|||+.   +.||||||+.|||+++.|.||++|||.|....+.+   
T Consensus       110 G-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn---  180 (948)
T KOG0577|consen  110 G-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN---  180 (948)
T ss_pred             c-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence            6 778877533  34578889999999999999999999   99999999999999999999999999998776543   


Q ss_pred             cccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          937 SELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .++|||.|||||++.   .+.|+-|+||||+|++..|+...++|.-....+           ... +.+...-+|... 
T Consensus       181 -sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----------SAL-YHIAQNesPtLq-  246 (948)
T KOG0577|consen  181 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SAL-YHIAQNESPTLQ-  246 (948)
T ss_pred             -cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----------HHH-HHHHhcCCCCCC-
Confidence             478999999999975   567999999999999999999999984322211           111 112222222221 


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+.+..+..++..|+++-|.+|||.++++..
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            12344567788888999999999999998863

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-34  Score=327.56  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=192.0

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.||+|+||.||+|++.      .++.||+|+++.............++..+.++. ||||++++++|...++.++||||
T Consensus        43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~  122 (401)
T cd05107          43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEY  122 (401)
T ss_pred             hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEec
Confidence            46899999999999864      235799999975433332223445666677786 99999999999999999999999


Q ss_pred             cCCCCHHHHHhcccc-----------------------------------------------------------------
Q 045493          855 LERGSLATILSNEAT-----------------------------------------------------------------  869 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~-----------------------------------------------------------------  869 (1048)
                      +++|+|.+++++.+.                                                                 
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (401)
T cd05107         123 CRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYA  202 (401)
T ss_pred             cCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhh
Confidence            999999999965321                                                                 


Q ss_pred             ------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceE
Q 045493          870 ------------------------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH  919 (1048)
Q Consensus       870 ------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~k  919 (1048)
                                                    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~k  279 (401)
T cd05107         203 DIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVK  279 (401)
T ss_pred             hhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEE
Confidence                                          12367778899999999999999998   999999999999999999999


Q ss_pred             EeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccch
Q 045493          920 VSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      ++|||+++.......  ......++..|||||.+.+..++.++|||||||++|||++ |+.||.....           .
T Consensus       280 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-----------~  348 (401)
T cd05107         280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-----------N  348 (401)
T ss_pred             EEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-----------h
Confidence            999999986543221  1123456788999999998889999999999999999998 8888753211           1


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+........  +......+.+++.+||+.+|++||+++|+++.|++
T Consensus       349 ~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         349 EQFYNAIKRGYRMAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111111111111110  11223568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-34  Score=310.79  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=198.1

Q ss_pred             eecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|....    +..+++|.+..............++..+..++|+||+++++++......++||||+++|
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            48999999999998864    77889998876544332233455666778889999999999999999999999999999


Q ss_pred             CHHHHHhcccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          859 SLATILSNEAT------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       859 ~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      +|.+++.....      ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            99999976421      25689999999999999999999998   9999999999999999999999999999876544


Q ss_pred             C--CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          933 S--SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       933 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      .  .......++..|+|||.+....++.++||||+||++|||++ |+.||....           ...............
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----------~~~~~~~~~~~~~~~  227 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----------NEEVLEYLRKGYRLP  227 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----------HHHHHHHHHcCCCCC
Confidence            3  22234557889999999988889999999999999999999 688876431           111222222221111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .   ......++.+++.+||+.+|++|||+.|+++.|+
T Consensus       228 ~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 K---PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C---CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1   1223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.5e-34  Score=312.99  Aligned_cols=248  Identities=26%  Similarity=0.378  Sum_probs=191.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|... +++.+|+|++....... ......++..+..++||||+++++++...+..++||||+++|+
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~   92 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS   92 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccch-HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence            345899999999999875 67788888886433222 2234456677788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.++++..   ..+++..+..++.|++.|+.|||+.   +|+|||+||+||+++.++.+||+|||++..+..........
T Consensus        93 L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          93 LQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence            99998643   3478899999999999999999998   99999999999999999999999999998765433333445


Q ss_pred             ccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCC-CCchhHH
Q 045493          940 AGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP-PPLGEVE 1015 (1048)
Q Consensus       940 ~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1015 (1048)
                      .|++.|+|||.+.   ...++.++||||+||++|||++|+.||.........           ..+...... +......
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~  235 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----------FLMSKSNFQPPKLKDKT  235 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----------eeeecCCCCCCCCcccc
Confidence            7889999999874   345788999999999999999999997533211100           000011111 1111112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      .....+.+++.+||+.+|++|||++++++.+
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            2345688999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-34  Score=309.04  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=191.2

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||.||+|.++++..+|+|.+......  ......++..++.++||||+++++++...+..++||||+++++|.
T Consensus        10 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd05059          10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL   87 (256)
T ss_pred             hhhccCCCceEEEeEecCCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence            358999999999999887778999987543221  123345667778889999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc-cccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW-SELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~  940 (1048)
                      +++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++......... ....
T Consensus        88 ~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  162 (256)
T cd05059          88 NYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK  162 (256)
T ss_pred             HHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCC
Confidence            9996533  2578999999999999999999999   99999999999999999999999999998654322111 1122


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+..+..++.++||||+|+++||+++ |+.||+..+..           ......... .....  ......
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------~~~~~~~~~-~~~~~--~~~~~~  228 (256)
T cd05059         163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----------EVVESVSAG-YRLYR--PKLAPT  228 (256)
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----------HHHHHHHcC-CcCCC--CCCCCH
Confidence            3457999999998899999999999999999999 78887632211           111111111 11000  012345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+.+|++|||+.|+++.|.
T Consensus       229 ~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         229 EVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            6889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=327.49  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=202.3

Q ss_pred             cceeeecccccccEEEEEEc-CCC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+..+||+|+||+||+|.+- .++    +||+|++.+....+..++..++.-.|.++.|||+++++|+|.... ..+|++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34557899999999999764 333    578888877666655556666677788999999999999998666 889999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      ||+.|+|.+|++.++  ..+..+..+.|..|||+||.|||++   ++|||||.++|||+.+..++|++|||+|+...++.
T Consensus       778 ~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999998754  3477788999999999999999999   99999999999999999999999999999988776


Q ss_pred             CCcccccc--ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 SNWSELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .......|  .+.|||-|.+....|+.++|||||||++||++| |..|++..+           .+++..-+.++..   
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------~~eI~dlle~geR---  918 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------AEEIPDLLEKGER---  918 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------HHHhhHHHhcccc---
Confidence            65544433  457999999999999999999999999999999 888876433           2222222222221   


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+.-+..+++.++.+||..|+..||+++++.+.+.
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence            2223445667999999999999999999999998765

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=334.17  Aligned_cols=247  Identities=20%  Similarity=0.234  Sum_probs=185.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|+.. +++.||+|++.....  .........++..++.++||||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g   85 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG   85 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence            456899999999999875 678899998864321  11112234566667888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC---
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS---  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~---  934 (1048)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....   
T Consensus        86 g~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          86 GDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999653   3478889999999999999999999   999999999999999999999999999964321100   


Q ss_pred             --------------------------------------------CccccccccccccccccccCCCCchhhHHHHHHHHH
Q 045493          935 --------------------------------------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL  970 (1048)
Q Consensus       935 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~  970 (1048)
                                                                  .....+||+.|+|||++.+..++.++||||+||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999989999999999999999


Q ss_pred             HHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCC---CCCHHHHHHH
Q 045493          971 EVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDC---RPTMQKVCNL 1045 (1048)
Q Consensus       971 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~---RPt~~evl~~ 1045 (1048)
                      ||++|+.||.....           ......+.................++.+++.+|+. +|.+   |+|+.|+++.
T Consensus       240 elltG~~Pf~~~~~-----------~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         240 ECLIGWPPFCSENS-----------HETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhcCCCCCCCCCH-----------HHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999863221           11111111111000001111223457788889997 6666   4699998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.2e-34  Score=313.80  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=190.3

Q ss_pred             eeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|.+..      +..||+|.+..............++..++.++|+||+++++++.+.+..++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            3468999999999998864      4567778765433322222344456667889999999999999988899999999


Q ss_pred             cCCCCHHHHHhcccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEecccccc
Q 045493          855 LERGSLATILSNEAT----AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAK  927 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~  927 (1048)
                      +++|+|.+++...+.    ...+++..+.+++.||+.|++|||+.   +++||||||+||+++.++   .+|++|||+++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcccc
Confidence            999999999975432    23588999999999999999999999   999999999999998754   59999999998


Q ss_pred             ccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ........  ......+..|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----------~~~~~~~~~  236 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----------QEVMEFVTG  236 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHHHHc
Confidence            76322211  112233568999999998899999999999999999997 9999763221           111111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......   .......+.+++.+||+.+|++|||+.+|++.|.+
T Consensus       237 ~~~~~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         237 GGRLDP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            111110   11223568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-34  Score=316.88  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=192.8

Q ss_pred             cceeeecccccccEEEEEE-----cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv  851 (1048)
                      .....||+|+||+||++..     .+++.||+|.+.............++++.++.++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            3445789999999988653     256788999886543322223345567778889999999999988653  468999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++|+|.+++...    .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999998642    389999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-cCCC--cccccchhhhhhhccC
Q 045493          932 DSSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL-LSLP--APAANMNIVVNDLIDS 1005 (1048)
Q Consensus       932 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~-~~~~--~~~~~~~~~~~~~~~~ 1005 (1048)
                      ....   .....++..|+|||+..+..++.++||||||+++|||++|+.||...... ....  ...........+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            3221   12234566799999998888999999999999999999999997542211 0000  0000001111111111


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+.  .......+.+++.+||+.+|++|||+++++++|++
T Consensus       240 ~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         240 GMRLPC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             CCCCCC--CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            111110  12234578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.1e-34  Score=318.89  Aligned_cols=194  Identities=20%  Similarity=0.360  Sum_probs=157.3

Q ss_pred             eeeecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  855 (1048)
                      ...||+|+||+||+|+.+   +++.+|+|++.....   .....++++.+++++||||+++++++..  ....|+||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            346899999999999865   457789998864322   2234567788899999999999998854  45689999998


Q ss_pred             CCCCHHHHHhccc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE----CCCCceEEecccc
Q 045493          856 ERGSLATILSNEA------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL----DLEYKAHVSDFGT  925 (1048)
Q Consensus       856 ~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~  925 (1048)
                      .+ ++.+++....      ....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            65 8888875321      123478889999999999999999999   99999999999999    4567899999999


Q ss_pred             ccccCCCCC---CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          926 AKFLKPDSS---NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       926 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      ++.+.....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            987653322   22346789999999998764 589999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.8e-34  Score=309.24  Aligned_cols=254  Identities=20%  Similarity=0.303  Sum_probs=199.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|... +++.+|+|.++......  .......++..+++++|++|+++++++...+..++||||+++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence            346899999999999887 78899999886432221  122344566777888999999999999999999999999999


Q ss_pred             CCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          858 GSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       858 g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      |+|.+++.... ....+++.++..++.+++.|++|||+.   +|+||||||+||+++.++.++++|||.+..........
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~  163 (267)
T cd08224          87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA  163 (267)
T ss_pred             CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence            99999986432 234478899999999999999999998   99999999999999999999999999998765443333


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....+++.|+|||+..+..++.++||||+||++|+|++|+.||....         ...............++..  ...
T Consensus       164 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~--~~~  232 (267)
T cd08224         164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------MNLYSLCKKIEKCDYPPLP--ADH  232 (267)
T ss_pred             ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---------ccHHHHHhhhhcCCCCCCC--hhh
Confidence            44568899999999998889999999999999999999999975221         0111111122122222111  123


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+.+++.+||+.+|++|||+.+++++|++
T Consensus       233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         233 YSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence            44568899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.1e-34  Score=312.32  Aligned_cols=253  Identities=21%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ..||+|+||.||+|... +++.+|||++.......  .......++..++.++||||+++++++.+.+..++||||++++
T Consensus         8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   87 (267)
T cd08229           8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG   87 (267)
T ss_pred             hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence            45899999999999864 78899999876533221  1122344566678889999999999999999999999999999


Q ss_pred             CHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.++++... ....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++...........
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd08229          88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH  164 (267)
T ss_pred             CHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccc
Confidence            9999986422 234578999999999999999999999   999999999999999999999999999987654443334


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...++..|+|||+..+..++.++||||+|+++|||++|..||.....         ........+.....++..  ....
T Consensus       165 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~--~~~~  233 (267)
T cd08229         165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------NLYSLCKKIEQCDYPPLP--SDHY  233 (267)
T ss_pred             cccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---------hHHHHhhhhhcCCCCCCC--cccc
Confidence            55788999999999888899999999999999999999999752210         011111111111111111  1234


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+.+++.+||+.||++||||.+|++++++
T Consensus       234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         234 SEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             cHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            5578899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-34  Score=312.18  Aligned_cols=248  Identities=22%  Similarity=0.359  Sum_probs=187.0

Q ss_pred             eecccccccEEEEEEcC-CC--ceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELTS-GD--TRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~-~~--~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +||+|+||.||+|..++ +.  .+++|.++.............++..+.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            47999999999998864 33  35777765433222222344566667777 7999999999999999999999999999


Q ss_pred             CHHHHHhccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          859 SLATILSNEA-------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       859 ~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      +|.+++....             ....+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            9999996532             122478899999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          926 AKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       926 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      +...... ........+..|+|||++....++.++|||||||++|||++ |..||.....           ......+..
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----------~~~~~~~~~  226 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AELYEKLPQ  226 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----------HHHHHHHhC
Confidence            8632211 11111233567999999988889999999999999999997 9999753221           111111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......   .......+.+++.+||+.+|.+|||+.|+++.|.+
T Consensus       227 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         227 GYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCCCCC---CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            111111   11233468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.5e-34  Score=318.20  Aligned_cols=258  Identities=21%  Similarity=0.310  Sum_probs=192.3

Q ss_pred             eeeecccccccEEEEEEcC-----------------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee
Q 045493          781 MVLHGTGGCGTVYKAELTS-----------------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS  843 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-----------------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~  843 (1048)
                      ...||+|+||.||+|....                 +..||+|++..............+++.+.+++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3458999999999997653                 23478888765433322233445677788899999999999999


Q ss_pred             eCCeEEEEEEccCCCCHHHHHhccc--------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC
Q 045493          844 HTQHLFLVYEYLERGSLATILSNEA--------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE  915 (1048)
Q Consensus       844 ~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~  915 (1048)
                      ..+..++||||+++++|.+++.+..        ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~  166 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCC
Confidence            9899999999999999999996543        122588999999999999999999998   99999999999999999


Q ss_pred             CceEEeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCcccccccCCCcc
Q 045493          916 YKAHVSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE--GKHPGHFLSLLLSLPAP  991 (1048)
Q Consensus       916 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~p~~~~~~~~~~~~~  991 (1048)
                      +.++++|||.++.......  ......++..|+|||+..+..++.++|||||||++|||++  |..||.......     
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-----  241 (296)
T cd05051         167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-----  241 (296)
T ss_pred             CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-----
Confidence            9999999999986543321  1223456778999999988889999999999999999998  566764322100     


Q ss_pred             cccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          992 AANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                        ..........................++.+++.+||+.||++|||+.|+++.|++
T Consensus       242 --~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 --VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              0000000000001111011111223568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.1e-34  Score=308.54  Aligned_cols=245  Identities=25%  Similarity=0.331  Sum_probs=187.9

Q ss_pred             eecccccccEEEEEEc---CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|.++   +++.+|+|++....... .......++..++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            3799999999999653   56788999875433221 1122344566678889999999999885 45678999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--  936 (1048)
                      +|.+++...   ..+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||.++.........  
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999999643   2478899999999999999999998   99999999999999999999999999998765433211  


Q ss_pred             -cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          937 -SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       937 -~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                       ....++..|+|||.+....++.++|||||||++|||++ |+.||.....           ......+.....++..   
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~~~~~i~~~~~~~~~---  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----------NEVTQMIESGERMECP---  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHCCCCCCCC---
Confidence             12234578999999988889999999999999999998 9999763321           1111111111111111   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....++.+++.+||+.||++||++++|.+.|++
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            1233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-34  Score=309.70  Aligned_cols=245  Identities=25%  Similarity=0.338  Sum_probs=189.0

Q ss_pred             eecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|.+..    +..+|+|.+..............++..++.+.|+||+++++++. .+..++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            48999999999997642    25788888765433222233445566778889999999999876 45689999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....   .+++..+..++.|++.|++|||..   +++||||||+||+++.++.+||+|||.++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            9999997543   478999999999999999999998   9999999999999999999999999999876544332211


Q ss_pred             ---cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          939 ---LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       939 ---~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                         ..++..|+|||...+..++.++|||||||++||+++ |+.||...+.           ......+......+.   .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~---~  220 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIAMLESGERLPR---P  220 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----------HHHHHHHHcCCcCCC---C
Confidence               123467999999998899999999999999999998 9999763321           111111111111111   1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+.+++.+||+.+|++||++.++++.|++
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            2233568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5e-35  Score=334.70  Aligned_cols=248  Identities=19%  Similarity=0.249  Sum_probs=185.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|.+.....  .........++..+.+++|+||+++++++.+.+..|+||||++
T Consensus         5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (376)
T cd05598           5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (376)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence            3456899999999999876 578899998864321  1112234456777888999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC---
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS---  933 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~---  933 (1048)
                      +|+|.+++.+.+   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+....   
T Consensus        85 ~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          85 GGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            999999996533   477888899999999999999999   99999999999999999999999999975331000   


Q ss_pred             ----------------------------------------CCccccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 045493          934 ----------------------------------------SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI  973 (1048)
Q Consensus       934 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ell  973 (1048)
                                                              ......+||+.|||||++.+..++.++||||+||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                    0011347999999999999999999999999999999999


Q ss_pred             hCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 045493          974 EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRP---TMQKVCNL 1045 (1048)
Q Consensus       974 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~evl~~ 1045 (1048)
                      +|+.||......           .....+..................+.+++.+|+ .+|++|+   |+.|+++.
T Consensus       239 ~G~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPA-----------ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHH-----------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999998643211           001111111000000001112334566677765 4999999   88988753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=314.80  Aligned_cols=243  Identities=23%  Similarity=0.348  Sum_probs=195.1

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      .+|-|.||.||.|.|+ -.-.||||.++.....  ..++..+...|+.++|||+|+++|+|+....+|+|+|||..|+|.
T Consensus       274 KLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL  351 (1157)
T KOG4278|consen  274 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL  351 (1157)
T ss_pred             ccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence            4799999999999987 3567899988653322  123344556678899999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG  941 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  941 (1048)
                      +|+++.. ..+++.-..+.++.||..|++||..+   ++||||+.++|+|+.++..||++|||+++.+..+...  ...|
T Consensus       352 dYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT--AHAG  425 (1157)
T KOG4278|consen  352 DYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT--AHAG  425 (1157)
T ss_pred             HHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee--cccC
Confidence            9997653 34567777889999999999999999   9999999999999999999999999999998755432  2333


Q ss_pred             ---ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          942 ---TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       942 ---t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                         ...|.|||.+....++.|+|||+|||++||+.| |..||...+           ..+++.-+..+....   .++.+
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------lSqVY~LLEkgyRM~---~PeGC  491 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------LSQVYGLLEKGYRMD---GPEGC  491 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------HHHHHHHHhcccccc---CCCCC
Confidence               457999999998899999999999999999999 777765332           223332222221111   12345


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...++++|+.||++.|.+||+++|+-+.+|
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            567999999999999999999999988775

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-34  Score=314.96  Aligned_cols=251  Identities=20%  Similarity=0.328  Sum_probs=191.0

Q ss_pred             eeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|..++      +..||+|.+.............++...++.++||||+++++++.+....++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            3468999999999996542      3468888875433222222234455667888999999999999999999999999


Q ss_pred             cCCCCHHHHHhcccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          855 LERGSLATILSNEAT-------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      +++|+|.++++....       ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||+++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccc
Confidence            999999999965321       23356778899999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .........  ....++..|+|||+..++.++.++|||||||++|||++ |+.||....           ..........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----------~~~~~~~~~~  236 (288)
T cd05061         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----------NEQVLKFVMD  236 (288)
T ss_pred             cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHc
Confidence            654332211  12235678999999998889999999999999999999 788875321           1112222222


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +......   ......+.+++.+||+.||++|||+.++++.|.+
T Consensus       237 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         237 GGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             CCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2222111   1223568899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-35  Score=317.25  Aligned_cols=250  Identities=26%  Similarity=0.444  Sum_probs=194.3

Q ss_pred             eeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccc-hhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGI-NQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~-~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||+||+++... ++.+|+|.+.......... ....+...+++++||||+++++++.+....++||||++++
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~   83 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG   83 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence            3568999999999999874 4579999987654433221 1123566678889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++..   ...+++..+..++.|+++||++||+.   +|+||||||+||++++++.++|+|||.+............
T Consensus        84 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~  157 (260)
T PF00069_consen   84 SLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP  157 (260)
T ss_dssp             BHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred             cccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            99999973   33478999999999999999999999   9999999999999999999999999999865334444556


Q ss_pred             cccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..++..|+|||+.. +..++.++||||+|+++|+|++|+.||.....        .........................
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--------DDQLEIIEKILKRPLPSSSQQSREK  229 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--------HHHHHHHHHHHHTHHHHHTTSHTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc--------hhhhhhhhhcccccccccccccchh
Confidence            77899999999998 77889999999999999999999999774310        0011111111111100000000111


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            267899999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=328.39  Aligned_cols=241  Identities=22%  Similarity=0.246  Sum_probs=182.6

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHHHhhc---ccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSEITEI---RHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ||+|+||+||+|+.. +++.||+|++.........  .....+...+...   +||||+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999876 5788999988542211100  0111122223222   699999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++...   ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            9999998653   3478899999999999999999999   999999999999999999999999999976544334445


Q ss_pred             ccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ..+||+.|+|||++.+. .++.++||||+||++|||++|+.||....           .......+.......+..   .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~---~  220 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----------TQQMYRNIAFGKVRFPKN---V  220 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----------HHHHHHHHHcCCCCCCCc---c
Confidence            56799999999998764 47999999999999999999999986322           111122222222211111   1


Q ss_pred             HHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRP----TMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RP----t~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++||    ++.++++
T Consensus       221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            234567889999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=307.89  Aligned_cols=245  Identities=21%  Similarity=0.222  Sum_probs=194.3

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+....+||+||||.||.++.. +|+.||.|++.+..-..  .+.....+-.+++.++.+.||.+--+|+..+..++|+.
T Consensus       186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt  265 (591)
T KOG0986|consen  186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT  265 (591)
T ss_pred             ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence            3445668999999999999776 78999999885532221  12223344556688899999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      .|.||+|.-+|.+.+. ..+++.+++.++.+|+.||++||..   +||+||+||+|||+|++|+++|+|.|+|..+....
T Consensus       266 lMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  266 LMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             eecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999987765 4589999999999999999999999   99999999999999999999999999999887544


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      . .+..+||.+|||||++..+.|+..+|.||+||++|||+.|+.||.....        ....+.++..   ....+...
T Consensus       342 ~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr---~~~~~~ey  409 (591)
T KOG0986|consen  342 P-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRR---TLEDPEEY  409 (591)
T ss_pred             c-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHH---Hhcchhhc
Confidence            3 4455999999999999999999999999999999999999999874331        1111111111   11111122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCC
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRP 1037 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RP 1037 (1048)
                      .+..+++..+++...+++||++|.
T Consensus       410 ~~kFS~eakslc~~LL~Kdp~~RL  433 (591)
T KOG0986|consen  410 SDKFSEEAKSLCEGLLTKDPEKRL  433 (591)
T ss_pred             ccccCHHHHHHHHHHHccCHHHhc
Confidence            244556677777788999999986

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-34  Score=342.76  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=189.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|.+. +++.||+|++.......  ......++++.++.++||||+++++++.+.+..++||||++|
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG   86 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG   86 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence            456899999999999876 58899999986532221  112234456667888999999999999999999999999999


Q ss_pred             CCHHHHHhccc--------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          858 GSLATILSNEA--------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       858 g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      |+|.+++....        .....++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceec
Confidence            99999986421        122356778899999999999999999   9999999999999999999999999999866


Q ss_pred             CCCC------------------CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcc
Q 045493          930 KPDS------------------SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAP  991 (1048)
Q Consensus       930 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  991 (1048)
                      ....                  ......+||+.|||||++.+..++.++||||+||++|||+||+.||.......     
T Consensus       164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-----  238 (932)
T PRK13184        164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-----  238 (932)
T ss_pred             ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-----
Confidence            2111                  01123469999999999999999999999999999999999999986422100     


Q ss_pred             cccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhh
Q 045493          992 AANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRP-TMQKVCNLLC 1047 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~ 1047 (1048)
                       .   ........+...   ....+....+.+++.+|++.||++|| +++++++.|+
T Consensus       239 -i---~~~~~i~~P~~~---~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        239 -I---SYRDVILSPIEV---APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             -h---hhhhhccChhhc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             0   000011111000   01122334577899999999999996 5566655543

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.5e-34  Score=315.79  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=190.5

Q ss_pred             eeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..||+|+||.||+|....      ...+++|.+..............++..++.++||||+++++++...+..++||||+
T Consensus         6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (290)
T cd05045           6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA   85 (290)
T ss_pred             ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence            458999999999997642      24577777654332222223445666778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccc---------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC
Q 045493          856 ERGSLATILSNEA---------------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL  914 (1048)
Q Consensus       856 ~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~  914 (1048)
                      ++|+|.+++....                     ....+++.+++.++.|++.|++|||+.   +|+||||||+||++++
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~  162 (290)
T cd05045          86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE  162 (290)
T ss_pred             CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcC
Confidence            9999999986421                     123478899999999999999999998   9999999999999999


Q ss_pred             CCceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcc
Q 045493          915 EYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAP  991 (1048)
Q Consensus       915 ~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~  991 (1048)
                      ++.+||+|||+++........  .....++..|+|||+..+..++.++||||||+++|||++ |+.||.....       
T Consensus       163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------  235 (290)
T cd05045         163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-------  235 (290)
T ss_pred             CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-------
Confidence            999999999999865433221  122345678999999988889999999999999999999 9988753211       


Q ss_pred             cccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          992 AANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                          .... +..........  .......+.+++.+||+.+|++||+++|+++.|++
T Consensus       236 ----~~~~-~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         236 ----ERLF-NLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             ----HHHH-HHHhCCCCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                1111 11111111110  12234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.9e-34  Score=317.18  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=191.2

Q ss_pred             eeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...||+|+||.||+|....      ...+|+|.+..............++..+..+ +|+||+++++++...+..++|||
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e   96 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE   96 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence            4568999999999998652      2567888876533222222233455556677 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhcc-------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEE
Q 045493          854 YLERGSLATILSNE-------------ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV  920 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl  920 (1048)
                      |+++|+|.++++..             .....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|+
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL  173 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKI  173 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEe
Confidence            99999999999643             2234688999999999999999999998   9999999999999999999999


Q ss_pred             eccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchh
Q 045493          921 SDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNI  997 (1048)
Q Consensus       921 ~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  997 (1048)
                      +|||.++.+......  .....++..|+|||+..+..++.++|||||||++||+++ |..||....           ...
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----------~~~  242 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----------VEE  242 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-----------HHH
Confidence            999999876543221  122234568999999988889999999999999999998 888865321           111


Q ss_pred             hhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          998 VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .............   .......+.+++.+||+.||++||||+|+++.|+
T Consensus       243 ~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         243 LFKLLKEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence            1111111111111   1123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.5e-34  Score=309.95  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=192.4

Q ss_pred             ceeeecccccccEEEEEEcC-CC---ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELTS-GD---TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~-~~---~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|..+. ++   .+|+|++..............+++.++.++|+||+++++++...+..++||||+
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (268)
T cd05063           9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM   88 (268)
T ss_pred             EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence            34568999999999998763 33   578888754332222223345566678889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++++|.+++...  ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++.........
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          89 ENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            999999998643  24588999999999999999999999   9999999999999999999999999999866433221


Q ss_pred             cc---ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          936 WS---ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       936 ~~---~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ..   ....+..|+|||++.+..++.++||||+||++||+++ |+.||.....           ......+......+. 
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----------~~~~~~i~~~~~~~~-  231 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------HEVMKAINDGFRLPA-  231 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----------HHHHHHHhcCCCCCC-
Confidence            11   1123457999999998889999999999999999998 9999753221           111112211111111 


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                        .......+.+++.+||+.+|++||++.++++.|.+
T Consensus       232 --~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         232 --PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence              12234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.7e-34  Score=309.85  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=193.1

Q ss_pred             eecccccccEEEEEEcC--C--CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELTS--G--DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~--~--~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|.+.+  +  ..+|+|.+..............+++.+++++||||+++++++.. ...++||||+++|
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            47999999999998753  2  25788888664442222334556677788999999999999988 8899999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC---
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN---  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~---  935 (1048)
                      +|.+++.+... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++.+......   
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999976442 4589999999999999999999999   9999999999999999999999999999876543221   


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....++..|+|||+..+..++.++||||+||++|||++ |+.||.....           ..............  ...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~--~~~  223 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----------SQILKKIDKEGERL--ERP  223 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHhcCCcC--CCC
Confidence            122456788999999998899999999999999999999 9999753221           11111111110000  011


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+.+++.+||+.+|++|||++|+++.|+.
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            2234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=287.24  Aligned_cols=243  Identities=21%  Similarity=0.356  Sum_probs=191.2

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHh----hcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT----EIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~----~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .+|.|+.|.||+++.. ++...|||.+......+   +.++++..+.    .-.+|+||+.+|||..+..+++.||.|..
T Consensus        99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke---e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hhcCCCccceEEEEEcccceEEEEEeecccCCHH---HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            3799999999999887 57888999987655443   2333333332    22379999999999999999999999966


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                       .++..+++-  ..++++.-+-++...++.||.||.+++  +|+|||+||+|||+|+.|++|+||||++-++.++.. .+
T Consensus       176 -C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-ht  249 (391)
T KOG0983|consen  176 -CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-HT  249 (391)
T ss_pred             -HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-cc
Confidence             777777653  334777777899999999999999986  999999999999999999999999999987765433 34


Q ss_pred             cccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          938 ELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ..+|-+.|||||.+.-   ..|+..+||||||+.++|++||+.||...+.          ..+....+.+ ..|+.....
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----------dFe~ltkvln-~ePP~L~~~  318 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----------DFEVLTKVLN-EEPPLLPGH  318 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----------cHHHHHHHHh-cCCCCCCcc
Confidence            4578899999998864   3688999999999999999999999874331          2233444444 334444444


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+..+.+++..|+++|+.+||...++++.
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            4577889999999999999999999998863

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9e-34  Score=307.79  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=191.6

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|... .++.+|+|++......  ......+++.+..++|+||+++++++...+..++||||+++|+|
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (263)
T cd05052          12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL   89 (263)
T ss_pred             eecCCcccceEEEEEEecCCceEEEEEecCCchH--HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence            35899999999999876 4778888887543211  12334566677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-cccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  939 (1048)
                      .+++.... ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.+......... ....
T Consensus        90 ~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~  165 (263)
T cd05052          90 LDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  165 (263)
T ss_pred             HHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence            99996533 34478999999999999999999998   9999999999999999999999999999876433211 1122


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .++..|+|||+..+..++.++|||||||++|||++ |..||.....           ......... .....  ......
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----------~~~~~~~~~-~~~~~--~~~~~~  231 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------SQVYELLEK-GYRME--RPEGCP  231 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHHHHC-CCCCC--CCCCCC
Confidence            34568999999998899999999999999999998 8888753211           111111111 11111  012233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.+||+.+|++|||+.+++++|+.
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            568889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.9e-34  Score=315.91  Aligned_cols=251  Identities=22%  Similarity=0.340  Sum_probs=193.0

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...||+|+||.||+|...      .+..+|+|+++.............++..++++ +||||+++++++...+..++|||
T Consensus        40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  119 (302)
T cd05055          40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE  119 (302)
T ss_pred             cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence            346899999999999752      24468888876543322222345566777888 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++|+|.++++... ...+++.++..++.+++.|++|||+.   +|+||||||+||+++.++.++++|||.++......
T Consensus       120 ~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  195 (302)
T cd05055         120 YCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS  195 (302)
T ss_pred             cCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence            999999999996533 23378999999999999999999998   99999999999999999999999999998664332


Q ss_pred             CC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 SN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..  .....++..|+|||++.+..++.++||||+||++|||++ |+.||.....           .....+.........
T Consensus       196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~  264 (302)
T cd05055         196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-----------DSKFYKLIKEGYRMA  264 (302)
T ss_pred             ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-----------hHHHHHHHHcCCcCC
Confidence            21  122345678999999998899999999999999999998 9999753221           111111111111111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .  .......+.+++.+||+++|++|||+.|+++.|++
T Consensus       265 ~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         265 Q--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             C--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            0  11123468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-34  Score=310.07  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=184.5

Q ss_pred             eecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee-eCCeEEEEEEccCC
Q 045493          783 LHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS-HTQHLFLVYEYLER  857 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~  857 (1048)
                      .||+|+||.||+|.+.+    ...+|+|++..............+...++.++||||+++++++. .++..++||||+++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            47999999999998642    34688888754322222223334555667889999999999875 45568999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC---
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS---  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~---  934 (1048)
                      |+|.+++.+..  ...++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++.+.....   
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          82 GDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999996532  2357778899999999999999998   999999999999999999999999999976543211   


Q ss_pred             -CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          935 -NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK-HPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       935 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                       ......++..|+|||+..+..++.++|||||||++|||++|. .||....           ..........+...... 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-  224 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----------SFDITVYLLQGRRLLQP-  224 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----------HHHHHHHHhcCCCCCCC-
Confidence             112334577899999998888999999999999999999964 4543211           11112222222222111 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                        ......+.+++.+||+.+|++||++.|+++.|++
T Consensus       225 --~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         225 --EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             --CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence              1223468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.9e-34  Score=315.57  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=186.6

Q ss_pred             eeecccccccEEEEEEcC-CC--ceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELTS-GD--TRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~--~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .+||+|+||.||+|..++ +.  .+++|.++.............++..+.++ +||||+++++++...+..++||||+++
T Consensus         8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~   87 (297)
T cd05089           8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY   87 (297)
T ss_pred             eeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCC
Confidence            468999999999998764 33  35777765433222222334455666677 799999999999998999999999999


Q ss_pred             CCHHHHHhccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          858 GSLATILSNEA-------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       858 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      |+|.++++...             ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  164 (297)
T cd05089          88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFG  164 (297)
T ss_pred             CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcC
Confidence            99999996532             123478899999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhc
Q 045493          925 TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       925 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ++...... ........+..|+|||+..+..++.++|||||||++|||++ |+.||.....           ........
T Consensus       165 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----------~~~~~~~~  232 (297)
T cd05089         165 LSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----------AELYEKLP  232 (297)
T ss_pred             CCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHHHh
Confidence            98643211 11111223457999999998889999999999999999998 9999753221           11112221


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ........   ......+.+++.+||+.+|.+|||++++++.|+
T Consensus       233 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         233 QGYRMEKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             cCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111   123356889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-34  Score=314.35  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=193.4

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..||+|+||.||+|...      ++..+|+|.+..............++..++.++||||+++++++.+.+..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (288)
T cd05050          11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM   90 (288)
T ss_pred             ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence            35799999999999864      457788998865433222233445667778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccc-------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC
Q 045493          856 ERGSLATILSNEA-------------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY  916 (1048)
Q Consensus       856 ~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~  916 (1048)
                      ++|+|.+++....                   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~  167 (288)
T cd05050          91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM  167 (288)
T ss_pred             CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCC
Confidence            9999999996421                   122467888999999999999999998   999999999999999999


Q ss_pred             ceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccc
Q 045493          917 KAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAA  993 (1048)
Q Consensus       917 ~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  993 (1048)
                      .++++|||.+..+......  ......+..|+|||+..+..++.++|||||||++|||++ |..||....          
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~----------  237 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA----------  237 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----------
Confidence            9999999998765432211  122334668999999998899999999999999999998 888864221          


Q ss_pred             cchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          994 NMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       .......+.+....+..   .....++.+++.+||+.||++|||+.|+++.|+|
T Consensus       238 -~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 -HEEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             11222222222222111   1233568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-34  Score=315.54  Aligned_cols=264  Identities=22%  Similarity=0.362  Sum_probs=196.3

Q ss_pred             CCcceeeecccccccEEEEEE-----cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEE
Q 045493          777 FEGKMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLF  849 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~  849 (1048)
                      ++.....||+|+||.||+|+.     .++..||+|.++.............++..++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            344556689999999999974     256789999986544333333455667778899999999999998765  5689


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+++++|.+++.+..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999999986432  3478999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-ccCC--Cc-ccccchhhhhhh
Q 045493          930 KPDSSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSL-LLSL--PA-PAANMNIVVNDL 1002 (1048)
Q Consensus       930 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~-~~~~--~~-~~~~~~~~~~~~ 1002 (1048)
                      ......   .....++..|+|||+..+..++.++||||+||++||+++++.|+..... ....  +. ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            543221   1234567789999999888899999999999999999998876432110 0000  00 000011111111


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+...+.   .......+.+++.+||+.+|++|||++++++.++.
T Consensus       240 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         240 EEGKRLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HcCccCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11111111   12234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.9e-34  Score=313.91  Aligned_cols=245  Identities=24%  Similarity=0.387  Sum_probs=193.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...+|+|+||.||+|... +++.+++|.+....... ......++..++.++|+||+++++++....+.|+||||+++|+
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~  103 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS  103 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence            446899999999999865 67889999886533322 2234455667788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++.+.    .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.............
T Consensus       104 L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         104 LTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             HHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence            99998542    368889999999999999999999   99999999999999999999999999988665443333445


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .+++.|+|||+..+..++.++|||||||++|||++|+.||......          .........+. + ..........
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----------~~~~~~~~~~~-~-~~~~~~~~~~  244 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------RALYLIATNGT-P-ELQNPEKLSA  244 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----------HhHHHHhcCCC-C-CCCCccccCH
Confidence            7899999999999888999999999999999999999998632211          00111111111 1 1111123345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.+++.+||..+|++|||+.|+++.
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            68889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.3e-34  Score=316.02  Aligned_cols=257  Identities=21%  Similarity=0.317  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEcC-----------------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee
Q 045493          781 MVLHGTGGCGTVYKAELTS-----------------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS  843 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-----------------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~  843 (1048)
                      ...||+|+||.||+++..+                 ...+|+|++..............+++.++.++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            3458999999999986432                 23578888764432222233455677788899999999999999


Q ss_pred             eCCeEEEEEEccCCCCHHHHHhcccc--------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC
Q 045493          844 HTQHLFLVYEYLERGSLATILSNEAT--------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE  915 (1048)
Q Consensus       844 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~  915 (1048)
                      ..+..++||||+++|+|.+++.....        ...+++.++..++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~  166 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCC
Confidence            99999999999999999999965321        12467889999999999999999999   99999999999999999


Q ss_pred             CceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCcccccccCCCcc
Q 045493          916 YKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE--GKHPGHFLSLLLSLPAP  991 (1048)
Q Consensus       916 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~p~~~~~~~~~~~~~  991 (1048)
                      +.++++|||+++.+......  .....++..|+|||+..++.++.++|||||||++|||++  |..||.........   
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~---  243 (296)
T cd05095         167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI---  243 (296)
T ss_pred             CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH---
Confidence            99999999999865433211  122334678999999888889999999999999999998  66776532211000   


Q ss_pred             cccchhhhhhhcc-CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          992 AANMNIVVNDLID-SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       992 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       ............ ...+.+    ..+...+.+++.+||+.||++|||+.|+++.|++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         244 -ENTGEFFRDQGRQVYLPKP----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -HHHHHHHhhccccccCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             000000000000 011111    1123568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.2e-34  Score=309.80  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=192.1

Q ss_pred             eeeecccccccEEEEEEc-C---CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-S---GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~---~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|++. +   +..+|+|.++.............++..++.++||||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            346899999999999874 2   236888887643322222234455666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+..+.......
T Consensus        89 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd05066          89 NGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  163 (267)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence            999999996532  3578999999999999999999998   99999999999999999999999999998765433221


Q ss_pred             c---ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          937 S---ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       937 ~---~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .   ...++..|+|||++.+..++.++|||||||++||+++ |+.||.....           ......+.+....+.. 
T Consensus       164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~-  231 (267)
T cd05066         164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----------QDVIKAIEEGYRLPAP-  231 (267)
T ss_pred             eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----------HHHHHHHhCCCcCCCC-
Confidence            1   1223568999999998889999999999999999887 9999763321           1111111111111111 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                        ......+.+++.+||+.+|++||++.++++.|++
T Consensus       232 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         232 --MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              1223467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.4e-34  Score=311.87  Aligned_cols=247  Identities=20%  Similarity=0.351  Sum_probs=187.8

Q ss_pred             eeeecccccccEEEEEEc-CCC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ...||+|+||+||+|++. +++    .||+|.+..............+...+..++||||+++++++... ..+++|||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~   90 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLM   90 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcC
Confidence            456899999999999864 344    37888876443332223334455667788999999999999754 478999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.++++..  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        91 ~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          91 PYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            999999999653  23588999999999999999999999   9999999999999999999999999999876533222


Q ss_pred             c--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 W--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .  ....+++.|+|||...+..++.++|||||||++||+++ |..||+....           ......+......+.. 
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~-  233 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----------REIPDLLEKGERLPQP-  233 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHHHHCCCcCCCC-
Confidence            1  22234678999999998899999999999999999998 8888753211           1111111111111111 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                        ......+.+++.+||+.||++||++.|+++.|+
T Consensus       234 --~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         234 --PICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             --ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence              123456888999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.8e-34  Score=311.13  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=179.9

Q ss_pred             eecccccccEEEEEEcCC---CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELTSG---DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~---~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .||+|+||.||+|....+   ..+|+|.+.............+++..++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            379999999999976543   34666665433222222223345556677899999999999999999999999999999


Q ss_pred             HHHHHhcccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--C
Q 045493          860 LATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--N  935 (1048)
Q Consensus       860 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--~  935 (1048)
                      |.+++.....  ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........  .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999975432  22346778899999999999999999   999999999999999999999999999875433221  1


Q ss_pred             cccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccC--
Q 045493          936 WSELAGTCGYIAPELAYT-------MRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-- 1005 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1005 (1048)
                      .....++..|+|||+...       ..++.++||||+||++|||++ |..||......           .........  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----------~~~~~~~~~~~  227 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----------QVLKQVVREQD  227 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----------HHHHHHhhccC
Confidence            123345678999998643       356889999999999999999 77786532210           111111111  


Q ss_pred             -CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1006 -RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1006 -~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ..+.+ .........+.+++..|| .||++|||++||+++|.
T Consensus       228 ~~~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence             11111 011223345566777888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.3e-34  Score=313.80  Aligned_cols=248  Identities=23%  Similarity=0.409  Sum_probs=192.5

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..||+|+||.||+|...      +...+++|.+....... .....+++..++.++|+||+++++++...+..++||||+
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (291)
T cd05094          11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM   89 (291)
T ss_pred             eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH-HHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence            35899999999999753      23457777765432211 123445667778899999999999999999999999999


Q ss_pred             CCCCHHHHHhccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          856 ERGSLATILSNEA-------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       856 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                      ++++|.+++....             ....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.++|+|
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~d  166 (291)
T cd05094          90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGD  166 (291)
T ss_pred             CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECC
Confidence            9999999996532             123488999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhh
Q 045493          923 FGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVV  999 (1048)
Q Consensus       923 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ||+++.......  ......++..|+|||++.+..++.++||||+||++|||+| |+.||.....           ....
T Consensus       167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----------~~~~  235 (291)
T cd05094         167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----------TEVI  235 (291)
T ss_pred             CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHH
Confidence            999976543321  1223456788999999998899999999999999999999 9999753221           1111


Q ss_pred             hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+..+......   ......+.+++.+||+.+|++|||+++|+++|+
T Consensus       236 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         236 ECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             HHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            222222222111   123356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.7e-34  Score=330.82  Aligned_cols=257  Identities=20%  Similarity=0.221  Sum_probs=184.4

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC--------CeE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--------QHL  848 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--------~~~  848 (1048)
                      +.....||+|+||.||+|... +++.||||++....     ....+++..++.++||||+++++++...        ...
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            334567899999999999875 67899999885422     2234577788999999999999876431        246


Q ss_pred             EEEEEccCCCCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccc
Q 045493          849 FLVYEYLERGSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTA  926 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a  926 (1048)
                      ++||||+++ ++.+++... .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++ .+||+|||+|
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            799999986 777766432 2334588999999999999999999999   999999999999999764 7999999999


Q ss_pred             cccCCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcc----cccchhhhhh
Q 045493          927 KFLKPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAP----AANMNIVVND 1001 (1048)
Q Consensus       927 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~----~~~~~~~~~~ 1001 (1048)
                      +.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||............    ..........
T Consensus       219 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        219 KNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             hhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            8765332 22345789999999998764 6899999999999999999999998643221000000    0000000000


Q ss_pred             ----hccCCCCCCc-hhH-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1002 ----LIDSRLPPPL-GEV-----EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1002 ----~~~~~~~~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                          ..+..++... ...     .....++.+++.+||+.||++|||+.|+++
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                0000111000 000     112356889999999999999999999985

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.2e-34  Score=312.27  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=192.6

Q ss_pred             eeeecccccccEEEEEEcC-----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELTS-----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  854 (1048)
                      ..+||+|+||.||+|.+..     +..|++|++..............+...++.++|+||+++++++.. ....++++||
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~   90 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY   90 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence            3568999999999998875     677888887643322222333455666788899999999998765 5678999999


Q ss_pred             cCCCCHHHHHhccccc-----cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          855 LERGSLATILSNEATA-----AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +++|+|.+++......     ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++.+
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            9999999999654322     4588999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          930 KPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       930 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      .+....  .....++..|+|||++.+..++.++||||+||++||+++ |+.||......           .....+.+. 
T Consensus       168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------~~~~~~~~~-  235 (280)
T cd05043         168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-----------EMAAYLKDG-  235 (280)
T ss_pred             cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-----------HHHHHHHcC-
Confidence            433221  122345678999999988889999999999999999999 99998643211           111111111 


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....  .......+.+++.+||+.||++|||+.|+++.|+
T Consensus       236 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         236 YRLAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             CCCCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            11110  1122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-34  Score=316.35  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=191.0

Q ss_pred             eeecccccccEEEEEEc--------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          782 VLHGTGGCGTVYKAELT--------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ..||+|+||.||+|+..        ++..+|+|.+..............++..++.+ +||||+++++++......++||
T Consensus        21 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  100 (304)
T cd05101          21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV  100 (304)
T ss_pred             ceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEE
Confidence            46899999999999742        23468888876432222222344556667777 7999999999999999999999


Q ss_pred             EccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceE
Q 045493          853 EYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH  919 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~k  919 (1048)
                      ||+++|+|.+++.....             ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~k  177 (304)
T cd05101         101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMK  177 (304)
T ss_pred             ecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEE
Confidence            99999999999975421             23478889999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccch
Q 045493          920 VSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      |+|||.++.+......  .....+++.|+|||++.+..++.++||||||+++||+++ |..||....           ..
T Consensus       178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----------~~  246 (304)
T cd05101         178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------VE  246 (304)
T ss_pred             ECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----------HH
Confidence            9999999876433222  122345678999999988889999999999999999998 777764221           11


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....+........   .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       247 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         247 ELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            11111111111111   12334568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-34  Score=327.04  Aligned_cols=249  Identities=19%  Similarity=0.234  Sum_probs=187.7

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||.||+|+.. +++.+|+|.+......  .......++...++.++||||+++++++.+.+..|+||||+
T Consensus        46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~  125 (371)
T cd05622          46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  125 (371)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence            34556899999999999887 5678888887542211  11122344566677889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-  934 (1048)
                      ++|+|.++++..    .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       126 ~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         126 PGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            999999998642    367888899999999999999999   999999999999999999999999999987653322 


Q ss_pred             CccccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          935 NWSELAGTCGYIAPELAYTMR----ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .....+||+.|||||++.+..    ++.++||||+||++|||++|+.||...+.           ......+........
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~  267 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGTYSKIMNHKNSLT  267 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCccc
Confidence            223567999999999987543    78999999999999999999999864321           112222222111111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1045 (1048)
                      ..........+.+++.+|+..++.+  ||+++|+++.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111233456778888899844443  7899998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-34  Score=316.35  Aligned_cols=256  Identities=20%  Similarity=0.296  Sum_probs=188.9

Q ss_pred             eeecccccccEEEEEEcCC---------------CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC
Q 045493          782 VLHGTGGCGTVYKAELTSG---------------DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ  846 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~---------------~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~  846 (1048)
                      ..||+|+||.||+++....               ..||+|+++.............+++.++.++|+||+++++++...+
T Consensus        11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   90 (295)
T cd05097          11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD   90 (295)
T ss_pred             hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence            4589999999999976421               2478888865432222223455677788999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcccc---------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc
Q 045493          847 HLFLVYEYLERGSLATILSNEAT---------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK  917 (1048)
Q Consensus       847 ~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~  917 (1048)
                      ..++||||+++++|.+++.....         ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~  167 (295)
T cd05097          91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYT  167 (295)
T ss_pred             ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCc
Confidence            99999999999999999864321         12368889999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCcccccccCCCcccc
Q 045493          918 AHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE--GKHPGHFLSLLLSLPAPAA  993 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~  993 (1048)
                      +|++|||++.........  .....++..|+|||+..++.++.++|||||||++|||++  |..||......       .
T Consensus       168 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-------~  240 (295)
T cd05097         168 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-------Q  240 (295)
T ss_pred             EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-------H
Confidence            999999999765433211  122345678999999998889999999999999999998  55665532110       0


Q ss_pred             cchhhhhhhccCC-CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          994 NMNIVVNDLIDSR-LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       994 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..... ....... ..............+.+++.+||+.||++|||++++++.|++
T Consensus       241 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 VIENT-GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHH-HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            00000 0000000 000000001123468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-33  Score=306.36  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=191.3

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      +.||+|+||+||+|.+.++..||+|++......  ......++..++.++||||+++++++.+ ...++||||+++|+|.
T Consensus        12 ~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~   88 (262)
T cd05071          12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL   88 (262)
T ss_pred             eecCCCCCCcEEEEEecCCceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHH
Confidence            458999999999998887778999988653221  1234556677788899999999998754 5579999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  940 (1048)
                      +++.... ...+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.++|+|||.++.+...... .....
T Consensus        89 ~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~  164 (262)
T cd05071          89 DFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK  164 (262)
T ss_pred             HHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCc
Confidence            9997532 33478999999999999999999998   9999999999999999999999999999866533222 12334


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+..+..++.++||||+||++||+++ |+.||....           ............ ..+.  ......
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----------~~~~~~~~~~~~-~~~~--~~~~~~  230 (262)
T cd05071         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----------NREVLDQVERGY-RMPC--PPECPE  230 (262)
T ss_pred             ccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----------hHHHHHHHhcCC-CCCC--ccccCH
Confidence            6678999999988899999999999999999999 787875321           111111111111 1111  123445


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+++|++|||+++++++|+
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            6889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.5e-34  Score=313.21  Aligned_cols=249  Identities=24%  Similarity=0.400  Sum_probs=192.0

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..+|+|+||.||++...      ++..+|+|.+...... .......++..++.++||||+++++++...+..++||||+
T Consensus        11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (288)
T cd05093          11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN-ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   89 (288)
T ss_pred             cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH-HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence            35899999999999753      2345788877543221 1223455666778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          856 ERGSLATILSNEA----------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       856 ~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      ++|+|.+++...+          ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~  166 (288)
T cd05093          90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM  166 (288)
T ss_pred             CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCc
Confidence            9999999996543          123489999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhh
Q 045493          926 AKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       926 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ++........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----------~~~~~~i  235 (288)
T cd05093         167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----------NEVIECI  235 (288)
T ss_pred             cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHH
Confidence            9865433211  122345778999999998889999999999999999999 8888753221           1122222


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .........   .....++.+++.+||+.||.+|||+.|+.+.|++
T Consensus       236 ~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         236 TQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             HcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            222221111   1223468999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=9.8e-34  Score=309.34  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=187.5

Q ss_pred             eeecccccccEEEEEEcCCC---ceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          782 VLHGTGGCGTVYKAELTSGD---TRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~---~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      ..||+|+||.||+|.+....   .+|+|.+....... .......+...++.++|+||+++++++...      ...++|
T Consensus         5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v   84 (272)
T cd05075           5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI   84 (272)
T ss_pred             cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence            45899999999999876443   57888775432221 112234455667888999999999987432      246899


Q ss_pred             EEccCCCCHHHHHhccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          852 YEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      |||+++|+|.+++....   ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++.
T Consensus        85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccc
Confidence            99999999999874322   223478999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          929 LKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       929 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      +......  .....+++.|+|||+..+..++.++|||||||++|||++ |+.||.....           ......+..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~~~~~~~~  230 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----------SEIYDYLRQG  230 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHHHHcC
Confidence            6533221  122345678999999998899999999999999999999 7888753211           1111222222


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......   ......+.+++.+||+.||++|||+.|+++.|++
T Consensus       231 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLKQP---PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            111111   1233457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.9e-34  Score=315.98  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=189.3

Q ss_pred             eeeecccccccEEEEEEcC--------CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS--------GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ...||+|+||.||+|+...        ...+|+|.+..............++..++.+ +||||+++++++...+..|+|
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  102 (307)
T cd05098          23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  102 (307)
T ss_pred             eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            3458999999999997632        2458888886532222222233455566667 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          852 YEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      |||+++|+|.+++.....             ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus       103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~  179 (307)
T cd05098         103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM  179 (307)
T ss_pred             EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcE
Confidence            999999999999975432             23478999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccc
Q 045493          919 HVSDFGTAKFLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      ||+|||.++.........  ....++..|+|||+..+..++.++||||+||++|||++ |+.||....           .
T Consensus       180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----------~  248 (307)
T cd05098         180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V  248 (307)
T ss_pred             EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----------H
Confidence            999999997654322111  12234568999999988889999999999999999998 888865221           1


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...............   ......++.+++.+||+.+|++|||+.|+++.|.
T Consensus       249 ~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         249 EELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             HHHHHHHHcCCCCCC---CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence            111111111111111   1223456888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.8e-34  Score=312.45  Aligned_cols=259  Identities=22%  Similarity=0.250  Sum_probs=190.8

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.||+|... +++.||+|++......+ .......++..+..++||||+++++++.+++..|+||||++ ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (285)
T cd07861           6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD   84 (285)
T ss_pred             eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence            45899999999999876 68889999886533222 12234556777888999999999999999999999999997 58


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.............
T Consensus        85 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (285)
T cd07861          85 LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE  161 (285)
T ss_pred             HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCC
Confidence            999886554445689999999999999999999998   99999999999999999999999999997654333333344


Q ss_pred             ccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------C-cccccchhhhhhh---ccC
Q 045493          940 AGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------P-APAANMNIVVNDL---IDS 1005 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~-~~~~~~~~~~~~~---~~~ 1005 (1048)
                      .+++.|+|||++.+. .++.++||||+||++|||+||+.||.........         + ...+.......+.   ...
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (285)
T cd07861         162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK  241 (285)
T ss_pred             cccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccc
Confidence            678899999987654 4689999999999999999999998643211000         0 0000000000000   000


Q ss_pred             CCCC-CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1006 RLPP-PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1006 ~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .... ..........++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         242 WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000 00001112356778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.2e-34  Score=311.51  Aligned_cols=247  Identities=23%  Similarity=0.350  Sum_probs=187.9

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeC------CeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHT------QHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~------~~~~l  850 (1048)
                      .....||+|+||.||+|... +++.+|+|.+......  ......++..+.++ +|+||+++++++...      ...|+
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            33456899999999999876 5677888887543322  22344556666676 699999999998652      46899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999987532 23478999999999999999999999   99999999999999999999999999998665


Q ss_pred             CCCCCccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          931 PDSSNWSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ..........|+..|+|||++.     +..++.++||||+||++|||++|+.||.......          .........
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----------~~~~~~~~~  232 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----------ALFLIPRNP  232 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----------HHHHHhcCC
Confidence            4333444567899999999986     3457889999999999999999999986332110          000000011


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....   .......+.+++.+||+.+|++|||++|+++
T Consensus       233 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         233 APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            10000   1122346789999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-33  Score=305.76  Aligned_cols=247  Identities=20%  Similarity=0.370  Sum_probs=193.6

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|..++++.+|+|.+......  ......++..++.++|+||+++++++. .+..++||||+++|+|
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L   87 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSL   87 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCH
Confidence            3468999999999999888999999988653322  223455677778899999999999874 4568999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~  939 (1048)
                      .+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+........ .....
T Consensus        88 ~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          88 VDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            99986543 34578999999999999999999998   999999999999999999999999999986653222 12233


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .++..|+|||++.+..++.++||||||+++||+++ |+.||.....           ......+......+..   ....
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~~  229 (260)
T cd05067         164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----------PEVIQNLERGYRMPRP---DNCP  229 (260)
T ss_pred             cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHcCCCCCCC---CCCC
Confidence            45678999999998889999999999999999999 9999763221           1111111111111111   1223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .++.+++.+||+.+|++|||++++.++|+.
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.1e-34  Score=311.32  Aligned_cols=247  Identities=21%  Similarity=0.283  Sum_probs=188.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||.||+|.+. +++.||+|.+......+.......++..+++++||||+++++++...+..++||||+++|+
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   85 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS   85 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence            346899999999999875 6788999987643222222233455666778899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +..+.       .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++......  .....
T Consensus        86 l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          86 LDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             hHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            97653       257788899999999999999999   9999999999999999999999999999765432  23345


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .||..|+|||++.+..++.++||||+||++|||++|+.||...........    .............+...  ......
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~  227 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM----PLQLLQCIVDEDPPVLP--VGQFSE  227 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc----hHHHHHHHhccCCCCCC--CCcCCH
Confidence            789999999999988999999999999999999999999864221111110    01111111111111100  111234


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ++.+++.+||+.+|++||+++|+++.
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            57889999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.5e-34  Score=313.52  Aligned_cols=249  Identities=21%  Similarity=0.253  Sum_probs=191.8

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|... +++.||+|++........  ......++..++.++|++|+++++++.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            3456899999999999876 678899998865322211  1123345667788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.... ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||++....... ..
T Consensus        84 g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05630          84 GGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI  158 (285)
T ss_pred             CCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence            999999986433 23478899999999999999999998   99999999999999999999999999987654322 22


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....|+..|+|||++.+..++.++||||+||++|||++|+.||......        ................   ....
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~~---~~~~  227 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------IKREEVERLVKEVQEE---YSEK  227 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc--------chHHHHHhhhhhhhhh---cCcc
Confidence            3457899999999999989999999999999999999999998632110        0001111111110000   0112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||     ++|+++
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            2345788999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.5e-34  Score=315.85  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=189.4

Q ss_pred             eeeecccccccEEEEEEc--------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT--------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ...||+|+||.||+|+..        ....+|+|.+..............+++.++.+ +||||+++++++.+.+..++|
T Consensus        17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv   96 (314)
T cd05099          17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI   96 (314)
T ss_pred             eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence            346899999999999753        23457888876433222222234456666777 699999999999998999999


Q ss_pred             EEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          852 YEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      |||+++|+|.+++.....             ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+
T Consensus        97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~  173 (314)
T cd05099          97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVM  173 (314)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcE
Confidence            999999999999965321             23488999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccc
Q 045493          919 HVSDFGTAKFLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      ||+|||.++.........  ....++..|||||++.+..++.++||||+||++|||++ |+.||.....           
T Consensus       174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----------  242 (314)
T cd05099         174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-----------  242 (314)
T ss_pred             EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----------
Confidence            999999998664322211  12234467999999988889999999999999999999 8888753211           


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...............   ......++.+++.+||+.+|++|||+.|+++.|++
T Consensus       243 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         243 EELFKLLREGHRMDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            111111111111111   11223467789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-33  Score=307.61  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=190.6

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ......||+|+||.||+|.+. ++..|++|.+...... ......+++..++.++|+||+++++++...+..++|+||++
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            334457899999999999866 5677889887643322 12234556777788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +++|.+++.........++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+|||.+.........
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            999999997542221227788889999999999999998   9999999999999986 679999999999866543333


Q ss_pred             ccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 WSELAGTCGYIAPELAYTMR--ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      .....+++.|+|||++.+..  ++.++||||+|+++|++++|+.||......         .............+.   .
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~---~  233 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---------QAAMFKVGMFKIHPE---I  233 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---------hhhHhhhhhhccCCC---C
Confidence            34456889999999986644  788999999999999999999997532110         000000000011111   1


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......++.+++.+||+.+|++|||+.|+++.
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            12234568889999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.8e-34  Score=312.81  Aligned_cols=249  Identities=19%  Similarity=0.239  Sum_probs=191.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|.+. +++.+|+|++.......  .......+++.++.++|++|+++++++..++..++||||++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            3456899999999999876 67889999886532211  11223446677788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.... ...+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.+||+|||++...... ...
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  158 (285)
T cd05632          84 GGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESI  158 (285)
T ss_pred             CccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Ccc
Confidence            999999886533 23589999999999999999999998   9999999999999999999999999999765432 222


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....|+..|+|||++.+..++.++||||+||++||+++|+.||......       ................    ....
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-------~~~~~~~~~~~~~~~~----~~~~  227 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-------VKREEVDRRVLETEEV----YSAK  227 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhhhccccc----cCcc
Confidence            3457899999999999888999999999999999999999998632210       0001111111111111    0112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||     +.++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            3345788999999999999999     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.6e-34  Score=317.31  Aligned_cols=248  Identities=21%  Similarity=0.352  Sum_probs=186.5

Q ss_pred             eeecccccccEEEEEEc-CCC--ceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGD--TRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~--~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ..||+|+||.||+|.++ ++.  .+++|++..............++..+.++ +||||+++++++...+..|+||||+++
T Consensus        13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   92 (303)
T cd05088          13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   92 (303)
T ss_pred             eeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence            45899999999999875 343  34666665332222222334456667778 899999999999999999999999999


Q ss_pred             CCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          858 GSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       858 g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      |+|.++++..+.             ...+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg  169 (303)
T cd05088          93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  169 (303)
T ss_pred             CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccc
Confidence            999999965431             23578999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhc
Q 045493          925 TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       925 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.....           ........
T Consensus       170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~~~~~~~~  237 (303)
T cd05088         170 LSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AELYEKLP  237 (303)
T ss_pred             cCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-----------HHHHHHHh
Confidence            98643211 11111234668999999988889999999999999999998 9999753221           11111111


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .. ....  ........+.+++.+||+.+|++||+++++++.++
T Consensus       238 ~~-~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         238 QG-YRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             cC-CcCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11 1100  01122346789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-34  Score=328.33  Aligned_cols=243  Identities=22%  Similarity=0.309  Sum_probs=184.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|++.....  .+.......+...+..++||+|+++++++.+.+..|+||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            3457899999999999876 578899998864321  1112223445666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      +|+|.+++.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........  
T Consensus        85 gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          85 GGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999996533   478899999999999999999999   999999999999999999999999999875432110  


Q ss_pred             ---------------------------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          935 ---------------------------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       935 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                                                       .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                             01134799999999999999999999999999999999999999864


Q ss_pred             cccccCCCcccccchhhhhhhcc--C--CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 045493          982 LSLLLSLPAPAANMNIVVNDLID--S--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT---MQKVCN 1044 (1048)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 1044 (1048)
                      ...           ......+..  .  .+++..    ....++.+++.+|+ .||++|++   +.|+++
T Consensus       239 ~~~-----------~~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 ETP-----------QETYRKVMNWKETLVFPPEV----PISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCH-----------HHHHHHHHcCCCceecCCCC----CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            321           111111111  1  111111    12234566666665 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-33  Score=303.71  Aligned_cols=246  Identities=23%  Similarity=0.363  Sum_probs=191.7

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||.||+|....+..+|+|++......  ......+++.++.++|+|++++++++.. +..++||||+++|+|.
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~   88 (260)
T cd05069          12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLL   88 (260)
T ss_pred             eeecCcCCCeEEEEEEcCCceEEEEEcccCCcc--HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHH
Confidence            458999999999999887778999987543221  2234556777888999999999998854 5678999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~  940 (1048)
                      ++++... ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.++....... ......
T Consensus        89 ~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (260)
T cd05069          89 DFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK  164 (260)
T ss_pred             HHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCc
Confidence            9996532 33478999999999999999999998   999999999999999999999999999986643322 112334


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+..+..++.++||||+||++|||++ |+.||.....           ......+......+.   ......
T Consensus       165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~---~~~~~~  230 (260)
T cd05069         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----------REVLEQVERGYRMPC---PQGCPE  230 (260)
T ss_pred             cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCC---CcccCH
Confidence            5678999999988889999999999999999999 8888753211           111111111111111   123345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.+++.+||++||++||+++++++.|++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            68889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-33  Score=305.49  Aligned_cols=246  Identities=23%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||.||+|...++..+|+|++......  .....+++..++.++|++|+++++++.. ...++||||+++++|.
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~   88 (260)
T cd05070          12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLL   88 (260)
T ss_pred             heeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHH
Confidence            358999999999999888888999998654332  2234566777888999999999998854 5589999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  940 (1048)
                      ++++... ...+++.++..++.+++.|++|||+.   +|+||||||+||++++++.++++|||.+..+...... .....
T Consensus        89 ~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  164 (260)
T cd05070          89 DFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAK  164 (260)
T ss_pred             HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCC
Confidence            9996532 23478999999999999999999999   9999999999999999999999999999876433221 12233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+..+..++.++||||||+++|||++ |+.||.....           ......+... ...+.  ......
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----------~~~~~~~~~~-~~~~~--~~~~~~  230 (260)
T cd05070         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----------REVLEQVERG-YRMPC--PQDCPI  230 (260)
T ss_pred             CCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcC-CCCCC--CCcCCH
Confidence            5668999999988889999999999999999999 8888753221           1111222111 11111  123345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.+++.+||+++|++|||++++.+.|++
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            68899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=308.82  Aligned_cols=250  Identities=20%  Similarity=0.311  Sum_probs=191.4

Q ss_pred             eeecccccccEEEEEEcC----CCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCe------EEE
Q 045493          782 VLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQH------LFL  850 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~------~~l  850 (1048)
                      ..||+|+||.||+|....    +..+|+|+++....... ......++..++.++||||+++++++...+.      .++
T Consensus         5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05035           5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV   84 (273)
T ss_pred             cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence            458999999999998752    36799998865332221 1223445666788899999999998865544      799


Q ss_pred             EEEccCCCCHHHHHhccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          851 VYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      ||||+++|+|.+++....   ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.++
T Consensus        85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  161 (273)
T cd05035          85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK  161 (273)
T ss_pred             EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcccee
Confidence            999999999999985432   223588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .+.......  ....++..|+|||+..+..++.++||||+||++|||++ |..||....           ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----------~~~~~~~~~~  230 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----------NHEIYDYLRH  230 (273)
T ss_pred             eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHc
Confidence            765433221  12235678999999988889999999999999999999 888875322           1112222222


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +.....   .......+.+++.+||+.||++|||+.|+++.|++
T Consensus       231 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNRLKQ---PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCCCC---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            221111   12344578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.8e-34  Score=311.19  Aligned_cols=249  Identities=21%  Similarity=0.366  Sum_probs=191.1

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..+|+|+||.||+|...      ++..+|+|.+...... .......+++.++.++|+||+++++++.+.+..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (280)
T cd05092          11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-ARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM   89 (280)
T ss_pred             cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH-HHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence            35899999999999643      3456778876543222 1223455667778899999999999999999999999999


Q ss_pred             CCCCHHHHHhcccc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          856 ERGSLATILSNEAT------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                      ++|+|.+++.....            ...+++.++..++.|++.|++|||+.   +|+||||||+||++++++.+||+||
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~df  166 (280)
T cd05092          90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDF  166 (280)
T ss_pred             CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCC
Confidence            99999999975432            13478999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhh
Q 045493          924 GTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       924 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      |+++........  .....+++.|+|||+..+..++.++|||||||++|||++ |+.||.....           .....
T Consensus       167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~~~  235 (280)
T cd05092         167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-----------TEAIE  235 (280)
T ss_pred             CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-----------HHHHH
Confidence            999765432211  122335678999999999899999999999999999998 8888753221           11111


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+......   ......+.+++.+||+.||++||+++|+++.|++
T Consensus       236 ~~~~~~~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQGRELERP---RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHcCccCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            12121111111   1223457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-33  Score=304.40  Aligned_cols=249  Identities=21%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||.++.. +++.+++|++...... ........++..+++++|+||+++++++.+.+..++||||+++
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (256)
T cd08221           4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG   83 (256)
T ss_pred             EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCC
Confidence            3457899999999999765 5788899987644322 2122344566778889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++.... ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+...........
T Consensus        84 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          84 GTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             CcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999997543 34578999999999999999999998   999999999999999999999999999987654443444


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...+++.|+|||+..+..++.++||||+|+++|||++|+.||....           .......+..+...+..   ...
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------~~~~~~~~~~~~~~~~~---~~~  225 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----------PLNLVVKIVQGNYTPVV---SVY  225 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHcCCCCCCc---ccc
Confidence            5678999999999988888999999999999999999999975321           11222222233322221   233


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      ...+.+++.+||+.+|++||+++|+++.+
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            45688899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.5e-34  Score=314.44  Aligned_cols=258  Identities=18%  Similarity=0.235  Sum_probs=190.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|+.. +++.||+|.+..............++..++.++||||+++++++...+..++||||++ ++
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~   89 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   89 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence            346899999999999876 5788999988654333333344567777889999999999999999999999999997 48


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.............
T Consensus        90 l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (301)
T cd07873          90 LKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE  164 (301)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence            999886532  3478899999999999999999999   99999999999999999999999999997654333333445


Q ss_pred             ccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhh-hhhhccCCCC
Q 045493          940 AGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIV-VNDLIDSRLP 1008 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~-~~~~~~~~~~ 1008 (1048)
                      .+++.|+|||++.+. .++.++||||+||++|||++|+.||...+...         ..+....+.... .........+
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (301)
T cd07873         165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP  244 (301)
T ss_pred             ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence            678999999988654 47889999999999999999999986433110         000000000000 0000000011


Q ss_pred             CCc-----hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1009 PPL-----GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1009 ~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...     .........+.+++.+|++.||.+|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000     000112345788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-33  Score=324.48  Aligned_cols=252  Identities=19%  Similarity=0.190  Sum_probs=186.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|.+. .++.||+|....       .....+++.+++++|+|||++++++...+..++|||++. ++
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~  245 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD  245 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence            446899999999999886 467788885321       123467788899999999999999999999999999995 68


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--Ccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--NWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~  937 (1048)
                      |.+++...  ...+++..+..++.|++.||+|||+.   +||||||||+|||++.++.+||+|||+++.......  ...
T Consensus       246 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        246 LYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            98888543  23589999999999999999999999   999999999999999999999999999987643322  123


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhh-----------------
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVN----------------- 1000 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 1000 (1048)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..|+...................+.                 
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            457999999999999999999999999999999999988664221100000000000000000                 


Q ss_pred             --hh----ccCCCC----CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 --DL----IDSRLP----PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 --~~----~~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        ..    .....+    +.+.........+.+++.+||+.||++|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence              00    000000    0011111222367889999999999999999999975

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-33  Score=307.55  Aligned_cols=246  Identities=26%  Similarity=0.382  Sum_probs=189.4

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|+.. +++.||+|.++...... .....+++..++.++||||+++++++...+..++||||+++|+|
T Consensus        15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L   93 (267)
T cd06645          15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL   93 (267)
T ss_pred             HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcH
Confidence            35799999999999875 57788888876443222 12234556677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++...+   .+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+..............
T Consensus        94 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  167 (267)
T cd06645          94 QDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI  167 (267)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccccc
Confidence            99986533   478999999999999999999999   999999999999999999999999999876654433344567


Q ss_pred             cccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC-CCCchhHHH
Q 045493          941 GTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL-PPPLGEVEE 1016 (1048)
Q Consensus       941 gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1016 (1048)
                      |+..|+|||++.   ...++.++||||+||++|||++|+.||.......           .......... ++.......
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06645         168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------ALFLMTKSNFQPPKLKDKMK  236 (267)
T ss_pred             CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----------hHHhhhccCCCCCcccccCC
Confidence            899999999874   4568899999999999999999999975322100           0000000111 111111111


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....+.+++.+||+.+|++|||++++++.
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            23457889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-33  Score=306.68  Aligned_cols=248  Identities=25%  Similarity=0.456  Sum_probs=190.7

Q ss_pred             eeeecccccccEEEEEEcC-CC---ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GD---TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~---~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|.... ++   .||+|.+..............++..++.++||||+++++++......++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            3468999999999998763 32   5899988654322222234455666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...  ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+..........
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          89 NGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             CCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence            99999998653  23588999999999999999999998   99999999999999999999999999987654332211


Q ss_pred             ---cccc--cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccC-CCCC
Q 045493          937 ---SELA--GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-RLPP 1009 (1048)
Q Consensus       937 ---~~~~--gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1009 (1048)
                         ....  .+..|+|||++.+..++.++||||+||++||+++ |..||.....           ......+... ..+.
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----------~~~~~~i~~~~~~~~  232 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------QDVINAIEQDYRLPP  232 (269)
T ss_pred             ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----------HHHHHHHHcCCcCCC
Confidence               1111  2457999999998899999999999999999887 9999753221           1111111111 1111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +    .+....+.+++.+||+.+|++||++.+++++|++
T Consensus       233 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         233 P----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             c----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1    2233457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.4e-34  Score=312.79  Aligned_cols=244  Identities=24%  Similarity=0.393  Sum_probs=192.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|.+. +++.||+|.+..............++..++.++||||+++++++......++||||+++++
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS   88 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence            345899999999999875 5677888887643333322344566777788999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++..    ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++++|||++.............
T Consensus        89 L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          89 ALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            9999853    3478899999999999999999998   99999999999999999999999999998765443333445


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||.......           .... .....++..  ......
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------~~~~-~~~~~~~~~--~~~~~~  227 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----------VLFL-IPKNSPPTL--EGQYSK  227 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----------HHhh-hhcCCCCCC--CcccCH
Confidence            68889999999998889999999999999999999999975322110           0001 111111111  112345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.+++.+||+.+|++|||+.|+++.
T Consensus       228 ~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         228 PFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHh
Confidence            68899999999999999999999873

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-33  Score=305.01  Aligned_cols=236  Identities=25%  Similarity=0.359  Sum_probs=182.8

Q ss_pred             eecccccccEEEEEEcCCC-----------ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          783 LHGTGGCGTVYKAELTSGD-----------TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~-----------~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      .||+|+||.||+|.+....           .+++|.+......  .....+++..++.++||||+++++++.. ...++|
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4799999999999887433           3556655433221  3344556677788999999999999987 778999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-------ceEEeccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-------KAHVSDFG  924 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-------~~kl~DfG  924 (1048)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++       .+|++|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999975432  578899999999999999999998   999999999999999887       79999999


Q ss_pred             cccccCCCCCCccccccccccccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhh
Q 045493          925 TAKFLKPDSSNWSELAGTCGYIAPELAYTM--RANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       925 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .+.....    .....++..|+|||++.+.  .++.++||||+||++||+++ |..||.....           ......
T Consensus       154 ~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----------~~~~~~  218 (259)
T cd05037         154 IPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----------SEKERF  218 (259)
T ss_pred             ccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----------hhHHHH
Confidence            9986543    2234567789999998876  78999999999999999999 5677653211           011111


Q ss_pred             hccC-CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1002 LIDS-RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1002 ~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .... ..+.+.      ...+.+++.+||..+|++|||+.|+++.|.
T Consensus       219 ~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 YQDQHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HhcCCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111 111111      157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-33  Score=303.87  Aligned_cols=248  Identities=27%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....+|+|+||.||+|... +++.+++|.+...... .......++..++.++||||+++++++...+..|++|||++++
T Consensus         7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~   85 (262)
T cd06613           7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence            3456899999999999876 5677888887654332 2234455667778899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+............
T Consensus        86 ~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          86 SLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             cHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            999998653  23478899999999999999999998   9999999999999999999999999999876544333445


Q ss_pred             cccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCC-CCchhH
Q 045493          939 LAGTCGYIAPELAYTM---RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP-PPLGEV 1014 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1014 (1048)
                      ..++..|+|||...+.   .++.++||||+||++|||++|+.||......           ............ ......
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~  229 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-----------RALFLISKSNFPPPKLKDK  229 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhccCCCccccch
Confidence            6788899999998876   7899999999999999999999997643211           001111111111 111112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+||+.+|.+|||+++++.
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            334456889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=304.94  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||.||+|... +++++|+|.+........    .....+++..+++++||||+++++++.+.+..++||||
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   85 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY   85 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence            3456899999999999875 688999998865432211    11234456667888999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++++|.+++....   .+++..+..++.|++.|+.|||+.   +|+||||+|+||++++++.++|+|||.++.......
T Consensus        86 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          86 MPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             CCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            99999999986543   378888999999999999999999   999999999999999999999999999976543221


Q ss_pred             C---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 N---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      .   .....++..|+|||++.+..++.++||||+|+++||+++|+.||......           .............. 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~-  227 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----------AAIFKIATQPTNPQ-  227 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----------HHHHHHhccCCCCC-
Confidence            1   13356788999999999988999999999999999999999997532110           11111111111111 


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ........+.+++.+||+.+|++|||+.|+++.
T Consensus       228 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 -LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             112334567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.9e-34  Score=335.46  Aligned_cols=247  Identities=24%  Similarity=0.433  Sum_probs=193.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC-------------
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT-------------  845 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-------------  845 (1048)
                      ...++|+||||.||+++.+ +|+.|||||+.-...........+++..+++++|||||++|..+.+.             
T Consensus       483 EL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~  562 (1351)
T KOG1035|consen  483 ELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD  562 (1351)
T ss_pred             HHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence            3457899999999999988 99999999997765433334456678888999999999997432000             


Q ss_pred             --------------------------------------------------------------------------------
Q 045493          846 --------------------------------------------------------------------------------  845 (1048)
Q Consensus       846 --------------------------------------------------------------------------------  845 (1048)
                                                                                                      
T Consensus       563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~  642 (1351)
T KOG1035|consen  563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL  642 (1351)
T ss_pred             hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence                                                                                            


Q ss_pred             --------------------------CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 045493          846 --------------------------QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP  899 (1048)
Q Consensus       846 --------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  899 (1048)
                                                ...|+-||||+...+++++++.....  .....++++++|++|++|+|+.   |
T Consensus       643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~---g  717 (1351)
T KOG1035|consen  643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ---G  717 (1351)
T ss_pred             CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC---c
Confidence                                      01478899999988888886543211  3567899999999999999999   9


Q ss_pred             eEeeCCCCCCeEECCCCceEEeccccccccC------------------CCCCCccccccccccccccccccCC---CCc
Q 045493          900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLK------------------PDSSNWSELAGTCGYIAPELAYTMR---ANE  958 (1048)
Q Consensus       900 iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~---~~~  958 (1048)
                      ||||||||.||++|+++.|||+|||+|+...                  ++....+..+||.-|+|||++.+..   |+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999998722                  0111335678999999999987654   999


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC
Q 045493          959 KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038 (1048)
Q Consensus       959 ~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 1038 (1048)
                      |+|+||+|||++||+.   ||.          ..+..........++.+|.+.....+....=..+|++++++||.+|||
T Consensus       798 KiDmYSLGIVlFEM~y---PF~----------TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFG----------TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCC----------chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence            9999999999999986   443          344455667777777777663334445555667888999999999999


Q ss_pred             HHHHHH
Q 045493         1039 MQKVCN 1044 (1048)
Q Consensus      1039 ~~evl~ 1044 (1048)
                      |.|++.
T Consensus       865 A~eLL~  870 (1351)
T KOG1035|consen  865 ATELLN  870 (1351)
T ss_pred             HHHHhh
Confidence            999985

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.9e-33  Score=307.63  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=194.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|.+. +++.+|+|.+..............++..++.++||||+++++++.+....++||||+++|
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            3445899999999999876 578889988764332222233445566678889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++..    ..+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++............
T Consensus        88 ~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          88 SALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999864    2378888999999999999999998   9999999999999999999999999999876544333344


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......           ..... .....++.  ......
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----------~~~~~-~~~~~~~~--~~~~~~  226 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----------RVLFL-IPKNNPPT--LTGEFS  226 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----------hHhhh-hhcCCCCC--Cchhhh
Confidence            56888999999998888999999999999999999999997632211           00111 11111111  123445


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            678899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-33  Score=318.94  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=188.3

Q ss_pred             ceeeecccccccEEEEEE------cCCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeee-CCeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAEL------TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSH-TQHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~------~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~-~~~~~lv  851 (1048)
                      ..+.||+|+||.||+|.+      .+++.||||+++.............++..+.++ +||||+++++++.. ....++|
T Consensus        11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (343)
T cd05103          11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (343)
T ss_pred             ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence            344689999999999974      246789999986543322222334456666777 68999999998865 4567999


Q ss_pred             EEccCCCCHHHHHhcccc--------------------------------------------------------------
Q 045493          852 YEYLERGSLATILSNEAT--------------------------------------------------------------  869 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~--------------------------------------------------------------  869 (1048)
                      |||+++|+|.+++.....                                                              
T Consensus        91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T cd05103          91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED  170 (343)
T ss_pred             EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence            999999999999864210                                                              


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--cccccccccc
Q 045493          870 --AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGY  945 (1048)
Q Consensus       870 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y  945 (1048)
                        ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++.........  .....++..|
T Consensus       171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  247 (343)
T cd05103         171 LYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  247 (343)
T ss_pred             hhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence              12367888899999999999999999   9999999999999999999999999999865433221  1223456789


Q ss_pred             ccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHH
Q 045493          946 IAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAV 1024 (1048)
Q Consensus       946 ~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1024 (1048)
                      +|||++.+..++.++||||+|+++|||++ |..||.....          .......+.........   ......+.++
T Consensus       248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~---~~~~~~~~~~  314 (343)
T cd05103         248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------DEEFCRRLKEGTRMRAP---DYTTPEMYQT  314 (343)
T ss_pred             ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----------cHHHHHHHhccCCCCCC---CCCCHHHHHH
Confidence            99999988889999999999999999997 8888753211          00111111111111111   1122458899


Q ss_pred             HHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1025 AFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1025 ~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +.+||+.||++|||+.|+++.|++
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHH
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-33  Score=311.28  Aligned_cols=258  Identities=22%  Similarity=0.291  Sum_probs=184.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHH---hhcccCceeeEeeEeee-----CCeEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEI---TEIRHRNIVKFYGFCSH-----TQHLFL  850 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l---~~l~h~niv~~~~~~~~-----~~~~~l  850 (1048)
                      ...||+|+||+||+|+.. +++.||+|.+........ ......++..+   ..++||||+++++++..     ....++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            346899999999999886 578899998865332221 11222334444   44579999999998854     345899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++ ++.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        85 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          85 VFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             EEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            9999985 8988886532 23478999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchh--hh
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNI--VV  999 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~--~~  999 (1048)
                      .. .......||..|+|||++.+..++.++||||+||++|||++|+.||.......         ..+........  ..
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         160 CQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             Cc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            32 22234568999999999998899999999999999999999999985432110         00000000000  00


Q ss_pred             hhhccCCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1000 NDLIDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1000 ~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+..+... .........+.+++.+|++.||++|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000000000 011123356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.6e-33  Score=304.73  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=194.6

Q ss_pred             eeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|.... ++.+++|.+.....   .....++++.++.++||||+++++++......|+++||+++++
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   84 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS   84 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence            3458999999999998874 78889998754322   2345566677788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++....  ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||.+.............
T Consensus        85 L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          85 VSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             HHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            999986432  3578999999999999999999999   99999999999999999999999999998765443333445


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||........           .... ................
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----------~~~~-~~~~~~~~~~~~~~~~  227 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----------IFMI-PNKPPPTLSDPEKWSP  227 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----------hhhh-ccCCCCCCCchhhcCH
Confidence            688999999999988899999999999999999999999864321110           0000 0011111111223345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhc
Confidence            6888999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-33  Score=313.12  Aligned_cols=257  Identities=20%  Similarity=0.266  Sum_probs=191.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|.+. ++..+|+|.+..............+++.+.+++||||+++++++...+..++||||+++|
T Consensus         5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~   84 (308)
T cd06615           5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   84 (308)
T ss_pred             EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence            3456899999999999876 567777787754322222223445667778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.++++..   ..+++..+..++.|++.|+.|||+.+  +++||||||+||+++.++.+|++|||++......  ....
T Consensus        85 ~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~  157 (308)
T cd06615          85 SLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS  157 (308)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--cccc
Confidence            999999754   34788999999999999999999742  8999999999999999999999999998765322  2234


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC------CCcccc-------------------
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS------LPAPAA-------------------  993 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~------~~~~~~-------------------  993 (1048)
                      ..|+..|+|||+..+..++.++||||+||++|||++|+.||........      ......                   
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            5789999999999888899999999999999999999999853221000      000000                   


Q ss_pred             cchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          994 NMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..............+ .. .......++.+++.+||+.+|++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         238 AIFELLDYIVNEPPP-KL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hHHHHHHHHhcCCCc-cC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000111111000 00 001134468899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-33  Score=292.72  Aligned_cols=247  Identities=20%  Similarity=0.232  Sum_probs=195.8

Q ss_pred             eeeecccccccEEEEEEcC-CCceeeEEeccCCCCccc--chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIG--INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|.-|+||.++..+ +..+|+|++.+.......  .....+..+++.+.||.++.+|+.++.++..|+|||||+|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG  161 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG  161 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence            4468999999999999874 478899998764332211  1223344556788999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC------
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP------  931 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~------  931 (1048)
                      |+|....+++. ...+++..++.++.+++.||+|||..   |||+||+||+||||.++|++.|+||.++.....      
T Consensus       162 GdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~  237 (459)
T KOG0610|consen  162 GDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK  237 (459)
T ss_pred             ccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence            99999987654 45689999999999999999999998   999999999999999999999999998743211      


Q ss_pred             -C-------------------------C-C-----------------------CccccccccccccccccccCCCCchhh
Q 045493          932 -D-------------------------S-S-----------------------NWSELAGTCGYIAPELAYTMRANEKCD  961 (1048)
Q Consensus       932 -~-------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D  961 (1048)
                       .                         . .                       ....++||-.|.|||++.+...+.++|
T Consensus       238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD  317 (459)
T KOG0610|consen  238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD  317 (459)
T ss_pred             cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence             0                         0 0                       001246899999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC---
Q 045493          962 VFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT--- 1038 (1048)
Q Consensus       962 vws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt--- 1038 (1048)
                      .|+|||++|||+.|+.||...+           ..+.+..++......+..  ...+..+.++|++.|.+||++|.-   
T Consensus       318 WWtfGIflYEmLyG~TPFKG~~-----------~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~r  384 (459)
T KOG0610|consen  318 WWTFGIFLYEMLYGTTPFKGSN-----------NKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKR  384 (459)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCC-----------chhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhcccc
Confidence            9999999999999999987433           334444454444333221  245567889999999999999997   


Q ss_pred             -HHHHHH
Q 045493         1039 -MQKVCN 1044 (1048)
Q Consensus      1039 -~~evl~ 1044 (1048)
                       |+|+-+
T Consensus       385 GA~eIK~  391 (459)
T KOG0610|consen  385 GAAEIKR  391 (459)
T ss_pred             chHHhhc
Confidence             777654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.4e-36  Score=327.04  Aligned_cols=367  Identities=28%  Similarity=0.475  Sum_probs=241.4

Q ss_pred             cCCCCCCEeeCCCCccc-cCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCc
Q 045493           45 SHLSKLKHLDFSTNQFS-GIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLV  123 (1048)
Q Consensus        45 ~~l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~  123 (1048)
                      +.|+..+-.|+++|.++ +..|......+.++.|-|...++. .+|+.++.+.+|++|.+++|++. .+-+.++.|+.|+
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            44556677777777777 667777777777888888877777 46777888888888888888877 5566677777888


Q ss_pred             eEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCccc
Q 045493          124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI  203 (1048)
Q Consensus       124 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~  203 (1048)
                      .+.+..|++...                                      -+|..+..|+.|+.|||++|++. ..|..+
T Consensus        82 sv~~R~N~LKns--------------------------------------GiP~diF~l~dLt~lDLShNqL~-EvP~~L  122 (1255)
T KOG0444|consen   82 SVIVRDNNLKNS--------------------------------------GIPTDIFRLKDLTILDLSHNQLR-EVPTNL  122 (1255)
T ss_pred             HHhhhccccccC--------------------------------------CCCchhcccccceeeecchhhhh-hcchhh
Confidence            888877776521                                      23444555566666666666665 555556


Q ss_pred             ccccccceeccccccccccCCc-cCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhh
Q 045493          204 GNLRSLSYLGLNKNQLSGSIPP-TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLK  282 (1048)
Q Consensus       204 ~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~  282 (1048)
                      ..-+++-+|+||+|+|. .+|. .|-+|+.|-+|||++|++. .+|+.+..+..|+.|.|++|++....-..+..+++|+
T Consensus       123 E~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~  200 (1255)
T KOG0444|consen  123 EYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLS  200 (1255)
T ss_pred             hhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhh
Confidence            66666666666666665 3333 3346666666666666665 4555666666666666666665533333444455566


Q ss_pred             hhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCC
Q 045493          283 HLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVN  362 (1048)
Q Consensus       283 ~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N  362 (1048)
                      .|++++.++-...+|.++..+.+|..+|++.|.+. .+|+.+.++.+|+.|+|++|+|+ .+........+|++|+||.|
T Consensus       201 vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrN  278 (1255)
T KOG0444|consen  201 VLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRN  278 (1255)
T ss_pred             hhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccc
Confidence            66666554444456666666777777777777766 56677777777777777777766 34445555667777777777


Q ss_pred             ccccCcChhhhccCCCcEEEeeccccc-CCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCC
Q 045493          363 KLNGSIPHCLGNLSNLKFFALRENELS-GSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIP  441 (1048)
Q Consensus       363 ~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  441 (1048)
                      +++ .+|++++.|++|+.|.+.+|+++ .-+|+.++.+..|+.+...+|.+. .+|..+|.+..|+.|.|+.|.+. ..|
T Consensus       279 QLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLP  355 (1255)
T KOG0444|consen  279 QLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLP  355 (1255)
T ss_pred             hhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-ech
Confidence            776 66777777777777777777665 245667777777777777666664 56666777777777777776665 356


Q ss_pred             CCcccccccceeEecCCc
Q 045493          442 RSLQNCTSLYSLRLERNQ  459 (1048)
Q Consensus       442 ~~l~~l~~L~~L~L~~n~  459 (1048)
                      +.+.-++.|..|++..|.
T Consensus       356 eaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  356 EAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             hhhhhcCCcceeeccCCc
Confidence            666666667777776664

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-33  Score=319.04  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=186.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      ....||+|+||.||+|... +++.||+|++...... .......+++..++.++||||+++++++...      ...|+|
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  104 (359)
T cd07876          25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV  104 (359)
T ss_pred             EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence            3456899999999999875 5789999998654222 1122334566677888999999999998643      357999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++ ++.+.+..     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       105 ~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         105 MELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             EeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            999976 56666532     267888999999999999999999   999999999999999999999999999976432


Q ss_pred             CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Cccccc----chhhhh
Q 045493          932 DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAAN----MNIVVN 1000 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~----~~~~~~ 1000 (1048)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+....+       ..+...    ......
T Consensus       176 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         176 N-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             C-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            2 2234457899999999999999999999999999999999999999744321100       000000    000000


Q ss_pred             hhccC--CCCC--------------CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDS--RLPP--------------PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~--~~~~--------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....  ..+.              ...........+.+++.+||+.||++|||++|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00000  0000              000001123467899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-33  Score=302.96  Aligned_cols=246  Identities=24%  Similarity=0.433  Sum_probs=194.8

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||.||+|...+++.+|+|.+......  .....+++..++.++|+||+++++++......++||||+++++|.
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   89 (261)
T cd05034          12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL   89 (261)
T ss_pred             eeeccCcceEEEEEEEcCCceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence            458999999999999888888999988653322  223456677788899999999999999888999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~  940 (1048)
                      +++.... ...+++.++..++.+++.|++|||+.   +++||||||+||+++.++.+|++|||.+........ ......
T Consensus        90 ~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  165 (261)
T cd05034          90 DFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAK  165 (261)
T ss_pred             HHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccC
Confidence            9996532 23588999999999999999999999   999999999999999999999999999986643211 112233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCC-CCCCchhHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR-LPPPLGEVEEKL 1018 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 1018 (1048)
                      ++..|+|||...+..++.++||||+||++||+++ |+.||....           .......+.... .+.+    ....
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~----~~~~  230 (261)
T cd05034         166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----------NREVLEQVERGYRMPRP----PNCP  230 (261)
T ss_pred             CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHcCCCCCCC----CCCC
Confidence            4568999999998889999999999999999999 999975321           111122222111 1111    1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            468899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-33  Score=308.00  Aligned_cols=249  Identities=23%  Similarity=0.356  Sum_probs=191.1

Q ss_pred             eecccccccEEEEEEcC-------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELTS-------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~-------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .||+|+||.||+|+..+       ++.+|+|.+..............++..++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            47999999999998753       24678887754332222233455667778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccc----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-----ceEEeccccc
Q 045493          856 ERGSLATILSNEA----TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-----KAHVSDFGTA  926 (1048)
Q Consensus       856 ~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-----~~kl~DfG~a  926 (1048)
                      ++|+|.+++....    ....+++.++..++.|++.|++|||+.   +++||||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999996532    123478899999999999999999998   999999999999999877     8999999999


Q ss_pred             cccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhc
Q 045493          927 KFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       927 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ........  ......++..|+|||++.++.++.++|||||||++|||++ |+.||.....           ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----------~~~~~~~~  227 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------QEVLQHVT  227 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----------HHHHHHHh
Confidence            76543221  1122345678999999999899999999999999999998 9999753221           11111111


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .......   .......+.+++.+||+.+|++||+++++++.|++
T Consensus       228 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGGRLQK---PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCccCC---cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1111111   12234568899999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-33  Score=309.88  Aligned_cols=245  Identities=25%  Similarity=0.401  Sum_probs=193.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||.|+||.||+|... +++.||+|.+....... ......++..++.++||||+++++++...+..++|+||+++|
T Consensus        23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch-HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence            3456899999999999864 68899999886433222 223345666778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...    .+++.++..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||++............
T Consensus       102 ~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655         102 SLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            999998542    378999999999999999999999   9999999999999999999999999998876544433444


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..++..|+|||.+.+..++.++|||||||++|++++|+.||...+...           ......... .+.........
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----------~~~~~~~~~-~~~~~~~~~~~  242 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----------ALYLIATNG-TPELQNPEKLS  242 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------HHHHHHhcC-CcccCCcccCC
Confidence            578899999999998889999999999999999999999986432110           011111111 11111112234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.+++.+||..||++|||+.+++.
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            46788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=307.18  Aligned_cols=243  Identities=26%  Similarity=0.394  Sum_probs=193.8

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||.|+||.||+|... +++.+|+|.+..............++..++.++|+||+++++++.+....|+|+||+++++|
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (274)
T cd06609           7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC   86 (274)
T ss_pred             hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence            35799999999999876 57889999886543222223345566677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++...    .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.++.............
T Consensus        87 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (274)
T cd06609          87 LDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV  159 (274)
T ss_pred             HHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence            9998643    578999999999999999999998   999999999999999999999999999987765434444567


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      +++.|+|||+..+..++.++||||+||++|||+||+.||......           .....+... .++.... ......
T Consensus       160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----------~~~~~~~~~-~~~~~~~-~~~~~~  226 (274)
T cd06609         160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----------RVLFLIPKN-NPPSLEG-NKFSKP  226 (274)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----------HHHHHhhhc-CCCCCcc-cccCHH
Confidence            889999999999888999999999999999999999998632210           111111111 1111111 113446


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +.+++.+||+.+|++|||++++++
T Consensus       227 ~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         227 FKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhh
Confidence            888999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-33  Score=301.23  Aligned_cols=245  Identities=22%  Similarity=0.362  Sum_probs=192.5

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..||+|+||.||+|.+.+++.+|+|++......  ......+++.++.++||+|+++++++......++||||+++|+|.
T Consensus        10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (256)
T cd05112          10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS   87 (256)
T ss_pred             eeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence            458999999999998877888999988643322  223455677788899999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~  940 (1048)
                      +++....  ..++++.+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||.++........ .....
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  162 (256)
T cd05112          88 DYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK  162 (256)
T ss_pred             HHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence            9986432  3478899999999999999999998   9999999999999999999999999998765432211 12233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++.+|+|||+..++.++.++||||+|+++||+++ |+.||.....           ................   .....
T Consensus       163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~~~  228 (256)
T cd05112         163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----------SEVVETINAGFRLYKP---RLASQ  228 (256)
T ss_pred             cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----------HHHHHHHhCCCCCCCC---CCCCH
Confidence            5678999999998889999999999999999998 8999753211           1111111111111000   11235


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+.+|++|||+.|++++|.
T Consensus       229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         229 SVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            6889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-33  Score=301.66  Aligned_cols=247  Identities=24%  Similarity=0.353  Sum_probs=192.8

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      .||+|+||.||+|...+++.||+|++......+.......++..++.+.|+||+++++++......++||||+++++|.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            47999999999999877899999988654333222344556677788899999999999999999999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--cccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SELA  940 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~  940 (1048)
                      ++....  ..+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||.+..........  ....
T Consensus        82 ~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          82 FLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            996532  3478889999999999999999999   99999999999999999999999999997654221111  1123


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||++.++.++.++||||+||++|||+| |..||.....           . .............  .......
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----------~-~~~~~~~~~~~~~--~~~~~~~  222 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----------Q-QTRERIESGYRMP--APQLCPE  222 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----------H-HHHHHHhcCCCCC--CCccCCH
Confidence            3567999999988889999999999999999999 7888653221           0 1111111111111  1122345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.+++.+||+.+|++|||+.|+++.|..
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            68899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-33  Score=308.75  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||+||+|... +++.+|+|++..............++..++.++||||+++++++......++||||+++|+|
T Consensus        11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (284)
T cd06620          11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL   90 (284)
T ss_pred             HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence            45899999999999876 57778888776543333233345566677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++...   ..+++..+..++.+++.|+.|||+..  +++||||||+||+++.++.++|+|||++......  ......
T Consensus        91 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~~~  163 (284)
T cd06620          91 DRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADTFV  163 (284)
T ss_pred             HHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCccc
Confidence            9998653   34789999999999999999999742  8999999999999999999999999998754322  122457


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      |+..|+|||++.+..++.++||||+||++||+++|+.||............................+...  .......
T Consensus       164 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  241 (284)
T cd06620         164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--SSDFPED  241 (284)
T ss_pred             cCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--chhcCHH
Confidence            89999999999888899999999999999999999999874332111000000011112222222111111  1224456


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.+++.+||+.||++|||++|++++
T Consensus       242 ~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         242 LRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcC
Confidence            8899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-33  Score=301.93  Aligned_cols=244  Identities=26%  Similarity=0.391  Sum_probs=193.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|... ++.||+|++.....  .......++..++.++|+||+++++++.+.+..++||||+++++|
T Consensus        11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   87 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL   87 (256)
T ss_pred             eeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence            346899999999999876 88899999865433  122344566677888999999999999988999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .++++... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.++.......   ...
T Consensus        88 ~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~  160 (256)
T cd05039          88 VDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGK  160 (256)
T ss_pred             HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---cCC
Confidence            99996543 23589999999999999999999999   999999999999999999999999999987632211   233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||++.++.++.++||||+|+++||+++ |+.||.....           ....... .......  .......
T Consensus       161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~-~~~~~~~--~~~~~~~  226 (256)
T cd05039         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDVVPHV-EKGYRME--APEGCPP  226 (256)
T ss_pred             CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHHH-hcCCCCC--CccCCCH
Confidence            4668999999988889999999999999999997 9988753211           1111111 1111110  0122345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.+++.+||+.+|++|||+.|++++|++
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            68899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.7e-33  Score=302.01  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=194.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~  857 (1048)
                      ...+|+|+||.||++..+ +++.+|+|++....... .......++..+++++|+|++++++.+.. ....++||||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG   84 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence            346899999999999876 56789999986433221 12234455666788899999999998764 4468999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      ++|.+++.... ...+++.++..++.+++.|++|||+.   +|+||||||+||+++.++.++|+|||++...........
T Consensus        85 ~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          85 GDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             CcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            99999997532 33478999999999999999999999   999999999999999999999999999987654444444


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...+++.|+|||+..+..++.++||||+||++||+++|+.||...+           .............+..   ....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----------~~~~~~~~~~~~~~~~---~~~~  226 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----------MNSLVYRIIEGKLPPM---PKDY  226 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----------HHHHHHHHHhcCCCCC---cccc
Confidence            5678999999999999899999999999999999999999976321           1111222222222221   1234


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+.+++.+||+.+|++|||+.++++.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            4578899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-33  Score=309.25  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=187.7

Q ss_pred             eeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|.... +..+++|.+..... ........++..++.++||||+++++++...+..++||||+++|+|
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l   89 (282)
T cd06643          11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV   89 (282)
T ss_pred             hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence            358999999999998874 56667777643321 1122234456677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      ..++.+.  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+|++|||++..............
T Consensus        90 ~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  164 (282)
T cd06643          90 DAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI  164 (282)
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence            9987542  23588999999999999999999999   999999999999999999999999999976544333334557


Q ss_pred             cccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          941 GTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       941 gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ++..|+|||++.     +..++.++||||+||++|||++|+.||.....           ............+. .....
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~~-~~~~~  232 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSEPPT-LAQPS  232 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----------HHHHHHHhhcCCCC-CCCcc
Confidence            899999999874     44578899999999999999999999763221           11111111111110 00111


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....+.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            233568899999999999999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-33  Score=307.27  Aligned_cols=260  Identities=22%  Similarity=0.349  Sum_probs=189.9

Q ss_pred             eeeecccccccEEEEEEc-----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  853 (1048)
                      ...||+|+||+||+|...     +++.||+|++....... ......+++.++.++||||+++++++..  ....++|||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   87 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME   87 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHH-HHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence            346899999999999743     57789999986543221 2234556777888999999999998743  346899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++|+|.+++.+..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          88 YLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             ecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            999999999996432  3478999999999999999999999   99999999999999999999999999998765433


Q ss_pred             CCc---cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-CCcccc---cchhhhhhhccCC
Q 045493          934 SNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-LPAPAA---NMNIVVNDLIDSR 1006 (1048)
Q Consensus       934 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~ 1006 (1048)
                      ...   ....++..|+|||+..+..++.++||||+||++|||++|..|+........ ......   .......+.....
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            211   112234569999999988899999999999999999998877542211000 000000   0000011111111


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+  ........+.+++.+||+.+|++||||+|+++.|++
T Consensus       243 ~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         243 GRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             CcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            1111  012233568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-33  Score=321.54  Aligned_cols=258  Identities=19%  Similarity=0.244  Sum_probs=188.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCC-----eEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQ-----HLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e  853 (1048)
                      ...||+|+||.||+|... +++.||+|++....... ......+++..++.++||||+++++++...+     ..|+|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            346899999999999875 68899999886432211 1122345566678889999999999998766     7899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+.+ +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~~-~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          85 LMQS-DLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             cccc-CHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9974 888887543   3488999999999999999999999   99999999999999999999999999998654332


Q ss_pred             -CCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccc---hhhh
Q 045493          934 -SNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANM---NIVV  999 (1048)
Q Consensus       934 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~---~~~~  999 (1048)
                       .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...+...         +.+......   ....
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence             223345678999999998874 47899999999999999999999986543210         000000000   0000


Q ss_pred             hhhccCCCCCCc-h----hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1000 NDLIDSRLPPPL-G----EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1000 ~~~~~~~~~~~~-~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+......++. .    .......++.+++.+|++.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            011111111100 0    001124568899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-33  Score=314.72  Aligned_cols=258  Identities=20%  Similarity=0.290  Sum_probs=186.4

Q ss_pred             eeccc--ccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTG--GCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G--~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +||+|  +||+||++..+ +++.||+|++...... .......++...++.++||||+++++++..++..++||||+++|
T Consensus         5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~   84 (327)
T cd08227           5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG   84 (327)
T ss_pred             hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCC
Confidence            57888  78899999775 6788999998654322 22223445666677889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC---
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN---  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~---  935 (1048)
                      +|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.........   
T Consensus        85 ~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          85 SAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999996432 23478999999999999999999998   9999999999999999999999999876443221111   


Q ss_pred             ----cccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC--------Ccccccchhhhhh
Q 045493          936 ----WSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL--------PAPAANMNIVVND 1001 (1048)
Q Consensus       936 ----~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 1001 (1048)
                          .....++..|+|||++.+  ..++.++||||+||++|||++|+.||.........        +..........++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence                122346778999999876  45899999999999999999999998643211000        0000000000000


Q ss_pred             h--------cc-----C-----CCC-----CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1002 L--------ID-----S-----RLP-----PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1002 ~--------~~-----~-----~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .        .+     .     ..+     ............+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0        00     0     000     000011223457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.1e-33  Score=301.33  Aligned_cols=242  Identities=25%  Similarity=0.360  Sum_probs=188.3

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee-eCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS-HTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|... +..+|+|.+.....   ......++..+++++|+|++++++++. .....++||||+++|+|
T Consensus        12 ~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L   87 (256)
T cd05082          12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   87 (256)
T ss_pred             eeecccCCCeEEEEEEc-CCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence            45899999999999876 78889998754321   223455677778899999999999764 45678999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .++++... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.+.......   ....
T Consensus        88 ~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~  160 (256)
T cd05082          88 VDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGK  160 (256)
T ss_pred             HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---CCCc
Confidence            99997543 23478999999999999999999998   99999999999999999999999999987643322   2234


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ++..|+|||+..+..++.++||||+||++|||++ |+.||.....           ......+... ....  .......
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------~~~~~~~~~~-~~~~--~~~~~~~  226 (256)
T cd05082         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDVVPRVEKG-YKMD--APDGCPP  226 (256)
T ss_pred             cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHhcC-CCCC--CCCCCCH
Confidence            5668999999998889999999999999999998 8988753211           1111111111 1111  0122345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.+++.+||+.+|++|||+.++++.|++
T Consensus       227 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         227 VVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            68889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-34  Score=306.87  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=192.8

Q ss_pred             CcceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +...+.||+||.+.||++...+.+.||+|++....... ...-...|+..+.++ .|.+||++++|-..++..||||||-
T Consensus       363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G  442 (677)
T KOG0596|consen  363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG  442 (677)
T ss_pred             hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence            34455689999999999999888999999886544332 222334555556666 4999999999999999999999987


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +. +|..+++..... ..+| .++.+.+||+.|+.++|..   ||||.|+||.|+|+- .|.+||+|||+|..+..+...
T Consensus       443 d~-DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  443 DI-DLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cc-cHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            65 999999764432 2334 6788999999999999999   999999999999995 689999999999988766543


Q ss_pred             --ccccccccccccccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh
Q 045493          936 --WSELAGTCGYIAPELAYTMR-----------ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       936 --~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                        ....+||+.|||||.+....           .+.++||||+|||+|+|+.|+.||....          .....+..+
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----------n~~aKl~aI  585 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----------NQIAKLHAI  585 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----------HHHHHHHhh
Confidence              34568999999999886543           4578999999999999999999987432          123344455


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .++.-..++....+ ..+++++|..||+.||.+|||..|+++.
T Consensus       586 ~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  586 TDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            55533222211111 1238899999999999999999999863

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.9e-33  Score=303.74  Aligned_cols=250  Identities=25%  Similarity=0.396  Sum_probs=195.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||+||+|... ++..+|+|++.............+++..++.++|+||+++++.+...+..++|||++++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS   85 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence            445899999999999875 5678888887644333323344556667788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC----
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN----  935 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~----  935 (1048)
                      |.++++.......+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||.+..+......    
T Consensus        86 l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  162 (267)
T cd06610          86 LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV  162 (267)
T ss_pred             HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence            999997644435688999999999999999999998   9999999999999999999999999999776543322    


Q ss_pred             ccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc--h
Q 045493          936 WSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL--G 1012 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 1012 (1048)
                      .....|+..|+|||++... .++.++||||+||++|||++|+.||.......           ...+......+...  .
T Consensus       163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~  231 (267)
T cd06610         163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----------VLMLTLQNDPPSLETGA  231 (267)
T ss_pred             cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----------hHHHHhcCCCCCcCCcc
Confidence            1334688999999998876 78999999999999999999999986432211           11111111111100  0


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ........+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            01234466889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-33  Score=311.00  Aligned_cols=193  Identities=20%  Similarity=0.368  Sum_probs=155.9

Q ss_pred             eeecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee--eCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS--HTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~  856 (1048)
                      ..||+|+||+||+|+..   ++..||+|++.....   .....+++..++.++||||+++++++.  .....++||||++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            46899999999999875   346789998764322   223456777888999999999999884  3567899999987


Q ss_pred             CCCHHHHHhccc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE----CCCCceEEeccccc
Q 045493          857 RGSLATILSNEA------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL----DLEYKAHVSDFGTA  926 (1048)
Q Consensus       857 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a  926 (1048)
                      + ++.+++....      ....+++..+..++.|++.||.|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 7888774321      223478889999999999999999999   99999999999999    45679999999999


Q ss_pred             cccCCCCC---CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          927 KFLKPDSS---NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       927 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      +.......   ......||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            87654322   22345789999999998764 579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-33  Score=301.55  Aligned_cols=238  Identities=22%  Similarity=0.326  Sum_probs=180.0

Q ss_pred             eecccccccEEEEEEcCC-------------CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEE
Q 045493          783 LHGTGGCGTVYKAELTSG-------------DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLF  849 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~-------------~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~  849 (1048)
                      .||+|+||.||+|.....             ..+++|.+..... .......++...+..++||||+++++++......+
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            479999999999975421             2467776544322 22223344556678889999999999999988999


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc-------eEEec
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK-------AHVSD  922 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~-------~kl~D  922 (1048)
                      +||||+++|+|..++...  ...+++..+.+++.||+.|++|||+.   +|+||||||+||+++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999998643  23478899999999999999999998   9999999999999987664       89999


Q ss_pred             cccccccCCCCCCccccccccccccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCcccccccCCCcccccchhhhh
Q 045493          923 FGTAKFLKPDSSNWSELAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       923 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ||.+......    ....++..|+|||++. +..++.++|||||||++|||+ +|+.||......            ...
T Consensus       156 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------------~~~  219 (262)
T cd05077         156 PGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------------EKE  219 (262)
T ss_pred             CCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------------HHH
Confidence            9998755322    2345788999999886 466899999999999999998 578876532110            001


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      ...........    ....++.+++.+||+.||++||++.++++.+
T Consensus       220 ~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            11111111111    1124578899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.3e-33  Score=304.10  Aligned_cols=252  Identities=22%  Similarity=0.288  Sum_probs=177.2

Q ss_pred             eecccccccEEEEEEcCCCc---eeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELTSGDT---RAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~---vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .||+|+||.||+|+..++..   +++|.+.............+++..++.++||||++++++|.+....|+||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            37999999999997654443   344444332222212223344455677899999999999999999999999999999


Q ss_pred             HHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--CCc
Q 045493          860 LATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNW  936 (1048)
Q Consensus       860 L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  936 (1048)
                      |.+++++... ....++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++.......  ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999975432 23456777889999999999999998   99999999999999999999999999986432221  112


Q ss_pred             ccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCC
Q 045493          937 SELAGTCGYIAPELAYT-------MRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ....++..|+|||+...       ..++.++|||||||++|||++ |..||.........   ............++...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL---NHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHhhcccccCCCccC
Confidence            34567889999998753       245789999999999999997 46676432210000   00000000011111111


Q ss_pred             CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1009 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .      .....+.+++..|| .+|++||+++|+++.|.
T Consensus       236 ~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 L------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             C------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1      12345677888899 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-33  Score=309.58  Aligned_cols=248  Identities=22%  Similarity=0.304  Sum_probs=191.1

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|... +++.+|+|.+..............++..+.+++|+||+++++++...+..++||||+++++|
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (286)
T cd06622           7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL   86 (286)
T ss_pred             hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence            45899999999999886 78889999886432222122334456667888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++........+++..+..++.+++.|+.|||+.+  +|+||||||+||+++.++.+|++|||.+..+...  ......
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~  162 (286)
T cd06622          87 DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNI  162 (286)
T ss_pred             HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--ccccCC
Confidence            999875433446899999999999999999999642  8999999999999999999999999999765322  223346


Q ss_pred             cccccccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          941 GTCGYIAPELAYTMR------ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~------~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      +++.|+|||++.+..      ++.++||||+||++|||++|+.||.....        ...............+..   .
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~---~  231 (286)
T cd06622         163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--------ANIFAQLSAIVDGDPPTL---P  231 (286)
T ss_pred             CccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--------hhHHHHHHHHhhcCCCCC---C
Confidence            888999999986543      47899999999999999999999853210        001111122222221111   1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            234567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-33  Score=320.22  Aligned_cols=256  Identities=19%  Similarity=0.259  Sum_probs=186.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      ....||+|+||.||+|... .++.+|+|++....... ......+++..++.++||||+++++++...      ...|+|
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  100 (355)
T cd07874          21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV  100 (355)
T ss_pred             EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence            4456899999999999875 67889999886543222 112233456667888999999999988543      357999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++ ++.+.+..     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       101 ~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         101 MELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             hhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            999976 67766642     378888999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------Ccccc--cchhhhh
Q 045493          932 DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------PAPAA--NMNIVVN 1000 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~--~~~~~~~ 1000 (1048)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....         +....  .......
T Consensus       172 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         172 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             c-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            2 2234457899999999999989999999999999999999999998643311000         00000  0000000


Q ss_pred             hhccC----------------CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDS----------------RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+...                ..+............+.+++.+|++.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000                0000000011123467899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-33  Score=304.63  Aligned_cols=246  Identities=22%  Similarity=0.353  Sum_probs=189.6

Q ss_pred             eeecccccccEEEEEEcC-CC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELTS-GD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.||+|+||.||+|.++. ++    .+|+|................++..++.++||||+++++++.. ...++||||++
T Consensus        13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   91 (279)
T cd05057          13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP   91 (279)
T ss_pred             ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence            468999999999998753 33    4777776544332222334456677788899999999999976 78899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++.........
T Consensus        92 ~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  166 (279)
T cd05057          92 LGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY  166 (279)
T ss_pred             CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence            999999997542  2488999999999999999999998   99999999999999999999999999998765433222


Q ss_pred             c--ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          937 S--ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       937 ~--~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      .  ...++..|+|||......++.++||||+||++||+++ |+.||.....           ......+......+..  
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~--  233 (279)
T cd05057         167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----------VEIPDLLEKGERLPQP--  233 (279)
T ss_pred             ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----------HHHHHHHhCCCCCCCC--
Confidence            1  2223568999999988889999999999999999999 9999763221           1111122222111111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ......+.+++.+||..+|.+|||+.++++.|.
T Consensus       234 -~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         234 -PICTIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             -CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence             112345788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.9e-33  Score=307.02  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=188.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEee-----eCCeEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCS-----HTQHLFL  850 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~-----~~~~~~l  850 (1048)
                      +.....||+|+||.||+|... +++.+|+|+.......  ......+...+..+ +||||+++++++.     ..+..++
T Consensus        20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch--HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            344456899999999999876 5678888876542221  12334456666777 6999999999874     3457899


Q ss_pred             EEEccCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          851 VYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      ||||+++|+|.++++... ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||.++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            999999999999886432 234578889999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYT-----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ...........|++.|+|||++..     ..++.++||||+||++|||++|+.||........           ......
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-----------~~~~~~  243 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-----------LFKIPR  243 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----------Hhhccc
Confidence            544333344578999999998753     4578899999999999999999999764321110           001000


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ...+...........+.+++.+||+.||++|||+.|+++.
T Consensus       244 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         244 -NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             0111100111123458889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-33  Score=313.98  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEcC--------CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS--------GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ...||+|+||.||+|+...        ...+|+|.+..............+++.++++ +||||++++++|.+.+..++|
T Consensus        17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv   96 (334)
T cd05100          17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL   96 (334)
T ss_pred             cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence            3468999999999997532        2257888776433222222344556667777 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          852 YEYLERGSLATILSNEA-------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      |||+++|+|.+++....             ....+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+
T Consensus        97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~  173 (334)
T cd05100          97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVM  173 (334)
T ss_pred             EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcE
Confidence            99999999999996532             123478899999999999999999998   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccc
Q 045493          919 HVSDFGTAKFLKPDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      ||+|||.++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||....           .
T Consensus       174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----------~  242 (334)
T cd05100         174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----------V  242 (334)
T ss_pred             EECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----------H
Confidence            999999998654322211  12234567999999999899999999999999999998 788865321           1


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+........   .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       243 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~  292 (334)
T cd05100         243 EELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR  292 (334)
T ss_pred             HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            111111111111111   11233468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.4e-33  Score=304.70  Aligned_cols=253  Identities=22%  Similarity=0.358  Sum_probs=193.7

Q ss_pred             ceeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....||+|+||.||+|+.+.      .+.+++|.+..............+++.+++++|+||+++++++.+.+..++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            34468999999999998652      345777776543322122334566777888999999999999999899999999


Q ss_pred             ccCCCCHHHHHhccccc------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          854 YLERGSLATILSNEATA------AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      |+++|+|.+++......      ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence            99999999999754422      2589999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCC-CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          928 FLKPDS-SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       928 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ...... .......++..|+|||.+.+..++.++||||+|+++|++++ |..||.....           ..........
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----------~~~~~~~~~~  234 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----------EEVLNRLQAG  234 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----------HHHHHHHHcC
Confidence            543221 22233456778999999988888999999999999999999 7788753221           1111111111


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......  .......+.+++.+||+.+|++|||+.|+++.|.|
T Consensus       235 ~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 KLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            111110  11233468889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-33  Score=308.43  Aligned_cols=259  Identities=20%  Similarity=0.310  Sum_probs=192.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|+.+ +++.||+|++....... .......++..++.++||||+++++++......++||||++++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT   85 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence            346899999999999887 57889999886543222 1223345677788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      .+..+....   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++............
T Consensus        86 ~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          86 VLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            888876542   3488999999999999999999998   9999999999999999999999999999877554433444


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc-------ccccchhhh--hhhc-cCCC
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-------PAANMNIVV--NDLI-DSRL 1007 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~--~~~~-~~~~ 1007 (1048)
                      ..++..|+|||++.+ ..++.++||||+||++|||++|+.||...........       .........  .... ....
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            567889999999876 4578999999999999999999999864332100000       000000000  0000 0000


Q ss_pred             CCCc------hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1008 PPPL------GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1008 ~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.+.      .........+.+++.+||+.+|++|||+.|++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            1000      0011224568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.6e-33  Score=301.88  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=196.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||++... +++.+|+|++...... ........++..++.++||||+++++++...+..++||||++++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG   84 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence            456899999999999875 6788999988643221 11223455667778899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+............
T Consensus        85 ~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          85 DLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             cHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            9999986532 23468889999999999999999998   9999999999999999999999999999876544333344


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..|++.|+|||+..+..++.++|||||||++|++++|+.||....           .......+..+..+...   ....
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----------~~~~~~~~~~~~~~~~~---~~~~  226 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----------MKNLVLKIIRGSYPPVS---SHYS  226 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----------HHHHHHHHhcCCCCCCc---ccCC
Confidence            568889999999998889999999999999999999999975211           11222233333322221   2334


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .++.+++.+||+.+|++||++.||++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         227 YDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            568899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=315.11  Aligned_cols=246  Identities=22%  Similarity=0.276  Sum_probs=183.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+++.. +++.||+|++......  .......++...+..++|+||+++++++.+.+..|+||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG   85 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence            456899999999999876 5788999998642111  1112234455566778999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-c
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-W  936 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~  936 (1048)
                      |+|.+++.+.  ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++......... .
T Consensus        86 ~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          86 GDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             CcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            9999999642  23478889999999999999999999   9999999999999999999999999999766543322 2


Q ss_pred             ccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC----CC
Q 045493          937 SELAGTCGYIAPELAYT-----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS----RL 1007 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 1007 (1048)
                      ....||+.|||||++..     ..++.++||||+||++|||++|+.||.....           ......+...    ..
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~  229 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKIMNHKEHFQF  229 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----------HHHHHHHHcCCCcccC
Confidence            23569999999999863     4578899999999999999999999863221           1111111111    11


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDAN--PDCRPTMQKVCNL 1045 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~evl~~ 1045 (1048)
                      ++..   ......+.+++.+|+..+  +..||+++++++.
T Consensus       230 ~~~~---~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PPDV---TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCcc---CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1111   112345666777766544  3448899998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-33  Score=305.59  Aligned_cols=239  Identities=23%  Similarity=0.337  Sum_probs=178.4

Q ss_pred             eecccccccEEEEEEcC-------------------------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceee
Q 045493          783 LHGTGGCGTVYKAELTS-------------------------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK  837 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~  837 (1048)
                      .||+|+||.||+|....                         ...||+|.+..... .......++...++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            48999999999997531                         12366776643221 11222334455667889999999


Q ss_pred             EeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-
Q 045493          838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-  916 (1048)
Q Consensus       838 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-  916 (1048)
                      +++++.+....++||||+++|+|..++...  ...+++..+..++.|+++|++|||+.   +|+||||||+||+++..+ 
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            999999999999999999999999998643  23578899999999999999999998   999999999999997643 


Q ss_pred             ------ceEEeccccccccCCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCcccccccCC
Q 045493          917 ------KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSL  988 (1048)
Q Consensus       917 ------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~ell-tg~~p~~~~~~~~~~  988 (1048)
                            .+|++|||.+......    ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......   
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS---  228 (274)
T ss_pred             ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH---
Confidence                  3899999988654322    22357788999998865 56799999999999999985 689887532210   


Q ss_pred             CcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          989 PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                           ........  ....+.+      ....+.+++.+||+.+|++|||++++++.|+
T Consensus       229 -----~~~~~~~~--~~~~~~~------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 -----EKERFYEK--KHRLPEP------SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----HHHHHHHh--ccCCCCC------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                 00000100  1111111      1235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-33  Score=337.49  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=185.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  856 (1048)
                      ...||+|+||+||+|.+. +++.+|+|.+....... .......++..+..++|||||+++++|.+  ...+|+||||++
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~   97 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD   97 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence            456899999999999887 45667777775432221 12233456677788999999999998854  457899999999


Q ss_pred             CCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeeCCCCCCeEECCC----------------
Q 045493          857 RGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCF----PPILHRDISSKKVLLDLE----------------  915 (1048)
Q Consensus       857 ~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~iiH~Dik~~NIll~~~----------------  915 (1048)
                      +|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+                
T Consensus        98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266         98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            999999996532 23458999999999999999999998521    259999999999999642                


Q ss_pred             -CceEEeccccccccCCCCCCcccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccc
Q 045493          916 -YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA  992 (1048)
Q Consensus       916 -~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  992 (1048)
                       +.+||+|||++..+... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....        
T Consensus       178 ~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--------  248 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--------  248 (1021)
T ss_pred             CCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--------
Confidence             35899999999866432 22334579999999999864  4578999999999999999999999863221        


Q ss_pred             ccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          993 ANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        .......+.... ..+.   ......+.+++..||+.+|++||++.|++.
T Consensus       249 --~~qli~~lk~~p-~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        249 --FSQLISELKRGP-DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             --HHHHHHHHhcCC-CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence              111111111111 1111   122356888999999999999999999984

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-35  Score=339.78  Aligned_cols=246  Identities=26%  Similarity=0.381  Sum_probs=197.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||.|.||.||.|... +|+-.|||.++-.... .......++...+..++|||+|++||+-.+++..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            446899999999999765 6778899977654332 22334567777788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC---
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN---  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~---  935 (1048)
                      +|.+.++..+.   .++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|.+|||.|..+....+.   
T Consensus      1320 sLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             cHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            99999965433   45566677889999999999999   9999999999999999999999999999988755322   


Q ss_pred             -ccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          936 -WSELAGTCGYIAPELAYTMR---ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                       ....+||+.|||||++.+..   ...++||||+|||+.||+||+.||...+          ........+-.+..|..+
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----------ne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----------NEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----------chhHHHhHHhccCCCCCc
Confidence             34578999999999998654   5678999999999999999999986433          222333344444444433


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .   ....+-.+++..|+..||++|.++.|+++.
T Consensus      1464 ~---~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 E---RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             h---hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2   255667788999999999999999998874

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=307.47  Aligned_cols=259  Identities=20%  Similarity=0.272  Sum_probs=189.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|..+ +++.||+|.+..............++..++.++|+||+++++++.+.+..++||||+++ 
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   87 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-   87 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence            3456899999999999876 67889999886543332223345577778899999999999999999999999999985 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||.++...........
T Consensus        88 ~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          88 DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            9999886533  3578899999999999999999999   9999999999999999999999999998754322222233


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccc----------cCCCcccccchh-hhhhhccCC
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL----------LSLPAPAANMNI-VVNDLIDSR 1006 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~----------~~~~~~~~~~~~-~~~~~~~~~ 1006 (1048)
                      ..++..|+|||+..+ ..++.++||||+||++|||++|+.||......          ...+........ .........
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            356889999999875 45789999999999999999999998643210          000000000000 000000000


Q ss_pred             CCCC-chhH------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 LPPP-LGEV------EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 ~~~~-~~~~------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .... ....      ......+.+++.+|++.+|++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000 0000      011256778999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-33  Score=304.19  Aligned_cols=244  Identities=25%  Similarity=0.409  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc---cCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|.+. +++.+|+|.+..............++..++.++   |||++++++++......++||||++
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            446899999999999874 678899998764332222223344555566665   9999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +++|.++++..    .+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||.+..........
T Consensus        86 ~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          86 GGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             CCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            99999998542    478999999999999999999999   99999999999999999999999999998776554444


Q ss_pred             cccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....|+..|+|||+..++ .++.++||||+||++|+|++|+.||.......           ..... ....++... ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----------~~~~~-~~~~~~~~~-~~  225 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----------AMMLI-PKSKPPRLE-DN  225 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----------hhhcc-ccCCCCCCC-cc
Confidence            455789999999988654 46899999999999999999999986432110           00000 111111110 11


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....++.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         226 GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            13456889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-33  Score=329.84  Aligned_cols=256  Identities=17%  Similarity=0.213  Sum_probs=179.6

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc------ccCceeeEeeEeeeC-CeEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------RHRNIVKFYGFCSHT-QHLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l------~h~niv~~~~~~~~~-~~~~  849 (1048)
                      +.....||+|+||+||+|.+. .++.||||+++......  .....++..+..+      +|.+++++++++... .++|
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT--RDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhH--HHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            334557899999999999875 56789999886432211  1122333334333      356699999988654 5789


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-------------
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-------------  916 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-------------  916 (1048)
                      +|||++ +++|.+++.+.   ..+++..+..|+.||+.||+|||+.+  +||||||||+|||++.++             
T Consensus       209 iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             EEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccccCC
Confidence            999988 66899888653   34889999999999999999999732  899999999999998765             


Q ss_pred             ---ceEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc-------
Q 045493          917 ---KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL-------  986 (1048)
Q Consensus       917 ---~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~-------  986 (1048)
                         .+||+|||.+....   ......+||+.|||||++.+..++.++||||+||++|||++|+.||+..+...       
T Consensus       283 ~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence               49999999886432   22345679999999999999999999999999999999999999997533210       


Q ss_pred             ---CCCcccc--cchhhhhhhccC--CC-CCCch------------hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          987 ---SLPAPAA--NMNIVVNDLIDS--RL-PPPLG------------EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       987 ---~~~~~~~--~~~~~~~~~~~~--~~-~~~~~------------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                         ..+....  .......++...  .. +....            ........+.+++.+||+.||++|||++|+++
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence               0000000  000000000000  00 00000            00011345779999999999999999999986

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-33  Score=310.77  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=192.8

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ++....||+|+||.||++... ++..||+|++...... .......++..++.++|+||+++++++...+..++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ-RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH-HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            334456899999999999875 5788999987543221 12223445566778899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++..........
T Consensus       103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658         103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            9999998853    2378899999999999999999999   99999999999999999999999999997665443333


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....|+..|+|||+..+..++.++||||+||++|||++|+.||......           .....+ ....+........
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----------~~~~~~-~~~~~~~~~~~~~  243 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----------QAMRRI-RDNLPPRVKDSHK  243 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHH-HhcCCCccccccc
Confidence            4457899999999998888999999999999999999999997632211           011111 1111111111112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            33457788999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.8e-33  Score=309.28  Aligned_cols=248  Identities=20%  Similarity=0.340  Sum_probs=186.3

Q ss_pred             ceeeecccccccEEEEEEc-CCC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||.||+|.+. +++    .+|+|.+..............++..++.++||||+++++++... ..++|+||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            3446899999999999875 344    35777765432222122334556667888999999999998654 46799999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        90 ~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          90 MPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             cCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence            9999999998653  23478889999999999999999999   999999999999999999999999999987653322


Q ss_pred             C--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 N--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      .  .....++..|+|||++.+..++.++|||||||++||+++ |+.||.....           ......+......+..
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~  233 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----------REIPDLLEKGERLPQP  233 (303)
T ss_pred             ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHCCCCCCCC
Confidence            2  123345678999999998899999999999999999998 8888753210           0001111111111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                         ......+.+++.+||..+|++||+++++++.|+
T Consensus       234 ---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         234 ---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence               112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.2e-33  Score=299.96  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=193.1

Q ss_pred             eeecccccccEEEEEEcC-----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELTS-----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..||+|+||.||+|....     +..+|+|++......+.......++..+..++|+||+++++++.+.+..+++|||++
T Consensus         5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~   84 (258)
T smart00219        5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME   84 (258)
T ss_pred             ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence            358999999999998864     377899988654433223344556677788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +++|.+++..... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+..........
T Consensus        85 ~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       85 GGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             CCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            9999999965332 1278999999999999999999999   99999999999999999999999999998765432221


Q ss_pred             c-ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          937 S-ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       937 ~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      . ...+++.|+|||...+..++.++||||+|+++|||++ |+.||....           .................   
T Consensus       161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~---  226 (258)
T smart00219      161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----------NEEVLEYLKKGYRLPKP---  226 (258)
T ss_pred             cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHhcCCCCCCC---
Confidence            1 2236789999999988889999999999999999998 788865311           11112222222222111   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      ......+.+++.+|++.||++|||+.|+++.|
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            12345688899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5e-33  Score=316.65  Aligned_cols=256  Identities=19%  Similarity=0.261  Sum_probs=185.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      ....||+|+||.||+|... .++.||||++....... ......+++..++.++||||+++++++...      ...|+|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv  107 (364)
T cd07875          28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV  107 (364)
T ss_pred             EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence            3456899999999999875 57889999986533221 122234456667888999999999987543      357999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++ ++.+++..     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       108 ~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         108 MELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             EeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            999976 77777642     367888999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------Cccc--ccchhhhh
Q 045493          932 DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------PAPA--ANMNIVVN 1000 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~~~~--~~~~~~~~ 1000 (1048)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....         +.+.  ........
T Consensus       179 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         179 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             C-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            2 2234457899999999999999999999999999999999999998643321100         0000  00000000


Q ss_pred             hhccCC----------------CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDSR----------------LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....+                .+............+.+++.+|++.||++|||+.|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000000                000000001123467899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.9e-33  Score=305.79  Aligned_cols=246  Identities=23%  Similarity=0.336  Sum_probs=188.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|+.. +++.+++|.+..... +.......++..++.++||||+++++++...+..++||||+++++
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            445899999999999886 477888888754322 112223445666788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +..++.+..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.............
T Consensus        96 l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  170 (292)
T cd06644          96 VDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF  170 (292)
T ss_pred             HHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccccccee
Confidence            998875432  3478999999999999999999998   99999999999999999999999999987654433333455


Q ss_pred             ccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          940 AGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       940 ~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .+++.|+|||++.     ...++.++||||+||++|||++|+.||.....           ............+ .....
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~-~~~~~  238 (292)
T cd06644         171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSEPP-TLSQP  238 (292)
T ss_pred             cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----------HHHHHHHhcCCCc-cCCCC
Confidence            6889999999984     34568899999999999999999999763221           1111111111111 11111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....++.+++.+||+.+|++||++.|+++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            223446788999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-33  Score=315.55  Aligned_cols=248  Identities=20%  Similarity=0.250  Sum_probs=186.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+++.. +++.||+|.+.....  ........++...+..++|++|+++++++.+.+..|+||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g   85 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG   85 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            456899999999999886 567789998764211  11111233445556777899999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-c
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-W  936 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~  936 (1048)
                      |+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......... .
T Consensus        86 g~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          86 GDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             CcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999996532  3478889999999999999999999   9999999999999999999999999999876543322 2


Q ss_pred             ccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC--CCC
Q 045493          937 SELAGTCGYIAPELAYT-----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR--LPP 1009 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1009 (1048)
                      ....||+.|+|||++.+     +.++.++||||+||++|||++|+.||...+.           ......+....  .+.
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~  229 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKIMNHEERFQF  229 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----------HHHHHHHHcCCCcccC
Confidence            33579999999999875     4678899999999999999999999863221           11111221111  111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCNL 1045 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1045 (1048)
                      + .........+.+++.+|+..++++  |++++++++.
T Consensus       230 p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 P-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1 111223456778888888866554  5688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-33  Score=320.76  Aligned_cols=253  Identities=18%  Similarity=0.214  Sum_probs=188.3

Q ss_pred             ceeeecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|...   .+..||+|.+...      ....++++.++.++||||+++++++......|+|||++.
T Consensus        96 i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  169 (392)
T PHA03207         96 ILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK  169 (392)
T ss_pred             EEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence            3456899999999999754   3467888877532      123467778899999999999999999999999999996


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                       +++.+++..   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......  
T Consensus       170 -~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        170 -CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             -CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence             588888843   23589999999999999999999999   999999999999999999999999999976654322  


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc-------------CCC--cccccchh--
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL-------------SLP--APAANMNI--  997 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~-------------~~~--~~~~~~~~--  997 (1048)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......             ..+  ........  
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            2234679999999999999999999999999999999999999986432110             000  00000000  


Q ss_pred             -hhhhhc---cCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          998 -VVNDLI---DSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       998 -~~~~~~---~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ......   .+....+.. .......++.+++.+|++.||++|||+.|++..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             000000   000000000 001123457788999999999999999999863

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.1e-33  Score=301.72  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ...||+|+||.||+|...+++.+|+|.+........     .....+++..++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            346899999999999888889999998865432211     112344566678889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--  933 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--  933 (1048)
                      ++++|.+++.+..   .+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++++|||.+.......  
T Consensus        85 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          85 PGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999996533   378889999999999999999998   99999999999999999999999999987653211  


Q ss_pred             ----CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc--CCC
Q 045493          934 ----SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID--SRL 1007 (1048)
Q Consensus       934 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1007 (1048)
                          .......|+..|+|||+..+..++.++||||+||++||+++|+.||...+..          .. ......  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~-~~~~~~~~~~~  227 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AA-MFYIGAHRGLM  227 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----------HH-HHHhhhccCCC
Confidence                1123456889999999999888999999999999999999999998632211          00 000000  011


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +..   .......+.+++.+||+.+|++|||+.|+++
T Consensus       228 ~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 PRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111   1123456788999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-33  Score=317.58  Aligned_cols=186  Identities=19%  Similarity=0.276  Sum_probs=155.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|+.. +++.||+|.....       ....+...++.++||||+++++++......++||||+. |
T Consensus        70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  141 (357)
T PHA03209         70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S  141 (357)
T ss_pred             EEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence            3456899999999999886 4566777764321       12345667889999999999999999999999999995 5


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...  ...+++..+..++.||+.||.|||+.   +||||||||+||+++.++.+||+|||.++..... .....
T Consensus       142 ~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~  215 (357)
T PHA03209        142 DLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLG  215 (357)
T ss_pred             cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-ccccc
Confidence            888888643  33588999999999999999999999   9999999999999999999999999999753322 22344


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPG  979 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  979 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||+++..|+
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            67999999999999999999999999999999999965553

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-33  Score=314.87  Aligned_cols=249  Identities=20%  Similarity=0.233  Sum_probs=185.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+++.+ +++.+|+|.+.+...  ........++...+..++|++|+++++++.+.+..|+||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~   85 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG   85 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence            456899999999999887 466788888754211  11111234455556778999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-c
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-W  936 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~  936 (1048)
                      |+|.+++++..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......... .
T Consensus        86 g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          86 GDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             CcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999996532  3478889999999999999999998   9999999999999999999999999999765433322 2


Q ss_pred             cccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC-C
Q 045493          937 SELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP-P 1010 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1010 (1048)
                      ...+||+.|+|||++.     ...++.++||||+||++|||++|+.||...+.           ......+....... .
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~  229 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKIMNHKERFQF  229 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----------HHHHHHHhCCCccccC
Confidence            3457999999999986     34578999999999999999999999863321           11111221111100 0


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1045 (1048)
                      ..........+.+++.+|+..+|.+  |++++|+++.
T Consensus       230 p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0111223456777888877655444  7899998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-33  Score=302.85  Aligned_cols=238  Identities=23%  Similarity=0.331  Sum_probs=181.1

Q ss_pred             eecccccccEEEEEEcC--------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          783 LHGTGGCGTVYKAELTS--------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      .||+|+||.||+|....        ..++|+|.+..... .......++...++.++||||+++++++...+..++||||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999997642        23477777643221 1122334556667888999999999999998899999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc--------eEEeccccc
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK--------AHVSDFGTA  926 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~--------~kl~DfG~a  926 (1048)
                      +++|+|.++++..+  ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.        ++++|||.+
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999997543  2478899999999999999999999   9999999999999987765        699999998


Q ss_pred             cccCCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCcccccccCCCcccccchhhhhhh-c
Q 045493          927 KFLKPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGK-HPGHFLSLLLSLPAPAANMNIVVNDL-I 1003 (1048)
Q Consensus       927 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1003 (1048)
                      ......    ....++..|+|||++.+. .++.++||||+||++|||++|. .|+......           ...... .
T Consensus       156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----------~~~~~~~~  220 (258)
T cd05078         156 ITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----------KKLQFYED  220 (258)
T ss_pred             cccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----------HHHHHHHc
Confidence            755322    234678899999998864 5789999999999999999985 554321110           000000 0


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....+.      ....++.+++.+||+.||++|||++++++.|.
T Consensus       221 ~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 RHQLPA------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cccCCC------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111221      12245789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.2e-33  Score=302.13  Aligned_cols=243  Identities=27%  Similarity=0.416  Sum_probs=190.2

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--------cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--------GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ..||+|+||.||+|... +++.+|+|.+........        ......++..++.++||||+++++++.+.+..++||
T Consensus         6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (267)
T cd06628           6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL   85 (267)
T ss_pred             ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence            46899999999999875 578899998865432211        012334556678889999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++.....
T Consensus        86 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          86 EYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             EecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            999999999999654   3478889999999999999999998   9999999999999999999999999999876532


Q ss_pred             CC------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          933 SS------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       933 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      ..      ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||......           ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~~~~  228 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----------QAIFKIGENA  228 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----------HHHHHHhccC
Confidence            11      112345788999999999888999999999999999999999998642211           1111111111


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+..   .......+.+++.+||+.||++||++.|+++
T Consensus       229 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         229 SPEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCcC---CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1111   1123456788999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.3e-33  Score=302.64  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=193.4

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||.||+|... +++.+|+|.+..............++..+++++||||+++++++......++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            344556899999999999875 6788999987543322222234455666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++..    ..+++..+..++.+++.|+.|||+.   +++|+||||+||+++.++.++++|||.+..........
T Consensus        86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            9999999864    2478999999999999999999998   99999999999999999999999999987665433333


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....++..|+|||+..+..++.++||||+||++|+|++|..||......           .....+.....+ ..  ...
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~-~~--~~~  224 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----------KVLFLIPKNNPP-TL--EGN  224 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----------HHHHHHhcCCCC-CC--Ccc
Confidence            4456888999999998888899999999999999999999997532210           111111111111 11  112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....+.+++.+||+.+|++||++.++++.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            33567889999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.3e-33  Score=305.46  Aligned_cols=245  Identities=25%  Similarity=0.397  Sum_probs=193.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|... +++.||+|.+....... ......++..++.++|+||+++++++...+..|+||||++++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~  101 (297)
T cd06656          23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  101 (297)
T ss_pred             eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCC
Confidence            3456899999999999874 78899999886433222 223345566778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.+.    .+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||.+............
T Consensus       102 ~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656         102 SLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            999998542    368889999999999999999998   9999999999999999999999999999876544443445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..+++.|+|||...+..++.++||||+||++|++++|+.||..........           ...... .+.........
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----------~~~~~~-~~~~~~~~~~~  242 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----------LIATNG-TPELQNPERLS  242 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----------eeccCC-CCCCCCccccC
Confidence            578899999999998889999999999999999999999986432211100           000000 01111112233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.+++.+||+.+|++||+++++++
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         243 AVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            45788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-33  Score=307.16  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=194.7

Q ss_pred             eeecccccccEEEEEEc-----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  854 (1048)
                      ..||+|+||.||+|++.     ++..+|+|.+..............++..++.++||||+++++++..  ....++||||
T Consensus        10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   89 (284)
T cd05038          10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY   89 (284)
T ss_pred             eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence            46899999999999864     3678999988754433122344556677788899999999999877  5578999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+........
T Consensus        90 ~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  164 (284)
T cd05038          90 LPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD  164 (284)
T ss_pred             CCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence            99999999996543  2488999999999999999999998   999999999999999999999999999987653322


Q ss_pred             Cc---cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---CcccccchhhhhhhccCCCC
Q 045493          935 NW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---PAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       935 ~~---~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ..   ....++..|+|||+..+..++.++||||+|+++|||++|+.|+.........   ............+.......
T Consensus       165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
T cd05038         165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER  244 (284)
T ss_pred             ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc
Confidence            11   1223456799999998888999999999999999999999997532211000   00000011111111111111


Q ss_pred             CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1009 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.  ......++.+++.+||+.+|++||||.|++++|++
T Consensus       245 ~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         245 LPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             CCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            111  12233568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=281.33  Aligned_cols=256  Identities=19%  Similarity=0.289  Sum_probs=199.5

Q ss_pred             eeecccccccEEEEE-EcCCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~-~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +++|+|+|+.|-.+. ..++.+||||++.+...... ...-++++.+.+. .|+||+++++||+++..+|+|||-|.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR-~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSR-SRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHH-HHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            468999999999885 46899999999977643321 1223344444555 49999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEeccccccccCCC----
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKFLKPD----  932 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~~~~~----  932 (1048)
                      |..+++...   .+++.++.+++++|+.||.|||.+   ||.|||+||+|||-....   -+|||||.++.-+.-.    
T Consensus       163 lLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            999997644   488999999999999999999999   999999999999997654   4899999987654321    


Q ss_pred             ---CCCccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccc----cchhhhh
Q 045493          933 ---SSNWSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA----NMNIVVN 1000 (1048)
Q Consensus       933 ---~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~ 1000 (1048)
                         .....+.+|+..|||||+..     ...|+.+.|.||+|||+|-|++|..||.....-.--+...+    -....++
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence               12234568999999999753     23578999999999999999999999975433111111111    1223456


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+-+++...+...+-..+.+..+++...+..||..|.++.++++
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            66777777777777777788888888899999999999998875

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-32  Score=304.04  Aligned_cols=260  Identities=20%  Similarity=0.242  Sum_probs=189.2

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...+.||+|+||.||+|... +++.||+|.+.............+++..++.++|+||+++++++...+..|+||||+. 
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-   86 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence            34556899999999999875 6889999988654433323344566777888999999999999999999999999996 


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +++.+++....  ..+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        87 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          87 TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence            57777764322  3467888899999999999999999   999999999999999999999999999976543333334


Q ss_pred             ccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC----------CCccccc-----chhhhhh
Q 045493          938 ELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS----------LPAPAAN-----MNIVVND 1001 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~~-----~~~~~~~ 1001 (1048)
                      ...+++.|+|||++.+. .++.++||||+||++|||++|+.||+.......          .+.....     .......
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            45678899999998754 478899999999999999999999864332100          0000000     0000000


Q ss_pred             hccCCCCCCchhH---HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1002 LIDSRLPPPLGEV---EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+......   ......+.+++.+|++.||++|||++|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000001000000   011346778999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.7e-33  Score=301.00  Aligned_cols=247  Identities=22%  Similarity=0.294  Sum_probs=189.0

Q ss_pred             eeeecccccccEEEEEEcCC----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTSG----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|.+.+.    ..+|+|................+++.++.++||||+++++++.+ ...++||||++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~   89 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP   89 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence            34689999999999986532    35788877654433323344556677788899999999999875 45789999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....  ..+++..+..++.+++.|++|+|+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        90 ~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  164 (270)
T cd05056          90 LGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK  164 (270)
T ss_pred             CCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence            999999996532  3478999999999999999999998   99999999999999999999999999998665432211


Q ss_pred             -cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          937 -SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       937 -~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                       ....++..|+|||.+....++.++||||+||++||+++ |+.||......           .....+......+..   
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~---  230 (270)
T cd05056         165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----------DVIGRIENGERLPMP---  230 (270)
T ss_pred             cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHcCCcCCCC---
Confidence             12234568999999988889999999999999999996 99997633211           111111111111111   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ......+.+++.+|+..+|++|||+.++++.|+
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            122346888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.2e-33  Score=301.07  Aligned_cols=250  Identities=24%  Similarity=0.413  Sum_probs=191.0

Q ss_pred             eeecccccccEEEEEEcC--CCceeeEEeccCCCC------cccchhhHHHHHH----hhcccCceeeEeeEeeeCCeEE
Q 045493          782 VLHGTGGCGTVYKAELTS--GDTRAVKKLHSLPTG------EIGINQKGFVSEI----TEIRHRNIVKFYGFCSHTQHLF  849 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~--~~~vavk~~~~~~~~------~~~~~~~~~~~~l----~~l~h~niv~~~~~~~~~~~~~  849 (1048)
                      ..||+|+||.||+|....  ++.+|+|.+......      .......+++.++    +.++||||+++++++.+.+..+
T Consensus         6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   85 (269)
T cd08528           6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY   85 (269)
T ss_pred             hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence            458999999999998875  677899987543211      1111222333333    3468999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          850 LVYEYLERGSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      +||||+++++|.+++... .....+++..+++++.|++.|+.|||+..  +++||||||+||+++.++.+||+|||.+..
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  163 (269)
T cd08528          86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ  163 (269)
T ss_pred             EEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccceee
Confidence            999999999999988542 22345888999999999999999999631  899999999999999999999999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCC
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ..... ......|+..|+|||+..+..++.++||||+|+++||+++|+.||.....           .............
T Consensus       164 ~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~  231 (269)
T cd08528         164 KQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----------LSLATKIVEAVYE  231 (269)
T ss_pred             ccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----------HHHHHHHhhccCC
Confidence            55433 33456688999999999988899999999999999999999999753211           1111122222211


Q ss_pred             CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1009 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +...  ......+.+++.+||+.||++||++.|+.++++
T Consensus       232 ~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         232 PLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111  123356888999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=279.93  Aligned_cols=252  Identities=20%  Similarity=0.253  Sum_probs=203.2

Q ss_pred             ccCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHH-HhhcccCceeeEeeEeee----CCeE
Q 045493          775 STFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSE-ITEIRHRNIVKFYGFCSH----TQHL  848 (1048)
Q Consensus       775 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~-l~~l~h~niv~~~~~~~~----~~~~  848 (1048)
                      .++....++||-|-.|.|..+..+ +++++|+|.+.....      .+++++. +..-.|||||.++++|..    .+..
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K------ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK------ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH------HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            344444567899999999999776 788999999865432      2233332 233469999999998753    5678


Q ss_pred             EEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEecccc
Q 045493          849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGT  925 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~  925 (1048)
                      .+|||.|+||.|...++.++. ..+++.++.+|++||+.|+.|||+.   .|.||||||+|+|.+.   +..+|++|||+
T Consensus       135 LiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            899999999999999987654 4589999999999999999999999   9999999999999975   45799999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          926 AKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       926 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      |+.-.. .....+.+-||.|.|||++...+|+...|+||+||++|-|++|..||.......    .   .......+..+
T Consensus       211 AK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----i---spgMk~rI~~g  282 (400)
T KOG0604|consen  211 AKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----I---SPGMKRRIRTG  282 (400)
T ss_pred             ccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----C---ChhHHhHhhcc
Confidence            986543 344556788999999999999999999999999999999999999987544321    1   11223345556


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++...++...++|+.++..+|++|.|+.|+++
T Consensus       283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            666677788888999999999999999999999999975

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-32  Score=302.69  Aligned_cols=254  Identities=23%  Similarity=0.321  Sum_probs=191.8

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  856 (1048)
                      ....||.|++|.||+|... +++.+|+|.+..............+++.++.++||||++++++|.+  .+..++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            3456899999999999886 5778888887654332223334556777788999999999998854  447899999999


Q ss_pred             CCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          857 RGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +++|.+++.... ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  160 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-  160 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence            999999875422 234478889999999999999999998   999999999999999999999999999876542221 


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc---CCCCCCch
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID---SRLPPPLG 1012 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 1012 (1048)
                       ....++..|+|||.+.+..++.++||||+||++|||++|+.||+.....      .............   +..+....
T Consensus       161 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         161 -GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP------PLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             -ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC------CCChHHHHHHHhcCCchhhccCCC
Confidence             2345788999999999889999999999999999999999998744220      0001111111111   11111111


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ........+.+++.+||+.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            01123456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-32  Score=303.85  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=189.5

Q ss_pred             cCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeC-----CeE
Q 045493          776 TFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHT-----QHL  848 (1048)
Q Consensus       776 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~-----~~~  848 (1048)
                      ..+.....||+|+||.||+|... +++.+|+|.+.....  .......++..+.++ +||||+++++++...     +..
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            33444556899999999999885 577888888754321  122334456666667 799999999998643     368


Q ss_pred             EEEEEccCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          849 FLVYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      ++||||+++|+|.++++... ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            99999999999999886422 234578999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCC-----CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMR-----ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .............|+..|+|||++....     ++.++||||+||++|||++|+.||......           .....+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----------~~~~~~  245 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----------KTLFKI  245 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----------HHHHHH
Confidence            7654333334456889999999876432     688999999999999999999997632211           111111


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .... ++...........+.+++.+||+.+|++||++.|+++
T Consensus       246 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 PRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111 1111111233456889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.8e-33  Score=303.85  Aligned_cols=259  Identities=20%  Similarity=0.284  Sum_probs=189.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|+.. +|+.+|+|++......+ .......++..+++++||||+++++++.+....++|+||+++ 
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   83 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-   83 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-
Confidence            346899999999999886 68889999886532221 122344567778889999999999999999999999999975 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.+++...  ...+++..+..++.||++|+.|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        84 ~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          84 DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            888887543  23488999999999999999999999   9999999999999999999999999999866543333344


Q ss_pred             cccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccC--------CCcccccchhhhhhhccC----
Q 045493          939 LAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS--------LPAPAANMNIVVNDLIDS---- 1005 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~---- 1005 (1048)
                      ..++..|+|||++.+.. ++.++||||+||++|||+||+.|+........        ................+.    
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            56788999999987654 68999999999999999999988532111000        000000000000000000    


Q ss_pred             CCCCCc---hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1006 RLPPPL---GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1006 ~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+...   ........++.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000   0001234567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-32  Score=297.28  Aligned_cols=242  Identities=25%  Similarity=0.392  Sum_probs=188.4

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|.. .++.+|+|++.....   ......++..++.++||||+++++++.... .++||||+++|+|
T Consensus        11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L   85 (254)
T cd05083          11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNL   85 (254)
T ss_pred             eeeeccCCCCceEeccc-CCCceEEEeecCcch---HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCH
Confidence            34689999999999975 578899998854321   123455667778899999999999987654 7999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++.... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+......   .....
T Consensus        86 ~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~~~  158 (254)
T cd05083          86 VNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSK  158 (254)
T ss_pred             HHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---CCCCC
Confidence            99997543 33478899999999999999999998   9999999999999999999999999998754322   12233


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .+..|+|||++.+..++.++||||+||++|||++ |+.||.....           ...............   ......
T Consensus       159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~---~~~~~~  224 (254)
T cd05083         159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----------KEVKECVEKGYRMEP---PEGCPA  224 (254)
T ss_pred             CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----------HHHHHHHhCCCCCCC---CCcCCH
Confidence            4568999999988899999999999999999998 8998753221           111111111111111   122345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .+.+++.+||+.+|++||+++++++.|++
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            67899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.6e-33  Score=302.09  Aligned_cols=248  Identities=22%  Similarity=0.341  Sum_probs=193.7

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|..+ +++.+|+|.+......+.......++..+++++||||+++++++...+..++|+||+++++|
T Consensus         7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (265)
T cd06605           7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL   86 (265)
T ss_pred             HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence            35899999999999887 57888999886544333223334556667788999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      .+++....  ..+++..+..++.|++.|++|+|+ .   +++||||||+||+++.++.++|+|||.+........  ...
T Consensus        87 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~  159 (265)
T cd06605          87 DKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTF  159 (265)
T ss_pred             HHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hcc
Confidence            99997542  457888999999999999999999 7   999999999999999999999999999876543222  126


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .++..|+|||+..+..++.++||||+|+++|+|++|+.||.....      .................+....  .....
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~--~~~~~  231 (265)
T cd06605         160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND------PPDGIFELLQYIVNEPPPRLPS--GKFSP  231 (265)
T ss_pred             cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc------ccccHHHHHHHHhcCCCCCCCh--hhcCH
Confidence            688899999999988999999999999999999999999764321      0011111222222222211111  11455


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+.+++.+||..+|++|||+.|+++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhh
Confidence            6889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.4e-33  Score=306.25  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=191.6

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc----ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE----IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..||+|+||.||+|... +++.||+|++......+    .......++..++.++|+||+++++++.+.+..++||||+ 
T Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   84 (298)
T cd07841           6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-   84 (298)
T ss_pred             eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence            46899999999999876 68899999987644321    1122234566678889999999999999999999999999 


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++....  ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||+++.........
T Consensus        85 ~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          85 ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            889999996543  3589999999999999999999999   99999999999999999999999999998765544444


Q ss_pred             ccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-------CCcccccchhh---hhhhccC
Q 045493          937 SELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-------LPAPAANMNIV---VNDLIDS 1005 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-------~~~~~~~~~~~---~~~~~~~ 1005 (1048)
                      ....+++.|+|||.+.+ ..++.++||||+||++|||++|..||........       ...+.......   .......
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            44567889999998865 4578999999999999999999877653322100       00000000000   0000000


Q ss_pred             CCCCC---chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1006 RLPPP---LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1006 ~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....   ..........+.+++.+||++||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000   00112234678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-32  Score=297.52  Aligned_cols=247  Identities=20%  Similarity=0.360  Sum_probs=192.2

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|....+..+|+|.+.....  ......+++..++.++|+||+++++++.+ ...++||||+++|+|
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L   87 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL   87 (260)
T ss_pred             EeEecCccceEEEEEEecCCccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence            345899999999999987788899998764321  11233456667788999999999999887 778999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-cccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  939 (1048)
                      .+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+......... ....
T Consensus        88 ~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          88 LDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             HHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            99997543 34578899999999999999999998   9999999999999999999999999999765432221 2223


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .++..|+|||++....++.++||||+||++|++++ |+.||...+.           ....... ......+  ......
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~~~-~~~~~~~--~~~~~~  229 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------PEVIRAL-ERGYRMP--RPENCP  229 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHHH-hCCCCCC--CcccCC
Confidence            45678999999998889999999999999999999 8988753221           0111111 1111111  112234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .++.+++.+||+++|++||++.++.++|+.
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=285.74  Aligned_cols=237  Identities=21%  Similarity=0.218  Sum_probs=189.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -.+++|+|.||.|..++-+ +++-||+|++++.......  .....+-+.+...+||.+..+--.|...++.|+||||+.
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence            3456899999999999876 6788999988764322211  112334555677899999999888999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      ||.|.-++.+.+   .+++.+.+.+-..|+.||.|||++   +||.||+|.+|.++|.||++||+|||+++.-...+..+
T Consensus       252 GGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~  325 (516)
T KOG0690|consen  252 GGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT  325 (516)
T ss_pred             CceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence            999999887643   378888899999999999999999   99999999999999999999999999999776677778


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      .++||||.|.|||++....|+.++|.|.+|||||||++|+.||...+.           +..++-+....+..+.    .
T Consensus       326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----------~kLFeLIl~ed~kFPr----~  390 (516)
T KOG0690|consen  326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----------EKLFELILMEDLKFPR----T  390 (516)
T ss_pred             ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----------hHHHHHHHhhhccCCc----c
Confidence            899999999999999999999999999999999999999999864331           2222222222222221    1


Q ss_pred             HHHHHHHHHHhccCCCCCCCC
Q 045493         1017 KLKSMIAVAFLCLDANPDCRP 1037 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RP 1037 (1048)
                      ...+...++...+.+||.+|.
T Consensus       391 ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhc
Confidence            122345566678999999996

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-32  Score=298.42  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|++|.||+|... +++.+++|++..............++..+.+++|+||+++++++...+..++||||+++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS   85 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence            356899999999999887 4889999988654432223344556666788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      |.+++...   ..+++..+..++.|+++|++|+|+ .   +++||||+|+||+++.++.++|+|||.+............
T Consensus        86 L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          86 LADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            99999654   447899999999999999999999 8   9999999999999999999999999999877554444445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH-H
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE-K 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1017 (1048)
                      ..++..|+|||...+..++.++||||||+++|||++|+.||.....        .........+.....+...   .. .
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~---~~~~  228 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--------PSFFELMQAICDGPPPSLP---AEEF  228 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------cCHHHHHHHHhcCCCCCCC---cccC
Confidence            5688999999999988899999999999999999999999864331        0111222222222222111   11 3


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+.+++.+||+.+|++|||+.|+++.
T Consensus       229 ~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         229 SPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            4578899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.8e-33  Score=302.29  Aligned_cols=243  Identities=19%  Similarity=0.199  Sum_probs=183.1

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHH---HHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFV---SEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +||+|+||.||+|... +++.+|+|.+........  .....++.   +.+...+||+|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3799999999999876 578899998865432211  11111222   22233479999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++......  ..
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~  152 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence            99999998653   3489999999999999999999999   9999999999999999999999999998755432  22


Q ss_pred             ccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....||..|+|||...+ ..++.++||||+||++|||++|+.||.....      .   .......... ...  .....
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~---~~~~~~~~~~-~~~--~~~~~  220 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT------K---DKHEIDRMTL-TVN--VELPD  220 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC------c---CHHHHHHHhh-cCC--cCCcc
Confidence            33468999999998864 5679999999999999999999999863221      0   0011111100 001  01112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      ....++.+++.+||+.||++||     |++|++++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2345688889999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.2e-33  Score=305.79  Aligned_cols=242  Identities=26%  Similarity=0.398  Sum_probs=191.3

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      .||+|+||.||+|... +++.||+|.+....... .....+++..+..++||||+++++++...+..++||||+++++|.
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccch-HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            5899999999999875 68889999885433222 223345566677889999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG  941 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  941 (1048)
                      +++..    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++..............|
T Consensus       107 ~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         107 DIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             HHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence            98753    3478899999999999999999999   9999999999999999999999999999766544444445678


Q ss_pred             ccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHH
Q 045493          942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSM 1021 (1048)
Q Consensus       942 t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1021 (1048)
                      +..|+|||++.+..++.++||||+||++|||++|+.||......           .....+ .................+
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------~~~~~~-~~~~~~~~~~~~~~~~~l  247 (297)
T cd06659         180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----------QAMKRL-RDSPPPKLKNAHKISPVL  247 (297)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHH-hccCCCCccccCCCCHHH
Confidence            99999999999888999999999999999999999997632211           001111 111111111111223457


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHH
Q 045493         1022 IAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1022 ~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+++.+||+.+|++||+++++++
T Consensus       248 ~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         248 RDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhh
Confidence            88899999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7e-33  Score=305.04  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=191.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|.++ +++.+|+|++....... ......++++.++.++||||+++++++...+..++||||++++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT   85 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence            356899999999999886 57889999876543322 1223445667778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.++....   ..+++.++..++.|++.|++|||+.   +|+||||+|+||++++++.++++|||++............
T Consensus        86 ~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          86 VLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             HHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            998876542   2378999999999999999999998   9999999999999999999999999999876544444445


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC----------CCcccc---cchhhhhhhcc
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS----------LPAPAA---NMNIVVNDLID 1004 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~---~~~~~~~~~~~ 1004 (1048)
                      ..++..|+|||+..+ ..++.++|||||||++|||++|+.||........          ......   ........+..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            568899999999875 3468899999999999999999998753221100          000000   00000000000


Q ss_pred             CCCCCCch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +.......   ........+.+++.+||+.+|++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000000   01123456889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.7e-33  Score=302.10  Aligned_cols=245  Identities=22%  Similarity=0.245  Sum_probs=188.8

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||+||+|... +++.+|+|.+......  ........++..++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            599999999999765 6788999988653221  1112224466778889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++.+... ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+..... ........
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence            999975432 3578999999999999999999999   999999999999999999999999999876543 22223446


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      ++..|+|||+..+..++.++||||+||++|+|++|+.||......       ...............    .........
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~----~~~~~~~~~  224 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-------VEKEELKRRTLEMAV----EYPDKFSPE  224 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-------ccHHHHHhccccccc----cCCccCCHH
Confidence            788999999998888999999999999999999999998633210       000111111111111    111123456


Q ss_pred             HHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      +.+++.+||+.||++||     ++.++++
T Consensus       225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         225 AKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            78999999999999999     7777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-32  Score=298.56  Aligned_cols=247  Identities=26%  Similarity=0.345  Sum_probs=193.2

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  857 (1048)
                      ..+|.|+||.||+|... +++.+|+|.+......+ .......++..++.++||||+++++++..  ....+++|||+++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~   85 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG   85 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence            45899999999999875 67788888876432222 11223445666788899999999998753  4568999999999


Q ss_pred             CCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          858 GSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMH-----HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       858 g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      ++|.+++.... ....+++..++.++.+++.|++|||     +.   +++||||||+||+++.++.+|++|||++.....
T Consensus        86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            99999996532 2345889999999999999999999     66   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          932 DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      .........+++.|+|||++.+..++.++||||+|+++|+|++|+.||....           .......+..+..+.. 
T Consensus       163 ~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~-  230 (265)
T cd08217         163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----------QLQLASKIKEGKFRRI-  230 (265)
T ss_pred             CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----------HHHHHHHHhcCCCCCC-
Confidence            4443445678999999999998889999999999999999999999976322           1111222222222211 


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        .......+.+++.+|++.+|++|||+++++++
T Consensus       231 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         231 --PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              12334578899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-32  Score=297.64  Aligned_cols=244  Identities=23%  Similarity=0.334  Sum_probs=184.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc----cchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI----GINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  853 (1048)
                      ...+|+|+||.||+|... ++..||+|++........    .....+++..++.++||||+++++++.+  ....+++||
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            456899999999999875 578899998764332211    1223445667788999999999998865  467899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC-
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-  932 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~-  932 (1048)
                      |+++++|.+++....   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... 
T Consensus        87 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          87 YMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            999999999996533   378889999999999999999998   9999999999999999999999999999765321 


Q ss_pred             --CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          933 --SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       933 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                        ........++..|+|||++.+..++.++||||+||++||+++|+.||.....           .............+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~  229 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------MAAIFKIATQPTNPQ  229 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----------HHHHHHHhcCCCCCC
Confidence              1122335588899999999988899999999999999999999999863211           111111111111111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .  .......+.+++ +||..+|++|||++|+++
T Consensus       230 ~--~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         230 L--PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C--chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1  112233455555 688899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-33  Score=312.60  Aligned_cols=254  Identities=20%  Similarity=0.270  Sum_probs=184.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      ....||+|+||.||+|... +++.||||++....... .......+++.++.++||||+++++++...      ...|++
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   98 (343)
T cd07878          19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV   98 (343)
T ss_pred             hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence            4456899999999999875 67789999886532221 112233567778889999999999987532      457899


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      +|++ +++|.++++.    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        99 ~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          99 TNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             eecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            9988 7799988753    2488999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccccc---chhh
Q 045493          932 DSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAAN---MNIV  998 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~---~~~~  998 (1048)
                      .   .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........         .+.....   ....
T Consensus       171 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             C---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence            2   234578999999999876 5689999999999999999999999864321100         0000000   0000


Q ss_pred             hhhhccCCCCCCc-hhH----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 VNDLIDSRLPPPL-GEV----EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 ~~~~~~~~~~~~~-~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...... ..+... ...    ......+.+++.+|++.||++|||++|+++.
T Consensus       248 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         248 ARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000 000000 000    0112347789999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.1e-32  Score=296.10  Aligned_cols=245  Identities=21%  Similarity=0.284  Sum_probs=186.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc----cchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI----GINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  853 (1048)
                      ...||+|+||.||+|... +++.||+|++........    ......+++.+++++||||+++++++.+  ....++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            456899999999999875 578899998754322111    1223446677788899999999998865  356889999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++|+|.+++.+..   .+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||.++......
T Consensus        87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          87 HMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            999999999986532   377888999999999999999999   99999999999999999999999999998654211


Q ss_pred             ---CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 ---SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                         .......|+..|+|||++.+..++.++|||||||++||+++|+.||......          .........+..+. 
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------~~~~~~~~~~~~~~-  229 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------AAIFKIATQPTNPV-  229 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------HHHHHHhcCCCCCC-
Confidence               1223456889999999998888999999999999999999999997632111          11111111111111 


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        .+......+.+++.+|+. +|++||+++|+++.
T Consensus       230 --~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         230 --LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              122344567788888985 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-33  Score=299.27  Aligned_cols=243  Identities=23%  Similarity=0.280  Sum_probs=184.6

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccc--hhhHH-HHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGI--NQKGF-VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~--~~~~~-~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||.||+|... +++.||+|.+..........  ....+ .......+|+||+++++++...+..|+||||++++
T Consensus         3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (260)
T cd05611           3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG   82 (260)
T ss_pred             cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence            4799999999999875 57889999886432211111  11111 12224457999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.++++...   .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||.+.....    ...
T Consensus        83 ~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~  152 (260)
T cd05611          83 DCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK  152 (260)
T ss_pred             CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence            9999996533   478889999999999999999998   999999999999999999999999999875432    233


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..++..|+|||...+..++.++||||+|+++|||++|..||.....           ......+.......+........
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~  221 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----------DAVFDNILSRRINWPEEVKEFCS  221 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhcccCCCCcccccCC
Confidence            4688899999999888889999999999999999999999863221           11112221111111111112334


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      ..+.+++.+||+.+|++|||+.++.+.+
T Consensus       222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         222 PEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            6788999999999999999886555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-32  Score=301.64  Aligned_cols=248  Identities=20%  Similarity=0.304  Sum_probs=185.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchh-hHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQ-KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~-~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|.+. +++.||+|++......+..... .+....++..+||||+++++++...+..|+||||++ |
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~   84 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T   84 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence            346899999999999886 6889999988654332211111 222223456789999999999999999999999997 5


Q ss_pred             CHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.+++... .....+++..+..++.|++.|++|||+.+  +++||||||+||+++.++.+||+|||.+....... ...
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~  161 (283)
T cd06617          85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKT  161 (283)
T ss_pred             cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc-ccc
Confidence            888887542 22345899999999999999999999853  89999999999999999999999999998654321 223


Q ss_pred             cccccccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          938 ELAGTCGYIAPELAYT----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ...++..|+|||++.+    ..++.++||||+||++|||++|+.||.....          .............+...  
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~--  229 (283)
T cd06617         162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----------PFQQLKQVVEEPSPQLP--  229 (283)
T ss_pred             cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----------CHHHHHHHHhcCCCCCC--
Confidence            3468889999998864    4568899999999999999999999753110          00111111111111110  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......++.+++.+||+.+|++|||++++++
T Consensus       230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1123456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-33  Score=302.95  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=190.5

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|+||.||+|... ++..+|+|.+....... ......++..+++++||||+++++++......|+||||+++|+|
T Consensus        11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (280)
T cd06611          11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE-LEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL   89 (280)
T ss_pred             HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH-HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence            35899999999999875 57788888875432211 12334456677889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++....  ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+..............
T Consensus        90 ~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (280)
T cd06611          90 DSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI  164 (280)
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceee
Confidence            99986532  3488999999999999999999999   999999999999999999999999999876554444444567


Q ss_pred             cccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          941 GTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       941 gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      +++.|+|||++.     ...++.++||||+||++|||++|+.||......           .....+.....+ ......
T Consensus       165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~-~~~~~~  232 (280)
T cd06611         165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----------RVLLKILKSEPP-TLDQPS  232 (280)
T ss_pred             cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----------HHHHHHhcCCCC-CcCCcc
Confidence            899999999874     344678999999999999999999998643211           111111111111 111112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         233 KWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            233467889999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.3e-32  Score=297.13  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=192.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|... +++.+++|.++..... ........++..++.++|+||+++++++...+..++|+||++++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG   84 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence            356899999999999875 6788999988654432 12233455666778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--  936 (1048)
                      +|.+++...   ..+++..+..++.+++.|+.|||+.   +|+||||+|+||++++++.+||+|||.+..........  
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          85 TLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             cHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            999999653   2367889999999999999999999   99999999999999999999999999998765443322  


Q ss_pred             --cccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          937 --SELAGTCGYIAPELAYTMR---ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       937 --~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                        ....++..|+|||++.+..   ++.++||||||+++||+++|+.||.....          .......... ...+..
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----------~~~~~~~~~~-~~~~~~  227 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGA-GHKPPI  227 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----------hHHHHHHHhc-CCCCCC
Confidence              2356788999999988766   78999999999999999999999863210          0011111111 111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +........+.+++.+||+.+|++|||+.|++.
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111222456778999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.6e-32  Score=301.76  Aligned_cols=260  Identities=20%  Similarity=0.291  Sum_probs=192.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|++|.||+|+.. +++.||+|++..............++..++.++|+||+++++++.+.+..++||||+++ +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~   83 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D   83 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence            456899999999999986 57889999886543332222334566777889999999999999999999999999985 8


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +.+++........+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.............
T Consensus        84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  160 (284)
T cd07836          84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE  160 (284)
T ss_pred             HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccc
Confidence            999886655445689999999999999999999998   99999999999999999999999999997654433333345


Q ss_pred             ccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Ccccccchhhhhh--hccCCCCC
Q 045493          940 AGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAANMNIVVND--LIDSRLPP 1009 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~--~~~~~~~~ 1009 (1048)
                      .++..|+|||++.+. .++.++||||+||++||+++|+.||.........       ..+..........  ......+.
T Consensus       161 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd07836         161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPR  240 (284)
T ss_pred             cccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccC
Confidence            678899999988654 4689999999999999999999998643211000       0000000000000  00011111


Q ss_pred             Cchh-----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 PLGE-----VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....     .......+.+++.+|++.||++||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         241 YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1000     1122456789999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-32  Score=304.89  Aligned_cols=249  Identities=22%  Similarity=0.227  Sum_probs=188.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...+|+|+||.||++... +++.||+|.+.......  ......+++..++.++||||+++++++..++..++||||+++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG   85 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence            356899999999999886 56789999876543211  111233455667888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC----
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS----  933 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~----  933 (1048)
                      |+|.+++...+   .+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+|++|||+++......    
T Consensus        86 ~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          86 GDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999996543   478899999999999999999998   99999999999999999999999999986421100    


Q ss_pred             -----------CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh
Q 045493          934 -----------SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       934 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                                 .......++..|+|||++.+..++.++|||||||++||+++|+.||....           ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----------~~~~~~~~  228 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----------PEELFGQV  228 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHH
Confidence                       00112457889999999988889999999999999999999999975221           11122222


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .......+... ......+.+++.+||+.||++||++.++.+.++
T Consensus       229 ~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         229 ISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            22221111111 123456789999999999999999665555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-32  Score=300.77  Aligned_cols=245  Identities=26%  Similarity=0.395  Sum_probs=192.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|++|.||+|... +++.+++|++....... .....+++..++.++||||+++++++...+..++|+||++++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~  101 (285)
T cd06648          23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG  101 (285)
T ss_pred             cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH-HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence            3457999999999999875 67889999875432221 222344566678889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||+|+||+++.++.++++|||.+............
T Consensus       102 ~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648         102 ALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            99999865    2478899999999999999999999   9999999999999999999999999998765544333344


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..|++.|+|||+..+..++.++||||+||++|||++|+.||.....           .......... .++.........
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~  242 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LQAMKRIRDN-LPPKLKNLHKVS  242 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----------HHHHHHHHhc-CCCCCcccccCC
Confidence            5689999999999888899999999999999999999999753221           0111111111 111111111233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.+++.+||+.+|++|||+.++++
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHcc
Confidence            56889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=305.34  Aligned_cols=247  Identities=21%  Similarity=0.235  Sum_probs=192.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+|... +++.+|+|.+.......  .......+...+..++|+||+++++++.+.+..|+||||+++
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG   85 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence            346899999999999886 48899999886543221  112234456667888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC---
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS---  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~---  934 (1048)
                      ++|.+++... ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++........   
T Consensus        86 ~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          86 GELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             CCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            9999998643 234588999999999999999999998   999999999999999999999999999875532211   


Q ss_pred             --------------------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC
Q 045493          935 --------------------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL  988 (1048)
Q Consensus       935 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  988 (1048)
                                                ......||..|+|||+..+..++.++||||+|+++|+|++|+.||...+.    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----  237 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR----  237 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch----
Confidence                                      11134678899999999998899999999999999999999999863321    


Q ss_pred             CcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 045493          989 PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPT----MQKVCN 1044 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 1044 (1048)
                             ......+.......+.  .......+.+++.+||+.||++|||    ++|+++
T Consensus       238 -------~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 -------DETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -------HHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence                   1112222222221111  1124567889999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-32  Score=297.03  Aligned_cols=243  Identities=26%  Similarity=0.372  Sum_probs=191.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc----ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE----IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ...||+|+||.||+|... +++.|++|.+.......    .......++..++.++|+||+++++++......++||||+
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            356899999999999887 78889999876543221    1223345566678889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++++|.+++.+.   ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.+||+|||.+....... .
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~  157 (258)
T cd06632          85 PGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-F  157 (258)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-c
Confidence            999999999653   3478899999999999999999999   99999999999999999999999999987654332 2


Q ss_pred             ccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc-CCCCCCchh
Q 045493          936 WSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID-SRLPPPLGE 1013 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1013 (1048)
                      .....++..|+|||.+.... ++.++||||+||++|++++|+.||......           ........ ...+..   
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~---  223 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----------AAVFKIGRSKELPPI---  223 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----------HHHHHHHhcccCCCc---
Confidence            34456889999999987766 899999999999999999999998632210           01111111 111111   


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......+.+++.+||+.+|++|||+.++++
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1123356788899999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=302.17  Aligned_cols=253  Identities=20%  Similarity=0.252  Sum_probs=176.1

Q ss_pred             eeeecccccccEEEEEEcCC---CceeeEEeccCCCCcccch-----------hhHHHHHHhhcccCceeeEeeEeeeCC
Q 045493          781 MVLHGTGGCGTVYKAELTSG---DTRAVKKLHSLPTGEIGIN-----------QKGFVSEITEIRHRNIVKFYGFCSHTQ  846 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~---~~vavk~~~~~~~~~~~~~-----------~~~~~~~l~~l~h~niv~~~~~~~~~~  846 (1048)
                      ...||+|+||+||+|...++   ..++++++...........           .......+..+.|++|+++++++....
T Consensus        17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   96 (294)
T PHA02882         17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR   96 (294)
T ss_pred             eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence            44689999999999987654   3334444332222111000           011122234568999999999775443


Q ss_pred             ----eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          847 ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       847 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                          ..++++|++.. ++.+.++...   ..++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        97 ~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         97 CRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             CCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEE
Confidence                34778888754 6777665422   246778899999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCC-------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccc
Q 045493          923 FGTAKFLKPDSS-------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       923 fG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      ||+|+.+.....       ......||+.|+|||+..+..++.++||||+||++|||++|+.||.........  .....
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~--~~~~~  247 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL--IHAAK  247 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--HHHhH
Confidence            999987643221       112346999999999999999999999999999999999999998743211000  00000


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ......+..+....     ....+.+.+++..||+.+|++||+++++++.|.
T Consensus       248 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        248 CDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            01112222222111     122356888999999999999999999998763

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=309.81  Aligned_cols=196  Identities=27%  Similarity=0.403  Sum_probs=171.8

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee------CCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH------TQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~  854 (1048)
                      +.+|+|+||.||+|+++ +|+.||||.+............-.+++.+++++|+|||++++.-+.      .+...+||||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            45899999999999965 8999999999876555445556778888999999999999987643      3467899999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC--CCCc--eEEeccccccccC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD--LEYK--AHVSDFGTAKFLK  930 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~--~~~~--~kl~DfG~a~~~~  930 (1048)
                      |.+|||+..+++......+++.+.+.++.+++.||.|||++   +||||||||.||++-  ++|+  .||+|||.|+.+.
T Consensus        99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~  175 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD  175 (732)
T ss_pred             cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence            99999999998887777899999999999999999999999   999999999999994  3443  7999999999887


Q ss_pred             CCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          931 PDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      ++ ......+||..|.+||++.. +.|+..+|.|||||++||++||..||..
T Consensus       176 d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  176 DN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             CC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            55 46778899999999999984 8899999999999999999999999853

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-32  Score=297.59  Aligned_cols=248  Identities=23%  Similarity=0.399  Sum_probs=191.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|... +++.+|+|.+........     ......+++.++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            456899999999999864 678899998864332111     12334556667888999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~  933 (1048)
                      +++++|.+++.+.+   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++ .+||+|||.+.......
T Consensus        85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          85 MAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             cCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            99999999996533   478899999999999999999999   999999999999998776 59999999998765432


Q ss_pred             C----CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          934 S----NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       934 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      .    ......++..|+|||++.+..++.++||||+|+++|++++|+.||.....       . ...............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~  230 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-------S-NHLALIFKIASATTAP  230 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-------c-chHHHHHHHhccCCCC
Confidence            1    12234688899999999888899999999999999999999999753211       0 0011111111111111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ........++.+++.+|++.+|++|||+.|+++
T Consensus       231 --~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 --SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              112334567888999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-32  Score=297.03  Aligned_cols=243  Identities=24%  Similarity=0.284  Sum_probs=191.3

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||.||+|... +++.+|+|.+......  ........++..++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999886 4788999988654322  1222344556667888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++.+..   .+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99996543   378889999999999999999998   99999999999999999999999999998765432 223456


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      +++.|+|||.+.+..++.++|+||+|+++|||++|+.||.....         ........+.........+  ......
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~--~~~~~~  222 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---------DPMEIYNDILKGNGKLEFP--NYIDKA  222 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---------CHHHHHHHHhccCCCCCCC--cccCHH
Confidence            88999999999888899999999999999999999999763221         1111222222111111111  112457


Q ss_pred             HHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      +.+++.+||+.+|++||+     ++|+++
T Consensus       223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            899999999999999999     788775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-32  Score=301.37  Aligned_cols=259  Identities=20%  Similarity=0.270  Sum_probs=189.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|... +++.||+|++....... .......+++.+++++||||+++++++.+.+..++||||+. +
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~   83 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q   83 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence            456899999999999876 67889999886533222 12234567777889999999999999999999999999996 5


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.... ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+............
T Consensus        84 ~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          84 DLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             CHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            8999886533 34588999999999999999999998   9999999999999999999999999999866543333344


Q ss_pred             cccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCCC-------cccccchhhhhh------hcc
Q 045493          939 LAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP-------APAANMNIVVND------LID 1004 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~~------~~~ 1004 (1048)
                      ..+++.|+|||+..+.. ++.++||||+||++|||+||+.||...+......       ............      ...
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP  239 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence            45788999999887654 5889999999999999999999985432110000       000000000000      000


Q ss_pred             CCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ........ ........+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000 00112345778999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.2e-32  Score=299.64  Aligned_cols=246  Identities=26%  Similarity=0.419  Sum_probs=195.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....+|+|+||.||+|.+. +++.+++|++.....  .......++..++.++|+||+++++++...+..|+|+||++++
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  100 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG  100 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence            3446899999999999887 678899998865333  1223445666778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....  ..+++..+..++.+++.|++|||+.   +|+|+||+|+||+++.++.++|+|||.+............
T Consensus       101 ~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614         101 SLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             cHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence            9999997643  3589999999999999999999998   9999999999999999999999999998765543333344


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..++..|+|||++.+..++.++||||+||++|+|++|+.||......           ...........+. ........
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~-~~~~~~~~  243 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----------RALFLITTKGIPP-LKNPEKWS  243 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcCCCC-CcchhhCC
Confidence            56788999999998888999999999999999999999997632211           0111111111111 11112234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.+++.+||+.+|.+|||+.++++
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhh
Confidence            56888999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-32  Score=297.74  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=188.7

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCccc---------chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG---------INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ..||+|+||.||+|... +++.+|+|++.........         .....++..++.++||||+++++++...+..++|
T Consensus         7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   86 (272)
T cd06629           7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF   86 (272)
T ss_pred             ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence            46899999999999765 6788999987542211110         1223455667888999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++|+|.+++++.   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.++....
T Consensus        87 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          87 LEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             EecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            9999999999999754   3478899999999999999999998   999999999999999999999999999976543


Q ss_pred             CCC--CccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC-
Q 045493          932 DSS--NWSELAGTCGYIAPELAYTMR--ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR- 1006 (1048)
Q Consensus       932 ~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1006 (1048)
                      ...  ......|+..|+|||++....  ++.++||||+|+++||+++|+.||......           ....+..... 
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~  229 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----------AAMFKLGNKRS  229 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----------HHHHHhhcccc
Confidence            211  123356888999999987654  789999999999999999999997532211           0011111010 


Q ss_pred             -CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1007 -LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1007 -~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ...+..........+.+++.+||+.+|++|||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence             011111112334678889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-32  Score=301.11  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=186.9

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeee------CCeE
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSH------TQHL  848 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~------~~~~  848 (1048)
                      .+.....+|+|+||.||+|... +++.+|+|.+......  ......++..+.++ +|+||+++++++..      ....
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE--EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH--HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            3334456899999999999885 5677888876443211  12234455556666 69999999999853      4578


Q ss_pred             EEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      |+||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            99999999999999986533 23477888899999999999999999   999999999999999999999999999876


Q ss_pred             cCCCCCCccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ............|++.|+|||.+.     ...++.++||||+||++|||++|+.||........           .....
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-----------~~~~~  239 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-----------LFLIP  239 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----------hhhHh
Confidence            543333334567899999999875     34578899999999999999999999863321100           00010


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+  ..........+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         240 RNPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hCCCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111  0011223456889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=298.96  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=191.6

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCC------eEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQ------HLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~------~~~  849 (1048)
                      +.-...||+|+||.||+|..+ +++.+++|.+......  ......++..++++ .|+||+++++++....      ..+
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            334456899999999999886 5678888887643321  12345566667777 6999999999996544      489


Q ss_pred             EEEEccCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          850 LVYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      +||||+++++|.++++... ....+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||.+..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            9999999999999986532 234588999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAYT-----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ............|+..|+|||++..     ..++.++||||+||++|||++|+.||......           .....+.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~  231 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----------RALFKIP  231 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----------HHHHHhh
Confidence            6544444445678999999998753     34678999999999999999999998632210           1111111


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ... .+...........+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         232 RNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111 11111122345678899999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.2e-32  Score=300.01  Aligned_cols=240  Identities=24%  Similarity=0.292  Sum_probs=191.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|.+. +++.+|+|.+......  ........+++.+++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG   85 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence            456899999999999876 5788999988643221  1122334566777888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.+||+|||++......   ..
T Consensus        86 ~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          86 GELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            9999999654   3478899999999999999999998   9999999999999999999999999999876433   33


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...+++.|+|||.+.+..++.++||||+|+++|+|++|+.||....           ...............+    ...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~----~~~  221 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----------PIQIYEKILEGKVRFP----SFF  221 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHhcCCccCC----ccC
Confidence            4568999999999988888999999999999999999999976322           1112222222222211    112


Q ss_pred             HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      ...+.+++.+||+.||++||     +++|+++
T Consensus       222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            35678899999999999999     7888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.6e-32  Score=302.00  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=190.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|... +++.+|+|++..... ........++..++.++|+||+++++++...+..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            456899999999999875 688899998753222 112223445566788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++...    .+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.............
T Consensus       104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            99987532    378899999999999999999999   99999999999999999999999999987665443333445


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .|++.|+|||+..+..++.++||||+||++|||++|+.||......           .... ......+...........
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----------~~~~-~~~~~~~~~~~~~~~~~~  244 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------KAMK-MIRDNLPPKLKNLHKVSP  244 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHH-HHHhhCCcccCCcccCCH
Confidence            6889999999998888899999999999999999999997532111           0000 111111111111122334


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+.+++.+||+.+|.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            5778899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.1e-32  Score=293.67  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=191.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|... +++.+|+|.+....... .......+++.++.++||||+++++.+...+..++||||++++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG   84 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence            456899999999999875 67788999886533221 1223345666778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.+++.... ...+++..+.+++.+++.|++|||+.   +|+||||||+||+++.+ +.+|++|||.+....... ...
T Consensus        85 ~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (256)
T cd08220          85 TLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY  159 (256)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence            9999996533 33478899999999999999999999   99999999999999865 468999999998764332 223


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...++..|+|||+..+..++.++||||+|+++|+|++|+.||.....           .............+..   ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~---~~~  225 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PALVLKIMSGTFAPIS---DRY  225 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----------HHHHHHHHhcCCCCCC---CCc
Confidence            45688999999999988889999999999999999999999753221           1111122222111111   123


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+.+++.+||+.+|++|||+.|+++
T Consensus       226 ~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         226 SPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-33  Score=286.17  Aligned_cols=248  Identities=22%  Similarity=0.283  Sum_probs=196.8

Q ss_pred             cchhhhcccCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhh--HHHHHHhh-cccCceeeEeeEee
Q 045493          768 NQELLSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQK--GFVSEITE-IRHRNIVKFYGFCS  843 (1048)
Q Consensus       768 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~--~~~~~l~~-l~h~niv~~~~~~~  843 (1048)
                      ..+.+.+++|.- ..+||+|+||.|..|..+ +.+-+|||++++....+....+-  .+-+.+.- -+-|.+++++.+|.
T Consensus       342 ~~d~i~~tDFnF-l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ  420 (683)
T KOG0696|consen  342 KRDRIKATDFNF-LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ  420 (683)
T ss_pred             cccceeecccce-EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence            344556666643 346899999999999776 45678999887653322211111  11111211 15789999999999


Q ss_pred             eCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       844 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                      ..++.|+||||+.||+|-..++.-+.   +.+..+..+|..||-||.+||++   +||+||+|.+||++|.+|++||+||
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence            99999999999999999999876554   66788899999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          924 GTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       924 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      |+++.-.-+.....+++|||.|+|||++...+|+..+|.|||||++|||+.|+.||+..           ..++.+..+.
T Consensus       495 GmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-----------DE~elF~aI~  563 (683)
T KOG0696|consen  495 GMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-----------DEDELFQAIM  563 (683)
T ss_pred             ccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-----------CHHHHHHHHH
Confidence            99987655666778899999999999999999999999999999999999999998743           2445555665


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCC
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRP 1037 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1037 (1048)
                      +....-+    ...+++.++++...+.+.|.+|.
T Consensus       564 ehnvsyP----KslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHNVSYP----KSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HccCcCc----ccccHHHHHHHHHHhhcCCcccc
Confidence            5554432    45566778888888999999985

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-32  Score=294.80  Aligned_cols=235  Identities=22%  Similarity=0.274  Sum_probs=181.3

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      +|+|+||.||++..+ +++.+|+|.+........    +.+...+ ..+||||+++++++...+..++||||+++|+|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~-~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQL-MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHH-hhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            699999999999876 567788888754322211    1111111 1269999999999999999999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCCCCcccccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSNWSELAG  941 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~g  941 (1048)
                      ++....   .+++..+..++.|+++|+.|||+.   +++||||||+||+++.++ .++++|||.++.....    ....+
T Consensus        99 ~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----~~~~~  168 (267)
T PHA03390         99 LLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SCYDG  168 (267)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----ccCCC
Confidence            997543   589999999999999999999999   999999999999999998 9999999998765432    22468


Q ss_pred             ccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHH
Q 045493          942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSM 1021 (1048)
Q Consensus       942 t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1021 (1048)
                      +..|+|||++.+..++.++||||+||++|||++|+.||......      ... ............    .........+
T Consensus       169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~~----~~~~~~~~~~  237 (267)
T PHA03390        169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------ELD-LESLLKRQQKKL----PFIKNVSKNA  237 (267)
T ss_pred             CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc------hhh-HHHHHHhhcccC----CcccccCHHH
Confidence            89999999999989999999999999999999999998632210      000 011111111111    1112345568


Q ss_pred             HHHHHhccCCCCCCCCC-HHHHHH
Q 045493         1022 IAVAFLCLDANPDCRPT-MQKVCN 1044 (1048)
Q Consensus      1022 ~~l~~~cl~~dP~~RPt-~~evl~ 1044 (1048)
                      .+++.+||+.+|++||+ ++|+++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhc
Confidence            89999999999999996 598875

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-32  Score=297.89  Aligned_cols=243  Identities=19%  Similarity=0.197  Sum_probs=184.1

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHH---HHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGF---VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +||+|+||.||+|... +++.||+|.+.........  .....+   .+.+....||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3799999999999875 5788999988654322111  111111   222344579999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++..+....  .
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            99999998643   3489999999999999999999998   99999999999999999999999999997654322  2


Q ss_pred             cccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....|+..|+|||++.++ .++.++||||+||++|||++|+.||......        ................    +.
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~----~~  220 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--------DKHEIDRMTLTMAVEL----PD  220 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc--------chHHHHHHhhccCCCC----CC
Confidence            345689999999998754 6899999999999999999999998643210        0000000110111111    11


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      .....+.+++.+|+..+|++||     ++.++++.
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            2245688899999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=299.07  Aligned_cols=259  Identities=21%  Similarity=0.270  Sum_probs=190.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||.|++|.||+|... ++..||+|++......+ .......++..++.++|||++++++++.+.+..|+||||++ +
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            346899999999999875 68889999886533221 11233456677888999999999999999999999999995 5


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++..... ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||.+............
T Consensus        83 ~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          83 DLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             CHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            89999865432 3589999999999999999999998   9999999999999999999999999999765433322333


Q ss_pred             cccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Cccccc-------chhhhhhhc
Q 045493          939 LAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAAN-------MNIVVNDLI 1003 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~-------~~~~~~~~~ 1003 (1048)
                      ..++..|+|||++.+. .++.++||||+|+++|||++|+.||.........       ..+...       .........
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            4568899999987664 4689999999999999999999998643321100       000000       000000000


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .................+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00001100111122356889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.7e-32  Score=298.85  Aligned_cols=245  Identities=25%  Similarity=0.394  Sum_probs=192.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|... +++.+|+|.+....... ......++..++.++||||+++++++...+..|+|+||+++|+
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS  102 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH-HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence            346899999999999765 57889999875432221 2233445566788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++.+.    .+++.++..++.+++.|+.|||+.   +++||||||+||+++.++.++|+|||.+.............
T Consensus       103 L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647         103 LTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence            99998642    367889999999999999999999   99999999999999999999999999987665544444455


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .+++.|+|||+..+..++.++|||||||++||+++|+.||..........           ...... .+..........
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----------~~~~~~-~~~~~~~~~~~~  243 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----------LIATNG-TPELQNPEKLSA  243 (293)
T ss_pred             cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----------ehhcCC-CCCCCCccccCH
Confidence            78899999999988889999999999999999999999986432211100           000000 011111222344


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.+++.+||+.+|++||++.+++.+
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            67889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-33  Score=279.74  Aligned_cols=195  Identities=23%  Similarity=0.366  Sum_probs=160.6

Q ss_pred             eeecccccccEEEEEEcC-----CCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELTS-----GDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-----~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  854 (1048)
                      ..||+|+||.||+|..++     ...+|+|+++...+. ......-+++..++.++||||+.+..++-. +..+++++||
T Consensus        30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY  109 (438)
T KOG0666|consen   30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY  109 (438)
T ss_pred             ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence            348999999999995432     237899999765332 233445567777789999999999998865 7889999999


Q ss_pred             cCCCCHHHHHhcc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC----CceEEeccccccc
Q 045493          855 LERGSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE----YKAHVSDFGTAKF  928 (1048)
Q Consensus       855 ~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~  928 (1048)
                      .+. +|.++++-.  .....++...+..|+.||+.|+.|||++   =|+|||+||.||++..+    |.|||+|||+++.
T Consensus       110 AEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~  185 (438)
T KOG0666|consen  110 AEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARL  185 (438)
T ss_pred             hhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence            999 999999643  3345688888999999999999999999   78999999999999877    8999999999998


Q ss_pred             cCCCCCC---ccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          929 LKPDSSN---WSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       929 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      +...-..   ...++-|..|+|||.+.+.. ||.+.||||+|||+.||+|-++.|.
T Consensus       186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            8654322   24567799999999998764 8999999999999999999887664

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.9e-32  Score=299.10  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=190.8

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.||+|.+. +++.||+|++...... ........++..+++++||||+++++++......++||||+ +++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~   84 (286)
T cd07832           6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD   84 (286)
T ss_pred             eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence            45899999999999875 6888999998654322 12233455666778889999999999999999999999999 999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  938 (1048)
                      |.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+........ ....
T Consensus        85 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          85 LSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            999986533  4588999999999999999999999   999999999999999999999999999987654332 2334


Q ss_pred             cccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC-------CCcccccchh------hhhhhcc
Q 045493          939 LAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-------LPAPAANMNI------VVNDLID 1004 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-------~~~~~~~~~~------~~~~~~~ 1004 (1048)
                      ..++..|+|||++.+. .++.++||||+||++|||++|+.||........       ..........      .......
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            5688999999998654 468999999999999999999877753221100       0000000000      0000000


Q ss_pred             CCCCC-Cc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 SRLPP-PL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 ~~~~~-~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..... .. ....+....+.+++.+|++.+|++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000 00 0011234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-32  Score=297.89  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=191.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|.+. +++.||+|+++...... .......+++.++.++|+||+++++++...+..++||||++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   85 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT   85 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence            346899999999999886 57789999886533222 2233456677778899999999999999999999999999997


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  937 (1048)
                      .+..+....   ..+++..+..++.+++.|++|||+.   +++|||++|+||++++++.+||+|||.+........ ...
T Consensus        86 ~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          86 LLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            777665432   3378899999999999999999999   999999999999999999999999999987654432 334


Q ss_pred             ccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc----------CCCcccccchhhhhhhccC-
Q 045493          938 ELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL----------SLPAPAANMNIVVNDLIDS- 1005 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~----------~~~~~~~~~~~~~~~~~~~- 1005 (1048)
                      ...++..|+|||++.+. .++.++||||+|+++|||++|+.||.......          ..+........ ......+ 
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  238 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS-SNPRFAGV  238 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc-cCcccccc
Confidence            45688899999999887 78999999999999999999999986432110          00000000000 0000000 


Q ss_pred             CCCCCch--h-----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1006 RLPPPLG--E-----VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1006 ~~~~~~~--~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+....  .     ......++.+++.+||+.+|++|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000000  0     01124678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.1e-32  Score=297.99  Aligned_cols=257  Identities=20%  Similarity=0.247  Sum_probs=188.5

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~  857 (1048)
                      ..||+|+||.||+|... +++.+|+|+++.....+ ......+++..+.+++||||+++++++...  +..|+||||+++
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~   90 (293)
T cd07843          11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH   90 (293)
T ss_pred             hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc
Confidence            45899999999999887 57789999886543322 112234566778889999999999998777  889999999975


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                       +|.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+...........
T Consensus        91 -~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  164 (293)
T cd07843          91 -DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT  164 (293)
T ss_pred             -CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccc
Confidence             9999886532  2589999999999999999999999   999999999999999999999999999987655433334


Q ss_pred             ccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Ccccccchhhhhhh---c---
Q 045493          938 ELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAANMNIVVNDL---I--- 1003 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~---~--- 1003 (1048)
                      ...+++.|+|||.+.+.. ++.++||||+|+++|||++|+.||.........       ..+..........+   .   
T Consensus       165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (293)
T cd07843         165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT  244 (293)
T ss_pred             cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccc
Confidence            456788999999887644 689999999999999999999998643221000       00000000000000   0   


Q ss_pred             --cCCCCCCchhHHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 --DSRLPPPLGEVEE--KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 --~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        .............  ....+.+++.+||+.+|++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              0000000000011  2456788999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-32  Score=297.15  Aligned_cols=244  Identities=24%  Similarity=0.339  Sum_probs=190.7

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||.||+|+.. +++.+++|.+......  ........+.+.+.+++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999887 4889999988653321  1222334456667888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC------
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS------  934 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~------  934 (1048)
                      .+++++.+   .+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++++|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997543   478999999999999999999998   999999999999999999999999999876543321      


Q ss_pred             --CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          935 --NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       935 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                        ......++..|+|||+.....++.++||||+|+++||+++|+.||....           ...............+..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~~  223 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----------PEEIFQNILNGKIEWPED  223 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHhcCCcCCCcc
Confidence              2234567889999999988889999999999999999999999976322           111222222222221111


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                        ......+.+++.+||+.+|++|||+.++.+.|
T Consensus       224 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         224 --VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence              11245688999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.1e-32  Score=293.85  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=193.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|... ++..+|+|.+....... .......++..++.++|+||+++++++......++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG   84 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence            456899999999999886 57788999875532211 1223345667778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.+++.+.. ...+++..+..++.|++.|++|||+.   +++||||||+||++++++ .+|++|||.+...........
T Consensus        85 ~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          85 DLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             cHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            9999996533 23478999999999999999999998   999999999999999885 469999999987654443334


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...|++.|+|||+..+..++.++||||+||++||+++|+.||.....           ................   ...
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~  226 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----------HQLVLKICQGYFAPIS---PNF  226 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHhcccCCCCC---CCC
Confidence            45688999999999888899999999999999999999999763221           1111122222221111   122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..++.+++.+||+.+|++|||+.|+++.
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         227 SRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            3468889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-34  Score=281.22  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=186.3

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHH----HhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~----l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .||.|+||+|+|..++ +|+..|||+++.....   ..+++...+    ++.-++||||++||.+...+..|+.||.|.-
T Consensus        71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~---keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE---KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HhcCCcchhhhhhhcCccCcEEEEEEeeeccch---HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            4799999999999886 7899999999876542   223333333    3555799999999999888889999999966


Q ss_pred             CCHHHHHhcc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          858 GSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       858 g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                       +++.+-+..  .....+++.-.-.|+....+||.||.+..  .|||||+||+|||++..|.+|+||||++-.+..+ ..
T Consensus       148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iA  223 (361)
T KOG1006|consen  148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IA  223 (361)
T ss_pred             -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-HH
Confidence             776655321  22345777777788888999999999875  8999999999999999999999999998766533 22


Q ss_pred             cccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC--c
Q 045493          936 WSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP--L 1011 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 1011 (1048)
                      .+.-+|-..|||||.+..  ..|+.++||||+|+++||++||+.||+.++..          -+.+..+..+..|..  .
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----------feql~~Vv~gdpp~l~~~  293 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----------FEQLCQVVIGDPPILLFD  293 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----------HHHHHHHHcCCCCeecCc
Confidence            233467788999998863  35899999999999999999999998754432          111222333333222  1


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+....+..++..|+.+|-..||+.+++.+
T Consensus       294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            222345678899999999999999999999875

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=3.7e-32  Score=299.49  Aligned_cols=250  Identities=24%  Similarity=0.285  Sum_probs=185.1

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.||++... +++.+|+|++..............++..+.++. |+||+++++++...+..+++|||+.. +
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~   88 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S   88 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence            35899999999999876 578899998865433322223344555566775 99999999999988899999999865 6


Q ss_pred             HHHHHhc--cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          860 LATILSN--EATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       860 L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +.++...  ......+++..+..++.+++.|++|||+..  +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  165 (288)
T cd06616          89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-KT  165 (288)
T ss_pred             HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-cc
Confidence            6554321  112245889999999999999999999742  899999999999999999999999999976543322 23


Q ss_pred             ccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC-chh
Q 045493          938 ELAGTCGYIAPELAYTM---RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP-LGE 1013 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1013 (1048)
                      ...|+..|+|||++.+.   .++.++||||+||++|||++|+.||.....          .............+.. ...
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHhhhcCCCCCcCCCcC
Confidence            34688899999998776   689999999999999999999999763220          0011111111111110 111


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......++.+++.+||+.+|++|||++++++.
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12345578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.98  E-value=7e-32  Score=294.85  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=187.7

Q ss_pred             eeecccccccEEEEEEc----CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCC------eEEE
Q 045493          782 VLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------HLFL  850 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------~~~l  850 (1048)
                      ..||+|+||.||+|.+.    +++.+|+|.+....... .......+++.++.++||||+++++++...+      ..++
T Consensus         5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05074           5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV   84 (273)
T ss_pred             hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence            35899999999999764    35789999886533222 1122344566778899999999999886432      2478


Q ss_pred             EEEccCCCCHHHHHhccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          851 VYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      ++||+++|+|.+++....   ....+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++
T Consensus        85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccc
Confidence            999999999998875322   223478889999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......  ......+++.|+|||......++.++||||+||++|||++ |+.||.....           ......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----------~~~~~~~~~  230 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----------SEIYNYLIK  230 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----------HHHHHHHHc
Confidence            6643321  1123345678999999988889999999999999999999 8888653211           111111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......   .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       231 ~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRLKQ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            111111   01233578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=6e-32  Score=299.01  Aligned_cols=261  Identities=20%  Similarity=0.237  Sum_probs=186.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCe-----EEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQH-----LFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~-----~~lv  851 (1048)
                      ....||+|+||.||+|.+. +++.||+|++....... .......++..++.+ +||||+++++++...+.     .|+|
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv   84 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV   84 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence            3456899999999999876 67889999876543222 122334456667777 46999999999876655     8999


Q ss_pred             EEccCCCCHHHHHhcccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccc
Q 045493          852 YEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKF  928 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~  928 (1048)
                      |||+++ ++.+++.....  ...+++..+..++.||+.||+|||+.   +|+||||||+||+++. ++.+||+|||.+..
T Consensus        85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            999986 89888865332  24579999999999999999999999   9999999999999998 89999999999986


Q ss_pred             cCCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC-------cccccchhhhh
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP-------APAANMNIVVN 1000 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~ 1000 (1048)
                      +...........+++.|+|||++.+ ..++.++||||+|+++|||++|+.||..........       .+.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            5433333333457889999998865 457899999999999999999999986432211000       00000000000


Q ss_pred             hh----ccCCCCCC--chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 DL----IDSRLPPP--LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ~~----~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..    ..+...+.  ..........+.+++.+||++||++|||++|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00    00000000  0001123456889999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.5e-32  Score=300.97  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=199.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc-chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG-INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~-~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|.|+.|..|++. ++..||+|.+.+..-.... ....++++.|+.++|||||+++.+.......|+||||+.+
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            3446899999999999876 7899999998776544322 2346778888999999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |.+++|+.+.+.   .....+..++.|+.+|++|||++   .|||||||++||+++.+.++||+|||++.++. ......
T Consensus       140 ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lq  212 (596)
T KOG0586|consen  140 GELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLMLQ  212 (596)
T ss_pred             chhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-cccccc
Confidence            999999987665   33477889999999999999999   99999999999999999999999999999887 445567


Q ss_pred             ccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ..+|++.|.|||++.+.+| ++.+|+||+|+++|-++.|..||+....           ...-..++.+++..+..    
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----------k~Lr~rvl~gk~rIp~~----  277 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----------KELRPRVLRGKYRIPFY----  277 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------ccccchheeeeecccce----
Confidence            7899999999999999887 6899999999999999999999984331           11122233333333221    


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++-+++++++..+|.+|++++++.+
T Consensus       278 ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  278 MSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eechhHHHHHHhhccCccccCCHHHhhh
Confidence            2234567888899999999999999875

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=1.3e-31  Score=297.66  Aligned_cols=244  Identities=23%  Similarity=0.360  Sum_probs=186.8

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||.||+|... +++.||+|++........  ......++..++.++||||++++++|.+.+..++||||+
T Consensus        18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   97 (307)
T cd06607          18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC   97 (307)
T ss_pred             hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence            34456899999999999876 678899998854322211  122345566678889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++ ++.+++....  ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++......   
T Consensus        98 ~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          98 LG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             CC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            74 7777765322  3478999999999999999999998   9999999999999999999999999998765332   


Q ss_pred             ccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 WSELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                       ....+++.|+|||++.   ...++.++||||||+++|||++|+.||.......           ..........+. . 
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----------~~~~~~~~~~~~-~-  234 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----------ALYHIAQNDSPT-L-  234 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----------HHHHHhcCCCCC-C-
Confidence             2346788999999874   3567899999999999999999999975322110           001111111111 1 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ........+.+++.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            112344568899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=4.5e-32  Score=301.82  Aligned_cols=260  Identities=24%  Similarity=0.294  Sum_probs=189.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|... +++.||+|+++...... .......++..+++++|+||+++++++.+.  +..++||||+
T Consensus        11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (309)
T cd07845          11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC   90 (309)
T ss_pred             EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence            3456899999999999876 58889999886433222 122334567778899999999999998654  5689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++ +|.+++....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.........
T Consensus        91 ~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          91 EQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             CC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            75 8888886432  4588999999999999999999999   9999999999999999999999999999876544333


Q ss_pred             cccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC-------cccccchhhhh------h
Q 045493          936 WSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP-------APAANMNIVVN------D 1001 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~------~ 1001 (1048)
                      .....++..|+|||++.+ ..++.++||||+||++|||++|+.||...+......       ...........      .
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK  244 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence            334456788999999865 457899999999999999999999986433211000       00000000000      0


Q ss_pred             hccCCCCCC-c-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1002 LIDSRLPPP-L-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1002 ~~~~~~~~~-~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+..+.. . .........+.+++.+|++.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000 0 0001124567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=6.3e-32  Score=296.81  Aligned_cols=256  Identities=20%  Similarity=0.233  Sum_probs=185.4

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeC--CeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHT--QHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~  857 (1048)
                      ..+|+|+||.||+|... +++.+|+|+++.............++..+.++. |+||+++++++.+.  +..++||||+++
T Consensus         5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   84 (282)
T cd07831           5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM   84 (282)
T ss_pred             eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc
Confidence            45899999999999875 678899998865433222222334555566664 99999999999877  889999999975


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                       ++.+.+....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++. +.+||+|||.++....... ..
T Consensus        85 -~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~  156 (282)
T cd07831          85 -NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YT  156 (282)
T ss_pred             -cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-cC
Confidence             8888876432  3589999999999999999999999   9999999999999999 9999999999987643322 23


Q ss_pred             cccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Ccccccchhhhh--hhccCCC
Q 045493          938 ELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAANMNIVVN--DLIDSRL 1007 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~--~~~~~~~ 1007 (1048)
                      ...++..|+|||+... ..++.++||||+||++|||++|+.||...+.....       ............  .......
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            3467889999997654 45789999999999999999999998643221000       000000000000  0000000


Q ss_pred             CCCc-----hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1008 PPPL-----GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1008 ~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +...     .........+.+++.+||+++|++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            1000     0012335679999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4e-32  Score=323.61  Aligned_cols=249  Identities=25%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             eecccccccEEEEEEc----C----CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          783 LHGTGGCGTVYKAELT----S----GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~----~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+|+|+||.||+|...    .    ...||||..+.............++..++.+ +|+||+.++|+|..++..++|+|
T Consensus       303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E  382 (609)
T KOG0200|consen  303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE  382 (609)
T ss_pred             eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence            6899999999999643    1    3468999987765554344445555556555 59999999999999999999999


Q ss_pred             ccCCCCHHHHHhccc-------c----c--cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEE
Q 045493          854 YLERGSLATILSNEA-------T----A--AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV  920 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl  920 (1048)
                      |++.|+|.++++..+       .    .  ..++....+.++.|||.|++||++.   ++||||+.++|||++++..+||
T Consensus       383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kI  459 (609)
T KOG0200|consen  383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKI  459 (609)
T ss_pred             eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEE
Confidence            999999999997655       0    0  2378889999999999999999999   9999999999999999999999


Q ss_pred             eccccccccCCCCCCc-ccccc--ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccch
Q 045493          921 SDFGTAKFLKPDSSNW-SELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       921 ~DfG~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      +|||+|+......... ....|  ...|||||.+....|+.|+|||||||++||++| |..||....          ...
T Consensus       460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~----------~~~  529 (609)
T KOG0200|consen  460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP----------PTE  529 (609)
T ss_pred             ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC----------cHH
Confidence            9999999765544332 22222  346999999999999999999999999999999 778864211          112


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..++.+.++.....+   ..+..+++++|..||+.+|++||++.|+.+.++
T Consensus       530 ~l~~~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  530 ELLEFLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             HHHHHHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            223344444433322   344667899999999999999999999999886

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=1.2e-34  Score=312.39  Aligned_cols=372  Identities=28%  Similarity=0.414  Sum_probs=253.9

Q ss_pred             CCCCCccEEeCCCCccc-ccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccc
Q 045493           21 LLFPQLAYLDLSVNQLF-GTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLN   99 (1048)
Q Consensus        21 ~~~~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~   99 (1048)
                      .+.|-++-.|+++|.+. +..|.+...++.+++|.|...++. .+|..++.+.+|++|.++||++++ +-..+..|+.|+
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLR   81 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhH
Confidence            45677889999999998 579999999999999999999998 799999999999999999999996 567789999999


Q ss_pred             cccccceeccc-ccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCC
Q 045493          100 ELALSYNRLNG-SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS  178 (1048)
Q Consensus       100 ~L~l~~n~~~~-~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~  178 (1048)
                      .+++.+|++.. -+|..+-+|.-|..||||+|++.                -+|..+.                      
T Consensus        82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~----------------EvP~~LE----------------------  123 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR----------------EVPTNLE----------------------  123 (1255)
T ss_pred             HHhhhccccccCCCCchhcccccceeeecchhhhh----------------hcchhhh----------------------
Confidence            99999998873 46777889999999999999987                2334444                      


Q ss_pred             CCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccc
Q 045493          179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL  258 (1048)
Q Consensus       179 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  258 (1048)
                        .-+++-.|+|++|+|..+..+-|.+|+.|-+||||+|++. .+|+....|.+|++|+|++|.+...--..+..+++|+
T Consensus       124 --~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~  200 (1255)
T KOG0444|consen  124 --YAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLS  200 (1255)
T ss_pred             --hhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhh
Confidence              4445555555555555333344455566666666666655 4555555566666666666655433333444555555


Q ss_pred             eeeccccccc-CCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeecc
Q 045493          259 YLYLSHNQLN-GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE  337 (1048)
Q Consensus       259 ~L~L~~n~l~-~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~  337 (1048)
                      +|.+++.+-+ ..+|.++..|.+|..++++. |++. .+|+.+-++.+|+.|+|++|+|+ .+....+.+.+|+.|+++.
T Consensus       201 vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~-N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSr  277 (1255)
T KOG0444|consen  201 VLHMSNTQRTLDNIPTSLDDLHNLRDVDLSE-NNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSR  277 (1255)
T ss_pred             hhhcccccchhhcCCCchhhhhhhhhccccc-cCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhcccc
Confidence            5555554432 23555566666666666654 4444 45666666666666666666666 3444555566666666666


Q ss_pred             ccccCCCCcchhccCCCCeEeccCCccccC-cChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCC
Q 045493          338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGS-IPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL  416 (1048)
Q Consensus       338 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  416 (1048)
                      |+++ .+|+.+..+++|+.|.+.+|+++.. +|..++.|.+|+++..++|.+. ..|+.+..+.+|++|.|+.|++. .+
T Consensus       278 NQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TL  354 (1255)
T KOG0444|consen  278 NQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TL  354 (1255)
T ss_pred             chhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-ec
Confidence            6666 5666666666677666666666532 5666666777777776666665 66667777777777777777665 35


Q ss_pred             CcccccCCcccEEEeecccccCCCC
Q 045493          417 PQNVCQSGSLTHFSVRNNNFVGPIP  441 (1048)
Q Consensus       417 ~~~~~~~~~L~~L~l~~N~l~~~~~  441 (1048)
                      |+.+.-++.|+.||+..|.-....|
T Consensus       355 PeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  355 PEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             hhhhhhcCCcceeeccCCcCccCCC
Confidence            6666666677777777665333333

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.98  E-value=1.6e-31  Score=288.24  Aligned_cols=245  Identities=28%  Similarity=0.430  Sum_probs=193.7

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|++|.||+|... +++.+++|++..... ........+++.++.++|++|+++++++......++++||+++++|
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   84 (253)
T cd05122           6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL   84 (253)
T ss_pred             eeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence            46899999999999886 678899998865443 1223345566677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++....  ..+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........ .....
T Consensus        85 ~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~  158 (253)
T cd05122          85 KDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV  158 (253)
T ss_pred             HHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-cccee
Confidence            99986532  4589999999999999999999998   999999999999999999999999999987654432 34456


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      ++..|+|||+..+..++.++||||+|+++|+|++|+.||...+.           ......... ...+...........
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~~  226 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----------MKALFKIAT-NGPPGLRNPEKWSDE  226 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----------HHHHHHHHh-cCCCCcCcccccCHH
Confidence            88999999999888899999999999999999999999763321           011111111 111111111112456


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         227 FKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcC
Confidence            8899999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=7.3e-32  Score=298.05  Aligned_cols=259  Identities=21%  Similarity=0.270  Sum_probs=186.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|++|+||+|... +++.||+|++...... ........+++.+++++||||+++++++......|+||||+++ 
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   85 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-   85 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-
Confidence            346899999999999876 6788999988653322 1122344567778889999999999999999999999999964 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      ++.+++..... ..+++..+..++.||+.||+|||+.   +|+||||+|+||+++. ++.+|++|||++...........
T Consensus        86 ~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (294)
T PLN00009         86 DLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT  161 (294)
T ss_pred             cHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccc
Confidence            88888754332 2357788889999999999999999   9999999999999985 56799999999976543333334


Q ss_pred             ccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccccc-hhhhhhhc--c
Q 045493          938 ELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAANM-NIVVNDLI--D 1004 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~-~~~~~~~~--~ 1004 (1048)
                      ...+++.|+|||++.+. .++.++||||+||++|+|+||+.||........         .+....+. .....+..  .
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T PLN00009        162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF  241 (294)
T ss_pred             cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc
Confidence            45678899999988664 578999999999999999999999864321100         00000000 00000000  0


Q ss_pred             CCCCCCc--hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPPL--GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +......  .........+.+++.+|++.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000  001122345788999999999999999999986

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=5.8e-32  Score=304.41  Aligned_cols=257  Identities=20%  Similarity=0.344  Sum_probs=186.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e  853 (1048)
                      ....||+|+||.||+|.+. +++.||+|++..............++..++.++||||+++++++...     ...|+|+|
T Consensus         9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   88 (336)
T cd07849           9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE   88 (336)
T ss_pred             EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence            3456899999999999875 67889999886433332223344567777889999999999987543     35799999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++ ++.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          89 LMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             hccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            9975 88888753    2488899999999999999999999   99999999999999999999999999997654322


Q ss_pred             CC---cccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhh--
Q 045493          934 SN---WSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIV--  998 (1048)
Q Consensus       934 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~--  998 (1048)
                      ..   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+...         +.+... .....  
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  239 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE-DLNCIIS  239 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH-HHHHhhc
Confidence            21   233568899999998654 468999999999999999999999986432110         000000 00000  


Q ss_pred             --hhhhccC-CCCC--Cch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 --VNDLIDS-RLPP--PLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 --~~~~~~~-~~~~--~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        ....... ....  +.. .......++.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000 0000  000 011234568899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=1.2e-31  Score=296.34  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=183.5

Q ss_pred             eeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||+|.+.. ++.||||.+..............++..+... .||||+++++++.+....|+||||+++ 
T Consensus        20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-   98 (296)
T cd06618          20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-   98 (296)
T ss_pred             eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-
Confidence            4568999999999999874 8889999986543222111122233333344 499999999999999999999999854 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.++.....  ..+++..+..++.|++.|++|||+..  +|+||||+|+||++++++.+||+|||.+..+..... ...
T Consensus        99 ~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~  173 (296)
T cd06618          99 CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTR  173 (296)
T ss_pred             CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-ccC
Confidence            7877765422  35889999999999999999999732  899999999999999999999999999976643322 233


Q ss_pred             cccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          939 LAGTCGYIAPELAYTMR----ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ..++..|+|||++.+..    ++.++||||||+++|||++|+.||.....          .............+.. ...
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~-~~~  242 (296)
T cd06618         174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----------EFEVLTKILQEEPPSL-PPN  242 (296)
T ss_pred             CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----------HHHHHHHHhcCCCCCC-CCC
Confidence            45788999999987654    78899999999999999999999753110          0111112222211111 011


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....++.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1234568899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=5e-32  Score=293.31  Aligned_cols=245  Identities=23%  Similarity=0.272  Sum_probs=193.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|.+. +++.+|+|.+......  .......++++.+++++||||+++++++......++|+||+++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG   84 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence            456899999999999886 5888999988653321  1122345566677889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      ++|.+++...   ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++++|||.+....... ...
T Consensus        85 ~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~  157 (258)
T cd05578          85 GDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTT  157 (258)
T ss_pred             CCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccc
Confidence            9999999654   3478899999999999999999998   99999999999999999999999999998664332 234


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...|+..|+|||+..+..++.++||||+|+++|+|++|+.||......        ................    +...
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~  225 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--------IRDQIRAKQETADVLY----PATW  225 (258)
T ss_pred             ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--------HHHHHHHHhccccccC----cccC
Confidence            456888999999999888999999999999999999999998643210        0111111111111111    1223


Q ss_pred             HHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTM--QKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~--~evl~ 1044 (1048)
                      ...+.+++.+||+.||.+||++  +|+++
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         226 STEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             cHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            3678899999999999999999  77764

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1e-31  Score=300.48  Aligned_cols=260  Identities=19%  Similarity=0.276  Sum_probs=187.6

Q ss_pred             eeecccccccEEEEEEcC---CCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELTS---GDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~---~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  854 (1048)
                      ..||+|+||.||+|....   ++.||+|.+.....  .........++..++.++||||+++++++.+.  +..++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            458999999999998764   68899999876331  11122334566677889999999999999887  889999999


Q ss_pred             cCCCCHHHHHhcccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC----CCceEEeccccccc
Q 045493          855 LERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL----EYKAHVSDFGTAKF  928 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~----~~~~kl~DfG~a~~  928 (1048)
                      +++ ++.+++.....  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+|++|||++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            976 77777643321  23578899999999999999999999   9999999999999999    89999999999987


Q ss_pred             cCCCCC---CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC--CCcccccchhhhh--
Q 045493          929 LKPDSS---NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS--LPAPAANMNIVVN-- 1000 (1048)
Q Consensus       929 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~-- 1000 (1048)
                      ......   ......+++.|+|||++.+. .++.++||||+||++|||++|+.||.....-..  .+.........+.  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL  241 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence            643322   12345678899999988764 578999999999999999999999864332110  0000000000000  


Q ss_pred             ----------------------hhccCCCCC-CchhHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 ----------------------DLIDSRLPP-PLGEVE----EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ----------------------~~~~~~~~~-~~~~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                                            .......+. ......    .....+.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                                  000000110 000000    233568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=2.6e-31  Score=287.70  Aligned_cols=248  Identities=22%  Similarity=0.360  Sum_probs=196.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|+||.||++.+. +++.+|+|++...... ........+++.++.++|+|++++++.+...+..++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~   84 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG   84 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence            346899999999999886 5788999988654332 22223345566678889999999999999999999999999999


Q ss_pred             CHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.+++.+.. ....+++.++..++.+++.|++|||+.   +++||||+|+||+++.++.++|+|||.+...........
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  161 (258)
T cd08215          85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK  161 (258)
T ss_pred             cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence            9999997542 135689999999999999999999999   999999999999999999999999999987655443334


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...|++.|+|||...+..++.++||||+|+++|+|++|+.||....           ..............+...   ..
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~~---~~  227 (258)
T cd08215         162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----------LLELALKILKGQYPPIPS---QY  227 (258)
T ss_pred             ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----------HHHHHHHHhcCCCCCCCC---CC
Confidence            4578899999999988889999999999999999999999976322           111222222222222111   23


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+.+++.+||..+|++|||+.|+++.
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            3568889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.7e-31  Score=300.70  Aligned_cols=258  Identities=20%  Similarity=0.225  Sum_probs=187.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-------------cchhhHHHHHHhhcccCceeeEeeEeeeCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-------------GINQKGFVSEITEIRHRNIVKFYGFCSHTQ  846 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-------------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~  846 (1048)
                      ...||+|+||+||+|.+. +++.||+|++........             ......++..++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            346899999999999876 688999998865332210             012345566678889999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccc
Q 045493          847 HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA  926 (1048)
Q Consensus       847 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a  926 (1048)
                      ..++||||++ |+|.+++...   ..+++.....++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence            9999999997 5999998643   3478899999999999999999998   9999999999999999999999999999


Q ss_pred             cccCC--------------CCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC----
Q 045493          927 KFLKP--------------DSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS----  987 (1048)
Q Consensus       927 ~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~----  987 (1048)
                      .....              .........++..|+|||++.+. .++.++||||+||++|||++|+.||........    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76541              11112233467889999998764 468999999999999999999999864332100    


Q ss_pred             -----CCcccccchh-hh--hhhccCCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          988 -----LPAPAANMNI-VV--NDLIDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       988 -----~~~~~~~~~~-~~--~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                           .+....+... ..  ........+... .........+.+++.+||+.+|++|||++|++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence                 0000000000 00  000000000000 0011224568899999999999999999999863

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=293.13  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=192.6

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|++|.||+|... +++.+++|++......+ .......++..+++++|+||+++++++...+..++||||+++ +
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            45899999999999876 67889999886543331 122334556677888999999999999999999999999976 8


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+.............
T Consensus        84 l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          84 LYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             HHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            888886532  4588999999999999999999999   99999999999999999999999999998775543233345


Q ss_pred             ccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccc--cchh----hhhhhc
Q 045493          940 AGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAA--NMNI----VVNDLI 1003 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~--~~~~----~~~~~~ 1003 (1048)
                      .++..|+|||...+. .++.++||||+|+++|+|++|+.||...+....         .+....  ....    ......
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            678899999998776 689999999999999999999999864332110         000000  0000    000000


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .................+.+++.+||++||.+||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            001111111123345678999999999999999999999863

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=4e-31  Score=294.97  Aligned_cols=243  Identities=23%  Similarity=0.348  Sum_probs=186.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|... +++.+|+|++.......  .......+++.++.++|||++++++++.+....++||||++
T Consensus        29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  108 (317)
T cd06635          29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL  108 (317)
T ss_pred             hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence            3445899999999999875 57889999876432221  11223445666788899999999999999999999999997


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      + ++.+++...  ...+++.++..++.+++.|+.|||+.   +|+||||+|+||+++.++.+||+|||++......    
T Consensus       109 g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         109 G-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             C-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            5 787777543  23488999999999999999999999   9999999999999999999999999998754322    


Q ss_pred             cccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          937 SELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ....|++.|+|||++.   .+.++.++||||+||++|||++|+.||....           .......+.....+...  
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~--  245 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHIAQNESPTLQ--  245 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHHhccCCCCC--
Confidence            2346888999999974   4568899999999999999999999975321           11111122221111111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence            12334568889999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=2.9e-31  Score=297.65  Aligned_cols=256  Identities=19%  Similarity=0.257  Sum_probs=184.3

Q ss_pred             eccc--ccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          784 HGTG--GCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       784 lG~G--~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ||+|  +||+||+|++. +++.||+|.+....... .....++++..++.++||||++++++|...+..++||||+.+|+
T Consensus         6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~   85 (328)
T cd08226           6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS   85 (328)
T ss_pred             hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCC
Confidence            5665  99999999875 78999999876433222 11233445555677899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc---
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~---  936 (1048)
                      +.+++.+... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+..........   
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          86 ANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             HHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999875432 3478889999999999999999998   99999999999999999999999998654332211111   


Q ss_pred             ----cccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCcccccc-------cCCCccccc---chhh--
Q 045493          937 ----SELAGTCGYIAPELAYTM--RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL-------LSLPAPAAN---MNIV--  998 (1048)
Q Consensus       937 ----~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~-------~~~~~~~~~---~~~~--  998 (1048)
                          ....++..|+|||++.+.  .++.++||||+||++|||++|+.||......       ...+.....   ....  
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence                112345679999998764  4789999999999999999999998643210       000000000   0000  


Q ss_pred             --------h-----h---------hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 --------V-----N---------DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 --------~-----~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                              .     .         .+......  ..........+.+++.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    0     0         00000000  11123455678999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2e-31  Score=288.22  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.||++... +++.+|+|++......+ .......++..++.++|+||+++++++.+....++||||+++++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (256)
T cd08530           6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD   85 (256)
T ss_pred             eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence            45899999999999765 67789999886533222 11222345566788899999999999999999999999999999


Q ss_pred             HHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          860 LATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       860 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      |.+++.+.. ....+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.+|++|||++......  ....
T Consensus        86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~  160 (256)
T cd08530          86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKT  160 (256)
T ss_pred             HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cccc
Confidence            999986532 224578899999999999999999999   9999999999999999999999999999876544  2233


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..+++.|+|||...+..++.++|+||+|+++||+++|+.||...+.           ............+...   ....
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~~  226 (256)
T cd08530         161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----------QDLRYKVQRGKYPPIP---PIYS  226 (256)
T ss_pred             ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhcCCCCCCc---hhhC
Confidence            5688899999999998899999999999999999999999863221           1111222222222221   2445


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .++.+++.+|++.+|++|||+.|+++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         227 QDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3e-31  Score=291.57  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=189.0

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||+||+|... +++.+++|++..............++..+++++ |+||+++++++.+.+..++||||+ +|+
T Consensus         5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~   83 (283)
T cd07830           5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN   83 (283)
T ss_pred             eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence            45899999999999886 467889998765433222222334566677788 999999999999999999999999 779


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      +.+++.... ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        84 l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~  158 (283)
T cd07830          84 LYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTDY  158 (283)
T ss_pred             HHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCCC
Confidence            999886543 23579999999999999999999998   99999999999999999999999999998664322 22345


Q ss_pred             cccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccch-hhhhhhccCCCC
Q 045493          940 AGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMN-IVVNDLIDSRLP 1008 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~-~~~~~~~~~~~~ 1008 (1048)
                      .++..|+|||++.. ..++.++||||||+++|||++|+.||.......         ..+....... ...........+
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP  238 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence            68889999998754 457899999999999999999999985432110         0000000000 000000111111


Q ss_pred             CCc----hh-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1009 PPL----GE-VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1009 ~~~----~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...    .. .......+.+++.+||+.+|++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000    00 01113568899999999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-31  Score=286.79  Aligned_cols=244  Identities=26%  Similarity=0.404  Sum_probs=194.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...||+|++|.||+|... +++.+++|.+...... ........+++.+++++|+|++++++++...+..++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG   84 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence            346899999999999876 5778999998765432 11223345566678889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.+.   ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+............
T Consensus        85 ~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          85 SLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             cHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence            999998654   3488999999999999999999999   9999999999999999999999999999877655444445


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..++..|+|||...+..++.++||||+|+++|+|++|+.||......           ...........+...   ....
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~---~~~~  224 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----------AALFRIVQDDHPPLP---EGIS  224 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHhccCCCCCC---CCCC
Confidence            67889999999998888899999999999999999999997632211           111111111111111   1223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.+++.+||+.+|++|||+.|++.
T Consensus       225 ~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         225 PELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            46788999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.7e-31  Score=300.55  Aligned_cols=259  Identities=20%  Similarity=0.248  Sum_probs=188.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~  852 (1048)
                      ....||+|+||+||+|... +++.||+|++...... ........++..++.++|+||+++++++...     ...|+||
T Consensus         9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07858           9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY   88 (337)
T ss_pred             EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence            3456899999999999875 6789999988653221 1122234456667888999999999988643     3579999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+. ++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          89 ELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             eCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            9996 5899888643   3488999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCccccc---chhhh
Q 045493          933 SSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAAN---MNIVV  999 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~---~~~~~  999 (1048)
                      ........++..|+|||.+.. ..++.++||||+||++|+|++|+.||......         .+.+.....   .....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence            333344568889999998765 46889999999999999999999998643210         000000000   00000


Q ss_pred             hhhccC--CCCC--CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1000 NDLIDS--RLPP--PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1000 ~~~~~~--~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......  ..+.  ...........+.+++.+||+.+|++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000  0000  001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=6e-31  Score=285.10  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=195.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  856 (1048)
                      ...||+|++|.||+|... +++.+++|++...... ........++..+++++|+||+++++++...  ...++|+||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            456899999999999887 6888999988654332 1122345566677888999999999999888  88999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      +++|.+++....   .+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........  
T Consensus        85 ~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          85 GGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999997543   589999999999999999999998   999999999999999999999999999987765432  


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......++..|+|||...+..++.++||||+|+++|++++|+.||.....          ..............+.  ..
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~--~~  226 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----------PMAALYKIGSSGEPPE--IP  226 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------hHHHHHhccccCCCcC--CC
Confidence            13445688999999999988899999999999999999999999864330          1111111111111111  11


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+|++.+|++||++.|+++
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            222467889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.6e-31  Score=314.23  Aligned_cols=262  Identities=18%  Similarity=0.201  Sum_probs=176.5

Q ss_pred             ceeeecccccccEEEEEEcC--CCceeeEEec--------------cC--CCCcccchhhHHHHHHhhcccCceeeEeeE
Q 045493          780 KMVLHGTGGCGTVYKAELTS--GDTRAVKKLH--------------SL--PTGEIGINQKGFVSEITEIRHRNIVKFYGF  841 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~--~~~vavk~~~--------------~~--~~~~~~~~~~~~~~~l~~l~h~niv~~~~~  841 (1048)
                      ....||+|+||+||+|..+.  +...+.|.+.              +.  ...........++..+.+++||||++++++
T Consensus       152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  231 (501)
T PHA03210        152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI  231 (501)
T ss_pred             EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence            34568999999999987642  2222222111              00  001111223456677788999999999999


Q ss_pred             eeeCCeEEEEEEccCCCCHHHHHhcccc--ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceE
Q 045493          842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH  919 (1048)
Q Consensus       842 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~k  919 (1048)
                      +...+..|+|+|++.+ ++.+++.....  ........+..++.|++.||+|||+.   +||||||||+|||++.++.+|
T Consensus       232 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~~vk  307 (501)
T PHA03210        232 LRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV  307 (501)
T ss_pred             EEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            9999999999999965 77777643221  12234566788999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCC-CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-Ccccccc---------cCC
Q 045493          920 VSDFGTAKFLKPDSS-NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP-GHFLSLL---------LSL  988 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p-~~~~~~~---------~~~  988 (1048)
                      |+|||+++.+..... ......||+.|+|||++.+..++.++||||+||++|||++|..+ +......         ...
T Consensus       308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~  387 (501)
T PHA03210        308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL  387 (501)
T ss_pred             EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence            999999987654332 22346799999999999999999999999999999999998754 3221100         000


Q ss_pred             Cccccc---chhhhhhhccC-CCCCCchhHH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          989 PAPAAN---MNIVVNDLIDS-RLPPPLGEVE------EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       989 ~~~~~~---~~~~~~~~~~~-~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......   ......+.+.. ..........      .....+.+++.+|++.||++|||+.|++++
T Consensus       388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            000000   00000000000 0000000000      112356778899999999999999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=300.72  Aligned_cols=255  Identities=23%  Similarity=0.368  Sum_probs=203.4

Q ss_pred             hcccCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhh-cccCceeeEeeEeee-----C
Q 045493          773 SASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITE-IRHRNIVKFYGFCSH-----T  845 (1048)
Q Consensus       773 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~-l~h~niv~~~~~~~~-----~  845 (1048)
                      ..++.+.-.+.||+|.+|.||+++.. +++..|||+.....+.+  .+.+.+.++++. -.|||++.+||+|..     +
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            34445555667999999999999876 56667777765544333  223333444433 369999999999853     5


Q ss_pred             CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          846 QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       846 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      +..|+|||||.+|+.-|++++.. ...+.|+.+..|++.+++|+.+||..   .++|||||-.|||++.++.||++|||.
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence            68999999999999999998765 66789999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhh
Q 045493          926 AKFLKPDSSNWSELAGTCGYIAPELAYTM-----RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       926 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      +..+........+..|||.|||||++.+.     .|+..+|+||+|++..||..|.+|+.+......+            
T Consensus       170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------------  237 (953)
T KOG0587|consen  170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------------  237 (953)
T ss_pred             eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------------
Confidence            99887776777788999999999998754     3678899999999999999999996543322111            


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+.+..|+....+....+++.++|..|+.+|.++||++.+++++
T Consensus       238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            112223344444466778899999999999999999999998763

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.8e-31  Score=300.86  Aligned_cols=256  Identities=20%  Similarity=0.290  Sum_probs=186.0

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~l  850 (1048)
                      .....||+|+||.||+|... +++.||+|++....... .......++..++.++||||+++++++...      ...|+
T Consensus        19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   98 (353)
T cd07850          19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL   98 (353)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence            34456899999999999876 68889999886432221 112233466677888999999999988543      35799


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+.+ ++.+.+...     ++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++...
T Consensus        99 v~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          99 VMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            9999965 888887532     78888999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccc--cchhhh
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAA--NMNIVV  999 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~--~~~~~~  999 (1048)
                      .. .......++..|+|||++.+..++.++||||+||++|+|++|+.||...+...         +.+....  ......
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         170 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CC-CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            32 22234567889999999999999999999999999999999999986432110         0000000  000000


Q ss_pred             hhhccCC---------------C-CCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1000 NDLIDSR---------------L-PPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1000 ~~~~~~~---------------~-~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+..               . +.... ........+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000000               0 00000 01123456789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=3.3e-31  Score=295.82  Aligned_cols=254  Identities=19%  Similarity=0.197  Sum_probs=182.8

Q ss_pred             ccccEEEEEEc-CCCceeeEEeccCC-CCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHh
Q 045493          788 GCGTVYKAELT-SGDTRAVKKLHSLP-TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILS  865 (1048)
Q Consensus       788 ~~g~Vy~~~~~-~~~~vavk~~~~~~-~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  865 (1048)
                      ++|.||.++.. +++.||+|++.... ..+.......++..++.++|+||+++++++...+..+++|||+++|++.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            45556655544 58899999986542 22222344566777788899999999999999999999999999999999997


Q ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-------Cccc
Q 045493          866 NEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-------NWSE  938 (1048)
Q Consensus       866 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-------~~~~  938 (1048)
                      ... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+........       ....
T Consensus        92 ~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          92 THF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             Hhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence            543 23478889999999999999999999   999999999999999999999999999876543221       1123


Q ss_pred             ccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Ccccc---cchhhhhh-----
Q 045493          939 LAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAA---NMNIVVND----- 1001 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~---~~~~~~~~----- 1001 (1048)
                      ..++..|+|||++.+  ..++.++||||+||++|||++|+.||.........       .....   ........     
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR  247 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence            456778999999876  35789999999999999999999998743211000       00000   00000000     


Q ss_pred             --hccCC--CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1002 --LIDSR--LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1002 --~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        ...+.  ..............+.+++.+||+.||++|||++++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              00000  001111122334578889999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=7.7e-31  Score=289.00  Aligned_cols=258  Identities=23%  Similarity=0.300  Sum_probs=186.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHH---hhcccCceeeEeeEeeeCCe-----EEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEI---TEIRHRNIVKFYGFCSHTQH-----LFL  850 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l---~~l~h~niv~~~~~~~~~~~-----~~l  850 (1048)
                      ...||+|+||.||+|+.+ +++.+|+|++......+ .......++..+   ..+.|+||+++++++...+.     .++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            346899999999999987 48899999986543321 111222233333   44569999999999987776     999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      +|||+.+ ++.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||.+....
T Consensus        84 ~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          84 VFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             Eehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9999975 89998865332 3589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------Ccc-cccchhh-h
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------PAP-AANMNIV-V  999 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~~~-~~~~~~~-~  999 (1048)
                      ... ......++..|+|||++.+..++.++||||+||++|||++|+.||.........         +.. ....... .
T Consensus       159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07838         159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP  237 (287)
T ss_pred             CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence            332 223345788999999999989999999999999999999999988643211000         000 0000000 0


Q ss_pred             hhhccCCCCC-CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1000 NDLIDSRLPP-PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1000 ~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......... ...........+.+++.+||+.||++||+++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000000011 11111234467789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-31  Score=290.10  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=189.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCC-CCcccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLP-TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~-~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|... +++.+|+|++.... ..........++..++.++|+|++++++++...  +..++||||++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD   83 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence            346899999999999887 47889999987653 111222334566777888999999999999887  88999999997


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-C
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-N  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~  935 (1048)
                      + +|.+++....  ..+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+|++|||.+........ .
T Consensus        84 ~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          84 H-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             c-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            5 8988886432  3588999999999999999999998   999999999999999999999999999987654332 2


Q ss_pred             cccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-------CCcccccchhhh-----hhh
Q 045493          936 WSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-------LPAPAANMNIVV-----NDL 1002 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~-----~~~ 1002 (1048)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........       ............     ...
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            233456888999998765 4578999999999999999999999864321100       000000000000     000


Q ss_pred             ccCCCCCC--c-hhHHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1003 IDSRLPPP--L-GEVEE-KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1003 ~~~~~~~~--~-~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ........  . ..... ....+.+++.+||+.+|++||+++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00000000  0 00011 14678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.2e-31  Score=285.17  Aligned_cols=245  Identities=22%  Similarity=0.288  Sum_probs=187.1

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC----cccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG----EIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  853 (1048)
                      ...||+|+||.||+|... +++.+|+|.+......    +.......++..++.++|+||+++++++.+.  ...++|+|
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (264)
T cd06653           7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE   86 (264)
T ss_pred             eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence            446899999999999875 5888999987532211    1112334566677889999999999998653  46889999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC-
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-  932 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~-  932 (1048)
                      |+++++|.+++....   .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.++..... 
T Consensus        87 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          87 YMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             eCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            999999999986532   378888999999999999999999   9999999999999999999999999999865321 


Q ss_pred             --CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          933 --SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       933 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                        ........++..|+|||+..+..++.++||||+||++||+++|+.||.....           .....+.......+ 
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~-  228 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----------MAAIFKIATQPTKP-  228 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----------HHHHHHHHcCCCCC-
Confidence              1122345688999999999988899999999999999999999999863211           11111221111111 


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ..+......+.+++.+||+ +|.+|||+.++++.
T Consensus       229 -~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         229 -MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             1122344568888999999 57999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=9.7e-31  Score=291.68  Aligned_cols=260  Identities=23%  Similarity=0.292  Sum_probs=185.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCC--------eEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--------HLF  849 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--------~~~  849 (1048)
                      ....||+|+||.||+|... +++.||+|++......+ .......+++.+++++||||+++++++...+        ..+
T Consensus        16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   95 (310)
T cd07865          16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY   95 (310)
T ss_pred             EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence            3456899999999999876 68889999886543222 1223345677788899999999999886543        459


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+.+ ++.+++...  ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+..+
T Consensus        96 lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          96 LVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            99999975 888887543  23478999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCC----CccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccC----------CCccccc
Q 045493          930 KPDSS----NWSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS----------LPAPAAN  994 (1048)
Q Consensus       930 ~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~----------~~~~~~~  994 (1048)
                      .....    ......++..|+|||+..+.. ++.++||||+|+++|||++|+.||........          .+.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            43222    123345788999999887654 68899999999999999999999864321100          0000000


Q ss_pred             chhhhhhhccCCCCCCch-hHH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          995 MNIVVNDLIDSRLPPPLG-EVE------EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~-~~~------~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .............+.... ...      .....+.+++.+||+.||++|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000000000000000 000      012456789999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=4.1e-31  Score=291.41  Aligned_cols=247  Identities=21%  Similarity=0.272  Sum_probs=186.6

Q ss_pred             eeeecccccccEEEEEEc----CCCceeeEEeccCCCCc---ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGE---IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~---~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ...||+|+||.||+|+..    +++.||+|.+.......   .......+++.+..+ +|++|+++++++..+...|+||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            346899999999999863    67889999886532211   112334566667777 5999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          85 DYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            999999999999653   3478889999999999999999998   9999999999999999999999999999865433


Q ss_pred             C-CCccccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          933 S-SNWSELAGTCGYIAPELAYTM--RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       933 ~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      . .......|+..|+|||+..+.  .++.++||||+|+++|+|++|+.||.....       ................+.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~  231 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-------KNSQAEISRRILKSEPPY  231 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-------cccHHHHHHHhhccCCCC
Confidence            2 222345688999999998753  467899999999999999999999753211       001111111111111111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                          .......+.+++.+||+.||++||     ++.++++
T Consensus       232 ----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         232 ----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                122345678899999999999997     7777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.7e-31  Score=286.84  Aligned_cols=245  Identities=22%  Similarity=0.332  Sum_probs=188.5

Q ss_pred             eeecccccccEEEEEEcC-CCceeeEEeccCCCCc----ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGE----IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..||+|+||.||++.+.. +..+++|..+.....+    .......+...++.++||||+++++++.+.+..++||||++
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (260)
T cd08222           6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE   85 (260)
T ss_pred             eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence            458999999999998764 3445555554322211    11223345566788899999999999999899999999999


Q ss_pred             CCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          857 RGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +++|.+++.... ....+++..+..++.|++.|+.|||+.   +++||||||+||+++. +.++++|||.+.........
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~  161 (260)
T cd08222          86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL  161 (260)
T ss_pred             CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCccc
Confidence            999999886422 234589999999999999999999998   9999999999999975 57999999999876544444


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....|++.|+|||...+..++.++||||+|+++|++++|+.||....           .............+..   ..
T Consensus       162 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~---~~  227 (260)
T cd08222         162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----------FLSVVLRIVEGPTPSL---PE  227 (260)
T ss_pred             ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHHcCCCCCC---cc
Confidence            445668899999999988888999999999999999999999975321           1111122222222221   12


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....++.+++.+||+.+|++||++.|+++
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         228 TYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             hhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            34457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.6e-31  Score=283.12  Aligned_cols=240  Identities=25%  Similarity=0.293  Sum_probs=190.9

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||.||++... +++.+|+|.+.......  .......++..++.++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            599999999999876 57889999876543221  112334556677888999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA  940 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~  940 (1048)
                      .+++....   .+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99996543   478999999999999999999998   999999999999999999999999999987654433344567


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      ++..|+|||...+...+.++|+||+|+++||+++|+.||...+.           ......+.......+.    .....
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~----~~~~~  219 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----------KEIYEKILKDPLRFPE----FLSPE  219 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHhcCCCCCCC----CCCHH
Confidence            88999999999888889999999999999999999999763221           1122222222222111    11356


Q ss_pred             HHHHHHhccCCCCCCCCCH---HHHHH
Q 045493         1021 MIAVAFLCLDANPDCRPTM---QKVCN 1044 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~---~evl~ 1044 (1048)
                      +.+++.+||..||++|||+   +++++
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            7889999999999999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.5e-31  Score=299.55  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=186.0

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhc-ccCceeeEeeEeeeC--CeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEI-RHRNIVKFYGFCSHT--QHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~  856 (1048)
                      ..||+|+||.||+|.+. +++.+|+|++...... ........++..+.++ +||||+++++++...  ...|+||||++
T Consensus        13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~   92 (337)
T cd07852          13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME   92 (337)
T ss_pred             HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence            45899999999999876 5788999988643211 1112234466777888 999999999998643  46899999997


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      + +|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+........  
T Consensus        93 ~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          93 T-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             c-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence            5 999988643    478889999999999999999998   999999999999999999999999999986654321  


Q ss_pred             ---Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-------CCcccc-cc----hhh
Q 045493          935 ---NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-------LPAPAA-NM----NIV  998 (1048)
Q Consensus       935 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-------~~~~~~-~~----~~~  998 (1048)
                         ......||..|+|||++.+ ..++.++||||+|+++|||++|+.||........       ...... ..    ...
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF  244 (337)
T ss_pred             cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence               2234568999999998765 4578999999999999999999999864321100       000000 00    000


Q ss_pred             hhhhcc----CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 VNDLID----SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 ~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+.+    ................+.+++.+||+.||++|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000111    11111111111234568899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=8.2e-31  Score=291.02  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=185.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCC----------eE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----------HL  848 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----------~~  848 (1048)
                      ...+|+|+||.||+|..+ +++.||+|+++..... ........++..++.++||||+++++++.+..          ..
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   91 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF   91 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence            346899999999999886 5788999988654322 22223445677778899999999999986644          78


Q ss_pred             EEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      ++|+||+++ ++.+.+...  ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.+..
T Consensus        92 ~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          92 YLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             EEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccccc
Confidence            999999986 777777543  33589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------Ccccccc--
Q 045493          929 LKPDSS-NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------PAPAANM--  995 (1048)
Q Consensus       929 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~--  995 (1048)
                      ...... ......++..|+|||.+.+. .++.++||||+||++|||++|+.||.........         +......  
T Consensus       166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T cd07864         166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV  245 (302)
T ss_pred             ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence            654332 22233567889999987653 4689999999999999999999998643221000         0000000  


Q ss_pred             hhh-hhhhccCCCC--CC-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          996 NIV-VNDLIDSRLP--PP-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       996 ~~~-~~~~~~~~~~--~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ... .....++...  .. ..........+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000 0000000000  00 0001112456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.9e-31  Score=300.03  Aligned_cols=258  Identities=19%  Similarity=0.284  Sum_probs=188.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|... +++.||+|++...... ........++..++.++||||+++++++..    ....++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            456899999999999876 6889999988654322 112223446677888999999999998753    3568999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +. |+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++........
T Consensus        90 ~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          90 ME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             hh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            96 5899988643   2388999999999999999999998   999999999999999999999999999976543322


Q ss_pred             C----cccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccc---cchh
Q 045493          935 N----WSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAA---NMNI  997 (1048)
Q Consensus       935 ~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~---~~~~  997 (1048)
                      .    .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||...+...         +.+....   ....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            1    234578899999998765 457899999999999999999999986432110         0000000   0000


Q ss_pred             hhhhhc---cCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          998 VVNDLI---DSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       998 ~~~~~~---~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......   ......+.. ........+.+++.+||+.+|++|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111111   111111111 012235678999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=3.6e-31  Score=291.52  Aligned_cols=250  Identities=22%  Similarity=0.280  Sum_probs=188.7

Q ss_pred             eeeecccccccEEEEEEc----CCCceeeEEeccCCCCc---ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGE---IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~---~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ...||+|+||.||+|+..    +++.+|||.++......   .......++..+.++ +||+|+++++.+...+..++||
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            356899999999999753    46789999886432211   112233456666777 5999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++|+|.+++...   ..+++..+..++.|+++|+.|||+.   +++||||||+||+++.++.++++|||+++.....
T Consensus        85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          85 DYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             ecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            999999999998643   3478889999999999999999998   9999999999999999999999999998875443


Q ss_pred             CCC-ccccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          933 SSN-WSELAGTCGYIAPELAYTMR--ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       933 ~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ... .....|+..|+|||...+..  .+.++||||+|+++|||++|+.||......       .........+.....+.
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-------NSQSEISRRILKSKPPF  231 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-------chHHHHHHHHHccCCCC
Confidence            322 22346889999999987655  688999999999999999999997532110       00011111222222111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +    ......+.+++.+||+.||++|||+.++.+.|.
T Consensus       232 ~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         232 P----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             C----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            1    122345788999999999999999988876654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.9e-32  Score=265.24  Aligned_cols=261  Identities=23%  Similarity=0.335  Sum_probs=191.8

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCC-CcccchhhHHHHHHhhcccCceeeEeeEeee--------CCeE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT-GEIGINQKGFVSEITEIRHRNIVKFYGFCSH--------TQHL  848 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--------~~~~  848 (1048)
                      .+...||+|.||.||+|+.+ ++++||+|++..... ....+...+++..+..++|+|++.+++.|..        ....
T Consensus        20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~   99 (376)
T KOG0669|consen   20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF   99 (376)
T ss_pred             HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence            34556899999999999876 677889988755332 2334556677788888899999999988743        3458


Q ss_pred             EEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      |+||++|+. +|.-.+.+.  ...++..++.++++++..||.|+|..   .|+|||+||+|+||+.+|.+||+|||+++.
T Consensus       100 ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen  100 YLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            999999998 898888653  23488899999999999999999999   999999999999999999999999999977


Q ss_pred             cCCCCC----CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC---------ccccc
Q 045493          929 LKPDSS----NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP---------APAAN  994 (1048)
Q Consensus       929 ~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~  994 (1048)
                      +.....    ..+..+-|..|++||.+.+. .|+++.|||+.|||+.||+|+.+-++.........         ..+.+
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            653322    23445668999999998764 58999999999999999999998876543321110         01100


Q ss_pred             ----chhhhhhhccCCCCC-CchhHHHHHH------HHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          995 ----MNIVVNDLIDSRLPP-PLGEVEEKLK------SMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       995 ----~~~~~~~~~~~~~~~-~~~~~~~~~~------~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                          .-..+..+..+..+. .....++..+      +..+++..++..||.+|+++++++..
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                011111111111110 0111122222      67788999999999999999999864

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-31  Score=298.35  Aligned_cols=258  Identities=20%  Similarity=0.269  Sum_probs=192.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC-CcccchhhHHHHHHhhcccCceeeEeeEeeeCC-----eEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT-GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ-----HLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e  853 (1048)
                      ...||+|+||.||+|... +++.+|+|++..... .........++..++.++|+||+++++++....     ..|+|||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            346899999999999876 488899998875432 222233455677778889999999999987765     7899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++ +|.+++.+..   .+++..+..++.+++.|++|||+.   +|+||||||+||+++.++.++|+|||.+.......
T Consensus        85 ~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          85 LMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             chhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            9985 8998886533   588999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ---CCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccc---cchh
Q 045493          934 ---SNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAA---NMNI  997 (1048)
Q Consensus       934 ---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~---~~~~  997 (1048)
                         .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.......         +.+....   ....
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence               223445678899999999887 78999999999999999999999986433210         0000000   0000


Q ss_pred             hhhhhcc---CCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          998 VVNDLID---SRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       998 ~~~~~~~---~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+...   ....... .........+.+++.+||+++|++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0000000   0000000 0011234568899999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=2.1e-30  Score=288.51  Aligned_cols=242  Identities=24%  Similarity=0.365  Sum_probs=184.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+|... +++.+++|++.........  .....++..++.++|||++++++++.+....|+||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            345899999999999875 5788899988653322211  123445666788899999999999999999999999996 


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |++.+++...  ...+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||.+.....    ..
T Consensus       105 ~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~  175 (313)
T cd06633         105 GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN  175 (313)
T ss_pred             CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence            4788877543  23478999999999999999999999   999999999999999999999999999864322    23


Q ss_pred             ccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          938 ELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ...|+..|+|||++.   ...++.++||||+||++|||++|+.||......           ...........+...  .
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~--~  242 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNDSPTLQ--S  242 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCC--c
Confidence            456889999999974   356788999999999999999999997532210           001111111111110  1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.+++.+||+.+|++||++.++++.
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223457789999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=267.13  Aligned_cols=244  Identities=21%  Similarity=0.253  Sum_probs=190.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHH-hhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEI-TEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      -..+||+|+|+.|..++++ +.+.||+|++++.-..+.  ..-...+-... ..-+||.+|.++.+|....+.++|.||+
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv  333 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV  333 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence            4567999999999999886 567789988876432221  11111121112 2347999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +||+|--+++++++   ++++.++.+...|..||.|||++   |||.||+|.+|||+|.+|++|++|+|+++.--.++..
T Consensus       334 ~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  334 NGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             cCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            99999888876554   88899999999999999999999   9999999999999999999999999999876666677


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC-CCCCchhH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR-LPPPLGEV 1014 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1014 (1048)
                      .++++|||.|.|||++.+..|+..+|.|++||+|+||+.|+.||+...    ...+..+.+.....++-.+ +..+    
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg----m~n~d~ntedylfqvilekqirip----  479 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG----MDNPDMNTEDYLFQVILEKQIRIP----  479 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec----CCCcccchhHHHHHHHhhhccccc----
Confidence            788999999999999999999999999999999999999999998544    2233344444433333222 2222    


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRP 1037 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RP 1037 (1048)
                      ...+.....++..-+++||++|.
T Consensus       480 rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhc
Confidence            12223344566677999999986

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.6e-30  Score=288.85  Aligned_cols=242  Identities=24%  Similarity=0.351  Sum_probs=184.8

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|+.. +++.+|+|++.......  .......++..++.++|+|++++++++......++||||+. 
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   98 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-   98 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence            345899999999999876 56788999875432211  11122345666788899999999999999999999999997 


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |++.+++....  ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.+......    .
T Consensus        99 ~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~  169 (308)
T cd06634          99 GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N  169 (308)
T ss_pred             CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc----c
Confidence            58888775432  3478899999999999999999998   9999999999999999999999999998765432    2


Q ss_pred             ccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          938 ELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ...+++.|+|||++.   ...++.++||||+||++|||++|+.||.....           ............+...  .
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~--~  236 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYHIAQNESPALQ--S  236 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----------HHHHHHHhhcCCCCcC--c
Confidence            346888999999874   34578899999999999999999999753211           1111111111111111  1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            2334568889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=287.11  Aligned_cols=257  Identities=25%  Similarity=0.314  Sum_probs=191.0

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.||+|... +++.+|+|++......+ .......++..++.++|+||+++++++.+.+..++||||+++ +
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-D   83 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-C
Confidence            45899999999999887 48889999887643211 122334456677888999999999999999999999999985 9


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++.+..  ..+++..+..++.+++.|++|||+.   +|+||||+|+||++++++.+||+|||.++............
T Consensus        84 l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          84 LKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             HHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            999997542  3588999999999999999999999   99999999999999999999999999998765443333344


Q ss_pred             ccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCC-------Ccccccchhhhhhh--ccCCCCC
Q 045493          940 AGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL-------PAPAANMNIVVNDL--IDSRLPP 1009 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~--~~~~~~~ 1009 (1048)
                      .++..|+|||++.+. .++.++||||+||++||+++|+.||.........       ..............  .+...+.
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            567889999998776 7899999999999999999999998643211000       00000000000000  0111110


Q ss_pred             C----c-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 P----L-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~----~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .    . .........+.+++.+||+.||++||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0    0 001112457899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=8.6e-31  Score=293.14  Aligned_cols=261  Identities=20%  Similarity=0.279  Sum_probs=188.4

Q ss_pred             cccCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEE
Q 045493          774 ASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFL  850 (1048)
Q Consensus       774 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~l  850 (1048)
                      .++.+.....||+|+||.||+|... +++.||+|++...... ........++..+..++||||+++++++.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3444555667999999999999876 7888999987643221 222334456777888999999999998865 567899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+ +++|.++++.    ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++++|||.+....
T Consensus        88 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          88 VTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             Eeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            99998 5589988853    2367788889999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccccc----ch
Q 045493          931 PDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAAN----MN  996 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~----~~  996 (1048)
                      .   ......++..|+|||++.+ ..++.++||||+||++|||++|+.||........         .+.....    ..
T Consensus       160 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd07856         160 P---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE  236 (328)
T ss_pred             C---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence            2   2233467889999998765 5689999999999999999999999864321100         0000000    00


Q ss_pred             hhhhhh--ccCCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          997 IVVNDL--IDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       997 ~~~~~~--~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......  .....+.+. .........+.+++.+||+.+|++|||+++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000  000001010 0011224578899999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=9.3e-31  Score=287.19  Aligned_cols=242  Identities=24%  Similarity=0.361  Sum_probs=190.4

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ..||+|+||.||+|... +++.+|+|.+.....  .........+...+.+++ ||||+++++++...+..++||||+++
T Consensus         7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd05581           7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN   86 (280)
T ss_pred             eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence            45899999999999876 688899998765321  111122344556667787 99999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC---
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS---  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~---  934 (1048)
                      ++|.+++.+.+   .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++........   
T Consensus        87 ~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          87 GELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            99999997543   489999999999999999999998   999999999999999999999999999986653321   


Q ss_pred             -----------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchh
Q 045493          935 -----------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI  997 (1048)
Q Consensus       935 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  997 (1048)
                                       ......++..|+|||+..+..++.++||||+|++++++++|+.||.....           ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~  229 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----------YL  229 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----------HH
Confidence                             12234578899999999888899999999999999999999999763321           11


Q ss_pred             hhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 045493          998 VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTM----QKVCN 1044 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~ 1044 (1048)
                      ............+    ......+.+++.+||+.+|++|||+    +++++
T Consensus       230 ~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1222222221111    1224568899999999999999999    88775

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=268.42  Aligned_cols=248  Identities=18%  Similarity=0.234  Sum_probs=188.7

Q ss_pred             eecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  855 (1048)
                      ++-+|.||.||.|.+.+      .+.|.||.++.....-.....-.+-..+....|||+.++.+++.+ ....+++|.++
T Consensus       291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~  370 (563)
T KOG1024|consen  291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT  370 (563)
T ss_pred             hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence            35789999999996653      345677776543322111111222222345579999999998854 56779999999


Q ss_pred             CCCCHHHHHh-----ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          856 ERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       856 ~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      .-|+|..++.     +......++..+...++.|++.|++|||..   +|||.||.++|.+||+.-++|++|=.+++.+.
T Consensus       371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF  447 (563)
T KOG1024|consen  371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLF  447 (563)
T ss_pred             CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccC
Confidence            9999999997     333344467778889999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCCc--cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          931 PDSSNW--SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       931 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      +.+...  ..-.....||+||.+....|+.++|||||||++|||+| |+.||...+           ..+....+.|+..
T Consensus       448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-----------PfEm~~ylkdGyR  516 (563)
T KOG1024|consen  448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----------PFEMEHYLKDGYR  516 (563)
T ss_pred             cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----------HHHHHHHHhccce
Confidence            655432  12234668999999999999999999999999999999 888865433           3344445555543


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      -..+   ..+..+++.+|..||..+|++||++++++.-|.
T Consensus       517 laQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  517 LAQP---FNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             ecCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            3222   234456888899999999999999999988764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=310.87  Aligned_cols=245  Identities=22%  Similarity=0.253  Sum_probs=186.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..++||+|+||.|..++++ +++.||+|++.+...-  .....+.++...|..-..+=|+.++-.|.+.+..|+|||||+
T Consensus        79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p  158 (1317)
T KOG0612|consen   79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP  158 (1317)
T ss_pred             HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence            3456899999999999987 6788999998763221  112233444444555567889999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      ||+|-..+.+..   .+++.-++.++..|..||..+|+.   |+|||||||+|||+|..|++||+|||.+..+..++.. 
T Consensus       159 GGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  159 GGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             CchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence            999999997543   478888899999999999999999   9999999999999999999999999999888755544 


Q ss_pred             ccccccccccccccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC--CC
Q 045493          936 WSELAGTCGYIAPELAY----T-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR--LP 1008 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~----~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1008 (1048)
                      ....+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||+..+           .-+.+.++.+.+  +.
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-----------lveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-----------LVETYGKIMNHKESLS  301 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-----------HHHHHHHHhchhhhcC
Confidence            45678999999999875    2 568999999999999999999999987433           222333333331  22


Q ss_pred             CCchhHHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 045493         1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPT---MQKVCN 1044 (1048)
Q Consensus      1009 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 1044 (1048)
                      .|  ...+.+.+..++|.+.+. +|+.|..   +.++..
T Consensus       302 FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  302 FP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             CC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            22  112234455566655444 6777766   666543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-31  Score=242.43  Aligned_cols=261  Identities=20%  Similarity=0.279  Sum_probs=194.0

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +++++.||+|.||+||+|+.. +++.||+|+++-....+ ......+++-.++.++|+|||++++....++..-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            345667999999999999876 56788999987654433 2334566777789999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      .. +|..|...  -.+.++.+.++.++.|+++|+.|+|++   ++.|||+||.|.+|..+|+.|++|||+++.+.-.-..
T Consensus        84 dq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   84 DQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             hH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            77 89988854  345588899999999999999999999   9999999999999999999999999999987654444


Q ss_pred             ccccccccccccccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCccccc-------ccCCCcccccchhhhhhhcc--
Q 045493          936 WSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIE-GKHPGHFLSL-------LLSLPAPAANMNIVVNDLID-- 1004 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-- 1004 (1048)
                      .+..+-|..|++|.++.+.+ |+...|+||.||++.|+.. |++.|...+.       +.....+.+..+..+...-+  
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            55667789999999998865 7899999999999999998 5544533221       01111111111111111111  


Q ss_pred             --CCCCCCchhHH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 --SRLPPPLGEVE----EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 --~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        +..++. ..+.    .....=.+++++.+.-+|..|.++++.++.
T Consensus       238 ~yp~ypat-tswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  238 PYPIYPAT-TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCcccc-chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence              111211 1111    112234567777888899999999998763

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=283.99  Aligned_cols=244  Identities=22%  Similarity=0.309  Sum_probs=197.5

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +++|.|.||+||-|.++ +|+.||||.+.+.... ..+...+.+++.+..++||.||.+.-.|+..++.++|||-+.| +
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence            35899999999999765 8999999999775332 2334567889999999999999999999999999999999966 6


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEeccccccccCCCCCCc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      ..+++-.. ..+.+++.....++.||+.||.|||.+   +|+|+|+||+|||+.+.   .++||||||.|+.+. +....
T Consensus       649 MLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg-EksFR  723 (888)
T KOG4236|consen  649 MLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG-EKSFR  723 (888)
T ss_pred             HHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc-hhhhh
Confidence            66655332 345588888888999999999999999   99999999999999753   589999999999875 34556


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      +..+|||.|.|||++..+.|...-|+||.||++|.-++|..||....+.             -+.+-...+.-+...+.+
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-------------ndQIQNAaFMyPp~PW~e  790 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-------------NDQIQNAAFMYPPNPWSE  790 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-------------hHHhhccccccCCCchhh
Confidence            6789999999999999999999999999999999999999998632211             111112223333445677


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+++|...+++.-++|-|.+..+.
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            7788899999999999999998887654

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-30  Score=294.25  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=183.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      ....||+|+||.||+|... +++.||+|++......+ .......++..++.++||||+++++++...      ..+++|
T Consensus        19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            3457899999999999875 68899999886532222 122334566777888999999999988643      356999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      +||+.. ++.++..     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++....
T Consensus        99 ~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          99 MPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             eccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            999975 7777652     2378899999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc-------ccccchhh-----
Q 045493          932 DSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-------PAANMNIV-----  998 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~-------~~~~~~~~-----  998 (1048)
                         ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...+.......       ........     
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence               2234567889999999876 4588999999999999999999999874332110000       00000000     


Q ss_pred             hhhhcc--CCCCCC-ch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 VNDLID--SRLPPP-LG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 ~~~~~~--~~~~~~-~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......  +..+.. .. ........+.+++.+||+.||++||+++|++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000  000000 00 001223467899999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.4e-30  Score=277.62  Aligned_cols=219  Identities=21%  Similarity=0.187  Sum_probs=173.2

Q ss_pred             cccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHh
Q 045493          787 GGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILS  865 (1048)
Q Consensus       787 G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  865 (1048)
                      |.||.||++++. +++.+|+|++.....      ...+...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999886 678899999865321      1222333445569999999999999999999999999999999986


Q ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccccccccc
Q 045493          866 NEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY  945 (1048)
Q Consensus       866 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y  945 (1048)
                      +..   .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.++++|||.+......   .....++..|
T Consensus        78 ~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y  148 (237)
T cd05576          78 KFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY  148 (237)
T ss_pred             Hhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence            532   378999999999999999999998   9999999999999999999999999988665432   2234567789


Q ss_pred             ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHH
Q 045493          946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVA 1025 (1048)
Q Consensus       946 ~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 1025 (1048)
                      +|||...+..++.++||||+|+++|||++|+.|+......             ........++      ......+.+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~~~~~~~------~~~~~~~~~li  209 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTHTTLNIP------EWVSEEARSLL  209 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccccccCCc------ccCCHHHHHHH
Confidence            9999998888999999999999999999999886422110             0000001111      11234578899


Q ss_pred             HhccCCCCCCCCCH
Q 045493         1026 FLCLDANPDCRPTM 1039 (1048)
Q Consensus      1026 ~~cl~~dP~~RPt~ 1039 (1048)
                      .+|++.||++|||+
T Consensus       210 ~~~l~~dp~~R~~~  223 (237)
T cd05576         210 QQLLQFNPTERLGA  223 (237)
T ss_pred             HHHccCCHHHhcCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=3.2e-30  Score=312.56  Aligned_cols=141  Identities=26%  Similarity=0.346  Sum_probs=120.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+|.+. +++.||+|+++......  .......++..+..++||||+++++++......|+||||+++
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g   88 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG   88 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence            456899999999999887 67889999986533211  112334556667788999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      |+|.+++...+   .+++..++.++.||+.||+|||..   +||||||||+|||++.++.+||+|||+++
T Consensus        89 ~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          89 GDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999996533   378889999999999999999998   99999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.8e-30  Score=293.00  Aligned_cols=258  Identities=19%  Similarity=0.253  Sum_probs=184.2

Q ss_pred             cCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------Ce
Q 045493          776 TFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QH  847 (1048)
Q Consensus       776 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~  847 (1048)
                      +.+.....||+|+||.||+|... +++.||+|++....... ......+++..+.+++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            33445567899999999999764 68889999886532211 112234466677888999999999988543      34


Q ss_pred             EEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       848 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      .+++++++ +++|.++++.    ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        97 ~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence            67888876 7799888753    2378999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccc---c
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAA---N  994 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~---~  994 (1048)
                      ....   ......++..|+|||...+ ..++.++||||+||++|||++|+.||...+....         .+....   .
T Consensus       169 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         169 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             cccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            6432   2234567889999998766 4678999999999999999999999853321100         000000   0


Q ss_pred             chhhhhhhcc--CCCCCC-ch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          995 MNIVVNDLID--SRLPPP-LG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       995 ~~~~~~~~~~--~~~~~~-~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..........  +..+.. .. ........+.+++.+|++.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            0000000000  000000 00 00112446889999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-31  Score=288.44  Aligned_cols=231  Identities=22%  Similarity=0.283  Sum_probs=181.9

Q ss_pred             ecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          784 HGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      +|.|+|+.|-.+.+. +++..+||.+.+.....    .++.-.....-+||||+++.+.+.+..+.|+|||.+.||-+.+
T Consensus       330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~----~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~  405 (612)
T KOG0603|consen  330 LGEGSFSAVKYCESSPTDQEPAVKIISKRADDN----QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLR  405 (612)
T ss_pred             cCCCCccceeeeeccccccchhheecccccccc----ccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHH
Confidence            799999999999775 67889999997652211    1111122334479999999999999999999999999998877


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE-CCCCceEEeccccccccCCCCCCcccccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL-DLEYKAHVSDFGTAKFLKPDSSNWSELAG  941 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll-~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  941 (1048)
                      .+....   .+. .++..|+.+|+.|+.|||++   ||||||+||+|||+ ++.++++|+|||.++....+   ....+-
T Consensus       406 ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~  475 (612)
T KOG0603|consen  406 RIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPAL  475 (612)
T ss_pred             HHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccch
Confidence            775432   233 67888999999999999998   99999999999999 58899999999999876654   333466


Q ss_pred             ccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHH
Q 045493          942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSM 1021 (1048)
Q Consensus       942 t~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1021 (1048)
                      |..|.|||+.....|++++|+||+|+++|+|++|+.||.....          ..+....+..+.+.      ...+...
T Consensus       476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~----------~~ei~~~i~~~~~s------~~vS~~A  539 (612)
T KOG0603|consen  476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA----------GIEIHTRIQMPKFS------ECVSDEA  539 (612)
T ss_pred             hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc----------hHHHHHhhcCCccc------cccCHHH
Confidence            8899999999999999999999999999999999999763221          12222222222222      3445567


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHH
Q 045493         1022 IAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1022 ~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+++..|++.||.+||+|.++..
T Consensus       540 KdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  540 KDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHHhccCChhhCcChhhhcc
Confidence            78888999999999999999864

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.4e-30  Score=288.69  Aligned_cols=258  Identities=21%  Similarity=0.283  Sum_probs=184.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC--------CeEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT--------QHLFL  850 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--------~~~~l  850 (1048)
                      ...||+|+||.||+|... +++.+|+|++......+ ......+++..++.++||||+++++++.+.        ...++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            445899999999999876 67889999886543322 122345667778899999999999987443        34699


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++ ++.+.+...  ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++|||+++...
T Consensus        93 v~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          93 VTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             EEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            9999976 677776542  33589999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCC-----------ccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CC
Q 045493          931 PDSSN-----------WSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LP  989 (1048)
Q Consensus       931 ~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~  989 (1048)
                      .....           .....+++.|+|||++.+. .++.++||||+||++|||++|+.||........         .+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            32211           1233568889999987654 578999999999999999999999864332110         00


Q ss_pred             cc-cccchhhhhh----hccCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          990 AP-AANMNIVVND----LIDSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       990 ~~-~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .. ..........    ......++... ........+.+++.+|++.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00 0000000000    00111111100 01122356889999999999999999999985

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.4e-30  Score=291.73  Aligned_cols=256  Identities=19%  Similarity=0.269  Sum_probs=185.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCC------eEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------HLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------~~~  849 (1048)
                      +.....||+|+||.||+|... +++.||||++....... .......++..++.++||||+++++++....      ..+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY   96 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence            344557899999999999765 68889999886432221 1122345677788999999999999886543      468


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+ +++|.+++..    ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+|++|||++...
T Consensus        97 lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          97 LVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             EEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence            999999 6799988853    2478999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc----ccccchhhhh----
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA----PAANMNIVVN---- 1000 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~---- 1000 (1048)
                      ...   .....+++.|+|||++.+ ..++.++||||+||++|++++|+.||...........    ..........    
T Consensus       169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            432   223467889999999876 4578999999999999999999999864321100000    0000000000    


Q ss_pred             ----hhcc--CCCCC-C-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 ----DLID--SRLPP-P-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ----~~~~--~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                          ....  +.... . ..........+.+++.+|++.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                0000  00000 0 0001122346889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.4e-30  Score=288.59  Aligned_cols=257  Identities=19%  Similarity=0.252  Sum_probs=181.3

Q ss_pred             eeeecccccccEEEEEEc-C--CCceeeEEeccCCCCc-ccchhhHHHHHHhhc-ccCceeeEeeEeee----CCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-S--GDTRAVKKLHSLPTGE-IGINQKGFVSEITEI-RHRNIVKFYGFCSH----TQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~--~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l-~h~niv~~~~~~~~----~~~~~lv  851 (1048)
                      ...||+|+||.||+|+.. .  +..+|+|++....... .......++..+.++ +||||+++++++..    ....+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            346899999999999876 3  6789999876432221 112233455556666 59999999987543    2457889


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      +||+. ++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++....
T Consensus        85 ~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          85 EELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             Eeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            99986 5899988643   3488999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCC----Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccccc--
Q 045493          932 DSS----NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAANM--  995 (1048)
Q Consensus       932 ~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~--  995 (1048)
                      ...    ......||..|+|||+..+ ..++.++||||+||++|++++|+.||...+....         .+......  
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            221    1234568999999998765 4689999999999999999999999864331100         00000000  


Q ss_pred             -hhh---hhhhccCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          996 -NIV---VNDLIDSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       996 -~~~---~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       ...   .............. ........+.+++.+|++.||++|||++|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             000   00000000000000 00112456889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=2.5e-30  Score=291.64  Aligned_cols=256  Identities=23%  Similarity=0.282  Sum_probs=182.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC-------------
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT-------------  845 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-------------  845 (1048)
                      ....||.|+||.||+|... +++.||+|++...... ......+++..++.++||||+++++++...             
T Consensus         9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (342)
T cd07854           9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE   87 (342)
T ss_pred             EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence            3456899999999999876 5788999988654332 223345567778889999999999876543             


Q ss_pred             -CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEecc
Q 045493          846 -QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDF  923 (1048)
Q Consensus       846 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~Df  923 (1048)
                       ...|+||||+++ +|.+++..    ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++. ++.+|++||
T Consensus        88 ~~~~~lv~e~~~~-~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          88 LNSVYIVQEYMET-DLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cceEEEEeecccc-cHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence             357999999974 89888753    2478899999999999999999998   9999999999999984 567899999


Q ss_pred             ccccccCCCCC---Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-------CCccc
Q 045493          924 GTAKFLKPDSS---NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-------LPAPA  992 (1048)
Q Consensus       924 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-------~~~~~  992 (1048)
                      |.++.......   ......++..|+|||++.+ ..++.++||||+||++|||++|+.||........       .+...
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99976543211   1123457889999998654 4578899999999999999999999864332100       00000


Q ss_pred             ccchhhh-----hhhc-cCCCC-CCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          993 ANMNIVV-----NDLI-DSRLP-PPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       993 ~~~~~~~-----~~~~-~~~~~-~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......     .... ..... .+.. .......++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000000     0000 00000 0000 01123356889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.7e-30  Score=293.12  Aligned_cols=255  Identities=19%  Similarity=0.260  Sum_probs=185.0

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCe------EEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQH------LFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~------~~l  850 (1048)
                      .....||+|+||.||+|+.. +++.||+|++....... .......++..++.++||||+++++++...+.      .++
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            34556899999999999886 57789999876432211 11222345666788899999999998765554      899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      |+||+ +++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+....
T Consensus        98 v~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          98 VTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            99998 5699999864    3488999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc----ccccchhhhh-----
Q 045493          931 PDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA----PAANMNIVVN----- 1000 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~----- 1000 (1048)
                      ..   .....++..|+|||...+ ..++.++||||+||++||+++|+.||...........    ..........     
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            32   334567889999998765 3678999999999999999999999863321100000    0000000000     


Q ss_pred             ---hhcc---CCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 ---DLID---SRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ---~~~~---~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                         ....   ....... .........+.+++.+|++.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence               0000   0000000 001122567889999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=273.28  Aligned_cols=249  Identities=26%  Similarity=0.345  Sum_probs=179.2

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccc-------hhhHHHHHHhhcccCceeeEeeEee-eCCeEEEEEE
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGI-------NQKGFVSEITEIRHRNIVKFYGFCS-HTQHLFLVYE  853 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~-------~~~~~~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e  853 (1048)
                      .++|+|||+.||+|-+-..+.||+.+++.....-.+.       ..-++.+.-+.+.||.||++|+|+. +.+.+|-|+|
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE  548 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE  548 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence            3589999999999976655544444444332221111       1123344457889999999999996 5667899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC---CCCceEEeccccccccC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD---LEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~  930 (1048)
                      ||+|.+|+-|++..+.   +++.+++.|+.||+.||.||.+. .++|||-|+||.|||+-   ..|.+||+|||+++.+.
T Consensus       549 YceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd  624 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD  624 (775)
T ss_pred             ecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence            9999999999986544   78899999999999999999987 46999999999999995   45889999999999887


Q ss_pred             CCCCC-------ccccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhh
Q 045493          931 PDSSN-------WSELAGTCGYIAPELAYTM----RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVV  999 (1048)
Q Consensus       931 ~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ++...       .+...||..|.+||.+.-+    +.+.|+||||+|||+|+++.|+.||.-.-.....     -....+
T Consensus       625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-----LqeNTI  699 (775)
T KOG1151|consen  625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-----LQENTI  699 (775)
T ss_pred             CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-----Hhhhch
Confidence            65432       3467899999999988644    3578999999999999999999998632111000     001111


Q ss_pred             hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                      .....-.+|+.    +....+..++|++|++..-++|....++.
T Consensus       700 lkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  700 LKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11111112221    12223466788899999888888776654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-31  Score=279.68  Aligned_cols=237  Identities=23%  Similarity=0.267  Sum_probs=188.2

Q ss_pred             eeecccccccEEEEEEcCCC-ceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          782 VLHGTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~-~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ..+|.|+||.|-.+...+.+ .+|+|.+++..-.+.  ......+.+.|...+.|.||++|-.|.+.+.+|+.||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            34799999999999877544 488887766432221  122234456677788999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      .++..++..+.   ++..+.+.++..+.+|++|||++   +||+||+||+|.++|.+|-+||.|||+|+.+..+.. .-+
T Consensus       506 ElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-TwT  578 (732)
T KOG0614|consen  506 ELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-TWT  578 (732)
T ss_pred             hhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc-eee
Confidence            99999976554   78888999999999999999999   999999999999999999999999999998875544 446


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      +||||.|.|||++..+..+.++|.||+|+++||+++|.+||...+++..+           ..++.+.-..  ..+....
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-----------n~ILkGid~i--~~Pr~I~  645 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-----------NLILKGIDKI--EFPRRIT  645 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----------HHHHhhhhhh--hcccccc
Confidence            89999999999999999999999999999999999999999865543211           1111111110  1112334


Q ss_pred             HHHHHHHHhccCCCCCCCCC
Q 045493         1019 KSMIAVAFLCLDANPDCRPT 1038 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt 1038 (1048)
                      +...+++.+.+..+|.+|.-
T Consensus       646 k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhc
Confidence            55677888888999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=9.3e-30  Score=300.22  Aligned_cols=259  Identities=16%  Similarity=0.160  Sum_probs=163.6

Q ss_pred             cceeeecccccccEEEEEEcC-----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeE------eeeCCe
Q 045493          779 GKMVLHGTGGCGTVYKAELTS-----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF------CSHTQH  847 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~------~~~~~~  847 (1048)
                      .....||+|+||.||+|++..     +..||+|++......+     ......+....+.+++.+...      +.....
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            344568999999999998864     5889999875422111     111111222222223222221      245667


Q ss_pred             EEEEEEccCCCCHHHHHhccccc-----------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 045493          848 LFLVYEYLERGSLATILSNEATA-----------------AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKV  910 (1048)
Q Consensus       848 ~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NI  910 (1048)
                      .++||||+++++|.+++......                 .......+..++.|++.||+|||+.   +|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence            99999999999999998643211                 0112234567999999999999998   999999999999


Q ss_pred             EECC-CCceEEeccccccccCCCC-CCccccccccccccccccccC----------------------CCCchhhHHHHH
Q 045493          911 LLDL-EYKAHVSDFGTAKFLKPDS-SNWSELAGTCGYIAPELAYTM----------------------RANEKCDVFNFG  966 (1048)
Q Consensus       911 ll~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dvws~G  966 (1048)
                      |++. ++.+||+|||+|+.+.... .......+|+.|||||.+...                      .++.++||||+|
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9986 5899999999998664332 223456789999999965322                      234567999999


Q ss_pred             HHHHHHHhCCCCCccccc-ccCCCcccccchhhhhhhccCCCCCC----chhHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 045493          967 VLVLEVIEGKHPGHFLSL-LLSLPAPAANMNIVVNDLIDSRLPPP----LGEVEEKLKSMIAVAFLCLDANPDCRPTMQK 1041 (1048)
Q Consensus       967 vvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1041 (1048)
                      |++|||+++..|++.... +.............+.....+...+.    ...........++++.+|++.||++|||++|
T Consensus       367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            999999998776542100 00000000000000111111111100    0000111234568999999999999999999


Q ss_pred             HHHH
Q 045493         1042 VCNL 1045 (1048)
Q Consensus      1042 vl~~ 1045 (1048)
                      ++++
T Consensus       447 ~L~H  450 (566)
T PLN03225        447 ALAH  450 (566)
T ss_pred             HhCC
Confidence            9863

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=243.64  Aligned_cols=191  Identities=23%  Similarity=0.376  Sum_probs=155.0

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHH----hhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEI----TEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l----~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      -||+|+||.|-+.++. +|+..|||++......   ..+++.++++    +...+|.+|.+||.+......|+.||.|..
T Consensus        53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~---q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t  129 (282)
T KOG0984|consen   53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS---QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT  129 (282)
T ss_pred             hhcCCccchhhheeeccCCeEEEEeeehhhcCh---HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence            3799999999999876 7888999999765442   2334444443    334599999999999888999999999977


Q ss_pred             CCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          858 GSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       858 g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                       +|+.+-+.. ......++.-.-+|+..+.+||.|||++.  .|||||+||+|||++.+|++|+||||.+-.+.++-. .
T Consensus       130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-k  205 (282)
T KOG0984|consen  130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-K  205 (282)
T ss_pred             -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH-H
Confidence             887775432 23445778888899999999999999985  899999999999999999999999999987654322 2


Q ss_pred             cccccccccccccccc----cCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          937 SELAGTCGYIAPELAY----TMRANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~----~~~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      +.-.|-..|||||.+.    ...|+.|+||||+|+++.||.++++||+
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            2235677899999875    3468999999999999999999999976

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=269.69  Aligned_cols=254  Identities=19%  Similarity=0.264  Sum_probs=186.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cC-----ceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HR-----NIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e  853 (1048)
                      +..+|+|+||.|..+.+. .+..||+|+++....  ......-+++.+.++. +.     -+|.+.+||...++.|+|+|
T Consensus        94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe  171 (415)
T KOG0671|consen   94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE  171 (415)
T ss_pred             hhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence            345799999999999765 467889998865432  1122333455555552 22     38889999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-------------------
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-------------------  914 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-------------------  914 (1048)
                      .+ |-|+.+++.+.. -.+++...++.|+.|++++++|||+.   +++|-|+||+||++.+                   
T Consensus       172 ll-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  172 LL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             cc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            98 559999997654 34588999999999999999999999   9999999999999932                   


Q ss_pred             -CCceEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC------
Q 045493          915 -EYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS------  987 (1048)
Q Consensus       915 -~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~------  987 (1048)
                       +..+|++|||.|++..   +..+..+.|..|+|||++.+-.+++++||||+|||++|+.||...|+..+....      
T Consensus       247 ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer  323 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER  323 (415)
T ss_pred             CCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence             2358999999998643   333667899999999999999999999999999999999999998875442110      


Q ss_pred             --CCcccccchhh-hhhh-ccCCC-----------------CCCch----hHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 045493          988 --LPAPAANMNIV-VNDL-IDSRL-----------------PPPLG----EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042 (1048)
Q Consensus       988 --~~~~~~~~~~~-~~~~-~~~~~-----------------~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 1042 (1048)
                        .+.+....... .++. ..+++                 +.+..    ..+.+..++++++.+|+..||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence              01111110000 0000 00000                 00100    113455689999999999999999999999


Q ss_pred             HH
Q 045493         1043 CN 1044 (1048)
Q Consensus      1043 l~ 1044 (1048)
                      +.
T Consensus       404 L~  405 (415)
T KOG0671|consen  404 LS  405 (415)
T ss_pred             hc
Confidence            85

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=290.97  Aligned_cols=240  Identities=25%  Similarity=0.381  Sum_probs=181.2

Q ss_pred             eeeeccccccc-EEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhh-cccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGT-VYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITE-IRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~-Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .+++|.|+-|+ ||+|... ++.||||++-....    ....+|+..+.. -.|||||++|+.-.++...|++.|.|.. 
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            44679999987 7999887 88999999854322    123444555433 3699999999999999999999999977 


Q ss_pred             CHHHHHhcccccccc-CHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---C--CceEEeccccccccCCC
Q 045493          859 SLATILSNEATAAEL-DWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---E--YKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l-~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~--~~~kl~DfG~a~~~~~~  932 (1048)
                      +|+++++........ .-...+.+..|++.|+++||+.   +|||||+||.||||+.   +  .+++|+|||+++.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            999999764111111 1134578899999999999998   9999999999999976   3  47999999999998766


Q ss_pred             CCCc---cccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCcccccccCCCcccccchhhhhhhccCCCC
Q 045493          933 SSNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEG-KHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       933 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ....   .+..||-+|+|||++....-+.++||||+|||+|+.++| .+||...-...             ..++.+...
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------------~NIl~~~~~  731 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------------ANILTGNYT  731 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------------hhhhcCccc
Confidence            5443   456799999999999998888999999999999999995 99987432110             011111110


Q ss_pred             -CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1009 -PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1009 -~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       .......++  ...++|.+|++++|..||+|.+|+.
T Consensus       732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             000011111  6788999999999999999999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=9.1e-29  Score=264.98  Aligned_cols=239  Identities=25%  Similarity=0.375  Sum_probs=189.3

Q ss_pred             ccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHhc
Q 045493          788 GCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSN  866 (1048)
Q Consensus       788 ~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  866 (1048)
                      +||.||+|... +++.+|+|++..............+++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999887 48889999987654433223445666677888999999999999999999999999999999999865


Q ss_pred             cccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccccccccc
Q 045493          867 EATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI  946 (1048)
Q Consensus       867 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~  946 (1048)
                      ...   +++..+..++.++++|+.|||+.   +++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM  153 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence            332   78899999999999999999999   99999999999999999999999999998765432 334456888999


Q ss_pred             cccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHH
Q 045493          947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAF 1026 (1048)
Q Consensus       947 aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 1026 (1048)
                      |||...+..++.++||||+|+++|++++|..||....          .................. ........+.+++.
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  222 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----------QLLELFKKIGKPKPPFPP-PEWKISPEAKDLIR  222 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------cHHHHHHHHhccCCCCcc-ccccCCHHHHHHHH
Confidence            9999988889999999999999999999999975311          111122222222221111 10113456888999


Q ss_pred             hccCCCCCCCCCHHHHHH
Q 045493         1027 LCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1027 ~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +||..+|++||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-31  Score=272.27  Aligned_cols=299  Identities=26%  Similarity=0.253  Sum_probs=218.8

Q ss_pred             eeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCC-CcCCCCCccc
Q 045493           13 GTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV-NQLNGLIPEE   91 (1048)
Q Consensus        13 ~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~-n~l~~~~~~~   91 (1048)
                      +++++||..+|+.++.|+|..|+|+.++|.+|+.+++|+.||||+|.|+.|-|++|.+|.+|..|-+.+ |+|+.+....
T Consensus        56 ~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~  135 (498)
T KOG4237|consen   56 KGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGA  135 (498)
T ss_pred             CCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhH
Confidence            567999999999999999999999999999999999999999999999999999999999999988877 9999988889


Q ss_pred             cccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCc-cCCCCCCCcEEecCCCc
Q 045493           92 LGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQ-DLGNLESPVSVSLHTNN  170 (1048)
Q Consensus        92 ~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~-~l~~l~~L~~l~l~~n~  170 (1048)
                      |.+|..|+.|.+..|++..+..++|..|++|..|.+..|.+.                .+++ .+..+.+++.+.+..|.
T Consensus       136 F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q----------------~i~~~tf~~l~~i~tlhlA~np  199 (498)
T KOG4237|consen  136 FGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ----------------SICKGTFQGLAAIKTLHLAQNP  199 (498)
T ss_pred             hhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh----------------hhccccccchhccchHhhhcCc
Confidence            999999999999999999888899999999999999999876                3333 55666666777776666


Q ss_pred             cccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCc-CCCCCC-eEeccCCccCCCCC
Q 045493          171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG-NLSNLK-FLYLHDNRLSGYIP  248 (1048)
Q Consensus       171 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~-~L~L~~N~l~~~~p  248 (1048)
                      +..     .++++.+..       +....|.+++..+-..-..+.++++..+.+.-|. .+..+. .+...++....-+.
T Consensus       200 ~ic-----dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~  267 (498)
T KOG4237|consen  200 FIC-----DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPA  267 (498)
T ss_pred             ccc-----ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChH
Confidence            321     122222221       1112334444555555555555555433333332 111111 11222223332222


Q ss_pred             cccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccccccccccc
Q 045493          249 PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS  328 (1048)
Q Consensus       249 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  328 (1048)
                      ..|+.+++|+.|+|++|+++.+.+.+|.++.++++|++.. |++...-...|.++..|+.|+|.+|+|+...|..|..+.
T Consensus       268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~-N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~  346 (498)
T KOG4237|consen  268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR-NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF  346 (498)
T ss_pred             HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc-chHHHHHHHhhhccccceeeeecCCeeEEEecccccccc
Confidence            3577777777777777777777777777777777777766 666655566677888888888888888887788888888


Q ss_pred             ccceeeeccccc
Q 045493          329 NIRGLYIRENML  340 (1048)
Q Consensus       329 ~L~~L~l~~n~l  340 (1048)
                      .|..|+|-.|.+
T Consensus       347 ~l~~l~l~~Np~  358 (498)
T KOG4237|consen  347 SLSTLNLLSNPF  358 (498)
T ss_pred             eeeeeehccCcc
Confidence            888887777654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=279.87  Aligned_cols=263  Identities=14%  Similarity=0.134  Sum_probs=172.7

Q ss_pred             CcceeeecccccccEEEEEE-----------------cCCCceeeEEeccCCCCcc-------------cchhhHHHHHH
Q 045493          778 EGKMVLHGTGGCGTVYKAEL-----------------TSGDTRAVKKLHSLPTGEI-------------GINQKGFVSEI  827 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavk~~~~~~~~~~-------------~~~~~~~~~~l  827 (1048)
                      +.....||+|+||+||+|..                 ..++.||||++........             .+....++..+
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            33455789999999999964                 2346799999864322110             01111223334


Q ss_pred             hhcccCc-----eeeEeeEeee--------CCeEEEEEEccCCCCHHHHHhcccc---------------------cccc
Q 045493          828 TEIRHRN-----IVKFYGFCSH--------TQHLFLVYEYLERGSLATILSNEAT---------------------AAEL  873 (1048)
Q Consensus       828 ~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l  873 (1048)
                      .+++|.+     ++++++||..        .+..++||||+++|+|.++++....                     ...+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            4555544     4677887753        3568999999999999999864211                     1235


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccccccccccccccccc
Q 045493          874 DWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELAGTCGYIAPELAY  952 (1048)
Q Consensus       874 ~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~  952 (1048)
                      ++..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||+++.+...... .....+|+.|+|||.+.
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            6778899999999999999998   9999999999999999999999999999765433211 11233578999999875


Q ss_pred             cCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          953 TMR--------------------A--NEKCDVFNFGVLVLEVIEGKH-PGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       953 ~~~--------------------~--~~~~Dvws~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ...                    +  ..+.||||+||++|||++|.. |+.....+.............+......... 
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~-  462 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD-  462 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC-
Confidence            432                    1  134799999999999999875 6543221111000000000001111111111 


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANP---DCRPTMQKVCNL 1045 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~ 1045 (1048)
                       ............+++.+++.++|   .+|+|++|++++
T Consensus       463 -~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        463 -FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence             11223345668889999999766   689999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.9e-28  Score=263.86  Aligned_cols=201  Identities=22%  Similarity=0.310  Sum_probs=162.4

Q ss_pred             CcceeeecccccccEEEEEEcC-CCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +-+.+-||-|+||.|..++..+ ...||+|.+.+...-  ......+.+..++..-..+-||++|-.|.+++.+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            3345568999999999997654 456788887654321  1122334555556666788999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC----
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK----  930 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~----  930 (1048)
                      ++||++-.+|-+-+   .+.+.-++.++.++..|+++.|..   |+|||||||+|||||.||++||+|||++.-+.    
T Consensus       711 IPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             cCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999999986533   477888899999999999999998   99999999999999999999999999986432    


Q ss_pred             -----CCCC----------C-----------------------ccccccccccccccccccCCCCchhhHHHHHHHHHHH
Q 045493          931 -----PDSS----------N-----------------------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV  972 (1048)
Q Consensus       931 -----~~~~----------~-----------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~el  972 (1048)
                           .+..          .                       ....+||+.|+|||++....|+..+|.||.|||+|||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 1000          0                       0124699999999999999999999999999999999


Q ss_pred             HhCCCCCccccc
Q 045493          973 IEGKHPGHFLSL  984 (1048)
Q Consensus       973 ltg~~p~~~~~~  984 (1048)
                      +.|+.||.....
T Consensus       865 ~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  865 LVGQPPFLADTP  876 (1034)
T ss_pred             hhCCCCccCCCC
Confidence            999999875443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-27  Score=249.83  Aligned_cols=124  Identities=25%  Similarity=0.372  Sum_probs=99.2

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc--------cCceeeEeeEeee----CCeEE
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR--------HRNIVKFYGFCSH----TQHLF  849 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~--------h~niv~~~~~~~~----~~~~~  849 (1048)
                      .+|.|.|++||.|.+. ..+.||+|++++..  ...+....+++.+++++        ..+||++++.|..    +.++|
T Consensus        85 KLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC  162 (590)
T KOG1290|consen   85 KLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC  162 (590)
T ss_pred             eccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence            4799999999999876 45667888876532  22334455666665553        3579999999965    56899


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL  912 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll  912 (1048)
                      ||+|+. |.+|..+|......+ ++...+.+|++||+.||.|||..|  +|||-||||+|||+
T Consensus       163 MVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  163 MVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             EEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            999999 559999987654433 789999999999999999999998  99999999999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-29  Score=247.04  Aligned_cols=256  Identities=21%  Similarity=0.295  Sum_probs=184.0

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~  855 (1048)
                      -||-|+||.||.+.+. +|+.||.||+......- .....-++..++...+|+||+..++.....     .+.|+|+|.|
T Consensus        60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm  139 (449)
T KOG0664|consen   60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM  139 (449)
T ss_pred             cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence            4799999999999876 78999999985432111 111223344555667899999998876432     3568899999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-C
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-S  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~  934 (1048)
                      .. +|..++-.   ...++...+.-+++||++||.|||+.   +|.||||||.|.|+.++...||||||+++....+. .
T Consensus       140 QS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  140 QS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             Hh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            76 88888754   34477788888999999999999999   99999999999999999999999999999765443 3


Q ss_pred             CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccccc---hhhhhh
Q 045493          935 NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAANM---NIVVND 1001 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~---~~~~~~ 1001 (1048)
                      .++..+-|..|+|||++++. .|+.++||||.||++.|++..+..|+..+..         .+-+..+...   +.....
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            45556678899999999876 4899999999999999999998887654332         2222211111   111122


Q ss_pred             hccCCCCCCch-------hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1002 LIDSRLPPPLG-------EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1002 ~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +++....++..       .......+.+.+...++..||+.|.+..+.+..
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            23322222111       111223456677778999999999999887654

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4e-28  Score=244.71  Aligned_cols=252  Identities=19%  Similarity=0.227  Sum_probs=183.7

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCC------eEEEEEEc
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------HLFLVYEY  854 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~  854 (1048)
                      .+|.|+- .|..|-+. .++.||+|+....... .......++...+..++|+||++++.+|+..+      ..|+|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            4677777 56666443 6889999998665222 11223345566678889999999999996543      57999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |.. +|.+.+.     .+++-.++..+..|++.|+.|||+.   +|+|||+||+||++..++.+||.|||+|+....+ -
T Consensus       103 m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~  172 (369)
T KOG0665|consen  103 MDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-F  172 (369)
T ss_pred             hhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-c
Confidence            966 9998885     2367788999999999999999999   9999999999999999999999999999865433 3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccc-----------cchhhh----
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA-----------NMNIVV----  999 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~-----------~~~~~~----  999 (1048)
                      ..+.++.|..|.|||++.+..|.+.+||||.||++.||++|+..|.+.+....+.....           ......    
T Consensus       173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv  252 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV  252 (369)
T ss_pred             ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence            45677889999999999999999999999999999999999987754332211111000           000000    


Q ss_pred             ------------hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1000 ------------NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1000 ------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                                  +.+-|..++.......-......+++.+|+..+|++|.++++++++
T Consensus       253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                        0011111111111111233467788999999999999999999863

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-28  Score=266.25  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=192.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...+|.|+||.||||+++ +++..|+|.++-....... ....++-+++..+|||||.++|.|-..+..|+.||||.+|+
T Consensus        20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~-~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS-GIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             eeeecCCcccchhhhcccccCchhhheeeeccCCcccc-ccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            345899999999999887 6788888888765544432 33445566788899999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |++.-+-   ...+++.++..+++...+|++|+|+.   +-+|||||-.||++++.|.+|++|||.+..+...-.+...+
T Consensus        99 lQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   99 LQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             ccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence            9998654   34588889999999999999999999   88999999999999999999999999998776555566678


Q ss_pred             ccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          940 AGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       940 ~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      .||+.|||||+..   .+.|..++|||+.|+...|+-.-+.|-.+....+          ..+---.....++.......
T Consensus       173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr----------~l~LmTkS~~qpp~lkDk~k  242 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR----------ALFLMTKSGFQPPTLKDKTK  242 (829)
T ss_pred             cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH----------HHHHhhccCCCCCcccCCcc
Confidence            8999999999864   5678999999999999999988777732221111          11100011111222222223


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.++++.|+.++|++|||+..++.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            3456778888899999999999987764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=3.5e-26  Score=239.12  Aligned_cols=212  Identities=31%  Similarity=0.538  Sum_probs=180.9

Q ss_pred             ecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          784 HGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      ||+|++|.||++.... ++.+++|++.............++++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            5899999999998864 888999998765433122345566777788899999999999999899999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCCCCcccccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDSSNWSELAG  941 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~g  941 (1048)
                      ++....  ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++++|||.+..............+
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            986532  3478899999999999999999999   9999999999999999 899999999999876544322344567


Q ss_pred             ccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHH
Q 045493          942 TCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020 (1048)
Q Consensus       942 t~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1048)
                      ...|++||..... .++.++|+|++|++++++                                              ..
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~~  189 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------PE  189 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------HH
Confidence            8899999998877 788999999999999998                                              46


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1021 l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      +.+++.+|++.+|++||++.++++.+
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            78889999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-27  Score=255.01  Aligned_cols=195  Identities=21%  Similarity=0.298  Sum_probs=162.1

Q ss_pred             CcceeeecccccccEEEEEEcCC-CceeeEEeccCCCCccc-------chhhHHHHHHhhcc---cCceeeEeeEeeeCC
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIG-------INQKGFVSEITEIR---HRNIVKFYGFCSHTQ  846 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~-~~vavk~~~~~~~~~~~-------~~~~~~~~~l~~l~---h~niv~~~~~~~~~~  846 (1048)
                      +.....+|.|+||.|+.|.++.. ..|++|.+.+..--...       -..-.+++.+..++   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            34456689999999999998854 56677777553221111       11234677777776   999999999999999


Q ss_pred             eEEEEEEcc-CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          847 HLFLVYEYL-ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       847 ~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      .+|++||-. ++.+|.+++....   .+++.++.-|++|++.|+++||+.   +|||||||-+||.++.+|-+|++|||.
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence            999999985 5569999997543   488899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCc
Q 045493          926 AKFLKPDSSNWSELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       926 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      |.....  .....++||.+|.|||++.+.+| +..-||||+|+++|-++....||.
T Consensus       717 aa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            987653  34567899999999999999988 677899999999999999888865

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=3e-27  Score=251.08  Aligned_cols=190  Identities=21%  Similarity=0.279  Sum_probs=159.3

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc------cCceeeEeeEeeeCCeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR------HRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~------h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ..|+|-|++|.+|.+. .|+.||||++..-..  ....-..+++.++.++      --|+++++-.|.+.+++|+|+|-+
T Consensus       439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L  516 (752)
T KOG0670|consen  439 YTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL  516 (752)
T ss_pred             ccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence            3599999999999875 578999999965322  1222344566666664      357899999999999999999998


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~~  934 (1048)
                      .- +|.++++..+....+....+..++.|+.-||..|..+   +|+|.||||.|||+.+. ...||||||.|.....  .
T Consensus       517 sl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e--n  590 (752)
T KOG0670|consen  517 SL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASE--N  590 (752)
T ss_pred             hc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccccccc--c
Confidence            66 9999999887777788999999999999999999998   99999999999999876 5689999999987643  3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      ..+.+.-+..|.|||++.+.+|+...|+||+||++||+.||+..|.
T Consensus       591 eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  591 EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            3344455778999999999999999999999999999999998764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=225.77  Aligned_cols=240  Identities=20%  Similarity=0.314  Sum_probs=170.8

Q ss_pred             ceeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHh----hcccCceeeEeeE-eeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEIT----EIRHRNIVKFYGF-CSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~----~l~h~niv~~~~~-~~~~~~~~lv~e  853 (1048)
                      ..+.+|+|.||.+-.++++. .+.+|+|.+.....     ..+++.++..    --.|.||+.-|+. |+..+.+++++|
T Consensus        28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             HHHHhcccceeeEEeeeccCCceEEEeeccCcchh-----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            34468999999999999884 45667777654332     3455666642    2259999998874 566778889999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC--CCceEEeccccccccCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL--EYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~  931 (1048)
                      |++.|+|.+-+...+    +.+....+++.|++.|+.|||++   .+||||||.+||||-.  ..++|+||||..+..+.
T Consensus       103 ~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999998875433    56677889999999999999999   9999999999999943  35899999999875432


Q ss_pred             CCCCccccccccccccccccccC---C--CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          932 DSSNWSELAGTCGYIAPELAYTM---R--ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~---~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                         .....-.+-.|.|||.....   .  ..+.+|||.||+++|.++||+.||+. ......++      ..+..+..+.
T Consensus       176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y------~~~~~w~~rk  245 (378)
T KOG1345|consen  176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPY------WEWEQWLKRK  245 (378)
T ss_pred             ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchH------HHHHHHhccc
Confidence               22223345679999976543   2  36789999999999999999999982 22211111      1222333333


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQK 1041 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1041 (1048)
                      .+..+...........++.++-+.++|++|=...+
T Consensus       246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             CccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence            33333333444556777778889999999943333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=3.8e-26  Score=239.83  Aligned_cols=192  Identities=22%  Similarity=0.344  Sum_probs=155.6

Q ss_pred             CCcceeeecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          777 FEGKMVLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      .+.....||.|+|++||+|.+..    .+.||+|.+.....-.   ....+++.+..+ .+.||+++.+++..++.+.+|
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            34445568999999999996543    5678999987654433   345566666665 599999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLK  930 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~  930 (1048)
                      +||++.....++...      ++...+..+++.+..||.++|..   |||||||||+|++.+.. +.-.|.|||+|....
T Consensus       114 lp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             ecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence            999999999998754      66788999999999999999999   99999999999999864 788999999997321


Q ss_pred             CCC--------------C------------------------------CccccccccccccccccccC-CCCchhhHHHH
Q 045493          931 PDS--------------S------------------------------NWSELAGTCGYIAPELAYTM-RANEKCDVFNF  965 (1048)
Q Consensus       931 ~~~--------------~------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~  965 (1048)
                      ...              .                              .....+||++|+|||++... ..+.++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            100              0                              00124699999999998754 46899999999


Q ss_pred             HHHHHHHHhCCCCCc
Q 045493          966 GVLVLEVIEGKHPGH  980 (1048)
Q Consensus       966 Gvvl~elltg~~p~~  980 (1048)
                      |||++.++++++||-
T Consensus       265 GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFF  279 (418)
T ss_pred             cceeehhhccccccc
Confidence            999999999999984

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=9.3e-26  Score=216.04  Aligned_cols=248  Identities=19%  Similarity=0.280  Sum_probs=180.9

Q ss_pred             eecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeC--CeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHT--QHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~g  858 (1048)
                      .+|+|-|+.||.|... +.++++||.++.....    ..++++..+..++ ||||+++++...+.  ....+|+||+.+.
T Consensus        45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkk----KIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~  120 (338)
T KOG0668|consen   45 KVGRGKYSEVFEGINITNNEKCVIKILKPVKKK----KIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNT  120 (338)
T ss_pred             HHcCccHhhHhcccccCCCceEEEeeechHHHH----HHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccc
Confidence            4799999999999754 6778888888764433    3566777777776 99999999998764  5678999999998


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +......      .++.-.++.++.+++.||.|+|+.   ||.|||+||.|++||.. ...+++|+|+|.++.+... ..
T Consensus       121 Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-Yn  190 (338)
T KOG0668|consen  121 DFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  190 (338)
T ss_pred             cHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce-ee
Confidence            8877652      256667889999999999999999   99999999999999964 6799999999999876543 33


Q ss_pred             cccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccc----cccCCC-------------cccccchhhh
Q 045493          938 ELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLS----LLLSLP-------------APAANMNIVV  999 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~----~~~~~~-------------~~~~~~~~~~  999 (1048)
                      -.+.+..|.-||.+.. ..|+..-|+|||||++++|+..+.||-.-.    .+....             ......+..+
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~  270 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF  270 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence            4466788999998765 457899999999999999999999973211    000000             0000111112


Q ss_pred             hhhccCCCCCCchhH------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1000 NDLIDSRLPPPLGEV------EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+++......++...      .-...+.++++.+.+..|-.+||||+|+++
T Consensus       271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            222211111111100      011357889999999999999999999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=5.1e-27  Score=242.39  Aligned_cols=421  Identities=23%  Similarity=0.239  Sum_probs=204.3

Q ss_pred             cEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceecccc-ccccccCCccCcCCCCCCeEeccC
Q 045493          162 VSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNK-NQLSGSIPPTAGNLSNLKFLYLHD  240 (1048)
Q Consensus       162 ~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~  240 (1048)
                      +++.|+.|.|+.++|++|+.+++|+.|||++|.|+.+.|++|..+.+|..|-+.+ |+|+......|.+|..|+.|.+.-
T Consensus        70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa  149 (498)
T KOG4237|consen   70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA  149 (498)
T ss_pred             eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence            4455555555555555555555555555555555555555555555544443333 555533333455555555555555


Q ss_pred             CccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccc
Q 045493          241 NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFI  320 (1048)
Q Consensus       241 N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  320 (1048)
                      |++.-...+.|..+++|..|.+..|.+..+-..+|..+.+++.+++....-+.      ..+++.+..       +....
T Consensus       150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic------dCnL~wla~-------~~a~~  216 (498)
T KOG4237|consen  150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC------DCNLPWLAD-------DLAMN  216 (498)
T ss_pred             hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc------ccccchhhh-------HHhhc
Confidence            55554444455555555555555555543333344444455544443211000      001111100       11122


Q ss_pred             ccccccccccceeeeccccccCCCCcchhcc-CCCCeEeccCCccccCcC-hhhhccCCCcEEEeecccccCCchhhhhh
Q 045493          321 PPSLGNLSNIRGLYIRENMLYGSIPEELGRL-KSLSQLSLSVNKLNGSIP-HCLGNLSNLKFFALRENELSGSIPQEIEN  398 (1048)
Q Consensus       321 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~  398 (1048)
                      |-.++...-..-..+..+++..+.+..|... .++..=..+.....+.-| .+|..|++|+.|+|++|+++++-+.+|..
T Consensus       217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~  296 (498)
T KOG4237|consen  217 PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEG  296 (498)
T ss_pred             hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcc
Confidence            3334444444444444444443333333321 122111112222222333 45777777777777777777777777777


Q ss_pred             hcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCc-ccccCCCCCCCee
Q 045493          399 MKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-SEVFGIYPDLELL  477 (1048)
Q Consensus       399 l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L  477 (1048)
                      ...++.|.|.+|++...-...|..+..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.-.- -..++.       
T Consensus       297 ~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------  369 (498)
T KOG4237|consen  297 AAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------  369 (498)
T ss_pred             hhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------
Confidence            777777777777776655566666667777777777777667777777777777777666553110 000000       


Q ss_pred             eCcCCcccCcccccccCCCCccEEEecCcccCcc---cCccccccCCCcEEEcccCcccCCcCccccCCCcc-CEEeecC
Q 045493          478 DLSNNNFFGEISSNWIKCPQLATLNMGGNEISGT---IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSL-TSLTLNG  553 (1048)
Q Consensus       478 ~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~  553 (1048)
                      .|..++..+..+.  ..-..++.+.++++.+...   .|+..+-.            -+..-|.   .++-+ ++...|+
T Consensus       370 Wlr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~------------~s~~cP~---~c~c~~tVvRcSn  432 (498)
T KOG4237|consen  370 WLRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCL------------TSSPCPP---PCTCLDTVVRCSN  432 (498)
T ss_pred             HHhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCCC------------CCCCCCC---CcchhhhhHhhcc
Confidence            0111111111110  1112345555555544421   11111100            0001111   11222 1223344


Q ss_pred             ccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCC
Q 045493          554 NQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHN  626 (1048)
Q Consensus       554 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  626 (1048)
                      +.++ .+|..+  ...-++|++.+|.++.++.+   .+..| .+|+|+|+|.......|.++++|.+|-||+|
T Consensus       433 k~lk-~lp~~i--P~d~telyl~gn~~~~vp~~---~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  433 KLLK-LLPRGI--PVDVTELYLDGNAITSVPDE---LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             cchh-hcCCCC--CchhHHHhcccchhcccCHH---HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            4444 344332  23455677777777766333   44566 7777777777777777777788887777765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=3.9e-24  Score=226.15  Aligned_cols=194  Identities=30%  Similarity=0.463  Sum_probs=162.8

Q ss_pred             eeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ..||+|++|.||+|.... ++++++|.+..............+...+..++|+|++++++++......++++||+++++|
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   84 (225)
T smart00221        5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL   84 (225)
T ss_pred             eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence            468999999999998875 7889999987644331223344556667788999999999999988999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-CCcccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  939 (1048)
                      .+++.....  .+++..+..++.+++.++.|||+.   +++|+|++|+||+++.++.++++|||.+....... ......
T Consensus        85 ~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       85 FDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             HHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            999975432  168889999999999999999999   99999999999999999999999999998765432 122345


Q ss_pred             cccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          940 AGTCGYIAPELA-YTMRANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       940 ~gt~~y~aPE~~-~~~~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      .++..|++||.. ....++.++||||+|++++||++|+.||.
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            678889999998 66677889999999999999999999975

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.91  E-value=9.3e-24  Score=270.85  Aligned_cols=341  Identities=21%  Similarity=0.287  Sum_probs=225.1

Q ss_pred             ccccccCCCCCCEeeCCCCc------cccCCCcCCCCC-CCCcEEeCCCCcCCCCCccccccccccccccccceeccccc
Q 045493           40 IPTQISHLSKLKHLDFSTNQ------FSGIIPPQIGIL-TNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSI  112 (1048)
Q Consensus        40 ~~~~~~~l~~L~~L~L~~n~------i~~~~p~~~~~l-~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~  112 (1048)
                      .+++|.++++|+.|.+.++.      +...+|..|..+ .+|+.|++.+|.++. +|..| ...+|++|++++|++. ..
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~L  626 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-KL  626 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-cc
Confidence            44566777777777775543      223355555554 347777777777764 45555 3567777777777776 45


Q ss_pred             CcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccc
Q 045493          113 PASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNN  192 (1048)
Q Consensus       113 ~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~  192 (1048)
                      +.++..+++|+.|+|++|..-+               .+| .++.+++|+.|++.+|.....+|..+..+++|+.|++++
T Consensus       627 ~~~~~~l~~Lk~L~Ls~~~~l~---------------~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~  690 (1153)
T PLN03210        627 WDGVHSLTGLRNIDLRGSKNLK---------------EIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR  690 (1153)
T ss_pred             ccccccCCCCCEEECCCCCCcC---------------cCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence            6666777777777777654221               222 355667777777777666666777777777777777777


Q ss_pred             cCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeeccccccc----
Q 045493          193 NRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN----  268 (1048)
Q Consensus       193 n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~----  268 (1048)
                      |...+.+|..+ ++++|++|+|++|.....+|..   ..+|+.|+|++|.+. .+|..+ .+++|++|++.++...    
T Consensus       691 c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~  764 (1153)
T PLN03210        691 CENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWE  764 (1153)
T ss_pred             CCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccc
Confidence            65444566554 6777778888777655455532   356777788877776 455544 4677777777664321    


Q ss_pred             ---CCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCC
Q 045493          269 ---GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIP  345 (1048)
Q Consensus       269 ---~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  345 (1048)
                         ...+..+...++|+.|++.++.. ...+|..++++++|+.|++++|..-+.+|... ++++|+.|++++|.....+|
T Consensus       765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~-l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p  842 (1153)
T PLN03210        765 RVQPLTPLMTMLSPSLTRLFLSDIPS-LVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP  842 (1153)
T ss_pred             cccccchhhhhccccchheeCCCCCC-ccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence               11222333456778888876433 34677778888888888888765444556554 67888888888875544455


Q ss_pred             cchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccc
Q 045493          346 EELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQ  411 (1048)
Q Consensus       346 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~  411 (1048)
                      ..   ..+|++|+|++|.++ .+|.++..+++|+.|+|++|.--..+|..+..++.|+.++++++.
T Consensus       843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            43   357888889888887 678888888899999988854434577777888888888877653

syringae 6; Provisional

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=4.9e-25  Score=274.75  Aligned_cols=195  Identities=17%  Similarity=0.239  Sum_probs=139.9

Q ss_pred             hccc-CceeeEeeEe-------eeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 045493          829 EIRH-RNIVKFYGFC-------SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI  900 (1048)
Q Consensus       829 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  900 (1048)
                      ..+| +||++++++|       .+.+.++.++||+ +++|.++++..  ...+++.++..++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            4456 6888888887       2334677888987 55999999643  23488999999999999999999998   99


Q ss_pred             EeeCCCCCCeEECC-------------------CCceEEeccccccccCCCC----------------CCcccccccccc
Q 045493          901 LHRDISSKKVLLDL-------------------EYKAHVSDFGTAKFLKPDS----------------SNWSELAGTCGY  945 (1048)
Q Consensus       901 iH~Dik~~NIll~~-------------------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y  945 (1048)
                      +||||||+|||++.                   ++.+|++|||+++......                ......+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999964                   3456666777665421100                001123578899


Q ss_pred             ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHH
Q 045493          946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVA 1025 (1048)
Q Consensus       946 ~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 1025 (1048)
                      ||||++.+..|+.++|||||||++|||++|..|+....             ...........++.   ..........++
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------------~~~~~~~~~~~~~~---~~~~~~~~~~~~  245 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------------RTMSSLRHRVLPPQ---ILLNWPKEASFC  245 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------------HHHHHHHHhhcChh---hhhcCHHHHHHH
Confidence            99999999999999999999999999999888754211             00111111111111   111223456778


Q ss_pred             HhccCCCCCCCCCHHHHHHH
Q 045493         1026 FLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1026 ~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+||+++|.+||||.|+++.
T Consensus       246 ~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHhCCCChhhCcChHHHhhc
Confidence            89999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=7.2e-24  Score=214.64  Aligned_cols=165  Identities=21%  Similarity=0.251  Sum_probs=124.1

Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.++++..  ...+++.+++.++.|++.||+|||+.   +      ||+||+++.++.+|+  ||.++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            6899999653  23489999999999999999999998   5      999999999999999  99998764322    


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                       ..||+.|||||++.+..++.++|||||||++|||+||+.||......      ........... ....+.........
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~~  135 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL------SAILEILLNGM-PADDPRDRSNLESV  135 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh------cHHHHHHHHHh-ccCCccccccHHHH
Confidence             25889999999999999999999999999999999999998632211      00011111111 11111100111222


Q ss_pred             HH--HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1018 LK--SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1018 ~~--~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..  .+.+++.+||+.+|++|||+.|+++.+.
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            22  6899999999999999999999998763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN03210 Resistant to P

Probab=99.90  E-value=5e-23  Score=264.10  Aligned_cols=342  Identities=21%  Similarity=0.264  Sum_probs=241.4

Q ss_pred             CCCcCCCCCCCCcEEeCCCCc------CCCCCcccccccc-ccccccccceecccccCcCcCCcCCCceEEeecccccCc
Q 045493           63 IIPPQIGILTNLVVLRLSVNQ------LNGLIPEELGELT-SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQ  135 (1048)
Q Consensus        63 ~~p~~~~~l~~L~~L~ls~n~------l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~  135 (1048)
                      +.+.+|.++.+|+.|.+..+.      +...+|+.|..++ +|+.|++.++.+. .+|..| ...+|+.|+|++|++.  
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~--  624 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE--  624 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc--
Confidence            445667788888888886653      2334566666664 6888888888887 667666 4678888888888775  


Q ss_pred             cCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccc
Q 045493          136 IPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLN  215 (1048)
Q Consensus       136 ~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~  215 (1048)
                                    .+|..+..+++|+.++|+++...+.+| .+..+++|+.|+|++|.....+|..+.++++|++|+++
T Consensus       625 --------------~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~  689 (1153)
T PLN03210        625 --------------KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS  689 (1153)
T ss_pred             --------------ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence                          455667778888888888776555666 47778888888888876656778888888888888888


Q ss_pred             cccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccc----
Q 045493          216 KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINK----  291 (1048)
Q Consensus       216 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~----  291 (1048)
                      +|.....+|..+ ++++|++|++++|.....+|..   ..+|++|++++|.+. .+|..+ .+++|+.|.+.++..    
T Consensus       690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~  763 (1153)
T PLN03210        690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLW  763 (1153)
T ss_pred             CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhcc
Confidence            875444666654 6788888888887655455543   357888888888876 455544 567777777754221    


Q ss_pred             --cCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcC
Q 045493          292 --LSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP  369 (1048)
Q Consensus       292 --l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  369 (1048)
                        +....+..+...++|+.|++++|...+.+|.+++++++|+.|++++|...+.+|..+ .+++|++|++++|.....+|
T Consensus       764 ~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p  842 (1153)
T PLN03210        764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP  842 (1153)
T ss_pred             ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence              111112223334678888888887776778888888888888888775444666655 67888888888876544555


Q ss_pred             hhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecc
Q 045493          370 HCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN  434 (1048)
Q Consensus       370 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N  434 (1048)
                      ..   .++|+.|+|++|.+. .+|..+..+++|+.|++++|+--..+|.....+++|+.+++++|
T Consensus       843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence            43   357888888888887 67778888888888888874433346666777777888777766

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.87  E-value=5.5e-22  Score=234.89  Aligned_cols=270  Identities=28%  Similarity=0.367  Sum_probs=165.0

Q ss_pred             CCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccc
Q 045493           24 PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL  103 (1048)
Q Consensus        24 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l  103 (1048)
                      .+-..|||+.|+|+ .+|..+..  +|+.|++++|+++ .+|.   .+++|++|+|++|+|+++ |..   .++|+.|++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCcc-cCc---ccccceeec
Confidence            34556677777776 45555543  6777777777776 3453   246667777777776643 332   245666666


Q ss_pred             cceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCC
Q 045493          104 SYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK  183 (1048)
Q Consensus       104 ~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~  183 (1048)
                      ++|+++ .+|..+   .+|+.|++++|+++                                       .+ |.   .++
T Consensus       270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt---------------------------------------~L-P~---~p~  302 (788)
T PRK15387        270 FSNPLT-HLPALP---SGLCKLWIFGNQLT---------------------------------------SL-PV---LPP  302 (788)
T ss_pred             cCCchh-hhhhch---hhcCEEECcCCccc---------------------------------------cc-cc---ccc
Confidence            666665 333322   34555666666554                                       21 21   124


Q ss_pred             CcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecc
Q 045493          184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLS  263 (1048)
Q Consensus       184 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  263 (1048)
                      +|+.|+|++|++++ +|..   ..+|+.|++++|+++ .+|..   ..+|++|+|++|+|++ +|..   ..+|+.|+++
T Consensus       303 ~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls  370 (788)
T PRK15387        303 GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAY  370 (788)
T ss_pred             ccceeECCCCcccc-CCCC---cccccccccccCccc-ccccc---ccccceEecCCCccCC-CCCC---Ccccceehhh
Confidence            56666777776663 3332   234666677777776 34431   2467777777777773 4432   2456667777


Q ss_pred             cccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCC
Q 045493          264 HNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGS  343 (1048)
Q Consensus       264 ~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  343 (1048)
                      +|++.. +|.                         .   ..+|+.|++++|++++ +|..   .++|+.|++++|.+++ 
T Consensus       371 ~N~L~~-LP~-------------------------l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-  416 (788)
T PRK15387        371 NNRLTS-LPA-------------------------L---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-  416 (788)
T ss_pred             cccccc-Ccc-------------------------c---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-
Confidence            776652 221                         0   1246666777777664 3332   2467777777777764 


Q ss_pred             CCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcc
Q 045493          344 IPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKK  401 (1048)
Q Consensus       344 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  401 (1048)
                      +|...   .+|+.|++++|+|+ .+|..++++++|+.|+|++|++++.++..+.++..
T Consensus       417 IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~s  470 (788)
T PRK15387        417 LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS  470 (788)
T ss_pred             CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHhc
Confidence            45432   46778899999998 67888889999999999999999888877765543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.87  E-value=3.3e-22  Score=236.75  Aligned_cols=121  Identities=25%  Similarity=0.329  Sum_probs=67.6

Q ss_pred             ccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECC
Q 045493          545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLS  624 (1048)
Q Consensus       545 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  624 (1048)
                      +|+.|+|++|+|+ .+|..   ..+|+.|++++|+|+.+ |..   ..+|+.|++++|+|+.++..    .++|+.|+++
T Consensus       343 ~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP~l----~s~L~~LdLS  410 (788)
T PRK15387        343 GLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSLPVL----PSELKELMVS  410 (788)
T ss_pred             ccceEecCCCccC-CCCCC---CcccceehhhccccccC-ccc---ccccceEEecCCcccCCCCc----ccCCCEEEcc
Confidence            4455555555554 22321   23444455555555543 221   13455555555555543221    2456677777


Q ss_pred             CCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          625 HNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       625 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      +|+|++ +|..   ..+|+.|++++|+|+ .+|..+..++.|+.|++++|+|+|.+|.
T Consensus       411 ~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        411 GNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            777763 4443   235667777777776 5666677777777777777777776654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.3e-22  Score=234.71  Aligned_cols=253  Identities=19%  Similarity=0.237  Sum_probs=180.4

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccC--CCCcccchhhHHHHH---HhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSL--PTGEIGINQKGFVSE---ITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~--~~~~~~~~~~~~~~~---l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ....++|.|++|.|+.+... .....+.|.+...  ..............+   -..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34567899999988877554 3444555544321  111100111111222   25678999999888887777666669


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |||++ +|...+.+.   ..++..++..+++|++.|+.|+|+.   ||.|||+|++|++++.+|.+||+|||.+..+.-+
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999998654   2477788999999999999999999   9999999999999999999999999999766433


Q ss_pred             CC----CccccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          933 SS----NWSELAGTCGYIAPELAYTMRAN-EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       933 ~~----~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ..    .....+|+..|+|||++.+..|. ..+||||.|++++.|.+|+.||..........     ....... .....
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~-~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSD-QRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccc-ccccc
Confidence            22    34567899999999999999985 57899999999999999999987433211100     0000000 00011


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.............++.+++++||.+|-|++++++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            1112223444556778899999999999999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=7.5e-22  Score=193.82  Aligned_cols=243  Identities=21%  Similarity=0.380  Sum_probs=174.6

Q ss_pred             ecccccccEEEEEEcCCCceeeEEeccCCC-CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHH
Q 045493          784 HGTGGCGTVYKAELTSGDTRAVKKLHSLPT-GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT  862 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  862 (1048)
                      +.+...|..|+|+++ |..+++|++..... ......+.++.-.++...||||++++|.|.......++..||+.|+|+.
T Consensus       198 l~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn  276 (448)
T KOG0195|consen  198 LAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN  276 (448)
T ss_pred             hccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence            577888999999998 45556666543221 1122233344444566689999999999999999999999999999999


Q ss_pred             HHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeE-eeCCCCCCeEECCCCceEEeccccccccCCCCCCcccccc
Q 045493          863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL-HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG  941 (1048)
Q Consensus       863 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii-H~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  941 (1048)
                      .++... ....+-.++.+++.++|+|++|||+..  +++ ---+.+..|++|++.+++|+ .+-+++....    ....-
T Consensus       277 vlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe----~gr~y  348 (448)
T KOG0195|consen  277 VLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----VGRAY  348 (448)
T ss_pred             HHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeec----ccccc
Confidence            998654 344677889999999999999999874  444 33688999999999888774 1212211111    12234


Q ss_pred             ccccccccccccCCC---CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          942 TCGYIAPELAYTMRA---NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       942 t~~y~aPE~~~~~~~---~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .|.||+||.+..++.   -.++|+|||++++||+-|...||.+.+..      +..+.... +-++..+|+-      ..
T Consensus       349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm------ecgmkial-eglrv~ippg------is  415 (448)
T KOG0195|consen  349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM------ECGMKIAL-EGLRVHIPPG------IS  415 (448)
T ss_pred             CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch------hhhhhhhh-ccccccCCCC------cc
Confidence            789999999987765   36899999999999999999998755432      11111111 1223333332      23


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.-|++.||.+||.++.++-+|||
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            446667777999999999999999999886

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=5.6e-20  Score=204.14  Aligned_cols=252  Identities=18%  Similarity=0.169  Sum_probs=176.2

Q ss_pred             ceeeecccccccEEEEEEcCC--CceeeEEeccCCCCcccchhhHHHHHHhhcc----cCceeeEeeEe-eeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTSG--DTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVKFYGFC-SHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~--~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~  852 (1048)
                      ....||+|+||.||.|.....  ..+|+|........... ..+.+...+..+.    .+++..+++.+ ......|+||
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM  100 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM  100 (322)
T ss_pred             EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence            344689999999999988754  36777776554333221 3334444444443    36889999988 5777889999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-----CceEEecccccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-----YKAHVSDFGTAK  927 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-----~~~kl~DfG~a~  927 (1048)
                      +.+ |.+|.++.+... ...++..++.+|+.|++.+|+++|+.   |++||||||.|+.+...     ..+.+.|||+|+
T Consensus       101 ~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  101 SLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             ecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            988 669999876544 56699999999999999999999999   99999999999999865     369999999998


Q ss_pred             --ccCCCCC-----C---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchh
Q 045493          928 --FLKPDSS-----N---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI  997 (1048)
Q Consensus       928 --~~~~~~~-----~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  997 (1048)
                        .+.....     .   .....||.+|++++...+...+.+.|+||++.++.|+..|..||........       ...
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------~~~  248 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------KSK  248 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------HHH
Confidence              3322211     0   1235699999999999999999999999999999999999999864332110       001


Q ss_pred             hhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          998 VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       998 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ......+.............   +..+...+-..+...+|....+.+.++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~  295 (322)
T KOG1164|consen  249 FEKDPRKLLTDRFGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLK  295 (322)
T ss_pred             HHHHhhhhccccccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence            11111111111001111222   333333345578899998888877653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=7.4e-21  Score=209.07  Aligned_cols=159  Identities=18%  Similarity=0.132  Sum_probs=119.7

Q ss_pred             cceeeecccccccEEEEEEc--CCCceeeEEeccCCC----CcccchhhHHHHHHhhcccCceee-EeeEeeeCCeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT--SGDTRAVKKLHSLPT----GEIGINQKGFVSEITEIRHRNIVK-FYGFCSHTQHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~--~~~~vavk~~~~~~~----~~~~~~~~~~~~~l~~l~h~niv~-~~~~~~~~~~~~lv  851 (1048)
                      .....||+|+||+||+|.+.  +++.+|||+......    .........+++.++.++|+||++ ++++    +..|+|
T Consensus        21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LV   96 (365)
T PRK09188         21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLV   96 (365)
T ss_pred             eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEE
Confidence            34456899999999999875  467779988653211    111233566777888999999985 4432    457999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC-CCCCeEECCCCceEEeccccccccC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI-SSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di-k~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      |||++|++|... ..   ..      ...++.++++||.|||+.   +|+|||| ||+||+++.++.+||+|||+|+.+.
T Consensus        97 mE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         97 RGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             EEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            999999999732 11   01      146788999999999999   9999999 9999999999999999999999775


Q ss_pred             CCCCC--------ccccccccccccccccccC
Q 045493          931 PDSSN--------WSELAGTCGYIAPELAYTM  954 (1048)
Q Consensus       931 ~~~~~--------~~~~~gt~~y~aPE~~~~~  954 (1048)
                      .....        .+...+++.|+|||++...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            44311        1345688899999987643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-19  Score=184.12  Aligned_cols=193  Identities=18%  Similarity=0.255  Sum_probs=159.1

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||.++.|..- +++.||+|.-.......   ....+.+..+.+ ..+.|...|-|..++.+-.+|+|.. |-+
T Consensus        34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP---QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS  109 (449)
T KOG1165|consen   34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP---QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS  109 (449)
T ss_pred             cccccCcceeeecccccccCceEEEEeccccCCcc---hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence            35899999999999754 78999999865544443   233444444444 5799999999999999999999998 669


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-----ceEEeccccccccCCCCC
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-----KAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-----~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|+..=.  ...++..++..||.|++.-++|+|++   .+|.|||||+|+||...+     .+.++|||+|+.+.+...
T Consensus       110 LEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  110 LEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             HHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            99988533  34589999999999999999999999   999999999999997543     589999999998875543


Q ss_pred             C-------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Q 045493          935 N-------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLS  983 (1048)
Q Consensus       935 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  983 (1048)
                      .       .....||.+||+-....+.+.+...|.=|+|-|+.+++.|..||+...
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            2       234579999999999999999999999999999999999999998543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.83  E-value=9.7e-21  Score=226.29  Aligned_cols=250  Identities=26%  Similarity=0.431  Sum_probs=157.9

Q ss_pred             CCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccc
Q 045493           21 LLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNE  100 (1048)
Q Consensus        21 ~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~  100 (1048)
                      +...+.+.|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|++|++++|++++ +|..+.  .+|+.
T Consensus       175 Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~  245 (754)
T PRK15370        175 CLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQE  245 (754)
T ss_pred             hcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccE
Confidence            34456677777777777 4455443  36777777777777 4555443  467777777777774 354443  35777


Q ss_pred             ccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCC
Q 045493          101 LALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG  180 (1048)
Q Consensus       101 L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~  180 (1048)
                      |+|++|++. .+|..+.  ++|+.|++++|+++.                +|..+.  .+|+.|++++|++++. |..+.
T Consensus       246 L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~----------------LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp  303 (754)
T PRK15370        246 MELSINRIT-ELPERLP--SALQSLDLFHNKISC----------------LPENLP--EELRYLSVYDNSIRTL-PAHLP  303 (754)
T ss_pred             EECcCCccC-cCChhHh--CCCCEEECcCCccCc----------------cccccC--CCCcEEECCCCccccC-cccch
Confidence            777777776 4555443  467777777777652                223232  3567777777777753 33332


Q ss_pred             CCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccccccee
Q 045493          181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYL  260 (1048)
Q Consensus       181 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  260 (1048)
                        ++|+.|++++|.++ .+|..+.  ++|++|++++|.++ .+|..+.  ++|+.|+|++|+++ .+|..+.  ++|++|
T Consensus       304 --~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~L  372 (754)
T PRK15370        304 --SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTL  372 (754)
T ss_pred             --hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEE
Confidence              46788888888887 3454442  57888888888887 4665553  67888888888887 4665553  578888


Q ss_pred             ecccccccCCCchhhhccchhhhhhhccccccCCCCCccc----CCCCCCcEEEccCceee
Q 045493          261 YLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI----GNLKSLSHLWLSKTQLS  317 (1048)
Q Consensus       261 ~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~----~~l~~L~~L~L~~n~l~  317 (1048)
                      ++++|++.. +|..+.  ..|+.|++++ |++. .+|..+    ..++++..|++.+|.++
T Consensus       373 dLs~N~Lt~-LP~~l~--~sL~~LdLs~-N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        373 DVSRNALTN-LPENLP--AALQIMQASR-NNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             ECCCCcCCC-CCHhHH--HHHHHHhhcc-CCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            888888874 454443  3567777765 5554 333322    33455666666666654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=4.8e-19  Score=200.28  Aligned_cols=255  Identities=27%  Similarity=0.366  Sum_probs=187.5

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccC-ceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHR-NIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...+|.|+||.||++...  ..+++|.+........  .....++......+.|+ +|+++++++......+++++++.+
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~   82 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG   82 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence            345899999999999887  7788888876544432  33445555566788887 799999999877778999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCCC--
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~--  934 (1048)
                      +++.+++........+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++.......  
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            99997775432112477889999999999999999999   999999999999999988 799999999986554432  


Q ss_pred             ----Ccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          935 ----NWSELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       935 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                          ......||..|+|||...+   ..+....|+||+|++++++++|..||......    ...............+..
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPTPSL  235 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCCccc
Confidence                2356789999999999987   57889999999999999999999996533211    000001111111111100


Q ss_pred             CCCchh--HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPPLGE--VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......  .......+.+++.+|+..+|..|.++.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            000000  0122346778888999999999999887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.9e-19  Score=174.55  Aligned_cols=193  Identities=20%  Similarity=0.245  Sum_probs=153.3

Q ss_pred             eeecccccccEEEEEE-cCCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||.|+||.+|.|.. .+|++||+|.-.+......-..   +.+....++ ...|..+..|+.+...-.+|||.. |.+
T Consensus        21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~y---EskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs   96 (341)
T KOG1163|consen   21 RKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLY---ESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS   96 (341)
T ss_pred             EeecCCchhheeeeeeccCCceEEEEeecccCCCcchhH---HHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence            4589999999999965 5799999998766554442222   222233343 356667777888888889999998 669


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEeccccccccCCCCCC-
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      |++...-.  ...++..+++-.+.|++.-++|+|.+   ++|||||||+|+|..-+   ..+.++|||+|+.+.+.... 
T Consensus        97 LEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   97 LEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             HHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            99988532  23478889999999999999999999   89999999999999743   56899999999887643322 


Q ss_pred             ------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Q 045493          936 ------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLS  983 (1048)
Q Consensus       936 ------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  983 (1048)
                            .+...||.+|.+-....+...+...|+=|+|.|+.++-.|..||+...
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence                  235679999999888888888999999999999999999999998543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.81  E-value=6.9e-20  Score=219.06  Aligned_cols=247  Identities=26%  Similarity=0.435  Sum_probs=180.7

Q ss_pred             CCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEe
Q 045493           48 SKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSL  127 (1048)
Q Consensus        48 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l  127 (1048)
                      .+.+.|++++++++ .+|..+  .++|+.|+|++|+|+++ |..+.  ++|++|++++|+++ .+|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~I--p~~L~~L~Ls~N~LtsL-P~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACI--PEQITTLILDNNELKSL-PENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCccc--ccCCcEEEecCCCCCcC-Chhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            46889999999999 577765  46899999999999964 55544  58999999999999 5566554  48999999


Q ss_pred             ecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCccccccc
Q 045493          128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR  207 (1048)
Q Consensus       128 ~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~  207 (1048)
                      ++|.+..                +|..+.  ++|+.|++++|+++. +|+.+.  ++|+.|++++|+++ .+|..+.  .
T Consensus       249 s~N~L~~----------------LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~  304 (754)
T PRK15370        249 SINRITE----------------LPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP--S  304 (754)
T ss_pred             cCCccCc----------------CChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch--h
Confidence            9999862                333332  478999999999995 566554  58999999999998 4565543  5


Q ss_pred             ccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhc
Q 045493          208 SLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVH  287 (1048)
Q Consensus       208 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~  287 (1048)
                      +|++|++++|+++ .+|..+.  ++|++|++++|.+++ +|..+.  ++|+.|++++|++. .+|..+.  +        
T Consensus       305 sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~--------  367 (754)
T PRK15370        305 GITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P--------  367 (754)
T ss_pred             hHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--C--------
Confidence            7999999999998 4665543  689999999999995 676654  69999999999987 4554331  2        


Q ss_pred             cccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchh----ccCCCCeEeccCCc
Q 045493          288 NINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELG----RLKSLSQLSLSVNK  363 (1048)
Q Consensus       288 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~Ls~N~  363 (1048)
                                       +|+.|++++|+++. +|..+.  ..|+.|++++|.+. .+|..+.    .++++..|++.+|.
T Consensus       368 -----------------~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Np  426 (754)
T PRK15370        368 -----------------TITTLDVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNP  426 (754)
T ss_pred             -----------------CcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCC
Confidence                             45566666666653 333332  24666666666665 3444333    34666777777777


Q ss_pred             cc
Q 045493          364 LN  365 (1048)
Q Consensus       364 l~  365 (1048)
                      ++
T Consensus       427 ls  428 (754)
T PRK15370        427 FS  428 (754)
T ss_pred             cc
Confidence            75

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=1.7e-19  Score=189.12  Aligned_cols=230  Identities=17%  Similarity=0.231  Sum_probs=141.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHH---hhc----------ccCceeeEeeEee--
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEI----------RHRNIVKFYGFCS--  843 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l---~~l----------~h~niv~~~~~~~--  843 (1048)
                      +..+||.|+++.||.+++. +++++|||.+....... ....++..++.   ..+          .|-.++-.++...  
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~-~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS-ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH-TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccc-hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            4557999999999999987 58899999987655222 22222222221   111          1323333333221  


Q ss_pred             -------eC---C-----eEEEEEEccCCCCHHHHHhc---c-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeC
Q 045493          844 -------HT---Q-----HLFLVYEYLERGSLATILSN---E-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRD  904 (1048)
Q Consensus       844 -------~~---~-----~~~lv~e~~~~g~L~~~l~~---~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D  904 (1048)
                             ..   .     ..+++|+-+.+ ||.+++.-   . .....+....+..+..|+++.+++||+.   |+||+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence                   11   1     23678898855 99888642   1 1122344556677889999999999999   999999


Q ss_pred             CCCCCeEECCCCceEEeccccccccCCCCCCccccccccccccccccccC--------CCCchhhHHHHHHHHHHHHhCC
Q 045493          905 ISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM--------RANEKCDVFNFGVLVLEVIEGK  976 (1048)
Q Consensus       905 ik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dvws~Gvvl~elltg~  976 (1048)
                      |||+|++++.+|.++|+||+.......   .......+..|.+||.....        .++.+.|.|++|+++|.|++|+
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            999999999999999999988765432   11213445789999976542        4689999999999999999999


Q ss_pred             CCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCC
Q 045493          977 HPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCR 1036 (1048)
Q Consensus       977 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 1036 (1048)
                      .||+........       ..   ++         ..+.+..+.+..+|..+++++|++|
T Consensus       248 lPf~~~~~~~~~-------~~---~f---------~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADP-------EW---DF---------SRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTS-------GG---GG---------TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccc-------cc---cc---------hhcCCcCHHHHHHHHHHccCCcccC
Confidence            998743221110       00   11         1111334467788889999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=5.7e-19  Score=178.82  Aligned_cols=138  Identities=18%  Similarity=0.143  Sum_probs=103.4

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCccc-------------------------chhhHHHHHHhhcccCceee
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG-------------------------INQKGFVSEITEIRHRNIVK  837 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~-------------------------~~~~~~~~~l~~l~h~niv~  837 (1048)
                      .||+|+||.||+|...+|+.||||+++........                         .....+.+.+.++.++++..
T Consensus         4 ~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~   83 (190)
T cd05147           4 CISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC   83 (190)
T ss_pred             ccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence            58999999999999888999999998764321111                         00122455566777776644


Q ss_pred             EeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeeCCCCCCeEECCCC
Q 045493          838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEY  916 (1048)
Q Consensus       838 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~Dik~~NIll~~~~  916 (1048)
                      ...+...  ..++||||++++++.......   ..++..++..++.|++.++.|+ |+.   +|+||||||+||+++ ++
T Consensus        84 p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~  154 (190)
T cd05147          84 PEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence            3333222  238999999998776553222   3478889999999999999999 687   999999999999998 57


Q ss_pred             ceEEecccccccc
Q 045493          917 KAHVSDFGTAKFL  929 (1048)
Q Consensus       917 ~~kl~DfG~a~~~  929 (1048)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=5.5e-19  Score=197.00  Aligned_cols=208  Identities=24%  Similarity=0.480  Sum_probs=157.8

Q ss_pred             hhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeeCCC
Q 045493          828 TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI-LHRDIS  906 (1048)
Q Consensus       828 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-iH~Dik  906 (1048)
                      +.+.|.|+.+++|.+.+....+.|.+||..|+|.|.+...  .-.++|.-...++++|+.|++|+|..   +| +|+.++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~   76 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK   76 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence            4678999999999999999999999999999999999762  34589999999999999999999998   45 899999


Q ss_pred             CCCeEECCCCceEEeccccccccCCCC--CCccccccccccccccccccCC-------CCchhhHHHHHHHHHHHHhCCC
Q 045493          907 SKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELAYTMR-------ANEKCDVFNFGVLVLEVIEGKH  977 (1048)
Q Consensus       907 ~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dvws~Gvvl~elltg~~  977 (1048)
                      ++|.++|..+.+|++|||+........  .......-..-|.|||.+....       .+.++||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311  1111112334699999987631       4678999999999999999999


Q ss_pred             CCcccccccCCCcccccchhhhhhhcc-CC--CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          978 PGHFLSLLLSLPAPAANMNIVVNDLID-SR--LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       978 p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ||+.....       ....+.+..+.+ +.  +.+......+....+..++..||..+|++||+++++-..++
T Consensus       157 ~~~~~~~~-------~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  157 PFDLRNLV-------EDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             cccccccc-------CChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            98743211       111223333333 22  11111111234446899999999999999999999877654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=3.3e-21  Score=176.80  Aligned_cols=181  Identities=31%  Similarity=0.571  Sum_probs=145.4

Q ss_pred             ccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCc
Q 045493           44 ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLV  123 (1048)
Q Consensus        44 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~  123 (1048)
                      +..+.+++.|.||+|+++ .+|..+..+.+|+.|++++|+|+. .|.+++.+++|++|+++-|++. +.|.+|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445678899999999999 788899999999999999999994 6888999999999999999998 8999999999999


Q ss_pred             eEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCccc
Q 045493          124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI  203 (1048)
Q Consensus       124 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~  203 (1048)
                      .|||+.|.++.                                      ..+|+.|..|+-|+.|+|+.|.+. ++|..+
T Consensus       106 vldltynnl~e--------------------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dv  146 (264)
T KOG0617|consen  106 VLDLTYNNLNE--------------------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDV  146 (264)
T ss_pred             hhhcccccccc--------------------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhh
Confidence            99999998763                                      245677777888888888888876 778888


Q ss_pred             ccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccc---ccceeeccccccc
Q 045493          204 GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLN  268 (1048)
Q Consensus       204 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~L~~n~l~  268 (1048)
                      +.+++|+.|.+++|.+. .+|..++.++.|+.|.+.+|+++ .+|+.++.+.   +=+.+.+.+|+..
T Consensus       147 g~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  147 GKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             hhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            88888888888888877 67778888888888888888887 5665555432   2234445555543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=7.6e-20  Score=202.66  Aligned_cols=225  Identities=25%  Similarity=0.275  Sum_probs=170.8

Q ss_pred             ecccccccEEEEE----EcCCCceeeEEeccCCCCcccc-hhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          784 HGTGGCGTVYKAE----LTSGDTRAVKKLHSLPTGEIGI-NQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       784 lG~G~~g~Vy~~~----~~~~~~vavk~~~~~~~~~~~~-~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      +|+|+||.|+.++    ...+.-+|+|..++........ ....+...+..++ ||.+|++...+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6999999999774    2346678888776644332222 2233344445555 99999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |++...+....   .++......+...++-|++++|+.   +|+|||+|++||+++.+|++++.|||.++..-+....  
T Consensus        82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99988875433   366677777888999999999999   9999999999999999999999999999876544332  


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                        +||..|||||++.  .+..++|.||||++++||+||..||..               .....+......    .+.+.
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------------~~~~~Il~~~~~----~p~~l  210 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------------DTMKRILKAELE----MPREL  210 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------HHHHHHhhhccC----Cchhh
Confidence              8999999999998  578899999999999999999999763               122222222222    22344


Q ss_pred             HHHHHHHHHhccCCCCCCCCCH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      .....+++..+...+|..|.-.
T Consensus       211 ~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  211 SAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hHHHHHHHHHHHhhCHHHHhcc
Confidence            4455666667788888887644

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=2.4e-19  Score=207.75  Aligned_cols=242  Identities=20%  Similarity=0.189  Sum_probs=171.0

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHH--HhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE--ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      +.+|.+.|=.|.+|++..|. |+||++.+....-.-....+.+++  ...++|||++++.-+-...+..|+|-+|+.+ +
T Consensus        29 ~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-n  106 (1431)
T KOG1240|consen   29 ENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-N  106 (1431)
T ss_pred             cccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-h
Confidence            35899999999999998777 888888665433222223333333  3456899999998887777778999999977 9


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc--cCCCCCC-c
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF--LKPDSSN-W  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~--~~~~~~~-~  936 (1048)
                      |+|.+..+   .-+...+..-|+.|++.|+.-+|..   ||+|||||.+||||+.=.=+.|+||..-+.  ++.+++. +
T Consensus       107 LyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  107 LYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             hhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            99988532   3356667778999999999999999   999999999999999877789999976532  2222221 2


Q ss_pred             ccc----ccccccccccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhh
Q 045493          937 SEL----AGTCGYIAPELAYTM----------R-ANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       937 ~~~----~gt~~y~aPE~~~~~----------~-~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ..+    ..-..|.|||.+...          . .+++.||||.|||++|+++ |++||.....+..........+...+
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le  260 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE  260 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH
Confidence            222    223369999977541          1 4678999999999999998 68887643322111111111122222


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+-+              ..+..++..|++.||+.|.+|++.++.
T Consensus       261 ~Ied--------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  261 KIED--------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hCcC--------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2211              246778888999999999999999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.76  E-value=1.1e-18  Score=177.75  Aligned_cols=166  Identities=9%  Similarity=0.133  Sum_probs=124.3

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccc--------hhhHHHHHHhhcccCceeeEeeEeeeC------
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGI--------NQKGFVSEITEIRHRNIVKFYGFCSHT------  845 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~--------~~~~~~~~l~~l~h~niv~~~~~~~~~------  845 (1048)
                      ...++|.|+||.||.+.. +++.+|+|.++.........        ..+++.+.+.++.|++|..+.+++...      
T Consensus        35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~  113 (232)
T PRK10359         35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR  113 (232)
T ss_pred             EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence            445689999999999766 57789999987543322111        124555567888999999999886533      


Q ss_pred             --CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          846 --QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       846 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                        ...++||||++|.+|.++..       ++.    ....+++.++..+|..   |++|||+||+||+++.+| ++++||
T Consensus       114 ~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        114 YAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEEC
Confidence              35899999999999988732       222    2456899999999999   999999999999999988 999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 045493          924 GTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI  973 (1048)
Q Consensus       924 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ell  973 (1048)
                      |.......+...            ..+.....+..++|+||+|+.+.-..
T Consensus       179 g~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence            988754322111            11334445677999999999987654

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=3.7e-20  Score=207.16  Aligned_cols=279  Identities=22%  Similarity=0.251  Sum_probs=158.0

Q ss_pred             EEEeeccccc-CCchhhhhhhcccceeeccccccCCC----CCcccccCCcccEEEeecccccCCCCCCcccccccceeE
Q 045493          380 FFALRENELS-GSIPQEIENMKKLNKYLLFENQFTGY----LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLR  454 (1048)
Q Consensus       380 ~L~L~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~----~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~  454 (1048)
                      .|+|..+.++ +..+..+..+..|+.+.+.++.++..    ++..+...+++++++++++.+.+. +..+          
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~-~~~~----------   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI-PRGL----------   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc-chHH----------
Confidence            4667777776 45566666777777777777776432    222233334455555555444310 0000          


Q ss_pred             ecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCC---ccEEEecCcccCc----ccCcccccc-CCCcEEE
Q 045493          455 LERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQ---LATLNMGGNEISG----TIPSEIGNM-TQLHKLD  526 (1048)
Q Consensus       455 L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~---L~~L~L~~N~i~~----~~~~~~~~l-~~L~~L~  526 (1048)
                             ......+..+++|+.|++++|.+.+..+..+..+.+   |++|++++|.+++    .+...+..+ ++|+.|+
T Consensus        71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~  143 (319)
T cd00116          71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV  143 (319)
T ss_pred             -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence                   011223344555555555555554433333333332   6666666666652    122233444 6666777


Q ss_pred             cccCcccCC----cCccccCCCccCEEeecCccccCC----CccccccccccceeecccCccccccc----ccccccccc
Q 045493          527 FSSNRLVGQ----IPKQLGKLTSLTSLTLNGNQLSGD----IPLELGLLAELGYLDLSANRLSKLIP----KNLGELRKL  594 (1048)
Q Consensus       527 Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L  594 (1048)
                      +++|.+++.    .+..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++...    ..+..+++|
T Consensus       144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            776666632    233445556677777777776632    22334445577777777777664332    334556778


Q ss_pred             cccccccccccchhhhhhcc-----ccccCeEECCCCcccC----cCCcCcCCccccCeEECCCCcccCCccc----ccc
Q 045493          595 HHLNLSNNQFSQEISIQIGK-----LVQLSKLDLSHNSLGG----NIPSEICNLESLEYMNLLQNKLSGPIPS----CFR  661 (1048)
Q Consensus       595 ~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~  661 (1048)
                      ++|++++|.+++.....+..     .++|+.|++++|.+++    .+...+..+++|+++++++|.++.....    .+.
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~  303 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL  303 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence            88888888777654444432     3678888888888763    2233445567888888888888855333    333


Q ss_pred             cc-CCccEEEecccee
Q 045493          662 RM-HGLSSIDVSYNEL  676 (1048)
Q Consensus       662 ~l-~~L~~l~ls~N~l  676 (1048)
                      .. +.|+++++.+|+|
T Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
T cd00116         304 EPGNELESLWVKDDSF  319 (319)
T ss_pred             hcCCchhhcccCCCCC
Confidence            44 6788888888764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=7e-18  Score=171.96  Aligned_cols=138  Identities=17%  Similarity=0.167  Sum_probs=105.2

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCccc-------------------------chhhHHHHHHhhcccCceee
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG-------------------------INQKGFVSEITEIRHRNIVK  837 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~-------------------------~~~~~~~~~l~~l~h~niv~  837 (1048)
                      .||+|+||.||+|...+|+.||||.+.........                         ...+.+.+.+.++.|++|..
T Consensus         4 ~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (190)
T cd05145           4 CISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV   83 (190)
T ss_pred             eeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            58999999999999888999999998764321000                         00123445567778888755


Q ss_pred             EeeEeeeCCeEEEEEEccCCCCHHHH-HhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCC
Q 045493          838 FYGFCSHTQHLFLVYEYLERGSLATI-LSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLE  915 (1048)
Q Consensus       838 ~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~  915 (1048)
                      ...+....  .++||||++++++... +..    ..++...+..++.+++.++.++|+ .   ||+||||||+||+++ +
T Consensus        84 p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~  153 (190)
T cd05145          84 PEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D  153 (190)
T ss_pred             ceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence            44443332  4899999999855433 322    236778889999999999999999 8   999999999999999 8


Q ss_pred             CceEEeccccccccC
Q 045493          916 YKAHVSDFGTAKFLK  930 (1048)
Q Consensus       916 ~~~kl~DfG~a~~~~  930 (1048)
                      +.++++|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            999999999998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=8.2e-20  Score=204.39  Aligned_cols=279  Identities=23%  Similarity=0.292  Sum_probs=177.8

Q ss_pred             eEeccCCccc-cCcChhhhccCCCcEEEeecccccCC----chhhhhhhcccceeeccccccCCCCCcccccCCcccEEE
Q 045493          356 QLSLSVNKLN-GSIPHCLGNLSNLKFFALRENELSGS----IPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFS  430 (1048)
Q Consensus       356 ~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~  430 (1048)
                      .|+|+.++++ ...+..+..+++|+.+++++|.++..    ++..+...+.++.+.++++.+.+. +..+          
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~-~~~~----------   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI-PRGL----------   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc-chHH----------
Confidence            5788899987 45566788899999999999998643    455666777899999999887631 1100          


Q ss_pred             eecccccCCCCCCcccccccceeEecCCccccCcccccCCCCC---CCeeeCcCCcccCc----ccccccCC-CCccEEE
Q 045493          431 VRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPD---LELLDLSNNNFFGE----ISSNWIKC-PQLATLN  502 (1048)
Q Consensus       431 l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~---L~~L~Ls~n~l~~~----~~~~~~~~-~~L~~L~  502 (1048)
                             ..++..+..+++|++|++++|.+....+..+..+..   |+.|++++|++++.    ....+..+ ++|++|+
T Consensus        71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~  143 (319)
T cd00116          71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV  143 (319)
T ss_pred             -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence                   112334444555555666555555433333333333   66666666666531    22233444 6677777


Q ss_pred             ecCcccCcc----cCccccccCCCcEEEcccCcccCC----cCccccCCCccCEEeecCccccCC----Ccccccccccc
Q 045493          503 MGGNEISGT----IPSEIGNMTQLHKLDFSSNRLVGQ----IPKQLGKLTSLTSLTLNGNQLSGD----IPLELGLLAEL  570 (1048)
Q Consensus       503 L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L  570 (1048)
                      +++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|
T Consensus       144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            777777632    233455566777777777777642    223344556788888888877633    23445667778


Q ss_pred             ceeecccCcccccccccccc-----cccccccccccccccchhh----hhhccccccCeEECCCCcccCcC----CcCcC
Q 045493          571 GYLDLSANRLSKLIPKNLGE-----LRKLHHLNLSNNQFSQEIS----IQIGKLVQLSKLDLSHNSLGGNI----PSEIC  637 (1048)
Q Consensus       571 ~~L~Ls~N~l~~~~~~~l~~-----l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~  637 (1048)
                      ++|++++|.+++.....+..     .+.|+.|++++|.+++...    ..+..+++|+.+|+++|.++...    ...+.
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~  303 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL  303 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence            88888888887543333332     3688888888888874333    33445678899999999888543    22333


Q ss_pred             Cc-cccCeEECCCCcc
Q 045493          638 NL-ESLEYMNLLQNKL  652 (1048)
Q Consensus       638 ~l-~~L~~L~L~~N~l  652 (1048)
                      .. +.|+++|+.+|++
T Consensus       304 ~~~~~~~~~~~~~~~~  319 (319)
T cd00116         304 EPGNELESLWVKDDSF  319 (319)
T ss_pred             hcCCchhhcccCCCCC
Confidence            33 6788888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.2e-17  Score=165.71  Aligned_cols=181  Identities=12%  Similarity=0.070  Sum_probs=133.9

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCccc---chhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG---INQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~---~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...+++|+||+||.+.. .+.+++.+.+.........   ...+.|++.+++++ |++|++++++    +..+++|||++
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45689999999998766 5677776666543331111   13456777788885 5889999886    34699999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC-CCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI-SSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di-k~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      |.+|.+....          ....++.++++++.++|+.   ||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             CccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            9998764311          1134778999999999999   9999999 799999999999999999999865543321


Q ss_pred             -----c--------cccccccccccccccccC-CCC-chhhHHHHHHHHHHHHhCCCCC
Q 045493          936 -----W--------SELAGTCGYIAPELAYTM-RAN-EKCDVFNFGVLVLEVIEGKHPG  979 (1048)
Q Consensus       936 -----~--------~~~~gt~~y~aPE~~~~~-~~~-~~~Dvws~Gvvl~elltg~~p~  979 (1048)
                           .        .....++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence                 0        012357788888865432 233 5679999999999999999884

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=2.5e-17  Score=196.32  Aligned_cols=186  Identities=22%  Similarity=0.216  Sum_probs=154.1

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc---cCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+|+|+||.||+|...+++.||+|.-+.....+..+..+    .+.+++   -+.|..+..++...+.-++|+||.+.|+
T Consensus       705 e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q----~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt  780 (974)
T KOG1166|consen  705 EIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQ----VMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT  780 (974)
T ss_pred             eeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHH----HHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence            479999999999998889999999987766655433222    223333   3556666666666777899999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-------CCceEEeccccccccC--
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-------EYKAHVSDFGTAKFLK--  930 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-------~~~~kl~DfG~a~~~~--  930 (1048)
                      |.+++.   ..+.++|.-...++.|+++-++.||..   +||||||||+|.++..       ...++|+|||.+..+.  
T Consensus       781 lld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  781 LLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             HHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            999996   344588999999999999999999999   9999999999999953       2458999999997654  


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP  978 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p  978 (1048)
                      ++.......++|-.+--+|+..++++++.+|.|.++.+++.|+.|++-
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            455567788899999999999999999999999999999999999863

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=2.2e-18  Score=187.47  Aligned_cols=176  Identities=21%  Similarity=0.372  Sum_probs=139.7

Q ss_pred             eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccc
Q 045493          847 HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA  926 (1048)
Q Consensus       847 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a  926 (1048)
                      ..|+.|++|+..+|.+++.+.......++.....++.|++.|+.|   +   +.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999877777778899999999999999999   5   8999999999999999999999999999


Q ss_pred             cccCCCC------CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhh
Q 045493          927 KFLKPDS------SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       927 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      .......      ...+...||..||+||.+.+..|+.|+||||+|++++|+++--   .          ..........
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f---~----------T~~er~~t~~  470 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQF---S----------TQFERIATLT  470 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHh---c----------cHHHHHHhhh
Confidence            8766544      1234567999999999999999999999999999999999721   1          1122233445


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ++.++.+++..-   .....=+.++..++.+.|++||++.++..
T Consensus       471 d~r~g~ip~~~~---~d~p~e~~ll~~lls~~p~~RP~~~~~~~  511 (516)
T KOG1033|consen  471 DIRDGIIPPEFL---QDYPEEYTLLQQLLSPSPEERPSAIEVAL  511 (516)
T ss_pred             hhhcCCCChHHh---hcCcHHHHHHHHhcCCCcccCchHHHHhh
Confidence            566666663221   11223346778899999999997776643

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.72  E-value=3.8e-19  Score=163.32  Aligned_cols=164  Identities=32%  Similarity=0.553  Sum_probs=133.0

Q ss_pred             CCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCC
Q 045493           69 GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHY  148 (1048)
Q Consensus        69 ~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~  148 (1048)
                      -.+.+.+.|-||||+++ .+|..+..+.+|+.|++++|+++ ..|.++++|+.|+.|+++-|++.               
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~---------------   92 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN---------------   92 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh---------------
Confidence            34556677777777777 45666777777777777777777 67777777777777777777664               


Q ss_pred             CCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccc-cCCcccccccccceeccccccccccCCccC
Q 045493          149 GSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG-SIPSEIGNLRSLSYLGLNKNQLSGSIPPTA  227 (1048)
Q Consensus       149 ~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~  227 (1048)
                                               +.|..|+.++.|+.|||..|.+.. .+|+.|..++-|+.|.|++|.+. .+|+.+
T Consensus        93 -------------------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dv  146 (264)
T KOG0617|consen   93 -------------------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDV  146 (264)
T ss_pred             -------------------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhh
Confidence                                     567888888999999999998874 68999999999999999999998 888999


Q ss_pred             cCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhc
Q 045493          228 GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGN  277 (1048)
Q Consensus       228 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~  277 (1048)
                      +++++|+.|.+.+|.+- .+|..++.+.+|++|++++|+++ .+|..++.
T Consensus       147 g~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  147 GKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN  194 (264)
T ss_pred             hhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence            99999999999999988 68899999999999999999998 45555544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=5e-17  Score=168.69  Aligned_cols=195  Identities=23%  Similarity=0.319  Sum_probs=135.9

Q ss_pred             ccCceeeEeeEeee---------------------------CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHH
Q 045493          831 RHRNIVKFYGFCSH---------------------------TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK  883 (1048)
Q Consensus       831 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  883 (1048)
                      +|||||++.++|.+                           ....|+||..++. +|.+|+..+.    .+...+.-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            49999998876532                           2357999999977 9999996432    45566778899


Q ss_pred             HHHHHHHHHHhCCCCCeEeeCCCCCCeEEC--CC--CceEEeccccccccCCCC------CCcccccccccccccccccc
Q 045493          884 GVANALSYMHHDCFPPILHRDISSKKVLLD--LE--YKAHVSDFGTAKFLKPDS------SNWSELAGTCGYIAPELAYT  953 (1048)
Q Consensus       884 ~i~~~L~~LH~~~~~~iiH~Dik~~NIll~--~~--~~~kl~DfG~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~  953 (1048)
                      |+++|+.|||.+   ||.|||+|++|||+.  +|  ...+++|||++---...+      ...-...|...-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   999999999999994  33  357899999874321111      11123457778999999875


Q ss_pred             CCC------CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHh
Q 045493          954 MRA------NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL 1027 (1048)
Q Consensus       954 ~~~------~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 1027 (1048)
                      .+-      -.|+|.|+.|.+.||+++...||.......-.      ..    ......+|+..   +.....+.+++..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------~r----~Yqe~qLPalp---~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------TR----TYQESQLPALP---SRVPPVARQLVFD  492 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------hh----hhhhhhCCCCc---ccCChHHHHHHHH
Confidence            432      35899999999999999999998742211000      00    01111222222   2223346677777


Q ss_pred             ccCCCCCCCCCHHHHHHHh
Q 045493         1028 CLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1028 cl~~dP~~RPt~~evl~~L 1046 (1048)
                      .++.||.+|+++.-....|
T Consensus       493 lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HhcCCccccCCccHHHhHH
Confidence            8999999999987665544

>PRK10345 hypothetical protein; Provisional

Probab=99.69  E-value=1.9e-16  Score=161.55  Aligned_cols=134  Identities=14%  Similarity=0.177  Sum_probs=99.3

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhc-----ccCceeeEeeEeeeCC---e-EEEE
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-----RHRNIVKFYGFCSHTQ---H-LFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv  851 (1048)
                      ..+||+|+||.||.  +......+||++...... ......+|+..++.+     .||||++++|++..+.   . +.+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            34689999999996  544444478887653222 223456667777777     5799999999998763   3 3378


Q ss_pred             EEc--cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeeCCCCCCeEECC----CCceEEeccc
Q 045493          852 YEY--LERGSLATILSNEATAAELDWSKRVNVIKGVANAL-SYMHHDCFPPILHRDISSKKVLLDL----EYKAHVSDFG  924 (1048)
Q Consensus       852 ~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~Dik~~NIll~~----~~~~kl~DfG  924 (1048)
                      +||  +++|+|.+++++.    .+++.  ..++.+++.++ +|||+.   +|+||||||+||+++.    ++.++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  6689999999652    24444  35677888777 999999   9999999999999974    3479999944


Q ss_pred             cc
Q 045493          925 TA  926 (1048)
Q Consensus       925 ~a  926 (1048)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.3e-16  Score=185.53  Aligned_cols=204  Identities=25%  Similarity=0.341  Sum_probs=133.6

Q ss_pred             CcceeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ++..++|..|+||.||.++++. .+.+|+ ++.+...         +.        +||..+.+      ..+.|     
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~-kiNkq~l---------il--------Rnilt~a~------npfvv-----  135 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL---------IL--------RNILTFAG------NPFVV-----  135 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhh-cccccch---------hh--------hccccccC------Cccee-----
Confidence            3445678999999999999884 456666 5433211         11        12222211      11222     


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                       |+-...++..+.   ++.        +++.+++|+|+.   +|+|||+||+|.+|+.-|++|++|||+++..-....  
T Consensus       136 -gDc~tllk~~g~---lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -GDCATLLKNIGP---LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -chhhhhcccCCC---Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence             454455543222   222        227889999999   999999999999999999999999999875321110  


Q ss_pred             -------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhh
Q 045493          935 -------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       935 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                                   ...+.+||+.|.|||++....|+..+|.|++|+++||++-|+.||.....           ++.+..
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-----------eelfg~  269 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----------EELFGQ  269 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-----------HHHHhh
Confidence                         12356899999999999999999999999999999999999999864321           111111


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCC
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRP 1037 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1037 (1048)
                      ++...+..+.. .+....+..+++...++.+|..|-
T Consensus       270 visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence            11111111111 122233466677778999999885

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.4e-15  Score=157.06  Aligned_cols=132  Identities=15%  Similarity=0.289  Sum_probs=101.8

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCccc-------chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG-------INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +||+|+||.||+|.+ ++..+++|+..........       .....+.+.+..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 4788899986543221110       11234555667777877665555555666779999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +|++|.+++.....          .++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999998743210          7899999999999999   999999999999999 899999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.62  E-value=2e-15  Score=157.56  Aligned_cols=134  Identities=16%  Similarity=0.287  Sum_probs=107.9

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCccc-------chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG-------INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .||+|++|.||+|.. .++.+++|+..........       .....+.+.+..++|++|.....++...+..++||||+
T Consensus         3 ~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          3 LIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             ccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            589999999999988 5788999976543322111       11234455567778899888777777777889999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      +|++|.+++....      + ++..++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.+..
T Consensus        82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999985421      2 7789999999999999999   999999999999999 78999999999874

>smart00090 RIO RIO-like kinase

Probab=99.62  E-value=1.7e-15  Score=158.96  Aligned_cols=138  Identities=17%  Similarity=0.186  Sum_probs=101.0

Q ss_pred             eeeecccccccEEEEE--EcCCCceeeEEeccCCCCcc-----------------------cchhhHHHHHHhhcccC--
Q 045493          781 MVLHGTGGCGTVYKAE--LTSGDTRAVKKLHSLPTGEI-----------------------GINQKGFVSEITEIRHR--  833 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~--~~~~~~vavk~~~~~~~~~~-----------------------~~~~~~~~~~l~~l~h~--  833 (1048)
                      ...||+|+||.||+|.  ..+|+.||+|+++.......                       ....+.+.+.+.++.+.  
T Consensus        33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i  112 (237)
T smart00090       33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV  112 (237)
T ss_pred             CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3468999999999998  45899999999875432100                       00113345555666542  


Q ss_pred             ceeeEeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeeCCCCCCeEE
Q 045493          834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP-ILHRDISSKKVLL  912 (1048)
Q Consensus       834 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dik~~NIll  912 (1048)
                      .+.+++++    ...++||||++++++.......   ......+...++.|++.++++||+.   + |+||||||+||++
T Consensus       113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli  182 (237)
T smart00090      113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV  182 (237)
T ss_pred             CCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence            23344433    2358999999998887654221   2345566789999999999999999   8 9999999999999


Q ss_pred             CCCCceEEecccccccc
Q 045493          913 DLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       913 ~~~~~~kl~DfG~a~~~  929 (1048)
                      + ++.++++|||.+...
T Consensus       183 ~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      183 H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             E-CCCEEEEEChhhhcc
Confidence            9 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.61  E-value=2.1e-15  Score=155.19  Aligned_cols=137  Identities=18%  Similarity=0.150  Sum_probs=101.3

Q ss_pred             CcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcc---------------------cchhhHHHHHHhhcccC--c
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI---------------------GINQKGFVSEITEIRHR--N  834 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~---------------------~~~~~~~~~~l~~l~h~--n  834 (1048)
                      +.....||+|+||.||+|...+++.+|||++........                     ......+...+..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            333456899999999999988899999998754321100                     00122334445556666  3


Q ss_pred             eeeEeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC
Q 045493          835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL  914 (1048)
Q Consensus       835 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~  914 (1048)
                      +.+.++.    ...++||||+++++|.+....         .....++.+++.++.++|+.   +|+||||||+||++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~  160 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence            4444442    345899999999999775421         23467889999999999998   9999999999999999


Q ss_pred             CCceEEeccccccccC
Q 045493          915 EYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       915 ~~~~kl~DfG~a~~~~  930 (1048)
                      ++.++|+|||++....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.58  E-value=1e-14  Score=173.34  Aligned_cols=134  Identities=16%  Similarity=0.246  Sum_probs=104.4

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCC-CCcc------cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLP-TGEI------GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~-~~~~------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ....||+|+||+||+|.+... .+++|+..... ....      ......+.+.+..++|++++..+.++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            345789999999999988644 44444432211 1110      112344566678889999998888887777789999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      ||+++++|.+++.           ....++.++++++.|||+.   +|+|||+||+||++ .++.++++|||+++..
T Consensus       416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999874           3467899999999999999   99999999999999 6789999999999753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=5.7e-14  Score=143.49  Aligned_cols=135  Identities=19%  Similarity=0.198  Sum_probs=92.8

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchh-----------------------hHHHHHHhhcccC--ceee
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQ-----------------------KGFVSEITEIRHR--NIVK  837 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~-----------------------~~~~~~l~~l~h~--niv~  837 (1048)
                      .||+|+||+||+|...+++.||||.+............                       ..+...+..+.+.  .+.+
T Consensus         4 ~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~   83 (187)
T cd05119           4 PIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPK   83 (187)
T ss_pred             ccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCc
Confidence            58999999999999888999999987653221110000                       1122222333322  2334


Q ss_pred             EeeEeeeCCeEEEEEEccCCCCHHHH-HhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCC
Q 045493          838 FYGFCSHTQHLFLVYEYLERGSLATI-LSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLE  915 (1048)
Q Consensus       838 ~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~  915 (1048)
                      .+++    ...++||||++++.+... +....    .. .++..++.+++.++.++|. .   +|+||||||+||+++ +
T Consensus        84 ~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          84 PIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D  150 (187)
T ss_pred             eEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence            4433    235899999999543211 11100    01 5678899999999999999 7   999999999999999 8


Q ss_pred             CceEEeccccccccC
Q 045493          916 YKAHVSDFGTAKFLK  930 (1048)
Q Consensus       916 ~~~kl~DfG~a~~~~  930 (1048)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.50  E-value=1e-13  Score=136.38  Aligned_cols=133  Identities=17%  Similarity=0.204  Sum_probs=107.5

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhccc--CceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH--RNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..+|+|.++.||++...+ ..+++|.......   ......+...+..++|  ..+.++++++...+..+++|||++++.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            458999999999999864 7888888755432   2234556666677765  588999998888788999999999977


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      +..+          +......++.+++++++++|.....+++|||++|+||+++..+.++++|||.++.
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543          4456678899999999999986444799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.8e-15  Score=175.41  Aligned_cols=246  Identities=20%  Similarity=0.244  Sum_probs=174.7

Q ss_pred             eecccccccEEEEEEcC--CCceeeEEeccCCCCc-ccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELTS--GDTRAVKKLHSLPTGE-IGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~--~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+|+.|-.+....  ...+|+|.+....... .......+...-+.+. |+|++.+++...+.+..+++.||..+|
T Consensus        27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~  106 (601)
T KOG0590|consen   27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG  106 (601)
T ss_pred             cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence            47999999998886643  3445566554433111 1111112222223344 999999999999999999999999999


Q ss_pred             CHHHHH-hccccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCC-CCC
Q 045493          859 SLATIL-SNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKP-DSS  934 (1048)
Q Consensus       859 ~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~-~~~  934 (1048)
                      ++.+-+ +...  ...+......++.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||+|..+.. .+.
T Consensus       107 ~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~  181 (601)
T KOG0590|consen  107 SLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA  181 (601)
T ss_pred             ccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence            999888 4332  12445567789999999999999 77   999999999999999999 999999999988765 322


Q ss_pred             --Ccccccc-ccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          935 --NWSELAG-TCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       935 --~~~~~~g-t~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                        .....+| ++.|+|||...+.. .....|+||.|+++.-+++|..||+....-..          ....+........
T Consensus       182 ~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~----------~~~~~~~~~~~~~  251 (601)
T KOG0590|consen  182 ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG----------RYSSWKSNKGRFT  251 (601)
T ss_pred             ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc----------cceeecccccccc
Confidence              2345678 99999999998854 47789999999999999999999875432211          1111111111101


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                      ...+........++..+++..+|..|.+.+++.
T Consensus       252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cCccccCChhhhhcccccccCCchhcccccccc
Confidence            111233334566778888999999999987764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.44  E-value=4.4e-13  Score=141.05  Aligned_cols=139  Identities=14%  Similarity=0.186  Sum_probs=102.3

Q ss_pred             cceeeec-ccccccEEEEEEcCCCceeeEEeccCC------CC------cccchhhHHHHHHhhcccCce--eeEeeEee
Q 045493          779 GKMVLHG-TGGCGTVYKAELTSGDTRAVKKLHSLP------TG------EIGINQKGFVSEITEIRHRNI--VKFYGFCS  843 (1048)
Q Consensus       779 ~~~~~lG-~G~~g~Vy~~~~~~~~~vavk~~~~~~------~~------~~~~~~~~~~~~l~~l~h~ni--v~~~~~~~  843 (1048)
                      ....++| .||.|+||.+... +..+|+|.+....      ..      ........+.+.+..++|++|  ++.+++..
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            3445688 8999999999886 7788998875321      10      111123446666778888775  66777653


Q ss_pred             eCC----eEEEEEEccCC-CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          844 HTQ----HLFLVYEYLER-GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       844 ~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      ...    ..++|||+++| .+|.+++...    .++..    .+.+++.++.+||+.   ||+||||||+|||++.++.+
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence            322    23599999997 6999988542    23332    367899999999999   99999999999999999999


Q ss_pred             EEecccccccc
Q 045493          919 HVSDFGTAKFL  929 (1048)
Q Consensus       919 kl~DfG~a~~~  929 (1048)
                      +++|||.++..
T Consensus       182 ~LIDfg~~~~~  192 (239)
T PRK01723        182 WLIDFDRGELR  192 (239)
T ss_pred             EEEECCCcccC
Confidence            99999998754

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.42  E-value=1.1e-14  Score=158.50  Aligned_cols=213  Identities=30%  Similarity=0.415  Sum_probs=174.2

Q ss_pred             eeEecCCccccCcccccC-CCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccC
Q 045493          452 SLRLERNQLTGNISEVFG-IYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN  530 (1048)
Q Consensus       452 ~L~L~~n~l~~~~~~~~~-~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N  530 (1048)
                      .|.|++-.++..+..++. .+..-...||+.|++. +.|..+..+-.|+.+.|.+|.|. .+|.+++++..|.+|||+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            455666666666555544 3344567899999986 66777778888999999999998 88999999999999999999


Q ss_pred             cccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhh
Q 045493          531 RLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISI  610 (1048)
Q Consensus       531 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~  610 (1048)
                      +++ ..|..++.++ |+.|.+++|+++ .+|..++.+..|..||.+.|.|..+ |..++++.+|+.|++..|++.+....
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~sl-psql~~l~slr~l~vrRn~l~~lp~E  207 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSL-PSQLGYLTSLRDLNVRRNHLEDLPEE  207 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhc-hHHhhhHHHHHHHHHhhhhhhhCCHH
Confidence            998 6777787775 899999999999 8899999999999999999999886 77789999999999999999876554


Q ss_pred             hhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcccccc---ccCCccEEEeccc
Q 045493          611 QIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR---RMHGLSSIDVSYN  674 (1048)
Q Consensus       611 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~l~ls~N  674 (1048)
                      . .. -.|..||+|+|++. .+|..|.+|+.|++|-|.+|+++ .+|..++   +..-.++|+..-.
T Consensus       208 l-~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  208 L-CS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             H-hC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            4 44 46999999999998 89999999999999999999998 4454443   2334566666554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.42  E-value=1.4e-14  Score=157.73  Aligned_cols=202  Identities=31%  Similarity=0.439  Sum_probs=165.7

Q ss_pred             EeeCCCCccccCC-CcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecc
Q 045493           52 HLDFSTNQFSGII-PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN  130 (1048)
Q Consensus        52 ~L~L~~n~i~~~~-p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n  130 (1048)
                      .|.|++-+++... +.+=..+..-...||+.|+.. .+|..++.+..|+.+.|.+|.+. .+|.++++|..|+.|+|+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            3455555554211 112246667778889999988 57888899999999999999998 78888999999999999999


Q ss_pred             cccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccc
Q 045493          131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLS  210 (1048)
Q Consensus       131 ~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~  210 (1048)
                      +++                .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+
T Consensus       132 qlS----------------~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr  192 (722)
T KOG0532|consen  132 QLS----------------HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR  192 (722)
T ss_pred             hhh----------------cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH
Confidence            887                5667777775 778888888888 66788889999999999999998 7888999999999


Q ss_pred             eeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhcc
Q 045493          211 YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL  278 (1048)
Q Consensus       211 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L  278 (1048)
                      .|.++.|++. .+|..+..|+ |..||+++|+++ .+|-.|..|..|++|-|.+|++. .+|..++..
T Consensus       193 ~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k  256 (722)
T KOG0532|consen  193 DLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK  256 (722)
T ss_pred             HHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence            9999999998 6777777665 999999999999 78999999999999999999998 677666543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=3.7e-13  Score=137.20  Aligned_cols=203  Identities=19%  Similarity=0.306  Sum_probs=139.2

Q ss_pred             HHHHHhhcccCceeeEeeEeeeC-----CeEEEEEEccCCCCHHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCC
Q 045493          823 FVSEITEIRHRNIVKFYGFCSHT-----QHLFLVYEYLERGSLATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDC  896 (1048)
Q Consensus       823 ~~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~  896 (1048)
                      ....+-++-|-|||+++.|+.+.     .+..+++|||+.|++.+++++.+. ...+......+|+.||..||.|||+. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            34445566799999999998654     357899999999999999976432 33466677789999999999999985 


Q ss_pred             CCCeEeeCCCCCCeEECCCCceEEeccccccccCCC-----CCCccccccccccccccccccCCCCchhhHHHHHHHHHH
Q 045493          897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-----SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLE  971 (1048)
Q Consensus       897 ~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~e  971 (1048)
                      .|+|+|+++..+-|++..+|-+|+.-- .-......     ......-.+-++|.|||+-.....+.++|||+||+...|
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             CCccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            689999999999999999988887421 11111000     011112346679999999887788899999999999999


Q ss_pred             HHhCCCC-CcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          972 VIEGKHP-GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       972 lltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      |.-+..- ....        .....++.....+-+--.          ..-..++.+|++..|..||+|.+++.+
T Consensus       275 mailEiq~tnse--------S~~~~ee~ia~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  275 MAILEIQSTNSE--------SKVEVEENIANVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHHheeccCCCc--------ceeehhhhhhhheeeccC----------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            9987753 1100        000001111111000000          001245677999999999999998754

>PLN03150 hypothetical protein; Provisional

Probab=99.40  E-value=6.4e-13  Score=159.40  Aligned_cols=118  Identities=31%  Similarity=0.530  Sum_probs=87.9

Q ss_pred             cccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEec
Q 045493          593 KLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVS  672 (1048)
Q Consensus       593 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls  672 (1048)
                      .++.|+|++|.+.+..+..++.+++|+.|+|++|.+.|.+|..+..+++|+.|+|++|+++|.+|..+..+++|+.|+++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            35667777777777777777777888888888888887888788888888888888888888888888888888888888


Q ss_pred             cceecCCCCCccc--ccccccccccCCccccCCCCCCCCCC
Q 045493          673 YNELQGSIPHSKA--FQNATIEAFQGNKELCGDVTGLPPCE  711 (1048)
Q Consensus       673 ~N~l~~~~p~~~~--~~~~~~~~~~~n~~lc~~~~~~~~c~  711 (1048)
                      +|+++|.+|..-.  +.......+.+|+.+|+.+ +.++|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence            8888888886421  1223344688999999854 356674

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=9.4e-13  Score=151.55  Aligned_cols=201  Identities=39%  Similarity=0.530  Sum_probs=148.6

Q ss_pred             EeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccc-ccccccccceecccccCcCcCCcCCCceEEeecc
Q 045493           52 HLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELT-SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN  130 (1048)
Q Consensus        52 ~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n  130 (1048)
                      .|+++.|.+. ..+..+..++.++.|++.+|.++. ++.....++ +|+.|++++|++. ..|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            5777777774 234556666777778888777775 444455553 7777888888777 55566777788888888888


Q ss_pred             cccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccc
Q 045493          131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLS  210 (1048)
Q Consensus       131 ~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~  210 (1048)
                      +++                .+|.....+.+|..|++++|++.. +|.....+.+|++|++++|++. ..+..+.++.++.
T Consensus       174 ~l~----------------~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~  235 (394)
T COG4886         174 DLS----------------DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS  235 (394)
T ss_pred             hhh----------------hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhccccc
Confidence            776                334444466777777787777774 4445566677999999999654 5677888999999


Q ss_pred             eeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhh
Q 045493          211 YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFG  276 (1048)
Q Consensus       211 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  276 (1048)
                      .|.+.+|++. ..+..++.+++++.|++++|.++. ++. ++.+.++++|++++|.+...+|....
T Consensus       236 ~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~  298 (394)
T COG4886         236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIAL  298 (394)
T ss_pred             ccccCCceee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhhc
Confidence            9999999987 447778888999999999999984 444 88899999999999998866665443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.33  E-value=4.9e-14  Score=145.38  Aligned_cols=184  Identities=21%  Similarity=0.298  Sum_probs=112.2

Q ss_pred             CCCCccEEEecCcccCcccCccc----cccCCCcEEEcccCcccCCc-------------CccccCCCccCEEeecCccc
Q 045493          494 KCPQLATLNMGGNEISGTIPSEI----GNMTQLHKLDFSSNRLVGQI-------------PKQLGKLTSLTSLTLNGNQL  556 (1048)
Q Consensus       494 ~~~~L~~L~L~~N~i~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~-------------~~~~~~l~~L~~L~L~~N~l  556 (1048)
                      .+++|++|+||+|.+....+..|    ..++.|++|.|.+|.+.-..             ......-+.|+++..++|++
T Consensus        90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl  169 (382)
T KOG1909|consen   90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL  169 (382)
T ss_pred             cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence            44455555555555543333322    23455555555555443111             11122345677777777776


Q ss_pred             cCC----CccccccccccceeecccCccccc----ccccccccccccccccccccccchhhh----hhccccccCeEECC
Q 045493          557 SGD----IPLELGLLAELGYLDLSANRLSKL----IPKNLGELRKLHHLNLSNNQFSQEISI----QIGKLVQLSKLDLS  624 (1048)
Q Consensus       557 ~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls  624 (1048)
                      ...    +...|...+.|+.+.++.|.|..-    ...+|..++.|+.|||.+|-++..+..    .+..+++|++|+++
T Consensus       170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~  249 (382)
T KOG1909|consen  170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG  249 (382)
T ss_pred             ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence            632    234455566777777777776532    234566778888888888887766543    34467778888888


Q ss_pred             CCcccCcCCcCcC-----CccccCeEECCCCcccCC----ccccccccCCccEEEeccceec
Q 045493          625 HNSLGGNIPSEIC-----NLESLEYMNLLQNKLSGP----IPSCFRRMHGLSSIDVSYNELQ  677 (1048)
Q Consensus       625 ~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~l~ls~N~l~  677 (1048)
                      ++.+...+...|.     ..|+|+.|.|.+|.|+-.    +..+....|.|..|+|++|.+.
T Consensus       250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            8888766555443     357888888888888732    3334556788888888888873

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.31  E-value=7.5e-14  Score=144.07  Aligned_cols=231  Identities=23%  Similarity=0.286  Sum_probs=170.2

Q ss_pred             cCCcccEEEeecccccCCCC----CCcccccccceeEecCCccccC-----------cccccCCCCCCCeeeCcCCcccC
Q 045493          422 QSGSLTHFSVRNNNFVGPIP----RSLQNCTSLYSLRLERNQLTGN-----------ISEVFGIYPDLELLDLSNNNFFG  486 (1048)
Q Consensus       422 ~~~~L~~L~l~~N~l~~~~~----~~l~~l~~L~~L~L~~n~l~~~-----------~~~~~~~~~~L~~L~Ls~n~l~~  486 (1048)
                      ...+++.+++++|.+...-.    ..+++.++|+..+++.= +++-           ...++...|.|++||||+|-|..
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~  106 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP  106 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence            34556666666666654322    33445566776666652 2211           12344566799999999999876


Q ss_pred             cccccc----cCCCCccEEEecCcccCcccCcc-------------ccccCCCcEEEcccCcccCCc----CccccCCCc
Q 045493          487 EISSNW----IKCPQLATLNMGGNEISGTIPSE-------------IGNMTQLHKLDFSSNRLVGQI----PKQLGKLTS  545 (1048)
Q Consensus       487 ~~~~~~----~~~~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~  545 (1048)
                      ..+..|    .++..|++|.|.+|.+.......             .+.-++|+++..++|++....    ...|...+.
T Consensus       107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~  186 (382)
T KOG1909|consen  107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT  186 (382)
T ss_pred             cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence            554443    46789999999999987322222             234578999999999997533    345677899


Q ss_pred             cCEEeecCccccCC----CccccccccccceeecccCccccc----ccccccccccccccccccccccchhhhhhc----
Q 045493          546 LTSLTLNGNQLSGD----IPLELGLLAELGYLDLSANRLSKL----IPKNLGELRKLHHLNLSNNQFSQEISIQIG----  613 (1048)
Q Consensus       546 L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~----  613 (1048)
                      |+++.+..|.|...    +...|..++.|+.|||..|-++..    ..+.++.++.|++|++++|.+...+...|.    
T Consensus       187 leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~  266 (382)
T KOG1909|consen  187 LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALK  266 (382)
T ss_pred             cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHh
Confidence            99999999999732    345688999999999999999843    346778899999999999999988877664    


Q ss_pred             -cccccCeEECCCCcccC----cCCcCcCCccccCeEECCCCccc
Q 045493          614 -KLVQLSKLDLSHNSLGG----NIPSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       614 -~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                       ..++|++|+|++|.|+.    .+...+...+.|+.|+|++|.+.
T Consensus       267 ~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  267 ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence             57899999999999984    23344556899999999999995

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.31  E-value=2.9e-11  Score=138.56  Aligned_cols=141  Identities=20%  Similarity=0.225  Sum_probs=94.1

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccc---------------------------------------hhhH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGI---------------------------------------NQKG  822 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~---------------------------------------~~~~  822 (1048)
                      +.+|.|++|.||+|+.++|+.||||+.+.........                                       ....
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            3589999999999999999999999986532111000                                       0000


Q ss_pred             HHHHHhhc----ccCceeeEeeEe-eeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHH-HHHHHHhCC
Q 045493          823 FVSEITEI----RHRNIVKFYGFC-SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN-ALSYMHHDC  896 (1048)
Q Consensus       823 ~~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~  896 (1048)
                      |.+.+.++    +|..-+.+-.++ ......++||||++|+++.++......  ..   .+.+++..+++ .+..+|.. 
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~-  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD-  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC-
Confidence            11111122    222222322222 223457999999999999887643211  11   23456666666 46788888 


Q ss_pred             CCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       897 ~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                        |++|+|+||.||+++.+++++++|||++..+.
T Consensus       277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              99999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=3.2e-12  Score=143.05  Aligned_cols=241  Identities=24%  Similarity=0.242  Sum_probs=168.1

Q ss_pred             eecc--cccccEEEEEE--c-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          783 LHGT--GGCGTVYKAEL--T-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~--G~~g~Vy~~~~--~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      -+|.  |.+|.||.++.  . ++..+|+|+-+...... ......++......+ .|++.++.+..+...+..|+-+|++
T Consensus       121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~  200 (524)
T KOG0601|consen  121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC  200 (524)
T ss_pred             ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence            3688  99999999977  3 67888998854433321 111122222222233 4999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVAN----ALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLK  930 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~  930 (1048)
                      . .++.++.+...  ..++....+.+..+...    |+.++|+.   +++|-|+||.||+...+ ..++++|||+...+.
T Consensus       201 ~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~  274 (524)
T KOG0601|consen  201 G-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS  274 (524)
T ss_pred             c-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEcc
Confidence            6 58888876432  22455667777888888    99999999   99999999999999999 889999999998877


Q ss_pred             CCCCCcc-----ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          931 PDSSNWS-----ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       931 ~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      +..-...     ...|...|++||...+ -++.++|+||+|.++.+..++-++..... ...|.+..           ..
T Consensus       275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-~~~W~~~r-----------~~  341 (524)
T KOG0601|consen  275 DGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-NSSWSQLR-----------QG  341 (524)
T ss_pred             CCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-CCCccccc-----------cc
Confidence            5542222     2257788999998765 68999999999999999999876532100 00000000           00


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .++  .+.......++...+..|++.+|..|++++.+.+
T Consensus       342 ~ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  342 YIP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            011  1111112223334677899999999999998865

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.27  E-value=5.3e-12  Score=145.32  Aligned_cols=43  Identities=42%  Similarity=0.575  Sum_probs=20.0

Q ss_pred             cccCCCCCCcEEEccCceeecccccccccccccceeeeccccccC
Q 045493          298 KEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG  342 (1048)
Q Consensus       298 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  342 (1048)
                      ..++.+++++.|++++|+++...+  ++.+.+++.|++++|.+..
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             chhccccccceecccccccccccc--ccccCccCEEeccCccccc
Confidence            334444445555555555443222  4444555555555554443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.25  E-value=4e-12  Score=124.38  Aligned_cols=126  Identities=32%  Similarity=0.376  Sum_probs=46.1

Q ss_pred             CCCccCEEeecCccccCCCccccc-cccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCe
Q 045493          542 KLTSLTSLTLNGNQLSGDIPLELG-LLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSK  620 (1048)
Q Consensus       542 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  620 (1048)
                      +..++++|+|++|+|+. + +.++ .+.+|+.||||+|+|+.+  +.+..++.|++|++++|+|+.+.......+++|++
T Consensus        17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            34456667777777763 2 2343 456677777777777765  35666777777777777777664433345778888


Q ss_pred             EECCCCcccCc-CCcCcCCccccCeEECCCCcccCCcc---ccccccCCccEEEe
Q 045493          621 LDLSHNSLGGN-IPSEICNLESLEYMNLLQNKLSGPIP---SCFRRMHGLSSIDV  671 (1048)
Q Consensus       621 L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~l~l  671 (1048)
                      |+|++|+|... ....+..+++|+.|+|.+|+++...-   ..+..+|+|+.||-
T Consensus        93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            88888888752 23455678888888888888874421   24567888888753

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.23  E-value=2.4e-12  Score=129.37  Aligned_cols=132  Identities=30%  Similarity=0.354  Sum_probs=80.7

Q ss_pred             CccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEEC
Q 045493          544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDL  623 (1048)
Q Consensus       544 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  623 (1048)
                      ..|+++|||+|.|+ .+.++..-.++++.|++|+|+|..+  +.+..+++|+.||||+|.++.. .++-.++-+.+.|.|
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEeeeeh
Confidence            34555666666665 4455555556666666666666554  3355566666666666666432 223335566667777


Q ss_pred             CCCcccCcCCcCcCCccccCeEECCCCcccCCc-cccccccCCccEEEeccceecCCCC
Q 045493          624 SHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI-PSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       624 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      +.|.|.  .-..+..+-+|++||+++|+|.... -..++++|.|..+.+.+||+.+...
T Consensus       360 a~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  360 AQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            777664  2245566677777777777776432 2456777888888888888876543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.21  E-value=1.6e-11  Score=149.98  Aligned_cols=104  Identities=33%  Similarity=0.351  Sum_probs=58.4

Q ss_pred             CccEEeCCCCc--ccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccc
Q 045493           25 QLAYLDLSVNQ--LFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELA  102 (1048)
Q Consensus        25 ~l~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~  102 (1048)
                      +++.|-+..|.  +....++.|..++.|++|||++|.--+.+|.+++.|.+||+|+|++..|. .+|..+..|+.|.+||
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            55555555554  44344444555666666666655444456666666666666666666665 3555566666666666


Q ss_pred             ccceecccccCcCcCCcCCCceEEeec
Q 045493          103 LSYNRLNGSIPASLGNLSNLVQLSLSN  129 (1048)
Q Consensus       103 l~~n~~~~~~~~~~~~L~~L~~L~l~~  129 (1048)
                      +.++.-...+|.....|++|++|.+..
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~  651 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPR  651 (889)
T ss_pred             cccccccccccchhhhcccccEEEeec
Confidence            665554434455555566666665543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.20  E-value=2.8e-12  Score=128.85  Aligned_cols=210  Identities=24%  Similarity=0.273  Sum_probs=147.5

Q ss_pred             CCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecC-cccCcccCcccc
Q 045493          439 PIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGG-NEISGTIPSEIG  517 (1048)
Q Consensus       439 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~-N~i~~~~~~~~~  517 (1048)
                      ..|-.+..+++|..+.++.+.-..+..- ...-|.|+.+...+..+... + .+.....+....-+. .-.+|.......
T Consensus       205 ~l~f~l~~f~~l~~~~~s~~~~~~i~~~-~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~D~~~~E~~t~~G~~~~~~d  281 (490)
T KOG1259|consen  205 RLSFNLNAFRNLKTLKFSALSTENIVDI-ELLKPTLQTICVHNTTIQDV-P-SLLPETILADPSGSEPSTSNGSALVSAD  281 (490)
T ss_pred             ccccchHHhhhhheeeeeccchhheece-eecCchhheeeeeccccccc-c-cccchhhhcCccCCCCCccCCceEEecc
Confidence            3444556667788888888765433222 22347788888776655421 1 111112222221111 111222222333


Q ss_pred             ccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccc
Q 045493          518 NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHL  597 (1048)
Q Consensus       518 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  597 (1048)
                      ....|+++|||+|.|+ .+.+...-.|.++.|++|+|.|+..  ..+..+++|+.||||+|.++.+ ..+=..+.+.+.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEeee
Confidence            4467999999999998 6777888889999999999999843  3488999999999999999986 4455678899999


Q ss_pred             ccccccccchhhhhhccccccCeEECCCCcccC-cCCcCcCCccccCeEECCCCcccCCcc
Q 045493          598 NLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG-NIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       598 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      .|+.|.|.+  -..+.++-+|..||+++|+|.. .-...++++|-|+.+.|.+|++.+...
T Consensus       358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            999999965  3456788899999999999985 335678999999999999999986543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.19  E-value=3.3e-12  Score=135.52  Aligned_cols=184  Identities=26%  Similarity=0.337  Sum_probs=102.3

Q ss_pred             cCCCCccEEEecCcccCc--ccCccccccCCCcEEEcccCcccCCcCcc-ccCCCccCEEeecCccccC-CCcccccccc
Q 045493          493 IKCPQLATLNMGGNEISG--TIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSG-DIPLELGLLA  568 (1048)
Q Consensus       493 ~~~~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~  568 (1048)
                      ..|++++.|||++|-+..  .+......+|+|+.|+|+.|++....... -..++.|+.|.|++|.++. .+......++
T Consensus       143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP  222 (505)
T KOG3207|consen  143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP  222 (505)
T ss_pred             hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence            345566666666665552  12223345677777777777765222111 1145677777777777762 2334455667


Q ss_pred             ccceeecccCcccccccccccccccccccccccccccchhh-hhhccccccCeEECCCCcccCc-CCcC-----cCCccc
Q 045493          569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLGGN-IPSE-----ICNLES  641 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~-~~~~-----~~~l~~  641 (1048)
                      +|+.|+|.+|....+-......+..|++|||++|++-+... ...+.++.|+.|+++.+.+... +|..     ...+++
T Consensus       223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~k  302 (505)
T KOG3207|consen  223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPK  302 (505)
T ss_pred             cHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccc
Confidence            77777777775333323334456677777777777655432 3445677777777777776642 1221     234567


Q ss_pred             cCeEECCCCcccCC-ccccccccCCccEEEecccee
Q 045493          642 LEYMNLLQNKLSGP-IPSCFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       642 L~~L~L~~N~l~~~-~~~~~~~l~~L~~l~ls~N~l  676 (1048)
                      |++|+++.|+|..- .-..+..+++|+.+....|.+
T Consensus       303 L~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~l  338 (505)
T KOG3207|consen  303 LEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYL  338 (505)
T ss_pred             ceeeecccCccccccccchhhccchhhhhhcccccc
Confidence            77777777777421 112333444444444444444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.18  E-value=3.2e-12  Score=135.57  Aligned_cols=210  Identities=26%  Similarity=0.278  Sum_probs=117.6

Q ss_pred             cccccceeEecCCccccCcc-cccCCCCCCCeeeCcCCcccCc--ccccccCCCCccEEEecCcccCcccCcc-ccccCC
Q 045493          446 NCTSLYSLRLERNQLTGNIS-EVFGIYPDLELLDLSNNNFFGE--ISSNWIKCPQLATLNMGGNEISGTIPSE-IGNMTQ  521 (1048)
Q Consensus       446 ~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~n~l~~~--~~~~~~~~~~L~~L~L~~N~i~~~~~~~-~~~l~~  521 (1048)
                      ++.+|++..|.++.+..... +....+++++.||||.|-+...  .......+|+|+.|+++.|.+..-.... -..++.
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            34455555555555443322 2334455555555555555432  1222334555666666665554221111 113456


Q ss_pred             CcEEEcccCcccCC-cCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccc-cccccccccccccc
Q 045493          522 LHKLDFSSNRLVGQ-IPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIP-KNLGELRKLHHLNL  599 (1048)
Q Consensus       522 L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L  599 (1048)
                      |+.|.|+.|.++.. +......+|+|+.|+|..|..-.........+..|++|||++|.+-...- ...+.++.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            66666666666521 12223445667777777664222333344556667777777776655421 33456677777777


Q ss_pred             ccccccchhhhh------hccccccCeEECCCCcccC-cCCcCcCCccccCeEECCCCcccCC
Q 045493          600 SNNQFSQEISIQ------IGKLVQLSKLDLSHNSLGG-NIPSEICNLESLEYMNLLQNKLSGP  655 (1048)
Q Consensus       600 s~N~l~~~~~~~------~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~  655 (1048)
                      +.|.|..+....      ...+++|+.|++++|+|.. .....+..+++|+.|.+..|.++-+
T Consensus       279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            777776543222      2467889999999999853 2234556678888889999999744

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.17  E-value=1.5e-10  Score=130.44  Aligned_cols=168  Identities=18%  Similarity=0.239  Sum_probs=126.3

Q ss_pred             EEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCH
Q 045493          796 ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDW  875 (1048)
Q Consensus       796 ~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~  875 (1048)
                      +..++.+|.|...+.... +.....++.+..++.++||||+++++.+...++.|+|+|.+.  .|..++++.+      .
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------K  103 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------H
Confidence            334678888887766554 444455667778899999999999999999999999999985  4777776533      3


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccccccccccccccccccCC
Q 045493          876 SKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR  955 (1048)
Q Consensus       876 ~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  955 (1048)
                      ....-.+.||+.||.|||..+  +++|++|.-.-|++++.|+.||++|..+..............---.|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            455667899999999999776  899999999999999999999999998865443222111112222466676543322


Q ss_pred             CCchhhHHHHHHHHHHHHhCC
Q 045493          956 ANEKCDVFNFGVLVLEVIEGK  976 (1048)
Q Consensus       956 ~~~~~Dvws~Gvvl~elltg~  976 (1048)
                        -..|.|-|||+++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.16  E-value=1.2e-10  Score=134.47  Aligned_cols=139  Identities=14%  Similarity=0.097  Sum_probs=85.3

Q ss_pred             eeecccccccEEEEEEcC-CCceeeEEeccCCCCcc----------------------c--------chh---------h
Q 045493          782 VLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEI----------------------G--------INQ---------K  821 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~----------------------~--------~~~---------~  821 (1048)
                      +.+|.|++|.||+|+.++ |+.||||+.+.......                      .        ...         .
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            458999999999999987 99999999875321100                      0        000         0


Q ss_pred             HHHHHHhhc----ccCceeeEeeEeee-CCeEEEEEEccCCCCHHHHH--hccc-cccccCHHHHHHHHHHHHHHHHHHH
Q 045493          822 GFVSEITEI----RHRNIVKFYGFCSH-TQHLFLVYEYLERGSLATIL--SNEA-TAAELDWSKRVNVIKGVANALSYMH  893 (1048)
Q Consensus       822 ~~~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH  893 (1048)
                      .+...+.++    .+...+.+-.++.+ ....++||||++|+++.++-  ...+ ....+....+..++.|+.       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence            011111111    13333333233322 34568999999999998752  2211 111122222333334433       


Q ss_pred             hCCCCCeEeeCCCCCCeEECCCC----ceEEeccccccccC
Q 045493          894 HDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAKFLK  930 (1048)
Q Consensus       894 ~~~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~~~~  930 (1048)
                      ..   |++|+|+||.||+++.+|    ++++.|||++..+.
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            35   999999999999999988    99999999987654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.12  E-value=4.2e-11  Score=117.25  Aligned_cols=60  Identities=35%  Similarity=0.457  Sum_probs=13.5

Q ss_pred             cCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcccc-ccccccceeecccCccc
Q 045493          519 MTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRLS  581 (1048)
Q Consensus       519 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~  581 (1048)
                      +.+|+.|+|++|.|+..  +.+..++.|++|++++|+|+. +...+ ..+++|++|+|++|+|.
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~  101 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKIS  101 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCC
Confidence            34444444444444421  134444444444444444442 22122 23444444444444443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.11  E-value=3e-10  Score=113.94  Aligned_cols=130  Identities=19%  Similarity=0.164  Sum_probs=90.9

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCcee-eEeeEeeeCCeEEEEEEccCCCCH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIV-KFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      +.++.|.++.||+++.. ++.+++|........  ....+.+...+..+.+..++ +++++..  ...++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            34789999999999876 778999987543321  12334455555555544444 4444432  335899999999877


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC--FPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      .+.     .      .....++.+++++++.||...  ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~-----~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE-----D------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-----c------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            542     0      011345678999999999883  12369999999999999 67899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.10  E-value=1.5e-11  Score=141.54  Aligned_cols=222  Identities=29%  Similarity=0.325  Sum_probs=160.6

Q ss_pred             CCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccc
Q 045493           20 FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLN   99 (1048)
Q Consensus        20 ~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~   99 (1048)
                      ...+++.+.+|..++.+...--. ...+..++.+.++.|.|+. .-..+..+++|+.|++.+|+|+.+ ...+..+.+|+
T Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~  121 (414)
T KOG0531|consen   45 QLVPSDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQ  121 (414)
T ss_pred             ccccchhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcch
Confidence            34567777778777765422111 1456677777788888874 335577888888888888888864 22267788888


Q ss_pred             cccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccC-CC
Q 045493          100 ELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIP-RS  178 (1048)
Q Consensus       100 ~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~-~~  178 (1048)
                      +|++++|+|+.+.  .+..++.|+.|++++|+++..                 ..+..+..|+.+++++|.+..+.+ . 
T Consensus       122 ~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~-----------------~~~~~l~~L~~l~l~~n~i~~ie~~~-  181 (414)
T KOG0531|consen  122 VLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI-----------------SGLESLKSLKLLDLSYNRIVDIENDE-  181 (414)
T ss_pred             heecccccccccc--chhhccchhhheeccCcchhc-----------------cCCccchhhhcccCCcchhhhhhhhh-
Confidence            8888888888553  366777788888888888632                 345557788888888888886655 3 


Q ss_pred             CCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCC--CCeEeccCCccCCCCCcccccccc
Q 045493          179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN--LKFLYLHDNRLSGYIPPKLGSFKS  256 (1048)
Q Consensus       179 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~  256 (1048)
                      ...+.+++.+++.+|.+..  ...+..+..+..+++..|.++..-+  +..+..  |+.+++++|.+. ..+..+..+..
T Consensus       182 ~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~  256 (414)
T KOG0531|consen  182 LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKN  256 (414)
T ss_pred             hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-ccccccccccc
Confidence            5788889999999999863  3456667777777999998873322  223333  899999999998 44467788889


Q ss_pred             cceeecccccccC
Q 045493          257 LLYLYLSHNQLNG  269 (1048)
Q Consensus       257 L~~L~L~~n~l~~  269 (1048)
                      +..|++..|++..
T Consensus       257 l~~l~~~~n~~~~  269 (414)
T KOG0531|consen  257 LPVLDLSSNRISN  269 (414)
T ss_pred             ccccchhhccccc
Confidence            9999999988863

>PLN03150 hypothetical protein; Provisional

Probab=99.05  E-value=4.5e-10  Score=134.99  Aligned_cols=113  Identities=34%  Similarity=0.498  Sum_probs=93.9

Q ss_pred             ccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECC
Q 045493          569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLL  648 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  648 (1048)
                      .++.|+|++|.+++..|..+..+++|+.|+|++|++.+..+..++.+++|+.|||++|++++.+|..++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36677888888887777788888888888888888887777788888899999999999999999999999999999999


Q ss_pred             CCcccCCcccccccc-CCccEEEeccceecCCCC
Q 045493          649 QNKLSGPIPSCFRRM-HGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       649 ~N~l~~~~~~~~~~l-~~L~~l~ls~N~l~~~~p  681 (1048)
                      +|+++|.+|..+..+ ..+..+++++|+..+..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999888764 467789999998666544

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.05  E-value=3.5e-11  Score=138.49  Aligned_cols=239  Identities=31%  Similarity=0.346  Sum_probs=168.2

Q ss_pred             CCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccc
Q 045493           22 LFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNEL  101 (1048)
Q Consensus        22 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L  101 (1048)
                      .+..+..+++..|.|+. +-..+..+++|+.|++.+|+|+.+ ...+..+.+|++|+|++|+|+.+  ..+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence            45677777888888873 445578888888888888888854 33377888888888888888876  457788888888


Q ss_pred             cccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCC
Q 045493          102 ALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGG  181 (1048)
Q Consensus       102 ~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~  181 (1048)
                      ++++|.|+.+  ..+..+..|+.+++++|++....+.              . +..+.+++.+.+..|.+..+  ..+..
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~--------------~-~~~~~~l~~l~l~~n~i~~i--~~~~~  206 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND--------------E-LSELISLEELDLGGNSIREI--EGLDL  206 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhhhhhhh--------------h-hhhccchHHHhccCCchhcc--cchHH
Confidence            8888888743  4566688888888888887632210              1 46677788888888888754  45666


Q ss_pred             CCCcceeeccccCccccCCccccccc--ccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccce
Q 045493          182 LKNLTFVYLNNNRIVGSIPSEIGNLR--SLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLY  259 (1048)
Q Consensus       182 l~~L~~L~L~~n~i~~~~p~~~~~l~--~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  259 (1048)
                      +..+..+++..|.++.+-+  +..+.  +|+.+++++|++. ..+..+..+.+++.|++.+|++...  ..+.....+..
T Consensus       207 ~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~  281 (414)
T KOG0531|consen  207 LKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSE  281 (414)
T ss_pred             HHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHH
Confidence            6777777888888874432  22233  3888888888887 4445677788888888888888743  34666677788


Q ss_pred             eecccccccCC---Cchh-hhccchhhhhhhcc
Q 045493          260 LYLSHNQLNGS---LPSS-FGNLSSLKHLHVHN  288 (1048)
Q Consensus       260 L~L~~n~l~~~---~p~~-~~~L~~L~~L~l~~  288 (1048)
                      +....|++...   .... ....+.++...+..
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
T KOG0531|consen  282 LWLNDNKLALSEAISQEYITSAAPTLVTLTLEL  314 (414)
T ss_pred             hccCcchhcchhhhhcccccccccccccccccc
Confidence            88888876522   1111 34455555555543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.98  E-value=4.1e-10  Score=126.37  Aligned_cols=241  Identities=18%  Similarity=0.183  Sum_probs=162.5

Q ss_pred             CcceeeecccccccEEEEEEc--CCCceeeEEeccCCCCccc--chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT--SGDTRAVKKLHSLPTGEIG--INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ++....||.|.|+.|+.....  ++..|++|...........  ....+.+.+.....|.+++..+..+...++.|+=-|
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e  346 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE  346 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence            344556899999999998644  5677888877554332211  111222222233458899998888877788889999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~  932 (1048)
                      |+++++......   ....++...++++..+++.++.++|+.   .++|+|+||+||++..+ +..++.|||....+.-.
T Consensus       347 ~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  347 FCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             hhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence            999998877662   233367778899999999999999988   99999999999999986 78899999998743211


Q ss_pred             CCCccccccccccc--cccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          933 SSNWSELAGTCGYI--APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ...   ..++-+++  +|+......+..++|+||+|.-+.|-++|..--.          .    ......+..+..+..
T Consensus       421 ~~~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~----------~----~~~~~~i~~~~~p~~  483 (524)
T KOG0601|consen  421 SGV---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE----------S----GVQSLTIRSGDTPNL  483 (524)
T ss_pred             ccc---ccccccccccchhhccccccccccccccccccccccccCcccCc----------c----cccceeeecccccCC
Confidence            111   11233344  5555566678899999999999999999875311          0    000111122222222


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ... .   .++..+...+..+++..||.+.++..+
T Consensus       484 ~~~-~---~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  484 PGL-K---LQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             Cch-H---HhhhhhhhhhcCCccccchhhhhhccc
Confidence            111 1   334455566899999999999887654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.95  E-value=5.4e-09  Score=110.09  Aligned_cols=143  Identities=17%  Similarity=0.172  Sum_probs=104.0

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhccc--CceeeEeeEeeeC---CeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH--RNIVKFYGFCSHT---QHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  856 (1048)
                      +.+|.|.++.||+++..+|+.+++|................+...++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            457999999999998876688999987654332122344555666666654  3456677776654   36789999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC----------------------------------------  896 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  896 (1048)
                      |+++.+.+..    ..++......++.++++++.+||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888765421    23566777788888888888888521                                        


Q ss_pred             -------------CCCeEeeCCCCCCeEECC--CCceEEeccccccc
Q 045493          897 -------------FPPILHRDISSKKVLLDL--EYKAHVSDFGTAKF  928 (1048)
Q Consensus       897 -------------~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~  928 (1048)
                                   ...++|||++|.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         146799999999999998  56789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=5.8e-09  Score=99.85  Aligned_cols=131  Identities=18%  Similarity=0.270  Sum_probs=90.4

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccC-CCCccc---c---hhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSL-PTGEIG---I---NQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~-~~~~~~---~---~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ++++|+-+.+|.+.+. |.++++|.-.+. ...+.-   .   ....+.+.+...+--.|...+=|..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4789999999999886 444555543222 221110   0   0122334444444334444444556677779999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      +|-.|.+++...          ...++..+-.-+.-||..   +|||||+.++||.+..++ +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888543          245677777778889999   999999999999998665 99999999974

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.94  E-value=6.5e-09  Score=104.05  Aligned_cols=136  Identities=15%  Similarity=0.130  Sum_probs=90.2

Q ss_pred             eecccccccEEEEEEcC-------CCceeeEEeccCCCC----------ccc-----------chh----hHHHHHHhhc
Q 045493          783 LHGTGGCGTVYKAELTS-------GDTRAVKKLHSLPTG----------EIG-----------INQ----KGFVSEITEI  830 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~-------~~~vavk~~~~~~~~----------~~~-----------~~~----~~~~~~l~~l  830 (1048)
                      .||.|--+.||.|...+       +..+|||..+.....          +..           ...    +.|.+.+.++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            47999999999997653       468899977542110          000           000    1333444444


Q ss_pred             cc--CceeeEeeEeeeCCeEEEEEEccCCCCHHH-HHhccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeeCCC
Q 045493          831 RH--RNIVKFYGFCSHTQHLFLVYEYLERGSLAT-ILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDIS  906 (1048)
Q Consensus       831 ~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~Dik  906 (1048)
                      ..  -++.+++++    ...++||||+.++.+.. .++.    ..++..+...+..+++.++.+| |..   +|||||++
T Consensus        84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs  152 (197)
T cd05146          84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS  152 (197)
T ss_pred             HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            32  344555554    34689999998753321 2221    1234455677889999999999 777   99999999


Q ss_pred             CCCeEECCCCceEEeccccccccC
Q 045493          907 SKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       907 ~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      +.||+++ ++.+.++|||.|....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 5789999999887553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.90  E-value=1.2e-09  Score=133.79  Aligned_cols=251  Identities=24%  Similarity=0.258  Sum_probs=137.9

Q ss_pred             CCcEEecCCCc--cccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEe
Q 045493          160 SPVSVSLHTNN--FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLY  237 (1048)
Q Consensus       160 ~L~~l~l~~n~--~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  237 (1048)
                      .|.+|-+..|.  +..+..+.|..|+.|+.|||++|.--+.+|..+++|.+|++|+|++..+. .+|..+++|..|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45666666665  44445555777888888888877655677888888888888888888877 6777788888888888


Q ss_pred             ccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCc----EEEccC
Q 045493          238 LHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLS----HLWLSK  313 (1048)
Q Consensus       238 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~----~L~L~~  313 (1048)
                      ++.+.-...+|.....+.+|++|.+...... .....+..+.+|++|..-.+..-+..+-..+..+..|.    .+.+.+
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~-~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~  703 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPRSALS-NDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEG  703 (889)
T ss_pred             cccccccccccchhhhcccccEEEeeccccc-cchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhcc
Confidence            8777765556666666788888877665422 11222333333333332221111111111222223222    333222


Q ss_pred             ceeecccccccccccccceeeeccccccCCCCcchhc------cCCCCeEeccCCccccCcChhhhccCCCcEEEeeccc
Q 045493          314 TQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR------LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE  387 (1048)
Q Consensus       314 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~  387 (1048)
                      +... ..+.++..+.+|+.|.+.++.+......+...      ++++..+...++... ..+.+..-.++|+.|.+..+.
T Consensus       704 ~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~  781 (889)
T KOG4658|consen  704 CSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCR  781 (889)
T ss_pred             cccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEeccc
Confidence            2222 34556667777777777777665333322211      112222222222211 223333345778888888777


Q ss_pred             ccCCchhhhhhhcccceeeccccccCC
Q 045493          388 LSGSIPQEIENMKKLNKYLLFENQFTG  414 (1048)
Q Consensus       388 l~~~~p~~~~~l~~L~~l~l~~N~l~~  414 (1048)
                      ....+......+..+..+.+..+.+.+
T Consensus       782 ~~e~~i~~~k~~~~l~~~i~~f~~~~~  808 (889)
T KOG4658|consen  782 LLEDIIPKLKALLELKELILPFNKLEG  808 (889)
T ss_pred             ccccCCCHHHHhhhcccEEeccccccc
Confidence            766666666666666554444444443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.90  E-value=1.1e-09  Score=128.85  Aligned_cols=192  Identities=23%  Similarity=0.314  Sum_probs=143.5

Q ss_pred             ccCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCe
Q 045493          831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKV  910 (1048)
Q Consensus       831 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NI  910 (1048)
                      ++|-++...--+......++|++|..++++...++..+.   .+....+.....+..+.+|||..   .++|||++|.|+
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~  935 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSL  935 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccch
Confidence            457777666656677889999999999999999976552   34445566677788899999998   789999999999


Q ss_pred             EECCCCceEEeccccccccCC---------------------CC----------CCccccccccccccccccccCCCCch
Q 045493          911 LLDLEYKAHVSDFGTAKFLKP---------------------DS----------SNWSELAGTCGYIAPELAYTMRANEK  959 (1048)
Q Consensus       911 ll~~~~~~kl~DfG~a~~~~~---------------------~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~  959 (1048)
                      +...+|+.+++|||......-                     ..          .......||+.|.|||...+......
T Consensus       936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen  936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred             hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence            999999999999983322110                     00          00123568999999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 045493          960 CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus       960 ~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      +|.|+.|++++|.++|..||....           .+..++.+..+.++.+.. .........+++...+..+|.+|-.|
T Consensus      1016 ad~~~~g~~l~e~l~g~pp~na~t-----------pq~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAET-----------PQQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             chhhhhhhhhhhhhcCCCCCCCcc-----------hhhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCc
Confidence            999999999999999999976322           223344555555554432 23444556677777889999999877


Q ss_pred             H
Q 045493         1040 Q 1040 (1048)
Q Consensus      1040 ~ 1040 (1048)
                      .
T Consensus      1084 ~ 1084 (1205)
T KOG0606|consen 1084 K 1084 (1205)
T ss_pred             c
Confidence            5

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.88  E-value=1.1e-09  Score=88.09  Aligned_cols=61  Identities=43%  Similarity=0.558  Sum_probs=44.9

Q ss_pred             CCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcC
Q 045493           24 PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQL   84 (1048)
Q Consensus        24 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l   84 (1048)
                      |+|++|++++|+|+.+.++.|..+++|++|++++|+++.+.|++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4677777777777766667777777777777777777777777777777777777777764

...

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=2.2e-08  Score=95.17  Aligned_cols=144  Identities=14%  Similarity=0.199  Sum_probs=97.6

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEecc-CCCCccc---chh---hHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHS-LPTGEIG---INQ---KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~-~~~~~~~---~~~---~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ...++-+|+-+.|+++.+. |+..+||.-.. ....+.-   ...   ..+.+.+.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4557889999999999987 77766664322 2222111   111   23334444444334444444555666678999


Q ss_pred             EccCC-CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEeccccccc
Q 045493          853 EYLER-GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKF  928 (1048)
Q Consensus       853 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~  928 (1048)
                      ||++| .++.+++........ ........++.|-+.+.-||..   +|||||+..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 588888865443332 2223367888999999999999   999999999999997664   458999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.84  E-value=9.5e-08  Score=101.71  Aligned_cols=255  Identities=16%  Similarity=0.215  Sum_probs=156.1

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeE------eee-CCeEEEEEE
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGF------CSH-TQHLFLVYE  853 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~------~~~-~~~~~lv~e  853 (1048)
                      .-+|+|+-+.+|...--  ..-+.|+++......    +...+.++... .||-+-.-+.+      ..+ .....+.|+
T Consensus        17 r~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          17 RPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             ccccCCccceeeecchh--hchhheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            34799999999966322  223566665543322    22333444332 34432221111      112 223678888


Q ss_pred             ccCCC-CHHHHH---hccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          854 YLERG-SLATIL---SNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       854 ~~~~g-~L~~~l---~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      .+++- ....+.   .+.......+|...+++++.+|.+.+.||..   |.+-||+.++|+|+++++.|.+.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            88764 222222   2334556689999999999999999999999   9999999999999999999999986543322


Q ss_pred             CCCCCCccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCcccccccCCCcccc--cchhhhhh
Q 045493          930 KPDSSNWSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEG-KHPGHFLSLLLSLPAPAA--NMNIVVND 1001 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg-~~p~~~~~~~~~~~~~~~--~~~~~~~~ 1001 (1048)
                       ..+......+|...|.+||.-.     +-.-+...|-|.+||++++++.| ++||........-+.+-+  .....+.+
T Consensus       168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence             2334455678999999999755     33346789999999999999986 999875443222111111  00111111


Q ss_pred             h---ccCCCCCCchhH-HHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHh
Q 045493         1002 L---IDSRLPPPLGEV-EEKLKSMIAVAFLCLDAN--PDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1002 ~---~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~d--P~~RPt~~evl~~L 1046 (1048)
                      .   -.+..+++...+ .-....+..+..+|+...  |.-|||++..+..|
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence            1   112222222211 222234555566677543  67899999887765

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.80  E-value=3e-09  Score=85.55  Aligned_cols=59  Identities=42%  Similarity=0.570  Sum_probs=34.7

Q ss_pred             CCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeeccc
Q 045493           73 NLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNS  131 (1048)
Q Consensus        73 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~  131 (1048)
                      +|++|++++|+|+.+.+++|.++++|++|++++|+++.+.|.+|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45555555555555555555555556666666565555555566666666666666654

...

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.68  E-value=2.2e-10  Score=128.47  Aligned_cols=127  Identities=35%  Similarity=0.354  Sum_probs=74.6

Q ss_pred             CCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccc
Q 045493          521 QLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS  600 (1048)
Q Consensus       521 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls  600 (1048)
                      .|...+.++|++. .....+.-++.|+.|+|++|+++.. . .+..++.|+.|||++|.+..++--...++. |..|.++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            3566666667666 4555566666667777777776632 2 566666677777777766665333333333 6666666


Q ss_pred             cccccchhhhhhccccccCeEECCCCcccCc-CCcCcCCccccCeEECCCCccc
Q 045493          601 NNQFSQEISIQIGKLVQLSKLDLSHNSLGGN-IPSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       601 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                      +|.++..  ..+.++.+|+.||+|+|-|.+. --.-++.+..|+.|+|.||++-
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            6666542  2344566666666666666541 1122344556666666666664

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.68  E-value=3e-10  Score=127.36  Aligned_cols=180  Identities=26%  Similarity=0.285  Sum_probs=110.2

Q ss_pred             CCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccC---cccc---cccC---CCCccEEEecCcccCcc
Q 045493          441 PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFG---EISS---NWIK---CPQLATLNMGGNEISGT  511 (1048)
Q Consensus       441 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~---~~~~---~~~~---~~~L~~L~L~~N~i~~~  511 (1048)
                      |-.+..+.+|+.|.+.++.|... .+....-.+|+.|-.. |.+..   +...   .+.+   ...|...++++|.+. .
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~-~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA-KGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh-hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence            44566677888888888877631 1111111233433322 22211   0100   1111   135677777888776 5


Q ss_pred             cCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccc-cccccccceeecccCcccccccccccc
Q 045493          512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGE  590 (1048)
Q Consensus       512 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~  590 (1048)
                      ....+.-++.|+.|||++|+++..  +.+..++.|++|||+.|+++ .+|.. ...+ .|..|.|++|.++.+  ..+.+
T Consensus       179 mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie~  252 (1096)
T KOG1859|consen  179 MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGIEN  252 (1096)
T ss_pred             HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhHHh
Confidence            555666677788888888887743  26677788888888888887 44432 2233 377888888877765  45677


Q ss_pred             cccccccccccccccchhh-hhhccccccCeEECCCCccc
Q 045493          591 LRKLHHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       591 l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  629 (1048)
                      +.+|+.|||+.|-|.+-.. ..++.+..|+.|+|.+|.+-
T Consensus       253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            7788888888887765433 33456777888888888775

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.68  E-value=6.1e-07  Score=98.42  Aligned_cols=169  Identities=21%  Similarity=0.315  Sum_probs=126.8

Q ss_pred             cccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee----eCCeEEEEEEccCC-CCHHH
Q 045493          789 CGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS----HTQHLFLVYEYLER-GSLAT  862 (1048)
Q Consensus       789 ~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-g~L~~  862 (1048)
                      -.+.|++... +|..|+.|+++-..... .......++.++++.|.|||++.+++.    .+...++||+|+++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4568999654 89999999995432221 112345577789999999999999875    34468999999987 47777


Q ss_pred             HHhccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          863 ILSNEA------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       863 ~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      +-....            .....++...|.++.|++.||.++|+.   |+..+-+.|++|+++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            653221            122367789999999999999999999   99999999999999999999999888877665


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP  978 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p  978 (1048)
                      .+..              |-+   .--.+-|.=.+|.+++.+.||..-
T Consensus       445 ~d~~--------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT--------------EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC--------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            4431              001   112456888999999999999743

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.67  E-value=1.9e-07  Score=99.34  Aligned_cols=134  Identities=25%  Similarity=0.226  Sum_probs=89.9

Q ss_pred             ccEEEEEEcCCCceeeEEeccCCCCc----------ccchhhHHHHHHhhcccCce--eeEeeEeee-----CCeEEEEE
Q 045493          790 GTVYKAELTSGDTRAVKKLHSLPTGE----------IGINQKGFVSEITEIRHRNI--VKFYGFCSH-----TQHLFLVY  852 (1048)
Q Consensus       790 g~Vy~~~~~~~~~vavk~~~~~~~~~----------~~~~~~~~~~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~  852 (1048)
                      ..|+++.. +|+.++||+.......+          .......+.+.+..+...+|  .+.++++..     ....++||
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34667665 47788899764322110          00013344444545432222  233444432     23578999


Q ss_pred             EccCCC-CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-------CCceEEeccc
Q 045493          853 EYLERG-SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-------EYKAHVSDFG  924 (1048)
Q Consensus       853 e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-------~~~~kl~DfG  924 (1048)
                      |++++. +|.+++.... ..+.+...+..++.+++..+.-||..   ||+|||++++|||++.       ++.+.++||+
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 8999985322 12345567778999999999999999   9999999999999975       4689999999


Q ss_pred             cccc
Q 045493          925 TAKF  928 (1048)
Q Consensus       925 ~a~~  928 (1048)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8864

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.65  E-value=3e-09  Score=106.15  Aligned_cols=163  Identities=22%  Similarity=0.182  Sum_probs=81.5

Q ss_pred             ccCCCCCCCeeeCcCCcccCcccc----cccCCCCccEEEecCcccCcccCccc-------------cccCCCcEEEccc
Q 045493          467 VFGIYPDLELLDLSNNNFFGEISS----NWIKCPQLATLNMGGNEISGTIPSEI-------------GNMTQLHKLDFSS  529 (1048)
Q Consensus       467 ~~~~~~~L~~L~Ls~n~l~~~~~~----~~~~~~~L~~L~L~~N~i~~~~~~~~-------------~~l~~L~~L~Ls~  529 (1048)
                      ++..+|.|+..+||+|.|....+.    .+++...|++|.|++|.+....-.-+             ++-|.|++.+...
T Consensus        87 aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgr  166 (388)
T COG5238          87 ALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGR  166 (388)
T ss_pred             HHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEecc
Confidence            344567777777777776654333    23345667777777776652211111             2235666666666


Q ss_pred             CcccCCcC----ccccCCCccCEEeecCccccCCC-----ccccccccccceeecccCcccccc----cccccccccccc
Q 045493          530 NRLVGQIP----KQLGKLTSLTSLTLNGNQLSGDI-----PLELGLLAELGYLDLSANRLSKLI----PKNLGELRKLHH  596 (1048)
Q Consensus       530 N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~  596 (1048)
                      |++..-..    ..|..-.+|+++.+.+|.|....     -..+..+.+|+.|||..|-++...    ..++..++.|++
T Consensus       167 NRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE  246 (388)
T COG5238         167 NRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE  246 (388)
T ss_pred             chhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence            66652111    11222245666666666665221     111234455666666666555322    233444555555


Q ss_pred             cccccccccchhhhhhc------cccccCeEECCCCccc
Q 045493          597 LNLSNNQFSQEISIQIG------KLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       597 L~Ls~N~l~~~~~~~~~------~l~~L~~L~Ls~N~l~  629 (1048)
                      |.+..|-++..+...+-      ..++|+.|-..+|.+.
T Consensus       247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~  285 (388)
T COG5238         247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR  285 (388)
T ss_pred             ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence            55555555544433221      2344555555555444

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.62  E-value=7e-09  Score=104.92  Aligned_cols=84  Identities=26%  Similarity=0.356  Sum_probs=40.2

Q ss_pred             ccccceeEecCCccccC--cccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcc-cCccccccCCCc
Q 045493          447 CTSLYSLRLERNQLTGN--ISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGT-IPSEIGNMTQLH  523 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~--~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~-~~~~~~~l~~L~  523 (1048)
                      ++.+++++|.+|.|+.-  ....+..+|.|+.|+|+.|.+...+...-....+|+.|.|.+..+.-. ....+..+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            34555666666655522  223334555556666666555543332223444555555555554411 122334445555


Q ss_pred             EEEcccC
Q 045493          524 KLDFSSN  530 (1048)
Q Consensus       524 ~L~Ls~N  530 (1048)
                      .|++|.|
T Consensus       150 elHmS~N  156 (418)
T KOG2982|consen  150 ELHMSDN  156 (418)
T ss_pred             hhhhccc
Confidence            5555555

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.56  E-value=1.2e-08  Score=102.06  Aligned_cols=114  Identities=21%  Similarity=0.183  Sum_probs=70.6

Q ss_pred             cccceeecccCcccccccc----cccccccccccccccccccchhhhh-----hccccccCeEECCCCcccCcC----Cc
Q 045493          568 AELGYLDLSANRLSKLIPK----NLGELRKLHHLNLSNNQFSQEISIQ-----IGKLVQLSKLDLSHNSLGGNI----PS  634 (1048)
Q Consensus       568 ~~L~~L~Ls~N~l~~~~~~----~l~~l~~L~~L~Ls~N~l~~~~~~~-----~~~l~~L~~L~Ls~N~l~~~~----~~  634 (1048)
                      +.|+..+...|++..-...    .|..=..|+++.+..|.|.-.+...     +..+.+|+.|||.+|-++-..    ..
T Consensus       157 p~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~  236 (388)
T COG5238         157 PKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLAD  236 (388)
T ss_pred             CCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHH
Confidence            4455566666655432111    1222246667777777665443222     235678888888888887432    33


Q ss_pred             CcCCccccCeEECCCCcccCCcccccc------ccCCccEEEeccceecCCCC
Q 045493          635 EICNLESLEYMNLLQNKLSGPIPSCFR------RMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       635 ~~~~l~~L~~L~L~~N~l~~~~~~~~~------~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      .++..+.|+.|++..|-++......+-      ..|+|..|-..||...|.+-
T Consensus       237 al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i  289 (388)
T COG5238         237 ALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGII  289 (388)
T ss_pred             HhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCcee
Confidence            455667789999999999877665442      25777888888887766543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.54  E-value=5.5e-07  Score=90.05  Aligned_cols=126  Identities=23%  Similarity=0.267  Sum_probs=75.5

Q ss_pred             cEEEEEEcCCCceeeEEeccCCCC-----------cc--------------cchhhHHHHHHhhcccC--ceeeEeeEee
Q 045493          791 TVYKAELTSGDTRAVKKLHSLPTG-----------EI--------------GINQKGFVSEITEIRHR--NIVKFYGFCS  843 (1048)
Q Consensus       791 ~Vy~~~~~~~~~vavk~~~~~~~~-----------~~--------------~~~~~~~~~~l~~l~h~--niv~~~~~~~  843 (1048)
                      .||.|...++..+|+|..+.....           ..              ....+.|.+.+.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389998888889999977542110           00              00113344445555444  345555442 


Q ss_pred             eCCeEEEEEEccC--CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeeCCCCCCeEECCCCceEE
Q 045493          844 HTQHLFLVYEYLE--RGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHV  920 (1048)
Q Consensus       844 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~Dik~~NIll~~~~~~kl  920 (1048)
                         ..++||||++  |..+..+....     ++......++.+++..+..+ |..   ||||||+.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               2379999999  65555443221     11344567788888866664 677   99999999999999877 8999


Q ss_pred             ecccccccc
Q 045493          921 SDFGTAKFL  929 (1048)
Q Consensus       921 ~DfG~a~~~  929 (1048)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.49  E-value=3.3e-08  Score=100.17  Aligned_cols=178  Identities=25%  Similarity=0.293  Sum_probs=99.0

Q ss_pred             CCCccEEEecCcccCc--ccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCcccc-CCCccccccccccc
Q 045493          495 CPQLATLNMGGNEISG--TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLS-GDIPLELGLLAELG  571 (1048)
Q Consensus       495 ~~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~  571 (1048)
                      ++.+++++|.+|.|+.  .+...+.+||.|++|+|+.|.+...+-..=..+.+|++|.|.+..+. ......+..++.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            3445555555555551  22223445566666666666555222111123445666666655554 12233445556666


Q ss_pred             eeecccCccccc--cccc----------ccccccccccccccccccchhhhhhccccccCeEECCCCcccCcC-CcCcCC
Q 045493          572 YLDLSANRLSKL--IPKN----------LGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNI-PSEICN  638 (1048)
Q Consensus       572 ~L~Ls~N~l~~~--~~~~----------l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~  638 (1048)
                      +|++|.|.+..+  ..+.          +..++.+..++++-|++..       -++++..+-+..|.|...- -..+..
T Consensus       150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~  222 (418)
T KOG2982|consen  150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEP  222 (418)
T ss_pred             hhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHh-------hcccchheeeecCcccchhhcccCCC
Confidence            666666643321  1111          1222334444444444432       3567788888888776422 234556


Q ss_pred             ccccCeEECCCCcccC-CccccccccCCccEEEeccceecCC
Q 045493          639 LESLEYMNLLQNKLSG-PIPSCFRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       639 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~l~ls~N~l~~~  679 (1048)
                      +|.+--|+|+.|+|.. .--.++.+++.|..|.+++||+..+
T Consensus       223 ~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~  264 (418)
T KOG2982|consen  223 FPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP  264 (418)
T ss_pred             CCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence            7778888999999864 2345677889999999999988554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.39  E-value=2.1e-08  Score=90.03  Aligned_cols=109  Identities=23%  Similarity=0.216  Sum_probs=50.8

Q ss_pred             cceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCC
Q 045493          570 LGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQ  649 (1048)
Q Consensus       570 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  649 (1048)
                      |+..+|++|.+.+.+++.-...+.++.|+|++|.|++++.. +..++.|+.|+++.|.+. ..|..+..+.+|-.|+..+
T Consensus        55 l~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~  132 (177)
T KOG4579|consen   55 LTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPE  132 (177)
T ss_pred             EEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCC
Confidence            33444555555444333333334555555555555443332 555555555555555554 3444444455555555555


Q ss_pred             CcccCCccccccccCCccEEEeccceecCCCC
Q 045493          650 NKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       650 N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      |.+- ++|..+---.....+++.+++|.+..+
T Consensus       133 na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  133 NARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             Cccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            5554 222222111222333445555655544

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=1.2e-07  Score=108.00  Aligned_cols=150  Identities=18%  Similarity=0.254  Sum_probs=98.5

Q ss_pred             HHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC----cc-----ccccccccccccccc
Q 045493          882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN----WS-----ELAGTCGYIAPELAY  952 (1048)
Q Consensus       882 ~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~----~~-----~~~gt~~y~aPE~~~  952 (1048)
                      +.+++.|+.|+|..  .++||++|.|++|.++..+..|++.|+.+....+....    +.     -......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34455999999987  49999999999999999999999999998765442221    00     112345799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCC
Q 045493          953 TMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDA 1031 (1048)
Q Consensus       953 ~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 1031 (1048)
                      ....+.++|+||+||++|.+.. |+.-+...+...... .+......-.....          .+...++.+=+.+++..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s----------~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYS----------NNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhccccccccccc----------ccCcHHHHHHHHHHhcC
Confidence            9888999999999999999995 444333221110000 00000000000000          11223455556678999


Q ss_pred             CCCCCCCHHHHHH
Q 045493         1032 NPDCRPTMQKVCN 1044 (1048)
Q Consensus      1032 dP~~RPt~~evl~ 1044 (1048)
                      ++.-||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.30  E-value=4.5e-06  Score=86.05  Aligned_cols=89  Identities=20%  Similarity=0.337  Sum_probs=71.1

Q ss_pred             eeeEeeEeeeC----CeEEEEEEccCCC-CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 045493          835 IVKFYGFCSHT----QHLFLVYEYLERG-SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKK  909 (1048)
Q Consensus       835 iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~N  909 (1048)
                      +.+.+++....    ...++|+|++++. +|.+++.....   .+......++.++++.++-||..   ||+|+|+++.|
T Consensus        75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~N  148 (206)
T PF06293_consen   75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSN  148 (206)
T ss_pred             CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCccc
Confidence            44455555442    2458999999984 89999865322   45566788999999999999999   99999999999


Q ss_pred             eEECCCC---ceEEecccccccc
Q 045493          910 VLLDLEY---KAHVSDFGTAKFL  929 (1048)
Q Consensus       910 Ill~~~~---~~kl~DfG~a~~~  929 (1048)
                      ||++.++   .+.++||+-++..
T Consensus       149 ILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  149 ILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             EEEeCCCCceeEEEEcchhceeC
Confidence            9999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1048
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-46
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-36
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-28
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-18
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-46
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-36
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-28
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-18
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-23
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-23
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-22
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-20
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		3e-11
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		9e-07
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		3e-11
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		9e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		2e-10
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		7e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-09
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		5e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-08
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		1e-08
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		5e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-08
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-08
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		3e-08
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		6e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-08
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-08
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		4e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
4fho_A	231	Crystal Structure Of An Internalin C2 (Inlc2) From		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-06
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		4e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-06
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		4e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-05
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		5e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-05
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		5e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-05
1h6u_A	308	Internalin H: Crystal Structure Of Fused N-Terminal		6e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-05
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		6e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-05
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		1e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-04
3twi_D	179	Variable Lymphocyte Receptor Recognition Of The Imm		1e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		2e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-04
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		2e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		3e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-04
3g3b_A	170	Structure Of A Lamprey Variable Lymphocyte Receptor		4e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-04
3g3a_A	178	Structure Of A Lamprey Variable Lymphocyte Receptor		6e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-04
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		7e-04
3g39_A	170	Structure Of A Lamprey Variable Lymphocyte Receptor		7e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-04
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		9e-04

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  185 bits (469), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 213/721 (29%), Positives = 301/721 (41%), Gaps = 114/721 (15%)
Query: 29  LDLSVNQLFG--TIPTQISHLSKLKHLDFSTN--QFSGIIPPQIGILTNLVVLRLSVNQL 84
           LDLS N L G  T  T +   S LK L+ S+N   F G +   +  L +L VL LS N +
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK-LNSLEVLDLSANSI 163
Query: 85  NG------LIPEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPP 138
           +G      ++ +  GEL     LA+S N+++G +                          
Sbjct: 164 SGANVVGWVLSDGCGEL---KHLAISGNKISGDVDVSRCVNLEFLD-------------- 206
Query: 139 NWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGS 198
               + S ++ +    LG+  +   + +  N  SG   R++     L  + +++N+ VG 
Sbjct: 207 ----VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPP-TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           IP     L+SL YL L +N+ +G IP   +G    L  L L  N   G +PP  GS   L
Sbjct: 263 IPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320
Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNI--NKLSGSIPKEIGNLK-SLSHLWLSKT 314
             L LS N  +G LP     L  ++ L V ++  N+ SG +P+ + NL  SL  L LS  
Sbjct: 321 ESLALSSNNFSGELP--MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 378
Query: 315 QLSGFIPPSLGN--LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCL 372
             SG I P+L     + ++ LY++ N   G IP  L     L  L LS N L+G+IP  L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 373 GNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVR 432
           G+LS L+   L  N L G IPQE+  +K L   +L  N  TG                  
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG------------------ 480
Query: 433 NNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW 492
                  IP  L NCT+L  + L  N+LTG I +  G   +L +L LSNN+F        
Sbjct: 481 ------EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF-------- 526
Query: 493 IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXX 552
                           SG IP+E+G+   L  LD ++N   G IP               
Sbjct: 527 ----------------SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 553 XXXXXGDIPXXXXXXXXXXX---------XXXSANRLSKLIPKNLGELRKLHH------- 596
                  I                          NRLS   P N+       H       
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 597 ------LNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN 650
                 L++S N  S  I  +IG +  L  L+L HN + G+IP E+ +L  L  ++L  N
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 651 KLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPC 710
           KL G IP     +  L+ ID+S N L G IP    F+      F  N  LCG    LP C
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRC 748
Query: 711 E 711
           +
Sbjct: 749 D 749

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  151 bits (381), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 156/516 (30%), Positives = 240/516 (46%), Gaps = 67/516 (12%)
Query: 162 VSVSLHTNNFSGVIPR--SLGGLKNLTFVYLNNNRIVGSIPSEIG---NLRSLSYLGLNK 216
            S+ L  N+ SG +    SLG    L F+ +++N +    P ++     L SL  L L+ 
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--DFPGKVSGGLKLNSLEVLDLSA 160
Query: 217 NQLSGSIPP---TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPS 273
           N +SG+       +     LK L +  N++SG +   +    +L +L +S N  +  +P 
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF 218
Query: 274 SFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGL 333
             G+ S+L+HL +   NKLSG   + I     L  L +S  Q  G IPP    L +++ L
Sbjct: 219 -LGDCSALQHLDISG-NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYL 274
Query: 334 YIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSI 392
            + EN   G IP+ L G   +L+ L LS N   G++P   G+ S L+  AL  N  SG +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 393 PQE-IENMKKLNKYLLFENQFTGYLPQNVCQ-SGSLTHFSVRNNNFVGPI-PRSLQNCTS 449
           P + +  M+ L    L  N+F+G LP+++   S SL    + +NNF GPI P   QN   
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN--- 391
Query: 450 LYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEIS 509
                  +N L              + L L NN F G+I      C +L +L++  N +S
Sbjct: 392 ------PKNTL--------------QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 510 GTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXX 569
           GTIPS +G++++L  L    N L                         G+IP        
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNML------------------------EGEIPQELMYVKT 467
Query: 570 XXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG 629
                   N L+  IP  L     L+ ++LSNN+ + EI   IG+L  L+ L LS+NS  
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 630 GNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHG 665
           GNIP+E+ +  SL +++L  N  +G IP+   +  G
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  125 bits (315), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 140/440 (31%), Positives = 196/440 (44%), Gaps = 23/440 (5%)
Query: 256 SLLYLYLSHNQLNGSLPS--SFGNLSSLKHLHVH-NINKLSGSIPKEIGNLKSLSHLWLS 312
           SL  L LS N L+G + +  S G+ S LK L+V  N     G +   +  L SL  L LS
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL-KLNSLEVLDLS 159
Query: 313 KTQLSG------FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG 366
              +SG       +    G L   + L I  N + G +  ++ R  +L  L +S N  + 
Sbjct: 160 ANSISGANVVGWVLSDGCGEL---KHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFST 214
Query: 367 SIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSL 426
            IP  LG+ S L+   +  N+LSG   + I    +L    +  NQF G +P    +S  L
Sbjct: 215 GIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--L 271
Query: 427 THFSVRNNNFVGPIPRSLQN-CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFF 485
            + S+  N F G IP  L   C +L  L L  N   G +   FG    LE L LS+NNF 
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
Query: 486 GEISSN-WIKCPQLATLNMGGNEISGTIPSEIGNMT-QLHKLDFSSNRLVGQI--PXXXX 541
           GE+  +  +K   L  L++  NE SG +P  + N++  L  LD SSN   G I       
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391
Query: 542 XXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXXSANRLSKLIPKNLGELRKLHHLNLSN 601
                           G IP              S N LS  IP +LG L KL  L L  
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR 661
           N    EI  ++  +  L  L L  N L G IPS + N  +L +++L  N+L+G IP    
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 662 RMHGLSSIDVSYNELQGSIP 681
           R+  L+ + +S N   G+IP
Sbjct: 512 RLENLAILKLSNNSFSGNIP 531

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 117/426 (27%), Positives = 181/426 (42%), Gaps = 51/426 (11%)
Query: 305 SLSHLWLSKTQLSGFIPP--SLGNLSNIRGLYIRENMLYGSIPEELG---RLKSLSQLSL 359
           SL+ L LS+  LSG +    SLG+ S ++ L +  N L    P ++    +L SL  L L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--DFPGKVSGGLKLNSLEVLDL 158
Query: 360 SVNKLNGS--IPHCLGN-LSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL 416
           S N ++G+  +   L +    LK  A+  N++SG +                        
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDV------------------------ 194
Query: 417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLEL 476
             +V +  +L    V +NNF   IP  L +C++L  L +  N+L+G+ S       +L+L
Sbjct: 195 --DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKL 251
Query: 477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQ 535
           L++S+N F G I    +K   L  L++  N+ +G IP  + G    L  LD S N   G 
Sbjct: 252 LNISSNQFVGPIPPLPLK--SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 536 IPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXX-XXXXXXSANRLSKLIPKNLGELRK- 593
           +P                    G++P               S N  S  +P++L  L   
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369
Query: 594 LHHLNLSNNQFSQEISIQIGKLVQ-----LSKLDLSHNSLGGNIPSEICNLESLEYMNLL 648
           L  L+LS+N FS  I   +  L Q     L +L L +N   G IP  + N   L  ++L 
Sbjct: 370 LLTLDLSSNNFSGPI---LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 649 QNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV-TGL 707
            N LSG IPS    +  L  + +  N L+G IP    +            +L G++ +GL
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
Query: 708 PPCEAL 713
             C  L
Sbjct: 487 SNCTNL 492

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  184 bits (468), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 213/721 (29%), Positives = 301/721 (41%), Gaps = 114/721 (15%)
Query: 29  LDLSVNQLFG--TIPTQISHLSKLKHLDFSTN--QFSGIIPPQIGILTNLVVLRLSVNQL 84
           LDLS N L G  T  T +   S LK L+ S+N   F G +   +  L +L VL LS N +
Sbjct: 102 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK-LNSLEVLDLSANSI 160
Query: 85  NG------LIPEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPP 138
           +G      ++ +  GEL     LA+S N+++G +                          
Sbjct: 161 SGANVVGWVLSDGCGELK---HLAISGNKISGDVDVSRCVNLEFLD-------------- 203
Query: 139 NWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGS 198
               + S ++ +    LG+  +   + +  N  SG   R++     L  + +++N+ VG 
Sbjct: 204 ----VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 259
Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPP-TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           IP     L+SL YL L +N+ +G IP   +G    L  L L  N   G +PP  GS   L
Sbjct: 260 IPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 317
Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNI--NKLSGSIPKEIGNL-KSLSHLWLSKT 314
             L LS N  +G LP     L  ++ L V ++  N+ SG +P+ + NL  SL  L LS  
Sbjct: 318 ESLALSSNNFSGELP--MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSN 375
Query: 315 QLSGFIPPSLGN--LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCL 372
             SG I P+L     + ++ LY++ N   G IP  L     L  L LS N L+G+IP  L
Sbjct: 376 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 435
Query: 373 GNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVR 432
           G+LS L+   L  N L G IPQE+  +K L   +L  N  TG                  
Sbjct: 436 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG------------------ 477
Query: 433 NNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW 492
                  IP  L NCT+L  + L  N+LTG I +  G   +L +L LSNN+F        
Sbjct: 478 ------EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF-------- 523
Query: 493 IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXX 552
                           SG IP+E+G+   L  LD ++N   G IP               
Sbjct: 524 ----------------SGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 567
Query: 553 XXXXXGDIPXXXXXXXXXXX---------XXXSANRLSKLIPKNLGELRKLHH------- 596
                  I                          NRLS   P N+       H       
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 627
Query: 597 ------LNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN 650
                 L++S N  S  I  +IG +  L  L+L HN + G+IP E+ +L  L  ++L  N
Sbjct: 628 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 687
Query: 651 KLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPC 710
           KL G IP     +  L+ ID+S N L G IP    F+      F  N  LCG    LP C
Sbjct: 688 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRC 745
Query: 711 E 711
           +
Sbjct: 746 D 746

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  150 bits (379), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 156/516 (30%), Positives = 240/516 (46%), Gaps = 67/516 (12%)
Query: 162 VSVSLHTNNFSGVIPR--SLGGLKNLTFVYLNNNRIVGSIPSEIG---NLRSLSYLGLNK 216
            S+ L  N+ SG +    SLG    L F+ +++N +    P ++     L SL  L L+ 
Sbjct: 100 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--DFPGKVSGGLKLNSLEVLDLSA 157
Query: 217 NQLSGSIPP---TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPS 273
           N +SG+       +     LK L +  N++SG +   +    +L +L +S N  +  +P 
Sbjct: 158 NSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF 215
Query: 274 SFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGL 333
             G+ S+L+HL +   NKLSG   + I     L  L +S  Q  G IPP    L +++ L
Sbjct: 216 -LGDCSALQHLDISG-NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYL 271
Query: 334 YIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSI 392
            + EN   G IP+ L G   +L+ L LS N   G++P   G+ S L+  AL  N  SG +
Sbjct: 272 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 331
Query: 393 PQE-IENMKKLNKYLLFENQFTGYLPQNVCQ-SGSLTHFSVRNNNFVGPI-PRSLQNCTS 449
           P + +  M+ L    L  N+F+G LP+++   S SL    + +NNF GPI P   QN   
Sbjct: 332 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN--- 388
Query: 450 LYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEIS 509
                  +N L              + L L NN F G+I      C +L +L++  N +S
Sbjct: 389 ------PKNTL--------------QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 428
Query: 510 GTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXX 569
           GTIPS +G++++L  L    N L                         G+IP        
Sbjct: 429 GTIPSSLGSLSKLRDLKLWLNML------------------------EGEIPQELMYVKT 464
Query: 570 XXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG 629
                   N L+  IP  L     L+ ++LSNN+ + EI   IG+L  L+ L LS+NS  
Sbjct: 465 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 524
Query: 630 GNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHG 665
           GNIP+E+ +  SL +++L  N  +G IP+   +  G
Sbjct: 525 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 560

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  125 bits (314), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 140/440 (31%), Positives = 196/440 (44%), Gaps = 23/440 (5%)
Query: 256 SLLYLYLSHNQLNGSLPS--SFGNLSSLKHLHVH-NINKLSGSIPKEIGNLKSLSHLWLS 312
           SL  L LS N L+G + +  S G+ S LK L+V  N     G +   +  L SL  L LS
Sbjct: 98  SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL-KLNSLEVLDLS 156
Query: 313 KTQLSG------FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG 366
              +SG       +    G L   + L I  N + G +  ++ R  +L  L +S N  + 
Sbjct: 157 ANSISGANVVGWVLSDGCGEL---KHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFST 211
Query: 367 SIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSL 426
            IP  LG+ S L+   +  N+LSG   + I    +L    +  NQF G +P    +S  L
Sbjct: 212 GIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--L 268
Query: 427 THFSVRNNNFVGPIPRSLQN-CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFF 485
            + S+  N F G IP  L   C +L  L L  N   G +   FG    LE L LS+NNF 
Sbjct: 269 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 328
Query: 486 GEISSN-WIKCPQLATLNMGGNEISGTIPSEIGNMT-QLHKLDFSSNRLVGQI--PXXXX 541
           GE+  +  +K   L  L++  NE SG +P  + N++  L  LD SSN   G I       
Sbjct: 329 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 388
Query: 542 XXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXXSANRLSKLIPKNLGELRKLHHLNLSN 601
                           G IP              S N LS  IP +LG L KL  L L  
Sbjct: 389 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 448
Query: 602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR 661
           N    EI  ++  +  L  L L  N L G IPS + N  +L +++L  N+L+G IP    
Sbjct: 449 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 508
Query: 662 RMHGLSSIDVSYNELQGSIP 681
           R+  L+ + +S N   G+IP
Sbjct: 509 RLENLAILKLSNNSFSGNIP 528

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 117/426 (27%), Positives = 181/426 (42%), Gaps = 51/426 (11%)
Query: 305 SLSHLWLSKTQLSGFIPP--SLGNLSNIRGLYIRENMLYGSIPEELG---RLKSLSQLSL 359
           SL+ L LS+  LSG +    SLG+ S ++ L +  N L    P ++    +L SL  L L
Sbjct: 98  SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--DFPGKVSGGLKLNSLEVLDL 155
Query: 360 SVNKLNGS--IPHCLGN-LSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL 416
           S N ++G+  +   L +    LK  A+  N++SG +                        
Sbjct: 156 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDV------------------------ 191
Query: 417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLEL 476
             +V +  +L    V +NNF   IP  L +C++L  L +  N+L+G+ S       +L+L
Sbjct: 192 --DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKL 248
Query: 477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQ 535
           L++S+N F G I    +K   L  L++  N+ +G IP  + G    L  LD S N   G 
Sbjct: 249 LNISSNQFVGPIPPLPLK--SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 306
Query: 536 IPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXX-XXXXXXSANRLSKLIPKNLGELRK- 593
           +P                    G++P               S N  S  +P++L  L   
Sbjct: 307 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 366
Query: 594 LHHLNLSNNQFSQEISIQIGKLVQ-----LSKLDLSHNSLGGNIPSEICNLESLEYMNLL 648
           L  L+LS+N FS  I   +  L Q     L +L L +N   G IP  + N   L  ++L 
Sbjct: 367 LLTLDLSSNNFSGPI---LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 423
Query: 649 QNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV-TGL 707
            N LSG IPS    +  L  + +  N L+G IP    +            +L G++ +GL
Sbjct: 424 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 483
Query: 708 PPCEAL 713
             C  L
Sbjct: 484 SNCTNL 489

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  151 bits (382), Expect = 1e-36,   Method: Composition-based stats.
 Identities = 97/286 (33%), Positives = 145/286 (50%), Gaps = 17/286 (5%)
Query: 772  LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHS--LPTGEIGINQKGFVSEITE 829
            +++  F  K +L G GG G VYK  L  G   AVK+L       GE+    +  V  I+ 
Sbjct: 35   VASDNFSNKNIL-GRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE--VEMISM 91
Query: 830  IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANA 888
              HRN+++  GFC       LVY Y+  GS+A+ L     +   LDW KR  +  G A  
Sbjct: 92   AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 151
Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK-PDSSNWSELAGTCGYIA 947
            L+Y+H  C P I+HRD+ +  +LLD E++A V DFG AK +   D      + GT G+IA
Sbjct: 152  LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIA 211
Query: 948  PELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRL 1007
            PE   T +++EK DVF +GV++LE+I G+                 +    V  L+  + 
Sbjct: 212  PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW---VKGLLKEKK 268
Query: 1008 PPPLGEV-------EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               L +V       +E+++ +I VA LC  ++P  RP M +V  +L
Sbjct: 269  LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  150 bits (380), Expect = 3e-36,   Method: Composition-based stats.
 Identities = 97/286 (33%), Positives = 145/286 (50%), Gaps = 17/286 (5%)
Query: 772  LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPT--GEIGINQKGFVSEITE 829
            +++  F  K +L G GG G VYK  L  G   AVK+L    T  GE+    +  V  I+ 
Sbjct: 27   VASDNFXNKNIL-GRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE--VEMISM 83
Query: 830  IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANA 888
              HRN+++  GFC       LVY Y+  GS+A+ L     +   LDW KR  +  G A  
Sbjct: 84   AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK-PDSSNWSELAGTCGYIA 947
            L+Y+H  C P I+HRD+ +  +LLD E++A V DFG AK +   D      + G  G+IA
Sbjct: 144  LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIA 203
Query: 948  PELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRL 1007
            PE   T +++EK DVF +GV++LE+I G+                 +    V  L+  + 
Sbjct: 204  PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW---VKGLLKEKK 260
Query: 1008 PPPLGEV-------EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               L +V       +E+++ +I VA LC  ++P  RP M +V  +L
Sbjct: 261  LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Composition-based stats.
 Identities = 69/197 (35%), Positives = 106/197 (53%), Gaps = 7/197 (3%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
           G G  GTV++AE    D  AVK L         +N+  F+ E+     +RH NIV F G 
Sbjct: 46  GAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNE--FLREVAIMKRLRHPNIVLFMGA 102
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            +   +L +V EYL RGSL  +L       +LD  +R+++   VA  ++Y+H+   PPI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRD+ S  +L+D +Y   V DFG ++            AGT  ++APE+     +NEK D
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 962 VFNFGVLVLEVIEGKHP 978
           V++FGV++ E+   + P
Sbjct: 222 VYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 2e-23,   Method: Composition-based stats.
 Identities = 68/197 (34%), Positives = 107/197 (54%), Gaps = 7/197 (3%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
           G G  GTV++AE    D  AVK L         +N+  F+ E+     +RH NIV F G 
Sbjct: 46  GAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNE--FLREVAIMKRLRHPNIVLFMGA 102
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            +   +L +V EYL RGSL  +L       +LD  +R+++   VA  ++Y+H+   PPI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HR++ S  +L+D +Y   V DFG ++       +    AGT  ++APE+     +NEK D
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 962 VFNFGVLVLEVIEGKHP 978
           V++FGV++ E+   + P
Sbjct: 222 VYSFGVILWELATLQQP 238

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 121/225 (53%), Gaps = 6/225 (2%)
Query: 169 NNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG 228
           NN  G IP ++  L  L ++Y+ +  + G+IP  +  +++L  L  + N LSG++PP+  
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 229 NLSNLKFLYLHDNRLSGYIPPKLGSFKSLLY-LYLSHNQLNGSLPSSFGNLSSLKHLHVH 287
           +L NL  +    NR+SG IP   GSF  L   + +S N+L G +P +F NL +L  + + 
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLS 205
Query: 288 NINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE 347
             N L G      G+ K+   + L+K  L+ F    +G   N+ GL +R N +YG++P+ 
Sbjct: 206 R-NMLEGDASVLFGSDKNTQKIHLAKNSLA-FDLGKVGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 348 LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE-LSGS 391
           L +LK L  L++S N L G IP   GNL      A   N+ L GS
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 114/243 (46%), Gaps = 26/243 (10%)
Query: 296 IPKEIGNLKSLSHLWLSK-TQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
           IP  + NL  L+ L++     L G IPP++  L+ +  LYI    + G+IP+ L ++K+L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
             L  S N L+G++P  + +L NL       N +SG+IP    +  KL            
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------------ 175
Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
                       T  ++  N   G IP +  N  +L  + L RN L G+ S +FG   + 
Sbjct: 176 -----------FTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 475 ELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG 534
           + + L+ N+   ++    +    L  L++  N I GT+P  +  +  LH L+ S N L G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLS-KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 535 QIP 537
           +IP
Sbjct: 283 EIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/336 (25%), Positives = 136/336 (40%), Gaps = 46/336 (13%)
Query: 393 PQEIENMKKLNKYLLFENQFTGYLPQN----------VCQSGSLTHFSVRNNNFVG---- 438
           PQ+ + + ++ K L      + +LP            +C + + T + V N +  G    
Sbjct: 5   PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQT-YRVNNLDLSGLNLP 63
Query: 439 ---PIPRSLQNCTSLYSLRLER-NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK 494
              PIP SL N   L  L +   N L G I         L  L +++ N  G I     +
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 495 CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPXXXXXXXXXXXXXXXXX 554
              L TL+   N +SGT+P  I ++  L  + F  NR+ G IP                 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI-- 181
Query: 555 XXXGDIPXXXXXXXXXXXXXXSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGK 614
                                S NRL+  IP     L  L  ++LS N    + S+  G 
Sbjct: 182 ---------------------SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
Query: 615 LVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYN 674
                K+ L+ NSL  ++  ++   ++L  ++L  N++ G +P    ++  L S++VS+N
Sbjct: 220 DKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 675 ELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPC 710
            L G IP     Q   + A+  NK LCG  + LP C
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSL---PTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
            G GG G VYK    +  T AVKKL ++    T E+       +  + + +H N+V+  GF
Sbjct: 40   GEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S    L LVY Y+  GSL   LS       L W  R  + +G AN ++++H +     +
Sbjct: 99   SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---I 155
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEK 959
            HRDI S  +LLD  + A +SDFG A+  +  +     S + GT  Y+APE A       K
Sbjct: 156  HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPK 214
Query: 960  CDVFNFGVLVLEVIEG-------KHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLG 1012
             D+++FGV++LE+I G       + P               +    + D ID ++     
Sbjct: 215  SDIYSFGVVLLEIITGLPAVDEHREP----QLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 +++M +VA  CL    + RP ++KV  LL
Sbjct: 271  ---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 128/274 (46%), Gaps = 24/274 (8%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSL---PTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
            G GG G VYK    +  T AVKKL ++    T E+       +  + + +H N+V+  GF
Sbjct: 40   GEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S    L LVY Y+  GSL   LS       L W  R  + +G AN ++++H +     +
Sbjct: 99   SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---I 155
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELAGTCGYIAPELAYTMRANEK 959
            HRDI S  +LLD  + A +SDFG A+  +    +     + GT  Y+APE A       K
Sbjct: 156  HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPK 214
Query: 960  CDVFNFGVLVLEVIEG-------KHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLG 1012
             D+++FGV++LE+I G       + P               +    + D ID ++     
Sbjct: 215  SDIYSFGVVLLEIITGLPAVDEHREP----QLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 +++M +VA  CL    + RP ++KV  LL
Sbjct: 271  ---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 128/274 (46%), Gaps = 24/274 (8%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSL---PTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
            G GG G VYK    +  T AVKKL ++    T E+       +  + + +H N+V+  GF
Sbjct: 34   GEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 92
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S    L LVY Y+  GSL   LS       L W  R  + +G AN ++++H +     +
Sbjct: 93   SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---I 149
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEK 959
            HRDI S  +LLD  + A +SDFG A+  +  +       + GT  Y+APE A       K
Sbjct: 150  HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPK 208
Query: 960  CDVFNFGVLVLEVIEG-------KHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLG 1012
             D+++FGV++LE+I G       + P               +    + D ID ++     
Sbjct: 209  SDIYSFGVVLLEIITGLPAVDEHREP----QLLLDIKEEIEDEEKTIEDYIDKKMNDADS 264
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 +++M +VA  CL    + RP ++KV  LL
Sbjct: 265  ---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
           G GG G VYK    +  T AVKKL ++        ++ F  EI    + +H N+V+  GF
Sbjct: 31  GEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            S    L LVY Y   GSL   LS       L W  R  + +G AN ++++H +     +
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---I 146
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELAGTCGYIAPELAYTMRANEK 959
           HRDI S  +LLD  + A +SDFG A+  +        S + GT  Y APE A       K
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPK 205
Query: 960 CDVFNFGVLVLEVIEG 975
            D+++FGV++LE+I G
Sbjct: 206 SDIYSFGVVLLEIITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 773 SASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE-ITEIR 831
           + + F+ K ++ G G  G VYK  L  G   A+K+    P    GI +     E ++  R
Sbjct: 37  ATNNFDHKFLI-GHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEIETLSFCR 93
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLAT-ILSNEATAAELDWSKRVNVIKGVANALS 890
           H ++V   GFC     + L+Y+Y+E G+L   +  ++     + W +R+ +  G A  L 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF-LKPDSSNWSELA-GTCGYIAP 948
           Y+H      I+HRD+ S  +LLD  +   ++DFG +K   + D ++   +  GT GYI P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVI 973
           E     R  EK DV++FGV++ EV+
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 773 SASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE-ITEIR 831
           + + F+ K ++ G G  G VYK  L  G   A+K+    P    GI +     E ++  R
Sbjct: 37  ATNNFDHKFLI-GHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETEIETLSFCR 93
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLAT-ILSNEATAAELDWSKRVNVIKGVANALS 890
           H ++V   GFC     + L+Y+Y+E G+L   +  ++     + W +R+ +  G A  L 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA----GTCGYI 946
           Y+H      I+HRD+ S  +LLD  +   ++DFG +K  K      + L     GT GYI
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYI 208
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVI 973
            PE     R  EK DV++FGV++ EV+
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+++  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 85
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  SE+ GT  ++APE+        K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E+IEG+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 68/269 (25%), Positives = 121/269 (44%), Gaps = 49/269 (18%)
Query: 803  RAVKKLHSLPTGEIGI----------NQKGFVSEITEIR---HRNIVKFYGFCSHTQHLF 849
            +A+K  H   TGE+ +           Q+ F+ E+  +R   H N++KF G     + L 
Sbjct: 25   QAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83
Query: 850  LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKK 909
             + EY++ G+L  I+  ++  ++  WS+RV+  K +A+ ++Y+H      I+HRD++S  
Sbjct: 84   FITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHN 138
Query: 910  VLLDLEYKAHVSDFGTAKFL--------------KPDSSNWSELAGTCGYIAPELAYTMR 955
             L+       V+DFG A+ +              KPD      + G   ++APE+     
Sbjct: 139  CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198
Query: 956  ANEKCDVFNFGVLVLEVIE--GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGE 1013
             +EK DVF+FG+++ E+I      P +             +  + V   +D   PP    
Sbjct: 199  YDEKVDVFSFGIVLCEIIGRVNADPDYL--------PRTMDFGLNVRGFLDRYCPPNCP- 249
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                  S   +   C D +P+ RP+  K+
Sbjct: 250  -----PSFFPITVRCCDLDPEKRPSFVKL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+++  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 86
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E+IEG+ P
Sbjct: 200 IWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+++  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 85
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E+IEG+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+++  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 29  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 85
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E+IEG+ P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  GTVY A ++ +G   A+++  L   P  E+ IN+   +  + E ++ NIV +   
Sbjct: 30  GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE---ILVMRENKNPNIVNYLDS 86
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V EYL  GSL  ++    T   +D  +   V +    AL ++H +    ++
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HR+I S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K D
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++ +E+IEG+ P
Sbjct: 200 IWSLGIMAIEMIEGEPP 216

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  +EL GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G GG G VY+A    GD  AVK     P  +I    +    E      ++H NI+   G 
Sbjct: 16   GIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C    +L LV E+   G L  +LS +    ++     VN    +A  ++Y+H +   PI+
Sbjct: 75   CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHDEAIVPII 130
Query: 902  HRDISSKKVLL-------DLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
            HRD+ S  +L+       DL  K   ++DFG A+  +   +     AG   ++APE+   
Sbjct: 131  HRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAYAWMAPEVIRA 188
Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGE 1013
               ++  DV+++GVL+ E++ G+ P  F             MN +    I S  P P  +
Sbjct: 189  SMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGVAMNKLALP-IPSTCPEPFAK 245
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            + E           C + +P  RP+   + + L
Sbjct: 246  LMED----------CWNPDPHSRPSFTNILDQL 268

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 43  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 102
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 103 FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VI 156
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS   +L GT  Y+ PE+      +EK D
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVD 214
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 215 LWSLGVLCYEFLVGKPP 231

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  ++L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY  RG +   L      ++ D  +    I  +ANALSY H      ++
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQK---LSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 194 LWSLGVLCYEFLVGKPP 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 78  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  ++L GT  Y+ PE+      +EK D
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 190 LWSLGVLCYEFLVGKPP 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 82  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  ++L GT  Y+ PE+      +EK D
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 194 LWSLGVLCYEFLVGKPP 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 33   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 91   KPQ-LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPELAYTMRAN 957
            D+ S  + L  +    + DFG    L  + S WS      +L+G+  ++APE+     +N
Sbjct: 145  DLKSNNIFLHEDNTVKIGDFG----LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 958  E---KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEV 1014
                + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V
Sbjct: 201  PYSFQSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 1015 EEKL-KSMIAVAFLCLDANPDCRPTMQKV 1042
                 K M  +   CL    D RP+  ++
Sbjct: 251  RSNCPKRMKRLMAECLKKKRDERPSFPRI 279

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
              +  ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDSTRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---KVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 43  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 102
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 103 FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VI 156
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 214
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 215 LWSLGVLCYEFLVGKPP 231

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  ++L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 123/265 (46%), Gaps = 25/265 (9%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 21   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 79   KPQ-LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 904  DISSKKVLLDLEYKAHVSDFG--TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE--- 958
            D+ S  + L  +    + DFG  T K     S  + +L+G+  ++APE+     +N    
Sbjct: 133  DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V    
Sbjct: 193  QSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIEMVGRGSLSPDLSKVRSNC 242
Query: 1019 -KSMIAVAFLCLDANPDCRPTMQKV 1042
             K M  +   CL    D RP+  ++
Sbjct: 243  PKRMKRLMAECLKKKRDERPSFPRI 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 80  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVD 191
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 192 LWSLGVLCYEFLVGKPP 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 80  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 192 LWSLGVLCYEFLVGKPP 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 34  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 93
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 94  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 147
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 205
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 206 LWSLGVLCYEFLVGKPP 222

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 82  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 194 LWSLGVLCYEFLVGKPP 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 80  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 192 LWSLGVLCYEFLVGKPP 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 80  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS   +L GT  Y+ PE+      +EK D
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 192 LWSLGVLCYEFLVGKPP 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 33   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 91   APQ-LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPELAYTMRAN 957
            D+ S  + L  +    + DFG    L  + S WS      +L+G+  ++APE+     +N
Sbjct: 145  DLKSNNIFLHEDNTVKIGDFG----LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 958  E---KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEV 1014
                + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V
Sbjct: 201  PYSFQSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 1015 EEKL-KSMIAVAFLCLDANPDCRPTMQKV 1042
                 K M  +   CL    D RP+  ++
Sbjct: 251  RSNCPKRMKRLMAECLKKKRDERPSFPRI 279

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY  RG +   L      ++ D  +    I  +ANALSY H      ++
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQK---LSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS    L GT  Y+ PE+      +EK D
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVD 193
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 194 LWSLGVLCYEFLVGKPP 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 16  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 75
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 76  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 129
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 187
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 188 LWSLGVLCYEFLVGKPP 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 21  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 81  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 134
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 193 LWSLGVLCYEFLVGKPP 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 78  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +      SS  + L+GT  Y+ PE+      +EK D
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVD 189
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 190 LWSLGVLCYEFLVGKPP 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 78  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 131
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS    L GT  Y+ PE+      +EK D
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 190 LWSLGVLCYEFLVGKPP 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 19  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 78
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 79  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 132
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS    L GT  Y+ PE+      +EK D
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVD 190
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 191 LWSLGVLCYEFLVGKPP 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 80  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS    L GT  Y+ PE+      +EK D
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 192 LWSLGVLCYEFLVGKPP 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 17  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 77  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 130
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS    L GT  Y+ PE+      +EK D
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 189 LWSLGVLCYEFLVGKPP 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 828 TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
           + +RH NI++ YG+      ++L+ EY     L T+       ++ D  +    I  +AN
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELAN 116
Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
           ALSY H      ++HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ 
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 171
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           PE+      +EK D+++ GVL  E + GK P
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 20  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 80  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  +++FG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 192 LWSLGVLCYEFLVGKPP 208

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 216
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQG---VI 269
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 330 IWSLGIMVIEMVDGEPP 346

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 19  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 78
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 79  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 132
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  +++FG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 190
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 191 LWSLGVLCYEFLVGKPP 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 22  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 81
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       ++ D  +    I  +ANALSY H      ++
Sbjct: 82  FHDATRVYLILEY---APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 135
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE       +EK D
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVD 193
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + GK P
Sbjct: 194 LWSLGVLCYEFLVGKPP 210

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 21  GKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       +  D  +    I  +ANALSY H      ++
Sbjct: 81  FHDATRVYLILEY---APLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVI 134
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS  + L GT  Y+ PE+      +EK D
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + G  P
Sbjct: 193 LWSLGVLCYEFLVGMPP 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 134/297 (45%), Gaps = 30/297 (10%)
Query: 762  GQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQ 820
            G +  ++ E+       G+ +  G+G  GTVYK +   GD  AVK L+ + PT +     
Sbjct: 1    GSDSSDDWEIPDGQITVGQRI--GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAF 56
Query: 821  KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
            K  V  + + RH NI+ F G+ +  Q L +V ++ E  SL   L    T  E+   K ++
Sbjct: 57   KNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLID 113
Query: 881  VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG--TAKFLKPDSSNWSE 938
            + +  A  + Y+H      I+HRD+ S  + L  +    + DFG  T K     S  + +
Sbjct: 114  IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 939  LAGTCGYIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNM 995
            L+G+  ++APE+      N    + DV+ FG+++ E++ G+ P               N 
Sbjct: 171  LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----------YSNINNR 220
Query: 996  NIVVNDLIDSRLPPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKV---CNLLCR 1048
            + ++  +    L P L +V     K+M  +   CL    D RP   ++     LL R
Sbjct: 221  DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 138/309 (44%), Gaps = 38/309 (12%)
Query: 754  RKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLH-SLP 812
            R R  +   ++  ++ E+       G+ +  G+G  GTVYK +   GD  AVK L+ + P
Sbjct: 8    RNRMKTLGRRDSSDDWEIPDGQITVGQRI--GSGSFGTVYKGKW-HGDV-AVKMLNVTAP 63
Query: 813  TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE 872
            T +     K  V  + + RH NI+ F G+ +  Q L +V ++ E  SL   L    T  E
Sbjct: 64   TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFE 122
Query: 873  LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD 932
            +   K +++ +  A  + Y+H      I+HRD+ S  + L  +    + DFG A     +
Sbjct: 123  M--IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA----TE 173
Query: 933  SSNWS------ELAGTCGYIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHPGHFXX 983
             S WS      +L+G+  ++APE+      N    + DV+ FG+++ E++ G+ P     
Sbjct: 174  KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----- 228
Query: 984  XXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKV 1042
                      N + ++  +    L P L +V     K+M  +   CL    D RP   ++
Sbjct: 229  -----YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 283
Query: 1043 ---CNLLCR 1048
                 LL R
Sbjct: 284  LASIELLAR 292

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 134/297 (45%), Gaps = 30/297 (10%)
Query: 762  GQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQ 820
            G +  ++ E+       G+ +  G+G  GTVYK +   GD  AVK L+ + PT +     
Sbjct: 1    GSDSSDDWEIPDGQITVGQRI--GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAF 56
Query: 821  KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
            K  V  + + RH NI+ F G+ +  Q L +V ++ E  SL   L    T  E+   K ++
Sbjct: 57   KNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLID 113
Query: 881  VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG--TAKFLKPDSSNWSE 938
            + +  A  + Y+H      I+HRD+ S  + L  +    + DFG  T K     S  + +
Sbjct: 114  IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 170
Query: 939  LAGTCGYIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNM 995
            L+G+  ++APE+      N    + DV+ FG+++ E++ G+ P               N 
Sbjct: 171  LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----------YSNINNR 220
Query: 996  NIVVNDLIDSRLPPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKV---CNLLCR 1048
            + ++  +    L P L +V     K+M  +   CL    D RP   ++     LL R
Sbjct: 221  DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQ--KGFVSEITEIRHRNIVKFYGF 841
           G G  G VY A E  S    A+K L      + G+    +  V   + +RH NI++ YG+
Sbjct: 21  GKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 80
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 ++L+ EY     L T+       +  D  +    I  +ANALSY H      ++
Sbjct: 81  FHDATRVYLILEY---APLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVI 134
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI  + +LL    +  ++DFG +  +   SS    L GT  Y+ PE+      +EK D
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVD 192
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL  E + G  P
Sbjct: 193 LWSLGVLCYEFLVGMPP 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/275 (23%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 785  GTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V +  L + G   +   + +L  G     ++ F+SE +   +  H NI++  G
Sbjct: 25   GAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEG 84
Query: 841  FCSHTQHLFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              +++  + ++ E++E G+L + L     + T  +L     V +++G+A+ + Y+    +
Sbjct: 85   VVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-----VGMLRGIASGMRYLAEMSY 139
Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRD++++ +L++      VSDFG ++FL+ +SS+ +E +   G I     APE   
Sbjct: 140  ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 953  TMRANEKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL 1011
              +     D +++G+++ EV+  G+ P               N +++     D RLPPP 
Sbjct: 197  FRKFTSASDAWSYGIVMWEVMSFGERP----------YWDMSNQDVINAIEQDYRLPPP- 245
Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                +   S+  +   C   + + RP   +V + L
Sbjct: 246  ---PDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 138/309 (44%), Gaps = 38/309 (12%)
Query: 754  RKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLH-SLP 812
            R R  +   ++  ++ E+       G+ +  G+G  GTVYK +   GD  AVK L+ + P
Sbjct: 16   RNRMKTLGRRDSSDDWEIPDGQITVGQRI--GSGSFGTVYKGKW-HGDV-AVKMLNVTAP 71
Query: 813  TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE 872
            T +     K  V  + + RH NI+ F G+ +  Q L +V ++ E  SL   L    T  E
Sbjct: 72   TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFE 130
Query: 873  LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD 932
            +   K +++ +  A  + Y+H      I+HRD+ S  + L  +    + DFG A     +
Sbjct: 131  M--IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA----TE 181
Query: 933  SSNWS------ELAGTCGYIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHPGHFXX 983
             S WS      +L+G+  ++APE+      N    + DV+ FG+++ E++ G+ P     
Sbjct: 182  KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----- 236
Query: 984  XXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKV 1042
                      N + ++  +    L P L +V     K+M  +   CL    D RP   ++
Sbjct: 237  -----YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 291
Query: 1043 ---CNLLCR 1048
                 LL R
Sbjct: 292  LASIELLAR 300

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 40/272 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V KA+  + D  A+K++ S         +K F+ E+   + + H NIVK YG 
Sbjct: 18   GRGAFGVVCKAKWRAKDV-AIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEA-----TAAE-LDWSKRVNVIKGVANALSYMHHD 895
            C +   + LV EY E GSL  +L         TAA  + W  + +  +GVA    Y+H  
Sbjct: 71   CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS--QGVA----YLHSM 122
Query: 896  CFPPILHRDISSKKVLLDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                ++HRD+    +LL        + DFGTA  ++   +N     G+  ++APE+    
Sbjct: 123  QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGS 179
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEV 1014
              +EKCDVF++G+++ EVI  + P  F             ++       +   PP +  +
Sbjct: 180  NYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWAVH-------NGTRPPLIKNL 230
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + ++S++     C   +P  RP+M+++  ++
Sbjct: 231  PKPIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 40/272 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V KA+  + D  A+K++ S         +K F+ E+   + + H NIVK YG 
Sbjct: 17   GRGAFGVVCKAKWRAKDV-AIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEA-----TAAE-LDWSKRVNVIKGVANALSYMHHD 895
            C +   + LV EY E GSL  +L         TAA  + W  + +  +GVA    Y+H  
Sbjct: 70   CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS--QGVA----YLHSM 121
Query: 896  CFPPILHRDISSKKVLLDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                ++HRD+    +LL        + DFGTA  ++   +N     G+  ++APE+    
Sbjct: 122  QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGS 178
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEV 1014
              +EKCDVF++G+++ EVI  + P  F             ++       +   PP +  +
Sbjct: 179  NYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWAVH-------NGTRPPLIKNL 229
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + ++S++     C   +P  RP+M+++  ++
Sbjct: 230  PKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 36/278 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 17   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 75   KPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPELAYTMRAN 957
            D+ S  + L  +    + DFG A     + S WS      +L+G+  ++APE+      N
Sbjct: 129  DLKSNNIFLHEDLTVKIGDFGLAT----EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 958  E---KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEV 1014
                + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V
Sbjct: 185  PYSFQSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 1015 EEKL-KSMIAVAFLCLDANPDCRPTMQKV---CNLLCR 1048
                 K+M  +   CL    D RP   ++     LL R
Sbjct: 235  RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 30/305 (9%)
Query: 754  RKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLH-SLP 812
            R R  +   ++  ++ E+       G+ +  G+G  GTVYK +   GD  AVK L+ + P
Sbjct: 16   RNRMKTLGRRDSSDDWEIPDGQITVGQRI--GSGSFGTVYKGKW-HGDV-AVKMLNVTAP 71
Query: 813  TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE 872
            T +     K  V  + + RH NI+ F G+ +  Q L +V ++ E  SL   L    T  E
Sbjct: 72   TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFE 130
Query: 873  LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG--TAKFLK 930
            +   K +++ +  A  + Y+H      I+HRD+ S  + L  +    + DFG  T K   
Sbjct: 131  M--IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 185
Query: 931  PDSSNWSELAGTCGYIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHPGHFXXXXXX 987
              S  + +L+G+  ++APE+      N    + DV+ FG+++ E++ G+ P         
Sbjct: 186  SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--------- 236
Query: 988  XXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKV---C 1043
                  N + ++  +    L P L +V     K+M  +   CL    D RP   ++    
Sbjct: 237  -YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295
Query: 1044 NLLCR 1048
             LL R
Sbjct: 296  ELLAR 300

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 28/274 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 19   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 76
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 77   KPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIHR 130
Query: 904  DISSKKVLLDLEYKAHVSDFG--TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE--- 958
            D+ S  + L  +    + DFG  T K     S  + +L+G+  ++APE+      N    
Sbjct: 131  DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V    
Sbjct: 191  QSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIFMVGRGYLSPDLSKVRSNC 240
Query: 1019 -KSMIAVAFLCLDANPDCRPTMQKV---CNLLCR 1048
             K+M  +   CL    D RP   ++     LL R
Sbjct: 241  PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A E  SG   AVK   L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 54  GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE---VVIMRDYQHFNVVEMYKS 110
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
               + L+++ E+L+ G+L  I+S       L+  +   V + V  AL+Y+H      ++
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVI 163
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL L+ +  +SDFG    +  D      L GT  ++APE+        + D
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVD 223
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 224 IWSLGIMVIEMVDGEPP 240

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 30/305 (9%)
Query: 754  RKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLH-SLP 812
            R R  +   ++  ++ E+       G+ +  G+G  GTVYK +   GD  AVK L+ + P
Sbjct: 15   RNRMKTLGRRDSSDDWEIPDGQITVGQRI--GSGSFGTVYKGKW-HGDV-AVKMLNVTAP 70
Query: 813  TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE 872
            T +     K  V  + + RH NI+ F G+ +  Q L +V ++ E  SL   L    T  E
Sbjct: 71   TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFE 129
Query: 873  LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG--TAKFLK 930
            +   K +++ +  A  + Y+H      I+HRD+ S  + L  +    + DFG  T K   
Sbjct: 130  M--IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 184
Query: 931  PDSSNWSELAGTCGYIAPELAYTMRANE---KCDVFNFGVLVLEVIEGKHPGHFXXXXXX 987
              S  + +L+G+  ++APE+      N    + DV+ FG+++ E++ G+ P         
Sbjct: 185  SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--------- 235
Query: 988  XXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKV---C 1043
                  N + ++  +    L P L +V     K+M  +   CL    D RP   ++    
Sbjct: 236  -YSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 294
Query: 1044 NLLCR 1048
             LL R
Sbjct: 295  ELLAR 299

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 28/274 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 17   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 75   KPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 904  DISSKKVLLDLEYKAHVSDFG--TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE--- 958
            D+ S  + L  +    + DFG  T K     S  + +L+G+  ++APE+      N    
Sbjct: 129  DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V    
Sbjct: 189  QSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 1019 -KSMIAVAFLCLDANPDCRPTMQKV---CNLLCR 1048
             K+M  +   CL    D RP   ++     LL R
Sbjct: 239  PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+     + D  A+K +      E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 14  GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           C     + LV+E++E G L+  L  +    AAE      ++V +G+A    Y+   C   
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC--- 121
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRA 956
           ++HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    R 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 957 NEKCDVFNFGVLVLEVI-EGKHP 978
           + K DV++FGVL+ EV  EGK P
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP 202

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+     + D  A+K +      E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 19  GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           C     + LV+E++E G L+  L  +    AAE      ++V +G+A    Y+   C   
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC--- 126
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRA 956
           ++HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    R 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 957 NEKCDVFNFGVLVLEVI-EGKHP 978
           + K DV++FGVL+ EV  EGK P
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIP 207

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+     + D  A+K +      E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 16  GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           C     + LV+E++E G L+  L  +    AAE      ++V +G+A    Y+   C   
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC--- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRA 956
           ++HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    R 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 957 NEKCDVFNFGVLVLEVI-EGKHP 978
           + K DV++FGVL+ EV  EGK P
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 28/274 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G+G  GTVYK +   GD  AVK L+ + PT +     K  V  + + RH NI+ F G+ +
Sbjct: 17   GSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              Q L +V ++ E  SL   L    T  E+   K +++ +  A  + Y+H      I+HR
Sbjct: 75   APQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 904  DISSKKVLLDLEYKAHVSDFG--TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE--- 958
            D+ S  + L  +    + DFG  T K     S  + +L+G+  ++APE+      N    
Sbjct: 129  DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            + DV+ FG+++ E++ G+ P               N + ++  +    L P L +V    
Sbjct: 189  QSDVYAFGIVLYELMTGQLP----------YSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 1019 -KSMIAVAFLCLDANPDCRPTMQKV---CNLLCR 1048
             K+M  +   CL    D RP   ++     LL R
Sbjct: 239  PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A E  +G   AVKK  L      E+  N+   V  + +  H N+V  Y  
Sbjct: 54  GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNE---VVIMRDYHHDNVVDMYSS 110
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALSY+H+     ++
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 163
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APE+   +    + D
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+I+G+ P
Sbjct: 224 IWSLGIMVIEMIDGEPP 240

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+     + D  A+K +      E  +++  F+ E   + ++ H  +V+ YG 
Sbjct: 36  GSGQFGLVHLGYWLNKDKVAIKTIK-----EGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           C     + LV+E++E G L+  L  +    AAE      ++V +G+A    Y+   C   
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC--- 143
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRA 956
           ++HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    R 
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRY 201
Query: 957 NEKCDVFNFGVLVLEVI-EGKHP 978
           + K DV++FGVL+ EV  EGK P
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIP 224

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 823 FVSEIT---EIRHRNIVKFYG--FCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWS 876
            VSE+    E++H NIV++Y          L++V EY E G LA++++      + LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 877 KRVNVIKGVANALSYMHH--DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             + V+  +  AL   H   D    +LHRD+    V LD +    + DFG A+ L  D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
              E  GT  Y++PE    M  NEK D+++ G L+ E+
Sbjct: 172 FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/275 (22%), Positives = 129/275 (46%), Gaps = 35/275 (12%)
Query: 785  GTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V +  L + G   +   + +L  G     ++ F+SE +   +  H NI++  G
Sbjct: 23   GAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEG 82
Query: 841  FCSHTQHLFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              +++  + ++ E++E G+L + L     + T  +L     V +++G+A+ + Y+    +
Sbjct: 83   VVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-----VGMLRGIASGMRYLAEMSY 137
Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRD++++ +L++      VSDFG ++FL+ +SS+ +  +   G I     APE   
Sbjct: 138  ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 953  TMRANEKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL 1011
              +     D +++G+++ EV+  G+ P               N +++     D RLPPP 
Sbjct: 195  FRKFTSASDAWSYGIVMWEVMSFGERP----------YWDMSNQDVINAIEQDYRLPPP- 243
Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                +   S+  +   C   + + RP   +V + L
Sbjct: 244  ---PDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 29  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 85
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVI 138
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 823 FVSEIT---EIRHRNIVKFYG--FCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWS 876
            VSE+    E++H NIV++Y          L++V EY E G LA++++      + LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 877 KRVNVIKGVANALSYMHH--DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             + V+  +  AL   H   D    +LHRD+    V LD +    + DFG A+ L  D+S
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
                 GT  Y++PE    M  NEK D+++ G L+ E+
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 38  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 94
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVI 147
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 208 IWSLGIMVIEMVDGEPP 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 62/272 (22%), Positives = 124/272 (45%), Gaps = 29/272 (10%)
Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L   G       + +L +G     ++ F+SE +   +  H N++   G
Sbjct: 42   GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEG 101
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + +  + ++ E++E GSL + L       +    + V +++G+A  + Y+    +   
Sbjct: 102  VVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMNY--- 156
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYTMR 955
            +HRD++++ +L++      VSDFG ++FL+ D+S+ +  +   G I     APE     +
Sbjct: 157  VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 956  ANEKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEV 1014
                 DV+++G+++ EV+  G+ P               N +++     D RLPPP+ + 
Sbjct: 217  FTSASDVWSYGIVMWEVMSYGERP----------YWDMTNQDVINAIEQDYRLPPPM-DC 265
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               L  ++     C   + + RP   ++ N L
Sbjct: 266  PSALHQLM---LDCWQKDRNHRPKFGQIVNTL 294

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 823 FVSEIT---EIRHRNIVKFYG--FCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWS 876
            VSE+    E++H NIV++Y          L++V EY E G LA++++      + LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 877 KRVNVIKGVANALSYMHH--DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             + V+  +  AL   H   D    +LHRD+    V LD +    + DFG A+ L  D+S
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
                 GT  Y++PE    M  NEK D+++ G L+ E+
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 33  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 89
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVI 142
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 203 IWSLGIMVIEMVDGEPP 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 40  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 96
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVI 149
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 210 IWSLGIMVIEMVDGEPP 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+     + D  A+K +      E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 17  GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           C     + LV E++E G L+  L  +    AAE      ++V +G+A    Y+   C   
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEEAC--- 124
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRA 956
           ++HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    R 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 957 NEKCDVFNFGVLVLEVI-EGKHP 978
           + K DV++FGVL+ EV  EGK P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 785 GTGGCGTVYKAEL-TSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A + +SG   AVKK  L      E+  N+   V  + + +H N+V+ Y  
Sbjct: 83  GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE---VVIMRDYQHENVVEMYNS 139
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L++V E+LE G+L  I+    T   ++  +   V   V  ALS +H      ++
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ---GVI 192
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRDI S  +LL  + +  +SDFG    +  +      L GT  ++APEL   +    + D
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ G++V+E+++G+ P
Sbjct: 253 IWSLGIMVIEMVDGEPP 269

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 125/275 (45%), Gaps = 35/275 (12%)
Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L   G       + +L +G     ++ F+SE +   +  H N++   G
Sbjct: 16   GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEG 75
Query: 841  FCSHTQHLFLVYEYLERGSLATILSN---EATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              + +  + ++ E++E GSL + L     + T  +L     V +++G+A  + Y+    +
Sbjct: 76   VVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLADMNY 130
Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPELAY 952
               +HR ++++ +L++      VSDFG ++FL+ D+S+ +  +   G     + APE   
Sbjct: 131  ---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 953  TMRANEKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL 1011
              +     DV+++G+++ EV+  G+ P               N +++     D RLPPP+
Sbjct: 188  YRKFTSASDVWSYGIVMWEVMSYGERP----------YWDMTNQDVINAIEQDYRLPPPM 237
Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                +   ++  +   C   + + RP   ++ N L
Sbjct: 238  ----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G+G  G V+     + D  A+K +      E  ++++ F+ E   + ++ H  +V+ YG 
Sbjct: 16  GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEAT--AAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           C     + LV+E++E G L+  L  +    AAE      ++V +G+A    Y+       
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA----YLEE---AS 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRA 956
           ++HRD++++  L+       VSDFG  +F+  D   ++   GT     + +PE+    R 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 957 NEKCDVFNFGVLVLEVI-EGKHP 978
           + K DV++FGVL+ EV  EGK P
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    F   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGF--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG A+ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 827  ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
            + ++ H  +VKFYG CS    +++V EY+  G L   L +      L+ S+ + +   V 
Sbjct: 57   MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVC 114
Query: 887  NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---C 943
              ++++    F   +HRD++++  L+D +    VSDFG  +++  D   +    GT    
Sbjct: 115  EGMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPV 169
Query: 944  GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDL 1002
             + APE+ +  + + K DV+ FG+L+ EV   GK P               N  +V+   
Sbjct: 170  KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP----------YDLYTNSEVVLKVS 219
Query: 1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
               RL  P         ++  + + C    P+ RPT Q++
Sbjct: 220  QGHRLYRP----HLASDTIYQIMYSCWHELPEKRPTFQQL 255

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH---RNIVKFYG 840
           G G  G+VYKA    +G   A+K++       +  + +  + EI+ ++     ++VK+YG
Sbjct: 38  GEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                  L++V EY   GS++ I+         D  +   +++     L Y+H   F   
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGLEYLH---FMRK 146
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRDI +  +LL+ E  A ++DFG A  L    +  + + GT  ++APE+   +  N   
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+  +E+ EGK P
Sbjct: 207 DIWSLGITAIEMAEGKPP 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 785 GTGGCGTVYKAEL--TSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFY 839
           G G  G VYK  L  +SG       + +L  G     +  F+ E   + +  H NI++  
Sbjct: 53  GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           G  S  + + ++ EY+E G+L   L  +    E    + V +++G+A  + Y+ +  +  
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMNY-- 168
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---TCGYIAPELAYTMRA 956
            +HRD++++ +L++      VSDFG ++ L+ D       +G      + APE     + 
Sbjct: 169 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 957 NEKCDVFNFGVLVLEVIE-GKHP 978
               DV++FG+++ EV+  G+ P
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP 250

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 784 HGTGGCGTVYKAELTSG----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFY 839
           H       + K++   G    D + ++K H     EI +        +  + H NI+K +
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL--------LKSLDHPNIIKLF 112
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
                 ++ +LV E+ E G L   + N     E D +   N++K + + + Y+H      
Sbjct: 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGICYLHK---HN 166
Query: 900 ILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
           I+HRDI  + +LL+ +       + DFG + F   D      L GT  YIAPE+    + 
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-GTAYYIAPEVL-KKKY 224
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
           NEKCDV++ GV++  ++ G  P
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPP 246

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 10/198 (5%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
           G GG  TVY AE T  + +   K   +P  E     K F  E+   +++ H+NIV     
Sbjct: 20  GGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                  +LV EY+E  +L+  + +      L     +N    + + + + H      I+
Sbjct: 80  DEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MRIV 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSELAGTCGYIAPELAYTMRANEKC 960
           HRDI  + +L+D      + DFG AK L   S +  + + GT  Y +PE A     +E  
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+++ E++ G+ P
Sbjct: 194 DIYSIGIVLYEMLVGEPP 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 42   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 101
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 102  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 156
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 157  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 216
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 217  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 262
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 263  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 33/241 (13%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G V    L     R V   + +L  G     ++ F+SE +   +  H NI++  G
Sbjct: 58   GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  +   +V EY+E GSL T L       +    + V +++GV   + Y+    +   
Sbjct: 118  VVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---TCGYIAPELAYTMRAN 957
            +HRD++++ VL+D      VSDFG ++ L+ D        G      + APE       +
Sbjct: 173  VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDS-----RLPPPL 1011
               DV++FGV++ EV+  G+ P                 N+   D+I S     RLP P+
Sbjct: 233  SASDVWSFGVVMWEVLAYGERP---------------YWNMTNRDVISSVEEGYRLPAPM 277
Query: 1012 G 1012
            G
Sbjct: 278  G 278

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 27/158 (17%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEAT---------AAELDWSKRVN 880
           + H  I++ +G     Q +F++ +Y+E G L ++L              AAE        
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-------- 114
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
               V  AL Y+H      I++RD+  + +LLD      ++DFG AK++ PD +    L 
Sbjct: 115 ----VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLC 164
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT  YIAPE+  T   N+  D ++FG+L+ E++ G  P
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 52   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 111
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 112  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 166
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 167  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 226
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 227  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 272
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 273  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 33/241 (13%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G V    L     R V   + +L  G     ++ F+SE +   +  H NI++  G
Sbjct: 58   GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  +   +V EY+E GSL T L       +    + V +++GV   + Y+    +   
Sbjct: 118  VVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ VL+D      VSDFG ++ L+ D  + ++   G     + APE       +
Sbjct: 173  VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDS-----RLPPPL 1011
               DV++FGV++ EV+  G+ P                 N+   D+I S     RLP P+
Sbjct: 233  SASDVWSFGVVMWEVLAYGERP---------------YWNMTNRDVISSVEEGYRLPAPM 277
Query: 1012 G 1012
            G
Sbjct: 278  G 278

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG  + L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 57/270 (21%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 25   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 84
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 85   VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY--- 139
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 140  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 200  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 245
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 246  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + K+YG       L+++ EYL  GS   +L     A   D  +   ++K +   L Y+H 
Sbjct: 83   VTKYYGSYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS 138
Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            +     +HRDI +  VLL  +    ++DFG A  L       +   GT  ++APE+    
Sbjct: 139  E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL-GE 1013
              + K D+++ G+  +E+ +G+ P                M ++   LI    PP L G+
Sbjct: 196  AYDSKADIWSLGITAIELAKGEPPN----------SDMHPMRVLF--LIPKNNPPTLVGD 243
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              +  K  I     CL+ +P  RPT +++
Sbjct: 244  FTKSFKEFIDA---CLNKDPSFRPTAKEL 269

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 33/233 (14%)
Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSN-----EATAAELDWSKR 878
            +  +++  H NIV +Y        L+LV + L  GS+  I+ +     E  +  LD S  
Sbjct: 59   IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 118
Query: 879  VNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-----S 933
              +++ V   L Y+H +     +HRD+ +  +LL  +    ++DFG + FL        +
Sbjct: 119  ATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 175
Query: 934  SNWSELAGTCGYIAPELAYTMRANE-KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXX 992
                   GT  ++APE+   +R  + K D+++FG+  +E+  G  P H            
Sbjct: 176  KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----------KY 225
Query: 993  XNMNIVVNDLIDSRLPPPL--GEVEEKL-----KSMIAVAFLCLDANPDCRPT 1038
              M +++  L +   PP L  G  ++++     KS   +  LCL  +P+ RPT
Sbjct: 226  PPMKVLMLTLQND--PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 33/233 (14%)
Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSN-----EATAAELDWSKR 878
            +  +++  H NIV +Y        L+LV + L  GS+  I+ +     E  +  LD S  
Sbjct: 64   IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 879  VNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-----S 933
              +++ V   L Y+H +     +HRD+ +  +LL  +    ++DFG + FL        +
Sbjct: 124  ATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 934  SNWSELAGTCGYIAPELAYTMRANE-KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXX 992
                   GT  ++APE+   +R  + K D+++FG+  +E+  G  P H            
Sbjct: 181  KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----------KY 230
Query: 993  XNMNIVVNDLIDSRLPPPL--GEVEEKL-----KSMIAVAFLCLDANPDCRPT 1038
              M +++  L +   PP L  G  ++++     KS   +  LCL  +P+ RPT
Sbjct: 231  PPMKVLMLTLQND--PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + K+YG       L+++ EYL  GS   +L        LD ++   +++ +   L Y+H 
Sbjct: 67   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS 122
Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            +     +HRDI +  VLL    +  ++DFG A  L       +   GT  ++APE+    
Sbjct: 123  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL-GE 1013
              + K D+++ G+  +E+  G+ P                M ++   LI    PP L G 
Sbjct: 180  AYDSKADIWSLGITAIELARGEPP----------HSELHPMKVLF--LIPKNNPPTLEGN 227
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + LK  +     CL+  P  RPT +++
Sbjct: 228  YSKPLKEFVEA---CLNKEPSFRPTAKEL 253

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + K+YG       L+++ EYL  GS   +L        LD ++   +++ +   L Y+H 
Sbjct: 87   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS 142
Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            +     +HRDI +  VLL    +  ++DFG A  L       +   GT  ++APE+    
Sbjct: 143  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL-GE 1013
              + K D+++ G+  +E+  G+ P                M ++   LI    PP L G 
Sbjct: 200  AYDSKADIWSLGITAIELARGEPP----------HSELHPMKVLF--LIPKNNPPTLEGN 247
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + LK  +     CL+  P  RPT +++
Sbjct: 248  YSKPLKEFVEA---CLNKEPSFRPTAKEL 273

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + K+YG       L+++ EYL  GS   +L        LD ++   +++ +   L Y+H 
Sbjct: 67   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS 122
Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            +     +HRDI +  VLL    +  ++DFG A  L       +   GT  ++APE+    
Sbjct: 123  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL-GE 1013
              + K D+++ G+  +E+  G+ P                M ++   LI    PP L G 
Sbjct: 180  AYDSKADIWSLGITAIELARGEPP----------HSELHPMKVLF--LIPKNNPPTLEGN 227
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + LK  +     CL+  P  RPT +++
Sbjct: 228  YSKPLKEFVEA---CLNKEPSFRPTAKEL 253

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 771  LLSASTFEGKMVLHGTGGCGTVYKAELTSGDTR--AVKKLH------SLPTGEI----GI 818
            L  AS FE   VL G G  G V KA   + D+R  A+KK+       S    E+     +
Sbjct: 2    LRYASDFEEIAVL-GQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 819  NQKGFVSEITE-IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK 877
            N +  V      +  RN VK          LF+  EY E G+L  ++ +E    + D   
Sbjct: 60   NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 878  RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-------FLK 930
            R+   + +  ALSY+H      I+HRD+    + +D      + DFG AK        LK
Sbjct: 120  RL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 931  PD-------SSNWSELAGTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFX 982
             D       S N +   GT  Y+A E L  T   NEK D+++ G++  E+I   +P    
Sbjct: 175  LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTG 231
Query: 983  XXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                       +++I          PP     + K+K    +  L +D +P+ RP  + +
Sbjct: 232  MERVNILKKLRSVSI--------EFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTL 281
Query: 1043 CN 1044
             N
Sbjct: 282  LN 283

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + K+YG       L+++ EYL  GS   +L        LD ++   +++ +   L Y+H 
Sbjct: 82   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS 137
Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            +     +HRDI +  VLL    +  ++DFG A  L       +   GT  ++APE+    
Sbjct: 138  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL-GE 1013
              + K D+++ G+  +E+  G+ P                M ++   LI    PP L G 
Sbjct: 195  AYDSKADIWSLGITAIELARGEPP----------HSELHPMKVLF--LIPKNNPPTLEGN 242
Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + LK  +     CL+  P  RPT +++
Sbjct: 243  YSKPLKEFVEA---CLNKEPSFRPTAKEL 268

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/270 (20%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V E +E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 114  VVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY--- 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGFC 842
           G G  G VYKA+   G+T A+KK+  L   + GI       +S + E++H NIVK Y   
Sbjct: 11  GEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 843 SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILH 902
              + L LV+E+L++  L  +L  +     L+     + +  + N ++Y H      +LH
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 903 RDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKCD 961
           RD+  + +L++ E +  ++DFG A+        ++    T  Y AP+ L  + + +   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 962 VFNFGVLVLEVIEG 975
           +++ G +  E++ G
Sbjct: 184 IWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGFC 842
           G G  G VYKA+   G+T A+KK+  L   + GI       +S + E++H NIVK Y   
Sbjct: 11  GEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 843 SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILH 902
              + L LV+E+L++  L  +L  +     L+     + +  + N ++Y H      +LH
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 903 RDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKCD 961
           RD+  + +L++ E +  ++DFG A+        ++    T  Y AP+ L  + + +   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 962 VFNFGVLVLEVIEG 975
           +++ G +  E++ G
Sbjct: 184 IWSVGCIFAEMVNG 197

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 2/200 (1%)
Query: 164 VSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN-QLSGS 222
           + LH N  S V   S    +NLT ++L++N +     +    L  L  L L+ N QL   
Sbjct: 36  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 95
Query: 223 IPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLK 282
            P T   L  L  L+L    L    P       +L YLYL  N L      +F +L +L 
Sbjct: 96  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 155
Query: 283 HLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG 342
           HL +H  N++S    +    L SL  L L + +++   P +  +L  +  LY+  N L  
Sbjct: 156 HLFLHG-NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 214
Query: 343 SIPEELGRLKSLSQLSLSVN 362
              E L  L++L  L L+ N
Sbjct: 215 LPTEALAPLRALQYLRLNDN 234

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 2/203 (0%)
Query: 236 LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS 295
           ++LH NR+S        + ++L  L+L  N L     ++F  L+ L+ L + +  +L   
Sbjct: 36  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 95
Query: 296 IPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR-LKSL 354
            P     L  L  L L +  L    P     L+ ++ LY+++N L  ++P++  R L +L
Sbjct: 96  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 154
Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
           + L L  N+++         L +L    L +N ++   P    ++ +L    LF N  + 
Sbjct: 155 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 214
Query: 415 YLPQNVCQSGSLTHFSVRNNNFV 437
              + +    +L +  + +N +V
Sbjct: 215 LPTEALAPLRALQYLRLNDNPWV 237

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 2/200 (1%)
Query: 164 VSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN-QLSGS 222
           + LH N  S V   S    +NLT ++L++N +     +    L  L  L L+ N QL   
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 223 IPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLK 282
            P T   L  L  L+L    L    P       +L YLYL  N L      +F +L +L 
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156
Query: 283 HLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG 342
           HL +H  N++S    +    L SL  L L + +++   P +  +L  +  LY+  N L  
Sbjct: 157 HLFLHG-NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 343 SIPEELGRLKSLSQLSLSVN 362
              E L  L++L  L L+ N
Sbjct: 216 LPTEALAPLRALQYLRLNDN 235

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 2/203 (0%)
Query: 236 LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS 295
           ++LH NR+S        + ++L  L+L  N L     ++F  L+ L+ L + +  +L   
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 296 IPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR-LKSL 354
            P     L  L  L L +  L    P     L+ ++ LY+++N L  ++P++  R L +L
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNL 155
Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
           + L L  N+++         L +L    L +N ++   P    ++ +L    LF N  + 
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 415 YLPQNVCQSGSLTHFSVRNNNFV 437
              + +    +L +  + +N +V
Sbjct: 216 LPTEALAPLRALQYLRLNDNPWV 238

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGFC 842
           G G  G VYKA+   G+T A+KK+  L   + GI       +S + E++H NIVK Y   
Sbjct: 11  GEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 843 SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILH 902
              + L LV+E+L++  L  +L  +     L+     + +  + N ++Y H      +LH
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 903 RDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKCD 961
           RD+  + +L++ E +  ++DFG A+        ++    T  Y AP+ L  + + +   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 962 VFNFGVLVLEVIEG 975
           +++ G +  E++ G
Sbjct: 184 IWSVGCIFAEMVNG 197

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 71/268 (26%), Positives = 126/268 (47%), Gaps = 43/268 (16%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 24   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +
Sbjct: 79   VSE-EPIYIVTEYMNKGSLLDFLKGE-TGKYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
            HRD+ +  +L+       V+DFG A+ +  + + W+   G      + APE A   R   
Sbjct: 134  HRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 959  KCDVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLG 1012
            K DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  
Sbjct: 192  KSDVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP-- 235
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQ 1040
            E  E L  ++     C    P+ RPT +
Sbjct: 236  ECPESLHDLMC---QCWRKEPEERPTFE 260

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 120/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G V+          A+K L           Q+  V  + ++RH  +V+ Y   S 
Sbjct: 276  GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV--MKKLRHEKLVQLYAVVSE 333
Query: 845  TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRD 904
             + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +HRD
Sbjct: 334  -EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 388
Query: 905  ISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKCDVF 963
            + +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K DV+
Sbjct: 389  LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 964  NFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEVEEK 1017
            +FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E  E 
Sbjct: 449  SFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--ECPES 492
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            L  ++     C    P+ RPT + +   L
Sbjct: 493  LHDLMC---QCWRKEPEERPTFEYLQAFL 518

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 12/215 (5%)
Query: 769 QELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIGINQKGFVSE- 826
            E    S FE   VL G G  G V+  +  SG D R +  +  L    + +  +      
Sbjct: 18  HEKADPSQFELLKVL-GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 827 ---ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              + E+ H  IVK +        L+L+ ++L  G L T LS E    E D       + 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLA 133
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +A AL ++H      I++RD+  + +LLD E    ++DFG +K             GT 
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 944 GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            Y+APE+       +  D ++FGVL+ E++ G  P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 12/215 (5%)
Query: 769 QELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIGINQKGFVSE- 826
            E    S FE   VL G G  G V+  +  SG D R +  +  L    + +  +      
Sbjct: 19  HEKADPSQFELLKVL-GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 77
Query: 827 ---ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              + E+ H  IVK +        L+L+ ++L  G L T LS E    E D       + 
Sbjct: 78  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLA 134
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +A AL ++H      I++RD+  + +LLD E    ++DFG +K             GT 
Sbjct: 135 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 944 GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            Y+APE+       +  D ++FGVL+ E++ G  P
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 12/215 (5%)
Query: 769 QELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIGINQKGFVSE- 826
            E    S FE   VL G G  G V+  +  SG D R +  +  L    + +  +      
Sbjct: 18  HEKADPSQFELLKVL-GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 827 ---ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              + E+ H  IVK +        L+L+ ++L  G L T LS E    E D       + 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLA 133
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +A AL ++H      I++RD+  + +LLD E    ++DFG +K             GT 
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 944 GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            Y+APE+       +  D ++FGVL+ E++ G  P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/270 (20%), Positives = 123/270 (45%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V E +E GSL + L      A+    + V +++G+A+ + Y+        
Sbjct: 114  VVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSD---MGA 168
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGT--CGYIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 169  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 229  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 274
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 275  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 31/262 (11%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G V+          A+K L           Q+  V  + ++RH  +V+ Y   S 
Sbjct: 193  GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV--MKKLRHEKLVQLYAVVSE 250
Query: 845  TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRD 904
             + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +HRD
Sbjct: 251  -EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 305
Query: 905  ISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKCDVF 963
            + +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K DV+
Sbjct: 306  LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 964  NFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLPPPLGEVEEKL 1018
            +FG+L+ E+  +G+  +PG               +N  V D ++   R+P P  E  E L
Sbjct: 366  SFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCP-PECPESL 410
Query: 1019 KSMIAVAFLCLDANPDCRPTMQ 1040
              ++     C    P+ RPT +
Sbjct: 411  HDLMC---QCWRKEPEERPTFE 429

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 31/262 (11%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G V+          A+K L           Q+  V  + ++RH  +V+ Y   S 
Sbjct: 193  GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV--MKKLRHEKLVQLYAVVSE 250
Query: 845  TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRD 904
             + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +HRD
Sbjct: 251  -EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 305
Query: 905  ISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKCDVF 963
            + +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K DV+
Sbjct: 306  LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 964  NFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLPPPLGEVEEKL 1018
            +FG+L+ E+  +G+  +PG               +N  V D ++   R+P P  E  E L
Sbjct: 366  SFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCP-PECPESL 410
Query: 1019 KSMIAVAFLCLDANPDCRPTMQ 1040
              ++     C    P+ RPT +
Sbjct: 411  HDLMC---QCWRKEPEERPTFE 429

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 785 GTGGCGTVYKAE---LTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKF 838
           G G  G V+ AE   L+    + +  + +L    +   +K F  E   +T ++H +IVKF
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVKF 82
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAA-------------ELDWSKRVNVIKGV 885
           YG C     L +V+EY++ G L   L      A             EL  S+ +++   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---- 941
           A+ + Y+    F   +HRD++++  L+       + DFG ++ +   S+++  + G    
Sbjct: 143 ASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGHTML 197
Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
              ++ PE     +   + DV++FGV++ E+   GK P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 56/270 (20%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     + +   + +L  G     ++ F+ E +   +  H NI++  G
Sbjct: 25   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 84
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V E +E GSL + L      A+    + V +++G+A+ + Y+    +   
Sbjct: 85   VVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY--- 139
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + +PE     +  
Sbjct: 140  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP+    +
Sbjct: 200  SASDVWSYGIVLWEVMSYGERP----------YWEMSNQDVIKAVDEGYRLPPPM----D 245
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C   + + RP  +++ ++L
Sbjct: 246  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 779 GKMVLHGTGGCGTVYKAEL----TSGDTRAVK-----KLHSLPT-GEIGINQKGFVSEIT 828
           G  VL  T G GT  K ++     +G   AVK     K+ SL   G+I    K  +  + 
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI----KREIQNLK 66
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
             RH +I+K Y   S     F+V EY+  G L   +       E++  +   + + + +A
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSA 123
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
           + Y H      ++HRD+  + VLLD    A ++DFG +  +  D     +  G+  Y AP
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYAAP 179
Query: 949 E-LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E ++  + A  + D+++ GV++  ++ G  P
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSL-PTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
           G+G  GTVYK +   GD  AVK L  + PT E     +  V+ + + RH NI+ F G+ +
Sbjct: 45  GSGSFGTVYKGKW-HGDV-AVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              +L +V ++ E  SL   L  + T  ++   + +++ +  A  + Y+H      I+HR
Sbjct: 103 -KDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---IIHR 156
Query: 904 DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPELAYTMRAN 957
           D+ S  + L       + DFG A       S WS      +  G+  ++APE+      N
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATV----KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 958 E---KCDVFNFGVLVLEVIEGKHP 978
               + DV+++G+++ E++ G+ P
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           V  + ++ H NI+K Y F     + +LV E    G L   + +    +E+D ++   +I+
Sbjct: 83  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIR 139
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSELA 940
            V + ++YMH +    I+HRD+  + +LL+ + K     + DFG +   +  S    +  
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKI 195
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT  YIAPE+ +    +EKCDV++ GV++  ++ G  P
Sbjct: 196 GTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPP 232

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 31/262 (11%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G V+          A+K L           Q+  V  + ++RH  +V+ Y   S 
Sbjct: 193  GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQV--MKKLRHEKLVQLYAVVSE 250
Query: 845  TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRD 904
             + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +HRD
Sbjct: 251  -EPIYIVGEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 305
Query: 905  ISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKCDVF 963
            + +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K DV+
Sbjct: 306  LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 964  NFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLPPPLGEVEEKL 1018
            +FG+L+ E+  +G+  +PG               +N  V D ++   R+P P  E  E L
Sbjct: 366  SFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCP-PECPESL 410
Query: 1019 KSMIAVAFLCLDANPDCRPTMQ 1040
              ++     C    P+ RPT +
Sbjct: 411  HDLMC---QCWRKEPEERPTFE 429

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 58/270 (21%), Positives = 120/270 (44%), Gaps = 27/270 (10%)
Query: 785  GTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     R +   + +L  G     ++ F+ E +   +  H NI+   G
Sbjct: 31   GAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEG 90
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              + ++ + +V EY+E GSL T L  +    +    + V +++G++  + Y+    +   
Sbjct: 91   VVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYLSDMGY--- 145
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + APE     +  
Sbjct: 146  VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLP P+    +
Sbjct: 206  SASDVWSYGIVMWEVVSYGERP----------YWEMTNQDVIKAVEEGYRLPSPM----D 251
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               ++  +   C     + RP   ++ N+L
Sbjct: 252  CPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G VY A E  S    A+K L      + G+  +    EI     + H NI++ Y 
Sbjct: 32  GKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ-LRREIEIQAHLHHPNILRLYN 90
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
           +    + ++L+ EY  RG L   L    T    D  +   +++ +A+AL Y H      +
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELADALMYCHGK---KV 144
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRDI  + +LL L+ +  ++DFG +  +   S     + GT  Y+ PE+      NEK 
Sbjct: 145 IHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D++  GVL  E++ G  P
Sbjct: 203 DLWCIGVLCYELLVGNPP 220

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 18  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 127
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPD---SSNWSELAGTCGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D   SS  S+      +  PE+    + + 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP--VRWSPPEVLMYSKFSS 185
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMP 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 124/302 (41%), Gaps = 48/302 (15%)
Query: 771  LLSASTFEGKMVLHGTGGCGTVYKAELTSGDTR--AVKKLH------SLPTGEI----GI 818
            L  AS FE   VL G G  G V KA   + D+R  A+KK+       S    E+     +
Sbjct: 2    LRYASDFEEIAVL-GQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 819  NQKGFVSEITE-IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK 877
            N +  V      +  RN VK          LF+  EY E  +L  ++ +E    + D   
Sbjct: 60   NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 878  RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-------FLK 930
            R+   + +  ALSY+H      I+HRD+    + +D      + DFG AK        LK
Sbjct: 120  RL--FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 931  PD-------SSNWSELAGTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFX 982
             D       S N +   GT  Y+A E L  T   NEK D+++ G++  E+I   +P    
Sbjct: 175  LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTG 231
Query: 983  XXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                       +++I          PP     + K+K    +  L +D +P+ RP  + +
Sbjct: 232  MERVNILKKLRSVSI--------EFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTL 281
Query: 1043 CN 1044
             N
Sbjct: 282  LN 283

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLH----SLPTGEIGINQKGFVSEITEIRHRNIVKFY 839
           G+G  G V+  E  +SG  R +K ++     +P  +I    +  +  +  + H NI+K +
Sbjct: 31  GSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI----EAEIEVLKSLDHPNIIKIF 86
Query: 840 GFCSHTQHLFLVYEYLERGS-LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                  ++++V E  E G  L  I+S +A    L       ++K + NAL+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143
Query: 899 PILHRDISSKKVLLDLEYKAH----VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            ++H+D+  + +L   +   H    + DFG A+  K D  + +  AGT  Y+APE+ +  
Sbjct: 144 HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPEV-FKR 200
Query: 955 RANEKCDVFNFGVLVLEVIEGKHP 978
               KCD+++ GV++  ++ G  P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 779 GKMVLHGTGGCGTVYKAEL----TSGDTRAVK-----KLHSLPT-GEIGINQKGFVSEIT 828
           G  VL  T G GT  K ++     +G   AVK     K+ SL   G+I    K  +  + 
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI----KREIQNLK 66
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
             RH +I+K Y   S     F+V EY+  G L   +       E++  +   + + + +A
Sbjct: 67  LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSA 123
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---Y 945
           + Y H      ++HRD+  + VLLD    A ++DFG +  +    S+   L  +CG   Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRTSCGSPNY 176
Query: 946 IAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            APE ++  + A  + D+++ GV++  ++ G  P
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 20   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +
Sbjct: 75   VSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---V 129
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 130  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 190  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 233
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C    P+ RPT +
Sbjct: 234  PESLHDLMC---QCWRKEPEERPTFE 256

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 24  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 133
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D   ++   G+     +  PE+    + + 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMP 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 17  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 126
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D   ++   G+     +  PE+    + + 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 18  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 127
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D   ++   G+     +  PE+    + + 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMP 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 33  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 142
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D    S   G+     +  PE+    + + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSS--VGSKFPVRWSPPEVLMYSKFSS 200
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 33  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 142
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D   ++   G+     +  PE+    + + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           GTG  G V   +       A+K +      E  +++  F+ E   +  + H  +V+ YG 
Sbjct: 13  GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
           C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQF---L 122
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPELAYTMRANE 958
           HRD++++  L++ +    VSDFG ++++  D   ++   G+     +  PE+    + + 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 959 KCDVFNFGVLVLEVIE-GKHP 978
           K D++ FGVL+ E+   GK P
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMP 201

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 2/204 (0%)
Query: 160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN-Q 218
           S   + LH N  S V   S    +NLT ++L++N + G   +    L  L  L L+ N Q
Sbjct: 32  SSQRIFLHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQ 91
Query: 219 LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
           L    P T   L +L  L+L    L    P       +L YLYL  N L     ++F +L
Sbjct: 92  LRVVDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDL 151
Query: 279 SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
            +L HL +H  N++          L SL  L L +  ++   P +  +L  +  LY+  N
Sbjct: 152 GNLTHLFLHG-NRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFAN 210
Query: 339 MLYGSIPEELGRLKSLSQLSLSVN 362
            L     E L  L+SL  L L+ N
Sbjct: 211 NLSMLPAEVLVPLRSLQYLRLNDN 234

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 4/204 (1%)
Query: 236 LYLHDNRLSGYIP-PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
           ++LH NR+S Y+P     S ++L  L+L  N L G   ++F  L+ L+ L + +  +L  
Sbjct: 36  IFLHGNRIS-YVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRV 94
Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR-LKS 353
             P     L  L  L L +  L    P     L+ ++ LY+++N L  ++P+   R L +
Sbjct: 95  VDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQ-ALPDNTFRDLGN 153
Query: 354 LSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFT 413
           L+ L L  N++     H    L +L    L +N ++   P    ++ +L    LF N  +
Sbjct: 154 LTHLFLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLS 213
Query: 414 GYLPQNVCQSGSLTHFSVRNNNFV 437
               + +    SL +  + +N +V
Sbjct: 214 MLPAEVLVPLRSLQYLRLNDNPWV 237

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 62/273 (22%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAV-KKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     R +   + +L  G     ++ F+SE +   +  H NI+   G
Sbjct: 17   GVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  + + ++ EY+E GSL   L            + V +++G+ + + Y+    +   
Sbjct: 77   VVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY--- 131
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + APE     +  
Sbjct: 132  VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 191
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP      
Sbjct: 192  SASDVWSYGIVMWEVMSYGERP----------YWDMSNQDVIKAIEEGYRLPPP------ 235
Query: 1017 KLKSMIAVAFLCLDA---NPDCRPTMQKVCNLL 1046
             +   IA+  L LD        RP   ++ N+L
Sbjct: 236  -MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 62/273 (22%), Positives = 118/273 (43%), Gaps = 33/273 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAV-KKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     R +   + +L  G     ++ F+SE +   +  H NI+   G
Sbjct: 23   GVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEG 82
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  + + ++ EY+E GSL   L            + V +++G+ + + Y+    +   
Sbjct: 83   VVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY--- 137
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + APE     +  
Sbjct: 138  VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 197
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP      
Sbjct: 198  SASDVWSYGIVMWEVMSYGERP----------YWDMSNQDVIKAIEEGYRLPPP------ 241
Query: 1017 KLKSMIAVAFLCLDA---NPDCRPTMQKVCNLL 1046
             +   IA+  L LD        RP   ++ N+L
Sbjct: 242  -MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 24   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +
Sbjct: 79   VSE-EPIYIVTEYMNKGSLLDFLKGE-TGKYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 134  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 194  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 237
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C    P+ RPT +
Sbjct: 238  PESLHDLMC---QCWRKEPEERPTFE 260

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 766 VNNQELLSASTFEGKMVLHGTGGCGTVY--KAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           V +   + +  ++G+ VL G G  G V   K ++T G   AVK +      +   +++  
Sbjct: 17  VQHSTAIFSDRYKGQRVL-GKGSFGEVILCKDKIT-GQECAVKVISKRQVKQ-KTDKESL 73
Query: 824 VSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
           + E+    ++ H NI+K Y F     + +LV E    G L   + +    +E+D ++   
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--- 130
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWS 937
           +I+ V + ++YMH +    I+HRD+  + +LL+ + K     + DFG +   +  S    
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMK 186
Query: 938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +  GT  YIAPE+ +    +EKCDV++ GV++  ++ G  P
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + +IRH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 828 TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
           + +RH NI++ Y +    + ++L+ E+  RG L   L         D  +    ++ +A+
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELAD 125
Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
           AL Y H      ++HRDI  + +L+  + +  ++DFG +  +   S     + GT  Y+ 
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLP 180
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           PE+      +EK D++  GVL  E + G  P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSL----PTGEIGINQK--GFVSEI---TEIRHRNI 835
           G GG G V+K  L     ++V  + SL      GE  + +K   F  E+   + + H NI
Sbjct: 28  GKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
           VK YG   +   +  V E++  G L   L ++A    + WS ++ ++  +A  + YM + 
Sbjct: 86  VKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQ 141
Query: 896 CFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
             PPI+HRD+ S  + L     +    A V+DFGT+   +    + S L G   ++APE 
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGLLGNFQWMAPET 197
Query: 951 --AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             A      EK D ++F +++  ++ G+ P
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 828 TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
           + +RH NI++ Y +    + ++L+ E+  RG L   L         D  +    ++ +A+
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELAD 126
Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
           AL Y H      ++HRDI  + +L+  + +  ++DFG +  +   S     + GT  Y+ 
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLP 181
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           PE+      +EK D++  GVL  E + G  P
Sbjct: 182 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 126/266 (47%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+++  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 766 VNNQELLSASTFEGKMVLHGTGGCGTVY--KAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           V +   + +  ++G+ VL G G  G V   K ++T G   AVK +      +   +++  
Sbjct: 40  VQHSTAIFSDRYKGQRVL-GKGSFGEVILCKDKIT-GQECAVKVISKRQVKQ-KTDKESL 96
Query: 824 VSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
           + E+    ++ H NI+K Y F     + +LV E    G L   + +    +E+D ++   
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--- 153
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWS 937
           +I+ V + ++YMH +    I+HRD+  + +LL+ + K     + DFG +   +  S    
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMK 209
Query: 938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +  GT  YIAPE+ +    +EKCDV++ GV++  ++ G  P
Sbjct: 210 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 766 VNNQELLSASTFEGKMVLHGTGGCGTVY--KAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           V +   + +  ++G+ VL G G  G V   K ++T G   AVK +      +   +++  
Sbjct: 41  VQHSTAIFSDRYKGQRVL-GKGSFGEVILCKDKIT-GQECAVKVISKRQVKQ-KTDKESL 97
Query: 824 VSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
           + E+    ++ H NI+K Y F     + +LV E    G L   + +    +E+D ++   
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--- 154
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWS 937
           +I+ V + ++YMH +    I+HRD+  + +LL+ + K     + DFG +   +  S    
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMK 210
Query: 938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +  GT  YIAPE+ +    +EKCDV++ GV++  ++ G  P
Sbjct: 211 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 772 LSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI 830
           L    FE   +L G G  G V+ AE   +    A+K L      ++ +        + E 
Sbjct: 15  LKIEDFELHKML-GKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDDDVECTMVEK 69
Query: 831 RHRNIVKFYGFCSH-------TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           R  ++   + F +H        ++LF V EYL  G L   + +  +  + D S+      
Sbjct: 70  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA 126
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +   L ++H      I++RD+    +LLD +    ++DFG  K      +  +E  GT 
Sbjct: 127 EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 944 GYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGH 980
            YIAPE+    + N   D ++FGVL+ E++ G+ P H
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 220

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVIEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQK--GFVSEITEIRHRNIVKFYGF 841
           G G    VY+AE + +G   A+K +      + G+ Q+    V    +++H +I++ Y +
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
              + +++LV E    G +   L N       + ++  + +  +   + Y+H      IL
Sbjct: 80  FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLHSH---GIL 134
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           HRD++   +LL       ++DFG A  LK        L GT  YI+PE+A       + D
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESD 194
Query: 962 VFNFGVLVLEVIEGKHP 978
           V++ G +   ++ G+ P
Sbjct: 195 VWSLGCMFYTLLIGRPP 211

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 58/260 (22%), Positives = 115/260 (44%), Gaps = 24/260 (9%)
Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G G  G VYK  +  + +  A+K +      +   + +  ++ +++     I +++G   
Sbjct: 28   GKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYL 87
Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
             +  L+++ EYL  GS   +L        L+ +    +++ +   L Y+H +     +HR
Sbjct: 88   KSTKLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSE---RKIHR 140
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVF 963
            DI +  VLL  +    ++DFG A  L       +   GT  ++APE+      + K D++
Sbjct: 141  DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIW 200
Query: 964  NFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPL-GEVEEKLKSMI 1022
            + G+  +E+ +G+ P                M ++   LI    PP L G+  +  K  +
Sbjct: 201  SLGITAIELAKGEPPN----------SDLHPMRVLF--LIPKNSPPTLEGQHSKPFKEFV 248
Query: 1023 AVAFLCLDANPDCRPTMQKV 1042
                 CL+ +P  RPT +++
Sbjct: 249  EA---CLNKDPRFRPTAKEL 265

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 41/167 (24%), Positives = 83/167 (49%), Gaps = 20/167 (11%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL----------ATILSNEATAAELDWS 876
           +T ++H +IVKFYG C     L +V+EY++ G L          A +++      EL  S
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
           + +++ + +A  + Y+    F   +HRD++++  L+       + DFG ++ +   S+++
Sbjct: 129 QMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDY 183
Query: 937 SELAG----TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
             + G       ++ PE     +   + DV++ GV++ E+   GK P
Sbjct: 184 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 777 FEGKMVLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRH 832
           FE K  L GTG    V  AE   +G   AVK    +P   +   +    +EI    +I+H
Sbjct: 24  FEFKETL-GTGAFSEVVLAEEKATGKLFAVK---CIPKKALKGKESSIENEIAVLRKIKH 79
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
            NIV          HL+LV + +  G L   +  +    E D S    +I+ V +A+ Y+
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAVYYL 136
Query: 893 HHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           H      I+HRD+  + +L    D E K  +SDFG +K ++      S   GT GY+APE
Sbjct: 137 HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPE 192
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +      ++  D ++ GV+   ++ G  P
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 123/265 (46%), Gaps = 37/265 (13%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G   ++ + F+ E   + ++RH  +V+ Y  
Sbjct: 194  GQGCFGEVWMGTW-NGTTRVAIK--TLKPG--NMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 249  VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 303
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG  + ++ +     + A     + APE A   R   K 
Sbjct: 304  HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLPPPLGEVE 1015
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P P  E  
Sbjct: 364  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCP-PECP 408
Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQ 1040
            E L  ++     C   +P+ RPT +
Sbjct: 409  ESLHDLMC---QCWRKDPEERPTFE 430

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVIEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 17   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + + +V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +
Sbjct: 72   VSE-EPIXIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---V 126
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 127  HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 187  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 230
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C    P+ RPT +
Sbjct: 231  PESLHDLMC---QCWRKEPEERPTFE 253

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 16   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 71   VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 125
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 126  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 186  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 229
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 230  PESLHDLMC---QCWRKDPEERPTFE 252

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 18   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 73   VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 127
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 128  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 188  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 231
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 232  PESLHDLMC---QCWRKDPEERPTFE 254

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 62/273 (22%), Positives = 117/273 (42%), Gaps = 33/273 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAV-KKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V    L     R +   + +L  G     ++ F+SE +   +  H NI+   G
Sbjct: 38   GVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEG 97
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              +  + + ++ EY+E GSL   L            + V +++G+ + + Y+        
Sbjct: 98   VVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSA 152
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-SSNWSELAGTCG--YIAPELAYTMRAN 957
            +HRD++++ +L++      VSDFG ++ L+ D  + ++   G     + APE     +  
Sbjct: 153  VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 212
Query: 958  EKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
               DV+++G+++ EV+  G+ P               N +++       RLPPP      
Sbjct: 213  SASDVWSYGIVMWEVMSYGERP----------YWDMSNQDVIKAIEEGYRLPPP------ 256
Query: 1017 KLKSMIAVAFLCLDA---NPDCRPTMQKVCNLL 1046
             +   IA+  L LD        RP   ++ N+L
Sbjct: 257  -MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 37  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 92
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 149
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 150 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A++  D++  G ++ +++ G  P
Sbjct: 207 TEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVCEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 37  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 92
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 149
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 150 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 207 TEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 46/242 (19%)
Query: 759 SQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIG 817
           + E   D++N +LL          L G G  G VYK  L   D R V  K+ S    +  
Sbjct: 5   ASEPSLDLDNLKLLE---------LIGRGRYGAVYKGSL---DERPVAVKVFSFANRQNF 52
Query: 818 INQKGFVSEITEIRHRNIVKFYG-----FCSHTQHLFLVYEYLERGSLATILSNEATAAE 872
           IN+K  +  +  + H NI +F                LV EY   GSL   LS   +   
Sbjct: 53  INEKN-IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--- 108
Query: 873 LDWSKRVNVIKGVANALSYMHHDC------FPPILHRDISSKKVLLDLEYKAHVSDFGTA 926
            DW     +   V   L+Y+H +        P I HRD++S+ VL+  +    +SDFG +
Sbjct: 109 -DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 927 ------KFLKP---DSSNWSELAGTCGYIAPEL---AYTMRANE----KCDVFNFGVLVL 970
                 + ++P   D++  SE+ GT  Y+APE+   A  +R  E    + D++  G++  
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 971 EV 972
           E+
Sbjct: 227 EI 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 38  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 93
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 150
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 151 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 34  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 89
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 146
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 147 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 268  GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 323  VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 378
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HR+++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 379  IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 435
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 436  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 482
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 483  CPEKVYELMRA----CWQWNPSDRPSFAEI 508

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGFC 842
           G G  G VYKA+ + G   A+K++  L   + GI       +S + E+ H NIV      
Sbjct: 30  GEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 843 SHTQHLFLVYEYLERGSLATILSNEATAAELDWSK--RVNVIKGVANALSYMHHDCFPPI 900
              + L LV+E++E+  L  +L    T  +    K     +++GVA+   + H      I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC--HQHR-----I 140
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEK 959
           LHRD+  + +L++ +    ++DFG A+       +++    T  Y AP+ L  + + +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 960 CDVFNFGVLVLEVIEGK 976
            D+++ G +  E+I GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 27   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 82   VCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 194
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 195  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 241
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 242  CPEKVYELMRA----CWQWNPSDRPSFAEI 267

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSL----PTGEIGINQK--GFVSEI---TEIRHRNI 835
           G GG G V+K  L     ++V  + SL      GE  + +K   F  E+   + + H NI
Sbjct: 28  GKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
           VK YG   +   +  V E++  G L   L ++A    + WS ++ ++  +A  + YM + 
Sbjct: 86  VKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQ 141
Query: 896 CFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
             PPI+HRD+ S  + L     +    A V+DFG +   +    + S L G   ++APE 
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNFQWMAPET 197
Query: 951 --AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             A      EK D ++F +++  ++ G+ P
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 42  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 97
Query: 834 NIVKFYGFC-SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
             VK Y FC    + L+    Y + G L   +         D +        + +AL Y+
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYL 153
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPEL 950
           H      I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL
Sbjct: 154 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 951 AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                A +  D++  G ++ +++ G  P
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGFC 842
           G G  G VYKA+ + G   A+K++  L   + GI       +S + E+ H NIV      
Sbjct: 30  GEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 843 SHTQHLFLVYEYLERGSLATILSNEATAAELDWSK--RVNVIKGVANALSYMHHDCFPPI 900
              + L LV+E++E+  L  +L    T  +    K     +++GVA+   + H      I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC--HQHR-----I 140
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEK 959
           LHRD+  + +L++ +    ++DFG A+       +++    T  Y AP+ L  + + +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 960 CDVFNFGVLVLEVIEGK 976
            D+++ G +  E+I GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 27   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 82   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 194
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 195  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 241
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 242  CPEKVYELMRA----CWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 35   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 90   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 145
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 146  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 202
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 203  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 249
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 250  CPEKVYELMRA----CWQWNPSDRPSFAEI 275

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 27   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 82   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 194
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 195  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 241
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 242  CPEKVYELMRA----CWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 189
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 190  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 236
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 26   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 81   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 136
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 137  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 193
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 194  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 240
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 241  CPEKVYELMRA----CWQWNPSDRPSFAEI 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 189
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 190  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 236
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 24   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 79   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 134
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 135  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 191
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 192  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 238
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 239  CPEKVYELMRA----CWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 24   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 79   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 134
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 135  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 191
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 192  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 238
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 239  CPEKVYELMRA----CWQWNPSDRPSFAEI 264

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 124/302 (41%), Gaps = 48/302 (15%)
Query: 771  LLSASTFEGKMVLHGTGGCGTVYKAELTSGDTR--AVKKLH------SLPTGEI----GI 818
            L  AS FE   VL G G  G V KA   + D+R  A+KK+       S    E+     +
Sbjct: 2    LRYASDFEEIAVL-GQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVXLLASL 59
Query: 819  NQKGFVSEITE-IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK 877
            N +  V      +  RN VK          LF+  EY E  +L  ++ +E    + D   
Sbjct: 60   NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 878  RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-------FLK 930
            R+   + +  ALSY+H      I+HR++    + +D      + DFG AK        LK
Sbjct: 120  RL--FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 931  PD-------SSNWSELAGTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFX 982
             D       S N +   GT  Y+A E L  T   NEK D ++ G++  E I   +P    
Sbjct: 175  LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTG 231
Query: 983  XXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                       +++I          PP   + + K++  I    L +D +P+ RP  + +
Sbjct: 232  XERVNILKKLRSVSI--------EFPPDFDDNKXKVEKKIIR--LLIDHDPNKRPGARTL 281
Query: 1043 CN 1044
             N
Sbjct: 282  LN 283

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 23   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 78   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 133
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 134  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESLAYN-KF 190
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 191  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 237
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 238  CPEKVYELMRA----CWQWNPSDRPSFAEI 263

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 14/194 (7%)
Query: 791 TVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHRNIVKFYGFCSHTQ 846
           TV   EL +    A+K L       I  N+  +V+     ++ + H   VK Y      +
Sbjct: 46  TVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 103
Query: 847 HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDIS 906
            L+    Y + G L   +         D +        + +AL Y+H      I+HRD+ 
Sbjct: 104 KLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLK 157
Query: 907 SKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELAYTMRANEKCDVFN 964
            + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL     A +  D++ 
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWA 217
Query: 965 FGVLVLEVIEGKHP 978
            G ++ +++ G  P
Sbjct: 218 LGCIIYQLVAGLPP 231

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NI+K Y F    ++ +LV E  + G L   + +     E+D +    +IK V + +
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQVLSGV 149
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           +Y+H      I+HRD+  + +LL+ + K     + DFG +   + +     E  GT  YI
Sbjct: 150 TYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYI 205
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+    + +EKCDV++ GV++  ++ G  P
Sbjct: 206 APEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 24   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 79   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 134
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 135  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKFPIKWTAPESLAYN-KF 191
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 192  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 238
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 239  CPEKVYELMRA----CWQWNPSDRPSFAEI 264

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 37  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 92
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 149
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 150 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 12  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 67
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 124
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 125 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 182 TEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 35  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 90
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 147
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 148 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 14  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 69
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 126
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 127 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 184 TEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 37  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 92
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 149
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 150 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 13  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 68
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 125
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 126 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 35  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 90
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 147
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 148 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 37  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 92
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 149
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 150 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 19  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 74
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 131
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 132 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 189 TEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 34  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 89
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 146
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 147 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 204 TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 38  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 93
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 150
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 151 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 208 TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 37  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 92
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 149
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 150 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 207 TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 15  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 70
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 127
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 128 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 185 TEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 40  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 95
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 152
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 153 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 210 TEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHR 833
           GK++  G G   TV  A EL +    A+K L       I  N+  +V+     ++ + H 
Sbjct: 35  GKIL--GEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHP 90
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
             VK Y      + L+    Y + G L   +         D +        + +AL Y+H
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH 147
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELA 951
                 I+HRD+  + +LL+ +    ++DFGTAK L P+S  +  +   GT  Y++PEL 
Sbjct: 148 GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 952 YTMRANEKCDVFNFGVLVLEVIEGKHP 978
               A +  D++  G ++ +++ G  P
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +G L   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVMEYMSKGCLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 189
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 190  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 236
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 189
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 190  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 236
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEI 262

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 39/266 (14%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+     +G TR   K  +L  G +  + + F+ E   + ++RH  +V+ Y  
Sbjct: 27   GQGCFGEVWMGTW-NGTTRVAIK--TLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +G L   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 82   VSE-EPIYIVTEYMSKGCLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 961  DVFNFGVLVLEV-IEGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDS--RLP-PPLGEV 1014
            DV++FG+L+ E+  +G+  +PG               +N  V D ++   R+P PP  E 
Sbjct: 197  DVWSFGILLTELTTKGRVPYPGM--------------VNREVLDQVERGYRMPCPP--EC 240
Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQ 1040
             E L  ++     C   +P+ RPT +
Sbjct: 241  PESLHDLMC---QCWRKDPEERPTFE 263

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 8/142 (5%)
Query: 841 FCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
           FC+    ++LF V EYL  G L   + +  +  + D S+       +   L ++H     
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--- 137
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            I++RD+    +LLD +    ++DFG  K      +  +   GT  YIAPE+    + N 
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNH 197
Query: 959 KCDVFNFGVLVLEVIEGKHPGH 980
             D ++FGVL+ E++ G+ P H
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFH 219

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 189
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 190  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 236
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 189
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 190  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 236
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 27   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 82   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 194
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 195  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 241
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 242  CPEKVYELMRA----CWQWNPSDRPSFAEI 267

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATA-----AELDWSKR 878
            V+ +  ++H NIV++         L++V +Y E G L   ++ +          LDW  +
Sbjct: 74   VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 879  VNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
            + +      AL ++H      ILHRDI S+ + L  +    + DFG A+ L         
Sbjct: 134  ICL------ALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 939  LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIV 998
              GT  Y++PE+      N K D++  G ++ E+   KH                +M  +
Sbjct: 185  CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH-----------AFEAGSMKNL 233
Query: 999  VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            V  +I    PP        L+S+++  F     NP  RP++  +
Sbjct: 234  VLKIISGSFPPVSLHYSYDLRSLVSQLF---KRNPRDRPSVNSI 274

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 229  GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 284  VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 339
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HR+++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 340  IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-KF 396
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 397  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 443
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 444  CPEKVYELMRA----CWQWNPSDRPSFAEI 469

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 41  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +A A  +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 97  YLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 151
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 971 EVI 973
           E+ 
Sbjct: 212 ELF 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 779 GKMVLHGTGGCGT-----VYKAELTSGDTRAVKKLHSLPTGEIGI--NQKGFVSEITEIR 831
           G  +L  T G GT     V K ELT G   AVK L+      + +    +  +  +   R
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           H +I+K Y   S    +F+V EY+  G L   +        LD  +   + + + + + Y
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDY 131
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAP 948
            H      ++HRD+  + VLLD    A ++DFG +  +    S+   L  +CG   Y AP
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM----SDGEFLRXSCGSPNYAAP 184
Query: 949 E-LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E ++  + A  + D+++ GV++  ++ G  P
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVS-EIT---EIRHRNIVKFY 839
           G GG    +  E++  DT+ V     +P   +   +Q+  +S EI+    + H+++V F+
Sbjct: 26  GKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           GF      +F+V E   R SL  +        E +       ++ +     Y+H +    
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQYLHRN---R 137
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRD+    + L+ + +  + DFG A  ++ D      L GT  YIAPE+      + +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            DV++ G ++  ++ GK P
Sbjct: 198 VDVWSIGCIMYTLLVGKPP 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 826 EITEIR----HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV 881
           EIT ++    H NIVK +       H FLV E L  G L   +  +   +E + S    +
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---YI 111
Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNW 936
           ++ + +A+S+MH      ++HRD+  + +L      +LE K  + DFG A+   PD+   
Sbjct: 112 MRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIK--IIDFGFARLKPPDNQPL 166
Query: 937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                T  Y APEL      +E CD+++ GV++  ++ G+ P
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 23   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 78   VCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 133
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+   +  AG      + APE LAY  + 
Sbjct: 134  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESLAYN-KF 190
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 191  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 237
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 238  CPEKVYELMRA----CWQWNPSDRPSFAEI 263

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVS-EIT---EIRHRNIVKFY 839
           G GG    +  E++  DT+ V     +P   +   +Q+  +S EI+    + H+++V F+
Sbjct: 26  GKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           GF      +F+V E   R SL  +        E +       ++ +     Y+H +    
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQYLHRN---R 137
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRD+    + L+ + +  + DFG A  ++ D      L GT  YIAPE+      + +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            DV++ G ++  ++ GK P
Sbjct: 198 VDVWSIGCIMYTLLVGKPP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVS-EIT---EIRHRNIVKFY 839
           G GG    +  E++  DT+ V     +P   +   +Q+  +S EI+    + H+++V F+
Sbjct: 30  GKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           GF      +F+V E   R SL  +        E +       ++ +     Y+H +    
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQYLHRN---R 141
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRD+    + L+ + +  + DFG A  ++ D      L GT  YIAPE+      + +
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            DV++ G ++  ++ GK P
Sbjct: 202 VDVWSIGCIMYTLLVGKPP 220

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 41/270 (15%)
Query: 785  GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
            G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 27   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E++    + +   +++A+ Y+    F   
Sbjct: 82   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF--- 137
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
            +HRD++++  L+   +   V+DFG ++ +  D+   +  AG      + APE LAY  + 
Sbjct: 138  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESLAYN-KF 194
Query: 957  NEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDL-IDSRLPPPLG 1012
            + K DV+ FGVL+ E+       +PG              +++ V   L  D R+  P G
Sbjct: 195  SIKSDVWAFGVLLWEIATYGMSPYPG-------------IDLSQVYELLEKDYRMERPEG 241
Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              E+  + M A    C   NP  RP+  ++
Sbjct: 242  CPEKVYELMRA----CWQWNPSDRPSFAEI 267

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 800 GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH-LFLVYEYLERG 858
           G+  AVK + +  T +  + +    S +T++RH N+V+  G     +  L++V EY+ +G
Sbjct: 29  GNKVAVKCIKNDATAQAFLAE---ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85
Query: 859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA 918
           SL   L +   +  L     +     V  A+ Y+  + F   +HRD++++ VL+  +  A
Sbjct: 86  SLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVA 141
Query: 919 HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            VSDFG     K  SS          + APE     + + K DV++FG+L+ E+
Sbjct: 142 KVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 800 GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH-LFLVYEYLERG 858
           G+  AVK + +  T +  + +    S +T++RH N+V+  G     +  L++V EY+ +G
Sbjct: 44  GNKVAVKCIKNDATAQAFLAE---ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100
Query: 859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA 918
           SL   L +   +  L     +     V  A+ Y+  + F   +HRD++++ VL+  +  A
Sbjct: 101 SLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVA 156
Query: 919 HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            VSDFG     K  SS          + APE     + + K DV++FG+L+ E+
Sbjct: 157 KVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 785 GTGGCGTVYKAELTSGDT-RAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
           G G  G V+   L + +T  AVK        ++   +  F+ E   + +  H NIV+  G
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLIG 179
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            C+  Q +++V E ++ G   T L  E   A L     + ++   A  + Y+   C    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-----TCGYIAPELAYTMR 955
           +HRD++++  L+  +    +SDFG +   + ++      +G        + APE     R
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS---REEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 956 ANEKCDVFNFGVLVLEVI 973
            + + DV++FG+L+ E  
Sbjct: 292 YSSESDVWSFGILLWETF 309

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 22/167 (13%)
Query: 824 VSEITEIRHRNIVKFYGF----CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV 879
           V  +  ++H NI++F G      S    L+L+  + E+GSL+  L     A  + W++  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELC 124
Query: 880 NVIKGVANALSYMHHDC-------FPPILHRDISSKKVLLDLEYKAHVSDFGTA-KFLKP 931
           ++ + +A  L+Y+H D         P I HRDI SK VLL     A ++DFG A KF   
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 932 DSSNWSE-LAGTCGYIAPE-----LAYTMRANEKCDVFNFGVLVLEV 972
            S+  +    GT  Y+APE     + +   A  + D++  G+++ E+
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVS-EIT---EIRHRNIVKFY 839
           G GG    +  E++  DT+ V     +P   +   +Q+  +S EI+    + H+++V F+
Sbjct: 50  GKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           GF      +F+V E   R SL  +        E +       ++ +     Y+H +    
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQYLHRN---R 161
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRD+    + L+ + +  + DFG A  ++ D      L GT  YIAPE+      + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            DV++ G ++  ++ GK P
Sbjct: 222 VDVWSIGCIMYTLLVGKPP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVS-EIT---EIRHRNIVKFY 839
           G GG    +  E++  DT+ V     +P   +   +Q+  +S EI+    + H+++V F+
Sbjct: 48  GKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           GF      +F+V E   R SL  +        E +       ++ +     Y+H +    
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQYLHRN---R 159
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRD+    + L+ + +  + DFG A  ++ D      L GT  YIAPE+      + +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            DV++ G ++  ++ GK P
Sbjct: 220 VDVWSIGCIMYTLLVGKPP 238

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           ++ + +I+H NIV          HL+L+ + +  G L   +  +    E D S+   +I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVL---LDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
            V +A+ Y+H      I+HRD+  + +L   LD + K  +SDFG +K   P S   S   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-LSTAC 179
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+      ++  D ++ GV+   ++ G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           ++ + +I+H NIV          HL+L+ + +  G L   +  +    E D S+   +I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVL---LDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
            V +A+ Y+H      I+HRD+  + +L   LD + K  +SDFG +K   P S   S   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-LSTAC 179
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+      ++  D ++ GV+   ++ G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           ++ + +I+H NIV          HL+L+ + +  G L   +  +    E D S+   +I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVL---LDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
            V +A+ Y+H      I+HRD+  + +L   LD + K  +SDFG +K   P S   S   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-LSTAC 179
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+      ++  D ++ GV+   ++ G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           ++ + +I+H NIV          HL+L+ + +  G L   +  +    E D S+   +I 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIF 123
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVL---LDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
            V +A+ Y+H      I+HRD+  + +L   LD + K  +SDFG +K   P S   S   
Sbjct: 124 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-LSTAC 179
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+      ++  D ++ GV+   ++ G  P
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 18/197 (9%)
Query: 785 GTGGCGTVYKAELTSGDT-RAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
           G G  G V+   L + +T  AVK        ++   +  F+ E   + +  H NIV+  G
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLIG 179
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            C+  Q +++V E ++ G   T L  E   A L     + ++   A  + Y+   C    
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG----TCGYIAPELAYTMRA 956
           +HRD++++  L+  +    +SDFG ++  +     ++   G       + APE     R 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 957 NEKCDVFNFGVLVLEVI 973
           + + DV++FG+L+ E  
Sbjct: 293 SSESDVWSFGILLWETF 309

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 20/196 (10%)
Query: 785 GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
           G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 20  GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 130
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
           +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG      + APE LAY  + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPESLAYN-KF 187
Query: 957 NEKCDVFNFGVLVLEV 972
           + K DV+ FGVL+ E+
Sbjct: 188 SIKSDVWAFGVLLWEI 203

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 766 VNNQELLSASTFEGKMVLHGTGGCGTVY--KAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           V +   + +  ++G+ VL G G  G V   K ++T G   AVK +      +   +++  
Sbjct: 17  VQHSTAIFSDRYKGQRVL-GKGSFGEVILCKDKIT-GQECAVKVISKRQVKQ-KTDKESL 73
Query: 824 VSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
           + E+    ++ H NI K Y F     + +LV E    G L   + +    +E+D ++   
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--- 130
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWS 937
           +I+ V + ++Y H +    I+HRD+  + +LL+ + K     + DFG +   +  S    
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKXK 186
Query: 938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +  GT  YIAPE+ +    +EKCDV++ GV++  ++ G  P
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 30   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 85   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 139
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 140  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 200  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 247
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 248  YQLM----RLCWKERPEDRPTFDYLRSVL 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 22   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 77   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 132  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 192  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 240  YQLM----RLCWKERPEDRPTFDYLRSVL 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 22   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 77   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 132  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 192  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 240  YQLM----RLCWKERPEDRPTFDYLRSVL 264

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 28   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 83   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 137
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 138  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 198  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 245
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 246  YQLM----RLCWKERPEDRPTFDYLRSVL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 23   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 78   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 132
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 133  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 193  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 240
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 241  YQLM----RLCWKERPEDRPTFDYLRSVL 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 24   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 79   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 133
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 134  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 194  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 241
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 242  YQLM----RLCWKERPEDRPTFDYLRSVL 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 31   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 86   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 140
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 141  HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 201  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 248
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 249  YQLM----RLCWKERPEDRPTFDYLRSVL 273

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
           + EI+H N+V+  G C+     ++V EY+  G+L   L  E    E+     + +   ++
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQIS 140
Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---C 943
           +A+ Y+    F   +HRD++++  L+   +   V+DFG ++ +  D+  ++  AG     
Sbjct: 141 SAMEYLEKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPI 195
Query: 944 GYIAPE-LAYTMRANEKCDVFNFGVLVLEV 972
            + APE LAY    + K DV+ FGVL+ E+
Sbjct: 196 KWTAPESLAYNT-FSIKSDVWAFGVLLWEI 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 48/199 (24%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G G  G V+     +    AVK   +L  G + +  + F+ E   +  ++H  +V+ Y  
Sbjct: 22  GAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYAV 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            +  + ++++ EY+ +GSL   L ++     L   K ++    +A  ++Y+    +   +
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---I 132
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
           HRD+ +  VL+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 961 DVFNFGVLVLEVIE-GKHP 978
           DV++FG+L+ E++  GK P
Sbjct: 193 DVWSFGILLYEIVTYGKIP 211

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 80/153 (52%), Gaps = 13/153 (8%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           H +I+        +  +FLV++ + +G L   L+ +   +E    +  ++++ +  A+S+
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEAVSF 215
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-L 950
           +H +    I+HRD+  + +LLD   +  +SDFG +  L+P      EL GT GY+APE L
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGTPGYLAPEIL 271
Query: 951 AYTMRAN-----EKCDVFNFGVLVLEVIEGKHP 978
             +M        ++ D++  GV++  ++ G  P
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 17/224 (7%)
Query: 827  ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV-NVIKGV 885
            + ++ H N++K+Y        L +V E  + G L+ ++ +      L   + V      +
Sbjct: 86   LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 886  ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY 945
             +AL +MH      ++HRDI    V +       + D G  +F    ++    L GT  Y
Sbjct: 146  CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202
Query: 946  IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDS 1005
            ++PE  +    N K D+++ G L+ E+   + P +             N+  +   +   
Sbjct: 203  MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---------GDKMNLYSLCKKIEQC 253
Query: 1006 RLPP-PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
              PP P     E+L+ ++    +C++ +P+ RP +  V ++  R
Sbjct: 254  DYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKR 294

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 785 GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
           G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 20  GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 130
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
           +HRD++++  L+   +   V+DFG ++ +  D+   +  AG      + APE LAY  + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESLAYN-KF 187
Query: 957 NEKCDVFNFGVLVLEV 972
           + K DV+ FGVL+ E+
Sbjct: 188 SIKSDVWAFGVLLWEI 203

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 785 GTGGCGTVY--KAELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
           G+G  G V   K +LT G  RA+K  K  S+ T     N    + E+    ++ H NI+K
Sbjct: 30  GSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTS---NSGALLDEVAVLKQLDHPNIMK 85
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDC 896
            Y F    ++ +LV E    G L   +      +E+D +    ++K V +  +Y+H H+ 
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHKHN- 141
Query: 897 FPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
              I+HRD+  + +LL+ + +     + DFG +   +       E  GT  YIAPE+   
Sbjct: 142 ---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV-LR 196
Query: 954 MRANEKCDVFNFGVLVLEVIEGKHP 978
            + +EKCDV++ GV++  ++ G  P
Sbjct: 197 KKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 785 GTGGCGTVYKAELTSGD-TRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYG 840
           G G  G VY+        T AVK L      E  +  + F+ E   + EI+H N+V+  G
Sbjct: 20  GGGQFGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 130
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT---CGYIAPE-LAYTMRA 956
           +HRD++++  L+   +   V+DFG ++ +  D+   +  AG      + APE LAY  + 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPESLAYN-KF 187
Query: 957 NEKCDVFNFGVLVLEV 972
           + K DV+ FGVL+ E+
Sbjct: 188 SIKSDVWAFGVLLWEI 203

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 109/371 (29%), Positives = 162/371 (43%), Gaps = 63/371 (16%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQ--------------------IGILTNLVVLRLSVNQ 83
           + +L+ L  ++FS NQ + I P +                    +  LTNL  L L  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 84  LNGLIPEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYL 143
           +  + P  L  LT+LN L LS N +   I A                        N   L
Sbjct: 119 ITDIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLSFSSNQVTDLKPLANLTTL 175
Query: 144 ----ISPHYG---SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI- 195
               IS +     S+   L NLES ++ +   N  S + P  LG L NL  + LN N++ 
Sbjct: 176 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITP--LGILTNLDELSLNGNQLK 230
Query: 196 -VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
            +G++ S    L +L+ L L  NQ+S  + P +G L+ L  L L  N++S   P  L   
Sbjct: 231 DIGTLAS----LTNLTDLDLANNQISN-LAPLSG-LTKLTELKLGANQISNISP--LAGL 282
Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
            +L  L L+ NQL    P    NL +L +L ++  N +S   P  + +L  L  L+ S  
Sbjct: 283 TALTNLELNENQLEDISP--ISNLKNLTYLTLY-FNNISDISP--VSSLTKLQRLFFSNN 337
Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLN 365
           ++S     SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N
Sbjct: 338 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 393
Query: 366 GSIPHCLGNLS 376
            SIP+ + N++
Sbjct: 394 VSIPNTVKNVT 404

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 120/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 22   GAGQAGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 77   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++       E A     + APE         K 
Sbjct: 132  HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 192  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 240  YQLM----RLCWKERPEDRPTFDYLRSVL 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 28   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 83   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 137
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 138  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 198  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 245
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 246  YQLM----RLCWKERPEDRPTFDYLRSVL 270

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 32   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 87   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 141
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 142  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 202  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 249
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 250  YQLM----RLCWKERPEDRPTFDYLRSVL 274

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 22   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 77   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 131
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 132  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 192  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 240  YQLM----RLCWKERPEDRPTFDYLRSVL 264

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 17   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 72   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 126
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 127  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 187  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 234
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 235  YQLM----RLCWKERPEDRPTFDYLRSVL 259

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/269 (23%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 27   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 82   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 136
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 137  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 197  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 244
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 245  YQLM----RLCWKERPEDRPTFDYLRSVL 269

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVS-EIT---EIRHRNIVKFY 839
           G GG    +  E++  DT+ V     +P   +   +Q+  +S EI+    + H+++V F+
Sbjct: 24  GKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
           GF      +F+V E   R SL  +        E +       ++ +     Y+H +    
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR---YYLRQIVLGCQYLHRN---R 135
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           ++HRD+    + L+ + +  + DFG A  ++ D      L GT  YIAPE+      + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            DV++ G ++  ++ GK P
Sbjct: 196 VDVWSIGCIMYTLLVGKPP 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 800 GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH-LFLVYEYLERG 858
           G+  AVK + +  T +  + +    S +T++RH N+V+  G     +  L++V EY+ +G
Sbjct: 216 GNKVAVKCIKNDATAQAFLAE---ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272
Query: 859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA 918
           SL   L +   +  L     +     V  A+ Y+  + F   +HRD++++ VL+  +  A
Sbjct: 273 SLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVA 328
Query: 919 HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            VSDFG     K  SS          + APE     + + K DV++FG+L+ E+
Sbjct: 329 KVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 11/174 (6%)
Query: 800 GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH-LFLVYEYLERG 858
           G+  AVK + +  T +  + +    S +T++RH N+V+  G     +  L++V EY+ +G
Sbjct: 35  GNKVAVKCIKNDATAQAFLAE---ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 91
Query: 859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA 918
           SL   L +   +  L     +     V  A+ Y+  + F   +HRD++++ VL+  +  A
Sbjct: 92  SLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVA 147
Query: 919 HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            VSDFG     K  SS          + APE       + K DV++FG+L+ E+
Sbjct: 148 KVSDFG---LTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSL----PTGEIGINQK--GFVSEI---TEIRHRNI 835
           G GG G V+K  L     ++V  + SL      GE  + +K   F  E+   + + H NI
Sbjct: 28  GKGGFGLVHKGRLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
           VK YG   +   +  V E++  G L   L ++A    + WS ++ ++  +A  + YM + 
Sbjct: 86  VKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQNQ 141
Query: 896 CFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
             PPI+HRD+ S  + L     +    A V+DF  +   +    + S L G   ++APE 
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGLLGNFQWMAPET 197
Query: 951 --AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             A      EK D ++F +++  ++ G+ P
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 20/232 (8%)
Query: 756 RTDSQEGQN-DVNNQELLSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT 813
           +  S+EG    VN+   L    FE   VL G G  G V  A +  +GD  AVK L     
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVL-GKGSFGKVMLARVKETGDLYAVKVLKK--- 58
Query: 814 GEIGINQKGFVSEITEIRHRNIVKFYGF------CSHT-QHLFLVYEYLERGSLATILSN 866
            ++ +        +TE R  ++ + + F      C  T   LF V E++  G L   +  
Sbjct: 59  -DVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK 117
Query: 867 EATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA 926
              +   D ++       + +AL ++H      I++RD+    VLLD E    ++DFG  
Sbjct: 118 ---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171
Query: 927 KFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           K    +    +   GT  YIAPE+   M      D +  GVL+ E++ G  P
Sbjct: 172 KEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 63/269 (23%), Positives = 122/269 (45%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          A+K   +L  G +  + + F+ E   + +++H  +V+ Y  
Sbjct: 18   GNGQFGEVWMGTWNGNTKVAIK---TLKPGTM--SPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L +    A L     V++   VA  ++Y+    +   +
Sbjct: 73   VSE-EPIYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNY---I 127
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HRD+ S  +L+       ++DFG A+ ++ +     + A     + APE A   R   K 
Sbjct: 128  HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++ +G+  +PG              N  ++       R+P P    ++ 
Sbjct: 188  DVWSFGILLTELVTKGRVPYPG------------MNNREVLEQVERGYRMPCP----QDC 231
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              S+  +   C   +P+ RPT + + + L
Sbjct: 232  PISLHELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G VY A ++ + +  A+KK+ S    +     +  + E+    ++RH N +++ G
Sbjct: 24  GHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 841 FCSHTQHL-FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
            C   +H  +LV EY   GS + +L  E     L   +   V  G    L+Y+H H+   
Sbjct: 83  -CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            ++HRD+ +  +LL       + DFG+A  + P +       GT  ++APE+   M   +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 959 ---KCDVFNFGVLVLEVIEGKHP 978
              K DV++ G+  +E+ E K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G VY A ++ + +  A+KK+ S    +     +  + E+    ++RH N +++ G
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 841 FCSHTQHL-FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
            C   +H  +LV EY   GS + +L  E     L   +   V  G    L+Y+H H+   
Sbjct: 122 -CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            ++HRD+ +  +LL       + DFG+A  + P +       GT  ++APE+   M   +
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 229
Query: 959 ---KCDVFNFGVLVLEVIEGKHP 978
              K DV++ G+  +E+ E K P
Sbjct: 230 YDGKVDVWSLGITCIELAERKPP 252

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 779 GKMVLHGTGGCGTVYKA------------ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE 826
           G  V+ G G  G VY              E+   D+R  + LH     EI +++      
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE----EIALHK------ 60
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
              ++H+NIV++ G  S    + +  E +  GSL+ +L ++    + +        K + 
Sbjct: 61  --HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 118
Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKA--HVSDFGTAKFLKPDSSNWSELAGTCG 944
             L Y+H +    I+HRDI    VL++  Y     +SDFGT+K L   +       GT  
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 945 YIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHP 978
           Y+APE+         +  D+++ G  ++E+  GK P
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
           + ++ H  +VK +        L+L+ ++L  G L T LS E    E D       +  +A
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAELA 140
Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
             L ++H      I++RD+  + +LLD E    ++DFG +K             GT  Y+
Sbjct: 141 LGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYM 197
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+      +   D +++GVL+ E++ G  P
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 32/216 (14%)
Query: 779 GKMVLHGTGGCGTVYKA------------ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE 826
           G  V+ G G  G VY              E+   D+R  + LH     EI +++      
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE----EIALHK------ 74
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
              ++H+NIV++ G  S    + +  E +  GSL+ +L ++    + +        K + 
Sbjct: 75  --HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 887 NALSYMHHDCFPPILHRDISSKKVLLDLEYKA--HVSDFGTAKFLKPDSSNWSELAGTCG 944
             L Y+H +    I+HRDI    VL++  Y     +SDFGT+K L   +       GT  
Sbjct: 133 EGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQ 188
Query: 945 YIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHP 978
           Y+APE+         +  D+++ G  ++E+  GK P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 17/161 (10%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           V  + ++ H NI+K +     +   ++V E    G L   +      +E D ++   +IK
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIK 128
Query: 884 GVANALSYMH-HDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSEL 939
            V + ++YMH H+    I+HRD+  + +LL+ + K     + DFG +   +  ++   + 
Sbjct: 129 QVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 940 AGTCGYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGKHP 978
            GT  YIAPE+   +R   +EKCDV++ GV++  ++ G  P
Sbjct: 184 IGTAYYIAPEV---LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/161 (27%), Positives = 83/161 (51%), Gaps = 17/161 (10%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           V  + ++ H NI+K +     +   ++V E    G L   +      +E D ++   +IK
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIK 128
Query: 884 GVANALSYMH-HDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSEL 939
            V + ++YMH H+    I+HRD+  + +LL+ + K     + DFG +   +  ++   + 
Sbjct: 129 QVFSGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 940 AGTCGYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGKHP 978
            GT  YIAPE+   +R   +EKCDV++ GV++  ++ G  P
Sbjct: 184 IGTAYYIAPEV---LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 50/215 (23%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 772 LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVK-KLHSLPTGEIGINQKGFVSEIT-- 828
           L AS  + + V+ G G  G V    L     R V   + +L  G     ++ F+ E +  
Sbjct: 40  LDASCIKIERVI-GAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 829 -EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
            +  H N+V   G  +  + + +V E++E G+L   L       +    + V +++G+A 
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD--GQFTVIQLVGMLRGIAA 156
Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---TCG 944
            + Y+    +   +HRD++++ +L++      VSDFG ++ ++ D        G      
Sbjct: 157 GMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR 213
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           + APE     +     DV+++G+++ EV+  G+ P
Sbjct: 214 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 11/190 (5%)
Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           IP D   L+      L +N  S +  ++   L  L  +YLN+N++  ++P+ I   L++L
Sbjct: 35  IPADTKKLD------LQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNL 87
Query: 210 SYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNG 269
             L +  N+L          L NL  L L  N+L    P    S   L YL L +N+L  
Sbjct: 88  ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ- 146
Query: 270 SLPSS-FGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
           SLP   F  L+SLK L ++N N+L          L  L  L L   QL      +  +L 
Sbjct: 147 SLPKGVFDKLTSLKELRLYN-NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205
Query: 329 NIRGLYIREN 338
            ++ L ++EN
Sbjct: 206 KLKMLQLQEN 215

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 5/184 (2%)
Query: 231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNI 289
           ++ K L L  N+LS            L  LYL+ N+L  +LP+  F  L +L+ L V + 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD- 94
Query: 290 NKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL- 348
           NKL          L +L+ L L + QL    P    +L+ +  L +  N L  S+P+ + 
Sbjct: 95  NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 349 GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLF 408
            +L SL +L L  N+L          L+ LK   L  N+L        ++++KL    L 
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 409 ENQF 412
           EN +
Sbjct: 214 ENPW 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 56  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 112 YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 166
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 167 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 226
Query: 971 EVI 973
           E+ 
Sbjct: 227 ELF 229

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 38  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 94  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 148
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D   +           + APE     + +   DV++FGV++ 
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 971 EVI 973
           E+ 
Sbjct: 209 ELF 211

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 783 LHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVK 837
           L G G  G VYK   + +G   A+K +      E  I Q     EI  ++    HRNI  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-----EINMLKKYSHHRNIAT 85
Query: 838 FYG-FCSHT-----QHLFLVYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALS 890
           +YG F           L+LV E+   GS+  ++ N +    + +W     + + +   LS
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLS 143
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           ++H      ++HRDI  + VLL    +  + DFG +  L       +   GT  ++APE+
Sbjct: 144 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 200
Query: 951 AYTMRANE-----KCDVFNFGVLVLEVIEGKHP 978
                  +     K D+++ G+  +E+ EG  P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+ A        AVK   ++  G + +  + F++E   +  ++H  +VK +  
Sbjct: 197  GAGQFGEVWMATYNKHTKVAVK---TMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV 251
Query: 842  CSHTQHLFLVYEYLERGSLATIL-SNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             +  + ++++ E++ +GSL   L S+E +   L   K ++    +A  ++++    +   
Sbjct: 252  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 305
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEK 959
            +HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K
Sbjct: 306  IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 960  CDVFNFGVLVLEVIE-GK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
             DV++FG+L++E++  G+  +PG              N  ++       R+P P    EE
Sbjct: 366  SDVWSFGILLMEIVTYGRIPYPG------------MSNPEVIRALERGYRMPRPENCPEE 413
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                +  +   C    P+ RPT + + ++L
Sbjct: 414  ----LYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 831  RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATA-------AELDWSKRVNVIK 883
            +H NIV   G C+H   + ++ EY   G L   L  +A A         L+    ++   
Sbjct: 108  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 884  GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG- 941
             VA  ++++   +C    +HRD++++ VLL   + A + DFG A+ +  DS+   +    
Sbjct: 168  QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 942  -TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNI 997
                ++APE  +      + DV+++G+L+ E+       +PG                 I
Sbjct: 224  LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG-----------------I 266
Query: 998  VVNDLIDSRLPPPLGEVEEKL--KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +VN      +       +     K++ ++   C    P  RPT Q++C+ L
Sbjct: 267  LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 56  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 111
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 112 YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 166
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 167 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 226
Query: 971 EVI 973
           E+ 
Sbjct: 227 ELF 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 785 GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V KA +     R   A+K++    + +   + + F  E+  +     H NI+ 
Sbjct: 24  GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIIN 80
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE-------------ATAAELDWSKRVNVIKG 884
             G C H  +L+L  EY   G+L   L                +TA+ L   + ++    
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           VA  + Y+    F   +HRD++++ +L+   Y A ++DFG ++           +  T G
Sbjct: 141 VARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMG 191
Query: 945 -----YIAPE-LAYTMRANEKCDVFNFGVLVLEVI 973
                ++A E L Y++      DV+++GVL+ E++
Sbjct: 192 RLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 785 GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V KA +     R   A+K++    + +   + + F  E+  +     H NI+ 
Sbjct: 34  GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIIN 90
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE-------------ATAAELDWSKRVNVIKG 884
             G C H  +L+L  EY   G+L   L                +TA+ L   + ++    
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           VA  + Y+    F   +HRD++++ +L+   Y A ++DFG ++           +  T G
Sbjct: 151 VARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMG 201
Query: 945 -----YIAPE-LAYTMRANEKCDVFNFGVLVLEVI 973
                ++A E L Y++      DV+++GVL+ E++
Sbjct: 202 RLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 235

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 38  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 94  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 148
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 971 EVI 973
           E+ 
Sbjct: 209 ELF 211

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 61/269 (22%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+          AVK   SL  G +  +   F++E   + +++H+ +V+ Y  
Sbjct: 18   GAGQFGEVWMGYYNGHTKVAVK---SLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++    +   +
Sbjct: 73   VTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNY---I 127
Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEKC 960
            HR++ +  +L+       ++DFG A+ ++ +     E A     + APE         K 
Sbjct: 128  HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 961  DVFNFGVLVLEVI-EGK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L+ E++  G+  +PG              N  ++ N     R+  P    EE 
Sbjct: 188  DVWSFGILLTEIVTHGRIPYPG------------MTNPEVIQNLERGYRMVRPDNCPEEL 235
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + M     LC    P+ RPT   + ++L
Sbjct: 236  YQLM----RLCWKERPEDRPTFDYLRSVL 260

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE------------LD 874
           +T ++H++IV+F+G C+  + L +V+EY+  G L   L +    A+            L 
Sbjct: 74  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 133
Query: 875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             + + V   VA  + Y+    F   +HRD++++  L+       + DFG ++ +   S+
Sbjct: 134 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--ST 188
Query: 935 NWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           ++  + G       ++ PE     +   + DV++FGV++ E+   GK P
Sbjct: 189 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE------------LD 874
           +T ++H++IV+F+G C+  + L +V+EY+  G L   L +    A+            L 
Sbjct: 68  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 127
Query: 875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             + + V   VA  + Y+    F   +HRD++++  L+       + DFG ++ +   S+
Sbjct: 128 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--ST 182
Query: 935 NWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           ++  + G       ++ PE     +   + DV++FGV++ E+   GK P
Sbjct: 183 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE------------LD 874
           +T ++H++IV+F+G C+  + L +V+EY+  G L   L +    A+            L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             + + V   VA  + Y+    F   +HRD++++  L+       + DFG ++ +   S+
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--ST 211
Query: 935 NWSELAGTC----GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           ++  + G       ++ PE     +   + DV++FGV++ E+   GK P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 785 GTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
           G G  G+V           +G+  AVKKL       +    + F  EI     ++H NIV
Sbjct: 23  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIV 78
Query: 837 KFYGFC--SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           K+ G C  +  ++L L+ EYL  GSL   L  +     +D  K +     +   + Y+  
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELA 951
             +   +HRD++++ +L++ E +  + DFG  K L  D               + APE  
Sbjct: 137 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 952 YTMRANEKCDVFNFGVLVLEVI 973
              + +   DV++FGV++ E+ 
Sbjct: 194 TESKFSVASDVWSFGVVLYELF 215

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 102/365 (27%), Positives = 155/365 (42%), Gaps = 52/365 (14%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL 103
           + +L+ L  ++FS NQ + I P  +  LT LV + ++ NQ+  + P  L  LT+L  L L
Sbjct: 59  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 114
Query: 104 SYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQD---LGNLES 160
             N++    P                      +      L   ++G+   D   L NL +
Sbjct: 115 FNNQITDIDPLKNLTNLNRLELSSNTISDISAL-SGLTSLQQLNFGNQVTDLKPLANLTT 173
Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
              + + +N  S +    L  L NL  +   NN+I    P  +G L +L  L LN NQL 
Sbjct: 174 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 229
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
                T  +L+NL  L L +N++S   P  L     L  L L  NQ++   P     L++
Sbjct: 230 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 283
Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP------------------- 321
           L +L + N N+L    P  I NLK+L++L L    +S   P                   
Sbjct: 284 LTNLEL-NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD 340
Query: 322 -PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLNGSIPHC 371
             SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N SIP+ 
Sbjct: 341 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 398
Query: 372 LGNLS 376
           + N++
Sbjct: 399 VKNVT 403

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 69  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 125 YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 179
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 971 EVI 973
           E+ 
Sbjct: 240 ELF 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 45  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 100
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 101 YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 155
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 156 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 215
Query: 971 EVI 973
           E+ 
Sbjct: 216 ELF 218

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 102/365 (27%), Positives = 155/365 (42%), Gaps = 52/365 (14%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL 103
           + +L+ L  ++FS NQ + I P  +  LT LV + ++ NQ+  + P  L  LT+L  L L
Sbjct: 59  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 114
Query: 104 SYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQD---LGNLES 160
             N++    P                      +      L   ++G+   D   L NL +
Sbjct: 115 FNNQITDIDPLKNLTNLNRLELSSNTISDISAL-SGLTSLQQLNFGNQVTDLKPLANLTT 173
Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
              + + +N  S +    L  L NL  +   NN+I    P  +G L +L  L LN NQL 
Sbjct: 174 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 229
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
                T  +L+NL  L L +N++S   P  L     L  L L  NQ++   P     L++
Sbjct: 230 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 283
Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP------------------- 321
           L +L + N N+L    P  I NLK+L++L L    +S   P                   
Sbjct: 284 LTNLEL-NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFSNNKVSD 340
Query: 322 -PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLNGSIPHC 371
             SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N SIP+ 
Sbjct: 341 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 398
Query: 372 LGNLS 376
           + N++
Sbjct: 399 VKNVT 403

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 38  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 94  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 148
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 971 EVI 973
           E+ 
Sbjct: 209 ELF 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 41  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 97  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 151
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 971 EVI 973
           E+ 
Sbjct: 212 ELF 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 43  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 98
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 99  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 153
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 154 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 213
Query: 971 EVI 973
           E+ 
Sbjct: 214 ELF 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 785 GTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
           G G  G+V           +G+  AVKKL       +    + F  EI     ++H NIV
Sbjct: 18  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIV 73
Query: 837 KFYGFC--SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           K+ G C  +  ++L L+ EYL  GSL   L  +     +D  K +     +   + Y+  
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELA 951
             +   +HRD++++ +L++ E +  + DFG  K L  D               + APE  
Sbjct: 132 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 952 YTMRANEKCDVFNFGVLVLEVI 973
              + +   DV++FGV++ E+ 
Sbjct: 189 TESKFSVASDVWSFGVVLYELF 210

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           H NI++           FLV++ +++G L   L+ + T +E +  K +  +  V  AL  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-L 950
           ++      I+HRD+  + +LLD +    ++DFG +  L P      E+ GT  Y+APE +
Sbjct: 143 LN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEII 195
Query: 951 AYTMRAN-----EKCDVFNFGVLVLEVIEGKHP 978
             +M  N     ++ D+++ GV++  ++ G  P
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           H NI++           FLV++ +++G L   L+ + T +E +  K +  +  V  AL  
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-L 950
           ++      I+HRD+  + +LLD +    ++DFG +  L P      E+ GT  Y+APE +
Sbjct: 130 LN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEII 182
Query: 951 AYTMRAN-----EKCDVFNFGVLVLEVIEGKHP 978
             +M  N     ++ D+++ GV++  ++ G  P
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 432 IVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 487
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 488 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 542
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 36  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 91
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 92  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 146
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 147 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 206
Query: 971 EVI 973
           E+ 
Sbjct: 207 ELF 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 433 IVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 488
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 489 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 543
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 129
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 130 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK--AQTHGKWPVKWYAPE 184
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 44  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 99
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HRD++++ +L++
Sbjct: 100 YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 154
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D               + APE     + +   DV++FGV++ 
Sbjct: 155 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 214
Query: 971 EVI 973
           E+ 
Sbjct: 215 ELF 217

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 57  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 112
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 167
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 168 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 223
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 24/264 (9%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G VYKA+       A  K+    + E   +    +  +    H NIVK      +
Sbjct: 46   GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY 105
Query: 845  TQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              +L+++ E+   G++ A +L  E    E   S+   V K   +AL+Y+H +    I+HR
Sbjct: 106  ENNLWILIEFCAGGAVDAVMLELERPLTE---SQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE----- 958
            D+ +  +L  L+    ++DFG +              GT  ++APE+     + +     
Sbjct: 160  DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            K DV++ G+ ++E+ E + P H              M +++   I    PP L +     
Sbjct: 220  KADVWSLGITLIEMAEIEPPHH----------ELNPMRVLLK--IAKSEPPTLAQPSRWS 267
Query: 1019 KSMIAVAFLCLDANPDCRPTMQKV 1042
             +       CL+ N D R T  ++
Sbjct: 268  SNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 43/284 (15%)
Query: 785  GTGGCGTVYKAELTS-GDTRAVKKL--HSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
            G G  G V +A     G   AV K+    L +      ++  +SE+  +    +H NIV 
Sbjct: 47   GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 106
Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATA-------AELDWSKRVNVIKGVANALS 890
              G C+H   + ++ EY   G L   L  +A A         L+    ++    VA  ++
Sbjct: 107  LLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMA 166
Query: 891  YM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT--CGYIA 947
            ++   +C    +HRD++++ VLL   + A + DFG A+ +  DS+   +        ++A
Sbjct: 167  FLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 948  PELAYTMRANEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDLID 1004
            PE  +      + DV+++G+L+ E+       +PG                 I+VN    
Sbjct: 223  PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG-----------------ILVNSKFY 265
Query: 1005 SRLPPPLGEVEEKL--KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              +       +     K++ ++   C    P  RPT Q++C+ L
Sbjct: 266  KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 24/264 (9%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G VYKA+       A  K+    + E   +    +  +    H NIVK      +
Sbjct: 46   GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY 105
Query: 845  TQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              +L+++ E+   G++ A +L  E    E   S+   V K   +AL+Y+H +    I+HR
Sbjct: 106  ENNLWILIEFCAGGAVDAVMLELERPLTE---SQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE----- 958
            D+ +  +L  L+    ++DFG +              GT  ++APE+     + +     
Sbjct: 160  DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            K DV++ G+ ++E+ E + P H              M +++   I    PP L +     
Sbjct: 220  KADVWSLGITLIEMAEIEPPHH----------ELNPMRVLLK--IAKSEPPTLAQPSRWS 267
Query: 1019 KSMIAVAFLCLDANPDCRPTMQKV 1042
             +       CL+ N D R T  ++
Sbjct: 268  SNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 58  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 113
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 168
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 169 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 224
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 770 ELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE-- 826
           E +    FE   VL G GG G V++  ++T  +T  +  +  L    I  N K       
Sbjct: 12  EKIRPECFELLRVL-GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 827 ----ITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV 881
               + E++H  IV   Y F +  + L+L+ EYL  G L   L  E    E         
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFY 126
Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
           +  ++ AL ++H      I++RD+  + ++L+ +    ++DFG  K    D +      G
Sbjct: 127 LAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCG 183
Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           T  Y+APE+      N   D ++ G L+ +++ G  P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIR-HRN-----IVK 837
           G GG    Y  E+T  DT+ V     +P   +   +QK  +S  TEI  H++     +V 
Sbjct: 35  GKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--TEIAIHKSLDNPHVVG 90
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHD 895
           F+GF      +++V E   R SL  +       T  E  +  R   I+GV     Y+H++
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN 145
Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               ++HRD+    + L+ +    + DFG A  ++ D     +L GT  YIAPE+     
Sbjct: 146 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            + + D+++ G ++  ++ GK P
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 46/275 (16%)
Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VYKA+   +G   A K + +    E+    + ++ EI       H  IVK  G
Sbjct: 20   GDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYIVEIEILATCDHPYIVKLLG 75
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVI-KGVANALSYMHHDC 896
               H   L+++ E+   G++  I+       ELD      ++ V+ + +  AL+++H   
Sbjct: 76   AYYHDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVVCRQMLEALNFLHSK- 128
Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFG-TAKFLKPDSSNWSELAGTCGYIAPELAY--T 953
               I+HRD+ +  VL+ LE    ++DFG +AK LK      S   GT  ++APE+    T
Sbjct: 129  --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCET 185
Query: 954  MRA---NEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPP 1010
            M+    + K D+++ G+ ++E+ + + P H              M +++   I    PP 
Sbjct: 186  MKDTPYDYKADIWSLGITLIEMAQIEPPHH----------ELNPMRVLLK--IAKSDPPT 233
Query: 1011 L---GEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            L    +   + +  + +A   LD NP+ RP+  ++
Sbjct: 234  LLTPSKWSVEFRDFLKIA---LDKNPETRPSAAQL 265

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 16/217 (7%)
Query: 770 ELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSE-- 826
           E +    FE   VL G GG G V++  ++T  +T  +  +  L    I  N K       
Sbjct: 12  EKIRPECFELLRVL-GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 827 ----ITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV 881
               + E++H  IV   Y F +  + L+L+ EYL  G L   L  E    E         
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFY 126
Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
           +  ++ AL ++H      I++RD+  + ++L+ +    ++DFG  K    D +      G
Sbjct: 127 LAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           T  Y+APE+      N   D ++ G L+ +++ G  P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 46/275 (16%)
Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VYKA+   +G   A K + +    E+    + ++ EI       H  IVK  G
Sbjct: 28   GDGAFGKVYKAKNKETGALAAAKVIETKSEEEL----EDYIVEIEILATCDHPYIVKLLG 83
Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVI-KGVANALSYMHHDC 896
               H   L+++ E+   G++  I+       ELD      ++ V+ + +  AL+++H   
Sbjct: 84   AYYHDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFG-TAKFLKPDSSNWSELAGTCGYIAPELAY--T 953
               I+HRD+ +  VL+ LE    ++DFG +AK LK      S   GT  ++APE+    T
Sbjct: 137  --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCET 193
Query: 954  MRA---NEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPP 1010
            M+    + K D+++ G+ ++E+ + + P H              M +++   I    PP 
Sbjct: 194  MKDTPYDYKADIWSLGITLIEMAQIEPPHH----------ELNPMRVLLK--IAKSDPPT 241
Query: 1011 L---GEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            L    +   + +  + +A   LD NP+ RP+  ++
Sbjct: 242  LLTPSKWSVEFRDFLKIA---LDKNPETRPSAAQL 273

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 785 GTGGCGTVY--KAELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
           G+G  G V   K +LT G  RA+K  K  S+ T     N    + E+    ++ H NI+K
Sbjct: 13  GSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTS---NSGALLDEVAVLKQLDHPNIMK 68
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
            Y F    ++ +LV E    G L   +      +E+D      ++K V +  +Y+H    
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVD---AAVIMKQVLSGTTYLHK--- 122
Query: 898 PPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
             I+HRD+  + +LL+ + +     + DFG +   +       E  GT  YIAPE+    
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV-LRK 180
Query: 955 RANEKCDVFNFGVLVLEVIEGKHP 978
           + +EKCDV++ GV++  ++ G  P
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIR-HRN-----IVK 837
           G GG    Y  E+T  DT+ V     +P   +   +QK  +S  TEI  H++     +V 
Sbjct: 51  GKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--TEIAIHKSLDNPHVVG 106
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHD 895
           F+GF      +++V E   R SL  +       T  E  +  R   I+GV     Y+H++
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN 161
Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               ++HRD+    + L+ +    + DFG A  ++ D     +L GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            + + D+++ G ++  ++ GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 24/264 (9%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G VYKA+       A  K+    + E   +    +  +    H NIVK      +
Sbjct: 46   GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY 105
Query: 845  TQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              +L+++ E+   G++ A +L  E    E   S+   V K   +AL+Y+H +    I+HR
Sbjct: 106  ENNLWILIEFCAGGAVDAVMLELERPLTE---SQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE----- 958
            D+ +  +L  L+    ++DFG +              GT  ++APE+     + +     
Sbjct: 160  DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 959  KCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL 1018
            K DV++ G+ ++E+ E + P H              M +++   I    PP L +     
Sbjct: 220  KADVWSLGITLIEMAEIEPPHH----------ELNPMRVLLK--IAKSEPPTLAQPSRWS 267
Query: 1019 KSMIAVAFLCLDANPDCRPTMQKV 1042
             +       CL+ N D R T  ++
Sbjct: 268  SNFKDFLKKCLEKNVDARWTTSQL 291

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 108/371 (29%), Positives = 161/371 (43%), Gaps = 63/371 (16%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQ--------------------IGILTNLVVLRLSVNQ 83
           + +L+ L  ++FS NQ + I P +                    +  LTNL  L L  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 84  LNGLIPEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYL 143
           +  + P  L  LT+LN L LS N +   I A                        N   L
Sbjct: 119 ITDIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLSFSSNQVTDLKPLANLTTL 175
Query: 144 ----ISPHYG---SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI- 195
               IS +     S+   L NLES ++ +   N  S + P  LG L NL  + LN N++ 
Sbjct: 176 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITP--LGILTNLDELSLNGNQLK 230
Query: 196 -VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
            +G++ S    L +L+ L L  NQ+S  + P +G L+ L  L L  N++S   P  L   
Sbjct: 231 DIGTLAS----LTNLTDLDLANNQISN-LAPLSG-LTKLTELKLGANQISNISP--LAGL 282
Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
            +L  L L+ NQL    P    NL +L +L ++  N +S   P  + +L  L  L+    
Sbjct: 283 TALTNLELNENQLEDISP--ISNLKNLTYLTLY-FNNISDISP--VSSLTKLQRLFFYNN 337
Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLN 365
           ++S     SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N
Sbjct: 338 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 393
Query: 366 GSIPHCLGNLS 376
            SIP+ + N++
Sbjct: 394 VSIPNTVKNVT 404

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 47/203 (23%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
           G G  G V+     +    AVK   +L  G + +  + F+ E   +  ++H  +V+ Y  
Sbjct: 21  GAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYAV 75
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            +  + ++++ E++ +GSL   L ++     L   K ++    +A  ++Y+    +   +
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---I 131
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPEL----AYTMRA 956
           HRD+ +  VL+       ++DFG A+ ++ +     E A     + APE      +T+++
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 957 NEKCDVFNFGVLVLEVIE-GKHP 978
           N    V++FG+L+ E++  GK P
Sbjct: 192 N----VWSFGILLYEIVTYGKIP 210

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 108/371 (29%), Positives = 161/371 (43%), Gaps = 63/371 (16%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQ--------------------IGILTNLVVLRLSVNQ 83
           + +L+ L  ++FS NQ + I P +                    +  LTNL  L L  NQ
Sbjct: 59  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 118
Query: 84  LNGLIPEELGELTSLNELALSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYL 143
           +  + P  L  LT+LN L LS N +   I A                        N   L
Sbjct: 119 ITDIDP--LKNLTNLNRLELSSNTI-SDISALSGLTSLQQLNFSSNQVTDLKPLANLTTL 175
Query: 144 ----ISPHYG---SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI- 195
               IS +     S+   L NLES ++ +   N  S + P  LG L NL  + LN N++ 
Sbjct: 176 ERLDISSNKVSDISVLAKLTNLESLIATN---NQISDITP--LGILTNLDELSLNGNQLK 230
Query: 196 -VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
            +G++ S    L +L+ L L  NQ+S  + P +G L+ L  L L  N++S   P  L   
Sbjct: 231 DIGTLAS----LTNLTDLDLANNQISN-LAPLSG-LTKLTELKLGANQISNISP--LAGL 282
Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
            +L  L L+ NQL    P    NL +L +L ++  N +S   P  + +L  L  L+    
Sbjct: 283 TALTNLELNENQLEDISP--ISNLKNLTYLTLY-FNNISDISP--VSSLTKLQRLFFYNN 337
Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLN 365
           ++S     SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N
Sbjct: 338 KVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 393
Query: 366 GSIPHCLGNLS 376
            SIP+ + N++
Sbjct: 394 VSIPNTVKNVT 404

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 78/337 (23%), Positives = 138/337 (40%), Gaps = 73/337 (21%)
Query: 347 ELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYL 406
           +L ++ +L    L +  ++G     L NL+ + F     N+L+   P  ++N+ KL   L
Sbjct: 39  DLDQVTTLQADRLGIKSIDGV--EYLNNLTQINF---SNNQLTDITP--LKNLTKLVDIL 91
Query: 407 LFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISE 466
           +  NQ     P  +    +LT  ++ NN      P  L+N T+L  L L  N ++ +IS 
Sbjct: 92  MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISA 146
Query: 467 VFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLD 526
           + G+                           L  LN   N+++   P  + N+T L +LD
Sbjct: 147 LSGLT-------------------------SLQQLNFSSNQVTDLKP--LANLTTLERLD 179
Query: 527 FSSNRLVGQIPXXXXXXXXXXXXXXXXXXXXGDIPXXXXXXXXXXXXXXSANRLSKLIPK 586
            SSN++                          DI               + N++S + P 
Sbjct: 180 ISSNKV-------------------------SDI-SVLAKLTNLESLIATNNQISDITP- 212
Query: 587 NLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMN 646
            LG L  L  L+L+ NQ  ++I   +  L  L+ LDL++N +    P  +  L  L  + 
Sbjct: 213 -LGILTNLDELSLNGNQL-KDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 267
Query: 647 LLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS 683
           L  N++S   P     +  L++++++ N+L+   P S
Sbjct: 268 LGANQISNISP--LAGLTALTNLELNENQLEDISPIS 302

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           ++V EY++  +L  I+  E         + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 909 KVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYTMRANEKCDVFNF 965
            +L+       V DFG A+ +    ++  + A   GT  Y++PE A     + + DV++ 
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 966 GVLVLEVIEGKHP 978
           G ++ EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           ++V EY++  +L  I+  E         + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 909 KVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYTMRANEKCDVFNF 965
            +++       V DFG A+ +    ++ ++ A   GT  Y++PE A     + + DV++ 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 966 GVLVLEVIEGKHP 978
           G ++ EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           ++V EY++  +L  I+  E         + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 909 KVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYTMRANEKCDVFNF 965
            +++       V DFG A+ +    ++ ++ A   GT  Y++PE A     + + DV++ 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 966 GVLVLEVIEGKHP 978
           G ++ EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           ++V EY++  +L  I+  E         + + VI     AL++ H +    I+HRD+   
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN---GIIHRDVKPA 162
Query: 909 KVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYTMRANEKCDVFNF 965
            +++       V DFG A+ +    ++ ++ A   GT  Y++PE A     + + DV++ 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 966 GVLVLEVIEGKHP 978
           G ++ EV+ G+ P
Sbjct: 223 GCVLYEVLTGEPP 235

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 123
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 124 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 178
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 135
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 136 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 190
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 145
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 146 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 200
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 145
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 146 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 200
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 125
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 126 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 180
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 129
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 130 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 184
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVKKL       +    + F  EI     ++H NIVK+ G C  +  ++L L+ E
Sbjct: 39  TGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 94
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           YL  GSL   L  +     +D  K +     +   + Y+    +   +HR+++++ +L++
Sbjct: 95  YLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRNLATRNILVE 149
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            E +  + DFG  K L  D   +           + APE     + +   DV++FGV++ 
Sbjct: 150 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 209
Query: 971 EVI 973
           E+ 
Sbjct: 210 ELF 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           ++V EY++  +L  I+  E         + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 909 KVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYTMRANEKCDVFNF 965
            +++       V DFG A+ +    ++ ++ A   GT  Y++PE A     + + DV++ 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 966 GVLVLEVIEGKHP 978
           G ++ EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 66/133 (49%), Gaps = 9/133 (6%)
Query: 849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           ++V EY++  +L  I+  E         + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTP---KRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 909 KVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYTMRANEKCDVFNF 965
            +++       V DFG A+ +    ++ ++ A   GT  Y++PE A     + + DV++ 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 966 GVLVLEVIEGKHP 978
           G ++ EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 31  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 86
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 141
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 142 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 197
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 38/213 (17%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI-----TEIRHRNIVKFY 839
           G G  G V++     G+  AVK   S        ++K +  E        +RH NI+ F 
Sbjct: 46  GKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFI 97
Query: 840 GFCSHTQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
                ++H    L+L+  Y E GSL   L        LD    + ++  +A+ L+++H +
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 896 CF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL-----AGTCGY 945
            F     P I HRD+ SK +L+    +  ++D G A  +   S+N  ++      GT  Y
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRY 212
Query: 946 IAPE-LAYTMRAN-----EKCDVFNFGVLVLEV 972
           +APE L  T++ +     ++ D++ FG+++ EV
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 102/365 (27%), Positives = 154/365 (42%), Gaps = 52/365 (14%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL 103
           + +L+ L  ++FS NQ + I P  +  LT LV + ++ NQ+  + P  L  LT+L  L L
Sbjct: 64  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
Query: 104 SYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQD---LGNLES 160
             N++    P                      +      L    +G+   D   L NL +
Sbjct: 120 FNNQITDIDPLKNLTNLNRLELSSNTISDISAL-SGLTSLQQLSFGNQVTDLKPLANLTT 178
Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
              + + +N  S +    L  L NL  +   NN+I    P  +G L +L  L LN NQL 
Sbjct: 179 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
                T  +L+NL  L L +N++S   P  L     L  L L  NQ++   P     L++
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 288
Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP------------------- 321
           L +L + N N+L    P  I NLK+L++L L    +S   P                   
Sbjct: 289 LTNLEL-NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD 345
Query: 322 -PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLNGSIPHC 371
             SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N SIP+ 
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 372 LGNLS 376
           + N++
Sbjct: 404 VKNVT 408

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 15/150 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   +   LV E  E G L   L       +      + ++  V+  + Y+  
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE 143
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G     + APE
Sbjct: 144 SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPE 198
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + K DV++FGVL+ E    G+ P
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 39  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 94
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 149
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 150 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 205
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 36  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 91
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 146
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 147 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 202
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 102/365 (27%), Positives = 154/365 (42%), Gaps = 52/365 (14%)
Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL 103
           + +L+ L  ++FS NQ + I P  +  LT LV + ++ NQ+  + P  L  LT+L  L L
Sbjct: 63  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 118
Query: 104 SYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQD---LGNLES 160
             N++    P                      +      L    +G+   D   L NL +
Sbjct: 119 FNNQITDIDPLKNLTNLNRLELSSNTISDISAL-SGLTSLQQLSFGNQVTDLKPLANLTT 177
Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
              + + +N  S +    L  L NL  +   NN+I    P  +G L +L  L LN NQL 
Sbjct: 178 LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 233
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
                T  +L+NL  L L +N++S   P  L     L  L L  NQ++   P     L++
Sbjct: 234 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 287
Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP------------------- 321
           L +L + N N+L    P  I NLK+L++L L    +S   P                   
Sbjct: 288 LTNLEL-NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD 344
Query: 322 -PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS--------VN-KLNGSIPHC 371
             SL NL+NI  L    N +    P  L  L  ++QL L+        VN K N SIP+ 
Sbjct: 345 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 402
Query: 372 LGNLS 376
           + N++
Sbjct: 403 VKNVT 407

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/270 (22%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+ A        AVK   ++  G + +  + F++E   +  ++H  +VK +  
Sbjct: 24   GAGQFGEVWMATYNKHTKVAVK---TMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV 78
Query: 842  CSHTQHLFLVYEYLERGSLATIL-SNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             +  + ++++ E++ +GSL   L S+E +   L   K ++    +A  ++++    +   
Sbjct: 79   VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 132
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG-TCGYIAPELAYTMRANEK 959
            +HRD+ +  +L+       ++DFG A+ ++ +     E A     + APE         K
Sbjct: 133  IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 960  CDVFNFGVLVLEVIE-GK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEE 1016
             DV++FG+L++E++  G+  +PG              N  ++       R+P P    EE
Sbjct: 193  SDVWSFGILLMEIVTYGRIPYPG------------MSNPEVIRALERGYRMPRPENCPEE 240
Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                M+     C    P+ RPT + + ++L
Sbjct: 241  LYNIMMR----CWKNRPEERPTFEYIQSVL 266

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 783 LHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           L G G  G V K     +G   A+KK   L + +  + +K  + EI    ++RH N+V  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALSYMH-HDC 896
              C   +  +LV+E+++     TIL + E     LD+      +  + N + + H H+ 
Sbjct: 90  LEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN- 144
Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY-TMR 955
              I+HRDI  + +L+       + DFG A+ L      + +   T  Y APEL    ++
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 956 ANEKCDVFNFGVLVLEVIEGK 976
             +  DV+  G LV E+  G+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGE 222

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 34  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 89
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 144
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 145 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 200
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 37  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 92
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 147
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 148 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 203
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 38  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 93
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 148
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS----NWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +         N +       ++A 
Sbjct: 149 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 38  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 93
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 148
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 149 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 204
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 39  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 94
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + Y+
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYL 149
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT-----CGYIA 947
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T       ++A
Sbjct: 150 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMA 205
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            E   T +   K DV++FGVL+ E++    P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 54/235 (22%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 831  RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELD---------WSKR--V 879
            +H NIV   G C+H   + ++ EY   G L   L  ++   E D          S R  +
Sbjct: 108  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 880  NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
            +    VA  ++++   +C    +HRD++++ VLL   + A + DFG A+ +  DS+   +
Sbjct: 168  HFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223
Query: 939  LAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXX 993
                    ++APE  +      + DV+++G+L+ E+       +PG              
Sbjct: 224  GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG-------------- 269
Query: 994  NMNIVVNDLIDSRLPPPLGEVEEKL--KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               I+VN      +       +     K++ ++   C    P  RPT Q++C+ L
Sbjct: 270  ---ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           V  + ++ H NI+K +     +   ++V E    G L   +      +E D ++   +IK
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIK 128
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELA 940
            V + ++YMH      I+HRD+  + +LL+ + K     + DFG +   + ++    +  
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRI 184
Query: 941 GTCGYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGKHP 978
           GT  YIAPE+   +R   +EKCDV++ GV++  ++ G  P
Sbjct: 185 GTAYYIAPEV---LRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 785 GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V KA +     R   A+K++    + +   + + F  E+  +     H NI+ 
Sbjct: 31  GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIIN 87
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE-------------ATAAELDWSKRVNVIKG 884
             G C H  +L+L  EY   G+L   L                +TA+ L   + ++    
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           VA  + Y+    F   +HR+++++ +L+   Y A ++DFG ++           +  T G
Sbjct: 148 VARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMG 198
Query: 945 -----YIAPE-LAYTMRANEKCDVFNFGVLVLEVI 973
                ++A E L Y++      DV+++GVL+ E++
Sbjct: 199 RLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIR-HRN-----IVK 837
           G GG    Y  E+T  DT+ V     +P   +   +QK  +S  TEI  H++     +V 
Sbjct: 51  GKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--TEIAIHKSLDNPHVVG 106
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHD 895
           F+GF      +++V E   R SL  +       T  E  +  R   I+GV     Y+H++
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN 161
Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               ++HRD+    + L+ +    + DFG A  ++ D      L GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            + + D+++ G ++  ++ GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIR-HRN-----IVK 837
           G GG    Y  E+T  DT+ V     +P   +   +QK  +S  TEI  H++     +V 
Sbjct: 51  GKGGFAKCY--EITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--TEIAIHKSLDNPHVVG 106
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHD 895
           F+GF      +++V E   R SL  +       T  E  +  R   I+GV     Y+H++
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN 161
Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               ++HRD+    + L+ +    + DFG A  ++ D      L GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            + + D+++ G ++  ++ GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 830 IRHRNIVKFYGFCSHTQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGV 885
           +RH NI+ F      ++H    L+L+  Y E GSL   L        LD    + ++  +
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSI 114
Query: 886 ANALSYMHHDCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
           A+ L+++H + F     P I HRD+ SK +L+    +  ++D G A  +   S+N  ++ 
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVG 173
Query: 941 -----GTCGYIAPE-LAYTMRAN-----EKCDVFNFGVLVLEV 972
                GT  Y+APE L  T++ +     ++ D++ FG+++ EV
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 25/163 (15%)
Query: 830 IRHRNIVKFYGFCSHTQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGV 885
           +RH NI+ F      ++H    L+L+  Y E GSL   L        LD    + ++  +
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSI 114
Query: 886 ANALSYMHHDCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
           A+ L+++H + F     P I HRD+ SK +L+    +  ++D G A  +   S+N  ++ 
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVG 173
Query: 941 -----GTCGYIAPE-LAYTMRAN-----EKCDVFNFGVLVLEV 972
                GT  Y+APE L  T++ +     ++ D++ FG+++ EV
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 117
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 118 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T E   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEE---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 118
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 119 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN-VIKGVANA 888
           + H N+VKFYG        +L  EY   G L   +  +    E D  +  + ++ GV   
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-- 119
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYI 946
             Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 18  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 75
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK--HKI 129
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L  + +N  E  GT  Y++PE       + + 
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMSPERLQGTHYSVQS 187
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 188 DIWSMGLSLVEMAVGRYP 205

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 785 GTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
           G G  G+V           +G+  AVKKL       +    + F  EI     ++H NIV
Sbjct: 22  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL----RDFEREIEILKSLQHDNIV 77
Query: 837 KFYGFC--SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           K+ G C  +  ++L L+ E+L  GSL   L  +     +D  K +     +   + Y+  
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL---AGTCGYIAPELA 951
             +   +HRD++++ +L++ E +  + DFG  K L  D               + APE  
Sbjct: 136 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 952 YTMRANEKCDVFNFGVLVLEVI 973
              + +   DV++FGV++ E+ 
Sbjct: 193 TESKFSVASDVWSFGVVLYELF 214

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLE 856
           +G+  AVK L     G    + K  +  +  + H NIVK+ G C+      + L+ E+L 
Sbjct: 37  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
            GSL   L        L   +++     +   + Y+    +   +HRD++++ VL++ E+
Sbjct: 97  SGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEH 151
Query: 917 KAHVSDFGTAKFLKPDSSNWS---ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
           +  + DFG  K ++ D    +   +      + APE     +     DV++FGV + E++
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 47/266 (17%)
Query: 804  AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVKFYGFCSHTQHLFLVYEYLERGS 859
            AVK L S    +    ++  +SE+  +    +H NIV   G C+H   + ++ EY   G 
Sbjct: 80   AVKMLKSTAHAD---EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 860  LATILSNEATAAELD---------WSKR--VNVIKGVANALSYM-HHDCFPPILHRDISS 907
            L   L  ++   E D          S R  ++    VA  ++++   +C    +HRD+++
Sbjct: 137  LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAA 192
Query: 908  KKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT--CGYIAPELAYTMRANEKCDVFNF 965
            + VLL   + A + DFG A+ +  DS+   +        ++APE  +      + DV+++
Sbjct: 193  RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 966  GVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEKL--KS 1020
            G+L+ E+       +PG                 I+VN      +       +     K+
Sbjct: 253  GILLWEIFSLGLNPYPG-----------------ILVNSKFYKLVKDGYQMAQPAFAPKN 295
Query: 1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046
            + ++   C    P  RPT Q++C+ L
Sbjct: 296  IYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLE 856
           +G+  AVK L     G    + K  +  +  + H NIVK+ G C+      + L+ E+L 
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
            GSL   L        L   +++     +   + Y+    +   +HRD++++ VL++ E+
Sbjct: 109 SGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEH 163
Query: 917 KAHVSDFGTAKFLKPDSSNWS---ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
           +  + DFG  K ++ D    +   +      + APE     +     DV++FGV + E++
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 21/229 (9%)
Query: 759 SQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGI 818
           S++ +   NN + +  + F   MVL G G  G V  A     D +  ++L+++   +  +
Sbjct: 3   SEDRKQPSNNLDRVKLTDFNFLMVL-GKGSFGKVMLA-----DRKGTEELYAIKILKKDV 56
Query: 819 NQKGFVSEITEIRHRNIV---------KFYGFCSHTQHLFLVYEYLERGSLATILSNEAT 869
             +    E T +  R +          + +        L+ V EY+  G L   +     
Sbjct: 57  VIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK 116
Query: 870 AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL 929
             E    + V     ++  L ++H      I++RD+    V+LD E    ++DFG  K  
Sbjct: 117 FKE---PQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 170
Query: 930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             D     E  GT  YIAPE+       +  D + +GVL+ E++ G+ P
Sbjct: 171 MMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           H NI++           FLV++ +++G L   L+ + T +E +  K +  +  V  AL  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-L 950
           ++      I+HRD+  + +LLD +    ++DFG +  L P       + GT  Y+APE +
Sbjct: 143 LN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRSVCGTPSYLAPEII 195
Query: 951 AYTMRAN-----EKCDVFNFGVLVLEVIEGKHP 978
             +M  N     ++ D+++ GV++  ++ G  P
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/269 (21%), Positives = 118/269 (43%), Gaps = 43/269 (15%)
Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVKFYGF 841
            G G  G V+ A        AVK   ++  G + +  + F++E   +  ++H  +VK +  
Sbjct: 191  GAGQFGEVWMATYNKHTKVAVK---TMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV 245
Query: 842  CSHTQHLFLVYEYLERGSLATIL-SNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             +  + ++++ E++ +GSL   L S+E +   L   K ++    +A  ++++    +   
Sbjct: 246  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY--- 299
Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRD+ +  +L+       ++DFG A+        W+         APE         K 
Sbjct: 300  IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGSFTIKS 350
Query: 961  DVFNFGVLVLEVIE-GK--HPGHFXXXXXXXXXXXXNMNIVVNDLIDSRLPPPLGEVEEK 1017
            DV++FG+L++E++  G+  +PG              N  ++       R+P P    EE 
Sbjct: 351  DVWSFGILLMEIVTYGRIPYPG------------MSNPEVIRALERGYRMPRPENCPEE- 397
Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               +  +   C    P+ RPT + + ++L
Sbjct: 398  ---LYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 146
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 207 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 258
Query: 939 LAGT------CGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 787 GGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ 846
           G  G V+KA+L + D  AVK +  L   +   +++   S    ++H N+++F        
Sbjct: 26  GRFGCVWKAQLMN-DFVAVK-IFPLQDKQSWQSEREIFS-TPGMKHENLLQFIAAEKRGS 82
Query: 847 HL----FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC------ 896
           +L    +L+  + ++GSL   L        + W++  +V + ++  LSY+H D       
Sbjct: 83  NLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 897 --FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPE--- 949
              P I HRD  SK VLL  +  A ++DFG A   +P     +     GT  Y+APE   
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 950 --LAYTMRANEKCDVFNFGVLVLEVI 973
             + +   A  + D++  G+++ E++
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 40  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 95
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 150
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGT---CGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+  L  +  +     G      ++A 
Sbjct: 151 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMAL 207
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 8/150 (5%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAV 126
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
            Y H      I+HRD+ ++ +LLD +    ++DFG +       +   E  G+  Y APE
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDEFCGSPPYAAPE 182
Query: 950 LAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           L    + +  + DV++ GV++  ++ G  P
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 89/193 (46%), Gaps = 10/193 (5%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 L+LV+E+L +     + ++  T   L   K  + +  +   LS+ H      +L
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFCHSH---RVL 125
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANEKC 960
           HRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  +   
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 185
Query: 961 DVFNFGVLVLEVI 973
           D+++ G +  E++
Sbjct: 186 DIWSLGCIFAEMV 198

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDX 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDX 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLP-TGEIGINQKGFVSEITEIRHRNIVKFYG 840
           G G   TVYK    T+G   A+K  KL S   T    I +   +S + E++H NIV+ Y 
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE---ISLMKELKHENIVRLYD 70
Query: 841 FCSHTQHLFLVYEY----LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                  L LV+E+    L++   +  + N     EL+  K       +   L++ H + 
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQGLAFCHEN- 127
Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              ILHRD+  + +L++   +  + DFG A+      + +S    T  Y AP++    R 
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 957 -NEKCDVFNFGVLVLEVIEGK 976
            +   D+++ G ++ E+I GK
Sbjct: 186 YSTSIDIWSCGCILAEMITGK 206

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE----LDWSKRVNVI 882
           I  + H +IV+  G C  +  L LV +YL  GSL   +     A      L+W  ++   
Sbjct: 69  IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI--- 124
Query: 883 KGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELA 940
              A  + Y+       ++HR+++++ VLL    +  V+DFG A  L PD     +SE  
Sbjct: 125 ---AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 178
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
               ++A E  +  +   + DV+++GV V E++  G  P
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           GTGG G V +     +G+  A+K+     + +   N++ +  EI    ++ H N+V    
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSARE 79
Query: 841 FCSHTQHL------FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                Q L       L  EY E G L   L+       L       ++  +++AL Y+H 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 895 DCFPPILHRDISSKKVLLD-----LEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           +    I+HRD+  + ++L      L +K  + D G AK L       +E  GT  Y+APE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHK--IIDLGYAKELD-QGELCTEFVGTLQYLAPE 193
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           L    +     D ++FG L  E I G  P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           GTGG G V +     +G+  A+K+     + +   N++ +  EI    ++ H N+V    
Sbjct: 24  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSARE 80
Query: 841 FCSHTQHL------FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                Q L       L  EY E G L   L+       L       ++  +++AL Y+H 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 895 DCFPPILHRDISSKKVLLD-----LEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           +    I+HRD+  + ++L      L +K  + D G AK L       +E  GT  Y+APE
Sbjct: 141 N---RIIHRDLKPENIVLQPGPQRLIHK--IIDLGYAKELD-QGELCTEFVGTLQYLAPE 194
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           L    +     D ++FG L  E I G  P
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 98  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 153
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 208
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL---KPDS-SNWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +   + DS  N +       ++A 
Sbjct: 209 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 16  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 75  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 127
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 187
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 188 AVDIWSLGCIFAEMV 202

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 122
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 122
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 13/139 (9%)
Query: 847 HLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPILHRDI 905
           HL+LV +Y   G L T+LS        D ++  +  +    +++  +H+      +HRDI
Sbjct: 164 HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDI 217
Query: 906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTM-----RANEK 959
               VLLD+     ++DFG+   +  D +  S +A GT  YI+PE+   M     +   +
Sbjct: 218 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 277
Query: 960 CDVFNFGVLVLEVIEGKHP 978
           CD ++ GV + E++ G+ P
Sbjct: 278 CDWWSLGVCMYEMLYGETP 296

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 19  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 78  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 130
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYST 190
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 191 AVDIWSLGCIFAEMV 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAA---ELDWSKRVNVIKGVANALSYMHHDCFP 898
                 L+LV+E+L +  L T +   A       L  S    +++G+A   S+       
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------ 126
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-AN 957
            +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  +
Sbjct: 127 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 958 EKCDVFNFGVLVLEVI 973
              D+++ G +  E++
Sbjct: 186 TAVDIWSLGCIFAEMV 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 124
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 184
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 44  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 99
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 154
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL---KPDS-SNWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +   + DS  N +       ++A 
Sbjct: 155 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 17/159 (10%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE----LDWSKRVNVI 882
           I  + H +IV+  G C  +  L LV +YL  GSL   +     A      L+W  ++   
Sbjct: 87  IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI--- 142
Query: 883 KGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELA 940
              A  + Y+       ++HR+++++ VLL    +  V+DFG A  L PD     +SE  
Sbjct: 143 ---AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK 196
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
               ++A E  +  +   + DV+++GV V E++  G  P
Sbjct: 197 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 40  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 95
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 150
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL---KPDS-SNWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +   + DS  N +       ++A 
Sbjct: 151 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 13/139 (9%)
Query: 847 HLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPILHRDI 905
           HL+LV +Y   G L T+LS        D ++  +  +    +++  +H+      +HRDI
Sbjct: 148 HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY------VHRDI 201
Query: 906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTM-----RANEK 959
               VLLD+     ++DFG+   +  D +  S +A GT  YI+PE+   M     +   +
Sbjct: 202 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 261
Query: 960 CDVFNFGVLVLEVIEGKHP 978
           CD ++ GV + E++ G+ P
Sbjct: 262 CDWWSLGVCMYEMLYGETP 280

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           ++H NIV+ +   S     +LV++ +  G L   +      +E D S   + I  +  ++
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQILESV 143
Query: 890 SYMH-HDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGY 945
           +++H HD    I+HRD+  + +LL  + K     ++DFG A  ++ +   W   AGT GY
Sbjct: 144 NHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY 199
Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++PE+       +  D++  GV++  ++ G  P
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 19  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 78  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 130
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 190
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 191 AVDIWSLGCIFAEMV 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 17/222 (7%)
Query: 758 DSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG 817
           D +   ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  
Sbjct: 4   DPKVTMNDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 818 INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK 877
           + Q      +T ++       Y F +H +  F V EY   G L   LS E    E    +
Sbjct: 63  VLQNTRHPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----E 110
Query: 878 RVNVIKG-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
           R       + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +  
Sbjct: 111 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 167
Query: 937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
               GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 796 ELTSGDTRAVKKLHSLPTGEIG----INQKGFVSEITE-----------IRHRNIVKFYG 840
           EL  G    V++   +PTG+      IN K   +   +           ++H NIV+ + 
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             S     +LV++ +  G L   +      +E D S  +  I      L  ++H     I
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI------LESVNHCHLNGI 124
Query: 901 LHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
           +HRD+  + +LL  + K     ++DFG A  ++ D   W   AGT GY++PE+       
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 958 EKCDVFNFGVLVLEVIEGKHP 978
           +  D++  GV++  ++ G  P
Sbjct: 185 KPVDMWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 796 ELTSGDTRAVKKLHSLPTGEIG----INQKGFVSEITE-----------IRHRNIVKFYG 840
           EL  G    V++   +PTG+      IN K   +   +           ++H NIV+ + 
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             S     +LV++ +  G L   +      +E D S  +  I      L  ++H     I
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI------LESVNHCHLNGI 124
Query: 901 LHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
           +HRD+  + +LL  + K     ++DFG A  ++ D   W   AGT GY++PE+       
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 958 EKCDVFNFGVLVLEVIEGKHP 978
           +  D++  GV++  ++ G  P
Sbjct: 185 KPVDMWACGVILYILLVGYPP 205

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 39  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 94
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 149
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL---KPDS-SNWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +   + DS  N +       ++A 
Sbjct: 150 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 37  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 92
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 147
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL---KPDS-SNWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +   + DS  N +       ++A 
Sbjct: 148 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 785 GTGGCGTVYKAELTSGDTR----AVKKLHSLP-TGEIGINQKGFVSE---ITEIRHRNIV 836
           G G  G VY   L   D +    AVK L+ +   GE+      F++E   + +  H N++
Sbjct: 39  GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGIIMKDFSHPNVL 94
Query: 837 KFYGFCSHTQ-HLFLVYEYLERGSLATILSNEA---TAAELDWSKRVNVIKGVANALSYM 892
              G C  ++    +V  Y++ G L   + NE    T  +L     +     VA  + ++
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFL 149
Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL---KPDS-SNWSELAGTCGYIAP 948
               F   +HRD++++  +LD ++   V+DFG A+ +   + DS  N +       ++A 
Sbjct: 150 ASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E   T +   K DV++FGVL+ E++    P
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           ++H NIV+ +   S     +LV++ +  G L   +      +E D S   + I+ +  A+
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV 116
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGYI 946
            + H      ++HRD+  + +LL  + K     ++DFG A  ++ D   W   AGT GY+
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYL 173
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +PE+       +  D++  GV++  ++ G  P
Sbjct: 174 SPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 17/234 (7%)
Query: 749 FNFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKL 808
              ++RKR ++   Q     +  L    FE K+   G G  G V+K           +KL
Sbjct: 1   MTLQQRKRLEAFLTQKQKVGE--LKDDDFE-KISELGAGNGGVVFKVSHKPSGLVMARKL 57
Query: 809 HSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGFCSHTQHLFLVYEYLERGSLATILS 865
             L       NQ   + E+  +   N   IV FYG       + +  E+++ GSL  +L 
Sbjct: 58  IHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 115
Query: 866 NEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG 924
                 E    K  + VIKG    L+Y+       I+HRD+    +L++   +  + DFG
Sbjct: 116 KAGRIPEQILGKVSIAVIKG----LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFG 169
Query: 925 TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            +  L    +N     GT  Y++PE       + + D+++ G+ ++E+  G++P
Sbjct: 170 VSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAV 126
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +  ++L   CG   Y 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDAFCGAPPYA 179
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 13/152 (8%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGVANAL 889
           H N+VKFYG        +L  EY   G L   +  +    E D ++R    ++ GV    
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV--- 119
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIA 947
            Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+A
Sbjct: 120 -YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 948 PELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           PEL      + E  DV++ G+++  ++ G+ P
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 13/152 (8%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGVANAL 889
           H N+VKFYG        +L  EY   G L   +  +    E D ++R    ++ GV    
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRFFHQLMAGVV--- 118
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIA 947
            Y+H      I HRDI  + +LLD      +SDFG A   + ++     +++ GT  Y+A
Sbjct: 119 -YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 948 PELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           PEL      + E  DV++ G+++  ++ G+ P
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAA---ELDWSKRVNVIKGVANALSYMHHDCFP 898
                 L+LV+E++ +  L T +   A       L  S    +++G+A   S+       
Sbjct: 70  IHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------ 122
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-AN 957
            +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  +
Sbjct: 123 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 958 EKCDVFNFGVLVLEVI 973
              D+++ G +  E++
Sbjct: 182 TAVDIWSLGCIFAEMV 197

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 38/152 (25%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           ++H NIV+ +   S   H +L+++ +  G L   +      +E D S   + I+ +  A+
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV 134
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGYI 946
            + H      ++HRD+  + +LL  + K     ++DFG A  ++ +   W   AGT GY+
Sbjct: 135 LHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 191
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +PE+       +  D++  GV++  ++ G  P
Sbjct: 192 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAK---FRQIVSAV 126
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +  ++L   CG   Y 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSN----EFTFGNKLDAFCGAPPYA 179
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 122
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 122
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+L+ EY   G +   L       E +   +    + + +A+
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAV 127
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +   +L   CG   Y 
Sbjct: 128 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN----EFTVGGKLDAFCGAPPYA 180
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 124
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 124
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 74  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 126
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 758 DSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGE 815
           D +   N+    +LL   TF GK++L      G  Y  ++   +    K    H+L    
Sbjct: 4   DPRVTMNEFEYLKLLGKGTF-GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 62
Query: 816 IGINQKGFVSEITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELD 874
           +  N           RH  +    Y F +H +  F V EY   G L   LS E   +E D
Sbjct: 63  VLQNS----------RHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE-D 110
Query: 875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
            ++       + +AL Y+H +    +++RD+  + ++LD +    ++DFG  K    D +
Sbjct: 111 RARFYGA--EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 166
Query: 935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                 GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 167 TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 125
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 17/231 (7%)
Query: 752 RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSL 811
           ++RKR ++   Q     +  L    FE K+   G G  G V+K           +KL  L
Sbjct: 47  QQRKRLEAFLTQKQKVGE--LKDDDFE-KISELGAGNGGVVFKVSHKPSGLVMARKLIHL 103
Query: 812 PTGEIGINQKGFVSEITEIRHRN---IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEA 868
                  NQ   + E+  +   N   IV FYG       + +  E+++ GSL  +L    
Sbjct: 104 EIKPAIRNQ--IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 161
Query: 869 TAAELDWSK-RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
              E    K  + VIKG    L+Y+       I+HRD+    +L++   +  + DFG + 
Sbjct: 162 RIPEQILGKVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 215
Query: 928 FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            L    +N     GT  Y++PE       + + D+++ G+ ++E+  G++P
Sbjct: 216 QLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 74  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 126
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 125
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  + Q   
Sbjct: 5   NDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              +T ++       Y F +H +  F V EY   G L   LS E    E    +R     
Sbjct: 64  HPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYG 111
Query: 884 G-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
             + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +      GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGT 168
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             Y+APE+          D +  GV++ E++ G+ P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  + Q   
Sbjct: 5   NDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              +T ++       Y F +H +  F V EY   G L   LS E    E    +R     
Sbjct: 64  HPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYG 111
Query: 884 G-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
             + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +      GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGT 168
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             Y+APE+          D +  GV++ E++ G+ P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  + Q   
Sbjct: 5   NDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              +T ++       Y F +H +  F V EY   G L   LS E    E    +R     
Sbjct: 64  HPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYG 111
Query: 884 G-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
             + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +      GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGT 168
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             Y+APE+          D +  GV++ E++ G+ P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 31  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 87
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 148 SCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLAR----DINNIDY 199
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 72  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 124
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 16  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 75  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 127
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 187
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 188 AVDIWSLGCIFAEMV 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  + Q   
Sbjct: 8   NDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 66
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              +T ++       Y F +H +  F V EY   G L   LS E    E    +R     
Sbjct: 67  HPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYG 114
Query: 884 G-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
             + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +      GT
Sbjct: 115 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 171
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             Y+APE+          D +  GV++ E++ G+ P
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  + Q   
Sbjct: 5   NDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              +T ++       Y F +H +  F V EY   G L   LS E    E    +R     
Sbjct: 64  HPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYG 111
Query: 884 G-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
             + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +      GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             Y+APE+          D +  GV++ E++ G+ P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 17/216 (7%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
           ND +  +LL   TF GK++L      G  Y  ++   +    K   +    E  + Q   
Sbjct: 5   NDFDYLKLLGKGTF-GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
              +T ++       Y F +H +  F V EY   G L   LS E    E    +R     
Sbjct: 64  HPFLTALK-------YAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYG 111
Query: 884 G-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
             + +AL Y+H      +++RDI  + ++LD +    ++DFG  K    D +      GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
             Y+APE+          D +  GV++ E++ G+ P
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/297 (21%), Positives = 119/297 (40%), Gaps = 56/297 (18%)
Query: 785  GTGGCGTVYKAELTS-GDTRAVKKL--HSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
            G G  G V +A     G   AV K+    L +      ++  +SE+  +    +H NIV 
Sbjct: 40   GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 99
Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAA--------------------ELDWSK 877
              G C+H   + ++ EY   G L   L  +A A                      L+   
Sbjct: 100  LLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRD 159
Query: 878  RVNVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             ++    VA  ++++   +C    +HRD++++ VLL   + A + DFG A+ +  DS+  
Sbjct: 160  LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 937  SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXX 991
             +        ++APE  +      + DV+++G+L+ E+       +PG            
Sbjct: 216  VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG------------ 263
Query: 992  XXNMNIVVNDLIDSRLPPPLGEVEEKL--KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 I+VN      +       +     K++ ++   C    P  RPT Q++C+ L
Sbjct: 264  -----ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 315

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 36  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 92
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 153 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 204
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 33  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 89
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L              N     ++ +   V
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 150 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 201
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 73  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 125
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 774 ASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGF--VSEIT 828
           A  +E K+   G G   TVYKA +  +    A+KK  L      + GIN+     +  + 
Sbjct: 9   AKRYE-KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           E+ H NI+       H  ++ LV++++E   L  I+ + +        K   ++      
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQG 124
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
           L Y+H      ILHRD+    +LLD      ++DFG AK     +  +     T  Y AP
Sbjct: 125 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAP 181
Query: 949 ELAYTMRA-NEKCDVFNFGVLVLEVI 973
           EL +  R      D++  G ++ E++
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREKH--KI 126
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 184
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 23/166 (13%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           ++NI++   F       +LV+E L+ GS+   +  +    E + S+   V++ VA AL +
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR---VVRDVAAALDF 126
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSS----NWSELAGTCG 944
           +H      I HRD+  + +L +   K     + DF     +K ++S       EL   CG
Sbjct: 127 LHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 945 ---YIAPEL--AYTMRA---NEKCDVFNFGVLVLEVIEGKHP--GH 980
              Y+APE+   +T +A   +++CD+++ GV++  ++ G  P  GH
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGH 229

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 17/231 (7%)
Query: 752 RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSL 811
           ++RKR ++   Q     +  L    FE K+   G G  G V+K           +KL  L
Sbjct: 12  QQRKRLEAFLTQKQKVGE--LKDDDFE-KISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68
Query: 812 PTGEIGINQKGFVSEITEIRHRN---IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEA 868
                  NQ   + E+  +   N   IV FYG       + +  E+++ GSL  +L    
Sbjct: 69  EIKPAIRNQ--IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126
Query: 869 TAAELDWSK-RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
              E    K  + VIKG    L+Y+       I+HRD+    +L++   +  + DFG + 
Sbjct: 127 RIPEQILGKVSIAVIKG----LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 928 FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            L    +N     GT  Y++PE       + + D+++ G+ ++E+  G++P
Sbjct: 181 QLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK--HKI 126
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 184
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK--HKI 126
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 184
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 759 SQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGEI 816
           S+   N+    +LL   TF GK++L      G  Y  ++   +    K    H+L    +
Sbjct: 3   SRVTMNEFEYLKLLGKGTF-GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 61
Query: 817 GINQKGFVSEITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDW 875
             N           RH  +    Y F +H +  F V EY   G L   LS E   +E D 
Sbjct: 62  LQNS----------RHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE-DR 109
Query: 876 SKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN 935
           ++       + +AL Y+H +    +++RD+  + ++LD +    ++DFG  K    D + 
Sbjct: 110 ARFYGA--EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 165
Query: 936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 166 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAV 126
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +  ++L   CG   Y 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDTFCGSPPYA 179
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 13/146 (8%)
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
           FY F    ++L++V EY+  G L  ++SN     +  W++       V  AL  +H   F
Sbjct: 140 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHSMGF 194
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTA-KFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              +HRD+    +LLD      ++DFGT  K  K          GT  YI+PE+  +   
Sbjct: 195 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 957 N----EKCDVFNFGVLVLEVIEGKHP 978
           +     +CD ++ GV + E++ G  P
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAV 126
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +  ++L   CG   Y 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDTFCGSPPYA 179
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAV 126
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +  ++L   CG   Y 
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDTFCGSPPYA 179
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK--HKI 126
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 184
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V+K           +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 15  GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + VIKG    L+Y+       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREKH--KI 126
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 184
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 185 DIWSMGLSLVEMAVGRYP 202

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 28/231 (12%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTRAVKKLHSLPTGEIGINQKG 822
           N   + E +    FE   VL GTG  G V+     SG DT  +  +  L    I   QK 
Sbjct: 43  NLTGHAEKVGIENFELLKVL-GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI--VQKA 99
Query: 823 FVSEITEIRHRNIVKF-----------YGFCSHTQHLFLVYEYLERGSLATILSNEATAA 871
             +E T    R +++            Y F + T+ L L+ +Y+  G L T LS      
Sbjct: 100 KTTEHTRTE-RQVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFT 157
Query: 872 ELDWSKRVNVIKG-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-FL 929
           E      V +  G +  AL ++H      I++RDI  + +LLD      ++DFG +K F+
Sbjct: 158 E----HEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210
Query: 930 KPDSSNWSELAGTCGYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGKHP 978
             ++    +  GT  Y+AP++     +  ++  D ++ GVL+ E++ G  P
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 13/146 (8%)
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
           FY F    ++L++V EY+  G L  ++SN     +  W++       V  AL  +H   F
Sbjct: 135 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHSMGF 189
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTA-KFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              +HRD+    +LLD      ++DFGT  K  K          GT  YI+PE+  +   
Sbjct: 190 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 957 N----EKCDVFNFGVLVLEVIEGKHP 978
           +     +CD ++ GV + E++ G  P
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           ++ + +I+H NIV        T H +LV + +  G L   +       E D S    VI+
Sbjct: 57  IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQ 113
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSSNWSELA 940
            V +A+ Y+H +    I+HRD+  + +L    +   K  ++DFG +K     +   S   
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC 168
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+      ++  D ++ GV+   ++ G  P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 20/218 (9%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGEIGINQK 821
           N+    +LL   TF GK++L      G  Y  ++   +    K    H+L    +  N  
Sbjct: 9   NEFEYLKLLGKGTF-GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS- 66
Query: 822 GFVSEITEIRHRNIVKF-YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
                    RH  +    Y F +H +  F V EY   G L   LS E   +E D ++   
Sbjct: 67  ---------RHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE-DRARFYG 115
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
               + +AL Y+H +    +++RD+  + ++LD +    ++DFG  K    D +      
Sbjct: 116 A--EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC 171
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 8/150 (5%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAV 127
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
            Y H      I+HRD+ ++ +LLD +    ++DFG +       +      G+  Y APE
Sbjct: 128 QYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTFCGSPPYAAPE 183
Query: 950 LAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           L    + +  + DV++ GV++  ++ G  P
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 8/150 (5%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+L+ EY   G +   L       E +   +    + + +A+
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAV 124
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
            Y H      I+HRD+ ++ +LLD +    ++DFG +              G+  Y APE
Sbjct: 125 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPPYAAPE 180
Query: 950 LAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           L    + +  + DV++ GV++  ++ G  P
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 49/290 (16%)
Query: 785  GTGGCGTVYKAELTS-GDTRAVKKL--HSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
            G G  G V +A     G   AV K+    L +      ++  +SE+  +    +H NIV 
Sbjct: 55   GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--VNVIKG 884
              G C+H   + ++ EY   G L   L            N +   E   S R  ++    
Sbjct: 115  LLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQ 174
Query: 885  VANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT- 942
            VA  ++++   +C    +HRD++++ VLL   + A + DFG A+ +  DS+   +     
Sbjct: 175  VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 943  -CGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPGHFXXXXXXXXXXXXNMNIV 998
               ++APE  +      + DV+++G+L+ E+       +PG                 I+
Sbjct: 231  PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG-----------------IL 273
Query: 999  VNDLIDSRLPPPLGEVEEKL--KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            VN      +       +     K++ ++   C    P  RPT Q++C+ L
Sbjct: 274  VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           + H NIVK +      + L+LV EY   G +   L       E +   +    + + +A+
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAK---FRQIVSAV 119
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
            Y H      I+HRD+ ++ +LLD +    ++DFG +     + +  ++L   CG   Y 
Sbjct: 120 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN----EFTFGNKLDTFCGSPPYA 172
Query: 947 APELAYTMRAN-EKCDVFNFGVLVLEVIEGKHP 978
           APEL    + +  + DV++ GV++  ++ G  P
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 13/146 (8%)
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
           FY F    ++L++V EY+  G L  ++SN     +  W++       V  AL  +H   F
Sbjct: 140 FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHSMGF 194
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTA-KFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              +HRD+    +LLD      ++DFGT  K  K          GT  YI+PE+  +   
Sbjct: 195 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 251
Query: 957 N----EKCDVFNFGVLVLEVIEGKHP 978
           +     +CD ++ GV + E++ G  P
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 134
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAA-------------ELDWSKRV 879
           +NI+   G C+    L+++ EY  +G+L   L                    +L     V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    VA  + Y+    C    +HRD++++ VL+  +    ++DFG A+ +         
Sbjct: 195 SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 939 LAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
             G     ++APE  +      + DV++FGVL+ E+ 
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 25/164 (15%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           HRN+++   F       +LV+E +  GS+ + +       EL+ S    V++ VA+AL +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDF 126
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVS-------DFGTAKFLKPDSSNWS--ELAGT 942
           +H+     I HRD+  + +L   E+   VS       D G+   L  D S  S  EL   
Sbjct: 127 LHNK---GIAHRDLKPENIL--CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 943 CG---YIAPEL--AYTMRA---NEKCDVFNFGVLVLEVIEGKHP 978
           CG   Y+APE+  A++  A   +++CD+++ GV++  ++ G  P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E++++     + ++  T   L   K     +++G+A   S+        
Sbjct: 74  IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 126
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +++H NIV+ +         +LV++ +  G L   +      +E D S   + I+ +  +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILES 117
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGY 945
           ++Y H +    I+HR++  + +LL  + K     ++DFG A  +  DS  W   AGT GY
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGY 173
Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++PE+      ++  D++  GV++  ++ G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +++H NIV+ +         +LV++ +  G L   +      +E D S   + I+ +  +
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILES 116
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGY 945
           ++Y H +    I+HR++  + +LL  + K     ++DFG A  +  DS  W   AGT GY
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGY 172
Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++PE+      ++  D++  GV++  ++ G  P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +++H NIV+ +         +LV++ +  G L   +      +E D S   + I+ +  +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILES 117
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKA---HVSDFGTAKFLKPDSSNWSELAGTCGY 945
           ++Y H +    I+HR++  + +LL  + K     ++DFG A  +  DS  W   AGT GY
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGY 173
Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++PE+      ++  D++  GV++  ++ G  P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+ K+  L T   G+       +S + E+ H NIVK    
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 71  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 123
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+ K+  L T   G+       +S + E+ H NIVK    
Sbjct: 11  GEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L +     + ++  T   L   K     +++G+A   S+        
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 122
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+    +  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 13  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L       + ++  T   L   K     +++G+A   S+        
Sbjct: 72  IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 124
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 22/219 (10%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGEIGINQK 821
           N+    +LL   TF GK++L      G  Y  ++   +    K    H+L    +  N +
Sbjct: 148 NEFEYLKLLGKGTF-GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 822 G-FVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
             F++ +           Y F +H + L  V EY   G L   LS E   +E     R  
Sbjct: 207 HPFLTALK----------YSFQTHDR-LCFVMEYANGGELFFHLSRERVFSE----DRAR 251
Query: 881 VIKG-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
                + +AL Y+H +    +++RD+  + ++LD +    ++DFG  K    D +     
Sbjct: 252 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 22/219 (10%)
Query: 764 NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKK--LHSLPTGEIGINQK 821
           N+    +LL   TF GK++L      G  Y  ++   +    K    H+L    +  N +
Sbjct: 151 NEFEYLKLLGKGTF-GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 209
Query: 822 G-FVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
             F++ +           Y F +H + L  V EY   G L   LS E   +E     R  
Sbjct: 210 HPFLTALK----------YSFQTHDR-LCFVMEYANGGELFFHLSRERVFSE----DRAR 254
Query: 881 VIKG-VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
                + +AL Y+H +    +++RD+  + ++LD +    ++DFG  K    D +     
Sbjct: 255 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 312
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 27/242 (11%)
Query: 752 RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLH--------GTGGCGTVYKAE-LTSGDT 802
           R R+ +   E    V   E L    +E +  +H        G G  G V++ E   +G  
Sbjct: 61  RSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQ 120
Query: 803 RAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT 862
            AVKK+       + + +   +     +    IV  YG       + +  E LE GSL  
Sbjct: 121 CAVKKV------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 174
Query: 863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVS 921
           ++  +    E    + +  +      L Y+H      ILH D+ +  VLL  +   A + 
Sbjct: 175 LVKEQGCLPE---DRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALC 228
Query: 922 DFGTAKFLKPDSSNWSELAG-----TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
           DFG A  L+PD    S L G     T  ++APE+      + K DV++   ++L ++ G 
Sbjct: 229 DFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGC 288
Query: 977 HP 978
           HP
Sbjct: 289 HP 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L       + ++  T   L   K     +++G+A   S+        
Sbjct: 74  IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 126
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           +V+ +      ++L++V EY+  G L  ++SN     +  W+K       V  AL  +H 
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYTA--EVVLALDAIHS 192
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS---NWSELAGTCGYIAPELA 951
                ++HRD+    +LLD      ++DFGT   +K D +   +     GT  YI+PE+ 
Sbjct: 193 ---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 952 YTMRAN----EKCDVFNFGVLVLEVIEGKHP 978
            +   +     +CD ++ GV + E++ G  P
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 14  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L       + ++  T   L   K     +++G+A   S+        
Sbjct: 73  IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 125
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
           AL Y+ +     I+HRD+    +LLD     H++DF  A  L P  +  + +AGT  Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYMA 182
Query: 948 PELAYTMRA---NEKCDVFNFGVLVLEVIEGKHPGH 980
           PE+  + +    +   D ++ GV   E++ G+ P H
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 799 SGDTRAVKKL-HSLPTGEIGINQKGFVSEITEIR--HRN-IVKFYG--FCSHTQHLFLVY 852
           +G   AVK+L HS P       Q+ F  EI  ++  H + IVK+ G  +    Q L LV 
Sbjct: 51  TGALVAVKQLQHSGPD-----QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 105
Query: 853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVL 911
           EYL  G L   L      A LD S+ +     +   + Y+    C    +HRD++++ +L
Sbjct: 106 EYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNIL 159
Query: 912 LDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVL 968
           ++ E    ++DFG AK L  D   +           + APE       + + DV++FGV+
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219
Query: 969 VLEV 972
           + E+
Sbjct: 220 LYEL 223

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA    +G+  A+KK+  L T   G+       +S + E+ H NIVK    
Sbjct: 15  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR--VNVIKGVANALSYMHHDCFPP 899
                 L+LV+E+L       + ++  T   L   K     +++G+A   S+        
Sbjct: 74  IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------- 126
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR-ANE 958
           +LHRD+  + +L++ E    ++DFG A+        +     T  Y APE+    +  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 959 KCDVFNFGVLVLEVI 973
             D+++ G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 15/142 (10%)
Query: 842 CSHTQ-HLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVIKGVANALSYMHHDCF 897
           C  T+  LF V EY+  G L   +  +    E     +S  +++      AL+Y+H    
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER-- 129
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRA 956
             I++RD+    VLLD E    ++D+G  K  L+P  +  S   GT  YIAPE+      
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAPEILRGEDY 187
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
               D +  GVL+ E++ G+ P
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSP 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   + L LV E    G L   L  +    E+  S    ++  V+  + Y+  
Sbjct: 72  IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE 128
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG-----YIAPE 949
             F   +HRD++++ VLL   + A +SDFG +K L  D S ++  A + G     + APE
Sbjct: 129 KNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--ARSAGKWPLKWYAPE 183
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
                + + + DV+++GV + E +  G+ P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 15/142 (10%)
Query: 842 CSHTQ-HLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVIKGVANALSYMHHDCF 897
           C  T+  LF V EY+  G L   +  +    E     +S  +++      AL+Y+H    
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHERG- 173
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKF-LKPDSSNWSELAGTCGYIAPELAYTMRA 956
             I++RD+    VLLD E    ++D+G  K  L+P  +  S   GT  YIAPE+      
Sbjct: 174 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDY 230
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
               D +  GVL+ E++ G+ P
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSP 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++  Y  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 15/142 (10%)
Query: 842 CSHTQ-HLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVIKGVANALSYMHHDCF 897
           C  T+  LF V EY+  G L   +  +    E     +S  +++      AL+Y+H    
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER-- 125
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRA 956
             I++RD+    VLLD E    ++D+G  K  L+P  +  S   GT  YIAPE+      
Sbjct: 126 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAPEILRGEDY 183
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
               D +  GVL+ E++ G+ P
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSP 205

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 799 SGDTRAVKKL-HSLPTGEIGINQKGFVSEITEIR--HRN-IVKFYG--FCSHTQHLFLVY 852
           +G   AVK+L HS P       Q+ F  EI  ++  H + IVK+ G  +    Q L LV 
Sbjct: 39  TGALVAVKQLQHSGPD-----QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 93
Query: 853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVL 911
           EYL  G L   L      A LD S+ +     +   + Y+    C    +HRD++++ +L
Sbjct: 94  EYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNIL 147
Query: 912 LDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVL 968
           ++ E    ++DFG AK L  D   +           + APE       + + DV++FGV+
Sbjct: 148 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 207
Query: 969 VLEV 972
           + E+
Sbjct: 208 LYEL 211

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
           +H NI+         +H++LV E +  G L   +  +   +E + S    V+  +   + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKTVE 135
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYK----AHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           Y+H      ++HRD+    +L   E        + DFG AK L+ ++        T  ++
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+      +E CD+++ G+L+  ++ G  P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 799 SGDTRAVKKL-HSLPTGEIGINQKGFVSEITEIR--HRN-IVKFYG--FCSHTQHLFLVY 852
           +G   AVK+L HS P       Q+ F  EI  ++  H + IVK+ G  +    Q L LV 
Sbjct: 38  TGALVAVKQLQHSGPD-----QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM 92
Query: 853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVL 911
           EYL  G L   L      A LD S+ +     +   + Y+    C    +HRD++++ +L
Sbjct: 93  EYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNIL 146
Query: 912 LDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVL 968
           ++ E    ++DFG AK L  D   +           + APE       + + DV++FGV+
Sbjct: 147 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 206
Query: 969 VLEV 972
           + E+
Sbjct: 207 LYEL 210

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 15/139 (10%)
Query: 848 LFLVYEYLERGSLATILSN--EATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI 905
           L+LV +Y   G L T+LS   +    E+       ++  + +++  +H+      +HRDI
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI-DSVHQLHY------VHRDI 201
Query: 906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTM-----RANEK 959
               +L+D+     ++DFG+   L  D +  S +A GT  YI+PE+   M     R   +
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 960 CDVFNFGVLVLEVIEGKHP 978
           CD ++ GV + E++ G+ P
Sbjct: 262 CDWWSLGVCMYEMLYGETP 280

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 15/142 (10%)
Query: 842 CSHTQ-HLFLVYEYLERGSLATILSNEATAAELD---WSKRVNVIKGVANALSYMHHDCF 897
           C  T+  LF V EY+  G L   +  +    E     +S  +++      AL+Y+H    
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHERG- 141
Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKF-LKPDSSNWSELAGTCGYIAPELAYTMRA 956
             I++RD+    VLLD E    ++D+G  K  L+P  +  S   GT  YIAPE+      
Sbjct: 142 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAPEILRGEDY 198
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
               D +  GVL+ E++ G+ P
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSP 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIG-----INQKGFVSEITEIRHRNIVKF 838
           G G  GTVYKA +  SG   A+K +  +P GE G     + +   +  +    H N+V+ 
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVR-VPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 839 YGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
              C+ ++      + LV+E++++  L T L ++A    L      ++++     L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
            +C   I+HRD+  + +L+       ++DFG A+      +  + +  T  Y APE+   
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVVTLWYRAPEVLLQ 185
Query: 954 MRANEKCDVFNFGVLVLEVIEGK 976
                  D+++ G +  E+   K
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRK 208

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 25/164 (15%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
           HRN+++   F       +LV+E +  GS+ + +       EL+ S    V++ VA+AL +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDF 126
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVS-----DFGTAKFLK--PDSSNWS--ELAGT 942
           +H+     I HRD+  + +L   E+   VS     DFG    +K   D S  S  EL   
Sbjct: 127 LHNK---GIAHRDLKPENIL--CEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP 181
Query: 943 CG---YIAPEL--AYTMRA---NEKCDVFNFGVLVLEVIEGKHP 978
           CG   Y+APE+  A++  A   +++CD+++ GV++  ++ G  P
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 43/220 (19%)
Query: 785 GTGGCGTVYKAELTSGD--------TRAVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D        T AVK L    T +   +    VSE+  ++    H
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEMEMMKMIGKH 100
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-------------NEATAAELDWSKRV 879
           +NI+   G C+    L+++  Y  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 880 NVIKGVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
           +    +A  + Y+    C    +HRD++++ VL+       ++DFG A+    D +N   
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 939 LAGTCG------YIAPELAYTMRANEKCDVFNFGVLVLEV 972
              T        ++APE  +      + DV++FGVL+ E+
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 18/183 (9%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFC--SHTQHLFLVYE 853
           +G+  AVK L +    +   ++ G+  EI  +R   H +I+K+ G C  +    L LV E
Sbjct: 59  TGEMVAVKALKADAGPQ---HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           Y+  GSL   L   +    +  ++ +   + +   ++Y+H   +   +HRD++++ VLLD
Sbjct: 116 YVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLD 168
Query: 914 LEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            +    + DFG AK +      +    +      + APE     +     DV++FGV + 
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 971 EVI 973
           E++
Sbjct: 229 ELL 231

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIG-----INQKGFVSEITEIRHRNIVKF 838
           G G  GTVYKA +  SG   A+K +  +P GE G     + +   +  +    H N+V+ 
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVR-VPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 839 YGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
              C+ ++      + LV+E++++  L T L ++A    L      ++++     L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
            +C   I+HRD+  + +L+       ++DFG A+      + +  +  T  Y APE+   
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAPEVLLQ 185
Query: 954 MRANEKCDVFNFGVLVLEVIEGK 976
                  D+++ G +  E+   K
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRK 208

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
           +H NI+         +H++LV E +  G L   +  +   +E + S    V+  +   + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKTVE 135
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYK----AHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           Y+H      ++HRD+    +L   E        + DFG AK L+ ++        T  ++
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+      +E CD+++ G+L+  ++ G  P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIG-----INQKGFVSEITEIRHRNIVKF 838
           G G  GTVYKA +  SG   A+K +  +P GE G     + +   +  +    H N+V+ 
Sbjct: 13  GVGAYGTVYKARDPHSGHFVALKSVR-VPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 839 YGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
              C+ ++      + LV+E++++  L T L ++A    L      ++++     L ++H
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
            +C   I+HRD+  + +L+       ++DFG A+      +    +  T  Y APE+   
Sbjct: 130 ANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWYRAPEVLLQ 185
Query: 954 MRANEKCDVFNFGVLVLEVIEGK 976
                  D+++ G +  E+   K
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRK 208

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 785 GTGGCGTVYK-AELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
           G G  G V++  E +S  T   K +    T ++ + ++  +S +   RHRNI+  +    
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE--ISILNIARHRNILHLHESFE 71
Query: 844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPILH 902
             + L +++E++    L        +A EL+  + V+ +  V  AL ++H H+    I H
Sbjct: 72  SMEELVMIFEFIS--GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN----IGH 125
Query: 903 RDISSKKVLLDLEYKAHVS--DFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            DI  + ++      + +   +FG A+ LKP   N+  L     Y APE+      +   
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G LV  ++ G +P
Sbjct: 185 DMWSLGTLVYVLLSGINP 202

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 785 GTGGCGTV----YKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE----ITEIRHRNIV 836
           G G  G V    +KAE      + ++K   L   E    +K  +SE    +  ++H  +V
Sbjct: 47  GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE----EKHIMSERNVLLKNVKHPFLV 102
Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
             +        L+ V +Y+  G L   L  E    E    +       +A+AL Y+H   
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---PRARFYAAEIASALGYLHSLN 159
Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              I++RD+  + +LLD +    ++DFG  K     +S  S   GT  Y+APE+ +    
Sbjct: 160 ---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
           +   D +  G ++ E++ G  P
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN---IVKFYGF 841
           G G  G V K +         +KL  L       NQ   + E+  +   N   IV FYG 
Sbjct: 25  GAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGA 82
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK-RVNVIKGVANALSYMHHDCFPPI 900
                 + +  E+++ GSL  +L       E    K  + V++G+A  L   H      I
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA-YLREKHQ-----I 136
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           +HRD+    +L++   +  + DFG +  L    +N     GT  Y+APE       + + 
Sbjct: 137 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMAPERLQGTHYSVQS 194
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D+++ G+ ++E+  G++P
Sbjct: 195 DIWSMGLSLVELAVGRYP 212

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLP-TGEIGINQKGFVSEITEIRHRNIVKFYGFC 842
           G G    V++     +GD  A+K  +++     + +  + F   + ++ H+NIVK +   
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF-EVLKKLNHKNIVKLFAIE 76
Query: 843 SHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             T  +H  L+ E+   GSL T+L   + A  L  S+ + V++ V   ++++  +    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 901 LHRDISSKKVLL----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL---AYT 953
           +HR+I    ++     D +    ++DFG A+ L+ D   +  L GT  Y+ P++   A  
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 954 MRANEK-----CDVFNFGVLVLEVIEGKHP 978
            + ++K      D+++ GV       G  P
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLP-TGEIGINQKGFVSEITEIRHRNIVKFYGFC 842
           G G    V++     +GD  A+K  +++     + +  + F   + ++ H+NIVK +   
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF-EVLKKLNHKNIVKLFAIE 76
Query: 843 SHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             T  +H  L+ E+   GSL T+L   + A  L  S+ + V++ V   ++++  +    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 901 LHRDISSKKVLL----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL---AYT 953
           +HR+I    ++     D +    ++DFG A+ L+ D   +  L GT  Y+ P++   A  
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDMYERAVL 192
Query: 954 MRANEK-----CDVFNFGVLVLEVIEGKHP 978
            + ++K      D+++ GV       G  P
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 47/185 (25%), Positives = 89/185 (48%), Gaps = 22/185 (11%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQK-GFVSEITEIR---HRNIVKFYGFCSHT--QHLFLVY 852
           +G+  AVK L +    + G   + G+  EI  +R   H +I+K+ G C     + L LV 
Sbjct: 42  TGEMVAVKALKA----DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVM 97
Query: 853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL 912
           EY+  GSL   L   +    +  ++ +   + +   ++Y+H   +   +HR+++++ VLL
Sbjct: 98  EYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHSQHY---IHRNLAARNVLL 150
Query: 913 DLEYKAHVSDFGTAKFLKPDSSNWSELA----GTCGYIAPELAYTMRANEKCDVFNFGVL 968
           D +    + DFG AK + P+   +  +         + APE     +     DV++FGV 
Sbjct: 151 DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 969 VLEVI 973
           + E++
Sbjct: 210 LYELL 214

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 93
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 43/214 (20%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQ-KGFVSEITEIRHRNIVKFYGF-- 841
           G GG G V++A+    D     K   LP  E+   +    V  + ++ H  IV+++    
Sbjct: 14  GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 842 ----------CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
                      S   +L++  +   + +L   ++   T  E + S  +++   +A A+ +
Sbjct: 74  EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA----------- 940
           +H      ++HRD+    +   ++    V DFG    +  D    + L            
Sbjct: 134 LHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 941 -GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
            GT  Y++PE  +    + K D+F+ G+++ E++
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 10/127 (7%)
Query: 155 LGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGL 214
           +  L+S  ++ L +   + V P  L GL NL  +YL+ N+I    P  +  L +L YL +
Sbjct: 109 IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 164
Query: 215 NKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS 274
             NQ++   P    NLS L  L   DN++S   P  L S  +L+ ++L  NQ++   P  
Sbjct: 165 GNNQVNDLTP--LANLSKLTTLRADDNKISDISP--LASLPNLIEVHLKDNQISDVSP-- 218
Query: 275 FGNLSSL 281
             NLS+L
Sbjct: 219 LANLSNL 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            IV  YG       + +  E LE GSL  ++       E    + +  +      L Y+H
Sbjct: 125 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH 181
Query: 894 HDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAG-----TCGYIA 947
                 ILH D+ +  VLL  +  +A + DFG A  L+PD    S L G     T  ++A
Sbjct: 182 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 238
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           PE+      + K D+++   ++L ++ G HP
Sbjct: 239 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 47/185 (25%), Positives = 89/185 (48%), Gaps = 22/185 (11%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQK-GFVSEITEIR---HRNIVKFYGFCSHT--QHLFLVY 852
           +G+  AVK L +    + G   + G+  EI  +R   H +I+K+ G C     + L LV 
Sbjct: 42  TGEMVAVKALKA----DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVM 97
Query: 853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL 912
           EY+  GSL   L   +    +  ++ +   + +   ++Y+H   +   +HR+++++ VLL
Sbjct: 98  EYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHY---IHRNLAARNVLL 150
Query: 913 DLEYKAHVSDFGTAKFLKPDSSNWSELA----GTCGYIAPELAYTMRANEKCDVFNFGVL 968
           D +    + DFG AK + P+   +  +         + APE     +     DV++FGV 
Sbjct: 151 DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 969 VLEVI 973
           + E++
Sbjct: 210 LYELL 214

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFY----- 839
           G G  G V+  +   G+  AVK   +  T E    ++  + +   +RH NI+ F      
Sbjct: 46  GKGRYGEVWMGKW-RGEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF-- 897
           G  S TQ L+L+ +Y E GSL   L     +  LD    + +     + L ++H + F  
Sbjct: 103 GTGSWTQ-LYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 898 ---PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW----SELAGTCGYIAPE- 949
              P I HRD+ SK +L+       ++D G A     D++      +   GT  Y+ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 950 LAYTMRANE-----KCDVFNFGVLVLEV 972
           L  ++  N        D+++FG+++ EV
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 27/242 (11%)
Query: 752 RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLH--------GTGGCGTVYKAE-LTSGDT 802
           R R+ +   E    V   E L    +E +  +H        G G  G V++ E   +G  
Sbjct: 42  RSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQ 101
Query: 803 RAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT 862
            AVKK+       + + +   +     +    IV  YG       + +  E LE GSL  
Sbjct: 102 CAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 155
Query: 863 ILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVS 921
           ++  +    E    + +  +      L Y+H      ILH D+ +  VLL  +   A + 
Sbjct: 156 LVKEQGCLPE---DRALYYLGQALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALC 209
Query: 922 DFGTAKFLKPDSSNWSELAG-----TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
           DFG A  L+PD      L G     T  ++APE+      + K DV++   ++L ++ G 
Sbjct: 210 DFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGC 269
Query: 977 HP 978
           HP
Sbjct: 270 HP 271

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 22  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 78
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 72/137 (52%), Gaps = 7/137 (5%)
Query: 178 SLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFL 236
           +L  L NLT++ L  N++  S+P+ +   L +L  L L +NQL          L+NL +L
Sbjct: 80  ALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 237 YLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGS 295
           YL+ N+L            +L  L L +NQL  SLP   F  L+ LK L + N N+L  S
Sbjct: 139 YLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQ-SLPEGVFDKLTQLKQLSL-NDNQLK-S 195
Query: 296 IPKEI-GNLKSLSHLWL 311
           +P  +   L SL+H+WL
Sbjct: 196 VPDGVFDRLTSLTHIWL 212

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 29  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 85
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 146 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 93
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 93
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 30  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 86
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 147 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 26  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 82
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 143 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 785 GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEIR----H 832
           G G  G V  AE    D          AVK L S  T +   +    +SE+  ++    H
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 93
Query: 833 RNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----------NEATAAELDWSKR--V 879
           +NI+   G C+    L+++ EY  +G+L   L            N +   E   S +  V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 880 NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 154 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 940 AG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            G     ++APE  +      + DV++FGVL+ E+
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 28/288 (9%)
Query: 272 PSSFGNLSSLKHLHVHNINKLSGSIPKE--IGNLKSLSHLWLSKTQL-SGFIPPSLGNLS 328
           P +F  L  L  L ++    LS ++ K+    NLK+L+ L LSK Q+ S ++ PS G L+
Sbjct: 90  PDAFQGLFHLFELRLY-FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLN 148
Query: 329 NIRGLYIRENMLYGSIPEELGRL--KSLSQLSLSVNKLNGSIP----HCLGNLSNLKFFA 382
           +++ +    N ++     EL  L  K+LS  SL+ N L   +      C+    N+    
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208
Query: 383 LREN------ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS-----GSLTHFSV 431
           L  +      +++G+    I   +  +  L       G+   N+          L   SV
Sbjct: 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268
Query: 432 RN----NNFVGPI-PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFG 486
           R+    + FV  +  R  +    L  L L  N++     E F    +L++L+LS  N  G
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS-YNLLG 327
Query: 487 EI-SSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLV 533
           E+ SSN+   P++A +++  N I+         + +L  LD   N L 
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            IV  YG       + +  E LE GSL  ++       E    + +  +      L Y+H
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLH 183
Query: 894 HDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAG-----TCGYIA 947
                 ILH D+ +  VLL  +  +A + DFG A  L+PD    S L G     T  ++A
Sbjct: 184 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 240
Query: 948 PELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           PE+      + K D+++   ++L ++ G HP
Sbjct: 241 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           + + L ++H      I++RD+  + VLLD +    +SD G A  LK   +     AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++APEL      +   D F  GV + E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           + + L ++H      I++RD+  + VLLD +    +SD G A  LK   +     AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++APEL      +   D F  GV + E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK--- 837
           G G  G V++A+L   D  A+KK+         +  K F +   +I    +H N+V    
Sbjct: 49  GNGSFGVVFQAKLVESDEVAIKKV---------LQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 838 -FYGFCSHTQHLF--LVYEYLERGSLATILSNEATAAELDWSKRVNVIK----GVANALS 890
            FY        +F  LV EY+      T+       A+L  +  + +IK     +  +L+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           Y+H      I HRDI  + +LLD       + DFG+AK L     N S +     Y APE
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAPE 211
Query: 950 LAY-TMRANEKCDVFNFGVLVLEVIEGK 976
           L +         D+++ G ++ E+++G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           + + L ++H      I++RD+  + VLLD +    +SD G A  LK   +     AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++APEL      +   D F  GV + E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 12/150 (8%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV  YG       + +  E LE GSL  ++       E    + +  +      L Y+H 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHT 168
Query: 895 DCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAG-----TCGYIAP 948
                ILH D+ +  VLL  +  +A + DFG A  L+PD    S L G     T  ++AP
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 949 ELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E+      + K D+++   ++L ++ G HP
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 885 VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           + + L ++H      I++RD+  + VLLD +    +SD G A  LK   +     AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++APEL      +   D F  GV + E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 783 LHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFY 839
           L G+GG G V+KA+    G T  +K++          N+K    V  + ++ H NIV + 
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAKLDHVNIVHYN 70
Query: 840 GFC-----------------SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVI 882
           G C                 S T+ LF+  E+ ++G+L   +       +LD    + + 
Sbjct: 71  G-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELF 128
Query: 883 KGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
           + +   + Y+H      +++RD+    + L    +  + DFG    LK D        GT
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-XRSKGT 184
Query: 943 CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
             Y++PE   +    ++ D++  G+++ E++
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 45/79 (56%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  LAGT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 829 EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +++H NIV+ +         +LV++ +  G L   +      +E D S   + I+ +  +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILES 140
Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSELAGTCGY 945
           ++Y H +    I+HR++  + +LL  + K     ++DFG A  +  DS  W   AGT GY
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGY 196
Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           ++PE+      ++  D++  GV++  ++ G  P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 7/138 (5%)
Query: 842 CSHT-QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
           C  T   L+ V EY+  G L   +       E      V     +A  L ++       I
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---PHAVFYAAEIAIGLFFLQSKG---I 142
Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
           ++RD+    V+LD E    ++DFG  K    D        GT  YIAPE+       +  
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSV 202
Query: 961 DVFNFGVLVLEVIEGKHP 978
           D + FGVL+ E++ G+ P
Sbjct: 203 DWWAFGVLLYEMLAGQAP 220

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 44/196 (22%), Positives = 90/196 (45%), Gaps = 34/196 (17%)
Query: 804 AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATI 863
           AVK L    + ++  + +   + + E  + NIVK  G C+  + + L++EY+  G L   
Sbjct: 81  AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140
Query: 864 L-------------SNEATAAE--------LDWSKRVNVIKGVANALSYMHHDCFPPILH 902
           L             S+ +T A         L  ++++ + + VA  ++Y+    F   +H
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VH 197
Query: 903 RDISSKKVLLDLEYKAHVSDFG------TAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
           RD++++  L+       ++DFG      +A + K D ++    A    ++ PE  +  R 
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND----AIPIRWMPPESIFYNRY 253
Query: 957 NEKCDVFNFGVLVLEV 972
             + DV+ +GV++ E+
Sbjct: 254 TTESDVWAYGVVLWEI 269

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K   + W+ L GT  Y+APE+  +   N+ 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLAPEIILSKGYNKA 239
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAA-------------EL 873
           + ++ H +++K YG CS    L L+ EY + GSL   L                     L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 874 DWSKRVNVIKGVANALSY-----MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF 928
           D      +  G   + ++     M +     ++HRD++++ +L+    K  +SDFG ++ 
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 929 LKPDSSNWSELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           +  + S      G     ++A E  +      + DV++FGVL+ E++  G +P
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 824 VSEITEIRHRNIVKFYGFCS--HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV 881
           ++ + ++ H N+VK        +  HL++V+E + +G +  + + +  + +       ++
Sbjct: 87  IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDL 146
Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
           IKG+     Y+H   +  I+HRDI    +L+  +    ++DFG +   K   +  S   G
Sbjct: 147 IKGI----EYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 942 TCGYIAPE-LAYTMR--ANEKCDVFNFGVLVLEVIEGKHP 978
           T  ++APE L+ T +  + +  DV+  GV +   + G+ P
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 40/79 (50%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           I++RD+    V+LD E    ++DFG  K    D        GT  YIAPE+       + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D + FGVL+ E++ G+ P
Sbjct: 523 VDWWAFGVLLYEMLAGQAP 541

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAA-------------EL 873
           + ++ H +++K YG CS    L L+ EY + GSL   L                     L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 874 DWSKRVNVIKGVANALSY-----MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF 928
           D      +  G   + ++     M +     ++HRD++++ +L+    K  +SDFG ++ 
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 929 LKPDSSNWSELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           +  + S      G     ++A E  +      + DV++FGVL+ E++  G +P
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 40/223 (17%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  GTV       G   AVK++  +   +I + +   ++E  +  H N++++Y  CS 
Sbjct: 42  GYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESDD--HPNVIRYY--CSE 96
Query: 845 TQHLFLVYEYLERGSL---ATILSNEATAAELDWSKRVN---VIKGVANALSYMHHDCFP 898
           T   FL Y  LE  +L     + S   +   L   K  N   +++ +A+ ++++H     
Sbjct: 97  TTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 152
Query: 899 PILHRDISSKKVLL--------DLEYKAH-----VSDFGTAKFLKPDS------SNWSEL 939
            I+HRD+  + +L+        D +  A      +SDFG  K  K DS       N +  
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNNP 210
Query: 940 AGTCGYIAPEL---AYTMRANEKCDVFNFGVLVLEVI-EGKHP 978
           +GT G+ APEL   +   R     D+F+ G +   ++ +GKHP
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 85/197 (43%), Gaps = 10/197 (5%)
Query: 785 GTGGCGTVYK-AELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
           GTG  G V++  E  +G+  A K + + P        +  +  ++ +RH  +V  +    
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMT-PHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
               + ++YE++  G L   +++E      D  + V  ++ V   L +MH + +   +H 
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENNY---VHL 279
Query: 904 DISSKKVLLDLEYKAHVS--DFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           D+  + ++   +    +   DFG    L P  S      GT  + APE+A         D
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL   ++ G  P
Sbjct: 339 MWSVGVLSYILLSGLSP 355

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 40/223 (17%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  GTV       G   AVK++  +   +I + +   ++E  +  H N++++Y  CS 
Sbjct: 42  GYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESDD--HPNVIRYY--CSE 96
Query: 845 TQHLFLVYEYLERGSL---ATILSNEATAAELDWSKRVN---VIKGVANALSYMHHDCFP 898
           T   FL Y  LE  +L     + S   +   L   K  N   +++ +A+ ++++H     
Sbjct: 97  TTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 152
Query: 899 PILHRDISSKKVLL--------DLEYKAH-----VSDFGTAKFLKPDS------SNWSEL 939
            I+HRD+  + +L+        D +  A      +SDFG  K  K DS       N +  
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNNP 210
Query: 940 AGTCGYIAPEL---AYTMRANEKCDVFNFGVLVLEVI-EGKHP 978
           +GT G+ APEL   +   R     D+F+ G +   ++ +GKHP
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSN--EATAAELDWSKRVNVIKGVANAL 889
            R I + +       +L+LV EY   G L T+LS   E   AE+    R  + + +  A+
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAE-IVMAI 175
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-GTCGYIAP 948
             +H   +   +HRDI    +LLD      ++DFG+   L+ D +  S +A GT  Y++P
Sbjct: 176 DSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 949 ELAYTMRANE-------KCDVFNFGVLVLEVIEGKHP 978
           E+   +           +CD +  GV   E+  G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 83  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 139
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 140 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 195
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 196 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 86/197 (43%), Gaps = 10/197 (5%)
Query: 785 GTGGCGTVYK-AELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
           GTG  G V++  E  +G+  A K + +    +    +K  +  ++ +RH  +V  +    
Sbjct: 60  GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE-IQTMSVLRHPTLVNLHDAFE 118
Query: 844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
               + ++YE++  G L   +++E      D  + V  ++ V   L +MH + +   +H 
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENNY---VHL 173
Query: 904 DISSKKVLLDLEYKAHVS--DFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
           D+  + ++   +    +   DFG    L P  S      GT  + APE+A         D
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-KVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 962 VFNFGVLVLEVIEGKHP 978
           +++ GVL   ++ G  P
Sbjct: 233 MWSVGVLSYILLSGLSP 249

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 21/173 (12%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAA-------------EL 873
           + ++ H +++K YG CS    L L+ EY + GSL   L                     L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 874 DWSKRVNVIKGVANALSY-----MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF 928
           D      +  G   + ++     M +     ++HRD++++ +L+    K  +SDFG ++ 
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 929 LKPDSSNWSELAG--TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
           +  + S      G     ++A E  +      + DV++FGVL+ E++  G +P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 63/131 (48%), Gaps = 9/131 (6%)
Query: 848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISS 907
           L++V EY+  G + + L      AE     R    + +     Y+H      +++RD+  
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFAEP--HARFYAAQ-IVLTFEYLHS---LDLIYRDLKP 169
Query: 908 KKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGV 967
           + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+  D +  GV
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGV 226
Query: 968 LVLEVIEGKHP 978
           L+ E+  G  P
Sbjct: 227 LIYEMAAGYPP 237

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 40/225 (17%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  GTV       G   AVK++  +   +I + +   ++E  +  H N++++Y  CS 
Sbjct: 24  GYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESDD--HPNVIRYY--CSE 78
Query: 845 TQHLFLVYEYLERGSL---ATILSNEATAAELDWSKRVN---VIKGVANALSYMHHDCFP 898
           T   FL Y  LE  +L     + S   +   L   K  N   +++ +A+ ++++H     
Sbjct: 79  TTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 899 PILHRDISSKKVLL--------DLEYKAH-----VSDFGTAKFLKPDSS----NWSELAG 941
            I+HRD+  + +L+        D +  A      +SDFG  K L    S    N +  +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 942 TCGYIAPE-------LAYTMRANEKCDVFNFGVLVLEVI-EGKHP 978
           T G+ APE       L    R     D+F+ G +   ++ +GKHP
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 25/155 (16%)
Query: 827 ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV------- 879
           IT+I++   +   G  ++   ++++YEY+E  S   IL  +     LD +          
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 880 -NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
             +IK V N+ SY+H++    I HRD+    +L+D   +  +SDFG ++++       S 
Sbjct: 154 KCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 939 LAGTCGYIAPELAYTMRANE------KCDVFNFGV 967
             GT  ++ PE      +NE      K D+++ G+
Sbjct: 212 --GTYEFMPPEFF----SNESSYNGAKVDIWSLGI 240

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHS--LPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A   T+G   A+K ++   L   ++    +  +S +  +RH +I+K Y  
Sbjct: 13  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 72
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 + +V EY        I+  +  + +    +     + + +A+ Y H      I+
Sbjct: 73  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---KIV 125
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKC 960
           HRD+  + +LLD      ++DFG +  +  D +      G+  Y APE ++  + A  + 
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 961 DVFNFGVLV 969
           DV++ GV++
Sbjct: 185 DVWSCGVIL 193

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHS--LPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A   T+G   A+K ++   L   ++    +  +S +  +RH +I+K Y  
Sbjct: 17  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 76
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 + +V EY        I+  +  + +    +     + + +A+ Y H      I+
Sbjct: 77  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---KIV 129
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKC 960
           HRD+  + +LLD      ++DFG +  +  D +      G+  Y APE ++  + A  + 
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 188
Query: 961 DVFNFGVLV 969
           DV++ GV++
Sbjct: 189 DVWSCGVIL 197

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 10/148 (6%)
Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
           IV+  G C   + L LV E    G L   L  +    E+  S    ++  V+  + Y+  
Sbjct: 398 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE 454
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG---TCGYIAPELA 951
             F   +HR+++++ VLL   + A +SDFG +K L  D S ++  +       + APE  
Sbjct: 455 KNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 952 YTMRANEKCDVFNFGVLVLEVIE-GKHP 978
              + + + DV+++GV + E +  G+ P
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W+ L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 111
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 112 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 167
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 60  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 116
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 117 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 172
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 12/189 (6%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHS--LPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A   T+G   A+K ++   L   ++    +  +S +  +RH +I+K Y  
Sbjct: 22  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 + +V EY        I+  +  + +    +     + + +A+ Y H      I+
Sbjct: 82  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---KIV 134
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKC 960
           HRD+  + +LLD      ++DFG +  +  D +      G+  Y APE ++  + A  + 
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEV 193
Query: 961 DVFNFGVLV 969
           DV++ GV++
Sbjct: 194 DVWSCGVIL 202

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 799 SGDTRAVKKL-HSLPTGEIGINQKGFVSEITEIR--HRN-IVKFYG--FCSHTQHLFLVY 852
           +G   AVK+L HS P       Q+ F  EI  ++  H + IVK+ G  +      L LV 
Sbjct: 35  TGALVAVKQLQHSGPD-----QQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVM 89
Query: 853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM-HHDCFPPILHRDISSKKVL 911
           EYL  G L   L      A LD S+ +     +   + Y+    C    +HRD++++ +L
Sbjct: 90  EYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNIL 143
Query: 912 LDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTMRANEKCDVFNFGVL 968
           ++ E    ++DFG AK L  D               + APE       + + DV++FGV+
Sbjct: 144 VESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 203
Query: 969 VLEV 972
           + E+
Sbjct: 204 LYEL 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 88/192 (45%), Gaps = 18/192 (9%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHS--LPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V  A   T+G   A+K ++   L   ++    +  +S +  +RH +I+K Y  
Sbjct: 23  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 82
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                 + +V EY        I+  +  + +    +     + + +A+ Y H      I+
Sbjct: 83  IKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH---KIV 135
Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPE-LAYTMRAN 957
           HRD+  + +LLD      ++DFG +  +    ++ + L  +CG   Y APE ++  + A 
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 958 EKCDVFNFGVLV 969
            + DV++ GV++
Sbjct: 192 PEVDVWSCGVIL 203

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLA 491
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 492 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYY 547
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W+ L GT  Y+APE+  +   N+ 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKA 204
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 205 VDWWALGVLIYEMAAGYPP 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 58  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 114
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 115 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 170
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 171 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/156 (25%), Positives = 74/156 (47%), Gaps = 9/156 (5%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           +S +  +RH +I+K Y   +    + +V EY   G L   +  +    E D  +R    +
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTE-DEGRRF--FQ 115
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +  A+ Y H      I+HRD+  + +LLD      ++DFG +  +  D +      G+ 
Sbjct: 116 QIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSP 171
Query: 944 GYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGKHP 978
            Y APE+    + A  + DV++ G+++  ++ G+ P
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           ++H NIV+ +   S   H +L+++ +  G L   +      +E D S   + I+ +  A+
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV 123
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
            + H      ++HR++  + +LL  + K     ++DFG A  ++ +   W   AGT GY+
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +PE+       +  D++  GV++  ++ G  P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF--- 841
           G G  G V++  L  G++ AVK   S    E    ++  +     +RH NI+ F      
Sbjct: 17  GKGRYGEVWRG-LWHGESVAVKIFSS--RDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 842 --CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF-- 897
              S TQ L+L+  Y E GSL   L  +     L  + R+ V    A  L+++H + F  
Sbjct: 74  SRNSSTQ-LWLITHYHEHGSLYDFLQRQTLEPHL--ALRLAV--SAACGLAHLHVEIFGT 128
Query: 898 ---PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-----GTCGYIAPE 949
              P I HRD  S+ VL+    +  ++D G A  +    S++ ++      GT  Y+APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 950 -LAYTMRAN-----EKCDVFNFGVLVLEV 972
            L   +R +     +  D++ FG+++ E+
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 830 IRHRNIVKFYGFCSHT----QHLFLVYEYLERGSLATILSN---EATAAELDWSKRVNVI 882
           ++H NIV+FY     T    + + LV E    G+L T L             W +++  +
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI--L 139
Query: 883 KGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSNWSELAG 941
           KG    L ++H    PPI+HRD+    + +        + D G A   +  +S    + G
Sbjct: 140 KG----LQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIG 192
Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           T  + APE  Y  + +E  DV+ FG   LE    ++P
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/143 (33%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 197 GSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKS 256
            S+P+ I     + YL  + NQ++   P    +L NLK LYL  N+L         S   
Sbjct: 32  ASVPAGIPTNAQILYL--HDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ 89
Query: 257 LLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQ 315
           L  L L  NQL   LPS+ F  L  LK L +   NKL+  +P+ I  L  L+HL L + Q
Sbjct: 90  LTVLDLGTNQLT-VLPSAVFDRLVHLKELFM-CCNKLT-ELPRGIERLTHLTHLALDQNQ 146
Query: 316 LSGFIPPSLGNLSNIRGLYIREN 338
           L      +   LS++   Y+  N
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGN 169

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 10/202 (4%)
Query: 780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFY 839
           K  + G G  G V+K E T+   +   K+      +     K  +S + ++ H N+++ Y
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 840 GFCSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                   + LV EY++ G L   I+       ELD    +  +K +   + +MH     
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---M 206
Query: 899 PILHRDISSKKVL-LDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
            ILH D+  + +L ++ + K   + DFG A+  KP         GT  ++APE+      
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFV 265
Query: 957 NEKCDVFNFGVLVLEVIEGKHP 978
           +   D+++ GV+   ++ G  P
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP 287

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           GTG  G V   + + +G+  A+K     K+  L   E  +N+K  +  +       +VK 
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKL 106
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                   +L++V EY+  G + + L      +E     R    + +     Y+H     
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQ-IVLTFEYLHS---L 160
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 959 KCDVFNFGVLVLEVIEGKHP 978
             D +  GVL+ E+  G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLA 491
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 492 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 547
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G V+K     +G   A+KK   L + +  + +K  + EI    +++H N+V    
Sbjct: 12  GEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKR---VNVIKGVA----NALSYMH 893
                + L LV+EY +     T+L       ELD  +R    +++K +      A+++ H
Sbjct: 70  VFRRKRRLHLVFEYCDH----TVLH------ELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 894 -HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAY 952
            H+C    +HRD+  + +L+       + DFG A+ L   S  + +   T  Y +PEL  
Sbjct: 120 KHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 953 -TMRANEKCDVFNFGVLVLEVIEG 975
              +     DV+  G +  E++ G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 51/220 (23%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 765 DVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFV 824
           D +N++ LS   FE +  L G G    VY+ +      +  +K ++L   +  +++K   
Sbjct: 44  DGSNRDALS-DFFEVESEL-GRGATSIVYRCK-----QKGTQKPYALKVLKKTVDKKIVR 96
Query: 825 SEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV 881
           +EI     + H NI+K          + LV E +  G L   +  +   +E D +   + 
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DA 153
Query: 882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPDSSNWSE 938
           +K +  A++Y+H +    I+HRD+  + +L      +    ++DFG +K ++        
Sbjct: 154 VKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKT 209
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT GY APE+        + D+++ G++   ++ G  P
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           GTG  G V   + + +G+  A+K     K+  L   E  +N+K  +  +       +VK 
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKL 106
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                   +L++V EY+  G + + L      +E     R    + +     Y+H     
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQ-IVLTFEYLHS---L 160
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 959 KCDVFNFGVLVLEVIEGKHP 978
             D +  GVL+ E+  G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 22/177 (12%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFYGF 841
           G G  G VYKA +  + +T A+K++  L   E G+       VS + E++HRNI++    
Sbjct: 43  GEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGVANALSYMH-HDCFP 898
             H   L L++EY E      +  N       D S RV  + +  + N +++ H   C  
Sbjct: 102 IHHNHRLHLIFEYAENDLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSRRC-- 153
Query: 899 PILHRDISSKKVLLDLEYKAH-----VSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
             LHRD+  + +LL +   +      + DFG A+        ++    T  Y  PE+
Sbjct: 154 --LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           GTG  G V   + + +G+  A+K     K+  L   E  +N+K  +  +       +VK 
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKL 106
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                   +L++V EY+  G + + L      +E     R    + +     Y+H     
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP--HARFYAAQ-IVLTFEYLHS---L 160
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 959 KCDVFNFGVLVLEVIEGKHP 978
             D +  GVL+ E+  G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 785 GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           GTG  G V   + + +G+  A+K     K+  L   E  +N+K  +  +       +VK 
Sbjct: 50  GTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN---FPFLVKL 106
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                   +L++V EY+  G + + L      +E     R    + +     Y+H     
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP--HARFYAAQ-IVLTFEYLHS---L 160
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+
Sbjct: 161 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 959 KCDVFNFGVLVLEVIEGKHP 978
             D +  GVL+ E+  G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 213
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 214 VDWWALGVLIYEMAAGYPP 232

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 46/224 (20%)
Query: 783 LHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIRHRNIVKFY 839
           L G+GG G V+KA+    G T  ++++          N+K    V  + ++ H NIV + 
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKY-------NNEKAEREVKALAKLDHVNIVHYN 71
Query: 840 GFC------------------------------SHTQHLFLVYEYLERGSLATILSNEAT 869
           G C                              S T+ LF+  E+ ++G+L   +     
Sbjct: 72  G-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-R 129
Query: 870 AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL 929
             +LD    + + + +   + Y+H      ++HRD+    + L    +  + DFG    L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
           K D    +   GT  Y++PE   +    ++ D++  G+++ E++
Sbjct: 187 KNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 44/227 (19%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  GTV       G   AVK++  +   +I + +   ++E  +  H N++++Y  CS 
Sbjct: 24  GYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESDD--HPNVIRYY--CSE 78
Query: 845 TQHLFLVYEYLERGSL---ATILSNEATAAELDWSKRVN---VIKGVANALSYMHHDCFP 898
           T   FL Y  LE  +L     + S   +   L   K  N   +++ +A+ ++++H     
Sbjct: 79  TTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 899 PILHRDISSKKVLL--------DLEYKAH-----VSDFGTAKFLKPDS------SNWSEL 939
            I+HRD+  + +L+        D +  A      +SDFG  K  K DS       N +  
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNLNNP 192
Query: 940 AGTCGYIAPE-------LAYTMRANEKCDVFNFGVLVLEVI-EGKHP 978
           +GT G+ APE       L    R     D+F+ G +   ++ +GKHP
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 111
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 112 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 167
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 52  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 108
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 109 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 164
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 57  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLA 113
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 114 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYY 169
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 170 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           +RH NIV+F        HL +V EY   G L   + N    +E    +     + + + +
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGV 128
Query: 890 SYMHHDCFPPILHRDISSKKVLLD--LEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
           SY H      + HRD+  +  LLD     +  ++DFG +K     S   S + GT  YIA
Sbjct: 129 SYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV-GTPAYIA 184
Query: 948 PELAYTMRANEK-CDVFNFGVLVLEVIEGKHP 978
           PE+      + K  DV++ GV +  ++ G +P
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLA 111
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+ +
Sbjct: 112 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYY 167
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 30/174 (17%)
Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNE-----------ATAAELDWSKRVN 880
           H NIV   G C+ +  ++L++EY   G L   L ++                L+  + +N
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 881 VIK---------GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP 931
           V+           VA  + ++    F   +HRD++++ VL+       + DFG A+ +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 932 DSSNWSELAGT---CGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
           D SN+           ++APE  +      K DV+++G+L+ E+       +PG
Sbjct: 225 D-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 45/202 (22%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 785 GTGGCGTVYKA-ELTSGDTR----AVKKLHSL--PTGEIGINQKGFVSEITEIRHRNIVK 837
           G+G  GTVYK   +  G+T     A+K L+    P   +    +  +  +  + H ++V+
Sbjct: 47  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI--MASMDHPHLVR 104
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAAELDWSKRVNVIKGVANALSYMH 893
             G C  +  + LV + +  G L   +     N  +   L+W  ++      A  + Y+ 
Sbjct: 105 LLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 157
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT--CGYIAPELA 951
                 ++HRD++++ VL+       ++DFG A+ L+ D   ++   G     ++A E  
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 952 YTMRANEKCDVFNFGVLVLEVI 973
           +  +   + DV+++GV + E++
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELM 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 45/202 (22%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 785 GTGGCGTVYKA-ELTSGDTR----AVKKLHSL--PTGEIGINQKGFVSEITEIRHRNIVK 837
           G+G  GTVYK   +  G+T     A+K L+    P   +    +  +  +  + H ++V+
Sbjct: 24  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI--MASMDHPHLVR 81
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAAELDWSKRVNVIKGVANALSYMH 893
             G C  +  + LV + +  G L   +     N  +   L+W  ++      A  + Y+ 
Sbjct: 82  LLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 134
Query: 894 HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT--CGYIAPELA 951
                 ++HRD++++ VL+       ++DFG A+ L+ D   ++   G     ++A E  
Sbjct: 135 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 952 YTMRANEKCDVFNFGVLVLEVI 973
           +  +   + DV+++GV + E++
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELM 213

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 205
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 206 VDWWALGVLIYEMAAGYPP 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 20/184 (10%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFCSHT--QHLFLVYE 853
           +G+  AVK L      ++   + G+  EI  +R   H +IVK+ G C     + + LV E
Sbjct: 36  TGEMVAVKALKEGCGPQL---RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 92
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           Y+  GSL   L           ++ +   + +   ++Y+H   +   +HR ++++ VLLD
Sbjct: 93  YVPLGSLRDYLPRHCVGL----AQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 145
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSELA----GTCGYIAPELAYTMRANEKCDVFNFGVLV 969
            +    + DFG AK + P+   +  +         + APE     +     DV++FGV +
Sbjct: 146 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 204
Query: 970 LEVI 973
            E++
Sbjct: 205 YELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 46/184 (25%), Positives = 85/184 (46%), Gaps = 20/184 (10%)
Query: 799 SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFCSHT--QHLFLVYE 853
           +G+  AVK L      ++   + G+  EI  +R   H +IVK+ G C     + + LV E
Sbjct: 37  TGEMVAVKALKEGCGPQL---RSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVME 93
Query: 854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD 913
           Y+  GSL   L           ++ +   + +   ++Y+H   +   +HR ++++ VLLD
Sbjct: 94  YVPLGSLRDYLPRHCVGL----AQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLD 146
Query: 914 LEYKAHVSDFGTAKFLKPDSSNWSELA----GTCGYIAPELAYTMRANEKCDVFNFGVLV 969
            +    + DFG AK + P+   +  +         + APE     +     DV++FGV +
Sbjct: 147 NDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 970 LEVI 973
            E++
Sbjct: 206 YELL 209

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 787 GGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVKFYGF 841
           GG   VY+A+ + SG   A+K+L S    +     +  + E+  ++    H NIV+F   
Sbjct: 39  GGFAFVYEAQDVGSGREYALKRLLSNEEEK----NRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 842 CS-------HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            S         Q  FL+   L +G L   L    +   L     + +      A+ +MH 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELA-----------G 941
              PPI+HRD+  + +LL  +    + DFG+A  +   PD S WS               
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS-WSAQRRALVEEEITRNT 212
Query: 942 TCGYIAPE---LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           T  Y  PE   L       EK D++  G ++  +   +HP
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 192 NNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKL 251
           +N  + +I + I     L+ L LN N L+  +P    NLSNL+ L L  NRL+  +P +L
Sbjct: 232 SNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS-LPAEL 289
Query: 252 GSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV 286
           GS   L Y Y   N +  +LP  FGNL +L+ L V
Sbjct: 290 GSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGF--VSEITEIR-HRNIVKFYG 840
           G G  G V+K+ +  +G+  AVKK+           Q+ F  +  +TE+  H NIV    
Sbjct: 18  GKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA-QRTFREIMILTELSGHENIVNLLN 76
Query: 841 F--CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                + + ++LV++Y+E    A I +N        +     V+  +   + Y+H     
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-----VVYQLIKVIKYLHSGG-- 129
Query: 899 PILHRDISSKKVLLDLEYKAHVSDFGTAKF---------------------LKPDSSNWS 937
            +LHRD+    +LL+ E    V+DFG ++                         D    +
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 938 ELAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGK 976
           +   T  Y APE+   + +  +  D+++ G ++ E++ GK
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 820 QKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
           ++ F+ E   +R   H +IVK  G  +    ++++ E    G L + L  +     LD +
Sbjct: 55  REKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLA 111
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
             +     ++ AL+Y+    F   +HRDI+++ VL+       + DFG +++++ DS+  
Sbjct: 112 SLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXX 167
Query: 937 SELAGT--CGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               G     ++APE     R     DV+ FGV + E++
Sbjct: 168 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 30/282 (10%)
Query: 206 LRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHN 265
           L +L YL LN NQ++   P    NL  L  LY+  N+++      L +  +L  LYL  N
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYL--N 118
Query: 266 QLNGSLPSSFGNLSSLKHLHV---HNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP 322
           + N S  S   NL+    L++   HN++ LS      + N   L++L ++++++    P 
Sbjct: 119 EDNISDISPLANLTKXYSLNLGANHNLSDLS-----PLSNXTGLNYLTVTESKVKDVTP- 172
Query: 323 SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFA 382
            + NL+++  L +  N +    P  L  L SL   +  VN++    P  + N + L    
Sbjct: 173 -IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANXTRLNSLK 227
Query: 383 LRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRN--NNFVGPI 440
           +  N+++   P  + N+ +L    +  NQ +     ++     LT     N  +N +  I
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQIS-----DINAVKDLTKLKXLNVGSNQISDI 280
Query: 441 PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNN 482
              L N + L SL L  NQL     EV G   +L  L LS N
Sbjct: 281 -SVLNNLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQN 321

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 73  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEA------TAAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 192
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+  +  PD     +  
Sbjct: 193 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
               ++APE  +      + DV++FGVL+ E+ 
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIISKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 34/152 (22%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
           +H NI+         +++++V E ++ G L   +  +   +E + S    V+  +   + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVE 130
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           Y+H      ++HRD+    +L   E        + DFG AK L+ ++        T  ++
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+      +  CD+++ GVL+  ++ G  P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1H6U|A Chain A, Internalin H: Crystal Structure Of Fused N-Terminal Domains Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 8/118 (6%)
Query: 155 LGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGL 214
           +  L+S  ++ L +   + V P  L GL NL  +YL+ N+I    P  +  L +L YL +
Sbjct: 103 IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSI 158
Query: 215 NKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLP 272
              Q+S   P    NLS L  L   DN++S   P  L S  +L+ ++L +NQ++   P
Sbjct: 159 GNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +++D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 89/315 (28%), Positives = 128/315 (40%), Gaps = 23/315 (7%)
Query: 190 LNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP 249
           L  NRI      E  +   L  L LN+N +S   P    NL NL+ L L  NRL   IP 
Sbjct: 39  LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIP- 96
Query: 250 KLGSF---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSL 306
            LG F    +L  L +S N++   L   F +L +LK L V + N L     +    L SL
Sbjct: 97  -LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD-NDLVYISHRAFSGLNSL 154
Query: 307 SHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS-VNKLN 365
             L L K  L+     +L +L  +  L +R   +         RL  L  L +S    L+
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 366 GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGS 425
              P+CL  L NL   ++    L+      + ++     YL F N    Y P +  + GS
Sbjct: 215 TMTPNCLYGL-NLTSLSITHCNLTAVPYLAVRHL----VYLRFLN--LSYNPISTIE-GS 266
Query: 426 LTH--FSVRNNNFVG-----PIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLD 478
           + H    ++    VG       P + +    L  L +  NQLT     VF    +LE L 
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326
Query: 479 LSNNNFFGEISSNWI 493
           L +N    +    W+
Sbjct: 327 LDSNPLACDCRLLWV 341

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 772 LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPT----------GE-IGINQ 820
           ++ +TF    VL G GG G     E+ +   RA  K+++             GE + +N+
Sbjct: 181 VTKNTFRQYRVL-GKGGFG-----EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 821 KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
           K  + ++     R +V           L LV   +  G L   + +   A     ++ V 
Sbjct: 235 KQILEKVN---SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVF 290
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
               +   L  +H +    I++RD+  + +LLD      +SD G A  + P+        
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV 346
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+    R     D +  G L+ E+I G+ P
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 771 LLSASTFEGKMVLH---GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI 827
           LL   T    +VL    G G  G V++ +   G+  AVK   S    E    ++  + + 
Sbjct: 21  LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQT 77
Query: 828 TEIRHRNIVKFYGFCSHTQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
             +RH NI+ F    +        L+LV +Y E GSL   L+      E      + +  
Sbjct: 78  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLAL 133
Query: 884 GVANALSYMHHDCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS- 937
             A+ L+++H +       P I HRD+ SK +L+       ++D G A  ++ DS+  + 
Sbjct: 134 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTI 191
Query: 938 -----ELAGTCGYIAPEL---AYTMRANE---KCDVFNFGVLVLEV 972
                   GT  Y+APE+   +  M+  E   + D++  G++  E+
Sbjct: 192 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 771 LLSASTFEGKMVLH---GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI 827
           LL   T    +VL    G G  G V++ +   G+  AVK   S    E    ++  + + 
Sbjct: 34  LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQT 90
Query: 828 TEIRHRNIVKFYGFCSHTQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
             +RH NI+ F    +        L+LV +Y E GSL   L+      E      + +  
Sbjct: 91  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLAL 146
Query: 884 GVANALSYMHHDCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS- 937
             A+ L+++H +       P I HRD+ SK +L+       ++D G A  ++ DS+  + 
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTI 204
Query: 938 -----ELAGTCGYIAPEL---AYTMRANE---KCDVFNFGVLVLEV 972
                   GT  Y+APE+   +  M+  E   + D++  G++  E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ ++  G  P
Sbjct: 219 VDWWALGVLIYQMAAGYPP 237

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 29/169 (17%)
Query: 775 STFEGKMVLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF-VSEITEIR- 831
           S +E K+   G G  G V+KA    +G   A+KK+  L   E    ++GF ++ + EI+ 
Sbjct: 18  SKYE-KLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENE----KEGFPITALREIKI 70
Query: 832 -----HRNIVKFYGFCSHTQH--------LFLVYEYLERGSLATILSNEATAAELDWSKR 878
                H N+V     C             ++LV+++ E   LA +LSN      L   KR
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 129
Query: 879 VNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
           V  ++ + N L Y+H +    ILHRD+ +  VL+  +    ++DFG A+
Sbjct: 130 V--MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           +RH NIV+F        HL ++ EY   G L   + N    +E    +     + + + +
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE---DEARFFFQQLLSGV 129
Query: 890 SYMHHDCFPPILHRDISSKKVLLD--LEYKAHVSDFGTAK----FLKPDSSNWSELAGTC 943
           SY H      I HRD+  +  LLD     +  + DFG +K      +P S+      GT 
Sbjct: 130 SYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTP 181
Query: 944 GYIAPELAYTMRANEK-CDVFNFGVLVLEVIEGKHP 978
            YIAPE+      + K  DV++ GV +  ++ G +P
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 772 LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPT----------GE-IGINQ 820
           ++ +TF    VL G GG G     E+ +   RA  K+++             GE + +N+
Sbjct: 181 VTKNTFRQYRVL-GKGGFG-----EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234
Query: 821 KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN 880
           K  + ++     R +V           L LV   +  G L   + +   A     ++ V 
Sbjct: 235 KQILEKVN---SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVF 290
Query: 881 VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
               +   L  +H +    I++RD+  + +LLD      +SD G A  + P+        
Sbjct: 291 YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV 346
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           GT GY+APE+    R     D +  G L+ E+I G+ P
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 815 EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELD 874
           +I  N K  +     +RH NIV+F        HL +V EY   G L   + N    +E  
Sbjct: 57  KIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-- 114
Query: 875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD--LEYKAHVSDFGTAK----F 928
             +     + + + +SY H      + HRD+  +  LLD     +  + DFG +K     
Sbjct: 115 -DEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 170
Query: 929 LKPDSSNWSELAGTCGYIAPELAYTMRANEK-CDVFNFGVLVLEVIEGKHP 978
            +P S+      GT  YIAPE+      + K  DV++ GV +  ++ G +P
Sbjct: 171 SQPKST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 774 ASTFEGKMVLH---GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI 830
            ST    +VL    G G  G V++ +   G+  AVK   S    E    ++  + +   +
Sbjct: 4   GSTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVML 60
Query: 831 RHRNIVKFYGFCSHTQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA 886
           RH NI+ F    +        L+LV +Y E GSL   L+      E      + +    A
Sbjct: 61  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTA 116
Query: 887 NALSYMHHDCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS---- 937
           + L+++H +       P I HRD+ SK +L+       ++D G A  ++ DS+  +    
Sbjct: 117 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIA 174
Query: 938 --ELAGTCGYIAPEL---AYTMRANE---KCDVFNFGVLVLEV 972
                GT  Y+APE+   +  M+  E   + D++  G++  E+
Sbjct: 175 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 28/164 (17%)
Query: 780 KMVLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF-VSEITEIR------ 831
           K+   G G  G V+KA    +G   A+KK+  L   E    ++GF ++ + EI+      
Sbjct: 22  KLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENE----KEGFPITALREIKILQLLK 75
Query: 832 HRNIVKFYGFCSHTQH--------LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           H N+V     C             ++LV+++ E   LA +LSN      L   KRV  ++
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQ 132
Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            + N L Y+H +    ILHRD+ +  VL+  +    ++DFG A+
Sbjct: 133 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 34  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L       +N    A    SK + +   +A+ ++
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 153 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 207
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 24  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L       +N    A    SK + +   +A+ ++
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 143 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 197
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 773 SASTFEGKMVLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF-VSEITEI 830
             S +E K+   G G  G V+KA    +G   A+KK+  L   E    ++GF ++ + EI
Sbjct: 16  EVSKYE-KLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENE----KEGFPITALREI 68
Query: 831 R------HRNIVKFYGFCSHTQH--------LFLVYEYLERGSLATILSNEATAAELDWS 876
           +      H N+V     C             ++LV+++ E   LA +LSN      L   
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 127
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
           KRV  ++ + N L Y+H +    ILHRD+ +  VL+  +    ++DFG A+
Sbjct: 128 KRV--MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 773 SASTFEGKMVLHGTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGF-VSEITEI 830
             S +E K+   G G  G V+KA    +G   A+KK+  L   E    ++GF ++ + EI
Sbjct: 15  EVSKYE-KLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENE----KEGFPITALREI 67
Query: 831 R------HRNIVKFYGFCSHTQH--------LFLVYEYLERGSLATILSNEATAAELDWS 876
           +      H N+V     C             ++LV+++ E   LA +LSN      L   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 126
Query: 877 KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
           KRV  ++ + N L Y+H +    ILHRD+ +  VL+  +    ++DFG A+
Sbjct: 127 KRV--MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 152 PQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSY 211
           P +   L++ V  S   N    V+P+  G  +++T +YL+ N+    +P E+ N + L+ 
Sbjct: 5   PTECTCLDTVVRCS---NKGLKVLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTL 58
Query: 212 LGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSL 271
           + L+ N++S     +  N++ L  L L  NRL    P      KSL  L L  N ++   
Sbjct: 59  IDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVP 118
Query: 272 PSSFGNLSSLKHLHV 286
             +F +LS+L HL +
Sbjct: 119 EGAFNDLSALSHLAI 133

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILS---NEATAAE------LDWSKRVNVIKGVAN 887
             G C+     L ++ E+ + G+L+T L    NE    +      L     +     VA 
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAK 155
Query: 888 ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELAGTCGY 945
            + ++        +HRD++++ +LL  +    + DFG A+  +  PD     +      +
Sbjct: 156 GMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 946 IAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
           +APE  +      + DV++FGVL+ E+       +PG
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 19  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG--TCGYIAP 948
           Y++ + F   +HRD++++  ++  ++   + DFG  + +           G     +++P
Sbjct: 138 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 949 ELAYTMRANEKCDVFNFGVLVLEV 972
           E           DV++FGV++ E+
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/204 (21%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 28  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG--TCGYIAP 948
           Y++ + F   +HRD++++  ++  ++   + DFG  + +           G     +++P
Sbjct: 147 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 949 ELAYTMRANEKCDVFNFGVLVLEV 972
           E           DV++FGV++ E+
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  G V++ +   G+  AVK   S    E    ++  + +   +RH NI+ F    + 
Sbjct: 13  GKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 845 TQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF--- 897
                  L+LV +Y E GSL   L+      E      + +    A+ L+++H +     
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEIVGTQ 125
Query: 898 --PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPE 949
             P I HRD+ SK +L+       ++D G A  ++ DS+  +         GT  Y+APE
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 950 L---AYTMRANE---KCDVFNFGVLVLEV 972
           +   +  M+  E   + D++  G++  E+
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  G V++ +   G+  AVK   S    E    ++  + +   +RH NI+ F    + 
Sbjct: 12  GKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 845 TQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF--- 897
                  L+LV +Y E GSL   L+      E      + +    A+ L+++H +     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEIVGTQ 124
Query: 898 --PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPE 949
             P I HRD+ SK +L+       ++D G A  ++ DS+  +         GT  Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 950 L---AYTMRANE---KCDVFNFGVLVLEV 972
           +   +  M+  E   + D++  G++  E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TWI|D Chain D, Variable Lymphocyte Receptor Recognition Of The Immunodominant Glycoprotein Of Bacillus Anthracis Spores Length = 179

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
            S+P  AG  +  + L+L+ N+++   P    S   L YL L+ NQL       F  L+ 
Sbjct: 32  ASVP--AGIPTTTQVLHLYINQITKLEPGVFDSLTQLTYLNLAVNQLTALPVGVFDKLTK 89
Query: 281 LKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
           L HL +H IN+L  SIP  +  NLKSL+H++L
Sbjct: 90  LTHLALH-INQLK-SIPMGVFDNLKSLTHIYL 119

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
           G G  G V++ +   G+  AVK   S    E    ++  + +   +RH NI+ F    + 
Sbjct: 15  GKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 845 TQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF--- 897
                  L+LV +Y E GSL   L+      E      + +    A+ L+++H +     
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHMEIVGTQ 127
Query: 898 --PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS------ELAGTCGYIAPE 949
             P I HRD+ SK +L+       ++D G A  ++ DS+  +         GT  Y+APE
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 950 L---AYTMRANE---KCDVFNFGVLVLEV 972
           +   +  M+  E   + D++  G++  E+
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+  +  PD     +  
Sbjct: 156 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS--GSIPPTAGNLSNLKFL 236
           L  LK LTF    +N+  G+  SE+ +L SL +L L++N LS  G    +    ++LK+L
Sbjct: 324 LKSLKRLTFT---SNK-GGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 237 YLHDNRLSGYIPPKLG------------------------SFKSLLYLYLSHNQLNGSLP 272
            L  N +       LG                        S ++L+YL +SH     +  
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 273 SSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRG 332
             F  LSSL+ L +   +     +P     L++L+ L LS+ QL    P +  +LS+++ 
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 333 LYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPH 370
           L +  N L  S+P+ +  RL SL ++ L  N  + S P 
Sbjct: 499 LNMASNQL-KSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 30/107 (28%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 821 KGFVSEIT---EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSK 877
           K F  E+    + RH N+V F G C    HL ++    +  +L +++ +      LD +K
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNK 131
Query: 878 RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG 924
              + + +   + Y+H      ILH+D+ SK V  D   K  ++DFG
Sbjct: 132 TRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 25  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 144 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 198
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 21  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 140 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 194
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 27  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 146 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 200
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 27  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 146 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 200
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 34  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 153 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 207
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 28  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 147 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 201
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 49/221 (22%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
             G C+     L ++ E+ + G+L+T L ++      ++    ++ K   + L+  H  C
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYKDLYK---DFLTLEHLIC 148
Query: 897 FP-------------PILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELAG 941
           +                +HRD++++ +LL  +    + DFG A+  +  PD     +   
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
              ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 56  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++  ++  ++   + DFG  + +    +++    G       ++
Sbjct: 175 YLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 229
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT  Y+AP +  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPAIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+  +  PD     +  
Sbjct: 156 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 830 IRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           +RH NIV+F        HL +V EY   G L   + N   A      +     + + + +
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGV 127
Query: 890 SYMHHDCFPPILHRDISSKKVLLD--LEYKAHVSDFGTAK----FLKPDSSNWSELAGTC 943
           SY H      + HRD+  +  LLD     +  + DFG +K      +P S+      GT 
Sbjct: 128 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTP 179
Query: 944 GYIAPELAYTMRANEK-CDVFNFGVLVLEVIEGKHP 978
            YIAPE+      + K  DV++ GV +  ++ G +P
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 761 EGQNDVNNQELLS--ASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLHSL-- 811
           +G  +  NQ LL     T   K+ + G+G  GTVYK        +     A+K+L     
Sbjct: 23  QGSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 82
Query: 812 PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNE 867
           P     I  + +V  +  + + ++ +  G C  T  + L+ + +  G L   +     N 
Sbjct: 83  PKANKEILDEAYV--MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI 139
Query: 868 ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            +   L+W  ++      A  ++Y+       ++HRD++++ VL+       ++DFG AK
Sbjct: 140 GSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 190
Query: 928 FLKPDSSNWSELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVI 973
            L  +   +    G     ++A E         + DV+++GV V E++
Sbjct: 191 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+  +  PD     +  
Sbjct: 147 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+  +  PD     +  
Sbjct: 147 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 38  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 97
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEATA------AELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 98  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSF 157
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK--FLKPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+  +  PD     +  
Sbjct: 158 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 34/152 (22%), Positives = 67/152 (44%), Gaps = 10/152 (6%)
Query: 831 RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
           +H NI+         +++++V E  + G L   +  +   +E + S    V+  +   + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASA---VLFTITKTVE 130
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           Y+H      ++HRD+    +L   E        + DFG AK L+ ++        T  ++
Sbjct: 131 YLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 947 APELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           APE+      +  CD+++ GVL+   + G  P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 44/208 (21%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 790 GTVYKAEL---TSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFCS 843
           G VYK  L     G+      + +L     G  ++ F  E      ++H N+V   G  +
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99
Query: 844 HTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVIKGVANALS 890
             Q L +++ Y   G L   L              +    + L+    V+++  +A  + 
Sbjct: 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 159
Query: 891 YM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC----G 944
           Y+  HH     ++H+D++++ VL+  +    +SD G   F +  ++++ +L G       
Sbjct: 160 YLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLGNSLLPIR 212
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEV 972
           ++APE     + +   D++++GV++ EV
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 44/208 (21%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 790 GTVYKAEL---TSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGFCS 843
           G VYK  L     G+      + +L     G  ++ F  E      ++H N+V   G  +
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 844 HTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVIKGVANALS 890
             Q L +++ Y   G L   L              +    + L+    V+++  +A  + 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142
Query: 891 YM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC----G 944
           Y+  HH     ++H+D++++ VL+  +    +SD G   F +  ++++ +L G       
Sbjct: 143 YLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADYYKLLGNSLLPIR 195
Query: 945 YIAPELAYTMRANEKCDVFNFGVLVLEV 972
           ++APE     + +   D++++GV++ EV
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 38/234 (16%)
Query: 760 QEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGI 818
           Q  Q ++N+ E L      G+M   G+G CG V+K     +G   AVK++    +G    
Sbjct: 18  QRYQAEINDLENL------GEM---GSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNKEE 66
Query: 819 NQKGFVSEITEIRHRN---IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDW 875
           N++  +     ++  +   IV+ +G       +F+  E +  G+ A  L           
Sbjct: 67  NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGP---I 121
Query: 876 SKRV--NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS 933
            +R+   +   +  AL Y+       ++HRD+    +LLD   +  + DFG +  L  D 
Sbjct: 122 PERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
Query: 934 SNWSELAGTCGYIAPELA---------YTMRANEKCDVFNFGVLVLEVIEGKHP 978
           +     AG   Y+APE           Y +RA    DV++ G+ ++E+  G+ P
Sbjct: 180 AK-DRSAGCAAYMAPERIDPPDPTKPDYDIRA----DVWSLGISLVELATGQFP 228

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 182 LKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
           L N+ ++ L  N++     S +  L +L+YL L  NQL          L+NLK L L +N
Sbjct: 62  LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
Query: 242 RLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI- 300
           +L            +L YL L+HNQL       F  L++L  L + + N+L  S+P+ + 
Sbjct: 120 QLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL-SYNQLQ-SLPEGVF 177
Query: 301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
             L  L  L L + QL          L++++ +++ +N    + P        +  LS  
Sbjct: 178 DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEW 230
Query: 361 VNKLNGSIPHCLGNLS 376
           +NK +G + +  G+++
Sbjct: 231 INKHSGVVRNSAGSVA 246

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 87  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+ +   PD     +  
Sbjct: 147 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL--KPDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+ +   PD     +  
Sbjct: 156 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 47/207 (22%), Positives = 91/207 (43%), Gaps = 23/207 (11%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH---------SLPTGEIGINQKGFVSEITEIRHRN 834
           G G  GTVYKA +  SG   A+K +           LP   +   +   +  +    H N
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV--REVALLRRLEAFEHPN 75
Query: 835 IVKFYGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
           +V+    C+ ++      + LV+E++++  L T L ++A    L      ++++     L
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQFLRGL 133
Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
            ++H +C   I+HRD+  + +L+       ++DFG A+      +  + +  T  Y APE
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRAPE 189
Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGK 976
           +          D+++ G +  E+   K
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 14/239 (5%)
Query: 190 LNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP 249
           L NN+I      +  NL++L  L L  N++S   P     L  L+ LYL  N+L   +P 
Sbjct: 59  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 117
Query: 250 KLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV-HNINKLSGSIPKEIGNLKSLSH 308
           K+   K+L  L +  N++     S F  L+ +  + +  N  K SG        +K LS+
Sbjct: 118 KMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175
Query: 309 LWLSKTQLSGF---IPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN 365
           + ++ T ++     +PPSL        L++  N +       L  L +L++L LS N ++
Sbjct: 176 IRIADTNITTIPQGLPPSLTE------LHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 229
Query: 366 GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSG 424
                 L N  +L+   L  N+L   +P  + + K +    L  N  +     + C  G
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 287

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNEAT------AAELDWSKRVNVIK------- 883
             G C+     L ++ E+ + G+L+T L ++         A  D  K    ++       
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 884 GVANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELA 940
            VA  + ++    C    +HRD++++ +LL  +    + DFG A+ +   PD     +  
Sbjct: 147 QVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
               ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 110/254 (43%), Gaps = 16/254 (6%)
Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLK 234
           +P+ L    +   + L NN+I      +  NL++L  L L  N++S   P     L  L+
Sbjct: 46  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 235 FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV-HNINKLS 293
            LYL  N+L   +P K+   K+L  L +  N++     S F  L+ +  + +  N  K S
Sbjct: 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 294 GSIPKEIGNLKSLSHLWLSKTQLSGF---IPPSLGNLSNIRGLYIRENMLYGSIPEELGR 350
           G        +K LS++ ++ T ++     +PPSL        L++  N +       L  
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE------LHLDGNKITKVDAASLKG 214
Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
           L +L++L LS N ++      L N  +L+   L  N+L   +P  + + K +    L  N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 411 QFTGYLPQNVCQSG 424
             +     + C  G
Sbjct: 274 NISAIGSNDFCPPG 287

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 38  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 97
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILS---NEATAAE--------LDWSKRVNVIKGV 885
             G C+     L ++ E+ + G+L+T L    NE    +        L     +     V
Sbjct: 98  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQV 157
Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELAGTC 943
           A  + ++        +HRD++++ +LL  +    + DFG A+ +   PD     +     
Sbjct: 158 AKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 944 GYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
            ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + ++ H N++  +    +   + L+ E +  G L   L+ + + +E    +  + IK
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIK 122
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEYK-AHVS--DFGTAKFLKPDSSNWSEL 939
            + + ++Y+H      I H D+  + + LLD      H+   DFG A  ++ D   +  +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + ++ H N++  +    +   + L+ E +  G L   L+ + + +E    +  + IK
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIK 122
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEYK-AHVS--DFGTAKFLKPDSSNWSEL 939
            + + ++Y+H      I H D+  + + LLD      H+   DFG A  ++ D   +  +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 44/206 (21%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 785 GTGGCGTVYKAELTSG------DTR-AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK 837
           G G  G VY+  +  G      +TR A+K ++   +    I      S + E    ++V+
Sbjct: 21  GQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 838 FYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANALS 890
             G  S  Q   ++ E + RG L + L        N    A    SK + +   +A+ ++
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT----CGYI 946
           Y++ + F   +HRD++++   +  ++   + DFG  + +    +++    G       ++
Sbjct: 140 YLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWM 194
Query: 947 APELAYTMRANEKCDVFNFGVLVLEV 972
           +PE           DV++FGV++ E+
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + ++ H N++  +    +   + L+ E +  G L   L+ + + +E    +  + IK
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIK 122
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEYK-AHVS--DFGTAKFLKPDSSNWSEL 939
            + + ++Y+H      I H D+  + + LLD      H+   DFG A  ++ D   +  +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + ++ H N++  +    +   + L+ E +  G L   L+ + + +E    +  + IK
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIK 122
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEYK-AHVS--DFGTAKFLKPDSSNWSEL 939
            + + ++Y+H      I H D+  + + LLD      H+   DFG A  ++ D   +  +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEK 959
           +++RD+  + +L+D +    V+DFG AK +K     W  L GT   +APE+  +   N+ 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALAPEIILSKGYNKA 218
Query: 960 CDVFNFGVLVLEVIEGKHP 978
            D +  GVL+ E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 120
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 175
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           G+G    V K  +  +G   A K  K   L +   G++++    E+    EIRH NI+  
Sbjct: 21  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 80
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
           +    +   + L+ E +  G L   L+ + +  E    +    +K + + + Y+H     
Sbjct: 81  HDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLKQILDGVHYLHSK--- 134
Query: 899 PILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            I H D+  + + LLD      +  + DFG A  ++   + +  + GT  ++APE+    
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYE 193
Query: 955 RANEKCDVFNFGVLVLEVIEGKHP 978
               + D+++ GV+   ++ G  P
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + ++ H N++  +    +   + L+ E +  G L   L+ + + +E    +  + IK
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIK 122
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEYK-AHVS--DFGTAKFLKPDSSNWSEL 939
            + + ++Y+H      I H D+  + + LLD      H+   DFG A  ++ D   +  +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNI 178
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 120
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 175
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           G+G    V K  +  +G   A K  K   L +   G++++    E+    EIRH NI+  
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 839 YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
           +    +   + L+ E +  G L   L+ + +  E    +    +K + + + Y+H     
Sbjct: 74  HDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLKQILDGVHYLHSK--- 127
Query: 899 PILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
            I H D+  + + LLD      +  + DFG A  ++   + +  + GT  ++APE+    
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYE 186
Query: 955 RANEKCDVFNFGVLVLEVIEGKHP 978
               + D+++ GV+   ++ G  P
Sbjct: 187 PLGLEADMWSIGVITYILLSGASP 210

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G+G  G+V  A +  +G   AVKKL S P   I I+ K    E+     ++H N++    
Sbjct: 27  GSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 841 FCSHTQHLFLVYE-YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             +  + L    + YL    +   L+N    A+L       +I  +   L Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANE 958
           I+HRD+    + ++ + +  + DFG A+    + + +     T  Y APE+    M  N+
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQ 198
Query: 959 KCDVFNFGVLVLEVIEGK 976
             D+++ G ++ E++ G+
Sbjct: 199 TVDIWSVGCIMAELLTGR 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 785 GTGGCGTVYKAELTSGDTRAVKK---LHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
           G G  G V +A+    D  A  +   +  L  G      +  +SE+  +     H N+V 
Sbjct: 37  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 96
Query: 838 FYGFCSHTQH-LFLVYEYLERGSLATILSNE-------ATAAEL--DWSKRVNVIK---G 884
             G C+     L ++ E+ + G+L+T L ++        T  +L  D+    ++I     
Sbjct: 97  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQ 156
Query: 885 VANALSYM-HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL--KPDSSNWSELAG 941
           VA  + ++    C    +HRD++++ +LL  +    + DFG A+ +   PD     +   
Sbjct: 157 VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 942 TCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE---GKHPG 979
              ++APE  +      + DV++FGVL+ E+       +PG
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3G3B|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant In Complex With A Protein Antigen Length = 170

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
            S+P   G  +  + LYL+DNR++   P        L  L L +NQL       F  L+ 
Sbjct: 22  ASVP--TGIPTTTQVLYLYDNRITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQ 79
Query: 281 LKHLHVHNINKLSGSIPK-EIGNLKSLSHLWL 311
           L  L + N N+L  SIP+    NL+SL+H+WL
Sbjct: 80  LTQLSL-NDNQLK-SIPRGAFDNLRSLTHIWL 109

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 762 GQNDVNNQELL---SASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLH--SL 811
           G  +  NQ LL     + F+   VL G+G  GTVYK        +     A+K+L   + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 812 PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNE 867
           P     I  + +V  +  + + ++ +  G C  T  + L+ + +  G L   +     N 
Sbjct: 60  PKANKEILDEAYV--MASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNI 116
Query: 868 ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            +   L+W  ++      A  ++Y+       ++HRD++++ VL+       ++DFG AK
Sbjct: 117 GSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 928 FLKPDSSNWSELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
            L  +   +    G     ++A E         + DV+++GV V E++  G  P
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 762 GQNDVNNQELL---SASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLH--SL 811
           G  +  NQ LL     + F+   VL G+G  GTVYK        +     A+K+L   + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 812 PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNE 867
           P     I  + +V  +  + + ++ +  G C  T  + L+ + +  G L   +     N 
Sbjct: 60  PKANKEILDEAYV--MASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNI 116
Query: 868 ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            +   L+W  ++      A  ++Y+       ++HRD++++ VL+       ++DFG AK
Sbjct: 117 GSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 928 FLKPDSSNWSELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
            L  +   +    G     ++A E         + DV+++GV V E++  G  P
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 36/159 (22%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           V+ + EIRH NI+  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 80  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLK 136
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSNWSEL 939
            + + + Y+H      I H D+  + + LLD      +  + DFG A  ++   + +  +
Sbjct: 137 QILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNI 192
Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 762 GQNDVNNQELL---SASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLH--SL 811
           G  +  NQ LL     + F+   VL G+G  GTVYK        +     A+K+L   + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 812 PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNE 867
           P     I  + +V  +  + + ++ +  G C  T  + L+ + +  G L   +     N 
Sbjct: 60  PKANKEILDEAYV--MASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNI 116
Query: 868 ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            +   L+W  ++      A  ++Y+       ++HRD++++ VL+       ++DFG AK
Sbjct: 117 GSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 928 FLKPDSSNWSELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
            L  +   +    G     ++A E         + DV+++GV V E++  G  P
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 762 GQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKL---HSLPTGEIG 817
           GQ     QE+   S  + K++  G G  G VY+A+L  SG+  A+KK+    +    E+ 
Sbjct: 11  GQGPDRPQEV---SYTDTKVI--GNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ 65
Query: 818 INQKGFVSEITEIRHRNIVKF-YGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAA 871
           I +K        + H NIV+  Y F S  +     +L LV +Y+     AT+       +
Sbjct: 66  IMRK--------LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ATVYRVARHYS 113
Query: 872 ELDWSKRVNVIK----GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA-HVSDFGTA 926
               +  V  +K     +  +L+Y+H      I HRDI  + +LLD +     + DFG+A
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 927 KFLKPDSSNWSELAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGK 976
           K L     N S +     Y APEL +         DV++ G ++ E++ G+
Sbjct: 171 KQLVRGEPNVSXICSR-YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 34/167 (20%)
Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK------FLKPDSSNWSE 938
            VA  + Y+    F   +HRD++++  +LD  +   V+DFG A+      +        + 
Sbjct: 133  VARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 939  LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFXXXXXXXXXXXXNMNIV 998
            L     + A E   T R   K DV++FGVL+ E++    P +               +I 
Sbjct: 190  LP--VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--------------RHID 233
Query: 999  VNDLID-----SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQ 1040
              DL        RLP P    E    S+  V   C +A+P  RPT +
Sbjct: 234  PFDLTHFLAQGRRLPQP----EYCPDSLYQVMQQCWEADPAVRPTFR 276

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 762 GQNDVNNQELL---SASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLH--SL 811
           G  +  NQ LL     + F+   VL G+G  GTVYK        +     A+K+L   + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 812 PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNE 867
           P     I  + +V  +  + + ++ +  G C  T  + L+ + +  G L   +     N 
Sbjct: 60  PKANKEILDEAYV--MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI 116
Query: 868 ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            +   L+W  ++      A  ++Y+       ++HRD++++ VL+       ++DFG AK
Sbjct: 117 GSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 928 FLKPDSSNWSELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
            L  +   +    G     ++A E         + DV+++GV V E++  G  P
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 762 GQNDVNNQELL---SASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLH--SL 811
           G  +  NQ LL     + F+   VL G+G  GTVYK        +     A+K+L   + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 812 PTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNE 867
           P     I  + +V  +  + + ++ +  G C  T  + L+ + +  G L   +     N 
Sbjct: 60  PKANKEILDEAYV--MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI 116
Query: 868 ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
            +   L+W  ++      A  ++Y+       ++HRD++++ VL+       ++DFG AK
Sbjct: 117 GSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 928 FLKPDSSNWSELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHP 978
            L  +   +    G     ++A E         + DV+++GV V E++  G  P
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 13/160 (8%)
Query: 824 VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
           VS + EI+H N++  +    +   + L+ E +  G L   L+ + +  E    +    +K
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE---EEATEFLK 121
Query: 884 GVANALSYMHHDCFPPILHRDISSKKV-LLDLEY---KAHVSDFGTAKFLKPDSSN-WSE 938
            + N + Y+H      I H D+  + + LLD      +  + DFG A   K D  N +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKN 176
Query: 939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           + GT  ++APE+        + D+++ GV+   ++ G  P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In Complex With A Protein Antigen Length = 178

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
            S+P   G  +  + LYL+DN+++   P        L  L L +NQL       F  L+ 
Sbjct: 30  ASVP--TGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQ 87
Query: 281 LKHLHVHNINKLSGSIPK-EIGNLKSLSHLWL 311
           L  L + N N+L  SIP+    NLKSL+H+WL
Sbjct: 88  LTQLSL-NDNQLK-SIPRGAFDNLKSLTHIWL 117

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 44/243 (18%)
Query: 759 SQEGQNDVNNQELLSASTFEGKMVLHGTGGCGT-VYKAELTSGDTRAVKKLHSLPTG-EI 816
            Q+  ++  +  ++   +F  K VL G G  GT VY+    + D  AVK++  LP     
Sbjct: 8   EQDDGDEETSVVIVGKISFCPKDVL-GHGAEGTIVYRGMFDNRDV-AVKRI--LPECFSF 63
Query: 817 GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWS 876
              +   + E  E  H N++++  FC+     F   +Y+     A  L  +    + D++
Sbjct: 64  ADREVQLLRESDE--HPNVIRY--FCTEKDRQF---QYIAIELCAATL--QEYVEQKDFA 114
Query: 877 ----KRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-----EYKAHVSDFGTAK 927
               + + +++   + L+++H      I+HRD+    +L+ +     + KA +SDFG  K
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 928 FL---KPDSSNWSELAGTCGYIAPELAYTMRANEKC--------DVFNFGVLVLEVI-EG 975
            L   +   S  S + GT G+IAPE+      +E C        D+F+ G +   VI EG
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEG 226
Query: 976 KHP 978
            HP
Sbjct: 227 SHP 229

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 81/206 (39%), Gaps = 43/206 (20%)
Query: 45  SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGL--IPEELGELTSLNELA 102
           S +S   HLDFS N  +  +    G LT L  L L +NQL  L  I E   ++ SL +L 
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 103 LSYNRLNGSIPAXXXXXXXXXXXXXXXXXXXXXIPPNWGYLISPHYGSIPQDLGNLESPV 162
           +S N                                      S  Y     D    +S +
Sbjct: 381 ISQN--------------------------------------SVSYDEKKGDCSWTKSLL 402
Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGS 222
           S+++ +N  +  I R L     +  + L++N+I  SIP ++  L +L  L +  NQL   
Sbjct: 403 SLNMSSNILTDTIFRCLPP--RIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSV 459
Query: 223 IPPTAGNLSNLKFLYLHDNRLSGYIP 248
                  L++L+ ++LH N      P
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPWDCSCP 485

>pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Length = 170

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
            S+P   G  +  + LYL+DN+++   P        L  L L +NQL       F  L+ 
Sbjct: 22  ASVP--TGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQ 79
Query: 281 LKHLHVHNINKLSGSIPK-EIGNLKSLSHLWL 311
           L  L + N N+L  SIP+    NLKSL+H+WL
Sbjct: 80  LTQLSL-NDNQLK-SIPRGAFDNLKSLTHIWL 109

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G+G  G+V  A +  +G   AVKKL S P   I I+ K    E+     ++H N++    
Sbjct: 51  GSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 841 FCSHTQHLFLVYE-YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             +  + L    + YL    +   L+N     +L       +I  +   L Y+H      
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 165
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANE 958
           I+HRD+    + ++ + +  + DFG A+    + + +     T  Y APE+    M  N+
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQ 222
Query: 959 KCDVFNFGVLVLEVIEGK 976
             D+++ G ++ E++ G+
Sbjct: 223 TVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G+G  G+V  A +  +G   AVKKL S P   I I+ K    E+     ++H N++    
Sbjct: 50  GSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 841 FCSHTQHLFLVYE-YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             +  + L    + YL    +   L+N     +L       +I  +   L Y+H      
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 164
Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANE 958
           I+HRD+    + ++ + +  + DFG A+    + + +     T  Y APE+    M  N+
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQ 221
Query: 959 KCDVFNFGVLVLEVIEGK 976
             D+++ G ++ E++ G+
Sbjct: 222 TVDIWSVGCIMAELLTGR 239

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 42/297 (14%)
Query: 768  NQELLS--ASTFEGKMVLHGTGGCGTVYKA-ELTSGDTR----AVKKL--HSLPTGEIGI 818
            NQ LL     T   K+ + G+G  GTVYK   +  G+      A+K L  ++ P     I
Sbjct: 7    NQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI 66
Query: 819  NQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT-ILSNEATAAELDWSK 877
              + +V  +  +    + +  G C  T  + LV + +  G L   +  N       D   
Sbjct: 67   LDEAYV--MAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDL-- 121
Query: 878  RVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS 937
             +N    +A  +SY+       ++HRD++++ VL+       ++DFG A+ L  D + + 
Sbjct: 122  -LNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 938  ELAGTC--GYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFXXXXXXXXXXXXN 994
               G     ++A E     R   + DV+++GV V E++  G  P                
Sbjct: 178  ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------- 229
Query: 995  MNIVVNDLID--SRLP-PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
                + DL++   RLP PP+  ++     MI V   C   + +CRP  +++ +   R
Sbjct: 230  ----IPDLLEKGERLPQPPICTID---VYMIMVK--CWMIDSECRPRFRELVSEFSR 277

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 10/118 (8%)
Query: 577 ANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ-IGKLVQLSKLDLSHNSLGGNIPSE 635
           AN   +L   N      L  L +  N    ++  + + KL  L KLDLSH+ +     S+
Sbjct: 309 ANSFDQLCQINAASFPSLRDLYIKGNMRKLDLGTRCLEKLENLQKLDLSHSDIEA---SD 365
Query: 636 ICNLE-----SLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
            CNL+      L+Y+NL  N+  G     F+    L  +DV++  L    PHS  FQN
Sbjct: 366 CCNLQLKNLRHLQYLNLSYNEPLGLEDQAFKECPQLELLDVAFTHLHVKAPHS-PFQN 422

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1048
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-149
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-123
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-109
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-108
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-97
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-99
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-95
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-56
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-89
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-89
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-83
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-35
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-27
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-88
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-85
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-82
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-71
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-58
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-78
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-78
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-77
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-75
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-79
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-79
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-72
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-62
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-61
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-59
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-59
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-52
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-61
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-59
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-59
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-56
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-38
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-57
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-52
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-48
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-29
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-56
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-55
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-55
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-52
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-47
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-11
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-52
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-51
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-48
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-06
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-50
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-49
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-48
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-38
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-37
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-46
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-46
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-43
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-46
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-45
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-44
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-42
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-37
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-44
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-29
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-44
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-43
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-42
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-41
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-22
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-44
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-43
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-22
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-42
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-42
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-39
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-38
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-38
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-37
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-40
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-40
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-39
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-39
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-36
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-35
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-21
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-38
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-36
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-33
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-32
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-33
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-32
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-30
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-17
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-31
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-31
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-27
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-14
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-30
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-29
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-14
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-26
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-24
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-26
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-23
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-09
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-06
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-08
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-19
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-19
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-17
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-10
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-19
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-06
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-19
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-18
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-18
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-09
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-06
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-17
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-11
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-08
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-15
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-14
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-15
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-15
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-12
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-05
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-14
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-14
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-14
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-13
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	9e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-13
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-13
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-13
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-13
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-04
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-06
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-11
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-11
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-09
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	9e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	6e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-11
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-10
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-09
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	9e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-09
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-08
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-07
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	4e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  635 bits (1640), Expect = 0.0
 Identities = 209/738 (28%), Positives = 324/738 (43%), Gaps = 43/738 (5%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLF--PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTN 58
           V SI+L+   L          L     L  L LS + + G++       + L  LD S N
Sbjct: 52  VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRN 110

Query: 59  QFSGIIPP--QIGILTNLVVLRLSVNQLNGLIP-EELGELTSLNELALSYNRLNGSIPAS 115
             SG +     +G  + L  L +S N L+         +L SL  L LS N ++G+    
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170

Query: 116 L---GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFS 172
                    L  L++S N +SG +                  +    +   + + +NNFS
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD-----------------VSRCVNLEFLDVSSNNFS 213

Query: 173 GVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN 232
             IP  LG    L  + ++ N++ G     I     L  L ++ NQ  G IPP    L +
Sbjct: 214 TGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS 270

Query: 233 LKFLYLHDNRLSGYIPPKL-GSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINK 291
           L++L L +N+ +G IP  L G+  +L  L LS N   G++P  FG+ S L+ L + + N 
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS-NN 329

Query: 292 LSGSIPKE-IGNLKSLSHLWLSKTQLSGFIPPSLGNLS-NIRGLYIRENMLYGSIPEELG 349
            SG +P + +  ++ L  L LS  + SG +P SL NLS ++  L +  N   G I   L 
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC 389

Query: 350 R--LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLL 407
           +    +L +L L  N   G IP  L N S L    L  N LSG+IP  + ++ KL    L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449

Query: 408 FENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEV 467
           + N   G +PQ +    +L    +  N+  G IP  L NCT+L  + L  N+LTG I + 
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509

Query: 468 FGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDF 527
            G   +L +L LSNN+F G I +    C  L  L++  N  +GTIP+ +   +       
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKI 565

Query: 528 SSNRLVGQIPKQLGKLTSLTSLTL--NGNQLSGDIPLELGLLAELGYLDLSANRLSKLIP 585
           ++N + G+    +             N  +  G    +L  L+     ++++        
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625

Query: 586 KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYM 645
                   +  L++S N  S  I  +IG +  L  L+L HN + G+IP E+ +L  L  +
Sbjct: 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685

Query: 646 NLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVT 705
           +L  NKL G IP     +  L+ ID+S N L G IP    F+      F  N  LCG   
Sbjct: 686 DLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP- 744

Query: 706 GLPPCEALTSNKGDSGKH 723
            LP C+   ++     + 
Sbjct: 745 -LPRCDPSNADGYAHHQR 761

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  462 bits (1190), Expect = e-149
 Identities = 174/622 (27%), Positives = 273/622 (43%), Gaps = 79/622 (12%)

Query: 93  GELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIP 152
            ++TS++  +   N    ++ +SL +L+ L  L LSN+ ++G +                
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-------------- 95

Query: 153 QDLGNLESPVSVSLHTNNFSGVIP--RSLGGLKNLTFVYLNNNRIVGSIPSEIG-NLRSL 209
                  S  S+ L  N+ SG +    SLG    L F+ +++N +        G  L SL
Sbjct: 96  --FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL 153

Query: 210 SYLGLNKNQLSGSIPPT---AGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
             L L+ N +SG+       +     LK L +  N++SG +   +    +L +L +S N 
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211

Query: 267 LNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGN 326
            +  +P   G+ S+L+HL +   NKLSG   + I     L  L +S  Q  G IPP    
Sbjct: 212 FSTGIPF-LGDCSALQHLDISG-NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--P 267

Query: 327 LSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRE 385
           L +++ L + EN   G IP+ L G   +L+ L LS N   G++P   G+ S L+  AL  
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327

Query: 386 NELSGSIPQE-IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL 444
           N  SG +P + +  M+                         L    +  N F G +P SL
Sbjct: 328 NNFSGELPMDTLLKMR------------------------GLKVLDLSFNEFSGELPESL 363

Query: 445 QNCT-SLYSLRLERNQLTGNISEVFGIYP--DLELLDLSNNNFFGEISSNWIKCPQLATL 501
            N + SL +L L  N  +G I       P   L+ L L NN F G+I      C +L +L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423

Query: 502 NMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIP 561
           ++  N +SGTIPS +G++++L  L    N L G+IP++L  + +L +L L+ N L+G+IP
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483

Query: 562 LELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKL 621
             L     L ++ LS NRL+  IPK +G L  L  L LSNN FS  I  ++G    L  L
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543

Query: 622 DLSHNSLGGNIPSEICNLESLEYMNLL----------------------QNKLSGPIPSC 659
           DL+ N   G IP+ +         N +                        +  G     
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603

Query: 660 FRRMHGLSSIDVSYNELQGSIP 681
             R+   +  +++     G   
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTS 625

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  391 bits (1007), Expect = e-123
 Identities = 162/710 (22%), Positives = 257/710 (36%), Gaps = 94/710 (13%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L + P  L   +  L+L+ NQL        +  S+L  LD   N  S + P     L  L
Sbjct: 16  LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
            VL L  N+L+ L  +     T+L EL L  N +            NL+ L LS+N L  
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL-- 133

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                                                S     +   L+NL  + L+NN+
Sbjct: 134 -------------------------------------SSTKLGTQVQLENLQELLLSNNK 156

Query: 195 IVGSIPSEIG--NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLG 252
           I      E+      SL  L L+ NQ+    P     +  L  L+L++ +L   +  KL 
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216

Query: 253 SF---KSLLYLYLSHNQLNGSLPSSFGNL--SSLKHLHVHNINKLSGSIPKEIGNLKSLS 307
                 S+  L LS++QL+ +  ++F  L  ++L  L +   N L+         L  L 
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY-NNLNVVGNDSFAWLPQLE 275

Query: 308 HLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGS 367
           + +L    +      SL  L N+R L ++ +                ++ S+S+  L   
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSISLASLPKI 320

Query: 368 IPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLT 427
                  L  L+   + +N++ G        +  L KYL         L  +     +LT
Sbjct: 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL-KYL--------SLSNSFTSLRTLT 371

Query: 428 HFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGE 487
                N  FV      L        L L +N+++   S+ F     LE+LDL  N    E
Sbjct: 372 -----NETFVSLAHSPLH------ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420

Query: 488 ISSN-WIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL--VGQIPKQLGKLT 544
           ++   W     +  + +  N+      +    +  L +L      L  V   P     L 
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL--------IPKNLGELRKLHH 596
           +LT L L+ N ++      L  L +L  LDL  N L++L            L  L  LH 
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540

Query: 597 LNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI 656
           LNL +N F +        L +L  +DL  N+L     S   N  SL+ +NL +N ++   
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600

Query: 657 PSCFRR-MHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVT 705
              F      L+ +D+ +N    +      F N   E      EL     
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  353 bits (907), Expect = e-109
 Identities = 124/619 (20%), Positives = 211/619 (34%), Gaps = 50/619 (8%)

Query: 96  TSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
            S      S+ +L   +P  L   +N+  L+L++N L                     + 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLR---------------RLPAANF 45

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLN 215
                  S+ +  N  S + P     L  L  + L +N +            +L+ L L 
Sbjct: 46  TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105

Query: 216 KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF 275
            N +            NL  L L  N LS          ++L  L LS+N++        
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165

Query: 276 G--NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLG---NLSNI 330
                SSLK L + + N++    P     +  L  L+L+  QL   +   L      ++I
Sbjct: 166 DIFANSSLKKLELSS-NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224

Query: 331 RGLYIRENMLYGSIPEELGRLK--SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
           R L +  + L  +       LK  +L+ L LS N LN         L  L++F L  N +
Sbjct: 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284

Query: 389 SGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS---------GSLTHFSVRNNNFVGP 439
                  +  +  +    L  +     +                  L H ++ +N+  G 
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344

Query: 440 IPRSLQNCTSLYSLRLERNQLTGN--ISEVFG--IYPDLELLDLSNNNFFGEISSNWIKC 495
                    +L  L L  +  +     +E F    +  L +L+L+ N      S  +   
Sbjct: 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404

Query: 496 PQLATLNMGGNEISGTIP-SEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGN 554
             L  L++G NEI   +   E   +  + ++  S N+ +         + SL  L L   
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464

Query: 555 QLSG--DIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ------ 606
            L      P     L  L  LDLS N ++ +    L  L KL  L+L +N  ++      
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524

Query: 607 --EISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMH 664
                  +  L  L  L+L  N           +L  L+ ++L  N L+    S F    
Sbjct: 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584

Query: 665 GLSSIDVSYNELQGSIPHS 683
            L S+++  N +       
Sbjct: 585 SLKSLNLQKNLITSVEKKV 603

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 45.4 bits (108), Expect = 9e-05
 Identities = 19/73 (26%), Positives = 31/73 (42%), Gaps = 5/73 (6%)

Query: 616 VQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNE 675
           V     D SH  L   +P ++    ++  +NL  N+L     + F R   L+S+DV +N 
Sbjct: 4   VSHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 676 LQGSIPHSKAFQN 688
           +    P     Q 
Sbjct: 61  ISKLEPE--LCQK 71

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  348 bits (896), Expect = e-108
 Identities = 88/609 (14%), Positives = 190/609 (31%), Gaps = 73/609 (11%)

Query: 80  SVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPN 139
            ++         L     +  L+L     +G +P ++G L+ L  L+L ++         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL- 123

Query: 140 WGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK--NLTFVYLNNNRIVG 197
                       P+ +    S         ++              +L    +N++    
Sbjct: 124 ----------FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           SI          + +G   N ++  +      L+ L+  Y+ ++        +    ++ 
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQL- 316
            Y      Q   +    + NL  L  + V+N       +P  +  L  +  + ++  +  
Sbjct: 233 EY-----AQQYKTEDLKWDNLKDLTDVEVYN-CPNLTKLPTFLKALPEMQLINVACNRGI 286

Query: 317 -------SGFIPPSLGNLSNIRGLYIRENML-YGSIPEELGRLKSLSQLSLSVNKLNGSI 368
                               I+ +YI  N L    +   L ++K L  L    N+L G +
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346

Query: 369 PHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSG--SL 426
           P   G+   L    L  N+++          +++       N+    +P          +
Sbjct: 347 P-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVM 404

Query: 427 THFSVRNNNFVG-------PIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDL 479
           +      N           P+  +     ++ S+ L  NQ++    E+F     L  ++L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464

Query: 480 SNNNF-------FGEISSNWIKCPQLATLNMGGNEISGTIPSEI--GNMTQLHKLDFSSN 530
             N           + + N+     L ++++  N+++  +  +     +  L  +D S N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYN 523

Query: 531 RLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGE 590
                 P Q    ++L    +                      D   NR  +  P+ +  
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITL 564

Query: 591 LRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN 650
              L  L + +N    +++ +I     +S LD+  N       S +C         L  +
Sbjct: 565 CPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

Query: 651 KLSGPIPSC 659
           K    I  C
Sbjct: 622 KTQD-IRGC 629

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  321 bits (824), Expect = 1e-97
 Identities = 95/637 (14%), Positives = 197/637 (30%), Gaps = 120/637 (18%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFG----TIPTQISHLSKLKHLDFS 56
           V  ++L G    G + +    L  +L  L L  +          P  IS     +     
Sbjct: 83  VTGLSLEGFGASGRVPDAIGQL-TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141

Query: 57  TNQFSGIIPPQIG--ILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA 114
              +             ++L+   ++ +     I +         ++    N +   +  
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSK 200

Query: 115 SLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS----PHYGSIPQDLGNLESPVSVSLHTNN 170
           ++  L+ L Q  + N+    +         +      Y +      NL+    V ++   
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIV--------GSIPSEIGNLRSLSYLGLNKNQL-SG 221
               +P  L  L  +  + +  NR +            ++      +  + +  N L + 
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSL 281
            +  +   +  L  L    N+L G   P  GS   L  L L++NQ+     +  G    +
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQV 379

Query: 282 KHLHVHNINKLSGSIPK--EIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENM 339
           ++L   + NKL   IP   +  ++  +S +  S  ++      +                
Sbjct: 380 ENLSFAH-NKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP------------- 424

Query: 340 LYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENM 399
               +     +  ++S ++LS N+++          S L    L  N L+  IP      
Sbjct: 425 ----LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IP------ 473

Query: 400 KKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQ 459
                                              N +     + +N   L S+ L  N+
Sbjct: 474 ----------------------------------KNSLKDENENFKNTYLLTSIDLRFNK 499

Query: 460 LTGNISEV-FGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGN 518
           LT    +      P L  +DLS N+F                            P++  N
Sbjct: 500 LTKLSDDFRATTLPYLVGIDLSYNSF-------------------------SKFPTQPLN 534

Query: 519 MTQL------HKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGY 572
            + L      ++ D   NR + + P+ +    SLT L +  N +   +  +  +   +  
Sbjct: 535 SSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK--ITPNISV 591

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEIS 609
           LD+  N    +    +    +     L  ++ +Q+I 
Sbjct: 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDK-TQDIR 627

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  316 bits (813), Expect = 7e-96
 Identities = 87/557 (15%), Positives = 166/557 (29%), Gaps = 51/557 (9%)

Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSG- 221
           + +   + +      SL     +T + L      G +P  IG L  L  L L  +     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 222 ---SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLG--SFKSLLYLYLSHNQLNGSLPSSFG 276
                P       + +                     F  L+   ++ +    S+  S  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
                  +   + N ++  + K +  L  L   ++  +              N       
Sbjct: 181 ITLKDTQIGQLS-NNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SE 233

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL-------- 388
               Y +   +   LK L+ + +        +P  L  L  ++   +  N          
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293

Query: 389 SGSIPQEIENMKKLNKYLLFENQF-TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNC 447
                 +    +K+    +  N   T  +  ++ +   L       N   G +P +  + 
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSE 352

Query: 448 TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEI--SSNWIKCPQLATLNMGG 505
             L SL L  NQ+T   +   G    +E L  ++N     I    +      ++ ++   
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNK-LKYIPNIFDAKSVSVMSAIDFSY 411

Query: 506 NEISG-------TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG 558
           NEI          +         +  ++ S+N++     +     + L+S+ L GN L+ 
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 559 -------DIPLELGLLAELGYLDLSANRLSKLIPK-NLGELRKLHHLNLSNNQFSQEISI 610
                  D          L  +DL  N+L+KL        L  L  ++LS N FS +   
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFPT 530

Query: 611 QIGKLVQLSKL------DLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMH 664
           Q      L         D   N      P  I    SL  + +  N +   +        
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TP 587

Query: 665 GLSSIDVSYNELQGSIP 681
            +S +D+  N       
Sbjct: 588 NISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  162 bits (412), Expect = 9e-42
 Identities = 49/278 (17%), Positives = 88/278 (31%), Gaps = 41/278 (14%)

Query: 24  PQLAYLDLSVNQLFGTIP--TQISHLSKLKHLDFSTNQFSGI-------IPPQIGILTNL 74
            Q+  L  + N+L   IP       +S +  +DFS N+   +       + P      N+
Sbjct: 377 EQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNG-------SIPASLGNLSNLVQLSL 127
             + LS NQ++    E     + L+ + L  N L             +  N   L  + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF 187
             N L+  +  ++                 L   V + L  N+FS   P        L  
Sbjct: 496 RFNKLTK-LSDDFR-------------ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540

Query: 188 VYLNN------NRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
             + N      NR +   P  I    SL+ L +  N +   +        N+  L + DN
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDN 597

Query: 242 RLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLS 279
                    +  +       L +++          ++ 
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIK 635

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  324 bits (832), Expect = 6e-99
 Identities = 110/607 (18%), Positives = 200/607 (32%), Gaps = 46/607 (7%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
             + P  L      LDLS N L            +L+ LD S  +   I       L++L
Sbjct: 19  FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L L+ N +  L       L+SL +L      L       +G+L  L +L++++N +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV----YL 190
                           +P+   NL +   + L +N    +    L  L  +  +     L
Sbjct: 139 --------------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYI-- 247
           + N +    P     +R L  L L  N  S ++  T    L+ L+   L           
Sbjct: 185 SLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 248 -PPKLGSFKSLLYLYLSHNQLN------GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
                 + + L  L +   +L         +   F  L+++    + +   +        
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS-VTIERVKD--F 300

Query: 301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
                  HL L   +   F    L +L  +     +     G        L SL  L LS
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK-----GGNAFSEVDLPSLEFLDLS 355

Query: 361 VNKLN--GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQ 418
            N L+  G         ++LK+  L  N +   +      +++L       +        
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 419 NV-CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-SEVFGIYPDLEL 476
           +V     +L +  + + +            +SL  L++  N    N   ++F    +L  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQI 536
           LDLS         + +     L  LNM  N            +  L  LD+S N ++   
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

Query: 537 PKQLGKL-TSLTSLTLNGNQLSGDIPLE--LGLLAELGYLDLSANRLSKLIPKNLGELRK 593
            ++L    +SL  L L  N  +     +  L  + +   L +   R+    P +   +  
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-P 593

Query: 594 LHHLNLS 600
           +  LN++
Sbjct: 594 VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  313 bits (805), Expect = 4e-95
 Identities = 113/554 (20%), Positives = 194/554 (35%), Gaps = 32/554 (5%)

Query: 150 SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL 209
            IP +L    S  ++ L  N    +   S      L  + L+   I         +L  L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 210 SYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNG 269
           S L L  N +          LS+L+ L   +  L+      +G  K+L  L ++HN +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 270 -SLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLS----HLWLSKTQLSGFIPPSL 324
             LP  F NL++L+HL + + NK+      ++  L  +      L LS   ++   P + 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSS-NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 325 GNLSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVNKLNGS------IPHCLGNLSN 377
             +  +  L +R N    ++ +  +  L  L    L + +              L  L N
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 378 LKFFALRENELSGS---IPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN 434
           L     R   L      I      +  ++ + L          ++   +    H  + N 
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNC 314

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNN--NFFGEISSNW 492
            F       L++   L           G  +      P LE LDLS N  +F G  S + 
Sbjct: 315 KFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369

Query: 493 IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTL 551
                L  L++  N +  T+ S    + QL  LDF  + L           L +L  L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428

Query: 552 NGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKN-LGELRKLHHLNLSNNQFSQEISI 610
           +              L+ L  L ++ N   +    +   ELR L  L+LS  Q  Q    
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 611 QIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHG-LSSI 669
               L  L  L++SHN+           L SL+ ++   N +        +     L+ +
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548

Query: 670 DVSYNELQGSIPHS 683
           +++ N+   +  H 
Sbjct: 549 NLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  203 bits (519), Expect = 8e-56
 Identities = 73/387 (18%), Positives = 131/387 (33%), Gaps = 33/387 (8%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQL------FGTIPTQISHLSKLKHLD 54
           V  + L     +G L++F       L  L +   +L         I    + L+ +    
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288

Query: 55  FSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA 114
             +     +             L L   +       +L  L  L      +    G    
Sbjct: 289 LVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAF 341

Query: 115 SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV 174
           S  +L +L  L LS N LS +             G   Q      S   + L  N     
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFK-------------GCCSQSDFGTTSLKYLDLSFNGVIT- 387

Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNL 233
           +  +  GL+ L  +   ++ +       +  +LR+L YL ++      +       LS+L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 234 KFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL 292
           + L +  N       P      ++L +L LS  QL    P++F +LSSL+ L++ + N  
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH-NNF 506

Query: 293 SGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNL-SNIRGLYIRENMLYGSIPEE--LG 349
                     L SL  L  S   +       L +  S++  L + +N    +   +  L 
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 566

Query: 350 RLKSLSQLSLSVNKLNGSIPHCLGNLS 376
            +K   QL + V ++  + P     + 
Sbjct: 567 WIKDQRQLLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  170 bits (433), Expect = 1e-44
 Identities = 71/423 (16%), Positives = 128/423 (30%), Gaps = 63/423 (14%)

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
           +  + ++    +      IP  +    S  +L LS   L      S  +   ++ L +  
Sbjct: 4   VEVVPNITYQCMELNFYKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
             +          L  LS L L+ N +          LS+L+     E  L+      I 
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
           ++K L +  +  N                             +P    N T+L  L L  
Sbjct: 122 HLKTLKELNVAHNLIQS-----------------------FKLPEYFSNLTNLEHLDLSS 158

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIG 517
           N++         +   + LL+LS                    L++  N ++   P    
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLS--------------------LDLSLNPMNFIQPGAFK 198

Query: 518 NMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLE---LGLLAELGYL 573
            + +LHKL   +N     + K  +  L  L    L   +   +  LE      L  L  L
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 574 DLSANRLSKL------IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNS 627
            +   RL+ L      I      L  +   +L +    +              L+L +  
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCK 315

Query: 628 LGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQ 687
            G     ++ +L+ L +         G        +  L  +D+S N L      S++  
Sbjct: 316 FGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 688 NAT 690
             T
Sbjct: 371 GTT 373

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  304 bits (781), Expect = 4e-89
 Identities = 87/638 (13%), Positives = 183/638 (28%), Gaps = 90/638 (14%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
            +  ++         + +  ++  L  +     G +P  IG LT L VL    +      
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 89  PEELGELTSLNELALSYNRLNGSI-PASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPH 147
                E  + +      +R+        L     L    L  ++++           +P 
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR----------NPE 413

Query: 148 YGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR 207
              I +D         +   TN  +  I +++  L  L  +Y  N+       +      
Sbjct: 414 MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472

Query: 208 SLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL 267
           +  Y      +   +   +  NL +L  + L++      +P  L     L  L ++ N+ 
Sbjct: 473 NSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 268 NGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP-SLGN 326
                    + +                +  +      +   ++    L  F    SL  
Sbjct: 528 IS-AAQLKADWT---------------RLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571

Query: 327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN 386
           +  +  L    N +     E  G    L+ L L  N++             ++      N
Sbjct: 572 MVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHN 629

Query: 387 ELSGSIPQ--EIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL 444
           +L   IP     +++  +       N+                                 
Sbjct: 630 KLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN-------------------ISCSMDD 669

Query: 445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF-------FGEISSNWIKCPQ 497
               +  ++ L  N++    +E+F     +  + LSNN               N+     
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729

Query: 498 LATLNMGGNEISGTIPSEI--GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
           L T+++  N+++ ++  +     +  L  +D S N      P Q    + L +  +    
Sbjct: 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQ- 786

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKL 615
                             D   NR+ +  P  +     L  L + +N       +     
Sbjct: 787 -----------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR---KVDEKLT 826

Query: 616 VQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS 653
            QL  LD++ N       + +C         LL +K  
Sbjct: 827 PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  303 bits (778), Expect = 8e-89
 Identities = 87/670 (12%), Positives = 202/670 (30%), Gaps = 79/670 (11%)

Query: 27  AYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNG 86
           A + + + +    I    +  +  + LD    ++            N    +  ++    
Sbjct: 255 ANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGD 313

Query: 87  LIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISP 146
               +L     +  L+L+     G +P ++G L+ L  LS   +S +          ++P
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373

Query: 147 HYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNL 206
                     + E    + +H         + L     L      N  +         +L
Sbjct: 374 --------DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISL 425

Query: 207 RSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
           +      L  N+++  I      L+ L+ +Y  ++  +                   + +
Sbjct: 426 KDTQIGNLT-NRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAK 478

Query: 267 LNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGN 326
              +   S+ NL  L  + ++N       +P  + +L  L  L ++  +          +
Sbjct: 479 QYENEELSWSNLKDLTDVELYN-CPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKAD 536

Query: 327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG-SIPHCLGNLSNLKFFALRE 385
            + +               ++      +    +  N L        L  +  L       
Sbjct: 537 WTRL--------------ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582

Query: 386 NELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQ-SGSLTHFSVRNNNFVG-PIPRS 443
           N++     +      KL    L  NQ    +P++ C  +  +      +N     P   +
Sbjct: 583 NKVR--HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFN 639

Query: 444 LQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNM 503
            ++   + S+    N++      +     D + ++ S                   T+ +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAS-------------------TVTL 680

Query: 504 GGNEISGTIPSEIGNMTQLHKLDFSSNRL-------VGQIPKQLGKLTSLTSLTLNGNQL 556
             NEI           + +  +  S+N +       +            LT++ L  N+L
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740

Query: 557 SGDIPLELGL--LAELGYLDLSANRLSKLIPKNLGELRKL------HHLNLSNNQFSQEI 608
           +  +  +     L  L  +D+S N  S   P       +L      H  +   N+  ++ 
Sbjct: 741 TS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798

Query: 609 SIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL-SGPIPSCFRRMHGLS 667
              I     L +L +  N +   +  ++     L  +++  N   S  + S         
Sbjct: 799 PTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTS-VCPYIEAG 854

Query: 668 SIDVSYNELQ 677
              + Y++ Q
Sbjct: 855 MYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  289 bits (741), Expect = 1e-83
 Identities = 106/735 (14%), Positives = 217/735 (29%), Gaps = 81/735 (11%)

Query: 22  LFPQLAYLDLSVNQLFGTIPTQISHL----------------SKLKHLDFSTNQFSGIIP 65
           LF  + Y+D++V   F  + T++  +                +  K++D         + 
Sbjct: 151 LFSNIRYVDVTVMNSFNRVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVW 210

Query: 66  PQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNG------SIPASLGNL 119
              G    +V               E   +       +  N+L         +  +   +
Sbjct: 211 LPAGTYQ-VVAYTTYSQSGIKRSELETQSVRG-ESFTVIDNKLTKDANVPIQLKETAEYI 268

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL 179
            +   L     +L G    NW Y     Y     +  +  +  + +   + +       L
Sbjct: 269 KDYKALKAIWEALDG---KNWRY-----YSGTINNTIHSLNW-NFNKELDMWGDQPGVDL 319

Query: 180 GGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLH 239
                +T + L      G +P  IG L  L  L    +  + S                 
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379

Query: 240 DNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSL---PSSFGNLSSLKHLHVHNINKLSGS 295
            +R+  +     L   + L    L  + +N +    P    +  SLK   + N+      
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF 439

Query: 296 IPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLS 355
           I K I  L  L  ++ + +  +          +N           Y +       LK L+
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN-----SDYAKQYENEELSWSNLKDLT 494

Query: 356 QLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSG---------SIPQEIENMKKLNKYL 406
            + L        +P  L +L  L+   +  N              +  + +   K+  + 
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554

Query: 407 LFENQFTGYLPQNV--CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI 464
           +  N      P +    +   L      +N        +      L  L+L+ NQ+    
Sbjct: 555 MGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIP 611

Query: 465 SEVFGIYPDLELLDLSNNNFFG-EISSNWIKCPQLATLNMGGNEISGTIPS-----EIGN 518
            +       +E L  S+N         N      + +++   N+I     +     +   
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671

Query: 519 MTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLS-------GDIPLELGLLAELG 571
                 +  S N +     +     + ++++ L+ N ++                   L 
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 572 YLDLSANRLSKLIPK-NLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSH----- 625
            +DL  N+L+ L        L  L ++++S N FS     Q     QL    + H     
Sbjct: 732 TIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790

Query: 626 -NSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL-QGSIPHS 683
            N +    P+ I    SL  + +  N +   +         L  +D++ N      +   
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSV 847

Query: 684 KAFQNATIEAFQGNK 698
             +  A +     +K
Sbjct: 848 CPYIEAGMYVLLYDK 862

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  216 bits (551), Expect = 2e-58
 Identities = 62/437 (14%), Positives = 133/437 (30%), Gaps = 81/437 (18%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGI- 63
             +    +   +E  +     L  ++L        +P  +  L +L+ L+ + N+     
Sbjct: 472 ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAA 531

Query: 64  --------IPPQIGILTNLVVLRLSVNQLNGLIPE-ELGELTSLNELALSYNRLNGSIPA 114
                   +         + +  +  N L        L ++  L  L   +N++   +  
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE- 589

Query: 115 SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV 174
           + G    L  L L  N +                  IP+D                    
Sbjct: 590 AFGTNVKLTDLKLDYNQIE----------------EIPEDFCAF---------------- 617

Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPS--EIGNLRSLSYLGLNKNQLSG-----SIPPTA 227
                     +  +  ++N++   IP+     ++  +  +  + N++       S     
Sbjct: 618 -------TDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669

Query: 228 GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL-------NGSLPSSFGNLSS 280
               N   + L  N +  +      +   +  + LS+N +             ++ N   
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729

Query: 281 LKHLHVHNINKLSGSIPKEI--GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE- 337
           L  + +   NKL+ S+  +     L  LS++ +S    S   P    N S ++   IR  
Sbjct: 730 LTTIDLRF-NKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786

Query: 338 -----NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL-SGS 391
                N +    P  +    SL QL +  N +   +   L     L    + +N   S  
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISID 843

Query: 392 IPQEIENMKKLNKYLLF 408
           +      ++     LL+
Sbjct: 844 VTSVCPYIEAGMYVLLY 860

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  145 bits (366), Expect = 2e-35
 Identities = 46/288 (15%), Positives = 84/288 (29%), Gaps = 42/288 (14%)

Query: 15  LQEFPFLLF---PQLAYLDLSVNQLFGTIP--TQISHLSKLKHLDFSTNQFSGIIP---- 65
           ++E P        Q+  L  S N+L   IP       +  +  +DFS N+          
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665

Query: 66  -PQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRL-------NGSIPASLG 117
                   N   + LS N++     E     + ++ + LS N +             +  
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725

Query: 118 NLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPR 177
           N   L  + L  N L+  +  ++                 L    ++ +  N FS   P 
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFR-------------ATTLPYLSNMDVSYNCFSS-FPT 770

Query: 178 SLGGLKNLTFVYL------NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLS 231
                  L    +        NRI+   P+ I    SL  L +  N +   +        
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TP 827

Query: 232 NLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLS 279
            L  L + DN         +  +       L +++           + 
Sbjct: 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  119 bits (300), Expect = 1e-27
 Identities = 37/249 (14%), Positives = 69/249 (27%), Gaps = 46/249 (18%)

Query: 2   VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFS 61
            S N  GS  +              + + LS N++        +  S +  +  S N  +
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

Query: 62  GI-------IPPQIGILTNLVVLRLSVNQLNGLIPE-ELGELTSLNELALSYNRLNGSIP 113
            I                 L  + L  N+L  L  +     L  L+ + +SYN  + S P
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFP 769

Query: 114 ASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSG 173
               N S L    + +                                       N    
Sbjct: 770 TQPLNSSQLKAFGIRHQRD---------------------------------AEGNRILR 796

Query: 174 VIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQL-SGSIPPTAGNLSN 232
             P  +    +L  + + +N I   +  ++     L  L +  N   S  +      +  
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEA 853

Query: 233 LKFLYLHDN 241
             ++ L+D 
Sbjct: 854 GMYVLLYDK 862

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  296 bits (759), Expect = 1e-88
 Identities = 116/602 (19%), Positives = 187/602 (31%), Gaps = 76/602 (12%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L E P  L      L+ S N L     T  S L  L  LD +  Q   I          L
Sbjct: 24  LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L L+ N L  +    L    +L  L      ++      L N   L  L L +N +S 
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL--NN 192
              P                   L+    +    N    +    +  L+  T + L  N 
Sbjct: 144 IKLP------------KGFPTEKLK---VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188

Query: 193 NRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGN--LSNLKFLYLHDNRLSGYIPPK 250
           N I   I     +      L     Q    I     N  + +L      D       P  
Sbjct: 189 NDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 251 LGSFK--SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSH 308
                  S+  + L  +       ++F   S L+ L +     LS  +P  +  L +L  
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA-THLS-ELPSGLVGLSTLKK 305

Query: 309 LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVNKLNGS 367
           L LS  +       S  N  ++  L I+ N     +    L  L++L +L LS + +  +
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-T 364

Query: 368 IPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLT 427
              C   L NL                                               L 
Sbjct: 365 SDCCNLQLRNLS---------------------------------------------HLQ 379

Query: 428 HFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISE-VFGIYPDLELLDLSNNNFFG 486
             ++  N  +     + + C  L  L L   +L    ++  F     L++L+LS++    
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439

Query: 487 EISSNWIKCPQLATLNMGGNEISGTIPSEIG---NMTQLHKLDFSSNRLVGQIPKQLGKL 543
                +   P L  LN+ GN        +      + +L  L  S   L          L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
             +  + L+ N+L+      L  L  + YL+L++N +S ++P  L  L +   +NL  N 
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP 558

Query: 604 FS 605
             
Sbjct: 559 LD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  287 bits (736), Expect = 2e-85
 Identities = 113/567 (19%), Positives = 191/567 (33%), Gaps = 33/567 (5%)

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN 184
            +  N  L+ +IP             +P     L          N    +   +   L N
Sbjct: 17  YNCENLGLN-EIPGT-----------LPNSTECL------EFSFNVLPTIQNTTFSRLIN 58

Query: 185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLS 244
           LTF+ L   +I         +   L  L L  N L             LK L+     +S
Sbjct: 59  LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118

Query: 245 GYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLK 304
                 L + K+L  LYL  N ++            LK L   N N +     +++ +L+
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN-NAIHYLSKEDMSSLQ 177

Query: 305 SLSHLWLSKTQLS-GFIPPSLGNLSNIRGLYIRENMLYGSIPEELG--RLKSLSQLSLSV 361
             ++L L+        I P   + +  + L          I + L    ++SL   +   
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237

Query: 362 NKLNGSIPHCLGNLS--NLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQN 419
                  P     L   +++   L+++               L +  L     +  LP  
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296

Query: 420 VCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-SEVFGIYPDLELLD 478
           +    +L    +  N F      S  N  SL  L ++ N     + +       +L  LD
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356

Query: 479 LSNNN--FFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQI 536
           LS+++       +        L +LN+  NE             QL  LD +  RL  + 
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 537 PK-QLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLI---PKNLGELR 592
            +     L  L  L L+ + L          L  L +L+L  N   K       +L  L 
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476

Query: 593 KLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL 652
           +L  L LS    S         L  ++ +DLSHN L  +    + +L+ + Y+NL  N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535

Query: 653 SGPIPSCFRRMHGLSSIDVSYNELQGS 679
           S  +PS    +    +I++  N L  +
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  279 bits (715), Expect = 2e-82
 Identities = 91/533 (17%), Positives = 184/533 (34%), Gaps = 18/533 (3%)

Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGS 222
           + +      +  IP +L    +   +  + N +     +    L +L++L L + Q+   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 223 IPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLK 282
              T  +   L  L L  N L       L   K+L +L+     ++        N  +L+
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 283 HLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLY- 341
            L++ + N +S     +    + L  L      +       + +L     L +  N    
Sbjct: 133 SLYLGS-NHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 342 GSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN--LSNLKFFALRENELSGSIPQEIENM 399
             I            L+    +    I   L N  + +L      + +     P   E +
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 400 KKLN-KYL-LFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
            +++ + + L ++ F             L    +   +    +P  L   ++L  L L  
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSA 310

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK-CPQLATLNMGGNEI--SGTIPS 514
           N+           +P L  L +  N    E+ +  ++    L  L++  ++I  S     
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 515 EIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYL 573
           ++ N++ L  L+ S N  +    +   +   L  L L   +L           L  L  L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 574 DLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGG 630
           +LS + L     +    L  L HLNL  N F +    +      L +L  L LS   L  
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 631 NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS 683
                  +L+ + +++L  N+L+         + G+  ++++ N +   +P  
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  248 bits (635), Expect = 2e-71
 Identities = 100/513 (19%), Positives = 180/513 (35%), Gaps = 39/513 (7%)

Query: 188 VYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYI 247
               N  +   IP  +    S   L  + N L      T   L NL FL L   ++    
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 248 PPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLS 307
                S   L  L L+ N L     ++     +LKHL       +S      + N K+L 
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ-TGISSIDFIPLHNQKTLE 132

Query: 308 HLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN-G 366
            L+L    +S    P       ++ L  + N ++    E++  L+  + LSL++N  +  
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 367 SIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSL 426
            I     + +  +       +    I + ++N                          SL
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN----------------------STIQSL 230

Query: 427 THFSVRNNNFVGPIPRSLQNC--TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
              +  + +     P   +     S+ S+ L+++      S  F  +  L+ LDL+  + 
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290

Query: 485 FGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKL 543
             E+ S  +    L  L +  N+          N   L  L    N    ++    L  L
Sbjct: 291 -SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349

Query: 544 TSLTSLTLNGNQL--SGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
            +L  L L+ + +  S    L+L  L+ L  L+LS N    L  +   E  +L  L+L+ 
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409

Query: 602 NQFSQEIS-IQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSC- 659
            +   + +      L  L  L+LSH+ L  +       L +L+++NL  N          
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

Query: 660 --FRRMHGLSSIDVSYNELQGSIPHSKAFQNAT 690
              + +  L  + +S+ +L        AF +  
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQ--HAFTSLK 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  211 bits (538), Expect = 3e-58
 Identities = 86/426 (20%), Positives = 146/426 (34%), Gaps = 35/426 (8%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISH--LSKLKHLDFSTNQFSGIIPPQIGIL--TNLVVLR 78
                 L+    Q    I   + +  +  L    F       I P     L   ++  + 
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260

Query: 79  LSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPP 138
           L  +    +        + L EL L+   L+  +P+ L  LS L +L LS N     +  
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN-LCQ 318

Query: 139 NWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVI-PRSLGGLKNLTFVYLNNNRI-- 195
                             N  S   +S+  N     +    L  L+NL  + L+++ I  
Sbjct: 319 I--------------SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364

Query: 196 VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK-LGSF 254
                 ++ NL  L  L L+ N+              L+ L L   RL          + 
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIG---NLKSLSHLWL 311
             L  L LSH+ L+ S    F  L +L+HL++   N       ++      L  L  L L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG-NHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 312 SKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHC 371
           S   LS     +  +L  +  + +  N L  S  E L  LK +  L+L+ N ++  +P  
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542

Query: 372 LGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS-GSLTHFS 430
           L  LS  +   LR+N L  +      +     ++     Q        +C++   L    
Sbjct: 543 LPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVR 597

Query: 431 VRNNNF 436
           + +   
Sbjct: 598 LSDVTL 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  150 bits (381), Expect = 5e-38
 Identities = 62/292 (21%), Positives = 109/292 (37%), Gaps = 20/292 (6%)

Query: 2   VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQL--FGTIPTQISHLSKLKHLDFSTNQ 59
             +++ G+  +  L          L  LDLS + +        Q+ +LS L+ L+ S N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387

Query: 60  FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEE-LGELTSLNELALSYNRLNGSIPASLGN 118
              +          L +L L+  +L     +     L  L  L LS++ L+ S       
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447

Query: 119 LSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS 178
           L  L  L+L  N            L         Q LG LE    + L   + S +   +
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSL---------QTLGRLE---ILVLSFCDLSSIDQHA 495

Query: 179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL 238
              LK +  V L++NR+  S    + +L+ + YL L  N +S  +P     LS  + + L
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554

Query: 239 HDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
             N L          F  L +   +  +L  +  +   N   L+ + + ++ 
Sbjct: 555 RQNPLDC--TCSNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  108 bits (271), Expect = 2e-24
 Identities = 45/214 (21%), Positives = 73/214 (34%), Gaps = 5/214 (2%)

Query: 500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGD 559
           T N     ++  IP  + N T+   L+FS N L         +L +LT L L   Q+   
Sbjct: 16  TYNCENLGLN-EIPGTLPNSTE--CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 560 IPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS 619
                     L  L L+AN L  +    L   + L HL       S    I +     L 
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 620 KLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLS--SIDVSYNELQ 677
            L L  N +      +    E L+ ++   N +          +   +  S++++ N++ 
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 678 GSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCE 711
           G  P +          F G + L     GL    
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  274 bits (703), Expect = 3e-84
 Identities = 91/312 (29%), Positives = 144/312 (46%), Gaps = 23/312 (7%)

Query: 88  IPEELGELTSL----NELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYL 143
           I ++LG  T+L               G +  +      +  L LS  +L    P      
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP------ 67

Query: 144 ISPHYGSIPQDLGNLESPVSVSLH-TNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSE 202
                  IP  L NL     + +   NN  G IP ++  L  L ++Y+ +  + G+IP  
Sbjct: 68  -------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120

Query: 203 IGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL-YLY 261
           +  +++L  L  + N LSG++PP+  +L NL  +    NR+SG IP   GSF  L   + 
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180

Query: 262 LSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP 321
           +S N+L G +P +F NL +L  + +   N L G      G+ K+   + L+K  L+  + 
Sbjct: 181 ISRNRLTGKIPPTFANL-NLAFVDLSR-NMLEGDASVLFGSDKNTQKIHLAKNSLAFDL- 237

Query: 322 PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFF 381
             +G   N+ GL +R N +YG++P+ L +LK L  L++S N L G IP   GNL      
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVS 296

Query: 382 ALRENELSGSIP 393
           A   N+     P
Sbjct: 297 AYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  259 bits (664), Expect = 1e-78
 Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 23/288 (7%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG--IIPPQIGILTNLVVLRLS-VNQLN 85
            D       G +    +   ++ +LD S         IP  +  L  L  L +  +N L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 86  GLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS 145
           G IP  + +LT L+ L +++  ++G+IP  L  +  LV L  S N+LSG +PP+      
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS------ 144

Query: 146 PHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNL-TFVYLNNNRIVGSIPSEIG 204
                    + +L + V ++   N  SG IP S G    L T + ++ NR+ G IP    
Sbjct: 145 ---------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
           NL +L+++ L++N L G      G+  N + ++L  N L+  +  K+G  K+L  L L +
Sbjct: 196 NL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRN 253

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLS 312
           N++ G+LP     L  L  L+V   N L G IP+  GNL+       +
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSF-NNLCGEIPQG-GNLQRFDVSAYA 299

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  257 bits (658), Expect = 5e-78
 Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 19/304 (6%)

Query: 111 SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
            I   LGN + L     S    +      W        G +           ++ L   N
Sbjct: 13  QIKKDLGNPTTLS----SWLPTTDCCNRTW-------LGVLCDTDTQTYRVNNLDLSGLN 61

Query: 171 FSGV--IPRSLGGLKNLTFVYL-NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA 227
                 IP SL  L  L F+Y+   N +VG IP  I  L  L YL +    +SG+IP   
Sbjct: 62  LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121

Query: 228 GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSL-KHLHV 286
             +  L  L    N LSG +PP + S  +L+ +    N+++G++P S+G+ S L   + +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181

Query: 287 HNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPE 346
              N+L+G IP    NL +L+ + LS+  L G      G+  N + +++ +N L   +  
Sbjct: 182 SR-NRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG- 238

Query: 347 ELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYL 406
           ++G  K+L+ L L  N++ G++P  L  L  L    +  N L G IPQ   N+++ +   
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSA 297

Query: 407 LFEN 410
              N
Sbjct: 298 YANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  255 bits (655), Expect = 2e-77
 Identities = 86/274 (31%), Positives = 128/274 (46%), Gaps = 20/274 (7%)

Query: 25  QLAYLDLSVNQLFGT--IPTQISHLSKLKHLDFS-TNQFSGIIPPQIGILTNLVVLRLSV 81
           ++  LDLS   L     IP+ +++L  L  L     N   G IPP I  LT L  L ++ 
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 82  NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWG 141
             ++G IP+ L ++ +L  L  SYN L+G++P S+ +L NLV ++   N +SG IP ++G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 142 YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPS 201
                                S+++  N  +G IP +   L NL FV L+ N + G    
Sbjct: 171 SFSK--------------LFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215

Query: 202 EIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLY 261
             G+ ++   + L KN L+  +    G   NL  L L +NR+ G +P  L   K L  L 
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 262 LSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS 295
           +S N L G +P   GNL         N   L GS
Sbjct: 275 VSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGS 307

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  249 bits (638), Expect = 4e-75
 Identities = 84/370 (22%), Positives = 130/370 (35%), Gaps = 78/370 (21%)

Query: 198 SIPSEIGNLRSLS----YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGS 253
            I  ++GN  +LS              G +  T      +  L L    L          
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK-------- 64

Query: 254 FKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSK 313
                            +PSS  NL  L  L++  IN L G IP  I  L  L +L+++ 
Sbjct: 65  --------------PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 314 TQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLG 373
           T +SG IP  L  +  +  L    N L G++P  +  L +L  ++   N+++G+IP   G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 374 NLSNL-KFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVR 432
           + S L     +  N L+G IP    N+                         +L    + 
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANL-------------------------NLAFVDLS 205

Query: 433 NNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW 492
            N   G       +  +   + L +N L  ++ +  G+  +L  LDL NN          
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRI-------- 256

Query: 493 IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLN 552
                            GT+P  +  +  LH L+ S N L G+IP Q G L         
Sbjct: 257 ----------------YGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299

Query: 553 GNQLSGDIPL 562
            N+     PL
Sbjct: 300 NNKCLCGSPL 309

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  220 bits (562), Expect = 2e-64
 Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 54/305 (17%)

Query: 433 NNNFVGPIPRSLQNCTSLYSLRLERNQLTG--NISEVFGIYPDLELLDLSNNNFFGEISS 490
           N  ++G +  +      + +L L    L     I       P L  L +   N       
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL----- 89

Query: 491 NWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLT 550
                              G IP  I  +TQLH L  +   + G IP  L ++ +L +L 
Sbjct: 90  ------------------VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131

Query: 551 LNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH-HLNLSNNQFSQEIS 609
            + N LSG +P  +  L  L  +    NR+S  IP + G   KL   + +S N+ + +I 
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

Query: 610 IQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSI 669
                L  L+ +DLS N L G+      + ++ + ++L +N L+  +         L+ +
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGL 249

Query: 670 DVSYNELQGSIPHS------------------------KAFQNATIEAFQGNKELCGDVT 705
           D+  N + G++P                             Q   + A+  NK LCG  +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--S 307

Query: 706 GLPPC 710
            LP C
Sbjct: 308 PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  209 bits (534), Expect = 9e-61
 Identities = 74/228 (32%), Positives = 107/228 (46%), Gaps = 20/228 (8%)

Query: 24  PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQ 83
            QL YL ++   + G IP  +S +  L  LDFS N  SG +PP I  L NLV +    N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 84  LNGLIPEELGELTSLNE-LALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGY 142
           ++G IP+  G  + L   + +S NRL G IP +  NL NL  + LS N L G        
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV---- 215

Query: 143 LISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSE 202
                        G+ ++   + L  N+ +  +   +G  KNL  + L NNRI G++P  
Sbjct: 216 -----------LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQG 263

Query: 203 IGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNR-LSGYIPP 249
           +  L+ L  L ++ N L G I P  GNL         +N+ L G   P
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  116 bits (292), Expect = 2e-28
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 7/156 (4%)

Query: 535 QIPKQLGKLTSLTS----LTLNGNQLSGDIPLELGLLAELGYLDLSANRLS--KLIPKNL 588
           QI K LG  T+L+S             G +         +  LDLS   L     IP +L
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 589 GELRKLHHLNLSN-NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNL 647
             L  L+ L +   N     I   I KL QL  L ++H ++ G IP  +  +++L  ++ 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 648 LQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS 683
             N LSG +P     +  L  I    N + G+IP S
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  271 bits (695), Expect = 1e-79
 Identities = 114/597 (19%), Positives = 201/597 (33%), Gaps = 48/597 (8%)

Query: 110 GSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTN 169
           GS+   +  + N+      +  LS ++P +           IP    N+       L  N
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDD-----------IPSSTKNI------DLSFN 42

Query: 170 NFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGN 229
               +   S      L ++ L+   I          L  LS L L  N +    P +   
Sbjct: 43  PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102

Query: 230 LSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNG-SLPSSFGNLSSLKHLHVHN 288
           L++L+ L   + +L+      +G   +L  L ++HN ++   LP+ F NL++L H+ +  
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162

Query: 289 INKLSGSIPKEIGNLKSLS----HLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSI 344
            N +      ++  L+        L +S   +  FI         +  L +R N    +I
Sbjct: 163 -NYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNI 220

Query: 345 PEELGR-LKSLSQLSLSVNKLNGSI------PHCLGNLSNLKFFALR--ENELSGSIPQE 395
            +   + L  L    L + +           P  +  L ++     R            +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
              +  ++   L          ++V +       S+            L     L SL L
Sbjct: 281 FHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTL 335

Query: 456 ERNQLTGNISEVFGIYPDLELLDLSNN--NFFGEISSNWIKCPQLATLNMGGNEISGTIP 513
             N+ +  IS      P L  LDLS N  +F G  S + +    L  L++  N     + 
Sbjct: 336 TMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMS 392

Query: 514 SEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGY 572
           +    + +L  LDF  + L           L  L  L ++      D       L  L  
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452

Query: 573 LDLSANRLSKLIPKN-LGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN 631
           L ++ N        N       L  L+LS  Q  Q        L +L  L++SHN+L   
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 632 IPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
             S    L SL  ++   N++             L+  +++ N +   I   + F  
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQ 568

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  269 bits (691), Expect = 4e-79
 Identities = 123/606 (20%), Positives = 190/606 (31%), Gaps = 85/606 (14%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L + P  +      +DLS N L        S+ S+L+ LD S  +   I       L +L
Sbjct: 23  LSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L L+ N +    P     LTSL  L     +L       +G L  L +L++++N +  
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV----YL 190
                           +P    NL + V V L  N    +    L  L+    V     +
Sbjct: 143 --------------CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIP- 248
           + N I   I  +      L  L L  N  S +I  T   NL+ L    L           
Sbjct: 189 SLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247

Query: 249 --PKLGSFKSL-----LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIG 301
              +    + L         L++          F  L+++  + +     +     +++ 
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG-VSIKY--LEDVP 304

Query: 302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
                  L + + QL  F      +L  ++ L +  N    SI  +   L SLS L LS 
Sbjct: 305 KHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSR 359

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
           N L+ S      +L                                              
Sbjct: 360 NALSFSGCCSYSDLGTN------------------------------------------- 376

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS-EVFGIYPDLELLDLS 480
              SL H  +  N  +  +  +      L  L  + + L        F     L  LD+S
Sbjct: 377 ---SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432

Query: 481 NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQ 539
             N   +    ++    L TL M GN       S +  N T L  LD S  +L       
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492

Query: 540 LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNL 599
              L  L  L ++ N L          L  L  LD S NR+           + L   NL
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552

Query: 600 SNNQFS 605
           +NN  +
Sbjct: 553 TNNSVA 558

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  240 bits (616), Expect = 6e-72
 Identities = 101/297 (34%), Positives = 150/297 (50%), Gaps = 34/297 (11%)

Query: 770  ELLSA-STFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKG---FVS 825
            EL  A   F  K +L G GG G VYK  L  G   AVK+L           Q G   F +
Sbjct: 24   ELQVASDNFSNKNIL-GRGGFGKVYKGRLADGTLVAVKRLKE------ERTQGGELQFQT 76

Query: 826  E---ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL-SNEATAAELDWSKRVNV 881
            E   I+   HRN+++  GFC       LVY Y+  GS+A+ L     +   LDW KR  +
Sbjct: 77   EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 882  IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS-ELA 940
              G A  L+Y+H  C P I+HRD+ +  +LLD E++A V DFG AK +    ++ +  + 
Sbjct: 137  ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 941  GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV-- 998
            GT G+IAPE   T +++EK DVF +GV++LE+I G+         L+  A   ++ ++  
Sbjct: 197  GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA-----FDLARLANDDDVMLLDW 251

Query: 999  ---------VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                     +  L+D  L     + E  ++ +I VA LC  ++P  RP M +V  +L
Sbjct: 252  VKGLLKEKKLEALVDVDLQGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  219 bits (559), Expect = 2e-62
 Identities = 112/498 (22%), Positives = 197/498 (39%), Gaps = 56/498 (11%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           F      +     L    +  T+    + L ++  L         I    +  L NL  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 73

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
             S NQL  + P  L  LT L ++ ++ N++    P  L NL+NL  L+L NN ++   P
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
                            L NL +   + L +N  S +    L GL +L  +   N     
Sbjct: 130 -----------------LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQV--- 167

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           +    + NL +L  L ++ N++S         L+NL+ L   +N++S   P  LG   +L
Sbjct: 168 TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
             L L+ NQL      +  +L++L  L + N N++S   P  +  L  L+ L L   Q+S
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLAN-NQISNLAP--LSGLTKLTELKLGANQIS 278

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSN 377
              P  L  L+ +  L + EN L    P  +  LK+L+ L+L  N ++   P  + +L+ 
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTK 332

Query: 378 LKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFV 437
           L+      N++S      + N+  +N      NQ +   P  +     +T   + +  + 
Sbjct: 333 LQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388

Query: 438 GPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN--FFGEISSNWIKC 495
                   N +   +++     L    +            D++ N   +  E+S  +   
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGALIAPAT--ISDGGSYTEPDITWNLPSYTNEVSYTF--- 443

Query: 496 PQLATLNMGGNEISGTIP 513
            Q  T+  G    SGT+ 
Sbjct: 444 SQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  216 bits (553), Expect = 1e-61
 Identities = 119/488 (24%), Positives = 210/488 (43%), Gaps = 53/488 (10%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
            +   L  +N+  T+         Q+  L      +       + +L+ L  ++FS NQ 
Sbjct: 26  KMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQL 80

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
           + I P  +  LT LV + ++ NQ+  + P  L  LT+L  L L  N++    P  L NL+
Sbjct: 81  TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLT 134

Query: 121 NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
           NL +L LS+N++S                     L  L S   +S   N  + + P  L 
Sbjct: 135 NLNRLELSSNTISD-----------------ISALSGLTSLQQLSFG-NQVTDLKP--LA 174

Query: 181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
            L  L  + +++N++  S  S +  L +L  L    NQ+S   P   G L+NL  L L+ 
Sbjct: 175 NLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNG 230

Query: 241 NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
           N+L       L S  +L  L L++NQ++   P     L+ L  L +   N++S   P  +
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA-NQISNISP--L 283

Query: 301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
             L +L++L L++ QL    P  + NL N+  L +  N +    P  +  L  L +L   
Sbjct: 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339

Query: 361 VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
            NK++      L NL+N+ + +   N++S   P  + N+ ++ +  L +  +T   P N 
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNY 394

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
             + S+ + +V+N       P ++ +  S     +  N  +   +EV   +     +   
Sbjct: 395 KANVSIPN-TVKNVTGALIAPATISDGGSYTEPDITWNLPSYT-NEVSYTFSQPVTIGKG 452

Query: 481 NNNFFGEI 488
              F G +
Sbjct: 453 TTTFSGTV 460

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  210 bits (538), Expect = 2e-59
 Identities = 102/493 (20%), Positives = 190/493 (38%), Gaps = 41/493 (8%)

Query: 166 LHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPP 225
                 + +       L       L    +  ++     +L  ++ L  ++  +      
Sbjct: 9   TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SID 62

Query: 226 TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLH 285
               L+NL  +   +N+L+   P  L +   L+ + +++NQ+     +   NL++L  L 
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLT 118

Query: 286 VHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIP 345
           + N N+++   P  + NL +L+ L LS   +S     +L  L++++ L     +   +  
Sbjct: 119 LFN-NQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV---TDL 170

Query: 346 EELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKY 405
           + L  L +L +L +S NK+  S    L  L+NL+      N++S   P  +  +  L++ 
Sbjct: 171 KPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226

Query: 406 LLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS 465
            L  NQ        +    +LT   + NN      P  L   T L  L+L  NQ++ NIS
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NIS 281

Query: 466 EVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKL 525
            + G+   L  L+L+ N       S       L  L +  N IS   P  + ++T+L +L
Sbjct: 282 PLAGL-TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336

Query: 526 DFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIP 585
            F +N++       L  LT++  L+   NQ+S   PL    L  +  L L+    +    
Sbjct: 337 FFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQAWTNAPV 392

Query: 586 KNLGELRKLHHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEY 644
                   +   N   N     I+   I      ++ D++ N                  
Sbjct: 393 NYKA---NVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYT-NEVSYTFSQPVT 448

Query: 645 MNLLQNKLSGPIP 657
           +       SG + 
Sbjct: 449 IGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  209 bits (534), Expect = 5e-59
 Identities = 107/516 (20%), Positives = 200/516 (38%), Gaps = 55/516 (10%)

Query: 26  LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLN 85
           L    ++ +     I T  + L++           +  +      L  +  L+     + 
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 86  GLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS 145
            +  + +  L +L ++  S N+L    P  L NL+ LV + ++NN ++   P        
Sbjct: 60  SI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-------- 107

Query: 146 PHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGN 205
                    L NL +   ++L  N  + + P  L  L NL  + L++N I  S  S +  
Sbjct: 108 ---------LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSG 154

Query: 206 LRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHN 265
           L SL  L    NQ++   P    NL+ L+ L +  N++S      L    +L  L  ++N
Sbjct: 155 LTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNN 209

Query: 266 QLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLG 325
           Q++    +  G L++L  L ++  N+L       + +L +L+ L L+  Q+S   P  L 
Sbjct: 210 QISDI--TPLGILTNLDELSLNG-NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LS 262

Query: 326 NLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRE 385
            L+ +  L +  N +    P  L  L +L+ L L+ N+L    P  + NL NL +  L  
Sbjct: 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318

Query: 386 NELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQ 445
           N +S   P  + ++ KL +   + N+ +     ++    ++   S  +N      P  L 
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 372

Query: 446 NCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWI-KCPQLATLNMG 504
           N T +  L L     T           ++ + +   N     I+   I         ++ 
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYK---ANVSIPNTVKNVTGALIAPATISDGGSYTEPDIT 429

Query: 505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
            N  S          +Q   +   +    G + + L
Sbjct: 430 WNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  200 bits (511), Expect = 6e-56
 Identities = 102/491 (20%), Positives = 189/491 (38%), Gaps = 52/491 (10%)

Query: 115 SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV 174
           +   L+  ++  L   +++  +                    +L+   ++         +
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS-----------------QTDLDQVTTLQADRLGIKSI 61

Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLK 234
               +  L NLT +  +NN++    P  + NL  L  + +N NQ++   P    NL+NL 
Sbjct: 62  DG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 115

Query: 235 FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
            L L +N+++   P  L +  +L  L LS N ++    S+   L+SL+ L   N  +++ 
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGN--QVTD 169

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
             P  + NL +L  L +S  ++S      L  L+N+  L    N +    P  LG L +L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
            +LSL+ N+L       L +L+NL    L  N++S   P  +  + KL +  L  NQ + 
Sbjct: 224 DELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
                +    +LT+  +  N      P  + N  +L  L L  N ++            L
Sbjct: 280 --ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333

Query: 475 ELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG 534
           + L   NN       S+      +  L+ G N+IS   P  + N+T++ +L  +      
Sbjct: 334 QRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389

Query: 535 QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKL 594
                   ++   ++      L    P  +         D++ N  S    +      + 
Sbjct: 390 APVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT-NEVSYTFSQP 446

Query: 595 HHLNLSNNQFS 605
             +      FS
Sbjct: 447 VTIGKGTTTFS 457

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  199 bits (507), Expect = 2e-55
 Identities = 115/450 (25%), Positives = 184/450 (40%), Gaps = 70/450 (15%)

Query: 19  PFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLR 78
                  L  ++ S NQL    P  + +L+KL  +  + NQ + I P  +  LTNL  L 
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 79  LSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPP 138
           L  NQ+  + P  L  LT+LN L LS N ++    ++L  L++L QLS  N         
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD----- 169

Query: 139 NWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGS 198
                         + L NL +   + + +N  S +    L  L NL  +   NN+I   
Sbjct: 170 -------------LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDI 214

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
            P  +G L +L  L LN NQL      T  +L+NL  L L +N++S   P  L     L 
Sbjct: 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 268

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
            L L  NQ++    S    L++L +L ++  N+L    P  I NLK+L++L L    +S 
Sbjct: 269 ELKLGANQISNI--SPLAGLTALTNLELNE-NQLEDISP--ISNLKNLTYLTLYFNNISD 323

Query: 319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNL 378
             P  + +L+ ++ L+   N +  S    L  L +++ LS   N+++   P  L NL+ +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRI 377

Query: 379 KFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN---- 434
               L +   + +      N+   N             P  +   GS T   +  N    
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY 435

Query: 435 -------------------NFVGPIPRSLQ 445
                               F G + + L+
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  190 bits (484), Expect = 2e-52
 Identities = 98/434 (22%), Positives = 173/434 (39%), Gaps = 36/434 (8%)

Query: 236 LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS 295
               D  ++        +    +   L    +  ++     +L  +  L     ++L   
Sbjct: 7   TITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTL---QADRLGIK 59

Query: 296 IPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLS 355
               +  L +L+ +  S  QL+   P  L NL+ +  + +  N +  +    L  L +L+
Sbjct: 60  SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLT 115

Query: 356 QLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGY 415
            L+L  N++    P  L NL+NL    L  N +S      +  +  L + L F NQ T  
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSL-QQLSFGNQVTDL 170

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
            P       +L    + +N         L   T+L SL    NQ++       GI  +L+
Sbjct: 171 KPLANLT--TLERLDISSNKVSDISV--LAKLTNLESLIATNNQISD--ITPLGILTNLD 224

Query: 476 LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQ 535
            L L+ N    +          L  L++  N+IS   P  +  +T+L +L   +N++   
Sbjct: 225 ELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 280

Query: 536 IPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
            P  L  LT+LT+L LN NQL    P  +  L  L YL L  N +S + P  +  L KL 
Sbjct: 281 SP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334

Query: 596 HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP 655
            L   NN+ S ++S  +  L  ++ L   HN +     + + NL  +  + L     +  
Sbjct: 335 RLFFYNNKVS-DVSS-LANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNA 390

Query: 656 IPSCFRRMHGLSSI 669
             +    +   +++
Sbjct: 391 PVNYKANVSIPNTV 404

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  218 bits (556), Expect = 4e-61
 Identities = 113/548 (20%), Positives = 190/548 (34%), Gaps = 36/548 (6%)

Query: 162 VSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSG 221
           ++      NF   IP +L    +   + L+ N +         +   L  L L++ ++  
Sbjct: 10  ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 222 SIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
           +I   A  +LS+L  L L  N +            SL  L      L        G+L +
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 281 LKHLHVHNINKL-SGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRG----LYI 335
           LK L+V + N + S  +P+   NL +L HL LS  ++       L  L  +      L +
Sbjct: 126 LKELNVAH-NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 336 RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPH-CLGNLSNLKFFALRENE------- 387
             N +   I     +   L +L+L  N  + ++   C+  L+ L+   L   E       
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 388 --LSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRS-L 444
                S  + + N+      L + + +   +        +++ FS+ +         S  
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG 504
                L  +  +  Q              L+ L  ++N      S   +  P L  L++ 
Sbjct: 304 FGWQHLELVNCKFGQFP------TLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLS 355

Query: 505 GNEIS--GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPL 562
            N +S  G         T L  LD S N ++  +      L  L  L    + L      
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 563 E-LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQI-GKLVQLSK 620
                L  L YLD+S              L  L  L ++ N F +     I  +L  L+ 
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 621 LDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSI 680
           LDLS   L    P+   +L SL+ +N+  N+L       F R+  L  I +  N    S 
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534

Query: 681 PHSKAFQN 688
           P       
Sbjct: 535 PRIDYLSR 542

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  213 bits (545), Expect = 2e-59
 Identities = 105/563 (18%), Positives = 192/563 (34%), Gaps = 60/563 (10%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
             + P  L      LDLS N L            +L+ LD S  +   I       L++L
Sbjct: 19  FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L L+ N +  L       L+SL +L      L       +G+L  L +L++++N +  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ- 137

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV----YL 190
                           +P+   NL +   + L +N    +    L  L  +  +     L
Sbjct: 138 -------------SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYL------HDNRL 243
           + N +   I         L  L L  N  S ++  T    L+ L+   L      ++  L
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 244 SGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNL 303
             +    L    +L         L+  L       + L ++   ++  ++    K+    
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 304 KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNK 363
               HL L   +   F    L +L   + L    N   G+   E+  L SL  L LS N 
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSL---KRLTFTSNKG-GNAFSEVD-LPSLEFLDLSRNG 358

Query: 364 LN--GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
           L+  G         ++LK+  L  N +  ++      ++                     
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE--------------------- 396

Query: 422 QSGSLTHFSVRNNNFVGPIPRS-LQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
               L H   +++N       S   +  +L  L +         + +F     LE+L ++
Sbjct: 397 ---QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453

Query: 481 NNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ 539
            N+F      +   +   L  L++   ++    P+   +++ L  L+ +SN+L       
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513

Query: 540 LGKLTSLTSLTLNGNQLSGDIPL 562
             +LTSL  + L+ N      P 
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  172 bits (438), Expect = 2e-45
 Identities = 97/466 (20%), Positives = 157/466 (33%), Gaps = 47/466 (10%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG 62
           ++ LTG+ ++ +L    F     L  L      L       I HL  LK L+ + N    
Sbjct: 80  TLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 63  I-IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL----NELALSYNRLNGSIPASLG 117
             +P     LTNL  L LS N++  +   +L  L  +      L LS N +N  I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197

Query: 118 NLSNLVQLSLSNNSLSGQIPPN---------WGYLISPHYGSIPQ----DLGNLESPVSV 164
               L +L+L NN  S  +               L+   + +       D   LE   ++
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 165 SLHTNN------FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIG--NLRSLSYLGLNK 216
           ++          +   I      L N++   L +  I   +         + L  +    
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKF 316

Query: 217 NQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN--GSLPSS 274
            Q           L +LK L    N+             SL +L LS N L+  G    S
Sbjct: 317 GQF------PTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 275 FGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPS-LGNLSNIRGL 333
               +SLK+L +   N +  ++      L+ L HL    + L      S   +L N+  L
Sbjct: 369 DFGTTSLKYLDLSF-NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 334 YIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSI-PHCLGNLSNLKFFALRENELSGSI 392
            I       +       L SL  L ++ N    +  P     L NL F  L + +L   +
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 485

Query: 393 PQEI-ENMKKLNKYLLFENQFTGYLPQNVCQS-GSLTHFSVRNNNF 436
                 ++  L    +  NQ    +P  +     SL    +  N +
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  122 bits (309), Expect = 4e-29
 Identities = 79/409 (19%), Positives = 128/409 (31%), Gaps = 69/409 (16%)

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
            IP  +    S  +L LS   L      S  +   ++ L +    +          L  L
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
           S L L+ N +          LS+L+     E  L+      I ++K L +  +  N    
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ- 137

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
                                    +P    N T+L  L L  N++         +   +
Sbjct: 138 ----------------------SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 475 ELLDLS---NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSE-IGNMTQLHKLDFSSN 530
            LL+LS   + N    I     K  +L  L +  N  S  +    I  +  L        
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235

Query: 531 RLVGQ---IPKQLGKLTSLTSLTLNGNQLSG------DIPLELGLLAELGYLDLSANRLS 581
               +          L  L +LT+   +L+       DI      L  +    L +  + 
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295

Query: 582 KLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLES 641
           ++  K+        HL L N +F Q       KL  L +L  + N  G N  SE+ +L S
Sbjct: 296 RV--KDFSYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGG-NAFSEV-DLPS 348

Query: 642 LEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNAT 690
           LE+++L                        S N L      S++    T
Sbjct: 349 LEFLDL------------------------SRNGLSFKGCCSQSDFGTT 373

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.4 bits (209), Expect = 6e-17
 Identities = 39/132 (29%), Positives = 54/132 (40%), Gaps = 1/132 (0%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG 62
            ++   SNLK   +   FL    L YLD+S            + LS L+ L  + N F  
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 63  IIPPQI-GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSN 121
              P I   L NL  L LS  QL  L P     L+SL  L ++ N+L          L++
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519

Query: 122 LVQLSLSNNSLS 133
           L ++ L  N   
Sbjct: 520 LQKIWLHTNPWD 531

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  213 bits (545), Expect = 1e-59
 Identities = 108/540 (20%), Positives = 199/540 (36%), Gaps = 29/540 (5%)

Query: 157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNK 216
           + ++       + +F+  IP  L     +  + L+ N+I      ++    +L  L L  
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 217 NQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNG-SLPSS 274
           ++++ +I   A  +L +L+ L L DN LS       G   SL YL L  N      + S 
Sbjct: 60  SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 275 FGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLY 334
           F NL++L+ L + N+   S     +   L SL+ L +    L  +   SL ++ +I  L 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 335 IRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQ 394
           +  +     +      L S+  L L    L       L                S    +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

Query: 395 EIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQ-NCTSLYSL 453
               + KL +Y+L        L +      +L      N +    +    +    ++  L
Sbjct: 239 SFNELLKLLRYIL-------ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291

Query: 454 RLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTI- 512
            + +  L  ++S V+ +   ++ + + N+  F    S       L  L++  N +     
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 513 --PSEIGNMTQLHKLDFSSNRL--VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLA 568
              +  G    L  L  S N L  + +  + L  L +LTSL ++ N     +P       
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
           ++ +L+LS+  +  +        + L  L++SNN      S  +  L +L +L +S N L
Sbjct: 411 KMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLD---SFSLF-LPRLQELYISRNKL 463

Query: 629 GGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
                 +      L  M + +N+L       F R+  L  I +  N    S P       
Sbjct: 464 --KTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 521

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  203 bits (518), Expect = 4e-56
 Identities = 104/584 (17%), Positives = 197/584 (33%), Gaps = 82/584 (14%)

Query: 24  PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQ 83
                 D        +IP+ ++  + +K LD S N+ + I    +    NL VL L  ++
Sbjct: 5   DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 84  LNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYL 143
           +N +  +    L SL  L LS N L+    +  G LS+L  L+L  N             
Sbjct: 62  INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ---------- 111

Query: 144 ISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPR-SLGGLKNLTFVYLNNNRIVGSIPSE 202
                  +     NL +  ++ +        I R    GL +L  + +    +       
Sbjct: 112 ----TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167

Query: 203 IGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYL 262
           + ++R + +L L+ ++ +  +   A  LS++++L L D  L+ +    L   +    +  
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 263 SHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP 322
              + +     SF  L  L    +            E  +         + ++       
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSE-------VEFDDCTLNGLGDFNPSESDVVSEL 280

Query: 323 SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFA 382
                  IR L+I +  L+  +      L+ + ++++  +K+         +L +L+F  
Sbjct: 281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLD 340

Query: 383 LRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPR 442
           L EN +     +                                                
Sbjct: 341 LSENLMVEEYLKN---------------------------------------------SA 355

Query: 443 SLQNCTSLYSLRLERNQLT--GNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLAT 500
                 SL +L L +N L       E+     +L  LD+S N  F  +  +     ++  
Sbjct: 356 CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT-FHPMPDSCQWPEKMRF 414

Query: 501 LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDI 560
           LN+    I   + + I     L  LD S+N L          L  L  L ++ N+L   +
Sbjct: 415 LNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL-DSFSLF---LPRLQELYISRNKLK-TL 466

Query: 561 PLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
           P +  L   L  + +S N+L  +       L  L  + L  N +
Sbjct: 467 P-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  151 bits (384), Expect = 1e-38
 Identities = 84/522 (16%), Positives = 175/522 (33%), Gaps = 94/522 (18%)

Query: 185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRL 243
                  +     SIPS +    ++  L L+ N+++  I        +NL+ L L  +R+
Sbjct: 7   SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI 62

Query: 244 SGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGN 302
           +  I      S  SL +L LS N L+    S FG LSSLK+L++      +  +     N
Sbjct: 63  N-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121

Query: 303 LKSLSHLWLSKTQLSGFIPP-SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
           L +L  L +   +    I       L+++  L I+   L     + L  ++ +  L+L +
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
           ++    +      LS++++  LR+  L+                    +        +  
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLAR----------------FQFSPLPVDEVSSPM 225

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
           +  +     + + +F   + + L+    L  +  +   L G           L   + S 
Sbjct: 226 KKLAFRGSVLTDESFN-ELLKLLRYILELSEVEFDDCTLNG-----------LGDFNPSE 273

Query: 482 NNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG 541
           ++   E+                                                     
Sbjct: 274 SDVVSELGKV-------------------------------------------------- 283

Query: 542 KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
           +  ++  L +    L  D+     LL ++  + +  +++  +       L+ L  L+LS 
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343

Query: 602 NQFSQEI---SIQIGKLVQLSKLDLSHNSLG--GNIPSEICNLESLEYMNLLQNKLSGPI 656
           N   +E    S   G    L  L LS N L         +  L++L  +++ +N    P+
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PM 402

Query: 657 PSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNK 698
           P   +    +  +++S   ++  +      Q   +     N 
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKTC-IPQTLEVLDVSNNN 442

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  118 bits (297), Expect = 1e-27
 Identities = 57/358 (15%), Positives = 121/358 (33%), Gaps = 25/358 (6%)

Query: 353 SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
           +             SIP  L   + +K   L  N+++     ++     L   +L  ++ 
Sbjct: 6   ASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 413 TGYLPQNVCQS-GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG-NISEVFGI 470
              +  +   S GSL H  + +N+            +SL  L L  N      ++ +F  
Sbjct: 63  N-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121

Query: 471 YPDLELLDLSNNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS 529
             +L+ L + N   F EI          L  L +    +       + ++  +H L    
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 530 NRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL------ 583
           +     +      L+S+  L L    L+      L +      +   A R S L      
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 584 ----IPKNLGELRKLHHLNLSNNQFSQEISIQIG--------KLVQLSKLDLSHNSLGGN 631
               + + + EL ++   + + N        +          + V + +L +    L  +
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301

Query: 632 IPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNA 689
           + +    LE ++ + +  +K+     S  + +  L  +D+S N +      + A + A
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  201 bits (514), Expect = 1e-57
 Identities = 89/372 (23%), Positives = 154/372 (41%), Gaps = 41/372 (11%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           FP     +     L    +   +      L  +  L  +  + + I    I  LTNL  L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYL 71

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
            L+ NQ+  + P  L  L  L  L +  N++  +  ++L NL+NL +L L+ +++S  I 
Sbjct: 72  NLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD-IS 126

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
           P                L NL    S++L  N+    +   L  +  L ++ +  +++  
Sbjct: 127 P----------------LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD 169

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
             P  I NL  L  L LN NQ+    P    +L++L +   + N+++   P  + +   L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANMTRL 223

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
             L + +N++     S   NLS L  L +   N++S      + +L  L  L +   Q+S
Sbjct: 224 NSLKIGNNKITDL--SPLANLSQLTWLEIGT-NQISD--INAVKDLTKLKMLNVGSNQIS 278

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSN 377
                 L NLS +  L++  N L     E +G L +L+ L LS N +    P  L +LS 
Sbjct: 279 DI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSK 334

Query: 378 LKFFALRENELS 389
           +         + 
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  186 bits (476), Expect = 2e-52
 Identities = 88/402 (21%), Positives = 168/402 (41%), Gaps = 55/402 (13%)

Query: 181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
           G   L  +    N+I         +L       L K  ++  +      L ++  L +  
Sbjct: 1   GAATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAG 53

Query: 241 NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
            +++      +    +L YL L+ NQ+     S   NL  L +L++   NK++      +
Sbjct: 54  EKVAS--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGT-NKIT--DISAL 106

Query: 301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
            NL +L  L+L++  +S   P  L NL+ +  L +  N    S    L  +  L+ L+++
Sbjct: 107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVT 163

Query: 361 VNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV 420
            +K+    P  + NL++L   +L  N++    P  + ++  L+ +  + NQ T       
Sbjct: 164 ESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD------ 213

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
                                  + N T L SL++  N++T            L  L++ 
Sbjct: 214 --------------------ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIG 251

Query: 481 NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
            N       +      +L  LN+G N+IS    S + N++QL+ L  ++N+L  +  + +
Sbjct: 252 TNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307

Query: 541 GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSK 582
           G LT+LT+L L+ N ++ DI   L  L+++   D +   + K
Sbjct: 308 GGLTNLTTLFLSQNHIT-DIR-PLASLSKMDSADFANQVIKK 347

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  173 bits (440), Expect = 1e-47
 Identities = 85/400 (21%), Positives = 166/400 (41%), Gaps = 55/400 (13%)

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
            ++L  L    IN++         +L       L K  ++     +   L +I  L +  
Sbjct: 2   AATLATLP-APINQIF-----PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAG 53

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
             +  +  + +  L +L  L+L+ N++    P  L NL  L    +  N+++      ++
Sbjct: 54  EKV--ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQ 107

Query: 398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
           N+  L +  L E+  +                              L N T +YSL L  
Sbjct: 108 NLTNLRELYLNEDNISD--------------------------ISPLANLTKMYSLNLGA 141

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIG 517
           N    ++S +  +   L  L ++ +    +  +       L +L++  N+I    P  + 
Sbjct: 142 NHNLSDLSPLSNM-TGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIEDISP--LA 196

Query: 518 NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA 577
           ++T LH      N++    P  +  +T L SL +  N+++   PL    L++L +L++  
Sbjct: 197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGT 252

Query: 578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEIC 637
           N++S +    + +L KL  LN+ +NQ S +IS+ +  L QL+ L L++N LG      I 
Sbjct: 253 NQISDI--NAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIG 308

Query: 638 NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ 677
            L +L  + L QN ++   P     +  + S D +   ++
Sbjct: 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 80.3 bits (199), Expect = 3e-16
 Identities = 29/161 (18%), Positives = 62/161 (38%), Gaps = 12/161 (7%)

Query: 522 LHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLS 581
              L      +  QI      L       L    ++  +  E   L  +  L ++  +++
Sbjct: 2   AATLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVTQEE--LESITKLVVAGEKVA 57

Query: 582 KLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLES 641
            +  + +  L  L +LNL+ NQ +    +    LV+L+ L +  N +     S + NL +
Sbjct: 58  SI--QGIEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 642 LEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH 682
           L  + L ++ +S   P     +  + S+++  N     +  
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  211 bits (539), Expect = 5e-57
 Identities = 121/604 (20%), Positives = 213/604 (35%), Gaps = 75/604 (12%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI-GILTNLVVLRLSV 81
                 L LS N +     +    L +L+ L+  +      I  +    L NL +L L  
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 82  NQLNGLIPEELGELTSLNELALSYNRLNGSI--PASLGNLSNLVQLSLSNNSLSGQIPPN 139
           +++  L P+    L  L EL L +  L+ ++       NL  L +L LS N +   +  +
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLH 141

Query: 140 WGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGL--KNLTFVYLNNNRIVG 197
                           G L S  S+   +N    V    L  L  K L+F  L  N +  
Sbjct: 142 P-------------SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS 188

Query: 198 SIPSEIGN-LRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKS 256
            +  + G  +     + L    +S       GN   +       N +S      L     
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITGNFSNAISKSQAFSLILAHH 241

Query: 257 LLYLYLSHNQLNGSLPSSFGNL--SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
           ++      + +     ++F  L  SS++HL + +   +     +    LK L  L L+  
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH-GFVFSLNSRVFETLKDLKVLNLAYN 300

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN 374
           +++     +   L N++ L +  N+L          L  ++ + L  N +          
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 375 LSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN 434
           L  L+   LR+N L+      I  +  +    L  N+                  ++   
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV----------------TLPKI 399

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLTG-NISEVFGIYPDLELLDLSNNNF-FGEISSNW 492
           N             +   + L  N+L   +I       P L++L L+ N F         
Sbjct: 400 NL------------TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447

Query: 493 IKCPQLATLNMGGNEISGTIPSEI-----GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLT 547
            + P L  L +G N +     +E+       ++ L  L  + N L    P     LT+L 
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 548 SLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQE 607
            L+LN N+L+  +     L A L  LD+S N+L    P        L  L++++N+F  E
Sbjct: 508 GLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICE 562

Query: 608 ISIQ 611
             + 
Sbjct: 563 CELS 566

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  201 bits (514), Expect = 9e-54
 Identities = 130/702 (18%), Positives = 241/702 (34%), Gaps = 86/702 (12%)

Query: 78  RLSVNQLNGL--IPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQ 135
           R++  +   L  +P+ L     L    LS+N +     +S   L  L  L L +      
Sbjct: 7   RIAFYRFCNLTQVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 136 IPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI 195
           I                ++L NL     + L ++    + P +  GL +L  + L    +
Sbjct: 64  IDKE-----------AFRNLPNLR---ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL 109

Query: 196 VGSI--PSEIGNLRSLSYLGLNKNQLSG-SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLG 252
             ++       NL++L+ L L+KNQ+    + P+ G L++LK +    N++      +L 
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169

Query: 253 SF--KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLW 310
               K+L +  L+ N L   +   +G   +     V  I  +S       GN  ++    
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITG 222

Query: 311 LSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLK--SLSQLSLSVNKLNGSI 368
                +S     SL    +I G     + +          L   S+  L LS   +    
Sbjct: 223 NFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282

Query: 369 PHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTH 428
                 L +LK   L  N+++                 + +  F G          +L  
Sbjct: 283 SRVFETLKDLKVLNLAYNKINK----------------IADEAFYG--------LDNLQV 318

Query: 429 FSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEI 488
            ++  N        +      +  + L++N +     + F     L+ LDL +N      
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL---- 374

Query: 489 SSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG-QIPKQLGKLTSLT 547
            +     P +  + + GN++  T+P         + +  S NRL    I   L ++  L 
Sbjct: 375 -TTIHFIPSIPDIFLSGNKLV-TLPKIN---LTANLIHLSENRLENLDILYFLLRVPHLQ 429

Query: 548 SLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRL-----SKLIPKNLGELRKLHHLNLSN 601
            L LN N+ S     +       L  L L  N L     ++L       L  L  L L++
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489

Query: 602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR 661
           N  +         L  L  L L+ N L   +        +LE +++ +N+L  P P  F 
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRL-TVLSHND-LPANLEILDISRNQLLAPNPDVFV 547

Query: 662 RMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCE-------ALT 714
               LS +D+++N+          F N              D+  + P         +L+
Sbjct: 548 S---LSVLDITHNKFICECEL-STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLS 603

Query: 715 SNKGDSGKHMTFLFVIVPLLSGAFLLSLVLIGMCFNFRRRKR 756
           +   D  + +  L   + ++    L   ++  +     R   
Sbjct: 604 TEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFC 645

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  185 bits (471), Expect = 2e-48
 Identities = 111/547 (20%), Positives = 195/547 (35%), Gaps = 56/547 (10%)

Query: 4   INLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGI 63
           + L       T+ +  F   P L  LDL  ++++   P     L  L  L       S  
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 64  IPPQIGI--LTNLVVLRLSVNQLNGL-IPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
           +        L  L  L LS NQ+  L +    G+L SL  +  S N++       L  L 
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172

Query: 121 --NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL---GNLESPVSVSLHTNNFSGVI 175
              L   SL+ NSL  ++  +WG  ++P    + + L   GN  +       +N  S   
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232

Query: 176 PRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR--SLSYLGLNKNQLSGSIPPTA-GNLSN 232
             SL    ++       + I     +    L   S+ +L L+   +  S+       L +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKD 291

Query: 233 LKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL 292
           LK L L  N+++           +L  L LS+N L     S+F  L  + ++ +   N +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK-NHI 350

Query: 293 SGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLK 352
           +    +    L+ L  L L    L+     ++  + +I  +++  N           +L 
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN-----------KLV 394

Query: 353 SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
           +L +++L+ N ++ S  + L NL  L F                  +  L   +L +N+F
Sbjct: 395 TLPKINLTANLIHLS-ENRLENLDILYFLL---------------RVPHLQILILNQNRF 438

Query: 413 TGYLPQNVCQS-GSLTHFSVRNNNFVGPI-----PRSLQNCTSLYSLRLERNQLTGNISE 466
           +            SL    +  N               +  + L  L L  N L      
Sbjct: 439 SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498

Query: 467 VFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLD 526
           VF     L  L L++N     + S+      L  L++  N++    P        L  LD
Sbjct: 499 VFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILDISRNQLLAPNPD---VFVSLSVLD 553

Query: 527 FSSNRLV 533
            + N+ +
Sbjct: 554 ITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  138 bits (349), Expect = 2e-33
 Identities = 95/514 (18%), Positives = 177/514 (34%), Gaps = 65/514 (12%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLS--KLKHLDFSTNQF 60
            ++L+ + ++       F     L  +D S NQ+F     ++  L    L     + N  
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186

Query: 61  SGIIPPQIGILTN------LVVLRLSVNQLNGLIP------------EELGELTSLNELA 102
              +    G   N      L +L +S N     I               L     +    
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246

Query: 103 LSYNRLNGSIPASLGNL--SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLES 160
             ++ +      +   L  S++  L LS+  +   +                     L+ 
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV--------------FETLKD 291

Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
              ++L  N  + +   +  GL NL  + L+ N +     S    L  ++Y+ L KN ++
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351

Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
                T   L  L+ L L DN L+      +    S+  ++LS N+L      +     +
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----T 402

Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL-GNLSNIRGLYIRENM 339
              +H+      +  I   +  +  L  L L++ + S            ++  L++ ENM
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462

Query: 340 LYGSIPEELGR-----LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQ 394
           L  +   EL       L  L  L L+ N LN   P    +L+ L+  +L  N L+  +  
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH 521

Query: 395 EIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLR 454
                  L    +  NQ       +V    SL+   + +N F+       +  T +  L 
Sbjct: 522 ND-LPANLEILDISRNQLL-APNPDVFV--SLSVLDITHNKFI----CECELSTFINWLN 573

Query: 455 LERNQLTGNISEVFGIYPD----LELLDLSNNNF 484
                + G  ++++ +YPD    + L  LS    
Sbjct: 574 HTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGC 607

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  123 bits (310), Expect = 8e-29
 Identities = 63/313 (20%), Positives = 111/313 (35%), Gaps = 35/313 (11%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
           V  ++L+   +  +L    F     L  L+L+ N++          L  L+ L+ S N  
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
             +       L  +  + L  N +  +  +    L  L  L L  N L      ++  + 
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIP 381

Query: 121 NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV-IPRSL 179
           ++  + LS N L                 ++P+          + L  N    + I   L
Sbjct: 382 SIPDIFLSGNKLV----------------TLPKINLTAN---LIHLSENRLENLDILYFL 422

Query: 180 GGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSG----SIPPTA-GNLSNL 233
             + +L  + LN NR       +      SL  L L +N L       +       LS+L
Sbjct: 423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482

Query: 234 KFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLS 293
           + LYL+ N L+   P       +L  L L+ N+L     +     ++L+ L +   N+L 
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISR-NQLL 539

Query: 294 GSIPKEIGNLKSL 306
              P    +L  L
Sbjct: 540 APNPDVFVSLSVL 552

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  197 bits (502), Expect = 2e-56
 Identities = 86/274 (31%), Positives = 133/274 (48%), Gaps = 24/274 (8%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI---RHRNIVKFYGF 841
            G GG G VYK  + +  T AVKKL ++        ++ F  EI  +   +H N+V+  GF
Sbjct: 40   GEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S    L LVY Y+  GSL   LS       L W  R  + +G AN ++++H +     +
Sbjct: 99   SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HI 155

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWSE-LAGTCGYIAPELAYTMRANEK 959
            HRDI S  +LLD  + A +SDFG A+   K   +  +  + GT  Y+APE A       K
Sbjct: 156  HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPK 214

Query: 960  CDVFNFGVLVLEVIEGK------HPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
             D+++FGV++LE+I G            L   L +     +    + D ID ++     +
Sbjct: 215  SDIYSFGVVLLEIITGLPAVDEHREPQLL---LDIKEEIEDEEKTIEDYIDKKM----ND 267

Query: 1014 VEEK-LKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             +   +++M +VA  CL    + RP ++KV  LL
Sbjct: 268  ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  195 bits (497), Expect = 1e-55
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 37/292 (12%)

Query: 770  ELLSA-STFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI- 827
            +L  A + F+ K ++ G G  G VYK  L  G   A+K+    P    GI +  F +EI 
Sbjct: 33   DLEEATNNFDHKFLI-GHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE--FETEIE 87

Query: 828  --TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKG 884
              +  RH ++V   GFC     + L+Y+Y+E G+L   L         + W +R+ +  G
Sbjct: 88   TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147

Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK-FLKPDSSNWS-ELAGT 942
             A  L Y+H      I+HRD+ S  +LLD  +   ++DFG +K   + D ++ S  + GT
Sbjct: 148  AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204

Query: 943  CGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV---- 998
             GYI PE     R  EK DV++FGV++ EV+  +         +    P   +N+     
Sbjct: 205  LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA-------IVQSLPREMVNLAEWAV 257

Query: 999  -------VNDLIDSRLPPPLGEV-EEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                   +  ++D  L     ++  E L+     A  CL  + + RP+M  V
Sbjct: 258  ESHNNGQLEQIVDPNLA---DKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  197 bits (504), Expect = 4e-55
 Identities = 107/567 (18%), Positives = 180/567 (31%), Gaps = 115/567 (20%)

Query: 87  LIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISP 146
            I       T L E     + L   +P    N+ +  +   + +      PP  G     
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 147 HYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNL 206
               +   L                           +    + LNN  +  S+P    +L
Sbjct: 61  AVSRLRDCL--------------------------DRQAHELELNNLGLS-SLPELPPHL 93

Query: 207 RSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
            SL     + N L+  +P    +L +L     +   LS   P        L YL +S+NQ
Sbjct: 94  ESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQ 142

Query: 267 LNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGN 326
           L   LP    N S LK + V N N L   +P    +L+    +     QL     P L N
Sbjct: 143 LE-KLPE-LQNSSFLKIIDVDN-NSLK-KLPDLPPSLE---FIAAGNNQLEEL--PELQN 193

Query: 327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN 386
           L  +  +Y   N L   +P+      SL  +    N L       L NL  L       N
Sbjct: 194 LPFLTAIYADNNSL-KKLPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYADNN 247

Query: 387 ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQN 446
            L  ++P    +++ LN   + +N  T                          +P   Q+
Sbjct: 248 LLK-TLPDLPPSLEALN---VRDNYLTD-------------------------LPELPQS 278

Query: 447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN 506
            T L       + L+          P+L  L+ S+N     +       P L  LN+  N
Sbjct: 279 LTFLDVSENIFSGLSELP-------PNLYYLNASSNEI-RSLCDLP---PSLEELNVSNN 327

Query: 507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL 566
           ++   +P+       L +L  S N L  ++P+      +L  L +  N L  + P     
Sbjct: 328 KLI-ELPALPPR---LERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPES 378

Query: 567 LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHN 626
           + +L       + L+++        + L  L++  N    E          +  L ++  
Sbjct: 379 VEDLRMN----SHLAEVPE----LPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSE 426

Query: 627 SLGGNIPSEICNLESLEYMNLLQNKLS 653
            +           + LE      +   
Sbjct: 427 RVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  189 bits (481), Expect = 4e-52
 Identities = 102/533 (19%), Positives = 187/533 (35%), Gaps = 91/533 (17%)

Query: 25  QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQL 84
            L       + L   +P +  ++        + +++    PP  G    + V RL     
Sbjct: 12  FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL- 69

Query: 85  NGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLI 144
                         +EL L+   L+ S+P    +L +   L  S NSL+           
Sbjct: 70  ----------DRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT----------- 104

Query: 145 SPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIG 204
                 +P+   +L+S +  + +    S + P        L ++ ++NN++   +P E+ 
Sbjct: 105 -----ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQ 150

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
           N   L  + ++ N L   +P       +L+F+   +N+L     P+L +   L  +Y  +
Sbjct: 151 NSSFLKIIDVDNNSLK-KLPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADN 204

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL 324
           N L   LP       SL+ +   N N L      E+ NL  L+ ++     L   +P   
Sbjct: 205 NSLK-KLPDL---PLSLESIVAGN-NIL--EELPELQNLPFLTTIYADNNLLKT-LPDLP 256

Query: 325 GNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR 384
            +L     L +R+N L   +PE    L  L       + L+   P       NL +    
Sbjct: 257 PSLEA---LNVRDNYL-TDLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNAS 305

Query: 385 ENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL 444
            NE+  S+     ++++LN   +  N+    LP        L       N+    +P   
Sbjct: 306 SNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALP---PRLERLIASFNHLAE-VPELP 356

Query: 445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG 504
           QN   L+   +E N L     ++        + DL  N+   E+         L  L++ 
Sbjct: 357 QNLKQLH---VEYNPLR-EFPDIPE-----SVEDLRMNSHLAEVPEL---PQNLKQLHVE 404

Query: 505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLS 557
            N +    P    +   +  L  +S R+V            L       +   
Sbjct: 405 TNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  179 bits (456), Expect = 9e-49
 Identities = 91/517 (17%), Positives = 171/517 (33%), Gaps = 82/517 (15%)

Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLK 234
           I         L     +++ +   +P E  N++S +      ++   + PP  G    + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 235 FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
              L D              +    L L++  L+ SLP    +   L+ L     N L+ 
Sbjct: 62  VSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPH---LESLVASC-NSLT- 104

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIP---------------PSLGNLSNIRGLYIRENM 339
            +P+   +LKSL     +   LS   P               P L N S ++ + +  N 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164

Query: 340 LYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENM 399
           L   +P+    L+    ++   N+L   +P  L NL  L       N L   +P    ++
Sbjct: 165 L-KKLPDLPPSLE---FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSL 217

Query: 400 KKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQ 459
           + +       N         +     LT     NN     +P    +  +L    +  N 
Sbjct: 218 ESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALN---VRDNY 268

Query: 460 LTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNM 519
           LT ++ E+      L++ +   +             P L  LN   NEI  ++     ++
Sbjct: 269 LT-DLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEIR-SLCDLPPSL 319

Query: 520 TQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANR 579
               +L+ S+N+L+ ++P    +   L  L  + N L+ ++P        L  L +  N 
Sbjct: 320 E---ELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ---NLKQLHVEYNP 368

Query: 580 LSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNL 639
           L +  P     +  L   +                   L +L +  N L    P    ++
Sbjct: 369 LREF-PDIPESVEDLRMNSHLAEVPEL--------PQNLKQLHVETNPL-REFPDIPESV 418

Query: 640 ESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL 676
           E L    +   ++  P          L      ++  
Sbjct: 419 EDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  174 bits (442), Expect = 7e-47
 Identities = 101/467 (21%), Positives = 160/467 (34%), Gaps = 81/467 (17%)

Query: 8   GSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQ 67
           G   +  +      L  Q   L+L+   L  ++P    H   L+ L  S N  +  +P  
Sbjct: 55  GEQREMAVSRLRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPEL 109

Query: 68  IGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSL 127
              L +L+V   ++  L+ L P        L  L +S N+L   +P  L N S L  + +
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDV 160

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF 187
            NNSL                  +P    +LE    ++   N     +P  L  L  LT 
Sbjct: 161 DNNSLK----------------KLPDLPPSLE---FIAAGNNQLE-ELP-ELQNLPFLTA 199

Query: 188 VYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYI 247
           +Y +NN +   +P    +L S+       N L     P   NL  L  +Y  +N L   +
Sbjct: 200 IYADNNSLK-KLPDLPLSLESIV---AGNNIL--EELPELQNLPFLTTIYADNNLLK-TL 252

Query: 248 PPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPK--------- 298
           P       SL  L +  N L   LP    +L+ L        + LS   P          
Sbjct: 253 PDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENI-FSGLSELPPNLYYLNASSN 307

Query: 299 ----EIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
                     SL  L +S  +L   +P     L     L    N L   +PE    LK  
Sbjct: 308 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVPELPQNLKQ- 361

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
             L +  N L    P    ++ +L+      N     +P+  +N+K+L+   +  N    
Sbjct: 362 --LHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNLKQLH---VETNPLR- 409

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT 461
             P       S+    + +   V P   + +    L     E +   
Sbjct: 410 EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 64.6 bits (158), Expect = 7e-11
 Identities = 25/140 (17%), Positives = 51/140 (36%), Gaps = 17/140 (12%)

Query: 543 LTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNN 602
            T L     + + L+ ++P+E   +        + +   +  P   GE R++    L + 
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 603 QFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRR 662
              Q             +L+L++  L  ++P    +LESL       N L+  +P   + 
Sbjct: 69  LDRQ-----------AHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQS 112

Query: 663 MHGLSSIDVSYNELQGSIPH 682
           +  L   + +   L    P 
Sbjct: 113 LKSLLVDNNNLKALSDLPPL 132

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  193 bits (491), Expect = 6e-55
 Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 35/285 (12%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
              G  G V+KA+L   +  AVK        +     +  V  +  ++H NI++F G    
Sbjct: 33   ARGRFGCVWKAQL-LNEYVAVKIFP--IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKR 89

Query: 845  TQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF--- 897
                   L+L+  + E+GSL+  L        + W++  ++ + +A  L+Y+H D     
Sbjct: 90   GTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLK 145

Query: 898  ----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS--ELAGTCGYIAPELA 951
                P I HRDI SK VLL     A ++DFG A   +   S        GT  Y+APE+ 
Sbjct: 146  DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205

Query: 952  -----YTMRANEKCDVFNFGVLVLEVIEGKHPGH---------FLSLLLSLPAPAANMNI 997
                 +   A  + D++  G+++ E+                 F   +   P+      +
Sbjct: 206  EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEV 265

Query: 998  VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            VV+      L     +    +  +      C D + + R +   V
Sbjct: 266  VVHKKKRPVLRDYWQK-HAGMAMLCETIEECWDHDAEARLSAGCV 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  185 bits (472), Expect = 2e-52
 Identities = 68/266 (25%), Positives = 118/266 (44%), Gaps = 28/266 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G G  G V KA+       A+K++ S         +K F+ E+     + H NIVK YG 
Sbjct: 17   GRGAFGVVCKAKWR-AKDVAIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C     + LV EY E GSL  +L           +  ++     +  ++Y+H      ++
Sbjct: 70   C--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 902  HRDISSKKVLLDLEYK-AHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            HRD+    +LL        + DFGTA  ++   +N     G+  ++APE+      +EKC
Sbjct: 128  HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAWMAPEVFEGSNYSEKC 184

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            DVF++G+++ EVI  + P   +            M  V N     R P     + + ++S
Sbjct: 185  DVFSWGIILWEVITRRKPFDEIG-----GPAFRIMWAVHNGT---RPPLIKN-LPKPIES 235

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046
            ++     C   +P  RP+M+++  ++
Sbjct: 236  LMT---RCWSKDPSQRPSMEEIVKIM 258

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  183 bits (466), Expect = 2e-51
 Identities = 49/354 (13%), Positives = 105/354 (29%), Gaps = 47/354 (13%)

Query: 26  LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLN 85
              L    +         +S   +  + D +                N    ++      
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRN-------RWHSAWRQANSNNPQIETRTGR 66

Query: 86  GL--IPEELGELTSLN--ELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWG 141
            L    + L + T      L L    L    P     LS+L  +++    L         
Sbjct: 67  ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-------- 117

Query: 142 YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPS 201
                    +P  +       +++L  N     +P S+  L  L  + +     +  +P 
Sbjct: 118 --------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168

Query: 202 EIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLY 261
            + +                        L NL+ L L    +   +P  + + ++L  L 
Sbjct: 169 PLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212

Query: 262 LSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP 321
           + ++ L+ +L  +  +L  L+ L +     L  + P   G    L  L L        +P
Sbjct: 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLP 270

Query: 322 PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNL 375
             +  L+ +  L +R  +    +P  + +L +   + +  +       H     
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  174 bits (444), Expect = 2e-48
 Identities = 55/315 (17%), Positives = 106/315 (33%), Gaps = 19/315 (6%)

Query: 89  PEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP----PNWGYLI 144
                  +    L    +         L           +    + +      P      
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT 64

Query: 145 SPHYGSIPQDLGNLESPVSVSLH-TNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI 203
                +    L +   P  V+L   +      P     L +L  + ++   ++  +P  +
Sbjct: 65  GRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 204 GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF--------- 254
                L  L L +N L  ++P +  +L+ L+ L +        +P  L S          
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
            +L  L L    +  SLP+S  NL +LK L + N + LS ++   I +L  L  L L   
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN-SPLS-ALGPAIHHLPKLEELDLRGC 239

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN 374
                 PP  G  + ++ L +++     ++P ++ RL  L +L L        +P  +  
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299

Query: 375 LSNLKFFALRENELS 389
           L       +  +  +
Sbjct: 300 LPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  165 bits (420), Expect = 2e-45
 Identities = 56/379 (14%), Positives = 106/379 (27%), Gaps = 55/379 (14%)

Query: 173 GVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN 232
           G              +Y   +  +      +   +       N+   +        N +N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 233 LKFLYLHDNRLSGYIPPKLGSFKS--LLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
            +        L       L        + L L    L    P     LS L+H+ +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA-A 114

Query: 291 KLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR 350
            L   +P  +     L  L L++  L   +P S+ +L+ +R L IR       +PE L  
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
                                   L NL+   L    +  S+P  I N++ L    +  +
Sbjct: 173 T---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI 470
             +  L   +     L    +R    +   P        L                    
Sbjct: 217 PLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL-------------------- 255

Query: 471 YPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN 530
               + L L + +    +  +  +  QL  L++ G      +PS I  +     +    +
Sbjct: 256 ----KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

Query: 531 RLVGQIPKQLGKLTSLTSL 549
            L  Q+ +      +  + 
Sbjct: 312 -LQAQLDQHR--PVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  154 bits (392), Expect = 1e-41
 Identities = 55/341 (16%), Positives = 109/341 (31%), Gaps = 30/341 (8%)

Query: 269 GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
           GS      + S  ++L+      L       +   +   +   ++            N +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALR-PYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56

Query: 329 NIRGLYIRENMLYGSIPEELGRLKS--LSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN 386
           N +        L  +  + L          L L    L    P     LS+L+   +   
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114

Query: 387 ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQN 446
            L   +P  ++    L    L  N     LP ++     L   S+R    +  +P  L +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN 506
             +    +   N               L+ L L        + ++      L +L +  +
Sbjct: 173 TDASGEHQGLVN---------------LQSLRLEWTGI-RSLPASIANLQNLKSLKIRNS 216

Query: 507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTL-NGNQLSGDIPLELG 565
            +S  +   I ++ +L +LD      +   P   G    L  L L + + L   +PL++ 
Sbjct: 217 PLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIH 274

Query: 566 LLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ 606
            L +L  LDL        +P  + +L     + +  +  +Q
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  154 bits (391), Expect = 2e-41
 Identities = 58/285 (20%), Positives = 97/285 (34%), Gaps = 34/285 (11%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII 64
             TG  LK T         P    L+L    L    P Q   LS L+H+          +
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGN------ 118
           P  +     L  L L+ N L  L P  +  L  L EL++        +P  L +      
Sbjct: 120 PDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 119 ---LSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVI 175
              L NL  L L    +                 S+P  + NL++  S+ +  +  S  +
Sbjct: 179 HQGLVNLQSLRLEWTGIR----------------SLPASIANLQNLKSLKIRNSPLSA-L 221

Query: 176 PRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGL-NKNQLSGSIPPTAGNLSNLK 234
             ++  L  L  + L     + + P   G    L  L L + + L  ++P     L+ L+
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLE 280

Query: 235 FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHN---QLNGSLPSSFG 276
            L L        +P  +    +   + +  +   QL+   P +  
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  129 bits (327), Expect = 5e-33
 Identities = 48/327 (14%), Positives = 92/327 (28%), Gaps = 41/327 (12%)

Query: 366 GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGS 425
           GS  H   + S  +    + +         +   ++                     S +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNN 57

Query: 426 LTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFF 485
               +             L++ T                       P    L+L +    
Sbjct: 58  PQIETRTGRALKA-TADLLEDATQ----------------------PGRVALELRSVPL- 93

Query: 486 GEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTS 545
            +      +   L  + +    +   +P  +     L  L  + N L   +P  +  L  
Sbjct: 94  PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151

Query: 546 LTSLTLNGNQLSGDIPLELG---------LLAELGYLDLSANRLSKLIPKNLGELRKLHH 596
           L  L++       ++P  L           L  L  L L    +  L P ++  L+ L  
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKS 210

Query: 597 LNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI 656
           L + N+  S  +   I  L +L +LDL   +   N P        L+ + L        +
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269

Query: 657 PSCFRRMHGLSSIDVSYNELQGSIPHS 683
           P    R+  L  +D+        +P  
Sbjct: 270 PLDIHRLTQLEKLDLRGCVNLSRLPSL 296

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.8 bits (117), Expect = 5e-06
 Identities = 19/96 (19%), Positives = 32/96 (33%), Gaps = 5/96 (5%)

Query: 5   NLTGSNLKGTLQEFP--FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG 62
           +L G      L+ +P  F     L  L L       T+P  I  L++L+ LD        
Sbjct: 235 DLRGCTA---LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 63  IIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL 98
            +P  I  L    ++ +  +    L         + 
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  179 bits (456), Expect = 2e-50
 Identities = 81/265 (30%), Positives = 128/265 (48%), Gaps = 20/265 (7%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G G  GTV++AE   G   AVK L              F+ E+     +RH NIV F G 
Sbjct: 46   GAGSFGTVHRAEW-HGSDVAVKILM--EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +   +L +V EYL RGSL  +L       +LD  +R+++   VA  ++Y+H+   PPI+
Sbjct: 103  VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
            HR++ S  +L+D +Y   V DFG ++       +    AGT  ++APE+     +NEK D
Sbjct: 162  HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221

Query: 962  VFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSM 1021
            V++FGV++ E+   + P   L+       PA  +  V       RL  P   +  ++ ++
Sbjct: 222  VYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFK--CKRLEIPRN-LNPQVAAI 271

Query: 1022 IAVAFLCLDANPDCRPTMQKVCNLL 1046
            I     C    P  RP+   + +LL
Sbjct: 272  IE---GCWTNEPWKRPSFATIMDLL 293

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  177 bits (452), Expect = 3e-50
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 31/273 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G GG G VY+A    GD  AVK     P  +I    +    E      ++H NI+   G 
Sbjct: 16   GIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C    +L LV E+   G L  +LS +     +     VN    +A  ++Y+H +   PI+
Sbjct: 75   CLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPII 130

Query: 902  HRDISSKKVLLDLEYKAH--------VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
            HRD+ S  +L+  + +          ++DFG A+     +      AG   ++APE+   
Sbjct: 131  HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPEVIRA 188

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
               ++  DV+++GVL+ E++ G+ P   +          A    V  +     LP P   
Sbjct: 189  SMFSKGSDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMN--KLALPIPST- 238

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              E    ++     C + +P  RP+   + + L
Sbjct: 239  CPEPFAKLME---DCWNPDPHSRPSFTNILDQL 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  176 bits (449), Expect = 1e-49
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 33/276 (11%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKG---FVSEIT---EIRHRNIVK 837
            G GG G V+K  L    +  A+K L    +       +    F  E+     + H NIVK
Sbjct: 28   GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK 87

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
             YG         +V E++  G L   L ++A    + WS ++ ++  +A  + YM +   
Sbjct: 88   LYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN-QN 142

Query: 898  PPILHRDISSKKVLLD-----LEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL-- 950
            PPI+HRD+ S  + L          A V+DFG ++      S    L G   ++APE   
Sbjct: 143  PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG---LLGNFQWMAPETIG 199

Query: 951  AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
            A      EK D ++F +++  ++ G+ P    S           +N++  +    R   P
Sbjct: 200  AEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMIREE--GLRPTIP 252

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                  +L+++I    LC   +P  RP    +   L
Sbjct: 253  ED-CPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  178 bits (454), Expect = 5e-48
 Identities = 107/505 (21%), Positives = 198/505 (39%), Gaps = 41/505 (8%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNR 242
           +   V  + N ++  +P ++   +  + L +++N +S  +  +   +LS L+ L +  NR
Sbjct: 1   SEFLVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNR 56

Query: 243 LSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL-SGSIPK 298
           +  Y+      FK      YL LSHN+L   +        +LKHL +   N   +  I K
Sbjct: 57  IQ-YLDI--SVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSF-NAFDALPICK 109

Query: 299 EIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLS 358
           E GN+  L  L LS T L       + +L+  + L +          E+   L+  +  S
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTES 167

Query: 359 LSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQ 418
           L +        H + ++S      L  + +   +          NK   F +        
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED--------NKCSYFLSILAKLQTN 219

Query: 419 NVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPD----- 473
               + +L +     N+F+  +   L   T+++   +   +L G +      Y       
Sbjct: 220 PKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277

Query: 474 LELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLV 533
           L +  + ++ F    S  +     +   N   +            ++    LDFS+N L 
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337

Query: 534 GQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSKLIPKNL-G 589
             + +  G LT L +L L  NQL  ++     +   +  L  LD+S N +S    K    
Sbjct: 338 DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396

Query: 590 ELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQ 649
             + L  LN+S+N  +  I   +    ++  LDL  N +  +IP ++  LE+L+ +N+  
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453

Query: 650 NKLSGPIPSCFRRMHGLSSIDVSYN 674
           N+L       F R+  L  I +  N
Sbjct: 454 NQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  150 bits (381), Expect = 2e-38
 Identities = 97/500 (19%), Positives = 178/500 (35%), Gaps = 44/500 (8%)

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN 184
           +  S N L   +P +           + Q    L       +  N  S +    +  L  
Sbjct: 5   VDRSKNGLI-HVPKD-----------LSQKTTILN------ISQNYISELWTSDILSLSK 46

Query: 185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL- 243
           L  + +++NRI     S     + L YL L+ N+L   I        NLK L L  N   
Sbjct: 47  LRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD 103

Query: 244 SGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNL 303
           +  I  + G+   L +L LS   L  S      +L+  K L V          P+ + + 
Sbjct: 104 ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF 163

Query: 304 --KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG------SIPEELGRLKSLS 355
             +SL  ++ +  +    +  S+  ++N+    I+  +         SI  +L     LS
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223

Query: 356 QLSLSVNKLNG-SIPHCLGNL--SNLKFFALRENELSGSIPQEIENMKKLN----KYLLF 408
            L+L+  +    S    L  +  + + +F++   +L G +     +    +         
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283

Query: 409 ENQFTGYLPQNVCQSGS-LTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEV 467
            +   G+    + +  S +   +   +             +    L    N LT  + E 
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343

Query: 468 FGIYPDLELLDLSNNNF--FGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHK 524
            G   +LE L L  N      +I+    +   L  L++  N +S             L  
Sbjct: 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403

Query: 525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLI 584
           L+ SSN L   I + L     +  L L+ N++   IP ++  L  L  L++++N+L  + 
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460

Query: 585 PKNLGELRKLHHLNLSNNQF 604
                 L  L  + L  N +
Sbjct: 461 DGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  145 bits (367), Expect = 8e-37
 Identities = 95/487 (19%), Positives = 167/487 (34%), Gaps = 35/487 (7%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L   P  L  +   L++S N +     + I  LSKL+ L  S N+   +          L
Sbjct: 12  LIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIP--ASLGNLSNLVQLSLSNNSL 132
             L LS N+L  +         +L  L LS+N  + ++P     GN+S L  L LS   L
Sbjct: 72  EYLDLSHNKLVKIS---CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127

Query: 133 SG-------QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNL 185
                     +  +   L+        +D   L+   + SLH    +      +  +   
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187

Query: 186 TFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSG 245
           T   L  + I   +     +        L  N            LSNL    +     S 
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNP----------KLSNLTLNNIETTWNSF 237

Query: 246 YIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLS--SLKHLHVHNINKLSGSIPKEIG-- 301
               +L    ++ Y  +S+ +L G L     + S  SLK L +H +       P+     
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297

Query: 302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
              +++    + +            +S    L    N+L  ++ E  G L  L  L L +
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357

Query: 362 NKLNGSIPHCLG---NLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLP 417
           N+L   +         + +L+   + +N +S    +      K L    +  N  T  + 
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416

Query: 418 QNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELL 477
           +  C    +    + +N     IP+ +    +L  L +  NQL      +F     L+ +
Sbjct: 417 R--CLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473

Query: 478 DLSNNNF 484
            L  N +
Sbjct: 474 WLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  112 bits (281), Expect = 6e-26
 Identities = 73/452 (16%), Positives = 139/452 (30%), Gaps = 67/452 (14%)

Query: 235 FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
            +    N L  ++P  L   +    L +S N ++    S   +LS L+ L + + N++  
Sbjct: 4   LVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISH-NRIQY 59

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
                    + L +L LS  +L                           I        +L
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLV-------------------------KIS--CHPTVNL 92

Query: 355 SQLSLSVNKLNGSIPHC--LGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
             L LS N  + ++P C   GN+S LKF  L    L  S    I ++      L+    +
Sbjct: 93  KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 413 TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYP 472
                    Q  +     +            + + +      LE + +            
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPT--NKEFHFILDVSVKTVANLELSNIKCV--------- 200

Query: 473 DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL 532
               L+ +  ++F  I +     P+L+ L +   E +      I  +     + + S   
Sbjct: 201 ----LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS--- 253

Query: 533 VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
                        ++++ L G     D       L  L    + ++              
Sbjct: 254 -------------ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300

Query: 593 KLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL 652
            ++  N + +       +   K+     LD S+N L   +     +L  LE + L  N+L
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 653 S--GPIPSCFRRMHGLSSIDVSYNELQGSIPH 682
                I     +M  L  +D+S N +      
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  101 bits (254), Expect = 1e-22
 Identities = 54/313 (17%), Positives = 102/313 (32%), Gaps = 57/313 (18%)

Query: 10  NLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIG 69
           ++   LQ  P L    L  ++ + N        Q+   + + +   S  +  G +  +  
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDFRDF 268

Query: 70  I-----LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
                 L  L + ++  +             +++N    + +            +S  + 
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN 184
           L  SNN L+                                    N         G L  
Sbjct: 329 LDFSNNLLT-------------------------------DTVFENC--------GHLTE 349

Query: 185 LTFVYLNNNRIVGSIPSEIG---NLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHD 240
           L  + L  N++   +         ++SL  L +++N +S            +L  L +  
Sbjct: 350 LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408

Query: 241 NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
           N L+  I   L     +  L L  N++  S+P     L +L+ L+V + N+L  S+P  I
Sbjct: 409 NILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS-NQLK-SVPDGI 463

Query: 301 -GNLKSLSHLWLS 312
              L SL  +WL 
Sbjct: 464 FDRLTSLQKIWLH 476

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 96.5 bits (240), Expect = 7e-21
 Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 23/237 (9%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI 68
             L     ++       L+   +  +             S +   +F+ +    +     
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLG---NLSNLVQL 125
             ++  + L  S N L   + E  G LT L  L L  N+L   +         + +L QL
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQL 379

Query: 126 SLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNL 185
            +S NS+S                    D    +S +S+++ +N  +  I R L     +
Sbjct: 380 DISQNSVSYDEKKG--------------DCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423

Query: 186 TFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
             + L++N+I  SIP ++  L +L  L +  NQL  S+P      L++L+ ++LH N
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  175 bits (445), Expect = 4e-47
 Identities = 91/557 (16%), Positives = 166/557 (29%), Gaps = 78/557 (14%)

Query: 40  IPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLN 99
           I     + ++ K    + +     +        N+  L LS N L+ +   +L   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 100 ELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLE 159
            L LS N L       L +LS L  L L+NN +                     +L    
Sbjct: 62  LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ--------------------ELLVGP 99

Query: 160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQL 219
           S  ++    NN S V      G KN+   YL NN+I      + G    + YL L  N++
Sbjct: 100 SIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156

Query: 220 SG-SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
              +    A +   L+ L L  N +   +  ++  F  L  L LS N+L   +   F + 
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSA 213

Query: 279 SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           + +  + + N NKL   I K +   ++L H  L                 N R   + + 
Sbjct: 214 AGVTWISLRN-NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQ 270

Query: 339 MLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIEN 398
            +     +        +                   L  LK          GS  +    
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER--- 327

Query: 399 MKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERN 458
                                                    +    +N      +   + 
Sbjct: 328 -----------------------------------------LECERENQARQREIDALKE 346

Query: 459 QLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQL-ATLNMGGNEISGTIPSEIG 517
           Q    I +V         L+        ++S+      +L  TL     +I     +E  
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ 406

Query: 518 NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA 577
           +  QL +        +  + +Q  +  ++    +  ++ +        L    G  DL+ 
Sbjct: 407 SPLQLLRAIVKRYEEM-YVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLAL 465

Query: 578 NRLSKLIPKNLGELRKL 594
              +  + + +   + L
Sbjct: 466 ASANATLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  175 bits (445), Expect = 4e-47
 Identities = 69/517 (13%), Positives = 164/517 (31%), Gaps = 40/517 (7%)

Query: 111 SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
           +I     N +      ++++SL  Q              S+ Q   N++    + L  N 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALA-----------SLRQSAWNVK---ELDLSGNP 45

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNL 230
            S +    L     L  + L++N +      ++ +L +L  L LN N +   +       
Sbjct: 46  LSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-ELLV----G 98

Query: 231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
            +++ L+  +N +S  +       +    +YL++N++        G  S +++L +   N
Sbjct: 99  PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL-N 154

Query: 291 KLSG-SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELG 349
           ++   +  +   +  +L HL L    +           + ++ L +  N L   +  E  
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKL-AFMGPEFQ 211

Query: 350 RLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFE 409
               ++ +SL  NKL   I   L    NL+ F LR N             K      + +
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAK 269

Query: 410 NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRS-LQNCTSLYSLRLERNQLTGN----I 464
                 L     +  ++             +P        +L           G+    +
Sbjct: 270 QTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERL 328

Query: 465 SEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHK 524
                       +D     +   I    ++     TL      +   + +      +L  
Sbjct: 329 ECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388

Query: 525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLS-GDIPLELGLLAELGYLDLSANRLSKL 583
               +   + ++     + + L  L     +     +  +      +   D+  ++ ++L
Sbjct: 389 TLQQAVGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQL 447

Query: 584 IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSK 620
             +N    +     +L+    +  +   + +   L+ 
Sbjct: 448 AEENARLKKLNGEADLALASANATLQELVVREQNLAS 484

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  174 bits (442), Expect = 1e-46
 Identities = 68/463 (14%), Positives = 143/463 (30%), Gaps = 25/463 (5%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           +I     N        +  + L  ++     +  N+K L L  N LS      L  F  L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
             L LS N L         +LS+L+ L ++N N +      E+    S+  L  +   +S
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNN-NYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG-SIPHCLGNLS 376
                      N   +Y+  N +      + G    +  L L +N+++  +      +  
Sbjct: 113 RVSCSRGQGKKN---IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 377 NLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNF 436
            L+   L+ N +   +  ++    KL    L  N+   ++      +  +T  S+RNN  
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 437 VGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCP 496
           V  I ++L+   +L    L  N         F    +  +  ++          N  +C 
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284

Query: 497 QLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL----VGQIPKQLGKLTSLTSLTLN 552
                + G              +  L + + +          ++  +         +   
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344

Query: 553 GNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS--QEISI 610
             Q    I            L+     L + +        +L             Q  + 
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404

Query: 611 QIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS 653
           +   L  L  +   +  +   +  +     ++   ++ Q+K +
Sbjct: 405 EQSPLQLLRAIVKRYEEM--YVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  173 bits (441), Expect = 1e-46
 Identities = 67/447 (14%), Positives = 143/447 (31%), Gaps = 37/447 (8%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRL 79
                +     ++ + L   + +       +K LD S N  S I    +   T L +L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 80  SVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPN 139
           S N L   +   L  L++L  L L+ N +       L    ++  L  +NN++S ++  +
Sbjct: 66  SSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117

Query: 140 WGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG-S 198
            G           Q   N+       L  N  + +     G    + ++ L  N I   +
Sbjct: 118 RG-----------QGKKNI------YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
                 +  +L +L L  N +   +       + LK L L  N+L+ ++ P+  S   + 
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
           ++ L +N+L   +  +     +L+H  +   N             K+     ++K  +  
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRG-NGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274

Query: 319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGS----IPHCLGN 374
               +    +     +               RL +L +   ++    GS    +     N
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334

Query: 375 LSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN 434
            +  +     + +    I Q     +        +      +         L     +  
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLT 461
             +  +  + +  + L  LR    +  
Sbjct: 395 GQIE-LQHATEEQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  168 bits (426), Expect = 1e-44
 Identities = 67/485 (13%), Positives = 160/485 (32%), Gaps = 25/485 (5%)

Query: 150 SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL 209
           +I +   N        +  ++    +        N+  + L+ N +     +++     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 210 SYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNG 269
             L L+ N L         +LS L+ L L++N +      +L    S+  L+ ++N ++ 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 270 SLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL-GNLS 328
            +  S       K++++ N NK++     + G    + +L L   ++       L  +  
Sbjct: 113 RVSCS--RGQGKKNIYLAN-NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
            +  L ++ N +Y  +  ++     L  L LS NKL   +     + + + + +LR N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 389 SGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT 448
              I + +   + L  + L  N F     ++   S +    +V          ++ + CT
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284

Query: 449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLS----NNNFFGEISSNWIKCPQLATLNMG 504
                           +        L+  + +      +    +        +   ++  
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344

Query: 505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL 564
             +    I            L+     L  Q+         L            ++    
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHAT 403

Query: 565 GLLAELGYLDLSANRLS-KLIPKNLGELRKLHHLNLSNNQFSQ--EISIQIGKLVQLSKL 621
              + L  L     R     + +   +   +   ++  ++ +Q  E + ++ KL   + L
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADL 463

Query: 622 DLSHN 626
            L+  
Sbjct: 464 ALASA 468

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  163 bits (413), Expect = 5e-43
 Identities = 74/479 (15%), Positives = 149/479 (31%), Gaps = 33/479 (6%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII 64
            +T S+LK             +  LDLS N L       ++  +KL+ L+ S+N      
Sbjct: 16  KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET- 73

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
              +  L+ L  L L+ N +     +EL    S+  L  + N ++  +  S         
Sbjct: 74  -LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RGQGKKN 124

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL-GGLK 183
           + L+NN ++  +                 D G       + L  N    V    L     
Sbjct: 125 IYLANNKIT-MLRDL--------------DEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
            L  + L  N I   +  ++     L  L L+ N+L+  + P   + + + ++ L +N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 244 SGYIPPKLGSFKSLLYLYLSHNQLN-GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGN 302
              I   L   ++L +  L  N  + G+L   F     ++ +    + KL+G   +E   
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 303 LKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR-ENMLYGSIPEELGRLKSLSQLSLSV 361
                +       L       L  L       +  +      +  E        ++    
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
            +    I               ++  L   +        +L+  L               
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           QS      ++        + +      ++    + +++ T    E   +       DL+
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLA 464

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  167 bits (424), Expect = 9e-46
 Identities = 69/300 (23%), Positives = 107/300 (35%), Gaps = 54/300 (18%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSE-----ITEIRHRNIVKFY 839
            G G  G VYK  L      AVK            N++ F++E     +  + H NI +F 
Sbjct: 22   GRGRYGAVYKGSL-DERPVAVKVFSF-------ANRQNFINEKNIYRVPLMEHDNIARFI 73

Query: 840  GFCSHT-----QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                           LV EY   GSL   LS        DW     +   V   L+Y+H 
Sbjct: 74   VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHT 129

Query: 895  D------CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE--------LA 940
            +        P I HRD++S+ VL+  +    +SDFG +  L  +                
Sbjct: 130  ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 941  GTCGYIAPE-------LAYTMRANEKCDVFNFGVLVLEVI---EGKHPGH--------FL 982
            GT  Y+APE       L     A ++ D++  G++  E+        PG         F 
Sbjct: 190  GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 983  SLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            + + + P       +V  +    + P    E    ++S+      C D + + R T Q  
Sbjct: 250  TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  173 bits (439), Expect = 2e-45
 Identities = 83/393 (21%), Positives = 146/393 (37%), Gaps = 62/393 (15%)

Query: 43  QISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELA 102
           +    +    L+   +  +  +P  +    ++  L +  N L  L P    EL +L    
Sbjct: 35  RACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PALPPELRTLE--- 87

Query: 103 LSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV 162
           +S N+L  S+P     L  L   S     L                 ++P  L  L    
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP----------------ALPSGLCKLW--- 127

Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGS 222
              +  N  +  +P    GL+ L    +++N++  S+P+    L  L       NQL+ S
Sbjct: 128 ---IFGNQLT-SLPVLPPGLQEL---SVSDNQL-ASLPALPSELCKLW---AYNNQLT-S 175

Query: 223 IPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLK 282
           +P      S L+ L + DN+L+  +P        L  L+  +N+L  SLP+     S LK
Sbjct: 176 LPM---LPSGLQELSVSDNQLA-SLPTLPS---ELYKLWAYNNRLT-SLPAL---PSGLK 224

Query: 283 HLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG 342
            L V   N+L+ S+P     LK    L +S  +L+  +P     L +   L +  N L  
Sbjct: 225 ELIVSG-NRLT-SLPVLPSELKE---LMVSGNRLTS-LPMLPSGLLS---LSVYRNQL-T 274

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKL 402
            +PE L  L S + ++L  N L+      L  +++   ++        +        + L
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334

Query: 403 NKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNN 435
             +L   +            +     F   +N 
Sbjct: 335 --HLAAADWLVPAREGEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  168 bits (428), Expect = 6e-44
 Identities = 90/407 (22%), Positives = 153/407 (37%), Gaps = 67/407 (16%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTN 73
            +Q+    L    A L++  + L  T+P  +   + +  L    N  +  +P        
Sbjct: 30  VVQKMRACLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPALPP---E 82

Query: 74  LVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLS 133
           L  L +S NQL  L P     L  L+  +     L           S L +L +  N L+
Sbjct: 83  LRTLEVSGNQLTSL-PVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT 134

Query: 134 GQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
                           S+P     L+    +S+  N  +  +P     L  L   +  NN
Sbjct: 135 ----------------SLPVLPPGLQ---ELSVSDNQLA-SLPALPSELCKL---WAYNN 171

Query: 194 RIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGS 253
           ++  S+P     L+ LS   ++ NQL+ S+P      S L  L+ ++NRL+  +P     
Sbjct: 172 QLT-SLPMLPSGLQELS---VSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALPS- 221

Query: 254 FKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSK 313
              L  L +S N+L  SLP      S LK L V   N+L+ S+P     L     L + +
Sbjct: 222 --GLKELIVSGNRLT-SLPVL---PSELKELMVSG-NRLT-SLPMLPSGLL---SLSVYR 270

Query: 314 TQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP---- 369
            QL+  +P SL +LS+   + +  N L     + L  + S    S  + + + +      
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329

Query: 370 --HCLGNLSNLKFFALRENELSG-SIPQEIENMKKLNKYLLFENQFT 413
               L   +       RE E +              + + LF ++ +
Sbjct: 330 ETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  162 bits (411), Expect = 7e-42
 Identities = 90/384 (23%), Positives = 146/384 (38%), Gaps = 64/384 (16%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L   P  L   +  L +  N L  ++P   +   +L+ L+ S NQ +  +P     L  L
Sbjct: 52  LTTLPDCLPAHITTLVIPDNNL-TSLP---ALPPELRTLEVSGNQLT-SLPVLPPGLLEL 106

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
            +    +  L    P     L  L    +  N+L  S+P     L     LS+S+N L+ 
Sbjct: 107 SIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLPPGLQE---LSVSDNQLA- 154

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                          S+P     L     +  + N  +  +P    GL+ L    +++N+
Sbjct: 155 ---------------SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQEL---SVSDNQ 192

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
           +  S+P+    L  L       N+L+ S+P      S LK L +  NRL+  +P      
Sbjct: 193 LA-SLPTLPSELYKLWAYN---NRLT-SLPA---LPSGLKELIVSGNRLT-SLPVLPS-- 241

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
             L  L +S N+L  SLP        L  L V+  N+L+  +P+ + +L S + + L   
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSG---LLSLSVYR-NQLT-RLPESLIHLSSETTVNLEGN 294

Query: 315 QLS---GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP-- 369
            LS         + +     G  IR +M   S P E   L   +   L   +     P  
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354

Query: 370 --HCLGNLSNLKFFALRENELSGS 391
             H  G   N   F+L  + LS +
Sbjct: 355 RWHMFGQEDNADAFSLFLDRLSET 378

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  152 bits (385), Expect = 1e-38
 Identities = 84/398 (21%), Positives = 137/398 (34%), Gaps = 71/398 (17%)

Query: 230 LSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNI 289
            +    L + ++ L+  +P  L     +  L +  N L  SLP+    L   + L V   
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPEL---RTLEVSG- 90

Query: 290 NKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELG 349
           N+L+ S+P     L  LS      T L           S +  L+I  N L  S+P    
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQL-TSLPVLPP 141

Query: 350 RLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFE 409
               L +LS+S N+L  S+P     L  L       N+L+ S+P     +++L+   + +
Sbjct: 142 ---GLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQELS---VSD 190

Query: 410 NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFG 469
           NQ    LP        L      NN     +P        L    +  N+LT ++  +  
Sbjct: 191 NQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPS 241

Query: 470 IYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS 529
              +L+ L +S N              +L +L           P        L  L    
Sbjct: 242 ---ELKELMVSGN--------------RLTSL-----------PMLPSG---LLSLSVYR 270

Query: 530 NRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLG 589
           N+L  ++P+ L  L+S T++ L GN LS      L  +           R          
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329

Query: 590 ELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNS 627
           E R LH    + +        +     +        N+
Sbjct: 330 ETRALH--LAAADWLVPAREGEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  140 bits (355), Expect = 9e-35
 Identities = 66/340 (19%), Positives = 125/340 (36%), Gaps = 44/340 (12%)

Query: 327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN 386
            +    L + E+ L  ++P+ L     ++ L +  N L  S+P     L  L+   +  N
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91

Query: 387 ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQN 446
           +L+ S+P     + +L+ +          LP        L    +  N     +P     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPA-LPSG------LCKLWIFGNQLTS-LPVLPPG 142

Query: 447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN 506
              L    +  NQL  ++  +     +L  L   NN     +         L  L++  N
Sbjct: 143 LQELS---VSDNQLA-SLPALPS---ELCKLWAYNNQL-TSLPMLP---SGLQELSVSDN 191

Query: 507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL 566
           +++ ++P+    + +L   +   NRL   +P        L  L ++GN+L+  +P+    
Sbjct: 192 QLA-SLPTLPSELYKLWAYN---NRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPS- 241

Query: 567 LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHN 626
             EL  L +S NRL+ L P     L     L++  NQ +  +   +  L   + ++L  N
Sbjct: 242 --ELKELMVSGNRLTSL-PMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 627 SLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGL 666
            L       +  + S    +    +      S  R    L
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  140 bits (353), Expect = 2e-34
 Identities = 76/383 (19%), Positives = 136/383 (35%), Gaps = 72/383 (18%)

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
            +    L+V   + L+ ++P  +     ++ L +    L+  +P     L     L +  
Sbjct: 39  NNGNAVLNVGE-SGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---LEVSG 90

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
           N L  S+P     L  LS  S  +  L    P     L  L    +  N+L+ S+P    
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLPP 141

Query: 398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
            +++L+   + +NQ    LP    +   L      NN     +P      + L  L +  
Sbjct: 142 GLQELS---VSDNQLAS-LPALPSE---LCKLWAYNNQLTS-LPMLP---SGLQELSVSD 190

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIG 517
           NQL  ++  +     +L  L   NN                            ++P+   
Sbjct: 191 NQLA-SLPTLPS---ELYKLWAYNNRL-------------------------TSLPALPS 221

Query: 518 NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA 577
               L +L  S NRL   +P        L  L ++GN+L+  +P+       L  L +  
Sbjct: 222 G---LKELIVSGNRL-TSLPVLPS---ELKELMVSGNRLT-SLPMLPS---GLLSLSVYR 270

Query: 578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLD---LSHNSLGGNIPS 634
           N+L++L P++L  L     +NL  N  S+     + ++          +  +  G + P 
Sbjct: 271 NQLTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329

Query: 635 EICNLESLEYMNLLQNKLSGPIP 657
           E   L       L+  +   P P
Sbjct: 330 ETRALHLAAADWLVPAREGEPAP 352

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  128 bits (324), Expect = 7e-31
 Identities = 67/306 (21%), Positives = 105/306 (34%), Gaps = 52/306 (16%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII 64
            L+  +   T    P L    L  L +  NQL  ++P     L   + L  S NQ + + 
Sbjct: 105 ELSIFSNPLT--HLPALP-SGLCKLWIFGNQL-TSLPVLPPGL---QELSVSDNQLASL- 156

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
           P        L  L    NQL  L P     L  L+   +S N+L  S+P     L  L  
Sbjct: 157 PALPS---ELCKLWAYNNQLTSL-PMLPSGLQELS---VSDNQLA-SLPTLPSELYKL-- 206

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLH-TNNFSGVIPRSLGGLK 183
               NN L+                S+P     L+      L  + N    +P     LK
Sbjct: 207 -WAYNNRLT----------------SLPALPSGLKE-----LIVSGNRLTSLPVLPSELK 244

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
            L    ++ NR+  S+P     L SLS   + +NQL+  +P +  +LS+   + L  N L
Sbjct: 245 EL---MVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

Query: 244 SGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNL 303
           S      L + + +         +     +        + LH+   + L  +   E    
Sbjct: 297 S---ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 304 KSLSHL 309
                 
Sbjct: 354 DRWHMF 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  126 bits (318), Expect = 4e-30
 Identities = 62/327 (18%), Positives = 122/327 (37%), Gaps = 68/327 (20%)

Query: 350 RLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFE 409
                + L++  + L  ++P CL    ++    + +N L+ S+P     ++ L    +  
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VSG 90

Query: 410 NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFG 469
           NQ T                          +P        L         L    S    
Sbjct: 91  NQLTS-------------------------LPVLPPGLLELSIFSNPLTHLPALPSG--- 122

Query: 470 IYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS 529
               L  L +  N     +       P L  L++  N+++ ++P+       L KL   +
Sbjct: 123 ----LCKLWIFGNQL-TSLPVL---PPGLQELSVSDNQLA-SLPALPSE---LCKLWAYN 170

Query: 530 NRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLG 589
           N+L   +P        L  L+++ NQL+  +P     L +L       NRL+ L P    
Sbjct: 171 NQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKL---WAYNNRLTSL-PALPS 221

Query: 590 ELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQ 649
            L++L    +S N+ +  + +      +L +L +S N L  ++P     L SL   ++ +
Sbjct: 222 GLKELI---VSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYR 270

Query: 650 NKLSGPIPSCFRRMHGLSSIDVSYNEL 676
           N+L+  +P     +   +++++  N L
Sbjct: 271 NQLTR-LPESLIHLSSETTVNLEGNPL 296

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 58.8 bits (142), Expect = 7e-09
 Identities = 28/137 (20%), Positives = 51/137 (37%), Gaps = 30/137 (21%)

Query: 562 LELGLLAELGYLDLSANRLSKL---IPKNL--------------GELRKLHHLNLSNNQF 604
           +   L      L++  + L+ L   +P ++                  +L  L +S NQ 
Sbjct: 34  MRACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQL 93

Query: 605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMH 664
           +  + +    L++LS        L    P+    L  L    +  N+L+  +P       
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL---WIFGNQLTS-LPVLPP--- 141

Query: 665 GLSSIDVSYNELQGSIP 681
           GL  + VS N+L  S+P
Sbjct: 142 GLQELSVSDNQLA-SLP 157

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  167 bits (425), Expect = 3e-45
 Identities = 69/390 (17%), Positives = 142/390 (36%), Gaps = 36/390 (9%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI 68
              +     F  +       +    + +       +    +++ L+ +  Q   I     
Sbjct: 30  MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF 89

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLS 128
                +  L +  N +  L P     +  L  L L  N L+        N   L  LS+S
Sbjct: 90  AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149

Query: 129 NNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV 188
           NN+L  +I  +             Q   +L+   ++ L +N  + V    L  + +L   
Sbjct: 150 NNNLE-RIEDD-----------TFQATTSLQ---NLQLSSNRLTHV---DLSLIPSLFHA 191

Query: 189 YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIP 248
            ++ N +     S +    ++  L  + N ++  +         L  L L  N L+    
Sbjct: 192 NVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--T 241

Query: 249 PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSH 308
             L ++  L+ + LS+N+L   +   F  +  L+ L++ N N+L  ++      + +L  
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN-NRLV-ALNLYGQPIPTLKV 299

Query: 309 LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSI 368
           L LS   L   +  +      +  LY+  N +  ++   L    +L  L+LS N  + + 
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNS 355

Query: 369 PHCLGNLSNLKFFALRENELSGSIPQEIEN 398
              L    N+   A+ + +    I  ++E+
Sbjct: 356 LRAL--FRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  155 bits (393), Expect = 5e-41
 Identities = 64/379 (16%), Positives = 128/379 (33%), Gaps = 38/379 (10%)

Query: 37  FGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELT 96
           +  I + + +      +             +   L N  ++    + +  L    L    
Sbjct: 10  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69

Query: 97  SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLG 156
            +  L L+  ++      +      + +L +  N++   +PP+           + Q++ 
Sbjct: 70  QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPH-----------VFQNVP 117

Query: 157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLN 215
            L     + L  N+ S +          LT + ++NN +   I  +      SL  L L+
Sbjct: 118 LLT---VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 173

Query: 216 KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF 275
            N+L+  +      + +L    +  N LS      L    ++  L  SHN +N  +    
Sbjct: 174 SNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG-- 222

Query: 276 GNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
                L  L + + N L+      + N   L  + LS  +L   +      +  +  LYI
Sbjct: 223 PVNVELTILKLQH-NNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279

Query: 336 RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
             N L  ++      + +L  L LS N L   +         L+   L  N +  ++   
Sbjct: 280 SNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 336

Query: 396 I-ENMKKLNKYLLFENQFT 413
               +K L    L  N + 
Sbjct: 337 THHTLKNLT---LSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (372), Expect = 3e-38
 Identities = 62/385 (16%), Positives = 133/385 (34%), Gaps = 40/385 (10%)

Query: 55  FSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA 114
                    I   +        + + +   +     E   L +   +    + +     A
Sbjct: 4   KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 63

Query: 115 SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV 174
            L +   +  L+L++  +  +I                     ++    + +  N    +
Sbjct: 64  LLDSFRQVELLNLNDLQIE-EIDTY-----------AFAYAHTIQ---KLYMGFNAIRYL 108

Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSN 232
            P     +  LT + L  N +  S+P  I  N   L+ L ++ N L   I        ++
Sbjct: 109 PPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTS 166

Query: 233 LKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL 292
           L+ L L  NRL+ ++        SL +  +S+N L     S+     +++ L   + N +
Sbjct: 167 LQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASH-NSI 217

Query: 293 SGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE-LGRL 351
           +  +   +     L+ L L    L+      L N   +  + +  N L   I      ++
Sbjct: 218 N-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKM 271

Query: 352 KSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQ 411
           + L +L +S N+L  ++      +  LK   L  N L   + +      +L    L  N 
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329

Query: 412 FTGYLPQNVCQSGSLTHFSVRNNNF 436
               L  +     +L + ++ +N++
Sbjct: 330 IV-TLKLSTHH--TLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  145 bits (368), Expect = 7e-38
 Identities = 84/449 (18%), Positives = 137/449 (30%), Gaps = 77/449 (17%)

Query: 146 PHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-G 204
           P Y  I  +L        V +               L N   V   N+ +   +P+ +  
Sbjct: 8   PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLD 66

Query: 205 NLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYL 262
           + R +  L LN  Q+   I   A      ++ LY+  N +  Y+PP    +   L  L L
Sbjct: 67  SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVL 124

Query: 263 SHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIP 321
             N L+      F N   L  L + N N L   I  +      SL +L LS  +L+    
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSN-NNLE-RIEDDTFQATTSLQNLQLSSNRLTHV-- 180

Query: 322 PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFF 381
             L  + ++    +  N+L       L    ++ +L  S N +N  +         L   
Sbjct: 181 -DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTIL 231

Query: 382 ALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIP 441
            L+ N L+                                                    
Sbjct: 232 KLQHNNLT-DTA------------------------------------------------ 242

Query: 442 RSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATL 501
             L N   L  + L  N+L   +   F     LE L +SNN     ++      P L  L
Sbjct: 243 -WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVL 300

Query: 502 NMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIP 561
           ++  N +   +        +L  L    N +V  +   L    +L +LTL+ N    +  
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN-- 354

Query: 562 LELGLLAELGYLDLSANRLSKLIPKNLGE 590
               L   +    +        I   L  
Sbjct: 355 SLRALFRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  144 bits (366), Expect = 1e-37
 Identities = 79/432 (18%), Positives = 145/432 (33%), Gaps = 68/432 (15%)

Query: 270 SLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSN 329
            + S+         +H+    +      ++I  L +   +    + +       L +   
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQ 70

Query: 330 IRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELS 389
           +  L + +  +            ++ +L +  N +    PH   N+  L    L  N+LS
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 390 GSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTS 449
            S+P                                                    N   
Sbjct: 131 -SLP-----------------------------------------------RGIFHNTPK 142

Query: 450 LYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEIS 509
           L +L +  N L     + F     L+ L LS+N     +  + I  P L   N+  N +S
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVDLSLI--PSLFHANVSYNLLS 199

Query: 510 GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAE 569
                 +     + +LD S N +   +   +     LT L L  N L+ D    L     
Sbjct: 200 -----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNY-PG 249

Query: 570 LGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG 629
           L  +DLS N L K++     ++++L  L +SNN+    +++    +  L  LDLSHN L 
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL- 307

Query: 630 GNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNA 689
            ++       + LE + L  N +   +       H L ++ +S+N+          F+N 
Sbjct: 308 LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNV 363

Query: 690 TIEAFQGNKELC 701
              A     + C
Sbjct: 364 ARPAVDDADQHC 375

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  169 bits (429), Expect = 2e-44
 Identities = 91/494 (18%), Positives = 173/494 (35%), Gaps = 45/494 (9%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNR 242
             + V  +N  +   +P ++        L L++N +S  +       LS L+ L L  NR
Sbjct: 32  LESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNR 87

Query: 243 LSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIP-- 297
           +   +      F       YL +SHN+L  ++      ++SL+HL +   N     +P  
Sbjct: 88  IR-SLDF--HVFLFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLSF-NDFD-VLPVC 139

Query: 298 KEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS-NIRGLYIRENMLYGSIPEELGRLKSLSQ 356
           KE GNL  L+ L LS  +        + +L  +   L +    + G   E L      + 
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTV 198

Query: 357 LSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGY- 415
           L L  +  +        +++ L    L   +L+    Q +                T   
Sbjct: 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258

Query: 416 ---------LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT-----SLYSLRLERNQLT 461
                              + + ++ N      I R     +     SL    ++     
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318

Query: 462 GNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQ 521
            +   ++ ++ ++ +  LS ++                 LN   N  + ++      + +
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 522 LHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQL----SGDIPLELGLLAELGYLDLSA 577
           L  L    N L     K      +++SL      L    S            +  L+LS+
Sbjct: 379 LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437

Query: 578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEIC 637
           N L+  + + L    K+  L+L NN+    I   +  L  L +L+++ N L  ++P  + 
Sbjct: 438 NMLTGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQL-KSVPDGVF 493

Query: 638 -NLESLEYMNLLQN 650
             L SL+Y+ L  N
Sbjct: 494 DRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  130 bits (329), Expect = 1e-31
 Identities = 87/447 (19%), Positives = 161/447 (36%), Gaps = 39/447 (8%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLR 78
                +L  L LS N++  ++   +      L++LD S N+   I       + +L  L 
Sbjct: 72  ISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQNI---SCCPMASLRHLD 127

Query: 79  LSVNQLNGL-IPEELGELTSLNELALSYNRLNGSIPASLGNLS-NLVQLSLSNNSLSGQI 136
           LS N  + L + +E G LT L  L LS  +        + +L  + + L L +  + G  
Sbjct: 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGE 187

Query: 137 PPNWGYLISPHYGSIPQDLGNLESPVSVSLHT----------------NNFSGVIPRSLG 180
             +     +     +          V++S++                       +     
Sbjct: 188 TESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247

Query: 181 G--LKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN--LKFL 236
           G  L N+T  ++           +    R + YL +    ++  I       S   LK L
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307

Query: 237 YLHDNRLSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLS 293
            +   +   ++  K   +          LS +           + SS   L+    N  +
Sbjct: 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ-NVFT 366

Query: 294 GSIPKEIGNLKSLSHLWLSKTQLSGFIPPS--LGNLSNIRGLYIRENML-YGSIPEELGR 350
            S+ +    LK L  L L +  L  F   +    N+S++  L +  N L   +       
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426

Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
            +S+  L+LS N L GS+  CL     +K   L  N +  SIP+++ +++ L +  +  N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483

Query: 411 QFTGYLPQNVCQS-GSLTHFSVRNNNF 436
           Q    +P  V     SL +  + +N +
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  128 bits (322), Expect = 7e-31
 Identities = 99/536 (18%), Positives = 185/536 (34%), Gaps = 95/536 (17%)

Query: 40  IPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLN 99
           +P  +    + K L  S N  S +  P I  L+ L VLRLS N++  L          L 
Sbjct: 46  VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103

Query: 100 ELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLE 159
            L +S+NRL  +I      +++L  L LS N                    +P       
Sbjct: 104 YLDVSHNRL-QNISC--CPMASLRHLDLSFNDFD----------------VLP------- 137

Query: 160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQL 219
                          + +  G L  LTF+ L+  +    +         LS + L+    
Sbjct: 138 ---------------VCKEFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCILLDLVSY 181

Query: 220 SGS-IPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
                   +  + N   L+L  +  S +      S  +L +L LS+ +LN          
Sbjct: 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241

Query: 279 -------SSLKHLHVHNINKLSGSIPKEIGNL--KSLSHLWLSKTQLSGFIPP-----SL 324
                   +L ++ + +I        K       + + +L +    ++  I       S 
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301

Query: 325 GNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR 384
             L ++   +++  +   S          ++   LS++        C  + S+  F    
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361

Query: 385 ENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFV----GPI 440
           +N  + S+ Q    +K+L   +L  N       +    + +++     + +         
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAY 420

Query: 441 PRSLQNCTSLYSLRLERNQLTGNISEVF-GIYPDLELLDLSNNNFFGEISSNWIKCPQLA 499
            R+     S+  L L  N LT     VF  + P +++LDL NN                 
Sbjct: 421 DRTCAWAESILVLNLSSNMLT---GSVFRCLPPKVKVLDLHNNRI--------------- 462

Query: 500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPK-QLGKLTSLTSLTLNGN 554
                      +IP ++ ++  L +L+ +SN+L   +P     +LTSL  + L+ N
Sbjct: 463 ----------MSIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  124 bits (313), Expect = 1e-29
 Identities = 95/545 (17%), Positives = 172/545 (31%), Gaps = 93/545 (17%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSL 127
            +      L LS N ++ L   ++  L+ L  L LS+NR+  S+   +     +L  L +
Sbjct: 49  DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS--LGGLKNL 185
           S+N L                 +I      + S   + L  N+F  V+P     G L  L
Sbjct: 108 SHNRLQ----------------NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKL 148

Query: 186 TFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGS-IPPTAGNLSNLKFLYLHDNRLS 244
           TF+ L+  +    +         LS + L+            +  + N   L+L  +  S
Sbjct: 149 TFLGLSAAKF-RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207

Query: 245 GYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLK 304
            +      S  +L +L LS+ +LN           S                      L 
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP---------------TLL 252

Query: 305 SLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKL 364
           +++   +  T               +  L I    +   I  E       +  SL +   
Sbjct: 253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE-- 310

Query: 365 NGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSG 424
                    ++ N  F   +E   S         M      +   +              
Sbjct: 311 ---------HVKNQVFLFSKEALYSV-----FAEMNIKMLSI---SDTPFIHMVCPPSPS 353

Query: 425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
           S T  +   N F   + +       L +L L+RN L  N  +V  +  ++  L+  + + 
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL 412

Query: 485 ----FGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
                            +  LN+  N ++G++   +    ++  LD  +NR+   IPK +
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI-MSIPKDV 469

Query: 541 GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKN-LGELRKLHHLNL 599
             L +L  L +  NQL                         K +P      L  L ++ L
Sbjct: 470 THLQALQELNVASNQL-------------------------KSVPDGVFDRLTSLQYIWL 504

Query: 600 SNNQF 604
            +N +
Sbjct: 505 HDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 98.4 bits (245), Expect = 2e-21
 Identities = 44/234 (18%), Positives = 85/234 (36%), Gaps = 17/234 (7%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI 68
             +      +       L    +       +     S  +++     S +    I     
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLS 128
              ++   L  + N     + +    L  L  L L  N L  +         N+  L   
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETL 408

Query: 129 NNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV 188
           + SL+     +          +  + +  L      +L +N  +G + R L     +  +
Sbjct: 409 DVSLN-----SLNSHAYDRTCAWAESILVL------NLSSNMLTGSVFRCL--PPKVKVL 455

Query: 189 YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
            L+NNRI  SIP ++ +L++L  L +  NQL  S+P      L++L++++LHDN
Sbjct: 456 DLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 98.0 bits (244), Expect = 3e-21
 Identities = 65/388 (16%), Positives = 126/388 (32%), Gaps = 21/388 (5%)

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKS 353
            +PK++        L LS+  +S    P +  LS +R L +  N +  S+   +    + 
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQD 101

Query: 354 LSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQ--EIENMKKLNKYLLFENQ 411
           L  L +S N+L  +I      +++L+   L  N+    +P   E  N+ KL    L   +
Sbjct: 102 LEYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157

Query: 412 FTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIY 471
           F       V             +  +           +   L L  +  +    +V    
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217

Query: 472 PDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNR 531
             L  L LSN         N   C +L T           +   + ++    K      +
Sbjct: 218 NALGHLQLSNIKL------NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271

Query: 532 LVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGEL 591
                P+ +  L ++ +LT+       +       L  L    +                
Sbjct: 272 FF--WPRPVEYL-NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328

Query: 592 RKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNK 651
            +++   LS +       +        + L+ + N    ++      L+ L+ + L +N 
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388

Query: 652 LS--GPIPSCFRRMHGLSSIDVSYNELQ 677
           L     +    + M  L ++DVS N L 
Sbjct: 389 LKNFFKVALMTKNMSSLETLDVSLNSLN 416

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 93.8 bits (233), Expect = 7e-20
 Identities = 44/265 (16%), Positives = 88/265 (33%), Gaps = 28/265 (10%)

Query: 10  NLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-----SHLSKLKHLDFSTNQFSGII 64
             K +++ F F     + YL++    +   I  +      + L  L         F    
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
                +   + +  LS++    +        +S   L  + N    S+      L  L  
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNF----SGVIPRSLG 180
           L L  N L                 +  +     ++  S+     +     S    R+  
Sbjct: 382 LILQRNGLK----------------NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA 425

Query: 181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
             +++  + L++N + GS+   +     +  L L+ N++  SIP    +L  L+ L +  
Sbjct: 426 WAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482

Query: 241 NRLSGYIPPKLGSFKSLLYLYLSHN 265
           N+L            SL Y++L  N
Sbjct: 483 NQLKSVPDGVFDRLTSLQYIWLHDN 507

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  162 bits (412), Expect = 2e-44
 Identities = 60/343 (17%), Positives = 118/343 (34%), Gaps = 34/343 (9%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRL 79
                +     ++ + L   + +       +K LD S N  S I    +   T L +L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 80  SVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPN 139
           S N L      +L  L++L  L L+ N +       L    ++  L  +NN++S ++  +
Sbjct: 66  SSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117

Query: 140 WGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG-S 198
            G           Q   N+       L  N  + +     G    + ++ L  N I   +
Sbjct: 118 RG-----------QGKKNI------YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
                 +  +L +L L  N +   +       + LK L L  N+L+ ++ P+  S   + 
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
           ++ L +N+L   +  +     +L+H  +   N             K+     ++K  +  
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRG-NGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274

Query: 319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELG-RLKSLSQLSLS 360
            +         +  L          +P     RL +L      
Sbjct: 275 -LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  159 bits (403), Expect = 4e-43
 Identities = 72/351 (20%), Positives = 119/351 (33%), Gaps = 37/351 (10%)

Query: 40  IPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLN 99
           I     + ++ K    + +     +        N+  L LS N L+ +   +L   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 100 ELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLE 159
            L LS N L       L +LS L  L L+NN +                     +L    
Sbjct: 62  LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ--------------------ELLVGP 99

Query: 160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQL 219
           S  ++    NN S V      G KN+   YL NN+I      + G    + YL L  N++
Sbjct: 100 SIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156

Query: 220 SG-SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
              +    A +   L+ L L  N +   +  ++  F  L  L LS N+L   +   F + 
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSA 213

Query: 279 SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           + +  + + N NKL   I K +   ++L H  L             G L +      R  
Sbjct: 214 AGVTWISLRN-NKLV-LIEKALRFSQNLEHFDLRGNGF------HCGTLRDFFSKNQRVQ 265

Query: 339 MLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELS 389
            +     ++L           ++          L      +  AL  +   
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  155 bits (394), Expect = 6e-42
 Identities = 59/353 (16%), Positives = 117/353 (33%), Gaps = 57/353 (16%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
                + +++ + L   +        ++ EL LS N L+    A L   + L  L+LS+N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL 190
            L  +                                           L  L  L  + L
Sbjct: 69  VLY-ETLD----------------------------------------LESLSTLRTLDL 87

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK 250
           NNN +      E+    S+  L    N +S  +          K +YL +N+++      
Sbjct: 88  NNNYV-----QELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLD 139

Query: 251 LGSFKSLLYLYLSHNQLNG-SLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHL 309
            G    + YL L  N+++  +      +  +L+HL++   N +   +  ++     L  L
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY-NFIY-DVKGQV-VFAKLKTL 196

Query: 310 WLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP 369
            LS  +L+ F+ P   + + +  + +R N L   I + L   ++L    L  N  +    
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH-CGT 253

Query: 370 HCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQ 422
                  N +   + +  +   +  + E    +     +       LP     
Sbjct: 254 LRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  153 bits (390), Expect = 2e-41
 Identities = 55/335 (16%), Positives = 115/335 (34%), Gaps = 33/335 (9%)

Query: 111 SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
           +I     N +      ++++SL  Q              S+ Q   N++    + L  N 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALA-----------SLRQSAWNVK---ELDLSGNP 45

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNL 230
            S +    L     L  + L++N +      ++ +L +L  L LN N +   +       
Sbjct: 46  LSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-ELLV----G 98

Query: 231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
            +++ L+  +N +S  +       +    +YL++N++        G  S +++L +   N
Sbjct: 99  PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL-N 154

Query: 291 KLSG-SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELG 349
           ++   +  +   +  +L HL L    +           + ++ L +  N L   +  E  
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKL-AFMGPEFQ 211

Query: 350 RLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFE 409
               ++ +SL  NKL   I   L    NL+ F LR N             K      + +
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAK 269

Query: 410 NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL 444
                 L     +  ++             +P   
Sbjct: 270 QTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPF 303

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  146 bits (371), Expect = 7e-39
 Identities = 59/306 (19%), Positives = 111/306 (36%), Gaps = 32/306 (10%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII 64
            +T S+LK             +  LDLS N L       ++  +KL+ L+ S+N      
Sbjct: 16  KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET- 73

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
              +  L+ L  L L+ N +     +EL    S+  L  + N ++  +  S         
Sbjct: 74  -LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RGQGKKN 124

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV-IPRSLGGLK 183
           + L+NN ++  +                 D G       + L  N    V          
Sbjct: 125 IYLANNKIT-MLRDL--------------DEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
            L  + L  N I   +  ++     L  L L+ N+L+  + P   + + + ++ L +N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 244 SGYIPPKLGSFKSLLYLYLSHNQLN-GSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGN 302
              I   L   ++L +  L  N  + G+L   F     ++ +    + KL+G   +E   
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 303 LKSLSH 308
                +
Sbjct: 286 PTLGHY 291

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (357), Expect = 4e-37
 Identities = 57/307 (18%), Positives = 108/307 (35%), Gaps = 17/307 (5%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           +I     N        +  + L  ++     +  N+K L L  N LS      L  F  L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
             L LS N L         +LS+L+ L ++N N +      E+    S+  L  +   +S
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNN-NYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG-SIPHCLGNLS 376
                S       + +Y+  N +      + G    +  L L +N+++  +      +  
Sbjct: 113 RV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 377 NLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNF 436
            L+   L+ N +   +  ++    KL    L  N+   ++      +  +T  S+RNN  
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 437 VGPIPRSLQNCTSLYSLRLERNQLT-GNISEVFGIYPDLELLDLSNNNFFGEISSNWIKC 495
           V  I ++L+   +L    L  N    G + + F     ++ +           +      
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 496 PQLATLN 502
           P L    
Sbjct: 286 PTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  138 bits (350), Expect = 4e-36
 Identities = 59/335 (17%), Positives = 112/335 (33%), Gaps = 22/335 (6%)

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
           +I +   N        ++ + L   +     +  N++ L +  N L      +L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
             L+LS N L       L +LS L+   L  N +      E+     +       N  + 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG-NISEVFGIYPD 473
            +  +  Q     +  + NN             + +  L L+ N++   N +E+      
Sbjct: 113 RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 474 LELLDLSNNNFFGEISS--NWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNR 531
           LE L+L  N     I      +   +L TL++  N+++  +  E  +   +  +   +N+
Sbjct: 171 LEHLNLQYNF----IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 532 LVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGEL 591
           LV  I K L    +L    L GN       L            ++   + KL      E 
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKL-TGQNEEE 282

Query: 592 RKLHHLNLSNNQFSQEISIQIG-KLVQLSKLDLSH 625
             +  L        +++      +L+ L      H
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (321), Expect = 3e-32
 Identities = 49/287 (17%), Positives = 104/287 (36%), Gaps = 16/287 (5%)

Query: 391 SIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSL 450
           +I +  +N  +     + ++     L      + ++    +  N         L   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 451 YSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISG 510
             L L  N L     ++  +   L  LDL+NN          +  P + TL+   N IS 
Sbjct: 61  ELLNLSSNVLY-ETLDLESL-STLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG-DIPLELGLLAE 569
            +    G       +  ++N++        G  + +  L L  N++   +          
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 570 LGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG 629
           L +L+L  N +   +   +    KL  L+LS+N+ +  +  +      ++ + L +N L 
Sbjct: 171 LEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL- 226

Query: 630 GNIPSEICNLESLEYMNLLQNKLS-GPIPSCFRRMHGLSSIDVSYNE 675
             I   +   ++LE+ +L  N    G +   F +   + ++     +
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  113 bits (286), Expect = 1e-27
 Identities = 45/215 (20%), Positives = 95/215 (44%), Gaps = 13/215 (6%)

Query: 464 ISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLH 523
           I E+       ++  +++++    ++S       +  L++ GN +S    +++   T+L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 524 KLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL 583
            L+ SSN L       L  L++L +L LN N +      EL +   +  L  + N +S++
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114

Query: 584 IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG-NIPSEICNLESL 642
              +    +   ++ L+NN+ +    +  G   ++  LDL  N +   N      + ++L
Sbjct: 115 ---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 643 EYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ 677
           E++NL  N +             L ++D+S N+L 
Sbjct: 172 EHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA 204

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  105 bits (263), Expect = 1e-24
 Identities = 34/194 (17%), Positives = 69/194 (35%), Gaps = 12/194 (6%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
            +     +  + +   + S   +   + +LD S N L       L   T L  L L+ N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKL 615
           L  +   +L  L+ L  LDL+ N +       L     +  L+ +NN  S    +   + 
Sbjct: 70  LY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS---RVSCSRG 119

Query: 616 VQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG-PIPSCFRRMHGLSSIDVSYN 674
                + L++N +      +      ++Y++L  N++              L  +++ YN
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 675 ELQGSIPHSKAFQN 688
            +   +     F  
Sbjct: 180 FIY-DVKGQVVFAK 192

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 31/179 (17%), Positives = 69/179 (38%), Gaps = 11/179 (6%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELG 571
           I     N  +      + + L   +        ++  L L+GN LS     +L    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN 631
            L+LS+N L + +   L  L  L  L+L+NN        ++     +  L  ++N++   
Sbjct: 62  LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113

Query: 632 IPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNAT 690
           +       +  + + L  NK++            +  +D+  NE+  ++  ++   ++ 
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  169 bits (430), Expect = 2e-44
 Identities = 95/618 (15%), Positives = 202/618 (32%), Gaps = 58/618 (9%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI 68
              +     F  +       +    + +       +    +++ L+ +  Q   I     
Sbjct: 36  MQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAF 95

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLS 128
                +  L +  N +  L P     +  L  L L  N L+        N   L  LS+S
Sbjct: 96  AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155

Query: 129 NNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV 188
           NN+L  +I  +             Q   +L+   ++ L +N  + V    L  + +L   
Sbjct: 156 NNNLE-RIEDD-----------TFQATTSLQ---NLQLSSNRLTHV---DLSLIPSLFHA 197

Query: 189 YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIP 248
            ++ N +     S +    ++  L  + N ++  +         L  L L  N L+    
Sbjct: 198 NVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--T 247

Query: 249 PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSH 308
             L ++  L+ + LS+N+L   +   F  +  L+ L++ N N+L  ++      + +L  
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN-NRLV-ALNLYGQPIPTLKV 305

Query: 309 LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSI 368
           L LS   L   +  +      +  LY+  N +  ++   L    +L  L+LS N  + + 
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCNS 361

Query: 369 PHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTH 428
              L    N+   A+ + +    I  ++E+       L  +     YL + +        
Sbjct: 362 LRAL--FRNVARPAVDDADQHCKIDYQLEHG------LCCKESDKPYLDRLL-------- 405

Query: 429 FSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEI 488
             +   + V  + R+   C++  ++   ++       +        E L+   N    E+
Sbjct: 406 QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465

Query: 489 SSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTS 548
                +  Q   L      + G       N+ +         R    + K    L    +
Sbjct: 466 QQLTNEQIQQEQL------LQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQA 519

Query: 549 LTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEI 608
             L   Q             E   L+     L K +     +  +L        Q  +++
Sbjct: 520 FKLRETQA--RRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQL 577

Query: 609 SIQIGKLVQLSKLDLSHN 626
             +  +     ++   H+
Sbjct: 578 EAKKNRNPDTRRVSHHHH 595

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  136 bits (343), Expect = 2e-33
 Identities = 76/425 (17%), Positives = 148/425 (34%), Gaps = 45/425 (10%)

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
           +   +  +V         I   +        + +       +       L+N + +  + 
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI- 396
           + +       L   + +  L+L+  ++     +       ++   +  N +   +P  + 
Sbjct: 61  STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119

Query: 397 ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLE 456
           +N+  L   +L  N  +  LP                            N   L +L + 
Sbjct: 120 QNVPLLTVLVLERNDLS-SLP-----------------------RGIFHNTPKLTTLSMS 155

Query: 457 RNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI 516
            N L     + F     L+ L LS+N     +  + I  P L   N+  N +     S +
Sbjct: 156 NNNLERIEDDTFQATTSLQNLQLSSNR-LTHVDLSLI--PSLFHANVSYNLL-----STL 207

Query: 517 GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLS 576
                + +LD S N +   +   +     LT L L  N L+ D    L     L  +DLS
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLS 262

Query: 577 ANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEI 636
            N L K++     ++++L  L +SNN+    +++    +  L  LDLSHN L  ++    
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQ 320

Query: 637 CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQG 696
              + LE + L  N +   +       H L ++ +S+N+          F+N    A   
Sbjct: 321 PQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDD 376

Query: 697 NKELC 701
             + C
Sbjct: 377 ADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  104 bits (261), Expect = 3e-23
 Identities = 63/473 (13%), Positives = 138/473 (29%), Gaps = 62/473 (13%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L      L P L + ++S N L     + ++    ++ LD S N  + +      +   L
Sbjct: 183 LTHVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRG---PVNVEL 234

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
            +L+L  N L       L     L E+ LSYN L   +      +  L +L +SNN L  
Sbjct: 235 TILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV- 291

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                                                   +      +  L  + L++N 
Sbjct: 292 ---------------------------------------ALNLYGQPIPTLKVLDLSHNH 312

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
           ++  +         L  L L+ N +  ++         LK L L  N            F
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDC--NSLRALF 366

Query: 255 KSLLYLYLSHNQLNGSLPSSFGN-LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSK 313
           +++    +     +  +     + L   +    +    L       +      +    S 
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSA 426

Query: 314 TQLSGFIPPSLGNLSNIRGLYIREN-MLYGSIPEELGRLKSLSQLSLSVNKLNGSIPH-C 371
           T     +      ++   G+ ++ N  L   + E    ++ L+   +   +L   +    
Sbjct: 427 TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEI 486

Query: 372 LGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSV 431
             NL   +         S ++ +   ++K+   + L E Q          +         
Sbjct: 487 DTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQK--ETEDLEQ 544

Query: 432 RNNNFVGPI-PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN 483
            N      +  +  +         L+R ++    ++         +    +++
Sbjct: 545 ENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHHH 597

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  161 bits (409), Expect = 2e-44
 Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 31/270 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
                 G ++K     G+   VK L              F  E        H N++   G 
Sbjct: 19   NENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRD--FNEECPRLRIFSHPNVLPVLGA 75

Query: 842  CSH--TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
            C      H  L+  ++  GSL  +L +E T   +D S+ V     +A  ++++H    P 
Sbjct: 76   CQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL---AYTMRA 956
            I    ++S+ V++D +  A +S        +              ++APE          
Sbjct: 134  IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEALQKKPEDTN 188

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
                D+++F VL+ E++  + P   LS +         M + +  L   R   P G +  
Sbjct: 189  RRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGL---RPTIPPG-ISP 238

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             +  ++    +C++ +P  RP    +  +L
Sbjct: 239  HVSKLMK---ICMNEDPAKRPKFDMIVPIL 265

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  164 bits (416), Expect = 3e-43
 Identities = 67/327 (20%), Positives = 122/327 (37%), Gaps = 22/327 (6%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
               P  +  +   LDL  N++      + +    L+ L+ + N  S + P     L NL
Sbjct: 23  FVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L L  N+L  +       L++L +L +S N++   +     +L NL  L + +N L  
Sbjct: 83  RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV- 141

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
            I                  L +LE    ++L   N + +   +L  L  L  + L +  
Sbjct: 142 YISHR-----------AFSGLNSLE---QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187

Query: 195 IVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK-LG 252
           I  +I       L  L  L ++      ++ P      NL  L +    L+  +P   + 
Sbjct: 188 IN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245

Query: 253 SFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
               L +L LS+N ++    S    L  L+ + +    +L+  +       L  L  L +
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG-GQLA-VVEPYAFRGLNYLRVLNV 303

Query: 312 SKTQLSGFIPPSLGNLSNIRGLYIREN 338
           S  QL+        ++ N+  L +  N
Sbjct: 304 SGNQLTTLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  157 bits (398), Expect = 5e-41
 Identities = 73/324 (22%), Positives = 137/324 (42%), Gaps = 31/324 (9%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQ 59
              ++L  + +K TL +  F  FP L  L+L+ N +   +     ++L  L+ L   +N+
Sbjct: 34  TRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNR 91

Query: 60  FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGN 118
              I       L+NL  L +S N++  L+     +L +L  L +  N L   I   +   
Sbjct: 92  LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSG 150

Query: 119 LSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS 178
           L++L QL+L   +L+  IP                 L +L   + + L   N + +   S
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEA--------------LSHLHGLIVLRLRHLNINAIRDYS 195

Query: 179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLY 237
              L  L  + +++   + ++        +L+ L +    L+ ++P  A  +L  L+FL 
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254

Query: 238 LHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
           L  N +S  I            L  + L   QL    P +F  L+ L+ L+V   N+L+ 
Sbjct: 255 LSYNPIS-TIEG--SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG-NQLT- 309

Query: 295 SIPKEI-GNLKSLSHLWLSKTQLS 317
           ++ + +  ++ +L  L L    L+
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  138 bits (350), Expect = 8e-35
 Identities = 80/327 (24%), Positives = 124/327 (37%), Gaps = 14/327 (4%)

Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGS 222
           +V  H   F   +P  +        + L  NRI      E  +   L  L LN+N +S +
Sbjct: 15  AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-A 70

Query: 223 IPPTA-GNLSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
           + P A  NL NL+ L L  NRL   IP        +L  L +S N++   L   F +L +
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 281 LKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENM 339
           LK L V + N L   I       L SL  L L K  L+     +L +L  +  L +R   
Sbjct: 130 LKSLEVGD-NDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187

Query: 340 LYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE-IEN 398
           +         RL  L  L +S      ++        NL   ++    L+ ++P   + +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246

Query: 399 MKKLNKYLLFENQFTGYLPQNVCQS-GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
           +  L    L  N  +  +  ++      L    +         P + +    L  L +  
Sbjct: 247 LVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNF 484
           NQLT     VF    +LE L L +N  
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  123 bits (311), Expect = 8e-30
 Identities = 61/342 (17%), Positives = 121/342 (35%), Gaps = 40/342 (11%)

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI-ENMKK 401
           ++PE +        L L  N++         +  +L+   L EN +S ++      N+  
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 402 LNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT 461
           L    L  N+    +P  V                           ++L  L +  N++ 
Sbjct: 82  LRTLGLRSNRLK-LIPLGV-----------------------FTGLSNLTKLDISENKIV 117

Query: 462 GNISEVFGIYPDLELLDLSNNNFFGEISSNWIK-CPQLATLNMGGNEISGTIPSEI-GNM 519
             +  +F    +L+ L++ +N+    IS         L  L +    ++ +IP+E   ++
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHL 175

Query: 520 TQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANR 579
             L  L      +         +L  L  L ++       +         L  L ++   
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235

Query: 580 LSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEI 636
           L+ +    +  L  L  LNLS N  S   +I+     +L++L ++ L    L   +    
Sbjct: 236 LTAVPYLAVRHLVYLRFLNLSYNPIS---TIEGSMLHELLRLQEIQLVGGQL-AVVEPYA 291

Query: 637 -CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ 677
              L  L  +N+  N+L+    S F  +  L ++ +  N L 
Sbjct: 292 FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 99.4 bits (248), Expect = 7e-22
 Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 10/191 (5%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
            +   L++G N I      E  +   L +L+ + N +    P     L +L +L L  N+
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91

Query: 556 LSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG- 613
           L   IPL     L+ L  LD+S N++  L+     +L  L  L + +N       I    
Sbjct: 92  LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV---YISHRA 147

Query: 614 --KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSID 670
              L  L +L L   +L  +IP+E   +L  L  + L    ++      F+R++ L  ++
Sbjct: 148 FSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 671 VSYNELQGSIP 681
           +S+     ++ 
Sbjct: 207 ISHWPYLDTMT 217

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  157 bits (400), Expect = 9e-43
 Identities = 54/279 (19%), Positives = 103/279 (36%), Gaps = 40/279 (14%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G G  G VY      G+  A++ +      +     K F  E+    + RH N+V F G 
Sbjct: 42   GKGRFGQVYHGRW-HGEV-AIRLID--IERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C    HL ++    +  +L +++ +      LD +K   + + +   + Y+H      IL
Sbjct: 98   CMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGIL 152

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAK-----FLKPDSSNWSELAGTCGYIAPEL------ 950
            H+D+ SK V  D   K  ++DFG                     G   ++APE+      
Sbjct: 153  HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211

Query: 951  ---AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007
                  +  ++  DVF  G +  E+   + P              A +  +   +   + 
Sbjct: 212  DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMGTGM---KP 261

Query: 1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                  + +++  ++     C     + RPT  K+ ++L
Sbjct: 262  NLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDML 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  156 bits (397), Expect = 2e-42
 Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 39/280 (13%)

Query: 785  GTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G   K     +G+   +K+L           Q+ F+ E+     + H N++KF G
Sbjct: 19   GKGCFGQAIKVTHRETGEVMVMKELIRFDEE----TQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                 + L  + EY++ G+L  I+ +  +  +  WS+RV+  K +A+ ++Y+H      I
Sbjct: 75   VLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNI 129

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFL--------------KPDSSNWSELAGTCGYI 946
            +HRD++S   L+       V+DFG A+ +              KPD      + G   ++
Sbjct: 130  IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 947  APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
            APE+      +EK DVF+FG+++ E+I   +                 M+  +N      
Sbjct: 190  APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL--------PRTMDFGLNVRGFLD 241

Query: 1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               P          +      C D +P+ RP+  K+ + L
Sbjct: 242  RYCPPN-CPPSFFPIT---VRCCDLDPEKRPSFVKLEHWL 277

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  155 bits (393), Expect = 5e-42
 Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 49/296 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------RHRNIVKF 838
            G G  G V++     G+  AVK   S        ++K +  E TE+      RH NI+ F
Sbjct: 17   GKGRYGEVWRGSW-QGENVAVKIFSS-------RDEKSWFRE-TELYNTVMLRHENILGF 67

Query: 839  YGFCSHTQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                  ++H    L+L+  Y E GSL   L        LD    + ++  +A+ L+++H 
Sbjct: 68   IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHI 123

Query: 895  DCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL----AGTCGY 945
            + F     P I HRD+ SK +L+    +  ++D G A      ++          GT  Y
Sbjct: 124  EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 946  IAPEL------AYTMRANEKCDVFNFGVLVLEVIEGKHPGH--------FLSLLLSLPAP 991
            +APE+           + ++ D++ FG+++ EV                F  ++ + P+ 
Sbjct: 184  MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 992  AANMNIVVNDLIDSRLP-PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 +V  D    R   P     +  L S+  +   C   NP  R T  ++   L
Sbjct: 244  EDMRKVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  151 bits (384), Expect = 2e-40
 Identities = 65/296 (21%), Positives = 110/296 (37%), Gaps = 49/296 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------RHRNIVKF 838
            G G  G V++ +   G+  AVK   S         ++ +  E  EI      RH NI+ F
Sbjct: 51   GKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFRE-AEIYQTVMLRHENILGF 101

Query: 839  YGFCSHTQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                +        L+LV +Y E GSL   L+       +     + +    A+ L+++H 
Sbjct: 102  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHM 157

Query: 895  DCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL----AGTCGY 945
            +       P I HRD+ SK +L+       ++D G A      +           GT  Y
Sbjct: 158  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 946  IAPEL------AYTMRANEKCDVFNFGVLVLEVIEGKHPGH--------FLSLLLSLPAP 991
            +APE+           + ++ D++  G++  E+      G         +  L+ S P+ 
Sbjct: 218  MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 992  AANMNIVVNDLIDSRLP-PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 +V       R   P   +  E L+ M  +   C  AN   R T  ++   L
Sbjct: 278  EEMRKVVCEQ--KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  151 bits (382), Expect = 3e-40
 Identities = 72/297 (24%), Positives = 111/297 (37%), Gaps = 51/297 (17%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------RHRNIVKF 838
            G G  G V+  +   G+  AVK   +         +  +  E TEI      RH NI+ F
Sbjct: 46   GKGRYGEVWMGKW-RGEKVAVKVFFT-------TEEASWFRE-TEIYQTVLMRHENILGF 96

Query: 839  YGFC----SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                         L+L+ +Y E GSL   L +      LD    + +     + L ++H 
Sbjct: 97   IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHT 152

Query: 895  DCF-----PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL----AGTCGY 945
            + F     P I HRD+ SK +L+       ++D G A     D++          GT  Y
Sbjct: 153  EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 946  IAPEL------AYTMRANEKCDVFNFGVLVL-EVIEGKHPGH--------FLSLLLSLPA 990
            + PE+          ++    D+++FG L+L EV      G         +  L+ S P+
Sbjct: 213  MPPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271

Query: 991  PAANMNIVVNDLIDSRLP-PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                  IV       R   P     +E L+ M  +   C   NP  R T  +V   L
Sbjct: 272  YEDMREIVCIK--KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  147 bits (372), Expect = 2e-39
 Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 27/270 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G+G  GTVYK +   GD  AVK L+   T       + F +E+    + RH NI+ F G+
Sbjct: 33   GSGSFGTVYKGKW-HGDV-AVKMLN--VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +    L +V ++ E  SL   L    T  + +  K +++ +  A  + Y+H      I+
Sbjct: 89   STA-PQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHA---KSII 142

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLK--PDSSNWSELAGTCGYIAPEL---AYTMRA 956
            HRD+ S  + L  +    + DFG A        S  + +L+G+  ++APE+     +   
Sbjct: 143  HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
            + + DV+ FG+++ E++ G+ P   ++             +    L             +
Sbjct: 203  SFQSDVYAFGIVLYELMTGQLPYSNIN-----NRDQIIEMVGRGSLSPDLSKVRSN-CPK 256

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            ++K ++A    CL    D RP+  ++   +
Sbjct: 257  RMKRLMA---ECLKKKRDERPSFPRILAEI 283

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  147 bits (374), Expect = 4e-39
 Identities = 68/311 (21%), Positives = 126/311 (40%), Gaps = 37/311 (11%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLV 123
           +P    +  +  +L L  N++  +   +   L +L+ L L  N+++   P +   L  L 
Sbjct: 46  VPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103

Query: 124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK 183
           +L LS N L  ++P             +P+ L  L       +H N  + V      GL 
Sbjct: 104 RLYLSKNQLK-ELPEK-----------MPKTLQEL------RVHENEITKVRKSVFNGLN 145

Query: 184 NLTFVYLNNNRI-VGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
            +  V L  N +    I +     ++ LSY+ +    ++ +IP   G   +L  L+L  N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202

Query: 242 RLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
           +++  +    L    +L  L LS N ++     S  N   L+ LH++N NKL   +P  +
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN-NKLV-KVPGGL 259

Query: 301 GNLKSLSHLWLSKTQLS-----GFIPPS-LGNLSNIRGLYIRENML-YGSIPEEL-GRLK 352
            + K +  ++L    +S      F PP      ++  G+ +  N + Y  I       + 
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

Query: 353 SLSQLSLSVNK 363
             + + L   K
Sbjct: 320 VRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  139 bits (352), Expect = 3e-36
 Identities = 68/309 (22%), Positives = 122/309 (39%), Gaps = 35/309 (11%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L++ P  L P  A LDL  N++         +L  L  L    N+ S I P     L  L
Sbjct: 43  LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL-S 133
             L LS NQL   +PE++    +L EL +  N +     +    L+ ++ + L  N L S
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159

Query: 134 GQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
             I                Q +  L     + +   N + +       L  L   +L+ N
Sbjct: 160 SGIENGA-----------FQGMKKLS---YIRIADTNITTIPQGLPPSLTEL---HLDGN 202

Query: 194 RIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKL 251
           +I   + +     L +L+ LGL+ N +S ++   +  N  +L+ L+L++N+L   +P  L
Sbjct: 203 KI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

Query: 252 GSFKSLLYLYLSHNQLNG------SLPSSFGNLSSLKHLHVHNINKLS-GSIPKEI-GNL 303
              K +  +YL +N ++         P      +S   + + + N +    I       +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS-NPVQYWEIQPSTFRCV 318

Query: 304 KSLSHLWLS 312
              + + L 
Sbjct: 319 YVRAAVQLG 327

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  137 bits (347), Expect = 1e-35
 Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 36/302 (11%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQ 59
              ++L  + +   +++  F     L  L L  N++   I     + L KL+ L  S NQ
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQ 111

Query: 60  FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSI--PASLG 117
              +      +   L  LR+  N++  +       L  +  + L  N L  S     +  
Sbjct: 112 LKEL---PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 118 NLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPR 177
            +  L  + +++ +++  IP             +P  L  L       L  N  + V   
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQG-----------LPPSLTELH------LDGNKITKVDAA 210

Query: 178 SLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLY 237
           SL GL NL  + L+ N I       + N   L  L LN N+L   +P    +   ++ +Y
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269

Query: 238 LHDNRLSG------YIPPKLGSFKSLLYLYLSHNQLNGSL--PSSFGNLSSLKHLHVHNI 289
           LH+N +S         P       S   + L  N +      PS+F  +     + + N 
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN- 328

Query: 290 NK 291
            K
Sbjct: 329 YK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (276), Expect = 3e-26
 Identities = 56/285 (19%), Positives = 109/285 (38%), Gaps = 25/285 (8%)

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
           +P+++          ++NN          +N  +L++L L  N+++      F     LE
Sbjct: 46  VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103

Query: 476 LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRL-V 533
            L LS N    E+         L  L +  NEI+  +   +   + Q+  ++  +N L  
Sbjct: 104 RLYLSKNQ-LKELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKS 159

Query: 534 GQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
             I       +  L+ + +    ++    +  GL   L  L L  N+++K+   +L  L 
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLN 216

Query: 593 KLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQ 649
            L  L LS N  S   ++  G       L +L L++N L   +P  + + + ++ + L  
Sbjct: 217 NLAKLGLSFNSIS---AVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHN 272

Query: 650 NKLSG------PIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
           N +S         P    +    S + +  N +Q        F+ 
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  106 bits (266), Expect = 5e-25
 Identities = 63/311 (20%), Positives = 120/311 (38%), Gaps = 26/311 (8%)

Query: 305 SLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKL 364
            L  +  S   L   +P  L    +   L ++ N +      +   LK+L  L L  NK+
Sbjct: 32  HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 365 NGSIPHCLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQS 423
           +   P     L  L+   L +N+L   +P+++ + +++L    + EN+ T  + ++V   
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELR---VHENEIT-KVRKSVFNG 143

Query: 424 -GSLTHFSVRNNNFVGPI--PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
              +    +  N          + Q    L  +R+    +T  I +  G+ P L  L L 
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLD 200

Query: 481 NNNFFGEISSNWIK-CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ 539
            N    ++ +  +K    LA L +  N IS      + N   L +L  ++N+LV ++P  
Sbjct: 201 GNK-ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258

Query: 540 LGKLTSLTSLTLNGNQLSG------DIPLELGLLAELGYLDLSANRL--SKLIPKNLGEL 591
           L     +  + L+ N +S         P      A    + L +N +   ++ P     +
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318

Query: 592 RKLHHLNLSNN 602
                + L N 
Sbjct: 319 YVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (258), Expect = 6e-24
 Identities = 63/312 (20%), Positives = 123/312 (39%), Gaps = 28/312 (8%)

Query: 377 NLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQS-GSLTHFSVRNN 434
           +L+     +  L   +P+++  +   L+   L  N+ T  +     ++  +L    + NN
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPPDTALLD---LQNNKITE-IKDGDFKNLKNLHTLILINN 86

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK 494
                 P +      L  L L +NQL     ++      L+ L +  N       S +  
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNG 143

Query: 495 CPQLATLNMGGNEI-SGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLN 552
             Q+  + +G N + S  I +     M +L  +  +   +   IP+ L    SLT L L+
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200

Query: 553 GNQLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ 611
           GN+++  +    L  L  L  L LS N +S +   +L     L  L+L+NN+   ++   
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGG 258

Query: 612 IGKLVQLSKLDLSHNSLGGNIPSE-------ICNLESLEYMNLLQNKLSGPI--PSCFRR 662
           +     +  + L +N++   I S             S   ++L  N +      PS FR 
Sbjct: 259 LADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

Query: 663 MHGLSSIDVSYN 674
           ++  +++ +   
Sbjct: 318 VYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 41/198 (20%), Positives = 85/198 (42%), Gaps = 12/198 (6%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
           P  A L++  N+I+     +  N+  LH L   +N++    P     L  L  L L+ NQ
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG-- 613
           L     L   +   L  L +  N ++K+       L ++  + L  N       I+ G  
Sbjct: 112 LKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGIENGAF 167

Query: 614 -KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVS 672
             + +LS + ++  ++   IP  +    SL  ++L  NK++    +  + ++ L+ + +S
Sbjct: 168 QGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224

Query: 673 YNELQGSIPHSKAFQNAT 690
           +N +  ++ +  +  N  
Sbjct: 225 FNSIS-AVDNG-SLANTP 240

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  137 bits (348), Expect = 9e-36
 Identities = 69/311 (22%), Positives = 122/311 (39%), Gaps = 38/311 (12%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLV 123
           +P    I  +  +L L  N ++ L  ++   L  L  L L  N+++     +   L  L 
Sbjct: 48  VPK--EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK 183
           +L +S N L  +IPPN           +P  L  L       +H N    V      GL+
Sbjct: 106 KLYISKNHLV-EIPPN-----------LPSSLVEL------RIHDNRIRKVPKGVFSGLR 147

Query: 184 NLTFVYLNNNRI-VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNR 242
           N+  + +  N +          +   L+YL +++ +L+  IP        L  L+L  N+
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNK 204

Query: 243 LSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIG 301
           +   I  + L  +  L  L L HNQ+      S   L +L+ LH+ N NKLS  +P  + 
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN-NKLS-RVPAGLP 261

Query: 302 NLKSLSHLWLSKTQLSGFIPPS-------LGNLSNIRGLYIRENML-YGSIPEELGR-LK 352
           +LK L  ++L    ++  +  +           +   G+ +  N + Y  +     R + 
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320

Query: 353 SLSQLSLSVNK 363
               +     K
Sbjct: 321 DRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  130 bits (330), Expect = 3e-33
 Identities = 65/310 (20%), Positives = 105/310 (33%), Gaps = 32/310 (10%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L+  P  + P    LDL  N +          L  L  L    N+ S I       L  L
Sbjct: 45  LKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L +S N L   IP  L   +SL EL +  NR+          L N+  + +  N L  
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE- 160

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                                 +      + +     +G IP+ L   + L  ++L++N+
Sbjct: 161 -------------NSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNK 204

Query: 195 IVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLG 252
           I  +I  E       L  LGL  NQ+   I   +   L  L+ L+L +N+LS  +P  L 
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261

Query: 253 SFKSLLYLYLSHNQLNGSLPSSF------GNLSSLKHLHVHNINKLSGSIPKEI-GNLKS 305
             K L  +YL  N +     + F         +    + + N       +       +  
Sbjct: 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321

Query: 306 LSHLWLSKTQ 315
              +     +
Sbjct: 322 RLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  127 bits (320), Expect = 5e-32
 Identities = 64/300 (21%), Positives = 115/300 (38%), Gaps = 38/300 (12%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQ 59
              ++L  +++   L++  F     L  L L  N++   I  +  S L KL+ L  S N 
Sbjct: 56  TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNH 113

Query: 60  FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRL-NGSIPASLGN 118
               IPP   + ++LV LR+  N++  +       L ++N + +  N L N        +
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 119 LSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS 178
              L  L +S   L+  IP +           +P+ L  L       L  N    +    
Sbjct: 171 GLKLNYLRISEAKLT-GIPKD-----------LPETLNEL------HLDHNKIQAIELED 212

Query: 179 LGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLY 237
           L     L  + L +N+I   I +     L +L  L L+ N+LS  +P    +L  L+ +Y
Sbjct: 213 LLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270

Query: 238 LHDNRLSGYIPPK-------LGSFKSLLYLYLSHNQLNGSL--PSSFGNLSSLKHLHVHN 288
           LH N ++  +                   + L +N +      P++F  ++    +   N
Sbjct: 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  107 bits (269), Expect = 2e-25
 Identities = 67/383 (17%), Positives = 117/383 (30%), Gaps = 96/383 (25%)

Query: 232 NLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINK 291
           +L+ +   D  L   +P ++        L L +N ++      F  L  L  L + N NK
Sbjct: 34  HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN-NK 89

Query: 292 LSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRL 351
           +S    K    L+ L  L++SK  L                           IP  L   
Sbjct: 90  ISKIHEKAFSPLRKLQKLYISKNHLV-------------------------EIPPNL--P 122

Query: 352 KSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQ 411
            SL +L +  N++          L N+    +  N                         
Sbjct: 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN------------------------- 157

Query: 412 FTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIY 471
                         L +       F G           L  LR+   +LTG   ++    
Sbjct: 158 -------------PLENSGFEPGAFDGL---------KLNYLRISEAKLTGIPKDLP--- 192

Query: 472 PDLELLDLSNNNFFGEISSN-WIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSS 529
             L  L L +N     I     ++  +L  L +G N+I   I +     +  L +L   +
Sbjct: 193 ETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDN 250

Query: 530 NRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIP-------LELGLLAELGYLDLSANRLS- 581
           N+L  ++P  L  L  L  + L+ N ++  +              A    + L  N +  
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308

Query: 582 -KLIPKNLGELRKLHHLNLSNNQ 603
            ++ P     +     +   N +
Sbjct: 309 WEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  102 bits (255), Expect = 2e-23
 Identities = 58/284 (20%), Positives = 111/284 (39%), Gaps = 24/284 (8%)

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
           +P+ +  S   T   ++NN+         +    LY+L L  N+++    + F     L+
Sbjct: 48  VPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 476 LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRL-V 533
            L +S N+   EI  N      L  L +  N I   +P  +   +  ++ ++   N L  
Sbjct: 106 KLYISKNHL-VEIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLEN 161

Query: 534 GQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRK 593
                       L  L ++  +L+G   +   L   L  L L  N++  +  ++L    K
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQAIELEDLLRYSK 218

Query: 594 LHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN 650
           L+ L L +NQ      I+ G    L  L +L L +N L   +P+ + +L+ L+ + L  N
Sbjct: 219 LYRLGLGHNQIR---MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274

Query: 651 KLSGPIPSCFRRMHG------LSSIDVSYNELQGSIPHSKAFQN 688
            ++    + F  +         + I +  N +         F+ 
Sbjct: 275 NITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 99.7 bits (249), Expect = 9e-23
 Identities = 61/311 (19%), Positives = 114/311 (36%), Gaps = 27/311 (8%)

Query: 377 NLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQS-GSLTHFSVRNN 434
           +L+     +  L  ++P+EI  +   L+   L  N  +  L ++  +    L    + NN
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPDTTLLD---LQNNDIS-ELRKDDFKGLQHLYALVLVNN 88

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK 494
                  ++      L  L + +N L      +      L  L + +N         +  
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSG 145

Query: 495 CPQLATLNMGGNEI-SGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNG 553
              +  + MGGN + +        +  +L+ L  S  +L   IPK L    +L  L L+ 
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDH 202

Query: 554 NQLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQI 612
           N++   I LE L   ++L  L L  N++  +   +L  L  L  L+L NN+ S  +   +
Sbjct: 203 NKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260

Query: 613 GKLVQLSKLDLSHNSLGGNIPSEI-------CNLESLEYMNLLQNKLSGPI--PSCFRRM 663
             L  L  + L  N++   +                   ++L  N +      P+ FR +
Sbjct: 261 PDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319

Query: 664 HGLSSIDVSYN 674
               +I     
Sbjct: 320 TDRLAIQFGNY 330

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  139 bits (352), Expect = 3e-35
 Identities = 86/469 (18%), Positives = 148/469 (31%), Gaps = 102/469 (21%)

Query: 196 VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF 254
           V  +P+       ++Y+ L+ N ++  +  T+   L +L+FL +        I     +F
Sbjct: 25  VPELPA------HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTF 75

Query: 255 ---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL-SGSIPKEI-GNLKSLSHL 309
               SL+ L L +NQ       +F  L++L+ L +     L    +       L SL  L
Sbjct: 76  RGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQ-CNLDGAVLSGNFFKPLTSLEML 134

Query: 310 WLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP 369
            L    +    P S                           ++    L L+ NK+     
Sbjct: 135 VLRDNNIKKIQPASF-----------------------FLNMRRFHVLDLTFNKVKSICE 171

Query: 370 HCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHF 429
             L N     F  LR                      L                      
Sbjct: 172 EDLLNFQGKHFTLLR----------------------LSSITLQ---------------- 193

Query: 430 SVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVF-GIYPDLELLDLSNNNFFGEI 488
            +           +    TS+ +L L  N    ++++ F       ++  L  +N +   
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253

Query: 489 SSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTS 548
           SS           +       G         + +   D S +++   +       T L  
Sbjct: 254 SS----FGHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQ 303

Query: 549 LTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS 605
           LTL  N+++    ++      L  L  L+LS N L  +  +    L KL  L+LS N   
Sbjct: 304 LTLAQNEIN---KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360

Query: 606 QEISIQIG---KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQN 650
              ++       L  L +L L  N L  ++P  I   L SL+ + L  N
Sbjct: 361 ---ALGDQSFLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  137 bits (346), Expect = 2e-34
 Identities = 84/386 (21%), Positives = 137/386 (35%), Gaps = 36/386 (9%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQ 59
           V  ++L+ +++   L E  F     L +L +        I       LS L  L    NQ
Sbjct: 32  VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 60  FSGIIPPQIGILTNLVVLRLSVNQLNGL-IPEEL-GELTSLNELALSYNRLNGSIPASL- 116
           F  +       L NL VL L+   L+G  +       LTSL  L L  N +    PAS  
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 117 GNLSNLVQLSLSNNSLSGQIPPN-WGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVI 175
            N+     L L+ N +   I           H+  +      L S     ++        
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLL-----RLSSITLQDMNEYWLGWEK 204

Query: 176 PRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYL-------------GLNKNQLSGS 222
             +     ++T + L+ N    S+     +  + + +                       
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 223 IPPTAGNL--SNLKFLYLHDNRLSGYIPPKL-GSFKSLLYLYLSHNQLNGSLPS-SFGNL 278
              T   L  S +K   L  +++   +   +   F  L  L L+ N++N  +   +F  L
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL 322

Query: 279 SSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
           + L  L++   N L  SI   +  NL  L  L LS   +      S   L N++ L +  
Sbjct: 323 THLLKLNLSQ-NFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

Query: 338 NMLYGSIPEE-LGRLKSLSQLSLSVN 362
           N L  S+P+    RL SL ++ L  N
Sbjct: 381 NQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  135 bits (341), Expect = 7e-34
 Identities = 83/413 (20%), Positives = 150/413 (36%), Gaps = 55/413 (13%)

Query: 22  LFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI-GILTNLVVLRLS 80
           L   + Y+DLS+N +     T  S L  L+ L         +I       L++L++L+L 
Sbjct: 28  LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87

Query: 81  VNQLNGLIPEELGELTSLNELALSYNRLNGSI--PASLGNLSNLVQLSLSNNSLSGQIPP 138
            NQ   L       L +L  L L+   L+G++        L++L  L L +N++  +I P
Sbjct: 88  YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQP 146

Query: 139 NWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGS 198
                      S   ++        + L  N    +    L   +   F  L        
Sbjct: 147 ----------ASFFLNMRRFH---VLDLTFNKVKSICEEDLLNFQGKHFTLL-------- 185

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
                  L S++   +N+  L           +++  L L  N     +  +     +  
Sbjct: 186 ------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239

Query: 259 YLY-------------LSHNQLNGSLPSSFGNL--SSLKHLHVHNINKLSGSIPKEI-GN 302
            +                H         +F  L  S +K   +   +K+  ++ K +  +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSK-SKIF-ALLKSVFSH 297

Query: 303 LKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSV 361
              L  L L++ +++     +   L+++  L + +N L GSI   +   L  L  L LS 
Sbjct: 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSY 356

Query: 362 NKLNGSIPHCL-GNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQF 412
           N +  ++       L NLK  AL  N+L  S+P  I + +  L K  L  N +
Sbjct: 357 NHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 97.5 bits (243), Expect = 2e-21
 Identities = 78/436 (17%), Positives = 137/436 (31%), Gaps = 106/436 (24%)

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLS 317
           Y+ LS N +     +SF  L  L+ L V         I       L SL  L L   Q  
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQ-QTPGLVIRNNTFRGLSSLIILKLDYNQFL 92

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSI--PHCLGNL 375
             +                              L +L  L+L+   L+G++   +    L
Sbjct: 93  -QLETGA-----------------------FNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128

Query: 376 SNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN 434
           ++L+   LR+N +    P     NM++ +   L  N+       ++C    L +F  ++ 
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-----SIC-EEDLLNFQGKH- 181

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK 494
                             LRL    L                 D++      E   N  K
Sbjct: 182 ---------------FTLLRLSSITL----------------QDMNEYWLGWEKCGNPFK 210

Query: 495 CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG--KLTSLTSLTLN 552
              + TL++ GN    ++     +     K+          +    G        + T  
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 553 GNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQI 612
           G + SG           +   DLS +++  L+         L  L L+ N+ ++      
Sbjct: 271 GLEASG-----------VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK------ 313

Query: 613 GKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVS 672
                     +  N+  G        L  L  +NL QN L       F  +  L  +D+S
Sbjct: 314 ----------IDDNAFWG--------LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS 355

Query: 673 YNELQGSIPHSKAFQN 688
           YN ++ ++   ++F  
Sbjct: 356 YNHIR-ALGD-QSFLG 369

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 96.0 bits (239), Expect = 7e-21
 Identities = 55/293 (18%), Positives = 105/293 (35%), Gaps = 46/293 (15%)

Query: 4   INLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQL----------FGTIPTQISHLSKLKHL 53
           + L  +N+K       FL   +   LDL+ N++          F      +  LS +   
Sbjct: 134 LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193

Query: 54  DFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIP 113
           D +               T++  L LS N     + +   +  +  ++       + ++ 
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253

Query: 114 ASLGN---------------LSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNL 158
           +S G+                S +    LS + +   +  +           +     +L
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKS-----------VFSHFTDL 301

Query: 159 ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKN 217
           E    ++L  N  + +   +  GL +L  + L+ N + GSI S +  NL  L  L L+ N
Sbjct: 302 EQ---LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYN 357

Query: 218 QLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLN 268
            +  ++   +   L NLK L L  N+L   +P        SL  ++L  N  +
Sbjct: 358 HIR-ALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 90.2 bits (224), Expect = 6e-19
 Identities = 51/300 (17%), Positives = 95/300 (31%), Gaps = 47/300 (15%)

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           C +  L          V  +P  +        + L  N +       F    DL+ L + 
Sbjct: 17  CINRGLHQ--------VPELPAHVN------YVDLSLNSIAELNETSFSRLQDLQFLKVE 62

Query: 481 NNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQI-- 536
                  I +N       L  L +  N+    + +     +  L  L  +   L G +  
Sbjct: 63  QQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLS 121

Query: 537 PKQLGKLTSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
                 LTSL  L L  N +    P      +     LDL+ N++  +  ++L   +  H
Sbjct: 122 GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKH 181

Query: 596 --HLNLSNNQFS-----QEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYM 645
              L LS+              + G   K   ++ LDLS N    ++     +  +   +
Sbjct: 182 FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKI 241

Query: 646 NLL-------------QNKLSGPIPSCFRRMH--GLSSIDVSYNELQGSIPHSKAFQNAT 690
             L                   P    F+ +   G+ + D+S +++  ++     F + T
Sbjct: 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL-KSVFSHFT 299

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 4e-15
 Identities = 29/187 (15%), Positives = 52/187 (27%), Gaps = 6/187 (3%)

Query: 520 TQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSAN 578
             ++ +D S N +         +L  L  L +        I       L+ L  L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 579 RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSE 635
           +  +L       L  L  L L+         +       L  L  L L  N++    P+ 
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNL-DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 636 I-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAF 694
              N+     ++L  NK+            G     +  + +     +            
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 695 QGNKELC 701
             N  + 
Sbjct: 209 FKNTSIT 215

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  137 bits (348), Expect = 1e-34
 Identities = 77/438 (17%), Positives = 142/438 (32%), Gaps = 70/438 (15%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
           N  S                 +   L+ L  L  H++ ++      +     L  L  + 
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTS 73

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL 324
           N +  +L       ++L +L   + NKL+ ++   +  L  L++L     +L+      +
Sbjct: 74  NNIT-TLD--LSQNTNLTYLACDS-NKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DV 123

Query: 325 GNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR 384
                +  L    N L   I   +     L++L   +NK    +   +   + L      
Sbjct: 124 SQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178

Query: 385 ENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL 444
            N+++     ++   K LN+     N  T            L                 L
Sbjct: 179 FNKITEL---DVSQNKLLNRLNCDTNNIT-----------KL----------------DL 208

Query: 445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG 504
                L  L    N+LT  I         L   D S N        +     +L TL+  
Sbjct: 209 NQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCI 262

Query: 505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL 564
             ++   I   + + TQL        R + ++   +   T L  L      ++    L+L
Sbjct: 263 QTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT---ELDL 314

Query: 565 GLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLS 624
               +L YL L+   L++L   ++    KL  L+  N     + S  +GK+  L+    +
Sbjct: 315 SQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369

Query: 625 HNSLGGNIPSEICNLESL 642
                  +P E     SL
Sbjct: 370 EGQT-ITMPKETLTNNSL 386

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  137 bits (348), Expect = 1e-34
 Identities = 75/405 (18%), Positives = 138/405 (34%), Gaps = 58/405 (14%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN 82
              L  LD   + +  T  T I  L+ L  L  ++N  + +    +   TNL  L    N
Sbjct: 41  LATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSN 95

Query: 83  QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGY 142
           +L  L   ++  LT L  L    N+L   +   +     L  L+ + N+L+         
Sbjct: 96  KLTNL---DVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--------- 140

Query: 143 LISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSE 202
                   I  D+ +      +  H N     +   +     LT +  + N+I      +
Sbjct: 141 -------EI--DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LD 186

Query: 203 IGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYL 262
           +   + L+ L  + N ++  +         L FL    N+L+  I   +     L Y   
Sbjct: 187 VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240

Query: 263 SHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP 322
           S N L   L  S   LS L  LH      L   I   + +   L +      +    +  
Sbjct: 241 SVNPLT-ELDVS--TLSKLTTLHCIQ-TDLL-EID--LTHNTQLIYFQAEGCRKIKELD- 292

Query: 323 SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFA 382
            + + + +  L  +   +   +   L +   L  L L+  +L   +   + + + LK  +
Sbjct: 293 -VTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345

Query: 383 LRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLT 427
                +       +  +  LN     E Q    +P+    + SLT
Sbjct: 346 CVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  135 bits (341), Expect = 8e-34
 Identities = 70/458 (15%), Positives = 146/458 (31%), Gaps = 59/458 (12%)

Query: 26  LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLN 85
            A    +  ++  T       L+ L  LD   +  + +    I  LT L  L  + N + 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77

Query: 86  GLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS 145
            L   +L + T+L  LA   N+L  ++   +  L+ L  L+   N L+            
Sbjct: 78  TL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT------------ 119

Query: 146 PHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGN 205
                   D+        ++   N  + +    +     LT +  + N+ +  +   +  
Sbjct: 120 ------KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTP 168

Query: 206 LRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHN 265
              L+ L  + N+++  +         L  L    N ++  +   L     L +L  S N
Sbjct: 169 QTQLTTLDCSFNKIT-ELDV--SQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSN 222

Query: 266 QLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLG 325
           +L   +      L+ L +      N L+  +   +  L  L+ L   +T L       L 
Sbjct: 223 KLT-EID--VTPLTQLTYFDCSV-NPLT-ELD--VSTLSKLTTLHCIQTDLLEI---DLT 272

Query: 326 NLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRE 385
           + + +             +  ++     L  L      +   +   L     L +  L  
Sbjct: 273 HNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNN 327

Query: 386 NELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQ 445
            EL+  +   + +  KL                +V +  +L +        +     +L 
Sbjct: 328 TELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLT 382

Query: 446 NCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN 483
           N +   ++  +     GN   +     D  + D + N 
Sbjct: 383 NNSLTIAVSPDLLDQFGNPMNI--EPGDGGVYDQATNT 418

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  130 bits (329), Expect = 3e-32
 Identities = 80/496 (16%), Positives = 164/496 (33%), Gaps = 92/496 (18%)

Query: 98  LNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGN 157
                 +   +  +   S   L+ L  L   N+S++                 +      
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT----------------DMT----- 58

Query: 158 LESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN 217
                                +  L  LT +   +N I  ++   +    +L+YL  + N
Sbjct: 59  --------------------GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSN 95

Query: 218 QLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGN 277
           +L+ ++      L+ L +L    N+L+  +   +     L YL  + N L   +     +
Sbjct: 96  KLT-NLD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLT-EID--VSH 146

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
            + L  L  H   K++     ++     L+ L  S  +++      +     +  L    
Sbjct: 147 NTQLTELDCHLNKKIT---KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDT 200

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
           N +   +   L +   L+ L  S NKL   I   +  L+ L +F    N L+  +   + 
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VS 251

Query: 398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER 457
            + KL      +         ++  +  L +F       +  +   + + T LY L  + 
Sbjct: 252 TLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA 306

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISS-NWIKCPQLATLNMGGNEISGTIPSEI 516
             +T          P L  L L+N      ++  +     +L +L+     I       +
Sbjct: 307 AGIT---ELDLSQNPKLVYLYLNNTE----LTELDVSHNTKLKSLSCVNAHIQ-DFS-SV 357

Query: 517 GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLT------SLTLNGNQLSGDIPLELGLLAEL 570
           G +  L+    +  + +  +PK+     SLT       L   GN ++  I    G + + 
Sbjct: 358 GKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQ 414

Query: 571 GYLDLSANRLSKLIPK 586
               ++   LS   P 
Sbjct: 415 ATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  127 bits (320), Expect = 5e-31
 Identities = 63/376 (16%), Positives = 131/376 (34%), Gaps = 52/376 (13%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           +          L YL    N+L   +   ++ L+KL +L+  TN+ + +    +     L
Sbjct: 76  ITTLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLL 129

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L  + N L  +   ++   T L EL    N+    +   +   + L  L  S N ++ 
Sbjct: 130 TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT- 183

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                           +  D+   +    ++  TNN + +    L     LTF+  ++N+
Sbjct: 184 ---------------EL--DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNK 223

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
           +   I   +  L  L+Y   + N L+  +      LS L  L+     L   I   L   
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT-ELDV--STLSKLTTLHCIQTDLL-EID--LTHN 274

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
             L+Y      +    L     + + L  L       ++  +   +     L +L+L+ T
Sbjct: 275 TQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA-AGIT-ELD--LSQNPKLVYLYLNNT 328

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN 374
           +L+      + + + ++ L      +       +G++ +L+    +  +        L N
Sbjct: 329 ELTEL---DVSHNTKLKSLSCVNAHI-QDFS-SVGKIPALNNNFEAEGQTITMPKETLTN 383

Query: 375 LSNLKFFALRENELSG 390
            S     +    +  G
Sbjct: 384 NSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  111 bits (280), Expect = 5e-26
 Identities = 66/358 (18%), Positives = 125/358 (34%), Gaps = 49/358 (13%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L +      P L YL+ + N L   I   +SH ++L  LD   N+   I    +   T L
Sbjct: 118 LTKLDVSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQL 172

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L  S N++  L   ++ +   LN L    N +   +   L     L  L  S+N L+ 
Sbjct: 173 TTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT- 225

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                           I  D+  L          N  + +    +  L  LT ++     
Sbjct: 226 ---------------EI--DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTD 265

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
           ++  I   + +   L Y      +    +     + + L  L      ++  +   L   
Sbjct: 266 LL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQN 317

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
             L+YLYL++ +L   L     + + LK L   N   +       +G + +L++ + ++ 
Sbjct: 318 PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN-AHIQ-DFS-SVGKIPALNNNFEAEG 371

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYG---SIPEELGRLKSLSQLSLSVNKLNGSIP 369
           Q       +L N S    +       +G   +I    G +   +  +++   L+   P
Sbjct: 372 QTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (265), Expect = 4e-24
 Identities = 62/375 (16%), Positives = 124/375 (33%), Gaps = 63/375 (16%)

Query: 302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
           N  S                 S   L+ +  L    + +  +    + +L  L++L  + 
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTS 73

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
           N +  ++   L   +NL + A   N+L+ ++   +  + KL       N+ T        
Sbjct: 74  NNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL------ 121

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
                                 +     L  L   RN LT            L  LD   
Sbjct: 122 ---------------------DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHL 157

Query: 482 NNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG 541
           N    ++        QL TL+   N+I+     ++     L++L+  +N +  ++   L 
Sbjct: 158 NKKITKLDVT--PQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LN 209

Query: 542 KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
           +   LT L  + N+L+    +++  L +L Y D S N L++L    L +L     L+   
Sbjct: 210 QNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLTELDVSTLSKLTT---LHCIQ 263

Query: 602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR 661
                   I +    QL                ++ +   L  ++     ++  +     
Sbjct: 264 TDLL---EIDLTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGIT-ELD--LS 315

Query: 662 RMHGLSSIDVSYNEL 676
           +   L  + ++  EL
Sbjct: 316 QNPKLVYLYLNNTEL 330

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (326), Expect = 3e-33
 Identities = 58/267 (21%), Positives = 101/267 (37%), Gaps = 38/267 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
            G G   TVYK  +  +    A    +   L   E     + F  E      ++H NIV+F
Sbjct: 35   GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER----QRFKEEAEMLKGLQHPNIVRF 90

Query: 839  YGFCSHT----QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            Y     T    + + LV E +  G+L T L        +      +  + +   L ++H 
Sbjct: 91   YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH- 146

Query: 895  DCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
               PPI+HRD+    + +        + D G A   +   +    + GT  ++APE+ Y 
Sbjct: 147  TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-YE 203

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
             + +E  DV+ FG+ +LE+   ++P             A     V + +     P     
Sbjct: 204  EKYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVK----PASF-- 251

Query: 1014 VEEKLKSMIAVAFL--CLDANPDCRPT 1038
              +K+        +  C+  N D R +
Sbjct: 252  --DKVAIPEVKEIIEGCIRQNKDERYS 276

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  128 bits (323), Expect = 1e-32
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 28/252 (11%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLN--GSIPASLGNLSNLVQLS 126
           GI ++   L L  N+L  L      +LT L +L+LS N L+  G    S    ++L  L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 127 LSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL-GGLKNL 185
           LS N +                 ++  +   LE    +    +N   +   S+   L+NL
Sbjct: 85  LSFNGVI----------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 128

Query: 186 TFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRL 243
            ++ +++        + I   L SL  L +  N    +  P     L NL FL L   +L
Sbjct: 129 IYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187

Query: 244 SGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-- 300
              + P    S  SL  L +SHN         +  L+SL+ L     N +  +  K+   
Sbjct: 188 E-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL-NHIM-TSKKQELQ 244

Query: 301 GNLKSLSHLWLS 312
               SL+ L L+
Sbjct: 245 HFPSSLAFLNLT 256

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  125 bits (316), Expect = 8e-32
 Identities = 62/268 (23%), Positives = 107/268 (39%), Gaps = 30/268 (11%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLN--G 86
           +  +   L  ++PT I   S    L+  +N+   +       LT L  L LS N L+  G
Sbjct: 12  IRCNSKGL-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 87  LIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISP 146
              +     TSL  L LS+N +  ++ ++   L  L  L   +++L  Q+          
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF------- 119

Query: 147 HYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GN 205
              S+   L NL     + +   +          GL +L  + +  N    +   +I   
Sbjct: 120 ---SVFLSLRNLI---YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

Query: 206 LRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF---KSLLYLY 261
           LR+L++L L++ QL   + PTA  +LS+L+ L +  N     +      +    SL  L 
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDT--FPYKCLNSLQVLD 229

Query: 262 LSHNQLNGSLPSSFGNL-SSLKHLHVHN 288
            S N +  S      +  SSL  L++  
Sbjct: 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQ 257

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  123 bits (311), Expect = 4e-31
 Identities = 55/262 (20%), Positives = 92/262 (35%), Gaps = 27/262 (10%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQ--FSGIIPPQIGILT 72
           L   P  +      L+L  N+L          L++L  L  S+N   F G         T
Sbjct: 19  LTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 73  NLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNS 131
           +L  L LS N +   +      L  L  L   ++ L      S+  +L NL+ L +S+  
Sbjct: 79  SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 132 LSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNF-SGVIPRSLGGLKNLTFVYL 190
                                     L S   + +  N+F    +P     L+NLTF+ L
Sbjct: 138 TR-VAFNGI--------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 191 NNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIP 248
           +  ++   +      +L SL  L ++ N    S+       L++L+ L    N +     
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSK 239

Query: 249 PKL--GSFKSLLYLYLSHNQLN 268
            +       SL +L L+ N   
Sbjct: 240 KQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  117 bits (296), Expect = 4e-29
 Identities = 61/269 (22%), Positives = 105/269 (39%), Gaps = 27/269 (10%)

Query: 124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK 183
           ++  ++  L+  +P             IP     L       L +N    +       L 
Sbjct: 11  EIRCNSKGLT-SVPTG-----------IPSSATRL------ELESNKLQSLPHGVFDKLT 52

Query: 184 NLTFVYLNNNRI-VGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
            LT + L++N +      S+      SL YL L+ N +  ++      L  L+ L    +
Sbjct: 53  QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 111

Query: 242 RLSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPK 298
            L   +      F    +L+YL +SH     +    F  LSSL+ L +   +     +P 
Sbjct: 112 NLK-QMSEF-SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169

Query: 299 EIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLS 358
               L++L+ L LS+ QL    P +  +LS+++ L +  N  +         L SL  L 
Sbjct: 170 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229

Query: 359 LSVNKLNGSIPHCLGNL-SNLKFFALREN 386
            S+N +  S    L +  S+L F  L +N
Sbjct: 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  116 bits (292), Expect = 1e-28
 Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 22/247 (8%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQL--FGTIPTQISHLSKLKHLDFSTNQF 60
            + L  + L+ +L    F    QL  L LS N L   G         + LK+LD S N  
Sbjct: 32  RLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 90

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEEL-GELTSLNELALSYNRLNGSIPASLGNL 119
              +      L  L  L    + L  +    +   L +L  L +S+     +       L
Sbjct: 91  I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL 179
           S+L  L ++ NS      P+           I  +L NL     + L       + P + 
Sbjct: 150 SSLEVLKMAGNSFQENFLPD-----------IFTELRNLT---FLDLSQCQLEQLSPTAF 195

Query: 180 GGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA--GNLSNLKFLY 237
             L +L  + +++N            L SL  L  + N +  +          S+L FL 
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLN 254

Query: 238 LHDNRLS 244
           L  N  +
Sbjct: 255 LTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (265), Expect = 6e-25
 Identities = 51/225 (22%), Positives = 81/225 (36%), Gaps = 9/225 (4%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEIS--GTIPSEIGNMTQLHKLD 526
           GI      L+L +N         + K  QL  L++  N +S  G         T L  LD
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRLSKLIP 585
            S N ++  +      L  L  L    + L       +   L  L YLD+S         
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143

Query: 586 KNLGELRKLHHLNLSNNQFSQEISIQI-GKLVQLSKLDLSHNSLGGNIPSEI-CNLESLE 643
                L  L  L ++ N F +     I  +L  L+ LDLS   L   +      +L SL+
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQ 202

Query: 644 YMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
            +N+  N         ++ ++ L  +D S N +  +       Q+
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ-ELQH 245

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (264), Expect = 7e-25
 Identities = 63/243 (25%), Positives = 96/243 (39%), Gaps = 8/243 (3%)

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT--GNISEVFGIYPD 473
           +P  +    S T   + +N             T L  L L  N L+  G  S+       
Sbjct: 22  VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 474 LELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRL 532
           L+ LDLS N     +SSN++   QL  L+   + +       +  ++  L  LD S    
Sbjct: 80  LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138

Query: 533 VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGEL 591
                     L+SL  L + GN    +   +    L  L +LDLS  +L +L P     L
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198

Query: 592 RKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNL-ESLEYMNLLQN 650
             L  LN+S+N F    +     L  L  LD S N +  +   E+ +   SL ++NL QN
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

Query: 651 KLS 653
             +
Sbjct: 259 DFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  101 bits (253), Expect = 2e-23
 Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 14/260 (5%)

Query: 232 NLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINK 291
           +   +  +   L+  +P  +    S   L L  N+L       F  L+ L  L + + N 
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS-NG 63

Query: 292 LS--GSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE-- 347
           LS  G   +      SL +L LS   +   +  +   L  +  L  + + L   + E   
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-KQMSEFSV 121

Query: 348 LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYL 406
              L++L  L +S      +       LS+L+   +  N    +   +I   ++ L    
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 407 LFENQFTGYLPQNVCQS-GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS 465
           L + Q    L      S  SL   ++ +NNF        +   SL  L    N +  +  
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240

Query: 466 EVF-GIYPDLELLDLSNNNF 484
           +        L  L+L+ N+F
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 36/148 (24%), Positives = 60/148 (40%), Gaps = 11/148 (7%)

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
           S T +  N   L+  +P   G+ +    L+L +N+L  L      +L +L  L+LS+N  
Sbjct: 8   SGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 605 SQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG-PIPSCF 660
           S               L  LDLS N +   + S    LE LE+++   + L      S F
Sbjct: 65  S-FKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122

Query: 661 RRMHGLSSIDVSYNELQGSIPHSKAFQN 688
             +  L  +D+S+   +     +  F  
Sbjct: 123 LSLRNLIYLDISHTHTR-VAF-NGIFNG 148

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  133 bits (335), Expect = 2e-32
 Identities = 49/300 (16%), Positives = 105/300 (35%), Gaps = 46/300 (15%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIP-PQIGILTNLVVLRLSVNQLNGL 87
            +   N + GT     S   K +         +  +   +  ++     L+L+   L+ L
Sbjct: 15  QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSSL 74

Query: 88  IPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPH 147
            P+ L     +  L ++ N L  S+P    +L     L   +N LS              
Sbjct: 75  -PDNLP--PQITVLEITQNAL-ISLPELPASLEY---LDACDNRLS-------------- 113

Query: 148 YGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR 207
             ++P+   +L+    + +  N  + ++P     L+ +     +NN++   +P    +L 
Sbjct: 114 --TLPELPASLK---HLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPTSLE 163

Query: 208 SLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL----LYLYLS 263
            LS   +  NQL+  +P       +L+ L +  N L   +P             ++    
Sbjct: 164 VLS---VRNNQLT-FLPEL---PESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCR 215

Query: 264 HNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPS 323
            N++   +P +  +L     + + + N LS  I + +    +       +   S      
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILED-NPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  118 bits (298), Expect = 7e-28
 Identities = 50/268 (18%), Positives = 94/268 (35%), Gaps = 44/268 (16%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII 64
            L G N    +      L  Q + L L+   L  ++P  +    ++  L+ + N     +
Sbjct: 40  ALPGENRNEAVSLLKECLINQFSELQLNRLNL-SSLPDNL--PPQITVLEITQNALI-SL 95

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
           P       +L  L    N+L+ L PE    L  L+   +  N+L   +P     L     
Sbjct: 96  PELPA---SLEYLDACDNRLSTL-PELPASLKHLD---VDNNQLT-MLPELPALLE---Y 144

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN 184
           ++  NN L+                 +P+   +LE    +S+  N  +  +P     L+ 
Sbjct: 145 INADNNQLT----------------MLPELPTSLE---VLSVRNNQLT-FLPELPESLEA 184

Query: 185 LTFVYLNNNRIVGSIPSEIGNLRSLS----YLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
           L    ++ N +  S+P+             +    +N+++  IP    +L     + L D
Sbjct: 185 L---DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239

Query: 241 NRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
           N LS  I   L    +    +      +
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  118 bits (296), Expect = 1e-27
 Identities = 69/405 (17%), Positives = 138/405 (34%), Gaps = 49/405 (12%)

Query: 270 SLPSSFGNLSSLKHLHVHN-INKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
           S+     N  SL     +N I+             +  +    ++ +    +   L  ++
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59

Query: 329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
               L +    L  S+P+ L     ++ L ++ N L  S+P    +L  L      +N L
Sbjct: 60  QFSELQLNRLNL-SSLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLD---ACDNRL 112

Query: 389 SGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT 448
           S ++P+   ++K L+   +  NQ T  LP+       L + +  NN     +P    +  
Sbjct: 113 S-TLPELPASLKHLD---VDNNQLT-MLPELP---ALLEYINADNNQLTM-LPELPTS-- 161

Query: 449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLAT----LNMG 504
            L  L +  NQLT     +  +   LE LD+S N     + +  ++              
Sbjct: 162 -LEVLSVRNNQLT----FLPELPESLEALDVSTN-LLESLPAVPVRNHHSEETEIFFRCR 215

Query: 505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE- 563
            N I+  IP  I ++     +    N L  +I + L + T+           S     + 
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274

Query: 564 ----LGLLAELGYLDLSANRLSKLIPKNLGEL-------RKLHHLNLSNN-----QFSQE 607
                   A   +   +       I                L  L+ + +      F ++
Sbjct: 275 TLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQ 334

Query: 608 ISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL 652
           ++  + KL   ++L     ++  +      +  +L + NL +  L
Sbjct: 335 VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  109 bits (274), Expect = 7e-25
 Identities = 54/240 (22%), Positives = 85/240 (35%), Gaps = 43/240 (17%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L   P  L PQ+  L+++ N L  ++P   + L   ++LD   N+ S  +P       +L
Sbjct: 71  LSSLPDNLPPQITVLEITQNAL-ISLPELPASL---EYLDACDNRLS-TLPELPA---SL 122

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L +  NQL  L PE    L  +N      N+L   +P    +L     LS+ NN L+ 
Sbjct: 123 KHLDVDNNQLTML-PELPALLEYIN---ADNNQLT-MLPELPTSLE---VLSVRNNQLT- 173

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLH-TNNFSGVIPRSLGGLKNLT----FVY 189
                           +P+   +LE+     L  + N    +P       +      F  
Sbjct: 174 ---------------FLPELPESLEA-----LDVSTNLLESLPAVPVRNHHSEETEIFFR 213

Query: 190 LNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP 249
              NRI   IP  I +L     + L  N LS  I  +    +     +      S     
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (270), Expect = 2e-24
 Identities = 54/304 (17%), Positives = 97/304 (31%), Gaps = 33/304 (10%)

Query: 367 SIPHCLGNLSNLKFFALREN--ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSG 424
           SI   + N  +L   +                +  +K        N+    L +  C   
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLIN 59

Query: 425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
             +   +   N    +P +L     +  L + +N L  ++ E+      LE LD  +N  
Sbjct: 60  QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNRL 112

Query: 485 FGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLT 544
              +         L  L++  N+++  +P        L  ++  +N+L   +P+     T
Sbjct: 113 -STLPELP---ASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELP---T 160

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKL----HHLNLS 600
           SL  L++  NQL+  +P    L   L  LD+S N L  L P                   
Sbjct: 161 SLEVLSVRNNQLT-FLP---ELPESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCR 215

Query: 601 NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
            N+ +  I   I  L     + L  N L   I   +    +    +  +   S       
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274

Query: 661 RRMH 664
               
Sbjct: 275 TLHR 278

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  104 bits (260), Expect = 3e-23
 Identities = 57/266 (21%), Positives = 96/266 (36%), Gaps = 31/266 (11%)

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
           LP N   S S   F    +        +             RN+    + E   +     
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFS 62

Query: 476 LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQ 535
            L L+  N    +  N    PQ+  L +  N +  ++P    +   L  LD   NRL   
Sbjct: 63  ELQLNRLNL-SSLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-T 114

Query: 536 IPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
           +P+      SL  L ++ NQL+  +P    LL  +   +   N+L+ L P+    L  L 
Sbjct: 115 LPELPA---SLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLTML-PELPTSLEVL- 165

Query: 596 HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLE----YMNLLQNK 651
             ++ NNQ    +         L  LD+S N L  ++P+        E    +    +N+
Sbjct: 166 --SVRNNQL-TFLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218

Query: 652 LSGPIPSCFRRMHGLSSIDVSYNELQ 677
           ++  IP     +    +I +  N L 
Sbjct: 219 ITH-IPENILSLDPTCTIILEDNPLS 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 67.7 bits (165), Expect = 1e-11
 Identities = 40/257 (15%), Positives = 69/257 (26%), Gaps = 37/257 (14%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHL-----------------SKLKHLDFST 57
           L   P L    L Y++   NQL   +P   + L                   L+ LD ST
Sbjct: 132 LTMLPELP-ALLEYINADNNQL-TMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVST 189

Query: 58  NQFSGIIPPQIGILTNL----VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIP 113
           N    + P       +     +  R   N++  + PE +  L     + L  N L+  I 
Sbjct: 190 NLLESL-PAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIR 247

Query: 114 ASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHY-------GSIPQDLGNLESPVSVSL 166
            SL   +            S                       +   D+  +        
Sbjct: 248 ESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEE 307

Query: 167 HTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPT 226
           H N FS      L    +         ++   +      L + + L      ++     +
Sbjct: 308 HANTFSA-FLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAVAADATES 362

Query: 227 AGNLSNLKFLYLHDNRL 243
             +   L +  L    L
Sbjct: 363 CEDRVALTWNNLRKTLL 379

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  129 bits (327), Expect = 4e-32
 Identities = 66/271 (24%), Positives = 103/271 (38%), Gaps = 32/271 (11%)

Query: 48  SKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNR 107
           ++   +         +  P  GI TN  +L L  NQ+  +       L  L  L LS N 
Sbjct: 43  NQFSKVICVRKNLREV--PD-GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 108 LNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLH 167
           +      +   L+NL  L L +N L+  IP                 L  L+    + L 
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGA-----------FVYLSKLK---ELWLR 144

Query: 168 TNNFSGVIPRSLGGLKNLTFVYL-NNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPP 225
            N    +   +   + +L  + L    R+   I       L +L YL L    L   I P
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EI-P 201

Query: 226 TAGNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPSSFGNLSSLK 282
               L  L  L L  N LS  I P  GSF+    L  L++  +Q+     ++F NL SL 
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRP--GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258

Query: 283 HLHVHNINKLSGSIPKEI-GNLKSLSHLWLS 312
            +++ + N L+  +P ++   L  L  + L 
Sbjct: 259 EINLAH-NNLT-LLPHDLFTPLHHLERIHLH 287

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  124 bits (312), Expect = 3e-30
 Identities = 63/258 (24%), Positives = 95/258 (36%), Gaps = 24/258 (9%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L+E P  +      L+L  NQ+         HL  L+ L  S N    I       L NL
Sbjct: 55  LREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLS 133
             L L  N+L  +       L+ L EL L  N +  SIP+     + +L +L L      
Sbjct: 115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173

Query: 134 GQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
             I                + L NL     ++L   N   +   +L  L  L  + L+ N
Sbjct: 174 SYISEG-----------AFEGLSNLRY---LNLAMCNLREI--PNLTPLIKLDELDLSGN 217

Query: 194 RIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPK- 250
            +  +I       L  L  L + ++Q+   I   A  NL +L  + L  N L+  +P   
Sbjct: 218 HLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274

Query: 251 LGSFKSLLYLYLSHNQLN 268
                 L  ++L HN  N
Sbjct: 275 FTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  113 bits (285), Expect = 1e-26
 Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 25/244 (10%)

Query: 2   VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQF 60
             +NL  + ++  ++   F     L  L LS N +  TI     + L+ L  L+   N+ 
Sbjct: 67  RLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRL 124

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS-YNRLNGSIPASLGNL 119
           + I       L+ L  L L  N +  +       + SL  L L    RL+     +   L
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL 179
           SNL  L+L+  +L                  IP +L  L     + L  N+ S + P S 
Sbjct: 185 SNLRYLNLAMCNLR----------------EIP-NLTPLIKLDELDLSGNHLSAIRPGSF 227

Query: 180 GGLKNLTFVYLNNNRIVGSIPSE-IGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLY 237
            GL +L  +++  ++I   I      NL+SL  + L  N L+  +P      L +L+ ++
Sbjct: 228 QGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIH 285

Query: 238 LHDN 241
           LH N
Sbjct: 286 LHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (270), Expect = 8e-25
 Identities = 70/307 (22%), Positives = 110/307 (35%), Gaps = 65/307 (21%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNR 242
             + V      +   +P  I    +   L L++NQ+   I   +  +L +L+ L L  N 
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99

Query: 243 LSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKE 299
           +   I    G+F    +L  L L  N+L      +F  LS LK L + N N +  SIP  
Sbjct: 100 IR-TIEI--GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN-NPIE-SIPSY 154

Query: 300 I-GNLKSLSHLWLSKT-QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQL 357
               + SL  L L +  +LS     +   LSN+R L +    L   IP  L  L  L +L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDEL 212

Query: 358 SLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLP 417
            LS N L+   P     L +L+   + ++++   I                         
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE------------------------ 247

Query: 418 QNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELL 477
                                    +  N  SL  + L  N LT    ++F     LE +
Sbjct: 248 -----------------------RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284

Query: 478 DLSNNNF 484
            L +N +
Sbjct: 285 HLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  106 bits (267), Expect = 2e-24
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 17/242 (7%)

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
           +P  +  S +    ++  N        S ++   L  L+L RN +       F    +L 
Sbjct: 58  VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115

Query: 476 LLDLSNNNFFGEISSNWIKC-PQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLV 533
            L+L +N     I +       +L  L +  N I  +IPS     +  L +LD    + +
Sbjct: 116 TLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173

Query: 534 GQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
             I +     L++L  L L    L  +IP  L  L +L  LDLS N LS + P +   L 
Sbjct: 174 SYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLM 231

Query: 593 KLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLL 648
            L  L +  +Q      I+      L  L +++L+HN+L   +P ++   L  LE ++L 
Sbjct: 232 HLQKLWMIQSQIQ---VIERNAFDNLQSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLH 287

Query: 649 QN 650
            N
Sbjct: 288 HN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 99.4 bits (248), Expect = 5e-22
 Identities = 59/225 (26%), Positives = 91/225 (40%), Gaps = 13/225 (5%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIK-CPQLATLNMGGNEISGTIPSEI-GNMTQLHKLD 526
           GI  +  LL+L  N     I  N  K    L  L +  N I  TI       +  L+ L+
Sbjct: 61  GISTNTRLLNLHENQI-QIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118

Query: 527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLS-ANRLSKLI 584
              NRL          L+ L  L L  N +   IP      +  L  LDL    RLS + 
Sbjct: 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYIS 177

Query: 585 PKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEI-CNLESLE 643
                 L  L +LNL+     +  ++    L++L +LDLS N L   I       L  L+
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLREIPNLT--PLIKLDELDLSGNHLS-AIRPGSFQGLMHLQ 234

Query: 644 YMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
            + ++Q+++     + F  +  L  I++++N L   +PH   F  
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD-LFTP 277

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 61/299 (20%), Positives = 94/299 (31%), Gaps = 54/299 (18%)

Query: 305 SLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKL 364
             S +   +  L   +P  +   +N R L + EN +          L+ L  L LS N +
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 365 NGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSG 424
                     L+NL    L +N L+ +IP                               
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIP------------------------------- 128

Query: 425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
                             +    + L  L L  N +    S  F   P L  LDL     
Sbjct: 129 ----------------NGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172

Query: 485 FGEISSNW-IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKL 543
              IS         L  LN+    +   IP+ +  + +L +LD S N L    P     L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNN 602
             L  L +  +Q+          L  L  ++L+ N L+ L       L  L  ++L +N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 50/197 (25%), Positives = 74/197 (37%), Gaps = 14/197 (7%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
            Q + +      +   +P  I   T+L  L+   N++          L  L  L L+ N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG-- 613
           +          LA L  L+L  NRL+ +       L KL  L L NN      SI     
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAF 156

Query: 614 -KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDV 671
            ++  L +LDL        I       L +L Y+NL    L   IP+    +  L  +D+
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDL 214

Query: 672 SYNELQGSIPHSKAFQN 688
           S N L  +I    +FQ 
Sbjct: 215 SGNHLS-AIR-PGSFQG 229

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (314), Expect = 3e-31
 Identities = 66/308 (21%), Positives = 106/308 (34%), Gaps = 54/308 (17%)

Query: 752  RRRKRTDSQEGQNDVNNQELLSASTFEG-----KMVLHGTGGCGTVYKA-ELTSGDTRAV 805
            R    T+  EG       + +     E           G G  G V++  +  +G   AV
Sbjct: 29   RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 806  KK--LHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATI 863
            KK  L      E+             +    IV  YG       + +  E LE GSL  +
Sbjct: 89   KKVRLEVFRVEELVACA--------GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140

Query: 864  LS-----NEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YK 917
            +       E  A           +      L Y+H      ILH D+ +  VLL  +  +
Sbjct: 141  IKQMGCLPEDRAL--------YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSR 189

Query: 918  AHVSDFGTAKFLKPDSSNWSE-----LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEV 972
            A + DFG A  L+PD    S      + GT  ++APE+      + K D+++   ++L +
Sbjct: 190  AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249

Query: 973  IEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL--CLD 1030
            + G HP                + I          PPP+ E+     + +    +   L 
Sbjct: 250  LNGCHP------WTQYFRGPLCLKIASE-------PPPIREIPPSC-APLTAQAIQEGLR 295

Query: 1031 ANPDCRPT 1038
              P  R +
Sbjct: 296  KEPVHRAS 303

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  124 bits (314), Expect = 4e-31
 Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 33/288 (11%)

Query: 37  FGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELT 96
             +IP+ ++    +K LD S N+ + I    +    NL  L L+ N +N +  +    L 
Sbjct: 43  LNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100

Query: 97  SLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
           SL  L LSYN L  ++ +S    LS+L  L+L  N     +             S+   L
Sbjct: 101 SLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGE----------TSLFSHL 148

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGL 214
             L+       + + F+ +  +   GL  L  + ++ + +  S   +   +++++S+L L
Sbjct: 149 TKLQIL--RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLIL 205

Query: 215 NKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSG----YIPP----KLGSFKSLLYLYLSHN 265
           +  Q    +        S+++ L L D  L       +       L    +   + ++  
Sbjct: 206 HMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264

Query: 266 QLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLS 312
            L   +      +S L  L     N+L  S+P  I   L SL  +WL 
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSR-NQLK-SVPDGIFDRLTSLQKIWLH 309

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  122 bits (309), Expect = 2e-30
 Identities = 68/358 (18%), Positives = 122/358 (34%), Gaps = 56/358 (15%)

Query: 19  PFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLR 78
           P  L+       +       +         +      S+   + I  P  G+   +  L 
Sbjct: 2   PHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSI--PS-GLTEAVKSLD 58

Query: 79  LSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNNSLSGQIP 137
           LS N++  +   +L    +L  L L+ N +N +I   S  +L +L  L LS N LS  + 
Sbjct: 59  LSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLS 116

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
            +W                                         L +LTF+ L  N    
Sbjct: 117 SSW--------------------------------------FKPLSSLTFLNLLGNPYKT 138

Query: 198 SIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFK 255
              + +  +L  L  L +        I       L+ L+ L +  + L  Y P  L S +
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198

Query: 256 SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN-------INKLSGSIPKEIGNLKSLSH 308
           ++ +L L   Q    L       SS++ L + +        ++LS      +    +  +
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258

Query: 309 LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVNKLN 365
           + ++   L   +   L  +S +  L    N L  S+P+    RL SL ++ L  N  +
Sbjct: 259 VKITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  116 bits (292), Expect = 3e-28
 Identities = 63/310 (20%), Positives = 119/310 (38%), Gaps = 37/310 (11%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNR 242
                  ++  +  SIPS +    ++  L L+ N+++  I  +      NL+ L L  N 
Sbjct: 32  RNGICKGSSGSL-NSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNG 87

Query: 243 LSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPK 298
           ++  I     SF    SL +L LS+N L  +L SS F  LSSL  L++   N    ++ +
Sbjct: 88  IN-TIEE--DSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLG-NPYK-TLGE 141

Query: 299 EI--GNLKSLSHLWLSKTQLSGFIPP-SLGNLSNIRGLYIRENMLYGSIPEE-LGRLKSL 354
                +L  L  L +        I       L+ +  L I  + L  S   + L  ++++
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNV 200

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
           S L L + +    +   +   S+++   LR+ +L      E+              +   
Sbjct: 201 SHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-----------GETNS 249

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
            + +   ++  +T         +  + + L   + L  L   RNQL      +F     L
Sbjct: 250 LIKKFTFRNVKITD------ESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSL 303

Query: 475 ELLDLSNNNF 484
           + + L  N +
Sbjct: 304 QKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  109 bits (273), Expect = 9e-26
 Identities = 49/265 (18%), Positives = 83/265 (31%), Gaps = 32/265 (12%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQI-GIL 71
            +          L  L L+ N +  TI     S L  L+HLD S N  S  +       L
Sbjct: 66  YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPL 123

Query: 72  TNLVVLRLSVNQLNGLIPEEL-GELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSN 129
           ++L  L L  N    L    L   LT L  L +        I       L+ L +L +  
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183

Query: 130 NSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVY 189
           + L     P              + + N+     + LH      ++   +    ++  + 
Sbjct: 184 SDLQ-SYEPKS-----------LKSIQNVS---HLILHMKQHILLLEIFVDVTSSVECLE 228

Query: 190 LNNNRIVGSIPSEI--------GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
           L +  +     SE+            +   + +    L   +      +S L  L    N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287

Query: 242 RLSGYIPPK-LGSFKSLLYLYLSHN 265
           +L   +P        SL  ++L  N
Sbjct: 288 QLKS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 54/296 (18%), Positives = 102/296 (34%), Gaps = 22/296 (7%)

Query: 406 LLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS 465
           ++          Q              + +    IP  L    ++ SL L  N++T   +
Sbjct: 13  VIISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGL--TEAVKSLDLSNNRITYISN 69

Query: 466 EVFGIYPDLELLDLSNNNFFGEISSNW-IKCPQLATLNMGGNEISGTIPSEI-GNMTQLH 523
                  +L+ L L++N     I  +       L  L++  N +S  + S     ++ L 
Sbjct: 70  SDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLT 127

Query: 524 KLDFSSNRLVGQIPKQ--LGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYLDLSANRL 580
            L+   N     + +      LT L  L +        I  +    L  L  L++ A+ L
Sbjct: 128 FLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186

Query: 581 SKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEIC--- 637
               PK+L  ++ + HL L   Q    + I +     +  L+L    L     SE+    
Sbjct: 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246

Query: 638 -----NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
                   +   + +    L   +     ++ GL  ++ S N+L+ S+P    F  
Sbjct: 247 TNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDG-IFDR 299

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 91.7 bits (228), Expect = 6e-20
 Identities = 62/388 (15%), Positives = 120/388 (30%), Gaps = 99/388 (25%)

Query: 219 LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
              S    + +             L+  IP   G  +++  L LS+N++     S     
Sbjct: 19  KEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRC 75

Query: 279 SSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
            +L+ L + + N ++ +I ++   +L SL HL LS   LS  +  S              
Sbjct: 76  VNLQALVLTS-NGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW------------- 119

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPH--CLGNLSNLKFFALRENELSGSIPQE 395
                        L SL+ L+L  N    ++       +L+ L+   +   +    I ++
Sbjct: 120 ----------FKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
                       F                 L    +  ++     P+SL++  ++  L L
Sbjct: 169 D-----------FAGL------------TFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205

Query: 456 ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSE 515
              Q    +     +   +E L+L +                L T +   +E+S    + 
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDT--------------DLDTFHF--SELSTGETNS 249

Query: 516 IGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDL 575
           +        +  +   L  Q+ K L +++ L  L  + NQL                   
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS----------------- 291

Query: 576 SANRLSKLIPKN-LGELRKLHHLNLSNN 602
                   +P      L  L  + L  N
Sbjct: 292 --------VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 86.3 bits (214), Expect = 4e-18
 Identities = 56/300 (18%), Positives = 101/300 (33%), Gaps = 45/300 (15%)

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKL 402
           SIP  L   +++  L LS N++       L    NL+   L  N ++ +I          
Sbjct: 45  SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE--------- 92

Query: 403 NKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG 462
                 E+ F+  L         L H  +  N          +  +SL  L L  N    
Sbjct: 93  ------EDSFSS-LGS-------LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK- 137

Query: 463 NISE--VFGIYPDLELLDLSNNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEIGNM 519
            + E  +F     L++L + N + F +I          L  L +  +++    P  + ++
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197

Query: 520 TQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG--------DIPLELGLLAELG 571
             +  L     + +  +   +   +S+  L L    L               L       
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSL 628
            + ++   L + + K L ++  L  L  S NQ     S+  G   +L  L K+ L  N  
Sbjct: 258 NVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK---SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 13/151 (8%)

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
                  +   L+  IP   GL   +  LDLS NR++ +   +L     L  L L++N  
Sbjct: 32  RNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88

Query: 605 SQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKLSG-PIPSC 659
           +   +I+      L  L  LDLS+N L  N+ S     L SL ++NLL N        S 
Sbjct: 89  N---TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL 144

Query: 660 FRRMHGLSSIDVSYNELQGSIPHSKAFQNAT 690
           F  +  L  + V   +    I   K F   T
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQR-KDFAGLT 174

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 18/104 (17%), Positives = 37/104 (35%), Gaps = 9/104 (8%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQIS--------HLSKLKHLDFSTNQFSGIIP 65
            L E    +   +  L+L    L     +++S             +++  +      +  
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQV-M 270

Query: 66  PQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLN 109
             +  ++ L+ L  S NQL  +       LTSL ++ L  N  +
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  126 bits (318), Expect = 7e-31
 Identities = 64/277 (23%), Positives = 100/277 (36%), Gaps = 46/277 (16%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L E P  +     YL+L  N +         HL  L+ L    N    I       L +L
Sbjct: 66  LSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNNSLS 133
             L L  N L  +       L+ L EL L  N +  SIP+ +   + +L++L L      
Sbjct: 126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL--- 181

Query: 134 GQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
                                                   +   +  GL NL ++ L   
Sbjct: 182 -----------------------------------KKLEYISEGAFEGLFNLKYLNLGMC 206

Query: 194 RIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPK-L 251
            I   +P+ +  L  L  L ++ N     I P +   LS+LK L++ ++++S  I     
Sbjct: 207 NIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAF 262

Query: 252 GSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
               SL+ L L+HN L+      F  L  L  LH+H+
Sbjct: 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  114 bits (288), Expect = 5e-27
 Identities = 59/246 (23%), Positives = 92/246 (37%), Gaps = 29/246 (11%)

Query: 2   VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQF 60
             +NL  +N++  +Q   F     L  L L  N +   I     + L+ L  L+   N  
Sbjct: 78  RYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWL 135

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS-YNRLNGSIPASLGNL 119
           + I       L+ L  L L  N +  +       + SL  L L    +L      +   L
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIP--QDLGNLESPVSVSLHTNNFSGVIPR 177
            NL  L+L   ++                  +P    L  LE    + +  N+F  + P 
Sbjct: 196 FNLKYLNLGMCNIK----------------DMPNLTPLVGLE---ELEMSGNHFPEIRPG 236

Query: 178 SLGGLKNLTFVYLNNNRIVGSIPSE-IGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKF 235
           S  GL +L  +++ N+++   I       L SL  L L  N LS S+P      L  L  
Sbjct: 237 SFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVE 294

Query: 236 LYLHDN 241
           L+LH N
Sbjct: 295 LHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (257), Expect = 4e-23
 Identities = 58/284 (20%), Positives = 97/284 (34%), Gaps = 41/284 (14%)

Query: 207 RSLSYLGLNKNQLSGSIPPTAGNL-SNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSH 264
              S +   +  LS  +P     + SN ++L L +N +   I          L  L L  
Sbjct: 54  NQFSKVVCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGR 108

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPP- 322
           N +      +F  L+SL  L + + N L+  IP      L  L  LWL    +   IP  
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFD-NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165

Query: 323 SLGNLSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFF 381
           +   + ++  L + E      I E     L +L  L+L +  +   +P+ L  L  L+  
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEEL 223

Query: 382 ALRENELSGSIPQE-IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPI 440
            +  N     I       +  L K  +  +Q              ++             
Sbjct: 224 EMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQ--------------VSLIE---------- 258

Query: 441 PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
             +     SL  L L  N L+    ++F     L  L L +N +
Sbjct: 259 RNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  100 bits (250), Expect = 3e-22
 Identities = 73/321 (22%), Positives = 111/321 (34%), Gaps = 35/321 (10%)

Query: 370 HCLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQS-GSLT 427
            C    S +         LS  +PQ I  N + LN   L EN     +  +  +    L 
Sbjct: 51  SCSNQFSKVV---CTRRGLS-EVPQGIPSNTRYLN---LMENNIQ-MIQADTFRHLHHLE 102

Query: 428 HFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGE 487
              +  N+       +     SL +L L  N LT   S  F     L  L L NN     
Sbjct: 103 VLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ES 161

Query: 488 ISSN-WIKCPQLATLNMGG-NEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQLGKLT 544
           I S  + + P L  L++G   ++   I       +  L  L+     +   +P  L  L 
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLV 218

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
            L  L ++GN      P     L+ L  L +  +++S +       L  L  LNL++N  
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278

Query: 605 SQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR 661
           S   S+       L  L +L L HN          C+ + L     L+  +      C R
Sbjct: 279 S---SLPHDLFTPLRYLVELHLHHNPW-------NCDCDILWLAWWLREYIPTNSTCCGR 328

Query: 662 -----RMHGLSSIDVSYNELQ 677
                 M G   ++V     Q
Sbjct: 329 CHAPMHMRGRYLVEVDQASFQ 349

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.8 bits (210), Expect = 3e-17
 Identities = 44/197 (22%), Positives = 69/197 (35%), Gaps = 14/197 (7%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
            Q + +      +S  +P  I   +    L+   N +          L  L  L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG-- 613
           +          LA L  L+L  N L+ +       L KL  L L NN      SI     
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE---SIPSYAF 167

Query: 614 -KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDV 671
            ++  L +LDL        I       L +L+Y+NL    +   +P+    + GL  +++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEM 225

Query: 672 SYNELQGSIPHSKAFQN 688
           S N     I    +F  
Sbjct: 226 SGNHFP-EIR-PGSFHG 240

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 75.2 bits (185), Expect = 3e-14
 Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 20/160 (12%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGILT 72
           ++  + F   P L  LDL   +    I       L  LK+L+        +  P +  L 
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLV 218

Query: 73  NLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
            L  L +S N    + P     L+SL +L +  ++++     +   L++LV+L+L++N+L
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278

Query: 133 SGQIPPNWGYLISPHYGSIPQD-LGNLESPVSVSLHTNNF 171
           S                S+P D    L   V + LH N +
Sbjct: 279 S----------------SLPHDLFTPLRYLVELHLHHNPW 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  121 bits (305), Expect = 1e-30
 Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 29/272 (10%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            GTG  G   K    + G     K+    S+   E    ++  VSE+    E++H NIV++
Sbjct: 15   GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRY 70

Query: 839  YG--FCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALSYMH-- 893
            Y          L++V EY E G LA++++      + LD    + V+  +  AL   H  
Sbjct: 71   YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
             D    +LHRD+    V LD +    + DFG A+ L  D+S      GT  Y++PE    
Sbjct: 131  SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
            M  NEK D+++ G L+ E+     P  F          A +   +   + + +       
Sbjct: 191  MSYNEKSDIWSLGCLLYELCALMPP--F---------TAFSQKELAGKIREGKFRRIPYR 239

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045
              ++L  +I      L+     RP+++++   
Sbjct: 240  YSDELNEIIT---RMLNLKDYHRPSVEEILEN 268

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  123 bits (311), Expect = 4e-30
 Identities = 64/308 (20%), Positives = 115/308 (37%), Gaps = 56/308 (18%)

Query: 760  QEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGIN 819
            Q+  ++  +  ++   +F  K VL G G  GT+    +      AVK++           
Sbjct: 9    QDDGDEETSVVIVGKISFCPKDVL-GHGAEGTIVYRGMFDNRDVAVKRI----------- 56

Query: 820  QKGFVSEIT-EIR-------HRNIVKFYGFCSHTQHLFLVYEYLERGSLA-TILSNEATA 870
                 S    E++       H N+++++      Q  ++  E     +L   +   +   
Sbjct: 57   LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH 115

Query: 871  AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGT 925
              L+    + +++   + L+++H      I+HRD+    +L+       + KA +SDFG 
Sbjct: 116  LGLE---PITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169

Query: 926  AKFLKPDSS---NWSELAGTCGYIAPEL---AYTMRANEKCDVFNFGVLVLEVI-EGKHP 978
             K L          S + GT G+IAPE+             D+F+ G +   VI EG HP
Sbjct: 170  CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

Query: 979  GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCR 1036
              F   L          NI++       L P   E         A   +   +  +P  R
Sbjct: 230  --FGKSLQR------QANILLGACSLDCLHPEKHEDVI------ARELIEKMIAMDPQKR 275

Query: 1037 PTMQKVCN 1044
            P+ + V  
Sbjct: 276  PSAKHVLK 283

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  117 bits (294), Expect = 8e-29
 Identities = 65/300 (21%), Positives = 122/300 (40%), Gaps = 33/300 (11%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           FP         +    + +  T+    + L  +  L       + I    +  L NL+ L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGL 68

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
            L  NQ+  L P  L  LT + EL LS N L  ++ A +  L ++  L L++  ++   P
Sbjct: 69  ELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP 124

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
                            L  L +   + L  N  + + P  L GL NL ++ + N ++  
Sbjct: 125 -----------------LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV-- 163

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           S  + + NL  L+ L  + N++S  I P A +L NL  ++L +N++S   P  L +  +L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKIS-DISPLA-SLPNLIEVHLKNNQISDVSP--LANTSNL 219

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
             + L++  +         NL     +   +   ++ +   + G   S +  W   + ++
Sbjct: 220 FIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFIN 279

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 60/286 (20%), Positives = 113/286 (39%), Gaps = 22/286 (7%)

Query: 371 CLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFS 430
               L+N    A  ++ ++ ++     ++  +     F    T    + V    +L    
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69

Query: 431 VRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISS 490
           +++N      P  L+N T +  L L  N L  N+S + G    ++ LDL++     +++ 
Sbjct: 70  LKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAG-LQSIKTLDLTSTQI-TDVTP 124

Query: 491 NWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLT 550
                  L  L +  N+I+    S +  +T L  L   + ++    P  L  L+ LT+L 
Sbjct: 125 LA-GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179

Query: 551 LNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISI 610
            + N++S DI   L  L  L  + L  N++S + P  L     L  + L+N   +   + 
Sbjct: 180 ADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT---NQ 232

Query: 611 QIGKLVQLSKLDLSHNSLGGNI-PSEICNLESLEYMNLLQNKLSGP 655
            +     L   ++     G  I P+ I +  +    NL  N  S  
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 22/263 (8%)

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
              +    K    ++  T  + Q       +T  S             +Q   +L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQADLDG--ITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70

Query: 456 ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS--SNWIKCPQLATLNMGGNEISGTIP 513
           + NQ+T +++        +  L+LS N     +   S       + TL++   +I+   P
Sbjct: 71  KDNQIT-DLAP-LKNLTKITELELSGNP----LKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 514 SEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYL 573
             +  ++ L  L    N++    P  L  LT+L  L++   Q+S D+   L  L++L  L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTL 178

Query: 574 DLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIP 633
               N++S + P  L  L  L  ++L NNQ S    +       L  + L++ ++     
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQTITNQPV 234

Query: 634 SEICNLESLEYMNLLQNKLSGPI 656
               NL     +         P 
Sbjct: 235 FYNNNLVVPNVVKGPSGAPIAPA 257

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 22/257 (8%)

Query: 302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
            L +   +   K+ ++  +     +L  I  L      +  +I E +  L +L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTI-EGVQYLNNLIGLELKD 72

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
           N++   +   L NL+ +    L  N L       I  ++ +    L   Q T      + 
Sbjct: 73  NQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDV--TPLA 126

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
              +L    +  N      P  L   T+L  L +   Q++ +++ +  +   L  L   +
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTPLANL-SKLTTLKADD 182

Query: 482 NNFFGEIS--SNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ 539
           N     IS  S     P L  +++  N+IS    S + N + L  +  ++  +  Q    
Sbjct: 183 NK----ISDISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFY 236

Query: 540 LGKLTSLTSLTLNGNQL 556
              L     +       
Sbjct: 237 NNNLVVPNVVKGPSGAP 253

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  116 bits (293), Expect = 9e-29
 Identities = 69/296 (23%), Positives = 123/296 (41%), Gaps = 42/296 (14%)

Query: 757  TDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGE 815
            T+  + ++D+   +       +  ++  G G  G VY   +L++    A+K        E
Sbjct: 5    TEEGDCESDLLEYDYEYDENGDRVVL--GKGTYGIVYAGRDLSNQVRIAIK--------E 54

Query: 816  IGINQKGFVSEI-TEI------RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEA 868
            I      +   +  EI      +H+NIV++ G  S    + +  E +  GSL+ +L ++ 
Sbjct: 55   IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114

Query: 869  TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTA 926
               + +        K +   L Y+H +    I+HRDI    VL++  Y   +  SDFGT+
Sbjct: 115  GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTS 170

Query: 927  KFLKPDSSNWSELAGTCGYIAPE--LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSL 984
            K L   +       GT  Y+APE          +  D+++ G  ++E+  GK P + L  
Sbjct: 171  KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG- 229

Query: 985  LLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPT 1038
                   AA   + +       + P +    E + S  A AF+  C + +PD R  
Sbjct: 230  ----EPQAAMFKVGMFK-----VHPEI---PESM-SAEAKAFILKCFEPDPDKRAC 272

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  116 bits (293), Expect = 1e-28
 Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 26/269 (9%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G    VY+A  L  G   A+KK  +  L   +    +   + EI    ++ H N++K+
Sbjct: 41   GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK---ARADCIKEIDLLKQLNHPNVIKY 97

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALSYMHHDCF 897
            Y        L +V E  + G L+ ++ +       +           + +AL +MH    
Sbjct: 98   YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR- 156

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
              ++HRDI    V +       + D G  +F    ++    L GT  Y++PE  +    N
Sbjct: 157  --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP-PLGEVEE 1016
             K D+++ G L+ E+   + P +             N+  +   +     PP P     E
Sbjct: 215  FKSDIWSLGCLLYEMAALQSPFY---------GDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045
            +L+ ++    +C++ +P+ RP +  V ++
Sbjct: 266  ELRQLVN---MCINPDPEKRPDVTYVYDV 291

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  117 bits (294), Expect = 2e-28
 Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 28/266 (10%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  G     +    G    +K+  +  + + E    ++    E+     ++H NIV++
Sbjct: 33   GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQY 88

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                     L++V +Y E G L   + N          + ++    +  AL ++H     
Sbjct: 89   RESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHD---R 144

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
             ILHRDI S+ + L  +    + DFG A+ L           GT  Y++PE+      N 
Sbjct: 145  KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204

Query: 959  KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018
            K D++  G ++ E+   KH   F          A +M  +V  +I    PP        L
Sbjct: 205  KSDIWALGCVLYELCTLKHA--FE---------AGSMKNLVLKIISGSFPPVSLHYSYDL 253

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044
            +S+++        NP  RP++  +  
Sbjct: 254  RSLVS---QLFKRNPRDRPSVNSILE 276

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  114 bits (288), Expect = 3e-28
 Identities = 51/234 (21%), Positives = 98/234 (41%), Gaps = 29/234 (12%)

Query: 111 SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
           ++P  +   +   ++ L  N +S  +P                      +   + LH+N 
Sbjct: 25  AVPVGI--PAASQRIFLHGNRIS-HVPAA--------------SFRACRNLTILWLHSNV 67

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-G 228
            + +   +  GL  L  + L++N  + S+       L  L  L L++  L   + P    
Sbjct: 68  LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126

Query: 229 NLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPSSFGNLSSLKHLH 285
            L+ L++LYL DN L   +P    +F+   +L +L+L  N+++     +F  L SL  L 
Sbjct: 127 GLAALQYLYLQDNALQ-ALPD--DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 286 VHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           +H  N+++  +      +L  L  L+L    LS     +L  L  ++ L + +N
Sbjct: 184 LHQ-NRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  113 bits (284), Expect = 1e-27
 Identities = 62/231 (26%), Positives = 90/231 (38%), Gaps = 22/231 (9%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           LQ  P  +      + L  N++             L  L   +N  + I       L  L
Sbjct: 23  LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 75  VVLRLSVN-QLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNNSL 132
             L LS N QL  + P     L  L+ L L    L   +       L+ L  L L +N+L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 133 SGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNN 192
              +P +             +DLGNL     + LH N  S V  R+  GL +L  + L+ 
Sbjct: 142 Q-ALPDDT-----------FRDLGNLT---HLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 193 NRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
           NR+   +      +L  L  L L  N LS ++P  A   L  L++L L+DN
Sbjct: 187 NRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  112 bits (282), Expect = 2e-27
 Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 24/234 (10%)

Query: 39  TIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL 98
            +P  I   +  + +    N+ S +         NL +L L  N L  +       L  L
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 99  NELALSYNRLNGSIPAS-LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGN 157
            +L LS N    S+  +    L  L  L L    L  ++ P              + L  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL-----------FRGLAA 130

Query: 158 LESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNK 216
           L+    + L  N    +   +   L NLT ++L+ NRI  S+P      L SL  L L++
Sbjct: 131 LQ---YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186

Query: 217 NQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLN 268
           N+++  + P A  +L  L  LYL  N LS  +P + L   ++L YL L+ N   
Sbjct: 187 NRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  103 bits (259), Expect = 2e-24
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 21/272 (7%)

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
           +P  +    +     +  N        S + C +L  L L  N L    +  F     LE
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 476 LLDLSNNNFFGEISSN-WIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLV 533
            LDLS+N     +    +    +L TL++    +   +   +   +  L  L    N L 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142

Query: 534 GQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
             +P      L +LT L L+GN++S         L  L  L L  NR++ + P    +L 
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 593 KLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQ 649
           +L  L L  N  S   ++       L  L  L L+ N    +     C    L +  L +
Sbjct: 202 RLMTLYLFANNLS---ALPTEALAPLRALQYLRLNDNPWVCD-----CRARPL-WAWLQK 252

Query: 650 NKLSGPIPSCF--RRMHGLSSIDVSYNELQGS 679
            + S     C   +R+ G     ++ N+LQG 
Sbjct: 253 FRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (250), Expect = 3e-23
 Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 28/238 (11%)

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           C    L             +P  +    +   + L  N+++   +  F    +L +L L 
Sbjct: 18  CPQQGLQA-----------VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLH 64

Query: 481 NNNFFGEISSNWIKC-PQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPK 538
           +N     I +        L  L++  N    ++       + +LH L      L  ++  
Sbjct: 65  SNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122

Query: 539 Q-LGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGELRKLHH 596
                L +L  L L  N L   +P +    L  L +L L  NR+S +  +    L  L  
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181

Query: 597 LNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQN 650
           L L  N+ +    +       L +L  L L  N+L   +P+E    L +L+Y+ L  N
Sbjct: 182 LLLHQNRVA---HVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 47/199 (23%), Positives = 73/199 (36%), Gaps = 13/199 (6%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGN 554
                + + GN IS    +       L  L   SN L  +I       L  L  L L+ N
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDN 90

Query: 555 QLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG 613
                +       L  L  L L    L +L P     L  L +L L +N      ++   
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ---ALPDD 147

Query: 614 ---KLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSI 669
               L  L+ L L  N +  ++P      L SL+ + L QN+++   P  FR +  L ++
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 670 DVSYNELQGSIPHSKAFQN 688
            +  N L  ++P   A   
Sbjct: 207 YLFANNLS-ALPTE-ALAP 223

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 44/181 (24%), Positives = 70/181 (38%), Gaps = 16/181 (8%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGILT 72
            +    F     L  LDLS N    ++       L +L  L         + P     L 
Sbjct: 70  RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129

Query: 73  NLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
            L  L L  N L  L  +   +L +L  L L  NR++     +   L +L +L L  N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 133 SGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNN 192
           +  + P+             +DLG L    ++ L  NN S +   +L  L+ L ++ LN+
Sbjct: 190 A-HVHPH-----------AFRDLGRLM---TLYLFANNLSALPTEALAPLRALQYLRLND 234

Query: 193 N 193
           N
Sbjct: 235 N 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 13/183 (7%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAEL 570
            +P  I       ++    NR+            +LT L L+ N L+         LA L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 571 GYLDLSAN-RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHN 626
             LDLS N +L  + P     L +LH L+L          +  G    L  L  L L  N
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQDN 139

Query: 627 SLGGNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKA 685
           +L   +P +   +L +L ++ L  N++S      FR +H L  + +  N +   +    A
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH-PHA 196

Query: 686 FQN 688
           F++
Sbjct: 197 FRD 199

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 52/286 (18%), Positives = 89/286 (31%), Gaps = 75/286 (26%)

Query: 320 IPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLK 379
           +P  +   +  + +++  N +           ++L+ L L  N L          L+ L+
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 380 FFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGP 439
              L +N    S+                                               
Sbjct: 84  QLDLSDNAQLRSVD---------------------------------------------- 97

Query: 440 IPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLA 499
            P +      L++L L+R  L                 +L    F G           L 
Sbjct: 98  -PATFHGLGRLHTLHLDRCGLQ----------------ELGPGLFRG--------LAALQ 132

Query: 500 TLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG 558
            L +  N +   +P +   ++  L  L    NR+     +    L SL  L L+ N+++ 
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 559 DIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
             P     L  L  L L AN LS L  + L  LR L +L L++N +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 34/149 (22%), Positives = 60/149 (40%), Gaps = 5/149 (3%)

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
            +   + L+GN++S            L  L L +N L+++       L  L  L+LS+N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 604 FSQEISIQI-GKLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFR 661
             + +       L +L  L L    L   +   +   L +L+Y+ L  N L       FR
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 662 RMHGLSSIDVSYNELQGSIPHSKAFQNAT 690
            +  L+ + +  N +  S+P   AF+   
Sbjct: 151 DLGNLTHLFLHGNRIS-SVPER-AFRGLH 177

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  114 bits (288), Expect = 3e-28
 Identities = 56/283 (19%), Positives = 110/283 (38%), Gaps = 58/283 (20%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+GG G V+KA+    G T  +K         +  N +    E+    ++ H NIV + G
Sbjct: 20   GSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALAKLDHVNIVHYNG 71

Query: 841  F----------------CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG 884
                              S T+ LF+  E+ ++G+L   +  +    +LD    + + + 
Sbjct: 72   CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQ 130

Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
            +   + Y+H      +++RD+    + L    +  + DFG    LK D     +   + G
Sbjct: 131  ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKG 183

Query: 945  ---YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVND 1001
               Y++PE   +    ++ D++  G+++ E             LL +   A   +    D
Sbjct: 184  TLRYMSPEQISSQDYGKEVDLYALGLILAE-------------LLHVCDTAFETSKFFTD 230

Query: 1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            L D  +        +K K+++      L   P+ RP   ++  
Sbjct: 231  LRDGIISDIFD---KKEKTLLQ---KLLSKKPEDRPNTSEILR 267

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (285), Expect = 1e-27
 Identities = 52/286 (18%), Positives = 110/286 (38%), Gaps = 50/286 (17%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G GG G V++A+        A+K++  LP  E+   +   + E+    ++ H  IV+++ 
Sbjct: 14   GRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREK--VMREVKALAKLEHPGIVRYFN 70

Query: 841  FC------------SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
                          S   +L++  +   + +L   ++   T  E + S  +++   +A A
Sbjct: 71   AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK------------PDSSNW 936
            + ++H      ++HRD+    +   ++    V DFG    +             P  +  
Sbjct: 131  VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 937  SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN 996
            +   GT  Y++PE  +    + K D+F+ G+++ E             LL   +      
Sbjct: 188  TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-------------LLYPFSTQMERV 234

Query: 997  IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
              + D+ + + PP   +       M+      L  +P  RP    +
Sbjct: 235  RTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINI 277

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  114 bits (288), Expect = 2e-27
 Identities = 63/274 (22%), Positives = 107/274 (39%), Gaps = 39/274 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G V+   L + +T  AVK        +    +  F+ E     +  H NIV+  G
Sbjct: 123  GRGNFGEVFSGRLRADNTLVAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIG 179

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+  Q +++V E ++ G   T L  E   A L     + ++   A  + Y+   C    
Sbjct: 180  VCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKCC--- 234

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYTMR 955
            +HRD++++  L+  +    +SDFG ++            +G    +     APE     R
Sbjct: 235  IHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGR 291

Query: 956  ANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLG 1012
             + + DV++FG+L+ E    G  P   LS            N    + ++   RLP P  
Sbjct: 292  YSSESDVWSFGILLWETFSLGASPYPNLS------------NQQTREFVEKGGRLPCPEL 339

Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              +   + M      C    P  RP+   +   L
Sbjct: 340  CPDAVFRLMEQ----CWAYEPGQRPSFSTIYQEL 369

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  113 bits (284), Expect = 1e-26
 Identities = 62/319 (19%), Positives = 118/319 (36%), Gaps = 65/319 (20%)

Query: 764  NDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGF 823
             ++ N E    +    + +L G G  GTV       G   AVK++              F
Sbjct: 4    ANIPNFEQSLKNLVVSEKIL-GYGSSGTVVFQGSFQGRPVAVKRM-----------LIDF 51

Query: 824  VSEIT-EI-------RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAA 871
                  EI        H N++++Y   +  + L++  E     +L  ++     ++    
Sbjct: 52   CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLK 110

Query: 872  ELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI-------SSKKVLLDLEYKAH----- 919
                   +++++ +A+ ++++H      I+HRD+       S+       +         
Sbjct: 111  LQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167

Query: 920  -VSDFGTAKFLKPDSSNW----SELAGTCGYIAPEL-------AYTMRANEKCDVFNFGV 967
             +SDFG  K L    S++    +  +GT G+ APEL           R     D+F+ G 
Sbjct: 168  LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

Query: 968  LVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDL-IDSRLPPPLGEVEEKLKSMIAVA 1025
            +   ++ +GKHP  F          +   NI+     +D         +  +   +I+  
Sbjct: 228  VFYYILSKGKHP--FGDKY------SRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS-- 277

Query: 1026 FLCLDANPDCRPTMQKVCN 1044
               +D +P  RPT  KV  
Sbjct: 278  -QMIDHDPLKRPTAMKVLR 295

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  108 bits (273), Expect = 3e-26
 Identities = 56/230 (24%), Positives = 88/230 (38%), Gaps = 31/230 (13%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSL 127
            +  +   L LS N L  L          L  L LS   +  +I      +LS+L  L L
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF 187
           + N +   +                  L +L+    +     N + +    +G LK L  
Sbjct: 84  TGNPIQ-SLALG-----------AFSGLSSLQK---LVAVETNLASLENFPIGHLKTLKE 128

Query: 188 VYLNNNRIVGSIPSE--IGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKF----LYLHD 240
           + + +N I  S        NL +L +L L+ N++  SI  T    L  +      L L  
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 241 NRLSGYIPPKLGSFK--SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
           N ++ +I P  G+FK   L  L L  NQL       F  L+SL+ + +H 
Sbjct: 187 NPMN-FIQP--GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 233

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  101 bits (253), Expect = 9e-24
 Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 25/234 (10%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI-GILTN 73
             + P  L      LDLS N L            +L+ LD S  +    I       L++
Sbjct: 19  FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 74  LVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSL 132
           L  L L+ N +  L       L+SL +L      L  S+     G+L  L +L++++N +
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136

Query: 133 SGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFV---- 188
                        P Y S   +L NLE    + L +N    +    L  L  +  +    
Sbjct: 137 Q--------SFKLPEYFS---NLTNLE---HLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 189 YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
            L+ N +   I         L  L L+ NQL  S+P      L++L+ ++LH N
Sbjct: 183 DLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 61/243 (25%), Positives = 98/243 (40%), Gaps = 35/243 (14%)

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           C   +     + +N     +P S +N      L L  N L    S  F  +P+L++LDLS
Sbjct: 14  CMELNFY--KIPDN-----LPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 481 NNNFFGEISS----NWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQ 535
                  I +     +     L+TL + GN I  ++       ++ L KL      L   
Sbjct: 61  RCE----IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL 115

Query: 536 IPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSKLIPKNLGELR 592
               +G L +L  L +  N +     L       L  L +LDLS+N++  +   +L  L 
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173

Query: 593 KL----HHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNL 647
           ++      L+LS N     I     K ++L +L L  N L  ++P  I   L SL+ + L
Sbjct: 174 QMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWL 231

Query: 648 LQN 650
             N
Sbjct: 232 HTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 52/224 (23%), Positives = 83/224 (37%), Gaps = 21/224 (9%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPSS-FGNLS 279
            IP       + K L L  N L  ++      SF  L  L LS  ++  ++    + +LS
Sbjct: 21  KIP--DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76

Query: 280 SLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
            L  L +   N +  S+       L SL  L   +T L+      +G+L  ++ L +  N
Sbjct: 77  HLSTLILTG-NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134

Query: 339 MLYGSIPEE--LGRLKSLSQLSLSVNKLNGSIPH-CLGNLSNLKFFALR----ENELSGS 391
           ++  S         L +L  L LS NK+  SI    L  L  +    L      N ++  
Sbjct: 135 LI-QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191

Query: 392 IPQEIENMKKLNKYLLFENQFTGYLPQNVCQS-GSLTHFSVRNN 434
           I        +L +  L  NQ    +P  +     SL    +  N
Sbjct: 192 IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 43/182 (23%), Positives = 69/182 (37%), Gaps = 15/182 (8%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGILT 72
           T+++  +     L+ L L+ N +  ++     S LS L+ L       + +    IG L 
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124

Query: 73  NLVVLRLSVNQLNGLIPEEL-GELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNS 131
            L  L ++ N +      E    LT+L  L LS N++  SI     +L  L Q+ L N S
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLS 181

Query: 132 LSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLN 191
           L          L       I            ++L TN    V       L +L  ++L+
Sbjct: 182 L---------DLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232

Query: 192 NN 193
            N
Sbjct: 233 TN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 45/186 (24%), Positives = 74/186 (39%), Gaps = 17/186 (9%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           IP  +   T+   LD S N L             L  L L+  ++     +E G    L+
Sbjct: 22  IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT---IEDGAYQSLS 76

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
            L  L L+ N +  L       L  L  L       +   +  IG L  L +L+++HN +
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 629 GGNIPSE--ICNLESLEYMNLLQNKLSGPIPSCFRRMHGL----SSIDVSYNELQGSIPH 682
             +        NL +LE+++L  NK+     +  R +H +     S+D+S N +   I  
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194

Query: 683 SKAFQN 688
             AF+ 
Sbjct: 195 G-AFKE 199

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  109 bits (273), Expect = 3e-26
 Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 33/223 (14%)

Query: 95  LTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQD 154
           + S  E+      L  ++P  L    +   L LS N L                      
Sbjct: 9   VASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLY-TFSLA--------------T 50

Query: 155 LGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGL 214
           L        ++L     + +  +  G L  L  + L++N++  S+P     L +L+ L +
Sbjct: 51  LMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107

Query: 215 NKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKS---LLYLYLSHNQLNGS 270
           + N+L+ S+P  A   L  L+ LYL  N L   +PP  G       L  L L++N L   
Sbjct: 108 SFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPP--GLLTPTPKLEKLSLANNNLT-E 162

Query: 271 LPSS-FGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLS 312
           LP+     L +L  L +   N L  +IPK       L   +L 
Sbjct: 163 LPAGLLNGLENLDTLLLQE-NSLY-TIPKGFFGSHLLPFAFLH 203

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 98.6 bits (246), Expect = 9e-23
 Identities = 51/204 (25%), Positives = 75/204 (36%), Gaps = 25/204 (12%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLV 123
           +PP   +  +  +L LS N L       L   T L +L L    L   +    G L  L 
Sbjct: 25  LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLG 80

Query: 124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK 183
            L LS+N L                 S+P     L +   + +  N  + +   +L GL 
Sbjct: 81  TLDLSHNQLQ----------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 184 NLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
            L  +YL  N +  ++P  +      L  L L  N L+  +P      L NL  L L +N
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182

Query: 242 RLSGYIPPKLGSFKSLLYLYLSHN 265
            L   IP        L + +L  N
Sbjct: 183 SLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 57/229 (24%), Positives = 81/229 (35%), Gaps = 47/229 (20%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L   P  L      L LS N L+      +   ++L  L+    + + +     G L  L
Sbjct: 22  LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVL 79

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLS 133
             L LS NQL  L P     L +L  L +S+NRL  S+P      L  L +L L  N L 
Sbjct: 80  GTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137

Query: 134 GQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
                           ++P                       P  L     L  + L NN
Sbjct: 138 ----------------TLP-----------------------PGLLTPTPKLEKLSLANN 158

Query: 194 RIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
            +   +P+ +   L +L  L L +N L  +IP        L F +LH N
Sbjct: 159 NLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 19/214 (8%)

Query: 443 SLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLN 502
            +    S   +  ++  LT  +     +  D  +L LS N  +    +  +   +L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 503 MGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPL 562
           +   E++  +  + G +  L  LD S N+L   +P     L +LT L ++ N+L+    L
Sbjct: 62  LDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS---L 115

Query: 563 ELGL---LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLV 616
            LG    L EL  L L  N L  L P  L    KL  L+L+NN  +    +  G    L 
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT---ELPAGLLNGLE 172

Query: 617 QLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN 650
            L  L L  NSL   IP        L +  L  N
Sbjct: 173 NLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 14/209 (6%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
            + S   +  +K  L+ ++PP      +   L+L +N L  +    L  +  L  L L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL 324
            +L   L    G L  L  L + + N+L  S+P     L +L+ L +S  +L+  +P   
Sbjct: 65  AELT-KLQV-DGTLPVLGTLDLSH-NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119

Query: 325 -GNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPH-CLGNLSNLKFF 381
              L  ++ LY++ N L  ++P  L      L +LSL+ N L   +P   L  L NL   
Sbjct: 120 LRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 382 ALRENELSGSIPQEIENMKKLNKYLLFEN 410
            L+EN L  +IP+       L    L  N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 21/186 (11%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI 68
            NL  T      + + +L  L+L   +L   +      L  L  LD S NQ   + P   
Sbjct: 40  ENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQV-DGTLPVLGTLDLSHNQLQSL-PLLG 96

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSL 127
             L  L VL +S N+L  L    L  L  L EL L  N L  ++P  L      L +LSL
Sbjct: 97  QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF 187
           +NN+L+ ++P             +   L NL+   ++ L  N+    IP+   G   L F
Sbjct: 156 ANNNLT-ELPAG-----------LLNGLENLD---TLLLQENSLYT-IPKGFFGSHLLPF 199

Query: 188 VYLNNN 193
            +L+ N
Sbjct: 200 AFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 50/197 (25%), Positives = 82/197 (41%), Gaps = 16/197 (8%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
                +N     ++  +P ++   T    L  S N L       L   T LT L L+  +
Sbjct: 10  ASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG-- 613
           L+  + ++  L   LG LDLS N+L  L P     L  L  L++S N+ +   S+ +G  
Sbjct: 67  LT-KLQVDGTL-PVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT---SLPLGAL 120

Query: 614 -KLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDV 671
             L +L +L L  N L   +P  +      LE ++L  N L+         +  L ++ +
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 672 SYNELQGSIPHSKAFQN 688
             N L  +IP    F +
Sbjct: 180 QENSLY-TIPKG-FFGS 194

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 41/172 (23%), Positives = 64/172 (37%), Gaps = 10/172 (5%)

Query: 518 NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA 577
            +    +++     L   +P         T L L+ N L       L     L  L+L  
Sbjct: 8   KVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEI- 636
             L+KL     G L  L  L+LS+NQ  Q + +    L  L+ LD+S N L  ++P    
Sbjct: 65  AELTKLQV--DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120

Query: 637 CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
             L  L+ + L  N+L    P        L  + ++ N L   +P       
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAG-LLNG 170

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 45/222 (20%), Positives = 70/222 (31%), Gaps = 50/222 (22%)

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKL 402
           ++P +L   K  + L LS N L       L   + L    L   EL+  +      +  L
Sbjct: 24  ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79

Query: 403 NKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG 462
               L  NQ                            +P   Q   +L  L +  N+LT 
Sbjct: 80  GTLDLSHNQLQS-------------------------LPLLGQTLPALTVLDVSFNRLTS 114

Query: 463 NISEVFGIYPDLELLDLSNNNFFGEISSNWIKC---------PQLATLNMGGNEISGTIP 513
                     +L+ L L  N          +K          P+L  L++  N ++  +P
Sbjct: 115 LPLGALRGLGELQELYLKGNE---------LKTLPPGLLTPTPKLEKLSLANNNLT-ELP 164

Query: 514 SEI-GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGN 554
           + +   +  L  L    N L   IPK       L    L+GN
Sbjct: 165 AGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  107 bits (269), Expect = 1e-25
 Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 61/295 (20%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V KA         A+KK+      ++       +SE+     + H+ +V++Y 
Sbjct: 15   GQGAFGQVVKARNALDSRYYAIKKI-RHTEEKL----STILSEVMLLASLNHQYVVRYYA 69

Query: 841  F-------------CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
                                LF+  EY E G+L  ++ +E    + D   R  + + +  
Sbjct: 70   AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--LFRQILE 127

Query: 888  ALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA------- 940
            ALSY+H      I+HRD+    + +D      + DFG AK +          +       
Sbjct: 128  ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 941  -------GTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA 992
                   GT  Y+A E L  T   NEK D+++ G++  E             ++   +  
Sbjct: 185  DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-------------MIYPFSTG 231

Query: 993  ANMNIVVNDL--IDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                 ++  L  +    PP       +  K +I    L +D +P+ RP  + + N
Sbjct: 232  MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  111 bits (278), Expect = 3e-25
 Identities = 58/331 (17%), Positives = 126/331 (38%), Gaps = 37/331 (11%)

Query: 98  LNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGN 157
           + E       +    P      +  ++ +L   S++  +                     
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT-----------------QNE 41

Query: 158 LESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKN 217
           L S   +  + ++   V  + +  L N+T ++LN N++   I   + NL++L +L L++N
Sbjct: 42  LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN 97

Query: 218 QLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGN 277
           ++   +     +L  LK L L  N +S  I   L     L  LYL +N++  +  +    
Sbjct: 98  KIK-DLSSLK-DLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKI--TDITVLSR 151

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRE 337
           L+ L  L + + N++S  I   +  L  L +L+LSK  +S      L  L N+  L +  
Sbjct: 152 LTKLDTLSLED-NQIS-DIV-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFS 206

Query: 338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE 397
                        L   + +  +   L    P  + +  + +   ++ + L     +   
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH-LPEFTNEVSF 263

Query: 398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTH 428
              +       + +F G + Q + +  ++++
Sbjct: 264 IFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  110 bits (275), Expect = 6e-25
 Identities = 63/293 (21%), Positives = 107/293 (36%), Gaps = 55/293 (18%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           FP   F +    +L    +   +    + L+ +  +  + +    +    I  L N+  L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 70

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
            L+ N+L  +  + L  L +L  L L  N++   +  SL +L  L  LSL +N +S  I 
Sbjct: 71  FLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DIN 125

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
                                                    L  L  L  +YL NN+I  
Sbjct: 126 G----------------------------------------LVHLPQLESLYLGNNKI-- 143

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           +  + +  L  L  L L  NQ+S  I P A  L+ L+ LYL  N +S      L   K+L
Sbjct: 144 TDITVLSRLTKLDTLSLEDNQIS-DIVPLA-GLTKLQNLYLSKNHISDLRA--LAGLKNL 199

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLW 310
             L L   +      +   NL     +   + + ++  I  + G+ +  +  W
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW 252

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 98.6 bits (245), Expect = 3e-21
 Identities = 65/276 (23%), Positives = 109/276 (39%), Gaps = 26/276 (9%)

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPR--SLQNCTSLYSL 453
            +   +  K  L +   T  + QN   S  +      N++    I     +Q   ++  L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSD----IKSVQGIQYLPNVTKL 70

Query: 454 RLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS--SNWIKCPQLATLNMGGNEISGT 511
            L  N+LT +I  +     +L  L L  N     I   S+     +L +L++  N IS  
Sbjct: 71  FLNGNKLT-DIKPLTN-LKNLGWLFLDENK----IKDLSSLKDLKKLKSLSLEHNGIS-D 123

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELG 571
           I   + ++ QL  L   +N++       L +LT L +L+L  NQ+S DI   L  L +L 
Sbjct: 124 ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 178

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN 631
            L LS N +S L  + L  L+ L  L L + +   +       LV  + +  +  SL   
Sbjct: 179 NLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 234

Query: 632 IPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLS 667
            P  I +    E  N+  +         F     ++
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVT 270

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 88.2 bits (218), Expect = 5e-18
 Identities = 52/290 (17%), Positives = 90/290 (31%), Gaps = 31/290 (10%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN 82
            P +  L L+ N+L  T    +++L  L  L    N+   +    +  L  L  L L  N
Sbjct: 64  LPNVTKLFLNGNKL--TDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHN 119

Query: 83  QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGY 142
            ++ +    L  L  L  L L  N++  +    L  L+ L  LSL +N +S         
Sbjct: 120 GISDI--NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD-------- 167

Query: 143 LISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSE 202
            I P        L  L    ++ L  N+ S +    L GLKNL  + L +   +    + 
Sbjct: 168 -IVP--------LAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINH 216

Query: 203 IGNLRSLSYLGLNKNQLSG----SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL 258
             NL   + +      L      S        +    L    N +S      +   K+  
Sbjct: 217 QSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSH 308
             +    Q    + +   ++                +             
Sbjct: 277 RFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKG 326

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.3 bits (213), Expect = 2e-17
 Identities = 52/280 (18%), Positives = 99/280 (35%), Gaps = 51/280 (18%)

Query: 281 LKHLHVHN--INKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           +      +  I ++                  L K  ++  +      L++I  +    +
Sbjct: 1   MGETITVSTPIKQIFP-----DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS 53

Query: 339 MLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIEN 398
            +  S+ + +  L ++++L L+ NKL   I   L NL NL +  L EN++      ++ +
Sbjct: 54  DI-KSV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-----DLSS 104

Query: 399 MKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERN 458
           +K L K                     L   S+ +N  +  I   L +   L SL L  N
Sbjct: 105 LKDLKK---------------------LKSLSLEHNG-ISDIN-GLVHLPQLESLYLGNN 141

Query: 459 QLTGNISEVFGIYPDLELLDLSNNNFFGEIS--SNWIKCPQLATLNMGGNEISGTIPSEI 516
           ++T +I+ V      L+ L L +N     IS         +L  L +  N I  +    +
Sbjct: 142 KIT-DIT-VLSRLTKLDTLSLEDNQ----ISDIVPLAGLTKLQNLYLSKNHI--SDLRAL 193

Query: 517 GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQL 556
             +  L  L+  S   + +       L    ++      L
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 14/107 (13%), Positives = 42/107 (39%), Gaps = 8/107 (7%)

Query: 570 LGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG 629
           +G     +  + ++ P       +    NL     +  ++    +L  + ++  +++ + 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI- 55

Query: 630 GNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL 676
            ++   I  L ++  + L  NKL+   P     +  L  + +  N++
Sbjct: 56  KSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 3e-25
 Identities = 63/312 (20%), Positives = 102/312 (32%), Gaps = 58/312 (18%)

Query: 751  FRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLH 809
            FR       Q    D +  E     +F+    L G G  G V+K      G   AVK+  
Sbjct: 33   FRGEASETLQSPGYDPSRPESFFQQSFQRLSRL-GHGSYGEVFKVRSKEDGRLYAVKRSM 91

Query: 810  SLPTGEIGINQKGFVSEITEI-------RHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT 862
            S          K    ++ E+       +H   V+          L+L  E     SL  
Sbjct: 92   SP-----FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQ 145

Query: 863  ILSN------EATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY 916
                      EA             ++    AL+++H      ++H D+    + L    
Sbjct: 146  HCEAWGASLPEAQVW--------GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRG 194

Query: 917  KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL---AYTMRANEKCDVFNFGVLVLEVI 973
            +  + DFG    L    +   +  G   Y+APEL   +Y        DVF+ G+ +LEV 
Sbjct: 195  RCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSY----GTAADVFSLGLTILEVA 249

Query: 974  EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL-GEVEEKLKSMIAVAFLCLDAN 1032
                           P            L    LPP     +  +L+S++    + L+ +
Sbjct: 250  CNMEL----------PHGGEGW----QQLRQGYLPPEFTAGLSSELRSVLV---MMLEPD 292

Query: 1033 PDCRPTMQKVCN 1044
            P  R T + +  
Sbjct: 293  PKLRATAEALLA 304

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (267), Expect = 3e-25
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 30/259 (11%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V+K  +  +    A+K +  L   E  I       EIT   +     + K+YG
Sbjct: 31   GKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIED--IQQEITVLSQCDSPYVTKYYG 87

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L+++ EYL  GS   +L        LD ++   +++ +   L Y+H +     
Sbjct: 88   SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KK 140

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRDI +  VLL    +  ++DFG A  L       +   GT  ++APE+      + K 
Sbjct: 141  IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 200

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL-GEVEEKLK 1019
            D+++ G+  +E+  G+ P         L        I  N+      PP L G   + LK
Sbjct: 201  DIWSLGITAIELARGEPP------HSELHPMKVLFLIPKNN------PPTLEGNYSKPLK 248

Query: 1020 SMIAVAFLCLDANPDCRPT 1038
              +     CL+  P  RPT
Sbjct: 249  EFVE---ACLNKEPSFRPT 264

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 4e-25
 Identities = 70/264 (26%), Positives = 120/264 (45%), Gaps = 39/264 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  GTVY A ++ +G   A+++  L   P  E+ IN      EI    E ++ NIV +
Sbjct: 29   GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN------EILVMRENKNPNIVNY 82

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                     L++V EYL  GSL  +++       +D  +   V +    AL ++H +   
Sbjct: 83   LDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN--- 135

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
             ++HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        
Sbjct: 136  QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 959  KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN-IVVNDLIDSRLPPPLGEVE-- 1015
            K D+++ G++ +E+IEG+ P            P  N N +    LI +   P L   E  
Sbjct: 196  KVDIWSLGIMAIEMIEGE-P------------PYLNENPLRALYLIATNGTPELQNPEKL 242

Query: 1016 -EKLKSMIAVAFLCLDANPDCRPT 1038
                +  +     CL+ + + R +
Sbjct: 243  SAIFRDFLN---RCLEMDVEKRGS 263

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (266), Expect = 5e-25
 Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 39/264 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  G V  A E  SG   AVK   L      E+  N      E+    + +H N+V+ 
Sbjct: 54   GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN------EVVIMRDYQHFNVVEM 107

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
            Y      + L+++ E+L+ G+L  I+    +   L+  +   V + V  AL+Y+H     
Sbjct: 108  YKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ--- 160

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
             ++HRDI S  +LL L+ +  +SDFG    +  D      L GT  ++APE+        
Sbjct: 161  GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220

Query: 959  KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV-VNDLIDSRLPPPLGEVE-- 1015
            + D+++ G++V+E+++G+ P            P  + + V     +    PP L      
Sbjct: 221  EVDIWSLGIMVIEMVDGE-P------------PYFSDSPVQAMKRLRDSPPPKLKNSHKV 267

Query: 1016 -EKLKSMIAVAFLCLDANPDCRPT 1038
               L+  +      L  +P  R T
Sbjct: 268  SPVLRDFLE---RMLVRDPQERAT 288

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  103 bits (259), Expect = 4e-24
 Identities = 49/286 (17%), Positives = 100/286 (34%), Gaps = 42/286 (14%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G GG   V   E L  G   A+K++      +   +++    E        H NI++   
Sbjct: 38   GEGGFSYVDLVEGLHDGHFYALKRIL-CHEQQ---DREEAQREADMHRLFNHPNILRLVA 93

Query: 841  FC----SHTQHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALSYMHHD 895
            +C          +L+  + +RG+L   +         L   + + ++ G+   L  +H  
Sbjct: 94   YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---------GTCGYI 946
                  HRD+    +LL  E +  + D G+            +            T  Y 
Sbjct: 153  --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 947  APEL----AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL 1002
            APEL    ++ +  +E+ DV++ G ++  ++ G+ P  +              + V   +
Sbjct: 211  APELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--Y-------DMVFQKGDSVALAV 260

Query: 1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
             +    P        L  ++      +  +P  RP +  + + L  
Sbjct: 261  QNQLSIPQSPRHSSALWQLLNS---MMTVDPHQRPHIPLLLSQLEA 303

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (255), Expect = 6e-24
 Identities = 46/286 (16%), Positives = 99/286 (34%), Gaps = 52/286 (18%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVKFY 839
            G+G  G+V+K  +   G   A+K+      G +       + E+       +H ++V+++
Sbjct: 20   GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA--LREVYAHAVLGQHSHVVRYF 77

Query: 840  GFCSHTQHLFLVYEYLERGSLATILS-NEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
               +   H+ +  EY   GSLA  +S N    +    ++  +++  V   L Y+H     
Sbjct: 78   SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--- 134

Query: 899  PILHRDISSKKVLLDLEYKAHVS-------------------DFGTAKFLKPDSSNWSEL 939
             ++H DI    + +      + +                   D G    +    S+    
Sbjct: 135  SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SSPQVE 190

Query: 940  AGTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV 998
             G   ++A E L        K D+F   + V+     +            P      + +
Sbjct: 191  EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----------PRNGDQWHEI 240

Query: 999  VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                   RLP     + ++   ++    + +  +P+ RP+   +  
Sbjct: 241  RQ----GRLPRIPQVLSQEFTELLK---VMIHPDPERRPSAMALVK 279

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (257), Expect = 1e-23
 Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 37/264 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VY A ++ + +  A+KK+ S    +     +  + E+    ++RH N +++ G
Sbjct: 63   GHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                    +LV EY   GS + +L  E     L   +   V  G    L+Y+H      +
Sbjct: 122  CYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 175

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA---N 957
            +HRD+ +  +LL       + DFG+A  + P +S      GT  ++APE+   M     +
Sbjct: 176  IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYD 231

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV-VNDLIDSRLPPPL--GEV 1014
             K DV++ G+  +E+ E K P            P  NMN +     I     P L  G  
Sbjct: 232  GKVDVWSLGITCIELAERK-P------------PLFNMNAMSALYHIAQNESPALQSGHW 278

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPT 1038
             E  ++ +     CL   P  RPT
Sbjct: 279  SEYFRNFVD---SCLQKIPQDRPT 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (255), Expect = 1e-23
 Identities = 64/262 (24%), Positives = 118/262 (45%), Gaps = 35/262 (13%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G+VYKA    +G   A+K++       +  + +  + EI+   +    ++VK+YG
Sbjct: 38   GEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEIIKEISIMQQCDSPHVVKYYG 91

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L++V EY   GS++ I+        L   +   +++     L Y+H       
Sbjct: 92   SYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHFM---RK 146

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRDI +  +LL+ E  A ++DFG A  L    +  + + GT  ++APE+   +  N   
Sbjct: 147  IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVA 206

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV-VNDLIDSRLPPPLGEVE---E 1016
            D+++ G+  +E+ EGK P            P A+++ +    +I +  PP   + E   +
Sbjct: 207  DIWSLGITAIEMAEGK-P------------PYADIHPMRAIFMIPTNPPPTFRKPELWSD 253

Query: 1017 KLKSMIAVAFLCLDANPDCRPT 1038
                 +     CL  +P+ R T
Sbjct: 254  NFTDFVK---QCLVKSPEQRAT 272

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (255), Expect = 1e-23
 Identities = 36/233 (15%), Positives = 85/233 (36%), Gaps = 31/233 (13%)

Query: 824  VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK 883
            +  +     +N V      S   +L++  +   + +L   ++   +  + +    +++  
Sbjct: 112  IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA--- 940
             +A A+ ++H      ++HRD+    +   ++    V DFG    +  D    + L    
Sbjct: 172  QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228

Query: 941  ---------GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAP 991
                     GT  Y++PE  +    + K D+F+ G+++ E             LL   + 
Sbjct: 229  AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-------------LLYSFST 275

Query: 992  AANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                  ++ D+ + + P    +   +   M+      L  +P  RP    +  
Sbjct: 276  QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDIIE 325

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  101 bits (253), Expect = 1e-23
 Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 55/293 (18%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           F    F +    +L    +   +    + L+ +  +  + +    +    I  L N+  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
            L+ N+L  +  + L  L +L  L L  N++   +  SL +L  L  LSL +N +S    
Sbjct: 74  FLNGNKLTDI--KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS---- 125

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
                           D+  L                       L  L  +YL NN+I  
Sbjct: 126 ----------------DINGLV---------------------HLPQLESLYLGNNKI-- 146

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           +  + +  L  L  L L  NQ+S  I P A  L+ L+ LYL  N +S      L   K+L
Sbjct: 147 TDITVLSRLTKLDTLSLEDNQIS-DIVPLA-GLTKLQNLYLSKNHISDLRA--LAGLKNL 202

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLW 310
             L L   +      +   NL     +   + + ++  I  + G+ +  +  W
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW 255

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 63/262 (24%), Positives = 106/262 (40%), Gaps = 26/262 (9%)

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPR--SLQNCTSLYSL 453
            +   +  K  L +   T  + QN   S  +      N++    I     +Q   ++  L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSD----IKSVQGIQYLPNVTKL 73

Query: 454 RLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS--SNWIKCPQLATLNMGGNEISGT 511
            L  N+LT +I  +     +L  L L  N     +   S+     +L +L++  N IS  
Sbjct: 74  FLNGNKLT-DIKPLAN-LKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEHNGIS-D 126

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELG 571
           I   + ++ QL  L   +N++       L +LT L +L+L  NQ+S DI   L  L +L 
Sbjct: 127 ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQ 181

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN 631
            L LS N +S L  + L  L+ L  L L + +   +       LV  + +  +  SL   
Sbjct: 182 NLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 237

Query: 632 IPSEICNLESLEYMNLLQNKLS 653
            P  I +    E  N+  +   
Sbjct: 238 TPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 43/232 (18%), Positives = 81/232 (34%), Gaps = 20/232 (8%)

Query: 426 LTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFF 485
               +++  +    +        S+  +    + +  ++       P++  L L+ N   
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNK-- 79

Query: 486 GEIS--SNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKL 543
             ++          L  L +  N++     S + ++ +L  L    N +       L  L
Sbjct: 80  --LTDIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDING--LVHL 133

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
             L SL L  N+++    L    L +L  L L  N++S +    L  L KL +L LS N 
Sbjct: 134 PQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNH 189

Query: 604 FSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP 655
            S ++   +  L  L  L+L          +   NL     +      L  P
Sbjct: 190 IS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 50/292 (17%), Positives = 108/292 (36%), Gaps = 45/292 (15%)

Query: 179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL 238
                      L    +  ++      L S+  +  N + +  S+      L N+  L+L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQ-YLPNVTKLFL 75

Query: 239 HDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN--INKLSGSI 296
           + N+L+   P  L + K+L +L+L  N++     SS  +L  LK L + +  I+ ++G  
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGISDING-- 129

Query: 297 PKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQ 356
              + +L  L  L+L   +++      L  L+ +  L + +N           ++  +  
Sbjct: 130 ---LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN-----------QISDIVP 173

Query: 357 LSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL 416
           L+                L+ L+   L +N +S  + + +  +K L+   LF  +     
Sbjct: 174 LA---------------GLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKP 216

Query: 417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVF 468
             +             + + V P   S        +++    + T  +S +F
Sbjct: 217 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIF 268

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 53/286 (18%), Positives = 96/286 (33%), Gaps = 42/286 (14%)

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
           +  +       N+ K S +       L S+  +  + + +       +  L N+  L++ 
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI 396
            N L   I + L  LK+L  L L  NK+   +   L +L  LK  +L  N +S     +I
Sbjct: 77  GNKL-TDI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-----DI 127

Query: 397 ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLE 456
             +  L +                     L    + NN         L   T L +L LE
Sbjct: 128 NGLVHLPQ---------------------LESLYLGNNKITDITV--LSRLTKLDTLSLE 164

Query: 457 RNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS--SNWIKCPQLATLNMGGNEISGTIPS 514
            NQ++ +I         L+ L LS N+    IS          L  L +   E      +
Sbjct: 165 DNQIS-DIVP-LAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPIN 218

Query: 515 EIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDI 560
              N+   + +  +   LV              ++  +  + + ++
Sbjct: 219 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score =  100 bits (251), Expect = 2e-23
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 53/231 (22%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNL 122
           IP    I  +   L L  N+L+ L  +    LT L  L L+ N+L  ++PA +   L NL
Sbjct: 31  IPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87

Query: 123 VQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGL 182
             L +++N L                 ++P                    GV       L
Sbjct: 88  ETLWVTDNKLQ----------------ALP-------------------IGV----FDQL 108

Query: 183 KNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHD 240
            NL  + L+ N++  S+P  +  +L  L+YL L  N+L  S+P      L++LK L L++
Sbjct: 109 VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYN 166

Query: 241 NRLSGYIPPKLGSF---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
           N+L   +P   G+F     L  L L +NQL      +F +L  LK L +  
Sbjct: 167 NQLKR-VPE--GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 52/177 (29%), Positives = 75/177 (42%), Gaps = 21/177 (11%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQI-GILTNLVVL 77
           F    +L  L L+ N+L  T+P  I   L  L+ L  + N+    +P  +   L NL  L
Sbjct: 57  FHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAEL 114

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQI 136
           RL  NQL  L P     LT L  L+L YN L  S+P  +   L++L +L L NN L  ++
Sbjct: 115 RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RV 172

Query: 137 PPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
           P                 L  L+   ++ L  N    V   +   L+ L  + L  N
Sbjct: 173 PEG-----------AFDKLTELK---TLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 55/185 (29%), Positives = 83/185 (44%), Gaps = 18/185 (9%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---L 567
            IPS I   T+  KLD  SN+L     K   +LT L  L LN N+L     L  G+   L
Sbjct: 30  AIPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT---LPAGIFKEL 84

Query: 568 AELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLS 624
             L  L ++ N+L  L      +L  L  L L  NQ     S+       L +L+ L L 
Sbjct: 85  KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK---SLPPRVFDSLTKLTYLSLG 141

Query: 625 HNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS 683
           +N L  ++P  +   L SL+ + L  N+L       F ++  L ++ +  N+L+  +P  
Sbjct: 142 YNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199

Query: 684 KAFQN 688
            AF +
Sbjct: 200 -AFDS 203

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 66/269 (24%), Positives = 100/269 (37%), Gaps = 91/269 (33%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSS-FGN 277
           +IP  +   ++ K L L  N+LS  +P    +F  L     LYL+ N+L  +LP+  F  
Sbjct: 30  AIP--SNIPADTKKLDLQSNKLS-SLPS--KAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE 83

Query: 278 LSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
           L +L+ L V + NKL  ++P  +   L +L+ L L + QL   +PP +            
Sbjct: 84  LKNLETLWVTD-NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV------------ 128

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLG---NLSNLKFFALRENELSGSIP 393
                         L  L+ LSL  N+L  S+P   G    L++LK   L  N+L   +P
Sbjct: 129 -----------FDSLTKLTYLSLGYNELQ-SLPK--GVFDKLTSLKELRLYNNQLK-RVP 173

Query: 394 QEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSL 453
                          E  F                                   T L +L
Sbjct: 174 ---------------EGAFDKL--------------------------------TELKTL 186

Query: 454 RLERNQLTGNISEVFGIYPDLELLDLSNN 482
           +L+ NQL       F     L++L L  N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 6/181 (3%)

Query: 425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
                 +++N       ++    T L  L L  N+L    + +F    +LE L +++N  
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97

Query: 485 FGEISSNWIKCP-QLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQL-G 541
              +          LA L +  N++  ++P  +  ++T+L  L    N L   +PK +  
Sbjct: 98  -QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 542 KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
           KLTSL  L L  NQL          L EL  L L  N+L ++       L KL  L L  
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

Query: 602 N 602
           N
Sbjct: 215 N 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 30/182 (16%)

Query: 305 SLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNK 363
               L L   +LS     +   L+ +R LY+ +N L  ++P  +   LK+L  L ++ NK
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNK 96

Query: 364 LNGSIPHCL-GNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVC 421
           L  ++P  +   L NL    L  N+L  S+P  + +++ KL    L  N+    LP+ V 
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV- 152

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
                         F       L   TSL  LRL  NQL       F    +L+ L L N
Sbjct: 153 --------------F-----DKL---TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190

Query: 482 NN 483
           N 
Sbjct: 191 NQ 192

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (251), Expect = 4e-23
 Identities = 58/294 (19%), Positives = 103/294 (35%), Gaps = 40/294 (13%)

Query: 760  QEGQNDVNNQEL-LSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIG 817
            Q G   +  Q      +  E    + G+G CG V+K     +G   AVK++      E  
Sbjct: 9    QTGYLTIGGQRYQAEINDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE- 66

Query: 818  INQKGFVSEIT----EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAEL 873
               K  + ++           IV+ +G       +F+  E +   +       +    E 
Sbjct: 67   --NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER 124

Query: 874  DWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS 933
               K   +   +  AL Y+       ++HRD+    +LLD   +  + DFG +  L  D 
Sbjct: 125  ILGK---MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DD 178

Query: 934  SNWSELAGTCGYIAPELAYTMRANE-----KCDVFNFGVLVLEVIEGKHPGHFLSLLLSL 988
                  AG   Y+APE        +     + DV++ G+ ++E+  G+ P        + 
Sbjct: 179  KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP------YKNC 232

Query: 989  PAPAANMNIVVNDLIDSRLPPPLGEVEEK----LKSMIAVAFLCLDANPDCRPT 1038
                  +  V+ +       PPL           +S +     CL  +   RP 
Sbjct: 233  KTDFEVLTKVLQE------EPPLLPGHMGFSGDFQSFVK---DCLTKDHRKRPK 277

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 99.2 bits (247), Expect = 1e-22
 Identities = 58/251 (23%), Positives = 87/251 (34%), Gaps = 22/251 (8%)

Query: 422 QSGSLTHFSVRNNNFVGPIPRS---LQNCTSLYSLRLERNQLTGNI--SEVFGIYPDLEL 476
           +S SL   +VR       I      +   + L  L LE  ++TG      +    PDL +
Sbjct: 66  KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 477 LDLSNNNFFGEISSNW----IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL 532
           L+L N ++    +          P L  L++           ++     L  LD S N  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 533 VGQIP----KQLGKLTSLTSLTLNGNQ---LSGDIPLELGLLAELGYLDLSANRLSKLIP 585
           +G+          K  +L  L L        SG          +L  LDLS N L     
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 586 KNLGE-LRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEY 644
               +   +L+ LNLS         +  G   +LS LDLS+N L  N       L  +  
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK---QVPKGLPAKLSVLDLSYNRLDRN--PSPDELPQVGN 300

Query: 645 MNLLQNKLSGP 655
           ++L  N     
Sbjct: 301 LSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 51/281 (18%), Positives = 86/281 (30%), Gaps = 31/281 (11%)

Query: 50  LKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLN 109
           LK +D   +        +   L  L V    +          +  ++ L EL L    + 
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 110 GSIPASLGNL--SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV--SVS 165
           G+ P  L      +L  L+L N S + +              +   +L     P    +S
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATR-------------DAWLAELQQWLKPGLKVLS 155

Query: 166 LHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSI-------PSEIGNLRSLSYLGLNKNQ 218
           +   +        +     L+ + L++N  +G         P +   L+ L+        
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 219 LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF-KSLLYLYLSHNQLNGSLPSSFGN 277
            SG     A     L+ L L  N L          +   L  L LS   L   +P   G 
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GL 272

Query: 278 LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
            + L  L +   N+L    P     L  + +L L       
Sbjct: 273 PAKLSVLDLSY-NRLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 95.3 bits (237), Expect = 2e-21
 Identities = 60/315 (19%), Positives = 98/315 (31%), Gaps = 58/315 (18%)

Query: 325 GNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHC---LGNLSNLKFF 381
           G  S    L   +         ++ +  SL +L++   ++   I      +  +S L+  
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 382 ALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIP 441
            L   E++G+ P  +      +                      L   ++RN ++     
Sbjct: 101 TLENLEVTGTAPPPLLEATGPD----------------------LNILNLRNVSWATRDA 138

Query: 442 R--SLQNC--TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQ 497
               LQ      L  L + +        E   ++P L  LDLS+N   GE       CP 
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP- 197

Query: 498 LATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNR---LVGQIPKQLGKLTSLTSLTLNGN 554
                                   L  L   +       G           L  L L+ N
Sbjct: 198 -------------------LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238

Query: 555 QLSGDIPLELGL-LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG 613
            L            ++L  L+LS   L ++ PK L    KL  L+LS N+  +  S    
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGL--PAKLSVLDLSYNRLDRNPSPD-- 293

Query: 614 KLVQLSKLDLSHNSL 628
           +L Q+  L L  N  
Sbjct: 294 ELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.7 bits (225), Expect = 8e-20
 Identities = 62/286 (21%), Positives = 87/286 (30%), Gaps = 36/286 (12%)

Query: 435 NFVGPIPR--SLQNCTSLY-------SLRLERNQLTGNISEVFGIYPD------LELLDL 479
           NF  P P   S  NC              LE      +     G + D      L+ L +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 480 SNNNFFGEISSNWIK---CPQLATLNMGGNEISGTIPSEIGNMT--QLHKLDFSSNRLVG 534
                   I    ++      L  L +   E++GT P  +   T   L+ L+  +     
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135

Query: 535 QIPK----QLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKN--- 587
           +       Q      L  L++           ++ +   L  LDLS N            
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

Query: 588 -LGELRKLHHLNLSNNQF---SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEIC-NLESL 642
              +   L  L L N      S   S      VQL  LDLSHNSL     +  C     L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255

Query: 643 EYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
             +NL    L         +   LS +D+SYN L    P       
Sbjct: 256 NSLNLSFTGLKQVPKGLPAK---LSVLDLSYNRLD-RNPSPDELPQ 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 48/278 (17%), Positives = 76/278 (27%), Gaps = 56/278 (20%)

Query: 5   NLTGSNLKGTLQEFPFLL----FPQLAYLDLSVNQLFGTIPTQIS--HLSKLKHLDFSTN 58
            LT    +   +     L       L  L L   ++ GT P  +       L  L+    
Sbjct: 72  RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 59  QFSGIIPP----QIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIP- 113
            ++         Q  +   L VL ++         E++    +L+ L LS N   G    
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

Query: 114 ---ASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
                      L  L+L N  +                                      
Sbjct: 192 ISALCPLKFPTLQVLALRNAGM------------------------------------ET 215

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTAGN 229
            SGV          L  + L++N +  +  +        L+ L L+   L   +P   G 
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GL 272

Query: 230 LSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL 267
            + L  L L  NRL     P       +  L L  N  
Sbjct: 273 PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.1 bits (213), Expect = 3e-18
 Identities = 48/243 (19%), Positives = 76/243 (31%), Gaps = 21/243 (8%)

Query: 165 SLHTNNFSGVIPRS---LGGLKNLTFVYLNNNRIVGSIPSEIGNL--RSLSYLGLNKNQL 219
           ++        I      + G+  L  + L N  + G+ P  +       L+ L L     
Sbjct: 74  TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133

Query: 220 SGSIPPTAG----NLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS- 274
           +      A         LK L +       +   ++  F +L  L LS N   G      
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193

Query: 275 ---FGNLSSLKHLHVHN--INKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL-GNLS 328
                   +L+ L + N  +   SG           L  L LS   L            S
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253

Query: 329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
            +  L +    L   +P+ L     LS L LS N+L+   P     L  +   +L+ N  
Sbjct: 254 QLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPF 308

Query: 389 SGS 391
             S
Sbjct: 309 LDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.8 bits (194), Expect = 6e-16
 Identities = 60/318 (18%), Positives = 97/318 (30%), Gaps = 58/318 (18%)

Query: 204 GNLRSLSYLGLNKNQLSGSIPPT-AGNLSNLKFLYLHDNRLSGYIPP---KLGSFKSLLY 259
           G  RSL YL    +  +     T      +LK L +   R+   I     ++     L  
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 260 LYLSHNQLNGSLPSSFGNL--SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
           L L + ++ G+ P          L  L++ N+               S +       +L 
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNV---------------SWATRDAWLAELQ 144

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPH----CLG 373
            ++ P L      + L I +        E++    +LS L LS N   G        C  
Sbjct: 145 QWLKPGL------KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198

Query: 374 NLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRN 433
               L+  ALR   +  +       +                          L    + +
Sbjct: 199 KFPTLQVLALRNAGME-TPSGVCSALAAARV--------------------QLQGLDLSH 237

Query: 434 NNFVG-PIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW 492
           N+        S    + L SL L    L        G+   L +LDLS N       S  
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLK---QVPKGLPAKLSVLDLSYNR-LDRNPSPD 293

Query: 493 IKCPQLATLNMGGNEISG 510
            + PQ+  L++ GN    
Sbjct: 294 -ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 54/296 (18%), Positives = 101/296 (34%), Gaps = 36/296 (12%)

Query: 275 FGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPS---LGNLSNIR 331
           +G   SL++L      +       +I    SL  L +   ++   I      +  +S ++
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 332 GLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGS-IPHCLGNLSNLKFFALRENELSG 390
            L +    + G+ P  L          L++  ++ +     L  L       L+   ++ 
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 391 SIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNC--- 447
                          L F  +     P       +L+   + +N  +G        C   
Sbjct: 159 ------------AHSLNFSCEQVRVFP-------ALSTLDLSDNPELGERGLISALCPLK 199

Query: 448 -TSLYSLRLERNQLT---GNISEVFGIYPDLELLDLSNNNFFGEI-SSNWIKCPQLATLN 502
             +L  L L    +    G  S +      L+ LDLS+N+      + +     QL +LN
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 503 MGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG 558
           +    +   +P  +    +L  LD S NRL    P    +L  + +L+L GN    
Sbjct: 260 LSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 45/254 (17%), Positives = 69/254 (27%), Gaps = 58/254 (22%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQL--FGTIPTQISHLSK--LKHLDFSTN 58
           ++ +TG+              P L  L+L             ++    K  LK L  +  
Sbjct: 104 NLEVTGT----APPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 59  QFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEE----LGELTSLNELALSYNRLN---GS 111
                   Q+ +   L  L LS N   G           +  +L  LAL    +    G 
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 112 IPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNF 171
             A       L  L LS+NSL                                       
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAP-------------------------------- 247

Query: 172 SGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLS 231
                 S      L  + L+   +   +P  +     LS L L+ N+L  +  P+   L 
Sbjct: 248 ------SCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELP 296

Query: 232 NLKFLYLHDNRLSG 245
            +  L L  N    
Sbjct: 297 QVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 26/166 (15%), Positives = 48/166 (28%), Gaps = 9/166 (5%)

Query: 539 QLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGEL---RKLH 595
             G  +    L     +       ++     L  L + A R+   I      +     L 
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 596 HLNLSNNQFSQEISIQIGKLV--QLSKLDLSHNSLGGNIPS----EICNLESLEYMNLLQ 649
            L L N + +      + +     L+ L+L + S           +      L+ +++ Q
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 650 NKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQ 695
                      R    LS++D+S N   G      A         Q
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 68/280 (24%), Positives = 118/280 (42%), Gaps = 48/280 (17%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G    V  A      +  A+K++ +L   +  +++   + EI    +  H NIV +Y 
Sbjct: 24   GSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDE--LLKEIQAMSQCHHPNIVSYYT 80

Query: 841  FCSHTQHLFLVYEYLERGSLATIL-----SNEATAAELDWSKRVNVIKGVANALSYMHHD 895
                   L+LV + L  GS+  I+       E  +  LD S    +++ V   L Y+H +
Sbjct: 81   SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA------GTCGYIAPE 949
                 +HRD+ +  +LL  +    ++DFG + FL     + +         GT  ++APE
Sbjct: 141  ---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA-TGGDITRNKVRKTFVGTPCWMAPE 196

Query: 950  LAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
            +   +R  + K D+++FG+  +E+  G  P          P     M  + ND      P
Sbjct: 197  VMEQVRGYDFKADIWSFGITAIELATGAAP------YHKYPPMKVLMLTLQND------P 244

Query: 1009 PPLGEVEEK----------LKSMIAVAFLCLDANPDCRPT 1038
            P L    +            + MI+   LCL  +P+ RPT
Sbjct: 245  PSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPT 281

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 99.7 bits (249), Expect = 1e-22
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 32/203 (15%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEIT---EIRHRNIVKFY 839
           G G    V +     +G   AVK +  +  T   G++ +    E +    ++H +IV+  
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 840 GFCSHTQHLFLVYEYL----------ERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
              S    L++V+E++          +R     + S EA A+          ++ +  AL
Sbjct: 93  ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-EAVASHY--------MRQILEAL 143

Query: 890 SYMH-HDCFPPILHRDISSKKVLLDLEYKAH---VSDFGTAKFLKPDSSNWSELAGTCGY 945
            Y H ++    I+HRD+    VLL  +  +    +  FG A  L           GT  +
Sbjct: 144 RYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 946 IAPELAYTMRANEKCDVFNFGVL 968
           +APE+       +  DV+  GV+
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVI 222

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 38/267 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VYKA    +G   A K + +    E+         EI       H  IVK  G
Sbjct: 28   GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV----EIEILATCDHPYIVKLLG 83

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
               H   L+++ E+   G++  I+        L   +   V + +  AL+++H      I
Sbjct: 84   AYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA---- 956
            +HRD+ +  VL+ LE    ++DFG +              GT  ++APE+          
Sbjct: 139  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198

Query: 957  -NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV-VNDLIDSRLPPPLGEV 1014
             + K D+++ G+ ++E+ + + P            P   +N + V   I    PP L   
Sbjct: 199  YDYKADIWSLGITLIEMAQIE-P------------PHHELNPMRVLLKIAKSDPPTLLTP 245

Query: 1015 E---EKLKSMIAVAFLCLDANPDCRPT 1038
                 + +  +    + LD NP+ RP+
Sbjct: 246  SKWSVEFRDFLK---IALDKNPETRPS 269

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 97.7 bits (244), Expect = 3e-22
 Identities = 44/205 (21%), Positives = 83/205 (40%), Gaps = 35/205 (17%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEI-----RHR 833
           G G    V +     +    AVK        S    E+   ++  + E+ +I      H 
Sbjct: 26  GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV-DILRKVSGHP 84

Query: 834 NIVKFYGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANA 888
           NI++           FLV++ +++G L   +      +E    ++        ++ +   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI--------MRALLEV 136

Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
           +  +H      I+HRD+  + +LLD +    ++DFG +  L P      E+ GT  Y+AP
Sbjct: 137 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLAP 192

Query: 949 E-LAYTMRANEK-----CDVFNFGV 967
           E +  +M  N        D+++ GV
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGV 217

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 50/271 (18%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIV 836
            G GG G VY+AE    DT      A+K +    + +     +    E      ++  ++V
Sbjct: 43   GRGGMGDVYEAE----DTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVV 97

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
              + F      L++    +    LA +L  +     L   + V +++ + +AL   H   
Sbjct: 98   PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA---GTCGYIAPELAYT 953
                 HRD+  + +L+  +  A++ DFG A          ++L    GT  Y+APE    
Sbjct: 154  --GATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSE 209

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHP--GHFLSLLLS-----LPAPAANMNIVVNDLIDSR 1006
              A  + D++    ++ E + G  P  G  LS++ +     +P P+          +   
Sbjct: 210  SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPST---------VRPG 260

Query: 1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRP 1037
            +P     V  +           +  NP+ R 
Sbjct: 261  IPVAFDAVIAR----------GMAKNPEDRY 281

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 99.8 bits (249), Expect = 5e-22
 Identities = 64/272 (23%), Positives = 116/272 (42%), Gaps = 37/272 (13%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VY+          AVK L      E  +  + F+ E     EI+H N+V+  G
Sbjct: 229  GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L       E+     + +   +++A+ Y+    F   
Sbjct: 284  VCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKNF--- 339

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI---APELAYTMRAN 957
            +HR+++++  L+   +   V+DFG ++ +  D+  ++  AG    I   APE     + +
Sbjct: 340  IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 958  EKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEV 1014
             K DV+ FGVL+ E+   G  P   +                V +L++   R+  P G  
Sbjct: 398  IKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYELLEKDYRMERPEGCP 445

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            E+  + M A    C   NP  RP+  ++    
Sbjct: 446  EKVYELMRA----CWQWNPSDRPSFAEIHQAF 473

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 66/275 (24%), Positives = 109/275 (39%), Gaps = 42/275 (15%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVKFY 839
            G G  G VYK   + +G   A+K +  +   E    ++    EI  ++    HRNI  +Y
Sbjct: 33   GNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQ----EINMLKKYSHHRNIATYY 87

Query: 840  G------FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            G             L+LV E+   GS+  ++ N      L       + + +   LS++H
Sbjct: 88   GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLH 146

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
                  ++HRDI  + VLL    +  + DFG +  L       +   GT  ++APE+   
Sbjct: 147  QHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203

Query: 954  MRA-----NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
                    + K D+++ G+  +E+ EG  P      L  +    A   I  N        
Sbjct: 204  DENPDATYDFKSDLWSLGITAIEMAEGAPP------LCDMHPMRALFLIPRNP------A 251

Query: 1009 PPLGEVE--EKLKSMIAVAFLCLDANPDCRPTMQK 1041
            P L   +  +K +S I     CL  N   RP  ++
Sbjct: 252  PRLKSKKWSKKFQSFIE---SCLVKNHSQRPATEQ 283

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (250), Expect = 9e-22
 Identities = 50/268 (18%), Positives = 94/268 (35%), Gaps = 58/268 (21%)

Query: 785  GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNI 835
              GG G +Y A     D         +K L    +G+    Q   ++E   + E+ H +I
Sbjct: 89   AHGGLGWIYLAL----DRNVNGRPVVLKGLV--HSGDAEA-QAMAMAERQFLAEVVHPSI 141

Query: 836  VKFYGFCSHTQH-----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
            V+ + F  HT        ++V EY+   SL           +L  ++ +  +  +  ALS
Sbjct: 142  VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALS 196

Query: 891  YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
            Y+H      +++ D+  + ++L  E +  + D G    +         L GT G+ APE+
Sbjct: 197  YLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPEI 248

Query: 951  AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLS-LLLSLPAPAANMNIVVNDLIDSRLPP 1009
              T       D++  G  +  +             +  LP     +          +   
Sbjct: 249  VRT-GPTVATDIYTVGRTLAALTLDLPT--RNGRYVDGLPEDDPVL----------KTYD 295

Query: 1010 PLGEVEEKLKSMIAVAFLCLDANPDCRP 1037
              G +  +           +D +P  R 
Sbjct: 296  SYGRLLRR----------AIDPDPRQRF 313

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 67/278 (24%), Positives = 113/278 (40%), Gaps = 51/278 (18%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G+G  G V+     + D  A+K +      E  ++++ F+ E     ++ H  +V+ YG 
Sbjct: 17   GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C     + LV E++E G L+  L  +           + +   V   ++Y+   C    +
Sbjct: 72   CLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV---I 126

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPD----SSN------WSELAGTCGYIAPELA 951
            HRD++++  L+       VSDFG  +F+  D    S+       W+         +PE+ 
Sbjct: 127  HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------SPEVF 177

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
               R + K DV++FGVL+ EV  EGK P    S            N  V + I +  RL 
Sbjct: 178  SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------------NSEVVEDISTGFRLY 225

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             P        + M      C    P+ RP   ++   L
Sbjct: 226  KPRLASTHVYQIMNH----CWRERPEDRPAFSRLLRQL 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 45/204 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           G G  G V K  +  +    AVK ++  S    +        + E+    ++ H NI+K 
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT----STILREVELLKKLDHPNIMKL 86

Query: 839 YGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMH 893
           +     +   ++V E    G L   I+     +E  AA +        IK V + ++YMH
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--------IKQVFSGITYMH 138

Query: 894 HDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
                 I+HRD+        SK+   D++    + DFG +   + ++    +  GT  YI
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIK----IIDFGLSTCFQQNTK-MKDRIGTAYYI 190

Query: 947 APEL---AYTMRANEKCDVFNFGV 967
           APE+    Y    +EKCDV++ GV
Sbjct: 191 APEVLRGTY----DEKCDVWSAGV 210

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 96.8 bits (241), Expect = 1e-21
 Identities = 45/256 (17%), Positives = 89/256 (34%), Gaps = 25/256 (9%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQI-GILTN 73
           + E P  L      L   + +L        S    L+ ++ S N    +I   +   L  
Sbjct: 21  VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 74  LVVLRLS-VNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNNS 131
           L  +R+   N L  + PE    L +L  L +S   +   +P     +    V L + +N 
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139

Query: 132 LSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLN 191
               I  N               L      V + L+ N    +   +  G +       +
Sbjct: 140 NIHTIERN-----------SFVGLSFES--VILWLNKNGIQEIHNSAFNGTQLDELNLSD 186

Query: 192 NNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPP 249
           NN +   +P+++         L +++ ++  S+P     NL  L+    ++ +    +P 
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 241

Query: 250 KLGSFKSLLYLYLSHN 265
            L    +L+   L++ 
Sbjct: 242 -LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 93.4 bits (232), Expect = 2e-20
 Identities = 53/252 (21%), Positives = 91/252 (36%), Gaps = 32/252 (12%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPAS-LGNLSNLVQLSL 127
            +  N + LR  + +L  +          L ++ +S N +   I A    NL  L ++ +
Sbjct: 27  DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 128 SN-NSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLT 186
              N+L   I P              Q+L NL+    + +       +            
Sbjct: 87  EKANNLL-YINPE-----------AFQNLPNLQ---YLLISNTGIKHLPDVHKIHSLQKV 131

Query: 187 FVYLNNNRIVGSIPSEI--GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLS 244
            + + +N  + +I      G       L LNKN +   I  +A N + L  L L DN   
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL 190

Query: 245 GYIPPKLGSFKSL---LYLYLSHNQLNGSLPS-SFGNLSSLKHLHVHNINKLSGSIPKEI 300
             +P     F      + L +S  +++ SLPS    NL  L+    +N+ KL       +
Sbjct: 191 EELPN--DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLP-----TL 242

Query: 301 GNLKSLSHLWLS 312
             L +L    L+
Sbjct: 243 EKLVALMEASLT 254

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 43/248 (17%), Positives = 81/248 (32%), Gaps = 16/248 (6%)

Query: 214 LNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLP 272
             +++++  IP       N   L     +L   I       F  L  + +S N +   + 
Sbjct: 16  CQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIE 71

Query: 273 SS-FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNI 330
           +  F NL  L  + +   N L   I  E   NL +L +L +S T +         +    
Sbjct: 72  ADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130

Query: 331 RGLYIRENMLYGSIPEEL--GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
             L I++N+   +I      G       L L+ N +              +      N L
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNL 190

Query: 389 SGSIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNC 447
              +P ++           +   +    LP    +  +L     R+   +  +P +L+  
Sbjct: 191 E-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE--NLKKLRARSTYNLKKLP-TLEKL 245

Query: 448 TSLYSLRL 455
            +L    L
Sbjct: 246 VALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 80.6 bits (199), Expect = 3e-16
 Identities = 55/289 (19%), Positives = 96/289 (33%), Gaps = 58/289 (20%)

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI-ENMKK 401
            IP +L   ++  +L   + KL            +L+   + +N++   I  ++  N+ K
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 402 LNK-YLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQL 460
           L++  +   N    Y+                        P + QN  +L  L +    +
Sbjct: 81  LHEIRIEKANNLL-YIN-----------------------PEAFQNLPNLQYLLISNTGI 116

Query: 461 TGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK--CPQLATLNMGGNEISGTIPSEIGN 518
                          LLD+ +N     I  N       +   L +  N I   I +   N
Sbjct: 117 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN 175

Query: 519 MTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN 578
            TQL +L+ S N            L  L +   +G              +    LD+S  
Sbjct: 176 GTQLDELNLSDNN----------NLEELPNDVFHG-------------ASGPVILDISRT 212

Query: 579 RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNS 627
           R+  L    L  L+KL   +  N +    +     KLV L +  L++ S
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNLKKLPTLE----KLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 39/196 (19%), Positives = 65/196 (33%), Gaps = 8/196 (4%)

Query: 498 LATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTL-NGNQ 555
              L     ++             L K++ S N ++  I       L  L  + +   N 
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQI--G 613
           L    P     L  L YL +S   +  L   +     +   L++ +N     I      G
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151

Query: 614 KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQ-NKLSGPIPSCFRRMHGLSSIDVS 672
              +   L L+ N +   I +   N   L+ +NL   N L       F    G   +D+S
Sbjct: 152 LSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210

Query: 673 YNELQGSIPHSKAFQN 688
              +  S+P S   +N
Sbjct: 211 RTRIH-SLP-SYGLEN 224

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 22/146 (15%), Positives = 47/146 (32%), Gaps = 6/146 (4%)

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
           S        ++++ +IP    L      L     +L  +          L  + +S N  
Sbjct: 10  SNRVFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 605 SQEISIQI-GKLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPSCFRR 662
            + I   +   L +L ++ +   +    I  E   NL +L+Y+ +    +          
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 126

Query: 663 MHGLSSIDVSYNELQGSIPHSKAFQN 688
                 +D+  N    +I    +F  
Sbjct: 127 SLQKVLLDIQDNINIHTIER-NSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 34/195 (17%), Positives = 53/195 (27%), Gaps = 23/195 (11%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFS 61
            I +  +N    +    F   P L YL +S   +   +P     H  +   LD   N   
Sbjct: 83  EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 62  GIIPPQI--GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNL 119
             I      G+    V+L L+ N +  +                  N L           
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGA 201

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSL 179
           S  V L +S   +   +P               ++L  L      +  T N   +    L
Sbjct: 202 SGPVILDISRTRIH-SLPSY-----------GLENLKKLR-----ARSTYNLKKLPT--L 242

Query: 180 GGLKNLTFVYLNNNR 194
             L  L    L    
Sbjct: 243 EKLVALMEASLTYPS 257

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.0 bits (247), Expect = 1e-21
 Identities = 69/290 (23%), Positives = 113/290 (38%), Gaps = 63/290 (21%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEI-TEIR------ 831
            G+G  G V    E      +A+K     +       +   N + F  EI  EI       
Sbjct: 45   GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVA 886
            H NI+K +      ++ +LV E+ E G L   I++    +E  AA         ++K + 
Sbjct: 105  HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN--------IMKQIL 156

Query: 887  NALSYMHHDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
            + + Y+H      I+HRDI        +K     L  K  + DFG + F   D     + 
Sbjct: 157  SGICYLHKHN---IVHRDIKPENILLENKN--SLLNIK--IVDFGLSSFFSKDYK-LRDR 208

Query: 940  AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS--LPAPAANMNI 997
             GT  YIAPE     + NEKCDV++ GV+             + +LL    P    N   
Sbjct: 209  LGTAYYIAPE-VLKKKYNEKCDVWSCGVI-------------MYILLCGYPPFGGQNDQD 254

Query: 998  VVNDLIDSRL---PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            ++  +   +          + ++ K +I    L L  + + R T ++  N
Sbjct: 255  IIKKVEKGKYYFDFNDWKNISDEAKELIK---LMLTYDYNKRCTAEEALN 301

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 785 GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIV 836
           G GG  TVY AE    DT      A+K +   P  +    ++ F  E    +++ H+NIV
Sbjct: 20  GGGGMSTVYLAE----DTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIV 74

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                       +LV EY+E  +L+  + +      L     +N    + + + + H   
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM- 130

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSELAGTCGYIAPELAYTMR 955
              I+HRDI  + +L+D      + DFG AK L   S +  + + GT  Y +PE A    
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            +E  D+++ G+++ E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 66/282 (23%), Positives = 104/282 (36%), Gaps = 35/282 (12%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIV 836
            G G  G+V                AVK+L      +    Q+ F  EI     +    IV
Sbjct: 32   GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ----QRDFQREIQILKALHSDFIV 87

Query: 837  KFYGFCSHTQH--LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            K+ G         L LV EYL  G L   L      A LD S+ +     +   + Y+  
Sbjct: 88   KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS 145

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APE 949
                  +HRD++++ +L++ E    ++DFG AK L  D   +       G       APE
Sbjct: 146  RRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFWYAPE 200

Query: 950  LAYTMRANEKCDVFNFGVLVLEVI-EGKHP--GHFLSLLLSLPAPAANMNIVVNDLIDS- 1005
                   + + DV++FGV++ E+              L +            + +L++  
Sbjct: 201  SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260

Query: 1006 -RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             RLP P     E  + M     LC   +P  RP+   +   L
Sbjct: 261  QRLPAPPACPAEVHELMK----LCWAPSPQDRPSFSALGPQL 298

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 63/272 (23%), Positives = 102/272 (37%), Gaps = 41/272 (15%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT----EIRHRNIVKFY 839
            G G  G+V K     SG   AVK++ S    +    QK  + ++           IV+FY
Sbjct: 31   GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---QKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 840  GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV--NVIKGVANALSYMHHDCF 897
            G        ++  E +   S         +  +    + +   +      AL+++  +  
Sbjct: 88   GALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-------- 949
              I+HRDI    +LLD      + DFG +  L  DS   +  AG   Y+APE        
Sbjct: 146  -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 950  LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009
              Y    + + DV++ G+ + E+  G+ P           +    +  VV         P
Sbjct: 204  QGY----DVRSDVWSLGITLYELATGRFP------YPKWNSVFDQLTQVVKG------DP 247

Query: 1010 P-LGEVEEKLKSMIAVAF--LCLDANPDCRPT 1038
            P L   EE+  S   + F  LCL  +   RP 
Sbjct: 248  PQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 59/286 (20%), Positives = 107/286 (37%), Gaps = 42/286 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
            G G  G V                AVK L     G    +      EI     + H NIV
Sbjct: 30   GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN---HIADLKKEIEILRNLYHENIV 86

Query: 837  KFYGFCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            K+ G C+      + L+ E+L  GSL   L       +++  +++     +   + Y+  
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS 144

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APE 949
              +   +HRD++++ VL++ E++  + DFG  K ++ D   ++              APE
Sbjct: 145  RQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWYAPE 199

Query: 950  LAYTMRANEKCDVFNFGVLVLEVI----EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
                 +     DV++FGV + E++        P      ++          + V  L+++
Sbjct: 200  CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG----QMTVTRLVNT 255

Query: 1006 -----RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 RLP P    +E  + M      C +  P  R + Q +    
Sbjct: 256  LKEGKRLPCPPNCPDEVYQLMR----KCWEFQPSNRTSFQNLIEGF 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 60/292 (20%)

Query: 772  LSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT-- 828
            + A   E  M L G G  G V K     SG   AVK++ +    +    QK  + ++   
Sbjct: 4    VKADDLEPIMEL-GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDIS 59

Query: 829  --EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVN------ 880
               +     V FYG       +++  E ++  SL            +D  + +       
Sbjct: 60   MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGK 113

Query: 881  VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
            +   +  AL ++H      ++HRD+    VL++   +  + DFG + +L  D       A
Sbjct: 114  IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDA 170

Query: 941  GTCGYIAPE--------LAYTMRANEKCDVFNFGVLVLEVIEGKHP----GHFLSLLLSL 988
            G   Y+APE          Y++++    D+++ G+ ++E+   + P    G     L   
Sbjct: 171  GCKPYMAPERINPELNQKGYSVKS----DIWSLGITMIELAILRFPYDSWGTPFQQL--- 223

Query: 989  PAPAANMNIVVNDLIDSRLPPPLGEVE--EKLKSMIAVAFLCLDANPDCRPT 1038
                    +V          P L   +   +     +    CL  N   RPT
Sbjct: 224  ------KQVVEEP------SPQLPADKFSAEFVDFTS---QCLKKNSKERPT 260

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 52/281 (18%), Positives = 116/281 (41%), Gaps = 46/281 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRHRN--IVK 837
            G+GG   V++         A+K   L       +      + +EI    +++  +  I++
Sbjct: 37   GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHSDKIIR 92

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDC 896
             Y +    Q++++V E      L + L  + +   +D  +R +  K +  A+  +H H  
Sbjct: 93   LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG- 147

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE--LAGTCGYIAPEL---- 950
               I+H D+     L+  +    + DFG A  ++PD+++  +    GT  Y+ PE     
Sbjct: 148  ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 951  -------AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
                       + + K DV++ G ++  +  GK P  F  ++  +      ++ +++   
Sbjct: 204  SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISK----LHAIIDPNH 257

Query: 1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            +   P      E+ L+ ++     CL  +P  R ++ ++  
Sbjct: 258  EIEFPD---IPEKDLQDVLK---CCLKRDPKQRISIPELLA 292

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.7 bits (238), Expect = 4e-21
 Identities = 51/308 (16%), Positives = 96/308 (31%), Gaps = 68/308 (22%)

Query: 784  HGTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
             G     TV  A    +G+   V++  L +     +   Q     E+       H NIV 
Sbjct: 35   KGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG----ELHVSKLFNHPNIVP 90

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILS-------NEATAAELDWSKRVNVIKGVANALS 890
            +         L++V  ++  GS   ++        NE   A         +++GV  AL 
Sbjct: 91   YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--------YILQGVLKALD 142

Query: 891  YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL-------KPDSSNWSELAGTC 943
            Y+HH      +HR + +  +L+ ++ K ++S   +   +       +             
Sbjct: 143  YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 944  GYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGK------HPGHFLSLLLSLPAPAANM 995
             +++PE+        + K D+++ G+   E+  G            L   L+   P    
Sbjct: 200  PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259

Query: 996  NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAF-------------------------LCLD 1030
               +     +  P           S+                               CL 
Sbjct: 260  TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319

Query: 1031 ANPDCRPT 1038
             NPD RP+
Sbjct: 320  RNPDARPS 327

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 94.6 bits (236), Expect = 4e-21
 Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 46/271 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIV 836
            G+G  GTVYK        +     A+K+L            K  + E   +  + + ++ 
Sbjct: 24   GSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASVDNPHVC 80

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +  G C  T  + L+ + +  G L   +        +     +N    +A  ++Y+    
Sbjct: 81   RLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELA 951
                +HRD++++ VL+       ++DFG AK L  +     E     G +     A E  
Sbjct: 138  L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---KEYHAEGGKVPIKWMALESI 191

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANM-NIVVNDLIDS--RL 1007
                   + DV+++GV V E++  G               P   +    ++ +++   RL
Sbjct: 192  LHRIYTHQSDVWSYGVTVWELMTFGS-------------KPYDGIPASEISSILEKGERL 238

Query: 1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
            P P     +    M      C   + D RP 
Sbjct: 239  PQPPICTIDVYMIMRK----CWMIDADSRPK 265

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 97.1 bits (242), Expect = 5e-21
 Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
            G+G  G V    +  +   RA+K  +  S+ T          + E+     + H NI+K 
Sbjct: 46   GSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN----SKLLEEVAVLKLLDHPNIMKL 101

Query: 839  YGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMH 893
            Y F    ++ +LV E  + G L   I+     NE  AA         +IK V + ++Y+H
Sbjct: 102  YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV--------IIKQVLSGVTYLH 153

Query: 894  HDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
                  I+HRD+  + +LL     D   K  + DFG +   +       E  GT  YIAP
Sbjct: 154  KHN---IVHRDLKPENLLLESKEKDALIK--IVDFGLSAVFENQKK-MKERLGTAYYIAP 207

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL- 1007
            E+    + +EKCDV++ GV++  ++ G  P  F                ++  +   +  
Sbjct: 208  EV-LRKKYDEKCDVWSIGVILFILLAGYPP--F---------GGQTDQEILRKVEKGKYT 255

Query: 1008 --PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
               P    V E  K +I      L  +   R + Q+   
Sbjct: 256  FDSPEWKNVSEGAKDLIK---QMLQFDSQRRISAQQALE 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 5e-21
 Identities = 64/294 (21%), Positives = 104/294 (35%), Gaps = 55/294 (18%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-------RHRNIV 836
              GG   VY+A+ + SG   A+K+L       +   ++   + I E+        H NIV
Sbjct: 37   AEGGFAFVYEAQDVGSGREYALKRL-------LSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 837  KFYGFCS-------HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANAL 889
            +F    S         Q  FL+   L +G L   L    +   L     + +      A+
Sbjct: 90   QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS---------ELA 940
             +MH    PPI+HRD+  + +LL  +    + DFG+A  +                 E  
Sbjct: 150  QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 941  GTCG---YIAPELAYTMR---ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN 994
                   Y  PE+          EK D++  G ++  +   +HP  F             
Sbjct: 209  TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--F---------EDGA 257

Query: 995  MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
               +VN        PP         S+I      L  NP+ R ++ +V + L  
Sbjct: 258  KLRIVNGKYS---IPPHDTQYTVFHSLIRA---MLQVNPEERLSIAEVVHQLQE 305

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 38/284 (13%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKL-HSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G+V                AVKKL HS        + + F  EI     ++H NI
Sbjct: 19   GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFEREIEILKSLQHDNI 73

Query: 836  VKFYGFCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            VK+ G C     ++L L+ EYL  GSL   L        +D  K +     +   + Y+ 
Sbjct: 74   VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 131

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----AP 948
               +   +HRD++++ +L++ E +  + DFG  K L  D   +       G       AP
Sbjct: 132  TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VKEPGESPIFWYAP 186

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVI---EGKHPGHFLSLLLSLPAPAANM-NIVVNDLID 1004
            E     + +   DV++FGV++ E+    E         + +        M    + +L+ 
Sbjct: 187  ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246

Query: 1005 S--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +  RLP P G  +E    M      C + N + RP+ + +   +
Sbjct: 247  NNGRLPRPDGCPDEIYMIMT----ECWNNNVNQRPSFRDLALRV 286

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 93.9 bits (234), Expect = 8e-21
 Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 41/277 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVK 837
            G+G  G V    L     R    A+K L +   G     ++ F+SE     +  H NI++
Sbjct: 58   GSGDSGEVCYGRLRVPGQRDVPVAIKALKA---GYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G  +  +   +V EY+E GSL T L       +    + V +++GV   + Y+    +
Sbjct: 115  LEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLGY 172

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRD++++ VL+D      VSDFG ++ L+ D        G  G I     APE   
Sbjct: 173  ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG--GKIPIRWTAPEAIA 227

Query: 953  TMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPP 1009
                +   DV++FGV++ EV+  G+ P   ++            N  V   ++   RLP 
Sbjct: 228  FRTFSSASDVWSFGVVMWEVLAYGERPYWNMT------------NRDVISSVEEGYRLPA 275

Query: 1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P+G      + M+     C   +   RP   ++ ++L
Sbjct: 276  PMGCPHALHQLMLD----CWHKDRAQRPRFSQIVSVL 308

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 69/323 (21%), Positives = 118/323 (36%), Gaps = 46/323 (14%)

Query: 752  RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHS 810
            ++RKR ++   Q     +  L    FE    L G G  G V+K     SG   A K +H 
Sbjct: 12   QQRKRLEAFLTQKQKVGE--LKDDDFEKISEL-GAGNGGVVFKVSHKPSGLVMARKLIHL 68

Query: 811  LPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNE 867
                 I   +   + E+    E     IV FYG       + +  E+++ GSL  +L   
Sbjct: 69   EIKPAI---RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125

Query: 868  ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
                E    K   V   V   L+Y+       I+HRD+    +L++   +  + DFG + 
Sbjct: 126  GRIPEQILGK---VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 928  FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP--------- 978
             L    S  +   GT  Y++PE       + + D+++ G+ ++E+  G++P         
Sbjct: 181  QL--IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

Query: 979  ----GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE-------VEEKLKSMIAVAF- 1026
                G  +    +   P         +       PP+         V E    + +  F 
Sbjct: 239  ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 298

Query: 1027 --------LCLDANPDCRPTMQK 1041
                     CL  NP  R  +++
Sbjct: 299  LEFQDFVNKCLIKNPAERADLKQ 321

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 41/274 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VY+          AVK L            + F+ E     EI+H N+V+  G
Sbjct: 22   GGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+    F   
Sbjct: 77   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKKNF--- 132

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYTMR 955
            +HRD++++  L+   +   V+DFG ++ +  D    +  A           APE     +
Sbjct: 133  IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 188

Query: 956  ANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLG 1012
             + K DV+ FGVL+ E+   G  P   +                V +L++   R+  P G
Sbjct: 189  FSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYELLEKDYRMERPEG 236

Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              E+  + M A    C   NP  RP+  ++    
Sbjct: 237  CPEKVYELMRA----CWQWNPSDRPSFAEIHQAF 266

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.9 bits (239), Expect = 1e-20
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 40/213 (18%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKL--HSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
           G G  G V    +  +G   AVK +    +       +++  + E+    ++ H NI+K 
Sbjct: 35  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKT---DKESLLREVQLLKQLDHPNIMKL 91

Query: 839 YGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMH 893
           Y F     + +LV E    G L   I+S    +E  AA         +I+ V + ++YMH
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--------IIRQVLSGITYMH 143

Query: 894 HDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
            +    I+HRD+  + +LL     D   +  + DFG +   +       +  GT  YIAP
Sbjct: 144 KNK---IVHRDLKPENLLLESKSKDANIR--IIDFGLSTHFEASKK-MKDKIGTAYYIAP 197

Query: 949 EL---AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           E+    Y    +EKCDV++ GV++  ++ G  P
Sbjct: 198 EVLHGTY----DEKCDVWSTGVILYILLSGCPP 226

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 39/230 (16%), Positives = 81/230 (35%), Gaps = 29/230 (12%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSL 127
            +  +   L+L    L  +       L +++ + +S +     + + S  NLS +  + +
Sbjct: 28  SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIP--RSLGGLKNL 185
            N      I P+             ++L  L+    + +       + P    +      
Sbjct: 88  RNTRNLTYIDPD-----------ALKELPLLK---FLGIFNTGLK-MFPDLTKVYSTDIF 132

Query: 186 TFVYLNNNRIVGSIPSEI-GNLRSLS-YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
             + + +N  + SIP      L + +  L L  N  + S+   A N + L  +YL+ N+ 
Sbjct: 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKY 191

Query: 244 SGYIPPKLGSFKSLL----YLYLSHNQLNGSLPS-SFGNLSSLKHLHVHN 288
              I     +F  +      L +S   +  +LPS    +L  L   +   
Sbjct: 192 LTVIDK--DAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 47/213 (22%), Positives = 76/213 (35%), Gaps = 14/213 (6%)

Query: 230 LSNLKFLYLHDNRLSGYIPPK-LGSFKSLLYLYLSHNQLNGSLPS-SFGNLSSLKHLHVH 287
             + + L L +  L   IP     +  ++  +Y+S +     L S SF NLS + H+ + 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 288 NINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPS-LGNLSNIRGLYIRENMLYGSIP 345
           N   L+  I  +    L  L  L +  T L  F   + + +      L I +N    SIP
Sbjct: 89  NTRNLT-YIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIP 147

Query: 346 EEL--GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI-ENMKKL 402
                G       L L  N    S+     N + L    L +N+    I ++    +   
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206

Query: 403 NKYL-LFENQFTGYLPQNVCQSGSLTHFSVRNN 434
              L + +   T  LP    +   L     RN 
Sbjct: 207 PSLLDVSQTSVT-ALPSKGLE--HLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 36/229 (15%), Positives = 78/229 (34%), Gaps = 16/229 (6%)

Query: 447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSN-WIKCPQLATLNMGG 505
           C      R+    +      +  + P  + L L   +    I S+ +   P ++ + +  
Sbjct: 10  CHQEEDFRVTCKDIQ----RIPSLPPSTQTLKLIETH-LRTIPSHAFSNLPNISRIYVSI 64

Query: 506 NEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSGDIP-- 561
           +     + S    N++++  ++  + R +  I    L +L  L  L +    L    P  
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL 123

Query: 562 LELGLLAELGYLDLSANRLSKLIPKNL--GELRKLHHLNLSNNQFSQEISIQIGKLVQLS 619
            ++        L+++ N     IP N   G   +   L L NN F   +        +L 
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLD 182

Query: 620 KLDLSHNSLGGNIPSEI-CNLES-LEYMNLLQNKLSGPIPSCFRRMHGL 666
            + L+ N     I  +    + S    +++ Q  ++         +  L
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 44/254 (17%), Positives = 81/254 (31%), Gaps = 52/254 (20%)

Query: 353 SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
           S   L L    L     H   NL N+    +  +     +                 + F
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE---------------SHSF 76

Query: 413 TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRS-LQNCTSLYSLRLERNQLTGNISEVFGIY 471
              L         +TH  +RN   +  I    L+    L  L +    L     ++  +Y
Sbjct: 77  YN-LS-------KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127

Query: 472 --PDLELLDLSNNNFFGEISSNWIK--CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDF 527
                 +L++++N +   I  N  +  C +  TL +  N  + ++     N T+L  +  
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186

Query: 528 SSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKN 587
           + N+           LT +      G            + +    LD+S   ++ L  K 
Sbjct: 187 NKNK----------YLTVIDKDAFGG------------VYSGPSLLDVSQTSVTALPSKG 224

Query: 588 LGELRKLHHLNLSN 601
           L  L++L   N   
Sbjct: 225 LEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 44/246 (17%), Positives = 85/246 (34%), Gaps = 52/246 (21%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFS 61
           ++ L  ++L+ T+    F   P ++ + +S++     + +    +LSK+ H++    +  
Sbjct: 35  TLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93

Query: 62  GIIPPQI-GILTNLVVLRLSVNQLNGLIPEE--LGELTSLNELALSYNRLNGSIPA-SLG 117
             I P     L  L  L +    L  + P+   +        L ++ N    SIP  +  
Sbjct: 94  TYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152

Query: 118 NLSN-LVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIP 176
            L N  + L L NN  +                               S+    F+G   
Sbjct: 153 GLCNETLTLKLYNNGFT-------------------------------SVQGYAFNGT-- 179

Query: 177 RSLGGLKNLTFVYLNNNRIVGSIPSEI--GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNL 233
                   L  VYLN N+ +  I  +   G     S L +++  ++ ++P     +L  L
Sbjct: 180 -------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKEL 231

Query: 234 KFLYLH 239
                 
Sbjct: 232 IARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 31/198 (15%), Positives = 59/198 (29%), Gaps = 24/198 (12%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQ 59
           +  I ++       L+   F    ++ ++++   +    I       L  LK L      
Sbjct: 57  ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG 116

Query: 60  FSGIIPPQIGI--LTNLVVLRLSVNQLNGLIPEEL--GELTSLNELALSYNRLNGSIPAS 115
              + P    +       +L ++ N     IP     G       L L  N    S+   
Sbjct: 117 LK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174

Query: 116 LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSV-SLHTNNFSGV 174
             N + L  + L+ N     I  +                G + S  S+  +   + + +
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDA--------------FGGVYSGPSLLDVSQTSVTAL 220

Query: 175 IPRSLGGLKNLTFVYLNN 192
             + L  LK L     N 
Sbjct: 221 PSKGLEHLKELIA--RNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 39/187 (20%), Positives = 68/187 (36%), Gaps = 10/187 (5%)

Query: 305 SLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNK 363
           S   L L +T L      +  NL NI  +Y+  ++    +       L  ++ + +   +
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 364 LNGSIPH-CLGNLSNLKFFALRENELSGSIPQE--IENMKKLNKYLLFENQFTGYLPQNV 420
               I    L  L  LKF  +    L    P    + +        + +N +   +P N 
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 421 CQ--SGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISE-VF-GIYPDLEL 476
            Q          + NN F   +     N T L ++ L +N+    I +  F G+Y    L
Sbjct: 151 FQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209

Query: 477 LDLSNNN 483
           LD+S  +
Sbjct: 210 LDVSQTS 216

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 22/148 (14%), Positives = 48/148 (32%), Gaps = 8/148 (5%)

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
                  +    +   IP    L      L L    L  +       L  +  + +S + 
Sbjct: 11  HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66

Query: 604 FSQEISIQI-GKLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSG-PIPSCF 660
             Q++       L +++ +++ +      I  +    L  L+++ +    L   P  +  
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126

Query: 661 RRMHGLSSIDVSYNELQGSIPHSKAFQN 688
                   ++++ N    SIP   AFQ 
Sbjct: 127 YSTDIFFILEITDNPYMTSIP-VNAFQG 153

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 42/286 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKL-HSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G+V                AVKKL HS        + + F  EI     ++H NI
Sbjct: 50   GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFEREIEILKSLQHDNI 104

Query: 836  VKFYGFCSHT--QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            VK+ G C     ++L L+ EYL  GSL   L        +D  K +     +   + Y+ 
Sbjct: 105  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 162

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----AP 948
               +   +HRD++++ +L++ E +  + DFG  K L  D   +       G       AP
Sbjct: 163  TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VKEPGESPIFWYAP 217

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVI---EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
            E     + +   DV++FGV++ E+    E         + +        M   V  LI+ 
Sbjct: 218  ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI--VFHLIEL 275

Query: 1006 -----RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 RLP P G  +E    M      C + N + RP+ + +   +
Sbjct: 276  LKNNGRLPRPDGCPDEIYMIMT----ECWNNNVNQRPSFRDLALRV 317

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 94.7 bits (236), Expect = 2e-20
 Identities = 44/206 (21%), Positives = 84/206 (40%), Gaps = 47/206 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKL--HSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           G G    V +  ++ +G   A   +    L   +     +    E      ++H NIV+ 
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH----QKLEREARICRLLKHPNIVRL 75

Query: 839 YGFCSHTQHLFLVYEYLERGSLA-TILS----NEATAAELDWSKRVNVIKGVANALSYMH 893
           +   S   H +L+++ +  G L   I++    +EA A+          I+ +  A+ + H
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQILEAVLHCH 127

Query: 894 -HDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGY 945
                  ++HR++       +SK     +  K   +DFG A  ++ +   W   AGT GY
Sbjct: 128 QMG----VVHRNLKPENLLLASKLKGAAV--KL--ADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 946 IAPEL----AYTMRANEKCDVFNFGV 967
           ++PE+     Y     +  D++  GV
Sbjct: 180 LSPEVLRKDPY----GKPVDLWACGV 201

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 51/278 (18%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G+G  G V   +       AVK +          ++  F  E     ++ H  +VKFYG 
Sbjct: 17   GSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            CS    +++V EY+  G L   L +      L+ S+ + +   V   ++++    F   +
Sbjct: 72   CSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF---I 126

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPD----SSN------WSELAGTCGYIAPELA 951
            HRD++++  L+D +    VSDFG  +++  D    S        WS         APE+ 
Sbjct: 127  HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------APEVF 177

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
            +  + + K DV+ FG+L+ EV   GK P    +            N  V   +    RL 
Sbjct: 178  HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT------------NSEVVLKVSQGHRLY 225

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             P    +   + M +    C    P+ RPT Q++ + +
Sbjct: 226  RPHLASDTIYQIMYS----CWHELPEKRPTFQQLLSSI 259

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 32/204 (15%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH----SLPTGEIGINQKGFVSEIT---EIRHRNIV 836
           G+G CG V  A E  +    A++ +     ++ +           +EI    ++ H  I+
Sbjct: 144 GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 203

Query: 837 KFYGFCSHTQHLFLVYEYLERGSL-ATILSN----EATAAELDWSKRVNVIKGVANALSY 891
           K   F    +  ++V E +E G L   ++ N    EAT               +  A+ Y
Sbjct: 204 KIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQMLLAVQY 254

Query: 892 MHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
           +H +    I+HRD+  + VLL   + +    ++DFG +K L   S     L GT  Y+AP
Sbjct: 255 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAP 310

Query: 949 E-LAYTMRA--NEKCDVFNFGVLV 969
           E L     A  N   D ++ GV++
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 51/281 (18%), Positives = 113/281 (40%), Gaps = 46/281 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRH--RNIVK 837
            G+GG   V++         A+K   L       +      + +EI    +++     I++
Sbjct: 18   GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHSDKIIR 73

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDC 896
             Y +    Q++++V E      L + L  + +   +D  +R +  K +  A+  +H H  
Sbjct: 74   LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG- 128

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE--LAGTCGYIAPEL---- 950
               I+H D+     L+  +    + DFG A  ++PD+++  +    GT  Y+ PE     
Sbjct: 129  ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 951  -------AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
                       + + K DV++ G ++  +  GK P         +    + ++ +++   
Sbjct: 185  SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAIIDPNH 238

Query: 1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            +   P      E+ L+ ++     CL  +P  R ++ ++  
Sbjct: 239  EIEFPD---IPEKDLQDVLK---CCLKRDPKQRISIPELLA 273

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 42/282 (14%)

Query: 779  GKMVLHGTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEI---TEIRH 832
              + L G G  G+V +        +   A+K L     G    + +  + E     ++ +
Sbjct: 14   ADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREAQIMHQLDN 69

Query: 833  RNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
              IV+  G C   + L LV E    G L   L  +    E+  S    ++  V+  + Y+
Sbjct: 70   PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYL 126

Query: 893  HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----A 947
                F   +HRD++++ VLL   + A +SDFG +K L  D S ++  +   G       A
Sbjct: 127  EEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA--GKWPLKWYA 181

Query: 948  PELAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS- 1005
            PE     + + + DV+++GV + E +  G+ P   +                V   I+  
Sbjct: 182  PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------------GPEVMAFIEQG 229

Query: 1006 -RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             R+  P     E    M      C     + RP    V   +
Sbjct: 230  KRMECPPECPPELYALMSD----CWIYKWEDRPDFLTVEQRM 267

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 29/230 (12%), Positives = 64/230 (27%), Gaps = 49/230 (21%)

Query: 16  QEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLV 75
              P   F       L  +    T     + ++ L ++  +    + +    I    N+ 
Sbjct: 15  VNIPDSTFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG--IEYAHNIK 69

Query: 76  VLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQ 135
            L ++        P  +  L++L  L +    +      +L  L++L  L +S+++    
Sbjct: 70  DLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127

Query: 136 IPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI 195
           I                                          +  L  +  + L+ N  
Sbjct: 128 ILTK---------------------------------------INTLPKVNSIDLSYNGA 148

Query: 196 VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSG 245
           +  I   +  L  L  L +  + +         +   L  LY     + G
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVH-DYRGIE-DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 29/224 (12%), Positives = 64/224 (28%), Gaps = 50/224 (22%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
               +   L  +    +   ++  LT +    L+   +       +    N+  L+++N 
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVTDLTG--IEYAHNIKDLTINNI 76

Query: 131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL 190
             +           +P                                + GL NL  + +
Sbjct: 77  HATN---------YNP--------------------------------ISGLSNLERLRI 95

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK 250
               +       +  L SL+ L ++ +    SI      L  +  + L  N     I P 
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP- 154

Query: 251 LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
           L +   L  L +  + ++        +   L  L+  +   + G
Sbjct: 155 LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS-QTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 28/159 (17%), Positives = 60/159 (37%), Gaps = 7/159 (4%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
             L  + +    ++    + I     +  L  ++       P  +  L++L  L + G  
Sbjct: 44  NSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKL 615
           ++ D    L  L  L  LD+S +     I   +  L K++ ++LS N    +I   +  L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158

Query: 616 VQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG 654
            +L  L++  + +  +    I +   L  +      + G
Sbjct: 159 PELKSLNIQFDGV-HDY-RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 32/210 (15%), Positives = 72/210 (34%), Gaps = 35/210 (16%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
             ++     L ++  +     T   +++L ++ L +  ++      +    ++  L +++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSL 324
                                       +      I  L +L  L +    ++    P+L
Sbjct: 76  IH----------------------ATNYNP-----ISGLSNLERLRIMGKDVTSDKIPNL 108

Query: 325 GNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR 384
             L+++  L I  +    SI  ++  L  ++ + LS N     I   L  L  LK   ++
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQ 167

Query: 385 ENELSGSIPQEIENMKKLNKYLLFENQFTG 414
            + +       IE+  KLN+   F     G
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 22/138 (15%), Positives = 52/138 (37%), Gaps = 7/138 (5%)

Query: 543 LTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNN 602
             +  +  L  +  +    +    +  L Y+ L+   ++ L    +     +  L ++N 
Sbjct: 22  FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76

Query: 603 QFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRR 662
             +   +  I  L  L +L +    +  +    +  L SL  +++  +     I +    
Sbjct: 77  HAT-NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 663 MHGLSSIDVSYNELQGSI 680
           +  ++SID+SYN     I
Sbjct: 135 LPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 26/208 (12%), Positives = 56/208 (26%), Gaps = 34/208 (16%)

Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
            K+     L  +            +++L +  L    ++  +   IE    +    +   
Sbjct: 22  FKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76

Query: 411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI 470
             T Y    +    +L    +   +       +L   TSL  L +  +    +I      
Sbjct: 77  HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 471 YPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN 530
            P +  +DLS N    +I                           +  + +L  L+   +
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-------------------------LKTLPELKSLNIQFD 169

Query: 531 RLVGQIPKQLGKLTSLTSLTLNGNQLSG 558
            +       +     L  L      + G
Sbjct: 170 GVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 47/212 (22%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G    V++     +GD  A+K                 + E     ++ H+NIVK + 
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 841 F--CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
               + T+H  L+ E+   GSL T+L   + A  L  S+ + V++ V   ++++  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 899 PILHRDISSKKVLLDLEYKAH----VSDFGTAKFLKPDSSNWSELAGTCGYIAPEL---- 950
            I+HR+I    ++  +         ++DFG A+ L+ D   +  L GT  Y+ P++    
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190

Query: 951 ----AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                +  +     D+++ GV       G  P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 42/278 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
            G G  G VYK  L +   +     A+K L +  T +    +  F+ E     +  H NI+
Sbjct: 53   GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK---QRVDFLGEAGIMGQFSHHNII 109

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +  G  S  + + ++ EY+E G+L   L  +    E    + V +++G+A  + Y+ +  
Sbjct: 110  RLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN 167

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELA 951
            +   +HRD++++ +L++      VSDFG ++ L+ D       +G  G I     APE  
Sbjct: 168  Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG--GKIPIRWTAPEAI 222

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
               +     DV++FG+++ EV+  G+ P   LS            N  V   I+   RLP
Sbjct: 223  SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------NHEVMKAINDGFRLP 270

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             P+       + M+     C       RP    + ++L
Sbjct: 271  TPMDCPSAIYQLMMQ----CWQQERARRPKFADIVSIL 304

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 93.3 bits (232), Expect = 3e-20
 Identities = 50/281 (17%), Positives = 112/281 (39%), Gaps = 46/281 (16%)

Query: 785  GTGGCGTVYKAELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRH--RNIVK 837
            G+GG   V++         A+K   L       +      + +EI    +++     I++
Sbjct: 65   GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL----DSYRNEIAYLNKLQQHSDKIIR 120

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDC 896
             Y +    Q++++V E      L + L  + +   +D  +R +  K +  A+  +H H  
Sbjct: 121  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHG- 175

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE--LAGTCGYIAPEL---- 950
               I+H D+     L+  +    + DFG A  ++PD+++  +    G   Y+ PE     
Sbjct: 176  ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 951  -------AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
                       + + K DV++ G ++  +  GK P         +    + ++ +++   
Sbjct: 232  SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAIIDPNH 285

Query: 1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            +   P      E+ L+ ++     CL  +P  R ++ ++  
Sbjct: 286  EIEFPD---IPEKDLQDVLK---CCLKRDPKQRISIPELLA 320

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 46/209 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH----SLPTGEIGINQKGFVSEIT---EIRHRNIV 836
           G+G CG V  A E  +    A+K +     ++ +           +EI    ++ H  I+
Sbjct: 19  GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 837 KFYGFCSHTQHLFLVYEYL----------ERGSLATILSNEATAAELDWSKRVNVIKGVA 886
           K   F    +  ++V E +              L      EAT               + 
Sbjct: 79  KIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL-----KEATCKLY--------FYQML 124

Query: 887 NALSYMHHDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
            A+ Y+H +    I+HRD+  + VLL     D   K  ++DFG +K L   S     L G
Sbjct: 125 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK--ITDFGHSKILGETSL-MRTLCG 178

Query: 942 TCGYIAPE-LAYTMRA--NEKCDVFNFGV 967
           T  Y+APE L     A  N   D ++ GV
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 45/203 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G+G    V+   +  +G   A+K +   P            +EI    +I+H NIV    
Sbjct: 18  GSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLED 73

Query: 841 FCSHTQHLFLVYEY----------LERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
               T H +LV +           LERG        E  A+ +        I+ V +A+ 
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVY-----TEKDASLV--------IQQVLSAVK 120

Query: 891 YMH-HDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
           Y+H +     I+HRD+  + +L      + +    ++DFG +K  +      S   GT G
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIM--ITDFGLSKMEQN--GIMSTACGTPG 172

Query: 945 YIAPELAYTMRANEKCDVFNFGV 967
           Y+APE+      ++  D ++ GV
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGV 195

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 54/204 (26%), Positives = 80/204 (39%), Gaps = 45/204 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           G G      K     S    AVK        +    EI   +           H NIVK 
Sbjct: 20  GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-EITALKL--CEG-----HPNIVKL 71

Query: 839 YGFCSHTQHLFLVYEYLERGSLAT-ILS----NEATAAELDWSKRVNVIKGVANALSYMH 893
           +       H FLV E L  G L   I      +E  A+         +++ + +A+S+MH
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY--------IMRKLVSAVSHMH 123

Query: 894 HDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
                 ++HRD+  + +L      +LE K  + DFG A+   PD+        T  Y AP
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIK--IIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

Query: 949 EL----AYTMRANEKCDVFNFGVL 968
           EL     Y    +E CD+++ GV+
Sbjct: 179 ELLNQNGY----DESCDLWSLGVI 198

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.5 bits (230), Expect = 4e-20
 Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 40/207 (19%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK----KLHSLPTGEIGINQKGFVSEITEI-----RHRN 834
           G G    V +     +G   AVK        L   ++   ++    E   I      H +
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET-HILRQVAGHPH 161

Query: 835 IVKFYGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANAL 889
           I+        +  +FLV++ + +G L   +      +E     +        ++ +  A+
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI--------MRSLLEAV 213

Query: 890 SYMHHDCFPPILHRDISSKK---VLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           S++H +    I+HRD+   K   +LLD   +  +SDFG +  L+P      EL GT GY+
Sbjct: 214 SFLHANN---IVHRDL---KPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYL 266

Query: 947 APE-LAYTMRA-----NEKCDVFNFGV 967
           APE L  +M        ++ D++  GV
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGV 293

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.4 bits (230), Expect = 5e-20
 Identities = 64/275 (23%), Positives = 122/275 (44%), Gaps = 37/275 (13%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVK 837
            G G  G V    L     +    A+K L    T +    ++ F+ E     +  H NI++
Sbjct: 54   GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK---QRRDFLGEASIMGQFDHPNIIR 110

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G  + ++ + +V EY+E GSL + L      A+    + V +++G+A+ + Y+    +
Sbjct: 111  LEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGY 168

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI---APELAYTM 954
               +HRD++++ +L++      VSDFG  + L+ D        G    I   +PE     
Sbjct: 169  ---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 955  RANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPL 1011
            +     DV+++G+++ EV+  G+ P   +S            N  V   +D   RLPPP+
Sbjct: 226  KFTSASDVWSYGIVLWEVMSYGERPYWEMS------------NQDVIKAVDEGYRLPPPM 273

Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                   + M+     C   + + RP  +++ ++L
Sbjct: 274  DCPAALYQLMLD----CWQKDRNNRPKFEQIVSIL 304

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 47/208 (22%), Positives = 85/208 (40%), Gaps = 45/208 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
           G+G    V K  +  +G   A K  K   L +   G++++    E+    EIRH NI+  
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 839 YGFCSHTQHLFLVYEYL----------ERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +    +   + L+ E +          E+ SL      E  A +         +K + + 
Sbjct: 74  HDIFENKTDVVLILELVSGGELFDFLAEKESL-----TEDEATQF--------LKQILDG 120

Query: 889 LSYMHHDCFPPILHRDISSKK----VLLDLEYKAH---VSDFGTAKFLKPDSSNWSELAG 941
           + Y+H      I H D+   K    +LLD         + DFG A  ++  +  +  + G
Sbjct: 121 VHYLHSKR---IAHFDL---KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFG 173

Query: 942 TCGYIAPE-LAYTMRANEKCDVFNFGVL 968
           T  ++APE + Y      + D+++ GV+
Sbjct: 174 TPEFVAPEIVNYE-PLGLEADMWSIGVI 200

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 93.6 bits (233), Expect = 6e-20
 Identities = 65/284 (22%), Positives = 108/284 (38%), Gaps = 62/284 (21%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEI---TEIRHRNIVKFY 839
            G G  G V K  +  +    AVK    +        +    + E+    ++ H NI+K +
Sbjct: 31   GKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 840  GFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMHH 894
                 +   ++V E    G L   I+     +E  AA         +IK V + ++YMH 
Sbjct: 88   EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--------IIKQVFSGITYMHK 139

Query: 895  DCFPPILHRDISSKK----VLLDLEYKAH--VSDFGTAKFLKPDSSNWSELAGTCGYIAP 948
                 I+HRD+   K    +L   E      + DFG +   + ++    +  GT  YIAP
Sbjct: 140  HN---IVHRDL---KPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAP 192

Query: 949  EL---AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS--LPAPAANMNIVVNDLI 1003
            E+    Y    +EKCDV++ GV+             L +LLS   P    N   ++  + 
Sbjct: 193  EVLRGTY----DEKCDVWSAGVI-------------LYILLSGTPPFYGKNEYDILKRVE 235

Query: 1004 DSRL---PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
              +     P    + +  K +I      L  +P  R T  +   
Sbjct: 236  TGKYAFDLPQWRTISDDAKDLIR---KMLTFHPSLRITATQCLE 276

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 94.2 bits (234), Expect = 6e-20
 Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 38/302 (12%)

Query: 757  TDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTR---AVKKLHSLPT 813
              S   +       L   +     + L G G  G+V +        +   A+K L     
Sbjct: 318  PFSDPEELKDKKLFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--- 373

Query: 814  GEIGINQKGFVSEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATA 870
            G    + +  + E     ++ +  IV+  G C   + L LV E    G L   L  +   
Sbjct: 374  GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKR-- 430

Query: 871  AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK 930
             E+  S    ++  V+  + Y+    F   +HR+++++ VLL   + A +SDFG +K L 
Sbjct: 431  EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALG 487

Query: 931  PDSSNWSELAGTCGYI---APELAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLL 986
             D S ++  +     +   APE     + + + DV+++GV + E +  G+ P   +    
Sbjct: 488  ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--- 544

Query: 987  SLPAPAANMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                        V   I+   R+  P     E    M      C     + RP    V  
Sbjct: 545  ---------GPEVMAFIEQGKRMECPPECPPELYALMSD----CWIYKWEDRPDFLTVEQ 591

Query: 1045 LL 1046
             +
Sbjct: 592  RM 593

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.8 bits (226), Expect = 9e-20
 Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 47/209 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           G+G    V K  E ++G   A K +      +   G++++    E++   EI+H N++  
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 839 YGFCSHTQHLFLVYEYL----------ERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +    +   + L+ E +          E+ SL      E  A E         +K + N 
Sbjct: 80  HEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEEATEF--------LKQILNG 126

Query: 889 LSYMH-HDCFPPILHRDISSKK----VLLDLEYKAH---VSDFGTAKFLKPDSSNWSELA 940
           + Y+H       I H D+   K    +LLD         + DFG A  +   +  +  + 
Sbjct: 127 VYYLHSLQ----IAHFDL---KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178

Query: 941 GTCGYIAPE-LAYTMRANEKCDVFNFGVL 968
           GT  ++APE + Y      + D+++ GV+
Sbjct: 179 GTPEFVAPEIVNYE-PLGLEADMWSIGVI 206

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 51/278 (18%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            GTG  G V   +       A+K +          ++  F+ E      + H  +V+ YG 
Sbjct: 33   GTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C+  + +F++ EY+  G L   L            + + + K V  A+ Y+    F   L
Sbjct: 88   CTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQF---L 142

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPD----SSN------WSELAGTCGYIAPELA 951
            HRD++++  L++ +    VSDFG ++++  D    S        WS          PE+ 
Sbjct: 143  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------PPEVL 193

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
               + + K D++ FGVL+ E+   GK P    +            N    + I    RL 
Sbjct: 194  MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------------NSETAEHIAQGLRLY 241

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             P    E+    M +    C     D RPT + + + +
Sbjct: 242  RPHLASEKVYTIMYS----CWHEKADERPTFKILLSNI 275

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 52/277 (18%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G GG    ++  +  + +  A K +      +    +K    EI+    + H+++V F+G
Sbjct: 24   GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82

Query: 841  FCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHD 895
            F      +F+V E   R SL  +        E  A           ++ +     Y+H +
Sbjct: 83   FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR--------YYLRQIVLGCQYLHRN 134

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPELAY 952
                ++HRD+    + L+ + +  + DFG A  ++ D          CG   YIAPE+  
Sbjct: 135  R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLS 188

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANM-----NIVVNDLIDSRL 1007
                + + DV++ G ++  ++ GK            P   + +      I  N+     +
Sbjct: 189  KKGHSFEVDVWSIGCIMYTLLVGK-----------PPFETSCLKETYLRIKKNEY---SI 234

Query: 1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            P     +     S+I      L  +P  RPT+ ++ N
Sbjct: 235  PK---HINPVAASLIQ---KMLQTDPTARPTINELLN 265

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 32/199 (16%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G+G  G V+   E +SG  R +K   ++      +  +   +EI     + H NI+K + 
Sbjct: 31  GSGAFGDVHLVEERSSGLERVIK---TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 841 FCSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
                 ++++V E  E G L   I+S +A    L       ++K + NAL+Y H      
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--- 144

Query: 899 PILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL- 950
            ++H+D+               ++    + DFG A+  K D    +  AGT  Y+APE+ 
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIK----IIDFGLAELFKSDEH-STNAAGTALYMAPEVF 198

Query: 951 --AYTMRANEKCDVFNFGV 967
                     KCD+++ GV
Sbjct: 199 KRDV----TFKCDIWSAGV 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 89.5 bits (223), Expect = 1e-19
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 44/204 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEIT---EIRHRNIVKFY 839
           G G    V +    T+G   A K    + T ++   + +    E     +++H NIV+ +
Sbjct: 15  GKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 840 GFCSHTQHLFLVYEYLERGSLA-TILS----NEATAAELDWSKRVNVIKGVANALSYMH- 893
                    +LV++ +  G L   I++    +EA A+          I+ +  +++Y H 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQILESIAYCHS 123

Query: 894 HDCFPPILHRDISSKK----VLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIA 947
           +     I+HR++   K    +L      A V  +DFG A  +    + W   AGT GY++
Sbjct: 124 NG----IVHRNL---KPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLS 175

Query: 948 PEL----AYTMRANEKCDVFNFGV 967
           PE+     Y    ++  D++  GV
Sbjct: 176 PEVLKKDPY----SKPVDIWACGV 195

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 26/209 (12%)

Query: 785 GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIV 836
           G GG   V+ A     D R     AVK L +    +     + F  E      + H  IV
Sbjct: 21  GFGGMSEVHLAR----DLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIV 75

Query: 837 KFY--GF--CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
             Y  G          ++V EY++  +L  I+  E     +   + + VI     AL++ 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS 132

Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPE 949
           H +    I+HRD+    +++       V DFG A+ +    ++    + + GT  Y++PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            A     + + DV++ G ++ EV+ G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 57/274 (20%), Positives = 106/274 (38%), Gaps = 46/274 (16%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G GG    ++  +  + +  A K +      +    +K    EI+    + H+++V F+G
Sbjct: 50   GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108

Query: 841  FCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHD 895
            F      +F+V E   R SL  +        E  A           ++ +     Y+H +
Sbjct: 109  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--------LRQIVLGCQYLHRN 160

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPELAY 952
                ++HRD+    + L+ + +  + DFG A  ++ D          CG   YIAPE+  
Sbjct: 161  R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLS 214

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHP--GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010
                + + DV++ G ++  ++ GK P     L              I  N+     +P  
Sbjct: 215  KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--------RIKKNEY---SIPK- 262

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
               +     S+I      L  +P  RPT+ ++ N
Sbjct: 263  --HINPVAASLIQ---KMLQTDPTARPTINELLN 291

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 44/286 (15%)

Query: 785  GTGGCGTVYKAELT-SGDTR----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
            G G  G V       + D      AVK L +    +   ++ G+  EI     + H +I+
Sbjct: 40   GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ---HRSGWKQEIDILRTLYHEHII 96

Query: 837  KFYGFCSHTQH--LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            K+ G C       L LV EY+  GSL   L        +  ++ +   + +   ++Y+H 
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APE 949
              +   +HRD++++ VLLD +    + DFG AK +      +       G       APE
Sbjct: 153  QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPE 207

Query: 950  LAYTMRANEKCDVFNFGVLVLEVI----EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005
                 +     DV++FGV + E++      + P      L+ +        + V  L + 
Sbjct: 208  CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG----QMTVLRLTEL 263

Query: 1006 -----RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 RLP P     E    M      C +     RPT + +  +L
Sbjct: 264  LERGERLPRPDKCPAEVYHLMK----NCWETEASFRPTFENLIPIL 305

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 91.1 bits (226), Expect = 2e-19
 Identities = 47/212 (22%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G    V++     +GD  A+K                 + E     ++ H+NIVK + 
Sbjct: 18  GQGATANVFRGRHKKTGDLFAIKVF---NNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 841 F--CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
               + T+H  L+ E+   GSL T+L   + A  L  S+ + V++ V   ++++  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 899 PILHRDISSKKVLLDLEYKAH----VSDFGTAKFLKPDSSNWSELAGTCGYIAPEL---- 950
            I+HR+I    ++  +         ++DFG A+ L+ D   +  L GT  Y+ P++    
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190

Query: 951 ----AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
                +  +     D+++ GV       G  P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 57/271 (21%), Positives = 120/271 (44%), Gaps = 37/271 (13%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V+ A        AVK +         ++ + F++E      ++H  +VK +  
Sbjct: 197  GAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ E++ +GSL   L ++  + +    K ++    +A  ++++    +   +
Sbjct: 252  VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNY---I 306

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI---APELAYTMRANE 958
            HRD+ +  +L+       ++DFG A+ ++ +   ++   G    I   APE         
Sbjct: 307  HRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 959  KCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVE 1015
            K DV++FG+L++E++  G+ P   +S            N  V   ++   R+P P    E
Sbjct: 365  KSDVWSFGILLMEIVTYGRIPYPGMS------------NPEVIRALERGYRMPRPENCPE 412

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            E    M+     C    P+ RPT + + ++L
Sbjct: 413  ELYNIMMR----CWKNRPEERPTFEYIQSVL 439

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 91.6 bits (228), Expect = 2e-19
 Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 49/275 (17%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V   +   G+  AVK + +          + F++E    T++RH N+V+  G 
Sbjct: 202  GKGEFGDVMLGDYR-GNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 842  CSHTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                +  L++V EY+ +GSL   L +    + L     +     V  A+ Y+  + F   
Sbjct: 255  IVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN------WSELAGTCGYIAPELAYTM 954
            +HRD++++ VL+  +  A VSDFG  K              W+         APE     
Sbjct: 311  VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREK 361

Query: 955  RANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPL 1011
            + + K DV++FG+L+ E+   G+ P   +                V   ++   ++  P 
Sbjct: 362  KFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPRVEKGYKMDAPD 409

Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            G        M      C   +   RPT  ++   L
Sbjct: 410  GCPPAVYDVMKN----CWHLDAATRPTFLQLREQL 440

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 91.4 bits (227), Expect = 2e-19
 Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 41/273 (15%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V+          A+K L         ++ + F+ E     ++RH  +V+ Y  
Sbjct: 193  GQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+    +   +
Sbjct: 248  VSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYTMRA 956
            HRD+ +  +L+       V+DFG A+ ++ +       A           APE A   R 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRF 358

Query: 957  NEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGE 1013
              K DV++FG+L+ E+  +G+ P   +             N  V D ++   R+P P   
Sbjct: 359  TIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYRMPCPPEC 406

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             E     M      C    P+ RPT + +   L
Sbjct: 407  PESLHDLMCQ----CWRKEPEERPTFEYLQAFL 435

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 44/270 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIV 836
            G+G  GTVYK        +     A+K+L            K  + E   +  + + ++ 
Sbjct: 24   GSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASVDNPHVC 80

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +  G C  T  + L+ + +  G L   +        +     +N    +A  ++Y+    
Sbjct: 81   RLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELA 951
                +HRD++++ VL+       ++DFG AK L  +     E     G +     A E  
Sbjct: 138  L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---KEYHAEGGKVPIKWMALESI 191

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
                   + DV+++GV V E++  G  P   +                ++ +++   RLP
Sbjct: 192  LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------------ASEISSILEKGERLP 239

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
             P     +    M+     C   + D RP 
Sbjct: 240  QPPICTIDVYMIMVK----CWMIDADSRPK 265

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 62/275 (22%), Positives = 110/275 (40%), Gaps = 49/275 (17%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V   +   G+  AVK + +          + F++E    T++RH N+V+  G 
Sbjct: 30   GKGEFGDVMLGDYR-GNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 842  CSHTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                +  L++V EY+ +GSL   L +    + L     +     V  A+ Y+  + F   
Sbjct: 83   IVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN------WSELAGTCGYIAPELAYTM 954
            +HRD++++ VL+  +  A VSDFG  K              W+         APE     
Sbjct: 139  VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREK 189

Query: 955  RANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPL 1011
            + + K DV++FG+L+ E+   G+ P   +                V   ++   ++  P 
Sbjct: 190  KFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPRVEKGYKMDAPD 237

Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            G      + M      C   +   RP+  ++   L
Sbjct: 238  GCPPAVYEVMKN----CWHLDAAMRPSFLQLREQL 268

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.0 bits (223), Expect = 3e-19
 Identities = 36/228 (15%), Positives = 69/228 (30%), Gaps = 26/228 (11%)

Query: 772 LSASTFEGKMVLHGTGGCGTVYKAE------LTSGDTRAVKKLHSLPTGEIGINQKGFVS 825
           L +       +L G G    VY+A         +     +K        E  I  +  + 
Sbjct: 62  LGSKLVYVHHLL-GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LME 119

Query: 826 EITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILS--NEATAAELDWSKRVNVIK 883
            +        +KFY          LV E    G+L   ++         +     ++   
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH-----------VSDFGTAKFLK-- 930
            +   +  +H      I+H DI     +L   +              + D G +  +K  
Sbjct: 180 RMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           P  + ++    T G+   E+      N + D F     V  ++ G + 
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 47/205 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK---KLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYG 840
           G G      +     +    AVK   K    PT EI I  +         +H NI+    
Sbjct: 31  GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR-------YGQHPNIITLKD 83

Query: 841 FCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMH-H 894
                +++++V E ++ G L   IL     +E  A+         V+  +   + Y+H  
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA--------VLFTITKTVEYLHAQ 135

Query: 895 DCFPPILHRDISSKK----VLLDLEYKAH---VSDFGTAKFLKPDSSNWSELAGTCGYIA 947
                ++HRD+   K    + +D         + DFG AK L+ ++        T  ++A
Sbjct: 136 G----VVHRDL---KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188

Query: 948 PEL----AYTMRANEKCDVFNFGVL 968
           PE+     Y    +  CD+++ GVL
Sbjct: 189 PEVLERQGY----DAACDIWSLGVL 209

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 62/280 (22%), Positives = 100/280 (35%), Gaps = 45/280 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVK 837
            G G  G V + E  +   +    AVK L      +       F+ E+     + HRN+++
Sbjct: 27   GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-FIREVNAMHSLDHRNLIR 85

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
             YG    T  + +V E    GSL   L                    VA  + Y+    F
Sbjct: 86   LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT------CGYIAPELA 951
               +HRD++++ +LL       + DFG  + L  +  ++            C   APE  
Sbjct: 143  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC---APESL 196

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANM-NIVVNDLIDS---R 1006
             T   +   D + FGV + E+   G+              P   +    +   ID    R
Sbjct: 197  KTRTFSHASDTWMFGVTLWEMFTYGQ-------------EPWIGLNGSQILHKIDKEGER 243

Query: 1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            LP P    E+  + +  V   C    P+ RPT   + + L
Sbjct: 244  LPRP----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 90.7 bits (225), Expect = 6e-19
 Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 41/273 (15%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V+          A+K L         ++ + F+ E     ++RH  +V+ Y  
Sbjct: 276  GQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E     L   + V++   +A+ ++Y+    +   +
Sbjct: 331  VSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 385

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYTMRA 956
            HRD+ +  +L+       V+DFG A+ ++ +       A           APE A   R 
Sbjct: 386  HRDLRAANILVGENLVCKVADFGLARLIEDNEYT----ARQGAKFPIKWTAPEAALYGRF 441

Query: 957  NEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPPLGE 1013
              K DV++FG+L+ E+  +G+ P   +             N  V D ++   R+P P   
Sbjct: 442  TIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYRMPCPPEC 489

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             E     M      C    P+ RPT + +   L
Sbjct: 490  PESLHDLMCQ----CWRKEPEERPTFEYLQAFL 518

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.1 bits (219), Expect = 7e-19
 Identities = 43/208 (20%), Positives = 83/208 (39%), Gaps = 45/208 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
           G+G    V K  E ++G   A K  K         G++++    E+    ++ H N++  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 839 YGFCSHTQHLFLVYEYL----------ERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +    +   + L+ E +          ++ SL     +E  A           IK + + 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKESL-----SEEEATSF--------IKQILDG 127

Query: 889 LSYMHHDCFPPILHRDISSKK----VLLDLEYKAH---VSDFGTAKFLKPDSSNWSELAG 941
           ++Y+H      I H D+   K    +LLD         + DFG A  ++     +  + G
Sbjct: 128 VNYLHTKK---IAHFDL---KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 942 TCGYIAPE-LAYTMRANEKCDVFNFGVL 968
           T  ++APE + Y      + D+++ GV+
Sbjct: 181 TPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 90.9 bits (225), Expect = 7e-19
 Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 24/209 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFY- 839
           GTGG G V +     +G+  A+K+     + +   N++ +  EI    ++ H N+V    
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK---NRERWCLEIQIMKKLNHPNVVSARE 79

Query: 840 -----GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                   +      L  EY E G L   L+       L       ++  +++AL Y+H 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 895 DCFPPILHRDISSKKVLLDLE-----YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           +    I+HRD+  + ++L        +K  + D G AK L       +E  GT  Y+APE
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHK--IIDLGYAKELDQGE-LCTEFVGTLQYLAPE 193

Query: 950 LAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           L    +     D ++FG L  E I G  P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 32/143 (22%), Positives = 65/143 (45%), Gaps = 16/143 (11%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           +P+ +  +       L  N    + P +    K L  + L+NN+I   +  +    LRSL
Sbjct: 30  LPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF---KSLLYLYLSHN 265
           + L L  N+++  +P +    L +L+ L L+ N+++  +     +F    +L  L L  N
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRV--DAFQDLHNLNLLSLYDN 138

Query: 266 QLNGSLPSSFGNLSSLKHLHVHN 288
           +L      +F  L +++ +H+  
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQ 161

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 15/147 (10%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF-- 254
            IP+ +    +++ + L +N +   IPP A      L+ + L +N++S  + P   +F  
Sbjct: 25  EIPTNL--PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQG 78

Query: 255 -KSLLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
            +SL  L L  N++   LP S F  L SL+ L ++  NK++  +  +   +L +L+ L L
Sbjct: 79  LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNA-NKIN-CLRVDAFQDLHNLNLLSL 135

Query: 312 SKTQLSGFIPPSLGNLSNIRGLYIREN 338
              +L      +   L  I+ +++ +N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 15/135 (11%)

Query: 184 NLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
            +T + L  N I   IP       + L  + L+ NQ+S  + P A   L +L  L L+ N
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90

Query: 242 RLSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPS-SFGNLSSLKHLHVHNINKLSGSIP 297
           +++  +P     F+   SL  L L+ N++N  L   +F +L +L  L +++ NKL  +I 
Sbjct: 91  KIT-ELPK--SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD-NKLQ-TIA 144

Query: 298 KEI-GNLKSLSHLWL 311
           K     L+++  + L
Sbjct: 145 KGTFSPLRAIQTMHL 159

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 33/181 (18%), Positives = 62/181 (34%), Gaps = 47/181 (25%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNL 122
           IP    +   +  +RL  N +  + P        L  + LS N+++  +   +   L +L
Sbjct: 26  IPT--NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 123 VQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGL 182
             L L  N ++                 +P                            GL
Sbjct: 83  NSLVLYGNKIT----------------ELP-----------------------KSLFEGL 103

Query: 183 KNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHD 240
            +L  + LN N+I   +  +   +L +L+ L L  N+L  +I       L  ++ ++L  
Sbjct: 104 FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQ 161

Query: 241 N 241
           N
Sbjct: 162 N 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 36/175 (20%), Positives = 65/175 (37%), Gaps = 43/175 (24%)

Query: 96  TSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
            ++ E+ L  N +    P +      L ++ LSNN +S                 +    
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS----------------ELA--- 72

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGL 214
                               P +  GL++L  + L  N+I   +P  +   L SL  L L
Sbjct: 73  --------------------PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111

Query: 215 NKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
           N N+++  +   A  +L NL  L L+DN+L           +++  ++L+ N   
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 32/146 (21%), Positives = 55/146 (37%), Gaps = 14/146 (9%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---L 567
            IP+ +       ++    N +    P        L  + L+ NQ+S    L       L
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE---LAPDAFQGL 79

Query: 568 AELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLS 624
             L  L L  N++++L       L  L  L L+ N+ +    +++     L  L+ L L 
Sbjct: 80  RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN---CLRVDAFQDLHNLNLLSLY 136

Query: 625 HNSLGGNIPSEICNLESLEYMNLLQN 650
            N L          L +++ M+L QN
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 29/119 (24%), Positives = 53/119 (44%), Gaps = 4/119 (3%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQI-GIL 71
            +    F  + +L  +DLS NQ+   +       L  L  L    N+ + + P  +   L
Sbjct: 46  VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKITEL-PKSLFEGL 103

Query: 72  TNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
            +L +L L+ N++N L  +   +L +LN L+L  N+L      +   L  +  + L+ N
Sbjct: 104 FSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 29/141 (20%), Positives = 54/141 (38%), Gaps = 10/141 (7%)

Query: 469 GIYPDLELLDLSNNNFFGEISSN-WIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLD 526
            +   +  + L  N     I    +    +L  +++  N+IS  +  +    +  L+ L 
Sbjct: 29  NLPETITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86

Query: 527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSKL 583
              N++          L SL  L LN N+++    L +     L  L  L L  N+L  +
Sbjct: 87  LYGNKITELPKSLFEGLFSLQLLLLNANKINC---LRVDAFQDLHNLNLLSLYDNKLQTI 143

Query: 584 IPKNLGELRKLHHLNLSNNQF 604
                  LR +  ++L+ N F
Sbjct: 144 AKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 9/114 (7%)

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLG 629
           + L  N +  + P      +KL  ++LSNNQ S    +       L  L+ L L  N + 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS---ELAPDAFQGLRSLNSLVLYGNKI- 92

Query: 630 GNIPSEI-CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH 682
             +P  +   L SL+ + L  NK++      F+ +H L+ + +  N+LQ +I  
Sbjct: 93  TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 28/130 (21%), Positives = 56/130 (43%), Gaps = 7/130 (5%)

Query: 260 LYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSG 318
           + L  N +    P +F     L+ + + N N++S  +  +    L+SL+ L L   +++ 
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSN-NQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94

Query: 319 FIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPH-CLGNLS 376
                   L +++ L +  N +   +  +    L +L+ LSL  NKL  +I       L 
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152

Query: 377 NLKFFALREN 386
            ++   L +N
Sbjct: 153 AIQTMHLAQN 162

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.6 bits (220), Expect = 8e-19
 Identities = 44/208 (21%), Positives = 83/208 (39%), Gaps = 45/208 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK--KLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
           G+G    V K  E ++G   A K  K         G+ ++    E++   ++ H NI+  
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 839 YGFCSHTQHLFLVYEYL----------ERGSLATILSNEATAAELDWSKRVNVIKGVANA 888
           +    +   + L+ E +          ++ SL     +E  A           IK + + 
Sbjct: 81  HDVYENRTDVVLILELVSGGELFDFLAQKESL-----SEEEATSF--------IKQILDG 127

Query: 889 LSYMHHDCFPPILHRDISSKK----VLLDLEYKAH---VSDFGTAKFLKPDSSNWSELAG 941
           ++Y+H      I H D+   K    +LLD         + DFG A  ++     +  + G
Sbjct: 128 VNYLHTKK---IAHFDL---KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFG 180

Query: 942 TCGYIAPE-LAYTMRANEKCDVFNFGVL 968
           T  ++APE + Y      + D+++ GV+
Sbjct: 181 TPEFVAPEIVNYE-PLGLEADMWSIGVI 207

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 88.4 bits (219), Expect = 8e-19
 Identities = 44/194 (22%), Positives = 76/194 (39%), Gaps = 28/194 (14%)

Query: 160 SPVSVSLHTNNFSGV---IPRSLGGLKNLTFVYLNNNRIVGSIPSEI--GNLRSLSYLGL 214
           +   +S        V   +P           + L++N +   + +E     L +L  L L
Sbjct: 19  ASNILSCSKQQLPNVPQSLPS------YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLL 71

Query: 215 NKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLNGS 270
           + N L+  I   A   + NL++L L  N L   +      F    +L  L L +N +   
Sbjct: 72  SHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDE--FLFSDLQALEVLLLYNNHIVVV 127

Query: 271 LPSSFGNLSSLKHLHVHNINKLSGSIPKEI----GNLKSLSHLWLSKTQLSGFIPPSLGN 326
             ++F +++ L+ L++   N++S   P E+      L  L  L LS  +L       L  
Sbjct: 128 DRNAFEDMAQLQKLYLSQ-NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185

Query: 327 LSNI--RGLYIREN 338
           L      GLY+  N
Sbjct: 186 LPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 86.8 bits (215), Expect = 3e-18
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 15/171 (8%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKC--PQLATLNMGGNEISGTIPSEI-GNMTQLHKL 525
            +     LLDLS+NN    + + W       L +L +  N ++  I SE    +  L  L
Sbjct: 36  SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93

Query: 526 DFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYLDLSANRLSKL 583
           D SSN L   + +     L +L  L L  N +   +       +A+L  L LS N++S+ 
Sbjct: 94  DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRF 151

Query: 584 IP---KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN 631
                K+  +L KL  L+LS+N+      + +  L +L     +   L  N
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLK---KLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 46/187 (24%), Positives = 74/187 (39%), Gaps = 21/187 (11%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQI--SHLSKLKHLDFSTNQFSGIIPPQI-GIL 71
           L   P  L    A LDLS N L   +  +   + L+ L  L  S N  +  I  +    +
Sbjct: 30  LPNVPQSLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 72  TNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNN 130
            NL  L LS N L+ L      +L +L  L L  N +   +   +  +++ L +L LS N
Sbjct: 88  PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146

Query: 131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLT--FV 188
            +S + P             + +D   L   + + L +N    +    L  L       +
Sbjct: 147 QIS-RFPVE-----------LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

Query: 189 YLNNNRI 195
           YL+NN +
Sbjct: 195 YLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 16/171 (9%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLE-LGLLA 568
            +P  + + T    LD S N L     +    +LT+L SL L+ N L+  I  E    + 
Sbjct: 32  NVPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSH 625
            L YLDLS+N L  L      +L+ L  L L NN       +       + QL KL LS 
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV---VVDRNAFEDMAQLQKLYLSQ 145

Query: 626 NSLGGNIPSEI----CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVS 672
           N +    P E+      L  L  ++L  NKL     +  +++       + 
Sbjct: 146 NQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 8/141 (5%)

Query: 4   INLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSG 62
           ++L+ +NL     E+       L  L LS N L   I ++    +  L++LD S+N    
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHT 102

Query: 63  IIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA----SLGN 118
           +       L  L VL L  N +  +      ++  L +L LS N+++   P         
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161

Query: 119 LSNLVQLSLSNNSLSGQIPPN 139
           L  L+ L LS+N L  ++P  
Sbjct: 162 LPKLMLLDLSSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 14/149 (9%)

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKN-LGELRKLHHLNLSNNQ 603
           +   L+ +  QL  ++P    L +    LDLS N LS+L  +     L  LH L LS+N 
Sbjct: 19  ASNILSCSKQQLP-NVPQ--SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75

Query: 604 FSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPSC 659
            +    I       +  L  LDLS N L   +   +  +L++LE + L  N +     + 
Sbjct: 76  LN---FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNA 131

Query: 660 FRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
           F  M  L  + +S N++    P     ++
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVE-LIKD 158

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 40/197 (20%), Positives = 66/197 (33%), Gaps = 34/197 (17%)

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPP--SLGNLSNIRGLYIRENMLYGSIPEE-LGRL 351
           ++P+ + +    + L LS   LS  +    +   L+N+  L +  N L   I  E    +
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPV 87

Query: 352 KSLSQLSLSVNKLNGSIP-HCLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFE 409
            +L  L LS N L+ ++      +L  L+   L  N +   + +   E+M +L K  L +
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145

Query: 410 NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFG 469
           NQ +                                    L  L L  N+L         
Sbjct: 146 NQIS----------------RFPVELIKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQ 184

Query: 470 IYPDLEL--LDLSNNNF 484
             P      L L NN  
Sbjct: 185 KLPAWVKNGLYLHNNPL 201

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 86.8 bits (216), Expect = 9e-19
 Identities = 60/276 (21%), Positives = 110/276 (39%), Gaps = 49/276 (17%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVKFY 839
            G G    VY+A  + +G   A+K +      + G+ Q+   +E+ +I    +H +I++ Y
Sbjct: 20   GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEV-KIHCQLKHPSILELY 77

Query: 840  GFCSHTQHLFLVYEYLERGSLATILS------NEATAAELDWSKRVNVIKGVANALSYMH 893
             +   + +++LV E    G +   L       +E  A         + +  +   + Y+H
Sbjct: 78   NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--------HFMHQIITGMLYLH 129

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
                  ILHRD++   +LL       ++DFG A  LK        L GT  YI+PE+A  
Sbjct: 130  SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN-----IVVNDLIDSRLP 1008
                 + DV++ G +   ++ G+            P     +      +V+ D     +P
Sbjct: 187  SAHGLESDVWSLGCMFYTLLIGR-----------PPFDTDTVKNTLNKVVLADY---EMP 232

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
              L    + L   +      L  NP  R ++  V +
Sbjct: 233  SFLSIEAKDLIHQL------LRRNPADRLSLSSVLD 262

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G VY A E  S    A+K L      + G+  +    E+   + +RH NI++ YG
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLYG 76

Query: 841 FCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHD 895
           +      ++L+ EY   G++   L      +E   A          I  +ANALSY H  
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--------TYITELANALSYCHSK 128

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               ++HRDI  + +LL    +  ++DFG +      SS  ++L GT  Y+ PE+     
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            +EK D+++ GVL  E + GK P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 88.5 bits (220), Expect = 9e-19
 Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 46/205 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEIT---EIRHRNIVKFY 839
           G G    V +    T+G   A K    + T ++   + +    E     +++H NIV+ +
Sbjct: 38  GKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 840 GFCSHTQHLFLVYEYLERGSLA-TILS----NEATAAELDWSKRVNVIKGVANALSYMH- 893
                    +LV++ +  G L   I++    +EA A+          I+ +  +++Y H 
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--------IQQILESIAYCHS 146

Query: 894 HDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           +     I+HR++       +SK     +  K   +DFG A  +    + W   AGT GY+
Sbjct: 147 NG----IVHRNLKPENLLLASKAKGAAV--KL--ADFGLAIEVNDSEA-WHGFAGTPGYL 197

Query: 947 APEL----AYTMRANEKCDVFNFGV 967
           +PE+     Y    ++  D++  GV
Sbjct: 198 SPEVLKKDPY----SKPVDIWACGV 218

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 42/226 (18%)

Query: 96  TSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
               +  L    +          L+++ Q+  +N+ +                     ++
Sbjct: 19  AETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQ-----------YLPNV 65

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLG---GLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSY 211
             L       L  N         +     L NLT++ L  N++  S+P+ +   L +L  
Sbjct: 66  RYLA------LGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKE 113

Query: 212 LGLNKNQLSGSIPPTAGN-LSNLKFLYLHDNRLSGYIPPKLGSFKSLL---YLYLSHNQL 267
           L L +NQL  S+P    + L+NL +L L  N+L   +P   G F  L     L LS+NQL
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS-LPK--GVFDKLTNLTELDLSYNQL 169

Query: 268 NGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
             SLP   F  L+ LK L ++  N+L  S+P  +   L SL ++WL
Sbjct: 170 Q-SLPEGVFDKLTQLKDLRLYQ-NQLK-SVPDGVFDRLTSLQYIWL 212

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 59/259 (22%), Positives = 96/259 (37%), Gaps = 65/259 (25%)

Query: 39  TIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL 98
             P      ++    +      +     Q   L ++  +  + + +  +    +  L ++
Sbjct: 12  IFPDDAF--AETIKANLKKKSVTDA-VTQNE-LNSIDQIIANNSDIKSVQG--IQYLPNV 65

Query: 99  NELALSYNRLNGSIPASLG---NLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
             LAL  N+L       +     L+NL  L L+ N L                       
Sbjct: 66  RYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ---------------------- 98

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGN-LRSLSYLGL 214
                    SL    F          L NL  + L  N++  S+P  + + L +L+YL L
Sbjct: 99  ---------SLPNGVFDK--------LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140

Query: 215 NKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLNGS 270
             NQL  S+P      L+NL  L L  N+L   +P   G F     L  L L  NQL  S
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPE--GVFDKLTQLKDLRLYQNQLK-S 195

Query: 271 LPS-SFGNLSSLKHLHVHN 288
           +P   F  L+SL+++ +H+
Sbjct: 196 VPDGVFDRLTSLQYIWLHD 214

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 28  YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGL 87
             +L    +     TQ   L+ +  +  + +    +    I  L N+  L L  N+L   
Sbjct: 23  KANLKKKSV-TDAVTQN-ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL--- 75

Query: 88  IPEELG---ELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYL 143
              ++    ELT+L  L L+ N+L  S+P  +   L+NL +L L  N L   +P      
Sbjct: 76  --HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDG---- 127

Query: 144 ISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI 203
                  +   L NL     ++L  N    +       L NLT + L+ N++  S+P  +
Sbjct: 128 -------VFDKLTNLTY---LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-QSLPEGV 176

Query: 204 -GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
              L  L  L L +NQL  S+P      L++L++++LHDN
Sbjct: 177 FDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 26/213 (12%)

Query: 448 TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNE 507
                  L++  +T   +        ++ +  +N++            P +  L +GGN+
Sbjct: 19  AETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNK 74

Query: 508 ISGTIPSEIG---NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL 564
           +      +I     +T L  L  + N+L         KLT+L  L L  NQL     L  
Sbjct: 75  LH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS---LPD 126

Query: 565 GL---LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQL 618
           G+   L  L YL+L+ N+L  L      +L  L  L+LS NQ     S+  G   KL QL
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ---SLPEGVFDKLTQL 183

Query: 619 SKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQN 650
             L L  N L  ++P  +   L SL+Y+ L  N
Sbjct: 184 KDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 26/162 (16%)

Query: 182 LKNLTFVYLNNNRIVGSIPSEIG---NLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLY 237
           L N+ ++ L  N++      +I     L +L+YL L  NQL  S+P      L+NLK L 
Sbjct: 62  LPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELV 115

Query: 238 LHDNRLSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLS 293
           L +N+L   +P   G F  L    YL L+HNQL  SLP   F  L++L  L +   N+L 
Sbjct: 116 LVENQLQ-SLPD--GVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSY-NQLQ 170

Query: 294 GSIPKEI-GNLKSLSHLWLSKTQLSGFIPP----SLGNLSNI 330
            S+P+ +   L  L  L L + QL   +P      L +L  I
Sbjct: 171 -SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYI 210

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 53/193 (27%), Positives = 84/193 (43%), Gaps = 35/193 (18%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQIS---HLSKLKHLDFSTNQFSGIIP 65
           ++   ++Q   +L  P + YL L  N+L       IS    L+ L +L  + NQ   +  
Sbjct: 50  NSDIKSVQGIQYL--PNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPN 102

Query: 66  PQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQ 124
                LTNL  L L  NQL  L      +LT+L  L L++N+L  S+P  +   L+NL +
Sbjct: 103 GVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTE 161

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQ----DLGNLESPVSVSLHTNNFSGVIPRSLG 180
           L LS N L                 S+P+     L  L+    + L+ N    V      
Sbjct: 162 LDLSYNQLQ----------------SLPEGVFDKLTQLK---DLRLYQNQLKSVPDGVFD 202

Query: 181 GLKNLTFVYLNNN 193
            L +L +++L++N
Sbjct: 203 RLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 17/176 (9%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAEL 570
             P +    T   K +     +   + +   +L S+  +  N + +     ++   L  +
Sbjct: 12  IFPDDAFAETI--KANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY--LPNV 65

Query: 571 GYLDLSANRLSKLIPKNLG---ELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNS 627
            YL L  N+L  +         EL  L +L L+ NQ     +    KL  L +L L  N 
Sbjct: 66  RYLALGGNKLHDI-----SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120

Query: 628 LGGNIPSEICN-LESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH 682
           L  ++P  + + L +L Y+NL  N+L       F ++  L+ +D+SYN+LQ S+P 
Sbjct: 121 LQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPE 174

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 66/276 (23%), Positives = 109/276 (39%), Gaps = 41/276 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKF 838
            G+G  GTV K            AVK L +        ++   ++E     ++ +  IV+ 
Sbjct: 26   GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE--LLAEANVMQQLDNPYIVRM 83

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
             G C   +   LV E  E G L   L        +     + ++  V+  + Y+    F 
Sbjct: 84   IGICE-AESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESNF- 138

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAYT 953
              +HRD++++ VLL  ++ A +SDFG +K L+ D + +   A T G       APE    
Sbjct: 139  --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINY 194

Query: 954  MRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPPP 1010
             + + K DV++FGVL+ E    G+ P   +                V  +++   R+  P
Sbjct: 195  YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------------GSEVTAMLEKGERMGCP 242

Query: 1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             G   E    M      C   + + RP    V   L
Sbjct: 243  AGCPREMYDLMNL----CWTYDVENRPGFAAVELRL 274

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 54/290 (18%), Positives = 99/290 (34%), Gaps = 64/290 (22%)

Query: 785  GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSE---ITEIRHR 833
            G G    ++K                  +K L            + F      ++++ H+
Sbjct: 17   GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY----SESFFEAASMMSKLSHK 72

Query: 834  NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH 893
            ++V  YG C       LV E+++ GSL T L        ++   ++ V K +A A+ ++ 
Sbjct: 73   HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE 130

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAH--------VSDFGTAKFLKPDSS-----NWSELA 940
             +     +H ++ +K +LL  E            +SD G +  + P         W    
Sbjct: 131  ENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184

Query: 941  GTCGYIAPE-LAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIV 998
                   PE +      N   D ++FG  + E+   G  P   L             +  
Sbjct: 185  ------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD------------SQR 226

Query: 999  VNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 +   +LP P      K   +  +   C+D  PD RP+ + +   L
Sbjct: 227  KLQFYEDRHQLPAP------KAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 45/203 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G V  A +  +   RA K    +P   +  +   F  EI     + H NI++ Y 
Sbjct: 18  GRGSWGEVKIAVQKGTRIRRAAK---KIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 841 FCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMH-H 894
                  ++LV E    G L   ++      E+ AA +        +K V +A++Y H  
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI--------MKDVLSAVAYCHKL 125

Query: 895 DCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIA 947
           +    + HRD+        +      L+    + DFG A   KP         GT  Y++
Sbjct: 126 N----VAHRDLKPENFLFLTDSPDSPLK----LIDFGLAARFKPG-KMMRTKVGTPYYVS 176

Query: 948 PEL---AYTMRANEKCDVFNFGV 967
           P++    Y      +CD ++ GV
Sbjct: 177 PQVLEGLY----GPECDEWSAGV 195

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 60/270 (22%), Positives = 101/270 (37%), Gaps = 44/270 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIV 836
            G+G  GTV+K               +K +      +   + +     +     + H +IV
Sbjct: 22   GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ---SFQAVTDHMLAIGSLDHAHIV 78

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +  G C     L LV +YL  GSL   +        L     +N    +A  + Y+    
Sbjct: 79   RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELA 951
                +HR+++++ VLL    +  V+DFG A  L PD     +L  +         A E  
Sbjct: 136  M---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWMALESI 189

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
            +  +   + DV+++GV V E++  G  P   L                V DL++   RL 
Sbjct: 190  HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR------------LAEVPDLLEKGERLA 237

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
             P     +    M+     C   + + RPT
Sbjct: 238  QPQICTIDVYMVMVK----CWMIDENIRPT 263

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 87.0 bits (215), Expect = 3e-18
 Identities = 23/294 (7%), Positives = 69/294 (23%), Gaps = 50/294 (17%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
              G    V+   ++   +  A+K    +         +           +   +  +   
Sbjct: 71   RVGDRSVVFLVRDVERLEDFALKVFT-MGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 841  FC--------------------------SHTQHLFLVYEYLERGSLATILS----NEATA 870
                                            +  L+        L  + S         
Sbjct: 130  RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 871  AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK 930
             +        +   +    + +       ++H   +   + +  + +  + D        
Sbjct: 189  GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242

Query: 931  PDSSNWSELAGTCGYIAPEL--AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL 988
               +     +    Y   E   A T       + +  G+ +  V     P   ++  +  
Sbjct: 243  KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302

Query: 989  PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                 ++ +   D +      PL +    +K++I      L+ +   R    + 
Sbjct: 303  SWKRPSLRVPGTDSLAFGSCTPLPDF---VKTLIG---RFLNFDRRRRLLPLEA 350

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 5e-18
 Identities = 57/278 (20%), Positives = 117/278 (42%), Gaps = 51/278 (18%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V+          AVK L      +  ++   F++E     +++H+ +V+ Y  
Sbjct: 22   GAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L   +   +L  +K +++   +A  ++++    +   +
Sbjct: 77   VTQ-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERNY---I 131

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPD----SSN------WSELAGTCGYIAPELA 951
            HRD+ +  +L+       ++DFG A+ ++ +             W+         APE  
Sbjct: 132  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------APEAI 182

Query: 952  YTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLP 1008
                   K DV++FG+L+ E++  G+ P   ++            N  V   ++   R+ 
Sbjct: 183  NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------------NPEVIQNLERGYRMV 230

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             P    EE  + M      C    P+ RPT   + ++L
Sbjct: 231  RPDNCPEELYQLMRL----CWKERPEDRPTFDYLRSVL 264

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.8 bits (213), Expect = 6e-18
 Identities = 45/201 (22%), Positives = 80/201 (39%), Gaps = 42/201 (20%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           G G    VY+  +  +    A+K         +   EIG+  +        + H NI+K 
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLR--------LSHPNIIKL 113

Query: 839 YGFCSHTQHLFLVYEYLERGSL-ATILS----NEATAAELDWSKRVNVIKGVANALSYMH 893
                    + LV E +  G L   I+     +E  AA+         +K +  A++Y+H
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA--------VKQILEAVAYLH 165

Query: 894 -HDCFPPILHRDISSKK----VLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYI 946
            +     I+HRD+   K    +       A +  +DFG +K ++        + GT GY 
Sbjct: 166 ENG----IVHRDL---KPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYC 217

Query: 947 APELAYTMRANEKCDVFNFGV 967
           APE+        + D+++ G+
Sbjct: 218 APEILRGCAYGPEVDMWSVGI 238

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 45/267 (16%), Positives = 91/267 (34%), Gaps = 54/267 (20%)

Query: 44  ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL 103
              L+     +      + ++      L+ +       + +  L    +   T+L EL L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70

Query: 104 SYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVS 163
           S+N+++  +   L +L+ L +LS++ N L                     +L  + S   
Sbjct: 71  SHNQIS-DLSP-LKDLTKLEELSVNRNRLK--------------------NLNGIPSA-- 106

Query: 164 VSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSI 223
                                L+ ++L+NN +       + +L++L  L +  N+L  SI
Sbjct: 107 --------------------CLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SI 143

Query: 224 PPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKH 283
                 LS L+ L LH N ++      L   K + ++ L+  +           L     
Sbjct: 144 VMLG-FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200

Query: 284 LHVHNINKLSGSIPKEIGNLKSLSHLW 310
           +   +   +S       G+      LW
Sbjct: 201 VKDPDGRWISPYYISNGGSYVDGCVLW 227

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 30/226 (13%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           FP          +L    +  T       LS +++ +   +    +    +   TNL  L
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
            LS NQ++ L P  L +LT L EL+++ NRL  ++  +    + L +L L NN L     
Sbjct: 69  HLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD--- 120

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
                            L +L++   +S+  N    ++   LG L  L  + L+ N I  
Sbjct: 121 ------TDS--------LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI-- 162

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
           +    +  L+ ++++ L   +           L     +   D R 
Sbjct: 163 TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 46/216 (21%), Positives = 91/216 (42%), Gaps = 17/216 (7%)

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
              +    K  L +   T  + Q       + +F+  N+N        +Q  T+L  L L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQKELSG--VQNFNGDNSNIQSLAG--MQFFTNLKELHL 70

Query: 456 ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISS-NWIKCPQLATLNMGGNEISGTIPS 514
             NQ++ ++S +  +   LE L ++ N     + + N I    L+ L +  NE+  T   
Sbjct: 71  SHNQIS-DLSPLKDL-TKLEELSVNRNR----LKNLNGIPSACLSRLFLDNNELRDT--D 122

Query: 515 EIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLD 574
            + ++  L  L   +N+L  +    LG L+ L  L L+GN+++ +    L  L ++ ++D
Sbjct: 123 SLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWID 178

Query: 575 LSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISI 610
           L+  +      K   EL   + +   + ++     I
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYI 214

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 42/213 (19%), Positives = 83/213 (38%), Gaps = 19/213 (8%)

Query: 443 SLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS--SNWIKCPQLAT 500
           S +  + + +   + + +  +++ +   + +L+ L LS+N     IS  S      +L  
Sbjct: 36  SQKELSGVQNFNGDNSNIQ-SLAGMQF-FTNLKELHLSHNQ----ISDLSPLKDLTKLEE 89

Query: 501 LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDI 560
           L++  N +             L +L   +N L  +    L  L +L  L++  N+L   I
Sbjct: 90  LSVNRNRLKNL---NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SI 143

Query: 561 PLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSK 620
              LG L++L  LDL  N ++      L  L+K++ ++L+  +   E      +L   + 
Sbjct: 144 V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200

Query: 621 LDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS 653
           +           P  I N  S     +L     
Sbjct: 201 VKDPDGRW--ISPYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 36/276 (13%), Positives = 86/276 (31%), Gaps = 68/276 (24%)

Query: 288 NINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE 347
            IN++          L +     L K  ++  +      LS ++      + +       
Sbjct: 8   PINQVFP-----DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAG 58

Query: 348 LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLL 407
           +    +L +L LS N+++  +   L +L+ L+  ++  N L       +  +        
Sbjct: 59  MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-----NLNGIPSAC---- 107

Query: 408 FENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEV 467
                             L+   + NN         L +  +L  L +  N+L       
Sbjct: 108 ------------------LSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK------ 141

Query: 468 FGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDF 527
                 + +L                   +L  L++ GNEI+      +  + +++ +D 
Sbjct: 142 -----SIVMLG---------------FLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDL 179

Query: 528 SSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE 563
           +  + V +  K   +L    ++     +      + 
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 35/207 (16%), Positives = 71/207 (34%), Gaps = 37/207 (17%)

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
               L +    N+ K S +       L  + +     + +       +   +N++ L++ 
Sbjct: 14  PDPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLS 71

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI 396
            N +  S    L  L  L +LS++ N+L         NL+ +    L    L  +  ++ 
Sbjct: 72  HNQI--SDLSPLKDLTKLEELSVNRNRLK--------NLNGIPSACLSRLFLDNNELRDT 121

Query: 397 ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLE 456
           +++  L                       L   S+RNN     +   L   + L  L L 
Sbjct: 122 DSLIHLKN---------------------LEILSIRNNKLKSIVM--LGFLSKLEVLDLH 158

Query: 457 RNQLTGNISEVFGIYPDLELLDLSNNN 483
            N++T N   +  +   +  +DL+   
Sbjct: 159 GNEIT-NTGGLTRL-KKVNWIDLTGQK 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 31/170 (18%), Positives = 56/170 (32%), Gaps = 18/170 (10%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L+    +    L+ L L  N+L       + HL  L+ L    N+   I+   +G L+ L
Sbjct: 97  LKNLNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKL 152

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
            VL L  N++       L  L  +N + L+  +           L     +   +     
Sbjct: 153 EVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-- 208

Query: 135 QIPPNW----GYLISPHYG-SIPQDLGNL----ESPVSVSLHTNNFSGVI 175
            I P +    G  +       +P     +       ++V      F G +
Sbjct: 209 -ISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTV 257

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.8 bits (208), Expect = 8e-18
 Identities = 59/277 (21%), Positives = 102/277 (36%), Gaps = 44/277 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G VY+   T+        AVK   +        N++ F+SE   +  + H +IVK
Sbjct: 21   GEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G     +  +++ E    G L   L        L     V     +  A++Y+     
Sbjct: 78   LIGIIE-EEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINC 134

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRDI+ + +L+       + DFG +++++ +         +   +     +PE   
Sbjct: 135  ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWMSPESIN 187

Query: 953  TMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPP 1009
              R     DV+ F V + E++  GK P  +L             N  V  +++   RLP 
Sbjct: 188  FRRFTTASDVWMFAVCMWEILSFGKQPFFWLE------------NKDVIGVLEKGDRLPK 235

Query: 1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P          M      C D +P  RP   ++   L
Sbjct: 236  PDLCPPVLYTLMT----RCWDYDPSDRPRFTELVCSL 268

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 42/209 (20%)

Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEITEIRHRNI 835
            K VL G G  G V +     +G   A+K L+       E+  + +            +I
Sbjct: 33  SKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQ-------ASGGPHI 84

Query: 836 VKFYGFC----SHTQHLFLVYEYLERGSL-------ATILSNEATAAELDWSKRVNVIKG 884
           V             + L ++ E +E G L             E  AAE        +++ 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE--------IMRD 136

Query: 885 VANALSYMHHDCFPPILHRDISSKKVLL-----DLEYKAHVSDFGTAKFLKPDSSNWSEL 939
           +  A+ ++H      I HRD+  + +L      D   K  ++DFG AK    ++      
Sbjct: 137 IGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLK--LTDFGFAKETTQNA--LQTP 189

Query: 940 AGTCGYIAPELAYTMRANEKCDVFNFGVL 968
             T  Y+APE+    + ++ CD+++ GV+
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 33/263 (12%), Positives = 69/263 (26%), Gaps = 56/263 (21%)

Query: 783  LHGTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRN 834
             HG       ++A     DT      A+  +         + Q+  +S    ++ I    
Sbjct: 38   FHGGVPPLQFWQAL----DTALDRQVALTFVDPQGVLPDDVLQE-TLSRTLRLSRIDKPG 92

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            + +            +V E++  GSL  +     +         +  ++ +A A    H 
Sbjct: 93   VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAHR 147

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                 +        +V         VS  G                     +        
Sbjct: 148  A---GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD------ 178

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
             AN + D+   G  +  ++  + P       L      + +     D    +   P    
Sbjct: 179  -ANPQDDIRGIGASLYALLVNRWP-------LPEAGVRSGLAPAERDT-AGQPIEPADID 229

Query: 1015 EEKLKSMIAVAFLCLDANPDCRP 1037
             +    + AVA   +  +   R 
Sbjct: 230  RDIPFQISAVAARSVQGDGGIRS 252

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.5 bits (211), Expect = 1e-17
 Identities = 33/297 (11%), Positives = 77/297 (25%), Gaps = 61/297 (20%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVK------------------------KLHSLPTGEIGIN 819
            G        +A    +G++  V                          L  +   +    
Sbjct: 87   GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146

Query: 820  QKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL----ERGSLAT----ILSNEATAA 871
               F+     ++     K        + ++++  +      + +L T    +LS+ +T  
Sbjct: 147  HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206

Query: 872  ELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL-K 930
             L    R+ +   V   L+ +HH     ++H  +    ++LD      ++ F        
Sbjct: 207  SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 931  PDSSNWSELAGTCGYIAPELAYTMRANEK-----CDVFNFGVLVLEVIEGKHPGHFLSLL 985
               S            A  +    + +        D +  G+ +  +     P       
Sbjct: 264  SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD-- 319

Query: 986  LSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042
                A       +        +P P+  + E            L    + R    + 
Sbjct: 320  ---DAALGGSEWIFRS--CKNIPQPVRALLEGF----------LRYPKEDRLLPLQA 361

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 59/281 (20%), Positives = 112/281 (39%), Gaps = 47/281 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G VY   L   D +    AVK L+ +           F++E   + +  H N++ 
Sbjct: 98   GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVLS 154

Query: 838  FYGFCSHTQH-LFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANALSYMH 893
              G C  ++    +V  Y++ G L   +   ++  T  +L     +     VA  + ++ 
Sbjct: 155  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFLA 209

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----AP 948
               F   +HRD++++  +LD ++   V+DFG A+ +  D    S    T   +     A 
Sbjct: 210  SKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMAL 265

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-- 1005
            E   T +   K DV++FGVL+ E++  G  P   ++               +   +    
Sbjct: 266  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------------TFDITVYLLQGR 313

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            RL  P    +   + M+     C     + RP+  ++ + +
Sbjct: 314  RLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRI 350

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 47/281 (16%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G VY   L   D +    AVK L+ +           F++E   + +  H N++ 
Sbjct: 34   GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVLS 90

Query: 838  FYGFCSHTQH-LFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANALSYMH 893
              G C  ++    +V  Y++ G L   +   ++  T  +L     +     VA  + Y+ 
Sbjct: 91   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLA 145

Query: 894  HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----AP 948
               F   +HRD++++  +LD ++   V+DFG A+ +  D   +S    T   +     A 
Sbjct: 146  SKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMAL 201

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDS-- 1005
            E   T +   K DV++FGVL+ E++  G  P   ++               +   +    
Sbjct: 202  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------------TFDITVYLLQGR 249

Query: 1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            RL  P    +   + M+     C     + RP+  ++ + +
Sbjct: 250  RLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRI 286

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 44/277 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G V++    S +      A+K   +  +      ++ F+ E   + +  H +IVK
Sbjct: 24   GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS---VREKFLQEALTMRQFDHPHIVK 80

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G  +    ++++ E    G L + L        LD +  +     ++ AL+Y+    F
Sbjct: 81   LIGVIT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRF 137

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRDI+++ VL+       + DFG +++++      +    + G +     APE   
Sbjct: 138  ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPESIN 190

Query: 953  TMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPP 1009
              R     DV+ FGV + E++  G  P   +             N  V   I++  RLP 
Sbjct: 191  FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------------NNDVIGRIENGERLPM 238

Query: 1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P          M      C   +P  RP   ++   L
Sbjct: 239  PPNCPPTLYSLMT----KCWAYDPSRRPRFTELKAQL 271

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 85.7 bits (212), Expect = 3e-17
 Identities = 42/192 (21%), Positives = 79/192 (41%), Gaps = 18/192 (9%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           GTG  G V++  E  +G+  A K    + T     +++    EI   + +RH  +V  + 
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAK---FVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHD 221

Query: 841 FCSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
                  + ++YE++  G L   +       +E +    V  ++ V   L +MH +    
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE---AVEYMRQVCKGLCHMHEN---N 275

Query: 900 ILHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
            +H D+  + ++   +    +   DFG    L P   +     GT  + APE+A      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVG 334

Query: 958 EKCDVFNFGVLV 969
              D+++ GVL 
Sbjct: 335 YYTDMWSVGVLS 346

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 63/226 (27%)

Query: 779 GKMVLHGTGGCGTVYKA-ELTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEI-- 830
            + VL G G    V     L +    AVK       H          +     E+ E+  
Sbjct: 17  QEDVL-GEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREV-EMLY 65

Query: 831 ---RHRNIVKFYGFCSHTQHLFLVYEYLERGSLAT-ILS----NEATAAELDWSKRVNVI 882
               HRN+++   F       +LV+E +  GS+ + I      NE  A+         V+
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV--------VV 117

Query: 883 KGVANALSYMHHDCFPPILHRDISSKK---VLLDLEYKAHVS-----DFGTAKFLKPDSS 934
           + VA+AL ++H      I HRD+   K   +L   E+   VS     DF     +K +  
Sbjct: 118 QDVASALDFLH---NKGIAHRDL---KPENIL--CEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 935 -------NWSELAGTCGYIAPE-LAYTMRA----NEKCDVFNFGVL 968
                        G+  Y+APE +          +++CD+++ GV+
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 42/193 (21%), Positives = 80/193 (41%), Gaps = 22/193 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G+G  G V++  E  +G     K +++       +++    +EI    ++ H  ++  + 
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHD 115

Query: 841 FCSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFP 898
                  + L+ E+L  G L   I + +   +E +    +N ++     L +MH H    
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEHS--- 169

Query: 899 PILHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMR 955
            I+H DI  + ++ + +  + V   DFG A  L PD         T  + APE +     
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP- 226

Query: 956 ANEKCDVFNFGVL 968
                D++  GVL
Sbjct: 227 VGFYTDMWAIGVL 239

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 31/206 (15%)

Query: 776 TFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIR 831
           T     +L G G  G V+K  E  +G   A K + +        +++   +EI+   ++ 
Sbjct: 90  TVSKTEIL-GGGRFGQVHKCEETATGLKLAAKIIKTRGM----KDKEEVKNEISVMNQLD 144

Query: 832 HRNIVKFYGFCSHTQHLFLVYEYLERGSL-ATILS-----NEATAAELDWSKRVNVIKGV 885
           H N+++ Y        + LV EY++ G L   I+       E              +K +
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF--------MKQI 196

Query: 886 ANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTC 943
              + +MH      ILH D+  + +L        +   DFG A+  KP         GT 
Sbjct: 197 CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTP 252

Query: 944 GYIAPE-LAYTMRANEKCDVFNFGVL 968
            ++APE + Y    +   D+++ GV+
Sbjct: 253 EFLAPEVVNYD-FVSFPTDMWSVGVI 277

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 46/208 (22%), Positives = 78/208 (37%), Gaps = 47/208 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-------HRNIV 836
           G G    V +    ++G   A K    L     G + +  +  + EI           ++
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEI--LHEIAVLELAKSCPRVI 92

Query: 837 KFYGFCSHTQHLFLVYEYLERGSL--------ATILSNEATAAELDWSKRVNVIKGVANA 888
             +    +T  + L+ EY   G +        A ++S E     L        IK +   
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS-ENDVIRL--------IKQILEG 143

Query: 889 LSYMHHDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG 941
           + Y+H +    I+H D+       SS   L D+  K    DFG ++ +        E+ G
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDI--KI--VDFGMSRKIGHACE-LREIMG 195

Query: 942 TCGYIAPE-LAYTMRANEKCDVFNFGVL 968
           T  Y+APE L Y        D++N G++
Sbjct: 196 TPEYLAPEILNYD-PITTATDMWNIGII 222

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 81.9 bits (203), Expect = 7e-17
 Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 43/203 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKG-----FVSEI---TEIRHRNI 835
           G G  G V++  E +S  T   K           +  KG        EI      RHRNI
Sbjct: 14  GRGEFGIVHRCVETSSKKTYMAKF----------VKVKGTDQVLVKKEISILNIARHRNI 63

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSL-ATILSNEATAAELDWSKRVNVIKGVANALSYMH- 893
           +  +      + L +++E++    +   I ++     E +    V+ +  V  AL ++H 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE---IVSYVHQVCEALQFLHS 120

Query: 894 HDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           H+    I H DI        +++       K    +FG A+ LKP   N+  L     Y 
Sbjct: 121 HN----IGHFDIRPENIIYQTRR---SSTIKI--IEFGQARQLKPG-DNFRLLFTAPEYY 170

Query: 947 APE-LAYTMRANEKCDVFNFGVL 968
           APE   + +  +   D+++ G L
Sbjct: 171 APEVHQHDV-VSTATDMWSLGTL 192

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 36/144 (25%), Positives = 58/144 (40%), Gaps = 17/144 (11%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSL-GGLKNLTFVYLNNNRIVGSIPSEI-GNLRS 208
           IPQ    L       L+ N F+ +    +   L  L  +  +NN+I   I          
Sbjct: 30  IPQYTAELR------LNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 209 LSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSH 264
           ++ + L  N+L  ++       L +LK L L  NR++  +     SF    S+  L L  
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGN--DSFIGLSSVRLLSLYD 138

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHN 288
           NQ+    P +F  L SL  L++  
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLA 162

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 38/182 (20%), Positives = 66/182 (36%), Gaps = 48/182 (26%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPE-ELGELTSLNELALSYNRLNGSIPA-SLGNLSN 121
           IP    I      LRL+ N+   L       +L  L ++  S N++   I   +    S 
Sbjct: 26  IPE--HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 122 LVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGG 181
           + ++ L++N L                                ++    F G        
Sbjct: 83  VNEILLTSNRLE-------------------------------NVQHKMFKG-------- 103

Query: 182 LKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLH 239
           L++L  + L +NRI   + ++    L S+  L L  NQ++ ++ P A   L +L  L L 
Sbjct: 104 LESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLL 161

Query: 240 DN 241
            N
Sbjct: 162 AN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 17/148 (11%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPK-QLGKLTSLTSLTLNGNQLSGDIPLELGL--- 566
            IP  I   T   +L  ++N            KL  L  +  + N+++    +E G    
Sbjct: 25  KIPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEEGAFEG 79

Query: 567 LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDL 623
            + +  + L++NRL  +  K    L  L  L L +N+ +    +       L  +  L L
Sbjct: 80  ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT---CVGNDSFIGLSSVRLLSL 136

Query: 624 SHNSLGGNIPSEI-CNLESLEYMNLLQN 650
             N +   +       L SL  +NLL N
Sbjct: 137 YDNQI-TTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 11/142 (7%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWI--KCPQLATLNMGGNEISGTIPSEI-GNMTQLHKL 525
            I      L L+NN F   + +  I  K PQL  +N   N+I+  I        + ++++
Sbjct: 29  HIPQYTAELRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI 86

Query: 526 DFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSK 582
             +SNRL     K    L SL +L L  N+++    +       L+ +  L L  N+++ 
Sbjct: 87  LLTSNRLENVQHKMFKGLESLKTLMLRSNRITC---VGNDSFIGLSSVRLLSLYDNQITT 143

Query: 583 LIPKNLGELRKLHHLNLSNNQF 604
           + P     L  L  LNL  N F
Sbjct: 144 VAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 33/161 (20%), Positives = 62/161 (38%), Gaps = 28/161 (17%)

Query: 39  TIPTQISHLSKLKHLDFSTNQFSGIIPPQI-GILTNLVVLRLSVNQLNGLIPEELGELTS 97
            IP  I        L  + N+F+ +    I   L  L  +  S N++  +        + 
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 98  LNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQD-- 154
           +NE+ L+ NRL  ++   +   L +L  L L +N ++                 +  D  
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT----------------CVGNDSF 125

Query: 155 --LGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
             L ++     +SL+ N  + V P +   L +L+ + L  N
Sbjct: 126 IGLSSVR---LLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 24/114 (21%), Positives = 51/114 (44%), Gaps = 6/114 (5%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQI-GILTNLVVL 77
           F   PQL  ++ S N++   I        S +  +  ++N+    +  ++   L +L  L
Sbjct: 53  FKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTL 110

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNN 130
            L  N++  +  +    L+S+  L+L  N++  ++   +   L +L  L+L  N
Sbjct: 111 MLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 23/129 (17%), Positives = 55/129 (42%), Gaps = 7/129 (5%)

Query: 288 NINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPE 346
           N N+ +      I   L  L  +  S  +++     +    S +  + +  N L  ++  
Sbjct: 40  NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-ENVQH 98

Query: 347 EL-GRLKSLSQLSLSVNKLNGSIPH-CLGNLSNLKFFALRENELSGSIPQEI-ENMKKLN 403
           ++   L+SL  L L  N++   + +     LS+++  +L +N+++ ++     + +  L+
Sbjct: 99  KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLS 156

Query: 404 KYLLFENQF 412
              L  N F
Sbjct: 157 TLNLLANPF 165

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 44/205 (21%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKL--HSLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V +     + +  A+K L        E+ ++ +         +  +IV+    
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR-------ASQCPHIVRIVDV 123

Query: 842 C----SHTQHLFLVYEYLERGSL-ATILS------NEATAAELDWSKRVNVIKGVANALS 890
                +  + L +V E L+ G L + I         E  A+E        ++K +  A+ 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--------IMKSIGEAIQ 175

Query: 891 YMHHDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
           Y+H      I HRD+       +SK+   +   K   +DFG AK     +S  +    T 
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKR--PNAILKL--TDFGFAKETTSHNS-LTTPCYTP 227

Query: 944 GYIAPELAYTMRANEKCDVFNFGVL 968
            Y+APE+    + ++ CD+++ GV+
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVI 252

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 59/271 (21%), Positives = 102/271 (37%), Gaps = 43/271 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G VY  E           A+K L  +   +     + F+ E   +  + H N++ 
Sbjct: 30   GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ---QVEAFLREGLLMRGLNHPNVLA 86

Query: 838  FYGFCSHTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
              G     +    ++  Y+  G L   + +            ++    VA  + Y+    
Sbjct: 87   LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELA 951
            F   +HRD++++  +LD  +   V+DFG A+ +  D   +S        +     A E  
Sbjct: 145  F---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARLPVKWTALESL 200

Query: 952  YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---PAPAANMNIVVNDLIDS-RL 1007
             T R   K DV++FGVL+ E+             L+    P    +   + + L    RL
Sbjct: 201  QTYRFTTKSDVWSFGVLLWEL-------------LTRGAPPYRHIDPFDLTHFLAQGRRL 247

Query: 1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPT 1038
            P P    +   + M      C +A+P  RPT
Sbjct: 248  PQPEYCPDSLYQVMQQ----CWEADPAVRPT 274

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 81.9 bits (203), Expect = 2e-16
 Identities = 78/459 (16%), Positives = 158/459 (34%), Gaps = 81/459 (17%)

Query: 231 SNLKFLYLHDNRLSGYIPPKLGS-FKSLLYLYLSHNQLN----GSLPSSFGNLSSLKHLH 285
            +++ L +    LS     +L    +    + L    L       + S+     +L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 286 VHNINKLSGSIPKEIGN-LKS----LSHLWLSKTQLS----GFIPPSLGNLSNIRGLYIR 336
           + + N+L       +   L++    +  L L    L+    G +  +L  L  ++ L++ 
Sbjct: 63  LRS-NELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 337 ENMLYGSIPEELGRL-----KSLSQLSLSVNKLN----GSIPHCLGNLSNLKFFALRENE 387
           +N+L  +  + L          L +L L    L+      +   L    + K   +  N+
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 388 LSGSIPQEI-----ENMKKLNKYLLFENQFT----GYLPQNVCQSGSLTHFSVRNNNF-- 436
           ++ +  + +     ++  +L    L     T      L   V    SL   ++ +N    
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241

Query: 437 --VGPIPRSLQNC-TSLYSLRLERNQLT----GNISEVFGIYPDLELLDLSNNNFFGE-- 487
             +  +   L +  + L +L +    +T    G++  V      L+ L L+ N    E  
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301

Query: 488 --ISSNWIKC-PQLATLNMGGNEISGT----IPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
             +    ++   QL +L +     +        S +     L +L  S+NRL     ++L
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361

Query: 541 GKL-----TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
            +      + L  L L    +S                D S + L+  +  N      L 
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVS----------------DSSCSSLAATLLAN----HSLR 401

Query: 596 HLNLSNNQFSQEISIQIGKLVQ-----LSKLDLSHNSLG 629
            L+LSNN       +Q+ + V+     L +L L      
Sbjct: 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 73.8 bits (182), Expect = 1e-13
 Identities = 64/352 (18%), Positives = 116/352 (32%), Gaps = 50/352 (14%)

Query: 352 KSLSQLSLSVNKLN-GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYL---- 406
             +  L +   +L+       L  L   +   L +  L+ +  ++I +  ++N  L    
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 407 LFENQFTGYLPQNVCQ-----SGSLTHFSVRNNNF----VGPIPRSLQNCTSLYSLRLER 457
           L  N+        V Q     S  +   S++N        G +  +L+   +L  L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 458 NQLTG----NISEVFG-IYPDLELLDLSNNNFFGE----ISSNWIKCPQLATLNMGGNEI 508
           N L       + E        LE L L   +        ++S     P    L +  N+I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 509 SGTIPSEIG-----NMTQLHKLDFSSNRL----VGQIPKQLGKLTSLTSLTLNGNQL--S 557
           +      +      +  QL  L   S  +       +   +    SL  L L  N+L   
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 558 GDIPLELGLLAE---LGYLDLSANRLS----KLIPKNLGELRKLHHLNLSNNQFSQEISI 610
           G   L  GLL     L  L +    ++      + + L     L  L+L+ N+   E + 
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302

Query: 611 QIGKLV-----QLSKLDLSHNSLGG----NIPSEICNLESLEYMNLLQNKLS 653
            + + +     QL  L +   S       +  S +     L  + +  N+L 
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.8 bits (174), Expect = 9e-13
 Identities = 77/490 (15%), Positives = 143/490 (29%), Gaps = 90/490 (18%)

Query: 72  TNLVVLRLSVNQLNGLIPEELGE-LTSLNELALSYNRLN----GSIPASLGNLSNLVQLS 126
            ++  L +   +L+     EL   L     + L    L       I ++L     L +L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 127 LSNNSLSGQIPPNWG-YLISPHYGSIPQDLGNLESPVSVSLHTNNFS----GVIPRSLGG 181
           L +N L        G + +     +    +  L      SL     +    GV+  +L  
Sbjct: 63  LRSNELGDV-----GVHCVLQGLQTPSCKIQKL------SLQNCCLTGAGCGVLSSTLRT 111

Query: 182 LKNLTFVYLNNNRIVGSIPSEIGNLR-----SLSYLGLNKNQLS----GSIPPTAGNLSN 232
           L  L  ++L++N +  +    +          L  L L    LS      +        +
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171

Query: 233 LKFLYLHDNRLSG----YIPPKLGSFK-SLLYLYLSHNQLN----GSLPSSFGNLSSLKH 283
            K L + +N ++      +   L      L  L L    +       L     + +SL+ 
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231

Query: 284 LHVHNINKLSGSIPKEIGN-----LKSLSHLWLSKTQLS----GFIPPSLGNLSNIRGLY 334
           L + + NKL      E+          L  LW+ +  ++    G +   L    +++ L 
Sbjct: 232 LALGS-NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290

Query: 335 IRENMLYGSIPEELGRL-----KSLSQLSLSVNKLNG----SIPHCLGNLSNLKFFALRE 385
           +  N L       L          L  L +                L     L    +  
Sbjct: 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN 350

Query: 386 NELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNF----VGPIP 441
           N L          +++L + L                   L    + + +        + 
Sbjct: 351 NRLED------AGVRELCQGLGQPGS-------------VLRVLWLADCDVSDSSCSSLA 391

Query: 442 RSLQNCTSLYSLRLERNQLTG----NISEVFGIY-PDLELLDLSNNNF----FGEISSNW 492
            +L    SL  L L  N L       + E        LE L L +  +       + +  
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 451

Query: 493 IKCPQLATLN 502
              P L  ++
Sbjct: 452 KDKPSLRVIS 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.6 bits (158), Expect = 9e-11
 Identities = 81/443 (18%), Positives = 144/443 (32%), Gaps = 71/443 (16%)

Query: 23  FPQLAYLDLSVNQL----FGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGIL-----TN 73
             Q   + L    L       I + +     L  L+  +N+   +    +          
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 74  LVVLRLSVNQLN----GLIPEELGELTSLNELALSYNRLNGS-----IPASLGNLSNLVQ 124
           +  L L    L     G++   L  L +L EL LS N L  +         L     L +
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG-GLK 183
           L L   SLS           +     +   L        +++  N+ +    R L  GLK
Sbjct: 147 LQLEYCSLS-----------AASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLK 195

Query: 184 ----NLTFVYLNNNRI----VGSIPSEIGNLRSLSYLGLNKNQLSGS-----IPPTAGNL 230
                L  + L +  +       +   + +  SL  L L  N+L         P      
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS 255

Query: 231 SNLKFLYLHDNRLS----GYIPPKLGSFKSLLYLYLSHNQLNGS-----LPSSFGNLSSL 281
           S L+ L++ +  ++    G +   L + +SL  L L+ N+L          +       L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315

Query: 282 KHLHVHNINKLSG----SIPKEIGNLKSLSHLWLSKTQL--SGFIPPSLG---NLSNIRG 332
           + L V +    +          +   + L  L +S  +L  +G      G     S +R 
Sbjct: 316 ESLWVKS-CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374

Query: 333 LYIRENML----YGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLG-----NLSNLKFFAL 383
           L++ +  +      S+   L    SL +L LS N L  +    L          L+   L
Sbjct: 375 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 434

Query: 384 RENELSGSIPQEIENMKKLNKYL 406
            +   S  +   ++ ++K    L
Sbjct: 435 YDIYWSEEMEDRLQALEKDKPSL 457

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 52/301 (17%), Positives = 105/301 (34%), Gaps = 59/301 (19%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLH---------SLPTGEIGINQKGFVSEI-TEI---- 830
              G    +   E       A+KK              +    I+ K    +   E+    
Sbjct: 40   NQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 831  --RHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIK 883
              ++   +   G  ++   ++++YEY+E  S+          ++     +       +IK
Sbjct: 99   DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
             V N+ SY+H+     I HRD+    +L+D   +  +SDFG ++++  D     ++ G+ 
Sbjct: 159  SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VD----KKIKGSR 211

Query: 944  G---YIAPEL-----AYTMRANEKCDVFNFGVLVLEVIEGKHP----GHFLSLL------ 985
            G   ++ PE      +Y      K D+++ G+ +  +     P       + L       
Sbjct: 212  GTYEFMPPEFFSNESSY---NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268

Query: 986  -LSLPAPAANMNIVVNDLIDSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043
             +  P    +    + +   +     L  E  + LK         L  NP  R T +   
Sbjct: 269  NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-------LRKNPAERITSEDAL 321

Query: 1044 N 1044
             
Sbjct: 322  K 322

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 80.3 bits (198), Expect = 4e-16
 Identities = 48/234 (20%), Positives = 83/234 (35%), Gaps = 55/234 (23%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEITEIRHRNIVKF 838
           G G  G V  A E  +   RA+K     K+  +   ++   +   V  + ++ H NI + 
Sbjct: 35  GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLHHPNIARL 93

Query: 839 YGFCSHTQHLFLVYEYLERGSL---------------------------ATILSNEATAA 871
           Y      Q++ LV E    G L                                     +
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 872 ELDWSKRVN----------VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV- 920
              + + ++          +++ + +AL Y+H+     I HRDI  +  L        + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 921 -SDFGTAKFLKP----DSSNWSELAGTCGYIAPE-LAYTMRA-NEKCDVFNFGV 967
             DFG +K        +    +  AGT  ++APE L  T  +   KCD ++ GV
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 82.2 bits (203), Expect = 4e-16
 Identities = 59/277 (21%), Positives = 106/277 (38%), Gaps = 44/277 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
            G G  G V++    S +      A+K   +  +      ++ F+ E     +  H +IVK
Sbjct: 399  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS---VREKFLQEALTMRQFDHPHIVK 455

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G  +    ++++ E    G L + L        LD +  +     ++ AL+Y+    F
Sbjct: 456  LIGVIT-ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKRF 512

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----APELAY 952
               +HRDI+++ VL+       + DFG +++++      +    + G +     APE   
Sbjct: 513  ---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPESIN 565

Query: 953  TMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--RLPP 1009
              R     DV+ FGV + E++  G  P   +             N  V   I++  RLP 
Sbjct: 566  FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------------NNDVIGRIENGERLPM 613

Query: 1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P          M      C   +P  RP   ++   L
Sbjct: 614  PPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 646

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 51/287 (17%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNI 835
            G G  G VY+ +++         + AVK L  + + +   ++  F+ E   I++  H+NI
Sbjct: 39   GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---DELDFLMEALIISKFNHQNI 95

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAAELDWSKRVNVIKGVANALSY 891
            V+  G    +   F++ E +  G L + L       +  + L     ++V + +A    Y
Sbjct: 96   VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHV---SDFGTAKFLKPDSSNWSELAGTCGYI-- 946
            +  + F   +HRDI+++  LL       V    DFG A+ +   S       G C  +  
Sbjct: 156  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKGGCAMLPV 209

Query: 947  ---APE-LAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVND 1001
                PE          K D ++FGVL+ E+   G  P    S            N  V +
Sbjct: 210  KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------------NQEVLE 256

Query: 1002 LIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + S  R+ PP        + M      C    P+ RP    +   +
Sbjct: 257  FVTSGGRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERI 299

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 57/288 (19%), Positives = 111/288 (38%), Gaps = 49/288 (17%)

Query: 785  GTGGCGTVYKAELTS-----GDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G VY+           +TR A+K ++   +      +  F++E     E    ++
Sbjct: 34   GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR---ERIEFLNEASVMKEFNCHHV 90

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANA 888
            V+  G  S  Q   ++ E + RG L + L       +N    A    SK + +   +A+ 
Sbjct: 91   VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-- 946
            ++Y++ + F   +HRD++++  ++  ++   + DFG  + +           G  G +  
Sbjct: 151  MAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---YYRKGGKGLLPV 204

Query: 947  ---APELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDL 1002
               +PE           DV++FGV++ E+    + P   LS            N  V   
Sbjct: 205  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------------NEQVLRF 252

Query: 1003 IDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048
            +     L  P    +   + M      C   NP  RP+  ++ + +  
Sbjct: 253  VMEGGLLDKPDNCPDMLFELMRM----CWQYNPKMRPSFLEIISSIKE 296

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 59/284 (20%), Positives = 101/284 (35%), Gaps = 44/284 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G+V +A+L   D      AVK L +       I +  F+ E   + E  H ++ K
Sbjct: 32   GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE--FLREAACMKEFDHPHVAK 89

Query: 838  FYGFCSHTQ------HLFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANA 888
              G    ++         ++  +++ G L   L           L     V  +  +A  
Sbjct: 90   LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-- 946
            + Y+    F   +HRD++++  +L  +    V+DFG ++ +           G    +  
Sbjct: 150  MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPV 203

Query: 947  ---APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003
               A E           DV+ FGV + E++               P        + N LI
Sbjct: 204  KWLALESLADNLYTVHSDVWAFGVTMWEIMT----------RGQTPYAGIENAEIYNYLI 253

Query: 1004 D-SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              +RL  P   +EE    M      C  A+P  RP+   +   L
Sbjct: 254  GGNRLKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMEL 293

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 79.8 bits (196), Expect = 2e-15
 Identities = 42/244 (17%), Positives = 77/244 (31%), Gaps = 29/244 (11%)

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
                    L    LSV +   ++  EL     L EL         +I   +  L  L+ 
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN 184
              +    S                  P     L+   S  L  N              +
Sbjct: 401 EKETLQYFSTLK------------AVDPMRAAYLDDLRSKFLLEN------SVLKMEYAD 442

Query: 185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLS 244
           +  ++L +  +  ++   +  L  +++L L+ N+L  ++PP    L  L+ L   DN L 
Sbjct: 443 VRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499

Query: 245 GYIPPKLGSFKSLLYLYLSHNQLNGSLPS--SFGNLSSLKHLHVHNINKLSGSIPKEIGN 302
             +   + +   L  L L +N+L     +     +   L  L++   N L          
Sbjct: 500 -NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQG-NSLC-QEEGIQER 554

Query: 303 LKSL 306
           L  +
Sbjct: 555 LAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 79.0 bits (194), Expect = 3e-15
 Identities = 47/278 (16%), Positives = 91/278 (32%), Gaps = 26/278 (9%)

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
              +   ++L       +   S+ +   +   +      ++    ++L +  L   + T 
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST- 362

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
            L   +     L      N          L     + +L     +      E    +  L
Sbjct: 363 VLQSELESCKELQELEPENK------WCLLTIILLMRALDPLLYE-----KETLQYFSTL 411

Query: 475 ELLDLSNNNFFGEISSNWIKCPQLA--------TLNMGGNEISGTIPSEIGNMTQLHKLD 526
           + +D     +  ++ S ++    +          L++   ++  T+   +  +  +  LD
Sbjct: 412 KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLD 469

Query: 527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL-IP 585
            S NRL   +P  L  L  L  L  + N L  ++   +  L  L  L L  NRL +    
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526

Query: 586 KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDL 623
           + L    +L  LNL  N   QE  IQ      L  +  
Sbjct: 527 QPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 79.0 bits (194), Expect = 4e-15
 Identities = 54/308 (17%), Positives = 103/308 (33%), Gaps = 22/308 (7%)

Query: 357 LSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL 416
           +S     L+      L   S +    L  +E   S+     + +    ++   +     L
Sbjct: 250 VSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASL 309

Query: 417 PQNVCQSGSLTHFSVRNNNFVGPI--------PRSLQNCTSLYSLRLERNQLTGNISEVF 468
              + Q      ++  ++     +         R       L+   L   + T   SE  
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSE-- 367

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS 528
            +    EL +L   N +  ++        L  L      +      +  +  +   LD  
Sbjct: 368 -LESCKELQELEPENKWCLLTIIL-LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNL 588
            ++ + +      +   +  L L    L+  +   L  L  + +LDLS NRL   +P  L
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPAL 482

Query: 589 GELRKLHHLNLSNNQFSQEISIQ-IGKLVQLSKLDLSHNSLGGNIPS--EICNLESLEYM 645
             LR L  L  S+N      ++  +  L +L +L L +N L     +   + +   L  +
Sbjct: 483 AALRCLEVLQASDNALE---NVDGVANLPRLQELLLCNNRL-QQSAAIQPLVSCPRLVLL 538

Query: 646 NLLQNKLS 653
           NL  N L 
Sbjct: 539 NLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 73.6 bits (180), Expect = 1e-13
 Identities = 51/329 (15%), Positives = 94/329 (28%), Gaps = 17/329 (5%)

Query: 250 KLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHL 309
           +       +++      L+          S +  L +           +        SH+
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299

Query: 310 WLSKT-------QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVN 362
           WL          QL       +   S+ +   +           +    + L +  LSV 
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359

Query: 363 KLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQ 422
           K    +   L +   L+     E E    +   I  M+ L+  L  +     +       
Sbjct: 360 KST-VLQSELESCKELQ---ELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415

Query: 423 SGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNN 482
                +     + F+            +  L L    LT  +         +  LDLS+N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHN 473

Query: 483 NFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG-QIPKQLG 541
                +         L  L    N +   +   + N+ +L +L   +NRL      + L 
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530

Query: 542 KLTSLTSLTLNGNQLSGDIPLELGLLAEL 570
               L  L L GN L  +  ++  L   L
Sbjct: 531 SCPRLVLLNLQGNSLCQEEGIQERLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 68.6 bits (167), Expect = 5e-12
 Identities = 35/178 (19%), Positives = 59/178 (33%), Gaps = 30/178 (16%)

Query: 41  PTQISHLSKLKHLDF--------STNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEEL 92
              + + S LK +D           ++F            ++ VL L+   L  L    L
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHL 459

Query: 93  GELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIP 152
            +L  +  L LS+NRL  ++P +L  L  L  L  S+N+L                 ++ 
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE----------------NVD 502

Query: 153 QDLGNLESPVSVSLHTNNFSGV-IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL 209
             + NL     + L  N        + L     L  + L  N +          L  +
Sbjct: 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 55.9 bits (134), Expect = 5e-08
 Identities = 31/179 (17%), Positives = 63/179 (35%), Gaps = 14/179 (7%)

Query: 513 PSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGY 572
             +     QL + + S  +    +  +L     L  L          I L +  L  L Y
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNI 632
              +    S L  K +  +R  +  +L +    +   +   +   +  L L+H  L    
Sbjct: 401 EKETLQYFSTL--KAVDPMRAAYLDDLRSKFLLENS-VLKMEYADVRVLHLAHKDL---- 453

Query: 633 PSEICNLE---SLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
            + +C+LE    + +++L  N+L   +P     +  L  +  S N L+ ++        
Sbjct: 454 -TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDGVANLPR 509

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 23/203 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
           G G  G VY A E  +    A+K L      + G+ +     EI   + +RH NI++ Y 
Sbjct: 23  GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMYN 81

Query: 841 FCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHD 895
           +    + ++L+ E+  RG L   L      +E  +A          ++ +A+AL Y H  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--------MEELADALHYCHER 133

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
               ++HRDI  + +L+  + +  ++DFG +    P     + + GT  Y+ PE+     
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYLPPEMIEGKT 188

Query: 956 ANEKCDVFNFGVLVLEVIEGKHP 978
            +EK D++  GVL  E + G  P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 51/287 (17%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNI 835
            G G  G VY+ +++         + AVK L  + + +   ++  F+ E   I++  H+NI
Sbjct: 80   GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---DELDFLMEALIISKFNHQNI 136

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL----SNEATAAELDWSKRVNVIKGVANALSY 891
            V+  G    +   F++ E +  G L + L       +  + L     ++V + +A    Y
Sbjct: 137  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHV---SDFGTAKFLKPDSSNWSELAGTCGYI-- 946
            +  + F   +HRDI+++  LL       V    DFG A+ +           G C  +  
Sbjct: 197  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYRKGGCAMLPV 250

Query: 947  ---APE-LAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVND 1001
                PE          K D ++FGVL+ E+   G  P    S            N  V +
Sbjct: 251  KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------------NQEVLE 297

Query: 1002 LIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             + S  R+ PP        + M      C    P+ RP    +   +
Sbjct: 298  FVTSGGRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERI 340

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 13/156 (8%)

Query: 189 YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYI 247
            L +  +     +    L  L++L L+ NQL  ++      +L+ L  L L +N+L+  +
Sbjct: 41  DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 248 PPKLGSFKS---LLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEI-GN 302
           P   G F     L  LYL  NQL  SLPS  F  L+ LK L ++  N+L  SIP      
Sbjct: 99  PL--GVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT-NQLQ-SIPAGAFDK 153

Query: 303 LKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           L +L  L LS  QL      +   L  ++ + +  N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 49/170 (28%), Positives = 67/170 (39%), Gaps = 25/170 (14%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
           LDL    L          L+KL  L+   NQ   +       LT L  L L+ NQL  L 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99

Query: 89  PEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPH 147
                 LT L++L L  N+L  S+P+ +   L+ L +L L+ N L               
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-------------- 144

Query: 148 YGSIPQ----DLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
             SIP      L NL+   ++SL TN    V   +   L  L  + L  N
Sbjct: 145 --SIPAGAFDKLTNLQ---TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 56/206 (27%), Positives = 82/206 (39%), Gaps = 47/206 (22%)

Query: 39  TIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL 98
           ++P+ I   +  + LD  +   + +       LT L  L L  NQL  L      +LT L
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 99  NELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGN 157
             L L+ N+L  S+P  +  +L+ L +L L  N L                 S+P     
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK----------------SLP----- 123

Query: 158 LESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNK 216
                         SGV  R    L  L  + LN N++  SIP+     L +L  L L+ 
Sbjct: 124 --------------SGVFDR----LTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLST 164

Query: 217 NQLSGSIPPTA-GNLSNLKFLYLHDN 241
           NQL  S+P  A   L  L+ + L  N
Sbjct: 165 NQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 16/166 (9%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---L 567
           ++PS I   T+  KLD  S  L          LT LT L L+ NQL     L  G+   L
Sbjct: 28  SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT---LSAGVFDDL 82

Query: 568 AELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLS 624
            ELG L L+ N+L+ L       L +L  L L  NQ     S+  G   +L +L +L L+
Sbjct: 83  TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK---SLPSGVFDRLTKLKELRLN 139

Query: 625 HNSLGGNIPSEICN-LESLEYMNLLQNKLSGPIPSCFRRMHGLSSI 669
            N L  +IP+   + L +L+ ++L  N+L       F R+  L +I
Sbjct: 140 TNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 52/173 (30%), Positives = 77/173 (44%), Gaps = 19/173 (10%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF-- 254
           S+PS I        L L    L+ ++       L+ L +L L  N+L   +    G F  
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQT-LSA--GVFDD 81

Query: 255 -KSLLYLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
              L  L L++NQL  SLP   F +L+ L  L++   N+L  S+P  +   L  L  L L
Sbjct: 82  LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGG-NQLK-SLPSGVFDRLTKLKELRL 138

Query: 312 SKTQLSGFIPPSL-GNLSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVN 362
           +  QL   IP      L+N++ L +  N L  S+P     RL  L  ++L  N
Sbjct: 139 NTNQLQS-IPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 15/160 (9%)

Query: 260 LYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSG 318
           L L    L     ++F  L+ L  L++   N+L  ++   +  +L  L  L L+  QL+ 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDY-NQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96

Query: 319 FIPPSL-GNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPHCLG--- 373
            +P  +  +L+ +  LY+  N L  S+P  +  RL  L +L L+ N+L  SIP   G   
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAFD 152

Query: 374 NLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQF 412
            L+NL+  +L  N+L  S+P    + + KL    LF NQF
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 48/129 (37%), Positives = 63/129 (48%), Gaps = 10/129 (7%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQ 67
           S    TL +  F    +L +L+L  NQL  T+   +   L++L  L  + NQ +  +P  
Sbjct: 44  STGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLAS-LPL- 100

Query: 68  IGI---LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLV 123
            G+   LT L  L L  NQL  L       LT L EL L+ N+L  SIPA     L+NL 
Sbjct: 101 -GVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQ 158

Query: 124 QLSLSNNSL 132
            LSLS N L
Sbjct: 159 TLSLSTNQL 167

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 10/149 (6%)

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
                L L    L+         L +L +L+L  N+L  L      +L +L  L L+NNQ
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 604 FSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPSC 659
            +   S+ +G    L QL KL L  N L   +PS +   L  L+ + L  N+L       
Sbjct: 95  LA---SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGA 150

Query: 660 FRRMHGLSSIDVSYNELQGSIPHSKAFQN 688
           F ++  L ++ +S N+LQ S+PH  AF  
Sbjct: 151 FDKLTNLQTLSLSTNQLQ-SVPHG-AFDR 177

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 55/200 (27%), Positives = 75/200 (37%), Gaps = 45/200 (22%)

Query: 421 CQSGSLT-----------HFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFG 469
           CQ  SL               +++         + +  T L  L L+ NQL    + VF 
Sbjct: 21  CQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD 80

Query: 470 IYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFS 528
              +L  L L+NN              QLA+L           P  +  ++TQL KL   
Sbjct: 81  DLTELGTLGLANN--------------QLASL-----------PLGVFDHLTQLDKLYLG 115

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSKLIP 585
            N+L         +LT L  L LN NQL     +  G    L  L  L LS N+L + +P
Sbjct: 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQS---IPAGAFDKLTNLQTLSLSTNQL-QSVP 171

Query: 586 KN-LGELRKLHHLNLSNNQF 604
                 L KL  + L  NQF
Sbjct: 172 HGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 36/99 (36%), Positives = 45/99 (45%), Gaps = 11/99 (11%)

Query: 15  LQEFPFLLF---PQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGI 70
           L   P  +F    QL  L L  NQL  ++P+ +   L+KLK L  +TNQ    IP   G 
Sbjct: 95  LASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQS-IPA--GA 150

Query: 71  ---LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYN 106
              LTNL  L LS NQL  +       L  L  + L  N
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 11/140 (7%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           IP +   L       LH N  + + P     L NL  +YL +N++  ++P  +  +L  L
Sbjct: 38  IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
           + L L  NQL+  +P      L +LK L++  N+L+  +P  +     L +L L  NQL 
Sbjct: 91  TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148

Query: 269 GSLPSSFGNLSSLKHLHVHN 288
                +F  LSSL H ++  
Sbjct: 149 SIPHGAFDRLSSLTHAYLFG 168

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 40/142 (28%), Positives = 56/142 (39%), Gaps = 9/142 (6%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           +P+ I    Q   L    N++    P     L +L  L L  NQL     L +G+   L 
Sbjct: 34  VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA---LPVGVFDSLT 88

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
           +L  LDL  N+L+ L       L  L  L +  N+   E+   I +L  L+ L L  N L
Sbjct: 89  QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147

Query: 629 GGNIPSEICNLESLEYMNLLQN 650
                     L SL +  L  N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 46/180 (25%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNL 122
           +P   GI TN  +L L  NQ+  L P     L +L EL L  N+L  ++P  +  +L+ L
Sbjct: 34  VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 123 VQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGL 182
             L L  N L+                 +P                   S V  R    L
Sbjct: 91  TVLDLGTNQLT----------------VLP-------------------SAVFDR----L 111

Query: 183 KNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
            +L  +++  N++   +P  I  L  L++L L++NQL  SIP  A   LS+L   YL  N
Sbjct: 112 VHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 36/108 (33%), Positives = 47/108 (43%), Gaps = 7/108 (6%)

Query: 28  YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGI---LTNLVVLRLSVNQL 84
            L L  NQ+    P     L  LK L   +NQ    +P   G+   LT L VL L  NQL
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPV--GVFDSLTQLTVLDLGTNQL 100

Query: 85  NGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
             L       L  L EL +  N+L   +P  +  L++L  L+L  N L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 47/144 (32%), Positives = 74/144 (51%), Gaps = 10/144 (6%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS-FGNLSS 280
           S+P  AG  +N + LYLHDN+++   P    S  +L  LYL  NQL  +LP   F +L+ 
Sbjct: 33  SVP--AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 281 LKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENM 339
           L  L +   N+L+  +P  +   L  L  L++   +L+  +P  +  L+++  L + +N 
Sbjct: 90  LTVLDLGT-NQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ 146

Query: 340 LYGSIPEE-LGRLKSLSQLSLSVN 362
           L  SIP     RL SL+   L  N
Sbjct: 147 L-KSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 36/129 (27%), Positives = 55/129 (42%), Gaps = 7/129 (5%)

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
           T+   L L+ NQ++   P     L  L  L L +N+L  L       L +L  L+L  NQ
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99

Query: 604 FSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF 660
            +    +      +LV L +L +  N L   +P  I  L  L ++ L QN+L       F
Sbjct: 100 LT---VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAF 155

Query: 661 RRMHGLSSI 669
            R+  L+  
Sbjct: 156 DRLSSLTHA 164

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 18/144 (12%)

Query: 51  KHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNG 110
           + L    NQ + + P     L NL  L L  NQL  L       LT L  L L  N+L  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 111 SIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTN 169
            +P+++   L +L +L +  N L+                 +P+ +  L     ++L  N
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT----------------ELPRGIERLTHLTHLALDQN 145

Query: 170 NFSGVIPRSLGGLKNLTFVYLNNN 193
               +   +   L +LT  YL  N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 46/183 (25%), Positives = 66/183 (36%), Gaps = 38/183 (20%)

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           C+S      SV        IP + Q       L L  NQ+T     VF    +L+ L L 
Sbjct: 26  CRSKRHA--SVPAG-----IPTNAQI------LYLHDNQITKLEPGVFDSLINLKELYLG 72

Query: 481 NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL 540
           +N              QL  L +G       +      +TQL  LD  +N+L        
Sbjct: 73  SN--------------QLGALPVG-------VFDS---LTQLTVLDLGTNQLTVLPSAVF 108

Query: 541 GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS 600
            +L  L  L +  N+L+  +P  +  L  L +L L  N+L  +       L  L H  L 
Sbjct: 109 DRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167

Query: 601 NNQ 603
            N 
Sbjct: 168 GNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 38/126 (30%), Positives = 54/126 (42%), Gaps = 9/126 (7%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQ 67
            N    L+   F     L  L L  NQL G +P  +   L++L  LD  TNQ +  +P  
Sbjct: 49  DNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTV-LPS- 105

Query: 68  IGI---LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQ 124
             +   L +L  L +  N+L   +P  +  LT L  LAL  N+L      +   LS+L  
Sbjct: 106 -AVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163

Query: 125 LSLSNN 130
             L  N
Sbjct: 164 AYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 32/156 (20%)

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLS 317
            LYL  NQ+    P  F +L +LK L++ + N+L  ++P  +  +L  L+ L L   QL+
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGS-NQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGSIPHCLGNLS 376
                                     +P  +  RL  L +L +  NKL   +P  +  L+
Sbjct: 102 -------------------------VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLT 135

Query: 377 NLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQ 411
           +L   AL +N+L  SIP    + +  L    LF N 
Sbjct: 136 HLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 38/145 (26%), Positives = 57/145 (39%), Gaps = 10/145 (6%)

Query: 357 LSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQFTGY 415
           L L  N++    P    +L NLK   L  N+L  ++P  + +++ +L    L  NQ T  
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 416 LPQNVCQS-GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
           LP  V      L    +  N     +PR ++  T L  L L++NQL       F     L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161

Query: 475 ELLDLSNNNFFGEIS-----SNWIK 494
               L  N +  E        NW+ 
Sbjct: 162 THAYLFGNPWDCECRDIMYLRNWVA 186

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 72/298 (24%)

Query: 785  GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI-----RHRNIV 836
            G G  G V KA +     R   A+K++    + +   + + F  E+ E+      H NI+
Sbjct: 34   GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGEL-EVLCKLGHHPNII 89

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVIK 883
               G C H  +L+L  EY   G+L   L                +TA+ L   + ++   
Sbjct: 90   NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 884  GVANALSY---MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
             VA  + Y            +HRD++++ +L+   Y A ++DFG ++        +    
Sbjct: 150  DVARGMDYLSQKQ------FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV--K 197

Query: 941  GTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPA 990
             T G +     A E L    YT       DV+++GVL+ E++  G  P   ++       
Sbjct: 198  KTMGRLPVRWMAIESLNYSVYTT----NSDVWSYGVLLWEIVSLGGTPYCGMT------- 246

Query: 991  PAANMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                    + + +    RL  PL   +E    M      C    P  RP+  ++   L
Sbjct: 247  -----CAELYEKLPQGYRLEKPLNCDDEVYDLMRQ----CWREKPYERPSFAQILVSL 295

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 73.1 bits (180), Expect = 7e-15
 Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 16/121 (13%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTA--GNLSNLKFLYLHDNRLSGYIPPKLGSFK 255
            IP +I      + L LN N+L   I      G L +L  L L  N+L+G I P   +F+
Sbjct: 22  EIPRDI--PLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEP--NAFE 75

Query: 256 SLL---YLYLSHNQLNGSLPS-SFGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLW 310
                  L L  N++   + +  F  L  LK L++++ N++S  +      +L SL+ L 
Sbjct: 76  GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYD-NQIS-CVMPGSFEHLNSLTSLN 132

Query: 311 L 311
           L
Sbjct: 133 L 133

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 64.3 bits (157), Expect = 8e-12
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 11/106 (10%)

Query: 189 YLNNNRIVGSIPSE--IGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSG 245
            LN+N +   I S+   G L  L  L L +NQL+  I P A    S+++ L L +N++  
Sbjct: 35  LLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE 92

Query: 246 YIPPKLGSF---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
            I      F     L  L L  NQ++  +P SF +L+SL  L++ +
Sbjct: 93  -ISN--KMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 31/112 (27%), Positives = 43/112 (38%), Gaps = 9/112 (8%)

Query: 544 TSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNN 602
              T L LN N+L       L G L  L  L+L  N+L+ + P        +  L L  N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 603 QFSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQN 650
           +      I       L QL  L+L  N +   +      +L SL  +NL  N
Sbjct: 89  KIK---EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 46/150 (30%)

Query: 96  TSLNELALSYNRLNGSIPAS--LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQ 153
               EL L+ N L   I +    G L +LV+L L  N L+                 I  
Sbjct: 29  LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT----------------GIE- 70

Query: 154 DLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYL 212
                                 P +  G  ++  + L  N+I   I +++   L  L  L
Sbjct: 71  ----------------------PNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTL 107

Query: 213 GLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
            L  NQ+S  + P +  +L++L  L L  N
Sbjct: 108 NLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 34/136 (25%), Positives = 55/136 (40%), Gaps = 28/136 (20%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEEL-GELTSLNELALSYNRLNGSIPASL-GNLSN 121
           IP    I  +   L L+ N+L  +  + L G L  L +L L  N+L   I  +     S+
Sbjct: 23  IPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 122 LVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQD----LGNLESPVSVSLHTNNFSGVIPR 177
           + +L L  N +                  I       L  L++   ++L+ N  S V+P 
Sbjct: 80  IQELQLGENKIK----------------EISNKMFLGLHQLKT---LNLYDNQISCVMPG 120

Query: 178 SLGGLKNLTFVYLNNN 193
           S   L +LT + L +N
Sbjct: 121 SFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 29/122 (23%), Positives = 48/122 (39%), Gaps = 9/122 (7%)

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSL-GNLSNIRGLYIRENMLYGSIPEEL-GRLK 352
            IP++I      + L L+  +L       L G L ++  L ++ N L   I         
Sbjct: 22  EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGAS 78

Query: 353 SLSQLSLSVNKLNGSIPH-CLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFEN 410
            + +L L  NK+   I +     L  LK   L +N++S  +     E++  L    L  N
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

Query: 411 QF 412
            F
Sbjct: 137 PF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 31/142 (21%), Positives = 49/142 (34%), Gaps = 35/142 (24%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWI--KCPQLATLNMGGNEISGTIPSEI-GNMTQLHKL 525
            I      L L N+N  G ISS+ +  + P L  L +  N+++  I        + + +L
Sbjct: 26  DIPLHTTELLL-NDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQEL 83

Query: 526 DFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIP 585
               N++     K    L  L +L L  NQ+                           + 
Sbjct: 84  QLGENKIKEISNKMFLGLHQLKTLNLYDNQI-------------------------SCVM 118

Query: 586 KNLG---ELRKLHHLNLSNNQF 604
              G    L  L  LNL++N F
Sbjct: 119 P--GSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 26/91 (28%), Positives = 36/91 (39%), Gaps = 8/91 (8%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGI---LTNLV 75
           F   P L  L+L  NQL   I        S ++ L    N+    I     +   L  L 
Sbjct: 50  FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIKE-ISN--KMFLGLHQLK 105

Query: 76  VLRLSVNQLNGLIPEELGELTSLNELALSYN 106
            L L  NQ++ ++P     L SL  L L+ N
Sbjct: 106 TLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 59/283 (20%), Positives = 106/283 (37%), Gaps = 43/283 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNIVK 837
            G G  G+V +  L   D      AVK +    + +  I +  F+SE   + +  H N+++
Sbjct: 43   GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE--FLSEAACMKDFSHPNVIR 100

Query: 838  FYGFCSHTQ-----HLFLVYEYLERGSLATIL---SNEATAAELDWSKRVNVIKGVANAL 889
              G C            ++  +++ G L T L     E     +     +  +  +A  +
Sbjct: 101  LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI--- 946
             Y+ +  F   LHRD++++  +L  +    V+DFG +K +           G    +   
Sbjct: 161  EYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAKMPVK 214

Query: 947  --APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004
              A E         K DV+ FGV + E+                P P    + + + L+ 
Sbjct: 215  WIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGMTPYPGVQNHEMYDYLLH 264

Query: 1005 -SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              RL  P   ++E  + M +    C   +P  RPT   +   L
Sbjct: 265  GHRLKQPEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQL 303

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 62/301 (20%), Positives = 109/301 (36%), Gaps = 65/301 (21%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSEITEI-----RHR 833
            G G  G V +A              AVK L           ++  +SE+ ++      H 
Sbjct: 32   GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT---EREALMSEL-KVLSYLGNHM 87

Query: 834  NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG--------- 884
            NIV   G C+      ++ EY   G L   L  +  +     +    +            
Sbjct: 88   NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 885  ------VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
                  VA  ++++        +HRD++++ +LL       + DFG A+ +K DS+    
Sbjct: 148  LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--- 201

Query: 939  LAGTCGYI-----APELA----YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP 989
            +      +     APE      YT     + DV+++G+ + E+            L S P
Sbjct: 202  VVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWELFS----------LGSSP 247

Query: 990  APAANMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047
             P   ++     +I    R+  P     E    M      C DA+P  RPT +++  L+ 
Sbjct: 248  YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT----CWDADPLKRPTFKQIVQLIE 303

Query: 1048 R 1048
            +
Sbjct: 304  K 304

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 44/129 (34%), Positives = 62/129 (48%), Gaps = 13/129 (10%)

Query: 189 YLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGN-LSNLKFLYLHDNRLSGYI 247
            L  N +          L SL+ L L  N+L  S+P    N L++L +L L  N+L   +
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SL 91

Query: 248 PPKLGSFKSLL---YLYLSHNQLNGSLPS-SFGNLSSLKHLHVHNINKLSGSIPKEI-GN 302
           P   G F  L     L L+ NQL  SLP   F  L+ LK L ++  N+L  S+P  +   
Sbjct: 92  PN--GVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ-NQLK-SVPDGVFDR 146

Query: 303 LKSLSHLWL 311
           L SL ++WL
Sbjct: 147 LTSLQYIWL 155

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 49/144 (34%), Positives = 73/144 (50%), Gaps = 18/144 (12%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGN-LRSL 209
           IP     L+      L TN+   +       L +LT +YL  N++  S+P+ + N L SL
Sbjct: 26  IPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHN 265
           +YL L+ NQL  S+P      L+ LK L L+ N+L   +P   G F     L  L L  N
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPD--GVFDKLTQLKDLRLYQN 134

Query: 266 QLNGSLPS-SFGNLSSLKHLHVHN 288
           QL  S+P   F  L+SL+++ +H+
Sbjct: 135 QLK-SVPDGVFDRLTSLQYIWLHD 157

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 51/146 (34%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           +P+ I   T    LD  +N L         +LTSLT L L GN+L     L  G+   L 
Sbjct: 22  VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS---LPNGVFNKLT 76

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSH 625
            L YL+LS N+L  L      +L +L  L L+ NQ     S+  G   KL QL  L L  
Sbjct: 77  SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ---SLPDGVFDKLTQLKDLRLYQ 133

Query: 626 NSLGGNIPSEIC-NLESLEYMNLLQN 650
           N L  ++P  +   L SL+Y+ L  N
Sbjct: 134 NQL-KSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 48/142 (33%), Positives = 65/142 (45%), Gaps = 18/142 (12%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           S+P+ I      +YL L  N L          L++L  LYL  N+L   +P   G F  L
Sbjct: 21  SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPN--GVFNKL 75

Query: 258 L---YLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLS 312
               YL LS NQL  SLP+  F  L+ LK L ++  N+L  S+P  +   L  L  L L 
Sbjct: 76  TSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNT-NQLQ-SLPDGVFDKLTQLKDLRLY 132

Query: 313 KTQLSGFIPP----SLGNLSNI 330
           + QL   +P      L +L  I
Sbjct: 133 QNQLKS-VPDGVFDRLTSLQYI 153

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 52/176 (29%), Positives = 75/176 (42%), Gaps = 45/176 (25%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGN-LSNLVQLSL 127
           GI      L L  N L  L      ELTSL +L L  N+L  S+P  + N L++L  L+L
Sbjct: 25  GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNL 83

Query: 128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF 187
           S N L                 S+P                   +GV  +    L  L  
Sbjct: 84  STNQLQ----------------SLP-------------------NGVFDK----LTQLKE 104

Query: 188 VYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
           + LN N++  S+P  +   L  L  L L +NQL  S+P      L++L++++LHDN
Sbjct: 105 LALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 39/109 (35%), Positives = 50/109 (45%), Gaps = 8/109 (7%)

Query: 28  YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGI---LTNLVVLRLSVNQL 84
           YLDL  N L          L+ L  L    N+    +P   G+   LT+L  L LS NQL
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPN--GVFNKLTSLTYLNLSTNQL 88

Query: 85  NGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSL 132
             L      +LT L ELAL+ N+L  S+P  +   L+ L  L L  N L
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 10/127 (7%)

Query: 9   SNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQ 67
           +N   +L    F     L  L L  N+L  ++P  + + L+ L +L+ STNQ    +P  
Sbjct: 37  TNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQS-LPN- 93

Query: 68  IGI---LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIP-ASLGNLSNLV 123
            G+   LT L  L L+ NQL  L      +LT L +L L  N+L  S+P      L++L 
Sbjct: 94  -GVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQ 151

Query: 124 QLSLSNN 130
            + L +N
Sbjct: 152 YIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 52/189 (27%), Positives = 69/189 (36%), Gaps = 47/189 (24%)

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           C S   T  SV        IP           L LE N L    + VF     L  L L 
Sbjct: 14  CYSQGRT--SVPTG-----IPAQTTY------LDLETNSLKSLPNGVFDELTSLTQLYLG 60

Query: 481 NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGN-MTQLHKLDFSSNRLVGQIPKQ 539
            N              +L +L           P+ + N +T L  L+ S+N+L       
Sbjct: 61  GN--------------KLQSL-----------PNGVFNKLTSLTYLNLSTNQLQSLPNGV 95

Query: 540 LGKLTSLTSLTLNGNQLSGDIPLELGL---LAELGYLDLSANRLSKLIPKN-LGELRKLH 595
             KLT L  L LN NQL     L  G+   L +L  L L  N+L K +P      L  L 
Sbjct: 96  FDKLTQLKELALNTNQLQS---LPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQ 151

Query: 596 HLNLSNNQF 604
           ++ L +N +
Sbjct: 152 YIWLHDNPW 160

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 37/113 (32%), Positives = 50/113 (44%), Gaps = 8/113 (7%)

Query: 544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ 603
              T L L  N L          L  L  L L  N+L  L      +L  L +LNLS NQ
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87

Query: 604 FSQEISIQIG---KLVQLSKLDLSHNSLGGNIPSEICN-LESLEYMNLLQNKL 652
                S+  G   KL QL +L L+ N L  ++P  + + L  L+ + L QN+L
Sbjct: 88  LQ---SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 27/159 (16%)

Query: 40  IPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLN 99
           +PT I   ++  +LD  TN    +       LT+L  L L  N+L  L      +LTSL 
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 100 ELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQ----D 154
            L LS N+L  S+P  +   L+ L +L+L+ N L                 S+P      
Sbjct: 80  YLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ----------------SLPDGVFDK 122

Query: 155 LGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
           L  L+    + L+ N    V       L +L +++L++N
Sbjct: 123 LTQLK---DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 10/128 (7%)

Query: 565 GLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKL 621
           G+ A+  YLDL  N L  L      EL  L  L L  N+     S+  G   KL  L+ L
Sbjct: 25  GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ---SLPNGVFNKLTSLTYL 81

Query: 622 DLSHNSLGGNIPSEICN-LESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSI 680
           +LS N L  ++P+ + + L  L+ + L  N+L       F ++  L  + +  N+L+ S+
Sbjct: 82  NLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SV 139

Query: 681 PHSKAFQN 688
           P    F  
Sbjct: 140 PDG-VFDR 146

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 33/128 (25%), Positives = 57/128 (44%), Gaps = 6/128 (4%)

Query: 288 NINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE 347
             N L          L SL+ L+L   +L          L+++  L +  N L  S+P  
Sbjct: 36  ETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-QSLPNG 94

Query: 348 L-GRLKSLSQLSLSVNKLNGSIPH-CLGNLSNLKFFALRENELSGSIPQEI-ENMKKLNK 404
           +  +L  L +L+L+ N+L  S+P      L+ LK   L +N+L  S+P  + + +  L  
Sbjct: 95  VFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQY 152

Query: 405 YLLFENQF 412
             L +N +
Sbjct: 153 IWLHDNPW 160

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 61/295 (20%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSEITEI-----RHR 833
            G G  G V +A            + AVK L S    +    ++  +SE+ +I     +H 
Sbjct: 55   GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD---EKEALMSEL-KIMSHLGQHE 110

Query: 834  NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIK---------- 883
            NIV   G C+H   + ++ EY   G L   L  ++   E D +  +              
Sbjct: 111  NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 884  -GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
              VA  ++++        +HRD++++ VLL   + A + DFG A+ +  DS+    +   
Sbjct: 171  SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---IVKG 224

Query: 943  CGYI-----APELA----YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA 993
               +     APE      YT+    + DV+++G+L+ E+          SL L+ P P  
Sbjct: 225  NARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIF---------SLGLN-PYPGI 270

Query: 994  NMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             +N     L+    ++  P    +     M A    C    P  RPT Q++C+ L
Sbjct: 271  LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICSFL 321

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 75.1 bits (185), Expect = 3e-14
 Identities = 56/350 (16%), Positives = 98/350 (28%), Gaps = 78/350 (22%)

Query: 324 LGNLSNIRGLYIRENMLYG----SIPEELGRLKSLSQLSLSVNKLNG----SIPHCLGNL 375
           +   S I G  ++ + +      S+   L    S+ ++ LS N +       +   + + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 376 SNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNN 435
            +L+     +        +  E ++ L + LL +                L    + +N 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALL-KCP-------------KLHTVRLSDNA 105

Query: 436 F----VGPIPRSLQNCTSLYSLRLERNQLT-------------GNISEVFGIYPDLELLD 478
           F      P+   L   T L  L L  N L                +++     P L  + 
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165

Query: 479 LSNNNFFGEISSNWI-----KCPQLATLNMGGNEI-----SGTIPSEIGNMTQLHKLDFS 528
              N      S             L T+ M  N I        +   +    +L  LD  
Sbjct: 166 CGRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 224

Query: 529 SNRL----VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLI 584
            N         +   L    +L  L LN   LS                   A  +    
Sbjct: 225 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLS----------------ARGAAAVVDAF 268

Query: 585 PKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQ-----LSKLDLSHNSLG 629
            K   E   L  L L  N+   +    +  ++      L  L+L+ N   
Sbjct: 269 SK--LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 49/320 (15%), Positives = 93/320 (29%), Gaps = 61/320 (19%)

Query: 26  LAYLDLSVNQL----FGTIPTQISHLSKLKHLDFSTNQFSG----IIPPQIGILTNLVVL 77
           +    L ++ +      ++   +     +K +  S N         +   I    +L + 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 78  RLSVNQLNGLIPEE----------LGELTSLNELALSYNRLNG----SIPASLGNLSNLV 123
             S      +  E           L +   L+ + LS N         +   L   + L 
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 124 QLSLSNNSLSGQIPPNWG------YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV--- 174
            L L NN L  Q             L         ++   L S   +    N        
Sbjct: 126 HLYLHNNGLGPQ-----AGAKIARALQELAVNKKAKNAPPLRS---IICGRNRLENGSMK 177

Query: 175 -IPRSLGGLKNLTFVYLNNNRI-----VGSIPSEIGNLRSLSYLGLNKNQLSG----SIP 224
              ++    + L  V +  N I        +   +   + L  L L  N  +     ++ 
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237

Query: 225 PTAGNLSNLKFLYLHDNRLSG----YIPP--KLGSFKSLLYLYLSHNQLNG----SLPSS 274
               +  NL+ L L+D  LS      +           L  L L +N++      +L + 
Sbjct: 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 297

Query: 275 FG-NLSSLKHLHVHNINKLS 293
               +  L  L ++  N+ S
Sbjct: 298 IDEKMPDLLFLELNG-NRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 56/376 (14%), Positives = 110/376 (29%), Gaps = 93/376 (24%)

Query: 74  LVVLRLSVNQLNG----LIPEELGELTSLNELALSYNRLNG----SIPASLGNLSNLVQL 125
           +    L ++ +       +   L E  S+ E+ LS N +       +  ++ +  +L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 126 SLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNL 185
             S+                          G ++  +  +L       ++ ++L     L
Sbjct: 66  EFSDIFT-----------------------GRVKDEIPEAL------RLLLQALLKCPKL 96

Query: 186 TFVYLNNNRI----VGSIPSEIGNLRSLSYLGLNKNQLS-------------GSIPPTAG 228
             V L++N         +   +     L +L L+ N L               ++   A 
Sbjct: 97  HTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAK 156

Query: 229 NLSNLKFLYLHDNRLSG----YIPPKLGSFKSLLYLYLSHNQLN-----GSLPSSFGNLS 279
           N   L+ +    NRL             S + L  + +  N +        L        
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216

Query: 280 SLKHLHVHNINKLSG----SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
            LK L + + N  +     ++   + +  +L  L L+   LS     + G  + +     
Sbjct: 217 ELKVLDLQD-NTFTHLGSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSK 270

Query: 336 RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLG-----NLSNLKFFALRENELS- 389
            EN               L  L L  N++       L       + +L F  L  N  S 
Sbjct: 271 LEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317

Query: 390 -GSIPQEIENMKKLNK 404
              +  EI  +     
Sbjct: 318 EDDVVDEIREVFSTRG 333

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 50/268 (18%), Positives = 84/268 (31%), Gaps = 58/268 (21%)

Query: 24  PQLAYLDLSVNQ---LFGTIPTQISHLSK-------LKHLDFSTNQFS--GIIP--PQIG 69
             L   + S      +   IP  +  L +       L  +  S N F      P    + 
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 70  ILTNLVVLRLSVNQL-------------NGLIPEELGELTSLNELALSYNRL-NGSIPA- 114
             T L  L L  N L                + ++      L  +    NRL NGS+   
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 115 --SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFS 172
             +  +   L  + +  N +    P    +L+        + L   +    + L  N F+
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIR---PEGIEHLLL-------EGLAYCQELKVLDLQDNTFT 229

Query: 173 G----VIPRSLGGLKNLTFVYLNNNRI-------VGSIPSEIGNLRSLSYLGLNKNQLSG 221
                 +  +L    NL  + LN+  +       V    S++ N   L  L L  N++  
Sbjct: 230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN-IGLQTLRLQYNEIEL 288

Query: 222 S-----IPPTAGNLSNLKFLYLHDNRLS 244
                        + +L FL L+ NR S
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 75.3 bits (185), Expect = 6e-14
 Identities = 54/253 (21%), Positives = 91/253 (35%), Gaps = 50/253 (19%)

Query: 750 NFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKL 808
            F    +        +V     L+ + F    ++ G GG G VY      +G   A+K L
Sbjct: 164 KFIESDKFTRFCQWKNVELNIHLTMNDFSVHRII-GRGGFGEVYGCRKADTGKMYAMKCL 222

Query: 809 ------------HSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ-HLFLVYEYL 855
                        +L       N++  +S ++      IV    +  HT   L  + + +
Sbjct: 223 DKKRIKMKQGETLAL-------NERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLM 274

Query: 856 ERGSLATILSNEAT---------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDIS 906
             G L   LS             AAE            +   L +MH+     +++RD+ 
Sbjct: 275 NGGDLHYHLSQHGVFSEADMRFYAAE------------IILGLEHMHNRF---VVYRDLK 319

Query: 907 SKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKCDVFNF 965
              +LLD      +SD G A        +     GT GY+APE L   +  +   D F+ 
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPH--ASVGTHGYMAPEVLQKGVAYDSSADWFSL 377

Query: 966 GVLVLEVIEGKHP 978
           G ++ +++ G  P
Sbjct: 378 GCMLFKLLRGHSP 390

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 62/308 (20%), Positives = 112/308 (36%), Gaps = 74/308 (24%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSEITEI-----RHR 833
            G+G  G V  A            + AVK L           ++  +SE+ ++      H 
Sbjct: 54   GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---EREALMSEL-KMMTQLGSHE 109

Query: 834  NIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG--------- 884
            NIV   G C+ +  ++L++EY   G L   L ++      D  +  N  +          
Sbjct: 110  NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 885  -----------VANALSYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP 931
                       VA  + ++          +HRD++++ VL+       + DFG A+ +  
Sbjct: 170  TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 932  DSSNWSELAGTCGYI-----APELA----YTMRANEKCDVFNFGVLVLEVIEGKHPGHFL 982
            DS   + +      +     APE      YT+    K DV+++G+L+ E+          
Sbjct: 225  DS---NYVVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYGILLWEIFS-------- 269

Query: 983  SLLLSLPAPAANMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQ 1040
              L   P P   ++     LI +  ++  P    EE    M +    C   +   RP+  
Sbjct: 270  --LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS----CWAFDSRKRPSFP 323

Query: 1041 KVCNLLCR 1048
             + + L  
Sbjct: 324  NLTSFLGC 331

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 64/298 (21%)

Query: 785  GTGGCGTVYKAEL-----TSGDTR-AVKKLHSLPTGEIGINQKGFVSEITEI-----RHR 833
            G G  G V +A+      T+     AVK L    T       +  +SE+ +I      H 
Sbjct: 36   GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSEL-KILIHIGHHL 91

Query: 834  NIVKFYGFCSHT-QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-------- 884
            N+V   G C+     L ++ E+ + G+L+T L ++            ++ K         
Sbjct: 92   NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 885  -----VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
                 VA  + ++        +HRD++++ +LL  +    + DFG A+ +  D      +
Sbjct: 152  CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---V 205

Query: 940  AGTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA 990
                  +     APE +    YT+    + DV++FGVL+ E+            L + P 
Sbjct: 206  RKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIF----------SLGASPY 251

Query: 991  PAANMNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P   ++      +    R+  P     E  ++M+     C    P  RPT  ++   L
Sbjct: 252  PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 305

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 72.1 bits (176), Expect = 2e-13
 Identities = 27/96 (28%), Positives = 39/96 (40%), Gaps = 4/96 (4%)

Query: 175 IPRSLGGLKNLTFVYLNNNRIVGSIPSE-IGNLRSLSYLGLNKNQLSGSIPPTA-GNLSN 232
               L G +NLT +Y+ N + +  +    +  L  L  L + K+ L   + P A      
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 233 LKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN 268
           L  L L  N L   +  K     SL  L LS N L+
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 64.4 bits (156), Expect = 5e-11
 Identities = 19/99 (19%), Positives = 32/99 (32%), Gaps = 4/99 (4%)

Query: 192 NNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPK 250
                      +    +L+ L +   Q    +       L  L+ L +  + L  ++ P 
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 251 LGSF-KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
              F   L  L LS N L      +   L SL+ L +  
Sbjct: 75  AFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSG 112

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.9 bits (147), Expect = 7e-10
 Identities = 19/99 (19%), Positives = 33/99 (33%), Gaps = 7/99 (7%)

Query: 217 NQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFK---SLLYLYLSHNQLNGSLPS 273
              +           NL  LY+ + +   ++       +    L  L +  + L    P 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLEL--RDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 274 SFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLS 312
           +F     L  L++   N L  S+  +     SL  L LS
Sbjct: 75  AFHFTPRLSRLNLSF-NALE-SLSWKTVQGLSLQELVLS 111

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 4e-09
 Identities = 26/101 (25%), Positives = 39/101 (38%), Gaps = 2/101 (1%)

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGYLDLSANRLSKLIPKN 587
           +          L    +LT L +   Q    + L  L  L EL  L +  + L  + P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 588 LGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
                +L  LNLS N     +S +  + + L +L LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.2 bits (140), Expect = 6e-09
 Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 4/96 (4%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNGNQLSGDIPLE-LGLLA 568
                +     L +L   + + +  +  + L  L  L +LT+  + L   +  +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
            L  L+LS N L  L      +   L  L LS N  
Sbjct: 81  RLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 21/100 (21%), Positives = 34/100 (34%), Gaps = 2/100 (2%)

Query: 34  NQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQ-IGILTNLVVLRLSVNQLNGLIPEEL 92
                     +     L  L     Q    +  + +  L  L  L +  + L  + P+  
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 93  GELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
                L+ L LS+N L  S+        +L +L LS N L
Sbjct: 77  HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 8e-08
 Identities = 20/114 (17%), Positives = 36/114 (31%), Gaps = 15/114 (13%)

Query: 106 NRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVS 165
                     L    NL +L + N      +                 DL  L    +++
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELR--------------DLRGLGELRNLT 62

Query: 166 LHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQL 219
           +  +    V P +      L+ + L+ N +  S+  +     SL  L L+ N L
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 25/109 (22%), Positives = 39/109 (35%), Gaps = 4/109 (3%)

Query: 2   VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQ-ISHLSKLKHLDFSTNQF 60
             +  T      +L   P      L  L +   Q    +  + +  L +L++L    +  
Sbjct: 11  SGLRCTRDGALDSLHHLPGA--ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLN 109
             + P        L  L LS N L  L   +  +  SL EL LS N L+
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 21/112 (18%), Positives = 43/112 (38%), Gaps = 5/112 (4%)

Query: 447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK-CPQLATLNMGG 505
                 LR  R+    ++  + G   +L  L + N      +    ++   +L  L +  
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 506 NEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQL 556
           + +   +  +      +L +L+ S N L   +  +  +  SL  L L+GN L
Sbjct: 66  SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 5/104 (4%)

Query: 264 HNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKE-IGNLKSLSHLWLSKTQLSGFIPP 322
                           +L  L++ N   L   +    +  L  L +L + K+ L  F+ P
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLR-FVAP 73

Query: 323 -SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN 365
            +      +  L +  N L  S+  +  +  SL +L LS N L+
Sbjct: 74  DAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 15/79 (18%), Positives = 26/79 (32%), Gaps = 4/79 (5%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEE-LGELTSLNELALSYNRLNGSIPA-SLGNLSN 121
               +    NL  L +   Q    +    L  L  L  L +  + L   +   +      
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 122 LVQLSLSNNSLSGQIPPNW 140
           L +L+LS N+L   +    
Sbjct: 82  LSRLNLSFNALE-SLSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 22/105 (20%), Positives = 40/105 (38%), Gaps = 4/105 (3%)

Query: 286 VHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP-SLGNLSNIRGLYIRENMLYGSI 344
           +      +      +   ++L+ L++   Q    +    L  L  +R L I ++ L   +
Sbjct: 13  LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFV 71

Query: 345 PEE-LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENEL 388
             +       LS+L+LS N L       +  LS L+   L  N L
Sbjct: 72  APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 4/87 (4%)

Query: 496 PQLATLNMGGNEISGTIPSE-IGNMTQLHKLDFSSNRLVGQIPKQ-LGKLTSLTSLTLNG 553
             L  L +   +    +    +  + +L  L    + L   +          L+ L L+ 
Sbjct: 31  ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSF 89

Query: 554 NQLSGDIPLELGLLAELGYLDLSANRL 580
           N L   +  +      L  L LS N L
Sbjct: 90  NALES-LSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 29/127 (22%)

Query: 578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEI-SIQIGKLVQLSKLDLSHNSLGGNIPSEI 636
              +     +L     L  L + N Q  Q +    +  L +L  L +  +          
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS---------- 66

Query: 637 CNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIE--AF 694
             L  +              P  F     LS +++S+N L+ S+   K  Q  +++    
Sbjct: 67  -GLRFVA-------------PDAFHFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVL 110

Query: 695 QGNKELC 701
            GN   C
Sbjct: 111 SGNPLHC 117

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 66/295 (22%), Positives = 111/295 (37%), Gaps = 63/295 (21%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSE---ITEIRHRNI 835
            G G  G V+ AE             AVK L           ++ F  E   +T ++H++I
Sbjct: 50   GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAELLTMLQHQHI 105

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL------------SNEATAAELDWSKRVNVIK 883
            V+F+G C+  + L +V+EY+  G L   L              +     L   + + V  
Sbjct: 106  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 884  GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
             VA  + Y+    F   +HRD++++  L+       + DFG ++ +           G  
Sbjct: 166  QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR 219

Query: 944  GYI-----APE-LAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMN 996
              +      PE + Y  +   + DV++FGV++ E+   GK P + LS            N
Sbjct: 220  TMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS------------N 266

Query: 997  IVVNDLIDS--RLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                D I     L  P     EV   ++        C    P  R +++ V   L
Sbjct: 267  TEAIDCITQGRELERPRACPPEVYAIMRG-------CWQREPQQRHSIKDVHARL 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 36/303 (11%), Positives = 82/303 (27%), Gaps = 72/303 (23%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVK------------------------KLHSLPTGEIGIN 819
            G        +A +  +G++  V                          L  +   +    
Sbjct: 82   GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141

Query: 820  QKGFVSEITEIRHRNIVKFYGFCSHTQH-----LFLVYEYLERGSLAT----ILSNEATA 870
               F+     ++     K        +       F +Y    + +L T    +LS+ +T 
Sbjct: 142  HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSSTH 200

Query: 871  AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK 930
              L    R+ +   V   L+ +HH     ++H  +    ++LD      ++ F       
Sbjct: 201  KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 931  PDSSNWSELAGTCGYIAPEL-----------AYTMRANEKCDVFNFGVLVLEVIEGKHPG 979
                     + + G+  PEL                     D +  G+++  +     P 
Sbjct: 257  ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 980  HFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTM 1039
                   +  A       +        +P P       +++++      L    + R   
Sbjct: 313  -I-----TKDAALGGSEWIFRS--CKNIPQP-------VRALLE---GFLRYPKEDRLLP 354

Query: 1040 QKV 1042
             + 
Sbjct: 355  LQA 357

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 68/300 (22%)

Query: 785  GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEI---TEI-RH 832
            G G  G V  AE    D          AVK L S  T +   +    +SE+     I +H
Sbjct: 78   GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 134

Query: 833  RNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG-------- 884
            +NI+   G C+    L+++ EY  +G+L   L               +  +         
Sbjct: 135  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 885  -----VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL 939
                 VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 195  SCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YYK 248

Query: 940  AGTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA 990
              T G +     APE L    YT     + DV++FGVL+ E+            L   P 
Sbjct: 249  KTTNGRLPVKWMAPEALFDRIYTH----QSDVWSFGVLLWEIFT----------LGGSPY 294

Query: 991  PAANMNIVVNDLIDS-RLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P   +  +   L +  R+  P     E+   ++        C  A P  RPT +++   L
Sbjct: 295  PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDL 347

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 69/303 (22%), Positives = 112/303 (36%), Gaps = 70/303 (23%)

Query: 785  GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEI-----R 831
            G G  G V  AE    D          AVK L    T +   +    VSE+ E+     +
Sbjct: 44   GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEM-EMMKMIGK 99

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG------- 884
            H+NI+   G C+    L+++ EY  +G+L   L                V +        
Sbjct: 100  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 885  ------VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE 938
                  +A  + Y+        +HRD++++ VL+       ++DFG A+ +         
Sbjct: 160  VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNID---YY 213

Query: 939  LAGTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP 989
               T G +     APE L    YT     + DV++FGVL+ E+            L   P
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFT----------LGGSP 259

Query: 990  APAANMNIVVNDLID-SRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045
             P   +  +   L +  R+  P     E+   ++        C  A P  RPT +++   
Sbjct: 260  YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD-------CWHAVPSQRPTFKQLVED 312

Query: 1046 LCR 1048
            L R
Sbjct: 313  LDR 315

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 71.2 bits (175), Expect = 4e-13
 Identities = 68/300 (22%), Positives = 110/300 (36%), Gaps = 68/300 (22%)

Query: 785  GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEI-----R 831
            G G  G V  AE    D          AVK L    T +   +    VSE+ E+     +
Sbjct: 90   GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEM-EMMKMIGK 145

Query: 832  HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG------- 884
            H+NI+   G C+    L+++ EY  +G+L   L                V +        
Sbjct: 146  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 885  ------VANALSYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW 936
                  +A  + Y+          +HRD++++ VL+       ++DFG A+ +       
Sbjct: 206  VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 259

Query: 937  SELAGTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS 987
                 T G +     APE L    YT     + DV++FGVL+ E+            L  
Sbjct: 260  --KKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIF----------TLGG 303

Query: 988  LPAPAANMNIVVNDLID-SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             P P   +  +   L +  R+  P     E    +  +   C  A P  RPT +++   L
Sbjct: 304  SPYPGIPVEELFKLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 359

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 42/120 (35%), Positives = 59/120 (49%), Gaps = 15/120 (12%)

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSFKS 256
           S+P+ I +  S + L L  N+L  S+P      L+ L  L L  N++   +P   G F  
Sbjct: 21  SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQS-LPD--GVFDK 74

Query: 257 LL---YLYLSHNQLNGSLPSS-FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
           L     LYL  N+L  SLP+  F  L+ LK L +   N+L  S+P  I   L SL  +WL
Sbjct: 75  LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDT-NQLK-SVPDGIFDRLTSLQKIWL 131

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 58.0 bits (141), Expect = 8e-10
 Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 12/109 (11%)

Query: 186 TFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG---NLSNLKFLYLHDNR 242
           T + L +N++          L  L+ L L++NQ+  S+P   G    L+ L  LYLH+N+
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--GVFDKLTKLTILYLHENK 87

Query: 243 LSGYIPPKLGSF---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
           L   +P   G F     L  L L  NQL       F  L+SL+ + +H 
Sbjct: 88  LQS-LPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 133

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 16/121 (13%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           IP     LE      L +N    +       L  LT + L+ N+I  S+P  +   L  L
Sbjct: 26  IPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF---KSLLYLYLSHN 265
           + L L++N+L  S+P      L+ LK L L  N+L   +P   G F    SL  ++L  N
Sbjct: 79  TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPD--GIFDRLTSLQKIWLHTN 134

Query: 266 Q 266
            
Sbjct: 135 P 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 35/119 (29%), Positives = 51/119 (42%), Gaps = 7/119 (5%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS-FGNLSS 280
           S+P   G  S+   L L  N+L             L  L LS NQ+  SLP   F  L+ 
Sbjct: 21  SVP--TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 281 LKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           L  L++H  NKL  S+P  +   L  L  L L   QL          L++++ +++  N
Sbjct: 78  LTILYLHE-NKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 34/113 (30%), Positives = 51/113 (45%), Gaps = 11/113 (9%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           +P+ I +     +L+  SN+L         KLT LT L+L+ NQ+     L  G+   L 
Sbjct: 22  VPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS---LPDGVFDKLT 76

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKL 621
           +L  L L  N+L  L      +L +L  L L  NQ     S+  G   +L+ L
Sbjct: 77  KLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK---SVPDGIFDRLTSL 126

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 35/135 (25%), Positives = 55/135 (40%), Gaps = 27/135 (20%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNL 122
           +P   GI ++   L L  N+L  L      +LT L +L+LS N++  S+P  +   L+ L
Sbjct: 22  VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 123 VQLSLSNNSLSGQIPPNWGYLISPHYGSIPQ----DLGNLESPVSVSLHTNNFSGVIPRS 178
             L L  N L                 S+P      L  L+    ++L TN    V    
Sbjct: 79  TILYLHENKLQ----------------SLPNGVFDKLTQLK---ELALDTNQLKSVPDGI 119

Query: 179 LGGLKNLTFVYLNNN 193
              L +L  ++L+ N
Sbjct: 120 FDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 8/102 (7%)

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSL 628
            L+L +N+L  L      +L +L  L+LS NQ     S+  G   KL +L+ L L  N L
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ---SLPDGVFDKLTKLTILYLHENKL 88

Query: 629 GGNIPSEIC-NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSI 669
             ++P+ +   L  L+ + L  N+L       F R+  L  I
Sbjct: 89  -QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI 129

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 10/108 (9%)

Query: 309 LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL-GRLKSLSQLSLSVNKLNGS 367
           L L   +L          L+ +  L + +N +  S+P+ +  +L  L+ L L  NKL  S
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 368 IPHCLG---NLSNLKFFALRENELSGSIPQEI-ENMKKLNKYLLFENQ 411
           +P+  G    L+ LK  AL  N+L  S+P  I + +  L K  L  N 
Sbjct: 91  LPN--GVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 29/86 (33%), Positives = 40/86 (46%), Gaps = 8/86 (9%)

Query: 25  QLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGI---LTNLVVLRLS 80
           QL  L LS NQ+  ++P  +   L+KL  L    N+    +P   G+   LT L  L L 
Sbjct: 53  QLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQS-LPN--GVFDKLTQLKELALD 108

Query: 81  VNQLNGLIPEELGELTSLNELALSYN 106
            NQL  +       LTSL ++ L  N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 39/138 (28%), Positives = 49/138 (35%), Gaps = 41/138 (29%)

Query: 421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLS 480
           C S  LT  SV        IP S         L LE N+L      VF     L  L LS
Sbjct: 14  CNSKGLT--SVPTG-----IPSSATR------LELESNKLQSLPHGVFDKLTQLTKLSLS 60

Query: 481 NNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRLVGQIPKQ 539
            N              Q+ +L           P  +   +T+L  L    N+L   +P  
Sbjct: 61  QN--------------QIQSL-----------PDGVFDKLTKLTILYLHENKL-QSLPNG 94

Query: 540 L-GKLTSLTSLTLNGNQL 556
           +  KLT L  L L+ NQL
Sbjct: 95  VFDKLTQLKELALDTNQL 112

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.6 bits (173), Expect = 1e-12
 Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 45/228 (19%)

Query: 772 LSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITE- 829
           ++ +TF    VL G GG G V   ++  +G   A KKL      +    +KG    + E 
Sbjct: 181 VTKNTFRQYRVL-GKGGFGEVCACQVRATGKMYACKKLEK----KRIKKRKGEAMALNEK 235

Query: 830 -----IRHRNIVKFYGFCSHTQ-HLFLVYEYLERGSLATILSNEAT-----------AAE 872
                +  R +V    +   T+  L LV   +  G L   + +              AAE
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294

Query: 873 LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTAKFLK 930
                       +   L  +H +    I++RD+  + +LLD     H+  SD G A  + 
Sbjct: 295 ------------ICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAVHVP 337

Query: 931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
              +      GT GY+APE+    R     D +  G L+ E+I G+ P
Sbjct: 338 EGQTIKG-RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 56/230 (24%)

Query: 785 GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
           G G  G V KA        +G T  AVK L    +       +  +SE     ++ H ++
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS---ELRDLLSEFNVLKQVNHPHV 88

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----------- 884
           +K YG CS    L L+ EY + GSL   L               +               
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 885 ----------VANALSYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD 932
                     ++  + Y+         ++HRD++++ +L+    K  +SDFG ++ +  +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 933 SSNWSELAGTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVI 973
            S    +  + G I     A E L    YT     + DV++FGVL+ E++
Sbjct: 204 DSY---VKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIV 246

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 59/294 (20%)

Query: 785  GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G    G VYK  L            A+K L     G     ++ F  E      ++H N+
Sbjct: 18   GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP---LREEFRHEAMLRARLQHPNV 74

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVI 882
            V   G  +  Q L +++ Y   G L   L              +    + L+    V+++
Sbjct: 75   VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 883  KGVANALSYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA 940
              +A  + Y+  HH     ++H+D++++ VL+  +    +SD G  + +   ++++ +  
Sbjct: 135  AQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYK-L 186

Query: 941  GTCGYI-----APELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAAN 994
                 +     APE     + +   D++++GV++ EV   G  P    S           
Sbjct: 187  LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----------- 235

Query: 995  MNIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             N  V ++I +   LP P          MI     C +  P  RP  + + + L
Sbjct: 236  -NQDVVEMIRNRQVLPCPDDCPAWVYALMIE----CWNEFPSRRPRFKDIHSRL 284

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 70.7 bits (172), Expect = 2e-12
 Identities = 83/589 (14%), Positives = 173/589 (29%), Gaps = 171/589 (29%)

Query: 310 WLSKTQLSGFIPPSLGNLSNIRGLYIRE-NMLYG----------SIPEELGRLKS-LSQL 357
           +L     +    PS+     +  +YI + + LY           S  +   +L+  L +L
Sbjct: 93  FLMSPIKTEQRQPSM-----MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL 147

Query: 358 S----LSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIE--NMKKLNK-YLLFEN 410
                + ++ + GS    +              ++   +  +I   N+K  N    + E 
Sbjct: 148 RPAKNVLIDGVLGSGKTWVALD------VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM 201

Query: 411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI 470
                  Q +                    P          +++L  + +   +  +   
Sbjct: 202 L------QKLL-----YQID----------PNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 471 --YPDLELLDLSNNNFFGEISSNWI------KCPQLATLNMGG--NEISGTIPSEIGNMT 520
             Y +  LL L N      + +          C  L T       + +S    + I   +
Sbjct: 241 KPYEN-CLLVLLN------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI---S 290

Query: 521 QLHKLD-FSSNRLVGQIPKQLG-KLTSLTSLTLNGNQLSGDIPLELGLLAEL-------- 570
             H     + + +   + K L  +   L    L  N      P  L ++AE         
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN------PRRLSIIAESIRDGLATW 344

Query: 571 -GYLDLSANRLSKLIPKNL-----GELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLS 624
             +  ++ ++L+ +I  +L      E RK+    LS   F     I    L         
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-RLS--VFPPSAHIPTILLS-------- 393

Query: 625 HNSLGGNIPSEICNLESLEYMNLLQNKL---SGPIPSCFRRMHGLSSIDVSYNELQGSIP 681
              +  ++       + +  +N L         P  S    +  +      Y EL+  + 
Sbjct: 394 --LIWFDVIKS----DVMVVVNKLHKYSLVEKQPKESTIS-IPSI------YLELKVKLE 440

Query: 682 HSKAFQNATIEAFQGNKELCGDVTGLPPCEALTSNKGDS------GKHMTFLFVIVPLLS 735
           +  A   + ++ +   K    D   +PP         D       G H+  +        
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSD-DLIPPYL-------DQYFYSHIGHHLKNI-----EHP 487

Query: 736 GAF-LLSLVLIGMCFNFRRRK-RTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVY 793
               L  +V +   F F  +K R DS       +    L    F               Y
Sbjct: 488 ERMTLFRMVFLD--FRFLEQKIRHDSTAWNASGSILNTLQQLKF---------------Y 530

Query: 794 KAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVKF 838
           K  +   D +  + ++++           F+ +I E     ++ ++++ 
Sbjct: 531 KPYICDNDPKYERLVNAI---------LDFLPKIEENLICSKYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 65.3 bits (158), Expect = 9e-11
 Identities = 110/699 (15%), Positives = 208/699 (29%), Gaps = 224/699 (32%)

Query: 52  HLDFSTNQ----FSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTS---LNELALS 104
           H+DF T +    +  I+     +  +  V           + +    + S   ++ + +S
Sbjct: 6   HMDFETGEHQYQYKDILS----VFEDAFVDNFDCKD----VQDMPKSILSKEEIDHIIMS 57

Query: 105 YNRLNGS---IPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESP 161
            + ++G+       L     +VQ       +   +  N+ +L+SP   +  +       P
Sbjct: 58  KDAVSGTLRLFWTLLSKQEEMVQ-----KFVEEVLRINYKFLMSP-IKTEQRQ------P 105

Query: 162 VSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSG 221
              S+ T  +     R      N  F   N +R           LR           L  
Sbjct: 106 ---SMMTRMYIEQRDRLYND--NQVFAKYNVSR-----LQPYLKLR---------QALL- 145

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSL 281
                   L   K + +      G     LGS K+ + L +  +     +          
Sbjct: 146 -------ELRPAKNVLID-----G----VLGSGKTWVALDVCLSY---KVQCKMDF---- 182

Query: 282 KHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLY 341
               +  +N  + + P+ +  L+ L  L     Q+    P       +   + +R +   
Sbjct: 183 ---KIFWLNLKNCNSPETV--LEMLQKLLY---QID---PNWTSRSDHSSNIKLRIH--- 228

Query: 342 GSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSN------LKFFALR----------- 384
            SI  EL RL                  +CL  L N         F L            
Sbjct: 229 -SIQAELRRLLKSKPY-----------ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276

Query: 385 -ENELSGSIPQEI------------ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSV 431
             + LS +    I            E    L KYL   +     LP+ V    +    S+
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL---DCRPQDLPREVLT-TNPRRLSI 332

Query: 432 RNNNFVGPIPRSLQN--CTSLYSLRLERNQLTGNIS---------------EVFGIYPD- 473
                   I  S+++   T      +  ++LT  I                +   ++P  
Sbjct: 333 --------IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPS 384

Query: 474 -------LELL--DLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPS-------EIG 517
                  L L+  D+  +    ++     K  + + +     E + +IPS       ++ 
Sbjct: 385 AHIPTILLSLIWFDVIKS----DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440

Query: 518 NMTQLHKLDFSSNRLVGQ--IPKQLGKLTSLTSLTLN-------GNQLSGDIPLELGLLA 568
           N   LH+       +V    IPK       L    L+       G+ L      E   L 
Sbjct: 441 NEYALHR------SIVDHYNIPKTF-DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLF 493

Query: 569 ELGYLDL-----------SANRLSKLIPKNLGELRK-LHHLNLSNNQFSQEISIQIGKLV 616
            + +LD            +A   S  I   L +L+    ++  ++ ++ + +        
Sbjct: 494 RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV-------- 545

Query: 617 QLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP 655
                    N++   +P    NL   +Y +LL+  L   
Sbjct: 546 ---------NAILDFLPKIEENLICSKYTDLLRIALMAE 575

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.5 bits (130), Expect = 2e-07
 Identities = 82/609 (13%), Positives = 171/609 (28%), Gaps = 186/609 (30%)

Query: 456  ERNQLTGNISEVFGIYPDLELLDLSNNN----FFGEISS---NWIKCPQLATLNMGGNEI 508
            E + +  +   V G       L          F  E+      ++  P + T     + +
Sbjct: 50   EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP-IKTEQRQPSMM 108

Query: 509  SGTIPSEIGNMTQ----LHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL 564
            +     +   +        K + S  +   ++ + L +L    ++ ++G  + G      
Sbjct: 109  TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VLG-----S 161

Query: 565  G---LLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKL 621
            G   +  ++      + ++   +        K+  LNL N    + +   + KL  L ++
Sbjct: 162  GKTWVALDV----CLSYKVQCKMD------FKIFWLNLKNCNSPETVLEMLQKL--LYQI 209

Query: 622  DLSHNSLGGNIPSEICNLESLEYM--NLLQNKLSGPIPSCFRRMHGLSSI--DVSYNELQ 677
            D +  S   +  +    + S++     LL++K   P  +C      L  +  +V   +  
Sbjct: 210  DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK---PYENCL-----L--VLLNVQNAK-- 257

Query: 678  GSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEAL--TSNKGDSGKHMTFLFVIVPLLS 735
                           AF        +++    C+ L  T  K            +   LS
Sbjct: 258  ------------AWNAF--------NLS----CKILLTTRFKQ-----------VTDFLS 282

Query: 736  GAFLLSLVLIGMCFNFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKA 795
             A    + L            T  +        + LL          L            
Sbjct: 283  AATTTHISLDHHSMTL-----TPDE-------VKSLLLK-------YLD-------CRPQ 316

Query: 796  ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL 855
            +L     R V   +      I  + +  ++     +H N  K     +      L    L
Sbjct: 317  DLP----REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL----TTIIESSL--NVL 366

Query: 856  E----RG---SLATILSNEA--TAAELD--WS---------------KRVNVIKGVANAL 889
            E    R     L+ +    A      L   W                K   V K    + 
Sbjct: 367  EPAEYRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL----KPDSSNWSELAGTC-- 943
              +        ++ ++  K   L+ EY  H         +     P + +  +L      
Sbjct: 426  ISIPS------IYLELKVK---LENEYALH------RSIVDHYNIPKTFDSDDLIPPYLD 470

Query: 944  GYIAPELAYTMRA---NEKCDVFNFGVLVLEVIEGK--HPGHFLSLLLSLPAPAANMNIV 998
             Y    + + ++     E+  +F    L    +E K  H         +  A  +    +
Sbjct: 471  QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS------TAWNASGS----I 520

Query: 999  VNDLIDSRL 1007
            +N L   + 
Sbjct: 521  LNTLQQLKF 529

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 4e-06
 Identities = 57/432 (13%), Positives = 120/432 (27%), Gaps = 136/432 (31%)

Query: 666  LSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALTS-------NKG 718
                   Y ++   +     F++A ++ F      C DV  +P    L+           
Sbjct: 11   TGEHQYQYKDI---LSV---FEDAFVDNFD-----CKDVQDMPK-SILSKEEIDHIIMSK 58

Query: 719  DSGKHMTFLFVIVPLLSGA----------------FLLSLV--------LIGMCFN-FRR 753
            D+      LF  + L                    FL+S +        ++   +   R 
Sbjct: 59   DAVSGTLRLFWTL-LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117

Query: 754  RKRTDSQE-GQNDVNNQE--------LLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRA 804
            R   D+Q   + +V+  +        LL        +++ G  G G   K  +      +
Sbjct: 118  RLYNDNQVFAKYNVSRLQPYLKLRQALLELRP-AKNVLIDGVLGSG---KTWVALDVCLS 173

Query: 805  VKKLHSLPTGE--IGINQKGFVSEITEI----RHRNIVKFYGFCSHTQHLFLVYEYLERG 858
             K    +      + +        + E+     ++    +     H+ ++ L    ++  
Sbjct: 174  YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-- 231

Query: 859  SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVL--LDLEY 916
                              +R+   K   N L          +L  ++ + K     +L  
Sbjct: 232  ---------------AELRRLLKSKPYENCLL---------VL-LNVQNAKAWNAFNLSC 266

Query: 917  K-------AHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLV 969
            K         V+DF +A      S +               + T+  +E   +    +  
Sbjct: 267  KILLTTRFKQVTDFLSAATTTHISLD-------------HHSMTLTPDEVKSLL---LKY 310

Query: 970  LEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE-------EKLKSMI 1022
            L+                LP      N     +I   +   L   +       +KL ++I
Sbjct: 311  LDCRPQD-----------LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359

Query: 1023 AVAFLCLDANPD 1034
              +   L+  P 
Sbjct: 360  ESSLNVLE--PA 369

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 65/287 (22%), Positives = 107/287 (37%), Gaps = 73/287 (25%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTG----EIGINQKGFVSEITEIRHRN 834
            G G    V  A  + +G   A+K     +L+         E+ I +         + H N
Sbjct: 24   GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI--------LNHPN 75

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANAL 889
            IVK +      + L+L+ EY   G +   L       E  A              + +A+
Sbjct: 76   IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--------IVSAV 127

Query: 890  SYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YI 946
             Y H      I+HRD+ ++ +LLD +    ++DFG +           +L   CG   Y 
Sbjct: 128  QYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----GKLDAFCGAPPYA 180

Query: 947  APEL----AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL--SLPAPAANMNIVVN 1000
            APEL     Y      + DV++ GV+             L  L+  SLP    N+  +  
Sbjct: 181  APELFQGKKY---DGPEVDVWSLGVI-------------LYTLVSGSLPFDGQNLKELRE 224

Query: 1001 DLIDS--RLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
             ++    R+P  +  + E  LK         L  NP  R T++++  
Sbjct: 225  RVLRGKYRIPFYMSTDCENLLKRF-------LVLNPIKRGTLEQIMK 264

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 70/293 (23%), Positives = 117/293 (39%), Gaps = 58/293 (19%)

Query: 785  GTGGCGTVYKAEL-----TSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G V+ AE      T      AVK L           +K F  E    T ++H +I
Sbjct: 24   GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTNLQHEHI 79

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRVNVI 882
            VKFYG C     L +V+EY++ G L   L                    EL  S+ +++ 
Sbjct: 80   VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 883  KGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
              +A+ + Y+    F   +HRD++++  L+       + DFG ++ +   S+++    G 
Sbjct: 140  SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR-VGG 193

Query: 943  CGYI-----APE-LAYTMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANM 995
               +      PE + Y  +   + DV++FGV++ E+   GK P   LS            
Sbjct: 194  HTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLS------------ 240

Query: 996  NIVVNDLIDS--RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            N  V + I     L  P    +E    M+     C    P  R  ++++  +L
Sbjct: 241  NTEVIECITQGRVLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEIYKIL 289

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 60/249 (24%)

Query: 759 SQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIG 817
           S +               F+   +L G G   TV  A EL +    A+K L         
Sbjct: 14  SLQHAQPPPQPRKKRPEDFKFGKIL-GEGSFSTVVLARELATSREYAIKIL--------- 63

Query: 818 INQKGFV----------SE---ITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATIL 864
             +K  +           E   ++ + H   VK Y      + L+    Y + G L   +
Sbjct: 64  --EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121

Query: 865 SNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDL 914
               +          AE            + +AL Y+H       I+HRD+  + +LL+ 
Sbjct: 122 RKIGSFDETCTRFYTAE------------IVSALEYLHGKG----IIHRDLKPENILLN- 164

Query: 915 EYKAHV--SDFGTAKFLKPDSSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLV 969
               H+  +DFGTAK L P+S      S   GT  Y++PEL     A +  D++  G ++
Sbjct: 165 -EDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPELLTEKSACKSSDLWALGCII 222

Query: 970 LEVIEGKHP 978
            +++ G  P
Sbjct: 223 YQLVAGLPP 231

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 40/123 (32%), Positives = 64/123 (52%), Gaps = 17/123 (13%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           IP+D+  L       L  N F+ ++P+ L   K+LT + L+NNRI  ++ ++   N+  L
Sbjct: 29  IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRLSGYIPPKLGSF---KSLLYLYLSHN 265
             L L+ N+L   IPP     L +L+ L LH N +S  +P   G+F    +L +L +  N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPE--GAFNDLSALSHLAIGAN 136

Query: 266 QLN 268
            L 
Sbjct: 137 PLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 3/103 (2%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
           L L  NQ    +P ++S+   L  +D S N+ S +       +T L+ L LS N+L  + 
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 89  PEELGELTSLNELALSYNRLNGSIP-ASLGNLSNLVQLSLSNN 130
           P     L SL  L+L  N ++  +P  +  +LS L  L++  N
Sbjct: 95  PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 11/101 (10%)

Query: 236 LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPS-SFGNLSSLKHLHVHNINKLSG 294
           LYL  N+ +  +P +L ++K L  + LS+N+++ +L + SF N++ L  L +   N+L  
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSY-NRLR- 91

Query: 295 SIPKEI-GNLKSLSHLWLSKTQLSGFIPP----SLGNLSNI 330
            IP      LKSL  L L    +S  +P      L  LS++
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 35/123 (28%), Positives = 53/123 (43%), Gaps = 14/123 (11%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           +P  I       +L    N+    +PK+L     LT + L+ N++S    L       + 
Sbjct: 25  LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST---LSNQSFSNMT 78

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
           +L  L LS NRL  + P+    L+ L  L+L  N  S    +  G    LS   LSH ++
Sbjct: 79  QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS---VVPEGAFNDLSA--LSHLAI 133

Query: 629 GGN 631
           G N
Sbjct: 134 GAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 41/158 (25%), Positives = 63/158 (39%), Gaps = 46/158 (29%)

Query: 64  IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNL 122
           +P   GI  ++  L L  NQ   L+P+EL     L  + LS NR++ ++      N++ L
Sbjct: 25  LPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 123 VQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGL 182
           + L LS N L                  IP                       PR+  GL
Sbjct: 81  LTLILSYNRLR----------------CIP-----------------------PRTFDGL 101

Query: 183 KNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQL 219
           K+L  + L+ N I   +P     +L +LS+L +  N L
Sbjct: 102 KSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPL 138

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 33/148 (22%), Positives = 52/148 (35%), Gaps = 44/148 (29%)

Query: 96  TSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
             + EL L  N+    +P  L N  +L  + LSNN +S                ++    
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS----------------TLS--- 70

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGL 214
                           +         +  L  + L+ NR+   IP      L+SL  L L
Sbjct: 71  ----------------NQSFSN----MTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSL 109

Query: 215 NKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
           + N +S  +P  A  +LS L  L +  N
Sbjct: 110 HGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQI-SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLR 78
              +  L  +DLS N++  T+  Q  S++++L  L  S N+   I P     L +L +L 
Sbjct: 50  LSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108

Query: 79  LSVNQLNGLIPEEL-GELTSLNELALSYN 106
           L  N ++  +PE    +L++L+ LA+  N
Sbjct: 109 LHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.4 bits (165), Expect = 8e-12
 Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 38/248 (15%)

Query: 750 NFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKL 808
           +F +               +  L    FE   V+ G G    V   ++  +G   A+K +
Sbjct: 41  DFLQWAEPIVVR-----LKEVRLQRDDFEILKVI-GRGAFSEVAVVKMKQTGQVYAMKIM 94

Query: 809 ---HSLPTGEIGINQKGFVSE---ITEIRHRNIVK-FYGFCSHTQHLFLVYEYLERGSLA 861
                L  GE+      F  E   +     R I +  + F     +L+LV EY   G L 
Sbjct: 95  NKWDMLKRGEV----SCFREERDVLVNGDRRWITQLHFAFQDEN-YLYLVMEYYVGGDLL 149

Query: 862 TILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV 920
           T+LS        + ++    +  +  A+  +H        +HRDI    +LLD     H+
Sbjct: 150 TLLSKFGERIPAEMARFY--LAEIVMAIDSVHRLG----YVHRDIKPDNILLD--RCGHI 201

Query: 921 --SDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTMRANEK-------CDVFNFGVLVL 970
             +DFG+   L+ D +  S +A GT  Y++PE+   +            CD +  GV   
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261

Query: 971 EVIEGKHP 978
           E+  G+ P
Sbjct: 262 EMFYGQTP 269

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 57/230 (24%), Positives = 91/230 (39%), Gaps = 46/230 (20%)

Query: 772 LSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITE- 829
           +    F    VL G GG G V+  ++  +G   A KKL+     +    +KG+   + E 
Sbjct: 182 MGEDWFLDFRVL-GRGGFGEVFACQMKATGKLYACKKLNK----KRLKKRKGYQGAMVEK 236

Query: 830 -----IRHRNIVKFYGFCSHTQ-HLFLVYEYLERGSLATILSNEAT-------------A 870
                +  R IV    +   T+  L LV   +  G +   + N                 
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 871 AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHV--SDFGTAKF 928
           A+            + + L ++H      I++RD+  + VLLD +   +V  SD G A  
Sbjct: 296 AQ------------IVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLAVE 338

Query: 929 LKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           LK   +     AGT G++APEL      +   D F  GV + E+I  + P
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 53/241 (21%), Positives = 89/241 (36%), Gaps = 58/241 (24%)

Query: 766 VNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFV 824
            +  E ++   FE    + G G  G V   +   +    A+K ++           K   
Sbjct: 6   FDENEDVNFDHFEILRAI-GKGSFGKVCIVQKNDTKKMYAMKYMN-----------KQKC 53

Query: 825 SEITEIRH----RNIVK-----F-----YGFCSHTQHLFLVYEYLERGSLATILSNEAT- 869
            E  E+R+      I++     F     Y F      +F+V + L  G L   L      
Sbjct: 54  VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHF 112

Query: 870 --------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV 920
                     EL              AL Y+        I+HRD+    +LLD     H+
Sbjct: 113 KEETVKLFICEL------------VMALDYLQNQR----IIHRDMKPDNILLDEHGHVHI 156

Query: 921 SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA---NEKCDVFNFGVLVLEVIEGKH 977
           +DF  A  L  ++   + +AGT  Y+APE+  + +    +   D ++ GV   E++ G+ 
Sbjct: 157 TDFNIAAMLPRETQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

Query: 978 P 978
           P
Sbjct: 216 P 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 49/251 (19%)

Query: 750 NFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKL 808
           NF  R +    + ++       + A  +E   V+ G G  G V      ++    A+K L
Sbjct: 49  NFLSRYKDTINKIRD-----LRMKAEDYEVVKVI-GRGAFGEVQLVRHKSTRKVYAMKLL 102

Query: 809 HSLPTGEIGINQKGFVSE----ITEIRHRNIVK-FYGFCSHTQHLFLVYEYLERGSLATI 863
                  I  +   F  E    +       +V+ FY F    ++L++V EY+  G L  +
Sbjct: 103 SKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNL 159

Query: 864 LSN----EATA----AELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDL 914
           +SN    E  A    AE            V  AL  +H        +HRD+    +LLD 
Sbjct: 160 MSNYDVPEKWARFYTAE------------VVLALDAIHSMG----FIHRDVKPDNMLLD- 202

Query: 915 EYKAHV--SDFGTAKFLKPDSSNWSELA-GTCGYIAPEL----AYTMRANEKCDVFNFGV 967
               H+  +DFGT   +  +     + A GT  YI+PE+            +CD ++ GV
Sbjct: 203 -KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261

Query: 968 LVLEVIEGKHP 978
            + E++ G  P
Sbjct: 262 FLYEMLVGDTP 272

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 60.7 bits (148), Expect = 8e-11
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 13/95 (13%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSS-FGN 277
           S+P   G  +  + LYL+DN+++  + P  G F  L     L L +NQL   LP+  F  
Sbjct: 23  SVP--TGIPTTTQVLYLYDNQITK-LEP--GVFDRLTQLTRLDLDNNQLT-VLPAGVFDK 76

Query: 278 LSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
           L+ L  L +++ N+L  SIP+    NLKSL+H+WL
Sbjct: 77  LTQLTQLSLND-NQLK-SIPRGAFDNLKSLTHIWL 109

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 15/111 (13%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNR 242
           + T V  +   +  S+P+ I    +   L L  NQ++  + P     L+ L  L L +N+
Sbjct: 10  SGTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQ 65

Query: 243 LSGYIPP----KLGSFKSLLYLYLSHNQLNGSLPS-SFGNLSSLKHLHVHN 288
           L+  +P     KL     L  L L+ NQL  S+P  +F NL SL H+ + N
Sbjct: 66  LTV-LPAGVFDKLT---QLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLN 111

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.2 bits (118), Expect = 9e-07
 Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 10/93 (10%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           IP     L       L+ N  + + P     L  LT + L+NN++   +P+ +   L  L
Sbjct: 28  IPTTTQVLY------LYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQL 80

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
           + L LN NQL  SIP  A  NL +L  ++L +N
Sbjct: 81  TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 27/65 (41%), Positives = 34/65 (52%), Gaps = 2/65 (3%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSL 127
           GI T   VL L  NQ+  L P     LT L  L L  N+L   +PA +   L+ L QLSL
Sbjct: 27  GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSL 85

Query: 128 SNNSL 132
           ++N L
Sbjct: 86  NDNQL 90

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.8 bits (112), Expect = 6e-06
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 8/90 (8%)

Query: 565 GLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKL 621
           G+      L L  N+++KL P     L +L  L+L NNQ +    +  G   KL QL++L
Sbjct: 27  GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT---VLPAGVFDKLTQLTQL 83

Query: 622 DLSHNSLGGNIPSEIC-NLESLEYMNLLQN 650
            L+ N L  +IP     NL+SL ++ LL N
Sbjct: 84  SLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 14/97 (14%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           +P+ I   TQ   L    N++    P    +LT LT L L+ NQL+    L  G+   L 
Sbjct: 24  VPTGIPTTTQ--VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV---LPAGVFDKLT 78

Query: 569 ELGYLDLSANRLSKLIPKNLG---ELRKLHHLNLSNN 602
           +L  L L+ N+L K IP+  G    L+ L H+ L NN
Sbjct: 79  QLTQLSLNDNQL-KSIPR--GAFDNLKSLTHIWLLNN 112

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 63.5 bits (155), Expect = 9e-11
 Identities = 61/310 (19%), Positives = 109/310 (35%), Gaps = 83/310 (26%)

Query: 785  GTGGCGTVYKAELT-----SGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G V++A           T  AVK L    + +    Q  F  E     E  + NI
Sbjct: 56   GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD---MQADFQREAALMAEFDNPNI 112

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----------- 884
            VK  G C+  + + L++EY+  G L   L + +       S      +            
Sbjct: 113  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 885  ----------VANALSYM--HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD 932
                      VA  ++Y+          +HRD++++  L+       ++DFG ++ +   
Sbjct: 173  CAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI--Y 225

Query: 933  SSNWSELAGTCGYI-----APE-LA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLS 983
            S+++ + A     I      PE +    YT     + DV+ +GV++ E+           
Sbjct: 226  SADYYK-ADGNDAIPIRWMPPESIFYNRYTT----ESDVWAYGVVLWEIF---------- 270

Query: 984  LLLSL---PAPAANMNIVVNDLID-SRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCR 1036
               S    P        V+  + D + L  P     E+   ++        C    P  R
Sbjct: 271  ---SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL-------CWSKLPADR 320

Query: 1037 PTMQKVCNLL 1046
            P+   +  +L
Sbjct: 321  PSFCSIHRIL 330

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 13/95 (13%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL---YLYLSHNQLNGSLPSS-FGN 277
           S+P  AG  ++ + L+L++N+++  + P  G F  L+    LY + N+L  ++P+  F  
Sbjct: 26  SVP--AGIPTDKQRLWLNNNQITK-LEP--GVFDHLVNLQQLYFNSNKLT-AIPTGVFDK 79

Query: 278 LSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWL 311
           L+ L  L +++ N L  SIP+    NLKSL+H++L
Sbjct: 80  LTQLTQLDLND-NHLK-SIPRGAFDNLKSLTHIYL 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 38/110 (34%), Positives = 57/110 (51%), Gaps = 13/110 (11%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNR 242
           + T V   N R+  S+P+ I        L LN NQ++  + P    +L NL+ LY + N+
Sbjct: 13  DQTLVNCQNIRLA-SVPAGI--PTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNK 68

Query: 243 LSGYIPPKLGSF---KSLLYLYLSHNQLNGSLPS-SFGNLSSLKHLHVHN 288
           L+  IP   G F     L  L L+ N L  S+P  +F NL SL H++++N
Sbjct: 69  LTA-IPT--GVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYN 114

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 151 IPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSL 209
           IP D   L       L+ N  + + P     L NL  +Y N+N++  +IP+ +   L  L
Sbjct: 31  IPTDKQRLW------LNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQL 83

Query: 210 SYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDN 241
           + L LN N L  SIP  A  NL +L  +YL++N
Sbjct: 84  TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 23/65 (35%), Positives = 35/65 (53%), Gaps = 2/65 (3%)

Query: 69  GILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASL-GNLSNLVQLSL 127
           GI T+   L L+ NQ+  L P     L +L +L  + N+L  +IP  +   L+ L QL L
Sbjct: 30  GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDL 88

Query: 128 SNNSL 132
           ++N L
Sbjct: 89  NDNHL 93

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 565 GLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKL 621
           G+  +   L L+ N+++KL P     L  L  L  ++N+ +   +I  G   KL QL++L
Sbjct: 30  GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT---AIPTGVFDKLTQLTQL 86

Query: 622 DLSHNSLGGNIPSEIC-NLESLEYMNLLQN 650
           DL+ N L  +IP     NL+SL ++ L  N
Sbjct: 87  DLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.4 bits (103), Expect = 9e-05
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 16/98 (16%)

Query: 512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL---LA 568
           +P+ I    Q  +L  ++N++    P     L +L  L  N N+L+    +  G+   L 
Sbjct: 27  VPAGIPTDKQ--RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA---IPTGVFDKLT 81

Query: 569 ELGYLDLSANRLSKLIPK----NLGELRKLHHLNLSNN 602
           +L  LDL+ N L K IP+    NL     L H+ L NN
Sbjct: 82  QLTQLDLNDNHL-KSIPRGAFDNLK---SLTHIYLYNN 115

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 52/281 (18%), Positives = 96/281 (34%), Gaps = 48/281 (17%)

Query: 444 LQNCTSLYSLRLERNQLTGN----ISEVF-GIYPDLELLDLSNNNFFGEISSNWI----- 493
                 + SL L  N L       + + F      +  L+LS N+  G  +S+ +     
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS-LGFKNSDELVQILA 76

Query: 494 -KCPQLATLNMGGNEISGTIPSEIGNM-----TQLHKLDFSSNRLVGQIPKQLGKL---- 543
                + +LN+ GN +S     E+          +  LD   N    +   +  +     
Sbjct: 77  AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136

Query: 544 -TSLTSLTLNGNQLS--GDIPLELGLLAE---LGYLDLSANRLSKLIPKNLGEL-----R 592
             S+TSL L GN L       L   L A    +  L+L  N L+      L +       
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 593 KLHHLNLSNNQFSQEISIQIGKLVQ-----LSKLDLSHNSLGGNIPSEICNLE----SLE 643
            +  L+LS N    +   ++  +       +  L+L  N L G     +  L+     L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 644 YMNLLQNKLSGP-------IPSCFRRMHGLSSIDVSYNELQ 677
            + L  + +          + + F  +  +  +D +  E+ 
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 52/252 (20%), Positives = 93/252 (36%), Gaps = 39/252 (15%)

Query: 464 ISEVFGIYPDLELLDLSNNNF----FGEISSNWIKCP-QLATLNMGGNEISGTIPSEIGN 518
           + E   I   +  LDLS NN       E+   +   P  + +LN+ GN +      E+  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 519 M-----TQLHKLDFSSNRLVGQIPKQLGKL-----TSLTSLTLNGNQLS--GDIPLELGL 566
           +       +  L+ S N L  +   +L K       ++T L L  N  S       +   
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 567 LAE---LGYLDLSANRLSKLIPKNLGEL-----RKLHHLNLSNNQFSQEISIQIGKLV-- 616
                 +  L+L  N L       L ++       ++ LNL  N  + +   ++ K +  
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193

Query: 617 ---QLSKLDLSHNSLGGNIPSEIC-----NLESLEYMNLLQNKLSGP----IPSCFRRMH 664
               ++ LDLS N LG    +E+          +  +NL  N L GP    +      + 
Sbjct: 194 IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253

Query: 665 GLSSIDVSYNEL 676
            L ++ + Y+ +
Sbjct: 254 HLQTVYLDYDIV 265

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 57/339 (16%), Positives = 115/339 (33%), Gaps = 63/339 (18%)

Query: 352 KSLSQLSLSVNKLNGSIPHCLG-----NLSNLKFFALRENELSGSIPQEIENMKKLNKYL 406
             ++ L LS+N L       L        +++    L  N L        +N  +L + L
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF------KNSDELVQIL 75

Query: 407 LFENQFTGYLPQNVCQSGSLTHFSVRNNNF----VGPIPRSLQNC-TSLYSLRLERNQLT 461
                             ++T  ++  N         + ++L     ++  L L  N  +
Sbjct: 76  AAIPA-------------NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122

Query: 462 GN----ISEVFGIYP-DLELLDLSNNNFFGEISSNWI----KCP--QLATLNMGGNEISG 510
                   + F   P  +  L+L  N+  G  SS+ +          + +LN+ GN ++ 
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGNNLAS 181

Query: 511 TIPSEIGNM-----TQLHKLDFSSNRLVGQIPKQLGKL-----TSLTSLTLNGNQLSGDI 560
              +E+          +  LD S+N L  +   +L  +       + SL L  N L G  
Sbjct: 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241

Query: 561 PLELGLLAE----LGYLDLSANRLSKLIPKN-------LGELRKLHHLNLSNNQFSQEIS 609
              L LL +    L  + L  + +  +  +           ++K+  ++ +  +     S
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301

Query: 610 IQIGKLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNL 647
           I I  L++         SL          +  ++E +N+
Sbjct: 302 IPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNI 340

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 26/116 (22%), Positives = 42/116 (36%), Gaps = 10/116 (8%)

Query: 443 SLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISS--NWIKCPQLAT 500
              N      L L   ++   I  +       + +D S+N    EI     +    +L T
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKT 68

Query: 501 LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL--VGQIPKQLGKLTSLTSLTLNGN 554
           L +  N I          +  L +L  ++N L  +G +   L  L SLT L +  N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.5 bits (142), Expect = 7e-10
 Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 10/129 (7%)

Query: 525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLI 584
           +  ++  L+ Q   Q         L L G ++   I      L +   +D S N + KL 
Sbjct: 2   VKLTAE-LIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57

Query: 585 PKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLE---S 641
                 LR+L  L ++NN+  +        L  L++L L++NSL      ++  L    S
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKS 114

Query: 642 LEYMNLLQN 650
           L Y+ +L+N
Sbjct: 115 LTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 33/150 (22%), Positives = 62/150 (41%), Gaps = 9/150 (6%)

Query: 477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQI 536
           + L+      E ++ +    +   L++ G +I   I +    + Q   +DFS N +  ++
Sbjct: 2   VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57

Query: 537 PKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL-IPKNLGELRKLH 595
                 L  L +L +N N++          L +L  L L+ N L +L     L  L+ L 
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 596 HLNLSNNQFSQEI---SIQIGKLVQLSKLD 622
           +L +  N  + +       I K+ Q+  LD
Sbjct: 117 YLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 23/115 (20%), Positives = 46/115 (40%), Gaps = 6/115 (5%)

Query: 514 SEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-LGLLAELGY 572
           ++  N  +  +LD    ++   I      L    ++  + N++     L+   LL  L  
Sbjct: 13  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 68

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ-IGKLVQLSKLDLSHN 626
           L ++ NR+ ++       L  L  L L+NN   +   +  +  L  L+ L +  N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 23/166 (13%), Positives = 47/166 (28%), Gaps = 43/166 (25%)

Query: 76  VLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQ 135
           +++L+   +      +        EL L   ++   I      L     +  S+N +   
Sbjct: 1   MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55

Query: 136 IPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI 195
                          +      L    ++ ++ N    +       L +LT + L NN  
Sbjct: 56  --------------KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS- 99

Query: 196 VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN 241
                  +  L  L  L                +L +L +L +  N
Sbjct: 100 -------LVELGDLDPL---------------ASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 3/92 (3%)

Query: 42  TQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNEL 101
            Q ++  + + LD    +   I       L     +  S N++  L  +    L  L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLGAT-LDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69

Query: 102 ALSYNRLNGSIPASLGNLSNLVQLSLSNNSLS 133
            ++ NR+          L +L +L L+NNSL 
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 22/111 (19%), Positives = 37/111 (33%), Gaps = 9/111 (8%)

Query: 178 SLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS--GSIPPTAGNLSNLKF 235
                     + L   +I   I +    L     +  + N++      P     L  LK 
Sbjct: 14  QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKT 68

Query: 236 LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV 286
           L +++NR+         +   L  L L++N L          L+SLK L  
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTY 117

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 23/86 (26%), Positives = 33/86 (38%), Gaps = 3/86 (3%)

Query: 22  LFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV 81
              Q   +D S N++          L +LK L  + N+   I       L +L  L L+ 
Sbjct: 40  TLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97

Query: 82  NQLNGL-IPEELGELTSLNELALSYN 106
           N L  L   + L  L SL  L +  N
Sbjct: 98  NSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 7/89 (7%)

Query: 567 LAELGYLDLSANRLSKLIPKNLGE-LRKLHHLNLSNNQFSQEISIQ-IGKLVQLSKLDLS 624
                 LDL   ++  +  +NLG  L +   ++ S+N+      +     L +L  L ++
Sbjct: 18  AVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVN 72

Query: 625 HNSLGGNIPSEICNLESLEYMNLLQNKLS 653
           +N +          L  L  + L  N L 
Sbjct: 73  NNRICRIGEGLDQALPDLTELILTNNSLV 101

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 43/190 (22%), Positives = 78/190 (41%), Gaps = 37/190 (19%)

Query: 785 GTGGCGTVYKA---ELTSGDTRAVKKLHSL-----PTGEIGINQKGFVSEITEIRHRNIV 836
           G G  G VYKA   +       A+K++           EI + +        E++H N++
Sbjct: 30  GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR--------ELKHPNVI 81

Query: 837 KFYG-FCSHTQH-LFLVYEYLERGSLATILSNEATAAELDWSKRVN--VIKGVA----NA 888
                F SH    ++L+++Y E   L  I+     +       ++   ++K +     + 
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 889 LSYMHHDCFPPILHRDISSKKVLLDLEYKAH----VSDFGTAKF----LKPDSSNWSELA 940
           + Y+H +    +LHRD+    +L+  E        ++D G A+     LKP +     + 
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 941 GTCGYIAPEL 950
            T  Y APEL
Sbjct: 198 -TFWYRAPEL 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 66/288 (22%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTGEIGINQKGFVSEIT---EIRHRNI 835
            G G  G V +     +   RAVK     KL  +P GE  + +     EI     +RH+N+
Sbjct: 14   GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-----EIQLLRRLRHKNV 68

Query: 836  VKFYGFCSH--TQHLFLVYEYLERGSLATILSNEATAAEL-DW--SKRVNVIKGVA---- 886
            ++      +   Q +++V EY   G             E+ D    KR  V +       
Sbjct: 69   IQLVDVLYNEEKQKMYMVMEYCVCGM-----------QEMLDSVPEKRFPVCQAHGYFCQ 117

Query: 887  --NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
              + L Y+H      I+H+DI    +LL       +S  G A+ L P +++      + G
Sbjct: 118  LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQG 173

Query: 945  ---YIAPELAYTMR--ANEKCDVFNFGVLVLEVIEGKHP--GHFLSLLLSLPAPAANMNI 997
               +  PE+A  +   +  K D+++ GV +  +  G +P  G  +  L          NI
Sbjct: 174  SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE--------NI 225

Query: 998  VVNDLIDSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                     +P   G  + + LK M       L+  P  R +++++  
Sbjct: 226  GKGSY---AIPGDCGPPLSDLLKGM-------LEYEPAKRFSIRQIRQ 263

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 63/256 (24%), Positives = 98/256 (38%), Gaps = 56/256 (21%)

Query: 750 NFRRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKL 808
            +    +  + + +     Q  L    FE   V+ G G  G V   +L  +    A+K L
Sbjct: 54  EYLEWAKPFTSKVK-----QMRLHREDFEILKVI-GRGAFGEVAVVKLKNADKVFAMKIL 107

Query: 809 ---HSLPTGEIGINQKGFVSE---ITEIRHRNIVK-FYGFCSHTQHLFLVYEYLERGSLA 861
                L   E       F  E   +     + I    Y F     +L+LV +Y   G L 
Sbjct: 108 NKWEMLKRAET----ACFREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLL 162

Query: 862 TILSN------EATA----AELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKV 910
           T+LS       E  A    AE+              A+  +H        +HRDI    +
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEM------------VIAIDSVHQLH----YVHRDIKPDNI 206

Query: 911 LLDLEYKAHV--SDFGTAKFLKPDSSNWSELA-GTCGYIAPELAYTMRANEK-----CDV 962
           L+D     H+  +DFG+   L  D +  S +A GT  YI+PE+   M   +      CD 
Sbjct: 207 LMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264

Query: 963 FNFGVLVLEVIEGKHP 978
           ++ GV + E++ G+ P
Sbjct: 265 WSLGVCMYEMLYGETP 280

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 60.3 bits (147), Expect = 7e-10
 Identities = 51/183 (27%), Positives = 69/183 (37%), Gaps = 37/183 (20%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTG---EIGINQKGFVSEITEIRHRNI 835
           G G  G V  A    + +  AVK     +    P     EI IN+         + H N+
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM--------LNHENV 67

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSL-ATILSN----EATAAELDWSKRVNVIKGVANALS 890
           VKFYG        +L  EY   G L   I  +    E  A              +   + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA--------QRFFHQLMAGVV 119

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIA 947
           Y+H      I HRDI  + +LLD      +SDFG A   + ++     L   CG   Y+A
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVA 175

Query: 948 PEL 950
           PEL
Sbjct: 176 PEL 178

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 51/236 (21%)

Query: 767 NNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVS 825
             +  ++ + FE   +L G G  G V   +   +G   A+K L           +K  + 
Sbjct: 140 KPKHRVTMNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKIL-----------KKEVIV 187

Query: 826 EITEIRH----RNIVK----------FYGFCSHTQHLFLVYEYLERGSLATILSNEAT-- 869
              E+ H      +++           Y F +H   L  V EY   G L   LS E    
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFS 246

Query: 870 -------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD 922
                   AE            + +AL Y+H +    +++RD+  + ++LD +    ++D
Sbjct: 247 EDRARFYGAE------------IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITD 292

Query: 923 FGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           FG  K    D +      GT  Y+APE+          D +  GV++ E++ G+ P
Sbjct: 293 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 59.1 bits (144), Expect = 2e-09
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 19/173 (10%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
           G G  G VYKA+   G+T A+KK+  L   + GI     + EI+   E++H NIVK Y  
Sbjct: 11  GEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA----NALSYMHHDCF 897
               + L LV+E+L++  L  +L       E          K       N ++Y H    
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV------TAKSFLLQLLNGIAYCHDRR- 120

Query: 898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
             +LHRD+  + +L++ E +  ++DFG A+        ++    T  Y AP++
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 54/287 (18%), Positives = 94/287 (32%), Gaps = 70/287 (24%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVK---KLHSLPTGEIGINQKGFVSEI-------TEIRHR 833
            G GG GTV+    LT     A+K   +   L    +  +      E+           H 
Sbjct: 40   GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP-LEVALLWKVGAGGGHP 98

Query: 834  NIVKFYGFCSHTQHLFLVYEYLERGS--LATILSN----EATAAELDWSKRVNVIKGVAN 887
             +++   +    +   LV E           I       E  +       R      V  
Sbjct: 99   GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-CFFGQVVA 150

Query: 888  ALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKFLKPDSSNWSELAGTCG 944
            A+ + H      ++HRDI  + +L+DL     K  + DFG+   L              G
Sbjct: 151  AIQHCHSRG---VVHRDIKDENILIDLRRGCAK--LIDFGSGALLHD-----EPYTDFDG 200

Query: 945  ---YIAPEL----AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI 997
               Y  PE      Y         V++ G+L+ +++ G  P  F                
Sbjct: 201  TRVYSPPEWISRHQY---HALPATVWSLGILLYDMVCGDIP--FER-------------- 241

Query: 998  VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
               +++++ L  P   V     ++I     CL   P  RP+++++  
Sbjct: 242  -DQEILEAELHFPAH-VSPDCCALIR---RCLAPKPSSRPSLEEILL 283

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 48/178 (26%), Positives = 72/178 (40%), Gaps = 28/178 (15%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G V   E   +G   AVK L+      + +  K    EI      RH +I+K Y 
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKLYQ 78

Query: 841 FCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHD 895
             S     F+V EY+  G L   +       E  A          + + + +A+ Y H  
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA--------RRLFQQILSAVDYCHRH 130

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPEL 950
               ++HRD+  + VLLD    A ++DFG +  +         L  +CG   Y APE+
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEV 181

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 51/183 (27%), Positives = 69/183 (37%), Gaps = 37/183 (20%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVK-----KLHSLPTG---EIGINQKGFVSEITEIRHRNI 835
           G G  G V  A    + +  AVK     +    P     EI IN+         + H N+
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM--------LNHENV 67

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSL-ATILSN----EATAAELDWSKRVNVIKGVANALS 890
           VKFYG        +L  EY   G L   I  +    E  A              +   + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA--------QRFFHQLMAGVV 119

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIA 947
           Y+H      I HRDI  + +LLD      +SDFG A   + ++     L   CG   Y+A
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVA 175

Query: 948 PEL 950
           PEL
Sbjct: 176 PEL 178

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 57/277 (20%), Positives = 102/277 (36%), Gaps = 52/277 (18%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVK---KLHSLPTGEIGINQKGFVS-EIT---EIRHRNIV 836
            G+G  G V+ A          VK   K   L    I   + G V+ EI     + H NI+
Sbjct: 33   GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92

Query: 837  KFYGFCSHTQHLFLVYEYLERGS-LATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
            K      +     LV E    G  L   +       E   S    + + + +A+ Y+   
Sbjct: 93   KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY---IFRQLVSAVGYLRLK 149

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPEL-- 950
                I+HRDI  + +++  ++   + DFG+A +L+            CG   Y APE+  
Sbjct: 150  D---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG----KLFYTFCGTIEYCAPEVLM 202

Query: 951  --AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
               Y      + ++++ GV +  ++  ++P  F  L             V   +     P
Sbjct: 203  GNPY---RGPELEMWSLGVTLYTLVFEENP--FCEL----------EETVEAAI---HPP 244

Query: 1009 PPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
              +  E+   +  +       L   P+ R T++K+  
Sbjct: 245  YLVSKELMSLVSGL-------LQPVPERRTTLEKLVT 274

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 20/174 (11%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVS----EIT---EIRHRNIV 836
           G G  G V K     +G   A+KK           + K        EI    ++RH N+V
Sbjct: 34  GEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                C   +  +LV+E+++  ++   L  E     LD+      +  + N + + H   
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
              I+HRDI  + +L+       + DFG A+ L      + +   T  Y APEL
Sbjct: 145 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 35/149 (23%), Positives = 57/149 (38%), Gaps = 22/149 (14%)

Query: 440 IPRSLQNCTSLYSLRLERNQLTGNISEVFGIY--PDLELLDLSNNNFFGEISSNWIKCPQ 497
           +  +L    +   L L  N     I ++  +    +L +L L  N    +I +       
Sbjct: 40  MDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLI-KKIENLDAVADT 94

Query: 498 LATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL--VGQIPKQLGKLTSLTSLTLNGNQ 555
           L  L +  N+I+ ++ S I  +  L  L  S+N++   G+I  +L  L  L  L L GN 
Sbjct: 95  LEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNP 151

Query: 556 LSGDIPLE----------LGLLAELGYLD 574
           L  D              +  L  L  LD
Sbjct: 152 LYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 33/162 (20%), Positives = 58/162 (35%), Gaps = 17/162 (10%)

Query: 473 DLELLDLSNN-NFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNR 531
           + E ++L        ++ +          L +  N I   I S +  M  L  L    N 
Sbjct: 24  EAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81

Query: 532 LVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIP-KNLGE 590
           +  +I        +L  L ++ NQ++  +   +  L  L  L +S N+++       L  
Sbjct: 82  IK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAA 138

Query: 591 LRKLHHLNLSNNQFSQEISIQ----------IGKLVQLSKLD 622
           L KL  L L+ N    +              + +L  L KLD
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 35/162 (21%), Positives = 58/162 (35%), Gaps = 28/162 (17%)

Query: 212 LGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK---LGSFKSLLYLYLSHNQLN 268
           L      +   +  T   L   K L L  N +      K   L   ++L  L L  N + 
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK 83

Query: 269 GSLPSSFGNLSSLKHLHVHN--INKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIP-PSLG 325
             + +      +L+ L +    I  LSG     I  L +L  L++S  +++ +     L 
Sbjct: 84  -KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLA 137

Query: 326 NLSNIRGLYIRENMLYGSIPEE----------LGRLKSLSQL 357
            L  +  L +  N LY    E           + RL +L +L
Sbjct: 138 ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 8/106 (7%)

Query: 29  LDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLI 88
           L   +  +   +   +S L   KHL  STN    I    +  + NL +L L  N +  + 
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLIKKI- 85

Query: 89  PEELGELT-SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLS 133
            E L  +  +L EL +SYN++  S+ + +  L NL  L +SNN ++
Sbjct: 86  -ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 35/189 (18%), Positives = 68/189 (35%), Gaps = 48/189 (25%)

Query: 82  NQLNGLIPEELGELTSLNELALSYNRLNG--SIPASLGNLSNLVQLSLSNNSLSGQIPPN 139
           + +      +    T   ++ L +  +     + A+L  L     L+LS N++       
Sbjct: 9   DAIRIFEERKSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE------ 61

Query: 140 WGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSI 199
                          + +L                      G++NL  + L  N I   I
Sbjct: 62  --------------KISSLS---------------------GMENLRILSLGRNLIK-KI 85

Query: 200 PSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIP-PKLGSFKSLL 258
            +      +L  L ++ NQ++ S+      L NL+ LY+ +N+++ +    KL +   L 
Sbjct: 86  ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143

Query: 259 YLYLSHNQL 267
            L L+ N L
Sbjct: 144 DLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 29/122 (23%), Positives = 44/122 (36%), Gaps = 12/122 (9%)

Query: 22  LFPQLAYLDLSVNQLFGTIPTQI---SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLR 78
                 +L LS N +      +I   S +  L+ L    N    I      +   L  L 
Sbjct: 46  TLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKKIENLD-AVADTLEELW 99

Query: 79  LSVNQLNGLIPEELGELTSLNELALSYNRLNG-SIPASLGNLSNLVQLSLSNNSLSGQIP 137
           +S NQ+  L    + +L +L  L +S N++        L  L  L  L L+ N L     
Sbjct: 100 ISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157

Query: 138 PN 139
            N
Sbjct: 158 EN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 27/144 (18%), Positives = 53/144 (36%), Gaps = 12/144 (8%)

Query: 257 LLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN--INKLSGSIPKEIGNLKSLSHLWLSKT 314
            + L+     +   + ++   L + KHL +    I K+S      +  +++L  L L + 
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRN 80

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG-SIPHCLG 373
            +   I         +  L+I  N +  +    + +L +L  L +S NK+        L 
Sbjct: 81  LIKK-IENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLA 137

Query: 374 NLSNLKFFALRENELSGSIPQEIE 397
            L  L+   L  N L     +   
Sbjct: 138 ALDKLEDLLLAGNPLYNDYKENNA 161

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 26/115 (22%), Positives = 46/115 (40%), Gaps = 16/115 (13%)

Query: 568 AELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ-IGKLVQLSKLDLSHN 626
           AE   L      + K +   L  L+   HL LS N       I  +  +  L  L L  N
Sbjct: 25  AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRN 80

Query: 627 SLGGNIPSEICNLE----SLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ 677
            +      +I NL+    +LE + +  N+++    S   ++  L  + +S N++ 
Sbjct: 81  LI-----KKIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT 128

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 58.0 bits (141), Expect = 5e-09
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 18/175 (10%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G VYKA +  + +T A+K++  L   E G+     + E++   E++HRNI++   
Sbjct: 43  GEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTA-IREVSLLKELQHRNIIELKS 100

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
              H   L L++EY E   L   +       ++      + +  + N +++ H       
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---C 153

Query: 901 LHRDISSKKVLLDLEYKAH-----VSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           LHRD+  + +LL +   +      + DFG A+        ++    T  Y  PE+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 57.7 bits (140), Expect = 6e-09
 Identities = 34/150 (22%), Positives = 63/150 (42%), Gaps = 26/150 (17%)

Query: 830 IRHRNIVKFYG--FCSHTQHLFLVYEYLERGSLATILSN----EATAAELDWSKRVNVIK 883
           + H N+VK        +  HL++V+E + +G +  + +     E  A            +
Sbjct: 93  LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA--------RFYFQ 144

Query: 884 GVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTC 943
            +   + Y+H+     I+HRDI    +L+  +    ++DFG +   K   +    L+ T 
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTV 198

Query: 944 G---YIAPELAYTMRAN---EKCDVFNFGV 967
           G   ++APE     R     +  DV+  GV
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 57.6 bits (140), Expect = 6e-09
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 11/169 (6%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
           G G  G VYKA+ + G   A+K++  L   + GI     + EI+   E+ H NIV     
Sbjct: 30  GEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87

Query: 842 CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
               + L LV+E++E+  L  +L    T  +    K    +  +   +++ H      IL
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK--IYLYQLLRGVAHCHQHR---IL 141

Query: 902 HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           HRD+  + +L++ +    ++DFG A+       +++    T  Y AP++
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 8e-09
 Identities = 41/209 (19%), Positives = 76/209 (36%), Gaps = 73/209 (34%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V +     + +  A+K L        E+ ++ +         +  +IV+    
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR-------ASQCPHIVRIVDV 79

Query: 842 C----SHTQHLFLVYEYLERGSL-ATILS------NEATAAELDWSKRVNVIKGVANALS 890
                +  + L +V E L+ G L + I         E  A+E        ++K +  A+ 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--------IMKSIGEAIQ 131

Query: 891 YMH-HDCFPPILHRDI-------SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGT 942
           Y+H  +    I HRD+       +SK+   +   K  ++DFG                  
Sbjct: 132 YLHSIN----IAHRDVKPENLLYTSKRP--NAILK--LTDFG------------------ 165

Query: 943 CGYIAPEL---AYTMRANEKCDVFNFGVL 968
               A E     Y    ++ CD+++ GV+
Sbjct: 166 ---FAKETTGEKY----DKSCDMWSLGVI 187

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 57.2 bits (139), Expect = 9e-09
 Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 12/170 (7%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G V+K     +G   A+KK       +  I  K  + EI    +++H N+V    
Sbjct: 12  GEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIK-KIALREIRMLKQLKHPNLVNLLE 69

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                + L LV+EY +  ++   L  +     +      ++      A+++ H       
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           +HRD+  + +L+       + DFG A+ L   S  + +   T  Y +PEL
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 55/248 (22%)

Query: 755 KRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPT 813
           K  +    + +  +Q       F+    L GTG  G V   +   SG+  A+K L     
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKIL----- 74

Query: 814 GEIGINQKGFVSEITEIRH----RNI---------VKFYGFCSHTQHLFLVYEYLERGSL 860
                  K  V ++ +I H    + I         VK         +L++V EY+  G +
Sbjct: 75  ------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128

Query: 861 ATILSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKV 910
            + L              AA+            +     Y+H  D    +++RD+  + +
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQ------------IVLTFEYLHSLD----LIYRDLKPENL 172

Query: 911 LLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
           L+D +    V+DFG AK  +     W+ L GT   +APE+  +   N+  D +  GVL+ 
Sbjct: 173 LIDQQGYIQVTDFGFAK--RVKGRTWT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 971 EVIEGKHP 978
           E+  G  P
Sbjct: 230 EMAAGYPP 237

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.8 bits (138), Expect = 1e-08
 Identities = 39/170 (22%), Positives = 79/170 (46%), Gaps = 12/170 (7%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  GTV+KA    + +  A+K++  L   + G+     + EI    E++H+NIV+ + 
Sbjct: 11  GEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSA-LREICLLKELKHKNIVRLHD 68

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                + L LV+E+ ++  L      ++   +LD     + +  +   L + H      +
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           LHRD+  + +L++   +  +++FG A+        +S    T  Y  P++
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 27/111 (24%), Positives = 51/111 (45%), Gaps = 4/111 (3%)

Query: 542 KLTSLTSLTLNGNQLS-GDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS 600
             + +  L L+ ++ + G +        EL +L      L+ +   NL +L KL  L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 601 NNQFSQEISIQIGKLVQLSKLDLSHNSLGG-NIPSEICNLESLEYMNLLQN 650
           +N+ S  + +   K   L+ L+LS N +   +    +  LE+L+ ++L   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 27/104 (25%), Positives = 41/104 (39%), Gaps = 4/104 (3%)

Query: 28  YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGL 87
            LD S +   G +        +L+ L       + I    +  L  L  L LS N+++G 
Sbjct: 23  VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG 79

Query: 88  IPEELGELTSLNELALSYNRLNG-SIPASLGNLSNLVQLSLSNN 130
           +     +  +L  L LS N++   S    L  L NL  L L N 
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 4/111 (3%)

Query: 518 NMTQLHKLDFSSNRL-VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLS 576
             + + +L   ++R   G++     +   L  L+     L+  I   L  L +L  L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 577 ANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ-IGKLVQLSKLDLSHN 626
            NR+S  +     +   L HLNLS N+     +I+ + KL  L  LDL + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 34/156 (21%), Positives = 66/156 (42%), Gaps = 29/156 (18%)

Query: 471 YPDLELLDLSNN-NFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS 529
             D++ L L N+ +  G++     +  +L  L+     ++ +I + +  + +L KL+ S 
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73

Query: 530 NRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLG 589
           NR+ G +     K  +LT L L+GN++          L+ +               + L 
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKD--------LSTI---------------EPLK 110

Query: 590 ELRKLHHLNLSNNQFSQEISIQ---IGKLVQLSKLD 622
           +L  L  L+L N + +     +      L QL+ LD
Sbjct: 111 KLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.9 bits (117), Expect = 6e-07
 Identities = 36/173 (20%), Positives = 56/173 (32%), Gaps = 48/173 (27%)

Query: 94  ELTSLNELALSYNRLN-GSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIP 152
             + + EL L  +R N G +         L  LS  N  L+                   
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT------------------- 55

Query: 153 QDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYL 212
             + NL                       L  L  + L++NR+ G +        +L++L
Sbjct: 56  -SIANLPK---------------------LNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93

Query: 213 GLNKNQLS--GSIPPTAGNLSNLKFLYLHDN---RLSGYIPPKLGSFKSLLYL 260
            L+ N++    +I P    L NLK L L +     L+ Y          L YL
Sbjct: 94  NLSGNKIKDLSTIEPLK-KLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 3/94 (3%)

Query: 173 GVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN 232
           G +       + L F+   N  +  SI + +  L  L  L L+ N++SG +   A    N
Sbjct: 32  GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89

Query: 233 LKFLYLHDNRLSGY-IPPKLGSFKSLLYLYLSHN 265
           L  L L  N++        L   ++L  L L + 
Sbjct: 90  LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 9/108 (8%)

Query: 182 LKNLTFVYLNNNRI-VGSIPSEIGNLRSLSYLGLNKNQLS--GSIPPTAGNLSNLKFLYL 238
             ++  + L+N+R   G +         L +L      L+   ++P     L+ LK L L
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLEL 71

Query: 239 HDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV 286
            DNR+SG +        +L +L LS N++     S+   L  L++L  
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKS 117

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 6/109 (5%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
           +++ L  L  +++   G +         L+FL   +  L+  I   L     L  L LS 
Sbjct: 18  DVKEL-VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSG-SIPKEIGNLKSLSHLWLS 312
           N+++G L        +L HL++   NK+   S  + +  L++L  L L 
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSG-NKIKDLSTIEPLKKLENLKSLDLF 121

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 26/112 (23%), Positives = 52/112 (46%), Gaps = 4/112 (3%)

Query: 567 LAELGYLDLSANRLSKL-IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSH 625
            +++  L L  +R ++  +     E  +L  L+  N   +  I+  + KL +L KL+LS 
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73

Query: 626 NSLGGNIPSEICNLESLEYMNLLQNKLSGP-IPSCFRRMHGLSSIDVSYNEL 676
           N + G +        +L ++NL  NK+         +++  L S+D+   E+
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 7/134 (5%)

Query: 350 RLKSLSQLSLSVNKLN-GSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLF 408
               + +L L  ++ N G +         L+F +     L+ SI   +  + KL K  L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 409 ENQFTGYLPQNVCQSGSLTHFSVRNNNFVGP-IPRSLQNCTSLYSLRLERNQLTGNI--- 464
           +N+ +G L     +  +LTH ++  N          L+   +L SL L   ++T      
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132

Query: 465 SEVFGIYPDLELLD 478
             VF + P L  LD
Sbjct: 133 ENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 21/89 (23%), Positives = 34/89 (38%), Gaps = 3/89 (3%)

Query: 46  HLSKLKHLDFSTNQFSGI-IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS 104
             S +K L    ++ +   +         L  L      L  +    L +L  L +L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 105 YNRLNGSIPASLGNLSNLVQLSLSNNSLS 133
            NR++G +        NL  L+LS N + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 7e-05
 Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 3/85 (3%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN 82
           F +L +L      L  T    +  L+KLK L+ S N+ SG +        NL  L LS N
Sbjct: 41  FEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98

Query: 83  QLNGL-IPEELGELTSLNELALSYN 106
           ++  L   E L +L +L  L L   
Sbjct: 99  KIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 27/128 (21%), Positives = 41/128 (32%), Gaps = 28/128 (21%)

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
             S +K L + N     G +       + L  L      L+     S+ NL         
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPK------- 62

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI 396
                         L  L +L LS N+++G +        NL    L  N++       I
Sbjct: 63  --------------LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTI 106

Query: 397 ENMKKLNK 404
           E +KKL  
Sbjct: 107 EPLKKLEN 114

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 49/185 (26%), Positives = 66/185 (35%), Gaps = 44/185 (23%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSE--ITEI------RHRNI 835
           G+G  G         + +  AVK           I +   + E    EI      RH NI
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVK---------Y-IERGAAIDENVQREIINHRSLRHPNI 78

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATILSN-----EATAAELDWSKRVNVIKGVANALS 890
           V+F        HL ++ EY   G L   + N     E  A          ++ GV    S
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ----QLLSGV----S 130

Query: 891 YMHHDCFPPILHRDISSKKVLLDLEYKAH--VSDFGTAKFLKPDSSNWSELAGTCG---Y 945
           Y H      I HRD+  +  LLD        + DFG +K         S+   T G   Y
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAY 183

Query: 946 IAPEL 950
           IAPE+
Sbjct: 184 IAPEV 188

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 21/174 (12%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVS----EIT---EIRHRNIV 836
           G G   TVYK     + +  A+K++  L   E      G       E++   +++H NIV
Sbjct: 11  GEGTYATVYKGKSKLTDNLVALKEIR-LEHEE------GAPCTAIREVSLLKDLKHANIV 63

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
             +      + L LV+EYL++  L   L +      +   K    +  +   L+Y H   
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCHRQK 120

Query: 897 FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
              +LHRD+  + +L++   +  ++DFG A+     +  +     T  Y  P++
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 28/178 (15%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G V   +   +G   AVK L+      + +  K    EI      RH +I+K Y 
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKLYQ 83

Query: 841 FCSHTQHLFLVYEYLERGSLATILS-----NEATAAELDWSKRVNVIKGVANALSYMHHD 895
             S    +F+V EY+  G L   +      +E  +          + + + + + Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--------RRLFQQILSGVDYCHRH 135

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPEL 950
               ++HRD+  + VLLD    A ++DFG +  +         L  +CG   Y APE+
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSCGSPNYAAPEV 186

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 64/340 (18%), Positives = 112/340 (32%), Gaps = 98/340 (28%)

Query: 785  GTGGCGTVYKAELTSGD------TRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRN 834
            G G  G V +A+    D      T AVK L    T       +  +SE+  +     H N
Sbjct: 31   GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILIHIGHHLN 87

Query: 835  IVKFYGFCS-HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGV-------- 885
            +V   G C+     L ++ E+ + G+L+T L ++        +K     +G         
Sbjct: 88   VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 886  ----------------------ANALSYMHHDCFPPILHRDI------------------ 905
                                    +LS +  +  P  L++D                   
Sbjct: 148  DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 906  --SSKK----------VLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYI-----AP 948
              +S+K          +LL  +    + DFG A+ +  D      +      +     AP
Sbjct: 208  FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAP 264

Query: 949  ELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS--R 1006
            E  +      + DV++FGVL+ E+            L + P P   ++      +    R
Sbjct: 265  ETIFDRVYTIQSDVWSFGVLLWEIFS----------LGASPYPGVKIDEEFCRRLKEGTR 314

Query: 1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +  P     E  ++M+     C    P  RPT  ++   L
Sbjct: 315  MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 350

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 21/149 (14%)

Query: 790 GTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGFCS 843
            TVYKA +  +    A+KK  L      + GIN+   + EI    E+ H NI+       
Sbjct: 24  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA-LREIKLLQELSHPNIIGLLDAFG 82

Query: 844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----VANALSYMHHDCFPP 899
           H  ++ LV++++E   L  I+ + +             IK         L Y+H      
Sbjct: 83  HKSNISLVFDFMET-DLEVIIKDNSLVLTPS------HIKAYMLMTLQGLEYLHQHW--- 132

Query: 900 ILHRDISSKKVLLDLEYKAHVSDFGTAKF 928
           ILHRD+    +LLD      ++DFG AK 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 27/109 (24%), Positives = 47/109 (43%), Gaps = 11/109 (10%)

Query: 543 LTSLTSLTLNGNQLS-GDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
             ++  L L+  + + G I         L +L L    L  +   NL +L KL  L LS 
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80

Query: 602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN 650
           N+    + +   KL  L+ L+LS N        ++ ++ +LE +  L+ 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGN--------KLKDISTLEPLKKLEC 121

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 32/137 (23%), Positives = 52/137 (37%), Gaps = 7/137 (5%)

Query: 491 NWIKCPQLATLNMGGNEIS-GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSL 549
                  +  L +   + + G I         L  L   +  L       L KL  L  L
Sbjct: 19  RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKL 76

Query: 550 TLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL-IPKNLGELRKLHHLNLSNNQFSQEI 608
            L+ N++ G + +    L  L +L+LS N+L  +   + L +L  L  L+L N + +   
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136

Query: 609 ---SIQIGKLVQLSKLD 622
                    L QL+ LD
Sbjct: 137 DYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 6/132 (4%)

Query: 499 ATLNMGGNEISGTIPSEIGNMT--QLHKLDFSSNRL-VGQIPKQLGKLTSLTSLTLNGNQ 555
            +    G ++   I  E+ N T   + +L   + +   G+I     +  +L  L+L    
Sbjct: 1   GSSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG 60

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ-IGK 614
           L   +   L  L +L  L+LS NR+   +     +L  L HLNLS N+     +++ + K
Sbjct: 61  LI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKK 118

Query: 615 LVQLSKLDLSHN 626
           L  L  LDL + 
Sbjct: 119 LECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 30/118 (25%), Positives = 51/118 (43%), Gaps = 10/118 (8%)

Query: 445 QNCTSLYSLRLERNQLT-GNISEVFGIYPDLELLDLSNNNFFGEISS--NWIKCPQLATL 501
           +   ++  L L+  +   G I  +   + +LE L L N      + S  N  K P+L  L
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKL 76

Query: 502 NMGGNEISGTIPSEIGNMTQLHKLDFSSNRL--VGQIPKQLGKLTSLTSLTLNGNQLS 557
            +  N I G +      +  L  L+ S N+L  +  + + L KL  L SL L   +++
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 3/100 (3%)

Query: 169 NNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG 228
            +  G I        NL F+ L N  ++ S+ + +  L  L  L L++N++ G +   A 
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 229 NLSNLKFLYLHDNRLSGY-IPPKLGSFKSLLYLYLSHNQL 267
            L NL  L L  N+L        L   + L  L L + ++
Sbjct: 93  KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 8e-06
 Identities = 27/112 (24%), Positives = 43/112 (38%), Gaps = 10/112 (8%)

Query: 177 RSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS--GSIPPTAGNLSNLK 234
           R+   ++ L      +N     I        +L +L L    L    ++P     L  LK
Sbjct: 21  RTPAAVRELVLDNCKSNDG--KIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLK 74

Query: 235 FLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV 286
            L L +NR+ G +        +L +L LS N+L     S+   L  L+ L  
Sbjct: 75  KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLKKLECLKS 124

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 4/106 (3%)

Query: 572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN 631
            LD   +   K I     E   L  L+L N      +S  + KL +L KL+LS N + G 
Sbjct: 30  VLDNCKSNDGK-IEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGG 86

Query: 632 IPSEICNLESLEYMNLLQNKLSGP-IPSCFRRMHGLSSIDVSYNEL 676
           +      L +L ++NL  NKL         +++  L S+D+   E+
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 30/107 (28%), Positives = 40/107 (37%), Gaps = 3/107 (2%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
           V  + L          E     F  L +L L    L     + +  L KLK L+ S N+ 
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRI 83

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGL-IPEELGELTSLNELALSYN 106
            G +      L NL  L LS N+L  +   E L +L  L  L L   
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 38/171 (22%), Positives = 52/171 (30%), Gaps = 44/171 (25%)

Query: 94  ELTSLNELALSYNRLN-GSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIP 152
              ++ EL L   + N G I        NL  LSL N  L                 S+ 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI----------------SV- 64

Query: 153 QDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYL 212
            +L  L     + L  N   G +      L NLT + L+ N++      +I  L  L   
Sbjct: 65  SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLK-- 117

Query: 213 GLNKNQLSGSIPPTAGNLSNLKFLYLHDN---RLSGYIPPKLGSFKSLLYL 260
                            L  LK L L +     L+ Y          L YL
Sbjct: 118 ----------------KLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 3/88 (3%)

Query: 47  LSKLKHLDFSTNQFSGI-IPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSY 105
            + ++ L     + +   I        NL  L L    L  +    L +L  L +L LS 
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80

Query: 106 NRLNGSIPASLGNLSNLVQLSLSNNSLS 133
           NR+ G +      L NL  L+LS N L 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 23/107 (21%), Positives = 48/107 (44%), Gaps = 8/107 (7%)

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG--G 630
           +D+      +L  +    +R+L   N  +N    +I     + V L  L L +  L    
Sbjct: 8   MDMKRRIHLELRNRTPAAVRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISVS 65

Query: 631 NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ 677
           N+P     L  L+ + L +N++ G +     ++  L+ +++S N+L+
Sbjct: 66  NLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 29/138 (21%), Positives = 47/138 (34%), Gaps = 27/138 (19%)

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
             ++++ L + N     G I        +L  L L    L      S+ NL         
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPK------- 69

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSG-SIPQE 395
                         L  L +L LS N++ G +      L NL    L  N+L   S  + 
Sbjct: 70  --------------LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115

Query: 396 IENMKKLNKYLLFENQFT 413
           ++ ++ L    LF  + T
Sbjct: 116 LKKLECLKSLDLFNCEVT 133

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 56.1 bits (134), Expect = 2e-08
 Identities = 28/164 (17%), Positives = 60/164 (36%), Gaps = 21/164 (12%)

Query: 462 GNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIG--NM 519
            ++S V    P L  L +   N    +S      P L +L +    +  ++  +I   ++
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 520 TQLHKLDF---SSNRLVGQIPKQL------GKLTSLTSLTLNGNQLSGDIPLELG---LL 567
             L KL       +                 +  +L  L +   +    +        +L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 568 AELGYLDLSANRLS----KLIPKNLGELRKLHHLNLSNNQFSQE 607
            +L  +D+SA  L+    +L+  ++ +++ L  +N+  N  S E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 3e-06
 Identities = 33/197 (16%), Positives = 67/197 (34%), Gaps = 26/197 (13%)

Query: 458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATL-----NMGGNEISGTI 512
           + +   I E    +   E L   + +F  +  S WI+   L+ +      +   +I GT 
Sbjct: 125 SDIADGIVENKEKFAHFEGLFWGDIDFEEQEIS-WIEQVDLSPVLDAMPLLNNLKIKGTN 183

Query: 513 PSEIGNM--TQLHKLDFSSNRLVGQIPKQLG--KLTSLTSLTL--NGNQLSGDIP----- 561
              IG      L  L+  S  L   + + +    L +L  L L         D       
Sbjct: 184 NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR 243

Query: 562 --LELGLLAELGYLDLSANRLSKLIPKNLGE---LRKLHHLNLSNNQFS----QEISIQI 612
                     L +L +       ++ +   E   L +L  +++S    +    + +   +
Sbjct: 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV 303

Query: 613 GKLVQLSKLDLSHNSLG 629
            K+  L  +++ +N L 
Sbjct: 304 DKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 26/150 (17%), Positives = 48/150 (32%), Gaps = 19/150 (12%)

Query: 5   NLTGSNLKGTLQ-EFPFLLFPQLAYLDLSVNQLFGTIPTQI--SHLSKLKHLDFSTNQFS 61
            L    +KGT          P L  L++    L  ++   I  S L  L+ L        
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232

Query: 62  GIIPPQIGILT---------NLVVLRLSVNQLNGLIPEELGE---LTSLNELALSYNRLN 109
                 + +           NL  L +   +   ++ E   E   L  L  + +S   L 
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292

Query: 110 GS----IPASLGNLSNLVQLSLSNNSLSGQ 135
                 +   +  + +L  +++  N LS +
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 5e-05
 Identities = 22/129 (17%), Positives = 42/129 (32%), Gaps = 17/129 (13%)

Query: 15  LQEFPFLLFPQLAYLDLSV---NQLFGTIPTQIS------HLSKLKHLDFSTNQFSGIIP 65
           +++      P L  L L V   +  F                  LK L     +   ++ 
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269

Query: 66  PQIG---ILTNLVVLRLSVNQLNG----LIPEELGELTSLNELALSYNRLNGSIPASLGN 118
                  IL  L  + +S   L      L+ + + ++  L  + + YN L+  +   L  
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

Query: 119 -LSNLVQLS 126
            L   + +S
Sbjct: 330 SLPMKIDVS 338

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 55.2 bits (134), Expect = 3e-08
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 11/170 (6%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G VYKA    +G+  A+KK+  L T   G+     + EI+   E+ H NIVK   
Sbjct: 12  GEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTA-IREISLLKELNHPNIVKLLD 69

Query: 841 FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                  L+LV+E+L +  L   +   A    +      + +  +   L++ H      +
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---V 124

Query: 901 LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE+
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 55.7 bits (135), Expect = 4e-08
 Identities = 39/182 (21%), Positives = 70/182 (38%), Gaps = 37/182 (20%)

Query: 785 GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
           G G  G V  A    +    A+K +      +  ++ +    EI+    +RH +I+K Y 
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKLYD 76

Query: 841 FCSHTQHLFLVYEY---------LERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
             +    + +V EY         +E+  +      E               + +  A+ Y
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRM-----TEDEG--------RRFFQQIICAIEY 123

Query: 892 MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAP 948
            H      I+HRD+  + +LLD      ++DFG +  +       + L  +CG   Y AP
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----NFLKTSCGSPNYAAP 176

Query: 949 EL 950
           E+
Sbjct: 177 EV 178

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 54.9 bits (133), Expect = 5e-08
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 24/178 (13%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVS----EIT---EIRHRNIV 836
           G G   TVYK    T+G   A+K++  L + E      G  S    EI+   E++H NIV
Sbjct: 14  GNGTYATVYKGLNKTTGVYVALKEVK-LDSEE------GTPSTAIREISLMKELKHENIV 66

Query: 837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA----NALSYM 892
           + Y        L LV+E+++   L   + +  T         +N++K         L++ 
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDSR-TVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 893 HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           H +    ILHRD+  + +L++   +  + DFG A+      + +S    T  Y AP++
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 55.0 bits (133), Expect = 7e-08
 Identities = 47/181 (25%), Positives = 70/181 (38%), Gaps = 32/181 (17%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKK--LHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGF 841
           G G  G V++A+L   D  A+KK          E+ I        +  ++H N+V    F
Sbjct: 49  GNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQI--------MRIVKHPNVVDLKAF 100

Query: 842 CSHTQH------LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----VANALSY 891
                       L LV EY+                 +     + +IK     +  +L+Y
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAY 156

Query: 892 MH-HDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
           +H       I HRDI  + +LLD       + DFG+AK L     N S +  +  Y APE
Sbjct: 157 IHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPE 211

Query: 950 L 950
           L
Sbjct: 212 L 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 57/289 (19%), Positives = 101/289 (34%), Gaps = 76/289 (26%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKL--HSLPTGEIGINQKGFVSEI---TEIRHR--NIV 836
            G+GG G+VY    ++     A+K +    +       N      E+    ++      ++
Sbjct: 52   GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111

Query: 837  KFYGFCSHTQHLFLVYEY-----------LERGSLATILSNEATAAELDWSKRVNVIKGV 885
            +   +        L+ E             ERG+L      E  A         +    V
Sbjct: 112  RLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-----QEELAR--------SFFWQV 158

Query: 886  ANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKFLKPDSSNWSELAGT 942
              A+ + H+     +LHRDI  + +L+DL     K  + DFG+   LK      +     
Sbjct: 159  LEAVRHCHNCG---VLHRDIKDENILIDLNRGELK--LIDFGSGALLKD-----TVYTDF 208

Query: 943  CG---YIAPEL----AYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANM 995
             G   Y  PE      Y  R      V++ G+L+ +++ G  P  F              
Sbjct: 209  DGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP--FEH------------ 251

Query: 996  NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                 ++I  ++      V  + + +I     CL   P  RPT +++ N
Sbjct: 252  ---DEEIIRGQVFFRQR-VSSECQHLIR---WCLALRPSDRPTFEEIQN 293

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.1 bits (131), Expect = 9e-08
 Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 50/240 (20%)

Query: 763 QNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTR---AVKKLHSLPTGEIGI 818
            +     E    S FE   VL G G  G V+  +  SG D R   A+K L      +  +
Sbjct: 12  HHVKEGHEKADPSQFELLKVL-GQGSFGKVFLVKKISGSDARQLYAMKVLK-----KATL 65

Query: 819 NQKGFVSEITE------IRHRNIVK-FYGFCSHTQHLFLVYEYLERGSLATILSNEAT-- 869
             +  V    E      + H  IVK  Y F +    L+L+ ++L  G L T LS E    
Sbjct: 66  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFT 124

Query: 870 -------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV- 920
                   AEL            A AL ++H       I++RD+  + +LLD E   H+ 
Sbjct: 125 EEDVKFYLAEL------------ALALDHLHSLG----IIYRDLKPENILLDEE--GHIK 166

Query: 921 -SDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
            +DFG +K  +  +   +S   GT  Y+APE+       +  D ++FGVL+ E++ G  P
Sbjct: 167 LTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 59/252 (23%), Positives = 96/252 (38%), Gaps = 55/252 (21%)

Query: 753 RRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSL 811
             K  ++    ++  N++ +  + F   MVL G G  G V  +E   + +  AVK L   
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVL-GKGSFGKVMLSERKGTDELYAVKIL--- 374

Query: 812 PTGEIGINQKGFVSEITEIRH----RNIVKFYG---------FCSHTQ-HLFLVYEYLER 857
                   +K  V +  ++      + ++   G          C  T   L+ V EY+  
Sbjct: 375 --------KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426

Query: 858 GSLATILSNEAT---------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSK 908
           G L   +              AAE            +A  L ++       I++RD+   
Sbjct: 427 GDLMYHIQQVGRFKEPHAVFYAAE------------IAIGLFFLQSK---GIIYRDLKLD 471

Query: 909 KVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFG 966
            V+LD E   H+  +DFG  K    D        GT  YIAPE+       +  D + FG
Sbjct: 472 NVMLDSE--GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529

Query: 967 VLVLEVIEGKHP 978
           VL+ E++ G+ P
Sbjct: 530 VLLYEMLAGQAP 541

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 88/563 (15%), Positives = 165/563 (29%), Gaps = 76/563 (13%)

Query: 101 LALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLES 160
           +AL Y      +     NL +L        ++   IP NWG  ++P    I  +L  L+S
Sbjct: 57  MALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKS 116

Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
            V       +   +   +     +L  + L+      +          L  +        
Sbjct: 117 -VHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTT--------DGLLSI-------- 159

Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF----KSLLYLYLSHNQLNG----SLP 272
                   +   +K L + ++  S      L        SL  L     +        L 
Sbjct: 160 ------VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLE 213

Query: 273 SSFGNLSSLKHLHVHNINKLSG-SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIR 331
           +   N  SL  + V +   L      K   NL+      L++         +L     + 
Sbjct: 214 TIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273

Query: 332 GLYIRENMLYGSIPEELGRLKSLSQLSLS-VNKLNGSIPHCLGNLSNLKFFALR---ENE 387
            L +   M    +P        + +L L             +    NL+    R    + 
Sbjct: 274 RLGLS-YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDR 332

Query: 388 LSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNC 447
               + Q  + +K+L      + Q        V Q G L   +              Q C
Sbjct: 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRG-LIALA--------------QGC 377

Query: 448 TSLYSLRLERNQLTGN----ISEVFGIYPDLELLDLSN---------NNFFGEISSNWIK 494
             L  + +  + +T      I        D  L+ L           +N    +      
Sbjct: 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG--- 434

Query: 495 CPQLATLN--MGGNEISGTIPSEIG-NMTQLHKLDFSSNRLVGQIPKQLGK-LTSLTSLT 550
           C +L      +    ++    S IG     +  +         +   +  +   +L  L 
Sbjct: 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLE 494

Query: 551 LNGNQLSGD-IPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEIS 609
           + G   S   I   +  L  L YL +   R S      +   R   ++ L  ++   E++
Sbjct: 495 MRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVN 554

Query: 610 IQIGKLVQLSKLD--LSHNSLGG 630
            Q G++ ++      L++ SL G
Sbjct: 555 QQ-GEIREMEHPAHILAYYSLAG 576

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 37/303 (12%), Positives = 88/303 (29%), Gaps = 31/303 (10%)

Query: 24  PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLS-VN 82
            +     L+ +         +    KL  L  S    + + P        +  L L    
Sbjct: 246 EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM-PILFPFAAQIRKLDLLYAL 304

Query: 83  QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGY 142
                    + +  +L  L       +  +         L +L +   +    +    G 
Sbjct: 305 LETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGL 364

Query: 143 LISPHYGSIPQDLGNLESPVSVSLHTNNFSGV----IPRSLGGLKNLTFVYLNNNRIVGS 198
           +      ++ Q    LE    ++++ ++ +      I   L  L +   V L+    +  
Sbjct: 365 VSQRGLIALAQGCQELE---YMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421

Query: 199 IPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN--RLSGYIPPKLGSF-K 255
           +P + G                  +         L+    +     L+      +G +  
Sbjct: 422 LPLDNG------------------VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463

Query: 256 SLLYLYLSHNQL-NGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
           ++ ++ L +    +  L        +L+ L +        +I   +  L SL +LW+   
Sbjct: 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGY 523

Query: 315 QLS 317
           + S
Sbjct: 524 RAS 526

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 53.4 bits (129), Expect = 2e-07
 Identities = 64/257 (24%), Positives = 100/257 (38%), Gaps = 56/257 (21%)

Query: 752 RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTR---AVKK 807
           +           N   + E +    FE   VL GTG  G V+     SG DT    A+K 
Sbjct: 31  QLLTVKHELRTANLTGHAEKVGIENFELLKVL-GTGAYGKVFLVRKISGHDTGKLYAMKV 89

Query: 808 LHSLPTGEIGINQKGFVSEITEIRHRNIVK-----------FYGFCSHTQHLFLVYEYLE 856
           L       I    K      TE   R +++            Y F + T  L L+ +Y+ 
Sbjct: 90  LKK---ATIVQKAKTTEHTRTE---RQVLEHIRQSPFLVTLHYAFQTET-KLHLILDYIN 142

Query: 857 RGSLATILSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDIS 906
            G L T LS               E+              AL ++H       I++RDI 
Sbjct: 143 GGELFTHLSQRERFTEHEVQIYVGEI------------VLALEHLHKLG----IIYRDIK 186

Query: 907 SKKVLLDLEYKAHV--SDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRA--NEKCD 961
            + +LLD     HV  +DFG +K F+  ++    +  GT  Y+AP++     +  ++  D
Sbjct: 187 LENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 244

Query: 962 VFNFGVLVLEVIEGKHP 978
            ++ GVL+ E++ G  P
Sbjct: 245 WWSLGVLMYELLTGASP 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 53.0 bits (128), Expect = 2e-07
 Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 61/248 (24%)

Query: 760 QEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGI 818
           +  +   + Q  L    F    +L G G  G V+ AE   +    A+K L          
Sbjct: 2   ELNKERPSLQIKLKIEDFILHKML-GKGSFGKVFLAEFKKTNQFFAIKAL---------- 50

Query: 819 NQKGFVSEITEIRH----RNIVK-----------FYGFCSHTQHLFLVYEYLERGSLATI 863
            +K  V    ++      + ++            F  F +   +LF V EYL  G L   
Sbjct: 51  -KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYH 108

Query: 864 LSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLD 913
           + +            AAE            +   L ++H       I++RD+    +LLD
Sbjct: 109 IQSCHKFDLSRATFYAAE------------IILGLQFLHSKG----IVYRDLKLDNILLD 152

Query: 914 LEYKAHV--SDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL 970
            +   H+  +DFG  K  +  D+   +   GT  YIAPE+    + N   D ++FGVL+ 
Sbjct: 153 KD--GHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209

Query: 971 EVIEGKHP 978
           E++ G+ P
Sbjct: 210 EMLIGQSP 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 37/184 (20%)

Query: 785 GTGGCGTVYKAELT-SGDTRAVKK--LHSLPTG-EIGINQKGFVSEITEIRHRNIVK-FY 839
           G G  G VY+A+L  SG+  A+KK          E+ I        + ++ H NIV+  Y
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI--------MRKLDHCNIVRLRY 114

Query: 840 GFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----VANALS 890
            F S  +     +L LV +Y+                 L     V  +K     +  +L+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSLA 170

Query: 891 YMH-HDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
           Y+H       I HRDI  + +LLD +    K  + DFG+AK L     N S +  +  Y 
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLK--LCDFGSAKQLVRGEPNVSYIC-SRYYR 223

Query: 947 APEL 950
           APEL
Sbjct: 224 APEL 227

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 53.0 bits (128), Expect = 3e-07
 Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 37/200 (18%)

Query: 773 SASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTG-------EIGINQKG 822
             S +E K+   G G  G V+KA    +G   A+KK  + +   G       EI I Q  
Sbjct: 15  EVSKYE-KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-- 71

Query: 823 FVSEITEIRHRNIVKFYG--------FCSHTQHLFLVYEYLERGSLATILSNEATAAELD 874
                  ++H N+V            +      ++LV+++ E   LA +LSN      L 
Sbjct: 72  ------LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 875 WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA-KFLKPDS 933
             K   V++ + N L Y+H +    ILHRD+ +  VL+  +    ++DFG A  F    +
Sbjct: 125 EIK--RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 934 SNWSELAG---TCGYIAPEL 950
           S  +       T  Y  PEL
Sbjct: 180 SQPNRYTNRVVTLWYRPPEL 199

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 34/165 (20%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKK--LHSLPTGEIGINQKGFVSEITEI---------RH 832
           G G  GTVYKA +  SG   A+K   + +   G  G+     +S + E+          H
Sbjct: 18  GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP----ISTVREVALLRRLEAFEH 73

Query: 833 RNIVKFYGFCSHTQH-----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA- 886
            N+V+    C+ ++      + LV+E++++  L T L                 IK +  
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-----GLPAETIKDLMR 127

Query: 887 ---NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF 928
                L ++H +C   I+HRD+  + +L+       ++DFG A+ 
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 51.9 bits (125), Expect = 5e-07
 Identities = 45/184 (24%), Positives = 72/184 (39%), Gaps = 31/184 (16%)

Query: 785 GTGGCGTVYKAELT-SGDTRAVKKLHSLPTG---EIGINQKGFVSEITEIRHRNIVK-FY 839
           G G  GTV   +   +G + A+KK+   P     E+ I Q     ++  + H NIV+   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-----DLAVLHHPNIVQLQS 86

Query: 840 GFCSHTQH------LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKG----VANAL 889
            F +  +       L +V EY+         +               +IK     +  ++
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP----PILIKVFLFQLIRSI 142

Query: 890 SYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKFLKPDSSNWSELAGTCGYI 946
             +H      + HRDI    VL++      K  + DFG+AK L P   N + +     Y 
Sbjct: 143 GCLHLPSVN-VCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLSPSEPNVAYICSRY-YR 198

Query: 947 APEL 950
           APEL
Sbjct: 199 APEL 202

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 48/257 (18%), Positives = 89/257 (34%), Gaps = 54/257 (21%)

Query: 758 DSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAE-LTSGDTRAVK------KLHS 810
               G +     E    + +     L G G   TV+ A+ + +    A+K          
Sbjct: 2   YRPGGYHPAFKGEPYKDARYILVRKL-GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE 60

Query: 811 LPTGEIGI----NQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEYLERGSLAT 862
               EI +    N      E +   + +I+K     +H      H+ +V+E L   +L  
Sbjct: 61  AAEDEIKLLQRVNDADNTKEDSMGAN-HILKLLDHFNHKGPNGVHVVMVFEVL-GENL-- 116

Query: 863 ILSNEATAAELDWSKR-------VNVIKGVA----NALSYMHHDCFPPILHRDISSKKVL 911
                     L   K+       +  +K ++      L YMH  C   I+H DI  + VL
Sbjct: 117 ----------LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 164

Query: 912 LDLEYKAH------VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNF 965
           +++           ++D G A +      +++    T  Y +PE+          D+++ 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACW---YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWST 221

Query: 966 GVLVLEVIEGKH--PGH 980
             L+ E+I G       
Sbjct: 222 ACLIFELITGDFLFEPD 238

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 51.4 bits (124), Expect = 8e-07
 Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 59/233 (25%)

Query: 772 LSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI 830
            S   F+    L GTG  G V+      +G   A+K L           +K  V  + ++
Sbjct: 3   YSLQDFQILRTL-GTGSFGRVHLIRSRHNGRYYAMKVL-----------KKEIVVRLKQV 50

Query: 831 RH----RNI---------VKFYGFCSHTQHLFLVYEYLERGSLATILSNEAT-------- 869
            H    R +         ++ +G     Q +F++ +Y+E G L ++L             
Sbjct: 51  EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF 110

Query: 870 -AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV--SDFGT 925
            AAE            V  AL Y+H  D    I++RD+  + +LLD     H+  +DFG 
Sbjct: 111 YAAE------------VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGF 152

Query: 926 AKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           AK        ++ L GT  YIAPE+  T   N+  D ++FG+L+ E++ G  P
Sbjct: 153 AK--YVPDVTYT-LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 51.1 bits (123), Expect = 9e-07
 Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 74/242 (30%)

Query: 772 LSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI 830
           ++ + F+   +L G G  G V       +G   A+K L           +K  +    E+
Sbjct: 2   VTMNDFDYLKLL-GKGTFGKVILVREKATGRYYAMKIL-----------RKEVIIAKDEV 49

Query: 831 RH----RNIVK----------FYGFCSHTQHLFLVYEYLERGSLATILSNEAT------- 869
            H      +++           Y F +H   L  V EY   G L   LS E         
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERAR 108

Query: 870 --AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV--SDFG 924
              AE            + +AL Y+H  D    +++RDI  + ++LD +   H+  +DFG
Sbjct: 109 FYGAE------------IVSALEYLHSRD----VVYRDIKLENLMLDKD--GHIKITDFG 150

Query: 925 TAKFLKPDSSNWSELAGT-CG---YIAPEL----AYTMRANEKCDVFNFGVLVLEVIEGK 976
             K    +  +      T CG   Y+APE+     Y        D +  GV++ E++ G+
Sbjct: 151 LCK----EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGR 202

Query: 977 HP 978
            P
Sbjct: 203 LP 204

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 50.6 bits (122), Expect = 1e-06
 Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 46/235 (19%)

Query: 767 NNQELLSASTFEGKMVLHGTGGCGTVYKAELTSG-DTR---AVKKLHSLPTGEIGINQKG 822
              E +    FE   VL G GG G V++    +G +T    A+K L       I  N K 
Sbjct: 9   RGPEKIRPECFELLRVL-GKGGYGKVFQVRKVTGANTGKIFAMKVLKK---AMIVRNAKD 64

Query: 823 FVSEITE------IRHRNIVK-FYGFCSHTQHLFLVYEYLERGSLATILSNEAT------ 869
                 E      ++H  IV   Y F +    L+L+ EYL  G L   L  E        
Sbjct: 65  TAHTKAERNILEEVKHPFIVDLIYAFQTGG-KLYLILEYLSGGELFMQLEREGIFMEDTA 123

Query: 870 ---AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV--SDF 923
               AE            ++ AL ++H       I++RD+  + ++L+ +   HV  +DF
Sbjct: 124 CFYLAE------------ISMALGHLHQKG----IIYRDLKPENIMLNHQ--GHVKLTDF 165

Query: 924 GTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           G  K    D +      GT  Y+APE+      N   D ++ G L+ +++ G  P
Sbjct: 166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 50.3 bits (121), Expect = 2e-06
 Identities = 64/257 (24%), Positives = 94/257 (36%), Gaps = 69/257 (26%)

Query: 755 KRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPT 813
           K +  +     VN+   L    FE   VL G G  G V  A +  +GD  AVK L     
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVL-GKGSFGKVMLARVKETGDLYAVKVL----- 56

Query: 814 GEIGINQKGFVSEITEIRH----RNIVK-----------FYGFCSHTQHLFLVYEYLERG 858
                 +K  + +  ++      + I+            F  F +    LF V E++  G
Sbjct: 57  ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-RLFFVMEFVNGG 109

Query: 859 SLATILSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSK 908
            L   +              AAE            + +AL ++H       I++RD+   
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAE------------IISALMFLHDKG----IIYRDLKLD 153

Query: 909 KVLLDLEYKAHV--SDFGTAK-FLKPDSSNWSELAGT-CG---YIAPELAYTMRANEKCD 961
            VLLD E   H   +DFG  K  +            T CG   YIAPE+   M      D
Sbjct: 154 NVLLDHE--GHCKLADFGMCKEGICNG-----VTTATFCGTPDYIAPEILQEMLYGPAVD 206

Query: 962 VFNFGVLVLEVIEGKHP 978
            +  GVL+ E++ G  P
Sbjct: 207 WWAMGVLLYEMLCGHAP 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 69/257 (26%)

Query: 755 KRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPT 813
           +  ++   +        L    F+   V+ G G    V    L  +    A++ +     
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFDLLRVI-GRGSYAKVLLVRLKKTDRIYAMRVV----- 85

Query: 814 GEIGINQKGFVSEITEIRH----RNI----------VKFYGFCSHTQ-HLFLVYEYLERG 858
                 +K  V++  +I      +++          V  +  C  T+  LF V EY+  G
Sbjct: 86  ------KKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGG 138

Query: 859 SLATILSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSK 908
            L   +  +           +AE            ++ AL+Y+H       I++RD+   
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAE------------ISLALNYLHERG----IIYRDLKLD 182

Query: 909 KVLLDLEYKAHV--SDFGTAK-FLKPDSSNWSELAGT-CG---YIAPELAYTMRANEKCD 961
            VLLD E   H+  +D+G  K  L+P      +   T CG   YIAPE+          D
Sbjct: 183 NVLLDSE--GHIKLTDYGMCKEGLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVD 235

Query: 962 VFNFGVLVLEVIEGKHP 978
            +  GVL+ E++ G+ P
Sbjct: 236 WWALGVLMFEMMAGRSP 252

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 60/251 (23%), Positives = 99/251 (39%), Gaps = 61/251 (24%)

Query: 757 TDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGE 815
             SQ+     ++      S F    V+ G G  G V  A         AVK L       
Sbjct: 20  APSQQINLGPSSNPHAKPSDFHFLKVI-GKGSFGKVLLARHKAEEVFYAVKVL------- 71

Query: 816 IGINQKGFVSEITEIRH----RNI----------VK-FYGFCSHTQHLFLVYEYLERGSL 860
               QK  + +  E +H    RN+          V   + F +    L+ V +Y+  G L
Sbjct: 72  ----QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYINGGEL 126

Query: 861 ATILSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKV 910
              L  E           AAE            +A+AL Y+H  +    I++RD+  + +
Sbjct: 127 FYHLQRERCFLEPRARFYAAE------------IASALGYLHSLN----IVYRDLKPENI 170

Query: 911 LLDLEYKAHV--SDFGTAK-FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGV 967
           LLD +   H+  +DFG  K  ++ +S+  +   GT  Y+APE+ +    +   D +  G 
Sbjct: 171 LLDSQ--GHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227

Query: 968 LVLEVIEGKHP 978
           ++ E++ G  P
Sbjct: 228 VLYEMLYGLPP 238

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 69/309 (22%), Positives = 114/309 (36%), Gaps = 89/309 (28%)

Query: 768  NQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSE 826
              + L    F+   V+ G G    V    L  +    A+K +           +K  V++
Sbjct: 2    AMDPLGLQDFDLLRVI-GRGSYAKVLLVRLKKTDRIYAMKVV-----------KKELVND 49

Query: 827  ITEIRH----RNI----------VKFYGFCSHTQ-HLFLVYEYLERGSLATILSNEAT-- 869
              +I      +++          V  +  C  T+  LF V EY+  G L   +  +    
Sbjct: 50   DEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP 108

Query: 870  -------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKVLLDLEYKAHV- 920
                   +AE            ++ AL+Y+H       I++RD+    VLLD E   H+ 
Sbjct: 109  EEHARFYSAE------------ISLALNYLHERG----IIYRDLKLDNVLLDSE--GHIK 150

Query: 921  -SDFGTAK-FLKPDSSNWSELAGT-CG---YIAPELAYTMRANEKCDVFNFGVLVLEVIE 974
             +D+G  K  L+P      +   T CG   YIAPE+          D +  GVL+ E++ 
Sbjct: 151  LTDYGMCKEGLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205

Query: 975  GKHPGHFLSLLLSLPAPAANM-----NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL-- 1027
            G+ P  F  +  S              I+   +   R+P  L        S+ A + L  
Sbjct: 206  GRSP--FDIVGSSDNPDQNTEDYLFQVILEKQI---RIPRSL--------SVKAASVLKS 252

Query: 1028 CLDANPDCR 1036
             L+ +P  R
Sbjct: 253  FLNKDPKER 261

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 49.5 bits (119), Expect = 3e-06
 Identities = 58/254 (22%), Positives = 98/254 (38%), Gaps = 67/254 (26%)

Query: 757 TDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGE 815
           T++    ++  N++ +  + F   MVL G G  G V  +E   + +  AVK L       
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFLMVL-GKGSFGKVMLSERKGTDELYAVKIL------- 53

Query: 816 IGINQKGFVSEITEIRH----RNI----------VKFYGFCSHTQ-HLFLVYEYLERGSL 860
               +K  V +  ++      + +           + +  C  T   L+ V EY+  G L
Sbjct: 54  ----KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL 108

Query: 861 ATILSNEAT---------AAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRDISSKKV 910
              +              AAE            +A  L ++        I++RD+    V
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAE------------IAIGLFFLQSKG----IIYRDLKLDNV 152

Query: 911 LLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGT-CG---YIAPELAYTMRANEKCDVFN 964
           +LD E   H+  +DFG  K    ++        T CG   YIAPE+       +  D + 
Sbjct: 153 MLDSE--GHIKIADFGMCK----ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 206

Query: 965 FGVLVLEVIEGKHP 978
           FGVL+ E++ G+ P
Sbjct: 207 FGVLLYEMLAGQAP 220

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 50.3 bits (120), Expect = 3e-06
 Identities = 72/513 (14%), Positives = 146/513 (28%), Gaps = 48/513 (9%)

Query: 5   NLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII 64
            +   N            FP++  ++L     F      +       ++       S   
Sbjct: 47  KVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADF--NLVPDGWGGYVYPWIEAMSSSY 104

Query: 65  PPQIGILTNLVVLRLSVNQLNGLIPEELGE-LTSLNELALSYNRL--NGSIPASLGNLSN 121
                    L  +RL    +     E + +   +   L LS         + A      N
Sbjct: 105 T-------WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRN 157

Query: 122 LVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG- 180
           L +L L  + +          +        P    +L S +++S   +  S      L  
Sbjct: 158 LKELDLRESDVDD--------VSGHWLSHFPDTYTSLVS-LNISCLASEVSFSALERLVT 208

Query: 181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
              NL  + LN    +  + + +     L  LG                     +     
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGG------------------YTAEVR 250

Query: 241 NRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEI 300
             +   +   L   K L  L    + +   LP+ +   S L  L++      S  + K +
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310

Query: 301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLS 360
                L  LW+        +        ++R L +  +  +   P      + L  +S+ 
Sbjct: 311 CQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG 370

Query: 361 VNKLNGSIPHCLGNLSNLKFFALREN--ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQ 418
             KL   +  C   ++N     +  N   ++      IE        L   +   G + +
Sbjct: 371 CPKLESVLYFC-RQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVE 429

Query: 419 NVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGN-ISEVFGIYPDLELL 477
           + C+   L   S+                  +  L +     +   +  V      L  L
Sbjct: 430 H-CK--DLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486

Query: 478 DLSNNNFFGE-ISSNWIKCPQLATLNMGGNEIS 509
           ++ +  F  + + +N  K   + +L M    +S
Sbjct: 487 EIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 48.7 bits (117), Expect = 5e-06
 Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 34/163 (20%)

Query: 785 GTGGCGTVYKA--ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI---------RHR 833
           G G  G V+KA      G   A+K++  + TGE G+     +S I E+          H 
Sbjct: 20  GEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMP----LSTIREVAVLRHLETFEHP 74

Query: 834 NIVKFY-----GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVA-- 886
           N+V+ +             L LV+E++++  L T L                 IK +   
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-----GVPTETIKDMMFQ 128

Query: 887 --NALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK 927
               L ++H      ++HRD+  + +L+    +  ++DFG A+
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 16/171 (9%)

Query: 444 LQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWI--KCPQLATL 501
           L  C+ L +L LE  +L+  I        +L  L+LS  + F E +   +   C +L  L
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173

Query: 502 NMGG-NEISGTIPSEI--GNMTQLHKLDFS------SNRLVGQIPKQLGKLTSLTSLTLN 552
           N+    + +              + +L+ S          +  + +   +  +L  L L+
Sbjct: 174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR---RCPNLVHLDLS 230

Query: 553 G-NQLSGDIPLELGLLAELGYLDLSA-NRLSKLIPKNLGELRKLHHLNLSN 601
               L  D   E   L  L +L LS    +       LGE+  L  L +  
Sbjct: 231 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 45/302 (14%), Positives = 84/302 (27%), Gaps = 51/302 (16%)

Query: 351 LKSLSQLSLSVNKLNGSIPHCLG-----NLSNLKFFALRENELSGSIPQEI-ENMKKLNK 404
           L SL QL+L+  ++       +          L    L   +L  +  + +     +  K
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 405 YLLFENQFT--------GYLPQNVCQSGSLTHFSVRNNNF----VGPIPRSLQNCTSLYS 452
             L  N             L  + C    +T   + NN      V  +   L   TS+  
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQC---QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187

Query: 453 LRLERNQLTGN----ISEVFGIYPDLELLDLSNNNFFGE----ISSNWIKCPQLATLNMG 504
           L L    L       ++        L+ L+++ N         ++    + P L  L++ 
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247

Query: 505 GNEISGT-------IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGK-LTSLTSLTLNGNQL 556
            NE+S         +        ++         +       L +   +L S      Q 
Sbjct: 248 FNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQR 307

Query: 557 SGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRK----LHHLNLSNNQFSQEISIQI 612
             +          L   DL  +R + L P    +L +    +  L               
Sbjct: 308 HLE----------LLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSPSGSWS 357

Query: 613 GK 614
             
Sbjct: 358 HP 359

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 66/359 (18%), Positives = 114/359 (31%), Gaps = 50/359 (13%)

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL 455
           I+N+  L      + +      Q +  S  L H              S +  +SL  L L
Sbjct: 22  IKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYE--FQNQRFSAEVLSSLRQLNL 79

Query: 456 ERNQLTGN----ISEVFGI-YPDLELLDLSNNNFFGEISSNWIKCPQLAT---LNMGGNE 507
              ++T      ++ V G     L+ ++L++           +  P       L +  N 
Sbjct: 80  AGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQL-DPAGLRTL-LPVFLRARKLGLQLNS 137

Query: 508 ISGTIPSEIG-----NMTQLHKLDFSSNRL----VGQIPKQLGKLTSLTSLTLNGNQLSG 558
           +      ++      +  Q+  L  S+N L    V  + + L   TS+T L+L    L G
Sbjct: 138 LGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGL-G 196

Query: 559 DIPLELGLLAE-------LGYLDLSANRLS----KLIPKNLGELRKLHHLNLSNNQFSQE 607
           D  LEL  LA        L  L+++ N         + +   E   L  L+L  N+ S E
Sbjct: 197 DEGLEL--LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254

Query: 608 ISIQIGKLVQLSK--LDLSHNSLGGNIPSEICNL---ESLEYMNLLQNKLSGPIPSCFRR 662
               +  L   ++    +  +   G   SE  ++   E    +N              +R
Sbjct: 255 GRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRAR-------VQR 307

Query: 663 MHGLSSIDVSYNELQGSIPHSKA---FQNATIEAFQGNKELCGDVTGLPPCEALTSNKG 718
              L   D+  +      P  KA        + A        G  +G           G
Sbjct: 308 HLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSPSGSWSHPQFEKGAG 366

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 40/209 (19%), Positives = 67/209 (32%), Gaps = 55/209 (26%)

Query: 785 GTGGCGTVYKAELT-SGDTRAVKKLHSLPTG---EIGINQKGFVSEITEIRHRNIVK-FY 839
           GTG  G V +     SG   A+KK+   P     E+          +  + H NI+K   
Sbjct: 16  GTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNREL--------DIMKVLDHVNIIKLVD 67

Query: 840 GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRV------------------NV 881
            F +         +  +  +     +N                                V
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127

Query: 882 IKGVAN-------------------ALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVS 921
           +K                       A+ ++H      I HRDI  + +L++ +     + 
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 922 DFGTAKFLKPDSSNWSELAGTCGYIAPEL 950
           DFG+AK L P   + + +  +  Y APEL
Sbjct: 185 DFGSAKKLIPSEPSVAYIC-SRFYRAPEL 212

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 22/202 (10%)

Query: 785 GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFY- 839
           G+G  G V  A         A+KKL      +   + K    E+     + H+NI+    
Sbjct: 34  GSGAQGIVCAAYDAILERNVAIKKLSR--PFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91

Query: 840 -----GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
                      Q +++V E ++  +L  ++       ELD  +   ++  +   + ++H 
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS 145

Query: 895 DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                I+HRD+    +++  +    + DFG A+         +    T  Y APE+   M
Sbjct: 146 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGM 201

Query: 955 RANEKCDVFNFGVLVLEVIEGK 976
              E  D+++ G ++ E+I+G 
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 46/235 (19%), Positives = 94/235 (40%), Gaps = 23/235 (9%)

Query: 752 RRRKRTDSQEGQNDVNNQELLSASTFEGKMVLHGTGGCGTVYKA-ELTSGDTRAVKKLHS 810
             + + D+Q    +V +        ++    + G+G  G V  A +       A+KKL  
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI-GSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 811 LPTGEIGINQKGFVSEI---TEIRHRNIVKFY------GFCSHTQHLFLVYEYLERGSLA 861
               +   + K    E+     + H+NI+               Q ++LV E ++  +L 
Sbjct: 98  --PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC 154

Query: 862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVS 921
            ++       ELD  +   ++  +   + ++H      I+HRD+    +++  +    + 
Sbjct: 155 QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206

Query: 922 DFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK 976
           DFG A+     S   +    T  Y APE+   M   E  D+++ G ++ E++  K
Sbjct: 207 DFGLARTA-GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 43.4 bits (103), Expect = 3e-04
 Identities = 42/214 (19%), Positives = 80/214 (37%), Gaps = 48/214 (22%)

Query: 785 GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-------HRNIV 836
           G G    V++A  +T+ +   VK L  +   +I            EI+         NI+
Sbjct: 45  GRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----------KREIKILENLRGGPNII 94

Query: 837 KFYGFC--SHTQHLFLVYEYLERGSLATI---LSNEATAAELDWSKRVNVIKGVANALSY 891
                     ++   LV+E++       +   L++               +  +  AL Y
Sbjct: 95  TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---------FYMYEILKALDY 145

Query: 892 MH-HDCFPPILHRDISSKKVLLDLEYKA-HVSDFGTAKFLKPDSSNWSELAGTCGYIAPE 949
            H       I+HRD+    V++D E++   + D+G A+F  P    ++    +  +  PE
Sbjct: 146 CHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPE 200

Query: 950 L-----AYTMRANEKCDVFNFGVLVLEVIEGKHP 978
           L      Y        D+++ G ++  +I  K P
Sbjct: 201 LLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 26/104 (25%), Positives = 46/104 (44%), Gaps = 9/104 (8%)

Query: 432 RNNNFVGPIPRSLQNCTSLYSLRLERNQLTG--NISEVFGIYPDLELLDLSNNNFFGEIS 489
           R +     +    +N   L SL L  N+L    ++S +    P+L++L+LS N    E  
Sbjct: 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 213

Query: 490 SNWIKCPQLATLNMGGNEISGTIPSEIGNMT-------QLHKLD 526
            + IK  +L  L + GN +  T   +   ++       +L +LD
Sbjct: 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 41/223 (18%), Positives = 70/223 (31%), Gaps = 53/223 (23%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT------EI------RH 832
            +G  G V     + G   A+K++ +  +    +N               EI       H
Sbjct: 31  SSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI--LSDSFLCKRVLREIRLLNHFHH 88

Query: 833 RNIVKFY-----GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVAN 887
            NI+                L+LV E +                  D ++   VI     
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT----------------DLAQ---VIHDQRI 129

Query: 888 ALSYMHHDCF-------------PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
            +S  H   F               ++HRD+    +LL       + DF  A+    D +
Sbjct: 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-A 188

Query: 935 NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGK 976
           N +       Y APEL        +  D+++ G ++ E+   K
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1048
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.9
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.86
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.71
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.68
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.68
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.68
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.66
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.64
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.6
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.45
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.42
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.41
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.21
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.19
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.14
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.1
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.01
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.0
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.98
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.88
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.83
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.66
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.62
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.59
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.41
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.22
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.16
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.11
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.01
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.95
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.94
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.87
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.86
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.82
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.77
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.72
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.58
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.47
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.42
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.25
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.24
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.81
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.72
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.68
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.51
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.4
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.29
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.2
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.95
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.66
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.41
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.01
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.36
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.06
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	86.74
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.16
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.0

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.6e-80  Score=771.71  Aligned_cols=668  Identities=29%  Similarity=0.421  Sum_probs=607.6

Q ss_pred             CCccEEeCCCCccccc---ccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcc--cccccccc
Q 045493           24 PQLAYLDLSVNQLFGT---IPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPE--ELGELTSL   98 (1048)
Q Consensus        24 ~~l~~L~L~~n~l~~~---~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~--~~~~l~~L   98 (1048)
                      .+++.|||+++++.+.   +|.+|+.+++|+.++++.|.+. ..|..|+.+++|++|+|++|.+++.+|.  .|..+++|
T Consensus        50 ~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L  128 (768)
T 3rgz_A           50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL  128 (768)
T ss_dssp             TEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTC
T ss_pred             CcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCC
Confidence            5799999999999987   8899999999999999999887 4778999999999999999999988888  89999999


Q ss_pred             ccccccceecccccCcCc-CCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCC
Q 045493           99 NELALSYNRLNGSIPASL-GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPR  177 (1048)
Q Consensus        99 ~~L~l~~n~~~~~~~~~~-~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~  177 (1048)
                      ++|++++|.+++..|..+ .++++|++|++++|++++..|..+            ..+.++++|++|++++|.+++..|.
T Consensus       129 ~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~------------~~~~~l~~L~~L~Ls~n~l~~~~~~  196 (768)
T 3rgz_A          129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW------------VLSDGCGELKHLAISGNKISGDVDV  196 (768)
T ss_dssp             CEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHH------------HHTTCCTTCCEEECCSSEEESCCBC
T ss_pred             CEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhh------------hhhccCCCCCEEECCCCcccccCCc
Confidence            999999999998888766 899999999999999886433211            1167889999999999999987664


Q ss_pred             CCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccccc
Q 045493          178 SLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL  257 (1048)
Q Consensus       178 ~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  257 (1048)
                        ..+++|++|+|++|.+++.+|. ++++++|++|+|++|++.+.+|..+..+++|++|+|++|.+++.+|..  .+++|
T Consensus       197 --~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L  271 (768)
T 3rgz_A          197 --SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSL  271 (768)
T ss_dssp             --TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTC
T ss_pred             --ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCC
Confidence              8899999999999999987776 999999999999999999888999999999999999999998777754  88999


Q ss_pred             ceeecccccccCCCchhhhcc-chhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccc-cccccccceeee
Q 045493          258 LYLYLSHNQLNGSLPSSFGNL-SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPS-LGNLSNIRGLYI  335 (1048)
Q Consensus       258 ~~L~L~~n~l~~~~p~~~~~L-~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l  335 (1048)
                      ++|++++|++.+.+|..+..+ ++|++|++++ |.+.+.+|..++++++|++|++++|.+++.+|.. ++.+++|+.|++
T Consensus       272 ~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~L  350 (768)
T 3rgz_A          272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSG-NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL  350 (768)
T ss_dssp             CEEECCSSEEEESCCCCSCTTCTTCSEEECCS-SEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEEC
T ss_pred             CEEECcCCccCCccCHHHHhhcCcCCEEECcC-CcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeC
Confidence            999999999998888888775 9999999987 7888889999999999999999999999777765 999999999999


Q ss_pred             ccccccCCCCcchhccC-CCCeEeccCCccccCcChhhhc--cCCCcEEEeecccccCCchhhhhhhcccceeecccccc
Q 045493          336 RENMLYGSIPEELGRLK-SLSQLSLSVNKLNGSIPHCLGN--LSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF  412 (1048)
Q Consensus       336 ~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l  412 (1048)
                      ++|.+.+.+|..+..++ +|++|++++|++++.+|..++.  +++|++|++++|.+++.+|..+.++++|+.|++++|++
T Consensus       351 s~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l  430 (768)
T 3rgz_A          351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL  430 (768)
T ss_dssp             CSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEE
T ss_pred             cCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcc
Confidence            99999989999999997 9999999999999888888877  88999999999999999999999999999999999999


Q ss_pred             CCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccc
Q 045493          413 TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW  492 (1048)
Q Consensus       413 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~  492 (1048)
                      ++..|..+..+++|+.|++++|.+++.+|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..|..+
T Consensus       431 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  510 (768)
T 3rgz_A          431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI  510 (768)
T ss_dssp             ESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred             cCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCc------------------
Q 045493          493 IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGN------------------  554 (1048)
Q Consensus       493 ~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N------------------  554 (1048)
                      ..+++|++|++++|.+++.+|..++.+++|++|++++|++++.+|..+.....+..+++..+                  
T Consensus       511 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (768)
T 3rgz_A          511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA  590 (768)
T ss_dssp             GGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSS
T ss_pred             hcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999988887766655544331                  


Q ss_pred             ----cccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccC
Q 045493          555 ----QLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       555 ----~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                          .+.+..+..+..+..+..++++.|.+++..|..+..+++|+.|+|++|++++..+..++.+++|+.|||++|+++|
T Consensus       591 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g  670 (768)
T 3rgz_A          591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG  670 (768)
T ss_dssp             EEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred             ccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCC
Confidence                2345566777888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCcccccccccccccCCccccCCCCCCCCC
Q 045493          631 NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPC  710 (1048)
Q Consensus       631 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~c  710 (1048)
                      .+|..++++++|++|+|++|+++|.+|..+..++.|++||+++|+++|.||...+|..+....|.||+++||.+.  ++|
T Consensus       671 ~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l--~~C  748 (768)
T 3rgz_A          671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--PRC  748 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS--CCC
T ss_pred             CCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC--cCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999875  378


Q ss_pred             CC
Q 045493          711 EA  712 (1048)
Q Consensus       711 ~~  712 (1048)
                      ..
T Consensus       749 ~~  750 (768)
T 3rgz_A          749 DP  750 (768)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.7e-75  Score=727.83  Aligned_cols=656  Identities=31%  Similarity=0.458  Sum_probs=598.7

Q ss_pred             CEEEEecCCcceeeecCCC--CCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCc--CCCCCCCCcE
Q 045493            1 VVSINLTGSNLKGTLQEFP--FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPP--QIGILTNLVV   76 (1048)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~p--~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~--~~~~l~~L~~   76 (1048)
                      |++++|++.++.+.+..+|  +.....|+.++++.|++. ..|..|+.+++|++|||++|.+++.+|.  .++.+++|++
T Consensus        52 v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~  130 (768)
T 3rgz_A           52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF  130 (768)
T ss_dssp             EEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCE
T ss_pred             EEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCE
Confidence            6889999999988733332  344588999999999886 4678999999999999999999998888  9999999999


Q ss_pred             EeCCCCcCCCCCcccc-ccccccccccccceecccccCcC---cCCcCCCceEEeecccccCccCCCCCcccCCCCCCCC
Q 045493           77 LRLSVNQLNGLIPEEL-GELTSLNELALSYNRLNGSIPAS---LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIP  152 (1048)
Q Consensus        77 L~ls~n~l~~~~~~~~-~~l~~L~~L~l~~n~~~~~~~~~---~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p  152 (1048)
                      |+|++|.+++..|..+ .++++|++|++++|++++..|..   +.++++|++|++++|.+.+..|               
T Consensus       131 L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---------------  195 (768)
T 3rgz_A          131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD---------------  195 (768)
T ss_dssp             EECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB---------------
T ss_pred             EECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC---------------
Confidence            9999999998888776 89999999999999999888877   8999999999999999986432               


Q ss_pred             ccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCC
Q 045493          153 QDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN  232 (1048)
Q Consensus       153 ~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  232 (1048)
                        +..+++|+.|++++|.+++.+|. +..+++|++|+|++|.+++..|..|..+++|++|+|++|++.+.+|..  .+++
T Consensus       196 --~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~  270 (768)
T 3rgz_A          196 --VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKS  270 (768)
T ss_dssp             --CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTT
T ss_pred             --cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCC
Confidence              37789999999999999998887 999999999999999999999999999999999999999999877765  8999


Q ss_pred             CCeEeccCCccCCCCCcccccc-cccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcc-cCCCCCCcEEE
Q 045493          233 LKFLYLHDNRLSGYIPPKLGSF-KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKE-IGNLKSLSHLW  310 (1048)
Q Consensus       233 L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~-~~~l~~L~~L~  310 (1048)
                      |++|+|++|.+++.+|..+... ++|++|++++|++.+..|..|+.+++|++|++++ |.+.+.+|.. +..+++|++|+
T Consensus       271 L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~ip~~~l~~l~~L~~L~  349 (768)
T 3rgz_A          271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS-NNFSGELPMDTLLKMRGLKVLD  349 (768)
T ss_dssp             CCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCS-SEEEEECCHHHHTTCTTCCEEE
T ss_pred             CCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCC-CcccCcCCHHHHhcCCCCCEEe
Confidence            9999999999998899888775 9999999999999999999999999999999998 7787777766 99999999999


Q ss_pred             ccCceeeccccccccccc-ccceeeeccccccCCCCcchhc--cCCCCeEeccCCccccCcChhhhccCCCcEEEeeccc
Q 045493          311 LSKTQLSGFIPPSLGNLS-NIRGLYIRENMLYGSIPEELGR--LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE  387 (1048)
Q Consensus       311 L~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~  387 (1048)
                      +++|.+++.+|..+..++ +|+.|++++|.+.+..|..+..  +++|++|++++|++++.+|..++++++|+.|++++|+
T Consensus       350 Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~  429 (768)
T 3rgz_A          350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY  429 (768)
T ss_dssp             CCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCc
Confidence            999999999999999998 9999999999999989988887  8999999999999999999999999999999999999


Q ss_pred             ccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccc
Q 045493          388 LSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEV  467 (1048)
Q Consensus       388 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~  467 (1048)
                      +++.+|..+..+++|+.|++++|++++.+|..+..+++|++|++++|.+++.+|..+..+++|++|++++|++++..+..
T Consensus       430 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  509 (768)
T 3rgz_A          430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW  509 (768)
T ss_dssp             EESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGG
T ss_pred             ccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccC-----------------
Q 045493          468 FGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN-----------------  530 (1048)
Q Consensus       468 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N-----------------  530 (1048)
                      |+.+++|++|+|++|++++..|..+..+++|+.|++++|.+++.+|..+.....+..+++..+                 
T Consensus       510 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (768)
T 3rgz_A          510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG  589 (768)
T ss_dssp             GGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCS
T ss_pred             HhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccc
Confidence            999999999999999999999999999999999999999999999999888766665554431                 


Q ss_pred             -----cccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccccccccc
Q 045493          531 -----RLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS  605 (1048)
Q Consensus       531 -----~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~  605 (1048)
                           .+.+..+..+..++.++.++++.|.+++.+|..++.+++|++|||++|++++.+|..++.++.|+.|+|++|+++
T Consensus       590 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~  669 (768)
T 3rgz_A          590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS  669 (768)
T ss_dssp             SEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             cccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccC
Confidence                 133455566677788888999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccce-ecCC
Q 045493          606 QEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNE-LQGS  679 (1048)
Q Consensus       606 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~-l~~~  679 (1048)
                      +..+..++.+++|+.||||+|+++|.+|..+..+++|++|++++|+++|.+|.. ..+..+....+.+|+ +.|.
T Consensus       670 g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred             CCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence            999999999999999999999999999999999999999999999999999974 233444455567776 6653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=3.1e-64  Score=623.10  Aligned_cols=591  Identities=24%  Similarity=0.266  Sum_probs=396.6

Q ss_pred             EEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccccee
Q 045493           28 YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNR  107 (1048)
Q Consensus        28 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~  107 (1048)
                      .+|+++++++ .+|..+.  +++++|+|++|.++++.+.+|+.+++|++|+|++|+++++.|++|.++++|++|++++|+
T Consensus         8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   84 (680)
T 1ziw_A            8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE   84 (680)
T ss_dssp             EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred             eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence            4455555554 3333332  345555555555554444445555555555555555555445555555555555555555


Q ss_pred             cccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcce
Q 045493          108 LNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTF  187 (1048)
Q Consensus       108 ~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~  187 (1048)
                      ++.+.+.+|+++++|++|++++|++.+                                       +.|..|..+++|++
T Consensus        85 l~~l~~~~~~~l~~L~~L~L~~n~l~~---------------------------------------~~~~~~~~l~~L~~  125 (680)
T 1ziw_A           85 LSQLSDKTFAFCTNLTELHLMSNSIQK---------------------------------------IKNNPFVKQKNLIT  125 (680)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCCCC---------------------------------------CCSCTTTTCTTCCE
T ss_pred             cCccChhhhccCCCCCEEECCCCccCc---------------------------------------cChhHccccCCCCE
Confidence            554333345555555555555554431                                       22233444444555


Q ss_pred             eeccccCccccCCcccccccccceeccccccccccCCccCc--CCCCCCeEeccCCccCCCCCcccccccccceeecccc
Q 045493          188 VYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG--NLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHN  265 (1048)
Q Consensus       188 L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n  265 (1048)
                      |+|++|.+++..|..++.+++|++|+|++|++++..+..+.  .+++|++|++++|.+++..|..|..+.+|+.|++++|
T Consensus       126 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~  205 (680)
T 1ziw_A          126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV  205 (680)
T ss_dssp             EECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTC
T ss_pred             EECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccc
Confidence            55555554444444455555555555555555443333322  3455666666666666555566666666666666666


Q ss_pred             cccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccc--cceeeeccccccCC
Q 045493          266 QLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSN--IRGLYIRENMLYGS  343 (1048)
Q Consensus       266 ~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~~~  343 (1048)
                      .+..   ..+..+.                  ..+ ..++|+.|++++|.+++..|..|..++.  |+.|++++|.+.+.
T Consensus       206 ~l~~---~~~~~~~------------------~~l-~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~  263 (680)
T 1ziw_A          206 QLGP---SLTEKLC------------------LEL-ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV  263 (680)
T ss_dssp             CCHH---HHHHHHH------------------HHH-TTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred             ccCh---hhHHHHH------------------HHh-hhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence            5431   1111000                  000 1245566666666666555555655543  66666666666655


Q ss_pred             CCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccC-----Cch----hhhhhhcccceeeccccccCC
Q 045493          344 IPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSG-----SIP----QEIENMKKLNKYLLFENQFTG  414 (1048)
Q Consensus       344 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~-----~~p----~~~~~l~~L~~l~l~~N~l~~  414 (1048)
                      .|..|..+++|++|++++|++++..|..|.++++|+.|++++|...+     .+|    ..|..+++|+.|++++|++++
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~  343 (680)
T 1ziw_A          264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG  343 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred             CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence            55566666666666666666665556666666666666666554332     122    255666677777777777776


Q ss_pred             CCCcccccCCcccEEEeecccccC--CCCCCcccc--cccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCccc-
Q 045493          415 YLPQNVCQSGSLTHFSVRNNNFVG--PIPRSLQNC--TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEIS-  489 (1048)
Q Consensus       415 ~~~~~~~~~~~L~~L~l~~N~l~~--~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~-  489 (1048)
                      ..+..+..+++|++|++++|.+..  .....|..+  ++|+.|++++|+++++.+..|..+++|+.|++++|.+.+..+ 
T Consensus       344 ~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  423 (680)
T 1ziw_A          344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG  423 (680)
T ss_dssp             CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCS
T ss_pred             CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCc
Confidence            666666777777777777776432  223344443  578899999999988888888888999999999999876554 


Q ss_pred             ccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCccc--CCcCccccCCCccCEEeecCccccCCCccccccc
Q 045493          490 SNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLV--GQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLL  567 (1048)
Q Consensus       490 ~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  567 (1048)
                      ..|..+++|++|++++|.+++..+..|..+++|+.|++++|.+.  +..|..|..+++|++|+|++|++++..+..|..+
T Consensus       424 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l  503 (680)
T 1ziw_A          424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL  503 (680)
T ss_dssp             GGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             ccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccc
Confidence            67888899999999999998888888889999999999999886  5678889999999999999999997777788999


Q ss_pred             cccceeecccCccccccc--------ccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCc
Q 045493          568 AELGYLDLSANRLSKLIP--------KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNL  639 (1048)
Q Consensus       568 ~~L~~L~Ls~N~l~~~~~--------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  639 (1048)
                      ++|++|+|++|+++++.+        ..|..+++|++|+|++|+|+.+.+..|..+++|++|||++|+|++..+..|..+
T Consensus       504 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l  583 (680)
T 1ziw_A          504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQ  583 (680)
T ss_dssp             TTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCC
Confidence            999999999999987633        237889999999999999998888889999999999999999998778888999


Q ss_pred             cccCeEECCCCcccCCcccccc-ccCCccEEEeccceecCCCCC
Q 045493          640 ESLEYMNLLQNKLSGPIPSCFR-RMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       640 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      ++|+.|+|++|+|++..+..+. .+++|+.+++++|+|.+.++.
T Consensus       584 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          584 VSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            9999999999999999988888 799999999999999998774

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.4e-63  Score=615.15  Aligned_cols=589  Identities=23%  Similarity=0.234  Sum_probs=424.4

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .+++++.++    +++|...++++++|||++|+|++..+..|+.+++|++|+|++|.++++.|.+|+.+++|++|+|++|
T Consensus         8 ~~~cs~~~L----~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            8 VADCSHLKL----TQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             EEECCSSCC----SSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             eeECCCCCc----cccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            466776655    5677777899999999999999888889999999999999999999999999999999999999999


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV  162 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~  162 (1048)
                      +++++.+..|.++++|++|++++|+++++.|.+|+++++|++|++++|.+++..               |..+.++++|+
T Consensus        84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~---------------~~~~~~l~~L~  148 (680)
T 1ziw_A           84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK---------------LGTQVQLENLQ  148 (680)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCC---------------CCSSSCCTTCC
T ss_pred             ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccC---------------chhhcccccCC
Confidence            999877778999999999999999999888899999999999999999987532               34566777788


Q ss_pred             EEecCCCccccccCCCCC--CCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCc---CCCCCCeEe
Q 045493          163 SVSLHTNNFSGVIPRSLG--GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG---NLSNLKFLY  237 (1048)
Q Consensus       163 ~l~l~~n~~~~~~~~~~~--~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~  237 (1048)
                      +|++++|.+++..+..+.  .+++|+.|++++|++++..|..|..+.+|+.|++++|++.......+.   ..++|+.|+
T Consensus       149 ~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~  228 (680)
T 1ziw_A          149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS  228 (680)
T ss_dssp             EEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEE
T ss_pred             EEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEE
Confidence            888888887777666554  347788888888877777777777777888887777776532211111   236677777


Q ss_pred             ccCCccCCCCCcccccccc--cceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCce
Q 045493          238 LHDNRLSGYIPPKLGSFKS--LLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQ  315 (1048)
Q Consensus       238 L~~N~l~~~~p~~~~~l~~--L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~  315 (1048)
                      +++|.+++..|..|.+++.  |++|++++|++.+..|..|                         +.+++|+.|++++|+
T Consensus       229 L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~-------------------------~~l~~L~~L~L~~n~  283 (680)
T 1ziw_A          229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF-------------------------AWLPQLEYFFLEYNN  283 (680)
T ss_dssp             CTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTT-------------------------TTCTTCCEEECCSCC
T ss_pred             ccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccc-------------------------cCcccccEeeCCCCc
Confidence            7777777666667766654  7777777777665444444                         444555555555555


Q ss_pred             eecccccccccccccceeeeccccccC-----CCC----cchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecc
Q 045493          316 LSGFIPPSLGNLSNIRGLYIRENMLYG-----SIP----EELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN  386 (1048)
Q Consensus       316 l~~~~~~~~~~l~~L~~L~l~~n~l~~-----~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n  386 (1048)
                      +++..|..|+.+++|+.|++++|...+     .+|    ..|..+++|++|++++|++++..+..|.++++|++|++++|
T Consensus       284 l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  363 (680)
T 1ziw_A          284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS  363 (680)
T ss_dssp             BSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTC
T ss_pred             cCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCC
Confidence            555555555555555555555443321     122    25666777777777777777666666777777777777777


Q ss_pred             cccCCc--hhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCcccc-C
Q 045493          387 ELSGSI--PQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG-N  463 (1048)
Q Consensus       387 ~l~~~~--p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~  463 (1048)
                      .++...  +..+..+                      ..++|+.|++++|++++..|..|..+++|++|++++|.+++ +
T Consensus       364 ~~~~~~l~~~~f~~~----------------------~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  421 (680)
T 1ziw_A          364 FTSLRTLTNETFVSL----------------------AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL  421 (680)
T ss_dssp             BSCCCEECTTTTGGG----------------------TTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEEC
T ss_pred             chhhhhcchhhhccc----------------------ccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcccc
Confidence            654211  1111111                      12356666666666666666666667777777777777654 3


Q ss_pred             cccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccC--cccCccccccCCCcEEEcccCcccCCcCcccc
Q 045493          464 ISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEIS--GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG  541 (1048)
Q Consensus       464 ~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  541 (1048)
                      +...|..+++|+.|++++|++.+..+..|..+++|+.|++++|.++  +..|..|..+++|++|+|++|++++..+..|.
T Consensus       422 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~  501 (680)
T 1ziw_A          422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE  501 (680)
T ss_dssp             CSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhc
Confidence            4456666777777777777776666666777777777777777765  45666777777777777777777766666677


Q ss_pred             CCCccCEEeecCccccCCC--------ccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhc
Q 045493          542 KLTSLTSLTLNGNQLSGDI--------PLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG  613 (1048)
Q Consensus       542 ~l~~L~~L~L~~N~l~~~~--------~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  613 (1048)
                      .+++|++|+|++|++++..        +..+..+++|++|+|++|+|+.+++..|.++++|+.|+|++|+|+++.+..|.
T Consensus       502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~  581 (680)
T 1ziw_A          502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN  581 (680)
T ss_dssp             TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhC
Confidence            7777777777777776431        12367777888888888888877666778888888888888888877777777


Q ss_pred             cccccCeEECCCCcccCcCCcCcC-CccccCeEECCCCcccCCcc
Q 045493          614 KLVQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       614 ~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      .+++|+.|+|++|+|++..+..+. .+++|+.|++++|++.+..+
T Consensus       582 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             TCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             CCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            888888888888888876666666 67788888888888876543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.4e-57  Score=555.80  Aligned_cols=533  Identities=22%  Similarity=0.217  Sum_probs=319.6

Q ss_pred             ecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccc
Q 045493           15 LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGE   94 (1048)
Q Consensus        15 ~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~   94 (1048)
                      ++++|...++++++|||++|+|++..|.+|+.+++|++|+|++|+++++.|++|+.+++|++|+|++|++++..|.+|.+
T Consensus        24 l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  103 (606)
T 3t6q_A           24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG  103 (606)
T ss_dssp             CSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS
T ss_pred             cccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc
Confidence            34555555556666666666666555566666666666666666666555566666666666666666665555555555


Q ss_pred             ccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccc
Q 045493           95 LTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV  174 (1048)
Q Consensus        95 l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~  174 (1048)
                      +++|++|++++|++++..|..|+++++|++|++++|+                                           
T Consensus       104 l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~-------------------------------------------  140 (606)
T 3t6q_A          104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH-------------------------------------------  140 (606)
T ss_dssp             CTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSC-------------------------------------------
T ss_pred             cccccEeeccccCcccCCcchhccCCcccEEECCCCc-------------------------------------------
Confidence            5555555555555554444444444444444444444                                           


Q ss_pred             cCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCC--eEeccCCccCCCCCcccc
Q 045493          175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLK--FLYLHDNRLSGYIPPKLG  252 (1048)
Q Consensus       175 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~p~~~~  252 (1048)
                                          +++..+..+..+++|++|+|++|++.+..|..++.+++|+  +|++++|.+++..|..|.
T Consensus       141 --------------------l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~  200 (606)
T 3t6q_A          141 --------------------ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD  200 (606)
T ss_dssp             --------------------CCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTT
T ss_pred             --------------------ccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhh
Confidence                                4332222223344455555555555444444455555555  555555555544444433


Q ss_pred             cccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccce
Q 045493          253 SFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRG  332 (1048)
Q Consensus       253 ~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  332 (1048)
                      . .+|++|++++|.   ..+..+.++.+++...+.-            ..+..+....++        +..|..+.    
T Consensus       201 ~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~------------~~~~~~~~~~i~--------~~~~~~l~----  252 (606)
T 3t6q_A          201 S-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWL------------GTFEDMDDEDIS--------PAVFEGLC----  252 (606)
T ss_dssp             T-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEEC------------CCCTTSCCCCCC--------GGGGGGGG----
T ss_pred             h-ccccccccCCch---hHHHHhhhccccchhheec------------hhhccccccccC--------hhHhchhh----
Confidence            3 456666666664   2233333333222111110            000111111111        11111111    


Q ss_pred             eeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeecccccc
Q 045493          333 LYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF  412 (1048)
Q Consensus       333 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l  412 (1048)
                                       . .+|+.|++++|.+++..+..|+++++|++|++++|.++ .+|..+..+++|+         
T Consensus       253 -----------------~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~---------  304 (606)
T 3t6q_A          253 -----------------E-MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK---------  304 (606)
T ss_dssp             -----------------G-SEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCC---------
T ss_pred             -----------------c-CceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCC---------
Confidence                             0 13444444444444444444444444444444444444 2232333333333         


Q ss_pred             CCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccc-cCcccccCCCCCCCeeeCcCCcccCcc--c
Q 045493          413 TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT-GNISEVFGIYPDLELLDLSNNNFFGEI--S  489 (1048)
Q Consensus       413 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~L~~L~Ls~n~l~~~~--~  489 (1048)
                                     +|++++|.+.+..|..+..+++|++|++++|.+. .++...|..+++|++|++++|.+++..  +
T Consensus       305 ---------------~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  369 (606)
T 3t6q_A          305 ---------------KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN  369 (606)
T ss_dssp             ---------------EEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEEST
T ss_pred             ---------------EEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcc
Confidence                           3333333333333444455555555555555554 333444566666666666666666554  5


Q ss_pred             ccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCc-cccCCCccCEEeecCccccCCCcccccccc
Q 045493          490 SNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPK-QLGKLTSLTSLTLNGNQLSGDIPLELGLLA  568 (1048)
Q Consensus       490 ~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  568 (1048)
                      ..+..+++|++|++++|.+++..|..|..+++|++|++++|++++..+. .+..+++|++|++++|.+++..|..+..++
T Consensus       370 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  449 (606)
T 3t6q_A          370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP  449 (606)
T ss_dssp             TTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCT
T ss_pred             hhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCC
Confidence            5666777777777777777777777777777788888888877765543 377778888888888888777777778888


Q ss_pred             ccceeecccCccccc---ccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeE
Q 045493          569 ELGYLDLSANRLSKL---IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYM  645 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~---~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  645 (1048)
                      +|++|++++|++++.   .+..+..+++|++|++++|+++++.+..|..+++|++|||++|++++.+|..+..+++| +|
T Consensus       450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L  528 (606)
T 3t6q_A          450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL  528 (606)
T ss_dssp             TCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred             CCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence            888888888887762   23567888888888888888888888888889999999999999998889999999999 99


Q ss_pred             ECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          646 NLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       646 ~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      ++++|++++.+|..+..++.|++|++++|+|++.++.
T Consensus       529 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             ECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             ECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            9999999998899899999999999999999988774

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.4e-57  Score=555.96  Aligned_cols=518  Identities=21%  Similarity=0.218  Sum_probs=359.7

Q ss_pred             CEEEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCC
Q 045493            1 VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLS   80 (1048)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls   80 (1048)
                      ++.++|++++++. ++.-.+..+++|++|||++|+|++..|.+|+.+++|++|+|++|++++..|.+|+++++|++|+++
T Consensus        35 l~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           35 TECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             CCEEECTTCCCSE-ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             CcEEEccCCccCc-CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            4678999999854 444456788999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCC
Q 045493           81 VNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLES  160 (1048)
Q Consensus        81 ~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~  160 (1048)
                      +|+++++.|..|.++++|++|++++|++++..+..+..+++|+.|++++|++.+                          
T Consensus       114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--------------------------  167 (606)
T 3t6q_A          114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY--------------------------  167 (606)
T ss_dssp             TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE--------------------------
T ss_pred             ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc--------------------------
Confidence            999999888999999999999999999997554555557888888887776642                          


Q ss_pred             CcEEecCCCccccccCCCCCCCCCcc--eeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEec
Q 045493          161 PVSVSLHTNNFSGVIPRSLGGLKNLT--FVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL  238 (1048)
Q Consensus       161 L~~l~l~~n~~~~~~~~~~~~l~~L~--~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  238 (1048)
                                   ..|..|..+++|+  .|++++|.+++..|..|.. .+|++|++++|..   ++..+..+.+++...+
T Consensus       168 -------------~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l  230 (606)
T 3t6q_A          168 -------------LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSL  230 (606)
T ss_dssp             -------------ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEE
T ss_pred             -------------cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhhe
Confidence                         3344566667777  6777788777666655543 5677777777652   2333333333333333


Q ss_pred             cCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeec
Q 045493          239 HDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG  318 (1048)
Q Consensus       239 ~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  318 (1048)
                      .-+.+.           .+...+        ..+..|.++                      .. .+|+.|++++|.+++
T Consensus       231 ~~~~~~-----------~~~~~~--------i~~~~~~~l----------------------~~-~~L~~L~l~~n~l~~  268 (606)
T 3t6q_A          231 WLGTFE-----------DMDDED--------ISPAVFEGL----------------------CE-MSVESINLQKHYFFN  268 (606)
T ss_dssp             ECCCCT-----------TSCCCC--------CCGGGGGGG----------------------GG-SEEEEEECTTCCCSS
T ss_pred             echhhc-----------cccccc--------cChhHhchh----------------------hc-CceeEEEeecCccCc
Confidence            222111           000001        111111111                      11 156777777777776


Q ss_pred             ccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhh-hh
Q 045493          319 FIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE-IE  397 (1048)
Q Consensus       319 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~-~~  397 (1048)
                      ..+..|+.+++|+.|++++|.++ .+|..+..+++|++|++++|++++..|..+.++++|+.|++++|.+.+.+|.. +.
T Consensus       269 ~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  347 (606)
T 3t6q_A          269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE  347 (606)
T ss_dssp             CCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTT
T ss_pred             cCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhh
Confidence            66666777777777777777766 56666777777777777777777666666777777777777777666443322 44


Q ss_pred             hhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCC--CCCcccccccceeEecCCccccCcccccCCCCCCC
Q 045493          398 NMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPI--PRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE  475 (1048)
Q Consensus       398 ~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~  475 (1048)
                      .+++|+.|++++|+++                        +..  +..+..+++|++|++++|.++++.+..|..+++|+
T Consensus       348 ~l~~L~~L~l~~n~l~------------------------~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  403 (606)
T 3t6q_A          348 NLENLRELDLSHDDIE------------------------TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE  403 (606)
T ss_dssp             TCTTCCEEECCSSCCC------------------------EEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCS
T ss_pred             ccCcCCEEECCCCccc------------------------cccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCC
Confidence            4444444444444443                        332  44566666666666666666666666666666677


Q ss_pred             eeeCcCCcccCcccc-cccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCC---cCccccCCCccCEEee
Q 045493          476 LLDLSNNNFFGEISS-NWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQ---IPKQLGKLTSLTSLTL  551 (1048)
Q Consensus       476 ~L~Ls~n~l~~~~~~-~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~L  551 (1048)
                      .|++++|++.+..+. .+..+++|++|++++|.+++..|..++.+++|++|++++|++++.   .+..+..+++|++|+|
T Consensus       404 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~L  483 (606)
T 3t6q_A          404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL  483 (606)
T ss_dssp             EEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEEC
T ss_pred             eEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEEC
Confidence            777777766655433 366677777777777777766666777777777777777777642   2345677777777777


Q ss_pred             cCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccC
Q 045493          552 NGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       552 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                      ++|++++..|..|..+++|++|+|++|++++..|..|..+++| .|++++|++++..+..+..+++|+.|++++|.+.+
T Consensus       484 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  561 (606)
T 3t6q_A          484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC  561 (606)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred             CCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence            7777776667777777777777777777777777777777777 78888888877777777777888888888888764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-56  Score=564.97  Aligned_cols=535  Identities=22%  Similarity=0.240  Sum_probs=334.4

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccc-cCCCcCCCCCCCCcEEeCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFS-GIIPPQIGILTNLVVLRLSV   81 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~ls~   81 (1048)
                      .+++++.+    ++++|. .++++++|||++|.|++..|.+|+.+++|++|+|++|.+. .+.|.+|+.+++|++|+|++
T Consensus         8 ~~dcs~~~----L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            8 IAFYRFCN----LTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEESCCC----SSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             EEEccCCC----CCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            34555544    456666 7788888888888888888888888888888888888444 34477888888888888888


Q ss_pred             CcCCCCCccccccccccccccccceecccccCcC--cCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCC
Q 045493           82 NQLNGLIPEELGELTSLNELALSYNRLNGSIPAS--LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLE  159 (1048)
Q Consensus        82 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~--~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~  159 (1048)
                      |+++++.|++|.++++|++|+|++|++++..|..  |+++++|++|+|++|.+.+..                       
T Consensus        83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~-----------------------  139 (844)
T 3j0a_A           83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY-----------------------  139 (844)
T ss_dssp             CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCC-----------------------
T ss_pred             CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccc-----------------------
Confidence            8888887888888888888888888887655543  778888888888887765321                       


Q ss_pred             CCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccc--cccceeccccccccccCCccCcCCCC-----
Q 045493          160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNL--RSLSYLGLNKNQLSGSIPPTAGNLSN-----  232 (1048)
Q Consensus       160 ~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~-----  232 (1048)
                                     ++..|..+++|++|+|++|.+++..|..+..+  ++|++|+|++|.+.+..|..++.+.+     
T Consensus       140 ---------------~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~  204 (844)
T 3j0a_A          140 ---------------LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM  204 (844)
T ss_dssp             ---------------CCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTC
T ss_pred             ---------------cchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccC
Confidence                           12346666777777777777776666666666  66777777777776655555444433     


Q ss_pred             -CCeEeccCCccCCCCCcccccc---cccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcE
Q 045493          233 -LKFLYLHDNRLSGYIPPKLGSF---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSH  308 (1048)
Q Consensus       233 -L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~  308 (1048)
                       |++|++++|.+++..+..+...   .+++.|.++++.+.                                        
T Consensus       205 ~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~----------------------------------------  244 (844)
T 3j0a_A          205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG----------------------------------------  244 (844)
T ss_dssp             CBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCB----------------------------------------
T ss_pred             ceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccc----------------------------------------
Confidence             5555555555444444333221   23333333322211                                        


Q ss_pred             EEccCceeecccccccccccccceeeeccccccCCCCcchhcc--CCCCeEeccCCccccCcChhhhccCCCcEEEeecc
Q 045493          309 LWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRL--KSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALREN  386 (1048)
Q Consensus       309 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n  386 (1048)
                               ..               ...+.+.+.....|..+  ++|++|++++|.+.+..|..|.++++|+.|+|++|
T Consensus       245 ---------~~---------------~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  300 (844)
T 3j0a_A          245 ---------AG---------------FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN  300 (844)
T ss_dssp             ---------CS---------------SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESC
T ss_pred             ---------cc---------------ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCC
Confidence                     00               00111111111122222  45555555555555555555555555555555555


Q ss_pred             cccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCccc
Q 045493          387 ELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISE  466 (1048)
Q Consensus       387 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~  466 (1048)
                      ++++..|..|..+++|+.|++++|++++..|..+..+++|+.|++++|.+.+..+..|..+++|++|++++|.++++.  
T Consensus       301 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~--  378 (844)
T 3j0a_A          301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH--  378 (844)
T ss_dssp             CCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS--
T ss_pred             cCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc--
Confidence            555444444444443333333333333333333333333333344444343334444445555555555555544322  


Q ss_pred             ccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcC-ccccCCCc
Q 045493          467 VFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIP-KQLGKLTS  545 (1048)
Q Consensus       467 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~  545 (1048)
                                                 .+++|+.|++++|.++ .+|..   ..+++.|++++|++++... ..+..+++
T Consensus       379 ---------------------------~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~  427 (844)
T 3j0a_A          379 ---------------------------FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPH  427 (844)
T ss_dssp             ---------------------------SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTT
T ss_pred             ---------------------------CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCc
Confidence                                       1445555555555555 22322   3456666666666664321 22345666


Q ss_pred             cCEEeecCccccCCCcc-ccccccccceeecccCccc-----ccccccccccccccccccccccccchhhhhhccccccC
Q 045493          546 LTSLTLNGNQLSGDIPL-ELGLLAELGYLDLSANRLS-----KLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS  619 (1048)
Q Consensus       546 L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  619 (1048)
                      |++|+|++|++++..+. .+..+++|++|+|++|.++     +..+..|..+++|+.|+|++|+|+++.+..|..+++|+
T Consensus       428 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  507 (844)
T 3j0a_A          428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR  507 (844)
T ss_dssp             CCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCS
T ss_pred             cceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhh
Confidence            77777777776643322 3455667777777777776     33456688889999999999999988888899999999


Q ss_pred             eEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          620 KLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       620 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      +|+|++|+|++..+..+.  ++|+.|+|++|+|++.+|..|   +.|+.+++++|++.+.++.
T Consensus       508 ~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          508 GLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             EEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred             eeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence            999999999987777776  899999999999999999876   4788999999999998875

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.5e-56  Score=543.47  Aligned_cols=530  Identities=21%  Similarity=0.194  Sum_probs=299.9

Q ss_pred             ecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccc
Q 045493           15 LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGE   94 (1048)
Q Consensus        15 ~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~   94 (1048)
                      ++++|...++++++|||++|++++..+..|+.+++|++|+|++|+++++.|.+|+++++|++|+|++|+++++.|++|.+
T Consensus        23 l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~  102 (606)
T 3vq2_A           23 LSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG  102 (606)
T ss_dssp             CSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTT
T ss_pred             cccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCC
Confidence            35566666677777777777777666667777777777777777777666667777777777777777777666777777


Q ss_pred             ccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccc
Q 045493           95 LTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV  174 (1048)
Q Consensus        95 l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~  174 (1048)
                      +++|++|++++|++++..+..|+++++|++|++++|.+.+.                                      .
T Consensus       103 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--------------------------------------~  144 (606)
T 3vq2_A          103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC--------------------------------------K  144 (606)
T ss_dssp             CTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCC--------------------------------------C
T ss_pred             cccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccce--------------------------------------e
Confidence            77777777777777665556666666677666666665421                                      1


Q ss_pred             cCCCCCCCCCcceeeccccCccccCCcccccccccc----eeccccccccccCCccCcCCCCCCeEeccCCccC-CCCCc
Q 045493          175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLS----YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLS-GYIPP  249 (1048)
Q Consensus       175 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~  249 (1048)
                      +|..|..+++|++|++++|++++..|..|+.+++|+    +|++++|++.+..+..+... +|++|++++|.++ +..|.
T Consensus       145 lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~  223 (606)
T 3vq2_A          145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKT  223 (606)
T ss_dssp             CCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHH
T ss_pred             chHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHH
Confidence            234455555555555555555555555555555443    45555555553333333222 4555555555443 22334


Q ss_pred             ccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCC--CCcEEEc-cCceeeccccccccc
Q 045493          250 KLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLK--SLSHLWL-SKTQLSGFIPPSLGN  326 (1048)
Q Consensus       250 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~--~L~~L~L-~~n~l~~~~~~~~~~  326 (1048)
                      .+.++++|+.+++..+.+...                   ..+....+..+..+.  .++.+++ ..|.++         
T Consensus       224 ~~~~l~~L~~l~l~~~~~~~~-------------------~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~---------  275 (606)
T 3vq2_A          224 CLQNLAGLHVHRLILGEFKDE-------------------RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS---------  275 (606)
T ss_dssp             HHHTTTTCEEEEEEEECCTTS-------------------CCCSCCCGGGGTTGGGSEEEEEEECCCTTCC---------
T ss_pred             HhccccccccccccccccccC-------------------CcccccChHHhhhhhhccHhheecccccccc---------
Confidence            444555555554443332210                   000000001111111  2333333 333333         


Q ss_pred             ccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceee
Q 045493          327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYL  406 (1048)
Q Consensus       327 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~  406 (1048)
                                     +..|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|.+. .+| .+ .++      
T Consensus       276 ---------------~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~------  328 (606)
T 3vq2_A          276 ---------------DDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLK-QFP-TL-DLP------  328 (606)
T ss_dssp             ---------------GGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCCS-SCC-CC-CCS------
T ss_pred             ---------------ccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccCc-ccc-cC-CCC------
Confidence                           33333 445555555555555554 233 4445555555555555542 222 11 222      


Q ss_pred             ccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccC
Q 045493          407 LFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFG  486 (1048)
Q Consensus       407 l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~  486 (1048)
                                        +|++|++++|...+..  .+..+++|++|++++|++++..                      
T Consensus       329 ------------------~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~----------------------  366 (606)
T 3vq2_A          329 ------------------FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSG----------------------  366 (606)
T ss_dssp             ------------------SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEE----------------------
T ss_pred             ------------------ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCc----------------------
Confidence                              2222222222111111  2333444444444444444331                      


Q ss_pred             cccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcC-ccccCCCccCEEeecCccccCCCccccc
Q 045493          487 EISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIP-KQLGKLTSLTSLTLNGNQLSGDIPLELG  565 (1048)
Q Consensus       487 ~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~  565 (1048)
                      ..+..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..+ ..|..+++|++|++++|.+++..|..+.
T Consensus       367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  445 (606)
T 3vq2_A          367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL  445 (606)
T ss_dssp             ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence            013334444445555555555442 33455556666666666666655544 4556666666666666666655666666


Q ss_pred             cccccceeecccCcccc-cccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCe
Q 045493          566 LLAELGYLDLSANRLSK-LIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEY  644 (1048)
Q Consensus       566 ~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  644 (1048)
                      .+++|++|++++|++++ ..|..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++.+|..+..+++|++
T Consensus       446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  525 (606)
T 3vq2_A          446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST  525 (606)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred             CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence            66666666666666665 35666677777777777777777766777777788888888888888777888888888888


Q ss_pred             EECCCCcccCCccccccccC-CccEEEeccceecCCCCC
Q 045493          645 MNLLQNKLSGPIPSCFRRMH-GLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       645 L~L~~N~l~~~~~~~~~~l~-~L~~l~ls~N~l~~~~p~  682 (1048)
                      |+|++|+|+ .+|..+..++ +|++|++++|+|.+.++.
T Consensus       526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            888888887 5555577886 588888888888887765

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.4e-55  Score=534.80  Aligned_cols=510  Identities=21%  Similarity=0.221  Sum_probs=366.9

Q ss_pred             CCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEecc
Q 045493          160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLH  239 (1048)
Q Consensus       160 ~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  239 (1048)
                      ++++|++++|.+++..+..|.++++|++|+|++|.++++.|.+|.++++|++|+|++|++.+..|..|+++++|++|+|+
T Consensus        33 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~  112 (606)
T 3vq2_A           33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV  112 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECT
T ss_pred             CcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEcc
Confidence            44444455555555555555566666666666666655555556666666666666666655555556666666666666


Q ss_pred             CCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecc
Q 045493          240 DNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGF  319 (1048)
Q Consensus       240 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  319 (1048)
                      +|.+++..+..|+.+++|++|++++|.+.+.                        .+|..++++++|++|++++|++++.
T Consensus       113 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------------------~lp~~~~~l~~L~~L~Ls~n~l~~~  168 (606)
T 3vq2_A          113 ETKLASLESFPIGQLITLKKLNVAHNFIHSC------------------------KLPAYFSNLTNLVHVDLSYNYIQTI  168 (606)
T ss_dssp             TSCCCCSSSSCCTTCTTCCEEECCSSCCCCC------------------------CCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred             CCccccccccccCCCCCCCEEeCCCCcccce------------------------echHhHhhcCCCCEEEccCCcceec
Confidence            6666544445555666666666666555421                        2233444445555555555555555


Q ss_pred             cccccccccccc----eeeeccccccCCCCcchhccCCCCeEeccCCccc-cCcChhhhccCCCcEEEeecccccC----
Q 045493          320 IPPSLGNLSNIR----GLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN-GSIPHCLGNLSNLKFFALRENELSG----  390 (1048)
Q Consensus       320 ~~~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L~~n~l~~----  390 (1048)
                      .+..|+.+++|+    .|++++|.+.+..+..+... +|++|++++|.++ +..|..+.+++.|+.+++..+.+.+    
T Consensus       169 ~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l  247 (606)
T 3vq2_A          169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL  247 (606)
T ss_dssp             CTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred             ChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc
Confidence            455555544443    45555555554333333332 5666666666554 2345556666666666555443321    


Q ss_pred             --Cchhhhhhhc--ccceeec-cccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcc
Q 045493          391 --SIPQEIENMK--KLNKYLL-FENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS  465 (1048)
Q Consensus       391 --~~p~~~~~l~--~L~~l~l-~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~  465 (1048)
                        ..+..+..+.  .++.+.+ ..|.+.+..|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|.+..++ 
T Consensus       248 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~~lp-  323 (606)
T 3vq2_A          248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLKQFP-  323 (606)
T ss_dssp             SCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCSSCC-
T ss_pred             cccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCcccc-
Confidence              1122222222  3555666 66777777776 7788889999999988875 44 7888999999999999996655 


Q ss_pred             cccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcc--cCccccccCCCcEEEcccCcccCCcCccccCC
Q 045493          466 EVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGT--IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKL  543 (1048)
Q Consensus       466 ~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  543 (1048)
                       .+ .+++|+.|++++|+..+..  .+..+++|++|++++|.+++.  .+..+..+++|++|++++|.+++ .|..|..+
T Consensus       324 -~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l  398 (606)
T 3vq2_A          324 -TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL  398 (606)
T ss_dssp             -CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTC
T ss_pred             -cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCC
Confidence             34 8899999999999655433  677899999999999999866  37889999999999999999985 66889999


Q ss_pred             CccCEEeecCccccCCCc-cccccccccceeecccCcccccccccccccccccccccccccccc-hhhhhhccccccCeE
Q 045493          544 TSLTSLTLNGNQLSGDIP-LELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ-EISIQIGKLVQLSKL  621 (1048)
Q Consensus       544 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L  621 (1048)
                      ++|++|++++|++++..| ..+..+++|++|++++|++++..|..+..+++|++|++++|++++ ..+..++.+++|++|
T Consensus       399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  478 (606)
T 3vq2_A          399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL  478 (606)
T ss_dssp             TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence            999999999999998877 689999999999999999999999999999999999999999988 467889999999999


Q ss_pred             ECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc-cccc-ccccccccCCcc
Q 045493          622 DLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS-KAFQ-NATIEAFQGNKE  699 (1048)
Q Consensus       622 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~-~~~~-~~~~~~~~~n~~  699 (1048)
                      +|++|++++..|..+..+++|++|+|++|++++.+|..|..+++|++|++++|++++ +|.. ..++ ....-.+.+|+.
T Consensus       479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~  557 (606)
T 3vq2_A          479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSV  557 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCC
T ss_pred             ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCc
Confidence            999999999999999999999999999999999999999999999999999999984 5543 2333 244456889999


Q ss_pred             ccCCC
Q 045493          700 LCGDV  704 (1048)
Q Consensus       700 lc~~~  704 (1048)
                      .|...
T Consensus       558 ~c~c~  562 (606)
T 3vq2_A          558 ACICE  562 (606)
T ss_dssp             CCSST
T ss_pred             ccCCc
Confidence            98754

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=527.95  Aligned_cols=514  Identities=22%  Similarity=0.191  Sum_probs=402.9

Q ss_pred             CCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccc-cCCcccccccccceeccccccccccCCccCc
Q 045493          150 SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG-SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAG  228 (1048)
Q Consensus       150 ~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~  228 (1048)
                      .+|.   -+++++.|+|+.|.++++.|..|.++++|++|+|++|...+ +.|.+|.++++|++|+|++|++.+..|..|.
T Consensus        18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~   94 (844)
T 3j0a_A           18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ   94 (844)
T ss_dssp             CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred             CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence            4555   34677778888888887777788888888888888774433 3467777888888888888887777777777


Q ss_pred             CCCCCCeEeccCCccCCCCCcc--cccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCC
Q 045493          229 NLSNLKFLYLHDNRLSGYIPPK--LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSL  306 (1048)
Q Consensus       229 ~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L  306 (1048)
                      ++++|++|+|++|.+++..|..  |+++++|++|+|++|.+.+..+                        +..|+++++|
T Consensus        95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~------------------------~~~~~~L~~L  150 (844)
T 3j0a_A           95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL------------------------HPSFGKLNSL  150 (844)
T ss_dssp             SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC------------------------CGGGGTCSSC
T ss_pred             CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc------------------------chhHhhCCCC
Confidence            8888888888888777655544  7777788888888777764332                        2344555556


Q ss_pred             cEEEccCceeecccccccccc--cccceeeeccccccCCCCcchhccCC------CCeEeccCCccccCcChhhhcc---
Q 045493          307 SHLWLSKTQLSGFIPPSLGNL--SNIRGLYIRENMLYGSIPEELGRLKS------LSQLSLSVNKLNGSIPHCLGNL---  375 (1048)
Q Consensus       307 ~~L~L~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~------L~~L~Ls~N~l~~~~~~~l~~l---  375 (1048)
                      ++|++++|.+++..+..++.+  ++|+.|++++|.+.+..|..+..+.+      |++|++++|.+++..+..+...   
T Consensus       151 ~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~  230 (844)
T 3j0a_A          151 KSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK  230 (844)
T ss_dssp             CEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCS
T ss_pred             CEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCc
Confidence            666666666655555555555  55666666666666555555444443      6677777776666666555442   


Q ss_pred             CCCcEEEee---------cccccCCchhhhhhh--cccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCc
Q 045493          376 SNLKFFALR---------ENELSGSIPQEIENM--KKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL  444 (1048)
Q Consensus       376 ~~L~~L~L~---------~n~l~~~~p~~~~~l--~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l  444 (1048)
                      ++++.+.++         .+.+.+..+..|..+  ++|+.|++++|.+.+..+..+..+++|+.|++++|.+++..|..|
T Consensus       231 ~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~  310 (844)
T 3j0a_A          231 SQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF  310 (844)
T ss_dssp             CCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTT
T ss_pred             ccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHh
Confidence            455666655         233444444555554  679999999999998888889999999999999999999999999


Q ss_pred             ccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcE
Q 045493          445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHK  524 (1048)
Q Consensus       445 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  524 (1048)
                      ..+++|++|+|++|.++++.+..|..+++|+.|++++|++....+..|..+++|++|++++|.+++.     ..+++|+.
T Consensus       311 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~  385 (844)
T 3j0a_A          311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPD  385 (844)
T ss_dssp             TTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSE
T ss_pred             cCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcch
Confidence            9999999999999999999999999999999999999999988888999999999999999999843     33889999


Q ss_pred             EEcccCcccCCcCccccCCCccCEEeecCccccCCC-ccccccccccceeecccCcccccccc-cccccccccccccccc
Q 045493          525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDI-PLELGLLAELGYLDLSANRLSKLIPK-NLGELRKLHHLNLSNN  602 (1048)
Q Consensus       525 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~Ls~N  602 (1048)
                      |++++|+++ .+|..   ..+++.|++++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|
T Consensus       386 L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N  461 (844)
T 3j0a_A          386 IFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN  461 (844)
T ss_dssp             EEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESC
T ss_pred             hccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCC
Confidence            999999998 44443   468999999999999542 33467899999999999999976553 4667899999999999


Q ss_pred             cccc-----hhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceec
Q 045493          603 QFSQ-----EISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ  677 (1048)
Q Consensus       603 ~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~  677 (1048)
                      .++.     ..+..|..+++|++|||++|+|++..+..|..+++|++|+|++|+|++.++..+.  ++|+.||+++|+++
T Consensus       462 ~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~  539 (844)
T 3j0a_A          462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLL  539 (844)
T ss_dssp             CCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCC
T ss_pred             ccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCC
Confidence            9974     3345688999999999999999999999999999999999999999998888776  89999999999999


Q ss_pred             CCCCCcccccccccccccCCccccCC
Q 045493          678 GSIPHSKAFQNATIEAFQGNKELCGD  703 (1048)
Q Consensus       678 ~~~p~~~~~~~~~~~~~~~n~~lc~~  703 (1048)
                      +.+|..  |.......+.||+..|.+
T Consensus       540 ~~~~~~--~~~L~~l~l~~Np~~C~c  563 (844)
T 3j0a_A          540 APNPDV--FVSLSVLDITHNKFICEC  563 (844)
T ss_dssp             CCCSCC--CSSCCEEEEEEECCCCSS
T ss_pred             CCChhH--hCCcCEEEecCCCccccc
Confidence            998864  666666778999999954

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=491.58  Aligned_cols=506  Identities=21%  Similarity=0.210  Sum_probs=298.8

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .+++++.    +++++|...++++++|||++|+|++..+.+|+.+++|++|+|++|+++++.|++|+.+++|++|+|++|
T Consensus        11 ~~~c~~~----~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n   86 (570)
T 2z63_A           11 TYQCMEL----NFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (570)
T ss_dssp             EEECCSS----CCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             EEEeCCC----CccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence            3555553    456777777889999999999999888889999999999999999999888888999999999999999


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV  162 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~  162 (1048)
                      +++++.|++|.++++|++|++++|+++...+..|+++++|++|++++|.+.+.              .            
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~--------------~------------  140 (570)
T 2z63_A           87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--------------K------------  140 (570)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCC--------------C------------
T ss_pred             cCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCcccee--------------c------------
Confidence            99988888899999999999999999876666788888888888888877531              1            


Q ss_pred             EEecCCCccccccCCCCCCCCCcceeeccccCccccCCccccccccc----ceeccccccccccCCccCcCCCCCCeEec
Q 045493          163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL----SYLGLNKNQLSGSIPPTAGNLSNLKFLYL  238 (1048)
Q Consensus       163 ~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L----~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  238 (1048)
                                  +|..|..+++|++|++++|++++..|..++.+++|    ++|++++|.+.+..|..+..+ +|+.|++
T Consensus       141 ------------lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l  207 (570)
T 2z63_A          141 ------------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL  207 (570)
T ss_dssp             ------------CCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEE
T ss_pred             ------------ChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEec
Confidence                        23344455555555555555554444555555555    455555555554444444333 4555555


Q ss_pred             cCCccCC-CCCcccccccccceeecccccccC------CCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEc
Q 045493          239 HDNRLSG-YIPPKLGSFKSLLYLYLSHNQLNG------SLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWL  311 (1048)
Q Consensus       239 ~~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L  311 (1048)
                      ++|.... ..+..+..+++++.+.+....+..      .....|.++.+                      + .++.+++
T Consensus       208 ~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~----------------------l-~l~~l~l  264 (570)
T 2z63_A          208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN----------------------L-TIEEFRL  264 (570)
T ss_dssp             ESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGG----------------------S-EEEEEEE
T ss_pred             ccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccc----------------------c-chhhhhh
Confidence            5543221 122333444444444433222110      11111111111                      1 1344444


Q ss_pred             cCc-eeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccC
Q 045493          312 SKT-QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSG  390 (1048)
Q Consensus       312 ~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~  390 (1048)
                      +++ .+.+..+..+..+++|+.|++++|.+. .+|..+..+ +|++|++++|.+. .+|.  ..+++|+.|++++|.+.+
T Consensus       265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~  339 (570)
T 2z63_A          265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGN  339 (570)
T ss_dssp             EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCC
T ss_pred             hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccc
Confidence            444 444444555555555555555555554 344444444 5555555555554 3332  244555555555555443


Q ss_pred             CchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCC--CCCcccccccceeEecCCccccCccccc
Q 045493          391 SIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPI--PRSLQNCTSLYSLRLERNQLTGNISEVF  468 (1048)
Q Consensus       391 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~--~~~l~~l~~L~~L~L~~n~l~~~~~~~~  468 (1048)
                      ..+.  .                        .+++|++|++++|.+++..  +..+..+++|++|++++|.++++++. |
T Consensus       340 ~~~~--~------------------------~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~  392 (570)
T 2z63_A          340 AFSE--V------------------------DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-F  392 (570)
T ss_dssp             BCCC--C------------------------BCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-E
T ss_pred             cccc--c------------------------cCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-c
Confidence            2222  2                        2334444444444443322  34445555555555555555554444 5


Q ss_pred             CCCCCCCeeeCcCCcccCccc-ccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCccc-CCcCccccCCCcc
Q 045493          469 GIYPDLELLDLSNNNFFGEIS-SNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLV-GQIPKQLGKLTSL  546 (1048)
Q Consensus       469 ~~~~~L~~L~Ls~n~l~~~~~-~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L  546 (1048)
                      ..+++|+.|++++|.+.+..+ ..+..+++|++|++++|.+++..|..|..+++|++|++++|+++ +.+|..+..+++|
T Consensus       393 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L  472 (570)
T 2z63_A          393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL  472 (570)
T ss_dssp             ETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             cccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC
Confidence            555556666666665555433 34555566666666666666555555666666666666666655 3455556666666


Q ss_pred             CEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccc
Q 045493          547 TSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       547 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  606 (1048)
                      ++|+|++|++++..|..+..+++|++|++++|+++++++..|..+++|+.|++++|+++.
T Consensus       473 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~  532 (570)
T 2z63_A          473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  532 (570)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence            666666666665555566666666666666666666655556666666666666666654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-50  Score=484.54  Aligned_cols=490  Identities=21%  Similarity=0.217  Sum_probs=356.2

Q ss_pred             CCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEecc
Q 045493          160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLH  239 (1048)
Q Consensus       160 ~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  239 (1048)
                      +++.|++++|.++++.+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|++.+..|..|+++++|++|+++
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  108 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence            45666666666666666677777777777777777776666777777777777777777776666677777777777777


Q ss_pred             CCccCCCCCcccccccccceeecccccccCC-CchhhhccchhhhhhhccccccCCCCCcccCCCCCC----cEEEccCc
Q 045493          240 DNRLSGYIPPKLGSFKSLLYLYLSHNQLNGS-LPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSL----SHLWLSKT  314 (1048)
Q Consensus       240 ~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L----~~L~L~~n  314 (1048)
                      +|.+++..+..|+.+++|++|++++|.+.+. +|..|+++++|++|++++ |.+.+..+..++.+++|    +.|++++|
T Consensus       109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~~~~~L~l~~n  187 (570)
T 2z63_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS-NKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (570)
T ss_dssp             TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTT-SCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcC-CccceecHHHccchhccchhhhhcccCCC
Confidence            7777755444677777777777777776542 344444444444444333 33333333333333333    45555555


Q ss_pred             eeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCcccc-CcChhhhccCCCcEEEeeccccc----
Q 045493          315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG-SIPHCLGNLSNLKFFALRENELS----  389 (1048)
Q Consensus       315 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~n~l~----  389 (1048)
                      .+++..+..|..+ +|+.|++++                        |.... ..+..+.++++++.+.+....+.    
T Consensus       188 ~l~~~~~~~~~~~-~L~~L~l~~------------------------n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~  242 (570)
T 2z63_A          188 PMNFIQPGAFKEI-RLHKLTLRN------------------------NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN  242 (570)
T ss_dssp             CCCEECTTTTTTC-EEEEEEEES------------------------CCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred             CceecCHHHhccC-cceeEeccc------------------------ccccccchhhhhcCccccceeeeccccccCchh
Confidence            5554444444433 444444444                        43221 12334444555544444322211    


Q ss_pred             --CCchhhhhhhc--ccceeecccc-ccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCc
Q 045493          390 --GSIPQEIENMK--KLNKYLLFEN-QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI  464 (1048)
Q Consensus       390 --~~~p~~~~~l~--~L~~l~l~~N-~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~  464 (1048)
                        ......+..+.  .++.+.+.++ .+.+..|..+..+++|++|++++|.+. .+|..+..+ +|++|++++|.+..++
T Consensus       243 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~  320 (570)
T 2z63_A          243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFP  320 (570)
T ss_dssp             CEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCC
T ss_pred             hhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccC
Confidence              11122233332  2456666666 667777777888888888888888887 467777777 8999999999888665


Q ss_pred             ccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCccc--CccccccCCCcEEEcccCcccCCcCccccC
Q 045493          465 SEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTI--PSEIGNMTQLHKLDFSSNRLVGQIPKQLGK  542 (1048)
Q Consensus       465 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  542 (1048)
                      .   ..+++|+.|++++|.+.+..+.  ..+++|++|++++|.+++..  +..+..+++|++|++++|++.+..+. +..
T Consensus       321 ~---~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~  394 (570)
T 2z63_A          321 T---LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLG  394 (570)
T ss_dssp             B---CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EET
T ss_pred             c---ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccc
Confidence            5   3567899999999988765554  67889999999999998654  67788999999999999999865444 899


Q ss_pred             CCccCEEeecCccccCCCc-cccccccccceeecccCccccccccccccccccccccccccccc-chhhhhhccccccCe
Q 045493          543 LTSLTSLTLNGNQLSGDIP-LELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS-QEISIQIGKLVQLSK  620 (1048)
Q Consensus       543 l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~  620 (1048)
                      +++|++|++++|.+++..+ ..+..+++|++|++++|++++..|..|..+++|++|++++|+++ +..+..+..+++|++
T Consensus       395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~  474 (570)
T 2z63_A          395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  474 (570)
T ss_dssp             CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence            9999999999999987665 57889999999999999999998999999999999999999997 456778899999999


Q ss_pred             EECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc
Q 045493          621 LDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       621 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      |+|++|++++..|..|..+++|++|++++|++++.++..|..+++|++|++++|+++|.+|..
T Consensus       475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            999999999888999999999999999999999999999999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-50  Score=439.81  Aligned_cols=249  Identities=20%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +.||+|+||+||+|++.      +++.||||+++............+|+..+++++|||||+++|+|.+.+..++|||||
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~  111 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC  111 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence            35899999999999863      457899999976544444445567778889999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          856 ERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                      ++|+|.++++....             ...++|.++.+|+.|||+||+|||+.   +||||||||+|||+++++.+||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECC
Confidence            99999999965321             24589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCC--CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhh
Q 045493          923 FGTAKFLKPDS--SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVV  999 (1048)
Q Consensus       923 fG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  999 (1048)
                      ||+|+......  ......+||++|||||++.++.|+.++|||||||++|||+| |+.||...+           .....
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-----------~~~~~  257 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----------NQDVV  257 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-----------HHHHH
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----------HHHHH
Confidence            99998765432  22345679999999999999999999999999999999999 899986432           12233


Q ss_pred             hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1000 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+..+..++..   ..+...+.+++.+||+.||++||||+||++.|+
T Consensus       258 ~~i~~~~~~~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~  302 (308)
T 4gt4_A          258 EMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR  302 (308)
T ss_dssp             HHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            333333333222   234456889999999999999999999999986

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.1e-49  Score=475.15  Aligned_cols=472  Identities=22%  Similarity=0.220  Sum_probs=300.9

Q ss_pred             CCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEec
Q 045493          159 ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL  238 (1048)
Q Consensus       159 ~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  238 (1048)
                      +++++|++++|.+++..|..|..+++|++|+|++|++++..|++|+.+++|++|+|++|++.+..|..++++++|++|+|
T Consensus        26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  105 (549)
T 2z81_A           26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL  105 (549)
T ss_dssp             TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred             CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence            44555555555555555555555555555555555555544555555555555555555555444434555555555555


Q ss_pred             cCCccCCC-CCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceee
Q 045493          239 HDNRLSGY-IPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS  317 (1048)
Q Consensus       239 ~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  317 (1048)
                      ++|.+++. .|..++++++|++|++++|.+                        +....+..+.++++|++|++++|.++
T Consensus       106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~------------------------~~~~~~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A          106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVET------------------------FSEIRRIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSS------------------------CCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             CCCcccccchhhhhhccCCccEEECCCCcc------------------------ccccCHhhhhcccccCeeeccCCccc
Confidence            55555431 234455555555555555542                        22222345666667777777777777


Q ss_pred             cccccccccccccceeeeccccccCCCCcc-hhccCCCCeEeccCCccccCc--C-hhhhccCCCcEEEeecccccCCch
Q 045493          318 GFIPPSLGNLSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVNKLNGSI--P-HCLGNLSNLKFFALRENELSGSIP  393 (1048)
Q Consensus       318 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~--~-~~l~~l~~L~~L~L~~n~l~~~~p  393 (1048)
                      +..|..++.+++|+.|++++|.+.. +|.. +..+++|++|++++|++++..  | .....+++|+.|++++|.+++..+
T Consensus       162 ~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  240 (549)
T 2z81_A          162 NYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF  240 (549)
T ss_dssp             EECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred             ccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence            6667777777777777777776653 3333 345677777777777776532  1 223346677777777777765444


Q ss_pred             hhh----hhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCc-----
Q 045493          394 QEI----ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-----  464 (1048)
Q Consensus       394 ~~~----~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-----  464 (1048)
                      ..+    ..++.|+.+++++|.+.+...-.                  ......+..+.+|+.|++.++.+....     
T Consensus       241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l  302 (549)
T 2z81_A          241 NELLKLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVETVTIRRLHIPQFYLFYDL  302 (549)
T ss_dssp             HHHHGGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCEEEEESCBCSCGGGSCCC
T ss_pred             HHHHHHhhhhcccccccccccccccccccc------------------ccchhhhhhhcccccccccccccchhhhcccc
Confidence            333    33445555555555554321100                  001122344455555555555544321     


Q ss_pred             ccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccC---ccccccCCCcEEEcccCcccCCcC--cc
Q 045493          465 SEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIP---SEIGNMTQLHKLDFSSNRLVGQIP--KQ  539 (1048)
Q Consensus       465 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~--~~  539 (1048)
                      ...+...++|+.|++++|+++......+..+++|++|++++|.+++..|   ..++.+++|++|+|++|++++..+  ..
T Consensus       303 ~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  382 (549)
T 2z81_A          303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI  382 (549)
T ss_dssp             CHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHH
T ss_pred             hhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhh
Confidence            1122334567777777777764333333567777888888887776553   346777888888888888875432  45


Q ss_pred             ccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccC
Q 045493          540 LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS  619 (1048)
Q Consensus       540 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  619 (1048)
                      +..+++|++|++++|+++ .+|..+..+++|++|++++|+|+.+.. .+  .++|++|+|++|+|++..    ..+++|+
T Consensus       383 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~-~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~  454 (549)
T 2z81_A          383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKT-CI--PQTLEVLDVSNNNLDSFS----LFLPRLQ  454 (549)
T ss_dssp             GGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCT-TS--CTTCSEEECCSSCCSCCC----CCCTTCC
T ss_pred             hhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccc-hh--cCCceEEECCCCChhhhc----ccCChhc
Confidence            777888888888888888 667778888888888888888876533 22  257888999999887743    5788999


Q ss_pred             eEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc
Q 045493          620 KLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       620 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      +|||++|+|+ .+|. ...+++|++|+|++|++++.+|..+..++.|++|++++|+|+|.+|..
T Consensus       455 ~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  516 (549)
T 2z81_A          455 ELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  516 (549)
T ss_dssp             EEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred             EEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence            9999999998 5665 467899999999999999999999999999999999999999998853

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.1e-48  Score=468.93  Aligned_cols=482  Identities=20%  Similarity=0.221  Sum_probs=257.4

Q ss_pred             eecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccc
Q 045493           14 TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELG   93 (1048)
Q Consensus        14 ~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~   93 (1048)
                      .++++|...++++++|||++|+|++..|..|+.+++|++|+|++|+++++.|++|+.+++|++|+|++|++++..|.+|.
T Consensus        16 ~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~   95 (549)
T 2z81_A           16 SFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG   95 (549)
T ss_dssp             CCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHT
T ss_pred             ccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhc
Confidence            56678877888999999999999988888899999999999999999988888899999999999999999988888889


Q ss_pred             cccccccccccceecccc-cCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccc
Q 045493           94 ELTSLNELALSYNRLNGS-IPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFS  172 (1048)
Q Consensus        94 ~l~~L~~L~l~~n~~~~~-~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~  172 (1048)
                      ++++|++|++++|++++. .|..|+++++|++|++++|++.+.+|              +..+.++++|++|++++|.++
T Consensus        96 ~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~--------------~~~~~~l~~L~~L~L~~n~l~  161 (549)
T 2z81_A           96 PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR--------------RIDFAGLTSLNELEIKALSLR  161 (549)
T ss_dssp             TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC--------------TTTTTTCCEEEEEEEEETTCC
T ss_pred             cCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC--------------HhhhhcccccCeeeccCCccc
Confidence            999999999999998863 56788889999999998887432222              123444455555555555555


Q ss_pred             cccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccC--C-ccCcCCCCCCeEeccCCccCCCCC-
Q 045493          173 GVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSI--P-PTAGNLSNLKFLYLHDNRLSGYIP-  248 (1048)
Q Consensus       173 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~p-  248 (1048)
                      +..|..+..+++|+.|++++|.+....+..+..+++|++|++++|++.+..  | .....+++|+.|++++|.+++..+ 
T Consensus       162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  241 (549)
T 2z81_A          162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN  241 (549)
T ss_dssp             EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred             ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence            555555555555555555555443211111233444555555554444321  1 111233444444444444432211 


Q ss_pred             ---cccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccc
Q 045493          249 ---PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLG  325 (1048)
Q Consensus       249 ---~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  325 (1048)
                         ..+..+++|+.+++++|.+.+...                   +.......+..+.+|+.|++.++.+....  .+ 
T Consensus       242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~-------------------~~~~~~~~~~~l~~L~~L~l~~~~i~~~~--~~-  299 (549)
T 2z81_A          242 ELLKLLRYILELSEVEFDDCTLNGLGD-------------------FNPSESDVVSELGKVETVTIRRLHIPQFY--LF-  299 (549)
T ss_dssp             HHHGGGGGCTTCCEEEEESCEEECCSC-------------------CCCCTTTCCCCCTTCCEEEEESCBCSCGG--GS-
T ss_pred             HHHHHhhhhcccccccccccccccccc-------------------ccccchhhhhhhcccccccccccccchhh--hc-
Confidence               112233344444444444332100                   00001112233444445554444433110  00 


Q ss_pred             cccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhh-hccCCCcEEEeecccccCCchhh---hhhhcc
Q 045493          326 NLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCL-GNLSNLKFFALRENELSGSIPQE---IENMKK  401 (1048)
Q Consensus       326 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~p~~---~~~l~~  401 (1048)
                                      ...+..+....+|++|++++|.+. .+|..+ .++++|++|++++|++++.+|..   +..+++
T Consensus       300 ----------------~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~  362 (549)
T 2z81_A          300 ----------------YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS  362 (549)
T ss_dssp             ----------------CCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTT
T ss_pred             ----------------ccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhcccc
Confidence                            011112223344555555555544 333332 34555555555555554433221   333334


Q ss_pred             cceeeccccccCCCCC--cccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeC
Q 045493          402 LNKYLLFENQFTGYLP--QNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDL  479 (1048)
Q Consensus       402 L~~l~l~~N~l~~~~~--~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L  479 (1048)
                      |+.|++++|++++..+  ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++.++...            
T Consensus       363 L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~------------  429 (549)
T 2z81_A          363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI------------  429 (549)
T ss_dssp             CCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTS------------
T ss_pred             CcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchh------------
Confidence            4444444443332211  11233333334444444333 23334444444444444444444332211            


Q ss_pred             cCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCC
Q 045493          480 SNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGD  559 (1048)
Q Consensus       480 s~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  559 (1048)
                                     .++|++|++++|++++.    ...+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.
T Consensus       430 ---------------~~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~  488 (549)
T 2z81_A          430 ---------------PQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSV  488 (549)
T ss_dssp             ---------------CTTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCC
T ss_pred             ---------------cCCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCc
Confidence                           13455555555555532    134556666666666665 3333 34556666666666666655


Q ss_pred             CccccccccccceeecccCcccc
Q 045493          560 IPLELGLLAELGYLDLSANRLSK  582 (1048)
Q Consensus       560 ~~~~~~~l~~L~~L~Ls~N~l~~  582 (1048)
                      .|..+..+++|++|++++|.+..
T Consensus       489 ~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          489 PDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             CTTGGGGCTTCCEEECCSSCBCC
T ss_pred             CHHHHhcCcccCEEEecCCCccC
Confidence            55556666666666666666654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7e-50  Score=434.37  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +.||+|+||+||+|++.      ++..||||+++.... .......+|++.+++++|||||+++|+|.+.+..|+|||||
T Consensus        19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~   97 (299)
T 4asz_A           19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   97 (299)
T ss_dssp             EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence            45899999999999874      367799999875432 22234456777788999999999999999999999999999


Q ss_pred             CCCCHHHHHhccc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          856 ERGSLATILSNEA----------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       856 ~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      ++|+|.++++..+          ....++|.++..|+.|||+||+|||++   +||||||||+|||+++++.+||+|||+
T Consensus        98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGl  174 (299)
T 4asz_A           98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM  174 (299)
T ss_dssp             TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred             CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCccc
Confidence            9999999997543          234689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhh
Q 045493          926 AKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       926 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      |+........  .....||++|||||++.+..|+.++|||||||++|||+| |+.||...+           ..+....+
T Consensus       175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-----------~~~~~~~i  243 (299)
T 4asz_A          175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----------NNEVIECI  243 (299)
T ss_dssp             HHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----------HHHHHHHH
T ss_pred             ceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----------HHHHHHHH
Confidence            9876543322  223568999999999999999999999999999999999 899986432           12233334


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+..++.+   ..+..++.+++.+||+.||++||||+|++++|+
T Consensus       244 ~~~~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          244 TQGRVLQRP---RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             HHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            343333222   223456889999999999999999999999886

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.7e-48  Score=475.20  Aligned_cols=533  Identities=21%  Similarity=0.201  Sum_probs=330.8

Q ss_pred             eecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccc
Q 045493           14 TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELG   93 (1048)
Q Consensus        14 ~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~   93 (1048)
                      ++++||..+++++++|||++|+|+++.+.+|+++++|++|||++|+|+++.|++|+++++|++|+|++|+|+++.+.+|.
T Consensus        42 ~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~  121 (635)
T 4g8a_A           42 NFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS  121 (635)
T ss_dssp             CCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGT
T ss_pred             CcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhc
Confidence            45788888888999999999999988888999999999999999999988888899999999999999999988888889


Q ss_pred             cccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCcccc
Q 045493           94 ELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSG  173 (1048)
Q Consensus        94 ~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~  173 (1048)
                      ++++|++|++++|+++++.+..|++|++|++|++++|.+.+.                                      
T Consensus       122 ~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~--------------------------------------  163 (635)
T 4g8a_A          122 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--------------------------------------  163 (635)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--------------------------------------
T ss_pred             CCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC--------------------------------------
Confidence            999999999999999877777888888888888888877531                                      


Q ss_pred             ccCCCCCCCCCcceeeccccCccccCCcccccccccc----eeccccccccccCCccCcCCCCCCeEeccCCccCCC-CC
Q 045493          174 VIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLS----YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGY-IP  248 (1048)
Q Consensus       174 ~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p  248 (1048)
                      ..|..+..+++|++|+|++|+++++.|..|..+.+++    .++++.|.+....+..+ ....++.+++.+|..... .+
T Consensus       164 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~  242 (635)
T 4g8a_A          164 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMK  242 (635)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHH
T ss_pred             CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccc
Confidence            1234556666777777777777666666666555443    34455555543222222 222344444444433211 11


Q ss_pred             cccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccccccccccc
Q 045493          249 PKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS  328 (1048)
Q Consensus       249 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  328 (1048)
                      ..+.++..++...+..+....                   ...+.......+..+..+...++..+.....         
T Consensus       243 ~~~~~l~~l~~~~l~~~~~~~-------------------~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~---------  294 (635)
T 4g8a_A          243 TCIQGLAGLEVHRLVLGEFRN-------------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYY---------  294 (635)
T ss_dssp             HHHHTTTTCEEEEEEEECCTT-------------------SCCCSCCCTTTTGGGGGSEEEEEEEECCCSC---------
T ss_pred             hhhcCCccccccccccccccc-------------------ccccccccccccccccchhhhhhhhhhhccc---------
Confidence            223333333333332221110                   0111111112222222333333322211100         


Q ss_pred             ccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeecc
Q 045493          329 NIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLF  408 (1048)
Q Consensus       329 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~  408 (1048)
                                  ....+..+..+.+++.+++.+|.+....  .+.....|+.|++.+|.+....+               
T Consensus       295 ------------~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---------------  345 (635)
T 4g8a_A          295 ------------LDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---------------  345 (635)
T ss_dssp             ------------EEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC---------------
T ss_pred             ------------ccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc---------------
Confidence                        0011223334445555555555544221  23333444444444444432111               


Q ss_pred             ccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCc-
Q 045493          409 ENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGE-  487 (1048)
Q Consensus       409 ~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~-  487 (1048)
                                  ..+..++.+++.+|.+...  .....                        +++|+.|++++|.+... 
T Consensus       346 ------------~~l~~L~~l~l~~n~~~~~--~~~~~------------------------l~~L~~L~ls~n~l~~~~  387 (635)
T 4g8a_A          346 ------------LKLKSLKRLTFTSNKGGNA--FSEVD------------------------LPSLEFLDLSRNGLSFKG  387 (635)
T ss_dssp             ------------CBCTTCCEEEEESCCSCCB--CCCCB------------------------CTTCCEEECCSSCCBEEE
T ss_pred             ------------ccchhhhhcccccccCCCC--ccccc------------------------ccccccchhhcccccccc
Confidence                        1122333333433333211  11223                        44455555555554322 


Q ss_pred             -ccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCc-CccccCCCccCEEeecCccccCCCccccc
Q 045493          488 -ISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQI-PKQLGKLTSLTSLTLNGNQLSGDIPLELG  565 (1048)
Q Consensus       488 -~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  565 (1048)
                       .+..+..+.+|+.++++.|.+. ..+..+..+++|+.++++.|+..... ...|..+++++.+++++|.+++..+..+.
T Consensus       388 ~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~  466 (635)
T 4g8a_A          388 CCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  466 (635)
T ss_dssp             ECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             ccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence             2333445556666666666665 33445666777777777766655433 34566677777777777777766677777


Q ss_pred             cccccceeecccCcc-cccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCe
Q 045493          566 LLAELGYLDLSANRL-SKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEY  644 (1048)
Q Consensus       566 ~l~~L~~L~Ls~N~l-~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  644 (1048)
                      .++.|++|+|++|++ ....|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++
T Consensus       467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  546 (635)
T 4g8a_A          467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  546 (635)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred             cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence            777777777777763 3456677777788888888888888777778888888888888888888777888888888888


Q ss_pred             EECCCCcccCCcccccccc-CCccEEEeccceecCCCC
Q 045493          645 MNLLQNKLSGPIPSCFRRM-HGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       645 L~L~~N~l~~~~~~~~~~l-~~L~~l~ls~N~l~~~~p  681 (1048)
                      |+|++|+|++.+|..+..+ ++|++|++++|+|++.+.
T Consensus       547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            8888888888888888887 578888888888888765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-49  Score=433.34  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=206.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +...+.||+|+||+||+|+++ +++.||||++....... .....+|+..++.++|||||+++++|.+.+..|+|||||+
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            445567999999999999886 68999999997543332 3345678888999999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      ||+|.+++++    ..+++.++..++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.+.......
T Consensus       155 gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  227 (346)
T 4fih_A          155 GGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  227 (346)
T ss_dssp             TEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             CCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence            9999999964    2489999999999999999999999   99999999999999999999999999999887666666


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.           ......+.. ..++....+..
T Consensus       228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~-~~~~~~~~~~~  295 (346)
T 4fih_A          228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAMKMIRD-NLPPRLKNLHK  295 (346)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHH-SSCCCCSCGGG
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHc-CCCCCCCcccc
Confidence            778999999999999999999999999999999999999999863221           111222222 12222222234


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++.+++.+||++||++|||++|+++
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            4567889999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=429.00  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=190.4

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||+||+|++.  ..||||+++...... ......+|+..+++++|||||+++|++.+ +..|+|||||++|+
T Consensus        41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            345899999999999875  358999986543322 22334567777889999999999999865 55899999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--CCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  937 (1048)
                      |.++++..  ...++|.++..|+.|||+||+|||+.   +||||||||+|||+++++.+||+|||+|+......  ....
T Consensus       118 L~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~  192 (307)
T 3omv_A          118 LYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE  192 (307)
T ss_dssp             HHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred             HHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence            99999653  24589999999999999999999999   99999999999999999999999999998765332  2345


Q ss_pred             cccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC-Cchh
Q 045493          938 ELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP-PLGE 1013 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1013 (1048)
                      ..+||+.|||||++.+   ++|+.++|||||||++|||+||+.||...+.          .......+......+ ....
T Consensus       193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----------~~~~~~~~~~~~~~p~~~~~  262 (307)
T 3omv_A          193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----------RDQIIFMVGRGYASPDLSKL  262 (307)
T ss_dssp             -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHHHHHHHTTCCCCCSTTS
T ss_pred             ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----------HHHHHHHHhcCCCCCCcccc
Confidence            6789999999999864   4689999999999999999999999864321          011111111111111 1111


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+...+.+++.+||+.||++||||+||++.|+
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            2234456889999999999999999999998875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.1e-49  Score=433.77  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=194.2

Q ss_pred             eeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      +.||+|+||+||+|++.      +++.||||+++.... .......+|++.+++++|||||+++|+|.+.+..|+|||||
T Consensus        47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~  125 (329)
T 4aoj_A           47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM  125 (329)
T ss_dssp             EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            35899999999999875      467899999975332 22234556777788999999999999999999999999999


Q ss_pred             CCCCHHHHHhcccc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          856 ERGSLATILSNEAT------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                      ++|+|.++++....            ...++|.+++.|+.|||+||+|||+.   +||||||||+|||+++++.+||+||
T Consensus       126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DF  202 (329)
T 4aoj_A          126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDF  202 (329)
T ss_dssp             TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEccc
Confidence            99999999975432            24589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhh
Q 045493          924 GTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       924 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      |+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||...+.           .....
T Consensus       203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----------~~~~~  271 (329)
T 4aoj_A          203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----------TEAID  271 (329)
T ss_dssp             C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----------HHHHH
T ss_pred             ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----------HHHHH
Confidence            99987654332  2245679999999999999999999999999999999999 8999864321           12223


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+..+..++..   ..+..++.+++.+||+.||++||||+||+++|+
T Consensus       272 ~i~~g~~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          272 CITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             HHHHTCCCCCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             HHHcCCCCCCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            33333222221   223456889999999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.6e-49  Score=434.01  Aligned_cols=248  Identities=22%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...+.||+|+||+||+|++. +++.||||++....... ......+|++.+++++|||||++++++.+.+..|+|||||+
T Consensus        27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~  106 (350)
T 4b9d_A           27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE  106 (350)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            34456899999999999886 68999999997643322 22334567777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      ||+|.+++...+ ...+++.+++.|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+.......
T Consensus       107 gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          107 GGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             TCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             CCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            999999996543 33478889999999999999999999   99999999999999999999999999998765433334


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|||||++.+..|+.++||||+||++|||+||+.||...+           .......+.....++...   .
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----------~~~~~~~i~~~~~~~~~~---~  248 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----------MKNLVLKIISGSFPPVSL---H  248 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHHTCCCCCCT---T
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHHHHHHHHcCCCCCCCc---c
Confidence            56789999999999999999999999999999999999999986422           223333444444433322   2


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++.+++.+||++||++|||++|+++
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3456888999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-48  Score=428.11  Aligned_cols=244  Identities=22%  Similarity=0.255  Sum_probs=196.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|+++ +++.||||+++...      ...+|+..++.++|||||++++++.+.+..|+|||||+||
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            3456899999999999986 68899999996532      2245777889999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCCCC--
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSSN--  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~--  935 (1048)
                      +|.+++++.+   .+++.++..++.||+.||+|||++   +||||||||+|||++.+| ++||+|||+|+.+..+...  
T Consensus       136 ~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          136 SLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999997543   489999999999999999999999   999999999999999997 6999999999987644321  


Q ss_pred             ---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 ---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                         ....+||+.|||||++.+..|+.++||||+||++|||+||+.||......           .....+.....+ ...
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----------~~~~~i~~~~~~-~~~  277 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-----------PLCLKIASEPPP-IRE  277 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-----------CCHHHHHHSCCG-GGG
T ss_pred             eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----------HHHHHHHcCCCC-chh
Confidence               23467999999999999999999999999999999999999998643211           111111111111 001


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+......+.+++.+||++||++|||++|+++.|.
T Consensus       278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            11233456888999999999999999999998764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-48  Score=419.05  Aligned_cols=244  Identities=22%  Similarity=0.316  Sum_probs=191.9

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      +.||+|+||+||+|.+. +++.||+|++....... ......+|++.+++++|||||+++++|.+    .+.+|+|||||
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            45899999999999886 67889999987543322 12234567777899999999999999864    35689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      ++|+|.+++++.   ..+++..+..++.||+.||+|||++. ++||||||||+|||++. +|.+||+|||+|+...  ..
T Consensus       112 ~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--~~  185 (290)
T 3fpq_A          112 TSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--AS  185 (290)
T ss_dssp             CSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--TT
T ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC--CC
Confidence            999999999754   34899999999999999999999981 13999999999999984 7999999999998643  23


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|||||++.+ +|+.++||||+||++|||+||+.||.....          .......+..+..+..  ..
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----------~~~~~~~i~~~~~~~~--~~  252 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIYRRVTSGVKPAS--FD  252 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHHHHHHHTTTCCCGG--GG
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----------HHHHHHHHHcCCCCCC--CC
Confidence            4456789999999998865 699999999999999999999999863221          1112222222222211  11


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....++.+++.+||++||++|||++|+++
T Consensus       253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222346888999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-48  Score=435.13  Aligned_cols=248  Identities=26%  Similarity=0.387  Sum_probs=205.9

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .+...+.||+|+||+||+|+++ +|+.||||++....... .....+|+..++.++|||||+++++|.+.+.+|+|||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            3455667999999999999886 68999999997543332 344567888889999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +||+|.++++..    .+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+......
T Consensus       231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            999999999642    389999999999999999999999   9999999999999999999999999999988766666


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.....           ......+.. ..++......
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------~~~~~~i~~-~~~~~~~~~~  371 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----------LKAMKMIRD-NLPPRLKNLH  371 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHH-SCCCCCSCTT
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------HHHHHHHHc-CCCCCCcccc
Confidence            6778999999999999999999999999999999999999999864321           111111111 1111111222


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....++.+++.+||++||++|||++|+++
T Consensus       372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          372 KVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            33456889999999999999999999986

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.4e-48  Score=469.59  Aligned_cols=463  Identities=19%  Similarity=0.249  Sum_probs=280.3

Q ss_pred             CCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeec
Q 045493          183 KNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYL  262 (1048)
Q Consensus       183 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  262 (1048)
                      .+++.|+|++|.+.|.+|.+|++|++|++|+|++|.+. ..+..++...           +...+|...  +..|+ +++
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~-----------~~~~~~~~~--~~~l~-l~l  145 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKG-----------ISANMSDEQ--KQKMR-MHY  145 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTS-----------BCTTCCHHH--HHHHH-THH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccc-----------cccCchHHH--HHHHH-hhH
Confidence            47888888888888888888888888888888888763 1121121100           011233332  45666 777


Q ss_pred             ccccccCCCchhhhc-cchhhhhhhccccccCCCCCcccCCCCCCcEEEcc--Cceeecccccccccccccceeeecccc
Q 045493          263 SHNQLNGSLPSSFGN-LSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLS--KTQLSGFIPPSLGNLSNIRGLYIRENM  339 (1048)
Q Consensus       263 ~~n~l~~~~p~~~~~-L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~--~n~l~~~~~~~~~~l~~L~~L~l~~n~  339 (1048)
                      ++|.+.+..|..+.. +..+..+++.. ..+.      ......++.+++.  .|++++ +|..++++++|+.|+|++|.
T Consensus       146 ~~~~l~~~~~~~~~~~~~~l~~~~l~~-~~~~------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~  217 (636)
T 4eco_A          146 QKTFVDYDPREDFSDLIKDCINSDPQQ-KSIK------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP  217 (636)
T ss_dssp             HHHHTCCCGGGGSCHHHHHHHHHCTTS-CCCC------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCC
T ss_pred             HHhhhccCchhhHHHHHHHHhhcCccc-cccc------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCc
Confidence            777776666655553 22333333321 0000      0111122222222  345555 55555555555555555555


Q ss_pred             ccCC-----------------CCcchh--ccCCCCeEeccCCccccCcChhhhccCCCcEEEeeccc-ccC-Cchhhhhh
Q 045493          340 LYGS-----------------IPEELG--RLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE-LSG-SIPQEIEN  398 (1048)
Q Consensus       340 l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~p~~~~~  398 (1048)
                      +++.                 +|..++  .+++|++|+|++|++.+.+|..++++++|++|++++|+ +++ .+|..+.+
T Consensus       218 l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~  297 (636)
T 4eco_A          218 FVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA  297 (636)
T ss_dssp             CCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHH
T ss_pred             cccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHh
Confidence            5553                 555555  66666666666666666666666666666666666665 555 55665555


Q ss_pred             h------cccceeeccccccCCCCCc--ccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCC
Q 045493          399 M------KKLNKYLLFENQFTGYLPQ--NVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI  470 (1048)
Q Consensus       399 l------~~L~~l~l~~N~l~~~~~~--~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~  470 (1048)
                      +      ++|+.|++++|+++ .+|.  .+..+++|++|++++|.+++.+| .+..+++|++|++++|+++.++ ..+..
T Consensus       298 L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp-~~l~~  374 (636)
T 4eco_A          298 LADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP-ANFCG  374 (636)
T ss_dssp             HHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECC-TTSEE
T ss_pred             hhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCcccccc-Hhhhh
Confidence            5      56666666666666 4555  56666666666666666665555 6666666666666666666333 33555


Q ss_pred             CCC-CCeeeCcCCcccCcccccccCCC--CccEEEecCcccCcccCcccc-------ccCCCcEEEcccCcccCCcCccc
Q 045493          471 YPD-LELLDLSNNNFFGEISSNWIKCP--QLATLNMGGNEISGTIPSEIG-------NMTQLHKLDFSSNRLVGQIPKQL  540 (1048)
Q Consensus       471 ~~~-L~~L~Ls~n~l~~~~~~~~~~~~--~L~~L~L~~N~i~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~  540 (1048)
                      +++ |+.|++++|+++ .+|..+..++  +|++|++++|.+++..|..+.       .+++|++|+|++|++++..+..+
T Consensus       375 l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~  453 (636)
T 4eco_A          375 FTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF  453 (636)
T ss_dssp             ECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHH
T ss_pred             hcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHH
Confidence            555 666666666665 4444444433  666666666666666666665       55666666666666664433444


Q ss_pred             cCCCccCEEeecCccccCCCccc-cccc-------cccceeecccCccccccccccc--ccccccccccccccccchhhh
Q 045493          541 GKLTSLTSLTLNGNQLSGDIPLE-LGLL-------AELGYLDLSANRLSKLIPKNLG--ELRKLHHLNLSNNQFSQEISI  610 (1048)
Q Consensus       541 ~~l~~L~~L~L~~N~l~~~~~~~-~~~l-------~~L~~L~Ls~N~l~~~~~~~l~--~l~~L~~L~Ls~N~l~~~~~~  610 (1048)
                      ..+++|++|+|++|+++ .+|.. +...       ++|++|+|++|+|+.+ |..+.  .+++|++|+|++|+|++ .+.
T Consensus       454 ~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~~~l~~L~~L~Ls~N~l~~-ip~  530 (636)
T 4eco_A          454 STGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL-SDDFRATTLPYLVGIDLSYNSFSK-FPT  530 (636)
T ss_dssp             HTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCCBC-CGGGSTTTCTTCCEEECCSSCCSS-CCC
T ss_pred             ccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCCcc-ChhhhhccCCCcCEEECCCCCCCC-cCh
Confidence            55666666666666666 33332 2222       2666666666666643 44444  66666666666666666 455


Q ss_pred             hhccccccCeEEC------CCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecC
Q 045493          611 QIGKLVQLSKLDL------SHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQG  678 (1048)
Q Consensus       611 ~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~  678 (1048)
                      .+..+++|++|+|      ++|++.+.+|..+..+++|++|+|++|+| +.+|..+.  +.|++||+++|++..
T Consensus       531 ~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             GGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             hhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence            5566666777766      67888889999999999999999999999 56777665  789999999997764

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.4e-48  Score=473.28  Aligned_cols=487  Identities=18%  Similarity=0.243  Sum_probs=248.1

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      +++.|+|++|++.|.+|.+|+.|++|++|+|++|.+. ..+..++...           +...+|...  +..|+ ++++
T Consensus        82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~-----------~~~~~~~~~--~~~l~-l~l~  146 (636)
T 4eco_A           82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKG-----------ISANMSDEQ--KQKMR-MHYQ  146 (636)
T ss_dssp             CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTS-----------BCTTCCHHH--HHHHH-THHH
T ss_pred             CEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccc-----------cccCchHHH--HHHHH-hhHH
Confidence            4555555555555555555555555555555555443 1112222110           011233333  55666 8888


Q ss_pred             ceecccccCcCcCCc-CCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEE--ecCCCccccccCCCCCC
Q 045493          105 YNRLNGSIPASLGNL-SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSV--SLHTNNFSGVIPRSLGG  181 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L-~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l--~l~~n~~~~~~~~~~~~  181 (1048)
                      +|.+.+..|..+..+ ..+..+++...++..                     .....++.+  ....|++++ +|..|+.
T Consensus       147 ~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~---------------------~~~~~l~~l~l~~~~n~l~~-ip~~l~~  204 (636)
T 4eco_A          147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKK---------------------SSRITLKDTQIGQLSNNITF-VSKAVMR  204 (636)
T ss_dssp             HHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC---------------------CCCCCCCTTTTTCCSCEEEE-ECGGGGG
T ss_pred             HhhhccCchhhHHHHHHHHhhcCcccccccc---------------------ccccchhhhhhccccCCCcc-CCHHHhc
Confidence            888777666665532 233333333322210                     000111111  112355555 4555555


Q ss_pred             CCCcceeeccccCcccc-CCcccccccccceeccccccccccCCccCc--CCCCCCeEeccCCccCCCCCcccccccccc
Q 045493          182 LKNLTFVYLNNNRIVGS-IPSEIGNLRSLSYLGLNKNQLSGSIPPTAG--NLSNLKFLYLHDNRLSGYIPPKLGSFKSLL  258 (1048)
Q Consensus       182 l~~L~~L~L~~n~i~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  258 (1048)
                      +++|++|+|++|++++. .+...        ..-+.+...+.+|..++  ++++|++|+|++|.+.+.+|..|+++++|+
T Consensus       205 l~~L~~L~Ls~n~l~~~~~~~~~--------~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  276 (636)
T 4eco_A          205 LTKLRQFYMGNSPFVAENICEAW--------ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ  276 (636)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSC--------SCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCC
T ss_pred             ccCCCEEECcCCccccccccccc--------cccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCC
Confidence            55555555555555542 00000        00000000001455555  555555555555555555555555555555


Q ss_pred             eeeccccc-ccC-CCchhhhcc------chhhhhhhccccccCCCCCc--ccCCCCCCcEEEccCceeeccccccccccc
Q 045493          259 YLYLSHNQ-LNG-SLPSSFGNL------SSLKHLHVHNINKLSGSIPK--EIGNLKSLSHLWLSKTQLSGFIPPSLGNLS  328 (1048)
Q Consensus       259 ~L~L~~n~-l~~-~~p~~~~~L------~~L~~L~l~~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  328 (1048)
                      +|++++|+ +++ .+|..++.+      ++|++|++++ |.++ .+|.  .++.+++|++|++++|+++|.+| .|+.++
T Consensus       277 ~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~-n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~  353 (636)
T 4eco_A          277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY-NNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI  353 (636)
T ss_dssp             EEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCS-SCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEE
T ss_pred             EEECcCCCCCccccchHHHHhhhccccCCCCCEEECCC-CcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCC
Confidence            55555555 444 445444443      3333333332 2233 3344  44555555555555555555555 555555


Q ss_pred             ccceeeeccccccCCCCcchhccCC-CCeEeccCCccccCcChhhhccC--CCcEEEeecccccCCchhhhhhhccccee
Q 045493          329 NIRGLYIRENMLYGSIPEELGRLKS-LSQLSLSVNKLNGSIPHCLGNLS--NLKFFALRENELSGSIPQEIENMKKLNKY  405 (1048)
Q Consensus       329 ~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~l~~l~--~L~~L~L~~n~l~~~~p~~~~~l~~L~~l  405 (1048)
                      +|+.|++++|.++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|+.|++++|.+++.+|..+....     
T Consensus       354 ~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~-----  426 (636)
T 4eco_A          354 KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD-----  426 (636)
T ss_dssp             EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTC-----
T ss_pred             CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccc-----
Confidence            5555555555555 44555555555 555555555555 4444444332  455555555555544444333000     


Q ss_pred             eccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCC-------CCCeee
Q 045493          406 LLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYP-------DLELLD  478 (1048)
Q Consensus       406 ~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~-------~L~~L~  478 (1048)
                                  .....+.+|++|++++|.++...+..+..+++|++|+|++|+++.++...+....       +|+.|+
T Consensus       427 ------------~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~  494 (636)
T 4eco_A          427 ------------PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID  494 (636)
T ss_dssp             ------------SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEE
T ss_pred             ------------cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEE
Confidence                        0001444566666666666644334445566667777777766666555554433       777777


Q ss_pred             CcCCcccCccccccc--CCCCccEEEecCcccCcccCccccccCCCcEEEccc------CcccCCcCccccCCCccCEEe
Q 045493          479 LSNNNFFGEISSNWI--KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS------NRLVGQIPKQLGKLTSLTSLT  550 (1048)
Q Consensus       479 Ls~n~l~~~~~~~~~--~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~  550 (1048)
                      |++|+++ .+|..+.  .+++|++|++++|++++ +|..+..+++|++|+|++      |++.+.+|..+..+++|++|+
T Consensus       495 Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~  572 (636)
T 4eco_A          495 LRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ  572 (636)
T ss_dssp             CCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEE
T ss_pred             CcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEE
Confidence            7777777 4555554  77788888888888876 677777888888888854      555555555555566666666


Q ss_pred             ecCccccCCCccccccccccceeecccCccccc
Q 045493          551 LNGNQLSGDIPLELGLLAELGYLDLSANRLSKL  583 (1048)
Q Consensus       551 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  583 (1048)
                      |++|+++ .+|..+.  ++|++|||++|++..+
T Consensus       573 Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          573 IGSNDIR-KVNEKIT--PNISVLDIKDNPNISI  602 (636)
T ss_dssp             CCSSCCC-BCCSCCC--TTCCEEECCSCTTCEE
T ss_pred             CCCCcCC-ccCHhHh--CcCCEEECcCCCCccc
Confidence            6666663 4444433  4555555555555543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-48  Score=421.33  Aligned_cols=243  Identities=21%  Similarity=0.299  Sum_probs=201.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -.+.||+|+||+||+|+++ +++.||||++.+...  ........+|++.++.++|||||++++++.+.+..|+|||||+
T Consensus        36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~  115 (311)
T 4aw0_A           36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK  115 (311)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence            4457899999999999886 688999999865321  1222345667788899999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--C
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--S  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~  934 (1048)
                      ||+|.+++++.+   .+++..++.++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.+....  .
T Consensus       116 gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          116 NGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999997543   489999999999999999999999   99999999999999999999999999999875443  2


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+           .......+.......+.   
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-----------~~~~~~~i~~~~~~~p~---  255 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----------EGLIFAKIIKLEYDFPE---  255 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCCCT---
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHcCCCCCCc---
Confidence            3456789999999999999999999999999999999999999986322           22233334333332221   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                       ..+.++.+++.+||++||++|||++|++
T Consensus       256 -~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          256 -KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             2234678899999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-48  Score=425.73  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=193.9

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  857 (1048)
                      +.||+|+||+||+|++. |+.||||++.....  .....+.++..+.+++|||||+++|+|.+.+    ..|+|||||++
T Consensus         9 ~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEECSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            45899999999999985 89999999865321  1122233444456789999999999997653    68999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC-----FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |+|.+++++.    .++|..+.+++.|+++||+|||+++     .++||||||||+|||++.++++||+|||+|+.....
T Consensus        86 gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           86 GSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            9999999753    3899999999999999999999762     358999999999999999999999999999877544


Q ss_pred             CCC----ccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCcccccccC----CCcccccchhh
Q 045493          933 SSN----WSELAGTCGYIAPELAYTM------RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS----LPAPAANMNIV  998 (1048)
Q Consensus       933 ~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~----~~~~~~~~~~~  998 (1048)
                      ...    ....+||+.|||||++.+.      .++.++|||||||++|||+||+.||........    ...........
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~  241 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence            322    2345799999999998764      367899999999999999999988754332111    10111111222


Q ss_pred             hhhhccCCCCCCch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          999 VNDLIDSRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+......+..+   ...+....+.+++.+||+.||++||||+||++.|++
T Consensus       242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            22222333222111   123456778999999999999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-47  Score=405.60  Aligned_cols=242  Identities=20%  Similarity=0.306  Sum_probs=184.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -...||+|+||+||+|++. +++.||+|++.+.....  ......+|++.++.++|||||++++++.+.+..|+||||+ 
T Consensus        17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-   95 (275)
T 3hyh_A           17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-   95 (275)
T ss_dssp             EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence            3456899999999999876 68999999997543222  2223456777789999999999999999999999999999 


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.+.+   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+..... ...
T Consensus        96 ~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  168 (275)
T 3hyh_A           96 GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL  168 (275)
T ss_dssp             CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence            679999997543   489999999999999999999999   9999999999999999999999999999876533 334


Q ss_pred             cccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ...+||+.|||||++.+..| +.++||||+||++|||+||+.||...+           .......+.......+.    
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----------~~~~~~~i~~~~~~~p~----  233 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----------IPVLFKNISNGVYTLPK----  233 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCCCT----
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHcCCCCCCC----
Confidence            56789999999999998876 589999999999999999999986322           12223333333322221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....++.+++.+||++||++|||++|+++
T Consensus       234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            12346788999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.8e-48  Score=416.57  Aligned_cols=245  Identities=23%  Similarity=0.288  Sum_probs=193.3

Q ss_pred             cceeeecccccccEEEEEEc----CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...+.||+|+||+||+|+..    +++.||+|++....... .......|++.+++++|||||++++++.+.+..|+|||
T Consensus        27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE  106 (304)
T 3ubd_A           27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD  106 (304)
T ss_dssp             EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence            34557899999999999863    35779999986543221 12233445666788899999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      ||+||+|.+++++.+   .+++.++..++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+......
T Consensus       107 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          107 FLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             CCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             cCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999997643   489999999999999999999999   99999999999999999999999999998766555


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+           .......+.......+.  
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----------~~~~~~~i~~~~~~~p~--  247 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-----------RKETMTMILKAKLGMPQ--  247 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT--
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC-----------HHHHHHHHHcCCCCCCC--
Confidence            55567899999999999999999999999999999999999999986422           12223333333333221  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTM-----QKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 1044 (1048)
                        ..+.++.+++.+||++||++|||+     +|+++
T Consensus       248 --~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          248 --FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              233467889999999999999995     57664

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-47  Score=424.82  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=197.2

Q ss_pred             eeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhccc-CceeeEeeEeee-CCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH-RNIVKFYGFCSH-TQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h-~niv~~~~~~~~-~~~~~lv~  852 (1048)
                      .+.||+|+||+||+|++..      ++.||||++..............+++.+.+++| ||||+++|+|.+ .+..|+||
T Consensus        69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~  148 (353)
T 4ase_A           69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  148 (353)
T ss_dssp             EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence            3468999999999998753      246899988764433323334556666777755 999999999976 45789999


Q ss_pred             EccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceE
Q 045493          853 EYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH  919 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~k  919 (1048)
                      |||++|+|.++++....             ...+++.++..++.|||+||+|||++   +||||||||+|||+++++.+|
T Consensus       149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vK  225 (353)
T 4ase_A          149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK  225 (353)
T ss_dssp             ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEE
Confidence            99999999999975432             24489999999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccch
Q 045493          920 VSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      |+|||+|+.+..+...  ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.....          ..
T Consensus       226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~----------~~  295 (353)
T 4ase_A          226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------DE  295 (353)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----------SH
T ss_pred             ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH----------HH
Confidence            9999999977554433  234678999999999999999999999999999999998 8999864221          11


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....+..+..++..   .....++.+++.+||+.||++||||+|++++|+
T Consensus       296 ~~~~~i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          296 EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            112222222222111   123456889999999999999999999999886

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=446.26  Aligned_cols=465  Identities=20%  Similarity=0.206  Sum_probs=259.6

Q ss_pred             cEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccce
Q 045493           27 AYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYN  106 (1048)
Q Consensus        27 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n  106 (1048)
                      ++||+++|+|+ .+|..+.  ++|++|+|++|.++++.|.+|+.+++|++|+|++|+++++.|+.|.++++|++|++++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            56777777777 4555554  67777777777777666667777777777777777777666667777777777777777


Q ss_pred             ecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcc
Q 045493          107 RLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLT  186 (1048)
Q Consensus       107 ~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~  186 (1048)
                      +++. +|..  .+++|++|++++|++++.                                      ..|..|..+++|+
T Consensus        80 ~l~~-lp~~--~l~~L~~L~L~~N~l~~~--------------------------------------~~p~~~~~l~~L~  118 (520)
T 2z7x_B           80 KLVK-ISCH--PTVNLKHLDLSFNAFDAL--------------------------------------PICKEFGNMSQLK  118 (520)
T ss_dssp             CCCE-EECC--CCCCCSEEECCSSCCSSC--------------------------------------CCCGGGGGCTTCC
T ss_pred             ceee-cCcc--ccCCccEEeccCCccccc--------------------------------------cchhhhccCCcce
Confidence            7763 3333  566666666666655421                                      2456778888888


Q ss_pred             eeeccccCccccCCccccccccc--ceeccccccc--cccCCccCcCCC-CCCeEeccCCccCCCCCc-cccccccccee
Q 045493          187 FVYLNNNRIVGSIPSEIGNLRSL--SYLGLNKNQL--SGSIPPTAGNLS-NLKFLYLHDNRLSGYIPP-KLGSFKSLLYL  260 (1048)
Q Consensus       187 ~L~L~~n~i~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L  260 (1048)
                      +|++++|++++   ..+..+++|  ++|+|++|++  .+..|..+..+. +...+++++|.+.+.+++ .+..+++|+.|
T Consensus       119 ~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L  195 (520)
T 2z7x_B          119 FLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS  195 (520)
T ss_dssp             EEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEEC
T ss_pred             EEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeec
Confidence            88888888874   456777777  8888888888  666776666554 234567777777655443 56677788888


Q ss_pred             ecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccc---cccccceeeecc
Q 045493          261 YLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLG---NLSNIRGLYIRE  337 (1048)
Q Consensus       261 ~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~---~l~~L~~L~l~~  337 (1048)
                      ++++|......                  ..+.+.+| .++.+++|+.|++++|.+++..+..+.   .+++|+.|++++
T Consensus       196 ~l~~n~~~~~~------------------~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~  256 (520)
T 2z7x_B          196 NIKCVLEDNKC------------------SYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN  256 (520)
T ss_dssp             CEEECCSTTTT------------------HHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEE
T ss_pred             ccccccccccc------------------ceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeec
Confidence            88877521100                  00111222 456677788888887777643222111   123444444444


Q ss_pred             ccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCch-hhhhhh---cccceeeccccccC
Q 045493          338 NMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIP-QEIENM---KKLNKYLLFENQFT  413 (1048)
Q Consensus       338 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l---~~L~~l~l~~N~l~  413 (1048)
                      |.+.+.+|..+...                   ..+++++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+.
T Consensus       257 n~l~~~~p~~~~~~-------------------~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~  315 (520)
T 2z7x_B          257 VKLQGQLDFRDFDY-------------------SGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMV  315 (520)
T ss_dssp             EEEESCCCCCCCCC-------------------CSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCC
T ss_pred             ccccCccccchhhc-------------------ccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccc
Confidence            44444444444000                   004455555555555555  222 333333   33444444444443


Q ss_pred             CCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCc--ccccCCCCCCCeeeCcCCcccCccccc
Q 045493          414 GYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI--SEVFGIYPDLELLDLSNNNFFGEISSN  491 (1048)
Q Consensus       414 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~~~~L~~L~Ls~n~l~~~~~~~  491 (1048)
                      ...  .+..+++|++|++++|.+++..|..+..+++|++|++++|++++++  +..|..+++|+.|++++|++++.++. 
T Consensus       316 ~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~-  392 (520)
T 2z7x_B          316 HML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK-  392 (520)
T ss_dssp             CCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG-
T ss_pred             ccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc-
Confidence            221  0123445555555555555555555555555555555555555432  23445555555555555555442221 


Q ss_pred             ccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccc
Q 045493          492 WIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELG  571 (1048)
Q Consensus       492 ~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  571 (1048)
                                            ..+..+++|++|++++|++++..+..+.  ++|++|+|++|+++ .+|..+..+++|+
T Consensus       393 ----------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~  447 (520)
T 2z7x_B          393 ----------------------GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ  447 (520)
T ss_dssp             ----------------------CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCC
T ss_pred             ----------------------chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCC
Confidence                                  1244444444444444444443333332  34555555555555 4444444555555


Q ss_pred             eeecccCcccccccccccccccccccccccccccc
Q 045493          572 YLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       572 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  606 (1048)
                      +|+|++|+|+.+++..|..+++|++|++++|+++.
T Consensus       448 ~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          448 ELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             EEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence            55555555554433335555555555555555544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-46  Score=464.22  Aligned_cols=353  Identities=18%  Similarity=0.205  Sum_probs=200.0

Q ss_pred             ceeecccccccc--cccccceeeeccccccCCCCcchhccCCCCeEeccCCc-ccc-CcChhhhccC-------CCcEEE
Q 045493          314 TQLSGFIPPSLG--NLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNK-LNG-SIPHCLGNLS-------NLKFFA  382 (1048)
Q Consensus       314 n~l~~~~~~~~~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l~-------~L~~L~  382 (1048)
                      |.+++.+|..++  ++++|+.|+|++|.+.+.+|..|..+++|++|+|++|+ +++ .+|..+++++       +|+.|+
T Consensus       475 n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~  554 (876)
T 4ecn_A          475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY  554 (876)
T ss_dssp             HHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred             ccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence            333344444444  45555555555555444555555555555555555554 444 4444444443       555555


Q ss_pred             eecccccCCchh--hhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccc-cceeEecCCc
Q 045493          383 LRENELSGSIPQ--EIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTS-LYSLRLERNQ  459 (1048)
Q Consensus       383 L~~n~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~-L~~L~L~~n~  459 (1048)
                      |++|.++ .+|.  .+.++++|+.|++++|+++ .+| .+..+++|+.|++++|.++ .+|..+..+++ |++|+|++|.
T Consensus       555 Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~  630 (876)
T 4ecn_A          555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK  630 (876)
T ss_dssp             CCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred             eeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCC
Confidence            5555555 4444  5555555555555555555 444 4555555666666666655 45555666666 6666666666


Q ss_pred             cccCcccccCCCC--CCCeeeCcCCcccCcccccc---c--CCCCccEEEecCcccCcccCccccccCCCcEEEcccCcc
Q 045493          460 LTGNISEVFGIYP--DLELLDLSNNNFFGEISSNW---I--KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL  532 (1048)
Q Consensus       460 l~~~~~~~~~~~~--~L~~L~Ls~n~l~~~~~~~~---~--~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l  532 (1048)
                      ++.++ ..+...+  +|+.|+|++|++.+.+|...   .  .+++|+.|++++|.++...+..+..+++|+.|+|++|+|
T Consensus       631 L~~lp-~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L  709 (876)
T 4ecn_A          631 LKYIP-NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM  709 (876)
T ss_dssp             CCSCC-SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCC
T ss_pred             CCcCc-hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcC
Confidence            66333 3444333  36666666666665443221   1  234677777777777733333344677777777777777


Q ss_pred             cCCcCccccC-------CCccCEEeecCccccCCCccccc--cccccceeecccCccccccccccccccccccccccc--
Q 045493          533 VGQIPKQLGK-------LTSLTSLTLNGNQLSGDIPLELG--LLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN--  601 (1048)
Q Consensus       533 ~~~~~~~~~~-------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~--  601 (1048)
                      +...+..+..       +++|++|+|++|+++ .+|..+.  .+++|+.|+|++|+|+++ |..+..+++|+.|+|++  
T Consensus       710 ~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~l-p~~l~~L~~L~~L~Ls~N~  787 (876)
T 4ecn_A          710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQR  787 (876)
T ss_dssp             SCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSC-CCGGGGCTTCCEEECCCCB
T ss_pred             CccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCcc-chhhhcCCCCCEEECCCCC
Confidence            7333323322       227777777777777 5666665  777777777777777773 66677777777777766  


Q ss_pred             ----ccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEecccee
Q 045493          602 ----NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       602 ----N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l  676 (1048)
                          |++.+..+..+..+++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++....+..+.....+..+.+++|++
T Consensus       788 ~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~  863 (876)
T 4ecn_A          788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT  863 (876)
T ss_dssp             CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred             CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence                555555555555555555555555555 34555443  4555555555555554445544444444455555543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-46  Score=408.81  Aligned_cols=246  Identities=19%  Similarity=0.331  Sum_probs=187.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC------------
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------------  846 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------------  846 (1048)
                      ..+.||+|+||+||+|+++ +++.||||++.............+|++.+++++|||||++++++.+.+            
T Consensus         9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~   88 (299)
T 4g31_A            9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV   88 (299)
T ss_dssp             EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred             EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence            3457999999999999886 688999999976543333334456778889999999999999986543            


Q ss_pred             eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccc
Q 045493          847 HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA  926 (1048)
Q Consensus       847 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a  926 (1048)
                      ..|+|||||++|+|.++++......+.++..++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|
T Consensus        89 ~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           89 YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             EEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccc
Confidence            3699999999999999998766656677788899999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCC------------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccccc
Q 045493          927 KFLKPDSS------------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN  994 (1048)
Q Consensus       927 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  994 (1048)
                      +.+.....            .....+||+.|||||++.+..|+.++||||+||++|||++   ||....          .
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----------~  232 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----------E  232 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----------H
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----------H
Confidence            87754322            1234579999999999999999999999999999999996   654211          1


Q ss_pred             chhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          995 MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......+.....+   ...........+++.+||++||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11122222333333   223444556778999999999999999999986

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=444.97  Aligned_cols=458  Identities=21%  Similarity=0.213  Sum_probs=296.6

Q ss_pred             ceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcc
Q 045493          123 VQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSE  202 (1048)
Q Consensus       123 ~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~  202 (1048)
                      ++|++++|.++                .+|..+.  ++++.|++++|.+++..|..|.++++|++|+|++|++++..|..
T Consensus         3 ~~l~ls~n~l~----------------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~   64 (520)
T 2z7x_B            3 FLVDRSKNGLI----------------HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV   64 (520)
T ss_dssp             CEEECTTSCCS----------------SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGG
T ss_pred             ceEecCCCCcc----------------ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHH
Confidence            46677777665                2333333  56666666666666666666666666666666666666666666


Q ss_pred             cccccccceeccccccccccCCccCcCCCCCCeEeccCCccCC-CCCcccccccccceeecccccccCCCchhhhccchh
Q 045493          203 IGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSG-YIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSL  281 (1048)
Q Consensus       203 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L  281 (1048)
                      |+++++|++|+|++|+++ .+|..  .+++|++|+|++|.+++ .+|..|+.+++|++|++++|++.+   ..|      
T Consensus        65 ~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~------  132 (520)
T 2z7x_B           65 FKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSV------  132 (520)
T ss_dssp             GTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGG------
T ss_pred             hhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhc------
Confidence            666666666666666666 34444  56666666666666664 245666666666666666666542   223      


Q ss_pred             hhhhhccccccCCCCCcccCCCCCC--cEEEccCcee--eccccccccccc-ccceeeeccccccCCCC-cchhccCCCC
Q 045493          282 KHLHVHNINKLSGSIPKEIGNLKSL--SHLWLSKTQL--SGFIPPSLGNLS-NIRGLYIRENMLYGSIP-EELGRLKSLS  355 (1048)
Q Consensus       282 ~~L~l~~~n~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~-~~~~~l~~L~  355 (1048)
                                         ..+++|  +.|++++|.+  .+..|..+..+. ....+++++|.+.+.++ ..+..+++|+
T Consensus       133 -------------------~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~  193 (520)
T 2z7x_B          133 -------------------LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE  193 (520)
T ss_dssp             -------------------GGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEE
T ss_pred             -------------------cccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhccccee
Confidence                               333444  6666666666  555555555544 23344555565554333 3455667777


Q ss_pred             eEeccCCc-------cccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccE
Q 045493          356 QLSLSVNK-------LNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTH  428 (1048)
Q Consensus       356 ~L~Ls~N~-------l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~  428 (1048)
                      .|++++|.       +.+.+| .++.+++|+.|++++|.+++..+..+...                     ...++|++
T Consensus       194 ~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~---------------------~~~~~L~~  251 (520)
T 2z7x_B          194 LSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQL---------------------VWHTTVWY  251 (520)
T ss_dssp             ECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHH---------------------HHTSSCSE
T ss_pred             eccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHH---------------------hhhCcccE
Confidence            77777765       554444 56777777777777777664332222110                     01124455


Q ss_pred             EEeecccccCCCCCCc-----ccccccceeEecCCccccCcccccCCC---CCCCeeeCcCCcccCcccccccCCCCccE
Q 045493          429 FSVRNNNFVGPIPRSL-----QNCTSLYSLRLERNQLTGNISEVFGIY---PDLELLDLSNNNFFGEISSNWIKCPQLAT  500 (1048)
Q Consensus       429 L~l~~N~l~~~~~~~l-----~~l~~L~~L~L~~n~l~~~~~~~~~~~---~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~  500 (1048)
                      |++++|.+++.+|..+     ..+++|+.+++++|.+ .++...+..+   .+|+.|++++|.+....  .+..+++|++
T Consensus       252 L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~  328 (520)
T 2z7x_B          252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLH  328 (520)
T ss_dssp             EEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCE
T ss_pred             EEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccE
Confidence            5555555555555555     5666666666666666 3443333222   45777777777765432  1256677888


Q ss_pred             EEecCcccCcccCccccccCCCcEEEcccCcccC--CcCccccCCCccCEEeecCccccCCCcc-ccccccccceeeccc
Q 045493          501 LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG--QIPKQLGKLTSLTSLTLNGNQLSGDIPL-ELGLLAELGYLDLSA  577 (1048)
Q Consensus       501 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~  577 (1048)
                      |++++|.+++..|..++.+++|++|++++|++++  ..|..+..+++|++|++++|.+++.+|. .+..+++|++|++++
T Consensus       329 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~  408 (520)
T 2z7x_B          329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS  408 (520)
T ss_dssp             EECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCS
T ss_pred             EEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcC
Confidence            8888888877777777888888888888888875  4456677888888888888888864555 477788888888888


Q ss_pred             CcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcc
Q 045493          578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       578 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      |++++..|..+.  ++|++|++++|+|+.++ ..+..+++|++|+|++|+|++..+..+..+++|++|++++|++++..+
T Consensus       409 N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          409 NILTDTIFRCLP--PRIKVLDLHSNKIKSIP-KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             SCCCGGGGGSCC--TTCCEEECCSSCCCCCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCCcchhhhhc--ccCCEEECCCCcccccc-hhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            888776666654  68888899999888544 444488999999999999995433448899999999999999987654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.4e-46  Score=460.26  Aligned_cols=457  Identities=17%  Similarity=0.216  Sum_probs=322.5

Q ss_pred             CCcEEecCCCccccccCCCCCCCCCcceeec-cccCccccCCcccccc----cccc--eeccc----------ccc----
Q 045493          160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL-NNNRIVGSIPSEIGNL----RSLS--YLGLN----------KNQ----  218 (1048)
Q Consensus       160 ~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L-~~n~i~~~~p~~~~~l----~~L~--~L~L~----------~n~----  218 (1048)
                      ....|+|++|.+.|.+|..|+.|++|++|+| ++|.+++..|-.....    ...+  .+...          ...    
T Consensus       324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l  403 (876)
T 4ecn_A          324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL  403 (876)
T ss_dssp             CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred             CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence            4566777777777777777777777777777 6666655432111000    0000  00000          000    


Q ss_pred             -------ccccCCccCcCCCCCCeEeccC--CccCCCCCcccccccccceeecccccccC-----------------CCc
Q 045493          219 -------LSGSIPPTAGNLSNLKFLYLHD--NRLSGYIPPKLGSFKSLLYLYLSHNQLNG-----------------SLP  272 (1048)
Q Consensus       219 -------l~~~~~~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p  272 (1048)
                             .....+........++.+.+..  |.+++ +|..|+++++|++|+|++|++++                 .+|
T Consensus       404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP  482 (876)
T 4ecn_A          404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN  482 (876)
T ss_dssp             HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred             HHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence                   0000111112233444444543  77775 67777777778888888777776                 267


Q ss_pred             hhhh--ccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCce-eec-cccccccccc-------ccceeeecccccc
Q 045493          273 SSFG--NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQ-LSG-FIPPSLGNLS-------NIRGLYIRENMLY  341 (1048)
Q Consensus       273 ~~~~--~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~l~~n~l~  341 (1048)
                      ..++  ++++|++|++++ |.+.+.+|..++++++|+.|+|++|+ +++ .+|..++.++       +|+.|++++|.+.
T Consensus       483 ~~l~f~~L~~L~~L~Ls~-N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          483 EELSWSNLKDLTDVELYN-CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             SCCCGGGCTTCCEEEEES-CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             hhhhhccCCCCCEEECcC-CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            7766  888888888876 66677888888888888888888887 887 7777776665       8899999999888


Q ss_pred             CCCCc--chhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcc-cceeeccccccCCCCCc
Q 045493          342 GSIPE--ELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKK-LNKYLLFENQFTGYLPQ  418 (1048)
Q Consensus       342 ~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~-L~~l~l~~N~l~~~~~~  418 (1048)
                       .+|.  .+..+++|++|+|++|+++ .+| .|+++++|+.|+|++|.++ .+|..+..+++ |+.|++++|+++ .+|.
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~  636 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN  636 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence             6777  8888899999999999888 677 8888889999999999988 78888888888 999999999888 6677


Q ss_pred             ccccCCc--ccEEEeecccccCCCCCCc---c--cccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCccccc
Q 045493          419 NVCQSGS--LTHFSVRNNNFVGPIPRSL---Q--NCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSN  491 (1048)
Q Consensus       419 ~~~~~~~--L~~L~l~~N~l~~~~~~~l---~--~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~  491 (1048)
                      .+.....  |+.|++++|.+.+.+|...   .  .+++|+.|+|++|+++.++...+..+++|+.|+|++|+++......
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~  716 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS  716 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred             hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence            6666544  9999999999988766432   2  3458999999999999888888888899999999999998544444


Q ss_pred             ccC-------CCCccEEEecCcccCcccCcccc--ccCCCcEEEcccCcccCCcCccccCCCccCEEeecC------ccc
Q 045493          492 WIK-------CPQLATLNMGGNEISGTIPSEIG--NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNG------NQL  556 (1048)
Q Consensus       492 ~~~-------~~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~------N~l  556 (1048)
                      +..       +++|++|+|++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++      |++
T Consensus       717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l  794 (876)
T 4ecn_A          717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI  794 (876)
T ss_dssp             SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBC
T ss_pred             hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccc
Confidence            433       338999999999999 6788876  89999999999999997 788899999999999987      555


Q ss_pred             cCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcc
Q 045493          557 SGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL  628 (1048)
Q Consensus       557 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  628 (1048)
                      .+.+|..+..+++|++|+|++|+|+.+ |..+.  ++|+.|+|++|++..+....+.....+..+.|++|.+
T Consensus       795 ~~~ip~~l~~L~~L~~L~Ls~N~L~~I-p~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~  863 (876)
T 4ecn_A          795 LRQWPTGITTCPSLIQLQIGSNDIRKV-DEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT  863 (876)
T ss_dssp             CCCCCTTGGGCSSCCEEECCSSCCCBC-CSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred             cccChHHHhcCCCCCEEECCCCCCCcc-CHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence            555566666666666666666666332 33333  3555555555555554444444444444445555444

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.9e-43  Score=432.48  Aligned_cols=519  Identities=20%  Similarity=0.188  Sum_probs=375.6

Q ss_pred             CCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcC
Q 045493          150 SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGN  229 (1048)
Q Consensus       150 ~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  229 (1048)
                      .+|..+.  .++++|+|++|+++++.+.+|.++++|++|+|++|+|+++.|++|.++++|++|+|++|++++..+..|.+
T Consensus        45 ~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~  122 (635)
T 4g8a_A           45 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG  122 (635)
T ss_dssp             SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTT
T ss_pred             ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcC
Confidence            4454442  35667777777777777777777777777777777777766777777777777777777777655566777


Q ss_pred             CCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEE
Q 045493          230 LSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHL  309 (1048)
Q Consensus       230 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L  309 (1048)
                      +++|++|+|++|++++..+..|+++++|++|++++|.+...                        ..|..++.+++|++|
T Consensus       123 L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~------------------------~~~~~~~~l~~L~~L  178 (635)
T 4g8a_A          123 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPEYFSNLTNLEHL  178 (635)
T ss_dssp             CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCGGGGGCTTCCEE
T ss_pred             CCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC------------------------CCchhhccchhhhhh
Confidence            77777777777777766566677777777777777776532                        123344445555555


Q ss_pred             EccCceeecccccccccccccc----eeeeccccccCCCCcchhccCCCCeEeccCCcccc-CcChhhhccCCCcEEEee
Q 045493          310 WLSKTQLSGFIPPSLGNLSNIR----GLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG-SIPHCLGNLSNLKFFALR  384 (1048)
Q Consensus       310 ~L~~n~l~~~~~~~~~~l~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~  384 (1048)
                      ++++|++++..+..|..+.+++    .++++.|.+....+..+ ....++.+++++|.... ..+..+..++.++...+.
T Consensus       179 ~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~  257 (635)
T 4g8a_A          179 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV  257 (635)
T ss_dssp             ECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEE
T ss_pred             cccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccc
Confidence            5555555555555555444433    34555555553333322 23344556666554432 223445566666655554


Q ss_pred             cccc------cCCchhhhhhhcccceeeccccccCCC---CCcccccCCcccEEEeecccccCCCCCCcccccccceeEe
Q 045493          385 ENEL------SGSIPQEIENMKKLNKYLLFENQFTGY---LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRL  455 (1048)
Q Consensus       385 ~n~l------~~~~p~~~~~l~~L~~l~l~~N~l~~~---~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L  455 (1048)
                      .+..      .......+..+..+....+..+.....   .+..+.....++.+++.++.+....  .+....+++.|++
T Consensus       258 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l  335 (635)
T 4g8a_A          258 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLEL  335 (635)
T ss_dssp             EECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEE
T ss_pred             ccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhc
Confidence            3322      222334445555555555444433221   2233455677888888888877543  3566678999999


Q ss_pred             cCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCc--ccCccccccCCCcEEEcccCccc
Q 045493          456 ERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISG--TIPSEIGNMTQLHKLDFSSNRLV  533 (1048)
Q Consensus       456 ~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~  533 (1048)
                      .+|.+..+...   .++.|+.+++++|.+...  ..+..+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+.
T Consensus       336 ~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~  410 (635)
T 4g8a_A          336 VNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI  410 (635)
T ss_dssp             ESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE
T ss_pred             ccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc
Confidence            99998877654   356788999999987643  345578999999999999973  34566778899999999999987


Q ss_pred             CCcCccccCCCccCEEeecCccccCCC-ccccccccccceeecccCcccccccccccccccccccccccccc-cchhhhh
Q 045493          534 GQIPKQLGKLTSLTSLTLNGNQLSGDI-PLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF-SQEISIQ  611 (1048)
Q Consensus       534 ~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l-~~~~~~~  611 (1048)
                       ..+..+..+++|+.+++++|...... +..+..+++++.++++.|++....+..+..++.|+.|+|++|++ ....+..
T Consensus       411 -~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~  489 (635)
T 4g8a_A          411 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI  489 (635)
T ss_dssp             -EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred             -cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchh
Confidence             45667889999999999998877554 45688999999999999999999999999999999999999985 4456778


Q ss_pred             hccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCcc-cc-ccc
Q 045493          612 IGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSK-AF-QNA  689 (1048)
Q Consensus       612 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~-~~-~~~  689 (1048)
                      |..+++|++|||++|+|++..|..|..+++|++|+|++|+|++.++..|..+++|++||+++|++++.+|..- .+ ...
T Consensus       490 ~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L  569 (635)
T 4g8a_A          490 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL  569 (635)
T ss_dssp             CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTC
T ss_pred             hhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999988642 22 334


Q ss_pred             ccccccCCccccCC
Q 045493          690 TIEAFQGNKELCGD  703 (1048)
Q Consensus       690 ~~~~~~~n~~lc~~  703 (1048)
                      ..-.+.+|+..|.+
T Consensus       570 ~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          570 AFLNLTQNDFACTC  583 (635)
T ss_dssp             CEEECTTCCBCCSG
T ss_pred             CEEEeeCCCCcccC
Confidence            55568899999874

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.4e-44  Score=430.63  Aligned_cols=444  Identities=20%  Similarity=0.204  Sum_probs=255.9

Q ss_pred             CCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEec
Q 045493          159 ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL  238 (1048)
Q Consensus       159 ~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  238 (1048)
                      ++++.|++++|.+++..|..|..+++|++|+|++|+++++.|++|.++++|++|+|++|+++ .+|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            44555555555555555555555555555555555555555555555555555555555555 33333  4555555555


Q ss_pred             cCCccCCC-CCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCC--cEEEccCce
Q 045493          239 HDNRLSGY-IPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSL--SHLWLSKTQ  315 (1048)
Q Consensus       239 ~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L--~~L~L~~n~  315 (1048)
                      ++|++++. .|..|+++++|++|++++|++..                            ..+..+++|  +.|++++|.
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~----------------------------~~~~~l~~L~L~~L~L~~n~  180 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ----------------------------LDLLPVAHLHLSCILLDLVS  180 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT----------------------------TTTGGGTTSCEEEEEEEESS
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCcccc----------------------------CchhhhhhceeeEEEeeccc
Confidence            55555532 23455555555555555555432                            122233333  777777777


Q ss_pred             e--eccccccccccc--ccceeeeccccccCCCCc-chhccCCCCeEeccCCc-----cccCcChhhhccCCCcEEEeec
Q 045493          316 L--SGFIPPSLGNLS--NIRGLYIRENMLYGSIPE-ELGRLKSLSQLSLSVNK-----LNGSIPHCLGNLSNLKFFALRE  385 (1048)
Q Consensus       316 l--~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~-----l~~~~~~~l~~l~~L~~L~L~~  385 (1048)
                      +  ++..|..+..+.  .+ .+++++|.+.+.++. .+..+++|+.|++++|+     +. .....+..+++|+.+++++
T Consensus       181 l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~-~~~~~l~~l~~L~~L~L~~  258 (562)
T 3a79_B          181 YHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM-TFLSELTRGPTLLNVTLQH  258 (562)
T ss_dssp             CCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHH-HHHHHHHSCSSCEEEEEEE
T ss_pred             ccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHH-HHHHHHhccCcceEEEecC
Confidence            7  666666666543  22 446666666554443 34566777777777764     22 1223466677777777777


Q ss_pred             ccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCc-----ccccccceeEecCCcc
Q 045493          386 NELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL-----QNCTSLYSLRLERNQL  460 (1048)
Q Consensus       386 n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l-----~~l~~L~~L~L~~n~l  460 (1048)
                      +.+++.....+.                    .. ....+|++|++++|.+++.+|..+     ..++.|+.++++.|.+
T Consensus       259 ~~l~~~~~~~~~--------------------~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~  317 (562)
T 3a79_B          259 IETTWKCSVKLF--------------------QF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF  317 (562)
T ss_dssp             EEECHHHHHHHH--------------------HH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC
T ss_pred             CcCcHHHHHHHH--------------------Hh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee
Confidence            666532111110                    00 112356666666666666666555     4555555555555554


Q ss_pred             ccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccc
Q 045493          461 TGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL  540 (1048)
Q Consensus       461 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  540 (1048)
                       .++.+.+..+                     ....+|++|++++|.+....  ....+++|++|++++|++++..|..+
T Consensus       318 -~~p~~~~~~~---------------------~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~  373 (562)
T 3a79_B          318 -LFSKEALYSV---------------------FAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGC  373 (562)
T ss_dssp             -SSCHHHHHHH---------------------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred             -ecChhhhhhh---------------------hccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhh
Confidence             2222211111                     01123444444444443211  11445556666666666665555566


Q ss_pred             cCCCccCEEeecCccccCC--CccccccccccceeecccCcccc-cccccccccccccccccccccccchhhhhhccccc
Q 045493          541 GKLTSLTSLTLNGNQLSGD--IPLELGLLAELGYLDLSANRLSK-LIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQ  617 (1048)
Q Consensus       541 ~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  617 (1048)
                      ..+++|++|+|++|++++.  +|..+..+++|++|++++|++++ +++..+..+++|++|++++|+|++..+..+.  ++
T Consensus       374 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~  451 (562)
T 3a79_B          374 STLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PK  451 (562)
T ss_dssp             CSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TT
T ss_pred             cccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--Cc
Confidence            6666666666666666542  23446666666666666666666 4444566667777777777777654443332  57


Q ss_pred             cCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc
Q 045493          618 LSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       618 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      |++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..++.|++|++++|+|+|.+|..
T Consensus       452 L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             CSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred             CCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence            888899999888 67776678899999999999998555555888999999999999999887753

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.1e-43  Score=428.01  Aligned_cols=464  Identities=22%  Similarity=0.238  Sum_probs=291.0

Q ss_pred             CCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccc
Q 045493           23 FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELA  102 (1048)
Q Consensus        23 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~  102 (1048)
                      ....+++|+++|++++ +|..+.  ++|++|+|++|.|+++.|.+|+.+++|++|+|++|+|+++.|++|.++++|++|+
T Consensus        30 ~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  106 (562)
T 3a79_B           30 NELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLD  106 (562)
T ss_dssp             ---CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEE
Confidence            3444667777777763 444443  5667777777777665556667777777777777776666666666666666666


Q ss_pred             ccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCC
Q 045493          103 LSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGL  182 (1048)
Q Consensus       103 l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l  182 (1048)
                      +++|+++ .+|..  .+++|++|++++|++++.                                      ..|..|..+
T Consensus       107 Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l--------------------------------------~~p~~~~~l  145 (562)
T 3a79_B          107 VSHNRLQ-NISCC--PMASLRHLDLSFNDFDVL--------------------------------------PVCKEFGNL  145 (562)
T ss_dssp             CTTSCCC-EECSC--CCTTCSEEECCSSCCSBC--------------------------------------CCCGGGGGC
T ss_pred             CCCCcCC-ccCcc--ccccCCEEECCCCCcccc--------------------------------------CchHhhccc
Confidence            6666666 34433  566666666666655421                                      123556666


Q ss_pred             CCcceeeccccCccccCCccccccccc--ceeccccccc--cccCCccCcCCC-CCCeEeccCCccCCCCCc-ccccccc
Q 045493          183 KNLTFVYLNNNRIVGSIPSEIGNLRSL--SYLGLNKNQL--SGSIPPTAGNLS-NLKFLYLHDNRLSGYIPP-KLGSFKS  256 (1048)
Q Consensus       183 ~~L~~L~L~~n~i~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~  256 (1048)
                      ++|++|++++|++++.   .+..+++|  ++|+|++|++  .+..|..+..+. ..-.+++++|.+.+.+++ .+..+++
T Consensus       146 ~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~  222 (562)
T 3a79_B          146 TKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH  222 (562)
T ss_dssp             TTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEE
T ss_pred             CcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccce
Confidence            7777777777766542   34444444  7777777776  556666665543 111456677777655443 4566778


Q ss_pred             cceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccc---ccccccccee
Q 045493          257 LLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPS---LGNLSNIRGL  333 (1048)
Q Consensus       257 L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~---~~~l~~L~~L  333 (1048)
                      |+.|++++|+..   -..+                 . .....+..+++|+.|+++++.+++.....   ....++|+.|
T Consensus       223 L~~L~l~~n~~~---~~~l-----------------~-~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L  281 (562)
T 3a79_B          223 LQLSNIKLNDEN---CQRL-----------------M-TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL  281 (562)
T ss_dssp             EEEEEEECCSTT---HHHH-----------------H-HHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEE
T ss_pred             EEEecccccccc---cchH-----------------H-HHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEE
Confidence            888888877521   0000                 0 00112344556666666666554321110   0112355666


Q ss_pred             eeccccccCCCCcch-----hccCCCCeEeccCCccccCcC-hhhhccCCCcEEEeecccccCCchhhhhhhcccceeec
Q 045493          334 YIRENMLYGSIPEEL-----GRLKSLSQLSLSVNKLNGSIP-HCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLL  407 (1048)
Q Consensus       334 ~l~~n~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l  407 (1048)
                      ++++|.+.+.+|..+     ..++.|+.++++.|.+  .+| ..+..+                     ....+|+.|++
T Consensus       282 ~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~---------------------~~~~~L~~L~l  338 (562)
T 3a79_B          282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV---------------------FAEMNIKMLSI  338 (562)
T ss_dssp             EEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH---------------------HHTCCCSEEEE
T ss_pred             EEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh---------------------hccCcceEEEc
Confidence            666666555555544     3344444444444443  122 222221                     00133444444


Q ss_pred             cccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCc--ccccCCCCCCCeeeCcCCccc
Q 045493          408 FENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI--SEVFGIYPDLELLDLSNNNFF  485 (1048)
Q Consensus       408 ~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~~~~L~~L~Ls~n~l~  485 (1048)
                      ++|.+....  ....+++|++|++++|.+++..|..+..+++|++|++++|++++++  +..|..+++|+.|++++|+++
T Consensus       339 ~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~  416 (562)
T 3a79_B          339 SDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN  416 (562)
T ss_dssp             ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred             cCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence            444443221  1145667888888888888778888888888888888888888765  356788888999999999988


Q ss_pred             C-cccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccc-
Q 045493          486 G-EISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-  563 (1048)
Q Consensus       486 ~-~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-  563 (1048)
                      + .....+..+++|++|++++|.+++..|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|.. 
T Consensus       417 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~  492 (562)
T 3a79_B          417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV  492 (562)
T ss_dssp             SCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTS
T ss_pred             CccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHH
Confidence            7 4445677888999999999998877666554  78999999999998 56666668999999999999999 45554 


Q ss_pred             cccccccceeecccCccccc
Q 045493          564 LGLLAELGYLDLSANRLSKL  583 (1048)
Q Consensus       564 ~~~l~~L~~L~Ls~N~l~~~  583 (1048)
                      +..+++|++|++++|.+...
T Consensus       493 ~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          493 FDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             TTTCTTCCCEECCSCCBCCC
T ss_pred             HhcCCCCCEEEecCCCcCCC
Confidence            88899999999999998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=396.27  Aligned_cols=259  Identities=19%  Similarity=0.274  Sum_probs=192.9

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee------CCeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH------TQHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~------~~~~~l  850 (1048)
                      .....||+|+||+||+|++. +|+.||||++....... ......+|++.++.++|||||++++++..      .+..|+
T Consensus        57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i  136 (398)
T 4b99_A           57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV  136 (398)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence            34567999999999999886 78999999997543322 12233457777889999999999998753      367899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      |||||+ |+|.+++...   ..+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+.
T Consensus       137 vmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          137 VLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            999996 6899999653   3589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CC----CCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccc-
Q 045493          931 PD----SSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANM-  995 (1048)
Q Consensus       931 ~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~-  995 (1048)
                      ..    .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||...+...         +.+...... 
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            33    2234567899999999998875 46999999999999999999999997533210         011000000 


Q ss_pred             --hhhhh---hhccCCCCCCchh-HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          996 --NIVVN---DLIDSRLPPPLGE-VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       996 --~~~~~---~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        .....   .......+.++.. ......++.+++.+||+.||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              00000   0011111111110 0112356889999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.2e-43  Score=390.42  Aligned_cols=193  Identities=23%  Similarity=0.304  Sum_probs=160.7

Q ss_pred             cCCcceeeecccccccEEEEEEc----CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEE
Q 045493          776 TFEGKMVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       776 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~l  850 (1048)
                      +.+.-...||+|+||+||+|+.+    +++.||+|++.....   .....++++.+..+ +|||||++++++.+.++.|+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            33445567999999999999864    457899999865332   22344566666666 69999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEecccccccc
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFL  929 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~  929 (1048)
                      ||||+++|+|.++++      .+++.+++.++.|++.||+|||++   +||||||||+|||++.+ +.+||+|||+|+..
T Consensus        98 vmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           98 AMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            999999999999984      278899999999999999999999   99999999999999877 89999999999865


Q ss_pred             CCCC----------------------------CCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          930 KPDS----------------------------SNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       930 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      ....                            ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            4321                            112345799999999999875 48999999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-42  Score=407.38  Aligned_cols=245  Identities=20%  Similarity=0.234  Sum_probs=193.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccc---hhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGI---NQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~---~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...+||+|+||.||+|+.+ +++.||+|++.+....  ....   .++.++..++.++|||||+++++|.+.+.+|+|||
T Consensus       193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE  272 (689)
T 3v5w_A          193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD  272 (689)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence            4457999999999999886 6889999998653211  1111   12223444566789999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      ||+||+|.+++.+.+   .+++..++.++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.+... 
T Consensus       273 y~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-  345 (689)
T 3v5w_A          273 LMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  345 (689)
T ss_dssp             CCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence            999999999997643   489999999999999999999999   9999999999999999999999999999876543 


Q ss_pred             CCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          934 SNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                       .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.....        .................+  
T Consensus       346 -~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~--------~~~~~i~~~i~~~~~~~p--  414 (689)
T 3v5w_A          346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--------KDKHEIDRMTLTMAVELP--  414 (689)
T ss_dssp             -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC--------CCHHHHHHHHHHCCCCCC--
T ss_pred             -CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhhcCCCCCCC--
Confidence             3345789999999999964 5799999999999999999999999864321        111122222222222221  


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                        ...+.++.+++.+||++||++|++     ++|+++
T Consensus       415 --~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          415 --DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence              123456788999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.9e-42  Score=405.33  Aligned_cols=247  Identities=18%  Similarity=0.274  Sum_probs=202.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|+++ +|+.||+|++....... .....++++.++.++|||||+++++|.+.+..|+|||||+||
T Consensus       161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~-~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg  239 (573)
T 3uto_A          161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG  239 (573)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence            3456899999999999886 68899999986543222 233456777889999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC--CceEEeccccccccCCCCCCc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE--YKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~--~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|.+++...  ...+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+... ...
T Consensus       240 ~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~  313 (573)
T 3uto_A          240 ELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV  313 (573)
T ss_dssp             BHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEE
T ss_pred             cHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC-Cce
Confidence            999999643  23588999999999999999999999   99999999999999864  89999999999987543 334


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||....           .......+.......+......
T Consensus       314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~~  382 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDETLRNVKSCDWNMDDSAFSG  382 (573)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHHHHHHHTTCCCCCSGGGTT
T ss_pred             eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----------HHHHHHHHHhCCCCCCcccccC
Confidence            56789999999999999999999999999999999999999986432           1222333333333322223334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++.+++.+||+.||++|||++|+++
T Consensus       383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          383 ISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4566889999999999999999999987

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.3e-40  Score=388.92  Aligned_cols=367  Identities=20%  Similarity=0.221  Sum_probs=283.9

Q ss_pred             CCCcEEEccCceeecccccccccccccceeeeccccccCCC-CcchhccCCCCeEeccCCccccCcChhhhccCCCcEEE
Q 045493          304 KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSI-PEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFA  382 (1048)
Q Consensus       304 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~  382 (1048)
                      ++|++|+|++|.+++..|..|+.+++|+.|++++|.+.+.+ +..|..+++|++|+|++|++++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            57888888888888777888888888888888888776433 56788888888888888888877788888888888888


Q ss_pred             eecccccCCchhh--hhhhcccceeeccccccCCCCCcc-cccCCcccEEEeecccccCCCCCCcccc--cccceeEecC
Q 045493          383 LRENELSGSIPQE--IENMKKLNKYLLFENQFTGYLPQN-VCQSGSLTHFSVRNNNFVGPIPRSLQNC--TSLYSLRLER  457 (1048)
Q Consensus       383 L~~n~l~~~~p~~--~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~L~~L~l~~N~l~~~~~~~l~~l--~~L~~L~L~~  457 (1048)
                      |++|.+++..+..  +..+++|+.|++++|++++..|.. +..+++|++|++++|.+++..+..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            8888888755555  777788888888888887776665 6677777777777777777777777665  5777777777


Q ss_pred             CccccCcccccC--------CCCCCCeeeCcCCcccCcccccccCC---CCccEEEecCcccCcccCccccccCCCcEEE
Q 045493          458 NQLTGNISEVFG--------IYPDLELLDLSNNNFFGEISSNWIKC---PQLATLNMGGNEISGTIPSEIGNMTQLHKLD  526 (1048)
Q Consensus       458 n~l~~~~~~~~~--------~~~~L~~L~Ls~n~l~~~~~~~~~~~---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  526 (1048)
                      |.+.++....+.        .+++|+.|++++|++++..+..+...   ++|+.|++++|.+.+..              
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------  255 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------  255 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence            777765544322        33555666666665555444444322   45555555555544221              


Q ss_pred             cccCcccCCcCccccC--CCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccc
Q 045493          527 FSSNRLVGQIPKQLGK--LTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF  604 (1048)
Q Consensus       527 Ls~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  604 (1048)
                      +..+.+.+..+..+..  .++|++|++++|.+++..|..++.+++|++|+|++|+++++.|..|..+++|++|+|++|++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  335 (455)
T 3v47_A          256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL  335 (455)
T ss_dssp             TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence            1112222222333333  36899999999999988888899999999999999999998888999999999999999999


Q ss_pred             cchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCcc
Q 045493          605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSK  684 (1048)
Q Consensus       605 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~  684 (1048)
                      +++.+..+..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..++.|++|++++|+++|.+|...
T Consensus       336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            99888899999999999999999998889999999999999999999998888889999999999999999999999643

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.2e-40  Score=389.08  Aligned_cols=379  Identities=20%  Similarity=0.214  Sum_probs=249.7

Q ss_pred             EEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCcccc-CCCcCCCCCCCCcEEeCCCC
Q 045493            4 INLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG-IIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         4 ~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      +++++.+    ++++|. .++++++|||++|+|++..|..|+.+++|++|+|++|.+.+ +.|.+|.++++|++|+|++|
T Consensus        15 ~~c~~~~----l~~lp~-l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           15 AICINRG----LHQVPE-LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EECCSSC----CSSCCC-CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             cCcCCCC----cccCCC-CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            4444443    345554 55777777777777777677777777777777777777753 33566777777777777777


Q ss_pred             cCCCCCccccccccccccccccceecccccCc--CcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCC
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPA--SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLES  160 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~--~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~  160 (1048)
                      ++++..|..|.++++|++|++++|++++..|.  .|+.+++|++|++++|++.+                          
T Consensus        90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~--------------------------  143 (455)
T 3v47_A           90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK--------------------------  143 (455)
T ss_dssp             TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCS--------------------------
T ss_pred             ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCc--------------------------
Confidence            77776677777777777777777777653333  36666677777776666653                          


Q ss_pred             CcEEecCCCccccccCCC-CCCCCCcceeeccccCccccCCcccccc--cccceeccccccccccCCcc--------CcC
Q 045493          161 PVSVSLHTNNFSGVIPRS-LGGLKNLTFVYLNNNRIVGSIPSEIGNL--RSLSYLGLNKNQLSGSIPPT--------AGN  229 (1048)
Q Consensus       161 L~~l~l~~n~~~~~~~~~-~~~l~~L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~--------~~~  229 (1048)
                                   ..|.. |..+++|++|++++|++++..|..+..+  .+|++|++++|.+.+..+..        +..
T Consensus       144 -------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~  210 (455)
T 3v47_A          144 -------------IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK  210 (455)
T ss_dssp             -------------CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTT
T ss_pred             -------------cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccc
Confidence                         33333 5666667777777777666666666655  56677777777766433322        235


Q ss_pred             CCCCCeEeccCCccCCCCCcccccc---cccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCC--CC
Q 045493          230 LSNLKFLYLHDNRLSGYIPPKLGSF---KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGN--LK  304 (1048)
Q Consensus       230 l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~--l~  304 (1048)
                      +++|++|++++|.+++..|..+..+   ++|+.|++++|.+.+.... .              +.+....+..+..  .+
T Consensus       211 ~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~-~--------------~~~~~~~~~~~~~~~~~  275 (455)
T 3v47_A          211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-H--------------TNFKDPDNFTFKGLEAS  275 (455)
T ss_dssp             TCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTT-C--------------CSSCCCCTTTTGGGTTS
T ss_pred             cceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccc-h--------------hhhccCccccccccccc
Confidence            5677777777777776666655444   6777777777765532110 0              1122122222222  35


Q ss_pred             CCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEee
Q 045493          305 SLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR  384 (1048)
Q Consensus       305 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  384 (1048)
                      +|+.|++++|.+++..|..|+.+++|+.|++++|.+.+..|..|..+++|++|+|++|.+++..|..+.++++|++|+|+
T Consensus       276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  355 (455)
T 3v47_A          276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLS  355 (455)
T ss_dssp             CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECC
T ss_pred             CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECC
Confidence            78888888888887777788888888888888888877777777788888888888888876667777777888888888


Q ss_pred             cccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCC
Q 045493          385 ENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIP  441 (1048)
Q Consensus       385 ~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~  441 (1048)
                      +|++++..|..+..+++|+.|++++|++++..+..+..+++|++|++++|.+++..|
T Consensus       356 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          356 YNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            777776666667666666666666666665544445555555555555555554433

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.9e-40  Score=369.61  Aligned_cols=280  Identities=34%  Similarity=0.548  Sum_probs=216.8

Q ss_pred             CcchhhhcccCCcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC
Q 045493          767 NNQELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ  846 (1048)
Q Consensus       767 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~  846 (1048)
                      ...++....+.+.....||+|+||.||+|+..+++.||||++..............++..++.++||||+++++++...+
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            44455555555566677999999999999988899999999976554444445566777788899999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          847 HLFLVYEYLERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       847 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      ..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999997643 334589999999999999999999998666899999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcc------cccchhh
Q 045493          926 AKFLKPDSSN-WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAP------AANMNIV  998 (1048)
Q Consensus       926 a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~------~~~~~~~  998 (1048)
                      ++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||+...........      .......
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            9876543332 34456999999999999888999999999999999999999998643211110000      0000111


Q ss_pred             hhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          999 VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....+......  ........+.+++.+||+.||++|||++||+++|++
T Consensus       261 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          261 LEALVDVDLQGN--YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             STTSSCTTCTTS--CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhcChhhccc--cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            112222222221  235667789999999999999999999999999974

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=6.6e-40  Score=381.19  Aligned_cols=390  Identities=25%  Similarity=0.318  Sum_probs=249.9

Q ss_pred             CCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEE
Q 045493          230 LSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHL  309 (1048)
Q Consensus       230 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L  309 (1048)
                      .++|++|++++|.+ +.+|..++++++|++|++++|.+.+.+|..++.+.+|+.+++..|..            .++++|
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~~l~~L   76 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQAHEL   76 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------HTCSEE
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------cCCCEE
Confidence            46777777777777 46777778888888888888887777788888888877777765421            467788


Q ss_pred             EccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeeccccc
Q 045493          310 WLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELS  389 (1048)
Q Consensus       310 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~  389 (1048)
                      ++++|.+++. |..   .++|+.|++++|.+++ +|..   +++|++|++++|++++ +|..   .++|++|++++|+++
T Consensus        77 ~l~~~~l~~l-p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~  144 (454)
T 1jl5_A           77 ELNNLGLSSL-PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE  144 (454)
T ss_dssp             ECTTSCCSCC-CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred             EecCCccccC-CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence            8888887753 332   3677888888888876 5543   3678888888888874 2321   157888888888887


Q ss_pred             CCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccC
Q 045493          390 GSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFG  469 (1048)
Q Consensus       390 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~  469 (1048)
                      + +| .++++++|+.|++++|++++ +|..+   .+|++|++++|.+++ +| .+..+++|++|++++|++++++..   
T Consensus       145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~---  213 (454)
T 1jl5_A          145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL---  213 (454)
T ss_dssp             S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC---
T ss_pred             C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC---
Confidence            5 55 47888888888888888876 44332   478888888888886 44 578888888888888888765432   


Q ss_pred             CCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEE
Q 045493          470 IYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSL  549 (1048)
Q Consensus       470 ~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  549 (1048)
                       .++|+.|++++|.++ .+| .+..+++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|++|
T Consensus       214 -~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L  282 (454)
T 1jl5_A          214 -PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL  282 (454)
T ss_dssp             -CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred             -cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence             257888888888887 444 37788888888888888874 3432   4778888888888875 4433   3678888


Q ss_pred             eecCccccCCCccccccccccceeecccCccccccccccccc-ccccccccccccccchhhhhhccccccCeEECCCCcc
Q 045493          550 TLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGEL-RKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL  628 (1048)
Q Consensus       550 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  628 (1048)
                      ++++|++++. |.   ..++|++|++++|+++++.     .+ ++|++|++++|+++++..    .+++|++|++++|++
T Consensus       283 ~ls~N~l~~l-~~---~~~~L~~L~l~~N~l~~i~-----~~~~~L~~L~Ls~N~l~~lp~----~~~~L~~L~L~~N~l  349 (454)
T 1jl5_A          283 DVSENIFSGL-SE---LPPNLYYLNASSNEIRSLC-----DLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHL  349 (454)
T ss_dssp             ECCSSCCSEE-SC---CCTTCCEEECCSSCCSEEC-----CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCC
T ss_pred             ECcCCccCcc-cC---cCCcCCEEECcCCcCCccc-----CCcCcCCEEECCCCccccccc----cCCcCCEEECCCCcc
Confidence            8888888752 21   1257888888888887642     22 478888888888876432    257888888888888


Q ss_pred             cCcCCcCcCCccccCeEECCCCcccC--Ccccccccc-------------CCccEEEeccceecC--CCCCc
Q 045493          629 GGNIPSEICNLESLEYMNLLQNKLSG--PIPSCFRRM-------------HGLSSIDVSYNELQG--SIPHS  683 (1048)
Q Consensus       629 ~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l-------------~~L~~l~ls~N~l~~--~~p~~  683 (1048)
                      + .+|.   .+++|++|++++|++++  .+|..+..+             ++|++||+++|+++|  .+|.+
T Consensus       350 ~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~s  417 (454)
T 1jl5_A          350 A-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPES  417 (454)
T ss_dssp             S-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-------------------------------
T ss_pred             c-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhh
Confidence            8 4555   36788888888888887  677777777             889999999999998  66653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.3e-39  Score=378.61  Aligned_cols=422  Identities=23%  Similarity=0.297  Sum_probs=178.5

Q ss_pred             CCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEE
Q 045493           47 LSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLS  126 (1048)
Q Consensus        47 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~  126 (1048)
                      .++|++|++++|.+ +.+|.+|+.+++|++|++++|++++..|.+++.+++|+.+++.+|..           .+|++|+
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~   77 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE   77 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence            35566666666666 35666666666666666666666655666666666666666655542           3456666


Q ss_pred             eecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccc
Q 045493          127 LSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNL  206 (1048)
Q Consensus       127 l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l  206 (1048)
                      +++|.+++.                |.                           ..++|++|++++|.+++ +|..   +
T Consensus        78 l~~~~l~~l----------------p~---------------------------~~~~L~~L~l~~n~l~~-lp~~---~  110 (454)
T 1jl5_A           78 LNNLGLSSL----------------PE---------------------------LPPHLESLVASCNSLTE-LPEL---P  110 (454)
T ss_dssp             CTTSCCSCC----------------CS---------------------------CCTTCSEEECCSSCCSS-CCCC---C
T ss_pred             ecCCccccC----------------CC---------------------------CcCCCCEEEccCCcCCc-cccc---c
Confidence            666665521                11                           01344555555555543 3321   2


Q ss_pred             cccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhh
Q 045493          207 RSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHV  286 (1048)
Q Consensus       207 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l  286 (1048)
                      ++|++|++++|++++ +|..   .++|++|++++|.+++ +| .|+++++|++|++++|++++ +|..+           
T Consensus       111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-----------  172 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-----------  172 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-----------
T ss_pred             CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-----------
Confidence            445555555555542 2211   1345555555555553 33 35555555555555555442 12110           


Q ss_pred             ccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCcccc
Q 045493          287 HNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNG  366 (1048)
Q Consensus       287 ~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  366 (1048)
                                       .+|++|++++|++++ +| .++.+++|+.|++++|.+++ +|...   ++|++|++++|.++ 
T Consensus       173 -----------------~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-  228 (454)
T 1jl5_A          173 -----------------PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-  228 (454)
T ss_dssp             -----------------TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-
T ss_pred             -----------------ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-
Confidence                             134444444444433 22 23444444444444444432 22111   24555555555554 


Q ss_pred             CcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCccc
Q 045493          367 SIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQN  446 (1048)
Q Consensus       367 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~  446 (1048)
                      .+|. ++++++|++|++++|++++ +|..   .++|+.|++++|++++ +|..   .++|++|++++|.+++. |..   
T Consensus       229 ~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---  295 (454)
T 1jl5_A          229 ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---  295 (454)
T ss_dssp             SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---
T ss_pred             cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---
Confidence            3332 4455555555555555543 2221   2445555555555554 2221   24566666666666652 111   


Q ss_pred             ccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEE
Q 045493          447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLD  526 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  526 (1048)
                      .++|++|++++|+++++..    ..++|+.|++++|++++ +|..   +++|++|++++|++++ +|.   .+++|++|+
T Consensus       296 ~~~L~~L~l~~N~l~~i~~----~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~  363 (454)
T 1jl5_A          296 PPNLYYLNASSNEIRSLCD----LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLH  363 (454)
T ss_dssp             CTTCCEEECCSSCCSEECC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred             CCcCCEEECcCCcCCcccC----CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEE
Confidence            1467777777777765321    12477778888777775 3322   4677788888887773 444   367788888


Q ss_pred             cccCcccC--CcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccc--ccccccccccccccccccc
Q 045493          527 FSSNRLVG--QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL--IPKNLGELRKLHHLNLSNN  602 (1048)
Q Consensus       527 Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~Ls~N  602 (1048)
                      +++|++++  .+|..+..        |+.|.+.+.+|..   +++|++||+++|+++++  +|      ..|+.|.+++|
T Consensus       364 L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP------~sl~~L~~~~~  426 (454)
T 1jl5_A          364 VEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP------ESVEDLRMNSE  426 (454)
T ss_dssp             CCSSCCSSCCCCCTTCCE--------EECCC-------------------------------------------------
T ss_pred             CCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch------hhHhheeCcCc
Confidence            88888776  44544432        2345555555542   47888999999998873  33      35677788888


Q ss_pred             cccchhhhh
Q 045493          603 QFSQEISIQ  611 (1048)
Q Consensus       603 ~l~~~~~~~  611 (1048)
                      .+.+..+..
T Consensus       427 ~~~~~~~~~  435 (454)
T 1jl5_A          427 RVVDPYEFA  435 (454)
T ss_dssp             ---------
T ss_pred             ccCCccccC
Confidence            887654433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.3e-40  Score=359.55  Aligned_cols=247  Identities=24%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||+||+|.+. +++.||+|++....... .....+++..++.++||||+++++++...+..++||||++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  100 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence            344557899999999999874 68899999986543332 2334566777788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus       101 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A          101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            99999999653    378899999999999999999999   99999999999999999999999999998876665556


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......           ...........+ .......
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~~~~~~~~~~~-~~~~~~~  241 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYLIATNGTP-ELQNPEK  241 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------HHHHHHHHHCSC-CCSCGGG
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhCCCC-CCCCccc
Confidence            6678999999999999999999999999999999999999998632211           011111111111 0111123


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            3456888999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.3e-40  Score=362.74  Aligned_cols=248  Identities=31%  Similarity=0.433  Sum_probs=190.0

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||+||+|+.. ++.||||++........ .....++++.+++++||||+++++++.+.+..++||||+++|+
T Consensus        42 ~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS  120 (309)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred             eeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence            456899999999999874 88899999865433221 1233456677788999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |.+++........+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||+++..........
T Consensus       121 L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  197 (309)
T 3p86_A          121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK  197 (309)
T ss_dssp             HHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence            999997655445589999999999999999999998   8  99999999999999999999999999986554444445


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh--ccCCCCCCchhHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL--IDSRLPPPLGEVE 1015 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 1015 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+  .......+    .
T Consensus       198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----------~~~~~~~~~~~~~~~~~----~  262 (309)
T 3p86_A          198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----------AQVVAAVGFKCKRLEIP----R  262 (309)
T ss_dssp             ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHHHSCCCCCCC----T
T ss_pred             cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhcCCCCCCC----c
Confidence            56799999999999999999999999999999999999999864321           1111111  11111111    1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....+.+++.+||+.||++|||++|+++.|+
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            22346888999999999999999999999886

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-39  Score=362.00  Aligned_cols=268  Identities=28%  Similarity=0.423  Sum_probs=207.5

Q ss_pred             cccCCcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          774 ASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       774 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....+.....||+|+||+||+|++.+++.||+|++....... .....+++..++.++||||+++++++.+.+..++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG-IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH-HHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH-HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            334445556799999999999998889999999886543222 2234556666788899999999999999999999999


Q ss_pred             ccCCCCHHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          854 YLERGSLATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999865432 23589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             C--CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccccc----chhhhhhhccCC
Q 045493          933 S--SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN----MNIVVNDLIDSR 1006 (1048)
Q Consensus       933 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 1006 (1048)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...............    .........++.
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            2  2233456899999999999889999999999999999999999998643321111000000    000111222222


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....  ...+....+.+++.+||+.||++|||++|+++.|+
T Consensus       273 ~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          273 LADK--IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CTTC--SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccc--cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            2221  23466778999999999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.4e-39  Score=363.40  Aligned_cols=249  Identities=18%  Similarity=0.215  Sum_probs=202.1

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      +.....||+|+||+||+|+.+ +++.||+|.+........     ......++..++.++||||+++++++.+.+..|+|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            334557899999999999887 688999999876543221     12345667778889999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC----ceEEecccccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAK  927 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~  927 (1048)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++    .+||+|||+++
T Consensus        94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           94 LELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            9999999999999653   3489999999999999999999999   999999999999998877    79999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ..... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||....           .......+.....
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-----------~~~~~~~i~~~~~  235 (361)
T 2yab_A          168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----------KQETLANITAVSY  235 (361)
T ss_dssp             ECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHHHHHHHTTCC
T ss_pred             EcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhcCC
Confidence            76543 33455689999999999999999999999999999999999999986322           1222333333333


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3322222334556889999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-39  Score=367.41  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=198.6

Q ss_pred             ceeeecccccccEEEEEEc--------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT--------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~l  850 (1048)
                      ....||+|+||.||+|++.        ++..||||+++.............++..++.+ +||||++++++|.+.+..|+
T Consensus        85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  164 (370)
T 2psq_A           85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  164 (370)
T ss_dssp             EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred             eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence            3456899999999999864        23468999986543322223345566677888 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc
Q 045493          851 VYEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK  917 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~  917 (1048)
                      ||||+++|+|.++++....             ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.
T Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  241 (370)
T 2psq_A          165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV  241 (370)
T ss_dssp             EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred             EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCC
Confidence            9999999999999976432             23478999999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCccccc
Q 045493          918 AHVSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAAN  994 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  994 (1048)
                      +||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....           
T Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-----------  310 (370)
T 2psq_A          242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----------  310 (370)
T ss_dssp             EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------
T ss_pred             EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----------
Confidence            99999999987654332  2234467889999999999999999999999999999999 999976322           


Q ss_pred             chhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          995 MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .......+.........   ......+.+++.+||+.||++|||+.|+++.|++
T Consensus       311 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          311 VEELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             GGGHHHHHHTTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11122222222211111   1233468889999999999999999999999863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.8e-39  Score=360.65  Aligned_cols=245  Identities=21%  Similarity=0.236  Sum_probs=198.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++.+...  .........+.+.++.++||||+++++++...+..|+||||++
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~   88 (337)
T 1o6l_A            9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            3456899999999999886 688999999865321  1112234456667788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.+.+   .+++..++.++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++.........
T Consensus        89 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           89 GGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             TCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            999999997543   488999999999999999999999   99999999999999999999999999998755555555


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+.    .
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----~  227 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------HERLFELILMEEIRFPR----T  227 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----T
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----------HHHHHHHHHcCCCCCCC----C
Confidence            67789999999999999999999999999999999999999986322           11222222222222211    2


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      ....+.+++.+||+.||++||     +++|+++.
T Consensus       228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            234678899999999999999     89998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-39  Score=360.53  Aligned_cols=244  Identities=20%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .....||+|+||.||+|++. +++.||+|++....... ......++++.++.++||||+++++++...+..|+||||++
T Consensus        18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   97 (328)
T 3fe3_A           18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence            34557899999999999884 78999999986643322 12223456777788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...+   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus        98 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  170 (328)
T 3fe3_A           98 GGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKL  170 (328)
T ss_dssp             TCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGG
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccc
Confidence            999999996543   488999999999999999999999   9999999999999999999999999999876543 334


Q ss_pred             cccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTMRAN-EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ...+||+.|+|||++.+..+. .++||||+||++|||++|+.||....           .......+..+....+.    
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----------~~~~~~~i~~~~~~~p~----  235 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----------LKELRERVLRGKYRIPF----  235 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCC----
Confidence            567899999999999888775 89999999999999999999986422           12223333333333222    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       236 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          236 YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            12345788999999999999999999976

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-39  Score=361.50  Aligned_cols=251  Identities=22%  Similarity=0.289  Sum_probs=183.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      +.+.||+|+||+||+|.+. +++.||||++....    .....+++..++.+. ||||+++++++.+....|+||||+++
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             TSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            3456899999999999886 67889999986431    223455666677776 99999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||+++.......
T Consensus        91 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           91 GELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             CBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            9999999754   3489999999999999999999999   999999999999998765   899999999987765555


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ...........+..+........+
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~~~~i~~~~~~~~~~~~  240 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL----TCTSAVEIMKKIKKGDFSFEGEAW  240 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc----ccccHHHHHHHHHcCCCCCCcccc
Confidence            5566788999999999999999999999999999999999999987433211    111122334444455554444444


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            555678999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-39  Score=363.12  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=197.5

Q ss_pred             cceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEEEc
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVYEY  854 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~  854 (1048)
                      .....||+|+||+||+|++. ++.||||++......  ......++..++.++||||+++++++....    ..++||||
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ--SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             hhhheecccCceEEEEEEEC-CCEEEEEEeecCchH--HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence            34556899999999999887 789999998643211  122334555567889999999999997643    47999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC-------FPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      +++|+|.++++..    .+++..+..++.|++.||+|||+.+       .++|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          104 HEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence            9999999999653    3899999999999999999999861       2379999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccc-----cc
Q 045493          928 FLKPDSS--NWSELAGTCGYIAPELAYTM-----RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA-----NM  995 (1048)
Q Consensus       928 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~-----~~  995 (1048)
                      .......  ......||+.|+|||++.+.     .++.++||||+||++|||+||+.||.........+....     ..
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            7654332  23346799999999998863     456789999999999999999999875433222211110     11


Q ss_pred             hhhhhhhccCCCCCCch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .............+...   ........+.+++.+||+.||++|||++|+++.|++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            11111222222222111   112445679999999999999999999999999873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=370.63  Aligned_cols=249  Identities=18%  Similarity=0.235  Sum_probs=200.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|... +++.+|+|++....... ......+++..++.++||||+++++++.+.+..|+||||+++
T Consensus        15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   94 (444)
T 3soa_A           15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTG   94 (444)
T ss_dssp             EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred             EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence            3456899999999999875 68889999987543322 122345667778889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC---CCCceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD---LEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++....   .+++..+..++.||+.|++|||+.   +|+||||||+||+++   .++.+||+|||+++.......
T Consensus        95 g~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           95 GELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999987543   488999999999999999999999   999999999999998   467899999999988766555


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+           .......+..+....+...+
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~  237 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----------QHRLYQQIKAGAYDFPSPEW  237 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHHTCCCCCTTTT
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----------HHHHHHHHHhCCCCCCcccc
Confidence            5566789999999999999899999999999999999999999985322           12223333333333222222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          238 DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            3344568899999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-39  Score=355.63  Aligned_cols=275  Identities=30%  Similarity=0.460  Sum_probs=210.5

Q ss_pred             CCcchhhhcccCCcce------eeecccccccEEEEEEcCCCceeeEEeccCCCCc---ccchhhHHHHHHhhcccCcee
Q 045493          766 VNNQELLSASTFEGKM------VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE---IGINQKGFVSEITEIRHRNIV  836 (1048)
Q Consensus       766 ~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~---~~~~~~~~~~~l~~l~h~niv  836 (1048)
                      +...++...+..+...      ..||+|+||.||+|.. +++.||||++.......   ......+++..++.++||||+
T Consensus        15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~   93 (307)
T 2nru_A           15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV   93 (307)
T ss_dssp             CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence            3444444444443333      6799999999999987 48899999987543222   122344566677888999999


Q ss_pred             eEeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC
Q 045493          837 KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY  916 (1048)
Q Consensus       837 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~  916 (1048)
                      ++++++.+.+..++||||+++|+|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~  170 (307)
T 2nru_A           94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF  170 (307)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred             EEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCC
Confidence            99999999999999999999999999997655555689999999999999999999999   999999999999999999


Q ss_pred             ceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccc--
Q 045493          917 KAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA--  992 (1048)
Q Consensus       917 ~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~--  992 (1048)
                      .+||+|||+++........  .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||.............  
T Consensus       171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (307)
T 2nru_A          171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE  249 (307)
T ss_dssp             CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH
T ss_pred             cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH
Confidence            9999999999876543222  234578999999998865 58999999999999999999999987533211110000  


Q ss_pred             -ccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          993 -ANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       993 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       ........+..++.....   .......+.+++.+||+.||++|||++|++++|++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          250 IEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             HHTTSCCHHHHSCSSCSCC---CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             hhhhhhhhhhhcccccccc---chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence             001111233334443332   24456678999999999999999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.4e-39  Score=355.98  Aligned_cols=246  Identities=27%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .....||+|+||.||+|+.. +++.||||++....... .....+++..++.++||||+++++++...+..++||||+++
T Consensus        48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS-HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH-HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            33457899999999999987 78999999986543322 23345667778889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus       127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (321)
T 2c30_A          127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  199 (321)
T ss_dssp             CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence            999999864    2489999999999999999999999   999999999999999999999999999987765545556


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.....+ ........
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~-~~~~~~~~  267 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----------VQAMKRLRDSPPP-KLKNSHKV  267 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSSCC-CCTTGGGS
T ss_pred             cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhcCCCC-CcCccccC
Confidence            67899999999999999999999999999999999999999863221           1111111111111 11111223


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+.+++.+||+.||++|||++|+++
T Consensus       268 ~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          268 SPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            456888999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-38  Score=361.44  Aligned_cols=248  Identities=20%  Similarity=0.245  Sum_probs=193.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++++.....  .......+...+.++ +||||+++++++.+.+..|+||||+
T Consensus        56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~  135 (396)
T 4dc2_A           56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV  135 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence            4457899999999999987 56789999987643221  122234455555555 8999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++.+.+   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.+|++||+|||+|+........
T Consensus       136 ~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          136 NGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence            9999999997543   489999999999999999999999   9999999999999999999999999999875545555


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.........  ...........+.......+.    
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--~~~~~~~~~~~i~~~~~~~p~----  283 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--DQNTEDYLFQVILEKQIRIPR----  283 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------CCHHHHHHHHHHCCCCCCT----
T ss_pred             cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--chhhHHHHHHHHhccccCCCC----
Confidence            66788999999999999999999999999999999999999998643211000  011111122233333322221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      ....++.+++.+||+.||++||++
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            223467889999999999999996

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-38  Score=359.87  Aligned_cols=250  Identities=21%  Similarity=0.244  Sum_probs=201.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC----CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT----GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~----~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||+||+|.+. +++.||+|++.....    ........+++..++.++||||+++++++.+.+..|+||||
T Consensus        28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  107 (351)
T 3c0i_A           28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF  107 (351)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            4456899999999999876 688999998854211    11123345677778889999999999999999999999999


Q ss_pred             cCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc---eEEeccccccccC
Q 045493          855 LERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLK  930 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~~  930 (1048)
                      +++|+|.+++.... ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.   +||+|||+++...
T Consensus       108 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~  184 (351)
T 3c0i_A          108 MDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG  184 (351)
T ss_dssp             CSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence            99999998885432 233478999999999999999999999   9999999999999987654   9999999998876


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||....            ......+........
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------------~~~~~~i~~~~~~~~  252 (351)
T 3c0i_A          185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------------ERLFEGIIKGKYKMN  252 (351)
T ss_dssp             TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------------HHHHHHHHHTCCCCC
T ss_pred             CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------------HHHHHHHHcCCCCCC
Confidence            55444556789999999999999999999999999999999999999986321            122333333333333


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+......+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2222334567889999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-39  Score=356.33  Aligned_cols=247  Identities=21%  Similarity=0.256  Sum_probs=201.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|.+. +++.+|+|.+....  .......+++..++.++||||+++++++.+.+..++||||+++|
T Consensus         9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~   86 (321)
T 1tki_A            9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence            3456899999999999887 57788999886432  22233456777788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC--CCceEEeccccccccCCCCCCc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL--EYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.  ++.+||+|||+++..... ...
T Consensus        87 ~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~  160 (321)
T 1tki_A           87 DIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNF  160 (321)
T ss_dssp             BHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEE
T ss_pred             CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Ccc
Confidence            999999643  23588999999999999999999999   9999999999999997  789999999999876543 334


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+..............
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~~  229 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----------NQQIIENIMNAEYTFDEEAFKE  229 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----------HHHHHHHHHcCCCCCChhhhcc
Confidence            55679999999999998889999999999999999999999986322           2223334444444433333334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...++.+++.+||+.||++|||+.|+++.
T Consensus       230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          230 ISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            45678899999999999999999999873

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=364.13  Aligned_cols=244  Identities=22%  Similarity=0.286  Sum_probs=190.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++.....  .........+.+.+..+ +||||+++++++.+.+..|+||||+
T Consensus        27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~  106 (353)
T 3txo_A           27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFV  106 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCC
Confidence            4456899999999999886 578899999865321  11112233445555555 6999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...+   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.+|++||+|||+|+........
T Consensus       107 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          107 NGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            9999999997543   489999999999999999999999   9999999999999999999999999999865545455


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+.    
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----  245 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-----------EDDLFEAILNDEVVYPT----  245 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----
T ss_pred             ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-----------HHHHHHHHHcCCCCCCC----
Confidence            566789999999999999899999999999999999999999986322           22233333333333221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTM------QKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 1044 (1048)
                      .....+.+++.+||++||++||++      +|+++
T Consensus       246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            123457889999999999999998      67664

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=355.37  Aligned_cols=250  Identities=19%  Similarity=0.224  Sum_probs=200.1

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      +.....||+|+||.||+|... +++.||+|++........     .....+++..++.++||||+++++++.+.+..++|
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   92 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   92 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            334557899999999999886 688999999876433221     12345667778889999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC----ceEEecccccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAK  927 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~  927 (1048)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||+++
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           93 LELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999653   3488999999999999999999999   999999999999999887    89999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.....
T Consensus       167 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~~~~~~~  234 (326)
T 2y0a_A          167 KIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----------KQETLANVSAVNY  234 (326)
T ss_dssp             ECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHHHHHHHHTCC
T ss_pred             ECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----------HHHHHHHHHhcCC
Confidence            76533 23345679999999999999999999999999999999999999985322           1112222222222


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..+..........+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22222222334568899999999999999999999873

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=353.17  Aligned_cols=256  Identities=21%  Similarity=0.278  Sum_probs=202.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC--eEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--HLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|++. +++.||||++.............++++.++.++||||+++++++....  ..++||||++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (319)
T 4euu_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP   92 (319)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCT
T ss_pred             EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCC
Confidence            3456899999999999887 588999999875443333334456777788999999999999987655  7899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE----CCCCceEEeccccccccCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL----DLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      +|+|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++.....
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A           93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             TCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            999999998765555589999999999999999999999   99999999999999    77888999999999876543


Q ss_pred             CCCccccccccccccccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh--
Q 045493          933 SSNWSELAGTCGYIAPELAY--------TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL-- 1002 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1002 (1048)
                      . ......||+.|+|||++.        +..++.++||||+||++|||++|+.||.......       ........+  
T Consensus       170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~  241 (319)
T 4euu_A          170 E-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-------RNKEVMYKIIT  241 (319)
T ss_dssp             C-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG-------GCHHHHHHHHH
T ss_pred             C-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc-------hhHHHHHHHhc
Confidence            3 334567999999999886        4678999999999999999999999986322110       000011111  


Q ss_pred             -------------------ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1003 -------------------IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1003 -------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                                         +.+..+............+.+++.+||+.||++|||++|+++..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                               11122222233356667789999999999999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-38  Score=356.64  Aligned_cols=247  Identities=17%  Similarity=0.321  Sum_probs=197.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC------------
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------------  846 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------------  846 (1048)
                      ....||+|+||.||+|++. +++.||||++.............++++.+++++||||+++++++.+..            
T Consensus        10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~   89 (332)
T 3qd2_B           10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW   89 (332)
T ss_dssp             EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred             eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence            3456899999999999987 788999999976544333344566777888999999999999985543            


Q ss_pred             ---------------------------------------------eEEEEEEccCCCCHHHHHhccccccccCHHHHHHH
Q 045493          847 ---------------------------------------------HLFLVYEYLERGSLATILSNEATAAELDWSKRVNV  881 (1048)
Q Consensus       847 ---------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i  881 (1048)
                                                                   ..++||||+++|+|.++++........++..+..+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i  169 (332)
T 3qd2_B           90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI  169 (332)
T ss_dssp             ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred             hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHH
Confidence                                                         38999999999999999987766666778889999


Q ss_pred             HHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC------------Ccccccccccccccc
Q 045493          882 IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS------------NWSELAGTCGYIAPE  949 (1048)
Q Consensus       882 ~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~gt~~y~aPE  949 (1048)
                      +.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......            ......||+.|+|||
T Consensus       170 ~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          170 FIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            99999999999999   999999999999999999999999999987765421            223457999999999


Q ss_pred             ccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhcc
Q 045493          950 LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCL 1029 (1048)
Q Consensus       950 ~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 1029 (1048)
                      ++.+..++.++||||+||++|||++|..|+..             .............+   .........+.+++.+||
T Consensus       247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l  310 (332)
T 3qd2_B          247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------------RVRIITDVRNLKFP---LLFTQKYPQEHMMVQDML  310 (332)
T ss_dssp             HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------------HHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHH
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------------HHHHHHHhhccCCC---cccccCChhHHHHHHHHc
Confidence            99999999999999999999999998876321             11112222222222   223445567789999999


Q ss_pred             CCCCCCCCCHHHHHHH
Q 045493         1030 DANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1030 ~~dP~~RPt~~evl~~ 1045 (1048)
                      +.||++|||++|+++.
T Consensus       311 ~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          311 SPSPTERPEATDIIEN  326 (332)
T ss_dssp             CSSGGGSCCHHHHHHS
T ss_pred             cCCCCcCCCHHHHhhc
Confidence            9999999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=349.96  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=195.7

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||+||+|.+. +++.||+|++.... .+......++++.++.++||||+++++++.+.+..++||||+++|+
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~   93 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT   93 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence            456899999999999886 57889999875432 2222334566777788999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc---
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~---  936 (1048)
                      |.++++..  ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........   
T Consensus        94 L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           94 LRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             HHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred             HHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence            99999753  23489999999999999999999999   99999999999999999999999999998765332211   


Q ss_pred             -----------cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          937 -----------SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       937 -----------~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                                 ....||+.|+|||++.+..++.++||||+||++|||++|..||.........  ...    ......+.
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~--~~~----~~~~~~~~  242 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--FGL----NVRGFLDR  242 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--SSB----CHHHHHHH
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--Hhh----hhhccccc
Confidence                       1457999999999999999999999999999999999999997643211110  011    11111111


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+..      ....+.+++.+||+.||++|||++|++++|+
T Consensus       243 ~~~~~------~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          243 YCPPN------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             TCCTT------CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCC------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11111      1234778999999999999999999999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=356.88  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             eeeecccccccEEEEEEc----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ...||+|+||.||+|++.    .+..||||++.............+++..++.++||||+++++++.+.+..++||||++
T Consensus        54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (325)
T 3kul_A           54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME  133 (325)
T ss_dssp             EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred             eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence            456899999999999885    2334999998754433333344566777788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|.++++..  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........ 
T Consensus       134 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  208 (325)
T 3kul_A          134 NGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA  208 (325)
T ss_dssp             TCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred             CCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence            99999999643  23589999999999999999999999   9999999999999999999999999999877544322 


Q ss_pred             --ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 --WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 --~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                        .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||....           .......+......+.. 
T Consensus       209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~-  276 (325)
T 3kul_A          209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-----------NRDVISSVEEGYRLPAP-  276 (325)
T ss_dssp             EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-----------HHHHHHHHHTTCCCCCC-
T ss_pred             eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-----------HHHHHHHHHcCCCCCCC-
Confidence              123346778999999998899999999999999999999 999985322           11222222222111111 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                        ......+.+++.+||+.||++|||++|++++|+
T Consensus       277 --~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          277 --MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              123346888999999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-38  Score=360.40  Aligned_cols=248  Identities=19%  Similarity=0.256  Sum_probs=199.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|.+. +++.||+|++....... ......+++..++.++||||+++++++.+.+..|+||||+++
T Consensus        33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g  112 (362)
T 2bdw_A           33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG  112 (362)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            3456899999999999886 68899999987543322 112345567777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.+   +.+||+|||++...... .
T Consensus       113 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~  185 (362)
T 2bdw_A          113 GELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  185 (362)
T ss_dssp             CBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-C
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-c
Confidence            9999998653   3488999999999999999999999   99999999999999865   45999999999876533 3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+...+
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~  254 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----------QHRLYAQIKAGAYDYPSPEW  254 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCCCTTGG
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHhCCCCCCcccc
Confidence            3445689999999999999899999999999999999999999986322           11222333333333222223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          255 DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            3345668899999999999999999999763

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-38  Score=350.75  Aligned_cols=252  Identities=24%  Similarity=0.325  Sum_probs=193.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|++. +++.||+|++........  .....+++..++.++||||+++++++.+.+..|+||||++
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   94 (294)
T 4eqm_A           15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE   94 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence            3456899999999999876 678899999865433221  1233456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-C
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-N  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~  935 (1048)
                      +|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        95 g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           95 GPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             SCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            999999997543   489999999999999999999999   999999999999999999999999999987654322 2


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC-chhH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP-LGEV 1014 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1014 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ............+.. ....
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~  237 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----------VSIAIKHIQDSVPNVTTDVR  237 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----------HHHHHHHHSSCCCCHHHHSC
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhhccCCCcchhcc
Confidence            3346799999999999999999999999999999999999999864321           111111111111111 0001


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhC
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRP-TMQKVCNLLCR 1048 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~ 1048 (1048)
                      ......+.+++.+||++||++|| +++++.+.|++
T Consensus       238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            12335688899999999999998 89999888763

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.5e-39  Score=364.74  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=197.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|++. +++.||||.++.....+......++++.++.++||||+++++++...+..|+||||+++|+
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  198 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD  198 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence            456899999999999987 6888999998754333333345667788899999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--c
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--S  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~  937 (1048)
                      |.++++..+  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........  .
T Consensus       199 L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~  273 (377)
T 3cbl_A          199 FLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG  273 (377)
T ss_dssp             HHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSS
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCC
Confidence            999997532  3488999999999999999999999   99999999999999999999999999998654321111  1


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+......+..   ..
T Consensus       274 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~  339 (377)
T 3cbl_A          274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----------QQTREFVEKGGRLPCP---EL  339 (377)
T ss_dssp             CCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----------HHHHHHHHTTCCCCCC---TT
T ss_pred             CCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---CC
Confidence            2235778999999998899999999999999999998 9999764221           1111112122111111   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....+.+++.+||+.||++|||++++++.|+
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            2346888999999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-38  Score=349.89  Aligned_cols=259  Identities=22%  Similarity=0.280  Sum_probs=192.3

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|++.+++.||+|++....... ......+++..++.++||||+++++++.+.+..++||||+++ 
T Consensus        25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-  103 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-  103 (311)
T ss_dssp             EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-
T ss_pred             hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-
Confidence            345689999999999999889999999986543222 122345667777889999999999999999999999999986 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      ++.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus       104 ~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          104 DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            888887643  23488999999999999999999999   9999999999999999999999999999877655455556


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccccc-hhhhhhhccCCC
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAANM-NIVVNDLIDSRL 1007 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~-~~~~~~~~~~~~ 1007 (1048)
                      ..||+.|+|||++.+ ..++.++||||+||++|||++|+.||........         .+...... ......+.....
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            688999999999876 5689999999999999999999999864322100         00000000 000000000000


Q ss_pred             C----CCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 P----PPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~----~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .    ... ........++.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0    000 001112356889999999999999999999987

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.2e-39  Score=358.83  Aligned_cols=243  Identities=22%  Similarity=0.286  Sum_probs=193.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.+ +++.||+|+++....  .........+...+..+ +||||+++++++.+.+..|+||||+
T Consensus        21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~  100 (345)
T 1xjd_A           21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL  100 (345)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence            3457899999999999986 578899999865321  11111223344445544 8999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...+   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++........
T Consensus       101 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A          101 NGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            9999999997533   488999999999999999999999   9999999999999999999999999999875544445


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+    .
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----------~~~~~~~i~~~~~~~p----~  239 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----------EEELFHSIRMDNPFYP----R  239 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCC----T
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-----------HHHHHHHHHhCCCCCC----c
Confidence            566789999999999999999999999999999999999999986322           1122222222222111    1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQ-KVC 1043 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~-evl 1043 (1048)
                      .....+.+++.+||+.||++||++. |++
T Consensus       240 ~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          240 WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1234678899999999999999997 654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.8e-39  Score=363.29  Aligned_cols=249  Identities=22%  Similarity=0.388  Sum_probs=186.0

Q ss_pred             ceeeecccccccEEEEEEc----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|++.    .+..||||+++............+++..+++++||||+++++++.+.+..++||||+
T Consensus        49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (373)
T 2qol_A           49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM  128 (373)
T ss_dssp             CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCC
Confidence            3456899999999999875    467799999875433332334456677778899999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.++++..  ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       129 ~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          129 ENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             TTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            999999999753  33589999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             ---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          936 ---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       936 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                         .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+......+..
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~  272 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----------QDVIKAVDEGYRLPPP  272 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------HHHHHHHHTTEECCCC
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC
Confidence               122345778999999999999999999999999999998 9999763221           1111222111111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                         ......+.+++.+||+.||++|||+.|++++|+
T Consensus       273 ---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          273 ---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             ---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence               123356888999999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-38  Score=354.48  Aligned_cols=247  Identities=23%  Similarity=0.297  Sum_probs=194.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|++. +++.||+|++.............+++..++.++||||+++++++.+.+..|+||||+++|
T Consensus        11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~   90 (323)
T 3tki_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   90 (323)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence            3456899999999999887 788899999865544433345567778888999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--CCc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNW  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  936 (1048)
                      +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+....  ...
T Consensus        91 ~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           91 ELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             EGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            999998643   3489999999999999999999999   99999999999999999999999999998654322  223


Q ss_pred             cccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....||+.|+|||++.+..+ +.++||||+||++|||++|+.||......          ...............  ...
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------~~~~~~~~~~~~~~~--~~~  232 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----------CQEYSDWKEKKTYLN--PWK  232 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT----------SHHHHHHHTTCTTST--TGG
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH----------HHHHHHHhcccccCC--ccc
Confidence            45689999999999987775 78999999999999999999998642210          011111111111111  112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          233 KIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            33456788999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.5e-38  Score=354.27  Aligned_cols=251  Identities=15%  Similarity=0.167  Sum_probs=198.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|+.. +++.||||.+......   .....+++.++.+ +||||+++++++...+..++||||+ +
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~   88 (330)
T 2izr_A           13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G   88 (330)
T ss_dssp             EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence            4456899999999999874 6888999988654322   2456677788888 8999999999999999999999999 9


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc-----eEEeccccccccCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK-----AHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~-----~kl~DfG~a~~~~~~  932 (1048)
                      |+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++.+...
T Consensus        89 ~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           89 PSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            9999999753  34589999999999999999999999   9999999999999999887     999999999876543


Q ss_pred             CCC-------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          933 SSN-------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       933 ~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ...       .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....        .........+...
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~--------~~~~~~~~~i~~~  235 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA--------DTLKERYQKIGDT  235 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------SSHHHHHHHHHHH
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc--------ccHHHHHHHHHhh
Confidence            321       2456799999999999999999999999999999999999999874321        1111111222111


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+.+.........++.+++..||+.||++||+++++.+.|+
T Consensus       236 ~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          236 KRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             hccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            111111111111127889999999999999999999999885

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-38  Score=343.55  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||+||+|.+.+++.||+|++.......  ....+++..+++++||||+++++++.+.+..++||||+++|+|
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eheecCCCccEEEEEEecCCCeEEEEEecccccCH--HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence            45689999999999999888999999997543322  3355677778899999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-CCcccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  939 (1048)
                      .+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus        93 ~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  167 (269)
T 4hcu_A           93 SDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  167 (269)
T ss_dssp             HHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             HHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCc
Confidence            9999653  23588999999999999999999999   99999999999999999999999999998664322 122334


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+|+.|+|||++.+..++.++||||+|+++|||++ |+.||....           .......+.........   ....
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~---~~~~  233 (269)
T 4hcu_A          168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------NSEVVEDISTGFRLYKP---RLAS  233 (269)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTTCCCCCC---TTSC
T ss_pred             ccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----------HHHHHHHHhcCccCCCC---CcCC
Confidence            57788999999999999999999999999999999 999986322           11222222222111111   1123


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.+||+.||++|||++|++++|++
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          234 THVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            458889999999999999999999999863

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=356.20  Aligned_cols=248  Identities=18%  Similarity=0.233  Sum_probs=185.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||.||+|++. +++.||+|++......   .....++..+++++||||+++++++...+..++||||++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK---KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhH---HHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            444567999999999999987 5778999998754322   234556777888999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~  933 (1048)
                      +|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++..... 
T Consensus       132 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          132 GGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             SCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            99999999653   3488999999999999999999999   9999999999999975   889999999999866432 


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....          .......+...........
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~~~~i~~~~~~~~~~~  274 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG----------DQFMFRRILNCEYYFISPW  274 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC----------HHHHHHHHHTTCCCCCTTT
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc----------cHHHHHHHHhCCCccCCch
Confidence            223456799999999999999999999999999999999999999853221          1112222222222222112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .......+.+++.+||+.||++|||+.|+++.
T Consensus       275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22334568899999999999999999999873

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.8e-38  Score=355.53  Aligned_cols=246  Identities=17%  Similarity=0.246  Sum_probs=196.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|.++ +++.||+|.+......     ..++++.+.++ +||||+++++++.+.+..|+||||+++
T Consensus        26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            3456899999999999886 6788999998654321     23455556555 799999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC----CceEEeccccccccCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE----YKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||++..+    +.+||+|||+++......
T Consensus       101 g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A          101 GELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            9999999654   3489999999999999999999999   99999999999998543    359999999999876655


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......+||+.|+|||++.+..++.++||||+||++|||++|+.||....        ..........+..+........
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~~~~i~~~~~~~~~~~  246 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--------DDTPEEILARIGSGKFSLSGGY  246 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--------TSCHHHHHHHHHHCCCCCCSTT
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--------cCCHHHHHHHHccCCcccCccc
Confidence            55566789999999999988889999999999999999999999986321        1112223333333333332222


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +......+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2334456889999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4e-38  Score=341.60  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=199.0

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ....||+|+||.||+|++.++..||+|++.......  ....+++..+.+++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH--HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            345689999999999999988889999987543322  234566777888999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~  938 (1048)
                      |.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+......... ...
T Consensus        90 L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           90 LLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             HHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred             HHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence            99999654  23488999999999999999999999   9999999999999999999999999999876543221 223


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....           ......+..........   ..
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~---~~  230 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------SEVVLKVSQGHRLYRPH---LA  230 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHHHHHHHTTCCCCCCT---TS
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----------HHHHHHHHcCCCCCCCC---cC
Confidence            456778999999998889999999999999999999 9999863221           11111222221111111   12


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+.+++.+||+.||++|||++|+++.|++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEP  261 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            3458889999999999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-38  Score=356.30  Aligned_cols=244  Identities=20%  Similarity=0.257  Sum_probs=194.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++.....  .........+.+.+..+ +||+|+++++++.+.+..|+||||+
T Consensus        24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~  103 (353)
T 2i0e_A           24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV  103 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence            3456899999999999987 478899999865321  11112233444555555 7999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...+   .+++..++.++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++........
T Consensus       104 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          104 NGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            9999999997543   488999999999999999999999   9999999999999999999999999999865544455


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+.    
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----  242 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----------EDELFQSIMEHNVAYPK----  242 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----------HHHHHHHHHhCCCCCCC----
Confidence            566789999999999999999999999999999999999999986322           12223333333332221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      ....++.+++.+||+.||++||+     ++|+++
T Consensus       243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            23346888999999999999995     567654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-38  Score=349.71  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=187.6

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      ....||+|+||+||+|++ +++.||||++......  ....+.++.....++||||+++++++..    ....++||||+
T Consensus        12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~   88 (301)
T 3q4u_A           12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH   88 (301)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             EEEeeccCCCcEEEEEEE-CCEEEEEEEeccccch--hhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence            345689999999999988 5889999998643211  1111222222334789999999998654    34689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH--------HDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      ++|+|.++++.    ..+++..+..++.|++.||+|||        +.   +|+||||||+||+++.++.+||+|||+++
T Consensus        89 ~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           89 EMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             TTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            99999999953    24899999999999999999999        77   99999999999999999999999999998


Q ss_pred             ccCCCCCC----ccccccccccccccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCcccccccC
Q 045493          928 FLKPDSSN----WSELAGTCGYIAPELAYTM------RANEKCDVFNFGVLVLEVIEG----------KHPGHFLSLLLS  987 (1048)
Q Consensus       928 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg----------~~p~~~~~~~~~  987 (1048)
                      ........    .....||+.|+|||++.+.      .++.++||||+||++|||++|          +.||.....   
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~---  238 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP---  238 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC---
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC---
Confidence            76544332    2334799999999999876      445799999999999999999          555432110   


Q ss_pred             CCcccccchhhhhhhc-cCCCCCCch--hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          988 LPAPAANMNIVVNDLI-DSRLPPPLG--EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       988 ~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                         ............. ....+....  ........+.+++.+||+.||++|||++|+++.|++
T Consensus       239 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          239 ---NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             ---SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence               0111111111111 111111111  123456789999999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.7e-38  Score=347.42  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=189.1

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .....||+|+||.||+|... +++.||+|++.............+++..++.++||||+++++++...+..++||||++ 
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-   86 (317)
T 2pmi_A            8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-   86 (317)
T ss_dssp             -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred             eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence            34456899999999999876 5788999998765443333445667788899999999999999999999999999998 


Q ss_pred             CCHHHHHhccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEA---TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++....   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            59999986532   123488999999999999999999999   999999999999999999999999999987765444


Q ss_pred             CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhhhhhhcc
Q 045493          935 NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......         +.+....+..........
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T 2pmi_A          164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN  243 (317)
T ss_dssp             CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred             cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence            45566899999999998764 68999999999999999999999986433210         000000000000000000


Q ss_pred             CCC----CCCchh------HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRL----PPPLGE------VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~----~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +..    +.....      .......+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000    000000      0012346889999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-38  Score=352.57  Aligned_cols=248  Identities=21%  Similarity=0.245  Sum_probs=192.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++........  ......+...+..+ +||||+++++++.+.+..|+||||+
T Consensus        13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~   92 (345)
T 3a8x_A           13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV   92 (345)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCC
Confidence            3456899999999999986 578899999876432221  11223445555555 8999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++.+.+   .+++..++.++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++........
T Consensus        93 ~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           93 NGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            9999999997543   488999999999999999999999   9999999999999999999999999999865544455


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.........  ...........+.......+.    
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~i~~~~~~~p~----  240 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--DQNTEDYLFQVILEKQIRIPR----  240 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHCCCCCCT----
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc--ccccHHHHHHHHHcCCCCCCC----
Confidence            56678999999999999999999999999999999999999998642211000  001111122222233222221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      .....+.+++.+||+.||++||++
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            223467889999999999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=359.59  Aligned_cols=251  Identities=22%  Similarity=0.302  Sum_probs=197.4

Q ss_pred             ceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....||+|+||+||+|++.      +++.||||++..............++..++.++||||+++++++......++|||
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  154 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE  154 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence            3456899999999999853      4567999998654433333344556667788899999999999999999999999


Q ss_pred             ccCCCCHHHHHhccc----cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEeccccc
Q 045493          854 YLERGSLATILSNEA----TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTA  926 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a  926 (1048)
                      |+++|+|.++++...    ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||++
T Consensus       155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a  231 (367)
T 3l9p_A          155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA  231 (367)
T ss_dssp             CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred             eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence            999999999997543    223588999999999999999999999   999999999999999655   5999999999


Q ss_pred             cccCCCC--CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhc
Q 045493          927 KFLKPDS--SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       927 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      +......  .......||+.|+|||++.+..++.++||||+||++|||++ |+.||....           .......+.
T Consensus       232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-----------~~~~~~~i~  300 (367)
T 3l9p_A          232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----------NQEVLEFVT  300 (367)
T ss_dssp             HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------HHHHHHHHH
T ss_pred             cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHH
Confidence            8653222  22334568999999999999999999999999999999998 999976322           112222222


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ........   ......+.+++.+||+.||++|||++|+++.|+
T Consensus       301 ~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          301 SGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             TTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCCC---ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22222111   122345888999999999999999999999885

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.9e-38  Score=351.52  Aligned_cols=245  Identities=22%  Similarity=0.300  Sum_probs=189.0

Q ss_pred             cceeeecccccccEEEEEE----cCCCceeeEEeccCCCC---cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAEL----TSGDTRAVKKLHSLPTG---EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavk~~~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      .....||+|+||.||+|+.    .+++.||+|+++.....   ........++..++.++||||+++++++...+..|+|
T Consensus        20 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   99 (327)
T 3a62_A           20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLI   99 (327)
T ss_dssp             EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEE
T ss_pred             EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEE
Confidence            3445789999999999987    46889999998764321   1222345567778889999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A          100 LEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999997543   478899999999999999999999   999999999999999999999999999986554


Q ss_pred             CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          932 DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ........+||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.......+.
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----------~~~~~~~i~~~~~~~p~  242 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-----------RKKTIDKILKCKLNLPP  242 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHHTCCCCCT
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHhCCCCCCC
Confidence            4444456789999999999999999999999999999999999999986322           11222233332222211


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                          .....+.+++.+||+.||++||     ++.|+++
T Consensus       243 ----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          243 ----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                1234678899999999999999     7778875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=359.78  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=198.6

Q ss_pred             eeeecccccccEEEEEEcC--------CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS--------GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ...||+|+||+||+|++..        +..||||++.............++++.++.+ +||||+++++++...+..++|
T Consensus        74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  153 (382)
T 3tt0_A           74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  153 (382)
T ss_dssp             EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence            4568999999999998642        2468999987654333223345566667777 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          852 YEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      |||+++|+|.+++.....             ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  230 (382)
T 3tt0_A          154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM  230 (382)
T ss_dssp             EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcE
Confidence            999999999999976432             23589999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccc
Q 045493          919 HVSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      ||+|||+++.......  ......+|+.|+|||++.+..++.++||||+||++|||++ |+.||....           .
T Consensus       231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-----------~  299 (382)
T 3tt0_A          231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V  299 (382)
T ss_dssp             EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------H
T ss_pred             EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----------H
Confidence            9999999987654332  2334567889999999999999999999999999999999 999976322           1


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+.........   .....++.+++.+||+.||++|||++|+++.|++
T Consensus       300 ~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  349 (382)
T 3tt0_A          300 EELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  349 (382)
T ss_dssp             HHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1122222222111111   1223468889999999999999999999999863

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=357.77  Aligned_cols=253  Identities=21%  Similarity=0.362  Sum_probs=200.2

Q ss_pred             cceeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .....||+|+||.||+|++..      ++.||+|+++............+++..++.++||||+++++++.+.+..++||
T Consensus        50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  129 (343)
T 1luf_A           50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF  129 (343)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence            344568999999999998853      37799999875443333334456777788899999999999999999999999


Q ss_pred             EccCCCCHHHHHhcccc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeE
Q 045493          853 EYLERGSLATILSNEAT---------------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVL  911 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIl  911 (1048)
                      ||+++|+|.++++....                     ...+++.+++.++.|+++||+|||+.   +|+||||||+||+
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence            99999999999975321                     14589999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeccccccccCCCC--CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCC
Q 045493          912 LDLEYKAHVSDFGTAKFLKPDS--SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSL  988 (1048)
Q Consensus       912 l~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~  988 (1048)
                      ++.++.+||+|||+++......  .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||....     
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----  281 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-----  281 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC-----
Confidence            9999999999999998654322  12234568899999999999999999999999999999999 999976322     


Q ss_pred             CcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          989 PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                            .......+..........   .....+.+++.+||+.||++|||+.|++++|++
T Consensus       282 ------~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~  332 (343)
T 1luf_A          282 ------HEEVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  332 (343)
T ss_dssp             ------HHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------hHHHHHHHhCCCcCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence                  112222233333222211   223468889999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3e-38  Score=356.99  Aligned_cols=241  Identities=21%  Similarity=0.221  Sum_probs=189.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHH-HhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSE-ITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++.+.......  .....+... ++.++||||+++++++.+.+..|+||||+
T Consensus        42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~  121 (373)
T 2r5t_A           42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI  121 (373)
T ss_dssp             EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence            4557899999999999987 5778999998764322111  111122222 35678999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++.+.+   .+++..++.++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++........
T Consensus       122 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          122 NGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence            9999999997543   478899999999999999999999   9999999999999999999999999999875544455


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+           .......+.......+.    
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~~----  260 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----------TAEMYDNILNKPLQLKP----  260 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----------HHHHHHHHHHSCCCCCS----
T ss_pred             cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----------HHHHHHHHHhcccCCCC----
Confidence            567789999999999999999999999999999999999999986322           12223333333222211    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQK 1041 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~e 1041 (1048)
                      .....+.+++.+||+.||++||++.+
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            12345788999999999999999853

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.9e-38  Score=350.95  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=191.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCc----eeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDT----RAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~----vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||+||+|.+. +++.    ||+|.+.............+++..++.++||||+++++++. .+..++||||
T Consensus        17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   95 (325)
T 3kex_A           17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY   95 (325)
T ss_dssp             EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred             eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence            3456899999999999876 4454    66666654443333344566777888899999999999986 4568999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        96 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           96 LPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             CTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             CCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            9999999999653  23588899999999999999999999   999999999999999999999999999988754432


Q ss_pred             --CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 --NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                        ......||+.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+.........
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~  239 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----------AEVPDLLEKGERLAQP  239 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----------THHHHHHHTTCBCCCC
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----------HHHHHHHHcCCCCCCC
Confidence              2344567889999999999999999999999999999999 9999864221           1111111111111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                         ......+.+++.+||+.||++|||++|+++.|+
T Consensus       240 ---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          240 ---QICTIDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             ---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             ---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence               112235778899999999999999999999886

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.6e-39  Score=365.16  Aligned_cols=246  Identities=20%  Similarity=0.252  Sum_probs=195.8

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCC--CCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLP--TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~--~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.....||+|+||+||+|+++ +++.||+|++.+..  .........++...++.++||||+++++++.+.+..|+||||
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~  150 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY  150 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            344567999999999999987 57889999886521  111223345667778889999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++++.    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+|+.......
T Consensus       151 ~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          151 MPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             CTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             CCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            9999999999643    378899999999999999999999   999999999999999999999999999987654332


Q ss_pred             -CccccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC----
Q 045493          935 -NWSELAGTCGYIAPELAYTMR----ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS---- 1005 (1048)
Q Consensus       935 -~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 1005 (1048)
                       .....+||+.|+|||++.+..    ++.++||||+||++|||++|+.||...+.           ......+...    
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----------VGTYSKIMNHKNSL  292 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTHHHHC
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----------hhHHHHHHhccccc
Confidence             234578999999999998765    78999999999999999999999863221           1122222211    


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCNL 1045 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 1045 (1048)
                      ..+..    ......+.+++.+||+.+|++  ||+++|++++
T Consensus       293 ~~p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 TFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cCCCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            12211    122346788899999999999  9999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-38  Score=352.81  Aligned_cols=242  Identities=19%  Similarity=0.292  Sum_probs=193.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -...||+|+||.||+|++. +++.||+|++.....  .+......+++..++.++||||+++++++...+..++||||+ 
T Consensus        13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-   91 (336)
T 3h4j_B           13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-   91 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence            3456899999999999974 788999999864321  122234556777788999999999999999999999999999 


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...+   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++...... ...
T Consensus        92 ~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~  164 (336)
T 3h4j_B           92 GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFL  164 (336)
T ss_dssp             CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTT
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC-ccc
Confidence            679999986543   489999999999999999999999   9999999999999999999999999999876543 334


Q ss_pred             cccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ...+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.....           .....+.......+    .
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------~~~~~i~~~~~~~p----~  229 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------NLFKKVNSCVYVMP----D  229 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------TCBCCCCSSCCCCC----T
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------HHHHHHHcCCCCCc----c
Confidence            55689999999999988776 78999999999999999999998642211           01111111111111    1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          230 FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            12345788999999999999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-38  Score=348.05  Aligned_cols=241  Identities=24%  Similarity=0.315  Sum_probs=195.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.+ +++.||+|++......  .......++...++.++||||+++++++.+.+..|+||||++
T Consensus        10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   89 (318)
T 1fot_A           10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence            3456899999999999886 6889999998653211  112233456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.++++...   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++....   ..
T Consensus        90 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~  160 (318)
T 1fot_A           90 GGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VT  160 (318)
T ss_dssp             SCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CB
T ss_pred             CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC---cc
Confidence            999999997543   488999999999999999999999   999999999999999999999999999987543   23


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.......+.    .
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----------~~~~~~~i~~~~~~~p~----~  225 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----------TMKTYEKILNAELRFPP----F  225 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHHHHCCCCCCT----T
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCC----C
Confidence            35689999999999999999999999999999999999999986322           11222333333322221    1


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      ...++.+++.+|++.||++||     +++|+++
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            234678899999999999999     8888875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-38  Score=360.89  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             CcceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCC-eEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQ-HLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~-~~~  849 (1048)
                      +.....||+|+||.||+|++.      +++.||||++..............+++.+.++ +||||+++++++.+.+ ..+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            334557899999999999743      35689999997644333333345566667777 7999999999997754 489


Q ss_pred             EEEEccCCCCHHHHHhcccc------------------------------------------------------------
Q 045493          850 LVYEYLERGSLATILSNEAT------------------------------------------------------------  869 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~------------------------------------------------------------  869 (1048)
                      +||||+++|+|.++++....                                                            
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999975432                                                            


Q ss_pred             ---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--ccccccccc
Q 045493          870 ---AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCG  944 (1048)
Q Consensus       870 ---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~  944 (1048)
                         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........  .....||+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence               11288999999999999999999999   9999999999999999999999999999876443322  234568899


Q ss_pred             cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHH
Q 045493          945 YIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIA 1023 (1048)
Q Consensus       945 y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1023 (1048)
                      |+|||++.+..++.++||||+||++|||++ |+.||.....          .......+.........   ......+.+
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~---~~~~~~l~~  327 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------DEEFCRRLKEGTRMRAP---DYTTPEMYQ  327 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----------SHHHHHHHHHTCCCCCC---TTCCHHHHH
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----------hHHHHHHHHcCCCCCCC---CCCCHHHHH
Confidence            999999999999999999999999999998 9999863221          11111111111111111   112345888


Q ss_pred             HHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1024 VAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1024 l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ++.+||+.||++|||++|++++|+
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHH
Confidence            999999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-38  Score=359.15  Aligned_cols=246  Identities=20%  Similarity=0.249  Sum_probs=184.7

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHH-hhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEI-TEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      ..||+|+||+||+|.+. +++.||||++...      ....+++..+ +..+||||+++++++..    ....|+||||+
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            46899999999999886 6788999998532      1233344443 45589999999998865    56789999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~  932 (1048)
                      ++|+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       142 ~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          142 DGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             CSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            9999999997543 23589999999999999999999999   9999999999999997   789999999999865432


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                       ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........       ......+..+....+..
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          218 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------CSHHHHHHHTCCCCCTT
T ss_pred             -CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------HHHHHHHHcCcccCCCc
Confidence             2334568999999999999999999999999999999999999998743321110       01111122222222211


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.....++.+++.+||+.||++|||++|+++.
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            222344568899999999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.7e-38  Score=344.98  Aligned_cols=257  Identities=19%  Similarity=0.267  Sum_probs=192.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||+|++........ .....+++..+++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   85 (292)
T 3o0g_A            6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence            3456899999999999886 578899999875443221 23344567777889999999999999999999999999987


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                       ++.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        86 -~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           86 -DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             -EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             -CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence             566555432  23489999999999999999999999   999999999999999999999999999987765555556


Q ss_pred             ccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccc----------cCCCcccccchhhhhhhccCC
Q 045493          938 ELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLL----------LSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      ...||+.|+|||++.+.. ++.++||||+||++|||++|+.||......          ...+....+  .......+..
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~  237 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW--PSMTKLPDYK  237 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC--TTGGGSTTCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh--hhhccccccc
Confidence            678999999999998766 799999999999999999998885321110          000000000  0000000000


Q ss_pred             -------CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 -------LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 -------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                             ..............+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   00000011123456789999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.3e-38  Score=354.74  Aligned_cols=246  Identities=23%  Similarity=0.333  Sum_probs=194.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|++.....  .........+++.++.++|||||++++++.+.+..|+||||++
T Consensus        19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   98 (384)
T 4fr4_A           19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL   98 (384)
T ss_dssp             EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            3456899999999999886 577899998865321  1112233456777788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.+|.+||+|||+++.+... ...
T Consensus        99 gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~  171 (384)
T 4fr4_A           99 GGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQI  171 (384)
T ss_dssp             TEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCB
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-Cce
Confidence            99999999753   3489999999999999999999999   9999999999999999999999999999876533 344


Q ss_pred             ccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          937 SELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ...+||+.|+|||++.+   ..++.++||||+||++|||++|+.||.....        .........+.......+   
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~p---  240 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--------TSSKEIVHTFETTVVTYP---  240 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT--------SCHHHHHHHHHHCCCCCC---
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC--------ccHHHHHHHHhhcccCCC---
Confidence            56789999999999864   4589999999999999999999999863221        111112222222222211   


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPT-MQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 1044 (1048)
                       ......+.+++.+||+.||++||+ ++++.+
T Consensus       241 -~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          241 -SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             122346889999999999999998 777654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.1e-38  Score=343.38  Aligned_cols=260  Identities=24%  Similarity=0.319  Sum_probs=190.9

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|+..+++.||+|++....... ......+++..++.++||||+++++++...+..++||||+++ 
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   84 (288)
T 1ob3_A            6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-   84 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred             hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence            345689999999999999889999999986543322 123344567777888999999999999999999999999986 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        85 ~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           85 DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            999998653  23488999999999999999999999   9999999999999999999999999999876544444455


Q ss_pred             cccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhhhhhhccCCCC
Q 045493          939 LAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      ..||+.|+|||++.+. .++.++||||+||++|||++|+.||.......         ..+....+.........++...
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence            6789999999998764 58999999999999999999999986432110         0000000000000000011110


Q ss_pred             ----CCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1009 ----PPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1009 ----~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                          .+.. ........+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                0000 011223567899999999999999999999863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.5e-38  Score=349.24  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=198.4

Q ss_pred             ceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....||+|+||.||+|.+.      +++.||+|++.............++++.++.++||||+++++++.+.+..++|||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  106 (314)
T 2ivs_A           27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE  106 (314)
T ss_dssp             EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence            3456899999999999863      3467899998754333322334556777788899999999999999999999999


Q ss_pred             ccCCCCHHHHHhcccc---------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE
Q 045493          854 YLERGSLATILSNEAT---------------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL  912 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll  912 (1048)
                      |+++|+|.+++.....                     ...+++.++..++.|++.||+|||+.   +|+||||||+||++
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli  183 (314)
T 2ivs_A          107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV  183 (314)
T ss_dssp             CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEE
Confidence            9999999999975432                     23488999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCC
Q 045493          913 DLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLP  989 (1048)
Q Consensus       913 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~  989 (1048)
                      +.++.+||+|||+++........  .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....     
T Consensus       184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----  258 (314)
T 2ivs_A          184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-----  258 (314)
T ss_dssp             ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            99999999999999876543322  233457889999999998889999999999999999999 9999863221     


Q ss_pred             cccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          990 APAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                            ......+.........   ......+.+++.+||+.||++|||++|+++.|++
T Consensus       259 ------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          259 ------ERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             ------GGHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHHHHHhhcCCcCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                  1111112121111111   1233468899999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.5e-38  Score=350.68  Aligned_cols=248  Identities=19%  Similarity=0.324  Sum_probs=187.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCc----eeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDT----RAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~----vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||+||+|++. +++.    ||+|++.............+++..+++++||||++++++|.... .++|+||
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~   97 (327)
T 3poz_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL   97 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEEC
T ss_pred             cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEe
Confidence            4457899999999999875 4444    46776654433333344556777788899999999999998755 7899999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        98 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           98 MPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            99999999997532  3588999999999999999999999   999999999999999999999999999987654433


Q ss_pred             C--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 N--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      .  .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+......+..
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~  241 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------SEISSILEKGERLPQP  241 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHHHHHTTCCCCCC
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----------HHHHHHHHcCCCCCCC
Confidence            2  233456889999999999999999999999999999999 9999864221           1111111111111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                         ......+.+++.+||+.||++|||++|+++.|+
T Consensus       242 ---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          242 ---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             ---TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             ---ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence               123346888999999999999999999999885

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.4e-38  Score=351.96  Aligned_cols=241  Identities=20%  Similarity=0.239  Sum_probs=196.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|++......  ........+.+.++.++||||+++++++.+.+..|+||||++
T Consensus        45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  124 (350)
T 1rdq_E           45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence            4457899999999999986 6889999998653211  112233456667788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.+.+   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+|.+||+|||+++.....   .
T Consensus       125 gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~  195 (350)
T 1rdq_E          125 GGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             TCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC---c
Confidence            999999997543   488999999999999999999999   9999999999999999999999999999876432   3


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+..+....+.    .
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----~  260 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----------PIQIYEKIVSGKVRFPS----H  260 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----T
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----------HHHHHHHHHcCCCCCCC----C
Confidence            35679999999999999999999999999999999999999986322           12223333333332221    2


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++||+     ++|+++
T Consensus       261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2346888999999999999998     888875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-38  Score=345.35  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=189.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-------------------------ccchhhHHHHHHhhcccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-------------------------IGINQKGFVSEITEIRHR  833 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-------------------------~~~~~~~~~~~l~~l~h~  833 (1048)
                      ....||+|+||.||+|++. +++.||+|++.......                         ......++++.++.++||
T Consensus        17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   96 (298)
T 2zv2_A           17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP   96 (298)
T ss_dssp             EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence            3456899999999999876 67889999986543211                         112345677778889999


Q ss_pred             ceeeEeeEeee--CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeE
Q 045493          834 NIVKFYGFCSH--TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVL  911 (1048)
Q Consensus       834 niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIl  911 (1048)
                      ||+++++++.+  .+..|+||||+++|+|.+++.    ...+++..+..++.|++.||+|||+.   +|+||||||+||+
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL  169 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence            99999999976  568999999999999987653    23589999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeccccccccCCCCCCccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCcccccccCC
Q 045493          912 LDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR---ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL  988 (1048)
Q Consensus       912 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  988 (1048)
                      ++.++.+||+|||+++.............||+.|+|||++.+..   ++.++||||+||++|||++|+.||.....    
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----  245 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI----  245 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH----
Confidence            99999999999999987765544455678999999999998765   37889999999999999999999863221    


Q ss_pred             CcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          989 PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                             ......+.......+.  .......+.+++.+||+.||++|||++|+++
T Consensus       246 -------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 -------MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             -------HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                   1111111111111110  0122345888999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.2e-37  Score=345.04  Aligned_cols=249  Identities=17%  Similarity=0.216  Sum_probs=199.5

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .....||+|+||.||+|+.. +++.||+|++........     .....+++..++.++||||+++++++.+.+..++||
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (321)
T 2a2a_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL   94 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            34456899999999999886 688899999876543221     123455677778899999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC----ceEEeccccccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAKF  928 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~~  928 (1048)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||+++.
T Consensus        95 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           95 ELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             CCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            999999999999653   3478999999999999999999999   999999999999999887    799999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCC
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      .... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+......
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~~~~i~~~~~~  236 (321)
T 2a2a_A          169 IEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----------KQETLANITSVSYD  236 (321)
T ss_dssp             CCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHHHHHHHTTCCC
T ss_pred             cCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHhcccc
Confidence            6543 23345679999999999999999999999999999999999999986322           11222222222222


Q ss_pred             CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1009 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+..........+.+++.+||+.||++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2221122334568899999999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=354.49  Aligned_cols=250  Identities=18%  Similarity=0.211  Sum_probs=197.9

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||.||+|... +++.+|+|++...... ......+++..++.++||||+++++++.+.+..++||||++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            344557899999999999886 5778888887653321 12344567777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC--CCceEEeccccccccCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL--EYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++..... .
T Consensus       132 gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~  205 (387)
T 1kob_A          132 GGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E  205 (387)
T ss_dssp             CCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred             CCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC-c
Confidence            99999998643  23589999999999999999999999   9999999999999984  478999999999876543 2


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+............
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----------~~~~~~i~~~~~~~~~~~~  274 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------LETLQNVKRCDWEFDEDAF  274 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------HHHHHHHHHCCCCCCSSTT
T ss_pred             ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCCCCcccc
Confidence            33455799999999999999999999999999999999999999864321           1111222222211111111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....++.+++.+||+.||++|||++|+++.
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            2334568899999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.4e-38  Score=367.00  Aligned_cols=244  Identities=20%  Similarity=0.233  Sum_probs=190.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCC--CCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLP--TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~--~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|++....  ..........+.+.++.++||||+++++++...+..|+||||++
T Consensus       152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  231 (446)
T 4ejn_A          152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN  231 (446)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred             EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence            4457899999999999876 68899999986532  11111223345555677889999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +|+|.+++....   .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+|+........
T Consensus       232 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          232 GGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             SCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            999999997543   48899999999999999999998 7   9999999999999999999999999999876555555


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.......+.    
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----  370 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------HEKLFELILMEEIRFPR----  370 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----
T ss_pred             cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----------HHHHHHHHHhCCCCCCc----
Confidence            566789999999999999999999999999999999999999986322           11222222222222211    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++||     |++|+++
T Consensus       371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1234678899999999999999     9999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-37  Score=343.37  Aligned_cols=251  Identities=16%  Similarity=0.192  Sum_probs=197.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|... +++.||+|++......   ....++++.+..+ +|++++++++++.+....++||||+ +
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   89 (298)
T 1csn_A           14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   89 (298)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence            3456899999999999874 6889999988654322   2455667777777 7999999999999999999999999 9


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc-----eEEeccccccccCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK-----AHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~-----~kl~DfG~a~~~~~~  932 (1048)
                      |+|.++++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++.....
T Consensus        90 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           90 PSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            99999997532  3489999999999999999999999   9999999999999988776     999999999876543


Q ss_pred             CC-------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          933 SS-------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       933 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ..       ......||+.|+|||++.+..++.++||||+||++|||++|+.||......        ........+...
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~  236 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------TNKQKYERIGEK  236 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--------CHHHHHHHHHHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--------ccHHHHHHHHhh
Confidence            22       134567999999999999999999999999999999999999998743210        111111111111


Q ss_pred             CCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1006 RLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1006 ~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....+. .........+.+++.+||+.||++|||++++++.|+
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            111110 001123456889999999999999999999999886

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.9e-38  Score=341.48  Aligned_cols=246  Identities=21%  Similarity=0.359  Sum_probs=195.3

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||+||+|++.++..||+|++.......  ....++++.+..++||||+++++++.+.+..++||||+++|+|
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL  106 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTSBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH--HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence            45689999999999999988899999997543322  3345677778889999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-CCcccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  939 (1048)
                      .+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus       107 ~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  181 (283)
T 3gen_A          107 LNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  181 (283)
T ss_dssp             HHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred             HHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence            9999653  23489999999999999999999999   99999999999999999999999999998664321 112234


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+..........   ...
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~---~~~  247 (283)
T 3gen_A          182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------SETAEHIAQGLRLYRPH---LAS  247 (283)
T ss_dssp             TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------HHHHHHHHTTCCCCCCT---TCC
T ss_pred             ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------hHHHHHHhcccCCCCCC---cCC
Confidence            56788999999999999999999999999999998 9999863221           11122222221111111   112


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+.+++.+||+.||++|||++|+++.|+
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            45888999999999999999999999886

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=351.71  Aligned_cols=252  Identities=21%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             ceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ....||+|+||.||+|++.      ++..||+|++..............++..+.++ +||||+++++++...+..++||
T Consensus        49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  128 (344)
T 1rjb_A           49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF  128 (344)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence            3457899999999999862      34579999987554433344456677778888 8999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccc--------------------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE
Q 045493          853 EYLERGSLATILSNEATA--------------------AELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL  912 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll  912 (1048)
                      ||+++|+|.+++......                    ..+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll  205 (344)
T 1rjb_A          129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLV  205 (344)
T ss_dssp             ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEE
T ss_pred             ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEE
Confidence            999999999999754321                    2378999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCC
Q 045493          913 DLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLP  989 (1048)
Q Consensus       913 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~  989 (1048)
                      +.++.+||+|||++.........  .....||+.|+|||++.+..++.++||||+||++|||+| |+.||.....     
T Consensus       206 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----  280 (344)
T 1rjb_A          206 THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-----  280 (344)
T ss_dssp             ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-----
T ss_pred             cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-----
Confidence            99999999999999876544332  234457889999999999999999999999999999998 9999864221     


Q ss_pred             cccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          990 APAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                            ................  .......+.+++.+||+.||++|||+.|++++|+
T Consensus       281 ------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          281 ------DANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             ------SHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence                  1111111111111110  0122346888999999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=353.11  Aligned_cols=246  Identities=21%  Similarity=0.261  Sum_probs=193.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||.||+|+.. +++.||+|++...... ......+++..++.++||||+++++++.+.+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK-DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            456899999999999875 6888999998754322 22344567777888999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE--CCCCceEEeccccccccCCCCCCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL--DLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll--~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||++  +.++.+||+|||+++.+.... ...
T Consensus       173 L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~  246 (373)
T 2x4f_A          173 LFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK  246 (373)
T ss_dssp             EHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCC
T ss_pred             HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccc
Confidence            99998643  23488999999999999999999999   99999999999999  567899999999998765432 334


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+...............
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~  315 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----------AETLNNILACRWDLEDEEFQDI  315 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCCSCSGGGTTS
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhccCCCChhhhccC
Confidence            45799999999999988999999999999999999999999863221           1222233333322222222334


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+.+++.+||+.||++|||++|+++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            457889999999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.2e-38  Score=349.54  Aligned_cols=254  Identities=19%  Similarity=0.309  Sum_probs=199.6

Q ss_pred             CcceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      +.....||+|+||.||+|.+.      +++.||+|++.............+++..++.++||||+++++++.+.+..++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            344567899999999999765      36789999987543333223345567777888999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          852 YEYLERGSLATILSNEAT-------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      |||+++|+|.++++....       ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence            999999999999965321       13468899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhh
Q 045493          925 TAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       925 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      +++........  .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||....           .......
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----------~~~~~~~  252 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----------NEQVLRF  252 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----------HHHHHHH
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-----------HHHHHHH
Confidence            99866433221  223456889999999999999999999999999999999 888876322           1122222


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +..........   .....+.+++.+||+.||++|||+.|+++.|++
T Consensus       253 ~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~  296 (322)
T 1p4o_A          253 VMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  296 (322)
T ss_dssp             HHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             HHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            22222222211   223457889999999999999999999999863

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-37  Score=351.89  Aligned_cols=259  Identities=22%  Similarity=0.207  Sum_probs=196.5

Q ss_pred             hcccCCcceeeecccccccEEEEEEc-CCCceeeEEeccCC----CCcccchhhHHHHHHhhcccCceeeEeeEeeeCCe
Q 045493          773 SASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLP----TGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH  847 (1048)
Q Consensus       773 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~----~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~  847 (1048)
                      ...+.+.....||+|+||+||+|... +++.||+|++....    .........++++.++.++||||+++++++.+.+.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            33333445567999999999999885 67788999886532    11222334556777888999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhccc-------------------------------------cccccCHHHHHHHHHHHHHHHH
Q 045493          848 LFLVYEYLERGSLATILSNEA-------------------------------------TAAELDWSKRVNVIKGVANALS  890 (1048)
Q Consensus       848 ~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~L~  890 (1048)
                      .++||||+++|+|.+++....                                     ....+++..+..++.|++.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            999999999999999985211                                     0112456778899999999999


Q ss_pred             HHHhCCCCCeEeeCCCCCCeEECCCC--ceEEeccccccccCCCCC----Ccccccccccccccccccc--CCCCchhhH
Q 045493          891 YMHHDCFPPILHRDISSKKVLLDLEY--KAHVSDFGTAKFLKPDSS----NWSELAGTCGYIAPELAYT--MRANEKCDV  962 (1048)
Q Consensus       891 ~LH~~~~~~iiH~Dik~~NIll~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv  962 (1048)
                      |||+.   +|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||++.+  ..++.++||
T Consensus       183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99999   999999999999998776  899999999986543221    2345679999999999875  678999999


Q ss_pred             HHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 045493          963 FNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042 (1048)
Q Consensus       963 ws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 1042 (1048)
                      ||+||++|||++|+.||....           .......+..................+.+++.+||+.||++|||+.|+
T Consensus       260 wslG~il~el~~g~~pf~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVN-----------DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCC-----------hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            999999999999999986322           122233333333333333333345678899999999999999999999


Q ss_pred             HHH
Q 045493         1043 CNL 1045 (1048)
Q Consensus      1043 l~~ 1045 (1048)
                      ++.
T Consensus       329 l~h  331 (345)
T 3hko_A          329 LQH  331 (345)
T ss_dssp             HHS
T ss_pred             hcC
Confidence            873

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.9e-38  Score=339.53  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=184.2

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCccc---chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG---INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|.+. ++.||||++.........   ....++...++.++||||+++++++.+.+..++||||++
T Consensus        11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (271)
T 3dtc_A           11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR   89 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred             eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence            3456899999999999986 889999998764333222   233456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC--------CCceEEeccccccc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL--------EYKAHVSDFGTAKF  928 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~--------~~~~kl~DfG~a~~  928 (1048)
                      +|+|.++++.    ..+++..+..++.|++.|++|||+....+|+||||||+||+++.        ++.+||+|||.++.
T Consensus        90 ~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           90 GGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             TEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             CCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            9999999853    34889999999999999999999992223999999999999986        67899999999986


Q ss_pred             cCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCC
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1048)
                      .....  .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.....           .............
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~  232 (271)
T 3dtc_A          166 WHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----------LAVAYGVAMNKLA  232 (271)
T ss_dssp             ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHHTSCCC
T ss_pred             ccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHhhhcCCCC
Confidence            64332  2245789999999999999999999999999999999999999864321           1111111111111


Q ss_pred             CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1009 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...  .......+.+++.+||+.||++|||++|++++|++
T Consensus       233 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          233 LPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            111  11223468889999999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=343.36  Aligned_cols=243  Identities=22%  Similarity=0.231  Sum_probs=185.5

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc-chhhHHHHHH-hhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG-INQKGFVSEI-TEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~-~~~~~~~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||+||+|++. +++.||||++......... .....++..+ ...+||||++++++|.+.+..++||||+
T Consensus        60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~  139 (311)
T 3p1a_A           60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC  139 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence            34456899999999999987 7889999987654332211 1111222222 3338999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                       +|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus       140 -~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~  212 (311)
T 3p1a_A          140 -GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GA  212 (311)
T ss_dssp             -CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC-CC
Confidence             669999886543  3589999999999999999999999   9999999999999999999999999999876433 22


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+ .++.++||||+||++|||++|..|+.....              ...+.....+  .....
T Consensus       213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------------~~~~~~~~~~--~~~~~  275 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------------WQQLRQGYLP--PEFTA  275 (311)
T ss_dssp             --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------------HHHHTTTCCC--HHHHT
T ss_pred             CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------------HHHHhccCCC--ccccc
Confidence            344569999999998876 799999999999999999999776442211              1112222211  11122


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....+.+++.+||+.||++|||++|+++.
T Consensus       276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          276 GLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            234578899999999999999999999863

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.5e-38  Score=364.92  Aligned_cols=248  Identities=20%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ....||+|+||.||+|.+.++..||||+++....  ......++++.++.++||||+++++++. .+..++||||+++|+
T Consensus       192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~  268 (454)
T 1qcf_A          192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS  268 (454)
T ss_dssp             EEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             EEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence            3456899999999999998888999999875332  2234556777788999999999999987 567899999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  938 (1048)
                      |.++++... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       269 L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~  344 (454)
T 1qcf_A          269 LLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG  344 (454)
T ss_dssp             HHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred             HHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence            999997532 23478899999999999999999999   999999999999999999999999999987643211 1223


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+|+.|+|||++....++.++|||||||++|||+| |+.||.....           ......+..+...+..   ...
T Consensus       345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~---~~~  410 (454)
T 1qcf_A          345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------PEVIRALERGYRMPRP---ENC  410 (454)
T ss_dssp             SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------HHHHHHHHHTCCCCCC---TTS
T ss_pred             CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---CCC
Confidence            446789999999998999999999999999999999 9999863221           1122222222111111   123


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+.+++.+||+.||++|||++++++.|+.
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~  441 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDD  441 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            4568899999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=349.44  Aligned_cols=259  Identities=18%  Similarity=0.235  Sum_probs=187.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|+.. +++.||+|++.............++++.++.++||||+++++++...+..++||||+++ 
T Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   84 (324)
T 3mtl_A            6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-   84 (324)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred             EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-
Confidence            3456899999999999887 68889999986544333333344567788899999999999999999999999999985 


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        85 ~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           85 DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            9999986532  3488999999999999999999999   9999999999999999999999999999876554445556


Q ss_pred             ccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccccc----chhhhhhhcc
Q 045493          939 LAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAAN----MNIVVNDLID 1004 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~----~~~~~~~~~~ 1004 (1048)
                      ..||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......         +.+.....    ..........
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            678999999999876 568999999999999999999999986433110         00000000    0000001000


Q ss_pred             CCCCCC--chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPP--LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +.....  ..........+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            110000  0011122356789999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.5e-38  Score=345.70  Aligned_cols=260  Identities=22%  Similarity=0.315  Sum_probs=192.9

Q ss_pred             ceeeecccccccEEEEEE-----cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  852 (1048)
                      ....||+|+||+||+|++     .+++.||||++..... .......+++..++.++||||+++++++..  ....++||
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   92 (295)
T 3ugc_A           14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM   92 (295)
T ss_dssp             EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEE
T ss_pred             hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEE
Confidence            345689999999999984     2578899999864322 112234566777888999999999999854  45689999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           93 EYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             ECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            9999999999997542  3488999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----cCCCcccccchhhhhhhcc
Q 045493          933 SSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL-----LSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       933 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ...   .....+|..|+|||++.+..++.++||||+|+++|||++|..||......     ...................
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            321   22345778899999999999999999999999999999999997643211     0111111111111112222


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+..   ......+.+++.+||+.||++|||++|+++.|++
T Consensus       248 ~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          248 NGRLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             TCCCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cCcCCCC---cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            2111111   2234568889999999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-38  Score=363.16  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=195.5

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.....||+|+||+||+|+++ +++.||+|++.+...  ........++...+..++||||++++++|.+.+..|+||||
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey  155 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY  155 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence            344567999999999999987 467889998865211  11122345667777888999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++.+.  ...+++..++.++.|++.||+|||+.   +||||||||+|||++.++.+||+|||+|+.......
T Consensus       156 ~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          156 YVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             CTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            9999999999752  23489999999999999999999999   999999999999999999999999999987654433


Q ss_pred             C-ccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc----c
Q 045493          935 N-WSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI----D 1004 (1048)
Q Consensus       935 ~-~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 1004 (1048)
                      . ....+||+.|+|||++.     ...++.++||||+||++|||++|+.||...+.           ......+.    .
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----------~~~~~~i~~~~~~  299 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VETYGKIMNHKER  299 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTHHHH
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----------hHHHHhhhhcccc
Confidence            2 23468999999999987     45689999999999999999999999864221           11111111    1


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDC--RPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 1044 (1048)
                      ..++...   ......+.+++.+|++.+|++  ||+++|+++
T Consensus       300 ~~~p~~~---~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          300 FQFPTQV---TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCCSSC---CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccCCccc---ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1222211   112345788899999998888  999999976

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-37  Score=338.95  Aligned_cols=247  Identities=19%  Similarity=0.259  Sum_probs=196.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|.+. +++.||+|++....... ......+++..++.++||||+++++++...+..++||||+++
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   89 (284)
T 3kk8_A           10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG   89 (284)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCC
Confidence            3456899999999999886 57889999986543322 112334566777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc---eEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|||.+...... .
T Consensus        90 ~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~  162 (284)
T 3kk8_A           90 GELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  162 (284)
T ss_dssp             CBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-C
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-c
Confidence            9999988654   3488999999999999999999999   9999999999999987655   999999999866533 3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....           .......+.......+....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----------~~~~~~~~~~~~~~~~~~~~  231 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----------QHRLYAQIKAGAYDYPSPEW  231 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCCCTTTT
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----------hhHHHHHHHhccccCCchhh
Confidence            3345679999999999999999999999999999999999999985322           11222222222222222122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            233456889999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.5e-37  Score=345.46  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=198.3

Q ss_pred             ceeeecccccccEEEEEE------cCCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAEL------TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~------~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ....||+|+||.||+|++      .+++.||+|++.............+++..++++ +||||+++++++...+..++||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  106 (313)
T 1t46_A           27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT  106 (313)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence            445689999999999985      245789999987544332233445666777888 8999999999999999999999


Q ss_pred             EccCCCCHHHHHhcccc---------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc
Q 045493          853 EYLERGSLATILSNEAT---------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK  917 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~  917 (1048)
                      ||+++|+|.+++.....               ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  183 (313)
T 1t46_A          107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI  183 (313)
T ss_dssp             ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTE
T ss_pred             ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCC
Confidence            99999999999975432               12489999999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCccccc
Q 045493          918 AHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAAN  994 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  994 (1048)
                      +||+|||+++........  .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....       ...
T Consensus       184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~  256 (313)
T 1t46_A          184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------DSK  256 (313)
T ss_dssp             EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-------SHH
T ss_pred             EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc-------hhH
Confidence            999999999876544332  233457889999999999999999999999999999999 9999763221       000


Q ss_pred             chhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          995 MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .............+      ......+.+++.+||+.||++|||++|++++|++
T Consensus       257 ~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          257 FYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             HHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCc------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            11111111111111      1223468889999999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1e-37  Score=340.82  Aligned_cols=248  Identities=21%  Similarity=0.292  Sum_probs=183.3

Q ss_pred             ceeeecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|.+..    +..||+|++.............+++..++.++||||+++++++. .+..++||||+
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~   97 (281)
T 1mp8_A           19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC   97 (281)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecC
Confidence            34568999999999998753    34588888765433332333455666778889999999999985 45689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        98 ~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           98 TLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             TTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            999999999653  23488999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             -ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 -WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+......+..  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----------~~~~~~i~~~~~~~~~--  239 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIGRIENGERLPMP--  239 (281)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHHHHHTTCCCCCC--
T ss_pred             ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----------HHHHHHHHcCCCCCCC--
Confidence             233456789999999998899999999999999999997 9999864321           1112222222211111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       240 -~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          240 -PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             122346788999999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-37  Score=350.19  Aligned_cols=250  Identities=21%  Similarity=0.243  Sum_probs=187.1

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||+||+|+.. +++.||+|++......  .....+++..++.++||||+++++++...+..++||||++
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            334556899999999999987 7888999998654322  2345567777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc--eEEeccccccccCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK--AHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~--~kl~DfG~a~~~~~~~~  934 (1048)
                      +|+|.+++...+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.  +||+|||+++..... .
T Consensus       100 ~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~  172 (361)
T 3uc3_A          100 GGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  172 (361)
T ss_dssp             SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-C
Confidence            999999996533   489999999999999999999999   9999999999999987765  999999999754322 2


Q ss_pred             CccccccccccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEK-CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||.....       ..........+.......+.. 
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~-  244 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PRDYRKTIQRILSVKYSIPDD-  244 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----------CCCHHHHHHHHHTTCCCCCTT-
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHHhcCCCCCCCc-
Confidence            2344579999999999988887655 8999999999999999999864321       111112222222222221110 


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ......+.+++.+||+.||++|||+.|+++.
T Consensus       245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          245 -IRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             1123467889999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-37  Score=347.69  Aligned_cols=253  Identities=20%  Similarity=0.270  Sum_probs=183.8

Q ss_pred             CcceeeecccccccEEEEEEcCCC----ceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeE----
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSGD----TRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHL----  848 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~~----~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~----  848 (1048)
                      +.....||+|+||+||+|++....    .||||++....... ......++++.+++++||||+++++++......    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            344567999999999999876433    68999886543222 223345566677888999999999999876655    


Q ss_pred             --EEEEEccCCCCHHHHHhcccc---ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          849 --FLVYEYLERGSLATILSNEAT---AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       849 --~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                        ++||||+++|+|.+++.....   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence              999999999999999965432   22488999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhh
Q 045493          924 GTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       924 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      |+++........  .....+|+.|+|||.+.+..++.++||||+||++|||++ |+.||.....           .....
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------~~~~~  250 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----------AEIYN  250 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHH
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----------HHHHH
Confidence            999876543321  223456789999999999999999999999999999999 8999864221           11222


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.........   ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       251 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          251 YLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             HHHTTCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcCCCCCCC---CccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            22222211111   122346889999999999999999999999886

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.3e-37  Score=359.31  Aligned_cols=242  Identities=25%  Similarity=0.354  Sum_probs=193.7

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC-eEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ-HLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|.+. ++.||||+++...   ......++++.+++++||||+++++++.+.+ ..|+||||+++|+
T Consensus       198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            456899999999999986 7899999987543   2234566777889999999999999987655 7999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.++++..+ ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   ....
T Consensus       274 L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  346 (450)
T 1k9a_A          274 LVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTG  346 (450)
T ss_dssp             HHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred             HHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCC
Confidence            999997543 23368899999999999999999999   9999999999999999999999999999854322   2233


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+++.|+|||++.+..++.++|||||||++|||+| |+.||.....           ......+..+...+..   ....
T Consensus       347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------~~~~~~i~~~~~~~~p---~~~~  412 (450)
T 1k9a_A          347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDVVPRVEKGYKMDAP---DGCP  412 (450)
T ss_dssp             CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----------TTHHHHHHTTCCCCCC---TTCC
T ss_pred             CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---CcCC
Confidence            57889999999999999999999999999999999 9999863221           1122222222111111   1234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+.+++.+||+.||++|||+.++++.|+
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            56888999999999999999999999886

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.6e-36  Score=354.53  Aligned_cols=347  Identities=25%  Similarity=0.383  Sum_probs=279.5

Q ss_pred             CCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEE
Q 045493          302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFF  381 (1048)
Q Consensus       302 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  381 (1048)
                      .+++++.|+++++.++. +| .+..+++|+.|++++|.+.+..+  +..+++|++|++++|++++..+  ++++++|++|
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  117 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  117 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence            35567777777777664 33 36667777777777777765433  7777777777777777775444  7777777777


Q ss_pred             EeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccc
Q 045493          382 ALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT  461 (1048)
Q Consensus       382 ~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~  461 (1048)
                      ++++|.+++..+  +..+++|+.|++++|++++.  ..+..+++|++|+++ |.+.+..  .+..+++|++|++++|.++
T Consensus       118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS  190 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence            777777775433  77777777777777777653  246777888888886 4555433  3888899999999999988


Q ss_pred             cCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCcccc
Q 045493          462 GNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG  541 (1048)
Q Consensus       462 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  541 (1048)
                      ++.  .+..+++|+.|++++|.+.+..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..+  +.
T Consensus       191 ~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~  262 (466)
T 1o6v_A          191 DIS--VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS  262 (466)
T ss_dssp             CCG--GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             CCh--hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence            764  47888999999999999987655  67789999999999999854  468889999999999999986654  88


Q ss_pred             CCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeE
Q 045493          542 KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKL  621 (1048)
Q Consensus       542 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  621 (1048)
                      .+++|++|++++|.+++..+  +..+++|++|++++|+++++.+  +..+++|+.|++++|++++..+  +..+++|++|
T Consensus       263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            89999999999999996544  8899999999999999998755  8889999999999999998766  7899999999


Q ss_pred             ECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCC
Q 045493          622 DLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       622 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~  679 (1048)
                      ++++|++++.  ..+..+++|++|++++|++++..|  +..++.|+.|++++|+|++.
T Consensus       337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            9999999865  578899999999999999998887  88999999999999999984

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=357.15  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=201.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC--eEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--HLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|++. +++.||||++.............+++..++.++||||+++++++.+.+  ..++||||++
T Consensus        13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~   92 (396)
T 4eut_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP   92 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred             EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence            3456899999999999887 588999999875443333334456777788999999999999997654  7899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE----CCCCceEEeccccccccCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL----DLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      +|+|.++++.......+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++.....
T Consensus        93 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A           93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             TEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            999999997655555589999999999999999999999   99999999999999    77788999999999876543


Q ss_pred             CCCcccccccccccccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh--
Q 045493          933 SSNWSELAGTCGYIAPELAYT--------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL-- 1002 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1002 (1048)
                       .......||+.|+|||++.+        ..++.++||||+||++|||++|+.||.......       ........+  
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~  241 (396)
T 4eut_A          170 -EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-------RNKEVMYKIIT  241 (396)
T ss_dssp             -GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT-------TCHHHHHHHHH
T ss_pred             -CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc-------chHHHHHHHhc
Confidence             22345679999999999865        567889999999999999999999986322100       000111111  


Q ss_pred             -------------------ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1003 -------------------IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1003 -------------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                                         +....+............+.+++.+||+.||++|||++|+++.++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence                               111222222223556677889999999999999999999988764

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=345.28  Aligned_cols=238  Identities=21%  Similarity=0.332  Sum_probs=194.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-------ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-------IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-------~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ....||+|+||+||+|++. +++.||||++.......       .......++..++.++||||+++++++.+.+..++|
T Consensus        28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  107 (335)
T 3dls_A           28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV  107 (335)
T ss_dssp             EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence            4456899999999999875 67889999987653221       122345678888999999999999999999999999


Q ss_pred             EEccCCC-CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          852 YEYLERG-SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       852 ~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      |||+.+| +|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       108 ~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999777 9999997543   489999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      .. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......                 .......
T Consensus       182 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~~~~~  243 (335)
T 3dls_A          182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VEAAIHP  243 (335)
T ss_dssp             TT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TTTCCCC
T ss_pred             CC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------HhhccCC
Confidence            43 33345679999999999988876 88999999999999999999998642211                 1111111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.    .....+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          244 PY----LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             Cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11    122457889999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-37  Score=344.85  Aligned_cols=261  Identities=21%  Similarity=0.340  Sum_probs=198.2

Q ss_pred             cceeeecccccccEEEEEE-----cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv  851 (1048)
                      .....||+|+||.||+|++     .+++.||+|++.............+++..++.++||||+++++++.+.  ...++|
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  103 (302)
T 4e5w_A           24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI  103 (302)
T ss_dssp             EEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEE
T ss_pred             hhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEE
Confidence            4456789999999999984     367889999987654433334456677778899999999999999876  678999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          104 MEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             EECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            99999999999996432  3488999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCC---CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----cCCCcccccchhhhhhhcc
Q 045493          932 DSS---NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL----LSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       932 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ...   ......||..|+|||++.+..++.++||||+|+++|||++|+.|+......    ................+..
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE  258 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence            432   223456888999999999989999999999999999999999986432110    0000111111111222222


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....+..   ......+.+++.+||+.||++|||++|+++.|+
T Consensus       259 ~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          259 GKRLPCP---PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             TCCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCCC---CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            2211111   123356889999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-37  Score=348.06  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=196.1

Q ss_pred             ceeeecccccccEEEEEEc--------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT--------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~l  850 (1048)
                      ....||+|+||.||+|++.        +++.||+|++..............++..++.+ +||||+++++++...+..++
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  118 (334)
T 2pvf_A           39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  118 (334)
T ss_dssp             EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred             EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence            3456899999999999874        45679999987543322223344566667777 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc
Q 045493          851 VYEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK  917 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~  917 (1048)
                      ||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  195 (334)
T 2pvf_A          119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV  195 (334)
T ss_dssp             EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCC
Confidence            9999999999999975432             23488999999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCccccc
Q 045493          918 AHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAAN  994 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  994 (1048)
                      +||+|||+++........  .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....          
T Consensus       196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------  265 (334)
T 2pvf_A          196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----------  265 (334)
T ss_dssp             EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------
T ss_pred             EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----------
Confidence            999999999876543221  233457889999999998889999999999999999999 9999763221          


Q ss_pred             chhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          995 MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       ......+.........   ......+.+++.+||+.||++|||++|+++.|++
T Consensus       266 -~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          266 -EELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             -HHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             1111122111111111   1223468889999999999999999999999863

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=364.04  Aligned_cols=346  Identities=17%  Similarity=0.185  Sum_probs=222.2

Q ss_pred             ceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeecccc
Q 045493          331 RGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN  410 (1048)
Q Consensus       331 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N  410 (1048)
                      +.++.+++.++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|+.|++++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            45666677666 4555443  46777777777777666677777777777777777777655666666666655555555


Q ss_pred             ccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccc
Q 045493          411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISS  490 (1048)
Q Consensus       411 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~  490 (1048)
                      ++++.                        .+..|.++++|++|+|++|+++++.+..|..+++|+.|++++|.+.+..+.
T Consensus        91 ~l~~~------------------------~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  146 (477)
T 2id5_A           91 RLKLI------------------------PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR  146 (477)
T ss_dssp             CCCSC------------------------CTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT
T ss_pred             cCCcc------------------------CcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh
Confidence            55543                        344455555555555555555555555555555666666666665555555


Q ss_pred             cccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcccccccccc
Q 045493          491 NWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAEL  570 (1048)
Q Consensus       491 ~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  570 (1048)
                      .|..+++|++|++++|.+++..+..|..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+.+|.......+|
T Consensus       147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L  226 (477)
T 2id5_A          147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL  226 (477)
T ss_dssp             SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred             hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence            56666666666666666665555556666666666666666665555566666666666666666555555555555567


Q ss_pred             ceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCC
Q 045493          571 GYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN  650 (1048)
Q Consensus       571 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  650 (1048)
                      ++|+|++|+|+.+++..|..+++|+.|+|++|+|+++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus       227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            77777777777665566667777777777777777666666777777777777777777777777777777777777777


Q ss_pred             cccCCccccccccCCccEEEeccceecCCCCCcccccccccccccCCccccCC
Q 045493          651 KLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGD  703 (1048)
Q Consensus       651 ~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  703 (1048)
                      +|++..+..|..+++|++|++++|+|.+.++..-.+.......+.++...|..
T Consensus       307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~  359 (477)
T 2id5_A          307 QLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT  359 (477)
T ss_dssp             CCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred             cCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCC
Confidence            77777777777777777777777777776553221121122234555555543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.3e-37  Score=355.85  Aligned_cols=363  Identities=18%  Similarity=0.190  Sum_probs=193.7

Q ss_pred             ccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcC
Q 045493           36 LFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPAS  115 (1048)
Q Consensus        36 l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  115 (1048)
                      +....+..++.+++|++|+|++|.+++. | +|+.+++|++|+|++|+++++ |  +..+++|++|++++|++++. |  
T Consensus        30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--  101 (457)
T 3bz5_A           30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--  101 (457)
T ss_dssp             CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred             cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--
Confidence            3334445566666666666666666643 4 566666666666666666653 2  56666666666666666643 2  


Q ss_pred             cCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCc
Q 045493          116 LGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI  195 (1048)
Q Consensus       116 ~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i  195 (1048)
                      ++++++|++|++++|++++                +|  +..+++|+.|++++|.+++.   .+..+++|++|++++|+.
T Consensus       102 ~~~l~~L~~L~L~~N~l~~----------------l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~  160 (457)
T 3bz5_A          102 VTPLTKLTYLNCDTNKLTK----------------LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKK  160 (457)
T ss_dssp             CTTCTTCCEEECCSSCCSC----------------CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSC
T ss_pred             cCCCCcCCEEECCCCcCCe----------------ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCc
Confidence            6666666666666666542                11  34445555555555555543   255555666666666643


Q ss_pred             cccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhh
Q 045493          196 VGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF  275 (1048)
Q Consensus       196 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~  275 (1048)
                      .+.+  .+..+++|++|++++|++++ +|  ++.+++|+.|++++|.+++.   .++.+++|++|++++|++++      
T Consensus       161 ~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~------  226 (457)
T 3bz5_A          161 ITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE------  226 (457)
T ss_dssp             CCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC------
T ss_pred             cccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc------
Confidence            3233  35555666666666666553 33  55555666666666666542   25555556666666555543      


Q ss_pred             hccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCC
Q 045493          276 GNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLS  355 (1048)
Q Consensus       276 ~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  355 (1048)
                                          +|  ++.+++|+.|++++|++++..   ++.+++|+.|++++|              +|+
T Consensus       227 --------------------ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~  267 (457)
T 3bz5_A          227 --------------------ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLL  267 (457)
T ss_dssp             --------------------CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCS
T ss_pred             --------------------cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCC
Confidence                                12  334455555555556555432   334455555555443              344


Q ss_pred             eEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeeccc
Q 045493          356 QLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNN  435 (1048)
Q Consensus       356 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~  435 (1048)
                      .|++++|.+.+.+|  ++++++|+.|++++|...+.+|.   ....|+.+++++|             ++|++|++++|+
T Consensus       268 ~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~  329 (457)
T 3bz5_A          268 EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTE  329 (457)
T ss_dssp             CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCC
T ss_pred             EEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCc
Confidence            55666666555544  34556666666666665554443   2233333333222             345555555555


Q ss_pred             ccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCc
Q 045493          436 FVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPS  514 (1048)
Q Consensus       436 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~  514 (1048)
                      +++.   .+..+++|+.|++++|+++++        +.|..|++++|.+.+.     ..+..|+.+++++|.++|.+|.
T Consensus       330 l~~l---~l~~l~~L~~L~l~~N~l~~l--------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          330 LTEL---DVSHNTKLKSLSCVNAHIQDF--------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             CSCC---CCTTCTTCSEEECCSSCCCBC--------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             cccc---ccccCCcCcEEECCCCCCCCc--------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence            5553   155555555555555555531        3444555555555443     1223344445555555554444

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.1e-38  Score=354.53  Aligned_cols=258  Identities=16%  Similarity=0.190  Sum_probs=187.9

Q ss_pred             cceeeecccccccEEEEEEcC------CCceeeEEeccCCCCccc----------chhhHHHHHHhhcccCceeeEeeEe
Q 045493          779 GKMVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIG----------INQKGFVSEITEIRHRNIVKFYGFC  842 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~----------~~~~~~~~~l~~l~h~niv~~~~~~  842 (1048)
                      .....||+|+||+||+|.+..      ++.||||++.........          .....+...+..++||||+++++++
T Consensus        38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  117 (364)
T 3op5_A           38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG  117 (364)
T ss_dssp             EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred             EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence            345568999999999998865      367899987653211000          0001122234567899999999998


Q ss_pred             eeC----CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC--CCC
Q 045493          843 SHT----QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD--LEY  916 (1048)
Q Consensus       843 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~--~~~  916 (1048)
                      ...    ...|+||||+ +|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++  .++
T Consensus       118 ~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          118 LHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred             eeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence            764    4589999999 99999999753  24589999999999999999999999   999999999999999  889


Q ss_pred             ceEEeccccccccCCCCCC-------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC
Q 045493          917 KAHVSDFGTAKFLKPDSSN-------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP  989 (1048)
Q Consensus       917 ~~kl~DfG~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  989 (1048)
                      .+||+|||+++.+......       .....||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            9999999999876533211       134559999999999999999999999999999999999999987422110000


Q ss_pred             c-ccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          990 A-PAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       990 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      . ...........+.++.++.     .....++.+++..||+.||++||++++++++|+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            0 0000000011111111100     111346888999999999999999999999886

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-37  Score=359.80  Aligned_cols=243  Identities=22%  Similarity=0.355  Sum_probs=197.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|++. +++.||||++......  +......+++..++.++||||+++++++...+..|+||||++
T Consensus        20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~   99 (476)
T 2y94_A           20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS   99 (476)
T ss_dssp             EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            3456899999999999986 7899999998653211  112234566777888999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus       100 gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~  172 (476)
T 2y94_A          100 GGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL  172 (476)
T ss_dssp             SEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCB
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccc
Confidence            99999999653   3489999999999999999999999   9999999999999999999999999999876543 334


Q ss_pred             cccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ...+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+...           .......+.++....+.    
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----  237 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----------VPTLFKKICDGIFYTPQ----  237 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----------SHHHHHHHHTTCCCCCT----
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----------HHHHHHHHhcCCcCCCc----
Confidence            55689999999999988776 789999999999999999999986322           12223333333322221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            12345788999999999999999999986

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=363.23  Aligned_cols=320  Identities=21%  Similarity=0.206  Sum_probs=211.6

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .+++++.    .++++|...++++++|||++|+|++..+..|+.+++|++|+|++|.++++.|.+|+.+++|++|+|++|
T Consensus        15 ~v~c~~~----~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRK----RFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSC----CCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCC----CcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            3555554    456778778889999999999999888889999999999999999999888889999999999999999


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV  162 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~  162 (1048)
                      +++++.+..|.++++|++|++++|+++...|..|..+++|++|++++|++.+                            
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------------  142 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY----------------------------  142 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE----------------------------
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce----------------------------
Confidence            9998777778888999999999999888888888888888888888887753                            


Q ss_pred             EEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCc
Q 045493          163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNR  242 (1048)
Q Consensus       163 ~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  242 (1048)
                                 ..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+.+..+..|..+++|++|++++|.
T Consensus       143 -----------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~  211 (477)
T 2id5_A          143 -----------ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP  211 (477)
T ss_dssp             -----------ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT
T ss_pred             -----------eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc
Confidence                       334455566666666666666665555556666666666666666665555566666666666666666


Q ss_pred             cCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccccc
Q 045493          243 LSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP  322 (1048)
Q Consensus       243 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  322 (1048)
                      ..+.+|..+....+|++|++++|+++...+..|..+                         ++|+.|+|++|.+++..+.
T Consensus       212 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-------------------------~~L~~L~Ls~n~l~~~~~~  266 (477)
T 2id5_A          212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHL-------------------------VYLRFLNLSYNPISTIEGS  266 (477)
T ss_dssp             TCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTC-------------------------TTCCEEECCSSCCCEECTT
T ss_pred             cccccCcccccCccccEEECcCCcccccCHHHhcCc-------------------------cccCeeECCCCcCCccChh
Confidence            555555555555566666666666654333333333                         3344444444444433334


Q ss_pred             ccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccC
Q 045493          323 SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSG  390 (1048)
Q Consensus       323 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~  390 (1048)
                      .|..+++|+.|++++|.+.+..|..|..+++|++|+|++|++++..+..|.++++|+.|+|++|++.+
T Consensus       267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             SCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             hccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            44444444444444444444444444444455555555555544444444445555555555555543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=343.72  Aligned_cols=246  Identities=25%  Similarity=0.411  Sum_probs=186.8

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||+||+|++. ++.||+|++....   .......+++.+++++||||+++++++.+  ..++||||+++|+|
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L   86 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred             eeEeecCCCceEEEEEEC-CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence            456899999999999886 7889999985422   12234556777788999999999999874  47999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc-eEEeccccccccCCCCCCcccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK-AHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~-~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      .++++.......+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+++.....   ....
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~  163 (307)
T 2eva_A           87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNN  163 (307)
T ss_dssp             HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred             HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccC
Confidence            999986655556788999999999999999999932128999999999999998886 799999999765432   2334


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||.....         ..............+...   .....
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~---~~~~~  231 (307)
T 2eva_A          164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG---------PAFRIMWAVHNGTRPPLI---KNLPK  231 (307)
T ss_dssp             -CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS---------SHHHHHHHHHTTCCCCCB---TTCCH
T ss_pred             CCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc---------cHHHHHHHHhcCCCCCcc---cccCH
Confidence            689999999999999999999999999999999999999863221         001111111122222111   12234


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .+.+++.+||+.||++|||++|++++|+
T Consensus       232 ~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          232 PIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            5788999999999999999999999886

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.2e-37  Score=344.71  Aligned_cols=257  Identities=18%  Similarity=0.258  Sum_probs=190.9

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhh-cccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITE-IRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ..||+|+||+||+|... +++.||||++....... .....++++.+.+ .+||||+++++++.+.+..|+||||+++|+
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC-HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh-HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            35899999999999875 68899999986543222 2233445555666 479999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc---eEEeccccccccCCCCC--
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~~~~~~--  934 (1048)
                      |.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++........  
T Consensus        98 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           98 ILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             HHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             HHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            999997543   488999999999999999999999   9999999999999998776   99999999986542211  


Q ss_pred             -----Ccccccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccc----cchhhhh
Q 045493          935 -----NWSELAGTCGYIAPELAYT-----MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA----NMNIVVN 1000 (1048)
Q Consensus       935 -----~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~ 1000 (1048)
                           .....+||+.|+|||++.+     ..++.++||||+||++|||++|+.||..............    .......
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  251 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE  251 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence                 1234569999999999875     4578999999999999999999999875432111100000    0111223


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .+.......+..........+.+++.+||+.||++|||++|+++.
T Consensus       252 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            333333333322222344578899999999999999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.1e-37  Score=336.58  Aligned_cols=248  Identities=26%  Similarity=0.393  Sum_probs=192.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc------chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG------INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ....||+|+||+||+|++. +++.||+|++.........      ....+++..++.++||||+++++++.+..  ++||
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~  100 (287)
T 4f0f_A           23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVM  100 (287)
T ss_dssp             EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEE
T ss_pred             ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEE
Confidence            3456899999999999885 6888999998654332211      23455667778889999999999997665  7999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEECCCCc-----eEEecccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLDLEYK-----AHVSDFGT  925 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~~~~~-----~kl~DfG~  925 (1048)
                      ||+++|+|.+++...  ...+++..+..++.|++.|++|||+.   +  |+||||||+||+++.++.     +||+|||+
T Consensus       101 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A          101 EFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             ECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             EecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence            999999999988653  33589999999999999999999998   7  999999999999988876     99999999


Q ss_pred             ccccCCCCCCccccccccccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          926 AKFLKPDSSNWSELAGTCGYIAPELAY--TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       926 a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ++....   ......||+.|+|||++.  ...++.++||||+||++|||++|+.||.....         ..........
T Consensus       176 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~~~~~  243 (287)
T 4f0f_A          176 SQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY---------GKIKFINMIR  243 (287)
T ss_dssp             CBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC---------CHHHHHHHHH
T ss_pred             cccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc---------cHHHHHHHHh
Confidence            975432   344567999999999984  44578999999999999999999999863221         0011111111


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....+..  .......+.+++.+||+.||++|||++|+++.|++
T Consensus       244 ~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 EEGLRPTI--PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ccCCCCCC--CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11111111  11233568899999999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-37  Score=349.17  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=196.1

Q ss_pred             ceeeecccccccEEEEEEcC-C-----CceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTS-G-----DTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~-~-----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ....||+|+||.||+|.+.. +     ..||+|.+..............++..++.+ +||||+++++++.+.+..++||
T Consensus        50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  129 (333)
T 2i1m_A           50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVIT  129 (333)
T ss_dssp             EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEE
Confidence            34568999999999998753 2     368899887654333333445667777888 8999999999999999999999


Q ss_pred             EccCCCCHHHHHhcccc-----------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEe
Q 045493          853 EYLERGSLATILSNEAT-----------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVS  921 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~  921 (1048)
                      ||+++|+|.+++.....           ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  206 (333)
T 2i1m_A          130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIG  206 (333)
T ss_dssp             ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBC
T ss_pred             ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEEC
Confidence            99999999999975421           23478999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhh
Q 045493          922 DFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIV  998 (1048)
Q Consensus       922 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  998 (1048)
                      |||+++........  .....+|+.|+|||++.+..++.++||||+||++|||+| |+.||.....       .......
T Consensus       207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~~~  279 (333)
T 2i1m_A          207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-------NSKFYKL  279 (333)
T ss_dssp             CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-------SHHHHHH
T ss_pred             ccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-------hHHHHHH
Confidence            99999876543322  233457889999999999999999999999999999999 8999763221       0001111


Q ss_pred             hhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          999 VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       999 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .........+.      .....+.+++.+||+.||++|||++|++++|+
T Consensus       280 ~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          280 VKDGYQMAQPA------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             HHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HhcCCCCCCCC------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence            11111111111      12346788999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-37  Score=345.96  Aligned_cols=263  Identities=23%  Similarity=0.342  Sum_probs=190.0

Q ss_pred             cceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC----CeEEEEEEc
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT----QHLFLVYEY  854 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~----~~~~lv~e~  854 (1048)
                      .....||+|+||.||+|++. ++.||||++......  ....+.++.....++||||+++++++...    ...++||||
T Consensus        40 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~--~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  116 (337)
T 3mdy_A           40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA--SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY  116 (337)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred             EEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccc--hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence            34557899999999999887 899999998543211  11112222222345899999999999876    789999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC-----FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +++|+|.++++..    .+++..+..++.|++.||+|||+..     .++|+||||||+||+++.++.+||+|||+++.+
T Consensus       117 ~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          117 HENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            9999999999643    4889999999999999999999762     238999999999999999999999999999876


Q ss_pred             CCCCCC----ccccccccccccccccccCCCCch------hhHHHHHHHHHHHHhCCCCCccccccc----CCCcccccc
Q 045493          930 KPDSSN----WSELAGTCGYIAPELAYTMRANEK------CDVFNFGVLVLEVIEGKHPGHFLSLLL----SLPAPAANM  995 (1048)
Q Consensus       930 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~Dvws~Gvvl~elltg~~p~~~~~~~~----~~~~~~~~~  995 (1048)
                      ......    .....||+.|+|||++.+..++.+      +||||+||++|||++|+.|+.......    .........
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            543322    124579999999999987766554      999999999999999955543211110    000011111


Q ss_pred             hhhhhhhccCCCCCCch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .............+...   ........+.+++.+||+.||++|||++|+++.|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            11111111111111111   123567789999999999999999999999999863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1e-36  Score=354.67  Aligned_cols=360  Identities=20%  Similarity=0.239  Sum_probs=195.7

Q ss_pred             cCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccc
Q 045493          175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF  254 (1048)
Q Consensus       175 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  254 (1048)
                      .+..+..+++|++|++++|.+++. | .+..+++|++|+|++|++++ +|  ++.+++|++|++++|.+++. +  ++.+
T Consensus        34 ~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l  105 (457)
T 3bz5_A           34 DTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPL  105 (457)
T ss_dssp             SEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTC
T ss_pred             cccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCC
Confidence            334555666666666666666643 3 46666666666666666664 23  56666666666666666643 2  6666


Q ss_pred             cccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceee
Q 045493          255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLY  334 (1048)
Q Consensus       255 ~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  334 (1048)
                      ++|++|++++|++++.                          |  ++.+++|++|++++|++++.   .++.+++|+.|+
T Consensus       106 ~~L~~L~L~~N~l~~l--------------------------~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~  154 (457)
T 3bz5_A          106 TKLTYLNCDTNKLTKL--------------------------D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELD  154 (457)
T ss_dssp             TTCCEEECCSSCCSCC--------------------------C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEE
T ss_pred             CcCCEEECCCCcCCee--------------------------c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEE
Confidence            6666666666665431                          1  34455566666666666543   255556666666


Q ss_pred             eccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCC
Q 045493          335 IRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG  414 (1048)
Q Consensus       335 l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~  414 (1048)
                      +++|...+.+  .+..+++|++|++++|++++ +|  ++.+++|+.|++++|++++.   .+..+++|+.|++++|++++
T Consensus       155 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          155 CHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             CTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred             CCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence            6666433333  35556666666666666664 33  55666666666666666643   24455555555555555554


Q ss_pred             CCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccC
Q 045493          415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK  494 (1048)
Q Consensus       415 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~  494 (1048)
                       +|  +..+++|+.|++++|.+++..   +..+++|+.|+++.|              +|+.|++++|.+.+..|  +..
T Consensus       227 -ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~  284 (457)
T 3bz5_A          227 -ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEG  284 (457)
T ss_dssp             -CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTT
T ss_pred             -cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccc
Confidence             22  444455555555555555432   233444555555443              23455555555544443  344


Q ss_pred             CCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceee
Q 045493          495 CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLD  574 (1048)
Q Consensus       495 ~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  574 (1048)
                      +++|+.|++++|...+.+|.   ..++|+.|++++|             ++|++|++++|++++.   .++.+++|+.|+
T Consensus       285 l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~  345 (457)
T 3bz5_A          285 CRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLS  345 (457)
T ss_dssp             CTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEE
T ss_pred             cccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccCCcCcEEE
Confidence            55555555555554444432   2233444433333             4556666666666642   255566666666


Q ss_pred             cccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcC
Q 045493          575 LSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSE  635 (1048)
Q Consensus       575 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  635 (1048)
                      +++|+|+++        +.|..|++++|.+.+.     +.+..|+.+++++|+++|.+|..
T Consensus       346 l~~N~l~~l--------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          346 CVNAHIQDF--------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             CCSSCCCBC--------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             CCCCCCCCc--------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence            666665542        3455555555555543     23444555555555555555443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-37  Score=364.32  Aligned_cols=248  Identities=22%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             eeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|.+.. +..||||+++.....  .....+++..+++++||||++++++|.+.+..|+||||+++|+
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~  302 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN  302 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence            4468999999999999874 788999998654322  2344566777888999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  938 (1048)
                      |.++++... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       303 L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  378 (495)
T 1opk_A          303 LLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  378 (495)
T ss_dssp             HHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred             HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence            999997533 34588999999999999999999999   999999999999999999999999999987653321 1223


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+++.|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+.........   ...
T Consensus       379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~  444 (495)
T 1opk_A          379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------SQVYELLEKDYRMERP---EGC  444 (495)
T ss_dssp             CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------GGHHHHHHTTCCCCCC---TTC
T ss_pred             CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---CCC
Confidence            456789999999998899999999999999999999 9999764321           1111111111111111   123


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+.+++.+||+.||++|||++|+++.|++
T Consensus       445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~  475 (495)
T 1opk_A          445 PEKVYELMRACWQWNPSDRPSFAEIHQAFET  475 (495)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            3568889999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=353.17  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=189.0

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee-----eCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS-----HTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~-----~~~~~~lv~e~  854 (1048)
                      ....||+|+||+||+|+. +++.||||++......  ....+.++..+..++||||+++++++.     ....+++||||
T Consensus        17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~--~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   93 (336)
T 3g2f_A           17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ--NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY   93 (336)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred             eeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh--hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence            345689999999999987 4889999998643211  111223333345679999999998553     23367899999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC------FPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      +++|+|.++++...    .++..+..++.|++.||+|||+.+      .++|+||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           94 YPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             CTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            99999999996532    478899999999999999999862      23899999999999999999999999999987


Q ss_pred             cCCCC--------CCcccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccc-
Q 045493          929 LKPDS--------SNWSELAGTCGYIAPELAYT-------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA-  992 (1048)
Q Consensus       929 ~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~-  992 (1048)
                      +....        .......||+.|+|||++.+       ..++.++||||+||++|||++|+.||............. 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            65322        11234579999999999886       456789999999999999999987764322211110000 


Q ss_pred             ------ccchh----hhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          993 ------ANMNI----VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       993 ------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                            .....    .......+.++............+.+++.+||+.||++|||++|+++.|+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence                  00000    01111122233322223345667999999999999999999999999886

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-37  Score=363.32  Aligned_cols=252  Identities=21%  Similarity=0.266  Sum_probs=199.7

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||.||+|+.+ +++.||+|++......  ........+.+.++.++||||+++++++...+..|+||||+
T Consensus       188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            34557999999999999986 6889999998653221  11123345667778899999999999999999999999999


Q ss_pred             CCCCHHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          856 ERGSLATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +||+|.+++..... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.+|++||+|||+++.+.....
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            99999999975432 34589999999999999999999999   999999999999999999999999999988765554


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ..........+.......+    
T Consensus       345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~-------~~~~~~~~~~i~~~~~~~p----  413 (543)
T 3c4z_A          345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE-------KVENKELKQRVLEQAVTYP----  413 (543)
T ss_dssp             CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC-------CCCHHHHHHHHHHCCCCCC----
T ss_pred             ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc-------chhHHHHHHHHhhcccCCC----
Confidence            45566899999999999999999999999999999999999999864321       0111222222323222221    


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTM-----QKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 1044 (1048)
                      ......+.+++.+||+.||++||++     +++++
T Consensus       414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            1223467889999999999999975     56653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-37  Score=345.13  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEcCC-----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELTSG-----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~-----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ...||+|+||.||+|.....     ..||+|++..............++..++.++||||+++++++...+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            45689999999999987632     2489999875433332233455667778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       129 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  203 (333)
T 1mqb_A          129 ENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  203 (333)
T ss_dssp             TTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             CCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence            999999999653  23588999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             ---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          936 ---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       936 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                         .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||....           .......+......+..
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----------~~~~~~~~~~~~~~~~~  272 (333)
T 1mqb_A          204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----------NHEVMKAINDGFRLPTP  272 (333)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTTCCCCCC
T ss_pred             ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-----------HHHHHHHHHCCCcCCCc
Confidence               123346789999999998899999999999999999999 999985322           11222222222211111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                         ......+.+++.+||+.||++||+++|++++|++
T Consensus       273 ---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          273 ---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             ---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               1233468889999999999999999999998863

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.8e-37  Score=347.89  Aligned_cols=195  Identities=23%  Similarity=0.284  Sum_probs=163.3

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-----cCceeeEeeEeeeCCeEEE
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-----HRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-----h~niv~~~~~~~~~~~~~l  850 (1048)
                      .+.....||+|+||+||+|++. +++.||||++....  ........+...++.++     ||||+++++++...+..++
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l  113 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL  113 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence            3444567899999999999885 67889999986421  11122334555555554     9999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC----------------
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL----------------  914 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~----------------  914 (1048)
                      ||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.                
T Consensus       114 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~  188 (360)
T 3llt_A          114 IFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG  188 (360)
T ss_dssp             EECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred             EEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence            99999 889999997543 23488999999999999999999999   9999999999999975                


Q ss_pred             ---------CCceEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          915 ---------EYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       915 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                               ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          189 KKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                     789999999999865432   2346789999999999999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.4e-37  Score=338.62  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=200.5

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .+.....||+|+||.||+|... +++.||+|++.............+++..++.++||||+++++++.+....++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  102 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL  102 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence            3445667999999999999875 678899999876544433344566677778889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++++|.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.........
T Consensus       103 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A          103 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             TTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence            99999999864    3488999999999999999999999   9999999999999999999999999999877655444


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......           .....+.....+...   .
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~---~  241 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----------KVLFLIPKNNPPTLE---G  241 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------HHHHHHHHSCCCCCC---S
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----------HHHHHhhcCCCCCCc---c
Confidence            55667999999999999989999999999999999999999998632211           111111111111111   1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            123458889999999999999999999863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-37  Score=337.55  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=189.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|+.. +++.+|+|++.............++++.++.++||||+++++++.+.+..++||||+++|
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  105 (285)
T 3is5_A           26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG  105 (285)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred             ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence            3456899999999999886 678899999876544433344566777888999999999999999999999999999999


Q ss_pred             CHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE---CCCCceEEeccccccccCCCCC
Q 045493          859 SLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       859 ~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++..... .
T Consensus       106 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~  181 (285)
T 3is5_A          106 ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-E  181 (285)
T ss_dssp             BHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             cHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-c
Confidence            9999986432 234589999999999999999999999   99999999999999   45688999999999876533 2


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh--ccCCCCCCch
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL--IDSRLPPPLG 1012 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 1012 (1048)
                      ......||+.|+|||++. ..++.++||||+||++|||++|+.||.....           .......  ........  
T Consensus       182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~--  247 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----------EEVQQKATYKEPNYAVE--  247 (285)
T ss_dssp             -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCC---
T ss_pred             cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----------HHHHhhhccCCcccccc--
Confidence            334567999999999876 4689999999999999999999999864221           1111111  11111111  


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       .......+.+++.+||+.||++|||++|+++
T Consensus       248 -~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          248 -CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0112345778999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-38  Score=356.70  Aligned_cols=247  Identities=21%  Similarity=0.223  Sum_probs=193.9

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.....||+|+||.||+|+.+ +++.||+|++.+...  ........++...+..++||||+++++++.+.+..|+||||
T Consensus        63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~  142 (412)
T 2vd5_A           63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY  142 (412)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence            344567999999999999986 688999999865321  11122345566677888999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++.+.+  ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.+|++||+|||+++.......
T Consensus       143 ~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          143 YVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             CCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            99999999997532  3488999999999999999999999   999999999999999999999999999987654433


Q ss_pred             C-ccccccccccccccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc--
Q 045493          935 N-WSELAGTCGYIAPELAY-------TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID-- 1004 (1048)
Q Consensus       935 ~-~~~~~gt~~y~aPE~~~-------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1004 (1048)
                      . ....+||+.|+|||++.       ...++.++||||+||++|||++|+.||...+.           ......+..  
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~i~~~~  286 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-----------AETYGKIVHYK  286 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTHH
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhcc
Confidence            2 23468999999999987       35689999999999999999999999863221           111112211  


Q ss_pred             --CCCCCCchhHHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 045493         1005 --SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCR---PTMQKVCN 1044 (1048)
Q Consensus      1005 --~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~ 1044 (1048)
                        ...+..   ......++.+++.+||+ +|++|   |+++|+++
T Consensus       287 ~~~~~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          287 EHLSLPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cCcCCCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence              111110   11234568889999999 99998   69999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-38  Score=348.60  Aligned_cols=248  Identities=23%  Similarity=0.326  Sum_probs=183.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCccc--chhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIG--INQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  852 (1048)
                      ....||+|+||.||+|++. +++.||+|++.........  ....+++..+.+++||||+++++++....    ..|+||
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~   95 (311)
T 3ork_A           16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   95 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence            4457899999999999874 6788999998764332211  12234444556778999999999986544    349999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++|+|.++++..+   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        96 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           96 EYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             ECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            9999999999997543   488999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC---CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          933 SS---NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       933 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ..   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....           .............+
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~  238 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVREDPIP  238 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCCCCC
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcCCCCC
Confidence            22   22345689999999999999999999999999999999999999863221           11111222222221


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +..........+.+++.+||+.||++||++.++++
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            11111223456889999999999999998877664

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-37  Score=338.01  Aligned_cols=247  Identities=22%  Similarity=0.273  Sum_probs=195.5

Q ss_pred             eeeecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|.+.   ++..||+|++.............++++.++.++||||+++++++ ..+..++||||+++
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~   93 (287)
T 1u59_A           15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG   93 (287)
T ss_dssp             EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             hccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence            336899999999999864   56779999987654333333445667777888999999999999 55669999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--  935 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--  935 (1048)
                      |+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........  
T Consensus        94 ~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  168 (287)
T 1u59_A           94 GPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  168 (287)
T ss_dssp             EEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             CCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence            9999999643  34589999999999999999999999   9999999999999999999999999999877543322  


Q ss_pred             -ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 -WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+.....+...  
T Consensus       169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~~~~~~i~~~~~~~~~--  235 (287)
T 1u59_A          169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------PEVMAFIEQGKRMECP--  235 (287)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----------HHHHHHHHTTCCCCCC--
T ss_pred             ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----------HHHHHHHhcCCcCCCC--
Confidence             223456889999999998889999999999999999999 9999863221           1111222222111111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       236 -~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          236 -PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             123346888999999999999999999999886

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=351.56  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=180.9

Q ss_pred             eeeecccccccEEEEEEcCC----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee-eCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELTSG----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS-HTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  855 (1048)
                      ...||+|+||+||+|++.+.    ..||+|.+.............+++..+++++||||+++++++. ..+..++||||+
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~  173 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  173 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence            35689999999999987532    3578888765333222223344555567889999999999875 456789999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-  934 (1048)
                      ++|+|.++++..  ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       174 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          174 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            999999999653  23478899999999999999999999   999999999999999999999999999986643321 


Q ss_pred             ---CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          935 ---NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       935 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                         ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....           ......+........
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----------~~~~~~~~~~~~~~~  317 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYLLQGRRLLQ  317 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----------SCHHHHHHTTCCCCC
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----------HHHHHHHHcCCCCCC
Confidence               1233457889999999999999999999999999999999 6667653221           111112222221111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .   ......+.+++.+||+.||++|||++|+++.|+
T Consensus       318 p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          318 P---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1   122346888999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.1e-37  Score=356.01  Aligned_cols=249  Identities=21%  Similarity=0.289  Sum_probs=186.5

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCC-------CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT-------GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~-------~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~l  850 (1048)
                      .....||+|+||+||+|... +++.||+|++.....       ........+++..+++++||||+++++++. .+..|+
T Consensus       138 ~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~l  216 (419)
T 3i6u_A          138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYI  216 (419)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEE
T ss_pred             EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEE
Confidence            34556899999999999876 578999999865321       111223456778889999999999999985 455899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEecccccc
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSDFGTAK  927 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~  927 (1048)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||+++
T Consensus       217 v~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          217 VLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             EEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence            99999999999988643   3489999999999999999999999   999999999999997544   59999999998


Q ss_pred             ccCCCCCCcccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ..... ......+||+.|+|||++.+   ..++.++||||+||++|||++|+.||.....          .......+..
T Consensus       291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----------~~~~~~~i~~  359 (419)
T 3i6u_A          291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----------QVSLKDQITS  359 (419)
T ss_dssp             SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----------SCCHHHHHHT
T ss_pred             ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----------hHHHHHHHhc
Confidence            76532 33445689999999999863   5678999999999999999999999863211          1111122222


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ................+.+++.+||+.||++|||++|+++.
T Consensus       360 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            33332222223345678899999999999999999999873

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.7e-36  Score=352.37  Aligned_cols=346  Identities=26%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             CCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccccccee
Q 045493          181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYL  260 (1048)
Q Consensus       181 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  260 (1048)
                      .+++|+.|+++++.+.. +| .+..+++|++|+|++|.+.+. |+ +.++++|++|++++|.+++..+  ++.+++|++|
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  117 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  117 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence            35677777777777763 44 366777777777777777643 33 6777777777777777774433  7777777777


Q ss_pred             ecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccc
Q 045493          261 YLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENML  340 (1048)
Q Consensus       261 ~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  340 (1048)
                      ++++|.+.+..+                           +..+++|++|++++|.+++. + .++.+++|+.|+++ |.+
T Consensus       118 ~L~~n~l~~~~~---------------------------~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~  167 (466)
T 1o6v_A          118 TLFNNQITDIDP---------------------------LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQV  167 (466)
T ss_dssp             ECCSSCCCCCGG---------------------------GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESC
T ss_pred             ECCCCCCCCChH---------------------------HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Ccc
Confidence            777776653211                           44556677777777776643 2 36667777777775 334


Q ss_pred             cCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCccc
Q 045493          341 YGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNV  420 (1048)
Q Consensus       341 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~  420 (1048)
                      .+.  ..+..+++|++|++++|.+++.  ..+..+++|+.|++++|.+.+..|  ++.+++|+.|++++|++++.  ..+
T Consensus       168 ~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l  239 (466)
T 1o6v_A          168 TDL--KPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTL  239 (466)
T ss_dssp             CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred             cCc--hhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhh
Confidence            322  2366777777777777777643  246677777777777777765544  55566666666666666543  234


Q ss_pred             ccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccE
Q 045493          421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLAT  500 (1048)
Q Consensus       421 ~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~  500 (1048)
                      ..+++|++|++++|.+.+..+  +..+++|++|++++|.++++++  +..+++|+.|++++|++++..+  +..+++|++
T Consensus       240 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~  313 (466)
T 1o6v_A          240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTY  313 (466)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSE
T ss_pred             hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCE
Confidence            445555555555555554433  5555555555555555554443  4455555555555555554332  445555555


Q ss_pred             EEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcc
Q 045493          501 LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRL  580 (1048)
Q Consensus       501 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  580 (1048)
                      |++++|.+++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|++|++++|++
T Consensus       314 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~  387 (466)
T 1o6v_A          314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW  387 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred             EECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence            5555555554433  44555555555555555533  244555555555555555554433  45555555555555555


Q ss_pred             cc
Q 045493          581 SK  582 (1048)
Q Consensus       581 ~~  582 (1048)
                      ++
T Consensus       388 ~~  389 (466)
T 1o6v_A          388 TN  389 (466)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-37  Score=338.86  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=191.1

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCC----cccchhhHHHHHHhhc---ccCceeeEeeEeeeCC----
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG----EIGINQKGFVSEITEI---RHRNIVKFYGFCSHTQ----  846 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~----~~~~~~~~~~~~l~~l---~h~niv~~~~~~~~~~----  846 (1048)
                      .....||+|+||+||+|++. +++.||+|++......    .......+++..++.+   +||||+++++++....    
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~   91 (308)
T 3g33_A           12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE   91 (308)
T ss_dssp             EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCc
Confidence            34556899999999999875 6888999998653321    1112333444444444   5999999999997654    


Q ss_pred             -eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          847 -HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       847 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                       ..++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           92 IKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             EEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             eeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence             5899999997 599999975432 3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccccc-c
Q 045493          926 AKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAAN-M  995 (1048)
Q Consensus       926 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~-~  995 (1048)
                      ++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......         ..+....+ .
T Consensus       167 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (308)
T 3g33_A          167 ARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  245 (308)
T ss_dssp             TTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred             ccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            9876433 33455689999999999999999999999999999999999999986432210         00000000 0


Q ss_pred             hh-hhhhhccCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          996 NI-VVNDLIDSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       996 ~~-~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .. ..........+.... ...+....+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            00 000000111111100 011233568899999999999999999999863

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.1e-37  Score=344.64  Aligned_cols=259  Identities=21%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             cceeeecccccccEEEEEEc-----CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-----SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv  851 (1048)
                      .....||+|+||+||++.+.     +++.||||++.............++++.++.++||||+++++++.+  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            44567999999999988653     5778999999765433333344567777888999999999999987  4678999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       114 ~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             ECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999653    388999999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----cCCCcccccchhhhhhhcc
Q 045493          932 DSSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL----LSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       932 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ....   .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.....-    ......... .....+...
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT-VLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH-HHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh-HHHHHHHHh
Confidence            4321   23456788999999999988999999999999999999999998643210    001100000 111111112


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .......  .......+.+++.+||+.||++|||++|+++.|+
T Consensus       266 ~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          266 RGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             TTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1111111  1223456889999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8e-37  Score=334.31  Aligned_cols=247  Identities=18%  Similarity=0.254  Sum_probs=194.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....||+|+||.||+|+.. +++.||+|.+........     .....+++..++.++||||+++++++.+.+..++|||
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   88 (283)
T 3bhy_A            9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE   88 (283)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence            3456899999999999987 688999999876433221     2234556677788999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC----ceEEecccccccc
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAKFL  929 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~~~  929 (1048)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||.+...
T Consensus        89 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           89 LVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            99999999999653   3489999999999999999999999   999999999999999877    8999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      .... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....           ......+.......
T Consensus       163 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~  230 (283)
T 3bhy_A          163 EAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----------QETLTNISAVNYDF  230 (283)
T ss_dssp             C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCCCC
T ss_pred             cCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----------HHHHHHhHhcccCC
Confidence            5332 23445799999999999998999999999999999999999999863221           11222222222222


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...........+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            22222233456889999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-37  Score=338.26  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=192.7

Q ss_pred             eeeecccccccEEEEEEcCC-C---ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeE-EEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELTSG-D---TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHL-FLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~-~---~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~  855 (1048)
                      ...||+|+||+||+|.+.+. +   .+|+|++.............+++..++.++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            35689999999999986533 2   58889886544333333445667777889999999999999766554 9999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--  933 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--  933 (1048)
                      .+|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus       106 ~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          106 CHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             cCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999653  34578899999999999999999999   99999999999999999999999999998654321  


Q ss_pred             --CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          934 --SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       934 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                        .......+|+.|+|||.+.+..++.++||||+||++|||++|..|+....          ........+......+..
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----------~~~~~~~~~~~~~~~~~~  250 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----------DPFDLTHFLAQGRRLPQP  250 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----------CGGGHHHHHHTTCCCCCC
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----------CHHHHHHHhhcCCCCCCC
Confidence              22334568899999999999999999999999999999999766643111          111111122122211111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                         ......+.+++.+||+.||++|||++|+++.|++
T Consensus       251 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          251 ---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               1123468889999999999999999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.2e-37  Score=333.48  Aligned_cols=245  Identities=21%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|.+. ++..+|+|++....... .....+++..++.++||||+++++++.+.+..++||||++++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (277)
T 3f3z_A           13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG   91 (277)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence            3456899999999999887 46688999987643332 234456777788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE---CCCCceEEeccccccccCCCCCC
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +|.+++....   .+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||++...... ..
T Consensus        92 ~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~  164 (277)
T 3f3z_A           92 ELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM  164 (277)
T ss_dssp             BHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SC
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cc
Confidence            9999986533   388999999999999999999999   99999999999999   78899999999999876543 33


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+ .++.++||||+|+++|||++|+.||....           .......+.......+.....
T Consensus       165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~~~~~  232 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT-----------DSEVMLKIREGTFTFPEKDWL  232 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCHHHHT
T ss_pred             hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHhCCCCCCchhhh
Confidence            345679999999999876 48999999999999999999999986322           122333333344333332222


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            34567889999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=349.69  Aligned_cols=255  Identities=18%  Similarity=0.179  Sum_probs=185.6

Q ss_pred             ceeeecccccccEEEEEEc----CCCceeeEEeccCCCCcc----------cchhhHHHHHHhhcccCceeeEeeEeee-
Q 045493          780 KMVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEI----------GINQKGFVSEITEIRHRNIVKFYGFCSH-  844 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~~~~----------~~~~~~~~~~l~~l~h~niv~~~~~~~~-  844 (1048)
                      ....||+|+||.||+|.+.    ++..+|+|++........          ......+...+..++||||+++++++.. 
T Consensus        41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~  120 (345)
T 2v62_A           41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE  120 (345)
T ss_dssp             EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred             EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence            3456899999999999886    567889998865432110          0011233444567789999999999987 


Q ss_pred             ---CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC--ceE
Q 045493          845 ---TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY--KAH  919 (1048)
Q Consensus       845 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~--~~k  919 (1048)
                         ....|+||||+ +++|.+++...+   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++  .+|
T Consensus       121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          121 FKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             SSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred             cCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence               77899999999 999999997543   589999999999999999999999   999999999999999887  999


Q ss_pred             EeccccccccCCCCC-------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccc
Q 045493          920 VSDFGTAKFLKPDSS-------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA  992 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  992 (1048)
                      |+|||+++.+.....       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ..
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~  267 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK------DP  267 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT------CH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc------cc
Confidence            999999987643221       12445799999999999999999999999999999999999999853110      00


Q ss_pred             ccchhhhhhhccCCCCCCchhH---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          993 ANMNIVVNDLIDSRLPPPLGEV---EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .... ..........+......   .....++.+++.+||+.||++|||++++++.|++
T Consensus       268 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  325 (345)
T 2v62_A          268 VAVQ-TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP  325 (345)
T ss_dssp             HHHH-HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred             HHHH-HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0000 00011111111100000   0223468899999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=343.16  Aligned_cols=249  Identities=19%  Similarity=0.322  Sum_probs=187.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCce----eeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTR----AVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~v----avk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ....||+|+||+||+|++. +++.+    |+|.+.............+++..++.++||||+++++++.... .++|+||
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~   97 (327)
T 3lzb_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL   97 (327)
T ss_dssp             EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECC
T ss_pred             EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEe
Confidence            4457899999999999875 45555    5565544333333344556777788899999999999998755 8899999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        98 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           98 MPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            99999999997532  3488999999999999999999999   999999999999999999999999999987654332


Q ss_pred             C--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 N--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      .  .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+......+..
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~  241 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------SEISSILEKGERLPQP  241 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHHHHHTTCCCCCC
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC
Confidence            2  233456889999999999999999999999999999999 9999864321           1111111111111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                         ......+.+++.+||+.||++|||++|+++.|++
T Consensus       242 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  275 (327)
T 3lzb_A          242 ---PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             ---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               1223458889999999999999999999998863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-37  Score=334.92  Aligned_cols=247  Identities=23%  Similarity=0.349  Sum_probs=198.5

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ....||+|+||.||+|.+.+++.||+|++.......  ....+++..++.++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (267)
T 3t9t_A           12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC   89 (267)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH--HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred             eeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH--HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence            345689999999999999888899999987643322  344566777888999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-CCccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SNWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~  938 (1048)
                      |.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++...... .....
T Consensus        90 L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           90 LSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             HHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             HHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            99999653  23478999999999999999999999   99999999999999999999999999998664321 11223


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+.........   ...
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~i~~~~~~~~~---~~~  230 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------SEVVEDISTGFRLYKP---RLA  230 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTTCCCCCC---TTS
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----------HHHHHHHhcCCcCCCC---ccC
Confidence            457889999999998899999999999999999999 8999763221           1122222222111111   112


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+.+++.+||+.||++|||++|+++.|+
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            345788999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-37  Score=359.36  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=192.4

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|.+..+..||||+++.....  .....++++.++.++||||+++++++.+ +..++||||+++|+|
T Consensus       189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL  265 (452)
T 1fmk_A          189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  265 (452)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred             eeeecCCCCeEEEEEEECCCceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence            4568999999999999988788999998754322  2345667777889999999999999976 678999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~  939 (1048)
                      .++++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus       266 ~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  341 (452)
T 1fmk_A          266 LDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  341 (452)
T ss_dssp             HHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence            99996432 23488999999999999999999999   999999999999999999999999999987653322 12334


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+..+...+..   ....
T Consensus       342 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~---~~~~  407 (452)
T 1fmk_A          342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------REVLDQVERGYRMPCP---PECP  407 (452)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCC---TTSC
T ss_pred             cccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---CCCC
Confidence            57789999999999999999999999999999999 9999763221           1222222222111111   1233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.+||+.||++|||++++++.|+.
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~  437 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLED  437 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            468889999999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.2e-37  Score=351.21  Aligned_cols=264  Identities=18%  Similarity=0.255  Sum_probs=194.9

Q ss_pred             Ccceeeeccc--ccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          778 EGKMVLHGTG--GCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       778 ~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      +.....||+|  +||+||+|++. +++.||||++....... ......+++..++.++|||||++++++.+.+..|+|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            4455678999  99999999987 68899999997643322 12233456777788999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++|+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.+.......
T Consensus       107 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          107 FMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             CCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             ccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            999999999997542 23489999999999999999999999   99999999999999999999999999986543221


Q ss_pred             -------CCcccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccccc----------
Q 045493          934 -------SNWSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN----------  994 (1048)
Q Consensus       934 -------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~----------  994 (1048)
                             .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||...............          
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence                   11223478999999999987  57899999999999999999999998643221000000000          


Q ss_pred             --chh------------hhhhhccCCC-------CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          995 --MNI------------VVNDLIDSRL-------PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       995 --~~~------------~~~~~~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        ...            ...+......       .+...........+.+++.+||+.||++|||++|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence              000            0000000000       00000112234568899999999999999999999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-37  Score=362.83  Aligned_cols=250  Identities=21%  Similarity=0.235  Sum_probs=197.8

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||.||+|+.. +++.||+|++.....  .........+.+.++.++||||+++++++.+.+..|+||||+
T Consensus       187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~  266 (576)
T 2acx_A          187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM  266 (576)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence            34557999999999999886 688999999865321  111223455677788899999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++...+ ...+++..+..++.||+.||+|||+.   +||||||||+||+++.+|++||+|||+++..... ..
T Consensus       267 ~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-~~  341 (576)
T 2acx_A          267 NGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT  341 (576)
T ss_dssp             CSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-CC
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC-cc
Confidence            9999999997543 23489999999999999999999999   9999999999999999999999999999876543 33


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....       ..........+.......+    .
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~-------~~~~~~i~~~i~~~~~~~p----~  410 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-------KIKREEVERLVKEVPEEYS----E  410 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS-------CCCHHHHHHHHHHCCCCCC----T
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc-------chhHHHHHHHhhcccccCC----c
Confidence            4456899999999999998999999999999999999999999874321       0011111111111111111    1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++||     +++|+++
T Consensus       411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            2235688899999999999999     7888875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=337.74  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=173.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||+|.+......  .......+++..++.++||||+++++++.+.+..++||||++
T Consensus        15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (278)
T 3cok_A           15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence            3456899999999999875 6889999998643211  111234556677788999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...  ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+..........
T Consensus        95 ~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           95 NGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             TEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            99999999753  24588999999999999999999999   99999999999999999999999999998765444444


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+|+++|||++|+.||.......           ............+    ..
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~----~~  234 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----------TLNKVVLADYEMP----SF  234 (278)
T ss_dssp             ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCCCCC----TT
T ss_pred             eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----------HHHHHhhcccCCc----cc
Confidence            45679999999999998889999999999999999999999986432110           0111111111111    11


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            2345788999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=347.51  Aligned_cols=248  Identities=19%  Similarity=0.306  Sum_probs=186.9

Q ss_pred             CcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcc-cchhhHHHHHHhhccc--CceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRH--RNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.....||+|+||.||+|...+++.||||++........ .....+++..+..++|  |||+++++++...+..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            344567899999999999998899999999875433221 1233456666777766  999999999999999999999 


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +.+|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||+++.......
T Consensus        90 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           90 CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            5678999999754   3488999999999999999999999   999999999999997 68899999999987654432


Q ss_pred             C--cccccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhh
Q 045493          935 N--WSELAGTCGYIAPELAYT-----------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       935 ~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      .  ....+||+.|+|||++.+           ..++.++||||+||++|||++|+.||.....          .......
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~~~~  232 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKLHA  232 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHH
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----------HHHHHHH
Confidence            2  335679999999999865           6789999999999999999999999863211          1111222


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ..++.......  ......+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          233 IIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhcCCcccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            22222111111  1112357889999999999999999999863

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-37  Score=368.66  Aligned_cols=245  Identities=22%  Similarity=0.276  Sum_probs=192.5

Q ss_pred             eecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .||+|+||.||+|.+.   ++..||||+++............++++.++.++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            5899999999999875   3556999998765443333445667777889999999999999976 56999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc---
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---  936 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~---  936 (1048)
                      |.+++...  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........   
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99999643  34589999999999999999999999   99999999999999999999999999998765432221   


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+..+......   .
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~p---~  562 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------PEVMAFIEQGKRMECP---P  562 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----------HHHHHHHHTTCCCCCC---T
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---C
Confidence            22345689999999999999999999999999999998 9999864221           1222222222221111   1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....+.+++.+||+.||++|||++++++.|+
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            23456889999999999999999999999886

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-37  Score=350.94  Aligned_cols=248  Identities=19%  Similarity=0.299  Sum_probs=188.7

Q ss_pred             CcceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcc--cCceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIR--HRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.....||+|+||.||+|....++.||||++....... ......+++..+..++  ||||+++++++...+..|+||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            34456799999999999998889999999986543322 1223355666677775  5999999999999999999999 


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +.+|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       137 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          137 CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            56889999997543   478889999999999999999999   999999999999995 58999999999987654332


Q ss_pred             --Ccccccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhh
Q 045493          935 --NWSELAGTCGYIAPELAYT-----------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       935 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                        .....+||+.|+|||++.+           ..++.++||||+||++|||++|+.||.....          .......
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~~~~~~~  279 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKLHA  279 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHHHHH
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------HHHHHHH
Confidence              2345679999999999865           4689999999999999999999999863211          1112223


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.++........  .....+.+++.+||+.||++|||++|+++.
T Consensus       280 ~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 IIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhCccccCCCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            333222211111  112457889999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.2e-37  Score=337.12  Aligned_cols=244  Identities=21%  Similarity=0.314  Sum_probs=196.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|++. +++.+|+|.+.......  .......++..++.++||||+++++++.+.+..++||||++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   98 (294)
T 2rku_A           19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence            4457899999999999987 46778888876543221  12233456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +++|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+..........
T Consensus        99 ~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           99 RRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             TCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            99999998653   3488999999999999999999999   99999999999999999999999999998776554445


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+|+++|||++|+.||.....           ......+.......+.    .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~----~  237 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIKKNEYSIPK----H  237 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCCCCCT----T
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhhccCCCcc----c
Confidence            566799999999999998899999999999999999999999863221           1111222222222111    1


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          238 INPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            2245788999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1e-36  Score=345.25  Aligned_cols=247  Identities=21%  Similarity=0.377  Sum_probs=195.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-------cchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-------GINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-------~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~l  850 (1048)
                      ....||+|+||.||+|++. +|+.||||++........       ......++..+.++ +||||+++++++......|+
T Consensus        98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  177 (365)
T 2y7j_A           98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL  177 (365)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred             cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence            3456899999999999986 689999999865432211       11223445556677 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..+.
T Consensus       178 v~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          178 VFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            99999999999999653   3489999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          931 PDSSNWSELAGTCGYIAPELAYT------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .. .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||....           .......+..
T Consensus       252 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----------~~~~~~~i~~  319 (365)
T 2y7j_A          252 PG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----------QILMLRMIME  319 (365)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHH
T ss_pred             CC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHh
Confidence            43 33445689999999999863      357899999999999999999999986322           1112222223


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .........+......+.+++.+||+.||++|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          320 GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3333222222233456889999999999999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=340.96  Aligned_cols=259  Identities=20%  Similarity=0.279  Sum_probs=188.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||+|++........ .....++++.++.++||||+++++++.+.+..++||||+++
T Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (311)
T 4agu_A            7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH   86 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence            3456899999999999986 588899998865433221 22234567777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      ++|.++++..   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++..........
T Consensus        87 ~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           87 TVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             chHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            9999988643   3488999999999999999999999   999999999999999999999999999987765555555


Q ss_pred             cccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC---------ccccc-chhhhhhhccCC
Q 045493          938 ELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP---------APAAN-MNIVVNDLIDSR 1006 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~-~~~~~~~~~~~~ 1006 (1048)
                      ...||+.|+|||++.+ ..++.++||||+||++|||++|+.||..........         ..... ............
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            6689999999999876 568999999999999999999999986433210000         00000 000000000001


Q ss_pred             CCCCc------hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 LPPPL------GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 ~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+.+.      .........+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            11100      000123456889999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.3e-37  Score=337.32  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=188.9

Q ss_pred             eeeecccccccEEEEEEcCC----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEe-eeCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELTSG----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFC-SHTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  855 (1048)
                      ...||+|+||+||+|.+...    ..+|+|++..............+...+++++||||+++++++ ...+..++||||+
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  109 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  109 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence            45689999999999986532    247888876544333333345667777889999999999986 4566789999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--  933 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--  933 (1048)
                      ++|+|.++++..  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus       110 ~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          110 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             TTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            999999999653  34478999999999999999999999   99999999999999999999999999998764332  


Q ss_pred             --CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 --SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK-HPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                        .......+|+.|+|||.+.+..++.++||||+|+++|||++|. .||....           ................
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~  253 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQ  253 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----------TTTHHHHHHTTCCCCC
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----------HHHHHHHHhcCCCCCC
Confidence              1223456788999999999999999999999999999999954 4543211           1111112222221111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..   .....+.+++.+||+.||++|||++|+++.|+
T Consensus       254 ~~---~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          254 PE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Cc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11   12245888999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-36  Score=359.95  Aligned_cols=246  Identities=22%  Similarity=0.342  Sum_probs=194.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||+|++...... .......+++..++.++||||++++++|.+....|+||||+++
T Consensus        41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  120 (494)
T 3lij_A           41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG  120 (494)
T ss_dssp             EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            4556899999999999986 6788999998764322 2223445677778899999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++..   +.+||+|||+++..... .
T Consensus       121 g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~  193 (494)
T 3lij_A          121 GELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-K  193 (494)
T ss_dssp             CBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-B
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-c
Confidence            9999988654   3488999999999999999999999   99999999999999764   55999999999876543 3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||....           .......+...........+
T Consensus       194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~i~~~~~~~~~~~~  261 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-----------DQEILRKVEKGKYTFDSPEW  261 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCCCSGGG
T ss_pred             cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCchhc
Confidence            344567999999999886 469999999999999999999999986322           12233333334433333333


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          262 KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            344567889999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.5e-37  Score=342.24  Aligned_cols=253  Identities=22%  Similarity=0.314  Sum_probs=195.0

Q ss_pred             cceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCC-eEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQ-HLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~-~~~l  850 (1048)
                      .....||+|+||+||+|++.      +++.||+|++..............++..+..+ +||||+++++++...+ ..++
T Consensus        30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l  109 (316)
T 2xir_A           30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  109 (316)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred             eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence            34557899999999999752      45789999987544332223344566666777 6999999999987654 5899


Q ss_pred             EEEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc
Q 045493          851 VYEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK  917 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~  917 (1048)
                      ||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCC
Confidence            9999999999999975432             12278899999999999999999999   9999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCccccc
Q 045493          918 AHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAAN  994 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  994 (1048)
                      +||+|||+++........  .....||+.|+|||++.+..++.++||||+||++|||++ |+.||.....          
T Consensus       187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----------  256 (316)
T 2xir_A          187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------  256 (316)
T ss_dssp             EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----------
T ss_pred             EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch----------
Confidence            999999999876544332  234567889999999999999999999999999999998 9999763221          


Q ss_pred             chhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          995 MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .......+.........   ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       257 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          257 DEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             SHHHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hHHHHHHhccCccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111111111111   112345888999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-37  Score=334.93  Aligned_cols=246  Identities=18%  Similarity=0.274  Sum_probs=190.0

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeC--CeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHT--QHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|++. ++.||||++........ .....+++..+++++||||+++++++.+.  +..++||||++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence            3456899999999999986 88899999876432221 11233444455677899999999999876  78899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +|+|.++++... ...+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.++++|||++.....   
T Consensus        93 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---  165 (271)
T 3kmu_A           93 YGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---  165 (271)
T ss_dssp             TCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred             CCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence            999999997543 23589999999999999999999998   7  99999999999999999999999998764332   


Q ss_pred             CccccccccccccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 NWSELAGTCGYIAPELAYTMRAN---EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~---~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                        ....||+.|+|||++.+..++   .++||||+||++|||++|+.||.....           .............+..
T Consensus       166 --~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------MEIGMKVALEGLRPTI  232 (271)
T ss_dssp             --TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------HHHHHHHHHSCCCCCC
T ss_pred             --cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------HHHHHHHHhcCCCCCC
Confidence              234689999999999876544   489999999999999999999863221           1111111111111111


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                        .......+.+++.+||+.||++|||++|+++.|++
T Consensus       233 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          233 --PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              01223468889999999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9e-37  Score=332.59  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ...||+|+||.||+|... +++.||+|++.............+++..++.++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            456899999999999886 6888999998654433333445566777788999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--CCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  937 (1048)
                      |.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.......  ....
T Consensus        92 L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  165 (276)
T 2yex_A           92 LFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (276)
T ss_dssp             GGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             HHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence            99998643   3488999999999999999999999   99999999999999999999999999998654322  2234


Q ss_pred             ccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...||+.|+|||++.+..+ +.++||||+|+++|||++|+.||......          ......+.......  .....
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~~--~~~~~  233 (276)
T 2yex_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----------CQEYSDWKEKKTYL--NPWKK  233 (276)
T ss_dssp             CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT----------SHHHHHHHTTCTTS--TTGGG
T ss_pred             CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH----------HHHHHHhhhccccc--Cchhh
Confidence            5678999999999987765 78999999999999999999998642210          01111111111111  11122


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          234 IDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            3446788999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-36  Score=360.62  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=197.0

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCC------------cccchhhHHHHHHhhcccCceeeEeeEeeeC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG------------EIGINQKGFVSEITEIRHRNIVKFYGFCSHT  845 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~------------~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~  845 (1048)
                      .....||+|+||+||+|+.. +++.||+|++......            ........++..++.++||||+++++++.+.
T Consensus        39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  118 (504)
T 3q5i_A           39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK  118 (504)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            34557899999999999886 5788999998754322            1122344567777889999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC---ceEEec
Q 045493          846 QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY---KAHVSD  922 (1048)
Q Consensus       846 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~---~~kl~D  922 (1048)
                      +..|+||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|
T Consensus       119 ~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          119 KYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999999986543   489999999999999999999999   999999999999999776   699999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh
Q 045493          923 FGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       923 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ||+++..... ......+||+.|+|||++. +.++.++||||+||++|+|++|+.||....           .......+
T Consensus       193 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~i  259 (504)
T 3q5i_A          193 FGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-----------DQDIIKKV  259 (504)
T ss_dssp             CTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHH
T ss_pred             CCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHH
Confidence            9999876543 3345567999999999987 468999999999999999999999986322           22333444


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...........+......+.+++.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            444444333333444567899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-36  Score=359.11  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=198.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC-cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||||++...... .......+++..++.++||||+++++++.+....|+||||+++
T Consensus        26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  105 (486)
T 3mwu_A           26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG  105 (486)
T ss_dssp             EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence            3456899999999999886 6889999998653221 1223345677778899999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC---CCCceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD---LEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++   .++.+||+|||+++..... .
T Consensus       106 ~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~  178 (486)
T 3mwu_A          106 GELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T  178 (486)
T ss_dssp             CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-C
Confidence            99999986543   488999999999999999999999   999999999999995   4567999999999876543 3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||....           .......+.........+.+
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~i~~~~~~~~~~~~  246 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----------EYDILKRVETGKYAFDLPQW  246 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCSCSGGG
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCCccc
Confidence            3445679999999999876 59999999999999999999999986322           12233333444444333334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            4455678899999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.2e-37  Score=334.35  Aligned_cols=242  Identities=26%  Similarity=0.380  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||+||+|.+. +++.||+|++......  .......+++..++.++||||+++++++.+.+..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   93 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence            456899999999999877 5668999988543211  1122345566777888999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++....   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......  ...
T Consensus        94 ~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~  165 (279)
T 3fdn_A           94 GTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRT  165 (279)
T ss_dssp             EEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc--ccc
Confidence            99999996543   488999999999999999999998   9999999999999999999999999998654332  234


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...||+.|+|||++.+..++.++||||+|+++|||++|+.||....           .......+.......+.    ..
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~----~~  230 (279)
T 3fdn_A          166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----------YQETYKRISRVEFTFPD----FV  230 (279)
T ss_dssp             --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHHHHTCCCCCT----TS
T ss_pred             ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----------HHHHHHHHHhCCCCCCC----cC
Confidence            5678999999999999999999999999999999999999986322           11112222222222111    12


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...+.+++.+||+.||++|||++|+++.
T Consensus       231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          231 TEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            3457789999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-36  Score=336.96  Aligned_cols=245  Identities=22%  Similarity=0.313  Sum_probs=195.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|+.. +++.||+|++....... .....+++..++.++||||+++++++.+.+..++||||+++|
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (304)
T 2jam_A           13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG   91 (304)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence            3456899999999999886 68899999987543222 234556777788999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE---CCCCceEEeccccccccCCCCCC
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +|.+++...+   .+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||.+.....  ..
T Consensus        92 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~  163 (304)
T 2jam_A           92 ELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI  163 (304)
T ss_dssp             BHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--BT
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--Cc
Confidence            9999986533   488999999999999999999999   99999999999999   7789999999999975432  22


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....           .......+.............
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~  232 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----------ESKLFEKIKEGYYEFESPFWD  232 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHHHHHHHCCCCCCTTTTT
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHcCCCCCCccccc
Confidence            344578999999999999999999999999999999999999986322           111222222222221111122


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            33456889999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-37  Score=338.72  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=183.9

Q ss_pred             cceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .....||+|+||+||+|++.  ..+|+|+++...... ......+++..++.++||||+++++++. ....++||||+++
T Consensus        27 ~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~  103 (289)
T 3og7_A           27 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEG  103 (289)
T ss_dssp             EEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCE
T ss_pred             eeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEEecCC
Confidence            34557899999999999865  359999886543322 1223455677788899999999999764 5568999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC--CCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD--SSN  935 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~--~~~  935 (1048)
                      ++|.+++...  ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ...
T Consensus       104 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          104 SSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             EEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             CcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            9999999643  34588999999999999999999999   9999999999999999999999999999865432  222


Q ss_pred             ccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 WSELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .....||+.|+|||++.   +..++.++||||+|+++|||++|+.||.....          .......+......+...
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----------RDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC----------HHHHHHHHHHTSCCCCTT
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch----------HHHHHHHhcccccCcchh
Confidence            34567999999999986   56788999999999999999999999863221          111111111122211111


Q ss_pred             -hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1013 -EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1013 -~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                       ........+.+++.+||+.||++|||++|+++.|++
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  285 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE  285 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             112234568899999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.4e-37  Score=341.10  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=193.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCc--eeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDT--RAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~--vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|++. ++..  +|+|++..............++..+.++ +||||+++++++.+.+..++||||+
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  108 (327)
T 1fvr_A           29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA  108 (327)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence            3456899999999999876 4444  4888887544444444556677778888 8999999999999999999999999


Q ss_pred             CCCCHHHHHhccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          856 ERGSLATILSNEA-------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       856 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                      ++|+|.+++....             ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~D  185 (327)
T 1fvr_A          109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  185 (327)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcc
Confidence            9999999997543             224589999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhh
Q 045493          923 FGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       923 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      ||+++..... .......+++.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......
T Consensus       186 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------~~~~~~  253 (327)
T 1fvr_A          186 FGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AELYEK  253 (327)
T ss_dssp             TTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHH
T ss_pred             cCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----------HHHHHH
Confidence            9999743321 12233457889999999998889999999999999999998 9999863221           111222


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +.........   ......+.+++.+||+.||++|||++|+++.|+
T Consensus       254 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          254 LPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN  296 (327)
T ss_dssp             GGGTCCCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhcCCCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2222111111   122346888999999999999999999999886

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.3e-37  Score=342.69  Aligned_cols=247  Identities=18%  Similarity=0.237  Sum_probs=190.5

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +.||+|+||.||+|... +++.||+|++........ ......++..+..+ +||||+++++++.+.+..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            56899999999999887 688999999876433221 22334455556666 5799999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCCCCC
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +|.+++... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++..... ..
T Consensus       115 ~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-~~  189 (327)
T 3lm5_A          115 EIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CE  189 (327)
T ss_dssp             EGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred             cHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc-cc
Confidence            999998543 234589999999999999999999999   9999999999999998   789999999999876533 22


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.............
T Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~~i~~~~~~~~~~~~~  258 (327)
T 3lm5_A          190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----------QETYLNISQVNVDYSEETFS  258 (327)
T ss_dssp             ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCCCCCTTTTT
T ss_pred             cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------hHHHHHHHhcccccCchhhc
Confidence            3456799999999999999999999999999999999999999863221           11111121212221112222


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          259 SVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            33456888999999999999999999976

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.7e-37  Score=371.80  Aligned_cols=244  Identities=20%  Similarity=0.259  Sum_probs=196.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.. +++.||||+++....  .........+.+.+..+ +||+|+++++++.+.+..|+||||+
T Consensus       345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~  424 (674)
T 3pfq_A          345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV  424 (674)
T ss_dssp             EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred             EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence            4456899999999999887 577899999875321  11112233344445554 7999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.++++..+   .+++..++.++.||+.||+|||+.   +||||||||+|||++.+|++||+|||+|+........
T Consensus       425 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          425 NGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence            9999999997643   489999999999999999999999   9999999999999999999999999999875555555


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+           .......+.......+.    
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----  563 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----------EDELFQSIMEHNVAYPK----  563 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHSSCCCCCT----
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----------HHHHHHHHHhCCCCCCc----
Confidence            667889999999999999999999999999999999999999986322           22333444444333221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTM-----QKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 1044 (1048)
                      ....++.+++.+||++||++||++     +|+++
T Consensus       564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            234568889999999999999998     66654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.9e-37  Score=335.77  Aligned_cols=248  Identities=22%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|.+. +++.||+|++.....  .......++..++.++||||+++++++.+.+..++||||+++|
T Consensus        17 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   94 (288)
T 3kfa_A           17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   94 (288)
T ss_dssp             EEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             EEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence            3456899999999999987 477899999864322  1233456677788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-cc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~  937 (1048)
                      +|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+......... ..
T Consensus        95 ~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           95 NLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             EHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred             cHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence            9999997543 34589999999999999999999999   9999999999999999999999999999876543322 23


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||.....           ......+.........   ..
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~  236 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------SQVYELLEKDYRMERP---EG  236 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------GGHHHHHHTTCCCCCC---TT
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHhccCCCCCC---CC
Confidence            3457889999999999999999999999999999999 9999763221           1111111111111111   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....+.+++.+||+.||++|||++|+++.|+
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence            2346888999999999999999999999886

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.5e-37  Score=343.23  Aligned_cols=244  Identities=21%  Similarity=0.314  Sum_probs=196.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|++. +++.+|+|++.......  .......++..++.++||||+++++++.+.+..|+||||++
T Consensus        45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  124 (335)
T 2owb_A           45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence            3456899999999999887 46778888876543221  12233456666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus       125 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          125 RRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             TCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            99999998653   3488999999999999999999999   99999999999999999999999999998776554455


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....           ......+.......+.    .
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~----~  263 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KETYLRIKKNEYSIPK----H  263 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHHTCCCCCT----T
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------HHHHHHHhcCCCCCCc----c
Confidence            567799999999999998899999999999999999999999863221           1111122222211111    1


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          264 INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2245778999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6e-37  Score=361.79  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=200.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|+.. +++.||||++......  .......+++..+++++||||+++++++.+.+..|+||||++
T Consensus        30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  109 (484)
T 3nyv_A           30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT  109 (484)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            3456899999999999887 7889999998654322  222334567777888999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE---CCCCceEEeccccccccCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      +|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++.+... 
T Consensus       110 ~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-  182 (484)
T 3nyv_A          110 GGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-  182 (484)
T ss_dssp             SCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence            99999998653   3488999999999999999999999   99999999999999   46789999999999876543 


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||....           .......+.........+.
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----------~~~~~~~i~~~~~~~~~~~  250 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-----------EYDILKKVEKGKYTFELPQ  250 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCSGG
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHcCCCCCCCcc
Confidence            33455679999999999876 69999999999999999999999986432           1223333444444433333


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +......+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            4445567889999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.1e-37  Score=338.99  Aligned_cols=255  Identities=20%  Similarity=0.321  Sum_probs=187.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc--ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE--IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|... +++.||+|++.......  ......+++..++.++||||+++++++...+..++||||++
T Consensus        36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  115 (310)
T 2wqm_A           36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD  115 (310)
T ss_dssp             EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence            3456899999999999875 68899999987533221  12233456667788899999999999999999999999999


Q ss_pred             CCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          857 RGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      +|+|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus       116 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  192 (310)
T 2wqm_A          116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  192 (310)
T ss_dssp             SCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             CCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence            999999996432 234588999999999999999999999   9999999999999999999999999999876554444


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+..++.++||||+|+++|||++|+.||....         .........+.....+....  .
T Consensus       193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~--~  261 (310)
T 2wqm_A          193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---------MNLYSLCKKIEQCDYPPLPS--D  261 (310)
T ss_dssp             ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC------------CCHHHHHHHHHTTCSCCCCT--T
T ss_pred             ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---------hhHHHHHHHhhcccCCCCcc--c
Confidence            445678999999999999999999999999999999999999975321         01111122222222221110  1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....+.+++.+||+.||++|||+++++++|++
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            223468889999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.7e-37  Score=346.36  Aligned_cols=244  Identities=15%  Similarity=0.096  Sum_probs=188.6

Q ss_pred             CcceeeecccccccEEEEE------EcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc---cCceeeEeeEeeeCCeE
Q 045493          778 EGKMVLHGTGGCGTVYKAE------LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFCSHTQHL  848 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~------~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~---h~niv~~~~~~~~~~~~  848 (1048)
                      +.....||+|+||+||+|.      ..+++.||+|++.....    .....+.+.+..++   |+||+++++++...+..
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            3344578999999999993      44688999999865321    22344455555554   99999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-----------C
Q 045493          849 FLVYEYLERGSLATILSNEA--TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-----------E  915 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-----------~  915 (1048)
                      |+||||+++|+|.++++...  ....+++..+..++.|++.||+|||+.   +||||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence            99999999999999996432  234589999999999999999999998   9999999999999998           8


Q ss_pred             CceEEeccccccccCC--CCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccc
Q 045493          916 YKAHVSDFGTAKFLKP--DSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAA  993 (1048)
Q Consensus       916 ~~~kl~DfG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  993 (1048)
                      +.+||+|||+|+.+..  ........+||+.|||||++.+..++.++||||+||++|||+||+.||......      . 
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-  292 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------E-  292 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------E-
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC------c-
Confidence            9999999999976542  223345668999999999999999999999999999999999999997532210      0 


Q ss_pred             cchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhh
Q 045493          994 NMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCR-PTMQKVCNLLC 1047 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~ 1047 (1048)
                             ...........     ....+.+++..|++.+|.+| |+++++.+.|+
T Consensus       293 -------~~~~~~~~~~~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          293 -------CKPEGLFRRLP-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             -------EEECSCCTTCS-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             -------eeechhccccC-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence                   00111111111     12245567788999999998 57777777664

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.9e-37  Score=333.12  Aligned_cols=248  Identities=21%  Similarity=0.277  Sum_probs=190.2

Q ss_pred             ceeeecccccccEEEEEEcCC----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELTSG----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||+||+|.+...    ..||+|.+.............+++..++.++||||+++++++.+. ..++||||+
T Consensus        16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~   94 (281)
T 3cc6_A           16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELY   94 (281)
T ss_dssp             EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECC
T ss_pred             EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecC
Confidence            345689999999999986532    248999887543333233345566777888999999999998754 468999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-  934 (1048)
                      ++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+........ 
T Consensus        95 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           95 PYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             TTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            999999999653  23478999999999999999999999   999999999999999999999999999987654322 


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+......+..  
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~--  236 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----------KDVIGVLEKGDRLPKP--  236 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----------GGHHHHHHHTCCCCCC--
T ss_pred             ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----------HHHHHHHhcCCCCCCC--
Confidence            2234457889999999998899999999999999999998 9999863221           1111111111111111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       237 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          237 -DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence             112345888999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.7e-37  Score=337.33  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEee--eCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCS--HTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|+.. +++.||+|++....... ......+++..+++++||||+++++++.  .....++||||+
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   89 (279)
T 2w5a_A           10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC   89 (279)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECC
T ss_pred             eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCC
Confidence            3456899999999999886 67889999987543222 1223445666778889999999999874  467899999999


Q ss_pred             CCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          856 ERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPP-----ILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       856 ~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      ++|+|.+++.... ....+++..+..++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|||.++..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             TTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             CCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            9999999997543 233489999999999999999999998   7     999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ...........||+.|+|||++.+..++.++||||+|+++|||++|+.||.....           ......+.....+.
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~i~~~~~~~  235 (279)
T 2w5a_A          167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------KELAGKIREGKFRR  235 (279)
T ss_dssp             ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHTCCCC
T ss_pred             ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----------HHHHHHHhhccccc
Confidence            5443333455789999999999998999999999999999999999999863321           11222222222222


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 1046 (1048)
                      ...   .....+.+++.+||+.||++|||++|+++.+
T Consensus       236 ~~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          236 IPY---RYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             CCc---ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            111   2234688899999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-36  Score=331.70  Aligned_cols=247  Identities=20%  Similarity=0.357  Sum_probs=195.6

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      ....||+|+||.||+|...+++.||+|++......  ......+++.++.++||||+++++++.+ +..++||||+++|+
T Consensus        17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~   93 (279)
T 1qpc_A           17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS   93 (279)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred             heeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCC
Confidence            34568999999999999988889999998654322  2344566777888999999999999874 45899999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  938 (1048)
                      |.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++....... ....
T Consensus        94 L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  169 (279)
T 1qpc_A           94 LVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG  169 (279)
T ss_dssp             HHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred             HHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence            999996532 22488999999999999999999999   999999999999999999999999999987654322 1233


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+.........   ...
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~  235 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------PEVIQNLERGYRMVRP---DNC  235 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCC---TTC
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----------HHHHHHHhcccCCCCc---ccc
Confidence            456789999999998889999999999999999999 8999763221           1111222121111111   122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+.+++.+||+.||++|||++++++.|+
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            346888999999999999999999999886

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-36  Score=337.69  Aligned_cols=254  Identities=19%  Similarity=0.278  Sum_probs=186.3

Q ss_pred             CcceeeecccccccEEEEEEcC----CCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCC-----e
Q 045493          778 EGKMVLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQ-----H  847 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~-----~  847 (1048)
                      +.....||+|+||.||+|....    ++.||+|++........ .....+++..++.++||||+++++++.+.+     .
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            3445568999999999997753    34799999865433221 123445667778899999999999997654     3


Q ss_pred             EEEEEEccCCCCHHHHHhcc---ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          848 LFLVYEYLERGSLATILSNE---ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       848 ~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      .++||||+++|+|.+++...   .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence            59999999999999998532   2334589999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhh
Q 045493          925 TAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVND 1001 (1048)
Q Consensus       925 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1048)
                      +++.......  ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.....           ......
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~~~~  261 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----------HEMYDY  261 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------GGHHHH
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHHHHH
Confidence            9987654322  1233457889999999999999999999999999999999 8888763221           112222


Q ss_pred             hccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1002 LIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1002 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      +.........   ......+.+++.+||+.||++|||++++++.|++
T Consensus       262 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          262 LLHGHRLKQP---EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             HHTTCCCCCB---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHcCCCCCCC---ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            2222222111   1233468889999999999999999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-36  Score=335.44  Aligned_cols=253  Identities=15%  Similarity=0.194  Sum_probs=192.6

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEe-eeCCeEEEEEEcc
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFC-SHTQHLFLVYEYL  855 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  855 (1048)
                      +.....||+|+||+||+|++. +++.||+|++......   .....+...++.++|++++..++++ ...+..++||||+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            344567899999999999874 6788999986554332   2355667777888887777666555 6778889999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE---CCCCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~  932 (1048)
                       +|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++.....
T Consensus        88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             -CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             -CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence             89999999643  23489999999999999999999999   99999999999999   78899999999999876544


Q ss_pred             CC-------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          933 SS-------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       933 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ..       ......||+.|+|||++.+..++.++||||+||++|||++|+.||........        ..........
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~  233 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--------RQKYERISEK  233 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--------SSHHHHHHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--------hhhhhhhhcc
Confidence            32       12356799999999999999999999999999999999999999874332111        0111111111


Q ss_pred             CCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1006 RLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1006 ~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ....+.. ........+.+++.+||+.||++|||++++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            1111100 00112356889999999999999999999999886

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-37  Score=351.40  Aligned_cols=258  Identities=21%  Similarity=0.316  Sum_probs=178.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcc-cCceeeEeeEeeeC--CeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIR-HRNIVKFYGFCSHT--QHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~  854 (1048)
                      ....||+|+||.||+|.+. +++.||||++....... ......+++..+..+. ||||+++++++...  ...|+||||
T Consensus        13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~   92 (388)
T 3oz6_A           13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY   92 (388)
T ss_dssp             EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred             EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence            3456899999999999876 68899999986542222 1122234555567776 99999999999754  378999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC--
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD--  932 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~--  932 (1048)
                      ++ |+|.++++.    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+.+...  
T Consensus        93 ~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           93 ME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             CS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             cC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            98 589999864    2478899999999999999999999   9999999999999999999999999999865321  


Q ss_pred             -------------------CCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc------
Q 045493          933 -------------------SSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL------  986 (1048)
Q Consensus       933 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~------  986 (1048)
                                         .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+...      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               112345689999999999876 678999999999999999999999986433210      


Q ss_pred             ---CCCcccc-------cchhhhhhh---c---cCCCCCCchhHH----------HHHHHHHHHHHhccCCCCCCCCCHH
Q 045493          987 ---SLPAPAA-------NMNIVVNDL---I---DSRLPPPLGEVE----------EKLKSMIAVAFLCLDANPDCRPTMQ 1040 (1048)
Q Consensus       987 ---~~~~~~~-------~~~~~~~~~---~---~~~~~~~~~~~~----------~~~~~l~~l~~~cl~~dP~~RPt~~ 1040 (1048)
                         +.+....       .........   .   ..........+.          ....++.+++.+||+.||++|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence               0000000       000000000   0   000000000000          1234688999999999999999999


Q ss_pred             HHHHH
Q 045493         1041 KVCNL 1045 (1048)
Q Consensus      1041 evl~~ 1045 (1048)
                      |+++.
T Consensus       325 e~l~H  329 (388)
T 3oz6_A          325 DALKH  329 (388)
T ss_dssp             HHTTS
T ss_pred             HHhCC
Confidence            99864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8e-37  Score=338.47  Aligned_cols=250  Identities=22%  Similarity=0.285  Sum_probs=187.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|++. +++.||+|++........  .....+++..++.++||||+++++++...+..|+||||++
T Consensus        38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 2h34_A           38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN  117 (309)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecC
Confidence            3456899999999999986 678899998865432221  1234456667788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-CC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-SN  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~  935 (1048)
                      +++|.+++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus       118 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          118 GVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            99999999754   3488999999999999999999999   99999999999999999999999999998765432 22


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.....            ...........+.......
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~~~~~~~~  259 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------------SVMGAHINQAIPRPSTVRP  259 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------------HHHHHHHHSCCCCGGGTST
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------------HHHHHHhccCCCCccccCC
Confidence            3355789999999999998999999999999999999999999864321            0111111111111111112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhh
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP-TMQKVCNLLC 1047 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~ 1047 (1048)
                      .....+.+++.+||+.||++|| |++++++.|+
T Consensus       260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence            2234578899999999999999 9999999886

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.8e-37  Score=342.93  Aligned_cols=243  Identities=23%  Similarity=0.361  Sum_probs=190.1

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      .....||+|+||+||+|+.. +++.||||++........  .....++++.++.++||||+++++++...+..++||||+
T Consensus        57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  136 (348)
T 1u5q_A           57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC  136 (348)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecC
Confidence            34556899999999999874 688899999865432221  122345666678889999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      + |++.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus       137 ~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          137 L-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             S-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             C-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            8 5888887543  23589999999999999999999999   9999999999999999999999999999866432   


Q ss_pred             ccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 WSELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                       ....||+.|+|||++.   ...++.++||||+||++|||++|+.||......           .....+.....+....
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~  275 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIAQNESPALQS  275 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------HHHHHHHHSCCCCCCC
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcCCCCCCC
Confidence             3457999999999984   567899999999999999999999997632211           1111111111111110


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ......+.+++.+||+.||++|||++++++
T Consensus       276 --~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          276 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              112345778999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9e-37  Score=335.22  Aligned_cols=244  Identities=25%  Similarity=0.329  Sum_probs=189.9

Q ss_pred             eecccccccEEEEEEc---CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          783 LHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .||+|+||+||+|.+.   +++.||||++........ ......+++.++.++||||+++++++ ..+..++||||+++|
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~  102 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG  102 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence            6899999999999653   457899999875433221 22345567777888999999999999 567789999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc--
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--  936 (1048)
                      +|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........  
T Consensus       103 ~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  176 (291)
T 1xbb_A          103 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  176 (291)
T ss_dssp             EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccc
Confidence            999999753   3488999999999999999999999   99999999999999999999999999998765443321  


Q ss_pred             -cccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          937 -SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       937 -~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                       ....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+.....+...   
T Consensus       177 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---  242 (291)
T 1xbb_A          177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------SEVTAMLEKGERMGCP---  242 (291)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCC---
T ss_pred             cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCC---
Confidence             22346789999999998889999999999999999999 9999864221           1111122122111111   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            123346888999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-36  Score=340.51  Aligned_cols=258  Identities=20%  Similarity=0.256  Sum_probs=184.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||+|++....... ......+++..++.++||||+++++++.+.+..++||||+++
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  117 (329)
T 3gbz_A           38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN  117 (329)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC
Confidence            3456899999999999876 67889999986543322 122345677778899999999999999999999999999985


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC-----CCCceEEeccccccccCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD-----LEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~-----~~~~~kl~DfG~a~~~~~~  932 (1048)
                       +|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++     .++.+||+|||+++.....
T Consensus       118 -~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          118 -DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             -EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             -CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence             9999997543   388999999999999999999999   999999999999994     4556999999999877655


Q ss_pred             CCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhhhhhh
Q 045493          933 SSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~ 1002 (1048)
                      ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.......         ..+.............
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD  270 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence            4455566789999999999875 48999999999999999999999986432210         0000000000000000


Q ss_pred             ccCCCCCCc-hhHH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1003 IDSRLPPPL-GEVE-----EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1003 ~~~~~~~~~-~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+... ....     ....++.+++.+||+.||++|||++|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000000000 0001     12356889999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.2e-37  Score=356.18  Aligned_cols=258  Identities=19%  Similarity=0.253  Sum_probs=186.8

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~  849 (1048)
                      +.....||+|+||+||+|.+. +++.||||++....... ......+++..++.++||||+++++++...      ...|
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            334567899999999999876 67889999987542221 122334566677888999999999999654      4679


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+++ ++.+.+..     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus       144 lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            99999987 46666632     378899999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccc--ccchhh
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPA--ANMNIV  998 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~--~~~~~~  998 (1048)
                      ... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+...         +.+...  ......
T Consensus       215 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          215 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             --C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            532 33455789999999999999999999999999999999999999997543210         000000  000000


Q ss_pred             hhhhccC----------------CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 VNDLIDS----------------RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 ~~~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .......                ..+...........++.+++.+||+.||++|||++|+++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0011110                0111111122335678999999999999999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-36  Score=331.95  Aligned_cols=244  Identities=21%  Similarity=0.290  Sum_probs=189.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e  853 (1048)
                      -...||+|+||+||+|.+. ++..||+|++....... ......+++..++.++||||+++++++..    ....++|||
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence            3446899999999999886 56778888886543222 12234556677788899999999998865    456899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEEC-CCCceEEeccccccccC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLD-LEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~  930 (1048)
                      |+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|||++....
T Consensus       110 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          110 LMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             ecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999999999753   3478999999999999999999998   7  99999999999998 78999999999997543


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .  .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....          .............+. 
T Consensus       184 ~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------~~~~~~~~~~~~~~~-  249 (290)
T 1t4h_A          184 A--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------AAQIYRRVTSGVKPA-  249 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------HHHHHHHHTTTCCCG-
T ss_pred             c--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc----------HHHHHHHHhccCCcc-
Confidence            2  23345679999999998764 699999999999999999999999863221          111122222221111 


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       .........+.+++.+||+.||++|||++|+++
T Consensus       250 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             111122346889999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.6e-37  Score=347.90  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=192.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|++. +++.||+|++.............+++..++.++||||+++++++...+..++||||+++|
T Consensus        37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  116 (360)
T 3eqc_A           37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG  116 (360)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence            3456899999999999887 678889998875433322233445566667889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.++++...   .+++..+..++.+++.|++|||+..  +|+||||||+||+++.++.+||+|||++......  ....
T Consensus       117 ~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  189 (360)
T 3eqc_A          117 SLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS  189 (360)
T ss_dssp             BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C---
T ss_pred             CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cccC
Confidence            9999997543   4889999999999999999999842  7999999999999999999999999999765322  2234


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC--------------CC---------------
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS--------------LP---------------  989 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~--------------~~---------------  989 (1048)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||........              .+               
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM  269 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred             CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence            5799999999999999999999999999999999999999864321000              00               


Q ss_pred             --cccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          990 --APAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       990 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ..................+...  .......+.+++.+||+.||++|||++|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          270 DSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              0000000111111111111111  0112346889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-36  Score=340.55  Aligned_cols=252  Identities=22%  Similarity=0.302  Sum_probs=192.8

Q ss_pred             cceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .....||+|+||.||+|++.      +++.||||++..............++..++.++||||+++++++.+.+..|+||
T Consensus        33 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (327)
T 2yfx_A           33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILM  112 (327)
T ss_dssp             EEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEE
Confidence            34456899999999999842      467899999865433333334455666778889999999999999999999999


Q ss_pred             EccCCCCHHHHHhcccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEecccc
Q 045493          853 EYLERGSLATILSNEAT----AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGT  925 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~  925 (1048)
                      ||+++|+|.+++.....    ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||+
T Consensus       113 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             ECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             ecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            99999999999976432    23488999999999999999999999   99999999999999954   4699999999


Q ss_pred             ccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhh
Q 045493          926 AKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       926 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ++.......  ......||+.|+|||++.+..++.++||||+||++|||+| |+.||....           .......+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----------~~~~~~~~  258 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-----------NQEVLEFV  258 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------HHHHHHHH
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-----------HHHHHHHH
Confidence            986543322  2234567899999999999999999999999999999998 899976322           11122222


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .........   ......+.+++.+||+.||++|||++|+++.|+
T Consensus       259 ~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          259 TSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hcCCCCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            222222111   122346888999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.8e-36  Score=329.18  Aligned_cols=239  Identities=23%  Similarity=0.399  Sum_probs=195.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee--------------
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH--------------  844 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~--------------  844 (1048)
                      ....||+|+||.||+|.+. +++.||+|++....     ....++++.++.++||||+++++++..              
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            4456899999999999987 78899999986532     234567788889999999999998854              


Q ss_pred             --CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEec
Q 045493          845 --TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSD  922 (1048)
Q Consensus       845 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~D  922 (1048)
                        ....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECc
Confidence              455899999999999999997542 34588999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhh
Q 045493          923 FGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       923 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      ||++....... ......||+.|+|||++.+..++.++||||+|+++|||++|..|+....             ......
T Consensus       166 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------------~~~~~~  231 (284)
T 2a19_B          166 FGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------------KFFTDL  231 (284)
T ss_dssp             CTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------------HHHHHH
T ss_pred             chhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------------HHHHHh
Confidence            99998765432 2344579999999999999999999999999999999999998854211             111222


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .....+..      ....+.+++.+||+.||++|||+.|+++.|.
T Consensus       232 ~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          232 RDGIISDI------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             HTTCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccccccc------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            22222221      1234778899999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=334.71  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=192.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...+||+|+||.||+|.+. +++.||+|++..... .......+++..++.++||||+++++++.+.+..++||||+++|
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  104 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG  104 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence            3446899999999999875 577899998865432 22234456677788899999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-CCceEEeccccccccCCCCCCcc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||.++..........
T Consensus       105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence            9999997654444567889999999999999999999   9999999999999987 89999999999987654444445


Q ss_pred             ccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          938 ELAGTCGYIAPELAYTMR--ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ...||+.|+|||++.+..  ++.++||||+|+++|||++|+.||......      .............+..+      .
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~------~  249 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMFKVHPEIP------E  249 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHHCCCCCCC------T
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhcccccccccc------c
Confidence            567999999999987654  889999999999999999999998632210      00000000011111111      1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22346788999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-37  Score=343.53  Aligned_cols=262  Identities=22%  Similarity=0.247  Sum_probs=193.8

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc----ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE----IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      +.....||+|+||.||+|++. +++.||+|++.......    ......+++..++.++||||+++++++.+.+..++||
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF   91 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence            344567999999999999886 58889999986533221    1223456677788899999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++ +|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        92 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           92 DFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             ECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            99987 899888653  23578889999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccch--hhhh
Q 045493          933 SSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMN--IVVN 1000 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~--~~~~ 1000 (1048)
                      ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.......         +.+....+..  ....
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence            5555567899999999998764 58999999999999999999999986433210         0000000000  0000


Q ss_pred             hhccCCCCCCc--hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1001 DLIDSRLPPPL--GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1001 ~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .......+...  .........+.+++.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000111100  0001223568899999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.5e-37  Score=335.24  Aligned_cols=241  Identities=22%  Similarity=0.327  Sum_probs=188.3

Q ss_pred             eeeecccccccEEEEEEcC-C-------CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS-G-------DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~-------~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      ...||+|+||+||+|++.. +       ..||+|++..... .......+++..++.++||||+++++++.+.+..++||
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (289)
T 4fvq_A           13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ   91 (289)
T ss_dssp             EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred             eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence            4468999999999998763 3       3588888854332 22233455677788899999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc--------eEEeccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK--------AHVSDFG  924 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~--------~kl~DfG  924 (1048)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.        +||+|||
T Consensus        92 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             ECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             ECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            9999999999997532  3488999999999999999999999   9999999999999998887        9999999


Q ss_pred             cccccCCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCC-CcccccccCCCcccccchhhhhhh
Q 045493          925 TAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHP-GHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       925 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      .+.....    .....||+.|+|||++.+ ..++.++||||+||++|||++|..| |....           ........
T Consensus       167 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~  231 (289)
T 4fvq_A          167 ISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----------SQRKLQFY  231 (289)
T ss_dssp             SCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----------HHHHHHHH
T ss_pred             ccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----------hHHHHHHh
Confidence            9975432    233568899999999987 6789999999999999999996554 33111           11111111


Q ss_pred             c-cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1003 I-DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1003 ~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      . ....+...      ...+.+++.+||+.||++|||++|+++.|++
T Consensus       232 ~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  272 (289)
T 4fvq_A          232 EDRHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLNS  272 (289)
T ss_dssp             HTTCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred             hccCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1 11112111      2347789999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-36  Score=340.89  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=191.0

Q ss_pred             cceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhh--cccCceeeEeeEeeeCC----eEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITE--IRHRNIVKFYGFCSHTQ----HLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~  852 (1048)
                      .....||+|+||.||+|++. ++.||+|++.....    .....+.+.+..  ++||||+++++++....    ..++||
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEECGGGH----HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             EEEeeecCCCCcEEEEEEEc-CccEEEEEeCchhH----HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            34456899999999999985 88999999864321    122333344443  78999999999998765    799999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH--------HDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      ||+++|+|.+++++.    .+++..+..++.|++.||+|||        +.   +|+||||||+||+++.++.+||+|||
T Consensus       120 e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          120 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             CCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999642    4889999999999999999999        66   99999999999999999999999999


Q ss_pred             cccccCCCCCC----ccccccccccccccccccCC------CCchhhHHHHHHHHHHHHhC----------CCCCccccc
Q 045493          925 TAKFLKPDSSN----WSELAGTCGYIAPELAYTMR------ANEKCDVFNFGVLVLEVIEG----------KHPGHFLSL  984 (1048)
Q Consensus       925 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gvvl~elltg----------~~p~~~~~~  984 (1048)
                      +++........    .....||+.|+|||++.+..      ++.++||||+||++|||++|          +.||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            99876544322    24457999999999987653      33789999999999999999          555542110


Q ss_pred             ccCCCcccccchhhhhhhccCCCCCCch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          985 LLSLPAPAANMNIVVNDLIDSRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                            ...........+......+...   ...+....+.+++.+||+.||++|||++|++++|++
T Consensus       273 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          273 ------SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             ------SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                  0111111122222222222111   123556789999999999999999999999999863

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-36  Score=366.65  Aligned_cols=245  Identities=24%  Similarity=0.319  Sum_probs=191.0

Q ss_pred             eeecccccccEEEEEEc---CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ..||+|+||+||+|.+.   .++.||||+++...... ......++++.++.++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            35899999999999654   45679999987643322 12344566777888999999999999964 558999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--  935 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--  935 (1048)
                      |+|.++++..   ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|||+++.+......  
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999653   3488999999999999999999999   9999999999999999999999999999877544322  


Q ss_pred             -ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 -WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....           ......+.........  
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------~~~~~~i~~~~~~~~p--  594 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------SEVTAMLEKGERMGCP--  594 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCC--
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCCC--
Confidence             223456789999999999999999999999999999998 9999864221           1122222222222111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       .....++.+++.+||+.||++|||++++++.|+
T Consensus       595 -~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          595 -AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             -CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             123356889999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.5e-36  Score=350.16  Aligned_cols=196  Identities=19%  Similarity=0.287  Sum_probs=158.8

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFL  850 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~l  850 (1048)
                      +.....||+|+||.||+|.+. +++.||||++....... ......++++.++.++||||+++++++...     ...|+
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  107 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI  107 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence            334557899999999999886 57789999997543221 112334566777888999999999999765     57999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++ +|.++++..   ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       108 v~e~~~~-~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          108 VLEIADS-DLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEECCSE-EHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEecCCc-CHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            9999875 999999653   3489999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC----------------------Ccccccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          931 PDSS----------------------NWSELAGTCGYIAPELA-YTMRANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       931 ~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      ....                      .....+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            4321                      23567899999999986 56679999999999999999999777764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-36  Score=354.68  Aligned_cols=191  Identities=21%  Similarity=0.281  Sum_probs=145.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee-----CCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH-----TQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~  852 (1048)
                      ....||+|+||+||+|++. +++.||||++....... ......+++..++.++||||+++++++..     ....|+||
T Consensus        57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  136 (458)
T 3rp9_A           57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL  136 (458)
T ss_dssp             ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence            3456899999999999876 68899999986543222 11233456777788899999999999843     35799999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+. |+|.++++..   ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|||+|+.....
T Consensus       137 e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          137 EIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            9985 6999998653   3489999999999999999999999   9999999999999999999999999999876432


Q ss_pred             C---------------------------CCcccccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCC
Q 045493          933 S---------------------------SNWSELAGTCGYIAPELA-YTMRANEKCDVFNFGVLVLEVIEGKH  977 (1048)
Q Consensus       933 ~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gvvl~elltg~~  977 (1048)
                      .                           ......+||+.|+|||++ .+..++.++||||+||++|||++|..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            1                           123456789999999976 46679999999999999999999533

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-36  Score=341.13  Aligned_cols=259  Identities=23%  Similarity=0.334  Sum_probs=189.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|++. +++.||+|++........ .....+++..++.++||||+++++++.+.+..++||||+++
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  108 (331)
T 4aaa_A           29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH  108 (331)
T ss_dssp             EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence            4457899999999999887 588899999865433221 12234566777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +++.++....   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus       109 ~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          109 TILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             EHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             chHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence            9999887543   3488999999999999999999999   999999999999999999999999999987665555555


Q ss_pred             ccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------Cccccc----chhhhhhhc
Q 045493          938 ELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------PAPAAN----MNIVVNDLI 1003 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~----~~~~~~~~~ 1003 (1048)
                      ...||+.|+|||++.+. .++.++||||+||++|||++|+.||.........         ......    .........
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            66799999999998875 6899999999999999999999998643321000         000000    000000000


Q ss_pred             cCCCCCCch---hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 DSRLPPPLG---EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 ~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+.......   ........+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111110000   01123457889999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-36  Score=333.10  Aligned_cols=252  Identities=15%  Similarity=0.198  Sum_probs=193.5

Q ss_pred             cceeeecccccccEEEEEE-cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEe-eeCCeEEEEEEccC
Q 045493          779 GKMVLHGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFC-SHTQHLFLVYEYLE  856 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~  856 (1048)
                      .....||+|+||.||+|++ .+++.||+|++......   .....+...++.++|++++..++++ ...+..++||||+ 
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            3455789999999999987 47889999988654332   2455677778888888766666555 6677889999999 


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC---CCCceEEeccccccccCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD---LEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      +|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++   .++.+||+|||+++......
T Consensus        88 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           88 GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            88999999643  23589999999999999999999999   999999999999994   78999999999998765443


Q ss_pred             CC-------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          934 SN-------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       934 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      ..       .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......        .......+....
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~  234 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--------KRQKYERISEKK  234 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--------SSSHHHHHHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh--------hhhhhhhhcccc
Confidence            21       245679999999999999999999999999999999999999987432110        001111111111


Q ss_pred             CCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1007 LPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1007 ~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+.. ........+.+++.+||+.||++|||++++++.|+
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            111100 00122356889999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=334.54  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||.||+|.+. +++.||+|++.....   ......++..+..++||||+++++++...+..++||||++
T Consensus        31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             EEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            344557899999999999886 588899999865332   2334566777888999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...  ...+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||.+..........
T Consensus       108 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          108 AGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             TEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            99999998632  23588999999999999999999999   99999999999999999999999999998776544444


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..++.++||||+|+++|||++|+.||......           ......... .++.......
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------~~~~~~~~~-~~~~~~~~~~  250 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----------RAIFMIPTN-PPPTFRKPEL  250 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----------HHHHHHHHS-CCCCCSSGGG
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHhcC-CCcccCCccc
Confidence            5667999999999999989999999999999999999999998643211           000111011 1111111122


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||+.++++
T Consensus       251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          251 WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            3356888999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-36  Score=343.98  Aligned_cols=250  Identities=21%  Similarity=0.287  Sum_probs=192.1

Q ss_pred             cceeeecccccccEEEEEE----cCCCceeeEEeccCCC---CcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAEL----TSGDTRAVKKLHSLPT---GEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavk~~~~~~~---~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~l  850 (1048)
                      .....||+|+||.||+|+.    .+++.||||+++....   .........+++.+..+ +||||+++++++...+..++
T Consensus        57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  136 (355)
T 1vzo_A           57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  136 (355)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence            3445689999999999988    3688999999865321   11122334566667777 59999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.
T Consensus       137 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          137 ILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999997543   488999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCC-CCcccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          931 PDS-SNWSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       931 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ... ......+||+.|+|||++.+  ..++.++||||+||++|||++|+.||.....       ................
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE-------KNSQAEISRRILKSEP  283 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS-------CCCHHHHHHHHHHCCC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc-------cchHHHHHHHHhccCC
Confidence            322 22334679999999999985  3478999999999999999999999863221       0111111222222221


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRP-----TMQKVCNL 1045 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 1045 (1048)
                      +.+    ......+.+++.+||+.||++||     |++|+++.
T Consensus       284 ~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          284 PYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            111    12234578899999999999999     99999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-36  Score=330.76  Aligned_cols=242  Identities=18%  Similarity=0.286  Sum_probs=188.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||+||+|.+. +++.||+|++....... .......++..+..+ +||||+++++++.+.+..++||||++
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   94 (289)
T 1x8b_A           15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN   94 (289)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence            3456899999999999887 78899999987543322 222233445555666 89999999999999999999999999


Q ss_pred             CCCHHHHHhcccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-------------------C
Q 045493          857 RGSLATILSNEAT-AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-------------------Y  916 (1048)
Q Consensus       857 ~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-------------------~  916 (1048)
                      +|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.+                   .
T Consensus        95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CC
T ss_pred             CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            9999999975422 24589999999999999999999999   99999999999999844                   4


Q ss_pred             ceEEeccccccccCCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccc
Q 045493          917 KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       917 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      .+||+|||.+.......    ...||+.|+|||++.+. .++.++||||+||++|||++|+.|+....            
T Consensus       172 ~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------------  235 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------------  235 (289)
T ss_dssp             CEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------------
T ss_pred             EEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------------
Confidence            79999999998765432    24589999999999876 56789999999999999999987753211            


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                        ....+.....+....   .....+.+++.+||+.||++|||++|+++.
T Consensus       236 --~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 --QWHEIRQGRLPRIPQ---VLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             --HHHHHHTTCCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --HHHHHHcCCCCCCCc---ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence              111222222222111   123457889999999999999999999863

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-36  Score=339.95  Aligned_cols=259  Identities=22%  Similarity=0.299  Sum_probs=197.0

Q ss_pred             ceeeecccccccEEEEEE-----cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee--eCCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS--HTQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~--~~~~~~lv~  852 (1048)
                      ....||+|+||.||+|++     .+++.||||++...... ......++++.++.++||||+++++++.  +....++||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~  105 (327)
T 3lxl_A           27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM  105 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred             hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH-HHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence            345689999999999984     35778999998654222 1223456677788899999999999886  456789999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       106 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          106 EYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             eecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            9999999999997532  3489999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc----CCCcccccchhhhhhhccC
Q 045493          933 SSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL----SLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       933 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      ...   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ...................
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            321   233468888999999999889999999999999999999999976432210    0000000111111111122


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+..   ......+.+++.+||+.||++|||++|++++|+
T Consensus       261 ~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          261 QRLPAP---PACPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCCC---CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111   223456889999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.5e-37  Score=362.65  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ...||+|+||.||+|.+..+..||||+++.....  .....++++.++.++||||+++++++.+ +..|+||||+++|+|
T Consensus       272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL  348 (535)
T 2h8h_A          272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  348 (535)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred             heecccCCCeEEEEEEECCCceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence            4468999999999999988888999998754322  2345667777889999999999999976 678999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~  939 (1048)
                      .++++... ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus       349 ~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  424 (535)
T 2h8h_A          349 LDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  424 (535)
T ss_dssp             HHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred             HHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence            99996432 23478999999999999999999999   999999999999999999999999999987643211 12234


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||....           .......+......+..   ....
T Consensus       425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-----------~~~~~~~i~~~~~~~~~---~~~~  490 (535)
T 2h8h_A          425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----------NREVLDQVERGYRMPCP---PECP  490 (535)
T ss_dssp             TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-----------HHHHHHHHHTTCCCCCC---TTCC
T ss_pred             cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHcCCCCCCC---CCCC
Confidence            56789999999999999999999999999999999 899976322           11222222222111111   1233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+.+++.+||+.||++|||+++++++|++
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~  520 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAFLED  520 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            468889999999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-36  Score=346.53  Aligned_cols=257  Identities=21%  Similarity=0.254  Sum_probs=188.7

Q ss_pred             cceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC------eEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------HLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------~~~lv~  852 (1048)
                      .....||+|+||+||+|++..+..+|+|++.....     ...++++.++.++||||+++++++...+      ..++||
T Consensus        43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            34557899999999999998777899999865322     2235778889999999999999985433      378999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC-CCCceEEeccccccccCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD-LEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~  931 (1048)
                      ||++++.+............+++..+..++.|+++||+|||+.   +|+||||||+||+++ .++.+||+|||+|+....
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            9998854444433223344588999999999999999999999   999999999999999 789999999999987654


Q ss_pred             CCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhhhhh
Q 045493          932 DSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIVVND 1001 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~ 1001 (1048)
                      .. ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+...         +.+.... .......
T Consensus       195 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~-~~~~~~~  272 (394)
T 4e7w_A          195 GE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ-IKTMNPN  272 (394)
T ss_dssp             TC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH-HHHHCGG
T ss_pred             CC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH-HHhhChh
Confidence            33 23456789999999998765 58999999999999999999999987533210         0000000 0000000


Q ss_pred             hccCCCCCCch-hH-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1002 LIDSRLPPPLG-EV-----EEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1002 ~~~~~~~~~~~-~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.... ..     .....++.+++.+||+.||++|||+.|+++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            11111111000 00     1123578899999999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.4e-36  Score=337.00  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=189.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC-------CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT-------GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~-------~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      ....||+|+||.||+|.+. +++.||||.+.....       ........+++..++.++||||+++++++...+ .|+|
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv   92 (322)
T 2ycf_A           14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIV   92 (322)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEE
T ss_pred             EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEE
Confidence            3456899999999999886 578899999865321       111223456777788999999999999987655 8999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc---eEEeccccccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKF  928 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~  928 (1048)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||+++.
T Consensus        93 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           93 LELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            9999999999998643   3488999999999999999999999   9999999999999987654   99999999987


Q ss_pred             cCCCCCCccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccC
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDS 1005 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1048)
                      .... .......||+.|+|||++.   ...++.++||||+||++|||++|+.||......          ......+...
T Consensus       167 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~~~~~~  235 (322)
T 2ycf_A          167 LGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----------VSLKDQITSG  235 (322)
T ss_dssp             CCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----------SCHHHHHHHT
T ss_pred             cccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----------HHHHHHHHhC
Confidence            6432 2233457899999999974   467899999999999999999999998632210          0111112222


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1006 RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1006 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...............+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            222222222234567889999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-36  Score=330.65  Aligned_cols=243  Identities=24%  Similarity=0.345  Sum_probs=185.8

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|+.. ++.||||.+....   ......+++..++.++||||+++++++.+ .+..++||||+++|
T Consensus        25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~  100 (278)
T 1byg_A           25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  100 (278)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             EEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence            4456899999999999886 8899999986532   22234556777888999999999998754 45789999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......   ...
T Consensus       101 ~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~  173 (278)
T 1byg_A          101 SLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDT  173 (278)
T ss_dssp             EHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---ccC
Confidence            9999996532 22378899999999999999999999   9999999999999999999999999999865432   223


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+.........   ...
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~---~~~  239 (278)
T 1byg_A          174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDVVPRVEKGYKMDAP---DGC  239 (278)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------GGHHHHHTTTCCCCCC---TTC
T ss_pred             CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHhcCCCCCCc---ccC
Confidence            457889999999999899999999999999999998 9999863221           1111222121111111   122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+.+++.+||+.||++|||+.|+++.|+
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence            346888999999999999999999999886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-36  Score=340.28  Aligned_cols=246  Identities=20%  Similarity=0.269  Sum_probs=169.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      .++||+|+||+||+|.+. +++.||+|++....     ....+....+..++||||+++++++..    ....++||||+
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~  108 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM  108 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence            446899999999999887 68899999985421     223344455677799999999999876    45589999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~  932 (1048)
                      ++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       109 ~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~  184 (336)
T 3fhr_A          109 EGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN  184 (336)
T ss_dssp             TTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence            9999999997543 23589999999999999999999999   9999999999999986   455999999999865432


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||..........       .....+.......+..
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          185 --ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-------GMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTT
T ss_pred             --ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------hHHHhhhccccccCch
Confidence              2344678999999999988889999999999999999999999986433211000       0001111111111111


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ........+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11233456888999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-36  Score=329.92  Aligned_cols=241  Identities=23%  Similarity=0.337  Sum_probs=193.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|+.. +++.||+|++.....  ........+++..++.++||||+++++++.+.+..++||||+++
T Consensus        19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   98 (284)
T 2vgo_A           19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR   98 (284)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence            456899999999999887 567899998864321  11122345667777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++....   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......  ...
T Consensus        99 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  170 (284)
T 2vgo_A           99 GELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRR  170 (284)
T ss_dssp             EEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CBC
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc--ccc
Confidence            99999997543   488999999999999999999999   9999999999999999999999999999765432  234


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...||+.|+|||++.+..++.++||||+|+++|||++|+.||.....           ......+.......+.    ..
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~----~~  235 (284)
T 2vgo_A          171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----------TETHRRIVNVDLKFPP----FL  235 (284)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------HHHHHHHHTTCCCCCT----TS
T ss_pred             cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----------hHHHHHHhccccCCCC----cC
Confidence            56799999999999998999999999999999999999999863221           1111222222221111    12


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          236 SDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            345788999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.8e-37  Score=348.92  Aligned_cols=251  Identities=7%  Similarity=-0.028  Sum_probs=172.2

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhc--ccCceeeEe-------eEeeeC-
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEI--RHRNIVKFY-------GFCSHT-  845 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l--~h~niv~~~-------~~~~~~-  845 (1048)
                      .....||+|+||+||+|++. +++.||+|++........  .....++...+..+  +||||++++       +++... 
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~  144 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS  144 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence            34557999999999999976 788999999977543221  11222332223333  699988755       444332 


Q ss_pred             ----------------CeEEEEEEccCCCCHHHHHhccccccccCHHHH------HHHHHHHHHHHHHHHhCCCCCeEee
Q 045493          846 ----------------QHLFLVYEYLERGSLATILSNEATAAELDWSKR------VNVIKGVANALSYMHHDCFPPILHR  903 (1048)
Q Consensus       846 ----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~iiH~  903 (1048)
                                      ...|+||||++ |+|.++++....  .+.+..+      ..++.|++.||+|||+.   +|+||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr  218 (371)
T 3q60_A          145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG  218 (371)
T ss_dssp             SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence                            34899999999 799999976422  2345555      67889999999999999   99999


Q ss_pred             CCCCCCeEECCCCceEEeccccccccCCCCCCcccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          904 DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       904 Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      ||||+|||++.++.+||+|||+|+....   ......+|+.|+|||++.+  ..++.++||||+||++|||++|+.||..
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986532   2224567799999999987  6799999999999999999999999875


Q ss_pred             cccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          982 LSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...........    ............  ..........+.+++.+||+.||++|||++|+++
T Consensus       296 ~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          296 VTPGIKGSWKR----PSLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CCTTCTTCCCB----CCTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cCcccccchhh----hhhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            42211000000    000000001111  1111123456888999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.9e-37  Score=350.93  Aligned_cols=238  Identities=14%  Similarity=0.088  Sum_probs=178.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHH---HHHhhcccCceeeEe-------eEeeeCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFV---SEITEIRHRNIVKFY-------GFCSHTQ  846 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~---~~l~~l~h~niv~~~-------~~~~~~~  846 (1048)
                      ....||+|+||+||+|++. +++.||||++........  .....+++   +.++.++|||||+++       +++...+
T Consensus        77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~  156 (377)
T 3byv_A           77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  156 (377)
T ss_dssp             EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred             EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence            3557999999999999874 689999999875422221  12223444   334556899999998       5555443


Q ss_pred             -----------------eEEEEEEccCCCCHHHHHhcccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC
Q 045493          847 -----------------HLFLVYEYLERGSLATILSNEAT----AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI  905 (1048)
Q Consensus       847 -----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di  905 (1048)
                                       ..|+||||+ +|+|.+++...+.    ...+++..+..++.||+.||+|||+.   +|+||||
T Consensus       157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi  232 (377)
T 3byv_A          157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL  232 (377)
T ss_dssp             SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence                             279999999 6799999975422    12244688889999999999999999   9999999


Q ss_pred             CCCCeEECCCCceEEeccccccccCCCCCCccccccccccccccccccC-----------CCCchhhHHHHHHHHHHHHh
Q 045493          906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM-----------RANEKCDVFNFGVLVLEVIE  974 (1048)
Q Consensus       906 k~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvws~Gvvl~ellt  974 (1048)
                      ||+|||++.++.+||+|||+|+...   ......+| +.|+|||++.+.           .++.++||||+||++|||++
T Consensus       233 kp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          233 RPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            9999999999999999999998532   23345567 999999999887           89999999999999999999


Q ss_pred             CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          975 GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       975 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      |+.||........           ...+.. ...       .....+.+++.+||+.||++|||+.|+++
T Consensus       309 g~~Pf~~~~~~~~-----------~~~~~~-~~~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          309 ADLPITKDAALGG-----------SEWIFR-SCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             SSCCC------CC-----------SGGGGS-SCC-------CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             CCCCCcccccccc-----------hhhhhh-hcc-------CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999864332110           111111 111       11245788999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-36  Score=341.28  Aligned_cols=257  Identities=18%  Similarity=0.249  Sum_probs=185.6

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~  849 (1048)
                      +.....||+|+||.||+|.+. +++.||||++....... ......++++.++.++||||+++++++...      ...|
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            344557899999999999885 68899999986543222 122334566777888999999999999765      3469


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+ +++|.++++.    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       107 lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             EEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            999999 7899999865    2478999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccc---cch
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAA---NMN  996 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~---~~~  996 (1048)
                      ..   .....++|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+...         +.+....   ...
T Consensus       179 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          179 DS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            43   2345678999999999877 679999999999999999999999987433210         0000000   000


Q ss_pred             hhhhhh---ccCCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          997 IVVNDL---IDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       997 ~~~~~~---~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......   ......... .........+.+++.+||+.||++|||++|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000000   000000000 0011224568899999999999999999999873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-36  Score=334.88  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=178.1

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .....||+|+||.||+|... +++.||+|++.............+++..++.++||||+++++++...+..++||||+++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            34557899999999999875 67899999886543322222334455566778999999999999999999999999999


Q ss_pred             CCHHHHHhcc-----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          858 GSLATILSNE-----ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |+|.+++...     .....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+......
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            9999998642     1234589999999999999999999999   9999999999999999999999999999866433


Q ss_pred             CC-----Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          933 SS-----NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       933 ~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      ..     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......           .........
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~  243 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-----------VLMLTLQND  243 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----------HHHHHHTSS
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-----------HHHHHhccC
Confidence            21     1234578999999999876 568999999999999999999999986432210           000000000


Q ss_pred             CCCCc------hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 LPPPL------GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 ~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .+...      .........+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000      000112346788999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.9e-37  Score=344.83  Aligned_cols=252  Identities=17%  Similarity=0.170  Sum_probs=192.2

Q ss_pred             cceeeecccccccEEEEEEcC---------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceee------------
Q 045493          779 GKMVLHGTGGCGTVYKAELTS---------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVK------------  837 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~---------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~------------  837 (1048)
                      .....||+|+||.||+|+...         ++.||+|.+...      ....+++..+++++||||++            
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            344568999999999998874         789999998643      23556777788889999887            


Q ss_pred             ---EeeEeee-CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC
Q 045493          838 ---FYGFCSH-TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD  913 (1048)
Q Consensus       838 ---~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~  913 (1048)
                         +++++.. .+..|+||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence               6677765 77899999999 999999997542 34589999999999999999999999   999999999999999


Q ss_pred             CCC--ceEEeccccccccCCCCC-------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Q 045493          914 LEY--KAHVSDFGTAKFLKPDSS-------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSL  984 (1048)
Q Consensus       914 ~~~--~~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  984 (1048)
                      .++  .+||+|||+++.+.....       ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  999999999987653321       12345799999999999999999999999999999999999999874321


Q ss_pred             ccCCCcccccchhhhhhhccCCC--CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          985 LLSLPAPAANMNIVVNDLIDSRL--PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .      ................  .............+.+++.+||+.||++|||+++++++|+
T Consensus       274 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          274 N------TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             C------HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             C------HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            0      0000011111111110  0000000112356888999999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-36  Score=327.71  Aligned_cols=243  Identities=22%  Similarity=0.349  Sum_probs=186.0

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...||+|+||.||+|++. +++.||+|++.....  .+......+++..++.++||||+++++++...+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG   95 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence            456899999999999987 788999999865321  11122345566777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      ++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+...... ....
T Consensus        96 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~  168 (276)
T 2h6d_A           96 GELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLR  168 (276)
T ss_dssp             CBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred             CcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC-ccee
Confidence            99999997543   478999999999999999999999   9999999999999999999999999999876533 2234


Q ss_pred             ccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||....           .......+.......+    ..
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~----~~  233 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----------VPTLFKKIRGGVFYIP----EY  233 (276)
T ss_dssp             --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCC----TT
T ss_pred             cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----------HHHHHHHhhcCcccCc----hh
Confidence            4578999999999988766 689999999999999999999986321           1111222222221111    11


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ....+.+++.+||+.||++|||++|+++.
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            23457889999999999999999999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-36  Score=335.59  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=189.2

Q ss_pred             hhhhcccCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeee---
Q 045493          770 ELLSASTFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSH---  844 (1048)
Q Consensus       770 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~---  844 (1048)
                      ++......+.....||+|+||.||+|++. +++.||+|++......  ......++..+.++ +||||+++++++..   
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            33344444555667999999999999885 6888999998653322  23445566667777 79999999999976   


Q ss_pred             ---CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEe
Q 045493          845 ---TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVS  921 (1048)
Q Consensus       845 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~  921 (1048)
                         .+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence               468899999999999999997542 34588999999999999999999999   99999999999999999999999


Q ss_pred             ccccccccCCCCCCccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccch
Q 045493          922 DFGTAKFLKPDSSNWSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       922 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      |||++..............||+.|+|||++.     +..++.++||||+||++|||++|+.||......           
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------  240 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----------  240 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----------
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----------
Confidence            9999987654433444567999999999987     566899999999999999999999998633211           


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+.....+...  .......+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          241 RALFLIPRNPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHSCCCCCS--CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhcCccccCC--ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            011111111111100  0112346788999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.2e-36  Score=337.03  Aligned_cols=259  Identities=22%  Similarity=0.286  Sum_probs=190.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee--------CCeEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH--------TQHLF  849 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~--------~~~~~  849 (1048)
                      ....||+|+||+||+|+.. +++.||+|++....... ......++++.++.++||||+++++++..        .+..+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~  100 (351)
T 3mi9_A           21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY  100 (351)
T ss_dssp             EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred             EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence            4456899999999999985 78899999986544332 22234567777888999999999999876        45689


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+++ ++.+.+...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+
T Consensus       101 lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A          101 LVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             EEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            99999986 777777543  23489999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCC----CCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCcccc--
Q 045493          930 KPD----SSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAA--  993 (1048)
Q Consensus       930 ~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~--  993 (1048)
                      ...    ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......         ........  
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  254 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  254 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            532    222345678999999999876 45799999999999999999999998743211         00000000  


Q ss_pred             --cchhhhhhhccCC-CCCCchhHH---HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          994 --NMNIVVNDLIDSR-LPPPLGEVE---EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       994 --~~~~~~~~~~~~~-~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ............. .........   .....+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence              0000000000000 000000000   01345889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.8e-36  Score=328.73  Aligned_cols=247  Identities=19%  Similarity=0.319  Sum_probs=194.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--------cchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--------GINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLF  849 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--------~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~  849 (1048)
                      ....||+|+||.||+|.+. +++.||+|++........        ......+++.++++. ||||+++++++...+..+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (298)
T 1phk_A           21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF  100 (298)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence            3456899999999999886 678899999865432111        112234455566775 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus       101 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          101 LVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            999999999999999753   3488999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCccccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          930 KPDSSNWSELAGTCGYIAPELAY------TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      ... .......||+.|+|||++.      ...++.++||||+|+++|||++|+.||.....           ......+.
T Consensus       175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~  242 (298)
T 1phk_A          175 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----------MLMLRMIM  242 (298)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHH
T ss_pred             CCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----------HHHHHHHh
Confidence            543 2334567999999999885      45678999999999999999999999753221           11222222


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .................+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            22222222222334456889999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=348.62  Aligned_cols=194  Identities=20%  Similarity=0.362  Sum_probs=149.2

Q ss_pred             eeeecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee--eCCeEEEEEEcc
Q 045493          781 MVLHGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS--HTQHLFLVYEYL  855 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~  855 (1048)
                      ...||+|+||+||+|++.   +++.||+|++.....   .....+++..++.++||||+++++++.  .....|+||||+
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~  102 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA  102 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence            346899999999999876   578899999864322   224556788889999999999999995  467899999999


Q ss_pred             CCCCHHHHHhccc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE----CCCCceEEecccc
Q 045493          856 ERGSLATILSNEA------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL----DLEYKAHVSDFGT  925 (1048)
Q Consensus       856 ~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~  925 (1048)
                      ++ +|.+++....      ....+++..++.++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus       103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            75 8888875322      122488999999999999999999999   99999999999999    6778999999999


Q ss_pred             ccccCCCC---CCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcc
Q 045493          926 AKFLKPDS---SNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHF  981 (1048)
Q Consensus       926 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~  981 (1048)
                      |+.+....   ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            98765332   223456799999999999874 589999999999999999999999964

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.1e-36  Score=347.36  Aligned_cols=251  Identities=16%  Similarity=0.202  Sum_probs=193.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhccc-CceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH-RNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|++. +++.||||++.......   ....+...+..++| ++|..+..++.+.+..++||||+ +
T Consensus        11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g   86 (483)
T 3sv0_A           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G   86 (483)
T ss_dssp             CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence            3456899999999999875 68889999876543322   34556667777776 56666777778888999999999 8


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE---CCCCceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL---DLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      ++|.+++...  ...+++..++.|+.||+.||+|||+.   +||||||||+|||+   +.++.+||+|||+++.+.....
T Consensus        87 ~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           87 PSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            9999999643  23589999999999999999999999   99999999999999   5789999999999987764432


Q ss_pred             C-------ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          935 N-------WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       935 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      .       .....||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+..+.....
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--------~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--------TKKQKYEKISEKKV  233 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--------SHHHHHHHHHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--------hHHHHHHHHhhccc
Confidence            2       22567999999999999999999999999999999999999998743210        11111111111111


Q ss_pred             CCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1008 PPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1008 ~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..... .......++.+++..||+.||++||++++++++|+
T Consensus       234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            11100 01122356889999999999999999999999886

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.2e-36  Score=336.90  Aligned_cols=247  Identities=24%  Similarity=0.317  Sum_probs=174.9

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEee--------eCCeE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCS--------HTQHL  848 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~--------~~~~~  848 (1048)
                      .....||+|+||.||+|++. +++.||+|++..... ........++..+.++. ||||+++++++.        .....
T Consensus        31 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            34457899999999999975 688999998855322 11223345566667775 999999999983        34568


Q ss_pred             EEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEECCCCceEEeccccc
Q 045493          849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLDLEYKAHVSDFGTA  926 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a  926 (1048)
                      ++||||+. |+|.+++........+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||++
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence            99999996 69999987644455689999999999999999999998   7  999999999999999999999999999


Q ss_pred             cccCCCCCC------------cccccccccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcc
Q 045493          927 KFLKPDSSN------------WSELAGTCGYIAPELA---YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAP  991 (1048)
Q Consensus       927 ~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  991 (1048)
                      +........            .....||+.|+|||++   .+..++.++||||+||++|||++|+.||.......     
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----  260 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----  260 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence            876543221            1134689999999998   56678999999999999999999999986432210     


Q ss_pred             cccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          992 AANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                            .......  .+..    ......+.+++.+||+.||++|||++|+++.|+
T Consensus       261 ------~~~~~~~--~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 ------IVNGKYS--IPPH----DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----------CC--CCTT----CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ------hhcCccc--CCcc----cccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                  0000000  0100    111123678899999999999999999999886

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.4e-36  Score=339.93  Aligned_cols=261  Identities=19%  Similarity=0.287  Sum_probs=192.3

Q ss_pred             cCCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEE
Q 045493          776 TFEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLF  849 (1048)
Q Consensus       776 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~  849 (1048)
                      ..+.....||+|+||.||+|.+. +++.||+|++.............++++.+..++||||+++++++...     ...|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            34455667999999999999876 67789999987543333223445667778889999999999998654     4689


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+++ +|.++++..    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       107 iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999985 999998642    388999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCC---Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC---------Ccccc---
Q 045493          930 KPDSS---NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL---------PAPAA---  993 (1048)
Q Consensus       930 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~---  993 (1048)
                      .....   .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........         +....   
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            53322   2345689999999998654 45899999999999999999999998643321100         00000   


Q ss_pred             cchhhhhhhc---cCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          994 NMNIVVNDLI---DSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       994 ~~~~~~~~~~---~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..........   ......+.. .......++.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000   000000000 00122356889999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=337.07  Aligned_cols=253  Identities=19%  Similarity=0.283  Sum_probs=190.6

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee----eCCeEEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS----HTQHLFLVYE  853 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e  853 (1048)
                      .....||+|+||.||+|+.. +++.||+|++..... .......+++..++.++||||+++++++.    .....++|||
T Consensus        32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            34556899999999999884 788999998865322 22233455677778899999999999986    2447899999


Q ss_pred             ccCCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          854 YLERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+......
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            999999999996532 234589999999999999999999999   9999999999999999999999999998765321


Q ss_pred             CCC---------ccccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhh
Q 045493          933 SSN---------WSELAGTCGYIAPELAYTMR---ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       933 ~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      ...         .....||+.|+|||++.+..   ++.++||||+||++|||++|+.||.......      ........
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~  261 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG------DSVALAVQ  261 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT------SCHHHHHH
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc------chhhHHhh
Confidence            111         12345799999999987554   6899999999999999999999986322110      00000111


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .  ....+..    ......+.+++.+||+.||++|||++|+++.|+
T Consensus       262 ~--~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          262 N--QLSIPQS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             C--C--CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c--cCCCCcc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            1  0111111    122346889999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.1e-36  Score=339.58  Aligned_cols=257  Identities=18%  Similarity=0.240  Sum_probs=183.6

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCC------eEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQ------HLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------~~~l  850 (1048)
                      .....||+|+||.||+|... +++.||||++....... ......+++..++.++||||+++++++...+      ..|+
T Consensus        28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l  107 (371)
T 2xrw_A           28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  107 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred             eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence            34556899999999999876 67889999987543222 1122345666778889999999999997654      7899


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+++ +|.+++..     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       108 v~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          108 VMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            9999986 78888742     378899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccc--ccchhhh
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPA--ANMNIVV  999 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~--~~~~~~~  999 (1048)
                      .. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+....         .+.+.  .......
T Consensus       179 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          179 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             cc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            32 223456799999999999999999999999999999999999999875432100         00000  0000000


Q ss_pred             hhh---------------ccC-CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1000 NDL---------------IDS-RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1000 ~~~---------------~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...               ... ..+............+.+++.+||+.||++|||++|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            000               000 0111111223345678999999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.9e-36  Score=331.15  Aligned_cols=249  Identities=19%  Similarity=0.291  Sum_probs=178.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccc-hhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGI-NQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~-~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||+|++.......... ...++...++.++||||+++++++.+.+..++||||+++
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   90 (290)
T 3fme_A           11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT   90 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE
T ss_pred             hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc
Confidence            3456899999999999885 68889999986543322111 122233335677999999999999999999999999985


Q ss_pred             CCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          858 GSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       858 g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                       +|.+++... .....+++..+..++.|++.|++|||+.+  +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        91 -~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  166 (290)
T 3fme_A           91 -SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AK  166 (290)
T ss_dssp             -EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             -chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccc-cc
Confidence             888887542 22345899999999999999999999853  89999999999999999999999999998765432 23


Q ss_pred             ccccccccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          937 SELAGTCGYIAPELA----YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      ....||+.|+|||++    .+..++.++||||+||++|||++|+.||....          ..............+... 
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~~~~~~~~~-  235 (290)
T 3fme_A          167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG----------TPFQQLKQVVEEPSPQLP-  235 (290)
T ss_dssp             ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS----------CHHHHHHHHHHSCCCCCC-
T ss_pred             cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC----------chHHHHHHHhccCCCCcc-
Confidence            345799999999996    56678999999999999999999999986321          011111122222211111 


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       .......+.+++.+||+.||++|||++|+++
T Consensus       236 -~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 -ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             1123346889999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9e-36  Score=344.59  Aligned_cols=194  Identities=17%  Similarity=0.249  Sum_probs=161.0

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc------ccCceeeEeeEeeeCCeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI------RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l------~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      .....||+|+||+||+|.+. +++.||||++.....  .......+++.++.+      +|+||+++++++...+..++|
T Consensus       100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  177 (429)
T 3kvw_A          100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT  177 (429)
T ss_dssp             EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence            34557899999999999876 578899999864321  112223344444444      578999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc--eEEecccccccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK--AHVSDFGTAKFL  929 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~--~kl~DfG~a~~~  929 (1048)
                      |||+. |+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||+++..
T Consensus       178 ~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          178 FELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             ECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            99996 59999987543 23489999999999999999999999   9999999999999999987  999999999764


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFL  982 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  982 (1048)
                      ..   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       253 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          253 HQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            32   233467999999999999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-35  Score=324.98  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|+.. +++.||+|++....... ......+++..+++++||||+++++++.+.+..++||||+++
T Consensus        26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  105 (287)
T 2wei_A           26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG  105 (287)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence            3456899999999999886 68889999986543322 223345567777889999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC---CceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE---YKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~  934 (1048)
                      ++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+   +.+||+|||++....... 
T Consensus       106 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-  178 (287)
T 2wei_A          106 GELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-  178 (287)
T ss_dssp             CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence            99999986533   488999999999999999999999   99999999999999764   479999999998765332 


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||.....           ......+..+.........
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~~~~  246 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----------YDILKRVETGKYAFDLPQW  246 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCCSGGG
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCCCCchhh
Confidence            2334568999999998876 489999999999999999999999863221           1222223333333222222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ......+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            334456889999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-35  Score=339.67  Aligned_cols=257  Identities=21%  Similarity=0.218  Sum_probs=187.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee------------
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH------------  844 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~------------  844 (1048)
                      +.....||+|+||+||+|++. +++.||+|++.....     ...+++..++.++||||+++++++..            
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            334557899999999999875 788999999865322     22357888899999999999999843            


Q ss_pred             --------------------------CCeEEEEEEccCCCCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 045493          845 --------------------------TQHLFLVYEYLERGSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCF  897 (1048)
Q Consensus       845 --------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  897 (1048)
                                                ....++||||+++ +|.+.+... .....+++..+..++.|+++||+|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      3348899999985 888777532 2234589999999999999999999999  


Q ss_pred             CCeEeeCCCCCCeEEC-CCCceEEeccccccccCCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhC
Q 045493          898 PPILHRDISSKKVLLD-LEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEG  975 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg  975 (1048)
                       +|+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence             999999999999998 68999999999998765433 33445789999999998765 489999999999999999999


Q ss_pred             CCCCcccccccC---------CCcccccch--hhhhhhccCCCCCC-ch--hHHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 045493          976 KHPGHFLSLLLS---------LPAPAANMN--IVVNDLIDSRLPPP-LG--EVEEKLKSMIAVAFLCLDANPDCRPTMQK 1041 (1048)
Q Consensus       976 ~~p~~~~~~~~~---------~~~~~~~~~--~~~~~~~~~~~~~~-~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 1041 (1048)
                      +.||........         .+.......  .......-+..... +.  ........+.+++.+||+.||++|||+.|
T Consensus       239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            999874332100         000000000  00000000000000 00  00112345889999999999999999999


Q ss_pred             HHH
Q 045493         1042 VCN 1044 (1048)
Q Consensus      1042 vl~ 1044 (1048)
                      +++
T Consensus       319 ~l~  321 (383)
T 3eb0_A          319 AMA  321 (383)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-35  Score=330.85  Aligned_cols=263  Identities=20%  Similarity=0.265  Sum_probs=191.2

Q ss_pred             cCCcceeeecccccccEEEEEEc--CCCceeeEEeccCCCCc-ccchhhHHHHHHh---hcccCceeeEeeEee-----e
Q 045493          776 TFEGKMVLHGTGGCGTVYKAELT--SGDTRAVKKLHSLPTGE-IGINQKGFVSEIT---EIRHRNIVKFYGFCS-----H  844 (1048)
Q Consensus       776 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~---~l~h~niv~~~~~~~-----~  844 (1048)
                      +.+.....||+|+||.||+|++.  +++.||+|++....... ......+++..++   .++||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            34445567999999999999983  57789999886543222 1223334444444   448999999999987     5


Q ss_pred             CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          845 TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       845 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                      ....++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            567899999998 59999997543 23488999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccc
Q 045493          925 TAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANM  995 (1048)
Q Consensus       925 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~  995 (1048)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......         ..+....+.
T Consensus       166 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          166 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             SCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             ccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            99865422 22344678999999999999999999999999999999999999987433210         000000000


Q ss_pred             hh--hhhhhccC-CCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          996 NI--VVNDLIDS-RLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       996 ~~--~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..  ........ ...............+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00  00000000 000000011123346788999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-36  Score=334.94  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             ceeeecccccccEEEEEE-----cCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC--eEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAEL-----TSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ--HLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~-----~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  852 (1048)
                      ....||+|+||.||+|++     .+++.||+|++..... .......+++..++.++||||+++++++...+  ..++||
T Consensus        45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~  123 (326)
T 2w1i_A           45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM  123 (326)
T ss_dssp             EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred             eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence            345689999999999984     3578899999865322 22233456677788899999999999986543  689999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          124 EYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             CCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             ECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            9999999999997542  3488999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-c---cCCCcc-cccchhhhhhhcc
Q 045493          933 SSN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSL-L---LSLPAP-AANMNIVVNDLID 1004 (1048)
Q Consensus       933 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~-~---~~~~~~-~~~~~~~~~~~~~ 1004 (1048)
                      ...   .....++..|+|||++.+..++.++||||+||++|||++|+.||..... .   ...... ..........+..
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence            322   1234577889999999988899999999999999999999998753211 0   000000 0000011111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+..   .....++.+++.+||+.||++|||+.|+++.|++
T Consensus       279 ~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          279 NGRLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             TCCCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCC---CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111111   1233568889999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5e-36  Score=329.51  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=183.8

Q ss_pred             ceeeecccccccEEEEEEcC--CC--ceeeEEeccCCCC--cccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELTS--GD--TRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~--~~--~vavk~~~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ....||+|+||+||+|++..  ++  .||+|+++.....  +......++++.++.++||||+++++++.... .++|||
T Consensus        22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e  100 (291)
T 1u46_A           22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE  100 (291)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred             eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence            34568999999999998642  23  5788888654322  11223345666678889999999999998765 889999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++|+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A          101 LAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             CCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             cccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            99999999999753  23488999999999999999999999   99999999999999999999999999998775443


Q ss_pred             CC---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          934 SN---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       934 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      ..   .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....           ......+.......
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~  244 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------SQILHKIDKEGERL  244 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTSCCCC
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----------HHHHHHHHccCCCC
Confidence            32   223457889999999998889999999999999999999 9999863221           11222222211111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      +.  .......+.+++.+||+.||++|||+++++++|+
T Consensus       245 ~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          245 PR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             CC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            11  1123456888999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.2e-36  Score=332.44  Aligned_cols=248  Identities=22%  Similarity=0.320  Sum_probs=188.4

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||.||+|++.  ..+|+|++....... ......+++..++.++||||+++++++.+.+..++||||++++
T Consensus        37 ~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~  114 (319)
T 2y4i_B           37 IGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR  114 (319)
T ss_dssp             CCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred             EeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence            3456899999999999886  358999887543222 2233445666778889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC-----C
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD-----S  933 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~-----~  933 (1048)
                      +|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||+++.....     .
T Consensus       115 ~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          115 TLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             EHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            999999653  23588899999999999999999999   999999999999998 689999999998765321     1


Q ss_pred             CCcccccccccccccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          934 SNWSELAGTCGYIAPELAYT---------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      .......||+.|+|||++.+         ..++.++||||+||++|||++|+.||.....           ......+..
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~  257 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----------EAIIWQMGT  257 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----------HHHHHHHHT
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHhcc
Confidence            22334568999999999874         4578999999999999999999999863221           111111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+....  ......+.+++.+||+.||++|||+++++++|++
T Consensus       258 ~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  299 (319)
T 2y4i_B          258 GMKPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK  299 (319)
T ss_dssp             TCCCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred             CCCCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11111110  0122357889999999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.2e-36  Score=338.45  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=194.2

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCccc----------------chhhHHHHHHhhcccCceeeEeeEee
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG----------------INQKGFVSEITEIRHRNIVKFYGFCS  843 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~----------------~~~~~~~~~l~~l~h~niv~~~~~~~  843 (1048)
                      ....||+|+||.||+|+. +++.||+|++.........                ....+++..++.++||||+++++++.
T Consensus        35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            345689999999999999 7999999998654322111                34456677788899999999999999


Q ss_pred             eCCeEEEEEEccCCCCHHHH------HhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCCC
Q 045493          844 HTQHLFLVYEYLERGSLATI------LSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLEY  916 (1048)
Q Consensus       844 ~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~~  916 (1048)
                      +.+..++||||+++|+|.++      +... ....+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTS
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCC
Confidence            99999999999999999998      5431 23558999999999999999999999 7   999999999999999999


Q ss_pred             ceEEeccccccccCCCCCCccccccccccccccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCcccccccCCCccccc
Q 045493          917 KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM-RANE-KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAAN  994 (1048)
Q Consensus       917 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  994 (1048)
                      .+||+|||.+......  ......||+.|+|||++.+. .++. ++||||+||++|||++|+.||......         
T Consensus       190 ~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------  258 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---------  258 (348)
T ss_dssp             CEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---------
T ss_pred             cEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---------
Confidence            9999999999876433  33456799999999999887 5665 999999999999999999998643220         


Q ss_pred             chhhhhhhccCCCCCCc---------------hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          995 MNIVVNDLIDSRLPPPL---------------GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       995 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                       ......+.......+.               .........+.+++.+||+.||++|||++|+++
T Consensus       259 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 -VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111111111111000               000223456889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-36  Score=331.65  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=188.3

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.....||+|+||.||+|++. +++.+|+|++....... ......++..++.++||||+++++++...+..++||||++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP   99 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC-HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH-HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence            344556899999999999987 57888999886543222 2234456677788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus       100 ~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A          100 GGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            99999998653  23488999999999999999999999   99999999999999999999999999976432222222


Q ss_pred             ccccccccccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          937 SELAGTCGYIAPELA-----YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~-----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ....||+.|+|||++     .+..++.++||||+|+++|||++|+.||.....           ............+.. 
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~-  242 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRVLLKIAKSDPPTL-  242 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHSCCCCC-
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHHHHHHhccCCccc-
Confidence            345789999999998     366789999999999999999999999864321           111111111111111 


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .........+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111223346888999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-35  Score=336.55  Aligned_cols=259  Identities=20%  Similarity=0.206  Sum_probs=177.2

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCe-------EEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH-------LFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~-------~~l  850 (1048)
                      .....||+|+||+||+|++. +++.||||++.....  ......++++.+..++||||+++++++...+.       .++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l  103 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV  103 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence            33456899999999999986 688999998865322  22344556666788899999999999865333       789


Q ss_pred             EEEccCCCCHHHHHhc-cccccccCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeeCCCCCCeEECC-CCceEEeccccc
Q 045493          851 VYEYLERGSLATILSN-EATAAELDWSKRVNVIKGVANALSYMH--HDCFPPILHRDISSKKVLLDL-EYKAHVSDFGTA  926 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a  926 (1048)
                      ||||+++ ++.+.+.. ......+++..+..++.|++.|+.|||  +.   +|+||||||+||+++. ++.+||+|||++
T Consensus       104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            9999987 55444432 223445788999999999999999999  77   9999999999999997 899999999999


Q ss_pred             cccCCCCCCccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccc----ccchhhhhh
Q 045493          927 KFLKPDSSNWSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA----ANMNIVVND 1001 (1048)
Q Consensus       927 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~----~~~~~~~~~ 1001 (1048)
                      +...... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||.............    .........
T Consensus       180 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          180 KKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             BCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             eecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            8765433 234557899999999987654 8999999999999999999999986432210000000    000000000


Q ss_pred             hccC--------CCCCCchh-----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1002 LIDS--------RLPPPLGE-----VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1002 ~~~~--------~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....        ....+...     .......+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000        00000000     0113457889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-35  Score=342.52  Aligned_cols=256  Identities=23%  Similarity=0.267  Sum_probs=186.2

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~lv  851 (1048)
                      .....||+|+||.||+|++. +++.||||++.....     ...++++.++.++|||||+++++|...      ...++|
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            34557999999999999986 588999999865321     234577888999999999999988432      236799


Q ss_pred             EEccCCCCHHHHHhcc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEecccccccc
Q 045493          852 YEYLERGSLATILSNE-ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFL  929 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~  929 (1048)
                      |||+++ ++.+.+... .....+++..+..++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.+
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999987 666665432 2334589999999999999999999999   99999999999999965 67899999999876


Q ss_pred             CCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCccc----ccchhhhhhh--
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA----ANMNIVVNDL-- 1002 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~----~~~~~~~~~~-- 1002 (1048)
                      .... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.............    ......+..+  
T Consensus       208 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          208 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             ccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            5432 23446789999999998764 78999999999999999999999987433210000000    0000000000  


Q ss_pred             --ccCCCCCCc-hhH-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1003 --IDSRLPPPL-GEV-----EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1003 --~~~~~~~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ....++... ..+     .....++.+++.+||+.||++|||+.|+++
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              000111000 000     112356889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-35  Score=331.88  Aligned_cols=251  Identities=18%  Similarity=0.220  Sum_probs=188.6

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeee--CCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSH--TQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~  855 (1048)
                      ....||+|+||+||+|++. +++.||+|++....    .....+++..++.++ ||||+++++++.+  ....++||||+
T Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            3457899999999999875 68899999986422    233556677778886 9999999999987  66789999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~  934 (1048)
                      ++++|.++++.      +++..+..++.|++.||+|||+.   +|+||||||+||+++.++ .+||+|||+++...... 
T Consensus       116 ~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-  185 (330)
T 3nsz_A          116 NNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  185 (330)
T ss_dssp             CCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             CchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence            99999999843      78889999999999999999999   999999999999999776 89999999998765433 


Q ss_pred             Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCC--------Cc---------ccccch
Q 045493          935 NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL--------PA---------PAANMN  996 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~--------~~---------~~~~~~  996 (1048)
                      ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........        ..         ......
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            3345678999999999877 66899999999999999999999998421110000        00         000000


Q ss_pred             hhhhhhccCCCCCC------chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          997 IVVNDLIDSRLPPP------LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.........      ..........+.+++.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000000000      0001113457889999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.9e-36  Score=336.90  Aligned_cols=258  Identities=19%  Similarity=0.278  Sum_probs=189.6

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~  852 (1048)
                      .....||+|+||.||+|++. +++.||||++.............+++..++.++||||+++++++...     ...++||
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            34456899999999999886 67889999986543322223344667777889999999999988654     6789999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||++ |+|.+++..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           94 ELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             CCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             eccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            9997 599999864    2488999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CC----------Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccc
Q 045493          933 SS----------NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPA  992 (1048)
Q Consensus       933 ~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~  992 (1048)
                      ..          ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+...         +.+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            21          1223578999999998764 678999999999999999999999987533110         000000


Q ss_pred             ----ccchhhhhhhccC--CCCCC-c-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          993 ----ANMNIVVNDLIDS--RLPPP-L-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       993 ----~~~~~~~~~~~~~--~~~~~-~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                          ........+....  ..+.. . .........+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                0000000111110  00000 0 001123456889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-35  Score=343.57  Aligned_cols=247  Identities=22%  Similarity=0.300  Sum_probs=179.3

Q ss_pred             ceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ...+||+|+||+||.+...+++.||||++....    ......++..+.++ +||||+++++++.+.+..|+||||+. |
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            345689999999987777789999999986432    12234556666655 89999999999999999999999996 5


Q ss_pred             CHHHHHhccccccc----cCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-------------CceEEe
Q 045493          859 SLATILSNEATAAE----LDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-------------YKAHVS  921 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-------------~~~kl~  921 (1048)
                      +|.+++........    .++..+..++.||+.||+|||+.   +|+||||||+||+++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            99999975432211    13345678999999999999999   99999999999999754             489999


Q ss_pred             ccccccccCCCCCC----cccccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCC
Q 045493          922 DFGTAKFLKPDSSN----WSELAGTCGYIAPELAYT-------MRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLP  989 (1048)
Q Consensus       922 DfG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~  989 (1048)
                      |||+++........    ....+||+.|+|||++.+       ..++.++||||+||++|||++ |+.||......    
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----  246 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----  246 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----
Confidence            99999877544322    234579999999999875       568999999999999999999 99998632110    


Q ss_pred             cccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          990 APAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                           ............... .........++.+++.+||+.||++|||+.|+++
T Consensus       247 -----~~~i~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 -----ESNIIRGIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -----HHHHHHTCCCCCCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHHhcCCCCccccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                 011111111111000 1112345567889999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-35  Score=336.18  Aligned_cols=265  Identities=17%  Similarity=0.202  Sum_probs=187.1

Q ss_pred             cccCCcceeeecccccccEEEEEEcCCCceeeEEeccCCCCccc----------chhhHHHHHHhhcccCceeeEeeEee
Q 045493          774 ASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG----------INQKGFVSEITEIRHRNIVKFYGFCS  843 (1048)
Q Consensus       774 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~----------~~~~~~~~~l~~l~h~niv~~~~~~~  843 (1048)
                      ....+.....||+|+||.||+|...+++.||||++.........          ....++++.++.++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            33445556679999999999999988999999998664333211          23355667778899999999999984


Q ss_pred             e-----CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          844 H-----TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       844 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      .     ....|+||||++ |+|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCE
Confidence            3     346899999998 5888888643  33589999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------C
Q 045493          919 HVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------L  988 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~  988 (1048)
                      ||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........         .
T Consensus       174 kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999854432 23345678999999999877 6789999999999999999999999864321100         0


Q ss_pred             Ccccc---cchhhhhhhccCCCCC-Cchh----HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          989 PAPAA---NMNIVVNDLIDSRLPP-PLGE----VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       989 ~~~~~---~~~~~~~~~~~~~~~~-~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +....   .......+........ +...    .......+.+++.+||+.||++|||++|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            00000   0000001111111100 0000    11223568899999999999999999999863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-35  Score=326.90  Aligned_cols=246  Identities=25%  Similarity=0.386  Sum_probs=181.8

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-------------C
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-------------T  845 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-------------~  845 (1048)
                      ....||+|+||.||+|+.. +++.||+|++....  .......+++..++.++||||+++++++.+             .
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (303)
T 1zy4_A           10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK   87 (303)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred             hhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence            3456899999999999875 68899999985421  112234456677788899999999998854             4


Q ss_pred             CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccc
Q 045493          846 QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGT  925 (1048)
Q Consensus       846 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~  925 (1048)
                      +..|+||||+++|+|.+++....  ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           88 STLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             CceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence            57899999999999999997532  3477889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC--------------CCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc
Q 045493          926 AKFLKPDS--------------SNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA  990 (1048)
Q Consensus       926 a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  990 (1048)
                      ++......              .......||+.|+|||++.+. .++.++||||+||++|||++   ||....       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-------  232 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-------  232 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-------
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-------
Confidence            98764321              122345689999999998864 68999999999999999998   433110       


Q ss_pred             ccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          991 PAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                         ........+.......+..........+.+++.+||+.||++|||++|+++.
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 ---ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ---HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence               0111112221111111111112333457889999999999999999999873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.8e-35  Score=356.96  Aligned_cols=248  Identities=21%  Similarity=0.294  Sum_probs=190.6

Q ss_pred             ceeeecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ....||+|+||.||+|.+..    +..||+|++.............+++..++.++||||+++++++.+ +..|+||||+
T Consensus       394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~  472 (656)
T 2j0j_A          394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELC  472 (656)
T ss_dssp             EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcC
Confidence            34568999999999998753    345788887654333322334556667788899999999999854 5689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.++++..  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       473 ~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          473 TLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             TTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            999999999753  23488999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             -ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 -WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .....+|+.|+|||++.+..++.++||||+||++|||++ |+.||.....           ......+......+..  
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~~--  614 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIGRIENGERLPMP--  614 (656)
T ss_dssp             ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHHTCCCCCC--
T ss_pred             eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----------HHHHHHHHcCCCCCCC--
Confidence             233457789999999999999999999999999999997 9999863221           1122222222211111  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       615 -~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          615 -PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             122346888999999999999999999999886

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.7e-36  Score=339.39  Aligned_cols=257  Identities=19%  Similarity=0.259  Sum_probs=173.2

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC------CeEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT------QHLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~------~~~~  849 (1048)
                      +.....||+|+||.||+|.+. +++.||||++....... ......++++.++.++||||+++++++...      ...|
T Consensus        31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~  110 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY  110 (367)
T ss_dssp             EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence            344567899999999999875 68889999986543221 122334566777888999999999998653      5689


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +|+|++ +++|.++++.    ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       111 lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          111 LVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             EEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             EEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            999999 6799998864    3489999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccc---ccch
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPA---ANMN  996 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~---~~~~  996 (1048)
                      ..   ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+...         +.+...   ....
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          183 AD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             cc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            43   2345679999999999877 678999999999999999999999986543210         000000   0000


Q ss_pred             hhhhhhccC--CCCC-Cch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          997 IVVNDLIDS--RLPP-PLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       997 ~~~~~~~~~--~~~~-~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .........  ..+. ... ........+.+++.+||+.||++|||++|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000011000  0010 000 001123568899999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=338.90  Aligned_cols=245  Identities=22%  Similarity=0.263  Sum_probs=180.3

Q ss_pred             CcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +....+||+|+||+||.....+++.||||++.....    ....++++.++.+ +|||||++++++.+....|+||||++
T Consensus        26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            344567999999997766666799999999865322    2245667777777 79999999999999999999999997


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-----CceEEeccccccccCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-----YKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-----~~~kl~DfG~a~~~~~  931 (1048)
                       |+|.+++.....  ...+..+..++.||+.||+|||+.   +|+||||||+||+++.+     ..+||+|||+|+....
T Consensus       102 -g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 -ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             -EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             -CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence             599999975432  244556789999999999999999   99999999999999532     3588999999987654


Q ss_pred             CC---CCccccccccccccccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhcc
Q 045493          932 DS---SNWSELAGTCGYIAPELAY---TMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004 (1048)
Q Consensus       932 ~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1048)
                      ..   ......+||+.|+|||++.   ...++.++||||+||++|||++ |+.||.....            ........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------------~~~~~~~~  243 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------------RQANILLG  243 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------------HHHHHHTT
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------------HHHHHHhc
Confidence            32   2234567999999999987   4567889999999999999999 8999752210            00111111


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1005 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ................+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111111111233445788999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.7e-35  Score=327.14  Aligned_cols=248  Identities=19%  Similarity=0.305  Sum_probs=185.3

Q ss_pred             CCcceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcc--cCceeeEeeEeeeCCeEEEEEE
Q 045493          777 FEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIR--HRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+.....||+|+||.||+|...+++.||||++....... ......+++..+..++  ||||+++++++...+..++|||
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            344456799999999999999889999999986543322 1223345566667776  5999999999999999999999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                       +.+|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||+++......
T Consensus       109 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          109 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             -CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             -cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence             56789999997543   478899999999999999999999   999999999999996 4899999999998765433


Q ss_pred             C--Ccccccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhh
Q 045493          934 S--NWSELAGTCGYIAPELAYT-----------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVN 1000 (1048)
Q Consensus       934 ~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1000 (1048)
                      .  ......||+.|+|||++.+           ..++.++||||+||++|||++|+.||.....          ......
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~~~~  250 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISKLH  250 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHH
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----------HHHHHH
Confidence            2  1234578999999999875           4688999999999999999999999863211          111122


Q ss_pred             hhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 DLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...++.......  ......+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 AIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhcccccCCc--ccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            222222111110  011245788999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.8e-35  Score=333.63  Aligned_cols=196  Identities=21%  Similarity=0.229  Sum_probs=158.1

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-c-----CceeeEeeEeeeCCeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-H-----RNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv  851 (1048)
                      .....||+|+||+||+|.+. +++.||||++....  ........+++.++.++ |     ++|+++++++...+..++|
T Consensus        57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  134 (382)
T 2vx3_A           57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV  134 (382)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence            34457899999999999876 57789999986421  11122233444444443 3     3599999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC--CCCceEEecccccccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD--LEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~--~~~~~kl~DfG~a~~~  929 (1048)
                      |||+++ +|.+++.... ...+++..+..++.|++.||.|||+.. .+|+||||||+||+++  .++.+||+|||+++..
T Consensus       135 ~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          135 FEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            999965 9999997543 234899999999999999999999521 2899999999999995  4688999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFL  982 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  982 (1048)
                      ...   .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       212 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          212 GQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            432   34567999999999999999999999999999999999999999743

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.8e-35  Score=322.78  Aligned_cols=245  Identities=20%  Similarity=0.279  Sum_probs=188.4

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC---cccchhhHHHHHHhhcccCceeeEeeEe--eeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG---EIGINQKGFVSEITEIRHRNIVKFYGFC--SHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~--~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|... +++.||+|++......   .......+++..++.++||||+++++++  .+....++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (305)
T 2wtk_C           10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY   89 (305)
T ss_dssp             CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence            456899999999999885 6788999998653211   1223345667777888999999999998  445688999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC-
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS-  933 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-  933 (1048)
                      +++| +.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+....... 
T Consensus        90 ~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           90 CVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA  164 (305)
T ss_dssp             CSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred             ccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence            9986 777775432 34589999999999999999999999   99999999999999999999999999998765322 


Q ss_pred             -CCccccccccccccccccccCCC--CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 -SNWSELAGTCGYIAPELAYTMRA--NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 -~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                       .......||+.|+|||++.+...  +.++||||+|+++|||++|+.||....           .......+.......+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----------~~~~~~~i~~~~~~~~  233 (305)
T 2wtk_C          165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----------IYKLFENIGKGSYAIP  233 (305)
T ss_dssp             SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHHCCCCCC
T ss_pred             ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----------HHHHHHHHhcCCCCCC
Confidence             22345578999999999876543  789999999999999999999986322           1112222222222211


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .    .....+.+++.+||+.||++|||++|+++.
T Consensus       234 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          234 G----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             S----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1    123457789999999999999999999863

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-34  Score=331.30  Aligned_cols=334  Identities=21%  Similarity=0.203  Sum_probs=217.4

Q ss_pred             ccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceee
Q 045493          327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYL  406 (1048)
Q Consensus       327 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~  406 (1048)
                      +++++.|++++|.+....+..+..+++|++|++++|.+++..+..|.++++|++|+|++|.+++..|             
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-------------  110 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP-------------  110 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCT-------------
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCH-------------
Confidence            4455555555555554333344555555555555555554444455555555555555555554444             


Q ss_pred             ccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccC
Q 045493          407 LFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFG  486 (1048)
Q Consensus       407 l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~  486 (1048)
                                 ..+..+++|++|++++|.++...+..|..+++|++|++++|.++++.+..|..+++|+.|++++|++++
T Consensus       111 -----------~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          111 -----------HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             -----------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred             -----------HHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence                       444445555555555555554444445666666666666666666666666666667777777766654


Q ss_pred             cccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcccccc
Q 045493          487 EISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL  566 (1048)
Q Consensus       487 ~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  566 (1048)
                      .   .+..+++|+.|++++|.+++     +...++|+.|++++|++... +..  ..++|++|++++|.+++.  ..+..
T Consensus       180 ~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~  246 (390)
T 3o6n_A          180 V---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLN  246 (390)
T ss_dssp             C---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGG
T ss_pred             c---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcC
Confidence            4   24455677777777777663     23345677788888777643 222  246788888888888743  46777


Q ss_pred             ccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEE
Q 045493          567 LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMN  646 (1048)
Q Consensus       567 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  646 (1048)
                      +++|++|+|++|+++++.|..|..+++|++|+|++|+++++. ..+..+++|++|+|++|+++ .+|..+..+++|++|+
T Consensus       247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~  324 (390)
T 3o6n_A          247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALN-LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  324 (390)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEE-CSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccC-cccCCCCCCCEEECCCCcce-ecCccccccCcCCEEE
Confidence            888888888888888877888888888888888888887653 34467788888899998888 5666677888899999


Q ss_pred             CCCCcccCCccccccccCCccEEEeccceecCCCCCcccccccccccccCCccccCC
Q 045493          647 LLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGD  703 (1048)
Q Consensus       647 L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  703 (1048)
                      |++|+|+...   +..++.|++|++++|+|++.... .-+.......+.+++..|..
T Consensus       325 L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~  377 (390)
T 3o6n_A          325 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI  377 (390)
T ss_dssp             CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred             CCCCccceeC---chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence            9999988553   66778899999999998875322 22233333345566666653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-35  Score=334.47  Aligned_cols=255  Identities=20%  Similarity=0.271  Sum_probs=185.5

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCeE------EE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQHL------FL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~------~l  850 (1048)
                      .....||+|+||.||+|.+. +++.||+|++......+. .....+++..++.++||||+++++++...+..      ++
T Consensus        45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  124 (371)
T 4exu_A           45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  124 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred             EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence            34456899999999999876 688999999875433221 22334566667888999999999999876654      99


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||++ |+|.+++..     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       125 v~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          125 VMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             EEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             EEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            999998 589888732     388999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccc---cc---
Q 045493          931 PDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPA---AN---  994 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~---~~---  994 (1048)
                      .   ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........         .+...   ..   
T Consensus       196 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 A---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             c---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            3   2344678999999999887 6789999999999999999999999874331100         00000   00   


Q ss_pred             -chhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          995 -MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       995 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                       ..........................+.+++.+||+.||++|||++|+++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence             000000000000000000011224578899999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.3e-35  Score=336.14  Aligned_cols=256  Identities=19%  Similarity=0.234  Sum_probs=186.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc--------cCceeeEeeEee----eCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR--------HRNIVKFYGFCS----HTQ  846 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~--------h~niv~~~~~~~----~~~  846 (1048)
                      ....||+|+||+||+|++. +++.||+|++....  .......++++.++.++        |+||+++++++.    ...
T Consensus        41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~  118 (397)
T 1wak_A           41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT  118 (397)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred             EEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence            3456899999999999876 57789999986421  11223344555566554        888999999987    556


Q ss_pred             eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC----------
Q 045493          847 HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY----------  916 (1048)
Q Consensus       847 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~----------  916 (1048)
                      ..++||||+ +|++.+++.... ...+++..+..++.||+.||+|||+++  +|+||||||+|||++.++          
T Consensus       119 ~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          119 HICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             eEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            899999999 556666664432 245899999999999999999999864  899999999999999775          


Q ss_pred             ---------------------------------------ceEEeccccccccCCCCCCccccccccccccccccccCCCC
Q 045493          917 ---------------------------------------KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN  957 (1048)
Q Consensus       917 ---------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  957 (1048)
                                                             .+||+|||.++.....   .....||+.|+|||++.+..++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  271 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYN  271 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCCCC
Confidence                                                   7999999999876432   3345789999999999999999


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCcccccccCC----------------CcccccchhhhhhhccC--------CCCC----
Q 045493          958 EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSL----------------PAPAANMNIVVNDLIDS--------RLPP---- 1009 (1048)
Q Consensus       958 ~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~--------~~~~---- 1009 (1048)
                      .++||||+||++|||++|+.||...+.....                +................        ...+    
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            9999999999999999999998643211000                00000000000000000        0000    


Q ss_pred             -----CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 -----PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 -----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                           ...........+.+++.+||+.||++|||++|+++
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                 00112455678999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-35  Score=326.54  Aligned_cols=237  Identities=21%  Similarity=0.319  Sum_probs=189.7

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-----ccchhhHHHHHHhhcc--cCceeeEeeEeeeCCeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-----IGINQKGFVSEITEIR--HRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-----~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~~~~l  850 (1048)
                      .....||+|+||.||+|.+. +++.||||++.......     .......++..++.++  |+||+++++++...+..++
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l  125 (320)
T 3a99_A           46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL  125 (320)
T ss_dssp             EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence            34456899999999999875 67889999987643322     1123345666777775  6999999999999999999


Q ss_pred             EEEccCC-CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC-CCCceEEeccccccc
Q 045493          851 VYEYLER-GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD-LEYKAHVSDFGTAKF  928 (1048)
Q Consensus       851 v~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~~  928 (1048)
                      |||++.+ ++|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+++.
T Consensus       126 v~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          126 ILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             EEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999986 8999999753   3488999999999999999999999   999999999999999 789999999999987


Q ss_pred             cCCCCCCccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          929 LKPDSSNWSELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       929 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ....  ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......                 .....
T Consensus       200 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----------------~~~~~  260 (320)
T 3a99_A          200 LKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----------------IRGQV  260 (320)
T ss_dssp             CCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------------HHCCC
T ss_pred             cccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----------------hcccc
Confidence            6532  2344679999999999887766 68899999999999999999998643211                 01111


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.    .....+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1000    11235788999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-34  Score=325.43  Aligned_cols=254  Identities=18%  Similarity=0.261  Sum_probs=188.1

Q ss_pred             ceeeecccccccEEEEEE-c-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccC------ceeeEeeEeeeCCeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAEL-T-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR------NIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~-~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~------niv~~~~~~~~~~~~~lv  851 (1048)
                      ....||+|+||+||+|.+ . +++.||+|++....  ........++..++.++|+      +|+++++++...+..++|
T Consensus        18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv   95 (339)
T 1z57_A           18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV   95 (339)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence            345689999999999987 3 57889999986422  1122334455556666554      599999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-----------------
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-----------------  914 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-----------------  914 (1048)
                      |||+ +++|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.                 
T Consensus        96 ~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           96 FELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            9999 889999997543 23578999999999999999999999   9999999999999987                 


Q ss_pred             --CCceEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-----
Q 045493          915 --EYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-----  987 (1048)
Q Consensus       915 --~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-----  987 (1048)
                        ++.+||+|||.++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+....     
T Consensus       171 ~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  247 (339)
T 1z57_A          171 LINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME  247 (339)
T ss_dssp             ESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred             ccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence              668999999999864432   3346789999999999999999999999999999999999999864321100     


Q ss_pred             -----CCccc----------------ccc----hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 045493          988 -----LPAPA----------------ANM----NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042 (1048)
Q Consensus       988 -----~~~~~----------------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 1042 (1048)
                           .+...                +..    .........+ ..............+.+++.+||+.||++|||++|+
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence                 00000                000    0000000000 000000112345678999999999999999999999


Q ss_pred             HH
Q 045493         1043 CN 1044 (1048)
Q Consensus      1043 l~ 1044 (1048)
                      ++
T Consensus       327 l~  328 (339)
T 1z57_A          327 LK  328 (339)
T ss_dssp             TT
T ss_pred             hc
Confidence            85

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.4e-34  Score=348.19  Aligned_cols=335  Identities=21%  Similarity=0.201  Sum_probs=225.0

Q ss_pred             ccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceee
Q 045493          327 LSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYL  406 (1048)
Q Consensus       327 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~  406 (1048)
                      +++++.+++++|.+....+..+..+++|++|+|++|.+++..|..|+++++|+.|+|++|.+++                
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~----------------  113 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY----------------  113 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC----------------
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC----------------
Confidence            3445555555555554444444555555555555555554444455555555555555555554                


Q ss_pred             ccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccC
Q 045493          407 LFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFG  486 (1048)
Q Consensus       407 l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~  486 (1048)
                              ..|..+..+++|++|++++|.+++..+..|..+++|++|+|++|.++++++..|..+++|+.|+|++|.+++
T Consensus       114 --------~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          114 --------LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             --------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             --------CCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence                    444444555555555555555555455555666666666666666666666666666666666666666665


Q ss_pred             cccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcccccc
Q 045493          487 EISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGL  566 (1048)
Q Consensus       487 ~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  566 (1048)
                      ..   +..+++|+.|++++|.+++     +...+.|+.|++++|.+....+. +  .++|+.|+|++|.+++  +..+..
T Consensus       186 ~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~  252 (597)
T 3oja_B          186 VD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLN  252 (597)
T ss_dssp             CC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGG
T ss_pred             cC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--Chhhcc
Confidence            42   3445667777777777663     23445677888888877643322 2  2578888888888875  356778


Q ss_pred             ccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEE
Q 045493          567 LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMN  646 (1048)
Q Consensus       567 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  646 (1048)
                      +++|++|+|++|.|+++.|..|..+++|+.|+|++|+++++ +..+..+++|+.|+|++|.++ .+|..+..+++|++|+
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~  330 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  330 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence            88888888888888888888888888888888888888775 344567888999999999998 5777788889999999


Q ss_pred             CCCCcccCCccccccccCCccEEEeccceecCCCCCcccccccccccccCCccccCCC
Q 045493          647 LLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDV  704 (1048)
Q Consensus       647 L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~  704 (1048)
                      |++|+|++..   +..++.|+.|++++|+|+|.... ..+.......+.++...|+..
T Consensus       331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            9999998653   56778999999999999886432 234444555677888888864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.5e-35  Score=324.05  Aligned_cols=257  Identities=21%  Similarity=0.267  Sum_probs=181.4

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEee--------------
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS--------------  843 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~--------------  843 (1048)
                      .....||+|+||.||+|.+. +++.||+|++..... .......+++..++.++||||+++++++.              
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            34556899999999999987 488899998864322 11223445677778899999999999873              


Q ss_pred             eCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC-CCCceEEec
Q 045493          844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD-LEYKAHVSD  922 (1048)
Q Consensus       844 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~-~~~~~kl~D  922 (1048)
                      +....++||||++ |+|.++++.    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++ +++.+||+|
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            4467899999998 599999854    3478899999999999999999999   999999999999997 567999999


Q ss_pred             cccccccCCCC---CCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC-------CCcc
Q 045493          923 FGTAKFLKPDS---SNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS-------LPAP  991 (1048)
Q Consensus       923 fG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-------~~~~  991 (1048)
                      ||+++......   .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||........       .+..
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998764322   22234567999999998865 6789999999999999999999999874332100       0000


Q ss_pred             cccchhh--------hhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          992 AANMNIV--------VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       992 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......        ..........+..........++.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000000        0000000000000001123456889999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.6e-35  Score=329.45  Aligned_cols=251  Identities=22%  Similarity=0.275  Sum_probs=168.9

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHH-HHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGF-VSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~-~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|... +++.||||++..............+ ...++.++||||+++++++...+..++||||+++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~  105 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST  105 (327)
T ss_dssp             C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred             ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence            3456899999999999886 6888999998754332211112222 2245667899999999999999999999999986


Q ss_pred             CCHHHHHhcc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          858 GSLATILSNE--ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       858 g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                       +|.+++...  .....+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||+++...... .
T Consensus       106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~  181 (327)
T 3aln_A          106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-A  181 (327)
T ss_dssp             -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred             -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-c
Confidence             888887531  12345889999999999999999999852  79999999999999999999999999998765332 2


Q ss_pred             cccccccccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC-
Q 045493          936 WSELAGTCGYIAPELA----YTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP- 1010 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1010 (1048)
                      .....||+.|+|||++    .+..++.++||||+||++|||++|+.||........          ..........+.. 
T Consensus       182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~~~~~~~~~~~~~~  251 (327)
T 3aln_A          182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----------QLTQVVKGDPPQLS  251 (327)
T ss_dssp             ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCCCSCCCCCC
T ss_pred             cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----------HHHHHhcCCCCCCC
Confidence            2344799999999998    456789999999999999999999999864321100          0111111111100 


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..........+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0001122346888999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.4e-35  Score=349.31  Aligned_cols=260  Identities=24%  Similarity=0.252  Sum_probs=193.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee------CCeEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH------TQHLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~------~~~~~lv~  852 (1048)
                      ....||+|+||+||+|.+. +++.||||++..............+++.++.++||||+++++++..      .+..++||
T Consensus        18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm   97 (676)
T 3qa8_A           18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM   97 (676)
T ss_dssp             CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence            3446899999999999875 6889999998654333323334556777888999999999998755      67789999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc---eEEecccccccc
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK---AHVSDFGTAKFL  929 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~  929 (1048)
                      ||+++|+|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||.++..
T Consensus        98 Ey~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A           98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             ECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             EeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            9999999999998765555688999999999999999999999   9999999999999997765   999999999876


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcc---cccchhhhhhh----
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAP---AANMNIVVNDL---- 1002 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~---- 1002 (1048)
                      .... ......||+.|+|||++.+..++.++||||+||++|||++|+.||........+...   .........+.    
T Consensus       175 ~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~  253 (676)
T 3qa8_A          175 DQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA  253 (676)
T ss_dssp             TSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSS
T ss_pred             cccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccc
Confidence            5432 334567999999999999999999999999999999999999998642111100000   00000000000    


Q ss_pred             --ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1003 --IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1003 --~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                        .....+.+..........+.+++.+||+.||++|||++|++
T Consensus       254 ~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence              11111212112233456788999999999999999997753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=321.98  Aligned_cols=236  Identities=21%  Similarity=0.320  Sum_probs=184.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-----ccchhhHHHHHHhhc----ccCceeeEeeEeeeCCeEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-----IGINQKGFVSEITEI----RHRNIVKFYGFCSHTQHLF  849 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-----~~~~~~~~~~~l~~l----~h~niv~~~~~~~~~~~~~  849 (1048)
                      ....||+|+||.||+|++. +++.||+|++.......     .......++..+.++    +||||+++++++...+..+
T Consensus        35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~  114 (312)
T 2iwi_A           35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM  114 (312)
T ss_dssp             EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred             EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence            4456899999999999875 67889999986543221     122334456666666    8999999999999999999


Q ss_pred             EEEEc-cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC-CCCceEEecccccc
Q 045493          850 LVYEY-LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD-LEYKAHVSDFGTAK  927 (1048)
Q Consensus       850 lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~  927 (1048)
                      +|||| +++++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+++
T Consensus       115 ~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          115 LVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             EEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            99999 78999999997533   489999999999999999999999   999999999999999 78999999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      .....  ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......                 ....
T Consensus       189 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------------~~~~  249 (312)
T 2iwi_A          189 LLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-----------------LEAE  249 (312)
T ss_dssp             ECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------------HHTC
T ss_pred             hcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-----------------hhhc
Confidence            76533  2345679999999999887766 45899999999999999999998632211                 0111


Q ss_pred             CCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1007 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+    ......+.+++.+||+.||++|||++|+++
T Consensus       250 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111    112345788999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.5e-35  Score=328.46  Aligned_cols=253  Identities=19%  Similarity=0.275  Sum_probs=184.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCCe------EEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQH------LFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~------~~lv  851 (1048)
                      ....||+|+||.||+|.+. +++.||||++......+. .....+++..++.++||||+++++++...+.      .|+|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  107 (353)
T 3coi_A           28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  107 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence            4456899999999999886 688999999865432221 1233456666788899999999999976543      5999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKP  931 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~  931 (1048)
                      |||++ |+|.+++..     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       108 ~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          108 MPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             EECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             ecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            99998 588877632     388999999999999999999999   999999999999999999999999999986542


Q ss_pred             CCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccc---ccch--
Q 045493          932 DSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPA---ANMN--  996 (1048)
Q Consensus       932 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~---~~~~--  996 (1048)
                      .   .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+....         .+...   ....  
T Consensus       179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence            2   334578999999999876 6789999999999999999999999875332100         00000   0000  


Q ss_pred             --hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          997 --IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       997 --~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        ........................+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000000000000000011223456889999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=323.13  Aligned_cols=247  Identities=20%  Similarity=0.289  Sum_probs=171.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccc-hhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGI-NQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~-~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||.||+|++. +++.||||++.......... ...++...++.++||||+++++++.+.+..++||||+ +
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~  107 (318)
T 2dyl_A           29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G  107 (318)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred             ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence            3456899999999999986 68899999987543322111 1222333456778999999999999999999999999 5


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH-DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +.+..+....  ...+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus       108 ~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~  181 (318)
T 2dyl_A          108 TCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AK  181 (318)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             CcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cc
Confidence            5666665432  2358899999999999999999998 5   89999999999999999999999999997664332 23


Q ss_pred             cccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          937 SELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      ....||+.|+|||++.     ...++.++||||+||++|||++|+.||.....          .............+.. 
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~~~~~~~~-  250 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----------DFEVLTKVLQEEPPLL-  250 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHHHHHHHHSCCCCC-
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----------cHHHHHHHhccCCCCC-
Confidence            3457899999999984     45688999999999999999999999863211          1111222222211111 


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .........+.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            001112345788999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.3e-34  Score=327.11  Aligned_cols=251  Identities=18%  Similarity=0.255  Sum_probs=184.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-----------cCceeeEeeEeeeCC-
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-----------HRNIVKFYGFCSHTQ-  846 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-----------h~niv~~~~~~~~~~-  846 (1048)
                      ....||+|+||+||+|++. +++.||||++.....  .......++..+.+++           ||||+++++++...+ 
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~  100 (373)
T 1q8y_A           23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP  100 (373)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC
Confidence            3456899999999999875 678899999864211  1122334444454443           899999999987654 


Q ss_pred             ---eEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC------CCCc
Q 045493          847 ---HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD------LEYK  917 (1048)
Q Consensus       847 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~------~~~~  917 (1048)
                         ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+  +|+||||||+||+++      ..+.
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A          101 NGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             TEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             CCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcce
Confidence               789999999 889999997543 234889999999999999999999953  899999999999994      4458


Q ss_pred             eEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchh
Q 045493          918 AHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI  997 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  997 (1048)
                      +||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .......
T Consensus       177 ~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~  252 (373)
T 1q8y_A          177 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-DDDHIAQ  252 (373)
T ss_dssp             EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-HHHHHHH
T ss_pred             EEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC-hHHHHHH
Confidence            999999999876432   234578999999999999999999999999999999999999987432110000 0000000


Q ss_pred             hh--------------------------------------hhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCH
Q 045493          998 VV--------------------------------------NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTM 1039 (1048)
Q Consensus       998 ~~--------------------------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 1039 (1048)
                      ..                                      ........    .........+.+++.+||+.||++|||+
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY----KFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT----CCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc----cCCcchHHHHHHHHHHHhccCccccCCH
Confidence            00                                      00000000    0113456789999999999999999999


Q ss_pred             HHHHH
Q 045493         1040 QKVCN 1044 (1048)
Q Consensus      1040 ~evl~ 1044 (1048)
                      +|+++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.9e-34  Score=322.66  Aligned_cols=254  Identities=17%  Similarity=0.245  Sum_probs=185.3

Q ss_pred             ceeeecccccccEEEEEEc-CC-CceeeEEeccCCCCcccchhhHHHHHHhhcccCc------eeeEeeEeeeCCeEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SG-DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN------IVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~-~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~n------iv~~~~~~~~~~~~~lv  851 (1048)
                      ....||+|+||+||+|... ++ +.||+|++....  ........++..++.++|++      ++.+++++...+..++|
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv  100 (355)
T 2eu9_A           23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA  100 (355)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence            4456899999999999886 34 578999886421  11223344556666666655      99999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE-------------------
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL-------------------  912 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll-------------------  912 (1048)
                      |||+ +|++.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||++                   
T Consensus       101 ~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A          101 FELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             Eecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccc
Confidence            9999 557777775432 23589999999999999999999999   99999999999999                   


Q ss_pred             CCCCceEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc------
Q 045493          913 DLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL------  986 (1048)
Q Consensus       913 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~------  986 (1048)
                      +.++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......      
T Consensus       176 ~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME  252 (355)
T ss_dssp             ESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            56789999999999864432   234679999999999999999999999999999999999999986432110      


Q ss_pred             ----CCCccccc----------------c----hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 045493          987 ----SLPAPAAN----------------M----NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKV 1042 (1048)
Q Consensus       987 ----~~~~~~~~----------------~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 1042 (1048)
                          ..+.....                .    ......... ...............+.+++.+||+.||++|||++|+
T Consensus       253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence                00000000                0    000000000 0000000012234578899999999999999999999


Q ss_pred             HH
Q 045493         1043 CN 1044 (1048)
Q Consensus      1043 l~ 1044 (1048)
                      ++
T Consensus       332 l~  333 (355)
T 2eu9_A          332 LL  333 (355)
T ss_dssp             TT
T ss_pred             hc
Confidence            85

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.9e-33  Score=314.64  Aligned_cols=307  Identities=26%  Similarity=0.397  Sum_probs=183.8

Q ss_pred             cccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccc
Q 045493          324 LGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLN  403 (1048)
Q Consensus       324 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  403 (1048)
                      +..+++|+.|++++|.+.. ++ .+..+++|++|++++|++++..+  +.++++|++|++++|.++. ++ .+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence            3456666777777766653 23 36666677777777776664332  6666666666666666653 22 355555555


Q ss_pred             eeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCc
Q 045493          404 KYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN  483 (1048)
Q Consensus       404 ~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~  483 (1048)
                      .|++++|++++.                        .+  +..+++|++|++++|......+ .+..+++|+.|++++|.
T Consensus       114 ~L~l~~n~i~~~------------------------~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~  166 (347)
T 4fmz_A          114 ELYLNEDNISDI------------------------SP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK  166 (347)
T ss_dssp             EEECTTSCCCCC------------------------GG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSC
T ss_pred             EEECcCCcccCc------------------------hh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCC
Confidence            555555555432                        22  4455555555555553322222 25555566666666666


Q ss_pred             ccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccc
Q 045493          484 FFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE  563 (1048)
Q Consensus       484 l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  563 (1048)
                      +.+..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..+  
T Consensus       167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--  238 (347)
T 4fmz_A          167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--  238 (347)
T ss_dssp             CCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred             cCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence            554333  5556666666666666654322  5566666666666666664333  5566666666666666664322  


Q ss_pred             cccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccC
Q 045493          564 LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLE  643 (1048)
Q Consensus       564 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  643 (1048)
                      +..+++|++|++++|+++.+  ..+..+++|++|++++|++++.  ..+..+++|++|++++|++++..+..+..+++|+
T Consensus       239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            66666666666666666654  3466666677777777766664  3456667777777777777766666667777777


Q ss_pred             eEECCCCcccCCccccccccCCccEEEeccceec
Q 045493          644 YMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ  677 (1048)
Q Consensus       644 ~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~  677 (1048)
                      +|++++|++++..|  +..++.|++|++++|+++
T Consensus       315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            77777777776555  666777777777777664

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.8e-33  Score=322.70  Aligned_cols=313  Identities=20%  Similarity=0.195  Sum_probs=228.0

Q ss_pred             CCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEE
Q 045493          302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFF  381 (1048)
Q Consensus       302 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  381 (1048)
                      .+++++.|++++|.++...+..|..+++|+.|++++|.+.+..+..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            35789999999999997766678899999999999999998888899999999999999999998888889999999999


Q ss_pred             EeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccc
Q 045493          382 ALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT  461 (1048)
Q Consensus       382 ~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~  461 (1048)
                      +|++|+++...+..|..+++|+.|++++|++++..                        +..|..+++|++|++++|+++
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~------------------------~~~~~~l~~L~~L~l~~n~l~  178 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE------------------------DDTFQATTSLQNLQLSSNRLT  178 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC------------------------TTTTSSCTTCCEEECCSSCCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC------------------------hhhccCCCCCCEEECCCCcCC
Confidence            99999998544444566666666666666655444                        444555555555555555555


Q ss_pred             cCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCcccc
Q 045493          462 GNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG  541 (1048)
Q Consensus       462 ~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  541 (1048)
                      ++.   +..+++|+.|++++|.+++.     ...++|++|++++|.++.. |..  ..++|+.|++++|++++.  ..+.
T Consensus       179 ~~~---~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~  245 (390)
T 3o6n_A          179 HVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLL  245 (390)
T ss_dssp             BCC---GGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGG
T ss_pred             ccc---cccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHc
Confidence            442   23345566666666655432     2234566677777766643 222  246677777777777643  4667


Q ss_pred             CCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeE
Q 045493          542 KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKL  621 (1048)
Q Consensus       542 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  621 (1048)
                      .+++|++|+|++|.+++..|..+..+++|++|+|++|+++++ +..+..+++|++|+|++|+++++ +..+..+++|++|
T Consensus       246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L  323 (390)
T 3o6n_A          246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRLENL  323 (390)
T ss_dssp             GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCCCC-GGGHHHHTTCSEE
T ss_pred             CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCcceec-CccccccCcCCEE
Confidence            777777777777777766677777777788888888877775 44556677888888888888754 3346778889999


Q ss_pred             ECCCCcccCcCCcCcCCccccCeEECCCCcccCCc
Q 045493          622 DLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI  656 (1048)
Q Consensus       622 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  656 (1048)
                      +|++|+|++. +  +..+++|++|++++|++++..
T Consensus       324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~  355 (390)
T 3o6n_A          324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS  355 (390)
T ss_dssp             ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred             ECCCCcccee-C--chhhccCCEEEcCCCCccchh
Confidence            9999988754 2  677889999999999998643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=9.5e-33  Score=311.51  Aligned_cols=309  Identities=27%  Similarity=0.363  Sum_probs=229.1

Q ss_pred             cccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCC
Q 045493          298 KEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSN  377 (1048)
Q Consensus       298 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~  377 (1048)
                      ..+..+++|++|++++|.++.. + .+..+++|+.|++++|.+++..+  +..+++|++|++++|.+++ + ..+.++++
T Consensus        38 ~~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~  111 (347)
T 4fmz_A           38 VTQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTN  111 (347)
T ss_dssp             ECHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTT
T ss_pred             ccchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCc
Confidence            3456789999999999999854 3 48899999999999999986443  9999999999999999985 3 46999999


Q ss_pred             CcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecC
Q 045493          378 LKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLER  457 (1048)
Q Consensus       378 L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~  457 (1048)
                      |++|++++|.+.+..+  +..+++|+.|++++|......+                         .+..+++|++|++++
T Consensus       112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-------------------------~~~~l~~L~~L~l~~  164 (347)
T 4fmz_A          112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-------------------------PLSNMTGLNYLTVTE  164 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-------------------------GGTTCTTCCEEECCS
T ss_pred             CCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-------------------------chhhCCCCcEEEecC
Confidence            9999999999996444  7788888888888775543322                         244455555555555


Q ss_pred             CccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcC
Q 045493          458 NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIP  537 (1048)
Q Consensus       458 n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  537 (1048)
                      |.+.++..  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..+
T Consensus       165 ~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~  238 (347)
T 4fmz_A          165 SKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP  238 (347)
T ss_dssp             SCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred             CCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc
Confidence            55554433  5556666666666666654433  5666677777777777764433  6677777777777777775433


Q ss_pred             ccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccc
Q 045493          538 KQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQ  617 (1048)
Q Consensus       538 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  617 (1048)
                        +..+++|++|++++|.+++.  ..+..+++|++|++++|+++++  ..+..+++|+.|++++|++++..+..+..+++
T Consensus       239 --~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~  312 (347)
T 4fmz_A          239 --LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN  312 (347)
T ss_dssp             --GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTT
T ss_pred             --hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhcccc
Confidence              67777777778877777743  4577777888888888887775  45777888888888888888877788888888


Q ss_pred             cCeEECCCCcccCcCCcCcCCccccCeEECCCCccc
Q 045493          618 LSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       618 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                      |++|++++|++++..|  +..+++|++|++++|+|+
T Consensus       313 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            8888888888886555  777888888888888875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-33  Score=307.68  Aligned_cols=224  Identities=21%  Similarity=0.273  Sum_probs=171.0

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHH-hhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEI-TEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      .+||+|+||.||+|... +++.||+|++...      ....+++..+ +..+||||+++++++..    ....++||||+
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~   97 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   97 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence            56899999999999885 6789999998532      1233344444 56689999999999876    67789999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~  932 (1048)
                      ++|+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||++....  
T Consensus        98 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           98 DGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             CSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            9999999997643 23589999999999999999999999   9999999999999998   7899999999987532  


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                                          +..++.++||||+||++|||++|+.||...........       ............+..
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYEFPNP  224 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SCCSSCTTCCSSCHH
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HHHHHhhccccCCch
Confidence                                13467899999999999999999999864332111100       001111111121211


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ........+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            12234567889999999999999999999986

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3.4e-33  Score=309.13  Aligned_cols=259  Identities=31%  Similarity=0.509  Sum_probs=218.8

Q ss_pred             cccceeEecCCcccc--CcccccCCCCCCCeeeCcC-CcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcE
Q 045493          448 TSLYSLRLERNQLTG--NISEVFGIYPDLELLDLSN-NNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHK  524 (1048)
Q Consensus       448 ~~L~~L~L~~n~l~~--~~~~~~~~~~~L~~L~Ls~-n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  524 (1048)
                      .++++|+|++|.+++  ..+..|..+++|++|++++ |.+.+..|..+..+++|++|++++|.+++..|..|..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            356667777777766  5566677777777777774 7777777777888888888888888888788888888888888


Q ss_pred             EEcccCcccCCcCccccCCCccCEEeecCccccCCCcccccccc-ccceeecccCccccccccccccccccccccccccc
Q 045493          525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLA-ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ  603 (1048)
Q Consensus       525 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~  603 (1048)
                      |+|++|++++..|..|..+++|++|+|++|++++.+|..+..++ +|++|++++|++++..|..+..+. |++|++++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            88888888888888888888888888888888878888888887 888888888888888888888887 9999999999


Q ss_pred             ccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc
Q 045493          604 FSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       604 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      +++..+..+..+++|+.|+|++|++++.++. +..+++|++|+|++|+|++.+|..+..++.|++|++++|+++|.+|..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            9888888888999999999999999876665 788899999999999999999999999999999999999999999998


Q ss_pred             ccccccccccccCCccccCCCCCCCCC
Q 045493          684 KAFQNATIEAFQGNKELCGDVTGLPPC  710 (1048)
Q Consensus       684 ~~~~~~~~~~~~~n~~lc~~~~~~~~c  710 (1048)
                      ..++......+.+|+++||.+.  ++|
T Consensus       288 ~~l~~L~~l~l~~N~~lc~~p~--~~C  312 (313)
T 1ogq_A          288 GNLQRFDVSAYANNKCLCGSPL--PAC  312 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEESTTS--SCC
T ss_pred             ccccccChHHhcCCCCccCCCC--CCC
Confidence            8888888888999999999753  356

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.6e-33  Score=305.55  Aligned_cols=225  Identities=12%  Similarity=0.087  Sum_probs=171.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ....||+|+||.||+|++. +++.||+|++........  .....++...+..++||||+++++++.+.+..|+||||++
T Consensus        35 i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  114 (286)
T 3uqc_A           35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIR  114 (286)
T ss_dssp             EEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecC
Confidence            3456899999999999986 488999999876543221  1233455666788899999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +++|.+++++.     ....++.+++.|++.||+|||+.   +|+||||||+||+++.+|.+||+++|            
T Consensus       115 g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          115 GGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             CCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------------
Confidence            99999999542     34557889999999999999999   99999999999999999999998543            


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                              |++       .++.++||||+||++|||+||+.||.............        .......+........
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  231 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADIDRD  231 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------BCTTSCBCCHHHHCTT
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------HHhccCCCChhhcccC
Confidence                    333       37899999999999999999999987543221110000        0001111111111112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ....+.+++.+||+.||++| |+.|+++.|++
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQ  262 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence            33568899999999999999 99999999863

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.5e-33  Score=335.07  Aligned_cols=312  Identities=20%  Similarity=0.191  Sum_probs=228.4

Q ss_pred             CCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEE
Q 045493          303 LKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFA  382 (1048)
Q Consensus       303 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~  382 (1048)
                      +.+++.+++++|.++.+.+..|..+++|+.|++++|.+.+..|..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            56889999999999987777788999999999999999988888999999999999999999988888899999999999


Q ss_pred             eecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCcccc
Q 045493          383 LRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTG  462 (1048)
Q Consensus       383 L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~  462 (1048)
                      |++|.+++..+..|..+++|+.|++++|.+++..                        |..|..+++|++|++++|.+++
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~------------------------~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE------------------------DDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC------------------------TTTTTTCTTCCEEECTTSCCSB
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCC------------------------hhhhhcCCcCcEEECcCCCCCC
Confidence            9999988655555566666666666665555444                        4445555555555555555554


Q ss_pred             CcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccC
Q 045493          463 NISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGK  542 (1048)
Q Consensus       463 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  542 (1048)
                      ++   +..+++|+.|++++|.+++.     ...++|+.|++++|.++...+..   .++|+.|+|++|.+++  +..+..
T Consensus       186 ~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~  252 (597)
T 3oja_B          186 VD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLN  252 (597)
T ss_dssp             CC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGG
T ss_pred             cC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhcc
Confidence            43   23345566666666655432     22345666666666666332221   2567777777777774  356777


Q ss_pred             CCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEE
Q 045493          543 LTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLD  622 (1048)
Q Consensus       543 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  622 (1048)
                      +++|++|+|++|.+++..|..|+.+++|++|+|++|+++++ |..+..+++|+.|+|++|+++.+ +..+..+++|+.|+
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~~i-~~~~~~l~~L~~L~  330 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRLENLY  330 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCCCC-GGGHHHHTTCSEEE
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCCcc-CcccccCCCCCEEE
Confidence            77777777777777777777777777788888888877775 55566678888888888888754 34567788899999


Q ss_pred             CCCCcccCcCCcCcCCccccCeEECCCCcccCCc
Q 045493          623 LSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI  656 (1048)
Q Consensus       623 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  656 (1048)
                      |++|.|++..   +..+++|++|++++|++++..
T Consensus       331 L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~  361 (597)
T 3oja_B          331 LDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNS  361 (597)
T ss_dssp             CCSSCCCCCC---CCTTCCCSEEECCSSCEEHHH
T ss_pred             CCCCCCCCcC---hhhcCCCCEEEeeCCCCCChh
Confidence            9999887542   667789999999999998654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-33  Score=343.82  Aligned_cols=231  Identities=22%  Similarity=0.268  Sum_probs=179.3

Q ss_pred             ceeeecccccccEEEEEEc--CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCe-----EEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT--SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQH-----LFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~--~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~-----~~lv~  852 (1048)
                      ....||+|+||+||+|.+.  +++.||||++......+.......+...+.+++||||+++++++.+.+.     .|+||
T Consensus        84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~  163 (681)
T 2pzi_A           84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM  163 (681)
T ss_dssp             EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence            3456899999999999886  5788999988654332222233455666788899999999999987655     79999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||+++++|.+++..     .+++.++..++.||+.||.|||+.   +||||||||+||+++.+ .+||+|||+++.....
T Consensus       164 E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          164 EYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             ECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             EeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            99999999988743     489999999999999999999999   99999999999999875 8999999999876533


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                          ....||+.|+|||++.+. ++.++|||||||++|||++|..||.....                    ...+. ..
T Consensus       235 ----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~--------------------~~~~~-~~  288 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV--------------------DGLPE-DD  288 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC--------------------SSCCT-TC
T ss_pred             ----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc--------------------ccccc-cc
Confidence                345799999999998765 48999999999999999999888652110                    00111 11


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQ-KVCNL 1045 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~~ 1045 (1048)
                      ........+.+++.+||++||++||+.. ++...
T Consensus       289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~  322 (681)
T 2pzi_A          289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ  322 (681)
T ss_dssp             HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             cccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence            1223345788999999999999999654 44443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-33  Score=321.23  Aligned_cols=238  Identities=15%  Similarity=0.085  Sum_probs=169.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhccc-Cce---------e----------
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRH-RNI---------V----------  836 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h-~ni---------v----------  836 (1048)
                      ...+||+|+||+||+|++. +++.||||++........  ....+++...+..++| ++.         +          
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            4457999999999999965 688999998874332221  2223445555566655 211         1          


Q ss_pred             --eEeeEeee-----CCeEEEEEEccCCCCHHHHHhcc----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCC
Q 045493          837 --KFYGFCSH-----TQHLFLVYEYLERGSLATILSNE----ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDI  905 (1048)
Q Consensus       837 --~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di  905 (1048)
                        .+..++..     ...++++|+++ +|+|.++++..    .....+++..+..++.|+++||+|||+.   +||||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence              11111111     22467778776 56999998421    1234578889999999999999999999   9999999


Q ss_pred             CCCCeEECCCCceEEeccccccccCCCCCCcccccccccccccccc----------ccCCCCchhhHHHHHHHHHHHHhC
Q 045493          906 SSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA----------YTMRANEKCDVFNFGVLVLEVIEG  975 (1048)
Q Consensus       906 k~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws~Gvvl~elltg  975 (1048)
                      ||+|||++.++.+||+|||+++.....   ....+| +.|+|||++          .+..++.++||||+||++|||++|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999999865432   344567 999999998          555688999999999999999999


Q ss_pred             CCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          976 KHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       976 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +.||.......           ......... ..       ....+.+++.+||+.||++|||+.|+++
T Consensus       314 ~~Pf~~~~~~~-----------~~~~~~~~~-~~-------~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          314 DLPNTDDAALG-----------GSEWIFRSC-KN-------IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SCCCCTTGGGS-----------CSGGGGSSC-CC-------CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCcchhh-----------hHHHHHhhc-cc-------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99986433211           111111111 11       1245888999999999999999988764

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=8.8e-32  Score=301.22  Aligned_cols=294  Identities=25%  Similarity=0.337  Sum_probs=156.7

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      +++++++++|+++ .+|..+.  ++|++|+|++|.++++.|.+|+.+++|++|+|++|+++++.|..|.++++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            4555666665555 3343332  355555555555555555555555555555555555555555555555555555555


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|+++ .+|..+.  ++|++|++++|++                                       ++..+..|..+++
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i---------------------------------------~~~~~~~~~~l~~  148 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRI---------------------------------------RKVPKGVFSGLRN  148 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCC---------------------------------------CCCCSGGGSSCSS
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCcc---------------------------------------CccCHhHhCCCcc
Confidence            55555 2333222  4455555555544                                       4444445566666


Q ss_pred             cceeeccccCccc--cCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeec
Q 045493          185 LTFVYLNNNRIVG--SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYL  262 (1048)
Q Consensus       185 L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  262 (1048)
                      |++|++++|.++.  ..|..+..+ +|++|++++|++++ +|..+.  ++|++|++++|.+++..+..|..+++|++|++
T Consensus       149 L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L  224 (332)
T 2ft3_A          149 MNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGL  224 (332)
T ss_dssp             CCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBC
T ss_pred             CCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            6666666666642  455556555 66666666666653 444332  46666666666666555556666666666666


Q ss_pred             ccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccC
Q 045493          263 SHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG  342 (1048)
Q Consensus       263 ~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  342 (1048)
                      ++|++.+..+..|..+++|++|++++ |.+. .+|..+..+++|+.|++++|++++..+..|+....             
T Consensus       225 ~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-------------  289 (332)
T 2ft3_A          225 GHNQIRMIENGSLSFLPTLRELHLDN-NKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF-------------  289 (332)
T ss_dssp             CSSCCCCCCTTGGGGCTTCCEEECCS-SCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC-------------
T ss_pred             CCCcCCcCChhHhhCCCCCCEEECCC-CcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc-------------
Confidence            66666554444444444444444433 3333 33444445555555555555555444443332100             


Q ss_pred             CCCcchhccCCCCeEeccCCccc--cCcChhhhccCCCcEEEeeccc
Q 045493          343 SIPEELGRLKSLSQLSLSVNKLN--GSIPHCLGNLSNLKFFALRENE  387 (1048)
Q Consensus       343 ~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~l~~l~~L~~L~L~~n~  387 (1048)
                           -....+|+.|++++|.+.  +..|..|..+++|+.+++++|+
T Consensus       290 -----~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          290 -----GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             -----CSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             -----ccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                 001245666777777665  4556667777777777776664

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.98  E-value=1.1e-32  Score=305.16  Aligned_cols=253  Identities=29%  Similarity=0.461  Sum_probs=222.5

Q ss_pred             CcccEEEeecccccC--CCCCCcccccccceeEecC-CccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccE
Q 045493          424 GSLTHFSVRNNNFVG--PIPRSLQNCTSLYSLRLER-NQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLAT  500 (1048)
Q Consensus       424 ~~L~~L~l~~N~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~  500 (1048)
                      .++++|++++|.+.+  .+|..+.++++|++|++++ |.+.+..+..|..+++|++|+|++|++++..|..+..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            467888888888887  7788888888888888884 8888777888888888888888888888888888888889999


Q ss_pred             EEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCC-ccCEEeecCccccCCCccccccccccceeecccCc
Q 045493          501 LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLT-SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANR  579 (1048)
Q Consensus       501 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  579 (1048)
                      |++++|.+++.+|..+..+++|++|+|++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |++|++++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            99999999888888888999999999999999888888888887 899999999999888888888887 9999999999


Q ss_pred             ccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcccc
Q 045493          580 LSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSC  659 (1048)
Q Consensus       580 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  659 (1048)
                      +++..|..|..+++|+.|+|++|++++..+. +..+++|++|+|++|+|++.+|..+..+++|++|+|++|++++.+|..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            9988888899999999999999999876555 778899999999999999999999999999999999999999988887


Q ss_pred             ccccCCccEEEeccce-ecCC
Q 045493          660 FRRMHGLSSIDVSYNE-LQGS  679 (1048)
Q Consensus       660 ~~~l~~L~~l~ls~N~-l~~~  679 (1048)
                       ..++.|+.+++++|+ ++|.
T Consensus       288 -~~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          288 -GNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             -TTGGGSCGGGTCSSSEEEST
T ss_pred             -ccccccChHHhcCCCCccCC
Confidence             889999999999998 6664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=4.1e-33  Score=312.71  Aligned_cols=234  Identities=11%  Similarity=0.081  Sum_probs=174.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCc-------ccchhhHHHHHHhhcc---------cCceeeEeeE---
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-------IGINQKGFVSEITEIR---------HRNIVKFYGF---  841 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-------~~~~~~~~~~~l~~l~---------h~niv~~~~~---  841 (1048)
                      ...||+|+||+||+|++ +++.||||++.......       ......+++..++.++         ||||+++.+.   
T Consensus        25 ~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~  103 (336)
T 2vuw_A           25 CEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCV  103 (336)
T ss_dssp             CEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEE
T ss_pred             eeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEe
Confidence            45689999999999998 58999999997654221       1122344555555554         6666665554   


Q ss_pred             --------------eee-------------CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHH-
Q 045493          842 --------------CSH-------------TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMH-  893 (1048)
Q Consensus       842 --------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-  893 (1048)
                                    +.+             .+..|+||||+++|++.+.+.+    ..+++..+..++.||+.||+||| 
T Consensus       104 ~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~  179 (336)
T 2vuw_A          104 QGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEA  179 (336)
T ss_dssp             ESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH
Confidence                          332             6789999999999976666633    34789999999999999999999 


Q ss_pred             hCCCCCeEeeCCCCCCeEECCCC--------------------ceEEeccccccccCCCCCCcccccccccccccccccc
Q 045493          894 HDCFPPILHRDISSKKVLLDLEY--------------------KAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT  953 (1048)
Q Consensus       894 ~~~~~~iiH~Dik~~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  953 (1048)
                      +.   +|+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|||||++.+
T Consensus       180 ~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          180 SL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCC
T ss_pred             hC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcC
Confidence            88   999999999999999887                    8999999999876532     3479999999999987


Q ss_pred             CCCCchhhHHHHHHH-HHHHHhCCCCCcccccccCCCcccccchhhhhhhc---cCCCCCCchhHHHHHHHHHHHHHhcc
Q 045493          954 MRANEKCDVFNFGVL-VLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI---DSRLPPPLGEVEEKLKSMIAVAFLCL 1029 (1048)
Q Consensus       954 ~~~~~~~Dvws~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl 1029 (1048)
                      .. +.++||||+|++ .+++++|..||.....          .......+.   ................++.+++.+||
T Consensus       252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW----------LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH----------HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             CC-ccceehhhhhCCCCcccccccCCCcchhh----------hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            66 899999998777 7888899999642110          001111111   11112223334567788999999999


Q ss_pred             CCCCCCCCCHHHHH
Q 045493         1030 DANPDCRPTMQKVC 1043 (1048)
Q Consensus      1030 ~~dP~~RPt~~evl 1043 (1048)
                      +.|     |++|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            976     999998

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=1.5e-31  Score=299.33  Aligned_cols=266  Identities=21%  Similarity=0.255  Sum_probs=172.1

Q ss_pred             cceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcC
Q 045493          402 LNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN  481 (1048)
Q Consensus       402 L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~  481 (1048)
                      ++.|++++|++++..|..+..+++|++|++++|.+++..|..|..+++|++|++++|+++.++...+   ++|++|++++
T Consensus        56 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~---~~L~~L~l~~  132 (332)
T 2ft3_A           56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRIHD  132 (332)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC---TTCCEEECCS
T ss_pred             CeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc---ccCCEEECCC
Confidence            3334444444433334444444555555555555555555566666666666666666665554443   5666666666


Q ss_pred             CcccCcccccccCCCCccEEEecCcccC--cccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCC
Q 045493          482 NNFFGEISSNWIKCPQLATLNMGGNEIS--GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGD  559 (1048)
Q Consensus       482 n~l~~~~~~~~~~~~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  559 (1048)
                      |+++...+..|..+++|++|++++|.++  +..+..+..+ +|++|++++|++++ +|..+.  ++|++|++++|.+++.
T Consensus       133 n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~  208 (332)
T 2ft3_A          133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAI  208 (332)
T ss_dssp             SCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCC
T ss_pred             CccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCcc
Confidence            6666555555666666777777776664  2455666666 77777777777764 343332  5777777777777766


Q ss_pred             CccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCC-
Q 045493          560 IPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICN-  638 (1048)
Q Consensus       560 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-  638 (1048)
                      .+..+..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+.+ +..+..+++|++|++++|+|++..+..|.. 
T Consensus       209 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~  287 (332)
T 2ft3_A          209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDLKLLQVVYLHTNNITKVGVNDFCPV  287 (332)
T ss_dssp             CTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBC-CTTGGGCTTCCEEECCSSCCCBCCTTSSSCS
T ss_pred             CHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeec-ChhhhcCccCCEEECCCCCCCccChhHcccc
Confidence            667777777777777777777777777777777777777777777643 344677777888888888877666666654 


Q ss_pred             -----ccccCeEECCCCccc--CCccccccccCCccEEEeccce
Q 045493          639 -----LESLEYMNLLQNKLS--GPIPSCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       639 -----l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~l~ls~N~  675 (1048)
                           .++|+.|++++|++.  +..|..|..++.|+.+++++|+
T Consensus       288 ~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          288 GFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                 356788888888876  5677777788888888887774

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=6.7e-35  Score=343.03  Aligned_cols=375  Identities=18%  Similarity=0.160  Sum_probs=256.2

Q ss_pred             CCCcEEEccCceeecccccc-cccccccceeeeccccccC----CCCcchhccCCCCeEeccCCccccCcChhhh-ccC-
Q 045493          304 KSLSHLWLSKTQLSGFIPPS-LGNLSNIRGLYIRENMLYG----SIPEELGRLKSLSQLSLSVNKLNGSIPHCLG-NLS-  376 (1048)
Q Consensus       304 ~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~l~-  376 (1048)
                      ++|++|++++|+++...... +..+++|+.|++++|.+..    .++..+..+++|++|+|++|.+++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            45667777777766443332 5666777777777776653    2344555667777777777777654343333 344 


Q ss_pred             ---CCcEEEeecccccC----CchhhhhhhcccceeeccccccCCCCCccccc-----CCcccEEEeecccccCCC----
Q 045493          377 ---NLKFFALRENELSG----SIPQEIENMKKLNKYLLFENQFTGYLPQNVCQ-----SGSLTHFSVRNNNFVGPI----  440 (1048)
Q Consensus       377 ---~L~~L~L~~n~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~-----~~~L~~L~l~~N~l~~~~----  440 (1048)
                         +|++|+|++|.++.    .++..+..+++|+.|++++|++++..+..++.     .++|++|++++|.+++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               57777777777763    44666667777777777777765443332222     346788888888777643    


Q ss_pred             CCCcccccccceeEecCCccccCcccccC-----CCCCCCeeeCcCCcccCc----ccccccCCCCccEEEecCcccCcc
Q 045493          441 PRSLQNCTSLYSLRLERNQLTGNISEVFG-----IYPDLELLDLSNNNFFGE----ISSNWIKCPQLATLNMGGNEISGT  511 (1048)
Q Consensus       441 ~~~l~~l~~L~~L~L~~n~l~~~~~~~~~-----~~~~L~~L~Ls~n~l~~~----~~~~~~~~~~L~~L~L~~N~i~~~  511 (1048)
                      +..+..+++|++|++++|.++......+.     ..++|+.|++++|.+++.    .+..+..+++|++|++++|.+++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            45566678888888888888765444443     256888888888888764    355666778888888888888754


Q ss_pred             cC-----ccccccCCCcEEEcccCcccCC----cCccccCCCccCEEeecCccccCCCccccccc-----cccceeeccc
Q 045493          512 IP-----SEIGNMTQLHKLDFSSNRLVGQ----IPKQLGKLTSLTSLTLNGNQLSGDIPLELGLL-----AELGYLDLSA  577 (1048)
Q Consensus       512 ~~-----~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~Ls~  577 (1048)
                      ..     ..+..+++|++|++++|++++.    ++..+..+++|++|+|++|.+++..+..+...     ++|++|++++
T Consensus       243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~  322 (461)
T 1z7x_W          243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  322 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCC
Confidence            32     2233578888888888888753    46667778888888888888875444444332     6888888888


Q ss_pred             Cccccc----ccccccccccccccccccccccchhhhhhcc-----ccccCeEECCCCcccC----cCCcCcCCccccCe
Q 045493          578 NRLSKL----IPKNLGELRKLHHLNLSNNQFSQEISIQIGK-----LVQLSKLDLSHNSLGG----NIPSEICNLESLEY  644 (1048)
Q Consensus       578 N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~  644 (1048)
                      |.++..    .+..+..+++|++|++++|+|++..+..+..     .++|++|+|++|++++    .++..+..+++|++
T Consensus       323 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~  402 (461)
T 1z7x_W          323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  402 (461)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             CCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccE
Confidence            888865    3455667788888888888888776665553     5688888888888885    56777777888888


Q ss_pred             EECCCCcccCCccccccc-----cCCccEEEeccceecC
Q 045493          645 MNLLQNKLSGPIPSCFRR-----MHGLSSIDVSYNELQG  678 (1048)
Q Consensus       645 L~L~~N~l~~~~~~~~~~-----l~~L~~l~ls~N~l~~  678 (1048)
                      |++++|++++.....+..     ...|+.|++.+|.+..
T Consensus       403 L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~  441 (461)
T 1z7x_W          403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  441 (461)
T ss_dssp             EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             EECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence            888888888654444332     2357788877776644

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=3.8e-31  Score=295.89  Aligned_cols=290  Identities=22%  Similarity=0.273  Sum_probs=191.3

Q ss_pred             CCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEe
Q 045493          352 KSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSV  431 (1048)
Q Consensus       352 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l  431 (1048)
                      .+++.++++++.++ .+|..+.  ++++.|+|++|.+++..+..|.++++|+.|++                        
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L------------------------   83 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLIL------------------------   83 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC------------------------
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEEC------------------------
Confidence            35677777777776 4444332  45666666666666544444555444444444                        


Q ss_pred             ecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCc-
Q 045493          432 RNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISG-  510 (1048)
Q Consensus       432 ~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~-  510 (1048)
                      ++|.+++..|..|..+++|++|++++|+++.++...+   ++|+.|++++|++++..+..|..+++|++|++++|.++. 
T Consensus        84 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  160 (330)
T 1xku_A           84 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS  160 (330)
T ss_dssp             CSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred             CCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCcc
Confidence            4444444445555555666666666666655444433   466666666666666555566666666666666666652 


Q ss_pred             -ccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccc
Q 045493          511 -TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLG  589 (1048)
Q Consensus       511 -~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  589 (1048)
                       ..+..+..+++|++|++++|++++ +|..+.  ++|++|++++|++++..|..+..+++|++|+|++|+++++.+..+.
T Consensus       161 ~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  237 (330)
T 1xku_A          161 GIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA  237 (330)
T ss_dssp             GBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred             CcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence             555667777777777777777764 343332  6777777777777766677777777777888888877777777777


Q ss_pred             ccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCC------ccccCeEECCCCcccC--Ccccccc
Q 045493          590 ELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICN------LESLEYMNLLQNKLSG--PIPSCFR  661 (1048)
Q Consensus       590 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~  661 (1048)
                      .+++|++|+|++|+|+.+ +..+..+++|++|++++|+|++..+..|+.      .++|+.|++++|++..  ..|..|.
T Consensus       238 ~l~~L~~L~L~~N~l~~l-p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~  316 (330)
T 1xku_A          238 NTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR  316 (330)
T ss_dssp             GSTTCCEEECCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred             CCCCCCEEECCCCcCccC-ChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccc
Confidence            777888888888877743 445677788888888888888766666653      3678888888888863  5677888


Q ss_pred             ccCCccEEEeccce
Q 045493          662 RMHGLSSIDVSYNE  675 (1048)
Q Consensus       662 ~l~~L~~l~ls~N~  675 (1048)
                      .++.++.+++++|+
T Consensus       317 ~~~~l~~l~L~~N~  330 (330)
T 1xku_A          317 CVYVRAAVQLGNYK  330 (330)
T ss_dssp             TCCCGGGEEC----
T ss_pred             cccceeEEEecccC
Confidence            88888888888884

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=3.4e-31  Score=296.27  Aligned_cols=295  Identities=23%  Similarity=0.309  Sum_probs=159.0

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      +++++++++++++ .+|..+.  ++|++|+|++|+++++.+.+|+.+++|++|+|++|+++++.|..|.++++|++|+++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            5566666666665 3443332  356666666666665555556666666666666666665555555555555555555


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|+++ .+|..+.  ++|++|++++|++                                       ++..+..|..+++
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l---------------------------------------~~~~~~~~~~l~~  146 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEI---------------------------------------TKVRKSVFNGLNQ  146 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCC---------------------------------------CBBCHHHHTTCTT
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCcc---------------------------------------cccCHhHhcCCcc
Confidence            55555 3333332  4555555555544                                       4444445555666


Q ss_pred             cceeeccccCccc--cCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeec
Q 045493          185 LTFVYLNNNRIVG--SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYL  262 (1048)
Q Consensus       185 L~~L~L~~n~i~~--~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  262 (1048)
                      |++|++++|.+..  ..+..|..+++|++|++++|+++ .+|..+.  ++|++|++++|.+++..|..|..+++|++|++
T Consensus       147 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  223 (330)
T 1xku_A          147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGL  223 (330)
T ss_dssp             CCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred             ccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            6666666666542  45555666666666666666665 3443332  55666666666666555556666666666666


Q ss_pred             ccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccC
Q 045493          263 SHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG  342 (1048)
Q Consensus       263 ~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  342 (1048)
                      ++|++.+..+..|..+++|++|++++ |.+. .+|..+..+++|++|++++|++++..+..|+...              
T Consensus       224 s~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~--------------  287 (330)
T 1xku_A          224 SFNSISAVDNGSLANTPHLRELHLNN-NKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG--------------  287 (330)
T ss_dssp             CSSCCCEECTTTGGGSTTCCEEECCS-SCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS--------------
T ss_pred             CCCcCceeChhhccCCCCCCEEECCC-CcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc--------------
Confidence            66666544444444444444433333 2332 3444455555555555555555544444332210              


Q ss_pred             CCCcchhccCCCCeEeccCCcccc--CcChhhhccCCCcEEEeeccc
Q 045493          343 SIPEELGRLKSLSQLSLSVNKLNG--SIPHCLGNLSNLKFFALRENE  387 (1048)
Q Consensus       343 ~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~n~  387 (1048)
                          ......+|+.|++++|.+..  ..|..|..+.+++.++|++|+
T Consensus       288 ----~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          288 ----YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             ----CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ----cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                00123566677777777643  445667777777777777764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=9.8e-34  Score=333.06  Aligned_cols=353  Identities=22%  Similarity=0.202  Sum_probs=288.6

Q ss_pred             ccccceeeeccccccCCCCcc-hhccCCCCeEeccCCcccc----CcChhhhccCCCcEEEeecccccCCchhhhh-hhc
Q 045493          327 LSNIRGLYIRENMLYGSIPEE-LGRLKSLSQLSLSVNKLNG----SIPHCLGNLSNLKFFALRENELSGSIPQEIE-NMK  400 (1048)
Q Consensus       327 l~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~  400 (1048)
                      .++|+.|++++|.++...... +..+++|++|++++|.+++    .++..+..+++|++|+|++|.+.+..+..+. .++
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            357899999999987544333 7789999999999999985    3467788889999999999999865555544 355


Q ss_pred             ----ccceeeccccccCC----CCCcccccCCcccEEEeecccccCCCCCCcc-----cccccceeEecCCccccCc---
Q 045493          401 ----KLNKYLLFENQFTG----YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQ-----NCTSLYSLRLERNQLTGNI---  464 (1048)
Q Consensus       401 ----~L~~l~l~~N~l~~----~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~-----~l~~L~~L~L~~n~l~~~~---  464 (1048)
                          +|+.|++++|+++.    .++..+..+++|++|++++|.+++..+..+.     ..++|++|++++|++++..   
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence                69999999999985    4577888999999999999999865554433     2567999999999998754   


Q ss_pred             -ccccCCCCCCCeeeCcCCcccCccccccc-----CCCCccEEEecCcccCcc----cCccccccCCCcEEEcccCcccC
Q 045493          465 -SEVFGIYPDLELLDLSNNNFFGEISSNWI-----KCPQLATLNMGGNEISGT----IPSEIGNMTQLHKLDFSSNRLVG  534 (1048)
Q Consensus       465 -~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~-----~~~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~Ls~N~l~~  534 (1048)
                       +..+..+++|+.|++++|.++...+..+.     ..++|++|++++|.+++.    ++..+..+++|++|++++|++++
T Consensus       162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  241 (461)
T 1z7x_W          162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  241 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence             45566779999999999999876554443     366999999999999964    46777889999999999999885


Q ss_pred             Cc-----CccccCCCccCEEeecCccccCC----CccccccccccceeecccCccccccccccccc-----ccccccccc
Q 045493          535 QI-----PKQLGKLTSLTSLTLNGNQLSGD----IPLELGLLAELGYLDLSANRLSKLIPKNLGEL-----RKLHHLNLS  600 (1048)
Q Consensus       535 ~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-----~~L~~L~Ls  600 (1048)
                      ..     +..+..+++|++|++++|.+++.    ++..+..+++|++|+|++|+++...+..+...     ++|++|+++
T Consensus       242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  321 (461)
T 1z7x_W          242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK  321 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence            43     23334689999999999999853    57778889999999999999987666666543     699999999


Q ss_pred             cccccchh----hhhhccccccCeEECCCCcccCcCCcCcCC-----ccccCeEECCCCcccC----CccccccccCCcc
Q 045493          601 NNQFSQEI----SIQIGKLVQLSKLDLSHNSLGGNIPSEICN-----LESLEYMNLLQNKLSG----PIPSCFRRMHGLS  667 (1048)
Q Consensus       601 ~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~  667 (1048)
                      +|.+++..    +..+..+++|++|||++|++++..+..+..     .++|++|+|++|++++    .++..+..+++|+
T Consensus       322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~  401 (461)
T 1z7x_W          322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR  401 (461)
T ss_dssp             TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred             CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence            99998874    445567799999999999998766655543     6799999999999996    7788888999999


Q ss_pred             EEEeccceecCC
Q 045493          668 SIDVSYNELQGS  679 (1048)
Q Consensus       668 ~l~ls~N~l~~~  679 (1048)
                      +|++++|++++.
T Consensus       402 ~L~l~~N~i~~~  413 (461)
T 1z7x_W          402 ELDLSNNCLGDA  413 (461)
T ss_dssp             EEECCSSSCCHH
T ss_pred             EEECCCCCCCHH
Confidence            999999998653

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=1.1e-30  Score=317.59  Aligned_cols=424  Identities=14%  Similarity=0.108  Sum_probs=275.1

Q ss_pred             CccCcCCCCCCeEeccCCccC---CCCCcccc------------cccccceeecccccccCCCchhhhcc-chhhhhhhc
Q 045493          224 PPTAGNLSNLKFLYLHDNRLS---GYIPPKLG------------SFKSLLYLYLSHNQLNGSLPSSFGNL-SSLKHLHVH  287 (1048)
Q Consensus       224 ~~~~~~l~~L~~L~L~~N~l~---~~~p~~~~------------~l~~L~~L~L~~n~l~~~~p~~~~~L-~~L~~L~l~  287 (1048)
                      +..+..+++|++|+|+++...   +.+|..++            .+++|++|+|++|.+.+..+..+... +        
T Consensus        66 ~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~--------  137 (592)
T 3ogk_B           66 DRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARA--------  137 (592)
T ss_dssp             HHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHG--------
T ss_pred             HHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhcc--------
Confidence            344567788999999775421   23333333            56777777777776654333333332 1        


Q ss_pred             cccccCCCCCcccCCCCCCcEEEccCce-eec-ccccccccccccceeeeccccccCCC----CcchhccCCCCeEeccC
Q 045493          288 NINKLSGSIPKEIGNLKSLSHLWLSKTQ-LSG-FIPPSLGNLSNIRGLYIRENMLYGSI----PEELGRLKSLSQLSLSV  361 (1048)
Q Consensus       288 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~Ls~  361 (1048)
                                      .+|++|++++|. ++. .++.....+++|+.|+|++|.+.+..    +..+..+++|++|++++
T Consensus       138 ----------------~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~  201 (592)
T 3ogk_B          138 ----------------DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYM  201 (592)
T ss_dssp             ----------------GGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTT
T ss_pred             ----------------ccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeec
Confidence                            125555555554 111 01122235566666666666655442    22344567777777777


Q ss_pred             Ccccc----CcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccC---CCCCcccccCCcccEEEeecc
Q 045493          362 NKLNG----SIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFT---GYLPQNVCQSGSLTHFSVRNN  434 (1048)
Q Consensus       362 N~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~---~~~~~~~~~~~~L~~L~l~~N  434 (1048)
                      |.+++    .++..+.++++|+.|++++|.+.+ +|..+..+++|+.+.++.....   ...+..+..+++|+.++++++
T Consensus       202 n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~  280 (592)
T 3ogk_B          202 TEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM  280 (592)
T ss_dssp             CCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred             cCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence            77752    334445667777777777777764 6677777777777777653322   223345566778888888875


Q ss_pred             cccCCCCCCcccccccceeEecCCccccCcc-cccCCCCCCCeeeCcCCcccCc-ccccccCCCCccEEEec--------
Q 045493          435 NFVGPIPRSLQNCTSLYSLRLERNQLTGNIS-EVFGIYPDLELLDLSNNNFFGE-ISSNWIKCPQLATLNMG--------  504 (1048)
Q Consensus       435 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~~~~L~~L~L~--------  504 (1048)
                      . ...+|..+..+++|++|++++|.+++... ..+..+++|+.|+++ +.+... .+.....+++|++|+++        
T Consensus       281 ~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~  358 (592)
T 3ogk_B          281 G-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGM  358 (592)
T ss_dssp             C-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTT
T ss_pred             c-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcccccc
Confidence            3 33567778888899999999988764433 446788899999998 445433 33334567889999998        


Q ss_pred             ---CcccCcccCcc-ccccCCCcEEEcccCcccCCcCccccC-CCccCEEeec----CccccCC-----Ccccccccccc
Q 045493          505 ---GNEISGTIPSE-IGNMTQLHKLDFSSNRLVGQIPKQLGK-LTSLTSLTLN----GNQLSGD-----IPLELGLLAEL  570 (1048)
Q Consensus       505 ---~N~i~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L  570 (1048)
                         .|.+++..... +..+++|++|+++.|++++..+..+.. +++|++|+++    .|.+++.     ++..+..+++|
T Consensus       359 ~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L  438 (592)
T 3ogk_B          359 EDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL  438 (592)
T ss_dssp             SSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTC
T ss_pred             ccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCC
Confidence               36676443222 445788999999888888766666665 8889999996    6677753     33446678888


Q ss_pred             ceeecccCc--ccccccccccc-cccccccccccccccchhhh-hhccccccCeEECCCCcccCcC-CcCcCCccccCeE
Q 045493          571 GYLDLSANR--LSKLIPKNLGE-LRKLHHLNLSNNQFSQEISI-QIGKLVQLSKLDLSHNSLGGNI-PSEICNLESLEYM  645 (1048)
Q Consensus       571 ~~L~Ls~N~--l~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L  645 (1048)
                      ++|++++|.  +++..+..+.. +++|++|++++|++++.... .+..+++|++|+|++|.+++.. +..+..+++|++|
T Consensus       439 ~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  518 (592)
T 3ogk_B          439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYL  518 (592)
T ss_dssp             CEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEE
T ss_pred             CEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCee
Confidence            899987543  66555555543 77888888888888775543 4467888888899888886543 3334567888888


Q ss_pred             ECCCCcccCCcccccc-ccCCccEEEeccc
Q 045493          646 NLLQNKLSGPIPSCFR-RMHGLSSIDVSYN  674 (1048)
Q Consensus       646 ~L~~N~l~~~~~~~~~-~l~~L~~l~ls~N  674 (1048)
                      +|++|++++.....+. .+|.+....+..+
T Consensus       519 ~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          519 WVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             EEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             ECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            8888888876555443 5677766665554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=6e-29  Score=274.87  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=219.8

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccC--CCcCCCCCCCCcEEeCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGI--IPPQIGILTNLVVLRLS   80 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~--~p~~~~~l~~L~~L~ls   80 (1048)
                      .|++++.    +++++|...++++++|+|++|++++..+..|+.+++|++|+|++|+++..  .|.++..+++|++|+|+
T Consensus        11 ~l~c~~~----~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           11 EIRCNSK----GLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             EEECCSS----CCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             EEEcCCC----CcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            4555554    46788888889999999999999977777789999999999999999833  36778889999999999


Q ss_pred             CCcCCCCCccccccccccccccccceecccccC-cCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCC
Q 045493           81 VNQLNGLIPEELGELTSLNELALSYNRLNGSIP-ASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLE  159 (1048)
Q Consensus        81 ~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~-~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~  159 (1048)
                      +|++++ +|..+.++++|++|++++|+++...+ ..+..+++|++|++++|.+.+.               .|..+..++
T Consensus        87 ~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~---------------~~~~~~~l~  150 (306)
T 2z66_A           87 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA---------------FNGIFNGLS  150 (306)
T ss_dssp             SCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEEC---------------STTTTTTCT
T ss_pred             CCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCcc---------------chhhcccCc
Confidence            999996 67779999999999999999997665 6899999999999999998753               345677889


Q ss_pred             CCcEEecCCCcccc-ccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEec
Q 045493          160 SPVSVSLHTNNFSG-VIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYL  238 (1048)
Q Consensus       160 ~L~~l~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  238 (1048)
                      +|++|++++|.+++ ..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|+|
T Consensus       151 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  230 (306)
T 2z66_A          151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY  230 (306)
T ss_dssp             TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEEC
T ss_pred             CCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeEC
Confidence            99999999999987 68999999999999999999999888999999999999999999999777778899999999999


Q ss_pred             cCCccCCCCCccccccc-ccceeecccccccCC
Q 045493          239 HDNRLSGYIPPKLGSFK-SLLYLYLSHNQLNGS  270 (1048)
Q Consensus       239 ~~N~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~  270 (1048)
                      ++|.+++..|..+..++ +|++|++++|++...
T Consensus       231 ~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             TTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             CCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            99999988888999984 999999999999854

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.9e-31  Score=322.57  Aligned_cols=459  Identities=14%  Similarity=0.076  Sum_probs=304.1

Q ss_pred             cCCcccccccccceecccccccc---ccCCccCc------------CCCCCCeEeccCCccCCCCCcccccc--ccccee
Q 045493          198 SIPSEIGNLRSLSYLGLNKNQLS---GSIPPTAG------------NLSNLKFLYLHDNRLSGYIPPKLGSF--KSLLYL  260 (1048)
Q Consensus       198 ~~p~~~~~l~~L~~L~L~~n~l~---~~~~~~~~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L  260 (1048)
                      ..+..+..+++|++|+|+++...   +.+|..++            .+++|++|+|++|.+++..+..+...  .+|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            34455678899999999886531   23443333            68999999999999886666666663  449999


Q ss_pred             ecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecc----cccccccccccceeeec
Q 045493          261 YLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGF----IPPSLGNLSNIRGLYIR  336 (1048)
Q Consensus       261 ~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~  336 (1048)
                      ++++|.-.  .+..+.                     ....++++|++|+|++|.+++.    ++..+..+++|+.|+++
T Consensus       144 ~L~~~~~~--~~~~l~---------------------~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~  200 (592)
T 3ogk_B          144 KLDKCSGF--TTDGLL---------------------SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY  200 (592)
T ss_dssp             EEESCEEE--EHHHHH---------------------HHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECT
T ss_pred             ECcCCCCc--CHHHHH---------------------HHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEee
Confidence            99998721  111111                     1112345677777777766544    23334556777777777


Q ss_pred             cccccCC----CCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeeccccc---CCchhhhhhhcccceeeccc
Q 045493          337 ENMLYGS----IPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELS---GSIPQEIENMKKLNKYLLFE  409 (1048)
Q Consensus       337 ~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~---~~~p~~~~~l~~L~~l~l~~  409 (1048)
                      +|.+++.    ++..+..+++|++|++++|.+.+ +|..+.++++|+.|+++.+...   +..+..+..+++|+.+.+++
T Consensus       201 ~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~  279 (592)
T 3ogk_B          201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY  279 (592)
T ss_dssp             TCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETT
T ss_pred             ccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccc
Confidence            7776522    23344567777888887777774 5677777778888777753322   23334556667777777776


Q ss_pred             cccCCCCCcccccCCcccEEEeecccccCCCC-CCcccccccceeEecCCcccc-CcccccCCCCCCCeeeCcC------
Q 045493          410 NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIP-RSLQNCTSLYSLRLERNQLTG-NISEVFGIYPDLELLDLSN------  481 (1048)
Q Consensus       410 N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~~~~L~~L~Ls~------  481 (1048)
                      +. .+.+|..+..+++|++|++++|.+++... ..+..+++|++|+++ +.+.. .....+..+++|+.|++++      
T Consensus       280 ~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~  357 (592)
T 3ogk_B          280 MG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQG  357 (592)
T ss_dssp             CC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSST
T ss_pred             cc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccc
Confidence            43 33456666677788888888887654333 335778889999998 44432 2334445678899999993      


Q ss_pred             -----CcccCccccc-ccCCCCccEEEecCcccCcccCccccc-cCCCcEEEcc----cCcccCC-----cCccccCCCc
Q 045493          482 -----NNFFGEISSN-WIKCPQLATLNMGGNEISGTIPSEIGN-MTQLHKLDFS----SNRLVGQ-----IPKQLGKLTS  545 (1048)
Q Consensus       482 -----n~l~~~~~~~-~~~~~~L~~L~L~~N~i~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~  545 (1048)
                           |.+++..... ...+++|++|+++.|.+++..+..++. +++|+.|+++    .|++++.     ++..+.++++
T Consensus       358 ~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~  437 (592)
T 3ogk_B          358 MEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKK  437 (592)
T ss_dssp             TSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTT
T ss_pred             cccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCC
Confidence                 5666443322 446899999999999999877777765 8999999996    7788764     3334677899


Q ss_pred             cCEEeecCcc--ccCCCccccc-cccccceeecccCccccc-ccccccccccccccccccccccchhhhh-hccccccCe
Q 045493          546 LTSLTLNGNQ--LSGDIPLELG-LLAELGYLDLSANRLSKL-IPKNLGELRKLHHLNLSNNQFSQEISIQ-IGKLVQLSK  620 (1048)
Q Consensus       546 L~~L~L~~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~  620 (1048)
                      |++|++++|.  +++..+..+. .+++|++|+|++|++++. .+..+..+++|++|++++|.+++..... ...+++|++
T Consensus       438 L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  517 (592)
T 3ogk_B          438 LRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY  517 (592)
T ss_dssp             CCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCE
T ss_pred             CCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCe
Confidence            9999998543  6654444444 478999999999999863 3455678899999999999997765444 457899999


Q ss_pred             EECCCCcccCcCCcCcC-CccccCeEECCCCcccCCccc-cccccCCccEEEeccceecCCCCCc
Q 045493          621 LDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSGPIPS-CFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       621 L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      |+|++|++++.....+. .+|.+....+..++-....|. .-........+ ..+|.+.|+.|+.
T Consensus       518 L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~g~~~~~  581 (592)
T 3ogk_B          518 LWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI-LAYYSLAGQRTDC  581 (592)
T ss_dssp             EEEESCBCCTTCTTGGGGCCTTEEEEEECCC---------------CCCEE-EEEECTTCSCSCC
T ss_pred             eECcCCcCCHHHHHHHHHhCCCcEEEEecCccccccccccCCcCCcchhhe-EeeeecCCCccCC
Confidence            99999999876555554 567777777666533221111 01112223333 2355567776654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=9.6e-29  Score=273.25  Aligned_cols=252  Identities=23%  Similarity=0.272  Sum_probs=210.8

Q ss_pred             cEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcc--cccccCCCCccEEEec
Q 045493          427 THFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEI--SSNWIKCPQLATLNMG  504 (1048)
Q Consensus       427 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~--~~~~~~~~~L~~L~L~  504 (1048)
                      +.++.+++.++. +|..+.  ++|++|++++|+++.++...|..+++|+.|+|++|+++...  +..+..+++|++|+++
T Consensus        10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            466777777764 343332  57888888888888888888888888888888888887432  5566678889999999


Q ss_pred             CcccCcccCccccccCCCcEEEcccCcccCCcC-ccccCCCccCEEeecCccccCCCccccccccccceeecccCcccc-
Q 045493          505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIP-KQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSK-  582 (1048)
Q Consensus       505 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-  582 (1048)
                      +|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|++|++++|++++ 
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            99888 466678889999999999999886655 578888999999999999988888888889999999999999887 


Q ss_pred             cccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccc
Q 045493          583 LIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRR  662 (1048)
Q Consensus       583 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  662 (1048)
                      ..|..+..+++|++|++++|+|++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|++++..|..+..
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  245 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH  245 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence            56888888999999999999998888888889999999999999998877778888999999999999999988988888


Q ss_pred             cC-CccEEEeccceecCCCCC
Q 045493          663 MH-GLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       663 l~-~L~~l~ls~N~l~~~~p~  682 (1048)
                      ++ .|++|++++|++++.++.
T Consensus       246 ~~~~L~~L~L~~N~~~~~c~~  266 (306)
T 2z66_A          246 FPSSLAFLNLTQNDFACTCEH  266 (306)
T ss_dssp             CCTTCCEEECTTCCEECSGGG
T ss_pred             hhccCCEEEccCCCeecccCh
Confidence            85 899999999999887653

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=285.36  Aligned_cols=283  Identities=18%  Similarity=0.178  Sum_probs=144.1

Q ss_pred             ccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCccccccccee
Q 045493          374 NLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSL  453 (1048)
Q Consensus       374 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L  453 (1048)
                      .++.....++++|.++ .+|..+.  ++|+.|++++|++++..+..+..+++|++|++++|.+++..+..|.++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            3444455666666666 3444332  245555555555554444444444555555555555544444444455555555


Q ss_pred             EecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccC-cc
Q 045493          454 RLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN-RL  532 (1048)
Q Consensus       454 ~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N-~l  532 (1048)
                      ++++|++++++...|..+++|++|++++|+++.....                       ..|..+++|++|++++| .+
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-----------------------~~~~~l~~L~~L~l~~n~~~  162 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET-----------------------SLFSHLTKLQILRVGNMDTF  162 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSS-----------------------CSCTTCTTCCEEEEEESSSC
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCch-----------------------hhhccCCCCcEEECCCCccc
Confidence            5555555444444444444555555555544433220                       24444445555555544 23


Q ss_pred             cCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhh
Q 045493          533 VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQI  612 (1048)
Q Consensus       533 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~  612 (1048)
                      .+..+..|..+++|++|++++|++++..|..+..+++|++|++++|+++.+.+..+..+++|+.|++++|++++.....+
T Consensus       163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l  242 (353)
T 2z80_A          163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL  242 (353)
T ss_dssp             CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--
T ss_pred             cccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccc
Confidence            33334444444555555555555544444444555555555555555444433333344555555555555544332222


Q ss_pred             c---cccccCeEECCCCcccC----cCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          613 G---KLVQLSKLDLSHNSLGG----NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       613 ~---~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      .   ....++.+++++|.+++    .+|..+..+++|++|+|++|+|+...+..|..+++|++|++++|+++|.+|.
T Consensus       243 ~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            1   23445555555555554    3455566667777777777777744444456777777777777777776653

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.9e-28  Score=267.80  Aligned_cols=223  Identities=25%  Similarity=0.255  Sum_probs=150.1

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .+++++.+    ++++|...++++++|+|++|+|++..+..|+.+++|++|+|++|.++++.|.+|+.+++|++|++++|
T Consensus        15 ~~~c~~~~----l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           15 TTSCPQQG----LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             EEECCSSC----CSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCcCC----cccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            45565544    45677777888999999999888777788888888999999998888877888888888999999888


Q ss_pred             c-CCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCC
Q 045493           83 Q-LNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESP  161 (1048)
Q Consensus        83 ~-l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L  161 (1048)
                      + ++.+.|..|..+++|++|++++|++++..|..|.++++|++|++++|++++..               +..+..+++|
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------------~~~~~~l~~L  155 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP---------------DDTFRDLGNL  155 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC---------------TTTTTTCTTC
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccC---------------HhHhccCCCc
Confidence            7 88777888888888888888888888777888888888888888888776321               1223444455


Q ss_pred             cEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCC
Q 045493          162 VSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN  241 (1048)
Q Consensus       162 ~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  241 (1048)
                      +.|++++|.+++..+..|..+++|+.|++++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|+|++|
T Consensus       156 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N  235 (285)
T 1ozn_A          156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN  235 (285)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred             cEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCC
Confidence            55555555555444444555555555555555554444444444444555555555444333333444444444444444


Q ss_pred             ccC
Q 045493          242 RLS  244 (1048)
Q Consensus       242 ~l~  244 (1048)
                      .+.
T Consensus       236 ~~~  238 (285)
T 1ozn_A          236 PWV  238 (285)
T ss_dssp             CEE
T ss_pred             Ccc
Confidence            444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3e-28  Score=284.63  Aligned_cols=239  Identities=23%  Similarity=0.209  Sum_probs=213.1

Q ss_pred             eecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccc
Q 045493           14 TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELG   93 (1048)
Q Consensus        14 ~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~   93 (1048)
                      +++++|...++++++|+|++|+|++..|..|+.+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+++.+..|.
T Consensus        65 ~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  144 (452)
T 3zyi_A           65 GLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFE  144 (452)
T ss_dssp             CCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSS
T ss_pred             CcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhc
Confidence            45778888889999999999999999999999999999999999999998889999999999999999999988888899


Q ss_pred             cccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCcccc
Q 045493           94 ELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSG  173 (1048)
Q Consensus        94 ~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~  173 (1048)
                      .+++|++|+|++|+++.+.+..|.++++|+.|++++|..-+.++              +..+.++++|+.|++++|++++
T Consensus       145 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~--------------~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYIS--------------EGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             SCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC--------------TTTTTTCTTCCEEECTTSCCSS
T ss_pred             ccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccC--------------hhhccCCCCCCEEECCCCcccc
Confidence            99999999999999998888899999999999999854332222              2357788899999999999987


Q ss_pred             ccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccc
Q 045493          174 VIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGS  253 (1048)
Q Consensus       174 ~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  253 (1048)
                      .  ..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++.+..+..|.++++|++|+|++|++++..+..|..
T Consensus       211 ~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  288 (452)
T 3zyi_A          211 M--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP  288 (452)
T ss_dssp             C--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred             c--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence            5  35889999999999999999888999999999999999999999888888999999999999999999777778889


Q ss_pred             ccccceeeccccccc
Q 045493          254 FKSLLYLYLSHNQLN  268 (1048)
Q Consensus       254 l~~L~~L~L~~n~l~  268 (1048)
                      +++|+.|+|++|++.
T Consensus       289 l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          289 LRYLVELHLHHNPWN  303 (452)
T ss_dssp             CTTCCEEECCSSCEE
T ss_pred             ccCCCEEEccCCCcC
Confidence            999999999999876

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=9.6e-29  Score=279.06  Aligned_cols=286  Identities=17%  Similarity=0.177  Sum_probs=226.4

Q ss_pred             hhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCccc
Q 045493          348 LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLT  427 (1048)
Q Consensus       348 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~  427 (1048)
                      -..++.....++++|.++ .+|..+.  ++|++|++++|.+++..+..+.++++|+.|++++|++++..|..+..+++|+
T Consensus        27 ~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (353)
T 2z80_A           27 SLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE  103 (353)
T ss_dssp             CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence            345666777999999999 5666554  5899999999999977777999999999999999999998888999999999


Q ss_pred             EEEeecccccCCCCCCcccccccceeEecCCccccCcc-cccCCCCCCCeeeCcCC-cccCcccccccCCCCccEEEecC
Q 045493          428 HFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS-EVFGIYPDLELLDLSNN-NFFGEISSNWIKCPQLATLNMGG  505 (1048)
Q Consensus       428 ~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~n-~l~~~~~~~~~~~~~L~~L~L~~  505 (1048)
                      +|++++|.+++..+..|..+++|++|++++|++++++. ..|..+++|+.|++++| .+....+..|..+++|++|++++
T Consensus       104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~  183 (353)
T 2z80_A          104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA  183 (353)
T ss_dssp             EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred             EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence            99999999998777779999999999999999998887 78999999999999998 46666677788888888888888


Q ss_pred             cccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccc
Q 045493          506 NEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIP  585 (1048)
Q Consensus       506 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  585 (1048)
                      |.+++..|..+..+++|++|++++|+++......+..+++|++|++++|.+++..+..+...                  
T Consensus       184 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~------------------  245 (353)
T 2z80_A          184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG------------------  245 (353)
T ss_dssp             TTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------------------
T ss_pred             CCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccc------------------
Confidence            88887778888888888888888888764444444557788888888888775443332211                  


Q ss_pred             ccccccccccccccccccccc----hhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcc
Q 045493          586 KNLGELRKLHHLNLSNNQFSQ----EISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       586 ~~l~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                         .....++.++|++|.+++    ..+..+..+++|++|||++|+|+...+..|..+++|++|+|++|++++..|
T Consensus       246 ---~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          246 ---ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ---cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence               112334444444444443    235567889999999999999995444446899999999999999997654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=4.9e-28  Score=281.86  Aligned_cols=240  Identities=23%  Similarity=0.218  Sum_probs=209.2

Q ss_pred             eeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccc
Q 045493           13 GTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEEL   92 (1048)
Q Consensus        13 ~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~   92 (1048)
                      ..++++|...++++++|+|++|+|++..+..|+.+++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+++.+..|
T Consensus        53 ~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  132 (440)
T 3zyj_A           53 KNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAF  132 (440)
T ss_dssp             CCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTS
T ss_pred             CCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHh
Confidence            34678888888999999999999998888999999999999999999998888899999999999999999998888889


Q ss_pred             ccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccc
Q 045493           93 GELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFS  172 (1048)
Q Consensus        93 ~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~  172 (1048)
                      ..+++|++|++++|+++.+.+..|.++++|+.|++++|...+.++              +..+.++++|+.|++++|.++
T Consensus       133 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~--------------~~~~~~l~~L~~L~L~~n~l~  198 (440)
T 3zyj_A          133 VYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS--------------EGAFEGLSNLRYLNLAMCNLR  198 (440)
T ss_dssp             CSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC--------------TTTTTTCSSCCEEECTTSCCS
T ss_pred             hccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC--------------cchhhcccccCeecCCCCcCc
Confidence            999999999999999998888899999999999999854332222              235778888999999999988


Q ss_pred             cccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccc
Q 045493          173 GVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLG  252 (1048)
Q Consensus       173 ~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  252 (1048)
                      .+ | .+..+++|+.|+|++|+++++.|..|.++++|++|+|++|++.+..+..|.++++|++|+|++|++++..+..|.
T Consensus       199 ~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  276 (440)
T 3zyj_A          199 EI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT  276 (440)
T ss_dssp             SC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTS
T ss_pred             cc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhc
Confidence            55 3 588889999999999999888888999999999999999999888888888999999999999999977777888


Q ss_pred             cccccceeeccccccc
Q 045493          253 SFKSLLYLYLSHNQLN  268 (1048)
Q Consensus       253 ~l~~L~~L~L~~n~l~  268 (1048)
                      .+++|+.|+|++|++.
T Consensus       277 ~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          277 PLHHLERIHLHHNPWN  292 (440)
T ss_dssp             SCTTCCEEECCSSCEE
T ss_pred             cccCCCEEEcCCCCcc
Confidence            8999999999999875

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=8.1e-28  Score=280.00  Aligned_cols=250  Identities=24%  Similarity=0.242  Sum_probs=166.1

Q ss_pred             cEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCc
Q 045493          427 THFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN  506 (1048)
Q Consensus       427 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N  506 (1048)
                      ..++.+++.++. +|..+.  ++++.|+|++|+++.+.+..|..+++|+.|+|++|+++...+..|.++++|++|+|++|
T Consensus        46 ~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           46 SKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             CEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            445555555542 333332  45666666666666666666666666666666666666655666666666666666666


Q ss_pred             ccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecC-ccccCCCccccccccccceeecccCccccccc
Q 045493          507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNG-NQLSGDIPLELGLLAELGYLDLSANRLSKLIP  585 (1048)
Q Consensus       507 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  585 (1048)
                      .|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++ |.++...+..|..+++|++|+|++|+|+.+. 
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-  201 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-  201 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-
T ss_pred             cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-
Confidence            66655555666666666666666666655555666666666676666 3344333345666677777777777776552 


Q ss_pred             ccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCC
Q 045493          586 KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHG  665 (1048)
Q Consensus       586 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  665 (1048)
                       .+..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..++.
T Consensus       202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  280 (440)
T 3zyj_A          202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH  280 (440)
T ss_dssp             -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred             -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence             3666677777777777777776777777777777777777777777777777777777777777777777777777777


Q ss_pred             ccEEEeccceecCCCC
Q 045493          666 LSSIDVSYNELQGSIP  681 (1048)
Q Consensus       666 L~~l~ls~N~l~~~~p  681 (1048)
                      |+.|++++|+|.+.+.
T Consensus       281 L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          281 LERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CCEEECCSSCEECSST
T ss_pred             CCEEEcCCCCccCCCC
Confidence            7777777777776554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=9.1e-28  Score=280.61  Aligned_cols=250  Identities=20%  Similarity=0.206  Sum_probs=155.6

Q ss_pred             cEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCc
Q 045493          427 THFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN  506 (1048)
Q Consensus       427 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N  506 (1048)
                      ..++.+++.++. +|..+.  +++++|+|++|+|+++.+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            344444444442 333222  35566666666666665566666666666666666666555556666666666666666


Q ss_pred             ccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecC-ccccCCCccccccccccceeecccCccccccc
Q 045493          507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNG-NQLSGDIPLELGLLAELGYLDLSANRLSKLIP  585 (1048)
Q Consensus       507 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  585 (1048)
                      .|++..+..|..+++|++|+|++|++++..+..|..+++|++|++++ |.++...+..|..+++|++|+|++|+|+++  
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~--  211 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--  211 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC--
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc--
Confidence            66655555566666666666666666655555566666666666666 334433333566666666666666666654  


Q ss_pred             ccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCC
Q 045493          586 KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHG  665 (1048)
Q Consensus       586 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  665 (1048)
                      ..+..+++|++|+|++|+|+++.+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++
T Consensus       212 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  291 (452)
T 3zyi_A          212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY  291 (452)
T ss_dssp             CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred             ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence            23556666667777777766666666667777777777777777666666777777777777777777666666677777


Q ss_pred             ccEEEeccceecCCCC
Q 045493          666 LSSIDVSYNELQGSIP  681 (1048)
Q Consensus       666 L~~l~ls~N~l~~~~p  681 (1048)
                      |+.|++++|+|.+.+.
T Consensus       292 L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          292 LVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CCEEECCSSCEECSTT
T ss_pred             CCEEEccCCCcCCCCC
Confidence            7777777777766554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=6.1e-28  Score=263.77  Aligned_cols=211  Identities=23%  Similarity=0.245  Sum_probs=128.4

Q ss_pred             CCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCc-ccCCcCccccCCCccCEEe
Q 045493          472 PDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNR-LVGQIPKQLGKLTSLTSLT  550 (1048)
Q Consensus       472 ~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~  550 (1048)
                      ++|+.|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|+ +++..+..|..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            345555555555554444455555555555555555555555555555566666666654 5544455555566666666


Q ss_pred             ecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccC
Q 045493          551 LNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       551 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                      +++|.+++..|..+..+++|++|++++|+++.+.+..|..+++|++|+|++|+|+++.+..+..+++|++|++++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            66666655555555666666666666666665555556666666666666666666555556666666666666666666


Q ss_pred             cCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          631 NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       631 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      ..|..|..+++|++|++++|++++..+..+..++.|++|++++|+|.+.++.
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~  243 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence            6666666666677777777766666666666666677777777766665543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=5.7e-28  Score=268.76  Aligned_cols=229  Identities=24%  Similarity=0.286  Sum_probs=139.8

Q ss_pred             CCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccc
Q 045493           24 PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL  103 (1048)
Q Consensus        24 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l  103 (1048)
                      +++++|||++|+++ .+|..++.+++|++|+|++|.++ .+|..|+.+++|++|+|++|+++ .+|..|..+++|++|++
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            45555555555555 44555555555555555555555 45555555555555555555555 34555555555555555


Q ss_pred             cceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCC
Q 045493          104 SYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK  183 (1048)
Q Consensus       104 ~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~  183 (1048)
                      ++|++.+..|..+..                              ..++..+.++++|+.|++++|.++ .+|..+..++
T Consensus       158 ~~n~~~~~~p~~~~~------------------------------~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~  206 (328)
T 4fcg_A          158 RACPELTELPEPLAS------------------------------TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ  206 (328)
T ss_dssp             EEETTCCCCCSCSEE------------------------------EC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCT
T ss_pred             CCCCCccccChhHhh------------------------------ccchhhhccCCCCCEEECcCCCcC-cchHhhcCCC
Confidence            555555555544432                              011122333445555555555555 4455666677


Q ss_pred             CcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecc
Q 045493          184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLS  263 (1048)
Q Consensus       184 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  263 (1048)
                      +|++|+|++|+++ .+|..+..+++|++|+|++|.+.+.+|..++.+++|++|+|++|.+.+.+|..+..+++|++|+++
T Consensus       207 ~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~  285 (328)
T 4fcg_A          207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR  285 (328)
T ss_dssp             TCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECT
T ss_pred             CCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCC
Confidence            7777777777776 345567777777777777777766777777777777777777777766777777777777777777


Q ss_pred             cccccCCCchhhhccchhhhhhhc
Q 045493          264 HNQLNGSLPSSFGNLSSLKHLHVH  287 (1048)
Q Consensus       264 ~n~l~~~~p~~~~~L~~L~~L~l~  287 (1048)
                      +|++.+.+|..++.+++|+.+++.
T Consensus       286 ~n~~~~~iP~~l~~L~~L~~l~l~  309 (328)
T 4fcg_A          286 GCVNLSRLPSLIAQLPANCIILVP  309 (328)
T ss_dssp             TCTTCCCCCGGGGGSCTTCEEECC
T ss_pred             CCCchhhccHHHhhccCceEEeCC
Confidence            777777777777777777776664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=6e-29  Score=275.87  Aligned_cols=246  Identities=20%  Similarity=0.195  Sum_probs=182.7

Q ss_pred             CcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEe
Q 045493          424 GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNM  503 (1048)
Q Consensus       424 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L  503 (1048)
                      ++|++|++++|.+++..|..|..+++|++|++++|++++..+  |..+++|++|++++|++++..     ..++|++|++
T Consensus        34 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l  106 (317)
T 3o53_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA  106 (317)
T ss_dssp             GGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred             CCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEEC
Confidence            345555555555555555566666666777777776665543  666777777777777776433     2367777777


Q ss_pred             cCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcccc-ccccccceeecccCcccc
Q 045493          504 GGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRLSK  582 (1048)
Q Consensus       504 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~  582 (1048)
                      ++|.+++..+..   +++|++|++++|++++..+..+..+++|++|+|++|.+++..+..+ ..+++|++|+|++|+|+.
T Consensus       107 ~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~  183 (317)
T 3o53_A          107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (317)
T ss_dssp             CSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             CCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence            777777554433   5678888888888887777777788888888888888876656655 467888888888888887


Q ss_pred             cccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCccc-CCcccccc
Q 045493          583 LIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS-GPIPSCFR  661 (1048)
Q Consensus       583 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~  661 (1048)
                      +.+  ...+++|++|+|++|+|+++.+. +..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+++ +..+..+.
T Consensus       184 ~~~--~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~  259 (317)
T 3o53_A          184 VKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (317)
T ss_dssp             EEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred             ccc--ccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence            632  33478888899999988876554 888899999999999998 56778889999999999999998 77888899


Q ss_pred             ccCCccEEEec-cceecCCCCCc
Q 045493          662 RMHGLSSIDVS-YNELQGSIPHS  683 (1048)
Q Consensus       662 ~l~~L~~l~ls-~N~l~~~~p~~  683 (1048)
                      .++.|+.++++ .+.++|..|..
T Consensus       260 ~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          260 KNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             TCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             ccccceEEECCCchhccCCchhc
Confidence            99999999999 45577776653

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.1e-28  Score=272.97  Aligned_cols=249  Identities=20%  Similarity=0.207  Sum_probs=195.5

Q ss_pred             ccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccC-cccccC-------CCCCCCeeeCcCCcccCcccccc
Q 045493          421 CQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGN-ISEVFG-------IYPDLELLDLSNNNFFGEISSNW  492 (1048)
Q Consensus       421 ~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~~~~-------~~~~L~~L~Ls~n~l~~~~~~~~  492 (1048)
                      +..++|+.|++++|.+  .+|..+...  |+.|++++|.++.. .+..+.       .+++|++|+|++|++++..|..+
T Consensus        40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  115 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL  115 (312)
T ss_dssp             EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred             ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence            4445566666666666  445444433  77778888777532 222222       57888888888888888777765


Q ss_pred             --cCCCCccEEEecCcccCcccCcccccc-----CCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCC--Cccc
Q 045493          493 --IKCPQLATLNMGGNEISGTIPSEIGNM-----TQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGD--IPLE  563 (1048)
Q Consensus       493 --~~~~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~  563 (1048)
                        ..+++|++|++++|.+++. |..++.+     ++|++|+|++|++++..+..|..+++|++|+|++|++.+.  .+..
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA  194 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence              7888999999999999876 7777777     8899999999999988888899999999999999997754  2334


Q ss_pred             c--ccccccceeecccCccccc---ccccccccccccccccccccccchhh-hhhccccccCeEECCCCcccCcCCcCcC
Q 045493          564 L--GLLAELGYLDLSANRLSKL---IPKNLGELRKLHHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLGGNIPSEIC  637 (1048)
Q Consensus       564 ~--~~l~~L~~L~Ls~N~l~~~---~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  637 (1048)
                      +  ..+++|++|+|++|+|+++   ....+..+++|++|+|++|+|++..+ ..+..+++|++|+|++|+|+ .+|..+.
T Consensus       195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~  273 (312)
T 1wwl_A          195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP  273 (312)
T ss_dssp             SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC
T ss_pred             HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc
Confidence            4  7889999999999999843   23445677899999999999988663 45667899999999999998 7777776


Q ss_pred             CccccCeEECCCCcccCCccccccccCCccEEEeccceecCC
Q 045493          638 NLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       638 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~  679 (1048)
                        ++|++|+|++|+|++. |. +..++.|++|++++|++++.
T Consensus       274 --~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          274 --AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             --SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             --CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence              8999999999999977 55 88999999999999999774

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.94  E-value=7.8e-27  Score=259.59  Aligned_cols=224  Identities=21%  Similarity=0.261  Sum_probs=159.6

Q ss_pred             ccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcc
Q 045493          449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS  528 (1048)
Q Consensus       449 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  528 (1048)
                      +++.|+|++|.++.++.. +..+++|++|+|++|.++ .+|..+..+++|++|++++|.++ .+|..++.+++|++|+|+
T Consensus        82 ~l~~L~L~~n~l~~lp~~-l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           82 GRVALELRSVPLPQFPDQ-AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             TCCEEEEESSCCSSCCSC-GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ceeEEEccCCCchhcChh-hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            444455555554433332 233455555555555554 44455555556666666666665 455556666666666666


Q ss_pred             cCcccCCcCcccc---------CCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccc
Q 045493          529 SNRLVGQIPKQLG---------KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNL  599 (1048)
Q Consensus       529 ~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  599 (1048)
                      +|++.+.+|..+.         ++++|++|+|++|+++ .+|..++.+++|++|+|++|+++++ |..+..+++|++|+|
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l-~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDL  236 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCC-CGGGGGCTTCCEEEC
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcC-chhhccCCCCCEEEC
Confidence            6555555555444         4788888888888887 6777788888888888888888875 446788888888888


Q ss_pred             ccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceec
Q 045493          600 SNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQ  677 (1048)
Q Consensus       600 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~  677 (1048)
                      ++|++.+..+..++.+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+..++.|+.+++..|.+.
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            888888777778888888888888888888888888888899999999999988889999999999999988877553

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=3.6e-28  Score=288.89  Aligned_cols=186  Identities=16%  Similarity=0.077  Sum_probs=127.8

Q ss_pred             ecccccccEEEEEE-cCCCceeeEEeccCCCCcc------cc---hhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEE
Q 045493          784 HGTGGCGTVYKAEL-TSGDTRAVKKLHSLPTGEI------GI---NQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~-~~~~~vavk~~~~~~~~~~------~~---~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .+.|++|.+..++. ..|+.++||.+........      ..   ...+|+..++++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            46677777776643 3689999999875432211      11   123345556666 6999999999999999999999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||++||+|.+++.+.+   +++..   +|+.||+.||+|+|++   |||||||||+|||++.+|++||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999997643   34443   5899999999999999   9999999999999999999999999999987666


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPG  979 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  979 (1048)
                      .......+||++|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            566667889999999999876 5678899999999999887766553

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=8.6e-28  Score=265.88  Aligned_cols=201  Identities=28%  Similarity=0.348  Sum_probs=100.3

Q ss_pred             hcccceeeccccccCCCCCccc--ccCCcccEEEeecccccCCCCCCcccc-----cccceeEecCCccccCcccccCCC
Q 045493          399 MKKLNKYLLFENQFTGYLPQNV--CQSGSLTHFSVRNNNFVGPIPRSLQNC-----TSLYSLRLERNQLTGNISEVFGIY  471 (1048)
Q Consensus       399 l~~L~~l~l~~N~l~~~~~~~~--~~~~~L~~L~l~~N~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~~~~~  471 (1048)
                      +++|+.|++++|++++..|..+  ..+++|++|++++|.+++. |..+..+     ++|++|++++|+++++++..|..+
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            3334444444444443444433  4445555555555555554 5555554     566666666666666665666666


Q ss_pred             CCCCeeeCcCCcccCc--cccc--ccCCCCccEEEecCcccCc---ccCccccccCCCcEEEcccCcccCCcC-ccccCC
Q 045493          472 PDLELLDLSNNNFFGE--ISSN--WIKCPQLATLNMGGNEISG---TIPSEIGNMTQLHKLDFSSNRLVGQIP-KQLGKL  543 (1048)
Q Consensus       472 ~~L~~L~Ls~n~l~~~--~~~~--~~~~~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l  543 (1048)
                      ++|+.|+|++|++.+.  .+..  +..+++|++|++++|.|++   .....+..+++|++|+|++|++++..| ..+..+
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  252 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP  252 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence            6666666666665443  1111  2455555555555555552   111223345555555555555554442 333445


Q ss_pred             CccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccccccccc
Q 045493          544 TSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS  605 (1048)
Q Consensus       544 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~  605 (1048)
                      ++|++|+|++|+++ .+|..+.  ++|++|||++|+|+++ |. +..+++|++|+|++|+|+
T Consensus       253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            55555555555555 4444333  4455555555555444 22 444444444444444443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=3.9e-26  Score=272.94  Aligned_cols=201  Identities=22%  Similarity=0.235  Sum_probs=92.5

Q ss_pred             CcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEe
Q 045493          424 GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNM  503 (1048)
Q Consensus       424 ~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L  503 (1048)
                      ++|++|++++|.+++..+    .+++|+.|++++|+++.++..    +++|+.|+|++|++++.. .   ..++|+.|++
T Consensus       101 ~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~~----l~~L~~L~Ls~N~l~~l~-~---~~~~L~~L~L  168 (622)
T 3g06_A          101 PGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPVL----PPGLQELSVSDNQLASLP-A---LPSELCKLWA  168 (622)
T ss_dssp             TTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSCCCCC----CTTCCEEECCSSCCSCCC-C---CCTTCCEEEC
T ss_pred             CCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCcCCCC----CCCCCEEECcCCcCCCcC-C---ccCCCCEEEC
Confidence            344444444444443221    234455555555555443321    244555555555554321 1   1234445555


Q ss_pred             cCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccc
Q 045493          504 GGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL  583 (1048)
Q Consensus       504 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  583 (1048)
                      ++|.|++ +|   ..+++|+.|++++|++++ +|..   +++|+.|++++|.++                        .+
T Consensus       169 ~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~------------------------~l  216 (622)
T 3g06_A          169 YNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT------------------------SL  216 (622)
T ss_dssp             CSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS------------------------SC
T ss_pred             CCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc------------------------cc
Confidence            5555542 22   223445555555555442 2211   234444455554444                        33


Q ss_pred             ccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcccccccc
Q 045493          584 IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRM  663 (1048)
Q Consensus       584 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  663 (1048)
                      . .   .+++|+.|+|++|+|+++.    ..+++|+.|+|++|+|+ .+|.   .+++|++|+|++|+|+ .+|..+..+
T Consensus       217 ~-~---~~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l  283 (622)
T 3g06_A          217 P-A---LPSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL  283 (622)
T ss_dssp             C-C---CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred             C-C---CCCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence            1 1   1234444444444444422    23345555555555555 2333   3455555555555555 445555555


Q ss_pred             CCccEEEeccceecCCCC
Q 045493          664 HGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       664 ~~L~~l~ls~N~l~~~~p  681 (1048)
                      ++|+.|++++|++++.+|
T Consensus       284 ~~L~~L~L~~N~l~~~~~  301 (622)
T 3g06_A          284 SSETTVNLEGNPLSERTL  301 (622)
T ss_dssp             CTTCEEECCSCCCCHHHH
T ss_pred             cccCEEEecCCCCCCcCH
Confidence            555666666665555444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=9.2e-28  Score=266.30  Aligned_cols=253  Identities=19%  Similarity=0.185  Sum_probs=112.0

Q ss_pred             eeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccC
Q 045493          334 YIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFT  413 (1048)
Q Consensus       334 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~  413 (1048)
                      +++.+.+.......+..+++|++|+|++|++++..|..|+++++|+.|+|++|.+++..+  +.                
T Consensus        16 ~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~----------------   77 (317)
T 3o53_A           16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LE----------------   77 (317)
T ss_dssp             SCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ET----------------
T ss_pred             eccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hh----------------
Confidence            444444433333333344455555555555554444555555555555555555543222  33                


Q ss_pred             CCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCccccccc
Q 045493          414 GYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWI  493 (1048)
Q Consensus       414 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~  493 (1048)
                              .+++|++|++++|.+++..     ..++|++|++++|+++++....   +++|+.|++++|++++..+..+.
T Consensus        78 --------~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~  141 (317)
T 3o53_A           78 --------SLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEG  141 (317)
T ss_dssp             --------TCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTG
T ss_pred             --------hcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhh
Confidence                    3333444444444333211     1244555555555554443322   23455555555555444444444


Q ss_pred             CCCCccEEEecCcccCcccCcccc-ccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccce
Q 045493          494 KCPQLATLNMGGNEISGTIPSEIG-NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGY  572 (1048)
Q Consensus       494 ~~~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  572 (1048)
                      .+++|++|++++|.+++..+..+. .+++|++|+|++|++++. + ....+++|++|+|++|++++ +|..+..+++|++
T Consensus       142 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~  218 (317)
T 3o53_A          142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW  218 (317)
T ss_dssp             GGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE
T ss_pred             ccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccE
Confidence            445555555555555444443332 344555555555554432 1 11224444444444444442 2223444444444


Q ss_pred             eecccCccccccccccccccccccccccccccc-chhhhhhccccccCeEECC
Q 045493          573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS-QEISIQIGKLVQLSKLDLS  624 (1048)
Q Consensus       573 L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls  624 (1048)
                      |+|++|+|+.+ |..+..+++|+.|++++|++. +..+..+..+++|+.|+++
T Consensus       219 L~L~~N~l~~l-~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          219 ISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             EECTTSCCCEE-CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             EECcCCcccch-hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            44444444432 333444444444444444443 3333333344444444444

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=7e-26  Score=270.71  Aligned_cols=269  Identities=28%  Similarity=0.358  Sum_probs=175.9

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      ++++|++++|+|+ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+|+++ |.   .+++|++|+++
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSL-PV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCC-CC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcC-CC---CCCCCCEEECc
Confidence            4666777777666 4555444  56667777776666 3443   456666666666666643 33   45566666666


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|++++ +|.   .+++|+.|++++|+++                                       ++ |..   +++
T Consensus       110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~---------------------------------------~l-p~~---l~~  142 (622)
T 3g06_A          110 SNPLTH-LPA---LPSGLCKLWIFGNQLT---------------------------------------SL-PVL---PPG  142 (622)
T ss_dssp             SCCCCC-CCC---CCTTCCEEECCSSCCS---------------------------------------CC-CCC---CTT
T ss_pred             CCcCCC-CCC---CCCCcCEEECCCCCCC---------------------------------------cC-CCC---CCC
Confidence            666663 232   3455666666666554                                       22 221   366


Q ss_pred             cceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeeccc
Q 045493          185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH  264 (1048)
Q Consensus       185 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  264 (1048)
                      |++|+|++|++++ +|.   .+.+|+.|++++|++++ +|   ..+++|+.|+|++|.+++ +|..   +++|+.|++++
T Consensus       143 L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~  210 (622)
T 3g06_A          143 LQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYN  210 (622)
T ss_dssp             CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred             CCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcC
Confidence            7777777777763 333   24567777777777773 44   345677777777777774 4432   36777777777


Q ss_pred             ccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecccccccccccccceeeeccccccCCC
Q 045493          265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSI  344 (1048)
Q Consensus       265 n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  344 (1048)
                      |.++. +|                         .   .+++|+.|++++|++++ +|   ..+++|+.|++++|.++. +
T Consensus       211 N~l~~-l~-------------------------~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-l  256 (622)
T 3g06_A          211 NRLTS-LP-------------------------A---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-L  256 (622)
T ss_dssp             SCCSS-CC-------------------------C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-C
T ss_pred             Ccccc-cC-------------------------C---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-C
Confidence            77652 11                         1   12467777777777775 33   445777778888887773 4


Q ss_pred             CcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcc
Q 045493          345 PEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKK  401 (1048)
Q Consensus       345 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  401 (1048)
                      |.   .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++..|..+..++.
T Consensus       257 p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~  309 (622)
T 3g06_A          257 PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS  309 (622)
T ss_dssp             CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHHH
T ss_pred             Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhccc
Confidence            44   5678899999999998 67888999999999999999999888888887764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=3.2e-27  Score=277.25  Aligned_cols=234  Identities=21%  Similarity=0.197  Sum_probs=148.6

Q ss_pred             cccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEec
Q 045493          425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG  504 (1048)
Q Consensus       425 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~  504 (1048)
                      +|++|++++|.+++..|..|..+++|++|+|++|.+++..+  |..+++|+.|+|++|.+++..+     .++|++|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            55666666666665555666666666666666666665443  6666666666666666654332     2566666666


Q ss_pred             CcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccc-cccccceeecccCccccc
Q 045493          505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELG-LLAELGYLDLSANRLSKL  583 (1048)
Q Consensus       505 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~  583 (1048)
                      +|.|++..+.   .+++|+.|+|++|++++..|..|..+++|++|+|++|.+++..|..+. .+++|++|+|++|.|+++
T Consensus       108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            6666654443   245666667777766666666666666677777777766665555554 566677777777776665


Q ss_pred             ccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCccc-CCccccccc
Q 045493          584 IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS-GPIPSCFRR  662 (1048)
Q Consensus       584 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~  662 (1048)
                      .+  +..+++|+.|+|++|+|+++++. +..+++|+.|||++|.|++ +|..+..+++|+.|++++|+++ +.+|..+..
T Consensus       185 ~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~  260 (487)
T 3oja_A          185 KG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK  260 (487)
T ss_dssp             EC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred             cc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence            22  23466677777777777665444 6666777777777777763 5556666777777777777776 455666666


Q ss_pred             cCCccEEEec
Q 045493          663 MHGLSSIDVS  672 (1048)
Q Consensus       663 l~~L~~l~ls  672 (1048)
                      ++.|+.++++
T Consensus       261 l~~L~~l~~~  270 (487)
T 3oja_A          261 NQRVQTVAKQ  270 (487)
T ss_dssp             CHHHHHHHHH
T ss_pred             CCCCcEEecc
Confidence            6666666665

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=1e-28  Score=300.27  Aligned_cols=443  Identities=13%  Similarity=0.120  Sum_probs=256.3

Q ss_pred             ceeccccccccccCCccCcCCCCCCeEeccCCccC---CCCCcc------------cccccccceeecccccccCCCchh
Q 045493          210 SYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLS---GYIPPK------------LGSFKSLLYLYLSHNQLNGSLPSS  274 (1048)
Q Consensus       210 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~p~~------------~~~l~~L~~L~L~~n~l~~~~p~~  274 (1048)
                      +.++++.+... ..+..+..+++|++|+++++...   +..|..            ...+++|++|++++|.+.+..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            34555554332 22234567788999999887532   122221            235677888888888766544444


Q ss_pred             hh-ccchhhhhhhccccccCCC-CCcccCCCCCCcEEEccCceeecccccccc----cccccceeeeccccccCCCCcch
Q 045493          275 FG-NLSSLKHLHVHNINKLSGS-IPKEIGNLKSLSHLWLSKTQLSGFIPPSLG----NLSNIRGLYIRENMLYGSIPEEL  348 (1048)
Q Consensus       275 ~~-~L~~L~~L~l~~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l~~L~~L~l~~n~l~~~~~~~~  348 (1048)
                      +. .+++|++|++.++..++.. ++..+.++++|++|++++|.+++..+..+.    .+++|+.|++++|. .......+
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l  203 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSAL  203 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHH
Confidence            43 4566666666554333321 222333555666666666655543333222    33455555555554 11111111


Q ss_pred             ----hccCCCCeEeccCC-ccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccC
Q 045493          349 ----GRLKSLSQLSLSVN-KLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS  423 (1048)
Q Consensus       349 ----~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~  423 (1048)
                          ..+++|++|++++| .+.+ ++..+.++++|+.|+++.+...                 +..|.+.+ ++..+..+
T Consensus       204 ~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~-----------------~~~~~~~~-l~~~l~~~  264 (594)
T 2p1m_B          204 ERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAE-----------------VRPDVYSG-LSVALSGC  264 (594)
T ss_dssp             HHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCC-----------------CCHHHHHH-HHHHHHTC
T ss_pred             HHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCc-----------------cchhhHHH-HHHHHhcC
Confidence                22355555555555 2322 4444555555555553332210                 11122221 11233444


Q ss_pred             CcccEE-EeecccccCCCCCCcccccccceeEecCCccccCc-ccccCCCCCCCeeeCcCCcccCcccc-cccCCCCccE
Q 045493          424 GSLTHF-SVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-SEVFGIYPDLELLDLSNNNFFGEISS-NWIKCPQLAT  500 (1048)
Q Consensus       424 ~~L~~L-~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~~~-~~~~~~~L~~  500 (1048)
                      ++|+.+ .+.+... ..++..+..+++|++|++++|.++... ...+..+++|+.|++++| ++..... ....+++|++
T Consensus       265 ~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~  342 (594)
T 2p1m_B          265 KELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE  342 (594)
T ss_dssp             TTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred             CCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence            555555 2222111 223444456777888888887765332 223456788888888877 4432222 2234778888


Q ss_pred             EEec---------CcccCcccCcccc-ccCCCcEEEcccCcccCCcCcccc-CCCccCEEeec--C----ccccCC----
Q 045493          501 LNMG---------GNEISGTIPSEIG-NMTQLHKLDFSSNRLVGQIPKQLG-KLTSLTSLTLN--G----NQLSGD----  559 (1048)
Q Consensus       501 L~L~---------~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~----  559 (1048)
                      |++.         .+.+++.....+. .+++|+.|+++.|.+++.....+. .+++|++|+++  +    |.+++.    
T Consensus       343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~  422 (594)
T 2p1m_B          343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI  422 (594)
T ss_dssp             EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred             EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence            8873         3556544333343 478888888888888765555554 47888888888  4    556522    


Q ss_pred             -CccccccccccceeecccCcccccccccccc-cccccccccccccccchhhhhh-ccccccCeEECCCCcccCcCCc-C
Q 045493          560 -IPLELGLLAELGYLDLSANRLSKLIPKNLGE-LRKLHHLNLSNNQFSQEISIQI-GKLVQLSKLDLSHNSLGGNIPS-E  635 (1048)
Q Consensus       560 -~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~  635 (1048)
                       ++..+..+++|++|+|++ .++...+..+.. +++|+.|+|++|.+++.....+ ..+++|++|+|++|.+++.... .
T Consensus       423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~  501 (594)
T 2p1m_B          423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN  501 (594)
T ss_dssp             HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT
T ss_pred             HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH
Confidence             122256778899999977 676655556655 7889999999999887776666 6788999999999998654443 3


Q ss_pred             cCCccccCeEECCCCcccCCccccc-cccCCccEEEecccee
Q 045493          636 ICNLESLEYMNLLQNKLSGPIPSCF-RRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       636 ~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~l~ls~N~l  676 (1048)
                      ...+++|++|++++|+++......+ ..+|.|+...+..+.-
T Consensus       502 ~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          502 ASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             GGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            4458899999999999865555555 5678887766666543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=6.1e-29  Score=302.26  Aligned_cols=437  Identities=16%  Similarity=0.161  Sum_probs=284.6

Q ss_pred             ceeeccccCccccCCcccccccccceeccccccccc---cCCc------------cCcCCCCCCeEeccCCccCCCCCcc
Q 045493          186 TFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSG---SIPP------------TAGNLSNLKFLYLHDNRLSGYIPPK  250 (1048)
Q Consensus       186 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~------------~~~~l~~L~~L~L~~N~l~~~~p~~  250 (1048)
                      +.++++++... ..+..+..+++|++|+|++|....   ..|.            .+..+++|++|+|++|.+++..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            35566554432 223456678999999999986321   1221            1246789999999999988666666


Q ss_pred             cc-cccccceeecccc-cccCC-CchhhhccchhhhhhhccccccCCCCCccc----CCCCCCcEEEccCce--eecc-c
Q 045493          251 LG-SFKSLLYLYLSHN-QLNGS-LPSSFGNLSSLKHLHVHNINKLSGSIPKEI----GNLKSLSHLWLSKTQ--LSGF-I  320 (1048)
Q Consensus       251 ~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~----~~l~~L~~L~L~~n~--l~~~-~  320 (1048)
                      +. .+++|++|++++| .+... ++..+..+++|++|+++++ .+.+..+..+    ..+++|++|++++|.  ++.. +
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~-~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l  203 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRES-DVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL  203 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTC-EEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCC-ccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHH
Confidence            65 6899999999999 45422 4455668999999999984 4655444333    467799999999997  2211 1


Q ss_pred             ccccccccccceeeeccc-cccCCCCcchhccCCCCeEeccCC-------ccccCcChhhhccCCCcEE-EeecccccCC
Q 045493          321 PPSLGNLSNIRGLYIREN-MLYGSIPEELGRLKSLSQLSLSVN-------KLNGSIPHCLGNLSNLKFF-ALRENELSGS  391 (1048)
Q Consensus       321 ~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~Ls~N-------~l~~~~~~~l~~l~~L~~L-~L~~n~l~~~  391 (1048)
                      +..+..+++|+.|++++| .+.+ ++..+..+++|++|+++.+       .+.+ ++..+.++++|+.+ .+.+... +.
T Consensus       204 ~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~  280 (594)
T 2p1m_B          204 ERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AY  280 (594)
T ss_dssp             HHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GG
T ss_pred             HHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hh
Confidence            222345799999999998 4544 7788889999999996544       4443 44577888888888 3443332 24


Q ss_pred             chhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCc-ccccCC
Q 045493          392 IPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-SEVFGI  470 (1048)
Q Consensus       392 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~~~~  470 (1048)
                      ++..+..+++|+.|++++|.+++....                       ..+..+++|++|++++| ++... ......
T Consensus       281 l~~~~~~~~~L~~L~L~~~~l~~~~l~-----------------------~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~  336 (594)
T 2p1m_B          281 LPAVYSVCSRLTTLNLSYATVQSYDLV-----------------------KLLCQCPKLQRLWVLDY-IEDAGLEVLAST  336 (594)
T ss_dssp             GGGGHHHHTTCCEEECTTCCCCHHHHH-----------------------HHHTTCTTCCEEEEEGG-GHHHHHHHHHHH
T ss_pred             HHHHHHhhCCCCEEEccCCCCCHHHHH-----------------------HHHhcCCCcCEEeCcCc-cCHHHHHHHHHh
Confidence            555555677777777777765432111                       11233444444444444 22111 111123


Q ss_pred             CCCCCeeeC---------cCCcccCccccccc-CCCCccEEEecCcccCcccCcccc-ccCCCcEEEcc--c----Cccc
Q 045493          471 YPDLELLDL---------SNNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEIG-NMTQLHKLDFS--S----NRLV  533 (1048)
Q Consensus       471 ~~~L~~L~L---------s~n~l~~~~~~~~~-~~~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls--~----N~l~  533 (1048)
                      +++|+.|++         +.+.+++.....+. .+++|++|.++.|.+++..+..+. .+++|+.|+++  +    |.++
T Consensus       337 ~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~  416 (594)
T 2p1m_B          337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT  416 (594)
T ss_dssp             CTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT
T ss_pred             CCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc
Confidence            455555555         23444443333333 377888888888888766555554 47888888888  3    5555


Q ss_pred             CCc-----CccccCCCccCEEeecCccccCCCcccccc-ccccceeecccCcccccccccc-cccccccccccccccccc
Q 045493          534 GQI-----PKQLGKLTSLTSLTLNGNQLSGDIPLELGL-LAELGYLDLSANRLSKLIPKNL-GELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       534 ~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~~L~Ls~N~l~~  606 (1048)
                      +..     +..+..+++|++|+|++ .+++..+..+.. +++|++|+|++|.+++..+..+ ..+++|++|+|++|++++
T Consensus       417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence            221     12256678889999977 666554555554 7889999999998876655555 668899999999999876


Q ss_pred             hhhhh-hccccccCeEECCCCcccCcCCcCc-CCccccCeEECCCCcc
Q 045493          607 EISIQ-IGKLVQLSKLDLSHNSLGGNIPSEI-CNLESLEYMNLLQNKL  652 (1048)
Q Consensus       607 ~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l  652 (1048)
                      ..... ...+++|+.|++++|+++......+ ..++.|+...+..+.-
T Consensus       496 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          496 KALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             HHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             HHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            65543 3458899999999998865444444 4567777777766654

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.4e-25  Score=243.81  Aligned_cols=210  Identities=24%  Similarity=0.287  Sum_probs=128.6

Q ss_pred             CCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeec
Q 045493          473 DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLN  552 (1048)
Q Consensus       473 ~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  552 (1048)
                      +|+.|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            34444444444444444444444455555555555544444445555555555555555554444455555555555555


Q ss_pred             CccccCCCccccccccccceeecccCcccccc-cccccccccccccccccccccchhhhhhccccccC----eEECCCCc
Q 045493          553 GNQLSGDIPLELGLLAELGYLDLSANRLSKLI-PKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS----KLDLSHNS  627 (1048)
Q Consensus       553 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  627 (1048)
                      +|.+++..+..+..+++|++|++++|+++.+. |..|..+++|++|++++|+++++.+..+..+.+|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            55555444444555555555555555555432 55555555555566666655555555555555555    78899999


Q ss_pred             ccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc
Q 045493          628 LGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       628 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      +++..+..+.. .+|++|+|++|++++..+..|..+++|+.|++++|+|++.+|.-
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            88665555544 58999999999999888888889999999999999999988754

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.4e-25  Score=243.73  Aligned_cols=218  Identities=24%  Similarity=0.249  Sum_probs=172.4

Q ss_pred             eecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccc
Q 045493           14 TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELG   93 (1048)
Q Consensus        14 ~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~   93 (1048)
                      .++++|...++++++|+|++|+|++..+..|+.+++|++|+|++|+++++.+.+|+.+++|++|+|++|++++..+..|.
T Consensus        18 ~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (276)
T 2z62_A           18 NFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS   97 (276)
T ss_dssp             CCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred             CccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhc
Confidence            45677777778899999999999988878899999999999999999887778899999999999999999988888888


Q ss_pred             cccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCcccc
Q 045493           94 ELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSG  173 (1048)
Q Consensus        94 ~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~  173 (1048)
                      ++++|++|++++|++++..+..++.+++|++|++++|++.+.                                      
T Consensus        98 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------------------------  139 (276)
T 2z62_A           98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF--------------------------------------  139 (276)
T ss_dssp             TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC--------------------------------------
T ss_pred             CCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee--------------------------------------
Confidence            899999999999988877776788888888888888877521                                      


Q ss_pred             ccCCCCCCCCCcceeeccccCccccCCcccccccccc----eeccccccccccCCccCcCCCCCCeEeccCCccCCCCCc
Q 045493          174 VIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLS----YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP  249 (1048)
Q Consensus       174 ~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  249 (1048)
                      .+|..|..+++|++|+|++|++++..+..|..+.+|+    +|++++|++.+..+..+. ..+|++|+|++|++++..+.
T Consensus       140 ~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~  218 (276)
T 2z62_A          140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDG  218 (276)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTT
T ss_pred             cCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHh
Confidence            1345566677777777777777766666777777766    778888888754444443 44788888888888866666


Q ss_pred             ccccccccceeecccccccCC
Q 045493          250 KLGSFKSLLYLYLSHNQLNGS  270 (1048)
Q Consensus       250 ~~~~l~~L~~L~L~~n~l~~~  270 (1048)
                      .|..+++|++|++++|++...
T Consensus       219 ~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          219 IFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             TTTTCCSCCEEECCSSCBCCC
T ss_pred             HhcccccccEEEccCCccccc
Confidence            677888888888888888743

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=1.3e-26  Score=272.10  Aligned_cols=243  Identities=21%  Similarity=0.213  Sum_probs=210.3

Q ss_pred             CCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccc
Q 045493           22 LFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNEL  101 (1048)
Q Consensus        22 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L  101 (1048)
                      .+++|++|||++|+|++..|..|+.+++|++|+|++|.+++..|  |+.+++|++|+|++|+|+++.+     .++|++|
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L  104 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL  104 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence            34589999999999999889999999999999999999997655  9999999999999999997533     3899999


Q ss_pred             cccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCC-
Q 045493          102 ALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG-  180 (1048)
Q Consensus       102 ~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~-  180 (1048)
                      ++++|++++..+..   +++|+.|+|++|.+++..               |..+.++++|+.|+|++|.+++..|..+. 
T Consensus       105 ~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~---------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~  166 (487)
T 3oja_A          105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLR---------------DLDEGCRSRVQYLDLKLNEIDTVNFAELAA  166 (487)
T ss_dssp             ECCSSCCCCEEECC---CSSCEEEECCSSCCCSGG---------------GBCGGGGSSEEEEECTTSCCCEEEGGGGGG
T ss_pred             ECcCCcCCCCCccc---cCCCCEEECCCCCCCCCC---------------chhhcCCCCCCEEECCCCCCCCcChHHHhh
Confidence            99999999776654   588999999999998643               34667789999999999999999998886 


Q ss_pred             CCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccccccee
Q 045493          181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYL  260 (1048)
Q Consensus       181 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  260 (1048)
                      .+++|++|+|++|.+++..+  +..+++|++|+|++|.+++ +|+.+..+++|++|+|++|.+++ +|..+..+++|+.|
T Consensus       167 ~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L  242 (487)
T 3oja_A          167 SSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF  242 (487)
T ss_dssp             GTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEE
T ss_pred             hCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEE
Confidence            79999999999999997633  4469999999999999996 55568899999999999999994 77789999999999


Q ss_pred             eccccccc-CCCchhhhccchhhhhhhccccccC
Q 045493          261 YLSHNQLN-GSLPSSFGNLSSLKHLHVHNINKLS  293 (1048)
Q Consensus       261 ~L~~n~l~-~~~p~~~~~L~~L~~L~l~~~n~l~  293 (1048)
                      ++++|++. +.+|..+..++.|+.+++.....+.
T Consensus       243 ~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~  276 (487)
T 3oja_A          243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT  276 (487)
T ss_dssp             ECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHT
T ss_pred             EcCCCCCcCcchHHHHHhCCCCcEEecccccccc
Confidence            99999997 6678889999999999986433333

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=2.6e-24  Score=232.61  Aligned_cols=186  Identities=23%  Similarity=0.251  Sum_probs=123.0

Q ss_pred             CccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecc
Q 045493          497 QLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLS  576 (1048)
Q Consensus       497 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  576 (1048)
                      ++++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+++
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            45555555555554444455555555555555555554444445556666666666666654444555666666666666


Q ss_pred             cCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCc
Q 045493          577 ANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI  656 (1048)
Q Consensus       577 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  656 (1048)
                      +|+++.+.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP  197 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence            66666666666666666666666666666666666677777777777777777666666777888888888888888777


Q ss_pred             cccccccCCccEEEeccceecCCCCC
Q 045493          657 PSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       657 ~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      +..|..++.|+.|++++|+|.+.++.
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          198 EGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             HHHhccccCCCEEEecCCCeeCCCcc
Confidence            77777788888888888888776653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=6.3e-24  Score=229.65  Aligned_cols=204  Identities=25%  Similarity=0.284  Sum_probs=154.1

Q ss_pred             cceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEccc
Q 045493          450 LYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS  529 (1048)
Q Consensus       450 L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~  529 (1048)
                      .+.++++++.++.++....   ++++.|+|++|++++..+..|..+++|++|++++|.++...+..|..+++|++|+|++
T Consensus        18 ~~~l~~~~~~l~~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLTAIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCSSCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCCccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            4556666666665443322   4566777777777666666677777777777777777755556667777777777777


Q ss_pred             CcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhh
Q 045493          530 NRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEIS  609 (1048)
Q Consensus       530 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  609 (1048)
                      |++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            77776666677777888888888888876666777788888888888888887777778888888888888888888777


Q ss_pred             hhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCc
Q 045493          610 IQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPI  656 (1048)
Q Consensus       610 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  656 (1048)
                      ..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++....
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  221 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC  221 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence            77888888999999999998777777888899999999999987543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=6.8e-24  Score=231.24  Aligned_cols=205  Identities=26%  Similarity=0.270  Sum_probs=109.1

Q ss_pred             cccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCc
Q 045493          444 LQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLH  523 (1048)
Q Consensus       444 l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~  523 (1048)
                      +.++++++++++++|.++.++...+   ++++.|+|++|.+++..+..|..+++|++|++++|.|++..+.  +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            4555666666666666666554432   4566666666666555555555555666666666655533221  4455555


Q ss_pred             EEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccccccc
Q 045493          524 KLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ  603 (1048)
Q Consensus       524 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~  603 (1048)
                      +|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|+.+++                  
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~------------------  141 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP------------------  141 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT------------------
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccCh------------------
Confidence            5555555555 344444555555555555555554444445555555555555555554444                  


Q ss_pred             ccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCC
Q 045493          604 FSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       604 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~  679 (1048)
                            ..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..++.|+.+++++|+|.+.
T Consensus       142 ------~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          142 ------GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             ------TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ------hhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence                  44444555555555555555444444455555555555555555 3344444445555555555555544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.2e-24  Score=235.50  Aligned_cols=224  Identities=25%  Similarity=0.289  Sum_probs=181.0

Q ss_pred             ccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEE
Q 045493          447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLD  526 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  526 (1048)
                      +..+..+++..+.+....  .+..+++|+.|++++|.++..  ..+..+++|++|++++|.+++.  ..+..+++|++|+
T Consensus        18 ~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHHhcCccccccc--ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            345556666666655432  234567778888888877643  2466778888888888888753  3678888888888


Q ss_pred             cccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccc
Q 045493          527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       527 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  606 (1048)
                      |++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|+++++.+..|..+++|++|++++|++++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            88888887777778888888888888888887777778888889999999998888888888888999999999999988


Q ss_pred             hhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCc
Q 045493          607 EISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       607 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      ..+..++.+++|++|++++|++++..+..+..+++|++|++++|++.+.       ++.|+.++++.|.++|.+|..
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~  241 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS  241 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred             cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence            8888888899999999999999988888889999999999999998854       457888999999999999875

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=2e-25  Score=252.54  Aligned_cols=253  Identities=21%  Similarity=0.230  Sum_probs=187.7

Q ss_pred             EEeecccccCCCCCCcccccccceeEecCCccccCcc----cccCCCC-CCCeeeCcCCcccCcccccccCC-----CCc
Q 045493          429 FSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS----EVFGIYP-DLELLDLSNNNFFGEISSNWIKC-----PQL  498 (1048)
Q Consensus       429 L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~~~-~L~~L~Ls~n~l~~~~~~~~~~~-----~~L  498 (1048)
                      ++++.|++++.+|..+...++|++|+|++|.+++...    ..|..++ +|++|+|++|++++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4566777777777666666668888888888887776    6677777 78888888888887766666654     888


Q ss_pred             cEEEecCcccCcccCcccccc-----CCCcEEEcccCcccCCcCcccc----C-CCccCEEeecCccccCCCccc----c
Q 045493          499 ATLNMGGNEISGTIPSEIGNM-----TQLHKLDFSSNRLVGQIPKQLG----K-LTSLTSLTLNGNQLSGDIPLE----L  564 (1048)
Q Consensus       499 ~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~~----~  564 (1048)
                      ++|++++|.+++..+..++..     ++|++|+|++|++++..+..+.    . .++|++|+|++|.+++..+..    +
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            888888888887666654443     7889999999988876655443    3 358899999999888544433    3


Q ss_pred             cccc-ccceeecccCccccccccccccc-----ccccccccccccccchhhh----hhcc-ccccCeEECCCCcccCcCC
Q 045493          565 GLLA-ELGYLDLSANRLSKLIPKNLGEL-----RKLHHLNLSNNQFSQEISI----QIGK-LVQLSKLDLSHNSLGGNIP  633 (1048)
Q Consensus       565 ~~l~-~L~~L~Ls~N~l~~~~~~~l~~l-----~~L~~L~Ls~N~l~~~~~~----~~~~-l~~L~~L~Ls~N~l~~~~~  633 (1048)
                      ..++ +|++|+|++|+|++..+..+...     ++|++|+|++|+|++....    .+.. .++|++|||++|.|++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            4444 89999999999988777655443     5899999999999875433    3333 4589999999999987554


Q ss_pred             ----cCcCCccccCeEECCCCcccCCccc-------cccccCCccEEEeccceecCCCC
Q 045493          634 ----SEICNLESLEYMNLLQNKLSGPIPS-------CFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       634 ----~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                          ..+..+++|++|+|++|.+++..+.       .+..++.|++||+++|++.+..+
T Consensus       243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence                3456678899999999996655443       56677889999999999876533

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=6.3e-24  Score=225.25  Aligned_cols=205  Identities=21%  Similarity=0.250  Sum_probs=142.8

Q ss_pred             ecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCc-cccCCCcCCCCCCCCcEEeCCC-CcCCCCCcccc
Q 045493           15 LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQ-FSGIIPPQIGILTNLVVLRLSV-NQLNGLIPEEL   92 (1048)
Q Consensus        15 ~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~p~~~~~l~~L~~L~ls~-n~l~~~~~~~~   92 (1048)
                      ++++|. .++++++|+|++|+|++..+..|+.+++|++|+|++|+ ++.+.+.+|+++++|++|++++ |+++++.+..|
T Consensus        23 l~~ip~-~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           23 IQRIPS-LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             CSSCCC-CCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             ccccCC-CCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            666666 66778888888888887777777788888888888886 7766666777777888888877 77777666677


Q ss_pred             ccccccccccccceecccccCcCcCCcCCCc---eEEeecc-cccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCC
Q 045493           93 GELTSLNELALSYNRLNGSIPASLGNLSNLV---QLSLSNN-SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHT  168 (1048)
Q Consensus        93 ~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~---~L~l~~n-~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~  168 (1048)
                      .++++|++|++++|++++ +|. |..+++|+   .|++++| .++                                   
T Consensus       102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-----------------------------------  144 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-----------------------------------  144 (239)
T ss_dssp             ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-----------------------------------
T ss_pred             CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchh-----------------------------------
Confidence            777777777777777774 444 66666666   6666666 543                                   


Q ss_pred             CccccccCCCCCCCCCcc-eeeccccCccccCCcccccccccceecccccc-ccccCCccCcCC-CCCCeEeccCCccCC
Q 045493          169 NNFSGVIPRSLGGLKNLT-FVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQ-LSGSIPPTAGNL-SNLKFLYLHDNRLSG  245 (1048)
Q Consensus       169 n~~~~~~~~~~~~l~~L~-~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~  245 (1048)
                          ++.+..|..+++|+ .|++++|+++.+.+..|.. ++|++|+|++|+ +++..+..|.++ ++|++|++++|++++
T Consensus       145 ----~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~  219 (239)
T 2xwt_C          145 ----SIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA  219 (239)
T ss_dssp             ----EECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred             ----hcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence                34445567777777 7777777777444444444 677777777774 765555667777 777777777777774


Q ss_pred             CCCcccccccccceeecccc
Q 045493          246 YIPPKLGSFKSLLYLYLSHN  265 (1048)
Q Consensus       246 ~~p~~~~~l~~L~~L~L~~n  265 (1048)
                       +|..  .+++|+.|+++++
T Consensus       220 -l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          220 -LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             -CCCT--TCTTCSEEECTTC
T ss_pred             -CChh--HhccCceeeccCc
Confidence             3332  4567777777665

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.90  E-value=2.2e-24  Score=233.44  Aligned_cols=234  Identities=24%  Similarity=0.291  Sum_probs=161.8

Q ss_pred             CCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccc
Q 045493           19 PFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL   98 (1048)
Q Consensus        19 p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L   98 (1048)
                      |-..+.++..+++..+.+.+..  .+..+++|+.|++++|.++. + .+++.+++|++|++++|++++.  ..+..+++|
T Consensus        14 ~~~~~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L   87 (272)
T 3rfs_A           14 PDDAFAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNL   87 (272)
T ss_dssp             CSHHHHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTC
T ss_pred             CCchHHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCC
Confidence            4445567777778888776553  35677888888888888873 3 4588888888888888888864  467888888


Q ss_pred             ccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCC
Q 045493           99 NELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS  178 (1048)
Q Consensus        99 ~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~  178 (1048)
                      ++|++++|++++..+..|.++++|++|++++|++++..               |..+..+++|+.|++++|.+++..+..
T Consensus        88 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~---------------~~~~~~l~~L~~L~L~~n~l~~~~~~~  152 (272)
T 3rfs_A           88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLP---------------DGVFDKLTNLTYLNLAHNQLQSLPKGV  152 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC---------------TTTTTTCTTCCEEECCSSCCCCCCTTT
T ss_pred             CEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccC---------------HHHhccCCCCCEEECCCCccCccCHHH
Confidence            88888888888777777888888888888888876322               123455566666666666666666666


Q ss_pred             CCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccc
Q 045493          179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL  258 (1048)
Q Consensus       179 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  258 (1048)
                      |..+++|+.|++++|++++..+..|..+++|++|+|++|++.+..+..+..+++|++|+|++|.+.+.       +++|+
T Consensus       153 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~  225 (272)
T 3rfs_A          153 FDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIR  225 (272)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTH
T ss_pred             hccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHH
Confidence            66666777777777766665555566666677777777666655555566666666666666665532       33566


Q ss_pred             eeecccccccCCCchhhhccch
Q 045493          259 YLYLSHNQLNGSLPSSFGNLSS  280 (1048)
Q Consensus       259 ~L~L~~n~l~~~~p~~~~~L~~  280 (1048)
                      .|++..|.+.|.+|.+++.+..
T Consensus       226 ~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          226 YLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             HHHHHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHHHHhCCCcccCcccccCC
Confidence            6666666666666666555443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=7.7e-25  Score=258.83  Aligned_cols=182  Identities=12%  Similarity=0.141  Sum_probs=142.0

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCccc-------chhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIG-------INQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+.||+|+||+||+|+.. ++.+++|+..........       ....+|++.+++++||||+++..++...+..|+|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            446899999999999554 788888886543222111       112556677788999999976666667777899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+++|+|.++++.           +..++.|+++||+|||++   +|+||||||+||+++.  .+||+|||+|+......
T Consensus       420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            9999999999864           457999999999999999   9999999999999998  99999999999775432


Q ss_pred             CC-------cccccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 045493          934 SN-------WSELAGTCGYIAPELAYT--MRANEKCDVFNFGVLVLEVIEGKHPG  979 (1048)
Q Consensus       934 ~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~  979 (1048)
                      ..       ....+||+.|||||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            21       135679999999999986  56788899999999999988887765

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=2.3e-23  Score=227.10  Aligned_cols=203  Identities=25%  Similarity=0.307  Sum_probs=135.5

Q ss_pred             ccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCc
Q 045493           44 ISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLV  123 (1048)
Q Consensus        44 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~  123 (1048)
                      ++.+++++.+++++|.++ .+|..+.  +++++|+|++|+++++.+..|..+++|++|++++|+++...+.  +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            344444555555555554 2333332  3455555555555544444555555555555555555533221  4555555


Q ss_pred             eEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCccc
Q 045493          124 QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI  203 (1048)
Q Consensus       124 ~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~  203 (1048)
                      .|++++|+++                .+|..+..+++|+.|++++|.+++..+..|.++++|++|+|++|++++..+..|
T Consensus        81 ~L~Ls~N~l~----------------~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  144 (290)
T 1p9a_G           81 TLDLSHNQLQ----------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL  144 (290)
T ss_dssp             EEECCSSCCS----------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             EEECCCCcCC----------------cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhc
Confidence            6666555553                233445555556666666666666667788888999999999999987777788


Q ss_pred             ccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeeccccccc
Q 045493          204 GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLN  268 (1048)
Q Consensus       204 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~  268 (1048)
                      ..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus       145 ~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            88999999999999998665666788999999999999998 57777778889999999999876

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=7.5e-25  Score=247.75  Aligned_cols=260  Identities=20%  Similarity=0.173  Sum_probs=144.1

Q ss_pred             EEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCccccc-ccceeEecCCc
Q 045493          381 FALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCT-SLYSLRLERNQ  459 (1048)
Q Consensus       381 L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~-~L~~L~L~~n~  459 (1048)
                      +.++.|.+++.+|+.+...++|+.|++++|++++..+..++                    ..|..++ +|++|+|++|.
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~--------------------~~l~~~~~~L~~L~Ls~N~   62 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELI--------------------QAFANTPASVTSLNLSGNS   62 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH--------------------HHHHTCCTTCCEEECCSSC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHH--------------------HHHHhCCCceeEEECcCCC
Confidence            56677777766666665555566666666666554431000                    3344444 45555555555


Q ss_pred             cccCcccccCCC-----CCCCeeeCcCCcccCccccccc----CC-CCccEEEecCcccCcccCccccc-----cCCCcE
Q 045493          460 LTGNISEVFGIY-----PDLELLDLSNNNFFGEISSNWI----KC-PQLATLNMGGNEISGTIPSEIGN-----MTQLHK  524 (1048)
Q Consensus       460 l~~~~~~~~~~~-----~~L~~L~Ls~n~l~~~~~~~~~----~~-~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~  524 (1048)
                      +++.....|...     ++|++|+|++|.+++..+..+.    .+ ++|++|++++|.|++..+..+..     .++|++
T Consensus        63 l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~  142 (362)
T 3goz_A           63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS  142 (362)
T ss_dssp             GGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred             CCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence            554444433332     5555555555555544433222    22 55666666666665544433332     246666


Q ss_pred             EEcccCcccCCcCc----cccCCC-ccCEEeecCccccCCCcccccc----c-cccceeecccCcccccc----cccccc
Q 045493          525 LDFSSNRLVGQIPK----QLGKLT-SLTSLTLNGNQLSGDIPLELGL----L-AELGYLDLSANRLSKLI----PKNLGE  590 (1048)
Q Consensus       525 L~Ls~N~l~~~~~~----~~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~~----~~~l~~  590 (1048)
                      |+|++|++++..+.    .+..++ +|++|+|++|++++..+..+..    + ++|++|||++|+|+...    +..+..
T Consensus       143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence            66666666643322    233343 6666666666666555443332    2 46777777777766532    233333


Q ss_pred             -cccccccccccccccchhhh----hhccccccCeEECCCCcccCc-------CCcCcCCccccCeEECCCCcccCCccc
Q 045493          591 -LRKLHHLNLSNNQFSQEISI----QIGKLVQLSKLDLSHNSLGGN-------IPSEICNLESLEYMNLLQNKLSGPIPS  658 (1048)
Q Consensus       591 -l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~L~~N~l~~~~~~  658 (1048)
                       .++|++|+|++|+|++.+..    .+..+++|++|+|++|.+.+.       ++..+..+++|++|++++|++.+..+.
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~  302 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSI  302 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence             34677777777777665442    234567777777777774432       233566677788888888888765444


Q ss_pred             cc
Q 045493          659 CF  660 (1048)
Q Consensus       659 ~~  660 (1048)
                      .+
T Consensus       303 ~~  304 (362)
T 3goz_A          303 PI  304 (362)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=4.5e-23  Score=218.66  Aligned_cols=196  Identities=14%  Similarity=0.167  Sum_probs=111.4

Q ss_pred             CCCeeeCcCCcccCcccccccCCCCccEEEecCcc-cCcccCccccccCCCcEEEccc-CcccCCcCccccCCCccCEEe
Q 045493          473 DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNE-ISGTIPSEIGNMTQLHKLDFSS-NRLVGQIPKQLGKLTSLTSLT  550 (1048)
Q Consensus       473 ~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~  550 (1048)
                      +++.|++++|++++..+..|..+++|++|++++|. ++...+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            44555555555544444445555555555555554 5444444555555555555555 555544445555555555555


Q ss_pred             ecCccccCCCccccccccccc---eeecccC-ccccccccccccccccc-ccccccccccchhhhhhccccccCeEECCC
Q 045493          551 LNGNQLSGDIPLELGLLAELG---YLDLSAN-RLSKLIPKNLGELRKLH-HLNLSNNQFSQEISIQIGKLVQLSKLDLSH  625 (1048)
Q Consensus       551 L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  625 (1048)
                      +++|++++ +|. +..+++|+   +|++++| +++.+.+..|..+++|+ +|++++|+++.+....+.. ++|++|++++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            55555553 333 55555555   6666666 66665555566666666 6666666666555544544 5666666666


Q ss_pred             Cc-ccCcCCcCcCCc-cccCeEECCCCcccCCccccccccCCccEEEeccc
Q 045493          626 NS-LGGNIPSEICNL-ESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYN  674 (1048)
Q Consensus       626 N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N  674 (1048)
                      |+ +++..+..|..+ ++|++|++++|+|++..+.   .++.|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            63 665555666666 6677777777777644433   4556666666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=2.4e-23  Score=230.10  Aligned_cols=202  Identities=18%  Similarity=0.185  Sum_probs=132.5

Q ss_pred             CCCCeeeCcCCcccCcccccc--cCCCCccEEEecCcccCcccC----ccccccCCCcEEEcccCcccCCcCccccCCCc
Q 045493          472 PDLELLDLSNNNFFGEISSNW--IKCPQLATLNMGGNEISGTIP----SEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTS  545 (1048)
Q Consensus       472 ~~L~~L~Ls~n~l~~~~~~~~--~~~~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  545 (1048)
                      ++|++|++++|++.+..+..+  ..+++|++|++++|.+++..+    ..+..+++|++|+|++|++.+..+..|..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            446666666666666665555  566666666666666665433    23345667777777777776666667777777


Q ss_pred             cCEEeecCccccCC--C--ccccccccccceeecccCcccccccc---cccccccccccccccccccchhhhhhccc---
Q 045493          546 LTSLTLNGNQLSGD--I--PLELGLLAELGYLDLSANRLSKLIPK---NLGELRKLHHLNLSNNQFSQEISIQIGKL---  615 (1048)
Q Consensus       546 L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~Ls~N~l~~~~~~---~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l---  615 (1048)
                      |++|+|++|++.+.  +  +..+..+++|++|+|++|+|+.+.+.   .+..+++|++|+|++|+|++..+..+..+   
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            77777777776531  1  12235667777777777777643221   24566777777777777777655555544   


Q ss_pred             cccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecC
Q 045493          616 VQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQG  678 (1048)
Q Consensus       616 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~  678 (1048)
                      ++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..++.|++|++++|+++.
T Consensus       251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            57888888888887 5566554  6888888888888764 22 5667888888888887754

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=1.8e-24  Score=247.19  Aligned_cols=242  Identities=20%  Similarity=0.278  Sum_probs=181.2

Q ss_pred             CCCCcccccccceeEecCCccccCcc----cccCCCCCCCeeeCcCCcc---cCcccccc-------cCCCCccEEEecC
Q 045493          440 IPRSLQNCTSLYSLRLERNQLTGNIS----EVFGIYPDLELLDLSNNNF---FGEISSNW-------IKCPQLATLNMGG  505 (1048)
Q Consensus       440 ~~~~l~~l~~L~~L~L~~n~l~~~~~----~~~~~~~~L~~L~Ls~n~l---~~~~~~~~-------~~~~~L~~L~L~~  505 (1048)
                      ++..+..+++|++|+|++|.++....    ..+..+++|+.|+|++|.+   ++.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            44556677778888888887776533    3366778888888887543   33334333       5778888888888


Q ss_pred             cccCc----ccCccccccCCCcEEEcccCcccCCcCcccc----CC---------CccCEEeecCcccc-CCCc---ccc
Q 045493          506 NEISG----TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG----KL---------TSLTSLTLNGNQLS-GDIP---LEL  564 (1048)
Q Consensus       506 N~i~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l---------~~L~~L~L~~N~l~-~~~~---~~~  564 (1048)
                      |.+++    .++..+..+++|++|+|++|.+++..+..+.    .+         ++|++|+|++|+++ ..++   ..+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            88886    4666778888888888888888654443333    33         88999999999887 3334   466


Q ss_pred             ccccccceeecccCcccc-----ccccccccccccccccccccccc----chhhhhhccccccCeEECCCCcccCc----
Q 045493          565 GLLAELGYLDLSANRLSK-----LIPKNLGELRKLHHLNLSNNQFS----QEISIQIGKLVQLSKLDLSHNSLGGN----  631 (1048)
Q Consensus       565 ~~l~~L~~L~Ls~N~l~~-----~~~~~l~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----  631 (1048)
                      ..+++|++|+|++|+|+.     +.+..+..+++|+.|+|++|+|+    ...+..+..+++|++|+|++|.|++.    
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~  263 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA  263 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence            778889999999998883     34447888899999999999986    33455677889999999999999865    


Q ss_pred             CCcCc--CCccccCeEECCCCcccC----Cccccc-cccCCccEEEeccceecCCCC
Q 045493          632 IPSEI--CNLESLEYMNLLQNKLSG----PIPSCF-RRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       632 ~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      ++..+  +.+++|++|+|++|+|++    .+|..+ ..++.|++|++++|++++..|
T Consensus       264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            44555  348899999999999987    467766 568999999999999987654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=2.4e-22  Score=214.66  Aligned_cols=181  Identities=28%  Similarity=0.312  Sum_probs=115.8

Q ss_pred             ccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeeccc
Q 045493          498 LATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA  577 (1048)
Q Consensus       498 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  577 (1048)
                      .++++++++.++ .+|..+.  +.++.|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            445555555555 3333332  4566666666666655555566666666666666666655555566666666666666


Q ss_pred             CcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcc
Q 045493          578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       578 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      |+|+.+.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+
T Consensus        93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  172 (251)
T 3m19_A           93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH  172 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence            66666655666666666666666666666666666666777777777777776555567777777777777777776666


Q ss_pred             ccccccCCccEEEeccceecCCCC
Q 045493          658 SCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       658 ~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      ..|..++.|++|++++|+|++..+
T Consensus       173 ~~~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          173 GAFDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             TTTTTCTTCCEEECCSCCBCTTST
T ss_pred             HHHhCCCCCCEEEeeCCceeCCcc
Confidence            667777777777777777776643

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.9e-22  Score=222.23  Aligned_cols=194  Identities=23%  Similarity=0.334  Sum_probs=111.9

Q ss_pred             ccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcE
Q 045493          445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHK  524 (1048)
Q Consensus       445 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  524 (1048)
                      ..+++|++|++++|.++.++  .+..+++|+.|++++|++++..+  +..+++|++|++++|.+++.  ..+..+++|++
T Consensus        38 ~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~  111 (308)
T 1h6u_A           38 ADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (308)
T ss_dssp             HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence            34455555555555555443  34455556666666665554433  55555666666666665532  24556666666


Q ss_pred             EEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccc
Q 045493          525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF  604 (1048)
Q Consensus       525 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  604 (1048)
                      |++++|++++. + .+..+++|++|++++|++++..+  +..+++|++|++++|+++++.+  +..+++|+.|++++|++
T Consensus       112 L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          112 LDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence            66666666543 2 25666666666666666663322  5566666666666666665433  55666666666666666


Q ss_pred             cchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccC
Q 045493          605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG  654 (1048)
Q Consensus       605 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  654 (1048)
                      +++.+  +..+++|++|+|++|++++..  .+..+++|++|+|++|++++
T Consensus       186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          186 SDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             CcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            55443  556666666666666666433  25666666666666666654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.8e-22  Score=222.34  Aligned_cols=215  Identities=20%  Similarity=0.310  Sum_probs=184.9

Q ss_pred             ccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEE
Q 045493          447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLD  526 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  526 (1048)
                      +..+..+.+..+.++++.  .+..+++|+.|++++|.++.. + .+..+++|++|++++|.+++..+  +..+++|++|+
T Consensus        18 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence            344555566666666533  234578999999999999864 3 58889999999999999996555  89999999999


Q ss_pred             cccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccc
Q 045493          527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       527 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  606 (1048)
                      |++|++++.  ..+..+++|++|+|++|++++. + .+..+++|++|++++|+++++.+  +..+++|+.|++++|++++
T Consensus        92 L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  165 (308)
T 1h6u_A           92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD  165 (308)
T ss_dssp             CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             ccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence            999999864  3689999999999999999954 4 38999999999999999998755  8899999999999999998


Q ss_pred             hhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCC
Q 045493          607 EISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       607 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~  679 (1048)
                      ..+  +..+++|+.|++++|++++..+  +..+++|++|+|++|++++..+  +..++.|+.|++++|++++.
T Consensus       166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            765  8899999999999999986543  8899999999999999997764  88999999999999999874

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=3.7e-24  Score=244.66  Aligned_cols=270  Identities=20%  Similarity=0.232  Sum_probs=149.7

Q ss_pred             CCCcchhccCCCCeEeccCCccccCcChh----hhccCCCcEEEeecccc---cCCchhhhhhhcccceeeccccccCCC
Q 045493          343 SIPEELGRLKSLSQLSLSVNKLNGSIPHC----LGNLSNLKFFALRENEL---SGSIPQEIENMKKLNKYLLFENQFTGY  415 (1048)
Q Consensus       343 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----l~~l~~L~~L~L~~n~l---~~~~p~~~~~l~~L~~l~l~~N~l~~~  415 (1048)
                      .++..+..+++|++|+|++|.++...+..    +..+++|+.|+|++|.+   ++.+|..+..+.               
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~---------------   87 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL---------------   87 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHH---------------
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHH---------------
Confidence            45667777788888888888877654333    55677888888877543   334444442221               


Q ss_pred             CCcccccCCcccEEEeecccccC----CCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCccccc
Q 045493          416 LPQNVCQSGSLTHFSVRNNNFVG----PIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSN  491 (1048)
Q Consensus       416 ~~~~~~~~~~L~~L~l~~N~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~  491 (1048)
                        ..+..+++|++|++++|.++.    .+|..+..+++|++|+|++|.++......+..                    .
T Consensus        88 --~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~  145 (386)
T 2ca6_A           88 --QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------A  145 (386)
T ss_dssp             --HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------H
T ss_pred             --HHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------H
Confidence              112233344444444444443    23334444445555555555444322222211                    1


Q ss_pred             ccCC---------CCccEEEecCcccC-cccC---ccccccCCCcEEEcccCcccC-----CcCccccCCCccCEEeecC
Q 045493          492 WIKC---------PQLATLNMGGNEIS-GTIP---SEIGNMTQLHKLDFSSNRLVG-----QIPKQLGKLTSLTSLTLNG  553 (1048)
Q Consensus       492 ~~~~---------~~L~~L~L~~N~i~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~  553 (1048)
                      +..+         ++|++|++++|.++ ...+   ..+..+++|++|+|++|+++.     ..+..+..+++|++|+|++
T Consensus       146 l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~  225 (386)
T 2ca6_A          146 LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD  225 (386)
T ss_dssp             HHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCS
T ss_pred             HHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcC
Confidence            1111         45555555555554 2222   244455666666666666652     2233556666667777776


Q ss_pred             cccc----CCCccccccccccceeecccCccccc----ccccccc--cccccccccccccccch----hhhhh-cccccc
Q 045493          554 NQLS----GDIPLELGLLAELGYLDLSANRLSKL----IPKNLGE--LRKLHHLNLSNNQFSQE----ISIQI-GKLVQL  618 (1048)
Q Consensus       554 N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~--l~~L~~L~Ls~N~l~~~----~~~~~-~~l~~L  618 (1048)
                      |.++    ..+|..+..+++|++|+|++|+|+..    .+..+..  +++|++|+|++|+|++.    .+..+ ..+++|
T Consensus       226 n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L  305 (386)
T 2ca6_A          226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL  305 (386)
T ss_dssp             SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTC
T ss_pred             CCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCc
Confidence            6664    34566666677777777777777654    3444432  67777778888877762    33333 557888


Q ss_pred             CeEECCCCcccCcCC--cCcC-CccccCeEECCC
Q 045493          619 SKLDLSHNSLGGNIP--SEIC-NLESLEYMNLLQ  649 (1048)
Q Consensus       619 ~~L~Ls~N~l~~~~~--~~~~-~l~~L~~L~L~~  649 (1048)
                      +.|+|++|++++..+  ..+. .+++++.+.+..
T Consensus       306 ~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~  339 (386)
T 2ca6_A          306 LFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE  339 (386)
T ss_dssp             CEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred             eEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence            888888888876553  2222 245555555544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.87  E-value=8.1e-23  Score=225.77  Aligned_cols=203  Identities=23%  Similarity=0.222  Sum_probs=151.9

Q ss_pred             ccccceeEecCCccccCccccc--CCCCCCCeeeCcCCcccCccc----ccccCCCCccEEEecCcccCcccCccccccC
Q 045493          447 CTSLYSLRLERNQLTGNISEVF--GIYPDLELLDLSNNNFFGEIS----SNWIKCPQLATLNMGGNEISGTIPSEIGNMT  520 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~--~~~~~L~~L~Ls~n~l~~~~~----~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~  520 (1048)
                      +++|++|++++|.+++..+..+  ..+++|+.|+|++|++++..+    ..+..+++|++|++++|.+++..+..|+.++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            4557777777777776666665  667777777777777775433    3344678888888888888877778888888


Q ss_pred             CCcEEEcccCcccCC--c--CccccCCCccCEEeecCccccCCCcc----ccccccccceeecccCccccccccccccc-
Q 045493          521 QLHKLDFSSNRLVGQ--I--PKQLGKLTSLTSLTLNGNQLSGDIPL----ELGLLAELGYLDLSANRLSKLIPKNLGEL-  591 (1048)
Q Consensus       521 ~L~~L~Ls~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-  591 (1048)
                      +|++|+|++|++.+.  .  +..+..+++|++|+|++|+++ .++.    .++.+++|++|||++|+|++..|..+..+ 
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  248 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM  248 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence            888888888887542  1  233467888888888888887 3333    25677888889999998888877777666 


Q ss_pred             --ccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCC
Q 045493          592 --RKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP  655 (1048)
Q Consensus       592 --~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  655 (1048)
                        ++|++|+|++|+|+.++. .+.  ++|++|||++|+|++. |. +..+++|++|+|++|+|+..
T Consensus       249 ~~~~L~~L~Ls~N~l~~lp~-~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~~  309 (310)
T 4glp_A          249 WSSALNSLNLSFAGLEQVPK-GLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLVP  309 (310)
T ss_dssp             CCTTCCCEECCSSCCCSCCS-CCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSCC
T ss_pred             CcCcCCEEECCCCCCCchhh-hhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCCC
Confidence              689999999999886533 332  7899999999999854 33 67789999999999999743

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=1.4e-23  Score=235.26  Aligned_cols=251  Identities=16%  Similarity=0.241  Sum_probs=194.4

Q ss_pred             cccEEEeecccccCCCCCCcccc--cccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCc-ccccccCCCCccEE
Q 045493          425 SLTHFSVRNNNFVGPIPRSLQNC--TSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGE-ISSNWIKCPQLATL  501 (1048)
Q Consensus       425 ~L~~L~l~~N~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~~~~L~~L  501 (1048)
                      .++.+++++|.+.   +..+..+  ++++.|++++|.+.+..+..+ .+++|+.|++++|.+++. .+..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~-~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhc-cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            3567777777665   4456666  778888888888887766644 578888888888888765 66677888899999


Q ss_pred             EecCcccCcccCccccccCCCcEEEcccC-cccCC-cCccccCCCccCEEeecCc-cccCC-Ccccccccc-ccceeecc
Q 045493          502 NMGGNEISGTIPSEIGNMTQLHKLDFSSN-RLVGQ-IPKQLGKLTSLTSLTLNGN-QLSGD-IPLELGLLA-ELGYLDLS  576 (1048)
Q Consensus       502 ~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls  576 (1048)
                      ++++|.+++..+..++.+++|++|++++| .+++. .+..+..+++|++|++++| .+++. ++..+..++ +|++|+++
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~  203 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS  203 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence            99999888778888888899999999998 67652 5666778889999999999 88753 566788888 99999999


Q ss_pred             cC--ccc-cccccccccccccccccccccc-ccchhhhhhccccccCeEECCCCc-ccCcCCcCcCCccccCeEECCCCc
Q 045493          577 AN--RLS-KLIPKNLGELRKLHHLNLSNNQ-FSQEISIQIGKLVQLSKLDLSHNS-LGGNIPSEICNLESLEYMNLLQNK  651 (1048)
Q Consensus       577 ~N--~l~-~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~  651 (1048)
                      +|  .++ ...+..+..+++|++|++++|. +++.....+..+++|++|++++|. +.......+.++++|++|++++| 
T Consensus       204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-  282 (336)
T 2ast_B          204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-  282 (336)
T ss_dssp             SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred             CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence            99  454 3446677888999999999999 777777888899999999999995 43333346788999999999999 


Q ss_pred             ccCCcccccccc-CCccEEEeccceecCCCCCc
Q 045493          652 LSGPIPSCFRRM-HGLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       652 l~~~~~~~~~~l-~~L~~l~ls~N~l~~~~p~~  683 (1048)
                      ++..   .+..+ ..++.|++++|++++..|..
T Consensus       283 i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          283 VPDG---TLQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             SCTT---CHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             cCHH---HHHHHHhhCcceEEecccCccccCCc
Confidence            5433   33333 23667779999999988764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=2.8e-22  Score=225.36  Aligned_cols=113  Identities=19%  Similarity=0.142  Sum_probs=65.0

Q ss_pred             cCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCC-CcCCCCCCCCcE-EeCCCCcCCCCCccccc
Q 045493           16 QEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGII-PPQIGILTNLVV-LRLSVNQLNGLIPEELG   93 (1048)
Q Consensus        16 ~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~-L~ls~n~l~~~~~~~~~   93 (1048)
                      +++|..+++++++|+|++|+|+++.+.+|+++++|++|+|++|++.+.+ +.+|.++++|++ +.+++|+|+++.|+.|.
T Consensus        22 t~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~  101 (350)
T 4ay9_X           22 TEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQ  101 (350)
T ss_dssp             CSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBC
T ss_pred             CccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhh
Confidence            4555555666666666666666555556666666666666666654333 345566665553 44455666655555566


Q ss_pred             cccccccccccceecccccCcCcCCcCCCceEEee
Q 045493           94 ELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLS  128 (1048)
Q Consensus        94 ~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~  128 (1048)
                      ++++|++|++++|+++...+..+....++..|++.
T Consensus       102 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~  136 (350)
T 4ay9_X          102 NLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ  136 (350)
T ss_dssp             CCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEE
T ss_pred             hccccccccccccccccCCchhhcccchhhhhhhc
Confidence            66666666666666655444455555555555553

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=1.3e-21  Score=208.89  Aligned_cols=159  Identities=25%  Similarity=0.279  Sum_probs=114.8

Q ss_pred             CccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecc
Q 045493          497 QLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLS  576 (1048)
Q Consensus       497 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  576 (1048)
                      +++.|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            55556666666665555566666666666666666666666666666666666666666665555666667777777777


Q ss_pred             cCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCC
Q 045493          577 ANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP  655 (1048)
Q Consensus       577 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  655 (1048)
                      +|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            7777766666677777777777777777777776777888888888888888877777888888899999999988866

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.86  E-value=1e-21  Score=220.72  Aligned_cols=247  Identities=18%  Similarity=0.175  Sum_probs=192.4

Q ss_pred             cccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcc-cccccCCCCc
Q 045493          420 VCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEI-SSNWIKCPQL  498 (1048)
Q Consensus       420 ~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~-~~~~~~~~~L  498 (1048)
                      +|.+. -++++.++++++. +|..+  .+++++|+|++|+|+.+++.+|..+++|++|+|++|++.+.+ +.+|.+++++
T Consensus         6 ~C~C~-~~~v~C~~~~Lt~-iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l   81 (350)
T 4ay9_X            6 ICHCS-NRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL   81 (350)
T ss_dssp             SSEEE-TTEEEEESTTCCS-CCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTC
T ss_pred             ccEee-CCEEEecCCCCCc-cCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhh
Confidence            34442 3567888888884 55555  257899999999999999899999999999999999986644 4678888887


Q ss_pred             cE-EEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecC-ccccCCCcccccccc-ccceeec
Q 045493          499 AT-LNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNG-NQLSGDIPLELGLLA-ELGYLDL  575 (1048)
Q Consensus       499 ~~-L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L  575 (1048)
                      ++ +.+++|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |.++...+..|..+. .++.|+|
T Consensus        82 ~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L  161 (350)
T 4ay9_X           82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL  161 (350)
T ss_dssp             CEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred             hhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcc
Confidence            75 66777999988888999999999999999999977777777788888898865 667755556677664 6889999


Q ss_pred             ccCcccccccccccccccccccccc-cccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccC
Q 045493          576 SANRLSKLIPKNLGELRKLHHLNLS-NNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG  654 (1048)
Q Consensus       576 s~N~l~~~~~~~l~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  654 (1048)
                      ++|+|+.+.+..|. ..+|++|+++ +|.++.+....|..+++|++|||++|+|+...+..|.+   |+.|.+.++.--.
T Consensus       162 ~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~  237 (350)
T 4ay9_X          162 NKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLK  237 (350)
T ss_dssp             CSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCC
T ss_pred             ccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcC
Confidence            99999988666665 4689999997 57888888888999999999999999999655555554   5555544443333


Q ss_pred             CccccccccCCccEEEeccce
Q 045493          655 PIPSCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       655 ~~~~~~~~l~~L~~l~ls~N~  675 (1048)
                      ..| .+.++++|+.++++++-
T Consensus       238 ~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          238 KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CCC-CTTTCCSCCEEECSCHH
T ss_pred             cCC-CchhCcChhhCcCCCCc
Confidence            555 47889999999998663

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.86  E-value=8.3e-23  Score=228.95  Aligned_cols=211  Identities=18%  Similarity=0.250  Sum_probs=102.7

Q ss_pred             ccccceeEecCCccccC-cccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCc-ccCcc-cCccccccCCCc
Q 045493          447 CTSLYSLRLERNQLTGN-ISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN-EISGT-IPSEIGNMTQLH  523 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~  523 (1048)
                      +++|++|++++|.+++. .+..+..+++|+.|+|++|.+++..+..+..+++|++|++++| .+++. ++..+..+++|+
T Consensus        92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~  171 (336)
T 2ast_B           92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  171 (336)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence            33444444444443322 2333444444444444444444444444444455555555554 34431 333344555555


Q ss_pred             EEEcccC-cccCC-cCccccCCC-ccCEEeecCc--ccc-CCCccccccccccceeecccCc-ccccccccccccccccc
Q 045493          524 KLDFSSN-RLVGQ-IPKQLGKLT-SLTSLTLNGN--QLS-GDIPLELGLLAELGYLDLSANR-LSKLIPKNLGELRKLHH  596 (1048)
Q Consensus       524 ~L~Ls~N-~l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~  596 (1048)
                      +|++++| .+++. .+..+..++ +|++|++++|  .++ +.++..+..+++|++|++++|. +++..+..+..+++|++
T Consensus       172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~  251 (336)
T 2ast_B          172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH  251 (336)
T ss_dssp             EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence            5555555 55432 234444555 5555555555  232 2334444555555555555555 44444455555566666


Q ss_pred             cccccc-cccchhhhhhccccccCeEECCCCcccCcCCcCcCCc-cccCeEECCCCcccCCcccccc
Q 045493          597 LNLSNN-QFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNL-ESLEYMNLLQNKLSGPIPSCFR  661 (1048)
Q Consensus       597 L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~  661 (1048)
                      |++++| .++......++.+++|+.|++++| ++.   ..+..+ .+++.|++++|++++..|..+.
T Consensus       252 L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          252 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             EECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             eeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence            666665 333333334555666666666666 321   122333 2355556666666666665544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=7.7e-21  Score=196.65  Aligned_cols=172  Identities=28%  Similarity=0.354  Sum_probs=114.4

Q ss_pred             ecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccc
Q 045493           15 LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGE   94 (1048)
Q Consensus        15 ~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~   94 (1048)
                      ++++|...++++++|+|++|++++..+..|+.+++|++|+|++|+++++.+..|+.+++|++|+|++|+++++.+..|..
T Consensus        19 l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~   98 (208)
T 2o6s_A           19 RTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDK   98 (208)
T ss_dssp             CSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             ccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcC
Confidence            45566666677777777777777666666777777777777777777655556677777777777777777666666666


Q ss_pred             ccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccc
Q 045493           95 LTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGV  174 (1048)
Q Consensus        95 l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~  174 (1048)
                      +++|++|++++|++++..+..|..+++|++|++++|+++                                       +.
T Consensus        99 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~---------------------------------------~~  139 (208)
T 2o6s_A           99 LTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK---------------------------------------SV  139 (208)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS---------------------------------------CC
T ss_pred             ccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc---------------------------------------ee
Confidence            777777777777776555555666666666666666554                                       23


Q ss_pred             cCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCC
Q 045493          175 IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSN  232 (1048)
Q Consensus       175 ~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  232 (1048)
                      .+..|..+++|++|++++|.+.+       .+++|++|+++.|++++.+|..++.++.
T Consensus       140 ~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          140 PDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            33445666677777777776542       3456777777777777777766665543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=3.7e-21  Score=208.06  Aligned_cols=148  Identities=14%  Similarity=0.082  Sum_probs=111.8

Q ss_pred             ccCCcceeeecccccccEEEEEEcCCCceeeEEeccCCCCcc-----------------cchhhHHHHHHhhcccCceee
Q 045493          775 STFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI-----------------GINQKGFVSEITEIRHRNIVK  837 (1048)
Q Consensus       775 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~-----------------~~~~~~~~~~l~~l~h~niv~  837 (1048)
                      ...+.....||+|+||.||+|.+.+++.||+|.++.......                 ......+...++.++  | ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            334444567999999999999997789999999864322110                 112345556667776  5 66


Q ss_pred             EeeEeeeCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCc
Q 045493          838 FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYK  917 (1048)
Q Consensus       838 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~  917 (1048)
                      +++++.. +..|+||||+++|+|.+ +..         .....++.|++.|++|||+.   +|+||||||+||+++ ++.
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~  230 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEG  230 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTE
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCc
Confidence            6666544 45699999999999988 421         23457999999999999999   999999999999999 999


Q ss_pred             eEEeccccccccCCCCCCcccccccccccccccccc
Q 045493          918 AHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT  953 (1048)
Q Consensus       918 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  953 (1048)
                      +||+|||+|+.             +..|+|||++.+
T Consensus       231 vkl~DFG~a~~-------------~~~~~a~e~l~r  253 (282)
T 1zar_A          231 IWIIDFPQSVE-------------VGEEGWREILER  253 (282)
T ss_dssp             EEECCCTTCEE-------------TTSTTHHHHHHH
T ss_pred             EEEEECCCCeE-------------CCCCCHHHHHHH
Confidence            99999999863             345789998753

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=2.8e-20  Score=192.44  Aligned_cols=140  Identities=27%  Similarity=0.283  Sum_probs=59.2

Q ss_pred             ccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccc
Q 045493          518 NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHL  597 (1048)
Q Consensus       518 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  597 (1048)
                      .+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+|+++.+..|..+++|++|
T Consensus        50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  129 (208)
T 2o6s_A           50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL  129 (208)
T ss_dssp             TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence            33333333333333333333333333333333333333333323333334444444444444443333334444444444


Q ss_pred             ccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccC
Q 045493          598 NLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMH  664 (1048)
Q Consensus       598 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  664 (1048)
                      ++++|+|+++.+..+..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|..++.++
T Consensus       130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             ECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            444444444333344444455555555554432       234455555555555555555554443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=7.4e-20  Score=215.81  Aligned_cols=189  Identities=24%  Similarity=0.376  Sum_probs=132.6

Q ss_pred             CCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEee
Q 045493           49 KLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLS  128 (1048)
Q Consensus        49 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~  128 (1048)
                      +|++|+|++|.+++ +|..+.  ++|++|+|++|+|++ +|   ..+++|++|++++|++++ +|. |..  +|+.|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            66677777766664 555442  566777777776664 34   335666677777776664 444 544  67777777


Q ss_pred             cccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccc
Q 045493          129 NNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRS  208 (1048)
Q Consensus       129 ~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~  208 (1048)
                      +|++++                +|.   .+++|+.|++++|.+++ +|.   .+++|+.|+|++|++++ +|. |.  ++
T Consensus       129 ~N~l~~----------------lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~  181 (571)
T 3cvr_A          129 NNQLTM----------------LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ES  181 (571)
T ss_dssp             SSCCSC----------------CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TT
T ss_pred             CCcCCC----------------CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CC
Confidence            776653                222   35566677777777765 343   56788899999999885 565 65  88


Q ss_pred             cceeccccccccccCCccCcCCCCC-------CeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccch
Q 045493          209 LSYLGLNKNQLSGSIPPTAGNLSNL-------KFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS  280 (1048)
Q Consensus       209 L~~L~L~~n~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~  280 (1048)
                      |++|+|++|+++ .+|. +..  +|       ++|+|++|.|+ .+|..+..+++|+.|+|++|++++..|..|..+..
T Consensus       182 L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          182 LEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             CCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            999999999988 5666 554  67       99999999999 57888888999999999999998888877766554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=5.2e-20  Score=217.13  Aligned_cols=151  Identities=25%  Similarity=0.336  Sum_probs=81.2

Q ss_pred             CCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeec
Q 045493          496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDL  575 (1048)
Q Consensus       496 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  575 (1048)
                      ++|++|++++|.|++ +|. +.+  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  167 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSV  167 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence            444444444444443 333 332  45555555555543 222   34455555555555543 332   3445555555


Q ss_pred             ccCcccccccccccccccccccccccccccchhhhhhcc-----ccccCeEECCCCcccCcCCcCcCCccccCeEECCCC
Q 045493          576 SANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGK-----LVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQN  650 (1048)
Q Consensus       576 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  650 (1048)
                      ++|+|+++ |. |.  ++|+.|+|++|+|+.++.  +..     ...|+.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       168 s~N~L~~l-p~-l~--~~L~~L~Ls~N~L~~lp~--~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N  240 (571)
T 3cvr_A          168 RNNQLTFL-PE-LP--ESLEALDVSTNLLESLPA--VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN  240 (571)
T ss_dssp             CSSCCSCC-CC-CC--TTCCEEECCSSCCSSCCC--CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred             CCCCCCCc-ch-hh--CCCCEEECcCCCCCchhh--HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCC
Confidence            55555543 22 33  455555555555543332  222     122378888888887 56777777888888888888


Q ss_pred             cccCCccccccccCC
Q 045493          651 KLSGPIPSCFRRMHG  665 (1048)
Q Consensus       651 ~l~~~~~~~~~~l~~  665 (1048)
                      +|++.+|..+..+..
T Consensus       241 ~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          241 PLSSRIRESLSQQTA  255 (571)
T ss_dssp             SCCHHHHHHHHHHHH
T ss_pred             cCCCcCHHHHHHhhc
Confidence            888877777766543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=6.9e-20  Score=199.74  Aligned_cols=150  Identities=25%  Similarity=0.392  Sum_probs=70.6

Q ss_pred             cccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccc
Q 045493          517 GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHH  596 (1048)
Q Consensus       517 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  596 (1048)
                      ..+++|++|+|++|++++..+  +..+++|++|+|++|++++ ++ .+..+++|++|++++|+|+++  ..+..+++|+.
T Consensus        65 ~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~  138 (291)
T 1h6t_A           65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLES  138 (291)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCE
T ss_pred             hcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCE
Confidence            334444444444444433222  3444444444444444432 11 244444444444444444443  23444444555


Q ss_pred             cccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEecccee
Q 045493          597 LNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       597 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l  676 (1048)
                      |++++|++++.  ..+..+++|++|++++|++++..+  +..+++|++|++++|+|++. + .+..++.|+.|++++|++
T Consensus       139 L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i  212 (291)
T 1h6t_A          139 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQEC  212 (291)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEE
T ss_pred             EEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcc
Confidence            55555554443  334455555555555555554332  55555555555555555543 2 255556666666666665


Q ss_pred             cC
Q 045493          677 QG  678 (1048)
Q Consensus       677 ~~  678 (1048)
                      +.
T Consensus       213 ~~  214 (291)
T 1h6t_A          213 LN  214 (291)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=4.2e-20  Score=220.62  Aligned_cols=204  Identities=27%  Similarity=0.378  Sum_probs=148.9

Q ss_pred             CCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccc
Q 045493           19 PFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL   98 (1048)
Q Consensus        19 p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L   98 (1048)
                      |-..+.++..+.|+.+.+++..+  +..|++|+.|+|++|.|+. +| .|+.+++|+.|+|++|+|+++.|  |..+++|
T Consensus        16 pd~~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L   89 (605)
T 1m9s_A           16 PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNL   89 (605)
T ss_dssp             CSHHHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTC
T ss_pred             CcHHHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCC
Confidence            33344567777888888876544  5778889999999999884 44 68889999999999999987654  8888888


Q ss_pred             ccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCC
Q 045493           99 NELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS  178 (1048)
Q Consensus        99 ~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~  178 (1048)
                      ++|+|++|+++. +| .+..+++|+.|+|++|++++                                       .  +.
T Consensus        90 ~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~---------------------------------------l--~~  126 (605)
T 1m9s_A           90 GWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD---------------------------------------I--NG  126 (605)
T ss_dssp             CEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC---------------------------------------C--GG
T ss_pred             CEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC---------------------------------------C--cc
Confidence            888888888874 33 67888888888888887652                                       1  23


Q ss_pred             CCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccc
Q 045493          179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLL  258 (1048)
Q Consensus       179 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  258 (1048)
                      +..+++|+.|+|++|+++++  ..+..+++|++|+|++|++.+..|  +..+++|+.|+|++|.|++ + ..+..+++|+
T Consensus       127 l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~  200 (605)
T 1m9s_A          127 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLD  200 (605)
T ss_dssp             GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCS
T ss_pred             ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCC
Confidence            55667777777777777654  567777777777777777775444  7777788888888887774 3 3577778888


Q ss_pred             eeecccccccCCCchhhhc
Q 045493          259 YLYLSHNQLNGSLPSSFGN  277 (1048)
Q Consensus       259 ~L~L~~n~l~~~~p~~~~~  277 (1048)
                      .|+|++|++.+.....+..
T Consensus       201 ~L~L~~N~l~~~p~~~~~~  219 (605)
T 1m9s_A          201 VLELFSQECLNKPINHQSN  219 (605)
T ss_dssp             EEECCSEEEECCCCCCCSS
T ss_pred             EEEccCCcCcCCccccccc
Confidence            8888888777544333333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=9.7e-20  Score=205.47  Aligned_cols=179  Identities=26%  Similarity=0.257  Sum_probs=113.1

Q ss_pred             EEEecCcccCcccCccccccCCCcEEEcccCcccCCcCcccc-CCCccCEEeecCccccCCCccccccccccceeecccC
Q 045493          500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLG-KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN  578 (1048)
Q Consensus       500 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  578 (1048)
                      .+++++|.++ .+|..+.  +.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            4555555555 2333322  2355666666666655555555 5666666666666666555555666666666666666


Q ss_pred             cccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCc---CCccccCeEECCCCcccCC
Q 045493          579 RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEI---CNLESLEYMNLLQNKLSGP  655 (1048)
Q Consensus       579 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~  655 (1048)
                      +|+.+.+..|..+++|++|+|++|+|+.+.+..|..+++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|++.
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence            6666666666666666677777777666666666777777777777777765444444   4577777777777777766


Q ss_pred             ccccccccCC--ccEEEeccceecCCCC
Q 045493          656 IPSCFRRMHG--LSSIDVSYNELQGSIP  681 (1048)
Q Consensus       656 ~~~~~~~l~~--L~~l~ls~N~l~~~~p  681 (1048)
                      .+..+..++.  ++.|++++|+|.+.+.
T Consensus       179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          179 PLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             CHHHhhhccHhhcceEEecCCCccCCcC
Confidence            6667777766  3778888888776543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=2.5e-19  Score=195.37  Aligned_cols=198  Identities=22%  Similarity=0.317  Sum_probs=169.4

Q ss_pred             ccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEE
Q 045493          447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLD  526 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  526 (1048)
                      +..+..+.+..+.++++..  +..+++|+.|++++|.+...  ..+..+++|++|++++|.+++..+  +..+++|++|+
T Consensus        23 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            4456666777777765432  34678999999999999865  348889999999999999997655  89999999999


Q ss_pred             cccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccc
Q 045493          527 FSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       527 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  606 (1048)
                      +++|++++ + ..+..+++|++|+|++|++++.  ..+..+++|++|++++|+++++  ..+..+++|++|++++|+|++
T Consensus        97 l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A           97 LDENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             CCSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             CCCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence            99999986 3 3489999999999999999964  5788999999999999999987  679999999999999999998


Q ss_pred             hhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccc
Q 045493          607 EISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF  660 (1048)
Q Consensus       607 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  660 (1048)
                      ..+  +..+++|+.|++++|+|++. + .+..+++|+.|++++|+++......+
T Consensus       171 ~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~~~~~  220 (291)
T 1h6t_A          171 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPINHQ  220 (291)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCCEECC
T ss_pred             chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCccccc
Confidence            766  88999999999999999853 3 48999999999999999986554443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=2.1e-19  Score=187.09  Aligned_cols=157  Identities=19%  Similarity=0.268  Sum_probs=110.6

Q ss_pred             cEEEcccCcccCCcCccccCCCccCEEeecCccccCCCc-cccccccccceeecccCccccccccccccccccccccccc
Q 045493          523 HKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIP-LELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN  601 (1048)
Q Consensus       523 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~  601 (1048)
                      +.+++++|.++. +|..+.  +.+++|+|++|++++..+ ..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            355566665553 343332  234566666666664433 3456666777777777777766666677777777777777


Q ss_pred             ccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCC
Q 045493          602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       602 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      |+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|++++|+|++.++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            77777777777777788888888888887777788888888888888888887778888888888888888888887766


Q ss_pred             C
Q 045493          682 H  682 (1048)
Q Consensus       682 ~  682 (1048)
                      .
T Consensus       171 l  171 (220)
T 2v70_A          171 L  171 (220)
T ss_dssp             G
T ss_pred             h
Confidence            3

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=2.2e-19  Score=186.97  Aligned_cols=136  Identities=23%  Similarity=0.304  Sum_probs=80.2

Q ss_pred             ccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECC
Q 045493          545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLS  624 (1048)
Q Consensus       545 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  624 (1048)
                      +|++|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+.+..|..+++|++|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            44555555555544334445555555555555555555555555555555555555555555555555566666666666


Q ss_pred             CCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCC
Q 045493          625 HNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSI  680 (1048)
Q Consensus       625 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~  680 (1048)
                      +|+|++..+..|..+++|++|+|++|+|++..+..|..++.|++|++++|+|.+..
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            66666666666666666666666666666666666666666666666666666543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.78  E-value=2.9e-19  Score=213.36  Aligned_cols=188  Identities=21%  Similarity=0.283  Sum_probs=98.3

Q ss_pred             cEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCc
Q 045493          427 THFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN  506 (1048)
Q Consensus       427 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N  506 (1048)
                      ..+.+..+.+....+  +..+++|+.|++++|.+..++  .+..+++|+.|+|++|++.+..+  +..+++|+.|+|++|
T Consensus        24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N   97 (605)
T 1m9s_A           24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN   97 (605)
T ss_dssp             HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             HHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence            334444444443322  345555666666666655443  34555556666666665554433  555555555555555


Q ss_pred             ccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccc
Q 045493          507 EISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPK  586 (1048)
Q Consensus       507 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  586 (1048)
                      .|++. + .+..+++|+.|+|++|++.+.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|+|+++.| 
T Consensus        98 ~l~~l-~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-  170 (605)
T 1m9s_A           98 KIKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  170 (605)
T ss_dssp             CCCCC-T-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred             CCCCC-h-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence            55532 2 455555555555555555532  2355555555555555555533  345555555555555555555443 


Q ss_pred             cccccccccccccccccccchhhhhhccccccCeEECCCCcccC
Q 045493          587 NLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       587 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                       +..+++|+.|+|++|+|+++  ..+..+++|+.|+|++|++.+
T Consensus       171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence             55555555555555555543  234455555555555555554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=9e-19  Score=183.66  Aligned_cols=155  Identities=27%  Similarity=0.296  Sum_probs=97.3

Q ss_pred             cEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccc
Q 045493          523 HKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNN  602 (1048)
Q Consensus       523 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N  602 (1048)
                      +.++.++++++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            34455555544 2333222  45555555555555555555555555555555555555555555566666666666666


Q ss_pred             cccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCC
Q 045493          603 QFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       603 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      +|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..++.|+.|++++|+|.+.++
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            666655556666677777777777776 566667777777777777777776666667777777777777777777665

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=7.1e-19  Score=183.13  Aligned_cols=153  Identities=22%  Similarity=0.260  Sum_probs=104.3

Q ss_pred             cEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccC
Q 045493          499 ATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN  578 (1048)
Q Consensus       499 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  578 (1048)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            34555555555 3333332  45666666666666555556666666666666666666555666666666777777777


Q ss_pred             cccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccC
Q 045493          579 RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG  654 (1048)
Q Consensus       579 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  654 (1048)
                      +|+.+++..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            7766666666677777777777777777767777777788888888888887777778888888888888888864

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=6.6e-19  Score=198.62  Aligned_cols=174  Identities=26%  Similarity=0.215  Sum_probs=79.7

Q ss_pred             eeEecCCccccCcccccCCCCCCCeeeCcCCcccCccccccc-CCCCccEEEecCcccCcccCccccccCCCcEEEcccC
Q 045493          452 SLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN  530 (1048)
Q Consensus       452 ~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~-~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N  530 (1048)
                      .++++++.++.++....   +.++.|+|++|+|++..+..|. .+++|++|+|++|.|++..+..|..+++|++|+|++|
T Consensus        22 ~l~c~~~~l~~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   98 (361)
T 2xot_A           22 ILSCSKQQLPNVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN   98 (361)
T ss_dssp             EEECCSSCCSSCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcCccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence            34444444444433221   2344555555555444444444 4455555555555555444444555555555555555


Q ss_pred             cccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccc---cccccccccccccccccch
Q 045493          531 RLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNL---GELRKLHHLNLSNNQFSQE  607 (1048)
Q Consensus       531 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l---~~l~~L~~L~Ls~N~l~~~  607 (1048)
                      +|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|+.+.+..|   ..+++|+.|+|++|+|+.+
T Consensus        99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  178 (361)
T 2xot_A           99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL  178 (361)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred             cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence            5554444445555555555555555554444445555555555555555554433333   2344444444444444443


Q ss_pred             hhhhhccccc--cCeEECCCCcc
Q 045493          608 ISIQIGKLVQ--LSKLDLSHNSL  628 (1048)
Q Consensus       608 ~~~~~~~l~~--L~~L~Ls~N~l  628 (1048)
                      ....+..++.  |+.|+|++|.+
T Consensus       179 ~~~~~~~l~~~~l~~l~l~~N~~  201 (361)
T 2xot_A          179 PLTDLQKLPAWVKNGLYLHNNPL  201 (361)
T ss_dssp             CHHHHHHSCHHHHTTEECCSSCE
T ss_pred             CHHHhhhccHhhcceEEecCCCc
Confidence            3333333333  23444444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=9.8e-19  Score=182.05  Aligned_cols=155  Identities=21%  Similarity=0.229  Sum_probs=107.2

Q ss_pred             EEEecCcccCcccCccccccCCCcEEEcccCcccCCcC-ccccCCCccCEEeecCccccCCCccccccccccceeecccC
Q 045493          500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIP-KQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN  578 (1048)
Q Consensus       500 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  578 (1048)
                      .+++++|.++ .+|..+.  +.+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            5555555555 2343332  234566666666665433 34566666666666666666555556667777777777777


Q ss_pred             cccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcc
Q 045493          579 RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       579 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      +|+++.+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..+
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            7777666667777777777777777777777777778888888888888887778888888888888888888876544

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=4.5e-19  Score=190.11  Aligned_cols=171  Identities=22%  Similarity=0.314  Sum_probs=86.7

Q ss_pred             cccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEE
Q 045493          446 NCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKL  525 (1048)
Q Consensus       446 ~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  525 (1048)
                      .+.++..+++++|.++++.  .+..+++|+.|++++|+++...  .+..+++|++|++++|+|++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4555666666666666544  3445566666666666665322  34555555555555555554333  5555555555


Q ss_pred             EcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccccccccc
Q 045493          526 DFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFS  605 (1048)
Q Consensus       526 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~  605 (1048)
                      +|++|++++. +. +.. ++|++|+|++|++++. + .+..+++|++|++++|+|+++                      
T Consensus        91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~----------------------  143 (263)
T 1xeu_A           91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI----------------------  143 (263)
T ss_dssp             ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC----------------------
T ss_pred             ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC----------------------
Confidence            5555555532 21 111 4555555555555421 1 344444444444444444443                      


Q ss_pred             chhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCC
Q 045493          606 QEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP  655 (1048)
Q Consensus       606 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  655 (1048)
                        .  .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.
T Consensus       144 --~--~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          144 --V--MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             --G--GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             --h--HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence              1  344444555555555555433  3444555555555555555543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.75  E-value=6.6e-18  Score=177.07  Aligned_cols=105  Identities=28%  Similarity=0.296  Sum_probs=66.9

Q ss_pred             ccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccc
Q 045493           26 LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSY  105 (1048)
Q Consensus        26 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~  105 (1048)
                      .+.+++++++++ .+|..+.  ++|++|+|++|+|+++.|..|+.+++|++|+|++|+|+.+.+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            345666666666 4443333  5666666666666666666666666666666666666665555566666666666666


Q ss_pred             eecccccCcCcCCcCCCceEEeeccccc
Q 045493          106 NRLNGSIPASLGNLSNLVQLSLSNNSLS  133 (1048)
Q Consensus       106 n~~~~~~~~~~~~L~~L~~L~l~~n~l~  133 (1048)
                      |++++..+..|..+++|+.|+|++|+++
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  125 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT  125 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc
Confidence            6666555556666666666666666654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=5.1e-18  Score=173.54  Aligned_cols=154  Identities=18%  Similarity=0.248  Sum_probs=96.9

Q ss_pred             cccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccc
Q 045493          517 GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHH  596 (1048)
Q Consensus       517 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  596 (1048)
                      +.+++|+.|++++|.++ .++ .+..+++|++|++++|.++ . +..+..+++|++|++++|++++..+..++.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            44555666666666665 233 4555666666666666554 2 235566666666666666666655666666677777


Q ss_pred             cccccccccchhhhhhccccccCeEECCCCc-ccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccce
Q 045493          597 LNLSNNQFSQEISIQIGKLVQLSKLDLSHNS-LGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       597 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~  675 (1048)
                      |++++|++++..+..++.+++|++|++++|+ ++ .++ .+..+++|++|++++|++++..  .+..++.|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            7777777766666666777777777777776 54 333 5667777777777777776533  56677777777777777


Q ss_pred             ecC
Q 045493          676 LQG  678 (1048)
Q Consensus       676 l~~  678 (1048)
                      +.+
T Consensus       193 i~~  195 (197)
T 4ezg_A          193 IGG  195 (197)
T ss_dssp             ---
T ss_pred             cCC
Confidence            643

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.74  E-value=2.5e-18  Score=184.30  Aligned_cols=170  Identities=21%  Similarity=0.292  Sum_probs=131.7

Q ss_pred             CCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceee
Q 045493          495 CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLD  574 (1048)
Q Consensus       495 ~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  574 (1048)
                      +.++..+++++|.+++..  .+..+++|++|++++|+++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            344555666666666433  46677777777777777764 33 56777777778887777775433  77777888888


Q ss_pred             cccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccC
Q 045493          575 LSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG  654 (1048)
Q Consensus       575 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  654 (1048)
                      |++|+|+++.+  +.. ++|++|+|++|+|++..  .+..+++|+.|+|++|+|++. + .+..+++|++|+|++|+|++
T Consensus        92 L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           92 VNRNRLKNLNG--IPS-ACLSRLFLDNNELRDTD--SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             CCSSCCSCCTT--CCC-SSCCEEECCSSCCSBSG--GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             CCCCccCCcCc--ccc-CcccEEEccCCccCCCh--hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            88888877533  222 78888888888888753  588899999999999999864 3 68899999999999999997


Q ss_pred             CccccccccCCccEEEeccceecCC
Q 045493          655 PIPSCFRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       655 ~~~~~~~~l~~L~~l~ls~N~l~~~  679 (1048)
                      .  ..+..++.|+.|++++|++++.
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             h--HHhccCCCCCEEeCCCCcccCC
Confidence            7  7788999999999999999887

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=1.2e-18  Score=194.02  Aligned_cols=221  Identities=13%  Similarity=0.093  Sum_probs=137.8

Q ss_pred             ccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCccc----CcccCccccccCCC
Q 045493          447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEI----SGTIPSEIGNMTQL  522 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i----~~~~~~~~~~l~~L  522 (1048)
                      |++|++|+|.+ .++.+...+|..+++|+.|++++|.+....+.+|..+.++..+.+..+..    ......+|.++..|
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            66666666666 66666666666666677777776666666666666666666665554221    22233445556666


Q ss_pred             c-EEEcccCcc-cCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccc
Q 045493          523 H-KLDFSSNRL-VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLS  600 (1048)
Q Consensus       523 ~-~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls  600 (1048)
                      + .+++....- .......-....+++.+.+.++-...........+++|+.|+|++|+++.+.+.+|.++.+|+.|+|+
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~  258 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP  258 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence            6 444443221 10011111123455666665542221111111236777777777777777777777777777777777


Q ss_pred             cccccchhhhhhccccccC-eEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEE
Q 045493          601 NNQFSQEISIQIGKLVQLS-KLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSID  670 (1048)
Q Consensus       601 ~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~  670 (1048)
                      +| ++.+...+|.++.+|+ .+++.+ .++...+..|.++++|+.+++++|+++...+.+|..+++|+.|+
T Consensus       259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            77 7777777777777787 788877 66666677777788888888878888777777787777777775

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=1.8e-18  Score=192.53  Aligned_cols=287  Identities=12%  Similarity=0.082  Sum_probs=212.3

Q ss_pred             ccCCCCeEeccCCccccCcChhhhc-cCCCcEEEeeccccc--CCchhhhhhhcccceeeccccccCCCCCccccc----
Q 045493          350 RLKSLSQLSLSVNKLNGSIPHCLGN-LSNLKFFALRENELS--GSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQ----  422 (1048)
Q Consensus       350 ~l~~L~~L~Ls~N~l~~~~~~~l~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~----  422 (1048)
                      .+.+++.|.++++ +.......+.. +++|+.|+|++|++.  ...+..+   +.+..+.+..|.+   .+..|..    
T Consensus        23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~   95 (329)
T 3sb4_A           23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNG   95 (329)
T ss_dssp             HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETT
T ss_pred             hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccc
Confidence            3678899999865 33222334555 788999999999998  2222222   2244445555533   3345666    


Q ss_pred             ----CCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCc----ccCcccccccC
Q 045493          423 ----SGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN----FFGEISSNWIK  494 (1048)
Q Consensus       423 ----~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~----l~~~~~~~~~~  494 (1048)
                          +++|+++++.+ +++.+.+.+|.+|++|++|++++|.+..+...+|....++..+.+..+.    .......+|..
T Consensus        96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~  174 (329)
T 3sb4_A           96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE  174 (329)
T ss_dssp             EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred             cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence                89999999999 8888888899999999999999999999999999988888888776633    23344566777


Q ss_pred             CCCcc-EEEecCcc-cCcccCccccccCCCcEEEcccCcccCCcCccc-cCCCccCEEeecCccccCCCccccccccccc
Q 045493          495 CPQLA-TLNMGGNE-ISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL-GKLTSLTSLTLNGNQLSGDIPLELGLLAELG  571 (1048)
Q Consensus       495 ~~~L~-~L~L~~N~-i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  571 (1048)
                      +..|+ .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|+.|+|++|.++...+.+|.++.+|+
T Consensus       175 ~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~  253 (329)
T 3sb4_A          175 GEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL  253 (329)
T ss_dssp             SCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred             ccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence            88887 55555322 11111111123567788888776332 112222 2478999999999999977777899999999


Q ss_pred             eeecccCccccccccccccccccc-ccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEEC
Q 045493          572 YLDLSANRLSKLIPKNLGELRKLH-HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNL  647 (1048)
Q Consensus       572 ~L~Ls~N~l~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  647 (1048)
                      .|+|++| ++.+.+.+|.++.+|+ .+++.+ .++.+...+|.++++|+.|++++|+++...+..|.++++|+.++.
T Consensus       254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            9999998 8888889999999999 999988 888889999999999999999999999888889999999999874

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.73  E-value=2.5e-20  Score=221.35  Aligned_cols=190  Identities=22%  Similarity=0.209  Sum_probs=134.9

Q ss_pred             cCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCc-------------CCCCCcccccccccccccc-ccceeccc
Q 045493           45 SHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQ-------------LNGLIPEELGELTSLNELA-LSYNRLNG  110 (1048)
Q Consensus        45 ~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~-------------l~~~~~~~~~~l~~L~~L~-l~~n~~~~  110 (1048)
                      ...++|+.|+|++|+++ .+|..++.+++|++|++++|.             +.+..|..+..+++|+.|+ ++.|.+  
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~--  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL--  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence            45667777777777776 567777777777777776664             4445566666666666666 555543  


Q ss_pred             ccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeec
Q 045493          111 SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL  190 (1048)
Q Consensus       111 ~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L  190 (1048)
                               ..|..+.+++|.+++..+                     ..|+.|+|++|.++++ |. |..+++|+.|+|
T Consensus       423 ---------~~L~~l~l~~n~i~~l~~---------------------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~L  470 (567)
T 1dce_A          423 ---------DDLRSKFLLENSVLKMEY---------------------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDL  470 (567)
T ss_dssp             ---------HHHHHHHHHHHHHHHHHH---------------------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEEC
T ss_pred             ---------chhhhhhhhcccccccCc---------------------cCceEEEecCCCCCCC-cC-ccccccCcEeec
Confidence                     234455566666552211                     1366778888877763 44 888888888888


Q ss_pred             cccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCC-CcccccccccceeecccccccC
Q 045493          191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYI-PPKLGSFKSLLYLYLSHNQLNG  269 (1048)
Q Consensus       191 ~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~n~l~~  269 (1048)
                      ++|.|+ .+|..|+.+++|++|+|++|++++ +| .++.+++|++|+|++|.+++.. |..|+.+++|+.|+|++|++++
T Consensus       471 s~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~  547 (567)
T 1dce_A          471 SHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  547 (567)
T ss_dssp             CSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             Cccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence            888887 677788888888888888888874 55 7788888888888888888665 7788888888888888888875


Q ss_pred             CCc
Q 045493          270 SLP  272 (1048)
Q Consensus       270 ~~p  272 (1048)
                      .+|
T Consensus       548 ~~~  550 (567)
T 1dce_A          548 EEG  550 (567)
T ss_dssp             SSS
T ss_pred             Ccc
Confidence            544

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=7.6e-18  Score=172.26  Aligned_cols=152  Identities=16%  Similarity=0.288  Sum_probs=95.1

Q ss_pred             CCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcccccccccccee
Q 045493          494 KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYL  573 (1048)
Q Consensus       494 ~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  573 (1048)
                      .+++|++|++++|.|+ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..++.+++|++|
T Consensus        42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            3455556666666665 333 45566666666666665542  2355666666666666666665555666666666666


Q ss_pred             ecccCccccccccccccccccccccccccc-ccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcc
Q 045493          574 DLSANRLSKLIPKNLGELRKLHHLNLSNNQ-FSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL  652 (1048)
Q Consensus       574 ~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  652 (1048)
                      ++++|++++..+..+..+++|++|++++|+ +++..  .+..+++|++|++++|++++ ++ .+..+++|++|++++|+|
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred             EecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence            666666666556666666777777777776 55543  46677777777777777774 22 667777788888888877


Q ss_pred             c
Q 045493          653 S  653 (1048)
Q Consensus       653 ~  653 (1048)
                      .
T Consensus       194 ~  194 (197)
T 4ezg_A          194 G  194 (197)
T ss_dssp             -
T ss_pred             C
Confidence            5

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.72  E-value=1.5e-19  Score=214.74  Aligned_cols=140  Identities=20%  Similarity=0.189  Sum_probs=98.5

Q ss_pred             ccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcc
Q 045493          449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS  528 (1048)
Q Consensus       449 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  528 (1048)
                      +|..+.+++|.++.++..      .|+.|+|++|+|++. |. +..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|+
T Consensus       424 ~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls  494 (567)
T 1dce_A          424 DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS  494 (567)
T ss_dssp             HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECC
T ss_pred             hhhhhhhhcccccccCcc------CceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECC
Confidence            344445555555543321      367777777777653 43 777777888888888877 667778888888888888


Q ss_pred             cCcccCCcCccccCCCccCEEeecCccccCCC-ccccccccccceeecccCcccccccc---ccccccccccccc
Q 045493          529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDI-PLELGLLAELGYLDLSANRLSKLIPK---NLGELRKLHHLNL  599 (1048)
Q Consensus       529 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~---~l~~l~~L~~L~L  599 (1048)
                      +|+|++ +| .+..+++|++|+|++|+|++.. |..++.+++|+.|+|++|+|++.++.   .+..+++|+.|++
T Consensus       495 ~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          495 DNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            888875 45 7778888888888888888665 77888888888888888888876542   2334677777754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.71  E-value=1.4e-17  Score=169.38  Aligned_cols=129  Identities=26%  Similarity=0.352  Sum_probs=67.4

Q ss_pred             cEEEcccCcccCCcCccccCCCccCEEeecCccccCCCcc-ccccccccceeecccCccccccccccccccccccccccc
Q 045493          523 HKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPL-ELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN  601 (1048)
Q Consensus       523 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~  601 (1048)
                      +.+++++|+++ .+|..+..  +|++|++++|++++..+. .|..+++|++|+|++|+|+++.|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            55666666665 34433322  556666666666543332 255555555555555555555555555555555555555


Q ss_pred             ccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccC
Q 045493          602 NQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG  654 (1048)
Q Consensus       602 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  654 (1048)
                      |+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            55555444444445555555555555554444444444455555555554443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.70  E-value=1e-17  Score=205.52  Aligned_cols=196  Identities=23%  Similarity=0.271  Sum_probs=104.5

Q ss_pred             CCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEe
Q 045493           48 SKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSL  127 (1048)
Q Consensus        48 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l  127 (1048)
                      +.++.|+|++|.+.. .|     ...|+.++|++|.|++              ++++.|++. ..|..|..+++|+.|+|
T Consensus       173 ~~~~~l~L~~n~~~~-~~-----~~~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L  231 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-AN-----QALLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL  231 (727)
T ss_dssp             ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred             CccceEEeeCCCCCc-ch-----hhHhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence            346666666666663 22     2234555666665553              355566666 66777778888888888


Q ss_pred             ecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCCcceeeccccCccccCCccccccc
Q 045493          128 SNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLR  207 (1048)
Q Consensus       128 ~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~  207 (1048)
                      ++|.+.                                        .+|..+..+++|++|+|++|.|+ .+|..|++|+
T Consensus       232 s~n~l~----------------------------------------~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  270 (727)
T 4b8c_D          232 SNLQIF----------------------------------------NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS  270 (727)
T ss_dssp             TTSCCS----------------------------------------CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred             CCCCCC----------------------------------------CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence            877764                                        22333446778888888888887 6778888888


Q ss_pred             ccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecccccccCCCchhhhccchh-hhhhh
Q 045493          208 SLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSL-KHLHV  286 (1048)
Q Consensus       208 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L-~~L~l  286 (1048)
                      +|++|+|++|+++ .+|..++.|++|++|+|++|.|+ .+|..|+.+++|++|+|++|++++.+|..+..+... ..+++
T Consensus       271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l  348 (727)
T 4b8c_D          271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYL  348 (727)
T ss_dssp             TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhh
Confidence            8888888888888 67888888888888888888887 567778888888888888888888888777665432 34666


Q ss_pred             ccccccCCCCCcccCCCCCCcEEEccCc
Q 045493          287 HNINKLSGSIPKEIGNLKSLSHLWLSKT  314 (1048)
Q Consensus       287 ~~~n~l~~~~~~~~~~l~~L~~L~L~~n  314 (1048)
                      .+ |.+++.+|.      .|+.|+++.|
T Consensus       349 ~~-N~l~~~~p~------~l~~l~l~~n  369 (727)
T 4b8c_D          349 RD-NRPEIPLPH------ERRFIEINTD  369 (727)
T ss_dssp             HH-CCCCCCCCC------C---------
T ss_pred             cc-CcccCcCcc------ccceeEeecc
Confidence            66 677766665      4555666665

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.68  E-value=6.4e-17  Score=164.39  Aligned_cols=133  Identities=23%  Similarity=0.360  Sum_probs=88.5

Q ss_pred             CEEeecCccccCCCccccccccccceeecccCcccccccc-cccccccccccccccccccchhhhhhccccccCeEECCC
Q 045493          547 TSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPK-NLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSH  625 (1048)
Q Consensus       547 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  625 (1048)
                      +.+++++|+++ .+|..+..  +|++|++++|+|+++.+. .|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56667777665 45554432  666777777777666553 366667777777777777666666666677777777777


Q ss_pred             CcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          626 NSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       626 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      |+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|++++|+|+|.++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l  144 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence            777666666666667777777777777766666666677777777777777666553

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.68  E-value=1.1e-16  Score=170.83  Aligned_cols=136  Identities=17%  Similarity=0.165  Sum_probs=99.8

Q ss_pred             cceeeecccccccEEEEEE-cCCCc--eeeEEeccCCCCcc-----------------------cchhhHHHHHHhhccc
Q 045493          779 GKMVLHGTGGCGTVYKAEL-TSGDT--RAVKKLHSLPTGEI-----------------------GINQKGFVSEITEIRH  832 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~-~~~~~--vavk~~~~~~~~~~-----------------------~~~~~~~~~~l~~l~h  832 (1048)
                      .....||+|+||.||+|.+ .+|+.  ||||.++.......                       ......+.+.+.+++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3445789999999999988 57888  99998754321100                       0123445666677777


Q ss_pred             Cce--eeEeeEeeeCCeEEEEEEccCC-C----CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeeC
Q 045493          833 RNI--VKFYGFCSHTQHLFLVYEYLER-G----SLATILSNEATAAELDWSKRVNVIKGVANALSYMH-HDCFPPILHRD  904 (1048)
Q Consensus       833 ~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH~D  904 (1048)
                      +++  ...+++    +..++||||+.+ |    +|.++...      .++..+..++.|++.|+.||| +.   +|+|||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD  196 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD  196 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence            754  333332    346899999942 4    77776432      234567889999999999999 88   999999


Q ss_pred             CCCCCeEECCCCceEEecccccccc
Q 045493          905 ISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       905 ik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999754

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.68  E-value=1.6e-17  Score=203.82  Aligned_cols=191  Identities=24%  Similarity=0.241  Sum_probs=115.1

Q ss_pred             CCccEEeCCCCcccccccccccCCCCCC-----EeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccc
Q 045493           24 PQLAYLDLSVNQLFGTIPTQISHLSKLK-----HLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSL   98 (1048)
Q Consensus        24 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~-----~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L   98 (1048)
                      +.++.|+|.+|.+... +..+.....|.     .++++.|.+. ..|..|..+.+|+.|+|++|++.. +|..+..+++|
T Consensus       173 ~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L  249 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN-ISANIFKYDFL  249 (727)
T ss_dssp             ---------------------------------------------------CCCCCCEEECTTSCCSC-CCGGGGGCCSC
T ss_pred             CccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCCC-CChhhcCCCCC
Confidence            6789999999999853 43332222222     2333445555 568889999999999999999995 56667799999


Q ss_pred             ccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCC
Q 045493           99 NELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRS  178 (1048)
Q Consensus        99 ~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~  178 (1048)
                      ++|+|++|+++ .+|.+|++|++|+.|+|++|+|+                .+|..+++|++|+.|+|++|.++ .+|..
T Consensus       250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~----------------~lp~~~~~l~~L~~L~L~~N~l~-~lp~~  311 (727)
T 4b8c_D          250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT----------------SLPAELGSCFQLKYFYFFDNMVT-TLPWE  311 (727)
T ss_dssp             SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS----------------SCCSSGGGGTTCSEEECCSSCCC-CCCSS
T ss_pred             CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC----------------ccChhhcCCCCCCEEECCCCCCC-ccChh
Confidence            99999999999 78889999999999999999886                45667788888888888888887 55777


Q ss_pred             CCCCCCcceeeccccCccccCCcccccccc-cceeccccccccccCCccCcCCCCCCeEeccCC
Q 045493          179 LGGLKNLTFVYLNNNRIVGSIPSEIGNLRS-LSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN  241 (1048)
Q Consensus       179 ~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  241 (1048)
                      |..|++|++|+|++|.+++.+|..+..+.. +..|+|++|.+++.+|.      .|+.|+++.|
T Consensus       312 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n  369 (727)
T 4b8c_D          312 FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD  369 (727)
T ss_dssp             TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred             hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence            888888888888888888888877766543 33478888888876664      3456666666

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.66  E-value=6.5e-16  Score=175.32  Aligned_cols=240  Identities=11%  Similarity=0.120  Sum_probs=143.1

Q ss_pred             ccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecC
Q 045493          426 LTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGG  505 (1048)
Q Consensus       426 L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~  505 (1048)
                      |+.+.+..+ ++.+...+|.++ +|+.+.+.. .++.+...+|..+++|+.+++++|+++.....+|. +.+|+.+.+..
T Consensus       137 L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~  212 (401)
T 4fdw_A          137 IAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPV  212 (401)
T ss_dssp             CSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCT
T ss_pred             ccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCC
Confidence            444444333 333444445443 455555553 45555555555555555555555555544444444 35555555553


Q ss_pred             cccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccc----
Q 045493          506 NEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLS----  581 (1048)
Q Consensus       506 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~----  581 (1048)
                      + ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+. |.++.....+|.++++|+.+++.+|.+.    
T Consensus       213 ~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~  288 (401)
T 4fdw_A          213 T-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPE  288 (401)
T ss_dssp             T-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTT
T ss_pred             c-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcc
Confidence            3 44445555556666666666554 34344455555 556666663 3344344555666666666666655544    


Q ss_pred             -ccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccc
Q 045493          582 -KLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF  660 (1048)
Q Consensus       582 -~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  660 (1048)
                       .+.+.+|.++++|+.++|. |.++.+...+|.++.+|+.++|..| ++......|.++ +|+.+++++|.+....+..|
T Consensus       289 ~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F  365 (401)
T 4fdw_A          289 AMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVW  365 (401)
T ss_dssp             CEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSC
T ss_pred             cEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccc
Confidence             4556677777777777777 4477777777777777777777554 665667777777 78888888887776666677


Q ss_pred             cccC-CccEEEecccee
Q 045493          661 RRMH-GLSSIDVSYNEL  676 (1048)
Q Consensus       661 ~~l~-~L~~l~ls~N~l  676 (1048)
                      ..++ .++.|++..|.+
T Consensus       366 ~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          366 YGFPDDITVIRVPAESV  382 (401)
T ss_dssp             CCSCTTCCEEEECGGGH
T ss_pred             cCCCCCccEEEeCHHHH
Confidence            7664 567777776643

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.65  E-value=1.5e-15  Score=172.26  Aligned_cols=266  Identities=14%  Similarity=0.159  Sum_probs=204.9

Q ss_pred             cCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEE
Q 045493          351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFS  430 (1048)
Q Consensus       351 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~  430 (1048)
                      +..++.+.+.+ .++.+...+|.++ +|+.+.+.++ +..+                        ...+|.. .+|+.+.
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I------------------------~~~aF~~-~~L~~i~  163 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSI------------------------GDMAFFN-STVQEIV  163 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEE------------------------CTTTTTT-CCCCEEE
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEE------------------------CHHhcCC-CCceEEE
Confidence            46677776654 3444555667664 5777776554 3322                        2233333 2466666


Q ss_pred             eecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCc
Q 045493          431 VRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISG  510 (1048)
Q Consensus       431 l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~  510 (1048)
                      +.+ .+..+.+.+|.+|++|+.+++.+|+++.++..+|. ..+|+.+.|.++ ++.+...+|.++++|+.+.+.+| ++.
T Consensus       164 lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~  239 (401)
T 4fdw_A          164 FPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VST  239 (401)
T ss_dssp             CCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCE
T ss_pred             eCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccC
Confidence            664 56666677888888888888888888888888887 478888888744 77777888888889999998875 565


Q ss_pred             ccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCcccc-----CCCccccccccccceeecccCccccccc
Q 045493          511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLS-----GDIPLELGLLAELGYLDLSANRLSKLIP  585 (1048)
Q Consensus       511 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  585 (1048)
                      ....+|.+ .+|+.+.+. |.++.....+|.++++|+.+++.+|.+.     ...+.+|.++++|+.++|. +.++.+..
T Consensus       240 I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~  316 (401)
T 4fdw_A          240 IGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQ  316 (401)
T ss_dssp             ECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECT
T ss_pred             cccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhh
Confidence            66777877 789999994 5566677888999999999999888765     3556789999999999999 56888888


Q ss_pred             ccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCcc-ccCeEECCCCccc
Q 045493          586 KNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLE-SLEYMNLLQNKLS  653 (1048)
Q Consensus       586 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  653 (1048)
                      .+|.++.+|+.++|.+| ++.+...+|.++ +|+.+++++|.+.......|..++ +++.|++..+.+.
T Consensus       317 ~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          317 GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            99999999999999665 888888999999 999999999999877778888874 7899999888875

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.64  E-value=6.4e-16  Score=156.91  Aligned_cols=126  Identities=26%  Similarity=0.354  Sum_probs=105.2

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .++++++++    +++|...++++++|+|++|+|+ .+|..|+.+++|++|+|++|+|+++.+.+|.++++|++|+|++|
T Consensus        14 ~l~~~~~~l----~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           14 VVRCSNKGL----KVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             EEECTTSCC----SSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEcCCCCC----CcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            356666554    4666667788999999999888 66688888889999999999998887788889999999999999


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeeccccc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLS  133 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~  133 (1048)
                      +|+++.|..|.++++|++|+|++|+++...+..|..+++|+.|++++|++.
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            998888888888889999999999988777777888888999999888875

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.64  E-value=4.4e-16  Score=154.70  Aligned_cols=132  Identities=24%  Similarity=0.276  Sum_probs=67.2

Q ss_pred             CCccEEEecCcccC-cccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceee
Q 045493          496 PQLATLNMGGNEIS-GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLD  574 (1048)
Q Consensus       496 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  574 (1048)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555554 34444555555555555555555543  4455555555555555555544454455555555555


Q ss_pred             cccCccccccc-ccccccccccccccccccccchhh---hhhccccccCeEECCCCccc
Q 045493          575 LSANRLSKLIP-KNLGELRKLHHLNLSNNQFSQEIS---IQIGKLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       575 Ls~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~  629 (1048)
                      |++|+|+++.. ..+..+++|++|++++|++++..+   ..+..+++|+.||+++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            55555554421 344444444444444444444333   34444444555555554443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.63  E-value=4.4e-16  Score=154.71  Aligned_cols=132  Identities=25%  Similarity=0.238  Sum_probs=74.3

Q ss_pred             CCCcEEEcccCccc-CCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccc
Q 045493          520 TQLHKLDFSSNRLV-GQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLN  598 (1048)
Q Consensus       520 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~  598 (1048)
                      ++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|++++|++++..|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56777777777776 45566666667777777777776643  5566666666666666666665455555555555555


Q ss_pred             cccccccchhh-hhhccccccCeEECCCCcccCcCC---cCcCCccccCeEECCCCccc
Q 045493          599 LSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLGGNIP---SEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       599 Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~  653 (1048)
                      |++|+|+++.. ..+..+++|++|++++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            55555554322 344444445555555554443322   23444444444444444443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.63  E-value=8.4e-16  Score=156.04  Aligned_cols=112  Identities=28%  Similarity=0.343  Sum_probs=68.2

Q ss_pred             ccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECC
Q 045493          569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLL  648 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  648 (1048)
                      +|++|+|++|+|+.+ |..|..+++|+.|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        32 ~l~~L~L~~n~i~~i-p~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCCSC-CGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCchh-HHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            444455555554433 3445555555555555555555555555566666666666666666666666666777777777


Q ss_pred             CCcccCCccccccccCCccEEEeccceecCCCC
Q 045493          649 QNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       649 ~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      +|+|+...+..|..++.|+.|++++|+|.+.+.
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            777766666666677777777777777766543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.7e-15  Score=151.85  Aligned_cols=130  Identities=26%  Similarity=0.307  Sum_probs=110.2

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .+++++++    ++++|...++++++|++++|++++..+..|+.+++|++|+|++|+++++.+..|+.+++|++|+|++|
T Consensus        11 ~l~~~~~~----l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           11 EIRCNSKG----LTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             EEECCSSC----CSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEecCCC----CccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            46666665    45677777889999999999999777788899999999999999999777777899999999999999


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCcc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQI  136 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~  136 (1048)
                      +++++.+..|..+++|++|++++|++++..+..|..+++|++|++++|++.+..
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            999887778889999999999999999777777888999999999999887543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=9.9e-16  Score=153.57  Aligned_cols=133  Identities=26%  Similarity=0.300  Sum_probs=88.2

Q ss_pred             CEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCC
Q 045493          547 TSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHN  626 (1048)
Q Consensus       547 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  626 (1048)
                      +.+++++|+++ .+|..+  .++|++|++++|+++++.+..|..+++|++|++++|+|+++.+..+..+++|++|+|++|
T Consensus        10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            44555555555 233222  245566666666666555555566666666666666666655556667777777777777


Q ss_pred             cccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCC
Q 045493          627 SLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPH  682 (1048)
Q Consensus       627 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~  682 (1048)
                      +|++..+..+..+++|++|++++|+|++..+..+..++.|++|++++|+++|.+|.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            77766666677777888888888888766666677778888888888888777664

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=8.5e-16  Score=149.23  Aligned_cols=127  Identities=24%  Similarity=0.280  Sum_probs=60.1

Q ss_pred             CCccEEEecCcccC-cccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceee
Q 045493          496 PQLATLNMGGNEIS-GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLD  574 (1048)
Q Consensus       496 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  574 (1048)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34445555555544 34444445555555555555555433  4444555555555555555543444444455555555


Q ss_pred             cccCcccccc-cccccccccccccccccccccchhh---hhhccccccCeEECC
Q 045493          575 LSANRLSKLI-PKNLGELRKLHHLNLSNNQFSQEIS---IQIGKLVQLSKLDLS  624 (1048)
Q Consensus       575 Ls~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls  624 (1048)
                      +++|+++++. +..+..+++|++|++++|++++..+   ..+..+++|+.||++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            5555554431 2344444444444444444444333   334444444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.60  E-value=1.1e-15  Score=148.55  Aligned_cols=128  Identities=24%  Similarity=0.236  Sum_probs=75.5

Q ss_pred             cCCCcEEEcccCccc-CCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccc
Q 045493          519 MTQLHKLDFSSNRLV-GQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHL  597 (1048)
Q Consensus       519 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  597 (1048)
                      .++|+.|++++|+++ +.+|..+..+++|++|++++|.+++.  ..++.+++|++|++++|++++..|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            356777777777776 55666667777777777777777644  556666666666666666666555555555566666


Q ss_pred             ccccccccchh-hhhhccccccCeEECCCCcccCcCC---cCcCCccccCeEECC
Q 045493          598 NLSNNQFSQEI-SIQIGKLVQLSKLDLSHNSLGGNIP---SEICNLESLEYMNLL  648 (1048)
Q Consensus       598 ~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~  648 (1048)
                      ++++|+|++.. +..++.+++|++|++++|++++..+   ..+..+++|++|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            66666555532 2444555555555555555553333   234444445544443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.60  E-value=1.7e-14  Score=164.66  Aligned_cols=238  Identities=13%  Similarity=0.097  Sum_probs=157.8

Q ss_pred             cccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCC
Q 045493          418 QNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQ  497 (1048)
Q Consensus       418 ~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~  497 (1048)
                      ..|..+.+|+.+.+.++ +..+....|.++.+|+.+.+..+ ++.+...+|.....|+.+.+..+...  +...+.....
T Consensus       156 ~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~  231 (394)
T 4fs7_A          156 EAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTG  231 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCC
T ss_pred             hhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCC
Confidence            45566667777777544 33355567777888888877765 66677777777777887777665432  2233344567


Q ss_pred             ccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeeccc
Q 045493          498 LATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA  577 (1048)
Q Consensus       498 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  577 (1048)
                      |+.+.+..+ ++.....+|..+..|+.+.+..+... .....|..+..++.+....+.+.   ...|..+.+|+.+.+..
T Consensus       232 l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~  306 (394)
T 4fs7_A          232 VKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLD  306 (394)
T ss_dssp             CCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECT
T ss_pred             CceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccccc
Confidence            777777643 33355566777788888888776544 55667777777877777666543   24567777777777765


Q ss_pred             CcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcc
Q 045493          578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       578 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      + ++.+...+|.++.+|+.+++.++ ++.++..+|.++.+|+.+++..| ++.....+|.++++|+.+++..+ ++ .+.
T Consensus       307 ~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~  381 (394)
T 4fs7_A          307 S-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYR  381 (394)
T ss_dssp             T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGG
T ss_pred             c-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehh
Confidence            4 66666677777777777777644 66677777777777777777766 66566677777777777777544 33 234


Q ss_pred             ccccccCCccEE
Q 045493          658 SCFRRMHGLSSI  669 (1048)
Q Consensus       658 ~~~~~l~~L~~l  669 (1048)
                      .+|...++|+++
T Consensus       382 ~~F~~c~~L~~I  393 (394)
T 4fs7_A          382 YDFEDTTKFKWI  393 (394)
T ss_dssp             GGBCTTCEEEEE
T ss_pred             heecCCCCCcEE
Confidence            456666666553

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.60  E-value=1.3e-14  Score=165.58  Aligned_cols=335  Identities=11%  Similarity=0.055  Sum_probs=189.2

Q ss_pred             cccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcc
Q 045493          171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK  250 (1048)
Q Consensus       171 ~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  250 (1048)
                      ++.+...+|.++++|+.+.+..+ ++.+-..+|.++++|+.++|..+ +.......|.++.+|+.+.+..+ ++......
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            44555667777777877777643 55566677777777777777654 44344556777777777666544 33234445


Q ss_pred             cccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccccccccccccc
Q 045493          251 LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNI  330 (1048)
Q Consensus       251 ~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  330 (1048)
                      |.+...++.........  +...+|.++++|+.+.+.+  .+.......|.++.+|+.+.+..+ ++.+....|.++..|
T Consensus       136 F~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~--~~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          136 FKGCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPD--SMETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCT--TCCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eecccccccccCccccc--cchhhhcccCCCcEEecCC--ccceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            55554333332222211  2233444444444444431  112122333444444444444433 222333344444444


Q ss_pred             ceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcccceeecccc
Q 045493          331 RGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN  410 (1048)
Q Consensus       331 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N  410 (1048)
                      +.+.+..+...  +.+.....                        ++|+.+.+..+. .......+..+..++.+.+..+
T Consensus       211 ~~i~~~~~~~~--i~~~~~~~------------------------~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          211 ENMEFPNSLYY--LGDFALSK------------------------TGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             CBCCCCTTCCE--ECTTTTTT------------------------CCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCT
T ss_pred             ceeecCCCceE--eehhhccc------------------------CCCceEEECCCc-eecccccccccccceeEEcCCC
Confidence            44444333221  11222223                        344444443221 1122233444444444444433


Q ss_pred             ccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccc
Q 045493          411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISS  490 (1048)
Q Consensus       411 ~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~  490 (1048)
                      ... .....+..+..++.+....+.+   ....|..+.+|+.+.+..+ ++.+...+|..+.+|+.+++.++ ++.+...
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~  337 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKR  337 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTT
T ss_pred             cce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHH
Confidence            221 3334455556666666655433   2356777888888888654 77778888888888888888644 6667778


Q ss_pred             cccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEE
Q 045493          491 NWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSL  549 (1048)
Q Consensus       491 ~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  549 (1048)
                      +|.+|.+|+.+.+..| ++.....+|.++++|+.+++..+ +. .+..+|.++++|+.+
T Consensus       338 aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          338 SFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             hccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            8888888998888776 66677778888999999988765 33 335678888888765

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=8.9e-17  Score=164.42  Aligned_cols=111  Identities=24%  Similarity=0.284  Sum_probs=58.5

Q ss_pred             cccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccc
Q 045493          515 EIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKL  594 (1048)
Q Consensus       515 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  594 (1048)
                      .+..+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+..+++|++|++++|+|+++ | .+..+++|
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~-~~~~l~~L  117 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-H-HHHHHHHS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-C-ccccCCCC
Confidence            55555556666666665554 33 5555555666666666555 3444445555555555555555553 2 34555555


Q ss_pred             cccccccccccchhh-hhhccccccCeEECCCCcccC
Q 045493          595 HHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       595 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                      ++|++++|+|++... ..+..+++|++|++++|.+++
T Consensus       118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~  154 (198)
T 1ds9_A          118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred             CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence            555555555554332 344445555555555555443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=9.6e-17  Score=164.20  Aligned_cols=157  Identities=24%  Similarity=0.269  Sum_probs=131.2

Q ss_pred             ccccCCCcEEEcccCcccCCcCc------cccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccc
Q 045493          516 IGNMTQLHKLDFSSNRLVGQIPK------QLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLG  589 (1048)
Q Consensus       516 ~~~l~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  589 (1048)
                      +.....++.++++.|.+.+..|.      .+..+++|++|+|++|.+++ +| .+..+++|++|++++|+|+.+ |..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l-~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKI-ENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSC-SSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccc-cchhh
Confidence            34455666667777776666555      89999999999999999996 66 899999999999999999975 67788


Q ss_pred             ccccccccccccccccchhhhhhccccccCeEECCCCcccCcCC-cCcCCccccCeEECCCCcccCCcccc---------
Q 045493          590 ELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIP-SEICNLESLEYMNLLQNKLSGPIPSC---------  659 (1048)
Q Consensus       590 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~---------  659 (1048)
                      .+++|++|++++|+|+++.  .+..+++|++|++++|++++..+ ..+..+++|++|++++|++++.+|..         
T Consensus        91 ~~~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           91 VADTLEELWISYNQIASLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHHCSEEEEEEEECCCHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCcCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            8899999999999999864  68899999999999999985433 47889999999999999998776653         


Q ss_pred             -ccccCCccEEEeccceecCC
Q 045493          660 -FRRMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       660 -~~~l~~L~~l~ls~N~l~~~  679 (1048)
                       +..++.|+.||  +|+++..
T Consensus       169 ~~~~l~~L~~Ld--~~~i~~~  187 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVDVD  187 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGTTT
T ss_pred             HHHhCCCcEEEC--CcccCHH
Confidence             78899999987  7777543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.55  E-value=1.9e-15  Score=166.66  Aligned_cols=146  Identities=8%  Similarity=0.022  Sum_probs=97.1

Q ss_pred             hhcccCCcceeeecccccccEEEEEEcCCCceeeEEeccCCCC------ccc----c---hhhHHHHHHhhcccCceeeE
Q 045493          772 LSASTFEGKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTG------EIG----I---NQKGFVSEITEIRHRNIVKF  838 (1048)
Q Consensus       772 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~------~~~----~---~~~~~~~~l~~l~h~niv~~  838 (1048)
                      ......+.-...||+|+||.||+|...+|+.||||.++.....      ...    .   ......+......|+|++++
T Consensus        91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            3344445556679999999999999999999999987542111      000    0   00111111112234444444


Q ss_pred             eeEeee------CCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEE
Q 045493          839 YGFCSH------TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLL  912 (1048)
Q Consensus       839 ~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll  912 (1048)
                      +.....      ....++||||++|+++.++..         ......++.|++.|+.|||+.   |||||||||.|||+
T Consensus       171 ~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl  238 (397)
T 4gyi_A          171 YEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILI  238 (397)
T ss_dssp             HHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             HhcCCCCCeeeeccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence            322110      112379999999988865431         123457889999999999998   99999999999999


Q ss_pred             CCCC----------ceEEecccccccc
Q 045493          913 DLEY----------KAHVSDFGTAKFL  929 (1048)
Q Consensus       913 ~~~~----------~~kl~DfG~a~~~  929 (1048)
                      +++|          .+.|+||+-+...
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             eCCCCcccccccccceEEEEeCCcccC
Confidence            8876          3899999988654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.55  E-value=3.9e-15  Score=148.95  Aligned_cols=107  Identities=24%  Similarity=0.341  Sum_probs=60.1

Q ss_pred             ccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCc--CcCCccccCeEE
Q 045493          569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPS--EICNLESLEYMN  646 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~  646 (1048)
                      +|++|++++|+|+++  ..|..+++|++|+|++|+|+++.+..+..+++|++|+|++|+|+ .+|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            444444444444443  34444555555555555555444444455566666666666664 3333  556666677777


Q ss_pred             CCCCcccCCccc---cccccCCccEEEeccceecC
Q 045493          647 LLQNKLSGPIPS---CFRRMHGLSSIDVSYNELQG  678 (1048)
Q Consensus       647 L~~N~l~~~~~~---~~~~l~~L~~l~ls~N~l~~  678 (1048)
                      +++|+++...+.   .+..++.|++||+++|....
T Consensus       120 l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A          120 ILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             ecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            777776633222   36677777777777776543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=9.6e-15  Score=146.10  Aligned_cols=85  Identities=22%  Similarity=0.227  Sum_probs=33.8

Q ss_pred             ccccceeecccCcccccccccccccccccccccccccccchhh-hhhccccccCeEECCCCcccCcCCcC----cCCccc
Q 045493          567 LAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLGGNIPSE----ICNLES  641 (1048)
Q Consensus       567 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~  641 (1048)
                      +++|++|+|++|+|+++++..|..+++|++|+|++|+|+.... ..+..+++|+.|++++|.++ .+|..    +..+++
T Consensus        63 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~  141 (176)
T 1a9n_A           63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQ  141 (176)
T ss_dssp             CSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTT
T ss_pred             CCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCc
Confidence            3333333333333333322333333444444444444433221 13334444444444444444 22221    444444


Q ss_pred             cCeEECCCCcc
Q 045493          642 LEYMNLLQNKL  652 (1048)
Q Consensus       642 L~~L~L~~N~l  652 (1048)
                      |++|++++|.+
T Consensus       142 L~~Ld~~~n~~  152 (176)
T 1a9n_A          142 VRVLDFQKVKL  152 (176)
T ss_dssp             CSEETTEECCH
T ss_pred             cceeCCCcCCH
Confidence            44454444444

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=9.7e-14  Score=137.62  Aligned_cols=106  Identities=30%  Similarity=0.337  Sum_probs=89.3

Q ss_pred             ccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccc
Q 045493           26 LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSY  105 (1048)
Q Consensus        26 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~  105 (1048)
                      .+++|+++|+++ .+|..+.  ++|++|+|++|+|+++.|..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            468889999888 4565553  7888999999999888788888999999999999999988777888889999999999


Q ss_pred             eecccccCcCcCCcCCCceEEeecccccC
Q 045493          106 NRLNGSIPASLGNLSNLVQLSLSNNSLSG  134 (1048)
Q Consensus       106 n~~~~~~~~~~~~L~~L~~L~l~~n~l~~  134 (1048)
                      |++++..+..|..+++|+.|+|++|++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            99987777788889999999999998763

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.45  E-value=2.1e-13  Score=135.69  Aligned_cols=105  Identities=25%  Similarity=0.342  Sum_probs=88.0

Q ss_pred             ccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccccc
Q 045493           26 LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSY  105 (1048)
Q Consensus        26 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~  105 (1048)
                      -+.+++++|+++ .+|..+.  ++|++|+|++|+|+++.|..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            368888888887 5565554  7888999999999888788888999999999999999887777788888999999999


Q ss_pred             eecccccCcCcCCcCCCceEEeeccccc
Q 045493          106 NRLNGSIPASLGNLSNLVQLSLSNNSLS  133 (1048)
Q Consensus       106 n~~~~~~~~~~~~L~~L~~L~l~~n~l~  133 (1048)
                      |++++..+..|..+++|+.|+|++|++.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcc
Confidence            9988766667888999999999998876

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.42  E-value=4.1e-13  Score=133.11  Aligned_cols=106  Identities=25%  Similarity=0.301  Sum_probs=96.5

Q ss_pred             EEEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCC
Q 045493            2 VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV   81 (1048)
Q Consensus         2 ~~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~   81 (1048)
                      +.++++++++    +++|...++++++|+|++|+|++..|..|+.+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus        12 ~~l~~s~n~l----~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           12 TTVDCSGKSL----ASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TEEECTTSCC----SSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCc----CccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            3577887765    557777789999999999999999999999999999999999999988888899999999999999


Q ss_pred             CcCCCCCccccccccccccccccceecccc
Q 045493           82 NQLNGLIPEELGELTSLNELALSYNRLNGS  111 (1048)
Q Consensus        82 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~  111 (1048)
                      |+|+++.+..|..+++|++|+|++|.++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            999998888899999999999999999843

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.41  E-value=3.6e-13  Score=133.93  Aligned_cols=112  Identities=24%  Similarity=0.242  Sum_probs=97.9

Q ss_pred             EEEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCC
Q 045493            2 VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV   81 (1048)
Q Consensus         2 ~~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~   81 (1048)
                      +.++++++++    +++|...++++++|+|++|+|++..|..|+.+++|++|+|++|+|+++.+..|+.+++|++|+|++
T Consensus        15 ~~l~~~~n~l----~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRL----ASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCC----SSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCC----CccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            3577777776    567777789999999999999999999999999999999999999987777789999999999999


Q ss_pred             CcCCCCCccccccccccccccccceecccccCcCcCC
Q 045493           82 NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGN  118 (1048)
Q Consensus        82 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  118 (1048)
                      |+|+++.+..|..+++|++|+|++|.+.. .+..+..
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~~~~~  126 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECRDIMY  126 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCT-TBGGGHH
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccc-ccccHHH
Confidence            99998877789999999999999999983 4433433

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.41  E-value=7e-15  Score=165.14  Aligned_cols=171  Identities=20%  Similarity=0.207  Sum_probs=80.1

Q ss_pred             CCCCeeeCcCCcccCcccccccC-----CCCccEEEecCcccCcccCcccc-ccCCCcEEEcccCcccCCcCcccc----
Q 045493          472 PDLELLDLSNNNFFGEISSNWIK-----CPQLATLNMGGNEISGTIPSEIG-NMTQLHKLDFSSNRLVGQIPKQLG----  541 (1048)
Q Consensus       472 ~~L~~L~Ls~n~l~~~~~~~~~~-----~~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~----  541 (1048)
                      +.|+.|+|++|.++......+..     .++|++|+|++|.|++.....+. .+++|+.|+|++|+|++.....+.    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            45677777777766543332222     24666666666666543333222 244555666666555433222221    


Q ss_pred             -CCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchh----hhhhcccc
Q 045493          542 -KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEI----SIQIGKLV  616 (1048)
Q Consensus       542 -~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~  616 (1048)
                       ..++|++|+|++|.|+......                    .+..+..+++|++|+|++|+|++.+    ...+...+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~--------------------l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~  211 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAV--------------------LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR  211 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHH--------------------HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred             hcCCccceeeCCCCCCChHHHHH--------------------HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence             2344455555555444211111                    1122233444555555555554433    22233445


Q ss_pred             ccCeEECCCCcccCcCC----cCcCCccccCeEECCCCcccCCccccccc
Q 045493          617 QLSKLDLSHNSLGGNIP----SEICNLESLEYMNLLQNKLSGPIPSCFRR  662 (1048)
Q Consensus       617 ~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  662 (1048)
                      +|++|||++|.|++...    ..+...++|++|+|++|+|+......+..
T Consensus       212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~  261 (372)
T 3un9_A          212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRD  261 (372)
T ss_dssp             CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred             CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence            55555555555553222    22223455666666666665544444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.41  E-value=7.1e-15  Score=165.09  Aligned_cols=136  Identities=19%  Similarity=0.168  Sum_probs=95.3

Q ss_pred             ccccceeEecCCccccCcccccCC-----CCCCCeeeCcCCcccCccccccc-CCCCccEEEecCcccCcccCcccc---
Q 045493          447 CTSLYSLRLERNQLTGNISEVFGI-----YPDLELLDLSNNNFFGEISSNWI-KCPQLATLNMGGNEISGTIPSEIG---  517 (1048)
Q Consensus       447 l~~L~~L~L~~n~l~~~~~~~~~~-----~~~L~~L~Ls~n~l~~~~~~~~~-~~~~L~~L~L~~N~i~~~~~~~~~---  517 (1048)
                      +++|++|+|++|.++......+..     .++|+.|+|++|.++......+. .+++|++|+|++|.|++.....++   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            467999999999998665544432     26999999999999765444443 467899999999999866555553   


Q ss_pred             --ccCCCcEEEcccCcccCC----cCccccCCCccCEEeecCccccCCC----ccccccccccceeecccCcccc
Q 045493          518 --NMTQLHKLDFSSNRLVGQ----IPKQLGKLTSLTSLTLNGNQLSGDI----PLELGLLAELGYLDLSANRLSK  582 (1048)
Q Consensus       518 --~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~  582 (1048)
                        ..++|++|+|++|.|++.    ++..+..+++|++|+|++|.|++..    +..+...++|++|+|++|.|+.
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence              468899999999999753    3334466777888888888876322    2333444445555555555443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=9.5e-12  Score=141.79  Aligned_cols=134  Identities=7%  Similarity=0.124  Sum_probs=66.7

Q ss_pred             cCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccc
Q 045493          512 IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGEL  591 (1048)
Q Consensus       512 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l  591 (1048)
                      ...+|.++..|+.+.+.++... ....+|.++++|+.+.+. +.++.....+|.++.+|+.++|..+ ++.+...+|.++
T Consensus       257 ~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C  333 (394)
T 4gt6_A          257 ETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC  333 (394)
T ss_dssp             CTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred             ccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence            3344555555555555444332 444455555555555554 2333333445555556666665533 555555566666


Q ss_pred             ccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcc
Q 045493          592 RKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL  652 (1048)
Q Consensus       592 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  652 (1048)
                      .+|+.+.+..+ ++.++..+|.++.+|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       334 ~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          334 EQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             CCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            66666666433 555566666666666666666665431   3445556666666655544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=7.4e-12  Score=142.70  Aligned_cols=308  Identities=12%  Similarity=0.132  Sum_probs=174.4

Q ss_pred             CCeEeccCCccccCcChhhhccCCCcEEEeeccc---ccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEE
Q 045493          354 LSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE---LSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFS  430 (1048)
Q Consensus       354 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~  430 (1048)
                      |+.+.+-.+ ++.+...+|.++++|+.+.+.+|.   ++.+-...|..+..|+.+.+..+ ++......+..+.+|+.+.
T Consensus        66 L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~  143 (394)
T 4gt6_A           66 LTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT  143 (394)
T ss_dssp             CCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred             CEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence            444444322 333334455555555555555442   22222344555555555544432 3333444566667777777


Q ss_pred             eecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCc
Q 045493          431 VRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISG  510 (1048)
Q Consensus       431 l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~  510 (1048)
                      +..+ +..+....|..+.+|+.+.+..+ ++.+...+|.. ..|+.+.+..+ +......+|..+..+.......+....
T Consensus       144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~-~~~i~~~af~~c~~l~~~~~~~~~~~~  219 (394)
T 4gt6_A          144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAK-VTRIGTNAFSECFALSTITSDSESYPA  219 (394)
T ss_dssp             CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTT-CCEECTTTTTTCTTCCEEEECCSSSCB
T ss_pred             ccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCc-ccccccchhhhccccceeccccccccc
Confidence            7543 34455567777778887777654 56666667754 46777777654 333556677777777777766555442


Q ss_pred             ccCcccc-------------ccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeeccc
Q 045493          511 TIPSEIG-------------NMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSA  577 (1048)
Q Consensus       511 ~~~~~~~-------------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  577 (1048)
                      .....+.             ....+..+.+.. .++.....+|.++.+|+.+.+..+..+ ....+|.++.+|+.+.+. 
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-  296 (394)
T 4gt6_A          220 IDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-  296 (394)
T ss_dssp             SSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-
T ss_pred             ccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-
Confidence            1111111             112233333332 233344566777777777777665443 455667777777777775 


Q ss_pred             CcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcc
Q 045493          578 NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIP  657 (1048)
Q Consensus       578 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  657 (1048)
                      +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.....+|.++++|+.+++.+|....   
T Consensus       297 ~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---  371 (394)
T 4gt6_A          297 SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---  371 (394)
T ss_dssp             TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---
T ss_pred             CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---
Confidence            4566666677777777777777654 66666777777777777777544 555556677777777777777765531   


Q ss_pred             ccccccCCccEEEeccce
Q 045493          658 SCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       658 ~~~~~l~~L~~l~ls~N~  675 (1048)
                      ..+.....|+.+.+..|.
T Consensus       372 ~~~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          372 NAISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             HTCBCCCCC---------
T ss_pred             hhhhccCCCCEEEeCCCC
Confidence            344555666666665554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.21  E-value=1.3e-11  Score=138.15  Aligned_cols=104  Identities=22%  Similarity=0.237  Sum_probs=90.3

Q ss_pred             cEEeCCCC-cccccccccccCCCCCCEeeCCC-CccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           27 AYLDLSVN-QLFGTIPTQISHLSKLKHLDFST-NQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        27 ~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      ..++++++ +|+ .+|. |+.+++|++|+|++ |+|+++.|.+|+++++|++|+|++|+|+++.|..|.++++|++|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688888 888 4666 99999999999996 99998877889999999999999999999888889999999999999


Q ss_pred             ceecccccCcCcCCcCCCceEEeeccccc
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLS  133 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~  133 (1048)
                      +|+++++.+..|..++ |+.|+|++|++.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            9999977777777776 999999999875

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.19  E-value=1.7e-11  Score=137.29  Aligned_cols=104  Identities=22%  Similarity=0.202  Sum_probs=64.3

Q ss_pred             EEeecCc-cccCCCccccccccccceeeccc-CcccccccccccccccccccccccccccchhhhhhccccccCeEECCC
Q 045493          548 SLTLNGN-QLSGDIPLELGLLAELGYLDLSA-NRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSH  625 (1048)
Q Consensus       548 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  625 (1048)
                      .++++++ +++ .+|. +..+++|++|+|++ |+|+++.+..|.++++|+.|+|++|+|+++.+..|..+++|+.|||++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3455555 565 3455 66666666666664 666666556666666666666666666666666666666666666666


Q ss_pred             CcccCcCCcCcCCccccCeEECCCCcccC
Q 045493          626 NSLGGNIPSEICNLESLEYMNLLQNKLSG  654 (1048)
Q Consensus       626 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  654 (1048)
                      |+|++..+..|..++ |+.|+|.+|+|..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            666655555555444 6666666666653

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.14  E-value=8.8e-10  Score=124.87  Aligned_cols=148  Identities=11%  Similarity=0.078  Sum_probs=86.0

Q ss_pred             CcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccC
Q 045493          463 NISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGK  542 (1048)
Q Consensus       463 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  542 (1048)
                      +....|....+|+.+.+..+ +......+|..+..|+.+.+..+ ++.....+|.++.+|+.+.+..+ +......+|.+
T Consensus       208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~  284 (379)
T 4h09_A          208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG  284 (379)
T ss_dssp             ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred             Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccc
Confidence            33444455555555555433 33344455566666666666554 44444556666666666666543 33344556666


Q ss_pred             CCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccc
Q 045493          543 LTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKL  615 (1048)
Q Consensus       543 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  615 (1048)
                      +++|+.+.+.++.++.....+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.++..+|.+.
T Consensus       285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            666666666666665444556666666666666543 55555666777777777766544 556666666554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.10  E-value=2e-09  Score=121.97  Aligned_cols=303  Identities=11%  Similarity=0.067  Sum_probs=141.9

Q ss_pred             cccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcEEEeecccccCCchhhhhhhcc
Q 045493          322 PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKK  401 (1048)
Q Consensus       322 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  401 (1048)
                      +++....+|+.+.+... ++.+...+|.++.+|+.++|..+ ++.+...+|.++ +|+.+.+-.+ +.......|.. .+
T Consensus        40 ~~~~~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~  114 (379)
T 4h09_A           40 PWYKDRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD  114 (379)
T ss_dssp             TTGGGGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred             cccccccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence            34555566666666543 34445556666677777766543 443445556655 4555554332 22111222222 23


Q ss_pred             cceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcC
Q 045493          402 LNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN  481 (1048)
Q Consensus       402 L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~  481 (1048)
                      |                        +.+.+..+ ++......|.++ +++.+.+.. .++.+...+|.....++.+.+..
T Consensus       115 L------------------------~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~  167 (379)
T 4h09_A          115 L------------------------DDFEFPGA-TTEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSS  167 (379)
T ss_dssp             C------------------------SEEECCTT-CCEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECT
T ss_pred             c------------------------ccccCCCc-cccccccccccc-eeeeeeccc-eeeccccchhccccccccccccc
Confidence            4                        44444332 121222333332 333333322 23334444444444444444433


Q ss_pred             CcccC------------cccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEE
Q 045493          482 NNFFG------------EISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSL  549 (1048)
Q Consensus       482 n~l~~------------~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  549 (1048)
                      +....            .....+..+..+..+.+..+.- ......+.....|+.+.+..+ +......+|.++.+|+.+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i  245 (379)
T 4h09_A          168 NNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEI  245 (379)
T ss_dssp             TCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEE
T ss_pred             ccceeecccceecccccceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEE
Confidence            22211            1111222333444444333222 133344455555565555444 222444455555666666


Q ss_pred             eecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCccc
Q 045493          550 TLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       550 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  629 (1048)
                      .+..+ ++.....+|..+.+|+.+.+.. .++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.++|..+ ++
T Consensus       246 ~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~  322 (379)
T 4h09_A          246 AIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK  322 (379)
T ss_dssp             EECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred             EcCCC-ccEeCccccceeehhccccccc-cceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence            66544 3333344555555566555543 244444455555666666666555555555556666666666666543 44


Q ss_pred             CcCCcCcCCccccCeEECCCCcccCCccccccc
Q 045493          630 GNIPSEICNLESLEYMNLLQNKLSGPIPSCFRR  662 (1048)
Q Consensus       630 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  662 (1048)
                      .....+|.++.+|+.+.+..+ ++.+...+|..
T Consensus       323 ~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~  354 (379)
T 4h09_A          323 TIQVYAFKNCKALSTISYPKS-ITLIESGAFEG  354 (379)
T ss_dssp             EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred             EEHHHHhhCCCCCCEEEECCc-cCEEchhHhhC
Confidence            444555666666666655433 44344444433

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.01  E-value=2.7e-10  Score=126.48  Aligned_cols=84  Identities=13%  Similarity=0.218  Sum_probs=38.1

Q ss_pred             ccccceeecccCccccccccccc---ccccccccccccccccchhhhhh----ccccccCeEECCCCcccCcCCcCcCCc
Q 045493          567 LAELGYLDLSANRLSKLIPKNLG---ELRKLHHLNLSNNQFSQEISIQI----GKLVQLSKLDLSHNSLGGNIPSEICNL  639 (1048)
Q Consensus       567 l~~L~~L~Ls~N~l~~~~~~~l~---~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l  639 (1048)
                      +++|++|+|++|.++...+..+.   .+++|++|+|+.|.|++.+...+    ..+++|+.|+|++|.|++.....+...
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a  330 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS  330 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence            34455555555554432222221   24555555555555555433222    234556666666665554333322220


Q ss_pred             cccCeEECCCCc
Q 045493          640 ESLEYMNLLQNK  651 (1048)
Q Consensus       640 ~~L~~L~L~~N~  651 (1048)
                      - ...++++.|+
T Consensus       331 l-g~~~~~~~~~  341 (362)
T 2ra8_A          331 L-PMKIDVSDSQ  341 (362)
T ss_dssp             C-CSEEECCSBC
T ss_pred             c-CCEEEecCCc
Confidence            0 2445555555

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.00  E-value=1.7e-10  Score=128.17  Aligned_cols=156  Identities=20%  Similarity=0.220  Sum_probs=101.9

Q ss_pred             ccccccCCCcEEEcccCc-ccCCcCccccCCCccCEEeecCccccCCCccccc--cccccceeeccc--Ccc------cc
Q 045493          514 SEIGNMTQLHKLDFSSNR-LVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELG--LLAELGYLDLSA--NRL------SK  582 (1048)
Q Consensus       514 ~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l------~~  582 (1048)
                      ..+..+|+|+.|+|++|. +.  .+. +. +++|++|+|..|.++......+.  .+++|+.|+|+.  |..      ..
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~  241 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV  241 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred             HHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence            344556777777777662 21  122 32 66777777777776633333333  567777777753  221      11


Q ss_pred             cccccc--cccccccccccccccccchhhhhhc---cccccCeEECCCCcccCcC----CcCcCCccccCeEECCCCccc
Q 045493          583 LIPKNL--GELRKLHHLNLSNNQFSQEISIQIG---KLVQLSKLDLSHNSLGGNI----PSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       583 ~~~~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                      + ...+  ..+++|++|+|++|.+++.....+.   .+++|++|||+.|.|++..    +..+..+++|+.|+|++|.|+
T Consensus       242 l-~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          242 F-RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             T-GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             H-HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            1 1122  2478999999999999876554443   5789999999999998743    333456799999999999998


Q ss_pred             CCccccccccCCccEEEeccce
Q 045493          654 GPIPSCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       654 ~~~~~~~~~l~~L~~l~ls~N~  675 (1048)
                      ......+...- ...+++++|+
T Consensus       321 d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          321 DEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHHHC-CSEEECCSBC
T ss_pred             HHHHHHHHHHc-CCEEEecCCc
Confidence            66666565411 3568888886

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.98  E-value=1.8e-09  Score=115.50  Aligned_cols=135  Identities=13%  Similarity=0.038  Sum_probs=100.1

Q ss_pred             eecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          783 LHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       783 ~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      ..|.|+.+.||++... ++.+++|......... ......|.+.++.+. +..+.++++++.+.+..|+||||++|.++.
T Consensus        21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   98 (263)
T 3tm0_A           21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS   98 (263)
T ss_dssp             CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred             eccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence            3577788899999765 6889999886532111 123455556666553 667888999998888999999999999998


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDC---------------------------------------------  896 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------  896 (1048)
                      +.+.        +......++.+++++++.||+..                                             
T Consensus        99 ~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A           99 EEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             HHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             hccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            7631        11233578899999999999810                                             


Q ss_pred             -----------CCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          897 -----------FPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       897 -----------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                                 .+.++|||++|.||+++.++.+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                       0358999999999999876556799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.88  E-value=4.2e-09  Score=112.46  Aligned_cols=129  Identities=12%  Similarity=0.046  Sum_probs=92.5

Q ss_pred             ec-ccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCc--eeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HG-TGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN--IVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG-~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ++ .|..+.||++...+|+.+++|......    ......+...++.+.+.+  +.+++++....+..++||||++|.++
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            44 556699999987777889999875431    123445556666665434  55688888887889999999999887


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC--------------------------------------------  896 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------  896 (1048)
                      .  ...      .+   ...++.++++.+..||+..                                            
T Consensus       103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence            4  211      11   2356777888888888642                                            


Q ss_pred             -----------CCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          897 -----------FPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       897 -----------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                                 .+.++|||++|.||+++.++.+.|+|||.+.
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       0139999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.83  E-value=9.6e-09  Score=115.27  Aligned_cols=142  Identities=13%  Similarity=0.192  Sum_probs=101.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEec--cCCCCcccchhhHHHHHHhhcc--cCceeeEeeEeeeC---CeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEITEIR--HRNIVKFYGFCSHT---QHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~--~~~~~~~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e  853 (1048)
                      ...++.|.++.||+.... +..+++|+..  .............+.+.++.+.  +..+.++++++.+.   +..|+|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            445799999999999876 4678888775  3221112234455666666665  45678888888766   45899999


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC-------------------------------------  896 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  896 (1048)
                      |++|..+.+.     ....++...+..++.+++++|+.||+..                                     
T Consensus       122 ~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999776431     1223667788899999999999999731                                     


Q ss_pred             ------------------CCCeEeeCCCCCCeEECCCCc--eEEeccccccc
Q 045493          897 ------------------FPPILHRDISSKKVLLDLEYK--AHVSDFGTAKF  928 (1048)
Q Consensus       897 ------------------~~~iiH~Dik~~NIll~~~~~--~kl~DfG~a~~  928 (1048)
                                        .+.++|||+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              147999999999999997753  68999998874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.66  E-value=3.6e-09  Score=105.99  Aligned_cols=70  Identities=16%  Similarity=0.129  Sum_probs=33.9

Q ss_pred             ccccCCCccCEEeecCc-cccCC----CccccccccccceeecccCccccccc----ccccccccccccccccccccch
Q 045493          538 KQLGKLTSLTSLTLNGN-QLSGD----IPLELGLLAELGYLDLSANRLSKLIP----KNLGELRKLHHLNLSNNQFSQE  607 (1048)
Q Consensus       538 ~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~  607 (1048)
                      ..+...++|++|+|++| .++..    +...+...++|++|+|++|+|+....    ..+...++|++|+|++|.|++.
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            34455566666666666 66522    22333444555555555555543221    2222334455555555555443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.62  E-value=4.7e-09  Score=105.14  Aligned_cols=116  Identities=16%  Similarity=0.192  Sum_probs=62.0

Q ss_pred             ccccccCCCcEEEcccC-cccCC----cCccccCCCccCEEeecCccccCC----CccccccccccceeecccCcccccc
Q 045493          514 SEIGNMTQLHKLDFSSN-RLVGQ----IPKQLGKLTSLTSLTLNGNQLSGD----IPLELGLLAELGYLDLSANRLSKLI  584 (1048)
Q Consensus       514 ~~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~  584 (1048)
                      ..+...+.|++|+|++| .|...    +...+...++|++|+|++|.|+..    +...+...++|++|+|++|.|+...
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            34455666777777766 66532    233344556677777777766532    2333444466677777777666432


Q ss_pred             ----ccccccccccccccc--ccccccchhhhhhc----cccccCeEECCCCccc
Q 045493          585 ----PKNLGELRKLHHLNL--SNNQFSQEISIQIG----KLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       585 ----~~~l~~l~~L~~L~L--s~N~l~~~~~~~~~----~l~~L~~L~Ls~N~l~  629 (1048)
                          ..++...++|++|+|  ++|.|++.+...+.    ..++|++|+|++|.++
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence                233444455666666  55555554433332    2344555555555443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.59  E-value=1.1e-08  Score=111.95  Aligned_cols=184  Identities=20%  Similarity=0.182  Sum_probs=113.7

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCc--eeeEeeEeeeCC---eEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRN--IVKFYGFCSHTQ---HLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  855 (1048)
                      ..++.|....||++.    +.+++|+....   ........+.+.+..+. +..  +.+.+.+.....   ..|+|||++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            347899999999863    56888875432   11223344555555552 222  344555443333   348899999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC---------------------------------------  896 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  896 (1048)
                      +|.++.+...     ..++..++..++.++++.++.||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988765332     22566777788888888888888511                                       


Q ss_pred             ----------------CCCeEeeCCCCCCeEECC--CCceEEeccccccccCCCCCC--cccc---cc---------ccc
Q 045493          897 ----------------FPPILHRDISSKKVLLDL--EYKAHVSDFGTAKFLKPDSSN--WSEL---AG---------TCG  944 (1048)
Q Consensus       897 ----------------~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~--~~~~---~g---------t~~  944 (1048)
                                      .+.++|||++|.||+++.  .+.+.++||+.+....+...-  ....   .+         ..+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            135899999999999998  456789999998754321000  0000   00         001


Q ss_pred             ccc-ccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 045493          945 YIA-PELAYTMRANEKCDVFNFGVLVLEVIEGKHPG  979 (1048)
Q Consensus       945 y~a-PE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  979 (1048)
                      +.. |+....  .....+.|++|.++|++.+|+.+|
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 222211  123468999999999999999774

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.41  E-value=7.4e-08  Score=101.10  Aligned_cols=63  Identities=33%  Similarity=0.345  Sum_probs=27.6

Q ss_pred             cccccccccccccccchh--hhhhccccccCeEECCCCcccCcCCcCcCCcc--ccCeEECCCCcccCC
Q 045493          591 LRKLHHLNLSNNQFSQEI--SIQIGKLVQLSKLDLSHNSLGGNIPSEICNLE--SLEYMNLLQNKLSGP  655 (1048)
Q Consensus       591 l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~  655 (1048)
                      +++|+.|+|++|+|+++.  +..+..+++|+.|||++|+|++.  ..+..+.  +|++|+|++|++.+.
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~  235 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDT  235 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGG
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccc
Confidence            344444444444444422  12334445555555555555432  2222222  555555555555543

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.22  E-value=4.6e-07  Score=95.03  Aligned_cols=94  Identities=21%  Similarity=0.214  Sum_probs=71.7

Q ss_pred             ccccccccc--cccccccccchh---hhhhccccccCeEECCCCcccC--cCCcCcCCccccCeEECCCCcccCCccccc
Q 045493          588 LGELRKLHH--LNLSNNQFSQEI---SIQIGKLVQLSKLDLSHNSLGG--NIPSEICNLESLEYMNLLQNKLSGPIPSCF  660 (1048)
Q Consensus       588 l~~l~~L~~--L~Ls~N~l~~~~---~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  660 (1048)
                      |...+.|..  ++++.|+.....   ......+++|+.|+||+|+|++  .++..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            555566666  777888654322   2223468999999999999997  4456677899999999999999976  334


Q ss_pred             cccC--CccEEEeccceecCCCCCc
Q 045493          661 RRMH--GLSSIDVSYNELQGSIPHS  683 (1048)
Q Consensus       661 ~~l~--~L~~l~ls~N~l~~~~p~~  683 (1048)
                      ..+.  .|++|++++|++++.+|..
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~  239 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQ  239 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSH
T ss_pred             hhcccCCcceEEccCCcCccccCcc
Confidence            4444  8999999999999988753

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.11  E-value=7e-07  Score=86.62  Aligned_cols=83  Identities=8%  Similarity=0.167  Sum_probs=44.0

Q ss_pred             ccceeecccCccccccccccccccccccccccccc-ccchhhhhhccc----cccCeEECCCCc-ccCcCCcCcCCcccc
Q 045493          569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ-FSQEISIQIGKL----VQLSKLDLSHNS-LGGNIPSEICNLESL  642 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L  642 (1048)
                      +|+.||++++.|+...-..+.++++|++|+|++|. |++.....++.+    ++|++|||++|. |++..-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34445555544444444444555555555555553 555555555443    356666666653 555444455556666


Q ss_pred             CeEECCCCc
Q 045493          643 EYMNLLQNK  651 (1048)
Q Consensus       643 ~~L~L~~N~  651 (1048)
                      ++|++++++
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.01  E-value=2.4e-06  Score=82.83  Aligned_cols=84  Identities=12%  Similarity=0.149  Sum_probs=44.2

Q ss_pred             CCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccc----ccccc
Q 045493          521 QLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGEL----RKLHH  596 (1048)
Q Consensus       521 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l----~~L~~  596 (1048)
                      .|+.||++++.|++.....+.++++|++|+|++|.                       .|+...-..++.+    ++|++
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~-----------------------~ItD~gL~~L~~~~~~~~~L~~  118 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCH-----------------------YIEDGCLERLSQLENLQKSMLE  118 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCT-----------------------TCCHHHHHHHHTCHHHHHHCCE
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCC-----------------------ccCHHHHHHHHhcccccCCCCE
Confidence            45555555555554444444555555555555553                       1333222333332    35666


Q ss_pred             ccccccc-ccchhhhhhccccccCeEECCCCc
Q 045493          597 LNLSNNQ-FSQEISIQIGKLVQLSKLDLSHNS  627 (1048)
Q Consensus       597 L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~  627 (1048)
                      |+|++|. |++.+...+..+++|+.|+|+++.
T Consensus       119 L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          119 MEIISCGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             EEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             EEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            6666653 666555556666666666666653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.94  E-value=3.2e-05  Score=82.56  Aligned_cols=135  Identities=13%  Similarity=0.114  Sum_probs=90.8

Q ss_pred             eeecccccc-cEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          782 VLHGTGGCG-TVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       782 ~~lG~G~~g-~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      +.+..|..| .||+..... +..+++|+-....    ......+...++.+. +--|.++++++.+.+..++|||+++|.
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSV----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETHH----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCCC----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            344556555 589987764 4567777754321    112333444444332 223667888998899999999999998


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC------------------------------------------  896 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------  896 (1048)
                      ++.+....       .......++.++++.++.||...                                          
T Consensus       106 ~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          106 TAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             EHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            88776532       11234456777778888887420                                          


Q ss_pred             -------------CCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          897 -------------FPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       897 -------------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                                   .+.++|||+.+.||+++.++.+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         0237899999999999987777799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.87  E-value=4.2e-05  Score=83.09  Aligned_cols=137  Identities=15%  Similarity=0.103  Sum_probs=86.0

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccC---ceeeEeeEee-eCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR---NIVKFYGFCS-HTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~  856 (1048)
                      ...++.|....||+.    ++.+++|+...   .........|.+.+..+.+.   .|.+.+.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            345788888899988    67788887432   11122344555556666532   3556666664 4556789999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD-----------------------------------------  895 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  895 (1048)
                      |.++.+..-.     .++......++.++++.++.||+.                                         
T Consensus        97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9887653210     123333444444444444444432                                         


Q ss_pred             ----------------CCCCeEeeCCCCCCeEECC---CCc-eEEecccccccc
Q 045493          896 ----------------CFPPILHRDISSKKVLLDL---EYK-AHVSDFGTAKFL  929 (1048)
Q Consensus       896 ----------------~~~~iiH~Dik~~NIll~~---~~~-~kl~DfG~a~~~  929 (1048)
                                      ..+.++|||++|.||+++.   ++. +.|+||+.+..-
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                            1236799999999999997   455 489999988643

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.86  E-value=4e-06  Score=82.95  Aligned_cols=86  Identities=13%  Similarity=0.159  Sum_probs=39.5

Q ss_pred             cccccccccccccccchhhhhhc----cccccCeEECCCCcccCcCC----cCcCCccccCeEECCCC---cccCC----
Q 045493          591 LRKLHHLNLSNNQFSQEISIQIG----KLVQLSKLDLSHNSLGGNIP----SEICNLESLEYMNLLQN---KLSGP----  655 (1048)
Q Consensus       591 l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N---~l~~~----  655 (1048)
                      ...|+.|+|++|+|++.+...++    ..+.|++|+|++|.|++...    ..+..-+.|++|+|++|   .+...    
T Consensus        69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~  148 (197)
T 1pgv_A           69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD  148 (197)
T ss_dssp             CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred             CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence            34444444444444443333222    33445555555555543222    22233345666666543   23321    


Q ss_pred             ccccccccCCccEEEecccee
Q 045493          656 IPSCFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       656 ~~~~~~~l~~L~~l~ls~N~l  676 (1048)
                      +...+..-+.|+.|++++|..
T Consensus       149 ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          149 MMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHhCCCcCeEeccCCCc
Confidence            233444556677777766543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.82  E-value=7e-06  Score=81.20  Aligned_cols=12  Identities=25%  Similarity=0.144  Sum_probs=5.4

Q ss_pred             cccCeEECCCCc
Q 045493          640 ESLEYMNLLQNK  651 (1048)
Q Consensus       640 ~~L~~L~L~~N~  651 (1048)
                      ++|+.|+++.|.
T Consensus       157 ~tL~~L~l~~~~  168 (197)
T 1pgv_A          157 ESLLRVGISFAS  168 (197)
T ss_dssp             SSCCEEECCCCC
T ss_pred             CCcCeEeccCCC
Confidence            444444444443

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.72  E-value=7.5e-05  Score=83.23  Aligned_cols=80  Identities=8%  Similarity=-0.080  Sum_probs=49.4

Q ss_pred             eee-cccccccEEEEEEc-------CCCceeeEEeccCCC--CcccchhhHHHHHHhhcc-c--CceeeEeeEeeeC---
Q 045493          782 VLH-GTGGCGTVYKAELT-------SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIR-H--RNIVKFYGFCSHT---  845 (1048)
Q Consensus       782 ~~l-G~G~~g~Vy~~~~~-------~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~-h--~niv~~~~~~~~~---  845 (1048)
                      +.+ +.|....+|+....       +++.+++|.......  .........|.+.++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999998764       256778877543220  101123444555555553 2  2466777777654   


Q ss_pred             CeEEEEEEccCCCCHH
Q 045493          846 QHLFLVYEYLERGSLA  861 (1048)
Q Consensus       846 ~~~~lv~e~~~~g~L~  861 (1048)
                      +..|+||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999986654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.58  E-value=0.00019  Score=79.46  Aligned_cols=30  Identities=27%  Similarity=0.397  Sum_probs=27.4

Q ss_pred             CCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      +.++|||+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            489999999999999888899999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.47  E-value=0.00033  Score=79.22  Aligned_cols=76  Identities=13%  Similarity=0.024  Sum_probs=42.2

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--C-c---ccchhhHHHHHHhhcc---cCceeeEeeEeeeCCeEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--G-E---IGINQKGFVSEITEIR---HRNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~-~---~~~~~~~~~~~l~~l~---h~niv~~~~~~~~~~~~~l  850 (1048)
                      ...+|.|.++.||++... +++.++||.......  . .   .......+.+.+..+.   ...+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            345799999999999764 467889987653221  0 0   1111233334444432   2234455544  3444689


Q ss_pred             EEEccCCC
Q 045493          851 VYEYLERG  858 (1048)
Q Consensus       851 v~e~~~~g  858 (1048)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.42  E-value=0.00039  Score=79.25  Aligned_cols=77  Identities=13%  Similarity=0.117  Sum_probs=49.6

Q ss_pred             CCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccccc--ccccccccccccC---CCCchhhHHHHHHHHHHH
Q 045493          898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAG--TCGYIAPELAYTM---RANEKCDVFNFGVLVLEV  972 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dvws~Gvvl~el  972 (1048)
                      +.++|||++|.||+++.++ ++++||+.+..-.+... ......  ...|++|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998876 99999998875321110 000111  2346777665421   112345666888888888


Q ss_pred             HhCC
Q 045493          973 IEGK  976 (1048)
Q Consensus       973 ltg~  976 (1048)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.25  E-value=0.00089  Score=72.24  Aligned_cols=138  Identities=14%  Similarity=0.115  Sum_probs=84.2

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc---cCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR---HRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .+.++.|....+|+... +++.+++|......    ......|.+.++.+.   ...+.++++++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            44579999999999986 46778888764321    122334444444442   35677888888878889999999999


Q ss_pred             CCHH--------HH---Hhcccc-c------------------cccCHHHHH---HHH----------------HHHHHH
Q 045493          858 GSLA--------TI---LSNEAT-A------------------AELDWSKRV---NVI----------------KGVANA  888 (1048)
Q Consensus       858 g~L~--------~~---l~~~~~-~------------------~~l~~~~~~---~i~----------------~~i~~~  888 (1048)
                      ..+.        +.   ++.... .                  ..-+|.+..   ++.                ..++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7642        11   122111 0                  012454322   111                111111


Q ss_pred             -HHHHHh-CCCCCeEeeCCCCCCeEECCCCceEEeccc
Q 045493          889 -LSYMHH-DCFPPILHRDISSKKVLLDLEYKAHVSDFG  924 (1048)
Q Consensus       889 -L~~LH~-~~~~~iiH~Dik~~NIll~~~~~~kl~DfG  924 (1048)
                       ...|.. ...+.++|+|+.+.||+++.++ +.|.||+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             123321 2235899999999999999887 8899984

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.24  E-value=0.00035  Score=64.58  Aligned_cols=44  Identities=20%  Similarity=0.257  Sum_probs=21.0

Q ss_pred             CCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCcc
Q 045493           17 EFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF   60 (1048)
Q Consensus        17 ~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i   60 (1048)
                      ++|..+++++++|||++|+|+.+.+..|..+++|++|+|++|.+
T Consensus        24 ~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           24 SLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             TSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             cCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            44444444555555555555544444444444444444444444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.81  E-value=0.0018  Score=59.74  Aligned_cols=60  Identities=15%  Similarity=0.205  Sum_probs=44.3

Q ss_pred             eEECCCCccc-CcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCC
Q 045493          620 KLDLSHNSLG-GNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       620 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      .+|.+++.|+ ..+|..+.  ++|++|+|++|+|+...+..|..++.|+.|+|++|+|.....
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~   72 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR   72 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence            6777777775 24554432  468888888888887777788888888888888888876543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.72  E-value=0.0062  Score=65.17  Aligned_cols=75  Identities=15%  Similarity=0.154  Sum_probs=47.6

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhccc---CceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH---RNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...+|.|..+.||+.+..+|+.+++|+....... .....+.|.+.++.+.-   --+.+++++.  .  .++||||+++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~l~~   94 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEECCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEeecc
Confidence            3457999999999999999999999986543221 12234445555554421   1234444442  2  3789999987


Q ss_pred             CCH
Q 045493          858 GSL  860 (1048)
Q Consensus       858 g~L  860 (1048)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.68  E-value=0.006  Score=66.89  Aligned_cols=32  Identities=31%  Similarity=0.369  Sum_probs=27.7

Q ss_pred             CCeEeeCCCCCCeEECCC----CceEEecccccccc
Q 045493          898 PPILHRDISSKKVLLDLE----YKAHVSDFGTAKFL  929 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~~  929 (1048)
                      +.++|||+.+.||+++.+    +.+.++||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999875    67999999988753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.51  E-value=0.0093  Score=64.26  Aligned_cols=29  Identities=17%  Similarity=0.213  Sum_probs=25.1

Q ss_pred             CeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          899 PILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       899 ~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            5899999999999 5667889999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.40  E-value=0.016  Score=63.22  Aligned_cols=142  Identities=11%  Similarity=0.075  Sum_probs=74.4

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccC--ceeeEeeE-----eeeCCeEEEEEEc
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHR--NIVKFYGF-----CSHTQHLFLVYEY  854 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~  854 (1048)
                      ..++ |....||+....+|+.+++|.........  .....+...+..+...  .+.+++..     ....+..++||||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~--~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA--DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH--HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH--HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 88889999887777789999876321111  1222233333333211  13333332     2235567899999


Q ss_pred             cCCCCHH-----HH---------Hhccc------cccccCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 045493          855 LERGSLA-----TI---------LSNEA------TAAELDWSKR----VNV---------------IKGVANALSYMHHD  895 (1048)
Q Consensus       855 ~~~g~L~-----~~---------l~~~~------~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~  895 (1048)
                      ++|..+.     .+         ++...      .....++...    ..+               ...+.+.++.+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9885431     11         11100      0011222111    001               11111122233221


Q ss_pred             ----CCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          896 ----CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       896 ----~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                          ....++|||+++.||+++ + .+.++||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                123688999999999999 4 899999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.29  E-value=0.026  Score=61.32  Aligned_cols=142  Identities=11%  Similarity=0.049  Sum_probs=73.9

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc-----cCceeeEe-e--EeeeCCeEEEEEE
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-----HRNIVKFY-G--FCSHTQHLFLVYE  853 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e  853 (1048)
                      ..++.|....+|+....++ .+++|........   .....+...+..+.     .|.++... |  +....+..++||+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            3467788899999987644 6888887642111   12233333343332     23333211 1  1223466799999


Q ss_pred             ccCCCCHHH-----H---------Hhccc----cc-----cccCHHHHHH------------HHHHHHHHHHHHHhC---
Q 045493          854 YLERGSLAT-----I---------LSNEA----TA-----AELDWSKRVN------------VIKGVANALSYMHHD---  895 (1048)
Q Consensus       854 ~~~~g~L~~-----~---------l~~~~----~~-----~~l~~~~~~~------------i~~~i~~~L~~LH~~---  895 (1048)
                      |++|..+..     +         ++...    ..     ....|.....            +...+.+.+++++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999864311     0         11110    00     0011222110            011234445555432   


Q ss_pred             -CCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          896 -CFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       896 -~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                       ...+++|+|+.+.||+++.++.+.++||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             12379999999999999877666899999775

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.20  E-value=0.019  Score=62.92  Aligned_cols=31  Identities=23%  Similarity=0.284  Sum_probs=27.8

Q ss_pred             CCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.95  E-value=0.028  Score=55.68  Aligned_cols=102  Identities=17%  Similarity=0.154  Sum_probs=66.2

Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.++++..  ..++++++++.++.|.+.+|.-.-.+.. + ..+=+.|..|++..+|.|...+ +.+.           
T Consensus        34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            899999653  4569999999999999999877622100 1 1223456889999999988764 1111           


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP  978 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p  978 (1048)
                       .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             1223467888763 3567899999999999998874443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.76  E-value=0.021  Score=64.74  Aligned_cols=72  Identities=15%  Similarity=0.155  Sum_probs=41.2

Q ss_pred             eeeecccccccEEEEEEcC--------CCceeeEEeccCCCCcccchhhHHHHHHhhcccCce-eeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS--------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNI-VKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  851 (1048)
                      .+.++.|....||++...+        ++.+++|+......   ......+...+..+...++ .++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            3457888889999998753        46677777633111   0112234444444432233 456665542    389


Q ss_pred             EEccCCCC
Q 045493          852 YEYLERGS  859 (1048)
Q Consensus       852 ~e~~~~g~  859 (1048)
                      +||++|-+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998633

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.66  E-value=0.047  Score=62.12  Aligned_cols=74  Identities=16%  Similarity=0.130  Sum_probs=43.5

Q ss_pred             eeeecccccccEEEEEEcC-CCceeeEEeccCCCCcccchhhHHHHHHhhcccCce-eeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNI-VKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .+.|+.|-...+|++...+ ++.+++|+.....  +.......+...+..+...++ .++++++.  +  ..||||++|-
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3457888899999998764 3667777664321  222233455555665543333 46677663  2  3599999874


Q ss_pred             CH
Q 045493          859 SL  860 (1048)
Q Consensus       859 ~L  860 (1048)
                      ++
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.55  E-value=0.029  Score=62.35  Aligned_cols=29  Identities=14%  Similarity=0.230  Sum_probs=24.4

Q ss_pred             CCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      ..++|+|+.+.||+++.++ +.++||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            3689999999999998654 8999998775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.41  E-value=0.036  Score=61.28  Aligned_cols=141  Identities=13%  Similarity=0.116  Sum_probs=74.9

Q ss_pred             eeecccccccEEEEEEcC--------CCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEE
Q 045493          782 VLHGTGGCGTVYKAELTS--------GDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~--------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      +.+..|-...+|++...+        ++.+++++.....  .......+|.+.++.+. +.-..++++++.+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            346778888999998752        3667777753211  11222334444454443 2223556666543    3899


Q ss_pred             EccCCCCHHH-----------H---H---hccc--cccccC--HHHHHHHHHHHHH-------------------HHHHH
Q 045493          853 EYLERGSLAT-----------I---L---SNEA--TAAELD--WSKRVNVIKGVAN-------------------ALSYM  892 (1048)
Q Consensus       853 e~~~~g~L~~-----------~---l---~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~L~~L  892 (1048)
                      ||++|..+..           +   +   +...  ......  |.++.++..++..                   .+.++
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999854421           1   1   1110  011122  3455555544322                   12333


Q ss_pred             H----hC-CCCCeEeeCCCCCCeEECCC----CceEEeccccccc
Q 045493          893 H----HD-CFPPILHRDISSKKVLLDLE----YKAHVSDFGTAKF  928 (1048)
Q Consensus       893 H----~~-~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~  928 (1048)
                      .    .. ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 12368999999999999876    7899999998763

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.36  E-value=0.89  Score=50.86  Aligned_cols=29  Identities=14%  Similarity=0.331  Sum_probs=25.9

Q ss_pred             CeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          899 PILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       899 ~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      .++|+|+.+.||+ +.++.+.++||..|..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            6889999999999 7788999999998763

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.06  E-value=0.096  Score=36.86  Aligned_cols=30  Identities=23%  Similarity=0.438  Sum_probs=19.5

Q ss_pred             EEehhhhhHHHHHHHhhhhceeeeeecccc
Q 045493          729 VIVPLLSGAFLLSLVLIGMCFNFRRRKRTD  758 (1048)
Q Consensus       729 i~~~~~~~~~~~~lv~~~~~~~~r~~~~~~  758 (1048)
                      |+.+++.|+++++++..+++|++|||+.++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            566677777776666666666666665543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=86.74  E-value=0.097  Score=36.71  Aligned_cols=30  Identities=20%  Similarity=0.432  Sum_probs=19.2

Q ss_pred             EEehhhhhHHHHHHHhhhhceeeeeecccc
Q 045493          729 VIVPLLSGAFLLSLVLIGMCFNFRRRKRTD  758 (1048)
Q Consensus       729 i~~~~~~~~~~~~lv~~~~~~~~r~~~~~~  758 (1048)
                      |+.+++.|+++++++..++++++|||++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~   41 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence            566666667766666666666666665544

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.16  E-value=2.2  Score=42.24  Aligned_cols=115  Identities=7%  Similarity=0.103  Sum_probs=80.7

Q ss_pred             ccCceeeEeeEeeeCCeEEEEEEccCCC-CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCC
Q 045493          831 RHRNIVKFYGFCSHTQHLFLVYEYLERG-SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKK  909 (1048)
Q Consensus       831 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~N  909 (1048)
                      .||+.++. .+-...+.+.+.|+.-+.+ ++.. +      ...+...+++++..|+....+++..     +|=-+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            58888876 5666667676667665432 2222 2      2367788999999999888777655     888999999


Q ss_pred             eEECCCCceEEeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCc
Q 045493          910 VLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGH  980 (1048)
Q Consensus       910 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~  980 (1048)
                      |+++.++.+++.=.|+-..+.                 |.     ..+...=.-.+=+++..++++++.|+
T Consensus       110 L~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999998777543322                 22     11222233467788899999998875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.00  E-value=0.28  Score=54.95  Aligned_cols=30  Identities=23%  Similarity=0.357  Sum_probs=24.9

Q ss_pred             CeEeeCCCCCCeEE------CCCCceEEeccccccc
Q 045493          899 PILHRDISSKKVLL------DLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       899 ~iiH~Dik~~NIll------~~~~~~kl~DfG~a~~  928 (1048)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567799999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1048
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-47
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-45
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-42
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-37
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-34
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-32
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-32
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-31
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-08
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-14
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-14
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-09
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-51
 Identities = 63/270 (23%), Positives = 118/270 (43%), Gaps = 27/270 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G+G  GTVYK +       AVK L+        +    F +E+    + RH NI+ F G+
Sbjct: 17   GSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQA--FKNEVGVLRKTRHVNILLFMGY 72

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +    L +V ++ E  SL   L    T  + +  K +++ +  A  + Y+H      I+
Sbjct: 73   STA-PQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA---KSII 126

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRAN-- 957
            HRD+ S  + L  +    + DFG A      S +  + +L+G+  ++APE+      N  
Sbjct: 127  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186

Query: 958  -EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
              + DV+ FG+++ E++ G+ P   ++    +      + +V    +   L        +
Sbjct: 187  SFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGYLSPDLSKVRSNCPK 240

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             +K ++A    CL    D RP   ++   +
Sbjct: 241  AMKRLMA---ECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-50
 Identities = 55/266 (20%), Positives = 112/266 (42%), Gaps = 27/266 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V+          AVK L      +  ++   F++E     +++H+ +V+ Y  
Sbjct: 22   GAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             +  + ++++ EY+E GSL   L    +  +L  +K +++   +A  ++++        +
Sbjct: 77   VTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE-LAGTCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       ++DFG A+ ++ +     E       + APE         K 
Sbjct: 132  HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            DV++FG+L+ E++               P P      V+ +L             E+L  
Sbjct: 192  DVWSFGILLTEIVTHGRI----------PYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046
            ++    LC    P+ RPT   + ++L
Sbjct: 242  LMR---LCWKERPEDRPTFDYLRSVL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 5e-48
 Identities = 66/267 (24%), Positives = 112/267 (41%), Gaps = 25/267 (9%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            GTG  G   K    + G     K+L           ++  VSE+    E++H NIV++Y 
Sbjct: 13   GTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 841  FCSHT--QHLFLVYEYLERGSLATILSNEATAAE-LDWSKRVNVIKGVANALSYMH--HD 895
                     L++V EY E G LA++++      + LD    + V+  +  AL   H   D
Sbjct: 71   RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
                +LHRD+    V LD +    + DFG A+ L  D+S      GT  Y++PE    M 
Sbjct: 131  GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 190

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
             NEK D+++ G L+ E+                P  A +   +   + + +         
Sbjct: 191  YNEKSDIWSLGCLLYELCALMP-----------PFTAFSQKELAGKIREGKFRRIPYRYS 239

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKV 1042
            ++L  +I      L+     RP+++++
Sbjct: 240  DELNEIIT---RMLNLKDYHRPSVEEI 263

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-47
 Identities = 56/266 (21%), Positives = 105/266 (39%), Gaps = 27/266 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            G+G  G V+     + D  A+K +      E  ++++ F+ E     ++ H  +V+ YG 
Sbjct: 14   GSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C     + LV+E++E G L+  L  +           + +   V   +    +     ++
Sbjct: 69   CLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGM---AYLEEACVI 123

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE-LAGTCGYIAPELAYTMRANEKC 960
            HRD++++  L+       VSDFG  +F+  D    S        + +PE+    R + K 
Sbjct: 124  HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            DV++FGVL+ EV                P    + + VV D+               +  
Sbjct: 184  DVWSFGVLMWEVFSEGKI----------PYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046
            ++     C    P+ RP   ++   L
Sbjct: 234  IMN---HCWKERPEDRPAFSRLLRQL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 8e-46
 Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 43/293 (14%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G V+K     SG   A K +H      I   +   + E+    E     IV FYG
Sbjct: 15   GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECNSPYIVGFYG 71

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   + +  E+++ GSL  +L        +       V   V   L+Y+       I
Sbjct: 72   AFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH--KI 126

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRD+    +L++   +  + DFG +  L    +N     GT  Y++PE       + + 
Sbjct: 127  MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQS 184

Query: 961  DVFNFGVLVLEVIEGKHP---------------------------GHFLSLLLSLPAPAA 993
            D+++ G+ ++E+  G++P                                  LS     +
Sbjct: 185  DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 994  NMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
               + + +L+D  +  P  ++   + S+    F+  CL  NP  R  ++++  
Sbjct: 245  RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 29/267 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYGF 841
            GTG  G V   +       A+K +      E  +++  F+ E      + H  +V+ YG 
Sbjct: 13   GTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
            C+  + +F++ EY+  G L   L            + + + K V  A+ Y+        L
Sbjct: 68   CTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFL 122

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE-LAGTCGYIAPELAYTMRANEKC 960
            HRD++++  L++ +    VSDFG ++++  D    S        +  PE+    + + K 
Sbjct: 123  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 961  DVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019
            D++ FGVL+ E+   GK P    +        +     +   L   RL  P    E+   
Sbjct: 183  DIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGL---RLYRPHLASEK--- 229

Query: 1020 SMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             +  + + C     D RPT + + + +
Sbjct: 230  -VYTIMYSCWHEKADERPTFKILLSNI 255

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 60/266 (22%), Positives = 105/266 (39%), Gaps = 31/266 (11%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V   +   G+  AVK + +          + F++E    T++RH N+V+  G 
Sbjct: 16   GKGEFGDVMLGDYR-GNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 842  CSHTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                +  L++V EY+ +GSL   L +   +  L     +     V  A+ Y+        
Sbjct: 69   IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNF 124

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRD++++ VL+  +  A VSDFG  K     SS          + APE     + + K 
Sbjct: 125  VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            DV++FG+L+ E+                P P   +  VV  +               +  
Sbjct: 182  DVWSFGILLWEIYSFGRV----------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046
            ++     C   +   RP+  ++   L
Sbjct: 232  VMK---NCWHLDAAMRPSFLQLREQL 254

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-45
 Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 35/289 (12%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH 844
            G G  G V++ +   G+  AVK   S    E    ++  + +   +RH NI+ F    + 
Sbjct: 12   GKGRFGEVWRGKWR-GEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 845  TQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF--- 897
                   L+LV +Y E GSL   L+       +     + +    A+ L+++H +     
Sbjct: 69   DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 898  --PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS----ELAGTCGYIAPELA 951
              P I HRD+ SK +L+       ++D G A      +           GT  Y+APE+ 
Sbjct: 125  GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 952  YTM------RANEKCDVFNFGVLVLEVIEGKHPG--------HFLSLLLSLPAPAANMNI 997
                      + ++ D++  G++  E+      G         +  L+ S P+      +
Sbjct: 185  DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 998  VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            V    +   +P      E  L+ M  +   C  AN   R T  ++   L
Sbjct: 245  VCEQKLRPNIPNRWQSCEA-LRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  161 bits (409), Expect = 8e-45
 Identities = 62/275 (22%), Positives = 123/275 (44%), Gaps = 35/275 (12%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
            G G  G V    L     R    A+K L S   G     ++ F+SE +   +  H N++ 
Sbjct: 35   GAGEFGEVCSGHLKLPGKREIFVAIKTLKS---GYTEKQRRDFLSEASIMGQFDHPNVIH 91

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G  + +  + ++ E++E GSL + L       +    + V +++G+A  + Y+     
Sbjct: 92   LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN- 148

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELA-----GTCGYIAPELAY 952
               +HRD++++ +L++      VSDFG ++FL+ D+S+ +  +         + APE   
Sbjct: 149  --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206

Query: 953  TMRANEKCDVFNFGVLVLEVI-EGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011
              +     DV+++G+++ EV+  G+ P   ++          N +++     D RLPPP+
Sbjct: 207  YRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----------NQDVINAIEQDYRLPPPM 256

Query: 1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                     +  +   C   + + RP   ++ N L
Sbjct: 257  DCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-44
 Identities = 58/271 (21%), Positives = 101/271 (37%), Gaps = 31/271 (11%)

Query: 785  GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G+G  GTV K            AVK L +        ++   ++E     ++ +  IV+ 
Sbjct: 16   GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE--LLAEANVMQQLDNPYIVRM 73

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
             G C   +   LV E  E G L   L        +     + ++  V+  + Y+      
Sbjct: 74   IGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS---ELAGTCGYIAPELAYTMR 955
              +HRD++++ VLL  ++ A +SDFG +K L+ D + +           + APE     +
Sbjct: 127  NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
             + K DV++FGVL+ E                 P      + V   L             
Sbjct: 187  FSSKSDVWSFGVLMWEAFSYGQK----------PYRGMKGSEVTAMLEKGERMGCPAGCP 236

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             ++  ++    LC   + + RP    V   L
Sbjct: 237  REMYDLMN---LCWTYDVENRPGFAAVELRL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-44
 Identities = 61/266 (22%), Positives = 110/266 (41%), Gaps = 27/266 (10%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G V+          A+K L         ++ + F+ E     ++RH  +V+ Y  
Sbjct: 26   GQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
             S  + +++V EY+ +GSL   L  E T   L   + V++   +A+ ++Y+        +
Sbjct: 81   VSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE-LAGTCGYIAPELAYTMRANEKC 960
            HRD+ +  +L+       V+DFG A+ ++ +     +       + APE A   R   K 
Sbjct: 136  HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            DV++FG+L+ E+                P P      V++ +      P   E  E L  
Sbjct: 196  DVWSFGILLTELTTKGRV----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCNLL 1046
            ++     C    P+ RPT + +   L
Sbjct: 246  LMC---QCWRKEPEERPTFEYLQAFL 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 54/271 (19%), Positives = 102/271 (37%), Gaps = 31/271 (11%)

Query: 785  GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G G  G+V +        +   A+K L          + +  + E     ++ +  IV+ 
Sbjct: 18   GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA---DTEEMMREAQIMHQLDNPYIVRL 74

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
             G C   + L LV E    G L   L  +    E+  S    ++  V+  + Y+      
Sbjct: 75   IGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE---K 128

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE---LAGTCGYIAPELAYTMR 955
              +HRD++++ VLL   + A +SDFG +K L  D S ++          + APE     +
Sbjct: 129  NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
             + + DV+++GV + E +               P        V+  +   +      E  
Sbjct: 189  FSSRSDVWSYGVTMWEALSYGQK----------PYKKMKGPEVMAFIEQGKRMECPPECP 238

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             +L ++++    C     + RP    V   +
Sbjct: 239  PELYALMS---DCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-43
 Identities = 59/273 (21%), Positives = 113/273 (41%), Gaps = 32/273 (11%)

Query: 785  GTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIV 836
            G G  G VYK  L +   +     A+K L +   G     +  F+ E     +  H NI+
Sbjct: 16   GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +  G  S  + + ++ EY+E G+L   L  +    E    + V +++G+A  + Y+ +  
Sbjct: 73   RLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN-- 128

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYT 953
                +HRD++++ +L++      VSDFG ++ L+ D       S       + APE    
Sbjct: 129  -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
             +     DV++FG+++ EV+      ++        +    M  + +     RLP P+  
Sbjct: 188  RKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMKAINDGF---RLPTPMDC 238

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                   +  +   C       RP    + ++L
Sbjct: 239  PSA----IYQLMMQCWQQERARRPKFADIVSIL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 4e-43
 Identities = 56/295 (18%), Positives = 104/295 (35%), Gaps = 52/295 (17%)

Query: 785  GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSEITEI----RHRN 834
            G+G  G V  A              AVK L           ++  +SE+  +     H N
Sbjct: 46   GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---EREALMSELKMMTQLGSHEN 102

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSN--------------------EATAAELD 874
            IV   G C+ +  ++L++EY   G L   L +                    E     L 
Sbjct: 103  IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 875  WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
            +   +     VA  + ++        +HRD++++ VL+       + DFG A+ +  DS+
Sbjct: 163  FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 935  N--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA 992
                        ++APE  +      K DV+++G+L+ E+                P P 
Sbjct: 220  YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----------PYPG 269

Query: 993  ANMNIVVNDLIDSRLPPPLGE-VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              ++     LI +           E++  ++     C   +   RP+   + + L
Sbjct: 270  IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 321

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 4e-43
 Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VY A         A+K L      + G+ +     E+   + +RH NI++ YG
Sbjct: 15   GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRLYG 73

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
            +      ++L+ EY   G++   L   +     D  +    I  +ANALSY H      +
Sbjct: 74   YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRV 127

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRDI  + +LL    +  ++DFG +      SS  + L GT  Y+ PE+      +EK 
Sbjct: 128  IHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIEGRMHDEKV 185

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D+++ GVL  E + GK P  F          A         +       P   V E  + 
Sbjct: 186  DLWSLGVLCYEFLVGKPP--F---------EANTYQETYKRISRVEFTFP-DFVTEGARD 233

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCN 1044
            +I+     L  NP  RP +++V  
Sbjct: 234  LIS---RLLKHNPSQRPMLREVLE 254

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 3e-42
 Identities = 55/294 (18%), Positives = 109/294 (37%), Gaps = 51/294 (17%)

Query: 785  GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G V++A              AVK L    + ++   Q  F  E     E  + NI
Sbjct: 22   GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAEFDNPNI 78

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATILSN---------------------EATAAELD 874
            VK  G C+  + + L++EY+  G L   L +                           L 
Sbjct: 79   VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 875  WSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS 934
             ++++ + + VA  ++Y+        +HRD++++  L+       ++DFG ++ +     
Sbjct: 139  CAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 935  NWSE--LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPA 992
              ++   A    ++ PE  +  R   + DV+ +GV++ E+                P   
Sbjct: 196  YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----------PYYG 245

Query: 993  ANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                 V+  + D  +         +L +++    LC    P  RP+   +  +L
Sbjct: 246  MAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRIL 296

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 3e-42
 Identities = 59/269 (21%), Positives = 106/269 (39%), Gaps = 30/269 (11%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G   TVYK   T +    A  +L           ++ F  E      ++H NIV+FY 
Sbjct: 18   GRGSFKTVYKGLDTETTVEVAWCELQ--DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 841  FCSHT----QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                T    + + LV E +  G+L T L        +      +  + +   L ++H   
Sbjct: 76   SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRT 132

Query: 897  FPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
             PPI+HRD+    + +        + D G A   +   +    + GT  ++APE+ Y  +
Sbjct: 133  -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YEEK 188

Query: 956  ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
             +E  DV+ FG+ +LE+   ++P             A     V + +  +          
Sbjct: 189  YDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKV---AI 239

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
             ++K +I     C+  N D R +++ + N
Sbjct: 240  PEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 4e-42
 Identities = 58/267 (21%), Positives = 108/267 (40%), Gaps = 31/267 (11%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VY A  + + +  A+KK+      +     +  + E+    ++RH N +++ G
Sbjct: 24   GHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                    +LV EY    +   +  ++     L   +   V  G    L+Y+H      +
Sbjct: 83   CYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS---HNM 136

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM---RAN 957
            +HRD+ +  +LL       + DFG+A  + P +S      GT  ++APE+   M   + +
Sbjct: 137  IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYD 192

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
             K DV++ G+  +E+ E K P                M+ + +   +       G   E 
Sbjct: 193  GKVDVWSLGITCIELAERKPP----------LFNMNAMSALYHIAQNESPALQSGHWSEY 242

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044
             ++ +     CL   P  RPT + +  
Sbjct: 243  FRNFVD---SCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (389), Expect = 4e-42
 Identities = 61/269 (22%), Positives = 112/269 (41%), Gaps = 30/269 (11%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VYKA+   +    A K + +    E+    + ++ EI       H NIVK   
Sbjct: 21   GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL----EDYMVEIDILASCDHPNIVKLLD 76

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
               +  +L+++ E+   G++  ++        L  S+   V K   +AL+Y+H      I
Sbjct: 77   AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKI 131

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA---- 956
            +HRD+ +  +L  L+    ++DFG +              GT  ++APE+     +    
Sbjct: 132  IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191

Query: 957  -NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015
             + K DV++ G+ ++E+ E + P H L+ +  L      + I  ++      P       
Sbjct: 192  YDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKSEPPTLAQPS---RWS 242

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
               K  +     CL+ N D R T  ++  
Sbjct: 243  SNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (387), Expect = 6e-42
 Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 29/268 (10%)

Query: 785  GTGGCGTVYKAELTSGDTR-AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VY+          AVK L      E  +  + F+ E     EI+H N+V+  G
Sbjct: 26   GGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
             C+     +++ E++  G+L   L  E    E+     + +   +++A+ Y+        
Sbjct: 81   VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 136

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSELAGTCGYIAPELAYTMRANEK 959
            +HRD++++  L+   +   V+DFG ++ +  D+    +       + APE     + + K
Sbjct: 137  IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI-DSRLPPPLGEVEEKL 1018
             DV+ FGVL+ E+                P P  +++ V   L  D R+  P G  E+  
Sbjct: 197  SDVWAFGVLLWEIATYGMS----------PYPGIDLSQVYELLEKDYRMERPEGCPEK-- 244

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              +  +   C   NP  RP+  ++    
Sbjct: 245  --VYELMRACWQWNPSDRPSFAEIHQAF 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 7e-42
 Identities = 63/264 (23%), Positives = 123/264 (46%), Gaps = 27/264 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  GTVY A ++ +G   A+++++     +    ++  ++EI    E ++ NIV +  
Sbjct: 29   GQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L++V EYL  GSL  +++        D  +   V +    AL ++H +    +
Sbjct: 85   SYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSNQ---V 137

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            +HRDI S  +LL ++    ++DFG    + P+ S  S + GT  ++APE+        K 
Sbjct: 138  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D+++ G++ +E+IEG+ P       L+     A   I  N   + + P    ++    + 
Sbjct: 198  DIWSLGIMAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPE---KLSAIFRD 248

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCN 1044
             +     CLD + + R + +++  
Sbjct: 249  FLN---RCLDMDVEKRGSAKELLQ 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 7e-42
 Identities = 56/274 (20%), Positives = 103/274 (37%), Gaps = 33/274 (12%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
            G G  G VY   L   D +    AVK L+ +           F++E     +  H N++ 
Sbjct: 36   GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG---EVSQFLTEGIIMKDFSHPNVLS 92

Query: 838  FYGFCSHTQ-HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
              G C  ++    +V  Y++ G L   + NE     +       +          M    
Sbjct: 93   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS----SNWSELAGTCGYIAPELAY 952
                +HRD++++  +LD ++   V+DFG A+ +         N +       ++A E   
Sbjct: 148  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 953  TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012
            T +   K DV++FGVL+ E++    P          P P  N   +   L+  R      
Sbjct: 208  TQKFTTKSDVWSFGVLLWELMTRGAP----------PYPDVNTFDITVYLLQGRRLLQPE 257

Query: 1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
               + L  ++     C     + RP+  ++ + +
Sbjct: 258  YCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-41
 Identities = 60/289 (20%), Positives = 108/289 (37%), Gaps = 45/289 (15%)

Query: 785  GTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI----RHRN 834
            G G  G V +A         +  T AVK L           ++  +SE+  +     H N
Sbjct: 32   GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREALMSELKVLSYLGNHMN 88

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSN---------------EATAAELDWSKRV 879
            IV   G C+      ++ EY   G L   L                 E     LD    +
Sbjct: 89   IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--S 937
            +    VA  ++++        +HRD++++ +LL       + DFG A+ +K DS+     
Sbjct: 149  SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 938  ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI 997
                   ++APE  +      + DV+++G+ + E+       +       +P  +    +
Sbjct: 206  NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-----GMPVDSKFYKM 260

Query: 998  VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +       R+  P     E    M  +   C DA+P  RPT +++  L+
Sbjct: 261  IKEGF---RMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 6e-41
 Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 40/282 (14%)

Query: 785  GTGGCGTVYKAELTSGDTR---AVKKLHSLPTGEIGINQKGFVSEITEI----RHRNIVK 837
            G G  G V KA +     R   A+K++    + +   + + F  E+  +     H NI+ 
Sbjct: 19   GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIIN 75

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSN-------------EATAAELDWSKRVNVIKG 884
              G C H  +L+L  EY   G+L   L                +TA+ L   + ++    
Sbjct: 76   LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 885  VANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG 944
            VA  + Y+        +HRD++++ +L+   Y A ++DFG ++  +              
Sbjct: 136  VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 191

Query: 945  YIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLID 1004
            ++A E           DV+++GVL+ E++               P        +   L  
Sbjct: 192  WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----------PYCGMTCAELYEKLPQ 241

Query: 1005 SRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                      ++++  ++     C    P  RP+  ++   L
Sbjct: 242  GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSL 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 4e-40
 Identities = 57/264 (21%), Positives = 100/264 (37%), Gaps = 22/264 (8%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G G  G V  A    + +  AVK +      +   N K  +     + H N+VKFYG   
Sbjct: 14   GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 73

Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
                 +L  EY   G L   +  +     +           +   + Y+H      I HR
Sbjct: 74   EGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG---ITHR 127

Query: 904  DISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMR-ANEKC 960
            DI  + +LLD      +SDFG A   + ++     +++ GT  Y+APEL        E  
Sbjct: 128  DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            DV++ G+++  ++ G+ P            P+ +     +         P  +++    +
Sbjct: 188  DVWSCGIVLTAMLAGELP---------WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCN 1044
            ++      L  NP  R T+  +  
Sbjct: 239  LLH---KILVENPSARITIPDIKK 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 9e-40
 Identities = 54/270 (20%), Positives = 106/270 (39%), Gaps = 30/270 (11%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVK 837
            G G  G V++    S +      A+K   +  +  +   ++ F+ E     +  H +IVK
Sbjct: 16   GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV---REKFLQEALTMRQFDHPHIVK 72

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
              G  +    ++++ E    G L + L     +  LD +  +     ++ AL+Y+     
Sbjct: 73   LIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES--- 126

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSELAGTCGYIAPELAYTMRA 956
               +HRDI+++ VL+       + DFG +++++  +    S+      ++APE     R 
Sbjct: 127  KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
                DV+ FGV + E++               P      N V+  + +    P       
Sbjct: 187  TSASDVWMFGVCMWEILMHGVK----------PFQGVKNNDVIGRIENGERLPMPPNCPP 236

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
             L S++     C   +P  RP   ++   L
Sbjct: 237  TLYSLMT---KCWAYDPSRRPRFTELKAQL 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  148 bits (375), Expect = 1e-39
 Identities = 54/269 (20%), Positives = 104/269 (38%), Gaps = 33/269 (12%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            GTG  G V++  E  +G+  A K + +        +++    EI   + +RH  +V  + 
Sbjct: 35   GTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRHPTLVNLHD 90

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   + ++YE++  G L   +++E     +   + V  ++ V   L +MH +     
Sbjct: 91   AFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---Y 145

Query: 901  LHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +H D+  + ++   +    +   DFG    L P  S      GT  + APE+A       
Sbjct: 146  VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGY 204

Query: 959  KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP---LGEVE 1015
              D+++ GVL   ++ G  P  F            N +  + ++              + 
Sbjct: 205  YTDMWSVGVLSYILLSGLSP--F---------GGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 1016 EKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            E  K  I      L A+P+ R T+ +   
Sbjct: 254  EDGKDFIR---KLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  146 bits (369), Expect = 7e-39
 Identities = 53/266 (19%), Positives = 99/266 (37%), Gaps = 27/266 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G V++  E  +G     K +++       +++    +EI+   ++ H  ++  + 
Sbjct: 38   GSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKNEISIMNQLHHPKLINLHD 93

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   + L+ E+L  G L   ++ E     +  ++ +N ++     L +MH      I
Sbjct: 94   AFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHE---HSI 148

Query: 901  LHRDISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANE 958
            +H DI  + ++ + +  + V   DFG A  L PD         T  + APE+        
Sbjct: 149  VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEIVDREPVGF 207

Query: 959  KCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018
              D++  GVL   ++ G  P      L +L       N+   D            V  + 
Sbjct: 208  YTDMWAIGVLGYVLLSGLSPFAGEDDLETL------QNVKRCDW--EFDEDAFSSVSPEA 259

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044
            K  I      L   P  R T+     
Sbjct: 260  KDFIK---NLLQKEPRKRLTVHDALE 282

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 55/272 (20%), Positives = 96/272 (35%), Gaps = 29/272 (10%)

Query: 785  GTGGCGTVYKAELTSGDTR----AVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVK 837
            G G  G V + E  +   +    AVK L      +       F+ E+     + HRN+++
Sbjct: 17   GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-FIREVNAMHSLDHRNLIR 75

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
             YG    T  + +V E    GSL   L                    VA  + Y+     
Sbjct: 76   LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--- 129

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW---SELAGTCGYIAPELAYTM 954
               +HRD++++ +LL       + DFG  + L  +  ++           + APE   T 
Sbjct: 130  KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
              +   D + FGV + E+                P    N + +++ +       P    
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQE----------PWIGLNGSQILHKIDKEGERLPR--P 237

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            E+  + +  V   C    P+ RPT   + + L
Sbjct: 238  EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-38
 Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 46/289 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR--------AVKKLHSLPTGEIGINQKGFVSEITEI----RH 832
            G G  G V  AE    D          AVK L S  T +   +    +SE+  +    +H
Sbjct: 22   GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMKMIGKH 78

Query: 833  RNIVKFYGFCSHTQHLFLVYEYLERGSLATIL-------------SNEATAAELDWSKRV 879
            +NI+   G C+    L+++ EY  +G+L   L              +     +L     V
Sbjct: 79   KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 880  NVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS-- 937
            +    VA  + Y+        +HRD++++ VL+  +    ++DFG A+ +          
Sbjct: 139  SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 938  ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNI 997
                   ++APE  +      + DV++FGVL+ E+                P P   +  
Sbjct: 196  NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----------PYPGVPVEE 245

Query: 998  VVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            +   L +            +L  M+     C  A P  RPT +++   L
Sbjct: 246  LFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-38
 Identities = 58/265 (21%), Positives = 105/265 (39%), Gaps = 26/265 (9%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLH-SLPTGEIGINQKGFVSEI-TEIRHRNIVKFYGF 841
            G G   TV  A EL +    A+K L       E  +       ++ + + H   VK Y  
Sbjct: 17   GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 76

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                + L+    Y + G L   +    +    D +        + +AL Y+H      I+
Sbjct: 77   FQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG---KGII 130

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SELAGTCGYIAPELAYTMRANEK 959
            HRD+  + +LL+ +    ++DFGTAK L P+S     +   GT  Y++PEL     A + 
Sbjct: 131  HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190

Query: 960  CDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019
             D++  G ++ +++ G  P  F          A N  ++   +I      P  +   K +
Sbjct: 191  SDLWALGCIIYQLVAGLPP--F---------RAGNEYLIFQKIIKLEYDFP-EKFFPKAR 238

Query: 1020 SMIAVAFLCLDANPDCRPTMQKVCN 1044
             ++      L  +   R   +++  
Sbjct: 239  DLVE---KLLVLDATKRLGCEEMEG 260

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-37
 Identities = 51/287 (17%), Positives = 106/287 (36%), Gaps = 33/287 (11%)

Query: 770  ELLSASTFEGKMVLHGTGGCGTVYKAELTSGDTR-----AVKKLHSLPTGEIGINQKGFV 824
             +L  + F+   VL G+G  GTVYK        +     A+K+L    + +     K  +
Sbjct: 4    RILKETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK---ANKEIL 59

Query: 825  SEI---TEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNV 881
             E      + + ++ +  G C  T  + L+ + +  G L   +        +     +N 
Sbjct: 60   DEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNW 116

Query: 882  IKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SEL 939
               +A  ++Y+       ++HRD++++ VL+       ++DFG AK L  +   +     
Sbjct: 117  CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

Query: 940  AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVV 999
                 ++A E         + DV+++GV V E++               P      + + 
Sbjct: 174  KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----------PYDGIPASEIS 223

Query: 1000 NDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            + L      P        +  ++     C   + D RP  +++    
Sbjct: 224  SILEKGERLPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIEF 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 7e-37
 Identities = 48/280 (17%), Positives = 107/280 (38%), Gaps = 37/280 (13%)

Query: 785  GTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNI 835
            G G  G VY+               A+K ++   +      +  F++E     E    ++
Sbjct: 29   GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR---ERIEFLNEASVMKEFNCHHV 85

Query: 836  VKFYGFCSHTQHLFLVYEYLERGSLATIL-------SNEATAAELDWSKRVNVIKGVANA 888
            V+  G  S  Q   ++ E + RG L + L       +N    A    SK + +   +A+ 
Sbjct: 86   VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 889  LSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--NWSELAGTCGYI 946
            ++Y++       +HRD++++  ++  ++   + DFG  + +          +      ++
Sbjct: 146  MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 947  APELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
            +PE           DV++FGV++ E+                P    +   V+  +++  
Sbjct: 203  SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----------PYQGLSNEQVLRFVMEGG 252

Query: 1007 LPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            L        + L  ++    +C   NP  RP+  ++ + +
Sbjct: 253  LLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSI 289

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (349), Expect = 1e-36
 Identities = 54/264 (20%), Positives = 101/264 (38%), Gaps = 22/264 (8%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            GTG    V  AE   +    A+K +       +   +    +EI    +I+H NIV    
Sbjct: 18   GTGAFSEVILAEDKRTQKLVAIKCIAK---KALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                  HL+L+ + +  G L   +  +             +I  V +A+ Y+H       
Sbjct: 75   IYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
              +  +     LD + K  +SDFG +K   P S   +   GT GY+APE+      ++  
Sbjct: 132  DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVLAQKPYSKAV 190

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D ++ GV+   ++ G  P +  +        A     ++    +    P   ++ +  K 
Sbjct: 191  DCWSIGVIAYILLCGYPPFYDEN-------DAKLFEQILKAEYEFD-SPYWDDISDSAKD 242

Query: 1021 MIAVAFLCLDANPDCRPTMQKVCN 1044
             I      ++ +P+ R T ++   
Sbjct: 243  FIR---HLMEKDPEKRFTCEQALQ 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-36
 Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 33/264 (12%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-------HRNIV 836
            G G  G V+ AE   +    A+K L      ++ +        + E R       H  + 
Sbjct: 11   GKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
              +      ++LF V EYL  G L   + +     + D S+       +   L ++H   
Sbjct: 67   HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG 123

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
               I++RD+    +LLD +    ++DFG  K      +  +   GT  YIAPE+    + 
Sbjct: 124  ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 957  NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016
            N   D ++FGVL+ E++ G+ P  F            +   + + +       P   +E+
Sbjct: 181  NHSVDWWSFGVLLYEMLIGQSP--F---------HGQDEEELFHSIRMDNPFYP-RWLEK 228

Query: 1017 KLKSMIAVAFLCLDANPDCRPTMQ 1040
            + K ++          P+ R  ++
Sbjct: 229  EAKDLLV---KLFVREPEKRLGVR 249

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  135 bits (340), Expect = 9e-36
 Identities = 51/276 (18%), Positives = 109/276 (39%), Gaps = 34/276 (12%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLH-----SLPTGEIGINQKGFVSEITEIR----HRN 834
            G G    V +     +    AVK +      S    E+   ++  + E+  +R    H N
Sbjct: 12   GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 71

Query: 835  IVKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            I++           FLV++ +++G L   L+ + T   L   +   +++ +   +  +H 
Sbjct: 72   IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHK 128

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                 I+HRD+  + +LLD +    ++DFG +  L P       + GT  Y+APE+    
Sbjct: 129  ---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSYLAPEIIECS 184

Query: 955  RA------NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
                     ++ D+++ GV++  ++ G  P                + ++++        
Sbjct: 185  MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRMIMSGNYQFG-S 236

Query: 1009 PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
            P   +  + +K +++     L   P  R T ++   
Sbjct: 237  PEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 9e-36
 Identities = 51/266 (19%), Positives = 106/266 (39%), Gaps = 28/266 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCS 843
            G G  G V++  E +S  T   K +    T ++ + ++  +S +   RHRNI+  +    
Sbjct: 14   GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE--ISILNIARHRNILHLHESFE 71

Query: 844  HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHR 903
              + L +++E++    +   ++  A   EL+  + V+ +  V  AL ++H      I H 
Sbjct: 72   SMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHS---HNIGHF 126

Query: 904  DISSKKVLLDLEYKAHV--SDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCD 961
            DI  + ++      + +   +FG A+ LKP  +    L     Y APE+      +   D
Sbjct: 127  DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVSTATD 185

Query: 962  VFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP---LGEVEEKL 1018
            +++ G LV  ++ G +P             A     ++ +++++          E+  + 
Sbjct: 186  MWSLGTLVYVLLSGINPF-----------LAETNQQIIENIMNAEYTFDEEAFKEISIEA 234

Query: 1019 KSMIAVAFLCLDANPDCRPTMQKVCN 1044
               +      L      R T  +   
Sbjct: 235  MDFVD---RLLVKERKSRMTASEALQ 257

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  134 bits (337), Expect = 3e-35
 Identities = 63/278 (22%), Positives = 115/278 (41%), Gaps = 26/278 (9%)

Query: 785  GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYGF 841
            G G  G VYKA+   G+T A+KK+      E   +    + EI    E++H NIVK Y  
Sbjct: 11   GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST--TIREISILKELKHSNIVKLYDV 68

Query: 842  CSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPIL 901
                + L LV+E+L++     +   E     L+     + +  + N ++Y H      +L
Sbjct: 69   IHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD---RRVL 122

Query: 902  HRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEKC 960
            HRD+  + +L++ E +  ++DFG A+        ++    T  Y AP+ L  + + +   
Sbjct: 123  HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 961  DVFNFGVLVLEVIEGKHP-------GHFLSLLLSLPAPAANMNIVVNDLID-----SRLP 1008
            D+++ G +  E++ G             + +   L  P +     V +L       +   
Sbjct: 183  DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 1009 PPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
            P   E   K      +  L   L  +P+ R T ++   
Sbjct: 243  PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-34
 Identities = 57/270 (21%), Positives = 111/270 (41%), Gaps = 29/270 (10%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTG--EIGINQKGFVSEITEIRHRNIVKFYGF 841
            G G  G V +     + +  A+K L   P    E+ ++ +         +  +IV+    
Sbjct: 21   GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR-------ASQCPHIVRIVDV 73

Query: 842  C----SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
                 +  + L +V E L+ G L + + +    A     +   ++K +  A+ Y+H    
Sbjct: 74   YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHSIN- 131

Query: 898  PPILHRDISSKKVLLDLEYK---AHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
              I HRD+  + +L   +       ++DFG AK     +S  +    T  Y+APE+    
Sbjct: 132  --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVLGPE 188

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
            + ++ CD+++ GV++  ++ G  P +    L   P     + +   +  +    P   EV
Sbjct: 189  KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN----PEWSEV 244

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
             E++K +I      L   P  R T+ +  N
Sbjct: 245  SEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 6e-34
 Identities = 50/270 (18%), Positives = 101/270 (37%), Gaps = 28/270 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEIT---EIRHRNIVKF 838
            G+G    V K  E ++G   A K +      +   G++++    E++   EI+H N++  
Sbjct: 19   GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 78

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
            +    +   + L+ E +  G L   L+ + +   L   +    +K + N + Y+H     
Sbjct: 79   HEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS---L 132

Query: 899  PILHRDISSKKVLLDLE----YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
             I H D+  + ++L        +  + DFG A  +   +     + GT  ++APE+    
Sbjct: 133  QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTPEFVAPEIVNYE 191

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
                + D+++ GV+   ++ G  P    +           +  V     +          
Sbjct: 192  PLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNYEFE-DEYFSNT 243

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
                K  I      L  +P  R T+Q    
Sbjct: 244  SALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  129 bits (324), Expect = 1e-33
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 29/265 (10%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G GG   V+ A  L      AVK L +    +     + F  E      + H  IV  Y 
Sbjct: 16   GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVYD 74

Query: 841  FCSHTQH----LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
                        ++V EY++  +L  I+  E     +   + + VI     AL++ H   
Sbjct: 75   TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ-- 129

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE---LAGTCGYIAPELAYT 953
               I+HRD+    +++       V DFG A+ +    ++ ++   + GT  Y++PE A  
Sbjct: 130  -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
               + + DV++ G ++ EV+ G+ P  F            +   V    +     PP   
Sbjct: 189  DSVDARSDVYSLGCVLYEVLTGEPP--F---------TGDSPVSVAYQHVREDPIPPSAR 237

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPT 1038
             E     + AV    L  NP+ R  
Sbjct: 238  HEGLSADLDAVVLKALAKNPENRYQ 262

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 56/288 (19%), Positives = 101/288 (35%), Gaps = 44/288 (15%)

Query: 785  GTGGCGTVYKAELTSGDTR------AVKKLHSLPTGEIGINQKGFVSEITEI----RHRN 834
            G G  G V +A+    D        AVK L     G      +  +SE+  +     H N
Sbjct: 22   GRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHLN 78

Query: 835  IVKFYGFCSHT-QHLFLVYEYLERGSLATILSN-------------EATAAELDWSKRVN 880
            +V   G C+     L ++ E+ + G+L+T L +             +     L     + 
Sbjct: 79   VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 881  VIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW--SE 938
                VA  + ++        +HRD++++ +LL  +    + DFG A+ +  D       +
Sbjct: 139  YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 939  LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIV 998
                  ++APE  +      + DV++FGVL+ E+                P P   ++  
Sbjct: 196  ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----------PYPGVKIDEE 245

Query: 999  VNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
                +           +     M      C    P  RPT  ++   L
Sbjct: 246  FCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 7e-33
 Identities = 60/285 (21%), Positives = 103/285 (36%), Gaps = 36/285 (12%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G G  G VY+A+L  SG+  A+KK+          +++    E+    ++ H NIV+   
Sbjct: 29   GNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHCNIVRLRY 80

Query: 841  FCSHT------QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
            F   +       +L LV +Y+                 L        +  +  +L+Y+H 
Sbjct: 81   FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140

Query: 895  DCFPPILHRDISSKKVLLDLEYKAH-VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYT 953
                 I HRDI  + +LLD +     + DFG+AK L     N S +          +   
Sbjct: 141  ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 954  MRANEKCDVFNFGVLVLEVIEGKHP-------GHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
                   DV++ G ++ E++ G+            + ++  L  P       +N      
Sbjct: 198  TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257

Query: 1007 LPP-----PLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
              P     P  +V        A+A     L+  P  R T  + C 
Sbjct: 258  KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-32
 Identities = 57/279 (20%), Positives = 108/279 (38%), Gaps = 26/279 (9%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G VYKA    +G+  A+KK+      E   +    + EI    E+ H NIVK   
Sbjct: 11   GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST--AIREISLLKELNHPNIVKLLD 68

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                   L+LV+E+L +     + ++  T   +      + +  +   L++ H      +
Sbjct: 69   VIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCHSHR---V 123

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRANEK 959
            LHRD+  + +L++ E    ++DFG A+        ++    T  Y APE L      +  
Sbjct: 124  LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183

Query: 960  CDVFNFGVLVLEVIEGKHP-------GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012
             D+++ G +  E++  +              +  +L  P   +   V  + D +   P  
Sbjct: 184  VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243

Query: 1013 EVEEKLK-----SMIAVAFL--CLDANPDCRPTMQKVCN 1044
              ++  K          + L   L  +P+ R + +    
Sbjct: 244  ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  126 bits (317), Expect = 2e-32
 Identities = 55/258 (21%), Positives = 103/258 (39%), Gaps = 29/258 (11%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            GTG  G V+      +G   A+K L       +   +     E    + + H  I++ +G
Sbjct: 13   GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-TNDERLMLSIVTHPFIIRMWG 71

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                 Q +F++ +Y+E G L ++L                 +         + +     I
Sbjct: 72   TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDI 125

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            ++RD+  + +LLD      ++DFG AK++         L GT  YIAPE+  T   N+  
Sbjct: 126  IYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D ++FG+L+ E++ G  P  F           +N       ++++ L  P     E +K 
Sbjct: 183  DWWSFGILIYEMLAGYTP--F---------YDSNTMKTYEKILNAELRFP-PFFNEDVKD 230

Query: 1021 MIAVAFLCLDANPDCRPT 1038
            +++     +  +   R  
Sbjct: 231  LLS---RLITRDLSQRLG 245

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  127 bits (319), Expect = 3e-32
 Identities = 54/264 (20%), Positives = 93/264 (35%), Gaps = 27/264 (10%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLHSLPTG-----EIGINQKGFVSEITEIRHRNIVKF 838
            G GG G VY      +G   A+K L            + +N++  +S ++      IV  
Sbjct: 13   GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 72

Query: 839  YGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFP 898
                     L  + + +  G L   LS     +E D          +   L +MH+    
Sbjct: 73   SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLEHMHN---R 126

Query: 899  PILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTMRAN 957
             +++RD+    +LLD      +SD G A        + S   GT GY+APE L   +  +
Sbjct: 127  FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQKGVAYD 184

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
               D F+ G ++ +++ G  P                  I    L  +   P       +
Sbjct: 185  SSADWFSLGCMLFKLLRGHSPFRQHK-------TKDKHEIDRMTLTMAVELPD--SFSPE 235

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQK 1041
            L+S++      L  + + R     
Sbjct: 236  LRSLLE---GLLQRDVNRRLGCLG 256

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 4e-32
 Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 27/280 (9%)

Query: 785  GTGGCGTVYKAELT-SGDTRAVKKLH-SLPTGEIGINQKGFVSEI---TEIRHRNIVKFY 839
            G G   TVYKA    +    A+KK+     +       +  + EI    E+ H NI+   
Sbjct: 7    GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66

Query: 840  GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
                H  ++ LV++++E      I  N      L  S     +      L Y+H      
Sbjct: 67   DAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHW--- 120

Query: 900  ILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA-NE 958
            ILHRD+    +LLD      ++DFG AK     +  ++    T  Y APEL +  R    
Sbjct: 121  ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 959  KCDVFNFGVLVLEVIEGKHP----------GHFLSLLLSLPAPAANMNIVVNDLIDSRLP 1008
              D++  G ++ E++                     L +           + D +  +  
Sbjct: 181  GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 1009 P--PLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
            P  PL  +         +  +      NP  R T  +   
Sbjct: 241  PGIPLHHIFSAA-GDDLLDLIQGLFLFNPCARITATQALK 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (311), Expect = 8e-32
 Identities = 39/278 (14%), Positives = 85/278 (30%), Gaps = 36/278 (12%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G+G  G +Y    + +G+  A+K         +         E      ++    +    
Sbjct: 16   GSGSFGDIYLGTDIAAGEEVAIKLEC------VKTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 841  FC-SHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
            +C +   +  +V E L                +      + +   + + + Y+H      
Sbjct: 70   WCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN--- 123

Query: 900  ILHRDISSKKVL---LDLEYKAHVSDFGTAKFLKPDSSN-------WSELAGTCGYIAPE 949
             +HRD+     L          ++ DFG AK  +   ++          L GT  Y +  
Sbjct: 124  FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 950  LAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009
                +  + + D+ + G +++    G  P   L         AA        + + ++  
Sbjct: 184  THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL--------KAATKRQKYERISEKKMST 235

Query: 1010 PLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
            P+  + +            C     D +P    +  L 
Sbjct: 236  PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (305), Expect = 5e-31
 Identities = 43/280 (15%), Positives = 78/280 (27%), Gaps = 38/280 (13%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVKFY 839
            G G  G +++   L +    A+K            +      E    +       I   Y
Sbjct: 14   GEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 840  GFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP 899
             F     H  LV + L       +                   K +   +  +H      
Sbjct: 68   YFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 900  ILHRDISSKKVLLDLEYKAH-----VSDFGTAKFLKPDSSN-------WSELAGTCGYIA 947
            +++RDI     L+      +     V DFG  KF +   +           L+GT  Y++
Sbjct: 122  LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 948  PELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007
                     + + D+   G + +  + G  P   L         AA        + + + 
Sbjct: 182  INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--------AATNKQKYERIGEKKQ 233

Query: 1008 PPPLGEVEEKL-KSMIAVAFLCLDANPDCRPTMQKVCNLL 1046
              PL E+     +          +   D  P    +  L 
Sbjct: 234  STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 49/285 (17%), Positives = 101/285 (35%), Gaps = 33/285 (11%)

Query: 785  GTGGCGTVYKAE--LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR------HRNIV 836
            G G  G V+KA      G   A+K++      E        + E+  +R      H N+V
Sbjct: 16   GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVV 73

Query: 837  KFYGFCSHTQ-----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSY 891
            + +  C+ ++      L LV+E++++     +         +      +++  +   L +
Sbjct: 74   RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDF 131

Query: 892  MHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELA 951
            +H      ++HRD+  + +L+    +  ++DFG A+      +  S +  T  Y APE+ 
Sbjct: 132  LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLWYRAPEVL 187

Query: 952  YTMRANEKCDVFNFGVLVLEVIEGKHP----------GHFLSLLLSLPAPAANMNIVVND 1001
                     D+++ G +  E+   K            G  L ++          ++ +  
Sbjct: 188  LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 1002 LIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
                       E        +    L  CL  NP  R +     +
Sbjct: 248  QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-30
 Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 38/270 (14%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLH--SLPTGEIGINQKGFVSEITEIR-----HRNIV 836
            G+GG G+VY    ++     A+K +    +       N      E+  ++        ++
Sbjct: 13   GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 72

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
            +   +        L+ E  E          E  A  L      +    V  A+ + H+  
Sbjct: 73   RLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN-- 128

Query: 897  FPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPE-LAYTM 954
               +LHRDI  + +L+DL   +  + DFG+   LK   + +++  GT  Y  PE + Y  
Sbjct: 129  -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHR 185

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014
                   V++ G+L+ +++ G  P               +  I+   +           V
Sbjct: 186  YHGRSAAVWSLGILLYDMVCGDIP------------FEHDEEIIRGQVF---FRQ---RV 227

Query: 1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044
              + + +I     CL   P  RPT +++ N
Sbjct: 228  SSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 6e-29
 Identities = 50/280 (17%), Positives = 101/280 (36%), Gaps = 28/280 (10%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  GTV+KA+   + +  A+K++      E   +    + EI    E++H+NIV+ + 
Sbjct: 11   GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--ALREICLLKELKHKNIVRLHD 68

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                 + L LV+E+ ++       S               V   +   L  +       +
Sbjct: 69   VLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA-NEK 959
            LHRD+  + +L++   +  +++FG A+        +S    T  Y  P++ +  +  +  
Sbjct: 123  LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 960  CDVFNFGVLVLEVIEGKHP--------GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011
             D+++ G +  E+     P             +   L  P       +  L D +  P  
Sbjct: 183  IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 1012 GEVEEKLK-----SMIAVAFL--CLDANPDCRPTMQKVCN 1044
                  +      +      L   L  NP  R + ++   
Sbjct: 243  PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 57/264 (21%), Positives = 95/264 (35%), Gaps = 32/264 (12%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR------HRNIVK 837
            G G  G V       +G   A+K L      E+ I +      +TE R      H  +  
Sbjct: 14   GKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 838  FYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
                      L  V EY   G L   LS E         +       + +AL Y+H    
Sbjct: 70   LKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHS--- 123

Query: 898  PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRAN 957
              +++RDI  + ++LD +    ++DFG  K    D +      GT  Y+APE+       
Sbjct: 124  RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 958  EKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017
               D +  GV++ E++ G+ P  F            +   +   ++   +  P   +  +
Sbjct: 184  RAVDWWGLGVVMYEMMCGRLP--F---------YNQDHERLFELILMEEIRFP-RTLSPE 231

Query: 1018 LKSMIAVAFLCLDANPDCRPTMQK 1041
             KS++A     L  +P  R     
Sbjct: 232  AKSLLA---GLLKKDPKQRLGGGP 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 3e-28
 Identities = 55/284 (19%), Positives = 91/284 (32%), Gaps = 30/284 (10%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G V  A +  +    A+KK+            +  + EI      RH NI+    
Sbjct: 17   GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY---CQRTLREIKILLRFRHENIIGIND 73

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                     +   YL    +   L        L        +  +   L Y+H      +
Sbjct: 74   IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANV 130

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCG---YIAPELAYT-MRA 956
            LHRD+    +LL+      + DFG A+   PD  +   L        Y APE+       
Sbjct: 131  LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 957  NEKCDVFNFGVLVLEVIEGKHP----------GHFLSLLLSLPAPAANMNIVVNDLIDSR 1006
             +  D+++ G ++ E++  +             H L +L S      N  I +       
Sbjct: 191  TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 1007 LPPPLGEVEEKLK----SMIAVAFL--CLDANPDCRPTMQKVCN 1044
              P   +V            A+  L   L  NP  R  +++   
Sbjct: 251  SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-27
 Identities = 56/294 (19%), Positives = 104/294 (35%), Gaps = 42/294 (14%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            G G  G V+KA    +G   A+KK+      E        + EI     ++H N+V    
Sbjct: 19   GQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 841  FCSHTQ--------HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYM 892
             C             ++LV+++ E      + +      +   S+   V++ + N L Y+
Sbjct: 77   ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133

Query: 893  HHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS----NWSELAGTCGYIAP 948
            H      ILHRD+ +  VL+  +    ++DFG A+      +     ++    T  Y  P
Sbjct: 134  HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 949  ELAYTMRA-NEKCDVFNFGVLVLEVIEGKHP---------GHFLSLLLSLPAPAANMNI- 997
            EL    R      D++  G ++ E+                  +S L     P    N+ 
Sbjct: 191  ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 998  -----VVNDLIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
                    +L+  +       ++  ++   A+  +   L  +P  R       N
Sbjct: 251  NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  109 bits (273), Expect = 3e-26
 Identities = 80/389 (20%), Positives = 146/389 (37%), Gaps = 41/389 (10%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           F      +     L    +  T+    + L ++  L         I    +  L NL  +
Sbjct: 16  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 71

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
             S NQL  + P  L  LT L ++ ++ N++    P +       + L  +  +    + 
Sbjct: 72  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
                       +   D+  L    S+   +        + L  L  L  + +++N++  
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS- 188

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
              S +  L +L  L    NQ+S   P     L+NL  L L+ N+L       L S  +L
Sbjct: 189 -DISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNL 243

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIP-------------------- 297
             L L++NQ++   P     L+ L  L +   N++S   P                    
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGA-NQISNISPLAGLTALTNLELNENQLEDI 300

Query: 298 KEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQL 357
             I NLK+L++L L    +S   P  + +L+ ++ L+   N +  S    L  L +++ L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWL 356

Query: 358 SLSVNKLNGSIPHCLGNLSNLKFFALREN 386
           S   N+++   P  L NL+ +    L + 
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  102 bits (255), Expect = 8e-24
 Identities = 74/386 (19%), Positives = 143/386 (37%), Gaps = 35/386 (9%)

Query: 302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
            L       L KT ++  +  +  +L  +  L      +  SI + +  L +L+Q++ S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE------IENMKKLNKYLLFENQFTGY 415
           N+L    P  L NL+ L    +  N+++   P           +       +   +    
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSL-------RLERNQLTGNISEVF 468
           L +    S +++  S  +              T L  L       RL+ +    +   V 
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS 528
               +LE L  +NN               L  L++ GN++       + ++T L  LD +
Sbjct: 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNL 588
           +N++    P  L  LT LT L L  NQ+S   PL          L+ +           +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISPI 303

Query: 589 GELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLL 648
             L+ L +L L  N  S    +    L +L +L  ++N +     S + NL ++ +++  
Sbjct: 304 SNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 649 QNKLSGPIPSCFRRMHGLSSIDVSYN 674
            N++S   P     +  ++ + ++  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  102 bits (254), Expect = 1e-23
 Identities = 80/386 (20%), Positives = 143/386 (37%), Gaps = 34/386 (8%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
            L       L K  ++ ++  T  +L  +  L      +       +    +L  +  S+
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP-- 322
           NQL    P    NL+ L  + ++N      +    + NL  L+      T +        
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 323 ---------SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCL- 372
                    ++ ++S + GL   + + +G+   +L  L +L+ L       N      + 
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 373 GNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVR 432
             L+NL+      N++S   P  I  +  L++  L  NQ        +    +LT   + 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 433 NNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNW 492
           NN      P  L   T L  L+L  NQ++  IS + G+     L    N           
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDIS---PI 303

Query: 493 IKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLN 552
                L  L +  N IS   P  + ++T+L +L F++N++       L  LT++  L+  
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 553 GNQLSGDIPLELGLLAELGYLDLSAN 578
            NQ+S   P  L  L  +  L L+  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  100 bits (249), Expect = 4e-23
 Identities = 80/398 (20%), Positives = 142/398 (35%), Gaps = 34/398 (8%)

Query: 157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNK 216
            L   +   L   N +  + ++   L  +T +  +   I  SI   +  L +L+ +  + 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 217 NQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFG 276
           NQL+   P    NL+ L  + +++N+++   P    +  + L L+ +       L +   
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
                 +    + N +S                    T         L NL+ +  L I 
Sbjct: 134 L-----NRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDIS 183

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEI 396
            N +         +L +L  L  + N+++   P     L+NL   +L  N+L       +
Sbjct: 184 SNKVSDISVL--AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTL 237

Query: 397 ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLE 456
            ++  L    L  NQ +   P  +     LT   +  N      P  L   T+L +L L 
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 293

Query: 457 RNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEI 516
            NQ             +L  L L  NN       +     +L  L    N++S    S +
Sbjct: 294 ENQ--LEDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSL 347

Query: 517 GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGN 554
            N+T ++ L    N++    P  L  LT +T L LN  
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.8 bits (237), Expect = 1e-21
 Identities = 75/384 (19%), Positives = 145/384 (37%), Gaps = 41/384 (10%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
           L   +   L    +   + +   +L  +  L      +  SI   +  L+NL Q++ SNN
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 76

Query: 131 SLSGQIP-------------------PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNF 171
            L+   P                         ++   G    +    +     +L   N 
Sbjct: 77  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136

Query: 172 SGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS-GSIPPTAGNL 230
             +   ++  +  L+ +        G+  +++  L +L+ L       +  S       L
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196

Query: 231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
           +NL+ L   +N++S   P  +    +L  L L+ NQL      +  +L++L  L + N N
Sbjct: 197 TNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN-N 251

Query: 291 KLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR 350
           ++S   P  +  L  L+ L L   Q+S   P  L  L+ +  L + EN L    P     
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--N 305

Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
           LK+L+ L+L  N ++   P  + +L+ L+      N++S      + N+  +N      N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 411 QFTGYLPQNVCQSGSLTHFSVRNN 434
           Q +   P  +     +T   + + 
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-26
 Identities = 51/286 (17%), Positives = 100/286 (34%), Gaps = 38/286 (13%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G V  A +  +G   A+KKL+     E+   +     E+     +RH N++    
Sbjct: 27   GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR--AYRELRLLKHMRHENVIGLLD 84

Query: 841  FCSHTQ------HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
              +  +        +LV  ++       +   +     L   +   ++  +   L Y+H 
Sbjct: 85   VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA 139

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                   HRD+    + ++ + +  + DFG A+    DS     +          +   M
Sbjct: 140  AGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWM 194

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLS-------LLLSLPAPAANMNIVVNDLIDSRL 1007
            R  +  D+++ G ++ E+I GK              ++     P A     +        
Sbjct: 195  RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254

Query: 1008 PPPLGEVEEKLKSMI-------AVAFL--CLDANPDCRPTMQKVCN 1044
               L E+E+K  + I       AV  L   L  + + R T  +   
Sbjct: 255  MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 5e-26
 Identities = 57/268 (21%), Positives = 101/268 (37%), Gaps = 28/268 (10%)

Query: 785  GTGGCGTVYKAELT----SGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHR-NIV 836
            GTG  G V+         +G   A+K L      +     +   +E      IR    +V
Sbjct: 33   GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 92

Query: 837  KFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC 896
              +        L L+ +Y+  G L T LS      E +    V         +  + H  
Sbjct: 93   TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GEIVLALEHLH 146

Query: 897  FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS-ELAGTCGYIAPELAYTMR 955
               I++RDI  + +LLD      ++DFG +K    D +  + +  GT  Y+AP++     
Sbjct: 147  KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206

Query: 956  A--NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013
            +  ++  D ++ GVL+ E++ G  P        ++     +   +   ++ S  P P  E
Sbjct: 207  SGHDKAVDWWSLGVLMYELLTGASP-------FTVDGEKNSQAEISRRILKSEPPYP-QE 258

Query: 1014 VEEKLKSMIAVAFLCLDANPDCRPTMQK 1041
            +    K +I      L  +P  R     
Sbjct: 259  MSALAKDLIQ---RLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  107 bits (267), Expect = 1e-25
 Identities = 52/292 (17%), Positives = 98/292 (33%), Gaps = 49/292 (16%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR----HRNIVKFY 839
            G G    V++A  +T+ +   VK L         + +K    EI  +       NI+   
Sbjct: 44   GRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLA 96

Query: 840  GFCSH--TQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCF 897
                   ++   LV+E++       +         L        +  +  AL Y H    
Sbjct: 97   DIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG- 149

Query: 898  PPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRA 956
              I+HRD+    V++D E  K  + D+G A+F  P    ++    +  +  PEL    + 
Sbjct: 150  --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQM 206

Query: 957  -NEKCDVFNFGVLVLEVIEGKHP---------------------GHFLSLLLSLPAPAAN 994
             +   D+++ G ++  +I  K P                       +  +          
Sbjct: 207  YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 995  MNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
             N ++      R    +    + L S  A+ FL   L  +   R T ++   
Sbjct: 267  FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (262), Expect = 6e-25
 Identities = 53/257 (20%), Positives = 93/257 (36%), Gaps = 29/257 (11%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEI---TEIRHRNIVKFYG 840
            GTG  G V   +   SG+  A+K L      ++   +   ++E      +    +VK   
Sbjct: 50   GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQAVNFPFLVKLEF 108

Query: 841  FCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPI 900
                  +L++V EY+  G + + L                    +     Y+H      +
Sbjct: 109  SFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---L 162

Query: 901  LHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKC 960
            ++RD+  + +L+D +    V+DFG AK           L GT   +APE+  +   N+  
Sbjct: 163  IYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 961  DVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLKS 1020
            D +  GVL+ E+  G  P              A+  I + + I S            LK 
Sbjct: 220  DWWALGVLIYEMAAGYPP------------FFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267

Query: 1021 MIAVAFLCLDANPDCRP 1037
            ++      L  +   R 
Sbjct: 268  LLR---NLLQVDLTKRF 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 6e-23
 Identities = 52/297 (17%), Positives = 99/297 (33%), Gaps = 49/297 (16%)

Query: 785  GTGGCGTVYKA-ELTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G V  A +       A+KKL      +    +     E+     + H+NI+    
Sbjct: 26   GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR--AYRELVLMKCVNHKNIISLLN 83

Query: 841  FCSHT------QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHH 894
              +        Q ++LV E ++      I          D  +   ++  +   + ++H 
Sbjct: 84   VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHS 137

Query: 895  DCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTM 954
                  +HRD+    +++  +    + DFG A+     S   +    T  Y APE+   M
Sbjct: 138  AGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 955  RANEKCDVFNFGVLVLEVIEGKHPGHFLS-----------LLLSLPAPAANMNIVVNDLI 1003
               E  D+++ G ++ E++  K                  L    P     +   V + +
Sbjct: 194  GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 1004 DSRLP--------------PPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
            ++R                 P      KLK+  A   L   L  +P  R ++     
Sbjct: 254  ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.0 bits (240), Expect = 2e-22
 Identities = 55/313 (17%), Positives = 101/313 (32%), Gaps = 39/313 (12%)

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
            +PK++      + L L   +++        NL N+  L +  N +    P     L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
            +L LS N+L          L  L+       ++  S+   +  M  +            
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV------------ 129

Query: 415 YLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDL 474
                                  G    + Q    L  +R+    +T   +   G+ P L
Sbjct: 130 -------------ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSL 173

Query: 475 ELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG 534
             L L  N      +++      LA L +  N IS      + N   L +L  ++N+LV 
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232

Query: 535 QIPKQLGKLTSLTSLTLNGNQLSG------DIPLELGLLAELGYLDLSANRLS--KLIPK 586
           ++P  L     +  + L+ N +S         P      A    + L +N +   ++ P 
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 587 NLGELRKLHHLNL 599
               +     + L
Sbjct: 293 TFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.9 bits (237), Expect = 5e-22
 Identities = 64/304 (21%), Positives = 114/304 (37%), Gaps = 27/304 (8%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L++ P  L P  A LDL  N++         +L  L  L    N+ S I P     L  L
Sbjct: 22  LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L LS NQL  L  +    L  L       N +     +    L+ ++ + L  N L  
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLK- 137

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
                         G        ++    + +   N + +     G   +LT ++L+ N+
Sbjct: 138 ------------SSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNK 182

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
           I     + +  L +L+ LGL+ N +S     +  N  +L+ L+L++N+L   +P  L   
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241

Query: 255 KSLLYLYLSHNQLNG------SLPSSFGNLSSLKHLHVHNINKLSGSI-PKEIGNLKSLS 307
           K +  +YL +N ++         P      +S   + + +       I P     +   +
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301

Query: 308 HLWL 311
            + L
Sbjct: 302 AVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.4 bits (228), Expect = 6e-21
 Identities = 48/269 (17%), Positives = 98/269 (36%), Gaps = 11/269 (4%)

Query: 425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNF 484
                 ++NN          +N  +L++L L  N+++      F     LE L LS N  
Sbjct: 32  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 485 FGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLT 544
                       +L        ++  ++ + +  M  +  L  +  +  G        + 
Sbjct: 92  KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
            L+ + +    ++    +  GL   L  L L  N+++K+   +L  L  L  L LS N  
Sbjct: 151 KLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR--- 661
           S   +  +     L +L L++N L   +P  + + + ++ + L  N +S    + F    
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266

Query: 662 ---RMHGLSSIDVSYNELQGSIPHSKAFQ 687
              +    S + +  N +Q        F+
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFR 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 91.6 bits (226), Expect = 1e-20
 Identities = 59/304 (19%), Positives = 103/304 (33%), Gaps = 17/304 (5%)

Query: 256 SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQ 315
            L  +  S   L   +P           L + N NK++     +  NLK+L  L L   +
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQN-NKITEIKDGDFKNLKNLHTLILINNK 66

Query: 316 LSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNL 375
           +S   P +   L  +  LY+ +N L     +    L+ L      + K+  S+ + L  +
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126

Query: 376 SNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNN 435
             ++       + SG      + MKKL+   + +   T  +PQ +    SLT   +  N 
Sbjct: 127 IVVELG-TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNK 182

Query: 436 FVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKC 495
                  SL+   +L  L L  N ++   +      P L  L L+NN             
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLA-DH 241

Query: 496 PQLATLNMGGNEISG------TIPSEIGNMTQLHKLDFSSNRL--VGQIPKQLGKLTSLT 547
             +  + +  N IS         P           +   SN +      P     +    
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301

Query: 548 SLTL 551
           ++ L
Sbjct: 302 AVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.7 bits (221), Expect = 6e-20
 Identities = 55/289 (19%), Positives = 107/289 (37%), Gaps = 17/289 (5%)

Query: 391 SIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTS 449
            +P+++  +   L+   L  N+ T     +     +L    + NN      P +      
Sbjct: 24  KVPKDLPPDTALLD---LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80

Query: 450 LYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEIS 509
           L  L L +NQL     ++     +L + +         + +   +   +  L     + S
Sbjct: 81  LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSS 139

Query: 510 GTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAE 569
           G        M +L  +  +   +   IP+ L    SLT L L+GN+++      L  L  
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 570 LGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG 629
           L  L LS N +S +   +L     L  L+L+NN+  +     +     +  + L +N++ 
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNIS 255

Query: 630 G------NIPSEICNLESLEYMNLLQNKLS--GPIPSCFRRMHGLSSID 670
                    P       S   ++L  N +      PS FR ++  +++ 
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.5 bits (205), Expect = 7e-18
 Identities = 58/293 (19%), Positives = 108/293 (36%), Gaps = 29/293 (9%)

Query: 1   VVSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQF 60
              ++L  + +   +++  F     L  L L  N++    P   + L KL+ L  S NQ 
Sbjct: 33  TALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91

Query: 61  SGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLS 120
             +       L  L V    + ++   +   L ++  +  L  +  + +G    +   + 
Sbjct: 92  KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150

Query: 121 NLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLG 180
            L  + +++ +++                +IPQ  G   S   + L  N  + V   SL 
Sbjct: 151 KLSYIRIADTNIT----------------TIPQ--GLPPSLTELHLDGNKITKVDAASLK 192

Query: 181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHD 240
           GL NL  + L+ N I       + N   L  L LN N+L   +P    +   ++ +YLH+
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 251

Query: 241 NRLSG------YIPPKLGSFKSLLYLYLSHNQLNGS--LPSSFGNLSSLKHLH 285
           N +S         P       S   + L  N +      PS+F  +     + 
Sbjct: 252 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.4 bits (202), Expect = 2e-17
 Identities = 43/230 (18%), Positives = 83/230 (36%), Gaps = 4/230 (1%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS 528
            + PD  LLDL NN        ++     L TL +  N+IS   P     + +L +L  S
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNL 588
            N+L     K    L  L        ++   +   L  +  +  L  +  + S +     
Sbjct: 88  KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAF 146

Query: 589 GELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLL 648
             ++KL ++ +++   +   +I  G    L++L L  N +     + +  L +L  + L 
Sbjct: 147 QGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203

Query: 649 QNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNK 698
            N +S            L  + ++ N+L          +   +     N 
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 9e-16
 Identities = 45/221 (20%), Positives = 89/221 (40%), Gaps = 8/221 (3%)

Query: 496 PQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
           P  A L++  N+I+     +  N+  LH L   +N++    P     L  L  L L+ NQ
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 556 LSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN--NQFSQEISIQIG 613
           L     L   +   L  L +  N ++K+       L ++  + L     + S   +    
Sbjct: 91  LKE---LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147

Query: 614 KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSY 673
            + +LS + ++  ++   IP  +    SL  ++L  NK++    +  + ++ L+ + +S+
Sbjct: 148 GMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 674 NELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPCEALT 714
           N +      S A      E    N +L     GL   + + 
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.3 bits (129), Expect = 3e-08
 Identities = 28/154 (18%), Positives = 53/154 (34%), Gaps = 3/154 (1%)

Query: 545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
            L  +  +   L   +P +L    +   LDL  N+++++   +   L+ LH L L NN+ 
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMH 664
           S+        LV+L +L LS N L          L+ L        K+   + +   +M 
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 665 GLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNK 698
            +                 +  +  +        
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 4e-21
 Identities = 51/285 (17%), Positives = 102/285 (35%), Gaps = 36/285 (12%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTGEIGINQKGFVSEIT---EIRHRNIVKFYG 840
            G+G  G+V  A    +G   AVKKL      +  I+ K    E+     ++H N++    
Sbjct: 27   GSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 841  FCSHTQHL-----FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
              +  + L       +  +L    L  I+  +    +L       +I  +   L Y+H  
Sbjct: 85   VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA 140

Query: 896  CFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMR 955
                  HRD+    + ++ + +  + DFG A+    D      +A         +   M 
Sbjct: 141  DII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195

Query: 956  ANEKCDVFNFGVLVLEVIEGKHP-------GHFLSLLLSLPAPAANMNIVVNDLID---- 1004
             N+  D+++ G ++ E++ G+              +L  +  P A +   ++        
Sbjct: 196  YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 1005 ---SRLPPPLGEVEEKLKSMIAVAFL--CLDANPDCRPTMQKVCN 1044
               +++P           + +AV  L   L  + D R T  +   
Sbjct: 256  QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.3 bits (217), Expect = 1e-19
 Identities = 51/256 (19%), Positives = 105/256 (41%), Gaps = 4/256 (1%)

Query: 231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
           +  + ++LH NR+S        + ++L  L+L  N L     ++F  L+ L+ L + +  
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 291 KLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGR 350
           +L    P     L  L  L L +  L    P     L+ ++ LY+++N L     +    
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
           L +L+ L L  N+++         L +L    L +N ++   P    ++ +L    LF N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI 470
             +    + +    +L +  + +N +V    R+      L   R   +++  ++ +    
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA- 269

Query: 471 YPDLELLDLSNNNFFG 486
               +L  L+ N+  G
Sbjct: 270 --GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (212), Expect = 5e-19
 Identities = 54/266 (20%), Positives = 90/266 (33%), Gaps = 9/266 (3%)

Query: 391 SIPQEI-ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTS 449
           ++P  I    +++    L  N+ +     +     +LT   + +N        +      
Sbjct: 25  AVPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81

Query: 450 LYSLRLERNQLTGNI-SEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEI 508
           L  L L  N    ++    F     L  L L            +     L  L +  N +
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 509 SGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLA 568
                    ++  L  L    NR+     +    L SL  L L+ N+++   P     L 
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSL 628
            L  L L AN LS L  + L  LR L +L L++N +  +          L K   S + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEV 260

Query: 629 GGNIPSEICNLESLEYMNLLQNKLSG 654
             ++P     L   +   L  N L G
Sbjct: 261 PCSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (195), Expect = 8e-17
 Identities = 64/281 (22%), Positives = 100/281 (35%), Gaps = 33/281 (11%)

Query: 159 ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQ 218
           E  V+ S         +P  +        ++L+ NRI     +     R+L+ L L+ N 
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67

Query: 219 -------------------------LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGS 253
                                    L    P T   L  L  L+L    L    P     
Sbjct: 68  LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127

Query: 254 FKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSK 313
             +L YLYL  N L      +F +L +L HL +H  N++S    +    L SL  L L +
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG-NRISSVPERAFRGLHSLDRLLLHQ 186

Query: 314 TQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLG 373
            +++   P +  +L  +  LY+  N L     E L  L++L  L L+ N           
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RP 245

Query: 374 NLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTG 414
             + L+ F    +E+  S+PQ +          L  N   G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.3 bits (191), Expect = 3e-16
 Identities = 51/265 (19%), Positives = 78/265 (29%), Gaps = 38/265 (14%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLK----------------------- 51
           LQ  P  +      + L  N++             L                        
Sbjct: 23  LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 52  --HLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLN 109
                    Q   + P     L  L  L L    L  L P     L +L  L L  N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 110 GSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLIS---------PHYGSIPQDLGNLES 160
                +  +L NL  L L  N +S      +  L S               P    +L  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 161 PVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
            +++ L  NN S +   +L  L+ L ++ LN+N  V    +       L     + +++ 
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261

Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSG 245
            S+P     L+      L  N L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (189), Expect = 6e-16
 Identities = 51/251 (20%), Positives = 91/251 (36%), Gaps = 14/251 (5%)

Query: 88  IPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPH 147
           +P  +    +   + L  NR++    AS     NL  L L +N L+      +  L    
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 148 YGSI----------PQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVG 197
              +          P     L    ++ L       + P    GL  L ++YL +N +  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 198 SIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
                  +L +L++L L+ N++S         L +L  L LH NR++   P        L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 258 LYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS 317
           + LYL  N L+     +   L +L++L +++ N               L     S +++ 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLND-NPWVCDCR-ARPLWAWLQKFRGSSSEVP 261

Query: 318 GFIPPSLGNLS 328
             +P  L    
Sbjct: 262 CSLPQRLAGRD 272

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (189), Expect = 6e-16
 Identities = 56/281 (19%), Positives = 97/281 (34%), Gaps = 8/281 (2%)

Query: 420 VCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDL 479
           VC +      S         +P  +    +   + L  N+++   +  F    +L +L L
Sbjct: 7   VCYNEPKVTTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 480 SNNNFFGEISSNWIKCPQLATLNMGGNEISGTI-PSEIGNMTQLHKLDFSSNRLVGQIPK 538
            +N      ++ +     L  L++  N    ++ P+    + +LH L      L    P 
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123

Query: 539 QLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLN 598
               L +L  L L  N L          L  L +L L  NR+S +  +    L  L  L 
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 599 LSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPS 658
           L  N+ +         L +L  L L  N+L       +  L +L+Y+ L  N       +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243

Query: 659 CFRRMHGLSSIDVSYNELQGSIPHS---KAFQNATIEAFQG 696
                  L     S +E+  S+P     +  +       QG
Sbjct: 244 RPLWAW-LQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.1 bits (154), Expect = 2e-11
 Identities = 43/209 (20%), Positives = 70/209 (33%), Gaps = 19/209 (9%)

Query: 13  GTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILT 72
            ++    F    +L  L L    L    P     L+ L++L    N    +       L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 73  NLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
           NL  L L  N+++ +       L SL+ L L  NR+    P +  +L  L+ L L  N+L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 133 SGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNN 192
           S                        L +   + L+ N +     R+      L     ++
Sbjct: 214 SALPTEAL---------------APLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSS 257

Query: 193 NRIVGSIPSEIGNLRSLSYLGLNKNQLSG 221
           + +  S+P     L       L  N L G
Sbjct: 258 SEVPCSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (120), Expect = 3e-07
 Identities = 28/125 (22%), Positives = 41/125 (32%), Gaps = 4/125 (3%)

Query: 10  NLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIG 69
           N   ++ E  F     L  L L  N++    P     L +L  L    N  S +    + 
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222

Query: 70  ILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSN 129
            L  L  LRL+ N               L +   S + +  S+P  L          L+ 
Sbjct: 223 PLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAA 278

Query: 130 NSLSG 134
           N L G
Sbjct: 279 NDLQG 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 84.3 bits (207), Expect = 7e-18
 Identities = 61/310 (19%), Positives = 107/310 (34%), Gaps = 54/310 (17%)

Query: 785  GTGGCGTVYKAE-LTSGDTRAVKKLHSLPTG------EIGINQKGFVSEITE---IRHRN 834
            G G   TV+ A+ + +    A+K +            EI + Q+   ++ T+   +   +
Sbjct: 22   GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81

Query: 835  IVKFYGFCSHTQ----HLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALS 890
            I+K     +H      H+ +V+E L    LA I   E     L + K++   K +   L 
Sbjct: 82   ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQLLLGLD 139

Query: 891  YMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLKPDSS--NWSELAGTCGYIA 947
            YMH  C   I+H DI  + VL+++     ++     A          +++    T  Y +
Sbjct: 140  YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 948  PELAYTMRANEKCDVFNFGVLVLEVIEGKHP----------------GHFLSLLLSLPAP 991
            PE+          D+++   L+ E+I G                      + LL  LP+ 
Sbjct: 198  PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 992  AANMNIVVNDLIDSRL---------PPPLGEVEEKLKSMI------AVAFL--CLDANPD 1034
                        +SR            PL +V  +              FL   L  +P 
Sbjct: 258  LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317

Query: 1035 CRPTMQKVCN 1044
             R     + N
Sbjct: 318  KRADAGGLVN 327

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 83.3 bits (204), Expect = 1e-17
 Identities = 65/295 (22%), Positives = 109/295 (36%), Gaps = 30/295 (10%)

Query: 419 NVCQSGSLTHFSVRNNNFVG--PIPRSLQNCTSLYSLRLERN-QLTGNISEVFGIYPDLE 475
              Q+  + +  +   N     PIP SL N   L  L +     L G I         L 
Sbjct: 45  TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104

Query: 476 LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQ 535
            L +++ N  G I     +   L TL+   N +SGT+P  I ++  L  + F  NR+ G 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 536 IPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
           IP   G  + L +                             NRL+  IP          
Sbjct: 165 IPDSYGSFSKLFTSMTISR-----------------------NRLTGKIPPT--FANLNL 199

Query: 596 HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGP 655
                +    +  +  +    + ++      +       ++   ++L  ++L  N++ G 
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259

Query: 656 IPSCFRRMHGLSSIDVSYNELQGSIPHSKAFQNATIEAFQGNKELCGDVTGLPPC 710
           +P    ++  L S++VS+N L G IP     Q   + A+  NK LCG  + LP C
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.9 bits (203), Expect = 1e-17
 Identities = 68/263 (25%), Positives = 107/263 (40%), Gaps = 6/263 (2%)

Query: 162 VSVSLHTNNFSGV--IPRSLGGLKNLTFVYL-NNNRIVGSIPSEIGNLRSLSYLGLNKNQ 218
            ++ L   N      IP SL  L  L F+Y+   N +VG IP  I  L  L YL +    
Sbjct: 53  NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112

Query: 219 LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
           +SG+IP     +  L  L    N LSG +PP + S  +L+ +    N+++G++P S+G+ 
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172

Query: 279 SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIREN 338
           S L      + N+L+G IP    NL                                   
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLF--GSDKNTQKIHLAK 230

Query: 339 MLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIEN 398
                   ++G  K+L+ L L  N++ G++P  L  L  L    +  N L G IP +  N
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289

Query: 399 MKKLNKYLLFENQFTGYLPQNVC 421
           +++ +      N+     P   C
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.5 bits (202), Expect = 2e-17
 Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 19/279 (6%)

Query: 117 GNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTN-NFSGVI 175
                +  L LS  +L    P             IP  L NL     + +    N  G I
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYP-------------IPSSLANLPYLNFLYIGGINNLVGPI 93

Query: 176 PRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKF 235
           P ++  L  L ++Y+ +  + G+IP  +  +++L  L  + N LSG++PP+  +L NL  
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153

Query: 236 LYLHDNRLSGYIPPKLGSFKSLLY-LYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG 294
           +    NR+SG IP   GSF  L   + +S N+L G +P +F NL+        N+ +   
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE--- 210

Query: 295 SIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
                +      +           F    +G   N+ GL +R N +YG++P+ L +LK L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270

Query: 355 SQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIP 393
             L++S N L G IP   GNL      A   N+     P
Sbjct: 271 HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.3 bits (199), Expect = 4e-17
 Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 12/259 (4%)

Query: 25  QLAYLDLSVNQLFG--TIPTQISHLSKLKHLDFSTN-QFSGIIPPQIGILTNLVVLRLSV 81
           ++  LDLS   L     IP+ +++L  L  L         G IPP I  LT L  L ++ 
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 82  NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWG 141
             ++G IP+ L ++ +L  L  SYN L+G++P S+ +L NLV ++   N +SG IP ++G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 142 YLISPHYGSIPQD--------LGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
                                       ++    + N        L G    T       
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

Query: 194 RIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGS 253
             +     ++G  ++L+ L L  N++ G++P     L  L  L +  N L G IP   G+
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGN 289

Query: 254 FKSLLYLYLSHNQLNGSLP 272
            +       ++N+     P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.8 bits (195), Expect = 1e-16
 Identities = 70/261 (26%), Positives = 107/261 (40%), Gaps = 12/261 (4%)

Query: 1   VVSINLTGSNLKGTLQEFPFLL-FPQLAYLDLSVN-QLFGTIPTQISHLSKLKHLDFSTN 58
           V +++L+G NL         L   P L +L +     L G IP  I+ L++L +L  +  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 59  QFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGN 118
             SG IP  +  +  LV L  S N L+G +P  +  L +L  +    NR++G+IP S G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 119 LSNLV--------QLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
            S L         +L+         +   +  L           L   +          N
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNL 230
                   +G  KNL  + L NNRI G++P  +  L+ L  L ++ N L G IP   GNL
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNL 290

Query: 231 SNLKFLYLHDNR-LSGYIPPK 250
                    +N+ L G   P 
Sbjct: 291 QRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 78.3 bits (191), Expect = 4e-16
 Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 24/284 (8%)

Query: 45  SHLSKLKHLDFSTNQFSGI--IPPQIGILTNLVVLRLSVN-QLNGLIPEELGELTSLNEL 101
           +   ++ +LD S         IP  +  L  L  L +     L G IP  + +LT L+ L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 102 ALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESP 161
            +++  ++G+IP  L  +  LV L  S N+                 G++P  + +L + 
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNA---------------LSGTLPPSISSLPNL 151

Query: 162 VSVSLHTNNFSGVIPRSLGGLKNLTF-VYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLS 220
           V ++   N  SG IP S G    L   + ++ NR+ G IP    NL              
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML-- 209

Query: 221 GSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
                                    +   K+G  K+L  L L +N++ G+LP     L  
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQ-LSGFIPPS 323
           L  L+V   N L G IP + GNL+       +  + L G   P+
Sbjct: 270 LHSLNVSF-NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 76.3 bits (186), Expect = 2e-15
 Identities = 67/296 (22%), Positives = 107/296 (36%), Gaps = 23/296 (7%)

Query: 54  DFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGL--IPEELGELTSLNELALSYN-RLNG 110
           D     + G++         +  L LS   L     IP  L  L  LN L +     L G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 111 SIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNN 170
            IP ++  L+ L  L +++ ++SG IP     + +                       N 
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF---------------SYNA 136

Query: 171 FSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSY-LGLNKNQLSGSIPPTAGN 229
            SG +P S+  L NL  +  + NRI G+IP   G+   L   + +++N+L+G IPPT  N
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196

Query: 230 LSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNI 289
           L+        +               +       ++              +   L     
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR---N 253

Query: 290 NKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIP 345
           N++ G++P+ +  LK L  L +S   L G I P  GNL          N      P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.9 bits (185), Expect = 3e-15
 Identities = 62/258 (24%), Positives = 95/258 (36%), Gaps = 26/258 (10%)

Query: 252 GSFKSLLYLYLSHNQLNG--SLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHL 309
                +  L LS   L     +PSS  NL  L  L++  IN L G IP  I  L  L +L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 310 WLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIP 369
           +++ T +SG IP  L  +  +  L    N L G++P  +  L +L  ++   N+++G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 370 HCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLL---------------------- 407
              G+ S L                       L    L                      
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 408 -FENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISE 466
                   +    V  S +L    +RNN   G +P+ L     L+SL +  N L G I +
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 467 VFGIYPDLELLDLSNNNF 484
             G     ++   +NN  
Sbjct: 287 -GGNLQRFDVSAYANNKC 303

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.4 bits (174), Expect = 1e-14
 Identities = 25/172 (14%), Positives = 46/172 (26%), Gaps = 28/172 (16%)

Query: 785 GTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGI---------NQKGFVSEITEIRHRNI 835
           G G    V+           VK      T    +         +             R +
Sbjct: 9   GEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 68

Query: 836 VKFYGFCSHTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHD 895
            K  G      + +      E  ++   L +      +       V+  +   ++  +H 
Sbjct: 69  QKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122

Query: 896 CFPPILHRDISSKKVLLDLEYKAHVSDFGTAK---------FLKPDSSNWSE 938
               I+H D+S   VL+  E    + DF  +           L+ D  N   
Sbjct: 123 G---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.2 bits (178), Expect = 1e-14
 Identities = 44/209 (21%), Positives = 67/209 (32%), Gaps = 14/209 (6%)

Query: 43  QISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELA 102
           ++S ++    ++      + + PP +    +  +L LS N L       L   T L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 103 LSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNL---- 158
           L    L          L  L  L LS+N L                      L +L    
Sbjct: 62  LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 159 ----ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGL 214
                    + L  N    + P  L     L  + L NN +       +  L +L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 215 NKNQLSGSIPPTAGNLSNLKFLYLHDNRL 243
            +N L  +IP        L F +LH N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (157), Expect = 5e-12
 Identities = 46/250 (18%), Positives = 88/250 (35%), Gaps = 14/250 (5%)

Query: 154 DLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLG 213
           ++  + S + V+    N +  +P  L   K+ T ++L+ N +     + +     L+ L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 214 LNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPS 273
           L++ +   +     G L  L  L L  N+L                +         SLP 
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL--TVLDVSFNRLTSLPL 117

Query: 274 SFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGL 333
                           N+L    P  +     L  L L+   L+      L  L N+  L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 334 YIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIP 393
            ++EN LY +IP+       L    L  N        C   +   + + L++N  +  + 
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW-----LCNCEILYFRRW-LQDNAENVYVW 230

Query: 394 QEIENMKKLN 403
           ++  ++K + 
Sbjct: 231 KQGVDVKAMT 240

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.9 bits (146), Expect = 1e-10
 Identities = 40/209 (19%), Positives = 70/209 (33%), Gaps = 8/209 (3%)

Query: 228 GNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVH 287
             +++   +      L+  +PP L   K    L+LS N L     ++    + L  L++ 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 288 NINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEE 347
                   +   +  L                +P     L  +  L +  N L       
Sbjct: 64  RAELTKLQVDGTLPVL----GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 348 LGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLL 407
           L  L  L +L L  N+L    P  L     L+  +L  N L+      +  ++ L+  LL
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 408 FENQFTGYLPQNVCQSGSLTHFSVRNNNF 436
            EN     +P+    S  L    +  N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 44/208 (21%), Positives = 70/208 (33%), Gaps = 7/208 (3%)

Query: 299 EIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLS 358
           E+  + S   +   K  L+  +PP L    +   L++ EN+LY      L     L+QL+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 359 LSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQ 418
           L   +L          L  L    L  N+L                 +   N+ T     
Sbjct: 62  LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV-SFNRLTSLPLG 118

Query: 419 NVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLD 478
            +   G L    ++ N      P  L     L  L L  N LT   + +     +L+ L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 479 LSNNNFFGEISSNWIKCPQLATLNMGGN 506
           L  N+ +  I   +     L    + GN
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (141), Expect = 5e-10
 Identities = 42/218 (19%), Positives = 69/218 (31%), Gaps = 22/218 (10%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
           + + + +      L   +P +L        L LS N L     A+L   + L QL+L   
Sbjct: 9   VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL 190
                               +   L  L +         +   +          LT + +
Sbjct: 66  E--------------LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL----PALTVLDV 107

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK 250
           + NR+       +  L  L  L L  N+L    P        L+ L L +N L+      
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167

Query: 251 LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
           L   ++L  L L  N L  ++P  F     L    +H 
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (137), Expect = 2e-09
 Identities = 54/260 (20%), Positives = 79/260 (30%), Gaps = 16/260 (6%)

Query: 420 VCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDL 479
           V +  S    +    N    +P  L        L L  N L          Y  L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 480 SNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQ 539
                        +            +    ++P     +  L  LD S NRL       
Sbjct: 63  DRAELTKLQVDGTLPVLG---TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 540 LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNL 599
           L  L  L  L L GN+L    P  L    +L  L L+ N L++L    L  L  L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 600 SNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSC 659
             N     I         L    L  N         +CN E L +   LQ+         
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW-------LCNCEILYFRRWLQDNAE--NVYV 229

Query: 660 FRRMHGLSSIDVSYNELQGS 679
           +++   + ++  +   +Q  
Sbjct: 230 WKQGVDVKAMTSNVASVQCD 249

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 3e-08
 Identities = 50/205 (24%), Positives = 70/205 (34%), Gaps = 19/205 (9%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           L   P  L      L LS N L+      +   ++L  L+    +         G L  L
Sbjct: 22  LTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL 79

Query: 75  VVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSG 134
             L LS NQL  L       L +L  L +S+NRL      +L  L  L +L L  N L  
Sbjct: 80  GTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 135 QIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNR 194
             P            S+                 NN + +    L GL+NL  + L  N 
Sbjct: 139 LPPGLLTPTPKLEKLSL---------------ANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQL 219
           +  +IP        L +  L+ N  
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 3e-07
 Identities = 48/210 (22%), Positives = 79/210 (37%), Gaps = 7/210 (3%)

Query: 443 SLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLN 502
            +    S   +  ++  LT  +     +  D  +L LS N  +    +  +   +L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 503 MGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPL 562
           +   E+      ++     +      S+  +  +P     L +LT L ++ N+L+     
Sbjct: 62  LDRAEL---TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 563 ELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLD 622
            L  L EL  L L  N L  L P  L    KL  L+L+NN  ++  +  +  L  L  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 623 LSHNSLGGNIPSEICNLESLEYMNLLQNKL 652
           L  NS    IP        L +  L  N  
Sbjct: 179 LQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 46/208 (22%), Positives = 71/208 (34%), Gaps = 6/208 (2%)

Query: 494 KCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNG 553
           K      +N     ++  +P ++   T    L  S N L       L   T LT L L+ 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 554 NQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIG 613
            +L+         L  LG LDLS N+L  L              ++S N+ +      + 
Sbjct: 65  AELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALR 121

Query: 614 KLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSY 673
            L +L +L L  N L    P  +     LE ++L  N L+         +  L ++ +  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 674 NELQGSIPHSKAFQNATIEAFQGNKELC 701
           N L                   GN  LC
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 23/96 (23%), Positives = 34/96 (35%), Gaps = 1/96 (1%)

Query: 14  TLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTN 73
           +L         +L  L L  N+L    P  ++   KL+ L  + N  + +    +  L N
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173

Query: 74  LVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLN 109
           L  L L  N L   IP+       L    L  N   
Sbjct: 174 LDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 60.4 bits (145), Expect = 1e-10
 Identities = 37/218 (16%), Positives = 75/218 (34%), Gaps = 9/218 (4%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
           L N + +    + +   + +   +L  +  L+     +  +I   +  L+NL+ L L +N
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73

Query: 131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL 190
            ++  + P                L N+ +   +             +            
Sbjct: 74  QIT-DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK 250
                +  I +        +   L+      S      NLS L  L   DN++S   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 251 LGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHN 288
           L S  +L+ ++L +NQ++   P    N S+L  + + N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 2e-06
 Identities = 36/219 (16%), Positives = 60/219 (27%), Gaps = 22/219 (10%)

Query: 397 ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLE 456
             +    K    ++  T  + Q       +T  S             +Q   +L  L L+
Sbjct: 16  PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71

Query: 457 RNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGG----------- 505
            NQ+T               L  +       I+          T                
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 506 ---NEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPL 562
                    I +        +    S           L  L+ LT+L  + N++S   PL
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL 191

Query: 563 ELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
               L  L  + L  N++S + P  L     L  + L+N
Sbjct: 192 --ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 2e-06
 Identities = 29/226 (12%), Positives = 76/226 (33%), Gaps = 18/226 (7%)

Query: 351 LKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFEN 410
           L +  +++   + +  ++     +L  +   +     ++ +I   ++ +  L    L +N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73

Query: 411 QFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGI 470
           Q       ++    +LT  +    +       S              +    +++ + G+
Sbjct: 74  QI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 471 YPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSN 530
                L          +I++            +       +  + + N+++L  L    N
Sbjct: 129 SNLQVL-----YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 531 RLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLS 576
           ++    P  L  L +L  + L  NQ+S   P  L   + L  + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 41/228 (17%), Positives = 74/228 (32%), Gaps = 19/228 (8%)

Query: 157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNK 216
            L + + ++   +N +  + ++   L  +T +      +       +  L +L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 217 NQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFG 276
           NQ++        NL+ +  L L  N L              L L  +       L     
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA---- 126

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
                   ++  +      I          +  +LS           L NLS +  L   
Sbjct: 127 -----GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKAD 181

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR 384
           +N +    P  L  L +L ++ L  N+++   P  L N SNL    L 
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 9e-06
 Identities = 28/227 (12%), Positives = 60/227 (26%), Gaps = 18/227 (7%)

Query: 302 NLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSV 361
            L +   +   K+ ++  +  +  +L  I  L      +  +  E +  L +L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72

Query: 362 NKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVC 421
           N++    P            +    +   +I                 +        N+ 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 422 QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
                 +     +   G       +  +     L                  L  L   +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP----------LANLSKLTTLKADD 182

Query: 482 NNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS 528
           N       S     P L  +++  N+IS   P  + N + L  +  +
Sbjct: 183 NKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 40/233 (17%), Positives = 74/233 (31%), Gaps = 38/233 (16%)

Query: 118 NLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPR 177
            L+N ++++   ++++  +                 DL  + +   +S      + +   
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQ--------------ADLDGITT---LSAFGTGVTTI--E 57

Query: 178 SLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPP------------ 225
            +  L NL  + L +N+I    P +     +   L  N  +   +I              
Sbjct: 58  GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117

Query: 226 --TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKH 283
             T                    I             YLS      S  +   NLS L  
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177

Query: 284 LHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
           L   + NK+S   P  + +L +L  + L   Q+S   P  L N SN+  + + 
Sbjct: 178 LKADD-NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 8e-04
 Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 5/65 (7%)

Query: 19  PFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLR 78
           P     +L  L    N++    P  ++ L  L  +    NQ S + P  +   +NL ++ 
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 79  LSVNQ 83
           L+ NQ
Sbjct: 224 LT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 29/220 (13%), Positives = 73/220 (33%), Gaps = 25/220 (11%)

Query: 277 NLSSLKHLHVHNINKLSGSIP-KEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
            L++   +     + ++ ++   ++  + +LS      T + G     +  L+N+ GL +
Sbjct: 17  ALANAIKIAAGK-SNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLEL 70

Query: 336 RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
           ++N +    P +     +  +LS +  K   +I       +         +    +    
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 396 IENMKKLNKYLLFENQFTGYLPQNVCQSG--------------SLTHFSVRNNNFVGPIP 441
           ++ +      +   +   G         G               LT     +N      P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 442 RSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSN 481
             L +  +L  + L+ NQ++           +L ++ L+N
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.5 bits (142), Expect = 8e-10
 Identities = 57/340 (16%), Positives = 109/340 (32%), Gaps = 29/340 (8%)

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
           +    L L++  L+ SLP    +L   + L     N L+  +P+   +LKSL     +  
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHL---ESLVASC-NSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN 374
            LS   P  L     +    + +     +           + L    +          GN
Sbjct: 92  ALSDLPP--LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149

Query: 375 LSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNN 434
               +   L+      +I  +  ++KKL    L                       +   
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209

Query: 435 NFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK 494
                + ++L +          R+    ++ E+                F     + +  
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSL-----------TFLDVSENIFSG 258

Query: 495 CPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGN 554
             +L       N  S  I S       L +L+ S+N+L+ ++P        L  L  + N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFN 314

Query: 555 QLSGDIPLELGLLAELGYLDLSANRLSKL--IPKNLGELR 592
            L+ ++P    L   L  L +  N L +   IP+++ +LR
Sbjct: 315 HLA-EVP---ELPQNLKQLHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 58.3 bits (139), Expect = 2e-09
 Identities = 52/326 (15%), Positives = 92/326 (28%), Gaps = 24/326 (7%)

Query: 231 SNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS--LKHLHVHN 288
                L L++  LS  +P        L  L  S N L   LP    +L S  + + ++  
Sbjct: 38  RQAHELELNNLGLSS-LPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 289 INKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEEL 348
           ++ L   +     +   L  L   +      I     N                +   +L
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 349 GRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLF 408
             L  L  L         +          L   ++           E++N+  L      
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 409 ENQFTGYLPQNVC--------QSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQL 460
            N                      +      ++  F+          + L       N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 461 TGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMT 520
           +  I  +  + P LE L++SNN    E+ +     P+L  L    N ++  +P    N  
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNK-LIELPALP---PRLERLIASFNHLA-EVPELPQN-- 325

Query: 521 QLHKLDFSSNRLVGQIPKQLGKLTSL 546
            L +L    N L  + P     +  L
Sbjct: 326 -LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.4 bits (129), Expect = 3e-08
 Identities = 55/326 (16%), Positives = 89/326 (27%), Gaps = 25/326 (7%)

Query: 328 SNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENE 387
                L +    L  S+PE    L+S   L  S N L   +P    +L +L         
Sbjct: 38  RQAHELELNNLGL-SSLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 388 LSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGP---IPRSL 444
           LS   P         N+             + +    +           +         L
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG 504
           +    L +L         N S        L L  +   N   E        P L T+   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 505 GNEISGTIPSEIGNMTQLHKLD--------FSSNRLVGQIPKQLGKLTSLTSLTLNGNQL 556
            N +               + +          S   +         L+ L       N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 557 SGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLV 616
           S +I     L   L  L++S N+L +L         +L  L  S N  ++   +      
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAEVPEL----PQ 324

Query: 617 QLSKLDLSHNSLGGNIPSEICNLESL 642
            L +L + +N L    P    ++E L
Sbjct: 325 NLKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.1 bits (128), Expect = 4e-08
 Identities = 48/314 (15%), Positives = 96/314 (30%), Gaps = 24/314 (7%)

Query: 304 KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNK 363
           +    L L+   LS  +P    +L +   L    N L   +PE    LKSL   + ++  
Sbjct: 38  RQAHELELNNLGLSS-LPELPPHLES---LVASCNSL-TELPELPQSLKSLLVDNNNLKA 92

Query: 364 LNGSIPHCLGNLSNLKF-----------FALRENELSGSIPQEIENMKKLNKYLLFENQF 412
           L+   P       +              F    +  + S+ +  +    L       NQ 
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 413 TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYP 472
                       +  +    +   +  +P SL++  +  ++  E  +L            
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 473 DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRL 532
           +  L  L +     E  +                       +    +++L    +  N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 533 VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
             +I        SL  L ++ N+L  ++P    L   L  L  S N L+++        +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAEVPE----LPQ 324

Query: 593 KLHHLNLSNNQFSQ 606
            L  L++  N   +
Sbjct: 325 NLKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.9 bits (125), Expect = 9e-08
 Identities = 23/95 (24%), Positives = 37/95 (38%), Gaps = 10/95 (10%)

Query: 237 YLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSI 296
             + N  S  I        SL  L +S+N+L   LP+       L+ L     N L+  +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASF-NHLA-EV 319

Query: 297 PKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIR 331
           P+   NLK    L +    L    P    ++ ++R
Sbjct: 320 PELPQNLK---QLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.9 bits (125), Expect = 1e-07
 Identities = 21/92 (22%), Positives = 37/92 (40%), Gaps = 9/92 (9%)

Query: 166 LHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPP 225
            + N  S  I        +L  + ++NN+++  +P+    L  L     + N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321

Query: 226 TAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
                 NLK L++  N L    P    S + L
Sbjct: 322 L---PQNLKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 2e-07
 Identities = 20/92 (21%), Positives = 33/92 (35%), Gaps = 9/92 (9%)

Query: 31  LSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPE 90
             +N     I +       L+ L+ S N+   +      +   L  L  S N L   +PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFNHLAE-VPE 321

Query: 91  ELGELTSLNELALSYNRLNGSIPASLGNLSNL 122
               L  L+   + YN L    P    ++ +L
Sbjct: 322 LPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.0 bits (120), Expect = 5e-07
 Identities = 54/341 (15%), Positives = 93/341 (27%), Gaps = 28/341 (8%)

Query: 183 KNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNR 242
           +    + LNN  +  S+P    +L SL     + N L+  +P       +LK L + +N 
Sbjct: 38  RQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPE---LPQSLKSLLVDNNN 89

Query: 243 LSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGN 302
           L       L     LL      N     LP    +         +N  K    +P  +  
Sbjct: 90  L-----KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144

Query: 303 LKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVN 362
           + + ++      +L      +     N     + +  L          +        ++ 
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204

Query: 363 KLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQ 422
            L           +        E           +N       L     F          
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEA------LNVRDNYLTDLPELPQSLTFLDVSENIFSG 258

Query: 423 SGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNN 482
              L       N     I        SL  L +  N+L     E+  + P LE L  S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFN 314

Query: 483 NFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLH 523
           +   E+         L  L++  N +    P    ++  L 
Sbjct: 315 H-LAEVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 5e-07
 Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 9/96 (9%)

Query: 285 HVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSI 344
           +++ +N  S  I        SL  L +S  +L   +P     L     L    N L   +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLER---LIASFNHL-AEV 319

Query: 345 PEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKF 380
           PE    LK    L +  N L    P    ++ +L+ 
Sbjct: 320 PELPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.4 bits (116), Expect = 1e-06
 Identities = 49/326 (15%), Positives = 91/326 (27%), Gaps = 25/326 (7%)

Query: 352 KSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQ 411
           +   +L L+   L+ S+P    +L +L       N L+  +P+  +++K L         
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 412 FTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQN---CTSLYSLRLERNQLTGNISEVF 468
            +   P       S                + +                 +     +   
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS 528
              P+L+ L      +    S   +    L+  ++           E+ N+  L  +   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELG--------YLDLSANRL 580
           +N L                     +       L    ++E                N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 581 SKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLE 640
           S  I         L  LN+SNN+   E+     +   L +L  S N L   +P    NL+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPELPQNLK 327

Query: 641 SLEYMNLLQNKLSGPIPSCFRRMHGL 666
            L   ++  N L    P     +  L
Sbjct: 328 QL---HVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 3e-06
 Identities = 24/94 (25%), Positives = 34/94 (36%), Gaps = 10/94 (10%)

Query: 52  HLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGS 111
              +  N  S  I     +  +L  L +S N+L   +P     L  L     S+N L   
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-E 318

Query: 112 IPASLGNLSNLVQLSLSNNSLSG--QIPPNWGYL 143
           +P    NL    QL +  N L     IP +   L
Sbjct: 319 VPELPQNLK---QLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 7e-06
 Identities = 20/90 (22%), Positives = 33/90 (36%), Gaps = 9/90 (10%)

Query: 10  NLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIG 69
           N           L P L  L++S N+L   +P   +   +L+ L  S N  + +      
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-IELP---ALPPRLERLIASFNHLAEVPE---- 321

Query: 70  ILTNLVVLRLSVNQLNGLIPEELGELTSLN 99
           +  NL  L +  N L    P+    +  L 
Sbjct: 322 LPQNLKQLHVEYNPLREF-PDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.4 bits (103), Expect = 4e-05
 Identities = 52/319 (16%), Positives = 88/319 (27%), Gaps = 18/319 (5%)

Query: 96  TSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDL 155
              +EL L+   L+ S+P    +L     L  S NSL+ ++P     L S    +     
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 156 GNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLN 215
            +   P+   L  +N        L     L  + ++NN +              +     
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 216 KNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSF 275
           +        P    +            L   +   +     L  L    N      P   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL-----PFLT 207

Query: 276 GNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYI 335
              +    L        S        N  +                     LS +     
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267

Query: 336 RENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
             N     I        SL +L++S NKL   +P     L  L       N L+  +P+ 
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPEL 322

Query: 396 IENMKKLNKYLLFENQFTG 414
            +N+K+L+   +  N    
Sbjct: 323 PQNLKQLH---VEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 19/107 (17%), Positives = 35/107 (32%), Gaps = 24/107 (22%)

Query: 103 LSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV 162
              N  +  I +      +L +L++SNN L                  +P     LE   
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI----------------ELPALPPRLE--- 307

Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL 209
            +    N+ +  +P     LK L   ++  N +    P    ++  L
Sbjct: 308 RLIASFNHLAE-VPELPQNLKQL---HVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 22/87 (25%), Positives = 32/87 (36%), Gaps = 9/87 (10%)

Query: 595 HHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSG 654
                  N  S EI         L +L++S+N L   +P+    LE L       N L+ 
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLERL---IASFNHLAE 318

Query: 655 PIPSCFRRMHGLSSIDVSYNELQGSIP 681
            +P        L  + V YN L+   P
Sbjct: 319 -VPEL---PQNLKQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 53/339 (15%), Positives = 102/339 (30%), Gaps = 31/339 (9%)

Query: 22  LFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV 81
           L  Q   L+L+   L  ++P    H   L+ L  S N  +  +P     L +L+V   ++
Sbjct: 36  LDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVDNNNL 90

Query: 82  NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWG 141
             L+ L P             L Y  ++ +    L  L N   L + +   +        
Sbjct: 91  KALSDLPPL------------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDL 138

Query: 142 YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPS 201
                   +    L  L    ++   T  ++            L+   +     +     
Sbjct: 139 PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELP 198

Query: 202 EIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLY 261
           E+ NL  L+ +  + N L           +         +                ++  
Sbjct: 199 ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 258

Query: 262 LSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS------IPKEIGNLKSLSHLWLSKTQ 315
           LS    N    ++  N          ++ +L+ S      +P     L+    L  S   
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNH 315

Query: 316 LSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSL 354
           L+  +P    NL     L++  N L    P+    ++ L
Sbjct: 316 LAE-VPELPQNLKQ---LHVEYNPLR-EFPDIPESVEDL 349

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.8 bits (138), Expect = 2e-09
 Identities = 41/275 (14%), Positives = 87/275 (31%), Gaps = 26/275 (9%)

Query: 3   SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG 62
           +++LTG NL         LL   +       + +   +    S   +++H+D S +    
Sbjct: 4   TLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60

Query: 63  IIPPQI-GILTNLVVLRLSVNQLNGLIPEELGELTSLNEL--ALSYNRLNGSIPASLGNL 119
                I    + L  L L   +L+  I   L + ++L  L  +        ++   L + 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 120 SNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLG----------------NLESPVS 163
           S L +L+LS      +              +     G                       
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 164 VSLHTNNFSGVIPRSLGGLKNLTFVYLNN-NRIVGSIPSEIGNLRSLSYLGLNKNQLSGS 222
               +        +    L  L  + L+    I+     E+G + +L  L +      G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 223 IPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSL 257
           +      L +L+   ++ +  +    P +G+ K+ 
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 3e-09
 Identities = 43/281 (15%), Positives = 76/281 (27%), Gaps = 27/281 (9%)

Query: 85  NGLIPEELGELTSLNELALSYNRLNGSIP-ASLGNLSNLVQLSLSNNSLSGQIPPNWGYL 143
             L P+  G L S   +A    R     P A   +   +  + LSN+ +           
Sbjct: 10  KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV--------- 60

Query: 144 ISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI 203
                 ++   L       ++SL     S  I  +L    NL  + L+          + 
Sbjct: 61  -----STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 115

Query: 204 GNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFK-------- 255
                     LN +                    +    LSGY      S          
Sbjct: 116 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 175

Query: 256 -SLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT 314
             +         L       F  L+ L+HL +     +      E+G + +L  L +   
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235

Query: 315 QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLS 355
              G +      L +++   I  +         +G  K+  
Sbjct: 236 VPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 4e-09
 Identities = 42/294 (14%), Positives = 91/294 (30%), Gaps = 28/294 (9%)

Query: 309 LW----LSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKL 364
           LW    L+   L   +   L +   +       + +   + E     + +  + LS + +
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI 58

Query: 365 NG-SIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQS 423
              ++   L   S L+  +L    LS  I   +     L +  L                
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL- 117

Query: 424 GSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNN 483
                               L      +        +   ++ V      L L     N 
Sbjct: 118 ---------------SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162

Query: 484 FFGEISSNWIKCPQLATLNMGGNE-ISGTIPSEIGNMTQLHKLDFSS-NRLVGQIPKQLG 541
              ++S+   +CP L  L++  +  +      E   +  L  L  S    ++ +   +LG
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222

Query: 542 KLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH 595
           ++ +L +L + G    G + L   L   L +L ++ +  + +    +G  +   
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 45/253 (17%), Positives = 83/253 (32%), Gaps = 16/253 (6%)

Query: 163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRI-VGSIPSEIGNLRSLSYLGLNKNQLSG 221
           ++ L   N     P   G L +   +     R  +    +E  +   + ++ L+ + +  
Sbjct: 4   TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60

Query: 222 -SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSS 280
            ++       S L+ L L   RLS  I   L    +L+ L LS      S  +    LSS
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-GFSEFALQTLLSS 119

Query: 281 LKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENML 340
              L   N++       K +    +     +++  LSG+      +  +         + 
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 341 Y---------GSIPEELGRLKSLSQLSLS-VNKLNGSIPHCLGNLSNLKFFALRENELSG 390
                         +E  +L  L  LSLS    +       LG +  LK   +      G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 391 SIPQEIENMKKLN 403
           ++    E +  L 
Sbjct: 240 TLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 4e-06
 Identities = 17/103 (16%), Positives = 43/103 (41%), Gaps = 3/103 (2%)

Query: 573 LDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN- 631
           LDL+   L   +   L   + +       +   Q ++ +     ++  +DLS++ +  + 
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62

Query: 632 IPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYN 674
           +   +     L+ ++L   +LS PI +   +   L  +++S  
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.8 bits (133), Expect = 4e-09
 Identities = 30/196 (15%), Positives = 64/196 (32%), Gaps = 8/196 (4%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
               +   L    +   + +   EL S++++  + + +       +  L N+ +L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 131 SLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYL 190
            L+   P      +   +    +            L + +        + GL +L  +  
Sbjct: 79  KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK 250
                       + +  +       ++     I P    L+ L+ LYL  N +S      
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-AGLTKLQNLYLSKNHISD--LRA 195

Query: 251 LGSFKSLLYLYLSHNQ 266
           L   K+L  L L  +Q
Sbjct: 196 LAGLKNLDVLELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.2 bits (116), Expect = 5e-07
 Identities = 45/217 (20%), Positives = 73/217 (33%), Gaps = 22/217 (10%)

Query: 391 SIPQEI------ENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSL 444
           ++P  I      +   +  K  L +   T  + QN  +  S+      N++        +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG 504
           Q   ++  L L  N+LT            L  L      F  E     +   +       
Sbjct: 65  QYLPNVTKLFLNGNKLTD--------IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116

Query: 505 GNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLEL 564
            +     I    G +                    L +LT L +L+L  NQ+S  +PL  
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPL-- 174

Query: 565 GLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSN 601
             L +L  L LS N +S L  + L  L+ L  L L +
Sbjct: 175 AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 38/204 (18%), Positives = 70/204 (34%), Gaps = 17/204 (8%)

Query: 157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNK 216
                +  +L   + +  + ++   L ++  +  NN+ I       I  L +++ L LN 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 217 NQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFG 276
           N+L+         L+NLK L       +             L      +     +     
Sbjct: 78  NKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
                     +N      +    +  L  L  L L   Q+S  +P  L  L+ ++ LY+ 
Sbjct: 133 LPQLESLYLGNNKI----TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186

Query: 337 ENMLYGSIPEELGRLKSLSQLSLS 360
           +N +  S    L  LK+L  L L 
Sbjct: 187 KNHI--SDLRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 4e-06
 Identities = 34/198 (17%), Positives = 64/198 (32%), Gaps = 9/198 (4%)

Query: 18  FPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVL 77
           F    F +    +L    +   +    + L+ +  +  + +    +    I  L N+  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73

Query: 78  RLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP 137
            L+ N+L     + L  L +L  L L  N++              + L  +  S    + 
Sbjct: 74  FLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131

Query: 138 PNWGYLISPHYGSIPQDLGNLESPVSVSLH-TNNFSGVIPRSLGGLKNLTFVYLNNNRIV 196
                       +   D+  L     +      +        L GL  L  +YL+ N I 
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI- 190

Query: 197 GSIPSEIGNLRSLSYLGL 214
            S    +  L++L  L L
Sbjct: 191 -SDLRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 32/204 (15%), Positives = 65/204 (31%), Gaps = 16/204 (7%)

Query: 326 NLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRE 385
             +      +++  +  ++ +    L S+ Q+  + + +       +  L N+    L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 386 NELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQ 445
           N+L+    + + N+K L    L EN+          +       S+   +        L 
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLK----KLKSLSLEHNGISDINGLV 131

Query: 446 NCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGG 505
           +   L SL L  N++T           D      S  +             +L  L +  
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTL----SLEDNQISDIVPLAGLTKLQNLYLSK 187

Query: 506 NEISGTIPSEIGNMTQLHKLDFSS 529
           N IS      +  +  L  L+  S
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 54.1 bits (128), Expect = 4e-08
 Identities = 45/340 (13%), Positives = 93/340 (27%), Gaps = 34/340 (10%)

Query: 304 KSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENML----YGSIPEELGRLKSLSQLSL 359
           KSL    ++       +   L    +++ + +  N +       + E +   K L     
Sbjct: 8   KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 360 SVN---KLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL 416
           S     ++   IP  L  L        + + +  S        ++     L ++    +L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT-GNISEVFGIYPDLE 475
             +    G      +        + +  +N   L S+   RN+L  G++ E    +    
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 476 LLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQ 535
           LL        G                    ++     +   ++          +    +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 536 IPKQLGKLTSLTSLTLNGNQLSGDIP------LELGLLAELGYLDLSANRLSKLIPKNLG 589
                          LN   LS                  L  L L  N +     + L 
Sbjct: 247 ELG------------LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294

Query: 590 E-----LRKLHHLNLSNNQFSQEISI--QIGKLVQLSKLD 622
                 +  L  L L+ N+FS+E  +  +I ++       
Sbjct: 295 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 53.3 bits (126), Expect = 7e-08
 Identities = 38/340 (11%), Positives = 92/340 (27%), Gaps = 30/340 (8%)

Query: 232 NLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNG----SLPSSFGNLSSLKHLHVH 287
           +LK   +        +   L    S+  + LS N +       L  +  +   L+     
Sbjct: 9   SLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 288 N--INKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIP 345
           +    ++   IP+ +  L            +                 ++ ++     + 
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 346 EELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKY 405
                L   +   ++      ++     N   L+      N L     +E     + ++ 
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 406 LLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNIS 465
           L         +     +   L   +      V  +  +                 +  ++
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH-----------LGSSALA 236

Query: 466 EVFGIYPDLELLDLSNNNFFGEISSNWIKC------PQLATLNMGGNEISGTIPSEI--- 516
                +P+L  L L++       ++  +          L TL +  NEI       +   
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296

Query: 517 --GNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGN 554
               M  L  L+ + NR   +    + ++  + S    G 
Sbjct: 297 IDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.0 bits (112), Expect = 3e-06
 Identities = 40/337 (11%), Positives = 81/337 (24%), Gaps = 27/337 (8%)

Query: 207 RSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSG----YIPPKLGSFKSLLYLYL 262
           +SL    +       S+        ++K + L  N +      ++   + S K L     
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 263 SHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPP 322
           S              L  L    +             +  ++   + +    Q       
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPK---------LHTVRLSDNAFGPTAQEPLIDFL 117

Query: 323 SLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFA 382
           S         L+                 +              SI      L N     
Sbjct: 118 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 177

Query: 383 LRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPR 442
             +   S  +   ++ ++   +    E+     L             +   +     +  
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237

Query: 443 SLQNCTSLYSLRLERNQLTGNISEVFGIY------PDLELLDLSNNNFFGEI-----SSN 491
           +L++  +L  L L    L+   +              L+ L L  N    +      +  
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297

Query: 492 WIKCPQLATLNMGGNEIS--GTIPSEIGNMTQLHKLD 526
             K P L  L + GN  S    +  EI  +       
Sbjct: 298 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.7 bits (101), Expect = 9e-05
 Identities = 39/320 (12%), Positives = 92/320 (28%), Gaps = 25/320 (7%)

Query: 183 KNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSG----SIPPTAGNLSNLKFLYL 238
           K+L    +       S+ + +    S+  + L+ N +       +     +  +L+    
Sbjct: 8   KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 239 HDNRLSGYIPPKLGSFKSLLYLYLSHNQL--NGSLPSSFGNLSSLKHLHVHNINKLSGSI 296
            D            + + LL   L   +L       ++FG  +    +   + +     +
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 297 PKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENML----YGSIPEELGRLK 352
                 L   +   +++      +     N   +R +    N L         +     +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 353 SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
            L  + +  N +       L          L+  +L  +    + +         + N  
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 413 TGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-----SEV 467
              L   +  +          +               L +LRL+ N++  +      + +
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSK---------LENIGLQTLRLQYNEIELDAVRTLKTVI 297

Query: 468 FGIYPDLELLDLSNNNFFGE 487
               PDL  L+L+ N F  E
Sbjct: 298 DEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (100), Expect = 9e-05
 Identities = 42/326 (12%), Positives = 90/326 (27%), Gaps = 44/326 (13%)

Query: 26  LAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG----IIPPQIGILTNLVVLRLSV 81
           L    ++      ++   +     +K +  S N         +   I    +L +   S 
Sbjct: 10  LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 82  NQLNGL----------IPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNS 131
                +          + + L +   L+ + LS N    +    L +  +          
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 132 LSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSL-HTNNFSGVIPRSLGGLKNLTFVYL 190
            +  + P  G  I+     +  +     +P   S+    N               +   L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 191 NNNRIVGSIPSEIGNLRSLSYLGLNKNQLS--------------GSIPPTAGNLSNLKFL 236
           +  ++V +     G    L        +L                ++     +  NL+ L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 237 YLHDNRLSGYIPPKLG------SFKSLLYLYLSHNQLNGSLPSS-----FGNLSSLKHLH 285
            L+D  LS      +           L  L L +N++      +        +  L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 286 VHNINKLS--GSIPKEIGNLKSLSHL 309
           ++  N+ S    +  EI  + S    
Sbjct: 309 LNG-NRFSEEDDVVDEIREVFSTRGR 333

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (100), Expect = 1e-04
 Identities = 35/327 (10%), Positives = 71/327 (21%), Gaps = 16/327 (4%)

Query: 43  QISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNG----LIPEELGELTSL 98
           + S   K   LD  T +    +   +    ++  + LS N +       + E +     L
Sbjct: 2   RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61

Query: 99  NELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNL 158
                S              L  L+Q  L    L      +  +  +     I     + 
Sbjct: 62  EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121

Query: 159 ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQ 218
                   +         +    L+ L       N           N      +      
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181

Query: 219 LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
                      +            L           K L     +   L  S  +     
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 279 SSLKHLHVHNINKLSGSIPKEIGN------LKSLSHLWLSKTQLSGFIPPSL-----GNL 327
                    N   LS      + +         L  L L   ++      +L       +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 328 SNIRGLYIRENMLYGSIPEELGRLKSL 354
            ++  L +  N       + +  ++ +
Sbjct: 302 PDLLFLELNGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 38/323 (11%), Positives = 88/323 (27%), Gaps = 33/323 (10%)

Query: 353 SLSQLSLSVNKLNG----SIPHCLGNLSNLKFFALRENELSG----SIPQEIENMKKLNK 404
           S+   SL ++ +      S+   L    ++K   L  N +       + + I + K L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 405 YLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI 464
               +        +       L    ++                +     ++       +
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 465 SEVF---GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQ 521
             ++             ++       ++      P L ++  G N +      E     Q
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 522 LHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLS 581
            H+L  +   +   I  +  +   L  L                L       +   +  S
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE-----------LKVLDLQDNTFTHLGS 232

Query: 582 KLIPKNLGELRKLHHLNLSNNQFSQEISIQIG------KLVQLSKLDLSHNSLGGNIPSE 635
             +   L     L  L L++   S   +  +       + + L  L L +N +  +    
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 636 IC-----NLESLEYMNLLQNKLS 653
           +       +  L ++ L  N+ S
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFS 315

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.5 bits (120), Expect = 4e-08
 Identities = 35/108 (32%), Positives = 47/108 (43%), Gaps = 6/108 (5%)

Query: 28  YLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGL 87
            L L+   L  T+   +  L  + HLD S N+    +PP +  L  L VL+ S N L  +
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58

Query: 88  IPEELGELTSLNELALSYNRLNG-SIPASLGNLSNLVQLSLSNNSLSG 134
                  L  L EL L  NRL   +    L +   LV L+L  NSL  
Sbjct: 59  DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 1e-07
 Identities = 29/112 (25%), Positives = 44/112 (39%), Gaps = 6/112 (5%)

Query: 500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGD 559
            L++   ++  T+   +  +  +  LD S NRL    P  L  L  L    L  +  + +
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALE 56

Query: 560 IPLELGLLAELGYLDLSANRLSKL-IPKNLGELRKLHHLNLSNNQFSQEISI 610
               +  L  L  L L  NRL +    + L    +L  LNL  N   QE  I
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 21/116 (18%), Positives = 34/116 (29%), Gaps = 10/116 (8%)

Query: 101 LALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIP------PNWGYLISPHYGSIPQD 154
           L L++  L  ++   L  L  +  L LS+N L    P             S +       
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 155 LGNLESPVSVSLHTNNFSGV-IPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL 209
           + NL     + L  N        + L     L  + L  N +          L  +
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 7e-06
 Identities = 27/125 (21%), Positives = 46/125 (36%), Gaps = 10/125 (8%)

Query: 259 YLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
            L+L+H  L  ++      L  + HL + + N+L    P  +  L+ L  L  S      
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSH-NRLRALPP-ALAALRCLEVLQASDNA--L 55

Query: 319 FIPPSLGNLSNIRGLYIRENML-YGSIPEELGRLKSLSQLSLSVNKL---NGSIPHCLGN 374
                + NL  ++ L +  N L   +  + L     L  L+L  N L    G        
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 375 LSNLK 379
           L ++ 
Sbjct: 116 LPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 3e-05
 Identities = 26/119 (21%), Positives = 42/119 (35%), Gaps = 6/119 (5%)

Query: 453 LRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTI 512
           L L    LT  +         +  LDLS+N       +       L  L    ++ +   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALA-ALRCLEVLQA--SDNALEN 57

Query: 513 PSEIGNMTQLHKLDFSSNRLVG-QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAEL 570
              + N+ +L +L   +NRL      + L     L  L L GN L  +  ++  L   L
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 31/107 (28%), Positives = 43/107 (40%), Gaps = 6/107 (5%)

Query: 549 LTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEI 608
           L L    L+  +   L  L  + +LDLS NRL  L P  L  LR L  L  S+N      
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 609 SIQIGKLVQLSKLDLSHNSL-GGNIPSEICNLESLEYMNLLQNKLSG 654
            +     +Q  +L L +N L        + +   L  +NL  N L  
Sbjct: 60  GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 19/114 (16%), Positives = 40/114 (35%), Gaps = 7/114 (6%)

Query: 440 IPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLA 499
           +   L+    +  L L  N+L      +  +     L  L  ++   E        P+L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPALAALR---CLEVLQASDNALENVDGVANLPRLQ 68

Query: 500 TLNMGGNEISGT-IPSEIGNMTQLHKLDFSSNRLVGQ---IPKQLGKLTSLTSL 549
            L +  N +  +     + +  +L  L+   N L  +     +    L S++S+
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 9e-05
 Identities = 21/124 (16%), Positives = 36/124 (29%), Gaps = 7/124 (5%)

Query: 357 LSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGYL 416
           L L+   L  ++   L  L  +    L  N L    P  +  ++ L      +N      
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLT---GNISEVFGIYPD 473
                           N        + L +C  L  L L+ N L    G    +  + P 
Sbjct: 60  GVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 474 LELL 477
           +  +
Sbjct: 119 VSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 1e-04
 Identities = 26/108 (24%), Positives = 37/108 (34%), Gaps = 5/108 (4%)

Query: 211 YLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGS 270
            L L    L+  +      L  +  L L  NRL    PP L + + L  L  S N L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN- 57

Query: 271 LPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSG 318
                 NL  L+ L + N      +  + + +   L  L L    L  
Sbjct: 58  -VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 25/107 (23%), Positives = 37/107 (34%), Gaps = 7/107 (6%)

Query: 23  FPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN 82
              + +LDLS N+L    P  ++ L  L+ L  S N    +          L  L L  N
Sbjct: 19  LLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLP--RLQELLLCNN 75

Query: 83  QLNGL-IPEELGELTSLNELALSYNRL---NGSIPASLGNLSNLVQL 125
           +L      + L     L  L L  N L    G        L ++  +
Sbjct: 76  RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 26/135 (19%), Positives = 39/135 (28%), Gaps = 22/135 (16%)

Query: 125 LSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN 184
           L L++  L+                 +   L  L     + L  N    + P +L  L+ 
Sbjct: 3   LHLAHKDLT-----------------VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRC 44

Query: 185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTA-GNLSNLKFLYLHDNRL 243
           L    L  +         + NL  L  L L  N+L  S       +   L  L L  N L
Sbjct: 45  LE--VLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

Query: 244 SGYIPPKLGSFKSLL 258
                        +L
Sbjct: 103 CQ-EEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.004
 Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 26/105 (24%)

Query: 597 LNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESL-------------- 642
           L+L++   +  +   + +L+ ++ LDLSHN L    P+ +  L  L              
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 643 --------EYMNLLQNKL-SGPIPSCFRRMHGLSSIDVSYNELQG 678
                   + + L  N+L              L  +++  N L  
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 5e-08
 Identities = 15/101 (14%), Positives = 34/101 (33%), Gaps = 5/101 (4%)

Query: 569 ELGYLDLSANRLSKL-IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQ----LSKLDL 623
           ++  LD+    LS     + L  L++   + L +   ++     I   ++    L++L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 624 SHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMH 664
             N LG      +          + +  L     +      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 2e-07
 Identities = 19/104 (18%), Positives = 30/104 (28%), Gaps = 5/104 (4%)

Query: 50  LKHLDFSTNQFSGIIPPQI-GILTNLVVLRLSVNQLNG----LIPEELGELTSLNELALS 104
           ++ LD    + S     ++  +L    V+RL    L       I   L    +L EL L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHY 148
            N L       +          +   SL        G  +    
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 9e-07
 Identities = 21/99 (21%), Positives = 34/99 (34%), Gaps = 5/99 (5%)

Query: 545 SLTSLTLNGNQLSGDIPLEL-GLLAELGYLDLSANRLS----KLIPKNLGELRKLHHLNL 599
            + SL +   +LS     EL  LL +   + L    L+    K I   L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 600 SNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICN 638
            +N+        + + +Q     +   SL     +    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 18/80 (22%), Positives = 29/80 (36%), Gaps = 9/80 (11%)

Query: 570 LGYLDLSANRLS----KLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQ-----LSK 620
           L  L L+   +S      +   L     L  L+LSNN       +Q+ + V+     L +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 621 LDLSHNSLGGNIPSEICNLE 640
           L L        +   +  LE
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 5e-06
 Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 9/84 (10%)

Query: 495 CPQLATLNMGGNEISGT----IPSEIGNMTQLHKLDFSSNRLVGQIPKQLGK-----LTS 545
              L  L +   ++S +    + + +     L +LD S+N L      QL +        
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 546 LTSLTLNGNQLSGDIPLELGLLAE 569
           L  L L     S ++   L  L +
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 18/87 (20%), Positives = 26/87 (29%), Gaps = 9/87 (10%)

Query: 518 NMTQLHKLDFSSNRL----VGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELG-----LLA 568
             + L  L  +   +       +   L    SL  L L+ N L     L+L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLH 595
            L  L L     S+ +   L  L K  
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 9e-06
 Identities = 10/82 (12%), Positives = 27/82 (32%), Gaps = 9/82 (10%)

Query: 471 YPDLELLDLSNNNFFGE----ISSNWIKCPQLATLNMGGNEISGTIPSEIG-----NMTQ 521
              L +L L++ +        +++  +    L  L++  N +      ++          
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 522 LHKLDFSSNRLVGQIPKQLGKL 543
           L +L         ++  +L  L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 19/75 (25%), Positives = 28/75 (37%), Gaps = 9/75 (12%)

Query: 72  TNLVVLRLSVNQLNGL----IPEELGELTSLNELALSYNRLNGSIPASLG-----NLSNL 122
           + L VL L+   ++      +   L    SL EL LS N L  +    L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 123 VQLSLSNNSLSGQIP 137
            QL L +   S ++ 
Sbjct: 429 EQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 15/91 (16%), Positives = 29/91 (31%), Gaps = 8/91 (8%)

Query: 205 NLRSLSYLGLNKNQLSGS-IPPTAGNLSNLKFLYLHDNRLSG----YIPPKLGSFKSLLY 259
           +++SL    +   +LS +        L   + + L D  L+      I   L    +L  
Sbjct: 3   DIQSLD---IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 260 LYLSHNQLNGSLPSSFGNLSSLKHLHVHNIN 290
           L L  N+L                  +  ++
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 10/93 (10%)

Query: 473 DLELLDLSNNNFFGEISSNWIKC-PQLATLNMGGNEISG----TIPSEIGNMTQLHKLDF 527
           D++ LD+          +  +    Q   + +    ++      I S +     L +L+ 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 528 SSNRLVGQIPKQLGKL-----TSLTSLTLNGNQ 555
            SN L       + +        +  L+L    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 6e-05
 Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 9/90 (10%)

Query: 326 NLSNIRGLYIRENML----YGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLG-----NLS 376
             S +R L++ +  +      S+   L    SL +L LS N L  +    L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 377 NLKFFALRENELSGSIPQEIENMKKLNKYL 406
            L+   L +   S  +   ++ ++K    L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 6e-05
 Identities = 14/89 (15%), Positives = 28/89 (31%), Gaps = 5/89 (5%)

Query: 498 LATLNMGGNEISGTIPSEI-GNMTQLHKLDFSSNRL----VGQIPKQLGKLTSLTSLTLN 552
           + +L++   E+S    +E+   + Q   +      L       I   L    +L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 553 GNQLSGDIPLELGLLAELGYLDLSANRLS 581
            N+L       +    +     +    L 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 8e-05
 Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 10/85 (11%)

Query: 229 NLSNLKFLYLHDNRLSG----YIPPKLGSFKSLLYLYLSHNQLNGSLPSSFG-----NLS 279
             S L+ L+L D  +S      +   L +  SL  L LS+N L  +              
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 280 SLKHLHVHNINKLSGSIPKEIGNLK 304
            L+ L +++    S  +   +  L+
Sbjct: 427 LLEQLVLYD-IYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 14/93 (15%), Positives = 25/93 (26%), Gaps = 9/93 (9%)

Query: 16  QEFPFLLFPQLAYLDLSVNQL----FGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIG-- 69
            +        L  L L+   +      ++   +     L+ LD S N        Q+   
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 70  ---ILTNLVVLRLSVNQLNGLIPEELGELTSLN 99
                  L  L L     +  + + L  L    
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 15/73 (20%), Positives = 28/73 (38%), Gaps = 5/73 (6%)

Query: 616 VQLSKLDLSHNSLGGNIPSEIC-NLESLEYMNLLQNKLSG----PIPSCFRRMHGLSSID 670
           + +  LD+    L     +E+   L+  + + L    L+      I S  R    L+ ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 671 VSYNELQGSIPHS 683
           +  NEL     H 
Sbjct: 62  LRSNELGDVGVHC 74

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 4e-04
 Identities = 17/88 (19%), Positives = 26/88 (29%), Gaps = 9/88 (10%)

Query: 41  PTQISHLSKLKHLDFSTNQFSGI----IPPQIGILTNLVVLRLSVNQLNGLIPEELGE-- 94
                  S L+ L  +    S      +   +    +L  L LS N L      +L E  
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 95  ---LTSLNELALSYNRLNGSIPASLGNL 119
                 L +L L     +  +   L  L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 8e-04
 Identities = 12/92 (13%), Positives = 30/92 (32%), Gaps = 6/92 (6%)

Query: 256 SLLYLYLSHNQLNGS-LPSSFGNLSSLKHLHVHNINKLSGSIPKEIG----NLKSLSHLW 310
            +  L +   +L+ +        L   + + + +   L+ +  K+I        +L+ L 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDD-CGLTEARCKDISSALRVNPALAELN 61

Query: 311 LSKTQLSGFIPPSLGNLSNIRGLYIRENMLYG 342
           L   +L       +          I++  L  
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 16/91 (17%), Positives = 32/91 (35%), Gaps = 5/91 (5%)

Query: 305 SLSHLWLSKTQLSGFIPPSL-GNLSNIRGLYIRENML----YGSIPEELGRLKSLSQLSL 359
            +  L +   +LS      L   L   + + + +  L       I   L    +L++L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 360 SVNKLNGSIPHCLGNLSNLKFFALRENELSG 390
             N+L     HC+          +++  L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 51.7 bits (122), Expect = 6e-08
 Identities = 32/190 (16%), Positives = 58/190 (30%), Gaps = 17/190 (8%)

Query: 97  SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPN----------WGYLISP 146
               +  +   L   IP  +    +  +L L++N L                      + 
Sbjct: 9   EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65

Query: 147 HYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNL 206
             G  P           + L  N    +  +   GL  L  + L +N+I   +P    +L
Sbjct: 66  LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125

Query: 207 RSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQ 266
            SL+ L    +         A     L+   L+        P K+   + +    L H++
Sbjct: 126 NSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSE 181

Query: 267 LNGSLPSSFG 276
              S  +S G
Sbjct: 182 FKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 49.4 bits (116), Expect = 4e-07
 Identities = 29/174 (16%), Positives = 51/174 (29%), Gaps = 6/174 (3%)

Query: 222 SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSL 281
            IP       +   L L+DN L       L      L            +  +    +S 
Sbjct: 22  EIP--RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 282 KHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLY 341
                   NK+     K    L  L  L L   Q+S  +P S  +L+++       +  +
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT-SLNLASNPF 138

Query: 342 GSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQE 395
                     + L + SL+        P     + +++   L  +E   S    
Sbjct: 139 NCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCSSENS 189

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.4 bits (103), Expect = 2e-05
 Identities = 38/191 (19%), Positives = 71/191 (37%), Gaps = 20/191 (10%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTI-PTQISHLSKLKHLDFSTNQFSGIIPPQIGILTN 73
           L+E P  +      L L+ N+L           L  L  L+   NQ +GI P      ++
Sbjct: 20  LKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 74  LVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLS 133
           +  L+L  N++  +  +    L  L  L L  N+++  +P S  +L++L  L+L++N  +
Sbjct: 80  IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

Query: 134 GQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNN 193
                 W                  E     SL+        P     ++++    L ++
Sbjct: 140 CNCHLAW----------------FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHS 180

Query: 194 RIVGSIPSEIG 204
               S  +  G
Sbjct: 181 EFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.0 bits (102), Expect = 2e-05
 Identities = 37/170 (21%), Positives = 65/170 (38%), Gaps = 6/170 (3%)

Query: 160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKNQ 218
              +V          IPR +    + T + LN+N +       + G L  L  L L +NQ
Sbjct: 9   EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65

Query: 219 LSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNL 278
           L+G  P      S+++ L L +N++             L  L L  NQ++  +P SF +L
Sbjct: 66  LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125

Query: 279 SSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLS 328
           +SL  L++ +               + L    L+        P  + ++ 
Sbjct: 126 NSLTSLNLASNPFN--CNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ 173

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 29/161 (18%), Positives = 49/161 (30%), Gaps = 29/161 (18%)

Query: 469 GIYPDLELLDLSNNNFFGEISSNWI-------------------------KCPQLATLNM 503
            I      L L++N      S                                 +  L +
Sbjct: 26  DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85

Query: 504 GGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE 563
           G N+I          + QL  L+   N++   +P     L SLTSL L  N  + +  L 
Sbjct: 86  GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145

Query: 564 LGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF 604
                 L    L+        P    ++R +   +L +++F
Sbjct: 146 -WFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (123), Expect = 8e-08
 Identities = 26/217 (11%), Positives = 61/217 (28%), Gaps = 6/217 (2%)

Query: 343 SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKL 402
            IP +L   ++  +L   + KL            +L+   + +N++   I  ++ +    
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 403 NKYLLFE----NQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERN 458
              +  E      +          +      S      +  + +       L  ++   N
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 459 QLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGN 518
             T   +   G+  +  +L L+ N      +  +             N +          
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 519 MTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQ 555
            +    LD S  R+       L  L  L + +    +
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 35/218 (16%), Positives = 65/218 (29%), Gaps = 15/218 (6%)

Query: 88  IPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPH 147
           IP +L    +  EL     +L      +     +L ++ +S N +   I  +    +   
Sbjct: 23  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 148 YGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNL-------------TFVYLNNNR 194
           +    +   NL      +         +  S  G+K+L               +  N N 
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 195 IVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSF 254
                 S +G       L LNKN +              +     +N L           
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 255 KSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKL 292
              + L +S  +++        NL  L+    +N+ KL
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL 238

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 39/239 (16%), Positives = 71/239 (29%), Gaps = 8/239 (3%)

Query: 417 PQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLEL 476
              +C   S   F  + +     IP  L    +   LR    +L       F  + DLE 
Sbjct: 2   HHRICHC-SNRVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 477 LDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTI--PSEIGNMTQLHKLDFSSNRLVG 534
           +++S N+    I ++                 +     P    N+  L  L  S+  +  
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 535 QIPK--QLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR 592
                        L  +  N N  + +    +GL  E   L L+ N + ++        +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 593 KLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNK 651
                   NN   +  +           LD+S   +       + NL+ L   +    K
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 28/247 (11%), Positives = 58/247 (23%), Gaps = 24/247 (9%)

Query: 236 LYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGS 295
               +++++  IP  L   ++ + L     +L      +F     L+ + +   + L   
Sbjct: 13  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69

Query: 296 IPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLS 355
                 NL  L  + + K     +I P            +  N     +P+         
Sbjct: 70  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD--------- 120

Query: 356 QLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQFTGY 415
                       +         L       N  +      +    +     L +N     
Sbjct: 121 ------------VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168

Query: 416 LPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLE 475
                  +         NNN            +    L + R ++    S        L 
Sbjct: 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 228

Query: 476 LLDLSNN 482
                N 
Sbjct: 229 ARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 28/228 (12%), Positives = 58/228 (25%), Gaps = 6/228 (2%)

Query: 160 SPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQL 219
           S        +  +  IP  L   +N   +     ++             L  + +++N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 220 SGSIPPTAGNLSNLKFLYLH---DNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFG 276
              I     +             +N L                L  +    +        
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIR 336
           +L  +      NIN  +      +G       LWL+K  +      +             
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 337 ENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFFALR 384
            N L     +          L +S  +++    + L NL  L+  +  
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 16/87 (18%), Positives = 25/87 (28%), Gaps = 3/87 (3%)

Query: 52  HLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGS 111
            L  + N    I            +     N L  L  +     +    L +S  R++  
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216

Query: 112 IPASLGNLSNLVQLSLSNNSLSGQIPP 138
               L NL  L   S  N     ++P 
Sbjct: 217 PSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 6e-04
 Identities = 30/235 (12%), Positives = 59/235 (25%), Gaps = 9/235 (3%)

Query: 353 SLSQLSLSVNKLNGSIPHCLGNLSNLKFFALRENELSGSIPQEIENMKKLNKYLLFENQF 412
           S        +K+   IP  L    N         +L             L K  + +N  
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 413 TGYLPQNVCQSGSLTHFSV----RNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVF 468
              +  +V  +    H        N  ++ P             +     +   ++ ++ 
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 469 GIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS 528
            +   L  +  + N    E +S      +   L +  N I                    
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL 583
           +N L           +    L ++  ++       L  L +L         L KL
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL 238

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 0.001
 Identities = 37/224 (16%), Positives = 63/224 (28%), Gaps = 16/224 (7%)

Query: 15  LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNL 74
           + E P  L      L   + +L        S    L+ ++ S N    +I   +      
Sbjct: 20  VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 75  VVLRLSVNQLNGLI--PEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSL 132
           +         N L   PE    L +L  L +S   +         +    V L + +N  
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 133 SGQIPPNWG----------YLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPR-SLGG 181
              I  N            +L       I     N      ++L  NN    +P     G
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHG 199

Query: 182 LKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPP 225
                 + ++  RI       + NL+ L        +    +P 
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 34/243 (13%), Positives = 65/243 (26%), Gaps = 21/243 (8%)

Query: 97  SLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLG 156
           S        +++   IP+ L    N ++L      L   I                    
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKG--------------AFS 50

Query: 157 NLESPVSVSLHTNNFSGVIPRSLGGLKNLTF--VYLNNNRIVGSIPSEIGNLRSLSYLGL 214
                  + +  N+   VI   +               N ++   P    NL +L YL +
Sbjct: 51  GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110

Query: 215 NKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSS 274
           +   +         +      L + DN     I        S   + L  N+       +
Sbjct: 111 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 170

Query: 275 FGNLSSLKHLHVHNINKLSGSIPKEI-GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGL 333
                +       + N     +P ++         L +S+T++       L NL  +R  
Sbjct: 171 CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230

Query: 334 YIR 336
              
Sbjct: 231 STY 233

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.4 bits (111), Expect = 2e-06
 Identities = 38/191 (19%), Positives = 67/191 (35%), Gaps = 9/191 (4%)

Query: 71  LTNLVVLRLSVNQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNN 130
           L   +   L    +   + +   +L  +  L      +  SI   +  L+NL Q++ SNN
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72

Query: 131 SLSGQIP-PNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVY 189
            L+   P  N   L+     +         + ++       F+  I              
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 190 LNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP 249
           L  +    S  S +  L SL  L  + NQ++   P    NL+ L+ L +  N++S     
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 188

Query: 250 KLGSFKSLLYL 260
            L    +L  L
Sbjct: 189 VLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 34/210 (16%), Positives = 64/210 (30%), Gaps = 37/210 (17%)

Query: 150 SIPQDLG--------NLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPS 201
           +I QD           L   +   L   N +  + ++   L  +T +  +   I      
Sbjct: 1   TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSID 56

Query: 202 EIGNLRSLSYLGLNKNQLSG------------------SIPPTAGNLSNLKFLYLHDNRL 243
            +  L +L+ +  + NQL+                    I       +      L     
Sbjct: 57  GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 116

Query: 244 SGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNL 303
                  L +  +L  L LS N ++     S        +   + +  L       + NL
Sbjct: 117 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK-----PLANL 171

Query: 304 KSLSHLWLSKTQLSGFIPPSLGNLSNIRGL 333
            +L  L +S  ++S      L  L+N+  L
Sbjct: 172 TTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 27/188 (14%), Positives = 58/188 (30%), Gaps = 19/188 (10%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
            L       L K  ++ ++  T  +L  +  L      +       +    +L  +  S+
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKT---------- 314
           NQL    P           ++ + I  ++           +L +  ++            
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 315 ---QLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHC 371
                S  I              +  +    +  + L  L +L +L +S NK++      
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 372 LGNLSNLK 379
           L  L+NL+
Sbjct: 190 LAKLTNLE 197

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (102), Expect = 2e-05
 Identities = 21/147 (14%), Positives = 43/147 (29%), Gaps = 3/147 (2%)

Query: 184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPP-TAGNLSNLKFLYLHDNR 242
             + +    +  +      +    +L+ L +   Q    +       L  L+ L +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 243 LSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGN 302
           L    P        L  L LS N    SL        SL+ L +           + +  
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 303 LKSLSHLWLSKTQLSGFIPPSLGNLSN 329
            +      + + +L       L ++ N
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPN 153

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 2e-04
 Identities = 28/144 (19%), Positives = 49/144 (34%), Gaps = 4/144 (2%)

Query: 447 CTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIK-CPQLATLNMGG 505
                 LR  R+    ++  + G     E L + N      +    ++   +L  L +  
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 506 NEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLE-L 564
           + +    P       +L +L+ S N L   +  +  +  SL  L L+GN L     L  L
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 565 GLLAELGYLDLSANRLSKLIPKNL 588
               E G   +   +L       L
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPL 148

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 5e-04
 Identities = 21/147 (14%), Positives = 44/147 (29%), Gaps = 4/147 (2%)

Query: 420 VCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNI-SEVFGIYPDLELLD 478
            C     +      +  +      L    +L  L +E  Q   ++         +L  L 
Sbjct: 4   ACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62

Query: 479 LSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLV-GQIP 537
           +  +         +   P+L+ LN+  N +  ++  +      L +L  S N L      
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCAL 121

Query: 538 KQLGKLTSLTSLTLNGNQLSGDIPLEL 564
           + L +        +   +L       L
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQGPL 148

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 5e-04
 Identities = 31/151 (20%), Positives = 47/151 (31%), Gaps = 5/151 (3%)

Query: 159 ESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEI-GNLRSLSYLGLNKN 217
                +    +         L G +NLT +Y+ N + +  +       L  L  L + K+
Sbjct: 8   HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 218 QLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQLNGSL-PSSFG 276
            L    P        L  L L  N L   +  K     SL  L LS N L+ S       
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125

Query: 277 NLSSLKHLHVHNINKLSGSIPKEIGNLKSLS 307
                    V    KL       + ++ + S
Sbjct: 126 RWEEEGLGGVPE-QKLQCHGQGPLAHMPNAS 155

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 21/137 (15%), Positives = 40/137 (29%), Gaps = 5/137 (3%)

Query: 150 SIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSL 209
            +   +         +L            L        +   ++    ++     N+  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 210 SYLGLNKNQLSG--SIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSHNQL 267
             L L+ N+L     +        NLK L L  N L             L  L+L  N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 268 NGSLPSSFGNLSSLKHL 284
           + +       +S+++  
Sbjct: 128 SDTFRDQSTYISAIRER 144

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 1e-04
 Identities = 28/129 (21%), Positives = 47/129 (36%), Gaps = 5/129 (3%)

Query: 535 QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKL 594
           Q+   + K    +   L+   L  D   +L        L+   + ++  +      + +L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRSD--PDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67

Query: 595 HHLNLSNNQFS--QEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKL 652
             LNLSNN+     ++S  + K   L  L+LS N L      +      LE + L  N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 653 SGPIPSCFR 661
           S        
Sbjct: 128 SDTFRDQST 136

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 7/117 (5%)

Query: 521 QLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRL 580
               LD    R        L        L    + ++  + +    + EL  L+LS NRL
Sbjct: 23  SQQALDLKGLR----SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRL 77

Query: 581 SKL--IPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSE 635
            +L  +   + +   L  LNLS N+   E  +   K ++L +L L  NSL      +
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.003
 Identities = 25/121 (20%), Positives = 41/121 (33%), Gaps = 10/121 (8%)

Query: 511 TIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSG--DIPLELGLLA 568
               ++        L+  S+     +      +  L SL L+ N+L    D+   +    
Sbjct: 33  RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91

Query: 569 ELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQ-------IGKLVQLSKL 621
            L  L+LS N L      +  +  KL  L L  N  S     Q         +  +L +L
Sbjct: 92  NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151

Query: 622 D 622
           D
Sbjct: 152 D 152

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 3e-04
 Identities = 22/132 (16%), Positives = 44/132 (33%), Gaps = 6/132 (4%)

Query: 205 NLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH 264
           N      L L   ++   I      L     +   DN +           + L  L +++
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72

Query: 265 NQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLS---KTQLSGFIP 321
           N++          L  L  L + N + +       + +LKSL++L +     T    +  
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132

Query: 322 PSLGNLSNIRGL 333
             +  +  +R L
Sbjct: 133 YVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 4e-04
 Identities = 31/140 (22%), Positives = 57/140 (40%), Gaps = 7/140 (5%)

Query: 489 SSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTS 548
           ++ +    +   L++ G +I   I +    + Q   +DFS N +          L  L +
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKT 67

Query: 549 LTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL-IPKNLGELRKLHHLNLSNNQFSQE 607
           L +N N++          L +L  L L+ N L +L     L  L+ L +L +  N  + +
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 608 ISIQ---IGKLVQLSKLDLS 624
              +   I K+ Q+  LD  
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 5e-04
 Identities = 16/102 (15%), Positives = 35/102 (34%), Gaps = 5/102 (4%)

Query: 575 LSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPS 634
           L+A  + +          +   L+L   +    I      L Q   +D S N +      
Sbjct: 3   LTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57

Query: 635 EICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNEL 676
               L  L+ + +  N++        + +  L+ + ++ N L
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 3/90 (3%)

Query: 20  FLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRL 79
           +    +   LDL   ++   I    + L +   +DFS N+   +      +L  L  L +
Sbjct: 14  YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLV 70

Query: 80  SVNQLNGLIPEELGELTSLNELALSYNRLN 109
           + N++  +       L  L EL L+ N L 
Sbjct: 71  NNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.002
 Identities = 25/138 (18%), Positives = 43/138 (31%), Gaps = 7/138 (5%)

Query: 443 SLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLN 502
              N      L L   ++   I  +       + +D S+N         +    +L TL 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69

Query: 503 MGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG-QIPKQLGKLTSLTSLTLNG---NQLSG 558
           +  N I          +  L +L  ++N LV       L  L SLT L +          
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 559 DIPLELGLLAELGYLDLS 576
                +  + ++  LD  
Sbjct: 130 YRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.003
 Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 3/91 (3%)

Query: 43  QISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELA 102
           Q ++  + + LD    +   +I      L     +  S N++  L  +    L  L  L 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 69

Query: 103 LSYNRLNGSIPASLGNLSNLVQLSLSNNSLS 133
           ++ NR+          L +L +L L+NNSL 
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.004
 Identities = 15/92 (16%), Positives = 26/92 (28%), Gaps = 3/92 (3%)

Query: 322 PSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKFF 381
               N    R L +R   +   I      L     +  S N++          L  LK  
Sbjct: 12  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 68

Query: 382 ALRENELSGSIPQEIENMKKLNKYLLFENQFT 413
            +  N +        + +  L + +L  N   
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1048
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.49
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.48
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.66
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.64
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.95
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.66
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.47
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.43
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.87
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.01
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.17
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.54

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=406.89  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=196.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ..+.||+|+||+||+|+++ +++.||||++......+......+|++.++.++|||||++++++.+.+..|+||||+++|
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg   88 (271)
T d1nvra_           9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   88 (271)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence            3457899999999999986 688999999876544443445667788889999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--CCc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNW  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  936 (1048)
                      +|.++++..   ..+++.++..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+|+......  ...
T Consensus        89 ~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          89 ELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             EGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            999998643   3589999999999999999999999   99999999999999999999999999998765332  234


Q ss_pred             cccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC-CCCCchhH
Q 045493          937 SELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR-LPPPLGEV 1014 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1014 (1048)
                      ...+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....          ............ ...+   .
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~----------~~~~~~~~~~~~~~~~~---~  229 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD----------SCQEYSDWKEKKTYLNP---W  229 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST----------TSHHHHHHHTTCTTSTT---G
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh----------HHHHHHHHhcCCCCCCc---c
Confidence            55789999999999988776 6789999999999999999999863221          111111111111 1111   1


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....++.+++.+||+.||++|||++|+++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            223456778999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=405.13  Aligned_cols=247  Identities=21%  Similarity=0.328  Sum_probs=190.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      .+.||+|+||+||+|++.+++.||||++......  .....++++.+++++|||||+++|+|.+.+..++||||+++|+|
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            4468999999999999988889999998753322  23456677778999999999999999999999999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-cccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~  939 (1048)
                      .+++...  ...+++..+..++.|||.||+|||+.   +|+||||||+||++++++.+||+|||+|+........ ....
T Consensus        88 ~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  162 (263)
T d1sm2a_          88 SDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  162 (263)
T ss_dssp             HHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             HHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence            9998653  34588999999999999999999999   9999999999999999999999999999876544332 2345


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP-GHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .||+.|||||++.+..|+.++|||||||++|||+|+..| |...           ........+..+......   ....
T Consensus       163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----------~~~~~~~~i~~~~~~~~p---~~~~  228 (263)
T d1sm2a_         163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----------SNSEVVEDISTGFRLYKP---RLAS  228 (263)
T ss_dssp             --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----------CHHHHHHHHHHTCCCCCC---TTSC
T ss_pred             ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----------CHHHHHHHHHhcCCCCCc---cccC
Confidence            789999999999999999999999999999999996544 3321           112222222222221111   1223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .++.+++.+||+.||++||||+|++++|++
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            468899999999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=406.64  Aligned_cols=247  Identities=24%  Similarity=0.386  Sum_probs=202.1

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +...+.||+|+||+||+|++. +++.||||++....... .....++++.++.++|||||++++++.+.+..|+||||++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            344556899999999999875 68999999987543322 2345667777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.+.    .+++.++..++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.+.......
T Consensus       101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~  173 (293)
T d1yhwa1         101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (293)
T ss_dssp             TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence            99999988542    488999999999999999999999   99999999999999999999999999999887666666


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||......           ...........+. ...+..
T Consensus       174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----------~~~~~~~~~~~~~-~~~~~~  241 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYLIATNGTPE-LQNPEK  241 (293)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------HHHHHHHHHCSCC-CSSGGG
T ss_pred             cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----------HHHHHHHhCCCCC-CCCccc
Confidence            6778999999999999999999999999999999999999998633211           1111111111111 111223


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3456888999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-47  Score=401.87  Aligned_cols=241  Identities=26%  Similarity=0.392  Sum_probs=198.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .+.||+|+||+||+|+++ +++.||+|++.....  ........+|++.++.++|||||++++++.+.+..|+||||+++
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~   90 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   90 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            456899999999999986 678899999865321  12223345667778899999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |+|.+++.+.+   .+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        91 g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~  162 (263)
T d2j4za1          91 GTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRT  162 (263)
T ss_dssp             CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCE
T ss_pred             CcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC--ccc
Confidence            99999997543   489999999999999999999999   9999999999999999999999999999866432  334


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+||+.|||||++.+..|+.++||||+||++|||++|+.||...+           .......+.......+    ...
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------~~~~~~~i~~~~~~~p----~~~  227 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----------YQETYKRISRVEFTFP----DFV  227 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHHHTTCCCCC----TTS
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-----------HHHHHHHHHcCCCCCC----ccC
Confidence            5689999999999999999999999999999999999999986422           1222233333332222    122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..++.+++.+||+.||++|||++|+++
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            346788999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-47  Score=411.47  Aligned_cols=249  Identities=23%  Similarity=0.399  Sum_probs=188.1

Q ss_pred             eeeecccccccEEEEEEcC-CC---ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTS-GD---TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~~---~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .+.||+|+||+||+|+++. ++   .||||++.............+|++.+++++|||||+++|+|.+.+..++|||||+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            4579999999999998863 33   4777877654443333344566777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|.+++...  ...+++.++..++.|||+||+|||+.   +|+||||||+|||++.++.+||+|||+|+.+...... 
T Consensus       111 ~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  185 (299)
T d1jpaa_         111 NGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  185 (299)
T ss_dssp             TEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence            99999998653  33589999999999999999999999   9999999999999999999999999999877544322 


Q ss_pred             ----ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          936 ----WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       936 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                          .....||+.|||||++.++.++.++|||||||++|||+| |+.||.....           ......+..+..++.
T Consensus       186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------~~~~~~i~~~~~~~~  254 (299)
T d1jpaa_         186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----------QDVINAIEQDYRLPP  254 (299)
T ss_dssp             ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------HHHHHHHHTTCCCCC
T ss_pred             eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHcCCCCCC
Confidence                123457899999999999999999999999999999998 8999763221           122222322222222


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .   ......+.+++.+||+.||++||||+||++.|++
T Consensus       255 ~---~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         255 P---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             C---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             C---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1   2234568889999999999999999999999863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-47  Score=405.94  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=187.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeee--CCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSH--TQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  855 (1048)
                      ..+.||+|+||+||+|+.+ +++.||||++......+. .....+|++.+++++|||||++++++.+  .+..|+||||+
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~   87 (269)
T d2java1           8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC   87 (269)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence            3457899999999999886 688999999876543321 2223456677788999999999999864  45689999999


Q ss_pred             CCCCHHHHHhccc-cccccCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEA-TAAELDWSKRVNVIKGVANALSYMHHDCF--PPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ++|+|.+++.+.. ....+++..++.++.|++.||+|||++..  .+||||||||+|||++.++.+||+|||+|+.+...
T Consensus        88 ~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1          88 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             TTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             CCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            9999999986532 33458999999999999999999998621  14999999999999999999999999999987665


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+           .......+..+..+....
T Consensus       168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~  236 (269)
T d2java1         168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----------QKELAGKIREGKFRRIPY  236 (269)
T ss_dssp             --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHHTCCCCCCT
T ss_pred             CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-----------HHHHHHHHHcCCCCCCCc
Confidence            555567789999999999999999999999999999999999999986322           122233333333332221


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                         ....++.+++.+||+.||++|||++|+++
T Consensus       237 ---~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         237 ---RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               22346888999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-46  Score=409.16  Aligned_cols=249  Identities=21%  Similarity=0.260  Sum_probs=187.5

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +.-...||+|+||+||+|+++ +++.||||++.............+|+..++.++|||||++++++.+.+..|+|||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            334557999999999999986 6888999998765443333445667888899999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC---CCCceEEeccccccccCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD---LEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      ||+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++   +++.+||+|||+|+..... 
T Consensus        91 gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-  163 (307)
T d1a06a_          91 GGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-  163 (307)
T ss_dssp             SCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             CCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence            99999999753   3489999999999999999999999   999999999999995   4789999999999866433 


Q ss_pred             CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          934 SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       934 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||....           .......+.......+...
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~  232 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----------DAKLFEQILKAEYEFDSPY  232 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----------HHHHHHHHHTTCCCCCTTT
T ss_pred             CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----------HHHHHHHHhccCCCCCCcc
Confidence            33345689999999999999999999999999999999999999986322           1222233333333322222


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.++.+++.+||++||++|||++|+++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            2334456889999999999999999999987

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=406.09  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=200.7

Q ss_pred             CCcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          777 FEGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ++.....||+|+||+||+|++. +++.||||++....... .....+|++.+++++|||||++++++.+.+..|+||||+
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG-GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH-HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4444567999999999999986 67889999987643332 334566788889999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      ++|+|.+++.+.  ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            999999998643  23489999999999999999999999   9999999999999999999999999999865433333


Q ss_pred             ccccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          936 WSELAGTCGYIAPELAY-----TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ....+||+.|||||++.     ...|+.++||||+||++|||+||+.||.....           ......+.....+. 
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----------~~~~~~i~~~~~~~-  234 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----------MRVLLKIAKSEPPT-  234 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----------GGHHHHHHHSCCCC-
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----------HHHHHHHHcCCCCC-
Confidence            44578999999999984     45689999999999999999999999864321           11222222222211 


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ...+.....++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112334457889999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=403.53  Aligned_cols=250  Identities=25%  Similarity=0.372  Sum_probs=190.2

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||+||+|+++  ..||||+++...... ......+++..+++++|||||++++++.+ +..++||||+++|+
T Consensus        13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS   89 (276)
T ss_dssp             CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred             EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence            346899999999999865  469999986543322 22334556777888999999999999865 45899999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC--CCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS--SNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~  937 (1048)
                      |.++++..  ...+++..+..++.|||+||+|||++   +||||||||+|||++.++.+||+|||+|+......  ....
T Consensus        90 L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~  164 (276)
T d1uwha_          90 LYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE  164 (276)
T ss_dssp             HHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence            99999653  23589999999999999999999999   99999999999999999999999999998765432  2335


Q ss_pred             cccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc-hh
Q 045493          938 ELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL-GE 1013 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1013 (1048)
                      ...||+.|||||++.+   ..|+.++|||||||++|||+||+.||.....          .......+.....++.. ..
T Consensus       165 ~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----------~~~~~~~~~~~~~~p~~~~~  234 (276)
T d1uwha_         165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----------RDQIIFMVGRGYLSPDLSKV  234 (276)
T ss_dssp             -CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHHHHHHHHTSCCCCGGGS
T ss_pred             ccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----------HHHHHHHHhcCCCCCcchhc
Confidence            5689999999999864   3589999999999999999999999864321          11111111111111111 11


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....+++.+++.+||+.||++||||+|+++.|++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            12334568899999999999999999999999863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=401.15  Aligned_cols=247  Identities=19%  Similarity=0.323  Sum_probs=197.2

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      .+.||+|+||+||+|++++++.||||+++.....  .....+++..+++++|||||+++|++.+ +..++||||+++|+|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L   94 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL   94 (272)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred             eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcH
Confidence            3468999999999999988889999998654322  2345667777889999999999998865 457999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~  939 (1048)
                      .+++.... ...+++..+.+++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+|+....... .....
T Consensus        95 ~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (272)
T d1qpca_          95 VDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (272)
T ss_dssp             HHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             HHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence            99886543 33589999999999999999999999   999999999999999999999999999998754432 23456


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .||+.|||||++.++.++.++|||||||++|||+||..|+...          .........+..+..+....   ....
T Consensus       171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~----------~~~~~~~~~i~~~~~~~~p~---~~~~  237 (272)
T d1qpca_         171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----------MTNPEVIQNLERGYRMVRPD---NCPE  237 (272)
T ss_dssp             CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT----------CCHHHHHHHHHTTCCCCCCT---TCCH
T ss_pred             CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC----------CCHHHHHHHHHhcCCCCCcc---cChH
Confidence            7899999999999989999999999999999999976654311          11122222332222222211   2334


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ++.+++.+||+.||++||||+||+++|+
T Consensus       238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         238 ELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            6888999999999999999999999886

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-46  Score=403.01  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||+||+|++. +++.||||+++.....  .....++++.+++++|||||+++|+|.+.+..++||||+++|+
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~   99 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN   99 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence            346899999999999886 5788999998654322  2334567788899999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-ccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-WSE  938 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~  938 (1048)
                      |.+++.... ...+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+....+... ...
T Consensus       100 l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~  175 (287)
T d1opja_         100 LLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  175 (287)
T ss_dssp             HHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred             hHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence            999996543 34589999999999999999999999   9999999999999999999999999999976544332 234


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      ..||+.|||||++.+..|+.++|||||||++|||++|..||....          ........+..+..++..   ....
T Consensus       176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----------~~~~~~~~i~~~~~~~~~---~~~~  242 (287)
T d1opja_         176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------DLSQVYELLEKDYRMERP---EGCP  242 (287)
T ss_dssp             EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----------CHHHHHHHHHTTCCCCCC---TTCC
T ss_pred             ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----------hHHHHHHHHhcCCCCCCC---ccch
Confidence            458899999999999999999999999999999999877753211          111111222112111111   1233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .++.+++.+||+.||++||||+|+++.|+
T Consensus       243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            56889999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=396.93  Aligned_cols=242  Identities=22%  Similarity=0.311  Sum_probs=191.3

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      +.||+|+||+||+|++. +++.||+|++....... ......+|++.+++++|||||++++++.+    ...+|+||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            35899999999999886 57889999987643322 22234567778899999999999999864    35689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeeCCCCCCeEEC-CCCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPP--ILHRDISSKKVLLD-LEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ++|+|.+++++..   .+++..++.++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+|+...  
T Consensus        95 ~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--  166 (270)
T d1t4ha_          95 TSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--  166 (270)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred             CCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc--
Confidence            9999999997543   488999999999999999999998   6  99999999999997 57999999999998643  


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                      .......+||+.|||||++.+ +++.++||||+||++|||++|+.||....          ........+..+..+..  
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----------~~~~~~~~i~~~~~~~~--  233 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----------NAAQIYRRVTSGVKPAS--  233 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----------SHHHHHHHHTTTCCCGG--
T ss_pred             CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----------cHHHHHHHHHcCCCCcc--
Confidence            233456789999999998865 69999999999999999999999986321          11122222222222211  


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......++.+++.+||++||++|||++|+++
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11223346788999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=400.97  Aligned_cols=244  Identities=23%  Similarity=0.278  Sum_probs=195.8

Q ss_pred             ecccccccEEEEEEc---CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          784 HGTGGCGTVYKAELT---SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       784 lG~G~~g~Vy~~~~~---~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      ||+|+||+||+|.++   ++..||||+++............+|++.+++++|||||+++|++.. +..|+||||+++|+|
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L   95 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL   95 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence            899999999999765   2346899998765443333344566777888999999999999865 468999999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC---cc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN---WS  937 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~---~~  937 (1048)
                      .+++...  ...+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+|+.+......   ..
T Consensus        96 ~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (285)
T d1u59a_          96 HKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  170 (285)
T ss_dssp             HHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             HHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence            9998543  34589999999999999999999999   9999999999999999999999999999877644322   23


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...||+.|||||++.++.++.++|||||||++|||+| |+.||....           .......+..+..++..   ..
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~p---~~  236 (285)
T d1u59a_         171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-----------GPEVMAFIEQGKRMECP---PE  236 (285)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------THHHHHHHHTTCCCCCC---TT
T ss_pred             ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHcCCCCCCC---Cc
Confidence            4568999999999999999999999999999999998 899986322           11222233333222221   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...++.+++.+||+.||++||||.++++.|+
T Consensus       237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            3356889999999999999999999998875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-46  Score=401.35  Aligned_cols=251  Identities=22%  Similarity=0.383  Sum_probs=193.0

Q ss_pred             ceeeecccccccEEEEEEcCC-----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELTSG-----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~~~-----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ..++||+|+||+||+|.++..     ..||||++.............++++.+++++|||||+++|++.+.+..++||||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence            456799999999999987643     368999986544433333445677778899999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +.+|++.+++...  ...+++.++..++.||+.|++|||+.   +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        91 ~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          91 MENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             CTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             cccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            9999999988643  34589999999999999999999999   999999999999999999999999999987654332


Q ss_pred             C---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 N---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                      .   .....||+.|||||++.++.++.++|||||||++|||++|..|+...          .........+.++..++..
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~----------~~~~~~~~~i~~~~~~~~~  235 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------LSNHEVMKAINDGFRLPTP  235 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----------CCHHHHHHHHHTTCCCCCC
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc----------CCHHHHHHHHhccCCCCCc
Confidence            2   23456899999999999999999999999999999999976664311          1122233333333322222


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                         ......+.+++.+||+.||++||||+||+++|++
T Consensus       236 ---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         236 ---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             ---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence               2234568899999999999999999999998863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=391.52  Aligned_cols=245  Identities=21%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCHH
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSLA  861 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  861 (1048)
                      +.||+|+||+||+|++++++.||||+++.....+  ....+++..+++++|||||+++|+|.+++..++||||+++|++.
T Consensus        10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~--~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~   87 (258)
T d1k2pa_          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL   87 (258)
T ss_dssp             CCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH--HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred             EEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH--HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence            4589999999999999888899999987644332  34567788889999999999999999999999999999999999


Q ss_pred             HHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Cccccc
Q 045493          862 TILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSELA  940 (1048)
Q Consensus       862 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~  940 (1048)
                      +++...  ...+++..+.+++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+|+....... ......
T Consensus        88 ~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  162 (258)
T d1k2pa_          88 NYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK  162 (258)
T ss_dssp             HHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred             Hhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence            997643  34578999999999999999999999   999999999999999999999999999987654433 233467


Q ss_pred             cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          941 GTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       941 gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      ||+.|+|||++.+..++.++|||||||++|||+| |+.||....           ..+....+..+...+..   .....
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----------~~~~~~~i~~~~~~~~p---~~~~~  228 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----------NSETAEHIAQGLRLYRP---HLASE  228 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----------HHHHHHHHHTTCCCCCC---TTCCH
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-----------HHHHHHHHHhCCCCCCc---ccccH
Confidence            8999999999999999999999999999999998 899986432           11222223232222221   12335


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ++.+++.+||+.||++||||+|+++.|.
T Consensus       229 ~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         229 KVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            6889999999999999999999999885

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=410.38  Aligned_cols=251  Identities=21%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             eeeecccccccEEEEEEcCCC------ceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTSGD------TRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~------~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+.||+|+||+||+|++....      .||||++.............+++..+.++ +|||||++++++.+.+..|+|||
T Consensus        42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (325)
T d1rjba_          42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  121 (325)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence            456899999999999876322      58888886554444344455667777777 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhcccc--------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC
Q 045493          854 YLERGSLATILSNEAT--------------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD  913 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~  913 (1048)
                      ||++|+|.++++....                    ...+++..++.++.||+.||+|||++   +||||||||+||+++
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~  198 (325)
T d1rjba_         122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT  198 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccc
Confidence            9999999999975431                    23488999999999999999999999   999999999999999


Q ss_pred             CCCceEEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCc
Q 045493          914 LEYKAHVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPA  990 (1048)
Q Consensus       914 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~  990 (1048)
                      .++.+||+|||+|+........  .....||+.|||||++.++.++.++|||||||++|||+| |+.||...+.      
T Consensus       199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~------  272 (325)
T d1rjba_         199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------  272 (325)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------
T ss_pred             cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH------
Confidence            9999999999999876554432  234568999999999999999999999999999999998 8999863221      


Q ss_pred             ccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493          991 PAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                           ......++......+.  +.....++.+++.+||+.||++||||+||+++|.
T Consensus       273 -----~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 -----DANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -----SHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----HHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                 1111222222211111  1123356889999999999999999999999984

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=411.07  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      ....||+|+||+||+|++. +++.||+|+++............+|+..+++++|||||+++++|.+.++.|+||||+++|
T Consensus        10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   89 (322)
T ss_dssp             EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            4456899999999999986 678899999876543333333455666678889999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCccc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSE  938 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  938 (1048)
                      +|.+++.+.+   .+++..+..++.|++.||.|||+++  +|+||||||+|||++.+|++||+|||+|+.+.+.  ....
T Consensus        90 ~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~~  162 (322)
T d1s9ja_          90 SLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS  162 (322)
T ss_dssp             EHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC--
T ss_pred             cHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--cccc
Confidence            9999997543   4899999999999999999999732  8999999999999999999999999999876432  2345


Q ss_pred             cccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc----------CCCc----c-c-----------
Q 045493          939 LAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL----------SLPA----P-A-----------  992 (1048)
Q Consensus       939 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~----------~~~~----~-~-----------  992 (1048)
                      .+||+.|||||++.+..|+.++||||+||++|||++|+.||...+...          +...    . .           
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM  242 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred             ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence            689999999999999999999999999999999999999986422100          0000    0 0           


Q ss_pred             -----ccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          993 -----ANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       993 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                           ...............+....  ...+.++.+++.+||+.||++||||+|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         243 DSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                 00000000000100000000  112356889999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=396.52  Aligned_cols=245  Identities=24%  Similarity=0.320  Sum_probs=191.3

Q ss_pred             eeecccccccEEEEEEcC---CCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELTS---GDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~---~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      +.||+|+||+||+|.+..   ++.||||+++...... ......+|++.+++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            358999999999998653   3579999986543322 12234556777788999999999999965 457899999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC--
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN--  935 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--  935 (1048)
                      |+|.++++..   ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||+|+.+......  
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            9999999753   3489999999999999999999999   9999999999999999999999999999876544332  


Q ss_pred             -ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          936 -WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       936 -~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                       .....||++|||||++.+..++.++|||||||++|||+| |+.||...+           .......+..+..++..  
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----------~~~~~~~i~~~~~~~~p--  232 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----------GSEVTAMLEKGERMGCP--  232 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------HHHHHHHHHTTCCCCCC--
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----------HHHHHHHHHcCCCCCCC--
Confidence             234568999999999999999999999999999999998 899986422           11222222222222221  


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       .....++.+++.+||+.||++||||++|+++|+
T Consensus       233 -~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         233 -AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             -TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             -cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence             123356888999999999999999999998875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=400.36  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=195.2

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      -.+.||+|+||+||+|+++ +++.||||++.....  ........++++.+++++|||||++++++.+.+..|+||||++
T Consensus        12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~   91 (288)
T d1uu3a_          12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK   91 (288)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence            3457899999999999986 688999999865321  1222334567777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC--
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS--  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~--  934 (1048)
                      +|+|.+++...+   .+++..++.++.|++.||+|||+.   +||||||||+||++++++.+||+|||+|+.+.....  
T Consensus        92 gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          92 NGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999999987543   489999999999999999999999   999999999999999999999999999987754332  


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+           .......+.......+    
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~~~~~~~i~~~~~~~p----  230 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-----------EYLIFQKIIKLEYDFP----  230 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHTTCCCCC----
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-----------HHHHHHHHHcCCCCCC----
Confidence            2345689999999999999999999999999999999999999986322           1222233333332222    


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVC 1043 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl 1043 (1048)
                      .....++.+++.+||+.||++|||++|++
T Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         231 EKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            12234678999999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-45  Score=395.47  Aligned_cols=249  Identities=19%  Similarity=0.227  Sum_probs=202.9

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      +...+.||+|+||+||+|+++ +|+.||||++........     .....+|++.+++++|||||++++++.+.+..|+|
T Consensus        12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            444567999999999999985 688999999875433221     12345667778899999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC----ceEEecccccc
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY----KAHVSDFGTAK  927 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~  927 (1048)
                      ||||++|+|.+++...+   .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+|++|||+|+
T Consensus        92 ~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          92 LELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999997543   489999999999999999999999   999999999999998876    59999999998


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ..... .......||+.|||||++.+..++.++||||+||++|||++|+.||...+           .......+.....
T Consensus       166 ~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~~~~~~~i~~~~~  233 (293)
T d1jksa_         166 KIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----------KQETLANVSAVNY  233 (293)
T ss_dssp             ECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHTTCC
T ss_pred             hcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-----------HHHHHHHHHhcCC
Confidence            76543 33445679999999999999999999999999999999999999986322           2222333333333


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..+.......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3333333344567889999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-45  Score=399.46  Aligned_cols=244  Identities=22%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +...+.||+|+||+||+|++. +++.||||++........  .....+|+..+++++|||||++++++.+.+..|+||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            445567999999999999876 678899999875443221  12234567778899999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |++|++..++...   ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.....  
T Consensus        97 ~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          97 CLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             CSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             cCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            9999998776543   3489999999999999999999999   9999999999999999999999999999865432  


Q ss_pred             Ccccccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCc
Q 045493          935 NWSELAGTCGYIAPELAYT---MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPL 1011 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1048)
                        ...+||+.|||||++.+   +.|+.++||||+||++|||++|+.||....           .......+.....+...
T Consensus       169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----------~~~~~~~i~~~~~~~~~  235 (309)
T d1u5ra_         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHIAQNESPALQ  235 (309)
T ss_dssp             --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----------HHHHHHHHHHSCCCCCS
T ss_pred             --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC-----------HHHHHHHHHhCCCCCCC
Confidence              34579999999999864   458999999999999999999999986322           11122222222222211


Q ss_pred             hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1012 GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1012 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .  ......+.+++.+||+.||++||||+|+++
T Consensus       236 ~--~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 S--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C--CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1  122346888999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.4e-45  Score=403.06  Aligned_cols=248  Identities=18%  Similarity=0.269  Sum_probs=201.8

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      -.+.||+|+||+||+|++. +|+.||||++....... .....+|++.+++++|||||++++++.+.+..|+|||||++|
T Consensus        30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg  108 (350)
T d1koaa2          30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG  108 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH-HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            3456999999999999886 68899999986543222 233456777788999999999999999999999999999999


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC--CCceEEeccccccccCCCCCCc
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL--EYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|.+++.+.  ...+++..+..++.||+.||+|||+.   +||||||||+|||++.  ++.+||+|||+|+.+... ...
T Consensus       109 ~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~  182 (350)
T d1koaa2         109 ELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV  182 (350)
T ss_dssp             BHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCE
T ss_pred             CHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc-ccc
Confidence            999999543  23489999999999999999999999   9999999999999964  588999999999876543 334


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|||||++.+..|+.++||||+||++|||++|+.||...+           .......+.......+......
T Consensus       183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~~  251 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDETLRNVKSCDWNMDDSAFSG  251 (350)
T ss_dssp             EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHTCCCSCCGGGGG
T ss_pred             ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCcccccC
Confidence            55789999999999999999999999999999999999999986322           1222333333333322222333


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ...++.+++.+||+.||++|||++|+++.
T Consensus       252 ~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         252 ISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            45578899999999999999999999873

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-45  Score=390.27  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=192.1

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCCH
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGSL  860 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  860 (1048)
                      .+.||+|+||.||+|+++++++||||+++.....  .....+++..+++++|||||+++|+|.+ +..++||||+++|++
T Consensus        22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l   98 (285)
T d1fmka3          22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL   98 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred             eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCch
Confidence            4458999999999999998889999998654332  2345667777889999999999999965 457899999999999


Q ss_pred             HHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-Ccccc
Q 045493          861 ATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-NWSEL  939 (1048)
Q Consensus       861 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~  939 (1048)
                      .+++.... ...++|.++..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+|+....... .....
T Consensus        99 ~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  174 (285)
T d1fmka3          99 LDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  174 (285)
T ss_dssp             HHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             hhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence            99986543 23489999999999999999999999   999999999999999999999999999987654332 23446


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKLK 1019 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1048)
                      .||+.|+|||++..+.++.++|||||||++|||+||..|+...          .........+......+..   ....+
T Consensus       175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~----------~~~~~~~~~i~~~~~~~~~---~~~~~  241 (285)
T d1fmka3         175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----------MVNREVLDQVERGYRMPCP---PECPE  241 (285)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT----------CCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred             cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC----------CCHHHHHHHHHhcCCCCCC---cccCH
Confidence            7899999999999999999999999999999999977664321          1112222222222222211   22345


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1020 SMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1020 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ++.+++.+||+.||++||||++|+++|+.
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~  270 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFEYLQAFLED  270 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence            68899999999999999999999998863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-44  Score=401.79  Aligned_cols=249  Identities=18%  Similarity=0.223  Sum_probs=201.9

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      +...+.||+|+||+||+|++. +++.||||++......+ .....+|+..+++++|||||++++++.+.+..|+|||||+
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            344567999999999999885 68999999986543222 2234567777899999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEEC--CCCceEEeccccccccCCCCC
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLD--LEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~--~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +|+|.+++...  ...+++.+++.++.||+.||+|||+.   +||||||||+|||++  .++.+||+|||+|+.+... .
T Consensus       110 gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~  183 (352)
T d1koba_         110 GGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E  183 (352)
T ss_dssp             CCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-S
T ss_pred             CChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC-C
Confidence            99999987543  33489999999999999999999999   999999999999998  5789999999999987643 3


Q ss_pred             CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          935 NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      ......||+.|||||++.+..|+.++||||+||++|||+||+.||....           .......+.......+....
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~  252 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----------DLETLQNVKRCDWEFDEDAF  252 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----------HHHHHHHHHHCCCCCCSSTT
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCCcccc
Confidence            3455689999999999999999999999999999999999999986322           11222333333332222222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....++.+++.+||++||++|||++|+++
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            334456889999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=397.27  Aligned_cols=244  Identities=21%  Similarity=0.238  Sum_probs=201.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      ..+.||+|+||.||+|+.+ +++.||||++.+...  .........|+..++.++|||||++++++.+.+..|+||||++
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~   88 (337)
T d1o6la_           9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence            3457899999999999885 789999999875321  1122234556777889999999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.+++.+.+   .+++..++.++.|++.||+|||+.   +||||||||+|||++.+|.+||+|||+|+.........
T Consensus        89 gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          89 GGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             TCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             CCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            999999997644   378899999999999999999999   99999999999999999999999999999776655666


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||...+           .......+.......+.    .
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----------~~~~~~~i~~~~~~~p~----~  227 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----------HERLFELILMEEIRFPR----T  227 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----T
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----------HHHHHHHHhcCCCCCCc----c
Confidence            67899999999999999999999999999999999999999986432           12223333333333221    2


Q ss_pred             HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                      .+.++.+++.+||++||++||+     ++|+++
T Consensus       228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            3345788999999999999995     788875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-45  Score=397.01  Aligned_cols=253  Identities=21%  Similarity=0.343  Sum_probs=201.9

Q ss_pred             cceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .-.+.||+|+||+||+|+++      +++.||||+++.....+......+++..+++++||||++++++|...+..++||
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            33456899999999999875      246799999876544443344566777889999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccc---------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeE
Q 045493          853 EYLERGSLATILSNEA---------------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVL  911 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIl  911 (1048)
                      ||+++|+|.++++...                     ....+++..+..++.|++.||+|||+.   +||||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence            9999999999996432                     123488999999999999999999999   9999999999999


Q ss_pred             ECCCCceEEeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCcccccccCC
Q 045493          912 LDLEYKAHVSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK-HPGHFLSLLLSL  988 (1048)
Q Consensus       912 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~  988 (1048)
                      ++.++.+||+|||+|+...+...  ......||+.|+|||++.+..|+.++|||||||++|||++|. .||...      
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~------  246 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM------  246 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC------
Confidence            99999999999999987644322  223467899999999999999999999999999999999986 455422      


Q ss_pred             CcccccchhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          989 PAPAANMNIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                           ...+....+.++..++...   ....++.+++.+||+.||++||||.||+++|+|
T Consensus       247 -----~~~e~~~~v~~~~~~~~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         247 -----AHEEVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  298 (301)
T ss_dssp             -----CHHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CHHHHHHHHHcCCCCCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 2223334444444433222   233468899999999999999999999999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=383.62  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=188.4

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||.||+|+++ +++||||+++....   .....+++..+++++||||++++|+|.+ .+..|+||||+++|+
T Consensus        12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             eEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            345899999999999986 78899999965332   2345677888899999999999999855 466899999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcccc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWSEL  939 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  939 (1048)
                      |.+++.... ...+++..+++|+.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++.....   ....
T Consensus        88 L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~~~  160 (262)
T d1byga_          88 LVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTG  160 (262)
T ss_dssp             HHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred             HHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---Cccc
Confidence            999996542 23489999999999999999999999   9999999999999999999999999999865432   2345


Q ss_pred             ccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHHH
Q 045493          940 AGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEKL 1018 (1048)
Q Consensus       940 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1048)
                      .+|+.|+|||++.++.++.++|||||||++|||+| |+.||....           .......+..+..++...   ...
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----------~~~~~~~i~~~~~~~~~~---~~~  226 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKDVVPRVEKGYKMDAPD---GCP  226 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----------GGGHHHHHTTTCCCCCCT---TCC
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----------HHHHHHHHHcCCCCCCCc---cCC
Confidence            68899999999999999999999999999999998 677765321           112222222222222211   223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1019 KSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1019 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .++.+++.+||+.||++||||+|++++|++
T Consensus       227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         227 PAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            467889999999999999999999999873

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.9e-44  Score=381.89  Aligned_cols=248  Identities=19%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccc--------hhhHHHHHHhhcc-cCceeeEeeEeeeCCeEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGI--------NQKGFVSEITEIR-HRNIVKFYGFCSHTQHLF  849 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~--------~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~  849 (1048)
                      ..+.||+|+||+||+|+.. +++.||||++..........        ...+|+..+++++ |||||++++++.+++..|
T Consensus         7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~   86 (277)
T d1phka_           7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF   86 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence            3456899999999999885 68899999987654332211        2234566667776 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+++|+|.++++..+   .+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.+
T Consensus        87 ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          87 LVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence            9999999999999997543   489999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhc
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYT------MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      .... .....+||+.|+|||++.+      ..++.++||||+||++|||++|+.||....           .......+.
T Consensus       161 ~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----------~~~~~~~i~  228 (277)
T d1phka_         161 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----------QMLMLRMIM  228 (277)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHH
T ss_pred             cCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----------HHHHHHHHH
Confidence            6533 3455789999999998853      346889999999999999999999986322           122223333


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      ......+.......++++.+++.+||++||++|||++|+++.
T Consensus       229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            333332222233455678899999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-44  Score=389.13  Aligned_cols=260  Identities=22%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             eeecccccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEEEccCC
Q 045493          782 VLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVYEYLER  857 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  857 (1048)
                      +.||+|+||+||+|++. |+.||||++.....  .....+.++..+..++|||||+++++|.+.+    ..|+|||||++
T Consensus         9 ~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEECCSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            35899999999999874 88999999864321  1122233344446779999999999997643    68999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDC-----FPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      |+|.+++++.    .++|..+.+++.|+|.|++|+|+..     .++||||||||+|||++.++.+||+|||+++.....
T Consensus        86 g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          86 GSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            9999999753    3899999999999999999999731     249999999999999999999999999999877544


Q ss_pred             CC----CccccccccccccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCcccccccCCC----cccccchhh
Q 045493          933 SS----NWSELAGTCGYIAPELAYTMR------ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP----APAANMNIV  998 (1048)
Q Consensus       933 ~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~  998 (1048)
                      ..    ......||++|||||++.+..      ++.++|||||||++|||+||+.||..........    .........
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence            32    233567999999999987543      5779999999999999999998875433211110    011111222


Q ss_pred             hhhhccCCCCCCc-h--hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          999 VNDLIDSRLPPPL-G--EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       999 ~~~~~~~~~~~~~-~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..........+.. .  ...+....+.+++.+||+.||++||||.||++.|++
T Consensus       242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            2222232322211 1  123455679999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-44  Score=388.18  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             eeecccccccEEEEEEcCC----CceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee-CCeEEEEEEccC
Q 045493          782 VLHGTGGCGTVYKAELTSG----DTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH-TQHLFLVYEYLE  856 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~----~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  856 (1048)
                      ++||+|+||+||+|++..+    ..||||+++............++++.+++++|||||+++|++.+ ++..++|||||+
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~  112 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  112 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence            4689999999999987542    24789998654433333445667777889999999999999865 568999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC-
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN-  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-  935 (1048)
                      +|+|.+++...  ....++..+.+++.|+++||.|+|+.   +|+||||||+|||+++++.+||+|||+++........ 
T Consensus       113 ~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         113 HGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             cCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999998653  33467888999999999999999999   9999999999999999999999999999876543222 


Q ss_pred             ---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          936 ---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       936 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                         .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.....          .......+..+..+....
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----------~~~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------TFDITVYLLQGRRLLQPE  257 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------CHHHHHTTCCCCCCT
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----------HHHHHHHHHcCCCCCCcc
Confidence               2345689999999999999999999999999999999998888652211          111122222222222211


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                         .....+.+++.+||+.||++||||.||+++|++
T Consensus       258 ---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~  290 (311)
T d1r0pa_         258 ---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  290 (311)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               223468899999999999999999999999863

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-44  Score=384.31  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=185.5

Q ss_pred             eeeecccccccEEEEEEcC----CCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTS----GDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~----~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .+.||+|+||.||+|++..    +..||||+++............+++..+++++|||||+++|++.+ +..|+||||++
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~   90 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCT   90 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEecc
Confidence            4568999999999998753    235778887654443333345567777889999999999999964 66899999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC-C
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS-N  935 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~  935 (1048)
                      +|++.+++...  ...+++..++.++.||++||+|||+.   +||||||||+||+++.++.+||+|||+|+....... .
T Consensus        91 ~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~  165 (273)
T d1mp8a_          91 LGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK  165 (273)
T ss_dssp             TEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             CCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCccee
Confidence            99999987543  33589999999999999999999999   999999999999999999999999999987654332 2


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEV 1014 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1048)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...+.           ......+..+..++...  
T Consensus       166 ~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----------~~~~~~i~~~~~~~~~~--  232 (273)
T d1mp8a_         166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIGRIENGERLPMPP--  232 (273)
T ss_dssp             -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHHHHHTTCCCCCCT--
T ss_pred             ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----------HHHHHHHHcCCCCCCCC--
Confidence            344568999999999999999999999999999999998 8888764321           12223333333222221  


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1015 EEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1015 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                       ....++.+++.+||+.||++||||+|+++.|+
T Consensus       233 -~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         233 -NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             23356889999999999999999999999886

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=390.49  Aligned_cols=245  Identities=20%  Similarity=0.248  Sum_probs=193.1

Q ss_pred             eeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHh-hcccCceeeEeeEeee----CCeEEEEEEcc
Q 045493          782 VLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEIT-EIRHRNIVKFYGFCSH----TQHLFLVYEYL  855 (1048)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~-~l~h~niv~~~~~~~~----~~~~~lv~e~~  855 (1048)
                      ++||+|+||+||+|++. +++.||||++...      ....+++..+. ..+|||||+++++|.+    ....|+|||||
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            46899999999999875 6889999998542      22344555544 4589999999999865    46789999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~  932 (1048)
                      +||+|.+++...+ ...+++.+++.++.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+|+.....
T Consensus        92 ~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          92 DGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             CSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCC
Confidence            9999999997543 24589999999999999999999999   9999999999999985   467999999999876543


Q ss_pred             CCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCch
Q 045493          933 SSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLG 1012 (1048)
Q Consensus       933 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1048)
                       ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.........       ......+.......+..
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------~~~~~~i~~~~~~~~~~  239 (335)
T d2ozaa1         168 -NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIRMGQYEFPNP  239 (335)
T ss_dssp             -CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSCCTT
T ss_pred             -CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-------HHHHHHHhcCCCCCCCc
Confidence             3345568999999999999999999999999999999999999998744321111       11111222222222223


Q ss_pred             hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1013 EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1013 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            33455677999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=391.26  Aligned_cols=249  Identities=19%  Similarity=0.322  Sum_probs=191.7

Q ss_pred             cceeeecccccccEEEEEEc-CCC----ceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGD----TRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~----~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ...+.||+|+||+||+|.+. +++    +||+|+++.....+......+++..+++++|||||+++|+|.+. ..+++||
T Consensus        12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e   90 (317)
T d1xkka_          12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   90 (317)
T ss_dssp             EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence            34567999999999999876 344    47888876544444334456677778899999999999999865 5678899


Q ss_pred             ccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCC
Q 045493          854 YLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~  933 (1048)
                      |+.+|+|.+++...  ...+++..+++++.|||.||+|||++   +||||||||+||+++.++.+||+|||+|+......
T Consensus        91 ~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          91 LMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             CCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            99999999988653  34589999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          934 SN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       934 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      ..  .....||+.|||||++.++.++.++|||||||++|||+| |+.||+..+           .......+..+..++.
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----------~~~~~~~i~~~~~~~~  234 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----------ASEISSILEKGERLPQ  234 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----------GGGHHHHHHHTCCCCC
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----------HHHHHHHHHcCCCCCC
Confidence            32  234568999999999999999999999999999999999 788876322           1112222222222221


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      .   ......+.+++.+||+.||++||||+|+++.|+
T Consensus       235 p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         235 P---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             C---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            1   123356888999999999999999999998875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-44  Score=390.56  Aligned_cols=259  Identities=22%  Similarity=0.228  Sum_probs=194.0

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc----ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE----IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      +.++||+|+||+||+|+++ +++.||||++.......    ......+|+..+++++|||||++++++.+.+..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4567999999999999986 68899999986543322    123345677788999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      ++++++..+...   ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            999887776643   33478889999999999999999999   999999999999999999999999999988766555


Q ss_pred             CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccc-h-hhhhhh
Q 045493          935 NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANM-N-IVVNDL 1002 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~-~-~~~~~~ 1002 (1048)
                      .....+||+.|||||++.+. .|+.++||||+||++|||++|+.||.......         +.+...... . ......
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            55667899999999998654 57999999999999999999999986433210         000000000 0 000000


Q ss_pred             ccCCCCCCc-h-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1003 IDSRLPPPL-G-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1003 ~~~~~~~~~-~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .....+... . .......++.+++.+||+.||++||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000111100 0 00122456889999999999999999999986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-43  Score=387.51  Aligned_cols=240  Identities=24%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      .+.||+|+||+||+|+++ +|+.||||+++....  ........+++..++.++|||||++++++.+.+..|+||||++|
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g   88 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   88 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence            456899999999999985 688999999865321  12223345667778899999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |++.+++....   .+++..+..++.||+.|++|||++   +||||||||+|||++.+|.+||+|||+|+.....   ..
T Consensus        89 g~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~  159 (316)
T d1fota_          89 GELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TY  159 (316)
T ss_dssp             CBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BC
T ss_pred             ccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---cc
Confidence            99999987543   377888999999999999999999   9999999999999999999999999999876532   34


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ..+||+.|||||++.+..|+.++||||+||++|||++|+.||...+           .......+.......+.    ..
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----~~  224 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----------TMKTYEKILNAELRFPP----FF  224 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHHHHCCCCCCT----TS
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-----------HHHHHHHHHcCCCCCCC----CC
Confidence            5789999999999999999999999999999999999999986322           12223333333332221    12


Q ss_pred             HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      ..++.+++.+||++||++||     |++|+++
T Consensus       225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            34578899999999999996     8999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=387.60  Aligned_cols=250  Identities=21%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             eeeecccccccEEEEEEcCC-C--ceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELTSG-D--TRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~-~--~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .+.||+|+||+||+|+++.+ .  .||||++......+......++++.++++ +|||||+++|+|.+.+..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            35699999999999988643 3  46788876554444444566778888888 79999999999999999999999999


Q ss_pred             CCCHHHHHhcc-------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          857 RGSLATILSNE-------------ATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       857 ~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                      +|+|.++++..             .....+++..+.+++.|||+|+.|+|+.   +|+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccc
Confidence            99999999653             2335689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC-CCcccccccCCCcccccchhhhhhh
Q 045493          924 GTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKH-PGHFLSLLLSLPAPAANMNIVVNDL 1002 (1048)
Q Consensus       924 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1048)
                      |+|+...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...+           .......+
T Consensus       172 G~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----------~~~~~~~i  239 (309)
T d1fvra_         172 GLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----------CAELYEKL  239 (309)
T ss_dssp             TCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHG
T ss_pred             cccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----------HHHHHHHH
Confidence            9998654322 2234568999999999999999999999999999999999765 554221           22223333


Q ss_pred             ccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1003 IDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1003 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ..+..++...   ....++.+++.+||+.||++||||+||++.|++
T Consensus       240 ~~~~~~~~~~---~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         240 PQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             GGTCCCCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhcCCCCCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            3332222221   233468889999999999999999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-44  Score=390.52  Aligned_cols=243  Identities=22%  Similarity=0.288  Sum_probs=194.9

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHH-hhcccCceeeEeeEeeeCCeEEEEEEccC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEI-TEIRHRNIVKFYGFCSHTQHLFLVYEYLE  856 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~  856 (1048)
                      .+.||+|+||+||+|+++ +++.||||++++...  .+.......+...+ ..++|||||++++++.+++..|+||||++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~   86 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN   86 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence            456899999999999886 688999999965321  11111122223333 46799999999999999999999999999


Q ss_pred             CCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCc
Q 045493          857 RGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNW  936 (1048)
Q Consensus       857 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~  936 (1048)
                      +|+|.++++...   .+++.++..++.||+.||+|||++   +|+||||||+|||+++++++||+|||+|+.........
T Consensus        87 ~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          87 GGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             CCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999997543   378899999999999999999999   99999999999999999999999999998776666666


Q ss_pred             cccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHH
Q 045493          937 SELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEE 1016 (1048)
Q Consensus       937 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1048)
                      ....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.           ......+.......+    ..
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----------~~~~~~i~~~~~~~p----~~  225 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----------EELFHSIRMDNPFYP----RW  225 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------HHHHHHHHHCCCCCC----TT
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----------HHHHHHHHcCCCCCC----cc
Confidence            677899999999999999999999999999999999999999864321           122222222222211    12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 045493         1017 KLKSMIAVAFLCLDANPDCRPTMQ-KVCN 1044 (1048)
Q Consensus      1017 ~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 1044 (1048)
                      ...++.+++.+||++||++|||+. |+++
T Consensus       226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            234578999999999999999995 6653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-44  Score=388.86  Aligned_cols=252  Identities=22%  Similarity=0.303  Sum_probs=183.5

Q ss_pred             eeeecccccccEEEEEEcC------CCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeee-CCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTS------GDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSH-TQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~------~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~  852 (1048)
                      .+.||+|+||.||+|++..      ++.||||+++.............+...+.++ +|+|||.+++++.+ ....++||
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence            4568999999999998652      3578999986544333222233333444444 69999999998865 45689999


Q ss_pred             EccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceE
Q 045493          853 EYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAH  919 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~k  919 (1048)
                      |||++|+|.++++....             ...+++.++..++.||++||+|||++   +||||||||+|||++.++.+|
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEE
Confidence            99999999999975432             23488999999999999999999999   999999999999999999999


Q ss_pred             EeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCcccccccCCCcccccch
Q 045493          920 VSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK-HPGHFLSLLLSLPAPAANMN  996 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~  996 (1048)
                      |+|||+|+.......  ......||+.|||||++.+..++.++|||||||++|||+||. .||.....          ..
T Consensus       175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~----------~~  244 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------DE  244 (299)
T ss_dssp             ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----------SH
T ss_pred             EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH----------HH
Confidence            999999987654433  234567999999999999999999999999999999999975 56542211          11


Q ss_pred             hhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          997 IVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       997 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .....+..+..+...   .....++.+++.+||+.||++||||+|++++|++
T Consensus       245 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         245 EFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             HHHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111112222222111   1223468899999999999999999999999863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-43  Score=382.89  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=191.8

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVY  852 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  852 (1048)
                      -.+.||+|+||+||+|++. +++.||||+++.......  .....+|++.++.++|||||++++++...+    ..|+||
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm   90 (277)
T d1o6ya_          11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   90 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence            3456899999999999875 788999999976443321  223455677778899999999999987543    489999


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      ||++||+|.+++...+   .+++.+++.++.||+.||+|||+.   +||||||||+||+++.++.++++|||.+......
T Consensus        91 E~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          91 EYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             ECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             ECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence            9999999999986543   489999999999999999999999   9999999999999999999999999998765433


Q ss_pred             C---CCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          933 S---SNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       933 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      .   ......+||+.|||||++.+..++.++||||+||++|||+||+.||...+.           .............+
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVREDPIP  233 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCCCCC
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----------HHHHHHHHhcCCCC
Confidence            2   233456799999999999999999999999999999999999999864321           11122222222222


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhC
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRP-TMQKVCNLLCR 1048 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~ 1048 (1048)
                      +.......+.++.+++.+||++||++|| |++++++.|.|
T Consensus       234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            1111223345688999999999999999 89999887754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=384.29  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=193.4

Q ss_pred             eeeecccccccEEEEEEcCC--------CceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTSG--------DTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLV  851 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~--------~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv  851 (1048)
                      .+.||+|+||.||+|+....        ..||||+++.............+...+.++ +|||||+++++|.+++..++|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence            34689999999999986532        368999987654433323334455556666 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcccc-------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          852 YEYLERGSLATILSNEAT-------------AAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      |||+++|+|.++++....             ...+++.++.+++.||+.||+|||+.   +||||||||+|||++.++.+
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~  174 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM  174 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCe
Confidence            999999999999965432             24589999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCC--CccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccc
Q 045493          919 HVSDFGTAKFLKPDSS--NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  995 (1048)
                      ||+|||+++.......  ......||+.|+|||++.++.|+.++|||||||++|||++ |+.||....           .
T Consensus       175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-----------~  243 (299)
T d1fgka_         175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----------V  243 (299)
T ss_dssp             EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------H
T ss_pred             EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-----------H
Confidence            9999999987754332  2344678999999999999999999999999999999998 677765322           1


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ......+..+..++..   ......+.+++.+||+.||++||||.||++.|++
T Consensus       244 ~~~~~~i~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         244 EELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HHHHHHHHTTCCCCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            2222222232222221   1233468899999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=386.90  Aligned_cols=245  Identities=21%  Similarity=0.273  Sum_probs=201.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+.||+|+||+||+|.++ +++.||||++......  .....+|++.++.++|||||++++++.+.+..|+|||||+||+
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~   87 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence            346899999999999886 6788999998654322  2334567777899999999999999999999999999999999


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC--CceEEeccccccccCCCCCCcc
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE--YKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~--~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      |.+++...  ...+++.+++.++.||+.||+|||+.   +|+||||||+|||++.+  +.+||+|||+++..... ....
T Consensus        88 L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~~  161 (321)
T d1tkia_          88 IFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFR  161 (321)
T ss_dssp             HHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEE
T ss_pred             HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-Cccc
Confidence            99999653  23489999999999999999999999   99999999999999854  58999999999876433 3344


Q ss_pred             ccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHHHH
Q 045493          938 ELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVEEK 1017 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1048)
                      ...+|+.|+|||...+..|+.++||||+||++|||++|+.||....           .......+.......+.......
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~~~~~~~~  230 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----------NQQIIENIMNAEYTFDEEAFKEI  230 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----------HHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----------HHHHHHHHHhCCCCCChhhccCC
Confidence            5679999999999999999999999999999999999999986322           22334444444444333333344


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1018 LKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1018 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ..++.+++.+||+.||++|||++|+++
T Consensus       231 s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         231 SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            567889999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=379.99  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=184.9

Q ss_pred             eeeecccccccEEEEEEcC--C--CceeeEEeccCCCCcc--cchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELTS--G--DTRAVKKLHSLPTGEI--GINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--~--~~vavk~~~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      .+.||+|+||.||+|++..  +  ..||||++........  .....+++..++.++|||||+++|+|.+ ...++||||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~   91 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL   91 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence            4468999999999998642  2  2689998865433221  2234556677788999999999999975 467899999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|++.+++...  ...+++..++.++.|||+||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        92 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~  166 (273)
T d1u46a_          92 APLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD  166 (273)
T ss_dssp             CTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred             ecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence            9999999988653  34589999999999999999999999   999999999999999999999999999998755433


Q ss_pred             C---ccccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCcccccccCCCcccccchhhhhhhccCCCCCC
Q 045493          935 N---WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIE-GKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPP 1010 (1048)
Q Consensus       935 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1048)
                      .   .....||..|+|||++.+..++.++|||||||++|||+| |+.||...+           .......+......++
T Consensus       167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-----------~~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----------GSQILHKIDKEGERLP  235 (273)
T ss_dssp             EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTSCCCCC
T ss_pred             cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-----------HHHHHHHHHhCCCCCC
Confidence            2   234567889999999999999999999999999999998 899986332           1122223322222111


Q ss_pred             chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1011 LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1011 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      .  .......+.+++.+||+.||++||||+||.+.|.+
T Consensus       236 ~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         236 R--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             C--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            1  11223468899999999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=384.03  Aligned_cols=252  Identities=19%  Similarity=0.306  Sum_probs=202.3

Q ss_pred             ceeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEE
Q 045493          780 KMVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      ..+.||+|+||+||+|.+.      +++.||||+++............+++..+++++|||||+++|+|...+..++|||
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e  103 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME  103 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence            3456899999999999874      2568999999754433322334567777888999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccc-------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccc
Q 045493          854 YLERGSLATILSNEA-------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTA  926 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a  926 (1048)
                      |+++|+|.+++....       ....+++..+.+++.|+|+||.|||++   +|+||||||+|||++.++++||+|||+|
T Consensus       104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla  180 (308)
T d1p4oa_         104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT  180 (308)
T ss_dssp             CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred             ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccc
Confidence            999999999986432       223468899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCcccccccCCCcccccchhhhhhhc
Q 045493          927 KFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGK-HPGHFLSLLLSLPAPAANMNIVVNDLI 1003 (1048)
Q Consensus       927 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1048)
                      +........  .....||+.|+|||.+.++.++.++|||||||++|||+||+ .||...           ........+.
T Consensus       181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----------~~~~~~~~i~  249 (308)
T d1p4oa_         181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----------SNEQVLRFVM  249 (308)
T ss_dssp             CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----------CHHHHHHHHH
T ss_pred             eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----------CHHHHHHHHH
Confidence            876544332  23446899999999999999999999999999999999985 555422           2233344444


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493         1004 DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus      1004 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ++..++...   .....+.+++.+||+.||++||||+||+++|++
T Consensus       250 ~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         250 EGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  291 (308)
T ss_dssp             TTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             hCCCCCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            444433322   233568899999999999999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-43  Score=392.82  Aligned_cols=244  Identities=19%  Similarity=0.225  Sum_probs=190.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCC--cccchh---hHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEc
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTG--EIGINQ---KGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEY  854 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~--~~~~~~---~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  854 (1048)
                      ...||+|+||.||+|++. +|+.||||++......  ......   ..+++.++.++|||||++++++.+.+..|+||||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~   88 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   88 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence            457899999999999986 6889999998643211  111112   2234445667899999999999999999999999


Q ss_pred             cCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCC
Q 045493          855 LERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       855 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      +++|+|.+++.+..   .+++..++.++.||+.||+|||+.   +||||||||+|||++.+|.+||+|||+|+.+...  
T Consensus        89 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--  160 (364)
T d1omwa3          89 MNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--  160 (364)
T ss_dssp             CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--
T ss_pred             cCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC--
Confidence            99999999997543   478899999999999999999999   9999999999999999999999999999876543  


Q ss_pred             Ccccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchh
Q 045493          935 NWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGE 1013 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1048)
                      .....+||+.|||||++.. ..|+.++||||+||++|||+||+.||.....        .................+   
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~~---  229 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--------KDKHEIDRMTLTMAVELP---  229 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS--------SCHHHHHHHSSSCCCCCC---
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcccCCCCCC---
Confidence            3345689999999999874 5689999999999999999999999864221        111111222222222111   


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 045493         1014 VEEKLKSMIAVAFLCLDANPDCRPT-----MQKVCN 1044 (1048)
Q Consensus      1014 ~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 1044 (1048)
                       .....++.+++.+||++||++|||     |+|+++
T Consensus       230 -~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         230 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             123346789999999999999999     688875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=386.85  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=197.6

Q ss_pred             eeeecccccccEEEEEEc------CCCceeeEEeccCCCCcccchhhHHHHHHhhc-ccCceeeEeeEeeeCCeEEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT------SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-RHRNIVKFYGFCSHTQHLFLVYE  853 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  853 (1048)
                      .+.||+|+||.||+|++.      +++.||||+++............+++..++.+ +|||||+++|+|.+.+..++|||
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence            346899999999999863      34579999997654433333345566666777 69999999999999999999999


Q ss_pred             ccCCCCHHHHHhccc---------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCce
Q 045493          854 YLERGSLATILSNEA---------------TAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKA  918 (1048)
Q Consensus       854 ~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~  918 (1048)
                      |+++|+|.++++...               ....+++..+.+++.||++|++|||++   +||||||||+||+++.++.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcc
Confidence            999999999997543               223588999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccccCCCCCC--ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CcccccccCCCcccccc
Q 045493          919 HVSDFGTAKFLKPDSSN--WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHP-GHFLSLLLSLPAPAANM  995 (1048)
Q Consensus       919 kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~  995 (1048)
                      |++|||.++........  ....+||+.|+|||++.++.++.++|||||||++|||+|+..| |....           .
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~-----------~  253 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-----------V  253 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------S
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC-----------H
Confidence            99999999977644332  2346789999999999999999999999999999999995544 43211           1


Q ss_pred             hhhhhhhccCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 045493          996 NIVVNDLIDSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLCR 1048 (1048)
Q Consensus       996 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 1048 (1048)
                      ...+.+++.....+...  ......+.+++.+||+.||++||||+|++++|++
T Consensus       254 ~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         254 DSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             SHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            12222222222222111  1233568899999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-43  Score=388.00  Aligned_cols=242  Identities=20%  Similarity=0.237  Sum_probs=197.9

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCC--CcccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEcc
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPT--GEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYL  855 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  855 (1048)
                      ...+.||+|+||+||+|+++ +|+.||||++.....  .........+++.++.++|||||++++++.+....++||||+
T Consensus        44 ~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~  123 (350)
T d1rdqe_          44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccc
Confidence            34557999999999999886 689999999864321  111223456677788999999999999999999999999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSN  935 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~  935 (1048)
                      .+|++.+++.+.+   .+++..++.++.||+.||.|||+.   +||||||||+|||++.+|.+||+|||+|+.+...   
T Consensus       124 ~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         124 AGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             TTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            9999999997543   489999999999999999999999   9999999999999999999999999999876532   


Q ss_pred             ccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCCCchhHH
Q 045493          936 WSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPPPLGEVE 1015 (1048)
Q Consensus       936 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1048)
                      ....+||+.|||||++.+..++.++||||+||++|||+||+.||...+           .......+.......+.    
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----------~~~~~~~i~~~~~~~p~----  259 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----------PIQIYEKIVSGKVRFPS----  259 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----------HHHHHHHHHHCCCCCCT----
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----------HHHHHHHHhcCCCCCCc----
Confidence            345689999999999999999999999999999999999999986322           12222333333322221    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1016 EKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1016 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      ....++.+++.+||+.||++|+     |++|+++
T Consensus       260 ~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            2234678899999999999994     8999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-42  Score=374.75  Aligned_cols=261  Identities=20%  Similarity=0.282  Sum_probs=194.3

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ..+.||+|+||+||+|++. +++.||||+++.....+ ......+|++.+++++|||||++++++.+.+..|+||||+.+
T Consensus         6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~   85 (298)
T d1gz8a_           6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ   85 (298)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence            4567999999999999885 68899999996543322 233455678888999999999999999999999999999977


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      + +.+++... ....+++..+..++.|++.||+|||+.   +||||||||+|||++.++.+||+|||.|+..........
T Consensus        86 ~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          86 D-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             E-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             c-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            5 44444322 234589999999999999999999999   999999999999999999999999999988766555566


Q ss_pred             ccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchhhhhhhccCCC
Q 045493          938 ELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ...||+.|+|||.+.... ++.++||||+||++|||++|+.||...+...         ..+..................
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            678999999999877666 4889999999999999999999996533210         000000000000000000001


Q ss_pred             CC----Cc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493         1008 PP----PL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus      1008 ~~----~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      +.    .. ........++.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00    00 0011223568899999999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-42  Score=370.13  Aligned_cols=235  Identities=22%  Similarity=0.340  Sum_probs=188.5

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-----cchhhHHHHHHhhcc--cCceeeEeeEeeeCCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-----GINQKGFVSEITEIR--HRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-----~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .+.||+|+||+||+|++. +++.||||++........     ......++..+++++  |||||++++++.+.+..|+||
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~   88 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL   88 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence            456899999999999886 688999999875432221     122346677777776  899999999999999999999


Q ss_pred             EccCC-CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCC-CceEEeccccccccC
Q 045493          853 EYLER-GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLE-YKAHVSDFGTAKFLK  930 (1048)
Q Consensus       853 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~  930 (1048)
                      ||+.+ +++.+++...   ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.+ +.+||+|||+|+...
T Consensus        89 e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          89 ERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             ECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceecc
Confidence            99986 6888888653   3489999999999999999999999   99999999999999854 799999999998654


Q ss_pred             CCCCCccccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCCCC
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMRA-NEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRLPP 1009 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1048)
                      .  ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||......                 .......
T Consensus       163 ~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-----------------~~~~~~~  223 (273)
T d1xwsa_         163 D--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----------------IRGQVFF  223 (273)
T ss_dssp             S--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------------HHCCCCC
T ss_pred             c--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-----------------hhcccCC
Confidence            3  33456789999999999987765 67799999999999999999998643211                 1111111


Q ss_pred             CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1010 PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1010 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      +.    ..+.++.+++.+||+.||++|||++|+++
T Consensus       224 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         224 RQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11    11245788999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.6e-42  Score=371.26  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=192.9

Q ss_pred             cceeeecccccccEEEEEEcCCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          779 GKMVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ...+.||+|+||+||+|++++++.||||++......+ ......+++..+++++|||||++++++.+.+..++||||+.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            3456789999999999999999999999996643322 233445667777899999999999999999999999999998


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +.+..+.+..   ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||.|...........
T Consensus        85 ~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          85 DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            8777776533   4489999999999999999999998   999999999999999999999999999988765555555


Q ss_pred             ccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCcccccchh-hh---hhhc
Q 045493          938 ELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAANMNI-VV---NDLI 1003 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~-~~---~~~~ 1003 (1048)
                      ...|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+...         +.+........ ..   ....
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            66799999999998754 46999999999999999999999996432110         00000000000 00   0000


Q ss_pred             cCCCCCC-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 DSRLPPP-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 ~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ....+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000100 0111223356889999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=368.38  Aligned_cols=260  Identities=19%  Similarity=0.268  Sum_probs=187.8

Q ss_pred             cceeeecccccccEEEEEEc-C-CCceeeEEeccCCCCc-ccchhhHHHHHHh---hcccCceeeEeeEeee-----CCe
Q 045493          779 GKMVLHGTGGCGTVYKAELT-S-GDTRAVKKLHSLPTGE-IGINQKGFVSEIT---EIRHRNIVKFYGFCSH-----TQH  847 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~-~~~vavk~~~~~~~~~-~~~~~~~~~~~l~---~l~h~niv~~~~~~~~-----~~~  847 (1048)
                      .....||+|+||+||+|++. + ++.||||+++.....+ ......+++..++   ..+||||++++++|..     ...
T Consensus        10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~   89 (305)
T d1blxa_          10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   89 (305)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred             EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence            34557899999999999884 4 4568999986543322 2223334455444   4579999999999853     346


Q ss_pred             EEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          848 LFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       848 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      .+++|||+++|++......  ....+++..++.++.|++.||+|||+.   +||||||||+|||++.++.+||+|||.++
T Consensus        90 ~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          90 LTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            8999999999877655433  334578999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccccc-chh
Q 045493          928 FLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPAAN-MNI  997 (1048)
Q Consensus       928 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~-~~~  997 (1048)
                      .... ........||+.|||||++.+..|+.++||||+||++|||++|+.||...+...         ..+..... ...
T Consensus       165 ~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         165 IYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            6432 233456789999999999999999999999999999999999999997543210         00000000 000


Q ss_pred             h-hhhhccCCCCCC-chhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          998 V-VNDLIDSRLPPP-LGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       998 ~-~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      . ...........+ ..........+.+++.+||+.||++||||+|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0 000000011111 0111122346778999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-40  Score=368.04  Aligned_cols=256  Identities=23%  Similarity=0.272  Sum_probs=188.2

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeee------CCeEEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSH------TQHLFLV  851 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~------~~~~~lv  851 (1048)
                      ...++||+|+||+||+|++. +++.||||++.....     ...+|++.+++++||||++++++|..      ..+.|+|
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            34567999999999999986 688999999865322     23457788899999999999999853      2357999


Q ss_pred             EEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccC
Q 045493          852 YEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLK  930 (1048)
Q Consensus       852 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~  930 (1048)
                      |||+++|.+....+.......+++.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++...
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99998865444443333445689999999999999999999998   999999999999999875 89999999998765


Q ss_pred             CCCCCcccccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccccchhhhh
Q 045493          931 PDSSNWSELAGTCGYIAPELAYT-MRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAANMNIVVN 1000 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~ 1000 (1048)
                      ... .....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........         .+... .......
T Consensus       175 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~-~~~~~~~  252 (350)
T d1q5ka_         175 RGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE-QIREMNP  252 (350)
T ss_dssp             TTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH-HHHHHCC
T ss_pred             CCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH-hhhhhcc
Confidence            433 3345689999999998765 5689999999999999999999999864332100         00000 0000000


Q ss_pred             hhccCCCCC----Cch--hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1001 DLIDSRLPP----PLG--EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1001 ~~~~~~~~~----~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......+.    +..  .......++.+++.+||+.||++||||+|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000111110    000  00122346888999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-40  Score=364.89  Aligned_cols=261  Identities=18%  Similarity=0.235  Sum_probs=187.6

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCceeeEeeEeeeCC----eEEEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRNIVKFYGFCSHTQ----HLFLVY  852 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  852 (1048)
                      +.....||+|+||+||+|.+. +++.||||++.............+|+..++.++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            344567999999999999875 789999999975443333334456777889999999999999986543    234455


Q ss_pred             EccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCC
Q 045493          853 EYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPD  932 (1048)
Q Consensus       853 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~  932 (1048)
                      +|+.+|+|.+++...    .+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        90 ~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          90 THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            667799999999643    489999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CC---Cccccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---------cCCCccccc-----
Q 045493          933 SS---NWSELAGTCGYIAPELAY-TMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLL---------LSLPAPAAN-----  994 (1048)
Q Consensus       933 ~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~-----  994 (1048)
                      ..   .....+||+.|+|||++. +..++.++||||+||++|||++|+.||......         ...+.....     
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            22   234567999999999985 456789999999999999999999998643210         000000000     


Q ss_pred             chhh-hhhhccCCCCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          995 MNIV-VNDLIDSRLPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       995 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .... ...........+.. .......++.+++.+||+.||++||||+|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 00000001111110 011123468899999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-39  Score=351.28  Aligned_cols=250  Identities=16%  Similarity=0.194  Sum_probs=192.6

Q ss_pred             eeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhccc-CceeeEeeEeeeCCeEEEEEEccCCC
Q 045493          781 MVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRH-RNIVKFYGFCSHTQHLFLVYEYLERG  858 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g  858 (1048)
                      .+.||+|+||+||+|++. +++.||||.+......   ....++.++++.++| +||+.+++++.+....++||||+ +|
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~   85 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   85 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence            456899999999999976 6788999987554322   234566777877765 89999999999999999999999 67


Q ss_pred             CHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC-----CCceEEeccccccccCCCC
Q 045493          859 SLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL-----EYKAHVSDFGTAKFLKPDS  933 (1048)
Q Consensus       859 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~-----~~~~kl~DfG~a~~~~~~~  933 (1048)
                      +|.++++...  ..+++.++..++.|++.||+|||+.   +||||||||+||+++.     ++.+||+|||+|+.+....
T Consensus        86 ~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          86 SLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            9999986533  3488999999999999999999999   9999999999999974     5789999999998765432


Q ss_pred             C-------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCC
Q 045493          934 S-------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSR 1006 (1048)
Q Consensus       934 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1048)
                      .       .....+||+.|||||++.+..++.++||||+||++|||+||+.||......        ........+...+
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--------~~~~~~~~i~~~~  232 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--------TNKQKYERIGEKK  232 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--------CHHHHHHHHHHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--------hHHHHHHHHHhcc
Confidence            1       123467999999999999999999999999999999999999998632211        0111111111111


Q ss_pred             CCCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1007 LPPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1007 ~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ...+.. ......+++.+++..|++.+|++||+++.+.+.|+
T Consensus       233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            111100 00112346788889999999999999999888765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-39  Score=352.11  Aligned_cols=259  Identities=19%  Similarity=0.245  Sum_probs=195.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      ....||+|+||+||+|++. +++.||||+++.....+ ......+++..++.++||||+++++++.+....++|+|++.+
T Consensus         6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~   85 (292)
T d1unla_           6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred             eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence            4457899999999999986 67889999986544332 223345677778899999999999999999999999999999


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccCCCCCCcc
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLKPDSSNWS  937 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  937 (1048)
                      +++..+++..   ..+++..++.++.|++.||+|||++   +||||||||+|||++.++.+|++|||.|+..........
T Consensus        86 ~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          86 DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             cccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            9998887643   3478899999999999999999999   999999999999999999999999999998766555555


Q ss_pred             ccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccc----------cCCCccccc-chhhhhhhc--
Q 045493          938 ELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLL----------LSLPAPAAN-MNIVVNDLI-- 1003 (1048)
Q Consensus       938 ~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~----------~~~~~~~~~-~~~~~~~~~-- 1003 (1048)
                      ...+++.|+|||.+.... ++.++||||+||++|||++|+.||......          ...+..... .........  
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            567888999999987665 689999999999999999999996321110          000000000 000000000  


Q ss_pred             --cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493         1004 --DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus      1004 --~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                        .................+.+++.+|++.||++||||+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000011111223356788999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-39  Score=357.09  Aligned_cols=261  Identities=20%  Similarity=0.252  Sum_probs=186.2

Q ss_pred             cceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeee--------CCeE
Q 045493          779 GKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSH--------TQHL  848 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~--------~~~~  848 (1048)
                      .....||+|+||+||+|++. +++.||||++......+ ......+|+..++.++||||+++++++..        .+..
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~   92 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   92 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence            34456899999999999985 78999999986543332 22334567777899999999999998754        3468


Q ss_pred             EEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          849 FLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       849 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      |+||||++++.+..+...   ...++...++.+++|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++.
T Consensus        93 ~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             EEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence            999999998777655432   33478899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC----CccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCcccc-
Q 045493          929 LKPDSS----NWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPAA-  993 (1048)
Q Consensus       929 ~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~-  993 (1048)
                      +.....    .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||+.......         .+.... 
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            653321    22345799999999998765 689999999999999999999999864321100         000000 


Q ss_pred             ---cchhhhhhhccCCCCC-Cchh---HHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          994 ---NMNIVVNDLIDSRLPP-PLGE---VEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       994 ---~~~~~~~~~~~~~~~~-~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                         ................ ....   .......+.+++.+||+.||++||||+|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence               0000000000000011 0000   01123467789999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-39  Score=352.57  Aligned_cols=251  Identities=16%  Similarity=0.190  Sum_probs=186.7

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcccCc-eeeEeeEeeeCCeEEEEEEccCC
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIRHRN-IVKFYGFCSHTQHLFLVYEYLER  857 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~  857 (1048)
                      -.+.||+|+||+||+|++. +++.||||.+......   .....+.+.++.++|++ |+.+.+++.+.+..++||||+. 
T Consensus        11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-   86 (299)
T d1ckia_          11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-   86 (299)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-
T ss_pred             EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-
Confidence            3456899999999999875 6789999987654332   23456677788887666 4555666678889999999995 


Q ss_pred             CCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECC---CCceEEeccccccccCCCCC
Q 045493          858 GSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDL---EYKAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       858 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~  934 (1048)
                      |++.+.+...  ...+++..+..++.|++.||+|||++   +||||||||+||+++.   +..+|++|||+|+.+.....
T Consensus        87 ~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          87 PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            4676666432  34589999999999999999999999   9999999999999864   45799999999998764332


Q ss_pred             -------CccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          935 -------NWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       935 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                             ......||+.|||||++.+..++.++|||||||++|||+||+.||...........        .........
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--------~~~~~~~~~  233 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--------YERISEKKM  233 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------------HHHHHHHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH--------HHHhhcccC
Confidence                   12346799999999999999999999999999999999999999864332111100        000000000


Q ss_pred             CCCch-hHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 045493         1008 PPPLG-EVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNLLC 1047 (1048)
Q Consensus      1008 ~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 1047 (1048)
                      ..+.. .......++.+++..||+.+|++||+++++.+.|+
T Consensus       234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            01100 01122356888999999999999999999988775

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-39  Score=361.44  Aligned_cols=257  Identities=18%  Similarity=0.243  Sum_probs=184.7

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeeeCC------eEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSHTQ------HLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~------~~~  849 (1048)
                      +.....||+|+||+||+|.+. +++.||||+++.....+. .....+++..++.++|||||+++++|...+      ++|
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            344567899999999999876 688999999975433221 223455677788999999999999997654      579


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+ ++++..+.+.    ..+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+|++|||+|+..
T Consensus       100 lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             EEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence            999999 5588887753    2489999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccc------c
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTM-RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPA------A  993 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~------~  993 (1048)
                      ..   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+....         .+...      .
T Consensus       172 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         172 DS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             CS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             CC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            43   33456899999999998764 568999999999999999999999864332100         00000      0


Q ss_pred             cchhhhhhhccCCCCCCc-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          994 NMNIVVNDLIDSRLPPPL-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       994 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .................. .........+.+++.+||+.||++||||+|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000000000000000 0111223467889999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-40  Score=359.21  Aligned_cols=249  Identities=22%  Similarity=0.292  Sum_probs=193.7

Q ss_pred             cceeeecccccccEEEEEEc----CCCceeeEEeccCCC---CcccchhhHHHHHHhhccc-CceeeEeeEeeeCCeEEE
Q 045493          779 GKMVLHGTGGCGTVYKAELT----SGDTRAVKKLHSLPT---GEIGINQKGFVSEITEIRH-RNIVKFYGFCSHTQHLFL  850 (1048)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavk~~~~~~~---~~~~~~~~~~~~~l~~l~h-~niv~~~~~~~~~~~~~l  850 (1048)
                      ...+.||+|+||+||+|+..    +|+.||||++.....   ........+|++.+++++| |||+++++++.+....++
T Consensus        27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~  106 (322)
T d1vzoa_          27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  106 (322)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceee
Confidence            34557999999999999863    467899999865322   1222344567888888876 899999999999999999


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||||+.+|+|.+++...+.   +....+..++.|++.|++|+|+.   +||||||||+||+++.++.+||+|||+|+.+.
T Consensus       107 v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         107 ILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999976543   67788999999999999999999   99999999999999999999999999998764


Q ss_pred             CCC-CCccccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCcccccccCCCcccccchhhhhhhccCCC
Q 045493          931 PDS-SNWSELAGTCGYIAPELAYTM--RANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPAPAANMNIVVNDLIDSRL 1007 (1048)
Q Consensus       931 ~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1048)
                      ... .......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.....       ................
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~-------~~~~~~i~~~~~~~~~  253 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE-------KNSQAEISRRILKSEP  253 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS-------CCCHHHHHHHHHHCCC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcccCCC
Confidence            332 223456799999999998764  468899999999999999999999874321       1111122222222222


Q ss_pred             CCCchhHHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 045493         1008 PPPLGEVEEKLKSMIAVAFLCLDANPDCRP-----TMQKVCN 1044 (1048)
Q Consensus      1008 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 1044 (1048)
                      +.+    .....++.+++.+||++||++||     |++|+++
T Consensus       254 ~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 PYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            221    12345688899999999999999     5888876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=355.10  Aligned_cols=258  Identities=19%  Similarity=0.247  Sum_probs=183.7

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcc-cchhhHHHHHHhhcccCceeeEeeEeee------CCeEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEI-GINQKGFVSEITEIRHRNIVKFYGFCSH------TQHLF  849 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~------~~~~~  849 (1048)
                      +.....||+|+||+||+|++. +++.||||++........ .....+++..+++++|||||+++++|..      ..+.|
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            344557999999999999987 689999999976543322 1234466777788999999999999853      46889


Q ss_pred             EEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecccccccc
Q 045493          850 LVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFL  929 (1048)
Q Consensus       850 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~  929 (1048)
                      +||||+.++.+. .+.     ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+|++|||+++..
T Consensus        99 iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          99 LVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence            999999875554 442     2378999999999999999999999   9999999999999999999999999998865


Q ss_pred             CCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccC---------CCccc--ccchhh
Q 045493          930 KPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLS---------LPAPA--ANMNIV  998 (1048)
Q Consensus       930 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~---------~~~~~--~~~~~~  998 (1048)
                      ... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+....         .+...  ......
T Consensus       170 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         170 GTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             ccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            432 334556799999999999999999999999999999999999999864321100         00000  000000


Q ss_pred             hhhhc----------------cCCCCCCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          999 VNDLI----------------DSRLPPPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       999 ~~~~~----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                      .....                ....+...........++.+++.+|++.||++||||+|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            01000                111122222334567789999999999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-38  Score=352.23  Aligned_cols=251  Identities=18%  Similarity=0.221  Sum_probs=186.4

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeee--CCeEEEEEEcc
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSH--TQHLFLVYEYL  855 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~  855 (1048)
                      ....||+|+||+||+|++. +++.||||+++...    .....+|+..++.++ ||||+++++++..  ....++||||+
T Consensus        39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            3456899999999999985 68889999986432    223456677778885 9999999999874  45689999999


Q ss_pred             CCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC-ceEEeccccccccCCCCC
Q 045493          856 ERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY-KAHVSDFGTAKFLKPDSS  934 (1048)
Q Consensus       856 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~  934 (1048)
                      ++|+|.++.+      .+++..++.++.||+.||+|||++   +||||||||+|||++.++ .+|++|||+|+...+. .
T Consensus       115 ~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~  184 (328)
T d3bqca1         115 NNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q  184 (328)
T ss_dssp             CSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-C
T ss_pred             CCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC-C
Confidence            9999977642      388999999999999999999999   999999999999998765 6999999999876543 2


Q ss_pred             CccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCcccccccCCCc-----------------ccccch
Q 045493          935 NWSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLPA-----------------PAANMN  996 (1048)
Q Consensus       935 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~-----------------~~~~~~  996 (1048)
                      .....++|+.|+|||.+.+.. ++.++||||+||++|||++|+.||...........                 ......
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            345567999999999987654 79999999999999999999999854221000000                 000000


Q ss_pred             hhhhhhccCCCC------CCchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          997 IVVNDLIDSRLP------PPLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       997 ~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      ............      ...........++.+++.+||+.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000000000      000011223456889999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-38  Score=349.57  Aligned_cols=257  Identities=18%  Similarity=0.226  Sum_probs=185.3

Q ss_pred             CcceeeecccccccEEEEEEc-CCCceeeEEeccCCCCc-ccchhhHHHHHHhhcccCceeeEeeEeeeC-----CeEEE
Q 045493          778 EGKMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGE-IGINQKGFVSEITEIRHRNIVKFYGFCSHT-----QHLFL  850 (1048)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~-----~~~~l  850 (1048)
                      +.....||+|+||+||+|++. +++.||||++....... ......++++.+++++|||||++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            344567899999999999875 68999999987543322 112334567778899999999999998532     34466


Q ss_pred             EEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEeccccccccC
Q 045493          851 VYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDFGTAKFLK  930 (1048)
Q Consensus       851 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~  930 (1048)
                      ||+|+.+|+|.++++..    .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.|....
T Consensus       100 i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             EEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             EEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            77888899999999542    489999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCccccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCccccccc---------CCCccc---ccchh
Q 045493          931 PDSSNWSELAGTCGYIAPELAYTMR-ANEKCDVFNFGVLVLEVIEGKHPGHFLSLLL---------SLPAPA---ANMNI  997 (1048)
Q Consensus       931 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---------~~~~~~---~~~~~  997 (1048)
                         .......||+.|+|||...+.. ++.++||||+||++|+|++|+.||...+...         ..+...   .....
T Consensus       173 ---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             ---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             ---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence               2334567899999999877654 6899999999999999999999986432110         000000   00000


Q ss_pred             hhhhhcc--CCCCCC-c-hhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 045493          998 VVNDLID--SRLPPP-L-GEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCN 1044 (1048)
Q Consensus       998 ~~~~~~~--~~~~~~-~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 1044 (1048)
                      .......  ...+.. . .........+.+++.+|++.||++||||+|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0000000  011100 0 001122356789999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-33  Score=316.29  Aligned_cols=259  Identities=16%  Similarity=0.184  Sum_probs=180.1

Q ss_pred             ceeeecccccccEEEEEEc-CCCceeeEEeccCCCCcccchhhHHHHHHhhc-----------ccCceeeEeeEeee--C
Q 045493          780 KMVLHGTGGCGTVYKAELT-SGDTRAVKKLHSLPTGEIGINQKGFVSEITEI-----------RHRNIVKFYGFCSH--T  845 (1048)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~~-~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l-----------~h~niv~~~~~~~~--~  845 (1048)
                      -...||+|+||+||+|++. +++.||||+++.....  .....+++..++.+           .|+||+++++++..  .
T Consensus        17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~--~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH--HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc--hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            3557899999999999985 7899999998653211  11223344444433           47899999998854  4


Q ss_pred             CeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCC------ceE
Q 045493          846 QHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEY------KAH  919 (1048)
Q Consensus       846 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~------~~k  919 (1048)
                      ...+++|+++..+..............+++..+..++.||+.|++|||+..  +|+||||||+|||++.++      .++
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccceee
Confidence            566777777766554444433444556888999999999999999999832  899999999999998665      399


Q ss_pred             EeccccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCcccccccCCC----------
Q 045493          920 VSDFGTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVLEVIEGKHPGHFLSLLLSLP----------  989 (1048)
Q Consensus       920 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~----------  989 (1048)
                      ++|||.|......   ....+||+.|+|||++.+..++.++||||+||+++||++|+.||..........          
T Consensus       173 l~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         173 IADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             ECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             Eeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            9999999865432   244679999999999999999999999999999999999999986432211000          


Q ss_pred             ------cccccchhhhhhhcc-----CCCCC------------CchhHHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 045493          990 ------APAANMNIVVNDLID-----SRLPP------------PLGEVEEKLKSMIAVAFLCLDANPDCRPTMQKVCNL 1045 (1048)
Q Consensus       990 ------~~~~~~~~~~~~~~~-----~~~~~------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 1045 (1048)
                            ..............+     .....            ...........+.+++.+|++.||++||||+|+++.
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  000000000000000     00000            001124556789999999999999999999999863

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=1.3e-29  Score=278.34  Aligned_cols=258  Identities=31%  Similarity=0.521  Sum_probs=220.5

Q ss_pred             ccceeEecCCccccC--cccccCCCCCCCeeeCcC-CcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEE
Q 045493          449 SLYSLRLERNQLTGN--ISEVFGIYPDLELLDLSN-NNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKL  525 (1048)
Q Consensus       449 ~L~~L~L~~n~l~~~--~~~~~~~~~~L~~L~Ls~-n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  525 (1048)
                      ++++|+|++|.+++.  .+..++.+++|++|+|++ |++++.+|..+.++++|++|+|++|++.+..+..+..++.|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            466677777766653  356677777788888875 77877788888888888888888888888888888888889999


Q ss_pred             EcccCcccCCcCccccCCCccCEEeecCccccCCCcccccccccc-ceeecccCcccccccccccccccccccccccccc
Q 045493          526 DFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAEL-GYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF  604 (1048)
Q Consensus       526 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  604 (1048)
                      ++++|++.+.+|..+..++.|+++++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999998888888888889999999999999888888888887775 889999999998888888776554 689999999


Q ss_pred             cchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCCCcc
Q 045493          605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIPHSK  684 (1048)
Q Consensus       605 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p~~~  684 (1048)
                      .+..+..+..+++|+.|++++|.+.+.++ .+..+++|++|+|++|+++|.+|..|.++++|++|||++|+++|.+|...
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            88888888899999999999999987654 68889999999999999999999999999999999999999999999888


Q ss_pred             cccccccccccCCccccCCCCCCCCC
Q 045493          685 AFQNATIEAFQGNKELCGDVTGLPPC  710 (1048)
Q Consensus       685 ~~~~~~~~~~~~n~~lc~~~~~~~~c  710 (1048)
                      .++.+....+.||+.+||.+  .|+|
T Consensus       289 ~L~~L~~l~l~~N~~l~g~p--lp~c  312 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSP--LPAC  312 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTT--SSCC
T ss_pred             cCCCCCHHHhCCCccccCCC--CCCC
Confidence            88888888999999999975  4677

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=2e-27  Score=269.40  Aligned_cols=344  Identities=23%  Similarity=0.329  Sum_probs=245.7

Q ss_pred             CCCCCCcEEEccCceeecccccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccccCcChhhhccCCCcE
Q 045493          301 GNLKSLSHLWLSKTQLSGFIPPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLNGSIPHCLGNLSNLKF  380 (1048)
Q Consensus       301 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  380 (1048)
                      ..+.+|++|+++++.|+..  +.+..+++|+.|++++|.+++. + .++.+++|++|++++|++.+..  .++++++|+.
T Consensus        41 ~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~  114 (384)
T d2omza2          41 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTG  114 (384)
T ss_dssp             HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred             HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc--cccccccccc
Confidence            3456777777777777643  3566777777777777777643 2 3777777888888887776443  2677777788


Q ss_pred             EEeecccccCCchhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCcc
Q 045493          381 FALRENELSGSIPQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQL  460 (1048)
Q Consensus       381 L~L~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l  460 (1048)
                      |++++|.+++..+  ......+.......|.+....+.................     ....+...+.........|..
T Consensus       115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  187 (384)
T d2omza2         115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKV  187 (384)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhcccccccccccccccc
Confidence            8777777764433  233445556666666655443332222222222222111     122344444445555555544


Q ss_pred             ccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccc
Q 045493          461 TGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQL  540 (1048)
Q Consensus       461 ~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  540 (1048)
                      .  ....+..+++++.+++++|.+++..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..  .+
T Consensus       188 ~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~  259 (384)
T d2omza2         188 S--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PL  259 (384)
T ss_dssp             C--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred             c--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cc
Confidence            3  23455677888999999998876644  45678899999999998743  36788899999999999988644  37


Q ss_pred             cCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCe
Q 045493          541 GKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSK  620 (1048)
Q Consensus       541 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  620 (1048)
                      ..+++|++|++++|++++..  .+..++.++.++++.|+++++  ..+..+++++.|++++|+|+++.  .+..+++|++
T Consensus       260 ~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~  333 (384)
T d2omza2         260 SGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQR  333 (384)
T ss_dssp             TTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCE
T ss_pred             cccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCE
Confidence            78899999999999998543  477888899999999999875  45788899999999999998864  3788999999


Q ss_pred             EECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccce
Q 045493          621 LDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       621 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~  675 (1048)
                      |++++|+|++ ++ .+.++++|++|++++|+|++..|  +..+++|++|++++|.
T Consensus       334 L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         334 LFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             EECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             EECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            9999999984 33 68889999999999999997765  7889999999999983

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=2.9e-29  Score=275.56  Aligned_cols=263  Identities=32%  Similarity=0.455  Sum_probs=219.4

Q ss_pred             eecCCCCCCCCCccEEeCCCCcccc--cccccccCCCCCCEeeCCC-CccccCCCcCCCCCCCCcEEeCCCCcCCCCCcc
Q 045493           14 TLQEFPFLLFPQLAYLDLSVNQLFG--TIPTQISHLSKLKHLDFST-NQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPE   90 (1048)
Q Consensus        14 ~~~~~p~~~~~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~   90 (1048)
                      +++.-+-....++++|||++|++++  .+|.+++.|++|++|+|++ |.++|.+|.+|+.+++|++|+|++|++++..+.
T Consensus        40 gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~  119 (313)
T d1ogqa_          40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD  119 (313)
T ss_dssp             TEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG
T ss_pred             CeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccc
Confidence            3333333344579999999999987  4789999999999999986 889989999999999999999999999999999


Q ss_pred             ccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCC-cEEecCCC
Q 045493           91 ELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESP-VSVSLHTN  169 (1048)
Q Consensus        91 ~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L-~~l~l~~n  169 (1048)
                      .+..++.|+.+++++|++...+|.+|++++.|+.+++++|.+.+.+|               ..+..+..+ +.+.++.|
T Consensus       120 ~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip---------------~~~~~l~~l~~~l~~~~n  184 (313)
T d1ogqa_         120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP---------------DSYGSFSKLFTSMTISRN  184 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC---------------GGGGCCCTTCCEEECCSS
T ss_pred             cccchhhhcccccccccccccCchhhccCcccceeeccccccccccc---------------cccccccccccccccccc
Confidence            99999999999999999999999999999999999999999886544               455556665 67888899


Q ss_pred             ccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCc
Q 045493          170 NFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPP  249 (1048)
Q Consensus       170 ~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  249 (1048)
                      ++++..|..+..+..+ .++++++...+.+|..+..+++|++|++++|.+.+.+ +.++.+++|++|+|++|++++.+|.
T Consensus       185 ~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~  262 (313)
T d1ogqa_         185 RLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQ  262 (313)
T ss_dssp             EEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCG
T ss_pred             cccccccccccccccc-ccccccccccccccccccccccccccccccccccccc-cccccccccccccCccCeecccCCh
Confidence            9998888888887655 6888888888888888888999999999999888554 4678888999999999999888888


Q ss_pred             ccccccccceeecccccccCCCchhhhccchhhhhhhccccccCC
Q 045493          250 KLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSG  294 (1048)
Q Consensus       250 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~  294 (1048)
                      .|+++++|++|+|++|+++|.+|. ++.+++|+.+++.+++.+.|
T Consensus       263 ~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         263 GLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             GGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred             HHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence            899999999999999998877774 56777777777776444444

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=4.7e-27  Score=266.21  Aligned_cols=82  Identities=22%  Similarity=0.311  Sum_probs=41.8

Q ss_pred             CCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccccccee
Q 045493          181 GLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYL  260 (1048)
Q Consensus       181 ~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  260 (1048)
                      .+.+|++|++++++|+.+  ..+..+++|++|+|++|++++. | .++++++|++|++++|.+++..  .++.+++|+.|
T Consensus        42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L  115 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL  115 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred             HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCccccccccccccccccc--ccccccccccc
Confidence            344555555555555432  2345555555555555555532 2 2555555555555555555322  25555555555


Q ss_pred             eccccccc
Q 045493          261 YLSHNQLN  268 (1048)
Q Consensus       261 ~L~~n~l~  268 (1048)
                      ++++|.++
T Consensus       116 ~~~~~~~~  123 (384)
T d2omza2         116 TLFNNQIT  123 (384)
T ss_dssp             ECCSSCCC
T ss_pred             cccccccc
Confidence            55555544

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=3.6e-26  Score=249.70  Aligned_cols=284  Identities=24%  Similarity=0.300  Sum_probs=211.9

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVN   82 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n   82 (1048)
                      .|++++.+    ++++|..+++++++|||++|+|+++.+.+|..+++|++|++++|+++.+.|.+|..+++|++|++++|
T Consensus        14 ~~~C~~~~----L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n   89 (305)
T d1xkua_          14 VVQCSDLG----LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN   89 (305)
T ss_dssp             EEECTTSC----CCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred             EEEecCCC----CCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence            35666544    57788888899999999999999777778999999999999999999888999999999999999999


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV  162 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~  162 (1048)
                      +|+.+ |..+  ...++.|++++|.+..+.+..+.....+..++...|......             ..+..+..+++|+
T Consensus        90 ~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~-------------~~~~~~~~l~~L~  153 (305)
T d1xkua_          90 QLKEL-PEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG-------------IENGAFQGMKKLS  153 (305)
T ss_dssp             CCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG-------------BCTTGGGGCTTCC
T ss_pred             ccCcC-ccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccC-------------CCccccccccccC
Confidence            99975 4432  357888999999999777777888888999998888654211             1234456677777


Q ss_pred             EEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCc
Q 045493          163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNR  242 (1048)
Q Consensus       163 ~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  242 (1048)
                      .+.+.+|.++.. |..  .+++|+.|++++|.+++..+..|..++.+++|++++|.+.+..+..+.++++|++|+|++|+
T Consensus       154 ~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~  230 (305)
T d1xkua_         154 YIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  230 (305)
T ss_dssp             EEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             ccccccCCcccc-Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccc
Confidence            888888877754 332  25677788888888777777777788888888888888877667777777888888888888


Q ss_pred             cCCCCCcccccccccceeecccccccCCCchhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceee--ccc
Q 045493          243 LSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLS--GFI  320 (1048)
Q Consensus       243 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~  320 (1048)
                      |+ .+|..|..+++|++|+|++|+|+.+....|..                   +.....+.+|+.|+|++|.++  ...
T Consensus       231 L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~-------------------~~~~~~~~~L~~L~L~~N~~~~~~~~  290 (305)
T d1xkua_         231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP-------------------PGYNTKKASYSGVSLFSNPVQYWEIQ  290 (305)
T ss_dssp             CS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC-------------------SSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred             cc-ccccccccccCCCEEECCCCccCccChhhccC-------------------cchhcccCCCCEEECCCCcCccCcCC
Confidence            77 45667777888888888888777443333321                   223345567888888888765  233


Q ss_pred             ccccccccc
Q 045493          321 PPSLGNLSN  329 (1048)
Q Consensus       321 ~~~~~~l~~  329 (1048)
                      |..|..+..
T Consensus       291 ~~~f~~~~~  299 (305)
T d1xkua_         291 PSTFRCVYV  299 (305)
T ss_dssp             GGGGTTCCC
T ss_pred             HhHhccccc
Confidence            444444433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.5e-25  Score=241.82  Aligned_cols=223  Identities=26%  Similarity=0.278  Sum_probs=162.3

Q ss_pred             EEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCC-CC
Q 045493            4 INLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLS-VN   82 (1048)
Q Consensus         4 ~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls-~n   82 (1048)
                      |.++..+    ++++|..+++.+++|||++|+|+++.+.+|..+++|++|++++|++..+.+..+..+..++.++.+ .|
T Consensus        16 v~c~~~~----L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          16 TSCPQQG----LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EECCSSC----CSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEcCCCC----CCccCCCCCCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            5565544    668888888899999999999987777889999999999999999998888888889999998764 56


Q ss_pred             cCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCc
Q 045493           83 QLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPV  162 (1048)
Q Consensus        83 ~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~  162 (1048)
                      .++++.+.+|.++++|++|++++|.+....+..++...+|+.+++++|.+++                            
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~----------------------------  143 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA----------------------------  143 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC----------------------------
T ss_pred             ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccc----------------------------
Confidence            7888778888888888888888888887777778888888888888887763                            


Q ss_pred             EEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCc
Q 045493          163 SVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNR  242 (1048)
Q Consensus       163 ~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  242 (1048)
                                 +.+..|..+++|+.|++++|+++++.+.+|.++++|+++++++|++.+..|..|.++++|++|++++|+
T Consensus       144 -----------i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~  212 (284)
T d1ozna_         144 -----------LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN  212 (284)
T ss_dssp             -----------CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             -----------cChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccc
Confidence                       233445555566666666666655555566666666666666666665555666666666666666666


Q ss_pred             cCCCCCcccccccccceeecccccccC
Q 045493          243 LSGYIPPKLGSFKSLLYLYLSHNQLNG  269 (1048)
Q Consensus       243 l~~~~p~~~~~l~~L~~L~L~~n~l~~  269 (1048)
                      +.+..+..|+.+++|++|++++|++..
T Consensus       213 i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         213 LSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             CSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             cccccccccccccccCEEEecCCCCCC
Confidence            665555556666666666666666553

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=6.8e-25  Score=239.49  Aligned_cols=246  Identities=22%  Similarity=0.272  Sum_probs=143.7

Q ss_pred             cccEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEec
Q 045493          425 SLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMG  504 (1048)
Q Consensus       425 ~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~  504 (1048)
                      .+++|++++|+|+...+.+|.++++|++|++++|.+..+.+..|..++.|+.|++++|+++.....   ..+.++.|.+.
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~~~  108 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVH  108 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc---hhhhhhhhhcc
Confidence            344555555555444444555555555555555555555555555555555555555555433221   12345555555


Q ss_pred             CcccCcccCccccccCCCcEEEcccCccc--CCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccc
Q 045493          505 GNEISGTIPSEIGNMTQLHKLDFSSNRLV--GQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSK  582 (1048)
Q Consensus       505 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  582 (1048)
                      +|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++++|.++ .+|..  .+++|+.|++++|.++.
T Consensus       109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~--~~~~L~~L~l~~n~~~~  185 (305)
T d1xkua_         109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITK  185 (305)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSS--CCTTCSEEECTTSCCCE
T ss_pred             ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCcc--cCCccCEEECCCCcCCC
Confidence            55555544444555555556665555432  223345555666666666666665 33332  24566666666666666


Q ss_pred             cccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccc--
Q 045493          583 LIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCF--  660 (1048)
Q Consensus       583 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--  660 (1048)
                      ..+..|..++.++.|++++|+++++.+..+..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+......|  
T Consensus       186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~  264 (305)
T d1xkua_         186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP  264 (305)
T ss_dssp             ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred             CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccC
Confidence            66666666666666666666666666666666777777777777776 456667777777777777777765443333  


Q ss_pred             ----cccCCccEEEeccceec
Q 045493          661 ----RRMHGLSSIDVSYNELQ  677 (1048)
Q Consensus       661 ----~~l~~L~~l~ls~N~l~  677 (1048)
                          ..++.|+.|++++|+|+
T Consensus       265 ~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         265 PGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             SSCCTTSCCCSEEECCSSSSC
T ss_pred             cchhcccCCCCEEECCCCcCc
Confidence                34566777777777774

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.8e-24  Score=233.28  Aligned_cols=209  Identities=23%  Similarity=0.246  Sum_probs=125.3

Q ss_pred             CCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcc-cCcccCCcCccccCCCccCEEee
Q 045493          473 DLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS-SNRLVGQIPKQLGKLTSLTSLTL  551 (1048)
Q Consensus       473 ~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L  551 (1048)
                      ++++|+|++|+|+...+..|.++++|++|++++|.+....+..+..++.++.++.+ .|.++...+..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            34455555555544444445555555555555555554444555555555555443 34444444555555566666666


Q ss_pred             cCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCc
Q 045493          552 NGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGN  631 (1048)
Q Consensus       552 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  631 (1048)
                      ++|.+....+..+....+|+.+++++|+|+.+++..|..+++|+.|++++|+|+.+.+..|.++++|+.+++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            66665544455555556666666666666665555666666666666666666666666666666666666666666666


Q ss_pred             CCcCcCCccccCeEECCCCcccCCccccccccCCccEEEeccceecCCCC
Q 045493          632 IPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSYNELQGSIP  681 (1048)
Q Consensus       632 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~N~l~~~~p  681 (1048)
                      .|..|..+++|++|++++|.+++..+..|..+++|++|++++|+|.+.++
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            66666666777777777777766666666667777777777777766554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.1e-22  Score=216.57  Aligned_cols=198  Identities=28%  Similarity=0.287  Sum_probs=109.9

Q ss_pred             ccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcc
Q 045493          449 SLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFS  528 (1048)
Q Consensus       449 ~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls  528 (1048)
                      .+.+++.+++.++.++....   +++++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|++|+|+
T Consensus        11 ~~~~v~C~~~~L~~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls   85 (266)
T d1p9ag_          11 SHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS   85 (266)
T ss_dssp             TCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred             CCeEEEccCCCCCeeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence            33444555555554433221   3455555555555544445555555555555555555522 2 23456666666666


Q ss_pred             cCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchh
Q 045493          529 SNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEI  608 (1048)
Q Consensus       529 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  608 (1048)
                      +|++++ .+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++.+.+..+..+++|+.|++++|+|+++.
T Consensus        86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~  164 (266)
T d1p9ag_          86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP  164 (266)
T ss_dssp             SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred             cccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence            666653 3445556666666666666666555555556666666666666666555555555555555555555555555


Q ss_pred             hhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCccc
Q 045493          609 SIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       609 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                      +..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus       165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            555555555555555555555 45555555555555555555554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.1e-22  Score=214.19  Aligned_cols=198  Identities=26%  Similarity=0.287  Sum_probs=141.6

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      ...+.|.++++|+ .+|..+.  +++++|+|++|+|+++.+++|.++++|++|+|++|+|+.+ | .+..+++|++|+++
T Consensus        11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls   85 (266)
T d1p9ag_          11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS   85 (266)
T ss_dssp             TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred             CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence            3445577777777 4555554  4677777777777766556677777777777777777753 2 34566667777777


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|+++ ..+..+.++++|+.|++++|++.                                       +..+..+..+.+
T Consensus        86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~---------------------------------------~~~~~~~~~l~~  125 (266)
T d1p9ag_          86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLT---------------------------------------SLPLGALRGLGE  125 (266)
T ss_dssp             SSCCS-SCCCCTTTCTTCCEEECCSSCCC---------------------------------------CCCSSTTTTCTT
T ss_pred             ccccc-ccccccccccccccccccccccc---------------------------------------eeeccccccccc
Confidence            77666 34556666666666666666554                                       344556677778


Q ss_pred             cceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeeccc
Q 045493          185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH  264 (1048)
Q Consensus       185 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  264 (1048)
                      ++.|++++|.++.+.+..+..+++|++|++++|++++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++
T Consensus       126 l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~  204 (266)
T d1p9ag_         126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG  204 (266)
T ss_dssp             CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred             cccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecC
Confidence            888888888887777777777888888888888888666667788888888888888888 6777777788888888888


Q ss_pred             cccc
Q 045493          265 NQLN  268 (1048)
Q Consensus       265 n~l~  268 (1048)
                      |++.
T Consensus       205 Np~~  208 (266)
T d1p9ag_         205 NPWL  208 (266)
T ss_dssp             CCBC
T ss_pred             CCCC
Confidence            8765

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=4.7e-21  Score=192.39  Aligned_cols=169  Identities=15%  Similarity=0.118  Sum_probs=114.4

Q ss_pred             eeeecccccccEEEEEEcCCCceeeEEeccCCCCcc---------c--------chhhHHHHHHhhcccCceeeEeeEee
Q 045493          781 MVLHGTGGCGTVYKAELTSGDTRAVKKLHSLPTGEI---------G--------INQKGFVSEITEIRHRNIVKFYGFCS  843 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~---------~--------~~~~~~~~~l~~l~h~niv~~~~~~~  843 (1048)
                      ...||+|+||+||+|+..+|++||||.++.......         .        .....+...+.++.|.+++..+++..
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~   84 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG   84 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred             CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC
Confidence            356899999999999998899999998753211100         0        00112344456778999988876642


Q ss_pred             eCCeEEEEEEccCCCCHHHHHhccccccccCHHHHHHHHHHHHHHHHHHHhCCCCCeEeeCCCCCCeEECCCCceEEecc
Q 045493          844 HTQHLFLVYEYLERGSLATILSNEATAAELDWSKRVNVIKGVANALSYMHHDCFPPILHRDISSKKVLLDLEYKAHVSDF  923 (1048)
Q Consensus       844 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik~~NIll~~~~~~kl~Df  923 (1048)
                          .++||||++++.+.+          ++...+..++.|+++|++|||+.   +|+||||||+|||++++ .++++||
T Consensus        85 ----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          85 ----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence                279999998864422          44556678999999999999999   99999999999999865 5899999


Q ss_pred             ccccccCCCCCCccccccccccccccccccCCCCchhhHHHHHHHHH
Q 045493          924 GTAKFLKPDSSNWSELAGTCGYIAPELAYTMRANEKCDVFNFGVLVL  970 (1048)
Q Consensus       924 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gvvl~  970 (1048)
                      |.|......... ......... -.|. ..+.|+.++||||..--+.
T Consensus       147 G~a~~~~~~~~~-~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         147 PQSVEVGEEGWR-EILERDVRN-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             TTCEETTSTTHH-HHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             CCcccCCCCCcH-HHHHHHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence            999765322110 000000000 0121 2356788999999865443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=9e-19  Score=194.67  Aligned_cols=200  Identities=29%  Similarity=0.299  Sum_probs=134.3

Q ss_pred             CCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCccccccccccccccc
Q 045493           24 PQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELAL  103 (1048)
Q Consensus        24 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l  103 (1048)
                      .++++|||++|+|+ .+|+.   +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++.+ ++ +.  +.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~-lp--~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SD-LP--PLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CS-CC--TTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hh-hc--cccccccc
Confidence            47889999999998 56653   468999999999998 67765   45788999999999864 32 21  46899999


Q ss_pred             cceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCC
Q 045493          104 SYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLK  183 (1048)
Q Consensus       104 ~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~  183 (1048)
                      ++|.+. .+|. ++.+++|+.|++++|.+....                ..   ...+..+.+..+...  ....+..++
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~----------------~~---~~~l~~l~~~~~~~~--~~~~l~~l~  162 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP----------------DL---PPSLEFIAAGNNQLE--ELPELQNLP  162 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC----------------CC---CTTCCEEECCSSCCS--SCCCCTTCT
T ss_pred             cccccc-cccc-hhhhccceeeccccccccccc----------------cc---cccccchhhcccccc--ccccccccc
Confidence            999998 4553 678999999999998876321                11   223444555444433  345567777


Q ss_pred             CcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeecc
Q 045493          184 NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLS  263 (1048)
Q Consensus       184 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  263 (1048)
                      .++.|++++|.+.. .+.   .....+.+..+.+.+. .++ .+..++.|+.+++++|... ..+..   ..++..+.+.
T Consensus       163 ~l~~L~l~~n~~~~-~~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~  232 (353)
T d1jl5a_         163 FLTAIYADNNSLKK-LPD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVR  232 (353)
T ss_dssp             TCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECC
T ss_pred             cceecccccccccc-ccc---cccccccccccccccc-ccc-ccccccccccccccccccc-ccccc---cccccccccc
Confidence            88888888877763 222   2233455666665554 333 3566777888888877766 33332   3456666666


Q ss_pred             ccccc
Q 045493          264 HNQLN  268 (1048)
Q Consensus       264 ~n~l~  268 (1048)
                      ++.+.
T Consensus       233 ~~~~~  237 (353)
T d1jl5a_         233 DNYLT  237 (353)
T ss_dssp             SSCCS
T ss_pred             ccccc
Confidence            66654

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.80  E-value=3.2e-18  Score=190.13  Aligned_cols=296  Identities=28%  Similarity=0.328  Sum_probs=189.5

Q ss_pred             EEEEecCCcceeeecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCC
Q 045493            2 VSINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV   81 (1048)
Q Consensus         2 ~~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~   81 (1048)
                      ++++|++++++ .+|+    .++++++|+|++|+|+ .+|+.   +.+|+.|++++|+++. ++.   -...|++|++++
T Consensus        41 ~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~---lp~~L~~L~L~~  107 (353)
T d1jl5a_          41 HELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD---LPPLLEYLGVSN  107 (353)
T ss_dssp             SEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS---CCTTCCEEECCS
T ss_pred             CEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch-hhh---hccccccccccc
Confidence            57888888774 3444    4589999999999999 66755   4579999999999984 443   235799999999


Q ss_pred             CcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCC
Q 045493           82 NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESP  161 (1048)
Q Consensus        82 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L  161 (1048)
                      |+++.+ |. +..+++|++|++++|.+.. .+..   ...+..+.+..+...                 .+..+..+..+
T Consensus       108 n~l~~l-p~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~-----------------~~~~l~~l~~l  164 (353)
T d1jl5a_         108 NQLEKL-PE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE-----------------ELPELQNLPFL  164 (353)
T ss_dssp             SCCSSC-CC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-----------------SCCCCTTCTTC
T ss_pred             cccccc-cc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc-----------------ccccccccccc
Confidence            999965 54 6889999999999999984 3433   456677777766543                 12456778888


Q ss_pred             cEEecCCCccccccCCCCCCCCCcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCC
Q 045493          162 VSVSLHTNNFSGVIPRSLGGLKNLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDN  241 (1048)
Q Consensus       162 ~~l~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  241 (1048)
                      +.+.+..|.......    .....+.+...++.+. ..+ .+..++.|+.+++++|... ..+.   ...++..+.+.++
T Consensus       165 ~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~  234 (353)
T d1jl5a_         165 TAIYADNNSLKKLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDN  234 (353)
T ss_dssp             CEEECCSSCCSSCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSS
T ss_pred             eeccccccccccccc----cccccccccccccccc-ccc-ccccccccccccccccccc-cccc---ccccccccccccc
Confidence            999999998875422    2334566777777765 333 4678999999999999887 3443   3467899999999


Q ss_pred             ccCCCCCcccccccccceeecccccccCCCchhhhccc-hhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeeccc
Q 045493          242 RLSGYIPPKLGSFKSLLYLYLSHNQLNGSLPSSFGNLS-SLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGFI  320 (1048)
Q Consensus       242 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~L~-~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  320 (1048)
                      .+.. .+..   ...+...++..+.+.+.     ..++ .....++.. +    .++.....+++|++|++++|+++. +
T Consensus       235 ~~~~-~~~~---~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~-~----~~~~~~~~~~~L~~L~Ls~N~l~~-l  299 (353)
T d1jl5a_         235 YLTD-LPEL---PQSLTFLDVSENIFSGL-----SELPPNLYYLNASS-N----EIRSLCDLPPSLEELNVSNNKLIE-L  299 (353)
T ss_dssp             CCSC-CCCC---CTTCCEEECCSSCCSEE-----SCCCTTCCEEECCS-S----CCSEECCCCTTCCEEECCSSCCSC-C
T ss_pred             cccc-cccc---ccccccccccccccccc-----ccccchhccccccc-C----ccccccccCCCCCEEECCCCccCc-c
Confidence            9873 3333   34555666655544311     0000 001111111 1    122222334566666666666653 3


Q ss_pred             ccccccccccceeeeccccccCCCCcchhccCCCCeEeccCCccc
Q 045493          321 PPSLGNLSNIRGLYIRENMLYGSIPEELGRLKSLSQLSLSVNKLN  365 (1048)
Q Consensus       321 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  365 (1048)
                      |.   .+++|+.|++++|.++ .+|+.   +.+|++|++++|+++
T Consensus       300 p~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         300 PA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             cc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence            32   2345555555555554 23322   234555555555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1.4e-21  Score=226.17  Aligned_cols=111  Identities=21%  Similarity=0.198  Sum_probs=62.1

Q ss_pred             cccceeecccccccCCC-chhhhccchhhhhhhccccccCCCCCcccCCCCCCcEEEccCceeecc----cccccccccc
Q 045493          255 KSLLYLYLSHNQLNGSL-PSSFGNLSSLKHLHVHNINKLSGSIPKEIGNLKSLSHLWLSKTQLSGF----IPPSLGNLSN  329 (1048)
Q Consensus       255 ~~L~~L~L~~n~l~~~~-p~~~~~L~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~  329 (1048)
                      .+|++||+++|+++... ...+..                         +++++.|+|++|.++..    +...+..+++
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~-------------------------l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~   56 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPL-------------------------LQQCQVVRLDDCGLTEARCKDISSALRVNPA   56 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHH-------------------------HTTCSEEEEESSCCCHHHHHHHHHHHHTCTT
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHh-------------------------CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCC
Confidence            36888899888886311 112222                         34555666666655421    2233445566


Q ss_pred             cceeeeccccccCCC----Ccchh-ccCCCCeEeccCCccccC----cChhhhccCCCcEEEeecccccC
Q 045493          330 IRGLYIRENMLYGSI----PEELG-RLKSLSQLSLSVNKLNGS----IPHCLGNLSNLKFFALRENELSG  390 (1048)
Q Consensus       330 L~~L~l~~n~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~n~l~~  390 (1048)
                      |+.|+|++|.++...    .+.+. ...+|++|+|++|++++.    ++..+..+++|++|++++|.++.
T Consensus        57 L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          57 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             CCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            666666666554211    11111 124677777777777643    23455667777777777777763

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.2e-19  Score=185.91  Aligned_cols=210  Identities=18%  Similarity=0.136  Sum_probs=112.7

Q ss_pred             ecCCCCCCCCCccEEeCCCCcccccccccccCCCCCCEeeCCCCcccc-CCCcCCCCCCCCcEEeCCC-CcCCCCCcccc
Q 045493           15 LQEFPFLLFPQLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSG-IIPPQIGILTNLVVLRLSV-NQLNGLIPEEL   92 (1048)
Q Consensus        15 ~~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~p~~~~~l~~L~~L~ls~-n~l~~~~~~~~   92 (1048)
                      ++++|...++++++|||++|+|+.+.+..|.++++|++|+|++|.+.. +.+.+|..++++++|++.+ |++....+..|
T Consensus        20 l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~   99 (242)
T d1xwdc1          20 VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF   99 (242)
T ss_dssp             CSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSE
T ss_pred             CCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccc
Confidence            455665566666667666666665555566666666666666666653 2344566666666666543 45555555555


Q ss_pred             ccccccccccccceecccccCc-CcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCcc
Q 045493           93 GELTSLNELALSYNRLNGSIPA-SLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNF  171 (1048)
Q Consensus        93 ~~l~~L~~L~l~~n~~~~~~~~-~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~  171 (1048)
                      .++++|++|++++|++....+. .+..+..|..+..+++.                                       +
T Consensus       100 ~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~---------------------------------------l  140 (242)
T d1xwdc1         100 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN---------------------------------------I  140 (242)
T ss_dssp             ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTT---------------------------------------C
T ss_pred             cccccccccccchhhhcccccccccccccccccccccccc---------------------------------------c
Confidence            5556666666665555422111 12222333333333333                                       3


Q ss_pred             ccccCCCCCCCC-CcceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcc
Q 045493          172 SGVIPRSLGGLK-NLTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPK  250 (1048)
Q Consensus       172 ~~~~~~~~~~l~-~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  250 (1048)
                      ..+.+..|.++. .++.|++++|+++.+.+..|.....++.+++++|+++...+..|.++++|++|+|++|+++...+..
T Consensus       141 ~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~  220 (242)
T d1xwdc1         141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG  220 (242)
T ss_dssp             CEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred             ccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence            333334444443 5666666666666444443333222333455666666433344666666666666666666444445


Q ss_pred             cccccccceeecc
Q 045493          251 LGSFKSLLYLYLS  263 (1048)
Q Consensus       251 ~~~l~~L~~L~L~  263 (1048)
                      |.++++|+.+++.
T Consensus       221 ~~~l~~L~~l~~~  233 (242)
T d1xwdc1         221 LENLKKLRARSTY  233 (242)
T ss_dssp             CTTCCEEESSSEE
T ss_pred             HcCCcccccCcCC
Confidence            6666666665554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.6e-21  Score=223.97  Aligned_cols=374  Identities=17%  Similarity=0.154  Sum_probs=246.5

Q ss_pred             CCcEEEccCceeeccc-ccccccccccceeeeccccccC----CCCcchhccCCCCeEeccCCccccCcChhhhc-----
Q 045493          305 SLSHLWLSKTQLSGFI-PPSLGNLSNIRGLYIRENMLYG----SIPEELGRLKSLSQLSLSVNKLNGSIPHCLGN-----  374 (1048)
Q Consensus       305 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~-----  374 (1048)
                      +|+.||+++|++++.. ...+..+++++.|+|++|.++.    .+...+..+++|++|||++|+|+......+..     
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            6899999999998643 3346678999999999998763    23445677899999999999986432223322     


Q ss_pred             cCCCcEEEeecccccCC----chhhhhhhcccceeeccccccCCCCCcccc-----cCCcccEEEeecccccCCC----C
Q 045493          375 LSNLKFFALRENELSGS----IPQEIENMKKLNKYLLFENQFTGYLPQNVC-----QSGSLTHFSVRNNNFVGPI----P  441 (1048)
Q Consensus       375 l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-----~~~~L~~L~l~~N~l~~~~----~  441 (1048)
                      ..+|+.|+|++|++++.    ++..+..++.|+.|++++|+++......+.     ..............+....    .
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  162 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence            35799999999999753    345667788999999999987643221111     1122333333333322111    1


Q ss_pred             CCcccccccceeEecCCccccCccc----cc-CCCCCCCeeeCcCCcccCcc----cccccCCCCccEEEecCcccCcc-
Q 045493          442 RSLQNCTSLYSLRLERNQLTGNISE----VF-GIYPDLELLDLSNNNFFGEI----SSNWIKCPQLATLNMGGNEISGT-  511 (1048)
Q Consensus       442 ~~l~~l~~L~~L~L~~n~l~~~~~~----~~-~~~~~L~~L~Ls~n~l~~~~----~~~~~~~~~L~~L~L~~N~i~~~-  511 (1048)
                      ..+.....++.+.++.+.+......    .+ ........+++.++.+....    ...+...+.++.+++++|.+... 
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence            1233456677888887766432111    11 12234667788877765432    22344567888999998887532 


Q ss_pred             ----cCccccccCCCcEEEcccCcccCC----cCccccCCCccCEEeecCccccCCCcccc-----ccccccceeecccC
Q 045493          512 ----IPSEIGNMTQLHKLDFSSNRLVGQ----IPKQLGKLTSLTSLTLNGNQLSGDIPLEL-----GLLAELGYLDLSAN  578 (1048)
Q Consensus       512 ----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N  578 (1048)
                          ..........++.+++++|.+...    ....+...+.++.+++++|.++......+     .....|+.+++++|
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~  322 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC  322 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence                223344567899999999987632    22344567889999999998874322222     23457899999999


Q ss_pred             cccccccccc----cccccccccccccccccchhhhhhc-----cccccCeEECCCCcccCc----CCcCcCCccccCeE
Q 045493          579 RLSKLIPKNL----GELRKLHHLNLSNNQFSQEISIQIG-----KLVQLSKLDLSHNSLGGN----IPSEICNLESLEYM  645 (1048)
Q Consensus       579 ~l~~~~~~~l----~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L  645 (1048)
                      .++......+    ...++|++|+|++|+|++.+...+.     ..+.|++|+|++|+|++.    ++..+..+++|++|
T Consensus       323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L  402 (460)
T d1z7xw1         323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL  402 (460)
T ss_dssp             CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred             chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence            8886544444    3456899999999999876554442     356699999999999753    23345566889999


Q ss_pred             ECCCCcccCCcccccc-----ccCCccEEEeccceecC
Q 045493          646 NLLQNKLSGPIPSCFR-----RMHGLSSIDVSYNELQG  678 (1048)
Q Consensus       646 ~L~~N~l~~~~~~~~~-----~l~~L~~l~ls~N~l~~  678 (1048)
                      +|++|+|+..+...+.     ....|+.|++++|.+..
T Consensus       403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            9999999865554443     22368999999988864

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.3e-18  Score=182.02  Aligned_cols=218  Identities=14%  Similarity=0.116  Sum_probs=110.2

Q ss_pred             cEEEeecccccCCCCCCcccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCc-ccccccCCCCccEEEecC
Q 045493          427 THFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGE-ISSNWIKCPQLATLNMGG  505 (1048)
Q Consensus       427 ~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~~~~L~~L~L~~  505 (1048)
                      +.++.++++++ .+|..+.  +++++|++++|+|+.++..+|..+++|++|++++|.+... .+..|..+++++++.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45666666666 3343332  3566666666666666666666666666666666666543 234555566666665543


Q ss_pred             -cccCcccCccccccCCCcEEEcccCcccCCcCc-cccCCCccCEEeecCccccCCCcccccccc-ccceeecccCcccc
Q 045493          506 -NEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPK-QLGKLTSLTSLTLNGNQLSGDIPLELGLLA-ELGYLDLSANRLSK  582 (1048)
Q Consensus       506 -N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~  582 (1048)
                       |.+....+..|.++++|++|++++|++....+. .+..+..++.+..+++.+....+..|..++ .++.|++++|+++.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~  167 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  167 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence             455555555566666666666666665532221 122334444444444455433333343332 44455555555554


Q ss_pred             cccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccc
Q 045493          583 LIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRR  662 (1048)
Q Consensus       583 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  662 (1048)
                      +.+..|.....++.++                        +++|+|+...+..|.++++|++|+|++|+|+...+..|..
T Consensus       168 i~~~~~~~~~l~~~~~------------------------l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~  223 (242)
T d1xwdc1         168 IHNCAFNGTQLDELNL------------------------SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN  223 (242)
T ss_dssp             ECTTTTTTCCEEEEEC------------------------TTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred             cccccccchhhhcccc------------------------ccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence            4333333222222233                        4444454333334455555555555555555444444555


Q ss_pred             cCCccEEEe
Q 045493          663 MHGLSSIDV  671 (1048)
Q Consensus       663 l~~L~~l~l  671 (1048)
                      ++.|+++++
T Consensus       224 l~~L~~l~~  232 (242)
T d1xwdc1         224 LKKLRARST  232 (242)
T ss_dssp             CCEEESSSE
T ss_pred             CcccccCcC
Confidence            555554444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=4.5e-19  Score=177.90  Aligned_cols=127  Identities=25%  Similarity=0.352  Sum_probs=104.2

Q ss_pred             EEEecCCcceeeecCCCCCCCCCccEEeCCCCcccc-cccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCC
Q 045493            3 SINLTGSNLKGTLQEFPFLLFPQLAYLDLSVNQLFG-TIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSV   81 (1048)
Q Consensus         3 ~~~~~~~~~~~~~~~~p~~~~~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~   81 (1048)
                      .|++++.++    +++|..+++++++|+|++|+|++ ..+..|+.+++|++|+|++|+++.+.+.+|..+.+|++|+|++
T Consensus        12 ~v~Cs~~~L----~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          12 TVDCTGRGL----KEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EEECTTSCC----SSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EEEEeCCCc----CccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            466776655    46777777888888888888875 4467778888888888888888888888888888888888888


Q ss_pred             CcCCCCCccccccccccccccccceecccccCcCcCCcCCCceEEeeccccc
Q 045493           82 NQLNGLIPEELGELTSLNELALSYNRLNGSIPASLGNLSNLVQLSLSNNSLS  133 (1048)
Q Consensus        82 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~L~~L~~L~l~~n~l~  133 (1048)
                      |+|+.+.|++|.++++|++|+|++|+|+++.|++|..+++|++|+|++|++.
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence            8888888888888888888888888888888888888888888888888775

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.8e-18  Score=178.84  Aligned_cols=186  Identities=23%  Similarity=0.322  Sum_probs=110.1

Q ss_pred             CCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEe
Q 045493          471 YPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLT  550 (1048)
Q Consensus       471 ~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  550 (1048)
                      +.+|+.|++++|+|+..  ..+..+++|++|++++|.|++..+  +..+++|+++++++|.++..  ..+.++++|+.++
T Consensus        40 l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~  113 (227)
T d1h6ua2          40 LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD  113 (227)
T ss_dssp             HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred             cCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccccc
Confidence            34455555555555432  234555555555555555553322  55556666666666655522  2355566666666


Q ss_pred             ecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccC
Q 045493          551 LNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGG  630 (1048)
Q Consensus       551 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  630 (1048)
                      +++|...+.  ..+...+.++.++++.+.+...  ..+...++|+.|++++|.+++..  .++.+++|++|||++|++++
T Consensus       114 l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~  187 (227)
T d1h6ua2         114 LTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD  187 (227)
T ss_dssp             CTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred             ccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCC
Confidence            666655432  2344555666666666666543  23555666777777777665433  25667777777777777764


Q ss_pred             cCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEec
Q 045493          631 NIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVS  672 (1048)
Q Consensus       631 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls  672 (1048)
                      .  ..++.+++|++|+|++|+|++..|  +..++.|++|+++
T Consensus       188 l--~~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         188 I--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             C--GGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             C--hhhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            2  236777777888888777775443  6677778887776

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=3e-18  Score=177.08  Aligned_cols=188  Identities=22%  Similarity=0.304  Sum_probs=105.6

Q ss_pred             ccccccceeEecCCccccCcccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCcccCcccCccccccCCCcE
Q 045493          445 QNCTSLYSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHK  524 (1048)
Q Consensus       445 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  524 (1048)
                      +.+.+|++|++.+|.|+.+.  .+..+++|+.|++++|++++..+  +..+++++.+++++|.++..  ..++.+++|+.
T Consensus        38 ~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~  111 (227)
T d1h6ua2          38 ADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT  111 (227)
T ss_dssp             HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred             HHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccc
Confidence            34445555555555554431  24445555555555555544322  45555555555555555522  23555666666


Q ss_pred             EEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccc
Q 045493          525 LDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQF  604 (1048)
Q Consensus       525 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  604 (1048)
                      ++++++...+.  ..+...+.++.+.++++.+...  ..+...++|++|++++|+++..  ..++.+++|+.|+|++|++
T Consensus       112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l  185 (227)
T d1h6ua2         112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI  185 (227)
T ss_dssp             EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence            66666655432  2344555666666666665532  2345556666666666666543  2356666666666666666


Q ss_pred             cchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECC
Q 045493          605 SQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLL  648 (1048)
Q Consensus       605 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  648 (1048)
                      +++.  .++.+++|++|+|++|+|++..  .+.++++|++|+++
T Consensus       186 ~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         186 SDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             CCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             CCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence            6543  2566677777777777776432  26677777777765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=9.4e-19  Score=175.48  Aligned_cols=172  Identities=25%  Similarity=0.284  Sum_probs=80.8

Q ss_pred             EEEecCcccCcccCccccccCCCcEEEcccCcccC-CcCccccCCCccCEEeecCccccCCCccccccccccceeecccC
Q 045493          500 TLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVG-QIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN  578 (1048)
Q Consensus       500 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  578 (1048)
                      +++.+++.++ .+|..+.  +.+++|+|++|+|++ ..+..|.++++|++|+|++|.++...+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4444444444 3333221  345555555555543 22344455555555555555555444555555555555555555


Q ss_pred             cccccccccccccccccccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccc
Q 045493          579 RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPS  658 (1048)
Q Consensus       579 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  658 (1048)
                      +|+.+.+.+|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|.+..... ...-...++.+.+..|.++...|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCCh
Confidence            5555555555555555555555555555444455555555555555555442111 111112234444455555444443


Q ss_pred             cccccCCccEEEeccceecC
Q 045493          659 CFRRMHGLSSIDVSYNELQG  678 (1048)
Q Consensus       659 ~~~~l~~L~~l~ls~N~l~~  678 (1048)
                      .+   ..++.++++.|.+.+
T Consensus       168 ~l---~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         168 KV---RDVQIKDLPHSEFKC  184 (192)
T ss_dssp             TT---TTSBGGGSCTTTCCC
T ss_pred             hh---cCCEeeecCHhhCcC
Confidence            32   223344455554443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=2.8e-18  Score=174.61  Aligned_cols=185  Identities=28%  Similarity=0.381  Sum_probs=119.9

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      ++....++.+.+++.++.  ..+.+|++|++++|.|+.. + ++..+++|++|+|++|+|+++.  .+..+++|++|+++
T Consensus        25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~   98 (210)
T d1h6ta2          25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLD   98 (210)
T ss_dssp             HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred             HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccc
Confidence            334456677777655442  2456677888888887743 2 4777778888888888777643  35677777777777


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|+++. +| .+..+++|+.|++++|.+..                                         ...+..+++
T Consensus        99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-----------------------------------------~~~l~~l~~  135 (210)
T d1h6ta2          99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISD-----------------------------------------INGLVHLPQ  135 (210)
T ss_dssp             SSCCCC-GG-GGTTCTTCCEEECTTSCCCC-----------------------------------------CGGGGGCTT
T ss_pred             cccccc-cc-cccccccccccccccccccc-----------------------------------------ccccccccc
Confidence            777763 33 46677777777777765431                                         123555666


Q ss_pred             cceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCcccccccccceeeccc
Q 045493          185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYLYLSH  264 (1048)
Q Consensus       185 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  264 (1048)
                      |+.+++++|.+++  +..+..+++|+++++++|++++ ++ .++++++|++|+|++|+++. +| .+.++++|++|+|++
T Consensus       136 l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         136 LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            7777777777653  3345667777777777777763 32 26677777777777777763 43 467777777777653

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=3.1e-17  Score=166.76  Aligned_cols=146  Identities=25%  Similarity=0.361  Sum_probs=74.0

Q ss_pred             ccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccc
Q 045493          516 IGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH  595 (1048)
Q Consensus       516 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  595 (1048)
                      +..+++|++|+|++|+|++..  .++.+++|+.|++++|++++ ++ .+..+++|+.|++++|.+..+  ..+..++.|+
T Consensus        64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~  137 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLE  137 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCC
T ss_pred             HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccccccccccc--cccccccccc
Confidence            334444444444444444321  23444444555554444442 22 344445555555555544432  2344455555


Q ss_pred             ccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEEEecc
Q 045493          596 HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSIDVSY  673 (1048)
Q Consensus       596 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l~ls~  673 (1048)
                      .+++++|.+++.  ..+..+++|+++++++|++++. + .+.++++|++|+|++|+|+.. + .+..+++|++|++++
T Consensus       138 ~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         138 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred             cccccccccccc--cccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence            555555555432  2344556666666666666532 2 255666666666666666532 2 366666666666653

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=5.3e-18  Score=171.03  Aligned_cols=181  Identities=29%  Similarity=0.398  Sum_probs=106.0

Q ss_pred             CccEEeCCCCcccccccccccCCCCCCEeeCCCCccccCCCcCCCCCCCCcEEeCCCCcCCCCCcccccccccccccccc
Q 045493           25 QLAYLDLSVNQLFGTIPTQISHLSKLKHLDFSTNQFSGIIPPQIGILTNLVVLRLSVNQLNGLIPEELGELTSLNELALS  104 (1048)
Q Consensus        25 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~  104 (1048)
                      ++..++++.+++++.++  ...+.++++|++++|.|+. + +.+..+++|++|++++|++++..|  |.++++|++|+++
T Consensus        19 ~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~   92 (199)
T d2omxa2          19 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN   92 (199)
T ss_dssp             HHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence            33445666666665433  2345667777777777763 3 346667777777777777775432  6666677777777


Q ss_pred             ceecccccCcCcCCcCCCceEEeecccccCccCCCCCcccCCCCCCCCccCCCCCCCcEEecCCCccccccCCCCCCCCC
Q 045493          105 YNRLNGSIPASLGNLSNLVQLSLSNNSLSGQIPPNWGYLISPHYGSIPQDLGNLESPVSVSLHTNNFSGVIPRSLGGLKN  184 (1048)
Q Consensus       105 ~n~~~~~~~~~~~~L~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~p~~l~~l~~L~~l~l~~n~~~~~~~~~~~~l~~  184 (1048)
                      +|.+... + .++++++|+.|++++|....                                       .  +.+..+++
T Consensus        93 ~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~---------------------------------------~--~~~~~l~~  129 (199)
T d2omxa2          93 NNQIADI-T-PLANLTNLTGLTLFNNQITD---------------------------------------I--DPLKNLTN  129 (199)
T ss_dssp             SSCCCCC-G-GGTTCTTCSEEECCSSCCCC---------------------------------------C--GGGTTCTT
T ss_pred             ccccccc-c-cccccccccccccccccccc---------------------------------------c--cccchhhh
Confidence            6666532 2 36666666666666665431                                       1  12445566


Q ss_pred             cceeeccccCccccCCcccccccccceeccccccccccCCccCcCCCCCCeEeccCCccCCCCCccccccccccee
Q 045493          185 LTFVYLNNNRIVGSIPSEIGNLRSLSYLGLNKNQLSGSIPPTAGNLSNLKFLYLHDNRLSGYIPPKLGSFKSLLYL  260 (1048)
Q Consensus       185 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  260 (1048)
                      |+.|++++|++.. + +.+..+++|++|++++|++++. + .++++++|++|++++|+++. ++ .++++++|+.|
T Consensus       130 L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         130 LNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             hHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            6666666666652 2 2455666666666666666532 2 35566666666666666653 22 35555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=5.1e-17  Score=163.69  Aligned_cols=142  Identities=30%  Similarity=0.477  Sum_probs=68.8

Q ss_pred             ccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccc
Q 045493          516 IGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH  595 (1048)
Q Consensus       516 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  595 (1048)
                      +..+++|++|++++|++++..+  +.++++|++|++++|.+.. ++ .+..+++|+.|++++|.+...  ..+..+++|+
T Consensus        58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~  131 (199)
T d2omxa2          58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN  131 (199)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred             cccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhH
Confidence            3444444455555444443221  4444455555555554442 22 244445555555555544443  2244455555


Q ss_pred             ccccccccccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCccccccccCCccEE
Q 045493          596 HLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFRRMHGLSSI  669 (1048)
Q Consensus       596 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~l  669 (1048)
                      .|++++|++....  .+..+++|+.|++++|++++.  ..+.++++|++|++++|+|++. + .+..+++|++|
T Consensus       132 ~L~l~~n~l~~~~--~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         132 RLELSSNTISDIS--ALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             EEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             Hhhhhhhhhcccc--cccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            5555555554322  344555555666666655532  1255566666666666666542 1 34555555543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.56  E-value=2.3e-16  Score=174.11  Aligned_cols=236  Identities=20%  Similarity=0.216  Sum_probs=135.4

Q ss_pred             cccccccceeEecCCccccCc----ccccCCCCCCCeeeCcCCcccCc----------ccccccCCCCccEEEecCcccC
Q 045493          444 LQNCTSLYSLRLERNQLTGNI----SEVFGIYPDLELLDLSNNNFFGE----------ISSNWIKCPQLATLNMGGNEIS  509 (1048)
Q Consensus       444 l~~l~~L~~L~L~~n~l~~~~----~~~~~~~~~L~~L~Ls~n~l~~~----------~~~~~~~~~~L~~L~L~~N~i~  509 (1048)
                      +.....|++|+|++|.+....    ...+...++|+.++++++.....          ....+..+++|++|+|++|.++
T Consensus        27 L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  106 (344)
T d2ca6a1          27 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG  106 (344)
T ss_dssp             HHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred             HhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccc
Confidence            444455555555555554221    22334455666666655443211          1222344566666666666665


Q ss_pred             cccC----ccccccCCCcEEEcccCcccCCcCcc-------------ccCCCccCEEeecCccccCC----Ccccccccc
Q 045493          510 GTIP----SEIGNMTQLHKLDFSSNRLVGQIPKQ-------------LGKLTSLTSLTLNGNQLSGD----IPLELGLLA  568 (1048)
Q Consensus       510 ~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~  568 (1048)
                      ....    ..+...++|+.|++++|.+.......             ....+.|+.+++++|.++..    +...+...+
T Consensus       107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~  186 (344)
T d2ca6a1         107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR  186 (344)
T ss_dssp             TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCT
T ss_pred             cccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhh
Confidence            4322    22334566777777766654211111             12345677777777776632    223345566


Q ss_pred             ccceeecccCccccc-----ccccccccccccccccccccccchhh----hhhccccccCeEECCCCcccCcCCcCcC--
Q 045493          569 ELGYLDLSANRLSKL-----IPKNLGELRKLHHLNLSNNQFSQEIS----IQIGKLVQLSKLDLSHNSLGGNIPSEIC--  637 (1048)
Q Consensus       569 ~L~~L~Ls~N~l~~~-----~~~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--  637 (1048)
                      .|++|+|++|+|+..     ....+..+++|+.|+|++|.++..+.    ..+..+++|++|+|++|.|++.....++  
T Consensus       187 ~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~  266 (344)
T d2ca6a1         187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA  266 (344)
T ss_dssp             TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred             hhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHH
Confidence            777777777777632     23445667778888888887766543    3345677788888888887754333332  


Q ss_pred             ----CccccCeEECCCCcccCCcccc----cc-ccCCccEEEeccceecCC
Q 045493          638 ----NLESLEYMNLLQNKLSGPIPSC----FR-RMHGLSSIDVSYNELQGS  679 (1048)
Q Consensus       638 ----~l~~L~~L~L~~N~l~~~~~~~----~~-~l~~L~~l~ls~N~l~~~  679 (1048)
                          ..+.|++|++++|+|+......    +. +.+.|+.|++++|+++..
T Consensus       267 l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             hhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence                2356888888888886543332    32 457788888888887543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.55  E-value=2.8e-16  Score=173.47  Aligned_cols=243  Identities=18%  Similarity=0.172  Sum_probs=154.9

Q ss_pred             hhhhhhhcccceeeccccccCCCCCcccccCCcccEEEeecccccCCCCCCcccccccceeEecCCccccC---------
Q 045493          393 PQEIENMKKLNKYLLFENQFTGYLPQNVCQSGSLTHFSVRNNNFVGPIPRSLQNCTSLYSLRLERNQLTGN---------  463 (1048)
Q Consensus       393 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~l~~l~~L~~L~L~~n~l~~~---------  463 (1048)
                      ...+.+...++.|++++|++.......                    +...+...++|+.|+++++.....         
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~--------------------l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~   83 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARW--------------------LSENIASKKDLEIAEFSDIFTGRVKDEIPEALR   83 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHH--------------------HHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHH--------------------HHHHHHhCCCCCEEECCCCcccccccccchHHH
Confidence            344555666666666666654321111                    112334445555555555433211         


Q ss_pred             -cccccCCCCCCCeeeCcCCcccCcc----cccccCCCCccEEEecCcccCcccCcc-------------ccccCCCcEE
Q 045493          464 -ISEVFGIYPDLELLDLSNNNFFGEI----SSNWIKCPQLATLNMGGNEISGTIPSE-------------IGNMTQLHKL  525 (1048)
Q Consensus       464 -~~~~~~~~~~L~~L~Ls~n~l~~~~----~~~~~~~~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L  525 (1048)
                       ....+...++|+.|+|++|.++...    ...+..+++|++|++++|.++......             ....+.|+.+
T Consensus        84 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l  163 (344)
T d2ca6a1          84 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI  163 (344)
T ss_dssp             HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred             HHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCccccee
Confidence             1233445667777777777776542    223345677888888877765321111             1235678888


Q ss_pred             EcccCcccCCc----CccccCCCccCEEeecCccccCC-----CccccccccccceeecccCccccc----ccccccccc
Q 045493          526 DFSSNRLVGQI----PKQLGKLTSLTSLTLNGNQLSGD-----IPLELGLLAELGYLDLSANRLSKL----IPKNLGELR  592 (1048)
Q Consensus       526 ~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~  592 (1048)
                      ++++|+++...    ...+...+.|++|+|++|.++..     +...+...++|+.|+|++|.++..    ....+..++
T Consensus       164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~  243 (344)
T d2ca6a1         164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP  243 (344)
T ss_dssp             ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred             ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc
Confidence            88888876432    23345677888999998888732     234567778899999999988753    234567788


Q ss_pred             cccccccccccccchhhhhhc------cccccCeEECCCCcccCcCCc----CcC-CccccCeEECCCCcccCC
Q 045493          593 KLHHLNLSNNQFSQEISIQIG------KLVQLSKLDLSHNSLGGNIPS----EIC-NLESLEYMNLLQNKLSGP  655 (1048)
Q Consensus       593 ~L~~L~Ls~N~l~~~~~~~~~------~l~~L~~L~Ls~N~l~~~~~~----~~~-~l~~L~~L~L~~N~l~~~  655 (1048)
                      +|++|+|++|.|++.+...+.      ..+.|++||+++|+|+.....    .+. +.++|++|+|++|++...
T Consensus       244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence            999999999999887665553      246799999999998754322    232 467899999999999743

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.2e-15  Score=145.17  Aligned_cols=111  Identities=20%  Similarity=0.219  Sum_probs=59.2

Q ss_pred             ccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccc
Q 045493          516 IGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLH  595 (1048)
Q Consensus       516 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~  595 (1048)
                      |.++.++++|||++|+|+. ++..+..+++|+.|+|++|+|+. + ..+..+++|++|++++|+|+.+.+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            4455566666666666663 34445556666666666666652 2 2355555666666666666555444444555555


Q ss_pred             ccccccccccchhh-hhhccccccCeEECCCCccc
Q 045493          596 HLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       596 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  629 (1048)
                      +|++++|+|++... ..+..+++|++|++++|.++
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc
Confidence            55555555544322 23344444444444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.4e-15  Score=162.23  Aligned_cols=224  Identities=17%  Similarity=0.208  Sum_probs=136.2

Q ss_pred             ceeEecCCccccCcccccCCCCCCCeeeCcCCcccCc-ccccccCCCCccEEEecCcccCcccCccccccCCCcEEEccc
Q 045493          451 YSLRLERNQLTGNISEVFGIYPDLELLDLSNNNFFGE-ISSNWIKCPQLATLNMGGNEISGTIPSEIGNMTQLHKLDFSS  529 (1048)
Q Consensus       451 ~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~l~~~-~~~~~~~~~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~  529 (1048)
                      ..+.+.+..+....... ....+|++||++++.++.. ....+..+++|++|++++|.+++..+..++.+++|++|++++
T Consensus        26 ~~lrl~~~~~~~~~~~~-~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          26 IAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             SEEECTTCEECSCCCSC-CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             eEeeccccccccchhhh-ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            34445544444322222 2345788888888877654 234466778888888888888777777777788888888887


Q ss_pred             C-cccCCc-CccccCCCccCEEeecCc-cccCC-Ccccccc-ccccceeecccC--cccccc-ccccccccccccccccc
Q 045493          530 N-RLVGQI-PKQLGKLTSLTSLTLNGN-QLSGD-IPLELGL-LAELGYLDLSAN--RLSKLI-PKNLGELRKLHHLNLSN  601 (1048)
Q Consensus       530 N-~l~~~~-~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~Ls~N--~l~~~~-~~~l~~l~~L~~L~Ls~  601 (1048)
                      + .+++.. ...+..+++|++|++++| .+++. +...+.. .++|+.|+++++  .++... ...+..+++|++|++++
T Consensus       105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~  184 (284)
T d2astb2         105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD  184 (284)
T ss_dssp             CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred             cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence            4 454322 122345778888888875 34421 1222322 357788888754  344321 22334567788888877


Q ss_pred             c-cccchhhhhhccccccCeEECCCC-cccCcCCcCcCCccccCeEECCCCcccCC-ccccccccCCccEEEeccceecC
Q 045493          602 N-QFSQEISIQIGKLVQLSKLDLSHN-SLGGNIPSEICNLESLEYMNLLQNKLSGP-IPSCFRRMHGLSSIDVSYNELQG  678 (1048)
Q Consensus       602 N-~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~l~ls~N~l~~  678 (1048)
                      | .+++.....+..+++|++|+|+++ .+++.....++++++|++|+++++ ++.. .+.....+|.|+   +..++++.
T Consensus       185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L~---i~~~~ls~  260 (284)
T d2astb2         185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHLQ---INCSHFTT  260 (284)
T ss_dssp             CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTSE---ESCCCSCC
T ss_pred             ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcccc---ccCccCCC
Confidence            5 466666667777778888888873 576666666777788888888777 3322 222223445443   45566554


Q ss_pred             C
Q 045493          679 S  679 (1048)
Q Consensus       679 ~  679 (1048)
                      .
T Consensus       261 ~  261 (284)
T d2astb2         261 I  261 (284)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=5.2e-15  Score=142.46  Aligned_cols=128  Identities=23%  Similarity=0.259  Sum_probs=81.0

Q ss_pred             ccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchhhhhhccccccC
Q 045493          540 LGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLS  619 (1048)
Q Consensus       540 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  619 (1048)
                      |.+..++++|+|++|+|+ .++..+..+++|+.|||++|+|+.+  +.|..+++|++|++++|+|+.+.+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            455566677777777776 3455556666777777777777665  3466667777777777777666655566667777


Q ss_pred             eEECCCCcccCcC-CcCcCCccccCeEECCCCcccCCc---cccccccCCccEEE
Q 045493          620 KLDLSHNSLGGNI-PSEICNLESLEYMNLLQNKLSGPI---PSCFRRMHGLSSID  670 (1048)
Q Consensus       620 ~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~l~  670 (1048)
                      .|++++|+|+... ...+..+++|++|++++|+++...   +..+..+|+|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            7777777766422 134566677777777777765332   22456667777665

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=2.7e-14  Score=130.44  Aligned_cols=101  Identities=28%  Similarity=0.329  Sum_probs=48.1

Q ss_pred             EEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCccccccccccccccccccccccccc
Q 045493          524 KLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQ  603 (1048)
Q Consensus       524 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~  603 (1048)
                      +|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|+.+                    
T Consensus         2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--------------------   58 (124)
T d1dcea3           2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--------------------   58 (124)
T ss_dssp             EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--------------------
T ss_pred             EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc--------------------
Confidence            45555555542 22 2445555555555555554 3344444455555555555554443                    


Q ss_pred             ccchhhhhhccccccCeEECCCCcccCcC-CcCcCCccccCeEECCCCccc
Q 045493          604 FSQEISIQIGKLVQLSKLDLSHNSLGGNI-PSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       604 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                          .  .++.+++|++|++++|+|+... ...+..+++|++|++++|+++
T Consensus        59 ----~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          59 ----D--GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             ----G--GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ----C--ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence                1  2344444555555555554321 133445555555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.49  E-value=2.4e-14  Score=130.75  Aligned_cols=103  Identities=27%  Similarity=0.386  Sum_probs=86.2

Q ss_pred             cEEEecCcccCcccCccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccC
Q 045493          499 ATLNMGGNEISGTIPSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN  578 (1048)
Q Consensus       499 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  578 (1048)
                      +.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|..+++|++|++++|+|++ +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57999999998 444 4899999999999999998 567789999999999999999994 44 5889999999999999


Q ss_pred             ccccccc-ccccccccccccccccccccc
Q 045493          579 RLSKLIP-KNLGELRKLHHLNLSNNQFSQ  606 (1048)
Q Consensus       579 ~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~  606 (1048)
                      +|+.+.. ..+..+++|+.|++++|++++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            9987643 556777777777777777754

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=7.9e-15  Score=156.24  Aligned_cols=210  Identities=18%  Similarity=0.224  Sum_probs=104.1

Q ss_pred             ccceeEecCCccccC-cccccCCCCCCCeeeCcCCcccCcccccccCCCCccEEEecCc-ccCcccC-ccccccCCCcEE
Q 045493          449 SLYSLRLERNQLTGN-ISEVFGIYPDLELLDLSNNNFFGEISSNWIKCPQLATLNMGGN-EISGTIP-SEIGNMTQLHKL  525 (1048)
Q Consensus       449 ~L~~L~L~~n~l~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~L~~N-~i~~~~~-~~~~~l~~L~~L  525 (1048)
                      +|++|++++|.++.. ....+..+++|++|+|++|.+++.....+..+++|++|+++++ .+++... ..+..+++|++|
T Consensus        47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L  126 (284)
T d2astb2          47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  126 (284)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence            444444444444322 1223444455555555555544444444445555555555552 3432211 112345556666


Q ss_pred             EcccC-cccCC-cCccccC-CCccCEEeecCcc--ccCC-CccccccccccceeecccC-cccccccccccccccccccc
Q 045493          526 DFSSN-RLVGQ-IPKQLGK-LTSLTSLTLNGNQ--LSGD-IPLELGLLAELGYLDLSAN-RLSKLIPKNLGELRKLHHLN  598 (1048)
Q Consensus       526 ~Ls~N-~l~~~-~~~~~~~-l~~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~  598 (1048)
                      +++++ .+++. ....+.. .++|+.|+++++.  ++.. +...+..+++|++|++++| .+++.....+..+++|++|+
T Consensus       127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~  206 (284)
T d2astb2         127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS  206 (284)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence            66553 23211 1111222 3456666666542  3311 2222345566777777664 35555556666677777777


Q ss_pred             cccc-cccchhhhhhccccccCeEECCCCcccCcCCcCcCCccccCeEECCCCcccCCcccccc
Q 045493          599 LSNN-QFSQEISIQIGKLVQLSKLDLSHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPSCFR  661 (1048)
Q Consensus       599 Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  661 (1048)
                      |++| .|++.....++.+++|+.|+++++ +++.....+.  ..+..|.+..++++...+..++
T Consensus       207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~--~~lp~L~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         207 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK--EALPHLQINCSHFTTIARPTIG  267 (284)
T ss_dssp             CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH--HHSTTSEESCCCSCCTTCSSCS
T ss_pred             CCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHH--HhCccccccCccCCCCCCCccC
Confidence            7773 566666666677777777777776 3322111111  2334444567777765555443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=1e-14  Score=145.58  Aligned_cols=112  Identities=23%  Similarity=0.263  Sum_probs=62.8

Q ss_pred             CccccccCCCcEEEcccCcccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccc
Q 045493          513 PSEIGNMTQLHKLDFSSNRLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELR  592 (1048)
Q Consensus       513 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~  592 (1048)
                      +..+..+++|++|+|++|+|+.. + .+..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.+  ..+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence            34455566666666666666532 2 3556666666666666665 3344444445566666666666553  2355556


Q ss_pred             cccccccccccccchhh-hhhccccccCeEECCCCccc
Q 045493          593 KLHHLNLSNNQFSQEIS-IQIGKLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       593 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~  629 (1048)
                      +|+.|++++|+|++... ..+..+++|+.|+|++|.+.
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccc
Confidence            66666666666655432 34555555555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=1e-14  Score=145.58  Aligned_cols=144  Identities=24%  Similarity=0.300  Sum_probs=113.2

Q ss_pred             CCcEEEcccC--cccCCcCccccCCCccCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccc
Q 045493          521 QLHKLDFSSN--RLVGQIPKQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLN  598 (1048)
Q Consensus       521 ~L~~L~Ls~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~  598 (1048)
                      .++.++++++  .+. ..+..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+.+ +..+..+++|++|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i-~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKI-ENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSC-SSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccccc-cccccccccccccc
Confidence            3455566554  233 445678889999999999999994 44 588999999999999999876 45556677899999


Q ss_pred             cccccccchhhhhhccccccCeEECCCCcccCcCC-cCcCCccccCeEECCCCcccCCcccc----------ccccCCcc
Q 045493          599 LSNNQFSQEISIQIGKLVQLSKLDLSHNSLGGNIP-SEICNLESLEYMNLLQNKLSGPIPSC----------FRRMHGLS  667 (1048)
Q Consensus       599 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L~  667 (1048)
                      +++|+|+.+.  .+..+++|+.|++++|+|+.... ..+..+++|++|+|++|++....+..          +..+|+|+
T Consensus       100 l~~N~i~~l~--~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~  177 (198)
T d1m9la_         100 ISYNQIASLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK  177 (198)
T ss_dssp             CSEEECCCHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred             cccccccccc--cccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence            9999998753  47788999999999999985322 46788999999999999997554432          56788999


Q ss_pred             EEE
Q 045493          668 SID  670 (1048)
Q Consensus       668 ~l~  670 (1048)
                      .||
T Consensus       178 ~LD  180 (198)
T d1m9la_         178 KLD  180 (198)
T ss_dssp             EES
T ss_pred             EeC
Confidence            886

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=3.3e-12  Score=121.58  Aligned_cols=107  Identities=21%  Similarity=0.141  Sum_probs=64.1

Q ss_pred             ccCEEeecCccccCCCccccccccccceeecccC-cccccccccccccccccccccccccccchhhhhhccccccCeEEC
Q 045493          545 SLTSLTLNGNQLSGDIPLELGLLAELGYLDLSAN-RLSKLIPKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDL  623 (1048)
Q Consensus       545 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  623 (1048)
                      ..+.++++++.++ ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|||
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3445666666665 44556666666666666544 366666666666666666666666666666666666666666666


Q ss_pred             CCCcccCcCCcCcCCccccCeEECCCCccc
Q 045493          624 SHNSLGGNIPSEICNLESLEYMNLLQNKLS  653 (1048)
Q Consensus       624 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  653 (1048)
                      ++|+|+...+..|. ..+|+.|+|++|++.
T Consensus        88 s~N~l~~l~~~~~~-~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQ-GLSLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTC-SCCCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhc-cccccccccCCCccc
Confidence            66666633333333 234666666666654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=4.1e-12  Score=120.96  Aligned_cols=46  Identities=30%  Similarity=0.319  Sum_probs=18.4

Q ss_pred             ccccCCCccCEEeecCccccCCCccccccccccceeecccCccccc
Q 045493          538 KQLGKLTSLTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKL  583 (1048)
Q Consensus       538 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  583 (1048)
                      .+|.++++|+.|+|++|+|+...+.+|..+++|++|+|++|+|+.+
T Consensus        50 ~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l   95 (156)
T d2ifga3          50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESL   95 (156)
T ss_dssp             GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCC
T ss_pred             hhhccccccCcceeeccccCCcccccccccccccceeccCCCCccc
Confidence            3344444444444444444333333344444444444444444433

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=1.5e-09  Score=103.58  Aligned_cols=67  Identities=34%  Similarity=0.310  Sum_probs=32.5

Q ss_pred             ccccccccceeecccCcccccc--cccccccccccccccccccccchhhhhhccccccCeEECCCCccc
Q 045493          563 ELGLLAELGYLDLSANRLSKLI--PKNLGELRKLHHLNLSNNQFSQEISIQIGKLVQLSKLDLSHNSLG  629 (1048)
Q Consensus       563 ~~~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  629 (1048)
                      .+..+++|++|+|++|+|+.+.  +..+..+++|+.|+|++|+|+++....+....+|++|++++|.+.
T Consensus        60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            3344555555555555555442  233444555555555555555444433333334455555555444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.64  E-value=2.2e-09  Score=102.40  Aligned_cols=124  Identities=25%  Similarity=0.161  Sum_probs=82.4

Q ss_pred             cCEEeecCccccCCCccccccccccceeecccCcccccccccccccccccccccccccccchh--hhhhccccccCeEEC
Q 045493          546 LTSLTLNGNQLSGDIPLELGLLAELGYLDLSANRLSKLIPKNLGELRKLHHLNLSNNQFSQEI--SIQIGKLVQLSKLDL  623 (1048)
Q Consensus       546 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L  623 (1048)
                      .+.|+++++...    ..+..+..+..++.++|.+.. .+..+..+++|++|+|++|+|+++.  ...+..+++|+.|||
T Consensus        24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L   98 (162)
T d1koha1          24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL   98 (162)
T ss_dssp             SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHHH-HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred             hCeeecccCCCC----chhhhccchhhcchhhhHhhh-hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence            444555544432    123334444445555554433 3455567899999999999998764  345678899999999


Q ss_pred             CCCcccCcCCcCcCCccccCeEECCCCcccCCccc-------cccccCCccEEEecccee
Q 045493          624 SHNSLGGNIPSEICNLESLEYMNLLQNKLSGPIPS-------CFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       624 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~l~ls~N~l  676 (1048)
                      ++|+|+...+-.+.....|+.|++++|+++.....       .+..+|+|+.||  ++++
T Consensus        99 s~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1          99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             TTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             ccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            99999854443344456789999999999865543       255788888875  5554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.95  E-value=1.8e-06  Score=82.17  Aligned_cols=61  Identities=13%  Similarity=0.099  Sum_probs=30.6

Q ss_pred             ccccCeEECCCCcccCcC----CcCcCCccccCeEECCCCcccCC-------ccccccccCCccEEEeccce
Q 045493          615 LVQLSKLDLSHNSLGGNI----PSEICNLESLEYMNLLQNKLSGP-------IPSCFRRMHGLSSIDVSYNE  675 (1048)
Q Consensus       615 l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~l~ls~N~  675 (1048)
                      .+.|++|+|++|.|++..    ...+...++|++|++++|.+...       +...+...+.|+.|+++++.
T Consensus        71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            344555555555554322    12233445566666666654432       22334445667777766654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.92  E-value=2.4e-06  Score=81.22  Aligned_cols=11  Identities=27%  Similarity=0.154  Sum_probs=5.0

Q ss_pred             cccCeEECCCC
Q 045493          640 ESLEYMNLLQN  650 (1048)
Q Consensus       640 ~~L~~L~L~~N  650 (1048)
                      ++|+.|+++.+
T Consensus       131 ~sL~~l~l~~~  141 (167)
T d1pgva_         131 ESLLRVGISFA  141 (167)
T ss_dssp             SSCCEEECCCC
T ss_pred             CCccEeeCcCC
Confidence            44444444443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.90  E-value=2.9e-05  Score=79.83  Aligned_cols=131  Identities=14%  Similarity=0.070  Sum_probs=86.1

Q ss_pred             cccccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEEEccCCCCHHHHHh
Q 045493          787 GGCGTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVYEYLERGSLATILS  865 (1048)
Q Consensus       787 G~~g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  865 (1048)
                      |+.+.||+... +++.+++|+........ ......+...+..+. +--+.++++++.+++..++||++++|.++.+...
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~  102 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence            33467998864 46778888775543322 222334444444332 3235677788888889999999999988866542


Q ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 045493          866 NEATAAELDWSKRVNVIKGVANALSYMHHDC-------------------------------------------------  896 (1048)
Q Consensus       866 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------------  896 (1048)
                      ..        .....++.++++.++.||+..                                                 
T Consensus       103 ~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         103 DE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             TC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             cc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            11        123345666677777777420                                                 


Q ss_pred             -------CCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          897 -------FPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       897 -------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                             .+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                   0237899999999999977666799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.66  E-value=9e-05  Score=75.56  Aligned_cols=130  Identities=12%  Similarity=0.079  Sum_probs=80.3

Q ss_pred             eeccccc-ccEEEEEEcCCCceeeEEeccCCCCcccchhhHHHHHHhhcc--cCceeeEeeEeeeCCeEEEEEEccCCCC
Q 045493          783 LHGTGGC-GTVYKAELTSGDTRAVKKLHSLPTGEIGINQKGFVSEITEIR--HRNIVKFYGFCSHTQHLFLVYEYLERGS  859 (1048)
Q Consensus       783 ~lG~G~~-g~Vy~~~~~~~~~vavk~~~~~~~~~~~~~~~~~~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~  859 (1048)
                      .+..|.. +.||+....++..+++|........    ....+...++.+.  .-.+.+++++..+.+..++|||+++|-+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445553 5789998887777888876443222    2333444443332  2235667888888888999999998865


Q ss_pred             HHHHHhccccccccCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 045493          860 LATILSNEATAAELDWSKRVNVIKGVANALSYMHH---------------------------------------------  894 (1048)
Q Consensus       860 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~---------------------------------------------  894 (1048)
                      +.+..        ..   ....+.++++.++-||+                                             
T Consensus        93 ~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          93 LLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            43210        11   11122333344444442                                             


Q ss_pred             ------CC----CCCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          895 ------DC----FPPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       895 ------~~----~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                            ..    .+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  11    1247999999999999987667899999775

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.47  E-value=2e-05  Score=74.63  Aligned_cols=86  Identities=15%  Similarity=0.180  Sum_probs=35.1

Q ss_pred             CCCccCEEeecCccccCC----CccccccccccceeecccCcccccc----cccccccccccc--cccccccccchhhhh
Q 045493          542 KLTSLTSLTLNGNQLSGD----IPLELGLLAELGYLDLSANRLSKLI----PKNLGELRKLHH--LNLSNNQFSQEISIQ  611 (1048)
Q Consensus       542 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~--L~Ls~N~l~~~~~~~  611 (1048)
                      ..++|++|+|++|.++..    +...+...+.++.+++++|.++...    .+.+...++|+.  |++++|.+++.+...
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~  123 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME  123 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence            344444445544444321    1122233344444444444443211    123334444543  333445554433222


Q ss_pred             h----ccccccCeEECCCCc
Q 045493          612 I----GKLVQLSKLDLSHNS  627 (1048)
Q Consensus       612 ~----~~l~~L~~L~Ls~N~  627 (1048)
                      +    ...++|+.|+++.+.
T Consensus       124 La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         124 IANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHhCCCcCEEeCcCCC
Confidence            2    244455555554443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.43  E-value=1.7e-05  Score=75.07  Aligned_cols=87  Identities=10%  Similarity=0.161  Sum_probs=41.8

Q ss_pred             ccccccccccccccccchhhhh----hccccccCeEECCCCcccCcC----CcCcCCccccCeEEC--CCCcccCC----
Q 045493          590 ELRKLHHLNLSNNQFSQEISIQ----IGKLVQLSKLDLSHNSLGGNI----PSEICNLESLEYMNL--LQNKLSGP----  655 (1048)
Q Consensus       590 ~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L--~~N~l~~~----  655 (1048)
                      ..+.|++|+|++|.++......    +...++++.|++++|.++...    ...+...++|+.++|  ++|++...    
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~  123 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME  123 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence            3344444455544444433222    223455556666655554322    233344555655433  34555432    


Q ss_pred             ccccccccCCccEEEecccee
Q 045493          656 IPSCFRRMHGLSSIDVSYNEL  676 (1048)
Q Consensus       656 ~~~~~~~l~~L~~l~ls~N~l  676 (1048)
                      +...+.+.+.|+.|++++|..
T Consensus       124 La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         124 IANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCCCcCEEeCcCCCC
Confidence            233344566677777666543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.87  E-value=0.0016  Score=70.38  Aligned_cols=29  Identities=17%  Similarity=0.263  Sum_probs=25.4

Q ss_pred             CeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          899 PILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       899 ~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      .++|||+.|.|||+++++ ++|+||..|..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            689999999999998764 89999988864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.01  E-value=0.013  Score=61.21  Aligned_cols=29  Identities=21%  Similarity=0.137  Sum_probs=24.0

Q ss_pred             CCeEeeCCCCCCeEECCCCceEEeccccccc
Q 045493          898 PPILHRDISSKKVLLDLEYKAHVSDFGTAKF  928 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~  928 (1048)
                      .++||+|+.+.||+++. + ..++||+-++.
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            47899999999999974 3 45899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.17  E-value=0.041  Score=56.89  Aligned_cols=30  Identities=20%  Similarity=0.201  Sum_probs=27.1

Q ss_pred             CCeEeeCCCCCCeEECCCCceEEecccccc
Q 045493          898 PPILHRDISSKKVLLDLEYKAHVSDFGTAK  927 (1048)
Q Consensus       898 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~  927 (1048)
                      .++||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            389999999999999988777899999886

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.54  E-value=0.063  Score=57.47  Aligned_cols=73  Identities=15%  Similarity=0.098  Sum_probs=42.4

Q ss_pred             eeeecccccccEEEEEEcCCC-------ceeeEEeccCCCCcccchhhHHHHHHhhcc-cCceeeEeeEeeeCCeEEEEE
Q 045493          781 MVLHGTGGCGTVYKAELTSGD-------TRAVKKLHSLPTGEIGINQKGFVSEITEIR-HRNIVKFYGFCSHTQHLFLVY  852 (1048)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~-------~vavk~~~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  852 (1048)
                      .+.++.|-.-.+|++...++.       ..++.++....  ........+.+.++.+. +.-..++++++.+    ++|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            345788888899999876432       22344443322  22234445555555553 3334467777643    6799


Q ss_pred             EccCCCC
Q 045493          853 EYLERGS  859 (1048)
Q Consensus       853 e~~~~g~  859 (1048)
                      ||++|..
T Consensus       121 efi~g~~  127 (395)
T d1nw1a_         121 EYIPSRP  127 (395)
T ss_dssp             CCCCEEE
T ss_pred             EEecccc
Confidence            9998753